PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Scaloni, F; Gianni, S; Federici, L; Falini, B; Brunori, M				Scaloni, Flavio; Gianni, Stefano; Federici, Luca; Falini, Brunangelo; Brunori, Maurizio			Folding mechanism of the C-terminal domain of nucleophosmin: residual structure in the denatured state and its pathophysiological significance	FASEB JOURNAL			English	Article						kinetics; acute myeloid leukemia; protein stability; Hammond effect; ground state effect	ACUTE MYELOID-LEUKEMIA; NUCLEAR EXPORT; ENERGY LANDSCAPE; UNFOLDED STATES; NPMC(+) AML; PROTEIN; INTERMEDIATE; TRANSITION; MUTANTS; CANCER	Nucleophosmin (NPM1) is a ubiquitously expressed protein and is one of the most abundant proteins found in the nucleolus. Naturally occurring mutations in the C-terminal domain of nucleophosmin (Cter-NPM1) are found in similar to 30% of patients with acute myeloid leukemia (AML). These mutations cause changes at the C terminus of NPM1 that lead to denaturation of the protein, a critical factor in determining aberrant translocation of NPM1 to the cytosol. Hence, this protein system represents an ideal candidate to investigate the relations between folding and unfolding and disease. Here we report the characterization of the folding and unfolding kinetics of Cter-NPM1. Data reveal that this small helical domain folds via a compact denatured state, displaying a malleable residual structure. Moreover, analysis of folding rate constants measured under different experimental conditions suggests that the existence of a preorganized structure in the denatured state accelerates folding, implying a native-like residual structure. Because a major feature of Cter-NPM1 mutants responsible for AML is a reduction in stability of the protein and thus prevalence of a denatured state even under physiological conditions, our findings may pave the way to further studies with the aim of designing chemicals capable of interacting with the "pathological" mutants to stabilize the native conformation.-Scaloni, F., Gianni, S., Federici, L., Falini, B., Brunori, M. Folding mechanism of the C-terminal domain of nucleophosmin: residual structure in the denatured state and its pathophysiological significance. FASEB J. 23, 2360-2365 (2009)	[Scaloni, Flavio; Gianni, Stefano; Brunori, Maurizio] Univ Roma La Sapienza, CNR, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol, I-00185 Rome, Italy; [Scaloni, Flavio; Gianni, Stefano; Brunori, Maurizio] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Federici, Luca] Univ G dAnnunzio, Ctr Studi Invecchiamento, Chieti, Italy; [Federici, Luca] Univ G dAnnunzio, Dipartimento Sci Biomed, Chieti, Italy; [Falini, Brunangelo] Univ Perugia, Sez Ematol & Immunol, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Perugia	Brunori, M (corresponding author), Univ Roma La Sapienza, CNR, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol, Ple A Moro 5, I-00185 Rome, Italy.	maurizio.brunori@uniroma1.it	gianni, stefano/C-8536-2009	FALINI, Brunangelo/0000-0002-7198-5965; Brunori, Maurizio/0000-0002-7795-1635; Gianni, Stefano/0000-0003-1653-1925	Associazione Italiana Ricerca sul Cancro	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro to M. B and B. F.	BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cellmer T, 2007, J AM CHEM SOC, V129, P14564, DOI 10.1021/ja0761939; Dalby PA, 1998, BIOCHEMISTRY-US, V37, P4674, DOI 10.1021/bi972798d; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V108, P1999, DOI 10.1182/blood-2006-03-007013; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; WANG DR, 1994, J BIOL CHEM, V269, P30994; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zhang YP, 2004, CELL CYCLE, V3, P259	41	28	28	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2360	2365		10.1096/fj.08-128306	http://dx.doi.org/10.1096/fj.08-128306			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19289604				2022-12-25	WOS:000268836700004
J	Tamma, R; Colaianni, G; Camerino, C; Di Benedetto, A; Greco, G; Strippoli, M; Vergari, R; Grano, A; Mancini, L; Mori, G; Colucci, S; Grano, M; Zallone, A				Tamma, Roberto; Colaianni, Graziana; Camerino, Claudia; Di Benedetto, Adriana; Greco, Giovanni; Strippoli, Maurizio; Vergari, Rosaria; Grano, Antonella; Mancini, Lucia; Mori, Giorgio; Colucci, Silvia; Grano, Maria; Zallone, Alberta			Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption	FASEB JOURNAL			English	Article						mechanical forces; osteoporosis; bone remodeling	MESENCHYMAL STEM-CELLS; MODELED MICROGRAVITY; SPACE-FLIGHT; INCREASES; DIFFERENTIATION; PROLIFERATION; ADIPOGENESIS; OSTEOBIOLOGY; STRAIN; LEVEL	During space flight, severe losses of bone mass are observed. Both bone formation and resorption are probably involved, but their relative importance remains unclear. The purpose of this research is to understand the role of osteoclasts and their precursors in microgravity-induced bone loss. Three experiments on isolated osteoclasts (OCs) and on their precursors, OSTEO, OCLAST, and PITS, were launched in the FOTON-M3 mission. The OSTEO experiment was conducted for 10 d in microgravity within bioreactors with a perfusion system, where the differentiation of precursors, cultured on a synthetic 3-dimensional bonelike biomaterial, skelite, toward mature OCs was assessed. In OCLAST and in PITS experiments, differentiated OCs were cultured on devitalized bovine bone slices for 4 d in microgravity. All of the experiments were replicated on ground in the same bioreactors, and OCLAST also had an inflight centrifuge as a control. Gene expression in microgravity, compared with ground controls, demonstrated a severalfold increase in genes involved in osteoclast maturation and activity. Increased bone resorption, proved by an increased amount of collagen telopeptides released VS ground and centrifuge control, was also found. These results indicate for the first time osteoclasts and their precursors as direct targets for microgravity and mechanical forces.-Tamma, R., Colaianni, G., Camerino, C., Di Benedetto, A., Greco, G., Strippoli, M., Vergari, R., Grano, A., Mancini, L., Mori, G., Colucci, S., Grano, M., Zallone, A. Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption. FASEB J. 23, 2549-2554 (2009)	[Tamma, Roberto; Colaianni, Graziana; Camerino, Claudia; Di Benedetto, Adriana; Greco, Giovanni; Strippoli, Maurizio; Vergari, Rosaria; Grano, Antonella; Mancini, Lucia; Mori, Giorgio; Colucci, Silvia; Grano, Maria; Zallone, Alberta] Univ Bari, Sch Med, Dept Human Anat & Histol, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro	Zallone, A (corresponding author), Univ Bari, Sch Med, Dept Human Anat & Histol, Piazza G Cesare 11, I-70124 Bari, Italy.	a.zallone@anatomia.uniba.it	tamma, roberto/C-3679-2016; Mori, Giorgio/P-1370-2014	Mori, Giorgio/0000-0001-6731-0247; Camerino, Claudia/0000-0001-7217-9327; TAMMA, Roberto/0000-0003-4623-5406; Camerino, Giulia Maria/0000-0003-1410-6327; Colaianni, Graziana/0000-0001-8501-5399; Grano, Maria/0000-0002-7121-5899; Colucci, Silvia/0000-0001-9970-3539	Italian Space Agency (Osteporosis and Muscle Atrophy project); European Space Agency (European Research in Space and Terrestrial Osteoporosis, Microgravity Applied Project)	Italian Space Agency (Osteporosis and Muscle Atrophy project)(Agenzia Spaziale Italiana (ASI)); European Space Agency (European Research in Space and Terrestrial Osteoporosis, Microgravity Applied Project)(European Space Agency)	This work was supported by grants from the Italian Space Agency (Osteporosis and Muscle Atrophy project) and from the European Space Agency (European Research in Space and Terrestrial Osteoporosis, Microgravity Applied Project) to A.Z.	Basso N, 2005, BONE, V36, P173, DOI 10.1016/j.bone.2004.09.016; Caillot-Augusseau A, 2000, CLIN CHEM, V46, P1136; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Grigoriev A I, 1998, Aviakosm Ekolog Med, V32, P21; Hughes-Fulford M, 2001, J Gravit Physiol, V8, pP1; Hughes-Fulford M, 2006, J CELL BIOCHEM, V99, P435, DOI 10.1002/jcb.20883; Kumei Y, 2006, ANN NY ACAD SCI, V1090, P311, DOI 10.1196/annals.1378.034; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Marie PJ, 2000, CALCIFIED TISSUE INT, V67, P2, DOI 10.1007/s00223001088; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120; Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059; Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022; Vico L, 2001, CALCIFIED TISSUE INT, V68, P1, DOI 10.1007/BF02684996; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156	16	92	107	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2549	2554		10.1096/fj.08-127951	http://dx.doi.org/10.1096/fj.08-127951			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19329761				2022-12-25	WOS:000268836700023
J	Mittelstadt, PR; Yamaguchi, H; Appella, E; Ashwell, JD				Mittelstadt, Paul R.; Yamaguchi, Hiroshi; Appella, Ettore; Ashwell, Jonathan D.			T Cell Receptor-mediated Activation of p38 alpha by Mono-phosphorylation of the Activation Loop Results in Altered Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT4 SERINE PHOSPHORYLATION; ATF2 TRANSCRIPTION FACTOR; P38 MAP KINASE; PROTEIN-KINASE; DUAL PHOSPHORYLATION; ACTIVE MUTANTS; IN-VIVO; GAMMA; EXPRESSION; MECHANISM	p38 MAPKs are typically activated by upstream MAPK kinases that phosphorylate a Thr-X-Tyr motif in the activation loop. An exception is the T cell antigen receptor signaling pathway, which bypasses the MAPK cascade and activates p38 alpha and p38 beta by phosphorylation of Tyr-323 and subsequent autophosphorylation of the activation loop. Here we show that, unlike the classic MAPK cascade, the alternative pathway results primarily in mono-phosphorylation of the activation loop residue Thr180. Recombinant mono-phosphorylated and dual phosphorylated p38 alpha differed widely with regard to activity and substrate preference. Altered substrate specificity was reproduced in T cells in which p38 was activated by the alternative or classical MAPK pathways. These findings suggest that T cells have evolved a mechanism to utilize p38 in a specialized manner independent of and distinct from the classical p38 MAPK signaling cascade.	[Mittelstadt, Paul R.; Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; [Yamaguchi, Hiroshi; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Rm 3002,37 Convent Dr, Bethesda, MD 20892 USA.	jda@mail.nih.gov			National Institutes of Health; NATIONAL CANCER INSTITUTE [Z01BC005599, Z01BC010774, ZIABC005599, ZIABC010774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Research Program, Center for Cancer Research.	Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Engelberg D, 2004, SEMIN CANCER BIOL, V14, P271, DOI 10.1016/j.semcancer.2004.04.006; Farley N, 2006, MOL CELL BIOL, V26, P2118, DOI 10.1128/MCB.26.6.2118-2129.2006; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GRONOSTAJSKI RM, 1985, J BIOL CHEM, V260, P3344; Hale KK, 1999, J IMMUNOL, V162, P4246; JIRMANOVA L, 2008, BLOOD; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Maayan Inbal, 2008, V20, P171, DOI 10.1007/4735_2007_0249; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Park WR, 2004, INT IMMUNOL, V16, P295, DOI 10.1093/intimm/dxh034; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rudd CE, 2005, NAT IMMUNOL, V6, P368, DOI 10.1038/ni0405-368; Salmon RA, 1997, J IMMUNOL, V159, P5309; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	44	41	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15469	15474		10.1074/jbc.M901004200	http://dx.doi.org/10.1074/jbc.M901004200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19324872	Green Published, hybrid			2022-12-25	WOS:000266501000015
J	Dangi, B; Obeng, M; Nauroth, JM; Teymourlouei, M; Needham, M; Raman, K; Arterburn, LM				Dangi, Bindi; Obeng, Marcus; Nauroth, Julie M.; Teymourlouei, Mah; Needham, Micah; Raman, Krishna; Arterburn, Linda M.			Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXY FATTY-ACIDS; DOCOSAHEXAENOIC ACID; LIPOXYGENASE PATHWAY; DOSE-RESPONSE; LIPOXINS; BRAIN; MEDIATORS; INFLAMMATION; PROTECTS; INHIBITION	Enzymatically oxygenated derivatives of the omega-3 fatty acids cis-4,7,10,13,16,19-docosahexaenoic acid (DHA) and cis-5,8,11,14,17-eicosapentaenoic acid, known as resolvins, have potent inflammation resolution activity (Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) J. Exp. Med. 192, 1197-1204; Hong, S., Gronert, K., Devchand, P. R., Moussignac, R., and Serhan, C. N. (2003) J. Biol. Chem. 278, 14677-14687). Our objective was to determine whether similar derivatives are enzymatically synthesized from other C-22 fatty acids and whether these molecules possess inflammation resolution properties. The reaction of DHA, DPAn-3, and DPAn-6 with 5-, 12-, and 15-lipoxygenases produced oxylipins, which were identified and characterized by liquid chromatography coupled with tandem mass-spectrometry. DPAn-6 and DPAn-3 proved to be good substrates for 15-lipoxygenase. 15-Lipoxygenase proved to be the most efficient enzyme of the three tested for conversion of long chain polyunsaturated fatty acids to corresponding oxylipins. Since DPAn-6 is a major component of Martek DHA-S (TM) oil, we focused our attention on reaction products obtained from the DPAn-6 and 15-lipoxygenase reaction. (17S)-hydroxy-DPAn-6 and (10,17S)-dihydroxy-DPAn-6 were the main products of this reaction. These compounds were purified by preparatory high performance liquid chromatography techniques and further characterized by NMR, UV spectrophotometry, and tandem mass spectrometry. We tested both compounds in two animal models of acute inflammation and demonstrated that both compounds are potent anti-inflammatory agents that are active on local intravenous as well as oral administration. These oxygenated DPAn-6 compounds can thus be categorized as a new class of DPAn-6-derived resolvins.	[Dangi, Bindi; Obeng, Marcus; Nauroth, Julie M.; Teymourlouei, Mah; Needham, Micah; Raman, Krishna; Arterburn, Linda M.] Martek Biosci Corp, Columbia, MD 21045 USA		Dangi, B (corresponding author), Martek Biosci Corp, 6480 Dobbin Rd, Columbia, MD 21045 USA.	bdangi@martek.com						Akiba S, 2000, BIOL PHARM BULL, V23, P1293, DOI 10.1248/bpb.23.1293; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; AVELDANO MI, 1983, J BIOL CHEM, V258, P9339; Bayer M, 2005, J CHROMATOGR B, V819, P323, DOI 10.1016/j.jchromb.2005.02.008; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Berry H, 1997, FEBS LETT, V408, P324, DOI 10.1016/S0014-5793(97)00453-5; Bonnans C, 2004, ALLERGY, V59, P1027, DOI 10.1111/j.1398-9995.2004.00617.x; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Butovich IA, 2006, J LIPID RES, V47, P854, DOI 10.1194/jlr.D500042-JLR200; Butovich IA, 2005, LIPIDS, V40, P249, DOI 10.1007/s11745-005-1379-z; Butovich IA, 2006, J LIPID RES, V47, P2462, DOI 10.1194/jlr.M600280-JLR200; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CAREAGA MM, 1984, J BIOL CHEM, V259, P4413; Conolly RB, 2004, TOXICOL SCI, V77, P151, DOI 10.1093/toxsci/kfh007; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; GARDNER HW, 1991, BIOCHIM BIOPHYS ACTA, V1084, P221, DOI 10.1016/0005-2760(91)90063-N; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Guilford WJ, 2005, PROSTAG LEUKOTR ESS, V73, P245, DOI 10.1016/j.plefa.2005.05.012; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Kohn MC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290113; KUHN H, 1987, ANAL BIOCHEM, V160, P24, DOI 10.1016/0003-2697(87)90609-9; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Levy BD, 2005, PROSTAG LEUKOTR ESS, V73, P231, DOI 10.1016/j.plefa.2005.05.010; Levy BD, 2003, ADV EXP MED BIOL, V525, P19; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Maderna P, 2000, AM J PHYSIOL-CELL PH, V279, pC945, DOI 10.1152/ajpcell.2000.279.4.C945; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087-JLR200; Moriguchi T, 2001, J LIPID RES, V42, P419; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murphy MG, 1999, LIPIDS, V34, P115, DOI 10.1007/s11745-999-0344-1; Murphy MG, 1997, MOL CELL BIOCHEM, V177, P257, DOI 10.1023/A:1006871524271; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; PIAZZA GJ, 1996, LIPOXYGENASE LIPOXYG, P1; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sangster J., 1997, OCTANOL WATER PARTIT; SCHILSTRA MJ, 1994, LIPIDS, V29, P225, DOI 10.1007/BF02536325; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Serhan Charles N, 2006, Anesthesiol Clin, V24, P341, DOI 10.1016/j.atc.2006.01.003; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; SHIMIZU T, 1990, METHOD ENZYMOL, V187, P296; Stark KD, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-13; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Tsuji M, 2003, PROSTAG LEUKOTR ESS, V68, P337, DOI 10.1016/S0952-3278(03)00025-5; Viswanadhan VN, 2002, CURR OPIN DRUG DISC, V5, P400; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	62	56	67	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14744	14759		10.1074/jbc.M809014200	http://dx.doi.org/10.1074/jbc.M809014200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324874	hybrid, Green Published			2022-12-25	WOS:000266288200010
J	Bonini, MG; Gabel, SA; Ranguelova, K; Stadler, K; DeRose, EF; London, RE; Mason, RP				Bonini, Marcelo G.; Gabel, Scott A.; Ranguelova, Kalina; Stadler, Krisztian; DeRose, Eugene F.; London, Robert E.; Mason, Ronald P.			Direct Magnetic Resonance Evidence for Peroxymonocarbonate Involvement in the Cu,Zn-Superoxide Dismutase Peroxidase Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ZINC SUPEROXIDE-DISMUTASE; CARBONATE-RADICAL-ANION; HYDROGEN-PEROXIDE; HYDROPEROXIDE ANION; NITROGEN-DIOXIDE; AQUEOUS-SOLUTION; ALPHA-SYNUCLEIN; MOTOR-NEURONS; HUMAN COPPER	Cu,Zn-superoxide dismutase (SOD1) is a copper- and zinc-dependent enzyme. The main function of SOD1 is believed to be the scavenging and detoxification of superoxide radicals. Nevertheless, the last 30 years have seen a rapid accumulation of evidence indicating that SOD1 may also act as a peroxidase, an alternative function that was implicated in the onset and progression of familial amyotrophic lateral sclerosis. Although SOD1 peroxidase activity and its dependence on carbon dioxide have been well described, the molecular basis of the SOD1 peroxidase cycle remains obscure, because none of the proposed catalytic intermediates have so far been identified. In view of recent observations, we hypothesized that the SOD1 peroxidase cycle relies on two steps: 1) reduction of SOD-Cu(II) by hydrogen peroxide followed by 2) oxidation of SOD-Cu(I) by peroxy-monocarbonate, the product of the spontaneous reaction of bicarbonate with hydrogen peroxide, to produce SOD-Cu(II) and carbonate radical anion. This hypothesis has been investigated through electron paramagnetic resonance and nuclear magnetic resonance to provide direct evidence for a peroxycarbonate-driven, SOD1-catalyzed carbonate radical production. The results gathered herein indicate that peroxymonocarbonate (HOOCO2-) is a key intermediate in the SOD1 peroxidase cycle and identify this species as the precursor of carbonate radical anions.	[Bonini, Marcelo G.; Ranguelova, Kalina; Stadler, Krisztian; Mason, Ronald P.] NIEHS, Pharmacol Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; [Gabel, Scott A.; DeRose, Eugene F.; London, Robert E.] NIEHS, Struct Biol Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bonini, MG (corresponding author), NIEHS, Pharmacol Lab, Natl Inst Hlth, MD F0-02,POB 12233, Res Triangle Pk, NC 27709 USA.	bonini@niehs.nih.gov	London, Robert E/F-7990-2019; Mason, Ronald P/G-5967-2019; Stadler, Krisztian/N-1992-2017	London, Robert E/0000-0001-9108-8463; Mason, Ronald P/0000-0002-1859-9109; 	National Institutes of Health; NIEHS; Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050139, Z01ES050110, Z01ES050139, ZIAES050110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health, NIEHS, Intramural Research Program.	Andrekopoulos C, 2004, BIOCHEM J, V378, P435, DOI 10.1042/BJ20031466; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Bennett DA, 2001, INORG CHEM, V40, P2996, DOI 10.1021/ic000910h; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BLECH DM, 1983, ARCH BIOCHEM BIOPHYS, V224, P579, DOI 10.1016/0003-9861(83)90245-X; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BOLANN BJ, 1992, BIOCHIM BIOPHYS ACTA, V1156, P27, DOI 10.1016/0304-4165(92)90091-8; Bonini MG, 2004, J BIOL CHEM, V279, P51836, DOI 10.1074/jbc.M406929200; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; BORS W, 1991, FREE RADICAL RES COM, V12-3, P411, DOI 10.3109/10715769109145811; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CHEN S, 1973, J PHYS CHEM-US, V77, P111; Dean J.A., 1979, LANGES HDB CHEM, Vtwelth, P5; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; FERRAUDI G, 1993, J PHYS CHEM-US, V97, P11929, DOI 10.1021/j100148a014; FUCHS HJR, 1983, BIOCHEM BIOPH RES CO, V116, P1107, DOI 10.1016/S0006-291X(83)80256-3; Goss SPA, 1999, J BIOL CHEM, V274, P28233, DOI 10.1074/jbc.274.40.28233; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hensley K, 2006, ANTIOXID REDOX SIGN, V8, P2075, DOI 10.1089/ars.2006.8.2075; HODGSON EK, 1973, BIOCHEM BIOPH RES CO, V54, P270, DOI 10.1016/0006-291X(73)90918-2; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jewett SL, 2000, BIOCHEM BIOPH RES CO, V274, P57, DOI 10.1006/bbrc.2000.3092; Karunakaran C, 2004, J BIOL CHEM, V279, P32534, DOI 10.1074/jbc.M314272200; Leinweber B, 2004, FREE RADICAL BIO MED, V36, P911, DOI 10.1016/j.freeradbiomed.2003.12.021; Liochev SI, 2002, J BIOL CHEM, V277, P34674, DOI 10.1074/jbc.M204726200; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 2004, ARCH BIOCHEM BIOPHYS, V421, P255, DOI 10.1016/j.abb.2003.11.015; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Lynch SM, 2004, BIOCHEMISTRY-US, V43, P16525, DOI 10.1021/bi048831v; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; MEDINAS DB, 2009, CHEM RES TO IN PRESS; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; RABANI J, 1973, J PHYS CHEM-US, V77, P1169, DOI 10.1021/j100628a018; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Ramirez DC, 2005, J BIOL CHEM, V280, P27402, DOI 10.1074/jbc.M504241200; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Roe JA, 2002, FREE RADICAL BIO MED, V32, P169, DOI 10.1016/S0891-5849(01)00778-X; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Trindade DF, 2006, CHEM RES TOXICOL, V19, P1475, DOI 10.1021/tx060146x; Yao HR, 2003, J AM CHEM SOC, V125, P6211, DOI 10.1021/ja0274756; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038; Zhang H, 2004, FREE RADICAL BIO MED, V36, P1355, DOI 10.1016/j.freeradbiomed.2004.02.038	55	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14618	14627		10.1074/jbc.M804644200	http://dx.doi.org/10.1074/jbc.M804644200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19286663	Green Published, hybrid			2022-12-25	WOS:000266286100067
J	Covian, R; Trumpower, BL				Covian, Raul; Trumpower, Bernard L.			The Rate-limiting Step in the Cytochrome bc(1) Complex (Ubiquinol-Cytochrome c Oxidoreductase) Is Not Changed by Inhibition of Cytochrome b-dependent Deprotonation IMPLICATIONS FOR THE MECHANISM OF UBIQUINOL OXIDATION AT CENTER P OF THE bc(1) COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; SUPEROXIDE-PRODUCTION; ELECTRON-TRANSFER; QUINOL OXIDATION; Q(O) SITE; Q-CYCLE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL; BINDING; SOLUBILIZATION	Quinol oxidation at center P of the cytochrome bc(1) complex involves bifurcated electron transfer to the Rieske iron-sulfur protein and cytochrome b. It is unknown whether both electrons are transferred from the same domain close to the Rieske protein, or if an unstable semiquinone anion intermediate diffuses rapidly to the vicinity of the b(L) heme. We have determined the pre-steady state rate and activation energy (E-a) for quinol oxidation in purified yeast bc(1) complexes harboring either a Y185F mutation in the Rieske protein, which decreases the redox potential of the FeS cluster, or a E272Q cytochrome b mutation, which eliminates the proton acceptor in cytochrome b. The rate of the bifurcated reaction in the E272Q mutant (< 10% of the wild type) was even lower than that of the Y185F enzyme (similar to 20% of the wild type). However, the E272Q enzyme showed the same E-a (61 kJ mol(-1)) with respect to the wild type (62 kJ mol(-1)), in contrast with the Y185F mutation, which increased Ea to 73 kJ mol(-1). The rate and E-a of the slow reaction of quinol with oxygen that are observed after cytochrome b is reduced were unaffected by the E272Q substitution, whereas the Y185F mutation modified only its rate. The Y185F/E272Q double mutation resulted in a synergistic decrease in the rate of quinol oxidation (0.7% of the wild type). These results are inconsistent with a sequential "movable semiquinone" mechanism but are consistent with a model in which both electrons are transferred simultaneously from the same domain in center P.	[Covian, Raul; Trumpower, Bernard L.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Trumpower, BL (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			National Institutes of Health Research [GM 20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM 20379.	BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; Cape JL, 2005, J AM CHEM SOC, V127, P4208, DOI 10.1021/ja043955g; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Covian R, 2007, J BIOL CHEM, V282, P22289, DOI 10.1074/jbc.M702132200; Crofts AR, 2006, BBA-BIOENERGETICS, V1757, P1019, DOI 10.1016/j.bbabio.2006.02.009; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HUMPHREYS KJ, 1968, J PHARM SCI-US, V57, P79, DOI 10.1002/jps.2600570115; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kessl JJ, 2007, BBA-BIOENERGETICS, V1767, P319, DOI 10.1016/j.bbabio.2007.02.014; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LJUNGDAHL P O, 1987, Biochimica et Biophysica Acta, V891, P227, DOI 10.1016/0005-2728(87)90218-0; Margoliash E, 1967, METHOD ENZYMOL, V10, P339; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Rich PR, 2004, BBA-BIOENERGETICS, V1658, P165, DOI 10.1016/j.bbabio.2004.04.021; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Seddiki N, 2008, BIOCHEMISTRY-US, V47, P2357, DOI 10.1021/bi701905a; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Wenz T, 2006, BIOCHEMISTRY-US, V45, P9042, DOI 10.1021/bi060280g; YU CA, 1972, J BIOL CHEM, V247, P1012; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	37	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14359	14367		10.1074/jbc.M109.000596	http://dx.doi.org/10.1074/jbc.M109.000596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19325183	Green Published, hybrid			2022-12-25	WOS:000266286100042
J	Irie, N; Takada, Y; Watanabe, Y; Matsuzaki, Y; Naruse, C; Asano, M; Iwakura, Y; Suda, T; Matsuo, K				Irie, Naoko; Takada, Yasunari; Watanabe, Yoshihiko; Matsuzaki, Yumi; Naruse, Chie; Asano, Masahide; Iwakura, Yoichiro; Suda, Toshio; Matsuo, Koichi			Bidirectional Signaling through EphrinA2-EphA2 Enhances Osteoclastogenesis and Suppresses Osteoblastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-GAMMA; GENE-EXPRESSION; STIMULATING-FACTOR; BONE HOMEOSTASIS; KEY REGULATOR; ACTIVATION; FOS; DIFFERENTIATION; PROTEINS; CLEAVAGE	Bone is remodeled constantly throughout life by bone-resorbing osteoclasts and bone-forming osteoblasts. To maintain bone volume and quality, differentiation of osteoclasts and osteoblasts is tightly regulated through communication between and within these two cell lineages. Previously we reported that cell-cell interaction mediated by ephrinB2 ligand on osteoclasts and EphB4 receptor on osteoblasts generates bidirectional anti-osteoclastogenic and pro-osteoblastogenic signals into respective cells and presumably facilitates transition from bone resorption to bone formation. Here we show that bidirectional ephrinA2-EphA2 signaling regulates bone remodeling at the initiation phase. EphrinA2 expression was rapidly induced by receptor activator of NF-kappa B ligand in osteoclast precursors; this was dependent on the transcription factor c-Fos but independent of the c-Fos target gene product NFATc1. Receptor EphA2 was expressed in osteoclast precursors and osteoblasts. Overexpression experiments revealed that both ephrinA2 and EphA2 in osteoclast precursors enhanced differentiation of multinucleated osteoclasts and that phospholipase C gamma 2 may mediate ephrinA2 reverse signaling. Moreover, ephrinA2 on osteoclasts was cleaved by metalloproteinases, and ephrinA2 released in the culture medium enhanced osteoclastogenesis. Interestingly, differentiation of osteoblasts lacking EphA2 was enhanced along with alkaline phosphatase, Runx2, and Osterix expression, indicating that EphA2 on osteoblasts generates anti-osteoblastogenic signals presumably by up-regulating RhoA activity. Therefore, ephrinA2-EphA2 interaction facilitates the initiation phase of bone remodeling by enhancing osteoclast differentiation and suppressing osteoblast differentiation.	[Irie, Naoko; Takada, Yasunari; Watanabe, Yoshihiko; Matsuo, Koichi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Irie, Naoko; Watanabe, Yoshihiko; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Tokyo 1608582, Japan; [Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Naruse, Chie; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan	Keio University; Keio University; Keio University; Kanazawa University; University of Tokyo	Matsuo, K (corresponding author), 35 Shinanomachi,Shinjuku Ku, Tokyo 1608582, Japan.	matsuo@sc.itc.keio.ac.jp	Suda, Toshio/H-6761-2013; Matsuo, Koichi/K-5695-2012; Iwakura, Yoichiro/E-5457-2011	Suda, Toshio/0000-0001-7540-1771; Matsuo, Koichi/0000-0002-1490-8955; Iwakura, Yoichiro/0000-0002-9934-5775; Matsuzaki, Yumi/0000-0002-3729-2997	Keio University;  [20-5884]	Keio University; 	This work was supported by Grant-in-aid for Japan Society for the Promotion of Science Fellows 20-5884, by a Keio University grant-in-aid for Encouragement of Young Medical Scientists, The 21st Century COE Program at Keio University, and by Medical School Faculty and Alumni Grants of the Keio University Medical Science Fund, Tokyo.	Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kuroda C, 2008, BIOCHEM BIOPH RES CO, V374, P22, DOI 10.1016/j.bbrc.2008.06.089; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura I, 2001, J CELL BIOL, V152, P361, DOI 10.1083/jcb.152.2.361; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; SELANDER K, 1994, CALCIFIED TISSUE INT, V55, P368, DOI 10.1007/BF00299317; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Verrier S, 2004, BONE, V35, P34, DOI 10.1016/j.bone.2003.12.029; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	32	131	148	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14637	14644		10.1074/jbc.M807598200	http://dx.doi.org/10.1074/jbc.M807598200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19299512	hybrid, Green Published			2022-12-25	WOS:000266286100069
J	Dagda, RK; Cherra, SJ; Kulich, SM; Tandon, A; Park, D; Chu, CT				Dagda, Ruben K.; Cherra, Salvatore J., III; Kulich, Scott M.; Tandon, Anurag; Park, David; Chu, Charleen T.			Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PARKINSONS-DISEASE; CELL-DEATH; RECESSIVE PARKINSONISM; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; SH-SY5Y CELLS; AUTOPHAGY; MUTATIONS	Mitochondrial dysregulation is strongly implicated in Parkinson disease. Mutations in PTEN-induced kinase 1 (PINK1) are associated with familial parkinsonism and neuropsychiatric disorders. Although overexpressed PINK1 is neuroprotective, less is known about neuronal responses to loss of PINK1 function. We found that stable knockdown of PINK1 induced mitochondrial fragmentation and autophagy in SH-SY5Y cells, which was reversed by the reintroduction of an RNA interference (RNAi)-resistant plasmid for PINK1. Moreover, stable or transient overexpression of wild-type PINK1 increased mitochondrial interconnectivity and suppressed toxin-induced autophagy/mitophagy. Mitochondrial oxidant production played an essential role in triggering mitochondrial fragmentation and autophagy in PINK1 shRNA lines. Autophagy/mitophagy served a protective role in limiting cell death, and overexpressing Parkin further enhanced this protective mitophagic response. The dominant negative Drp1 mutant inhibited both fission and mitophagy in PINK1-deficient cells. Interestingly, RNAi knockdown of autophagy proteins Atg7 and LC3/Atg8 also decreased mitochondrial fragmentation without affecting oxidative stress, suggesting active involvement of autophagy in morphologic remodeling of mitochondria for clearance. To summarize, loss of PINK1 function elicits oxidative stress and mitochondrial turnover coordinated by the autophagic and fission/fusion machineries. Furthermore, PINK1 and Parkin may cooperate through different mechanisms to maintain mitochondrial homeostasis.	[Dagda, Ruben K.; Cherra, Salvatore J., III; Kulich, Scott M.; Chu, Charleen T.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Chu, Charleen T.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kulich, Scott M.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA; [Tandon, Anurag] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M55 3H2, Canada; [Park, David] Univ Ottawa, Neurosci Grp, Ottawa Hlth Res Inst, Ottawa, ON K1H 8M5, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Chu, CT (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.	ctc4@pitt.edu	Chu, Charleen T/B-1601-2008	Chu, Charleen T/0000-0002-5052-8271; Dagda, Ruben/0000-0002-9946-9591; Park, David/0000-0002-4490-3784	National Institutes of Health [AG026389, DC009120, NS053777, F32 AG030821]; Pittsburgh Foundation, Emmerling Fund; American Parkinson Disease Association; Veterans Administration Advanced Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG030821, R01AG026389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K18DC009120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Foundation, Emmerling Fund; American Parkinson Disease Association; Veterans Administration Advanced Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants AG026389, DC009120, and NS053777 ( to C. T. C.). This work was also supported by grants from the Pittsburgh Foundation, Emmerling Fund ( to C. T. C.), the American Parkinson Disease Association ( to S. M. K.), and a Veterans Administration Advanced Career Development Award ( to S. M. K.).; Supported in part by National Institutes of Health Grant F32 AG030821.	Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Betarbet R, 2002, BRAIN PATHOL, V12, P499; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Patel MN, 2003, AGING CELL, V2, P219, DOI 10.1046/j.1474-9728.2003.00055.x; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	60	716	729	0	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13843	13855		10.1074/jbc.M808515200	http://dx.doi.org/10.1074/jbc.M808515200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19279012	hybrid, Green Published			2022-12-25	WOS:000265877300061
J	Cho, HY; Cho, HJ; Kim, YM; Oh, JI; Kang, BS				Cho, Ha Yeon; Cho, Hyo Je; Kim, Young Min; Oh, Jeong Il; Kang, Beom Sik			Structural Insight into the Heme-based Redox Sensing by DosS from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SENSOR; 2-COMPONENT SYSTEM; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; GAF DOMAINS; DEVS; BINDING; PROTEIN; MECHANISM; KINASES	Mycobacterium tuberculosis is thought to undergo transformation into its non-replicating persistence state under the influence of hypoxia or nitric oxide (NO). This transformation is thought to be mediated via two sensor histidine kinases, DosS and DosT, each of which contains two GAF domains that are responsible for detecting oxygen tension. In this study we determined the crystal structures of the first GAF domain (GAF-A) of DosS, which shows an interaction with a heme. A b-type heme was embedded in a hydrophobic cavity of the GAF-A domain and was roughly perpendicular to the beta-sheet of the GAF domain. The heme iron was liganded by His-149 at the proximal heme axial position. The iron, in the oxidized form, was six-coordinated with a water molecule at the distal position. Upon reduction, the iron, in ferrous form, was five-coordinated, and when the GAF domain was exposed to atmospheric O-2, the ferrous form was oxidized to generate the Met form rather than a ferrous O-2-bound form. Because the heme is isolated inside the GAF domain, its accessibility is restricted. However, a defined hydrogen bond network found at the heme site could accelerate the electron transferability and would explain why DosS was unable to bind O-2. Flavin nucleotides were shown to reduce the heme iron of DosS while NADH was unable to do so. These results suggest that DosS is a redox sensor and detects hypoxic conditions by its reduction.	[Cho, Ha Yeon; Cho, Hyo Je; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Oh, Jeong Il] Pusan Natl Univ, Dept Microbiol, Pusan 609735, South Korea; [Kim, Young Min] Yonsei Univ, Dept Biol, Seoul 120749, South Korea	Kyungpook National University; Pusan National University; Yonsei University	Kang, BS (corresponding author), 1370 Sangyeok Dong, Taegu 702701, South Korea.	bskang2@knu.ac.kr			21C Frontier Microbial Genomics and Application Center Program; Ministry of Education Science, and Technology, Republic of Korea	21C Frontier Microbial Genomics and Application Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the 21C Frontier Microbial Genomics and Application Center Program, Ministry of Education Science, and Technology, Republic of Korea.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Ely Fernanda, 2008, BMC Biochemistry, V9, P13, DOI 10.1186/1471-2091-9-13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Smulevich G, 1999, J BIOL INORG CHEM, V4, P39, DOI 10.1007/s007750050287; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	34	80	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13057	13067		10.1074/jbc.M808905200	http://dx.doi.org/10.1074/jbc.M808905200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276084	hybrid, Green Published			2022-12-25	WOS:000265688300053
J	Allen, JM; Zamurs, L; Brachvogel, B; Schlotzer-Schrehardt, U; Hansen, U; Lamande, SR; Rowley, L; Fitzgerald, J; Bateman, JF				Allen, Justin M.; Zamurs, Laura; Brachvogel, Bent; Schloetzer-Schrehardt, Ursula; Hansen, Uwe; Lamande, Shireen R.; Rowley, Lynn; Fitzgerald, Jamie; Bateman, John F.			Mice Lacking the Extracellular Matrix Protein WARP Develop Normally but Have Compromised Peripheral Nerve Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE PERICELLULAR MATRIX; BASEMENT-MEMBRANES; ARTICULAR-CARTILAGE; COLLAGEN-VI; EXPRESSION; COMPONENT; CHAINS; FRAS1; CELLS; SKIN	WARP is a recently identified extracellular matrix molecule with restricted expression in permanent cartilages and a distinct subset of basement membranes in peripheral nerves, muscle, and the central nervous system vasculature. WARP interacts with perlecan, and we also demonstrate here that WARP binds type VI collagen, suggesting a function in bridging connective tissue structures. To understand the in vivo function of WARP, we generated a WARP-deficient mouse strain. WARP-null mice were healthy, viable, and fertile with no overt abnormalities. Motor function and behavioral testing demonstrated that WARP-null mice exhibited a significantly delayed response to acute painful stimulus and impaired fine motor coordination, although general motor function was not affected, suggesting compromised peripheral nerve function. Immunostaining of WARP-interacting ligands demonstrated that the collagen VI microfibrillar matrix was severely reduced and mislocalized in peripheral nerves of WARP-null mice. Further ultrastructural analysis revealed reduced fibrillar collagen deposition within the peripheral nerve extracellular matrix and abnormal partial fusing of adjacent Schwann cell basement membranes, suggesting an important function for WARP in stabilizing the association of the collagenous interstitial matrix with the Schwann cell basement membrane. In contrast, other WARP-deficient tissues such as articular cartilage, intervertebral discs, and skeletal muscle showed no detectable abnormalities, and basement membranes formed normally. Our data demonstrate that although WARP is not essential for basement membrane formation or musculoskeletal development, it has critical roles in the structure and function of peripheral nerves.	[Allen, Justin M.; Zamurs, Laura; Brachvogel, Bent; Lamande, Shireen R.; Rowley, Lynn; Fitzgerald, Jamie; Bateman, John F.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Brachvogel, Bent] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany; [Fitzgerald, Jamie] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97239 USA; [Hansen, Uwe] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Cologne; University of Erlangen Nuremberg; Oregon Health & Science University; University of Munster	Bateman, JF (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	john.bateman@mcri.edu.au		Lamande, Shireen/0000-0003-2938-2711; Bateman, John/0000-0001-8542-0730; Brachvogel, Bent/0000-0002-3923-0554	National Health and Medical Research Council of Australia; Muscular Dystrophy Association [4076]; Murdoch Children's Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055957] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Muscular Dystrophy Association(Muscular Dystrophy Association); Murdoch Children's Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Health and Medical Research Council of Australia, Muscular Dystrophy Association Grant 4076, and the Murdoch Children's Research Institute.	Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Allen JM, 2008, MATRIX BIOL, V27, P295, DOI 10.1016/j.matbio.2008.01.005; Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; Fitzgerald J, 2003, FEBS LETT, V552, P91, DOI 10.1016/S0014-5793(03)00968-2; Fitzgerald J, 2002, FEBS LETT, V517, P61, DOI 10.1016/S0014-5793(02)02579-6; Gregory KE, 2001, J BONE MINER RES, V16, P2005, DOI 10.1359/jbmr.2001.16.11.2005; Guilak F, 2006, ANN NY ACAD SCI, V1068, P498, DOI 10.1196/annals.1346.011; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Keene DR, 1998, J HISTOCHEM CYTOCHEM, V46, P215, DOI 10.1177/002215549804600210; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lee HK, 2007, J NEUROCHEM, V102, P686, DOI 10.1111/j.1471-4159.2007.04580.x; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Sambrook J., 2001, MOL CLONING LAB MANU; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; Wallquist W, 2002, J COMP NEUROL, V454, P284, DOI 10.1002/cne.10434; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006	27	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12020	12030		10.1074/jbc.M806968200	http://dx.doi.org/10.1074/jbc.M806968200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19279005	Green Published, hybrid			2022-12-25	WOS:000265494600034
J	Guo, Y; Schoell, MC; Freeman, RS				Guo, Y.; Schoell, M. C.; Freeman, R. S.			The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIMEL	ONCOGENE			English	Article						VHL; BIMEL; renal cell carcinoma; apoptosis; protein stability	TUMOR-SUPPRESSOR PROTEIN; PROLYL HYDROXYLASE; MOLECULAR-BASIS; GENE-PRODUCT; HIF-ALPHA; CANCER; PHOSPHORYLATION; EXPRESSION; COMPLEX; FAMILY	von Hippel-Lindau (VHL) disease is caused by germ-line mutations in the VHL tumor suppressor gene and is the most common cause of inherited renal cell carcinoma (RCC). Mutations in the VHL gene also occur in a large majority of sporadic cases of clear-cell RCC, which have high intrinsic resistance to chemotherapy and radiotherapy. Here we show that VHL-deficient RCC cells express lower levels of the proapoptotic Bcl-2 family protein BIMEL and are more resistant to etoposide and UV radiation-induced death compared to the same cells stably expressing the wild-type VHL protein (pVHL). Reintroducing pVHL into VHL-null cells increased the half-life of BIMEL protein without affecting its mRNA expression, and overexpressing pVHL inhibited BIMEL polyubiquitination. Suppressing pVHL expression with RNA interference resulted in a decrease in BIMEL protein and a corresponding decrease in the sensitivity of RCC cells to apoptotic stimuli. Directly inhibiting BIMEL expression in pVHL-expressing RCC cells caused a similar decrease in cell death. These results demonstrate that pVHL acts to promote BIMEL protein stability in RCC cells, and that destabilization of BIMEL in the absence of pVHL contributes to the increased resistance of VHL-null RCC cells to certain apoptotic stimuli.	[Schoell, M. C.; Freeman, R. S.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Guo, Y.] Univ Rochester, Sch Med, Interdept Grad Program Neurosci, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Freeman, RS (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, 601 Elmwood Ave,Room 4-6718, Rochester, NY 14642 USA.	robert_freeman@urmc.rochester.edu			National Institutes of Health [NS034400, NS058868]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034400, R01NS034400, R01NS058868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr William Kaelin for providing cell lines and Dr Thomas Benzing and Dr Patricia Hinkle for providing plasmids used in this study. This work was supported by grants NS034400 and NS058868 from the National Institutes of Health.	Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cohen HT, 1999, CURR OPIN NEPHROL HY, V8, P325, DOI 10.1097/00041552-199905000-00008; Devarajan P, 2001, J BIOL CHEM, V276, P40599, DOI 10.1074/jbc.M103424200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gorospe M, 1999, MOL CELL BIOL, V19, P1289; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Qi H, 2003, CANCER RES, V63, P7076; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schoenfeld AR, 2000, ONCOGENE, V19, P5851, DOI 10.1038/sj.onc.1203985; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; van Houwelingen KP, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-57; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xie L, 2005, J CELL BIOL, V168, P911, DOI 10.1083/jcb.200407079; YAGODA A, 1995, SEMIN ONCOL, V22, P42; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zantl N, 2007, ONCOGENE, V26, P7038, DOI 10.1038/sj.onc.1210510; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	42	25	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2009	28	16					1864	1874		10.1038/onc.2009.35	http://dx.doi.org/10.1038/onc.2009.35			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PW	19305426	Green Accepted			2022-12-25	WOS:000265640500005
J	Hsu, HJ; Lee, CF; Kaunas, R				Hsu, Hui-Ju; Lee, Chin-Fu; Kaunas, Roland			A Dynamic Stochastic Model of Frequency-Dependent Stress Fiber Alignment Induced by Cyclic Stretch	PLOS ONE			English	Article								Background: Actin stress fibers (SFs) are mechanosensitive structural elements that respond to forces to affect cell morphology, migration, signal transduction and cell function. Cells are internally stressed so that SFs are extended beyond their unloaded lengths, and SFs tend to self-adjust to an equilibrium level of extension. While there is much evidence that cells reorganize their SFs in response to matrix deformations, it is unclear how cells and their SFs determine their specific response to particular spatiotemporal changes in the matrix. Methodology/Principal Findings: Bovine aortic endothelial cells were subjected to cyclic uniaxial stretch over a range of frequencies to quantify the rate and extent of stress fiber alignment. At a frequency of 1 Hz, SFs predominantly oriented perpendicular to stretch, while at 0.1 Hz the extent of SF alignment was markedly reduced and at 0.01 Hz there was no alignment at all. The results were interpreted using a simple kinematic model of SF networks in which the dynamic response depended on the rates of matrix stretching, SF turnover, and SF self-adjustment of extension. For these cells, the model predicted a threshold frequency of 0.01 Hz below which SFs no longer respond to matrix stretch, and a saturation frequency of 1 Hz above which no additional SF alignment would occur. The model also accurately described the dependence of SF alignment on matrix stretch magnitude. Conclusions: The dynamic stochastic model was capable of describing SF reorganization in response to diverse temporal and spatial patterns of stretch. The model predicted that at high frequencies, SFs preferentially disassembled in the direction of stretch and achieved a new equilibrium by accumulating in the direction of lowest stretch. At low stretch frequencies, SFs self-adjusted to dissipate the effects of matrix stretch. Thus, SF turnover and self-adjustment are each important mechanisms that cells use to maintain mechanical homeostasis.	[Hsu, Hui-Ju; Lee, Chin-Fu; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hsu, HJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	rkaunas@tamu.edu			American Heart Association [0730238N]	American Heart Association(American Heart Association)	The authors were supported by an American Heart Association Grant (0730238N) awarded to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Chen YG, 1998, J ASIAN NAT PROD RES, V1, P125, DOI 10.1080/10286029808039854; Civelekoglu-Scholey G, 2005, J THEOR BIOL, V232, P569, DOI 10.1016/j.jtbi.2004.09.004; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; De R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031923; Deguchi S., 2005, Molecular & Cellular Biomechanics, V2, P125; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kakisis JD, 2004, ENDOTHELIUM-J ENDOTH, V11, P17, DOI 10.1080/10623320490432452; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; KAUNAS R, 2008, J THEORETIC IN PRESS; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Malek AM, 1996, J CELL SCI, V109, P713; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Na S, 2004, BIOMECH MODEL MECHAN, V3, P75, DOI 10.1007/s10237-004-0051-x; Noria S, 2004, AM J PATHOL, V164, P1211, DOI 10.1016/S0002-9440(10)63209-9; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Sotoudeh M, 2002, AM J PHYSIOL-HEART C, V282, pH1709, DOI 10.1152/ajpheart.00744.2001; Takemasa T, 1998, EUR J CELL BIOL, V77, P91, DOI 10.1016/S0171-9335(98)80076-9; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; WANG DL, 1993, BIOCHEM BIOPH RES CO, V195, P1050, DOI 10.1006/bbrc.1993.2150; WANG DL, 1995, CIRC RES, V77, P294, DOI 10.1161/01.RES.77.2.294; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745; Wille JJ, 2004, J BIOMECH ENG-T ASME, V126, P545, DOI 10.1115/1.1798053; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076	34	96	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4853	10.1371/journal.pone.0004853	http://dx.doi.org/10.1371/journal.pone.0004853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319193	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499200001
J	Kuo, MW; Wang, SH; Chang, JC; Chang, CH; Huang, LJ; Lin, HH; Yu, ALT; Li, WH; Yu, J				Kuo, Ming-Wei; Wang, Sheng-Hung; Chang, Jui-Chin; Chang, Chien-Huei; Huang, Ling-Jyun; Lin, Hsin-Hung; Yu, Alice Lin-Tsing; Li, Wen-Hsiung; Yu, John			A Novel puf-A Gene Predicted from Evolutionary Analysis Is Involved in the Development of Eyes and Primordial Germ-Cells	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; ZEBRAFISH; PUMILIO; EXPRESSION; VISUALIZATION; REVEALS	Although the human genome project has been completed for some time, the issue of the number of transcribed genes with identifiable biological functions remains unresolved. We used zebrafish as a model organism to study the functions of Ka/Ks-predicted novel human exons, which were identified from a comparative evolutionary genomics analysis. In this study, a novel gene, designated as puf-A, was cloned and functionally characterized, and its homologs in zebrafish, mouse, and human were identified as one of the three homolog clusters which were consisted of 14 related proteins with Puf repeats. Computer modeling of human Puf-A structure and a pull-down assay for interactions with RNA targets predicted that it was a RNA-binding protein. Specifically, Puf-A contained a special six Puf-repeat domain, which constituted a unique superhelix half doughnut-shaped Puf domain with a topology similar to, but different from the conventional eight-repeat Pumilio domain. Puf-A transcripts were uniformly distributed in early embryos, but became restricted primarily to eyes and ovaries at a later stage of development. In mice, puf-A expression was detected primarily in retinal ganglion and pigmented cells. Knockdown of puf-A in zebrafish embryos resulted in microphthalmia, a small head, and abnormal primordial germ-cell (PGC) migration. The latter was confirmed by microinjecting into embryos puf-A siRNA containing nanos 39 UTR that expressed in PGC only. The importance of Puf-A in the maturation of germline stem cells was also implicated by its unique expression in the most primitive follicles (stage I) in adult ovaries, followed by a sharp decline of expression in later stages of folliculogenesis. Taken together, our study shows that puf-A plays an important role not only in eye development, but also in PGC migration and the specification of germ cell lineage. These studies represent an exemplary implementation of a unique platform to uncover unknown function(s) of human genes and their roles in development regulation.	[Kuo, Ming-Wei; Wang, Sheng-Hung; Chang, Chien-Huei; Huang, Ling-Jyun; Yu, John] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chang, Jui-Chin; Lin, Hsin-Hung; Yu, Alice Lin-Tsing; Li, Wen-Hsiung; Yu, John] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Li, Wen-Hsiung] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Li, Wen-Hsiung] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of Chicago; Academia Sinica - Taiwan	Kuo, MW (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	johnyu@gate.sinica.edu.tw	yu, john/AAA-9255-2021; Lin, Hsin-Hung/J-5254-2013; YU, JOHN/G-8954-2012	Lin, Hsin-Hung/0000-0001-8327-6835; Li, Wen-Hsiung/0000-0003-1086-1456; Yu, John/0000-0002-3237-4272; yu, alice/0000-0003-2444-0505	National Science Council [NSC96-3111-B-001-005]; Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants from the National Science Council (#NSC96-3111-B-001-005) and from Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Fishman MC, 1999, P NATL ACAD SCI USA, V96, P10554, DOI 10.1073/pnas.96.19.10554; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Koprunner M, 2001, GENE DEV, V15, P2877; Kuo MW, 2005, J BIOMED SCI, V12, P629, DOI 10.1007/s11373-005-7457-z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nekrutenko A, 2003, NUCLEIC ACIDS RES, V31, P3564, DOI 10.1093/nar/gkg597; Nekrutenko A, 2003, TRENDS GENET, V19, P306, DOI 10.1016/S0168-9525(03)00114-8; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Saito T, 2006, INT J DEV BIOL, V50, P691, DOI 10.1387/ijdb.062143ts; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zamore PD, 1997, RNA, V3, P1421	37	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4980	10.1371/journal.pone.0004980	http://dx.doi.org/10.1371/journal.pone.0004980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319195	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499200012
J	Greco, D; Volpicelli, F; Di Lieto, A; Leo, D; Perrone-Capano, C; Auvinen, P; di Porzio, U				Greco, Dario; Volpicelli, Floriana; Di Lieto, Antonio; Leo, Damiana; Perrone-Capano, Carla; Auvinen, Petri; di Porzio, Umberto			Comparison of Gene Expression Profile in Embryonic Mesencephalon and Neuronal Primary Cultures	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; TRANSCRIPTION FACTOR; MOLECULAR-MECHANISMS; NURR1; TARGET; CELLS; INDUCTION; DIFFERENTIATION	In the mammalian central nervous system (CNS) an important contingent of dopaminergic neurons are localized in the substantia nigra and in the ventral tegmental area of the ventral midbrain. They constitute an anatomically and functionally heterogeneous group of cells involved in a variety of regulatory mechanisms, from locomotion to emotional/motivational behavior. Midbrain dopaminergic neuron (mDA) primary cultures represent a useful tool to study molecular mechanisms involved in their development and maintenance. Considerable information has been gathered on the mDA neurons development and maturation in vivo, as well as on the molecular features of mDA primary cultures. Here we investigated in detail the gene expression differences between the tissue of origin and ventral midbrain primary cultures enriched in mDA neurons, using microarray technique. We integrated the results based on different re-annotations of the microarray probes. By using knowledge-based gene network techniques and promoter sequence analysis, we also uncovered mechanisms that might regulate the expression of CNS genes involved in the definition of the identity of specific cell types in the ventral midbrain. We integrate bioinformatics and functional genomics, together with developmental neurobiology. Moreover, we propose guidelines for the computational analysis of microarray gene expression data. Our findings help to clarify some molecular aspects of the development and differentiation of DA neurons within the midbrain.	[Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Volpicelli, Floriana; Leo, Damiana; Perrone-Capano, Carla; di Porzio, Umberto] CNR, Inst Genet & Biophys, Naples, Italy; [Di Lieto, Antonio] Univ Helsinki, Neurosci Ctr, FIN-00014 Helsinki, Finland; [Perrone-Capano, Carla] Univ Naples Federico II, Naples, Italy	University of Helsinki; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Helsinki; University of Naples Federico II	Greco, D (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	dario.greco@helsinki.fi	Auvinen, Petri/AAP-8117-2021; Greco, Dario/T-7113-2019; Perrone-Capano, Carla/O-7708-2015; Auvinen, Petri/D-5044-2009; Perrone-Capano, Carla/AAX-3217-2020	Greco, Dario/0000-0001-9195-9003; Perrone-Capano, Carla/0000-0002-6327-9753; Auvinen, Petri/0000-0002-3947-4778; Perrone-Capano, Carla/0000-0002-6327-9753; di Porzio, Umberto/0000-0002-2139-8754; Leo, Damiana/0000-0001-9219-5498; Volpicelli, Floriana/0000-0003-0618-5504	Institute of Biotechnology, University of Helsinki (Finland); COFIN MIUR/PRIN 2007 (Italy); Suomen Kulttuurirahasto (Finland); Ehrnrooth Foundation (Finland); FEBS [summer fellowship]	Institute of Biotechnology, University of Helsinki (Finland); COFIN MIUR/PRIN 2007 (Italy)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Suomen Kulttuurirahasto (Finland); Ehrnrooth Foundation (Finland); FEBS	This study has been funded by the Institute of Biotechnology, University of Helsinki (Finland) and by COFIN MIUR/PRIN 2007 (Italy). Dario Greco was funded by the Suomen Kulttuurirahasto (Finland) and by the Ehrnrooth Foundation (Finland). Damiana Leo was recipient of a FEBS summer fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Carter SL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-107; Chow S, 2005, EUL DIAGR WORKSH 200; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; DIPORZIO U, 1990, INT J DEV NEUROSCI, V8, P523; DIPORZIO U, 1980, NATURE, V288, P370, DOI 10.1038/288370a0; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hornykiewicz O, 2001, J CHEM NEUROANAT, V22, P3, DOI 10.1016/S0891-0618(01)00100-4; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Lin JC, 2003, SEMIN CELL DEV BIOL, V14, P175, DOI 10.1016/S1084-9521(03)00009-0; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Park CH, 2006, J CELL SCI, V119, P2310, DOI 10.1242/jcs.02955; PARMAN C, 2008, AFFYQCREPORT PACKAGE; Pernas-Alonso R, 1999, BRAIN RES PROTOC, V4, P395, DOI 10.1016/S1385-299X(99)00045-8; Perrone-Capano C, 2008, REND LINCEI-SCI FIS, V19, P271, DOI 10.1007/s12210-008-0019-3; PerroneCapano C, 1996, MOL BRAIN RES, V39, P160, DOI 10.1016/0169-328X(96)00022-8; PERRONECAPANO C, 1994, NEUROREPORT, V5, P1145, DOI 10.1097/00001756-199405000-00031; PROCHIANTZ A, 1979, P NATL ACAD SCI USA, V76, P5387, DOI 10.1073/pnas.76.10.5387; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Sharma N, 2002, NEUROL CLIN, V20, P759, DOI 10.1016/S0733-8619(01)00014-7; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STEEL MC, 1993, MOL PHARMACOL, V43, P694; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Volpicelli F, 2004, J NEUROCHEM, V88, P1283, DOI 10.1046/j.1471-4159.2003.02254.x; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Volpicelli Floriana, 2004, Neural Plasticity, V11, P45, DOI 10.1155/NP.2004.45; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4977	10.1371/journal.pone.0004977	http://dx.doi.org/10.1371/journal.pone.0004977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305503	Green Published, gold			2022-12-25	WOS:000265498800019
J	Scheckhuber, CQ; Grief, J; Boilan, E; Luce, K; Debacq-Chainiaux, F; Rittmeyer, C; Gredilla, R; Kolbesen, BO; Toussaint, O; Osiewacz, HD				Scheckhuber, Christian Q.; Grief, Jurgen; Boilan, Emmanuelle; Luce, Karin; Debacq-Chainiaux, Florence; Rittmeyer, Claudia; Gredilla, Ricardo; Kolbesen, Bernd O.; Toussaint, Olivier; Osiewacz, Heinz D.			Age-Related Cellular Copper Dynamics in the Fungal Ageing Model Podospora anserina and in Ageing Human Fibroblasts	PLOS ONE			English	Article							PLASMID-LIKE DNA; METALLOTHIONEIN GENE; OXIDATIVE STRESS; PRION PROTEIN; LIFE-SPAN; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; TRANSCRIPTION FACTOR; FILAMENTOUS FUNGUS; DELIVERING COPPER	In previous investigations an impact of cellular copper homeostasis on ageing of the ascomycete Podospora anserina has been demonstrated. Here we provide new data indicating that mitochondria play a major role in this process. Determination of copper in the cytosolic fraction using total reflection X-ray fluorescence spectroscopy analysis and eGfp reporter gene studies indicate an age-related increase of cytosolic copper levels. We show that components of the mitochondrial matrix (i.e. eGFP targeted to mitochondria) become released from the organelle during ageing. Decreasing the accessibility of mitochondrial copper in P. anserina via targeting a copper metallothionein to the mitochondrial matrix was found to result in a switch from a copper-dependent cytochrome-c oxidase to a copper-independent alternative oxidase type of respiration and results in lifespan extension. In addition, we demonstrate that increased copper concentrations in the culture medium lead to the appearance of senescence biomarkers in human diploid fibroblasts (HDFs). Significantly, expression of copper-regulated genes is induced during in vitro ageing in medium devoid of excess copper suggesting that cytosolic copper levels also increase during senescence of HDFs. These data suggest that the identified molecular pathway of age-dependent copper dynamics may not be restricted to P. anserina but may be conserved from lower eukaryotes to humans.	[Scheckhuber, Christian Q.; Grief, Jurgen; Luce, Karin; Gredilla, Ricardo; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Boilan, Emmanuelle; Debacq-Chainiaux, Florence; Toussaint, Olivier] Univ Namur, Res Unit Cellular Biol, Namur, Belgium; [Rittmeyer, Claudia; Kolbesen, Bernd O.] Goethe Univ Frankfurt, Inst Inorgan Chem Analyt Chem, D-6000 Frankfurt, Germany	Goethe University Frankfurt; University of Namur; Goethe University Frankfurt	Osiewacz, HD (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	osiewacz@bio.uni-frankfurt.de	Scheckhuber, Christian Q./A-6462-2012; Osiewacz, Heinz D./D-3454-2011	Scheckhuber, Christian Q./0000-0002-2924-7547; GREDILLA, RICARDO/0000-0003-4501-1355; Debacq-Chainiaux, Florence/0000-0003-3949-395X	Deutsche Forschungsgemeinschaft, Bonn, Germany [Os75/7-5]; European Commission [FP6-518230]; Spanish Ministry of Education [postdoctoral fellowship]; Belgian FNRS; Belgian FRIA	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education(Spanish Government); Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian FRIA(Fonds de la Recherche Scientifique - FNRS)	This work is supported by a grant of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, Bonn, Germany, Os75/7-5) and the European Commission (http://erc.europa.eu/, Integrated Project: PROTEOMAGE, Contract No. FP6-518230). R. Gredilla received a postdoctoral fellowship from the Spanish Ministry of Education. O. Toussaint and F. Debacq-Chainiaux are Research Associate and post-doctoral Researcher, respectively, of the Belgian FNRS. E. Boilan receives a fellowship from the Belgian FRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; ARRETZ M, 1994, J BIOL CHEM, V269, P4959; Averbeck NB, 2001, MOL GEN GENET, V264, P604, DOI 10.1007/s004380000346; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x; Debacq-Chainiaux F, 2008, FREE RADICAL BIO MED, V44, P1817, DOI 10.1016/j.freeradbiomed.2008.02.001; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Eliseev RA, 2002, MITOCHONDRION, V1, P361, DOI 10.1016/S1567-7249(01)00039-3; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Greco M, 1998, FEBS LETT, V427, P179, DOI 10.1016/S0014-5793(98)00419-0; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hamann A, 2005, CURR GENET, V48, P270, DOI 10.1007/s00294-005-0018-1; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Himelblau E, 1998, PLANT PHYSIOL, V117, P1227, DOI 10.1104/pp.117.4.1227; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; IGBAVBOA U, 1989, BIOCHEM BIOPH RES CO, V161, P619, DOI 10.1016/0006-291X(89)92644-2; INOUE T, 1993, BIOCHIM BIOPHYS ACTA, V1140, P313, DOI 10.1016/0005-2728(93)90071-M; KARIN M, 1982, NUCLEIC ACIDS RES, V10, P3165, DOI 10.1093/nar/10.10.3165; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; KUCK U, 1981, CURR GENET, V3, P151, DOI 10.1007/BF00365719; Kumar KS, 2005, FEMS MICROBIOL LETT, V242, P45, DOI 10.1016/j.femsle.2004.10.040; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LIAO YCJ, 1986, SCIENCE, V233, P364, DOI 10.1126/science.3014653; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mattie MD, 2004, AM J PHYSIOL-CELL PH, V286, pC293, DOI 10.1152/ajpcell.00293.2003; Mira H, 2002, PLANTA, V214, P939, DOI 10.1007/s00425-001-0706-0; Moraga D, 2005, COMP BIOCHEM PHYS C, V141, P151, DOI 10.1016/j.cca.2005.05.014; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; OSIEWACZ HD, 1984, CURR GENET, V8, P299, DOI 10.1007/BF00419728; OSIEWACZ HD, 1991, APPL MICROBIOL BIOT, V35, P38; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; Pierrel F, 2007, BIOMETALS, V20, P675, DOI 10.1007/s10534-006-9052-9; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; RIZET G, 1953, CR HEBD ACAD SCI, V237, P838; SADHU C, 1989, MOL CELL BIOL, V9, P5738, DOI 10.1128/MCB.9.12.5738; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; SCHULTE E, 1988, MOL GEN GENET, V211, P342, DOI 10.1007/BF00330614; Song MO, 2005, MOL CELL BIOCHEM, V279, P141, DOI 10.1007/s11010-005-8286-0; STAHL U, 1982, P NATL ACAD SCI-BIOL, V79, P3641, DOI 10.1073/pnas.79.11.3641; STAHL U, 1978, MOL GEN GENET, V162, P341, DOI 10.1007/BF00268860; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Treiber Carina, 2008, V459, P161, DOI 10.1007/978-1-59745-234-2_12; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Varela-Nallar L, 2006, AM J PHYSIOL-CELL PH, V290, pC271, DOI 10.1152/ajpcell.00160.2005; Wittershagen A, 1997, SPECTROCHIM ACTA B, V52, P1033, DOI 10.1016/S0584-8547(96)01639-4; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Zickermann V, 1997, BIOCHEMISTRY-US, V36, P3232, DOI 10.1021/bi962040e; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	82	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4919	10.1371/journal.pone.0004919	http://dx.doi.org/10.1371/journal.pone.0004919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305496	Green Published, Green Submitted, gold			2022-12-25	WOS:000265498800003
J	Taylor, AR				Taylor, Alison R.			A Fast Na+/Ca2+-Based Action Potential in a Marine Diatom	PLOS ONE			English	Article								Background: Electrical impulses in animals play essential roles in co-ordinating an array of physiological functions including movement, secretion, environmental sensing and development. Underpinning many of these electrical signals is a fast Na+-based action potential that has been fully characterised only in cells associated with the neuromuscular systems of multicellular animals. Such rapid action potentials are thought to have evolved with the first metazoans, with cnidarians being the earliest representatives. The present study demonstrates that a unicellular protist, the marine diatom Odontella sinensis, can also generate a fast Na+/Ca2+ based action potential that has remarkably similar biophysical and pharmacological properties to invertebrates and vertebrate cardiac and skeletal muscle cells. Methodology/Principal Findings: The kinetic, ionic and pharmacological properties of the rapid diatom action potential were examined using single electrode current and voltage clamp techniques. Overall, the characteristics of the fast diatom currents most closely resemble those of vertebrate and invertebrate muscle Na+/Ca2+ currents. Conclusions/Significance: This is the first demonstration of voltage-activated Na+ channels and the capacity to generate fast Na+-based action potentials in a unicellular photosynthetic organism. The biophysical and pharmacological characteristics together with the presence of a voltage activated Na+/Ca2+ channel homologue in the recently sequenced genome of the diatom Thalassiosira pseudonana, provides direct evidence supporting the hypothesis that this rapid signalling mechanism arose in ancestral unicellular eukaryotes and has been retained in at least two phylogenetically distant lineages of eukaryotes; opisthokonts and the stramenopiles. The functional role of the fast animal-like action potential in diatoms remains to be elucidated but is likely involved in rapid environmental sensing of these widespread and successful marine protists.	[Taylor, Alison R.] Marine Biol Assoc UK, Plymouth, Devon, England; [Taylor, Alison R.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC USA	Marine Biological Association United Kingdom; University of North Carolina; University of North Carolina Wilmington	Taylor, AR (corresponding author), Marine Biol Assoc UK, Citadel Hill, Plymouth, Devon, England.	taylora@uncw.edu		Berger, Frederic/0000-0002-3609-8260	Marine Biological Association of the UK [Fellowship]; Natural and Environmental Research Council UK; Biotechnology and Biological Sciences Research Council UK; EU Framework 6 [512035]	Marine Biological Association of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural and Environmental Research Council UK; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Framework 6	ART acknowledges a Marine Biological Association of the UK Fellowship and financial support from both the Natural and Environmental Research Council UK and Biotechnology and Biological Sciences Research Council UK. This paper represents a contribution to the objectives of the Diatomics consortium, a specific targeted research project supported by EU Framework 6 funding (EU contract number 512035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PAV, 1987, J EXP BIOL, V133, P231; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BADEN DG, 1989, FASEB J, V3, P1807, DOI 10.1096/fasebj.3.7.2565840; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BEILBY MJ, 1982, PHILOS T ROY SOC B, V299, P435, DOI 10.1098/rstb.1982.0142; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Boyd CM, 1999, J EXP BOT, V50, P445, DOI 10.1093/jexbot/50.333.445; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Davey MS, 2003, J PHYCOL, V39, P1132, DOI 10.1111/j.0022-3646.2003.02-200.x; ECKERT R, 1979, ANNU REV BIOPHYS BIO, V8, P353, DOI 10.1146/annurev.bb.08.060179.002033; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; FEBVRECHEVALIER C, 1986, J EXP BIOL, V122, P177; FROMM J, 1994, J EXP BOT, V45, P463, DOI 10.1093/jxb/45.4.463; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 2002, J EXP BIOL, V205, P575; Gradmann D, 2000, J MEMBRANE BIOL, V175, P149, DOI 10.1007/s002320001063; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Kuo CC, 2004, J GEN PHYSIOL, V124, P27, DOI 10.1085/jgp.200409054; Li WI, 2001, P NATL ACAD SCI USA, V98, P7599, DOI 10.1073/pnas.121085898; LUNEVSKY VZ, 1983, J MEMBRANE BIOL, V72, P43, DOI 10.1007/BF01870313; Makita N, 1997, PROTOPLASMA, V197, P86, DOI 10.1007/BF01279887; OAMI K, 1995, J COMP PHYSIOL A, V176, P635, DOI 10.1007/BF01021583; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Stahlberg R, 1997, PLANT PHYSIOL, V113, P209, DOI 10.1104/pp.113.1.209; Taylor AR, 2003, PLANT PHYSIOL, V131, P1391, DOI 10.1104/pp.011791; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; PROTEIN ID 2207	34	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4966	10.1371/journal.pone.0004966	http://dx.doi.org/10.1371/journal.pone.0004966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305505	Green Published, Green Submitted, gold			2022-12-25	WOS:000265498800014
J	Rosset, MB; Sacquin, A; Lecollinet, S; Chaigneau, T; Adam, M; Crespeau, F; Eloit, M				Rosset, Martine Bruley; Sacquin, Antoine; Lecollinet, Sylvie; Chaigneau, Thomas; Adam, Micheline; Crespeau, Francois; Eloit, Marc			Dendritic Cell-Mediated-Immunization with Xenogenic PrP and Adenoviral Vectors Breaks Tolerance and Prolongs Mice Survival against Experimental Scrapie	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; HUMORAL IMMUNE-RESPONSE; PRION PROTEIN-PEPTIDES; WILD-TYPE MICE; T-CELLS; MONOCLONAL-ANTIBODIES; VACCINATION; REPLICATION; INDUCTION; INHIBIT	In prion diseases, PrPc, a widely expressed protein, is transformed into a pathogenic form called PrPSc, which is in itself infectious. Antibodies directed against PrPc have been shown to inhibit PrPc to PrPSc conversion in vitro and protect in vivo from disease. Other effectors with potential to eliminate PrPSc-producing cells are cytotoxic T cells directed against PrP-derived peptides but their ability to protect or to induce deleterious autoimmune reactions is not known. The natural tolerance to PrPc makes difficult to raise efficient adaptive responses. To break tolerance, adenovirus (Ad) encoding human PrP (hPrP) or control Ad were administered to wild-type mice by direct injection or by transfer of Ad-transduced dendritic cells (DCs). Control Ad-transduced DCs from Tg650 mice overexpressing hPrP were also used for immunization. DC-mediated but not direct administration of AdhPrP elicited antibodies that bound to murine native PrPc. Frequencies of PrP-specific IFN gamma-secreting T cells were low and in vivo lytic activity only targeted cells strongly expressing hPrP. Immunohistochemical analysis revealed that CD3(+) T cell infiltration was similar in the brain of vaccinated and unvaccinated 139A-infected mice suggesting the absence of autoimmune reactions. Early splenic PrPSc replication was strongly inhibited ten weeks post infection and mean survival time prolonged from 209 days in untreated 139A-infected mice to 246 days in mice vaccinated with DCs expressing the hPrP. The efficacy appeared to be associated with antibody but not with cytotoxic cell-mediated PrP-specific responses.	[Rosset, Martine Bruley; Sacquin, Antoine; Chaigneau, Thomas] INSERM, UMR 938, Paris, France; [Rosset, Martine Bruley; Sacquin, Antoine; Chaigneau, Thomas] Univ Paris 06, Med Ctr, Hop St Antoine, F-75252 Paris, France; [Lecollinet, Sylvie; Adam, Micheline; Eloit, Marc] Ecole Natl Vet Alfort, AFSSA, INRA, UMR1161 Virol, Maisons Alfort, France; [Crespeau, Francois] Ecole Natl Vet Alfort, Lab Anatomopathol, Maisons Alfort, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA)	Rosset, MB (corresponding author), INSERM, UMR 938, Paris, France.	martine.rosset@inserm.fr	Lecollinet, Sylvie/M-1728-2019; sacquin, Antoine/M-5532-2014; Lecollinet, Sylvie/AAV-5276-2021	Lecollinet, Sylvie/0000-0001-8535-2133	INSERM; Neuroprion network of excellence, European FP6; France Alzheimer Association [PhD fellowship]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Neuroprion network of excellence, European FP6; France Alzheimer Association	This work was supported by funds from INSERM and the Neuroprion network of excellence, European FP6. Antoine Sacquin received a PhD fellowship from "France Alzheimer Association". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrabal S, 2001, BIOCHEM BIOPH RES CO, V285, P623, DOI 10.1006/bbrc.2001.5208; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Bade S, 2006, VACCINE, V24, P1242, DOI 10.1016/j.vaccine.2005.12.051; Ballerini C, 2006, J IMMUNOL, V176, P7254, DOI 10.4049/jimmunol.176.12.7254; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; del Hoyo GM, 2006, J IMMUNOL, V177, P6137, DOI 10.4049/jimmunol.177.9.6137; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fernandez-Borges N, 2006, J VIROL, V80, P9970, DOI 10.1128/JVI.01210-06; Gilch S, 2003, J BIOL CHEM, V278, P18524, DOI 10.1074/jbc.M210723200; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; Gregoire S, 2005, J IMMUNOL, V175, P6443, DOI 10.4049/jimmunol.175.10.6443; Gregoire S, 2004, J LEUKOCYTE BIOL, V76, P125, DOI 10.1189/jlb.1203656; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Handisurya A, 2007, FEBS J, V274, P1747, DOI 10.1111/j.1742-4658.2007.05721.x; Hensley SE, 2005, J IMMUNOL, V175, P6032, DOI 10.4049/jimmunol.175.9.6032; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Holdener M, 2008, J EXP MED, V205, P1409, DOI 10.1084/jem.20071859; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Ishibashi D, 2007, VACCINE, V25, P985, DOI 10.1016/j.vaccine.2006.09.078; Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Levavasseur E, 2007, J GEN VIROL, V88, P2353, DOI 10.1099/vir.0.82816-0; Lewicki H, 2003, J VIROL, V77, P3799, DOI 10.1128/JVI.77.6.3799-3808.2003; Lotscher M, 2003, J IMMUNOL, V170, P6040, DOI 10.4049/jimmunol.170.12.6040; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Magri G, 2005, VACCINE, V23, P2862, DOI 10.1016/j.vaccine.2004.11.067; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mennuni C, 2005, INT J CANCER, V117, P444, DOI 10.1002/ijc.21188; Nikles D, 2005, J VIROL, V79, P4033, DOI 10.1128/JVI.79.7.4033-4042.2005; Nitschke C, 2007, VET MICROBIOL, V123, P367, DOI 10.1016/j.vetmic.2007.03.032; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PORTER DD, 1973, J IMMUNOL, V111, P1407; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rosset MB, 2004, J IMMUNOL, V172, P5168, DOI 10.4049/jimmunol.172.9.5168; Sacquin A, 2008, J IMMUNOL, V181, P768, DOI 10.4049/jimmunol.181.1.768; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Shibagaki N, 2002, J IMMUNOL, V168, P2393, DOI 10.4049/jimmunol.168.5.2393; Tal Y, 2003, J NEUROSCI RES, V71, P286, DOI 10.1002/jnr.10474; TANG Y, 2008, BLOOD, V104, P2704; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Xiang M, 2006, VIRAL IMMUNOL, V19, P210, DOI 10.1089/vim.2006.19.210; Yamanaka H, 2006, VACCINE, V24, P2815, DOI 10.1016/j.vaccine.2005.12.054; Yang TC, 2007, EXPERT REV VACCINES, V6, P347, DOI 10.1586/14760584.6.3.347	54	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4917	10.1371/journal.pone.0004917	http://dx.doi.org/10.1371/journal.pone.0004917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295917	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496700007
J	Weyermann, P; Dallmann, R; Magyar, J; Anklin, C; Hufschmid, M; Dubach-Powell, J; Courdier-Fruh, I; Hennebohle, M; Nordhoff, S; Mondadori, C				Weyermann, Philipp; Dallmann, Robert; Magyar, Josef; Anklin, Corinne; Hufschmid, Martina; Dubach-Powell, Judith; Courdier-Fruh, Isabelle; Henneboehle, Marco; Nordhoff, Sonja; Mondadori, Cesare			Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice	PLOS ONE			English	Article								Background: Cachexia is among the most debilitating and life-threatening aspects of cancer. It represents a metabolic syndrome affecting essential functional circuits involved in the regulation of homeostasis, and includes anorexia, fat and muscle tissue wasting. The anorexigenic peptide alpha-MSH is believed to be crucially involved in the normal and pathologic regulation of food intake. It was speculated that blockade of its central physiological target, the melanocortin (MC)-4 receptor, might provide a promising anti-cachexia treatment strategy. This idea is supported by the fact that in animal studies, agouti-related protein (AgRP), the endogenous inverse agonist at the MC-4 receptor, was found to affect two hallmark features of cachexia, i.e. to increase food intake and to reduce energy expenditure. Methodology/Principal Findings: SNT207707 and SNT209858 are two recently discovered, non peptidic, chemically unrelated, orally active MC-4 receptor antagonists penetrating the blood brain barrier. Both compounds were found to distinctly increase food intake in healthy mice. Moreover, in mice subcutaneously implanted with C26 adenocarcinoma cells, repeated oral administration (starting the day after tumor implantation) of each of the two compounds almost completely prevented tumor induced weight loss, and diminished loss of lean body mass and fat mass. Conclusions/Significance: In contrast to the previously reported peptidic and small molecule MC-4 antagonists, the compounds described here work by the oral administration route. Orally active compounds might offer a considerable advantage for the treatment of cachexia patients.	[Weyermann, Philipp; Dallmann, Robert; Magyar, Josef; Anklin, Corinne; Hufschmid, Martina; Dubach-Powell, Judith; Courdier-Fruh, Isabelle; Henneboehle, Marco; Nordhoff, Sonja; Mondadori, Cesare] Santhera Pharmaceut Switzerland Ltd, Liestal, Switzerland		Weyermann, P (corresponding author), Santhera Pharmaceut Switzerland Ltd, Liestal, Switzerland.	philipp.weyermann@santhera.com	Dallmann, Bob/AAA-4929-2022	Dallmann, Robert/0000-0002-7490-0218	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd. funded and approved the publication of this work.	Argiles JM, 2008, DRUG DISCOV TODAY, V13, P73, DOI 10.1016/j.drudis.2007.10.008; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Chen C, 2008, BIOORGAN MED CHEM, V16, P5606, DOI 10.1016/j.bmc.2008.03.072; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Foster AC, 2005, IDRUGS, V8, P314; Foster AC, 2007, CURR TOP MED CHEM, V7, P1131; Frost RA, 2005, CURR OPIN CLIN NUTR, V8, P255, DOI 10.1097/01.mco.0000165003.16578.2d; Heinrichs SC, 2001, BEHAV BRAIN RES, V125, P81, DOI 10.1016/S0166-4328(01)00287-X; Hoggard N, 2004, J MOL ENDOCRINOL, V33, P693, DOI 10.1677/jme.1.01632; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Joppa MA, 2005, PEPTIDES, V26, P2294, DOI 10.1016/j.peptides.2005.03.002; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Laviano A, 1996, NUTRITION, V12, P358, DOI 10.1016/S0899-9007(96)80061-X; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mak RH, 2006, PEDIATR NEPHROL, V21, P1807, DOI 10.1007/s00467-006-0194-3; Markison S, 2005, ENDOCRINOLOGY, V146, P2766, DOI 10.1210/en.2005-0142; Marks DL, 2001, CANCER RES, V61, P1432; Nicholson JR, 2006, J PHARMACOL EXP THER, V317, P771, DOI 10.1124/jpet.105.097725; O'Riordain MG, 1999, INT J ONCOL, V15, P823; Plauth M, 2002, INT J CARDIOL, V85, P83, DOI 10.1016/S0167-5273(02)00236-X; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; Santhera Pharmaceuticals (Switzerland) AG, 2009, Subsituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators, Patent No. [WO 2009/010299 A1, 2009010299]; Santhera Pharmaceuticals (Switzerland) AG, 2008, Preparation of imidazopyridines as melanocortin-4 receptor antagonists, Patent No. [WO 2008/116665 A1, 2008116665]; Scarlett JM, 2005, EXPERT OPIN INV DRUG, V14, P1233, DOI 10.1517/13543784.14.10.1233; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Trayhurn P, 2006, PHILOS T R SOC B, V361, P1237, DOI 10.1098/rstb.2006.1859; Tung YCL, 2006, ENDOCRINOLOGY, V147, P5940, DOI 10.1210/en.2006-0866; Vos TJ, 2004, J MED CHEM, V47, P1602, DOI 10.1021/jm034244g; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6	34	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4774	10.1371/journal.pone.0004774	http://dx.doi.org/10.1371/journal.pone.0004774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295909	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496700001
J	Huang, P; Zhao, XYS; Fields, M; Ransohoff, RM; Zhou, L				Huang, Ping; Zhao, Xinyu S.; Fields, Matthew; Ransohoff, Richard M.; Zhou, Lan			Imatinib attenuates skeletal muscle dystrophy in mdx mice	FASEB JOURNAL			English	Article						necrosis; inflammation; fibrosis; c-abl; TGF-beta; PDGF	DUCHENNE MUSCULAR-DYSTROPHY; MESSENGER-RNA EXPRESSION; GROWTH-FACTOR; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; INFLAMMATORY RESPONSE; KINASE INHIBITOR; LIVER FIBROSIS; IN-VITRO; MOUSE	Duchenne-Meryon muscular dystrophy (DMD) is the most common and lethal genetic muscle disease. Ameliorating muscle necrosis, inflammation, and fibrosis represents an important therapeutic approach for DMD. Imatinib, an antineoplastic agent, demonstrated antiinflammatory and antifibrotic effects in liver, kidney, lung, and skin of various animal models. This study tested antiinflammatory and antifibrotic effects of imatinib in mdx mice, a DMD mouse model. We treated mdx mice with intraperitoneal injections of imatinib at the peak of limb muscle inflammation and the onset of diaphragm fibrosis. Controls received PBS vehicle or were left untreated. Muscle necrosis, inflammation, fibrosis, and function were evaluated by measuring serum CK activity, endomysial CD45 immunoreactive inflammation area, endomysial collagen III deposition, and hind limb grip strength. Phosphorylation of the tyrosine kinase targets of imatinib was assessed by Western blot in diaphragm tissue and in primary cultures of peritoneal macrophages and skeletal muscle fibroblasts. Imatinib markedly reduced muscle necrosis, inflammation, and fibrosis, and significantly improved hind limb grip strength in mdx mice. Reduced clinical disease was accompanied by inhibition of c-abl and PDGFR phosphorylation and suppression of TNF-alpha and IL-1 beta expression. Imatinib therapy for DMD may hold promise for ameliorating muscle necrosis, inflammation, and fibrosis by inhibiting c-abl and PDGFR signaling pathways and downstream inflammatory cytokine and fibrotic gene expression.-Huang, P., Zhao, X. S., Fields, M., Ransohoff, R. M., Zhou, L. Imatinib attenuates skeletal muscle dystrophy in mdx mice. FASEB J. 23, 2539-2548 (2009)	[Zhou, Lan] Cleveland Clin, Dept Neurol, Neurol Inst,Dept Neurosci, Lerner Res Inst,Neuroinflammat Res Ctr, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Zhou, L (corresponding author), Cleveland Clin, Dept Neurol, Neurol Inst,Dept Neurosci, Lerner Res Inst,Neuroinflammat Res Ctr, 9500 Euclid Ave,S90, Cleveland, OH 44195 USA.	zhoul2@ccf.org			NIH [K08 NS049346, K24 NS51400]; MDA [91682]; The Frankino Charity Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS049346, K24NS051400] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA(Muscular Dystrophy Association); The Frankino Charity Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants K08 NS049346 (L. Z.), and K24 NS51400 (R. M. R.), MDA ( award 91682) (L. Z.), and The Frankino Charity Foundation (L. Z.). We thank our statistician, Dr. Jianbo Li, for his assistance in statistical analysis.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Andreetta F, 2006, J NEUROIMMUNOL, V175, P77, DOI 10.1016/j.jneuroim.2006.03.005; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bueso-Ramos CE, 2004, CANCER-AM CANCER SOC, V101, P332, DOI 10.1002/cncr.20380; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; CULLEN MJ, 1988, ACTA NEUROPATHOL, V77, P69, DOI 10.1007/BF00688245; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Dewar AL, 2005, IMMUNOL CELL BIOL, V83, P48, DOI 10.1111/j.1440-1711.2004.01296.x; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Gonzalo T, 2007, J PHARMACOL EXP THER, V321, P856, DOI 10.1124/jpet.106.114496; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; HOPPE G, 1994, J CLIN INVEST, V94, P1506, DOI 10.1172/JCI117490; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Liu LP, 2006, J IMMUNOL, V176, P4399, DOI 10.4049/jimmunol.176.7.4399; Melone MAB, 2000, J CELL PHYSIOL, V185, P143, DOI 10.1002/1097-4652(200010)185:1<143::AID-JCP14>3.0.CO;2-U; Sadanaga A, 2005, ARTHRITIS RHEUM-US, V52, P3987, DOI 10.1002/art.21424; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; TIDBALL JG, 1992, EXP CELL RES, V203, P141, DOI 10.1016/0014-4827(92)90049-E; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wolf AM, 2005, P NATL ACAD SCI USA, V102, P13622, DOI 10.1073/pnas.0501758102; Yoshiji H, 2005, AM J PHYSIOL-GASTR L, V288, pG907, DOI 10.1152/ajpgi.00420.2004; Zhao YJ, 2003, J PATHOL, V201, P149, DOI 10.1002/path.1414; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029; Zoja C, 2006, KIDNEY INT, V70, P97, DOI 10.1038/sj.ki.5001528	37	77	83	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2539	2548		10.1096/fj.09-129833	http://dx.doi.org/10.1096/fj.09-129833			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19289603	Green Published			2022-12-25	WOS:000268836700022
J	James, SJ; Rose, S; Melnyk, S; Jernigan, S; Blossom, S; Pavliv, O; Gaylor, DW				James, S. Jill; Rose, Shannon; Melnyk, Stepan; Jernigan, Stefanie; Blossom, Sarah; Pavliv, Oleksandra; Gaylor, David W.			Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism	FASEB JOURNAL			English	Article						autistic disorder; oxidative stress; nitric oxide	COULOMETRIC ELECTROCHEMICAL DETECTION; INCREASED OXIDATIVE STRESS; NITRIC-OXIDE; PATHOPHYSIOLOGICAL MECHANISMS; NEURODEGENERATIVE DISEASES; SPECTRUM DISORDERS; NITROSATIVE STRESS; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; BIPOLAR DISORDER	Research into the metabolic phenotype of autism has been relatively unexplored despite the fact that metabolic abnormalities have been implicated in the pathophysiology of several other neurobehavioral disorders. Plasma biomarkers of oxidative stress have been reported in autistic children; however, intracellular redox status has not yet been evaluated. Lymphoblastoid cells (LCLs) derived from autistic children and unaffected controls were used to assess relative concentrations of reduced glutathione (GSH) and oxidized disulfide glutathione (GSSG) in cell extracts and isolated mitochondria as a measure of intracellular redox capacity. The results indicated that the GSH/GSSG redox ratio was decreased and percentage oxidized glutathione increased in both cytosol and mitochondria in the autism LCLs. Exposure to oxidative stress via the sulfhydryl reagent thimerosal resulted in a greater decrease in the GSH/GSSG ratio and increase in free radical generation in autism compared to control cells. Acute exposure to physiological levels of nitric oxide decreased mitochondrial membrane potential to a greater extent in the autism LCLs, although GSH/GSSG and ATP concentrations were similarly decreased in both cell lines. These results suggest that the autism LCLs exhibit a reduced glutathione reserve capacity in both cytosol and mitochondria that may compromise antioxidant defense and detoxification capacity under prooxidant conditions.-James, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S., Pavliv, O., Gaylor, D. W. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J. 23, 2374-2383 (2009)	[James, S. Jill; Rose, Shannon; Melnyk, Stepan; Jernigan, Stefanie; Blossom, Sarah; Pavliv, Oleksandra] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Res Inst, Dept Pediat, Little Rock, AR 72202 USA; [Gaylor, David W.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Res Inst, Dept Biostat, Little Rock, AR 72202 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	James, SJ (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Hosp, Res Inst, Dept Pediat, 1120 Marshall St,Slot 512-41 B, Little Rock, AR 72202 USA.	jamesjill@uams.edu	Blossom, Sarah/AAG-2852-2019	Blossom, Sarah/0000-0003-3110-4577; Rose, Shannon/0000-0003-0595-4367	National Institute of Child Health and Human Development [RO1 HD051873]; Safeminds, Inc.; Arkansas Biosciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051873] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Safeminds, Inc.; Arkansas Biosciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the many autism families that participated in the Autism Genetic Research Exchange program. This research was supported, in part, with funding from the National Institute of Child Health and Human Development (RO1 HD051873) to S.J.J., and by grants from Safeminds, Inc., and the Arkansas Biosciences Institute (S.J.J.).	Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Antunes F, 2007, ANTIOXID REDOX SIGN, V9, P1569, DOI 10.1089/ars.2007.1677; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aw TY, 2003, NEWS PHYSIOL SCI, V18, P201, DOI 10.1152/nips.01448.2003; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Baldelli S, 2008, INT J BIOCHEM CELL B, V40, P2660, DOI 10.1016/j.biocel.2008.05.013; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; Berendji D, 1999, FREE RADICAL BIO MED, V27, P773, DOI 10.1016/S0891-5849(99)00123-9; Berk M, 2008, BIOL PSYCHIAT, V64, P468, DOI 10.1016/j.biopsych.2008.04.022; Beversdorf DQ, 2007, J AUTISM DEV DISORD, V37, P1040, DOI 10.1007/s10803-006-0242-7; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; Boso M, 2006, NEUROSCI LETT, V410, P169, DOI 10.1016/j.neulet.2006.08.092; Brorson JR, 1999, J NEUROSCI, V19, P147, DOI 10.1523/JNEUROSCI.19-01-00147.1999; Brorson JR, 1997, J NEUROCHEM, V68, P95; BUTTKE TM, 1995, FREE RADICAL RES, V22, P389, DOI 10.3109/10715769509147548; Cao ZX, 2004, BIOCHEM BIOPH RES CO, V316, P1043, DOI 10.1016/j.bbrc.2004.02.156; Cecchi C, 1999, NEUROSCI LETT, V275, P152, DOI 10.1016/S0304-3940(99)00751-X; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chugani DC, 1999, PROG NEURO-PSYCHOPH, V23, P635, DOI 10.1016/S0278-5846(99)00022-6; COLEMAN M, 1985, J AUTISM DEV DISORD, V15, P1, DOI 10.1007/BF01837894; Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6; DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; EKLOW L, 1981, FEBS LETT, V127, P125, DOI 10.1016/0014-5793(81)80357-2; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; James SJ, 2005, NEUROTOXICOLOGY, V26, P1, DOI 10.1016/j.neuro.2004.07.012; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111; LASZLO A, 1994, CLIN CHIM ACTA, V229, P205, DOI 10.1016/0009-8981(94)90243-7; Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336; Lenton KJ, 1999, ANAL BIOCHEM, V274, P125, DOI 10.1006/abio.1999.4258; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Lombard J, 1998, MED HYPOTHESES, V50, P497, DOI 10.1016/S0306-9877(98)90270-5; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Makani S, 2002, GENES IMMUN, V3, P270, DOI 10.1038/sj.gene.6363854; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Noble M, 2003, ANN NY ACAD SCI, V991, P251; OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Pani G, 2000, IUBMB LIFE, V49, P381; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Poling JS, 2006, J CHILD NEUROL, V21, P170, DOI 10.1177/08830738060210021401; Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quiroz JA, 2008, NEUROPSYCHOPHARMACOL, V33, P2551, DOI 10.1038/sj.npp.1301671; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Serra JA, 2001, J NEURAL TRANSM, V108, P1135, DOI 10.1007/s007020170003; Sogut S, 2003, CLIN CHIM ACTA, V331, P111, DOI 10.1016/S0009-8981(03)00119-0; Takabayashi A, 2000, ANTIOXID REDOX SIGN, V2, P673, DOI 10.1089/ars.2000.2.4-673; Tsao CY, 2007, J CHILD NEUROL, V22, P1121, DOI 10.1177/0883073807306266; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yorbik O, 2002, PROSTAG LEUKOTR ESS, V67, P341, DOI 10.1054/plef.2002.0439; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7; Zoroglu SS, 2003, CELL BIOCHEM FUNCT, V21, P55, DOI 10.1002/cbf.989	87	155	160	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2374	2383		10.1096/fj.08-128926	http://dx.doi.org/10.1096/fj.08-128926			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19307255	Green Published			2022-12-25	WOS:000268836700006
J	Moroy, G; Martin, E; Dejaegere, A; Stote, RH				Moroy, Gautier; Martin, Elyette; Dejaegere, Annick; Stote, Roland H.			Molecular Basis for Bcl-2 Homology 3 Domain Recognition in the Bcl-2 Protein Family IDENTIFICATION OF CONSERVED HOT SPOT INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY DECOMPOSITION; PEPTIDE COMPLEX; ANTISENSE BCL-2; BH3-ONLY PROTEINS; BINDING-ENERGY; FORCE-FIELDS; BH4 DOMAIN; CLUSTAL-W; DYNAMICS; SENSITIVITY	The proteins of the Bcl-2 family are important regulators of apoptosis, or programmed cell death. These proteins regulate this fundamental biological process via the formation of heterodimers involving both pro- and anti-apoptotic family members. Disruption of the balance between anti- and pro- apoptotic Bcl-2 proteins is the cause of numerous pathologies. Bcl-xl, an anti- apoptotic protein of this family, is known to form heterodimers with multiple pro- apoptotic proteins, such as Bad, Bim, Bak, and Bid. To elucidate the molecular basis of this recognition process, we used molecular dynamics simulations coupled with the Molecular Mechanics/Poisson-Boltzmann Surface Area approach to identify the amino acids that make significant energetic contributions to the binding free energy of four complexes formed between Bcl-xl and pro- apoptotic Bcl-2 homology 3 peptides. A fifth protein-peptide complex composed of another anti- apoptotic protein, Bcl-w, in complex with the peptide from Bim was also studied. The results identified amino acids of both the anti- apoptotic proteins as well as the Bcl-2 homology 3 (BH3) domains of the pro- apoptotic proteins that make strong, recurrent interactions in the protein complexes. The calculations show that the two anti- apoptotic proteins, Bcl-xl and Bcl-w, share a similar recognition mechanism. Our results provide insight into the molecular basis for the promiscuous nature of this molecular recognition process by members of the Bcl-2 protein family. These amino acids could be targeted in the design of new mimetics that serve as scaffolds for dew antitumoral molecules.	[Martin, Elyette; Dejaegere, Annick; Stote, Roland H.] Univ Strasbourg, Dept Biol & Genom Struct, CNRS INSERM ULP, UMR 7104,IGBMC, F-67404 Illkirch Graffenstaden, France; [Moroy, Gautier; Martin, Elyette; Stote, Roland H.] Univ Strasbourg, UMR 7177, Inst Chim, Mol Biophys Lab, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Stote, RH (corresponding author), Univ Strasbourg, Dept Biol & Genom Struct, CNRS INSERM ULP, UMR 7104,IGBMC, F-67404 Illkirch Graffenstaden, France.	rstote@igbmc.fr	Moroy, Gautier/AAT-1608-2020	Moroy, Gautier/0000-0002-8973-0477	Universite de Strasbourg; CNRS; INSERM; Agence Nationale de la Recherche	Universite de Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Universite de Strasbourg, CNRS, INSERM, and the Agence Nationale de la Recherche.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Browning C, 2007, J BIOL CHEM, V282, P32924, DOI 10.1074/jbc.M705559200; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CRUZREYES J, 1995, GENE, V158, P171, DOI 10.1016/0378-1119(95)00159-4; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Doshi JM, 2006, J MED CHEM, V49, P7731, DOI 10.1021/jm060968r; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; IORGENSEN WL, 1983, J CHEM PHYS, V79, P926; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2177, DOI 10.1002/cncr.20636; Kim R, 2005, CANCER-AM CANCER SOC, V103, P2199, DOI 10.1002/cncr.21029; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Reynolds CH, 2007, BIOORG MED CHEM LETT, V17, P4258, DOI 10.1016/j.bmcl.2007.05.038; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Sadowsky JD, 2005, J AM CHEM SOC, V127, P11966, DOI 10.1021/ja053678t; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schaefer M, 1998, ADV PROTEIN CHEM, V51, P1; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sorenson CM, 2004, J BIOL CHEM, V279, P11368, DOI 10.1074/jbc.M310079200; Spiegel M.R., 1975, SCHAUMS OUTLINE SERI; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tanabe K, 2003, INT J ONCOL, V22, P875; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vorobjev YN, 1998, PROTEINS, V32, P399, DOI 10.1002/(SICI)1097-0134(19980901)32:4<399::AID-PROT1>3.0.CO;2-C; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	64	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17499	17511		10.1074/jbc.M805542200	http://dx.doi.org/10.1074/jbc.M805542200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19293158	hybrid, Green Published			2022-12-25	WOS:000267202500016
J	Green, LA; Liu, Y; He, JJ				Green, Linden A.; Liu, Ying; He, Johnny J.			Inhibition of HIV-1 Infection and Replication by Enhancing Viral Incorporation of Innate Anti-HIV-1 Protein A3G A NON-PATHOGENIC Nef MUTANT-BASED ANTI-HIV STRATEGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-SURFACE CD4; DOWN-REGULATION; TYPE-1 NEF; RHESUS MACAQUES; ENZYME APOBEC3G; VIF PROTEIN; PARTICLES; ACTIVATION; IDENTIFICATION	APOBEC3G (A3G) is a cellular protein that has been identified as an innate anti-human immunodeficiency virus type 1 (HIV-1) factor. One of the major functions of HIV-1 virion infectivity protein (Vif) protein is to target A3G for ubiquitination/proteasome-mediated degradation and, as a result, evade the host innate defense mechanism. Thus, we wished to devise a strategy to restore the anti-HIV activity of A3G by actively targeting it into HIV-1 virions and countering HIV-1 Vif-targeted degradation. In the current study we performed a series of proof-of-concept experiments for this strategy using as a delivery vehicle of A3G, a derivate of non-pathogenic Nef mutant Nef7 that is capable of being efficiently incorporated into HIV-1 virions. We demonstrate that the Nef7. A3G fusion protein retains several important properties of Nef7; that is, the higher virion incorporation efficiency, no PAK-2 (p21-activated kinase 2) activation, and no CD4 and major histocompatibility complex I down-regulation. Meanwhile, we show that virion incorporated Nef7. A3G possesses the anti-HIV infectivity function of A3G. Moreover, we show that virus-like particle-mediated inverse fusion delivery of Nef7. A3G into HIV-infected CD4+ T lymphocytes leads to potent inhibition of HIV-1 replication in these cells. Taken together, these results indicate that Nef7. A3G can effectively restrict HIV infection and replication by restoring the virion incorporation of A3G, even in the presence of Vif.	[He, Johnny J.] Indiana Univ, Sch Med, Ctr AIDS Res, Indianapolis, IN 46202 USA; [Green, Linden A.; Liu, Ying; He, Johnny J.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [He, Johnny J.] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; [He, Johnny J.] Walther Canc Inst, Indianapolis, IN 46206 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	He, JJ (corresponding author), Indiana Univ, Sch Med, Ctr AIDS Res, R2 302,950 W Walnut St, Indianapolis, IN 46202 USA.	jjhe@iupui.edu			National Institutes of Health [R01NS039804, R21DA022986, R21DA025487]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025487, R21DA022986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS039804, R21DA022986, and R21DA025487 (to J. J. H.).	Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Crotti A, 2006, J VIROL, V80, P10663, DOI 10.1128/JVI.02621-05; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; D'Aloja P, 1998, J VIROL, V72, P4308; D'Aloja P, 2001, J GEN VIROL, V82, P2735, DOI 10.1099/0022-1317-82-11-2735; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Endres MJ, 1997, SCIENCE, V278, P1462, DOI 10.1126/science.278.5342.1462; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; Hua J, 1997, J VIROL, V71, P6742, DOI 10.1128/JVI.71.9.6742-6748.1997; Hua J, 1997, VIROLOGY, V231, P231, DOI 10.1006/viro.1997.8517; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; JAMIESON BD, 1994, J VIROL, V68, P3478, DOI 10.1128/JVI.68.6.3478-3485.1994; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khan IH, 1998, J VIROL, V72, P5820, DOI 10.1128/JVI.72.7.5820-5830.1998; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Peretti S, 2006, VIROLOGY, V345, P115, DOI 10.1016/j.virol.2005.09.054; Peretti S, 2005, MOL THER, V12, P1185, DOI 10.1016/j.ymthe.2005.06.474; Qi ML, 2008, VIROLOGY, V373, P287, DOI 10.1016/j.virol.2007.12.001; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Sawai ET, 1996, CURR BIOL, V6, P1519, DOI 10.1016/S0960-9822(96)00757-9; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Singh SP, 2001, VIROLOGY, V283, P78, DOI 10.1006/viro.2001.0849; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Wei BL, 2005, J VIROL, V79, P14976, DOI 10.1128/JVI.79.23.14976-14980.2005; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027	47	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13363	13372		10.1074/jbc.M806631200	http://dx.doi.org/10.1074/jbc.M806631200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324886	Green Published, hybrid			2022-12-25	WOS:000265877300012
J	Tatham, AL; Crabtree, MJ; Warrick, N; Cai, SJ; Alp, NJ; Channon, KM				Tatham, Amy L.; Crabtree, Mark J.; Warrick, Nicholas; Cai, Shijie; Alp, Nicholas J.; Channon, Keith M.			GTP Cyclohydrolase I Expression, Protein, and Activity Determine Intracellular Tetrahydrobiopterin Levels, Independent of GTP Cyclohydrolase Feedback Regulatory Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; VASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE PRODUCTION; HYDROGEN-PEROXIDE; SMOOTH-MUSCLE; HPH-1 MOUSE; LPS; HYPERPHENYLALANINEMIA; METABOLISM; INDUCTION	GTP cyclohydrolase I (GTPCH) is a key enzyme in the synthesis of tetrahydrobiopterin (BH4), a required cofactor for nitric-oxide synthases and aromatic amino acid hydroxylases. Alterations of GTPCH activity and BH4 availability play an important role in human disease. GTPCH expression is regulated by inflammatory stimuli, in association with reduced expression of GTP cyclohydrolase feedback regulatory protein (GFRP). However, the relative importance of GTPCH expression versus GTPCH activity and the role of GFRP in relation to BH4 bioavailability remain uncertain. We investigated these relationships in a cell line with tet-regulated GTPCH expression and in the hph-1 mouse model of GTPCH deficiency. Doxycycline exposure resulted in a dose-dependent decrease in GTPCH protein and activity, with a strong correlation between GTPCH expression and BH4 levels (r(2) = 0.85, p < 0.0001). These changes in GTPCH and BH4 had no effect on GFRP expression or protein levels. GFRP overexpression and knockdown in tet-GCH cells did not alter GTPCH activity or BH4 levels, and GTPCH-specific knockdown in sEnd. 1 endothelial cells had no effect on GFRP protein. In mouse liver we observed a graded reduction of GTPCH expression, protein, and activity, from wild type, heterozygote, to homozygote littermates, with a striking linear correlation between GTPCH expression and BH4 levels (r(2) = 0.82, p < 0.0001). Neither GFRP expression nor protein differed between wild type, heterozygote, nor homozygote mice, despite the substantial differences in BH4. We suggest that GTPCH expression is the primary regulator of BH4 levels, and changes in GTPCH or BH4 are not necessarily accompanied by changes in GFRP expression.	[Tatham, Amy L.; Crabtree, Mark J.; Warrick, Nicholas; Cai, Shijie; Alp, Nicholas J.; Channon, Keith M.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Channon, KM (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	keith.channon@cardiov.ox.ac.uk		channon, keith/0000-0002-1043-4342; Crabtree, Mark/0000-0003-3298-2697	British Heart Foundation [RG/07/003/23133] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Gesierich A, 2003, BASIC RES CARDIOL, V98, P69, DOI 10.1007/s00395-003-0394-y; GROSS SS, 1993, ADV EXP MED BIOL, V338, P295; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATTORI Y, 1993, BIOCHEM BIOPH RES CO, V195, P435, DOI 10.1006/bbrc.1993.2062; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Hesslinger C, 1998, J BIOL CHEM, V273, P21616, DOI 10.1074/jbc.273.34.21616; HOWELLS DW, 1986, J CHROMATOGR, V381, P285, DOI 10.1016/S0378-4347(00)83594-X; Ishii M, 2005, J PHARMACOL SCI, V97, P299, DOI 10.1254/jphs.SC0040146; Kalivendi S, 2005, FREE RADICAL BIO MED, V38, P481, DOI 10.1016/j.freeradbiomed.2004.11.004; Katusic ZS, 1998, ARTERIOSCL THROM VAS, V18, P27, DOI 10.1161/01.ATV.18.1.27; Khoo JP, 2004, MOL GENET METAB, V82, P251, DOI 10.1016/j.ymgme.2004.04.006; MCDONALD JD, 1988, PEDIATR RES, V23, P63, DOI 10.1203/00006450-198801000-00014; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; NAKAYAMA DK, 1994, AM J PHYSIOL, V266, pL455, DOI 10.1152/ajplung.1994.266.4.L455; Nandi M, 2008, VASC MED, V13, P29, DOI 10.1177/1358863X07085916; PONZONE A, 1993, CLIN CHIM ACTA, V216, P63, DOI 10.1016/0009-8981(93)90139-U; Shimizu S, 2003, FREE RADICAL BIO MED, V34, P1343, DOI 10.1016/S0891-5849(03)00172-2; Walter R, 1998, IMMUNOL LETT, V60, P13, DOI 10.1016/S0165-2478(97)00123-5; Werner ER, 2002, J BIOL CHEM, V277, P10129, DOI 10.1074/jbc.M107326200; Werner-Felmayer G, 1996, METHODS NITRIC OXIDE, P271; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102	23	43	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13660	13668		10.1074/jbc.M807959200	http://dx.doi.org/10.1074/jbc.M807959200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19286659	Green Published, hybrid			2022-12-25	WOS:000265877300043
J	Yu, LY; Min, W; He, Y; Qin, LF; Zhang, HF; Bennett, AM; Chen, H				Yu, Luyang; Min, Wang; He, Yun; Qin, Lingfeng; Zhang, Haifeng; Bennett, Anton M.; Chen, Hong			JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FLUID SHEAR-STRESS; ASK1-MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; INDEPENDENT MANNER; INHIBITOR 14-3-3; FAMILY-MEMBERS; KINASE 1; ACTIVATION; DISSOCIATION	Previously we have shown that tyrosine 718 of ASK1 when phosphorylated is critical for SOCS1 binding and SOCS1-mediated degradation of ASK1. However, the kinase and phosphatase responsible for phosphorylation and dephosphorylation of ASK1 at Tyr-718 are unknown. In this study, we identified JAK2 and SHP2 as a Tyr-718-specific kinase and phosphatase, respectively. Interferon-gamma (IFN-gamma) induced degradation of ASK1 in normal but not in SOCS1-KO endothelial cells (EC). IFN-gamma-induced tyrosine phosphorylation of ASK1 at Tyr-718 was blocked by a JAK2-specific inhibitor. IFN-gamma enhanced the association between JAK2 and ASK1, and the ASK1-JAK2 complex was labile and was stabilized by the proteasomal inhibitor MG132. Furthermore, JAK2, but not JAK1, directly bound to and phosphorylated ASK1 at Tyr-718, leading to an enhanced association of ASK1 with SOCS1 and subsequent ASK1 degradation. Next, we showed that overexpression of the SH2-containing protein-tyrosine phosphatase-2 (SHP2) augmented, whereas a phosphatase-inactive mutant of SHP2 inhibited, TNF-induced ASK1 dephosphorylation. SHP2 associated with ASK1 in response to tumor necrosis factor in EC. An SHP-2 substrate-trapping mutant formed a complex with tyrosine-phosphorylated ASK1, suggesting that ASK1 is a direct SHP2 substrate. Moreover, SHP2 wild type, but not a catalytically inactive mutant, dissociated SOCS1 from ASK1. IFN-gamma-induced ASK1 Tyr(P)-718 was enhanced in mouse EC deficient in SHP2 (SHP2-KO). In contrast, tumor necrosis factor-induced dephosphorylation of ASK1 at Tyr(P)-718 and activation of ASK1-JNK signaling, as well as EC apoptosis, are significantly reduced in SHP2-KO EC. Our data suggest that JAK2-SOCS1 and SHP2 reciprocally regulate ASK1 phosphorylation and stability in response to cytokines.	[Yu, Luyang; Min, Wang; He, Yun; Qin, Lingfeng; Zhang, Haifeng] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, Dept Pathol, New Haven, CT 06520 USA; [Min, Wang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Hong] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Yale University; Sun Yat Sen University; Yale University; Oklahoma Medical Research Foundation	Min, W (corresponding author), Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplantat, 10 Amistad St, New Haven, CT 06520 USA.	wang.min@yale.edu	qin, lingfeng/D-9242-2012	Yu, Luyang/0000-0002-1301-6285; Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [P01HL070295-6, R01 HL-65978-9, AR46504]; National Nature Science Foundation of China [30828032]; American Heart Association [0835544N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065978, P01HL070295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL070295-6 and R01 HL-65978-9 and AR46504 (to A. M. B.). This work was also supported by National Nature Science Foundation of China Grant 30828032 (to W. M.) and Scientific Development Grant 0835544N from the American Heart Association (to H. C.).	Ali S, 2003, J BIOL CHEM, V278, P52021, DOI 10.1074/jbc.M306758200; Berk BC, 2002, DRUG NEWS PERSPECT, V15, P133, DOI 10.1358/dnp.2002.15.3.704684; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Izumi Y, 2003, CIRCULATION, V108, P2812, DOI 10.1161/01.CIR.0000096486.01652.FC; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Min W, 2008, CIRC RES, V102, P840, DOI 10.1161/CIRCRESAHA.107.168153; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	33	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13481	13488		10.1074/jbc.M809740200	http://dx.doi.org/10.1074/jbc.M809740200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19287004	Green Published, hybrid			2022-12-25	WOS:000265877300024
J	Chang, DK; Chiu, CY; Kuo, SY; Lin, WC; Lo, A; Wang, YP; Li, PC; Wu, HC				Chang, De-Kuan; Chiu, Chien-Yu; Kuo, Szu-Yao; Lin, Wei-Chuan; Lo, Albert; Wang, Yi-Ping; Li, Pi-Chun; Wu, Han-Chung			Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL HYPERTENSION; MACROMOLECULAR THERAPEUTICS; ANTI-HER2 IMMUNOLIPOSOMES; CHEMOTHERAPEUTIC-AGENTS; DOXORUBICIN DOXIL; DRUG-DELIVERY; GROWTH-FACTOR; HUMAN BREAST; PHASE-I; CANCER	It is known that solid tumors recruit new blood vessels to support tumor growth, but the molecular diversity of receptors in tumor angiogenic vessels might also be used clinically to develop better targeted therapy. In vivo phage display was used to identify peptides that specifically target tumor blood vessels. Several novel peptides were identified as being able to recognize tumor vasculature but not normal blood vessels in severe combined immunodeficiency (SCID) mice bearing human tumors. These tumor-homing peptides also bound to blood vessels in surgical specimens of various human cancers. The peptide-linked liposomes containing fluorescent substance were capable of translocating across the plasma membrane through endocytosis. With the conjugation of peptides and liposomal doxorubicin, the targeted drug delivery systems enhanced the therapeutic efficacy of the chemotherapeutic agent against human cancer xenografts by decreasing tumor angiogenesis and increasing cancer cell apoptosis. Furthermore, the peptide-mediated targeting liposomes improved the pharmacokinetics and pharmacodynamics of the drug they delivered compared with nontargeting liposomes or free drugs. Our results indicate that the tumor-homing peptides can be used specifically target tumor vasculature and have the potential to improve the systemic treatment of patients with solid tumors.	[Chang, De-Kuan; Chiu, Chien-Yu; Kuo, Szu-Yao; Lin, Wei-Chuan; Lo, Albert; Wang, Yi-Ping; Li, Pi-Chun; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan	Wu, HC (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169; Wang, Yi-Ping/0000-0001-9574-2194	Academia Sinica and National Science Council Taiwan [NSC97-2323-B-001-002, NSC97-3111-B-001-004]	Academia Sinica and National Science Council Taiwan	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC97-2323-B-001-002 and NSC97-3111-B-001-004 (to H.-C. W.).	Al-Batran SE, 2006, BRIT J CANCER, V94, P1615, DOI 10.1038/sj.bjc.6603158; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; Bosslet K, 1998, CANCER RES, V58, P1195; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOUCHER Y, 1991, CANCER RES, V51, P6691; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Colbern GT, 1999, J LIPOSOME RES, V9, P523, DOI 10.3109/08982109909035551; Drummond DC, 1999, PHARMACOL REV, V51, P691; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; GABIZON A, 1994, CANCER RES, V54, P987; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; GUTMANN R, 1992, CANCER RES, V52, P1993; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JAIN RK, 1987, CANCER RES, V47, P3039; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; LESS JR, 1992, CANCER RES, V52, P6371; Liu IJ, 2004, J INFECT DIS, V190, P797, DOI 10.1086/422753; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Marina NM, 2002, CLIN CANCER RES, V8, P413; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Matsumura Y, 2004, ANN ONCOL, V15, P517, DOI 10.1093/annonc/mdh092; Mayer LD, 1997, J PHARMACOL EXP THER, V280, P1406; Muggia F, 2001, EUR J CANCER, V37, pS15; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Park JW, 2002, CLIN CANCER RES, V8, P1172; Pastorino F, 2003, CANCER RES, V63, P86; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SENIOR J, 1991, BIOCHIM BIOPHYS ACTA, V1062, P77, DOI 10.1016/0005-2736(91)90337-8; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; VAAGE J, 1994, CANCER, V73, P1478, DOI 10.1002/1097-0142(19940301)73:5<1478::AID-CNCR2820730526>3.0.CO;2-1; Vasey PA, 1999, CLIN CANCER RES, V5, P83; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Wu H, 2006, J CANC MOL, V2, P57; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Wu  HC, 2008, J CANC MOL, V4, P37	50	84	88	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12905	12916		10.1074/jbc.M900280200	http://dx.doi.org/10.1074/jbc.M900280200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276080	Green Published, hybrid			2022-12-25	WOS:000265688300036
J	Courtney, HS; Li, Y; Twal, WO; Argraves, WS				Courtney, Harry S.; Li, Yi; Twal, Waleed O.; Argraves, W. Scott			Serum Opacity Factor Is a Streptococcal Receptor for the Extracellular Matrix Protein Fibulin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING PROTEIN; SURFACE PROTEIN; PYOGENES; FIBRINOGEN; VIRULENCE; DOMAIN; MECHANISMS; ADHESION; INVASION	The adhesion of bacteria to host tissues is often mediated by interactions with extracellular matrices. Herein, we report on the interactions of the group A streptococcus, Streptococcus pyogenes, with the extracellular matrix protein fibulin-1. S. pyogenes bound purified fibulin-1 in a dose-dependent manner. Genetic ablation of serum opacity factor (SOF), a virulence determinant of S. pyogenes, reduced binding by similar to 50%, and a recombinant peptide of SOF inhibited binding of fibulin-1 to streptococci by similar to 45%. Fibulin-1 bound to purified SOF2 in a dose-dependent manner with high affinity (K-d = 1.6 nM). The fibulin-1-binding domain was localized to amino acid residues 457-806 of SOF2, whereas the fibronectin-binding domain is contained within residues 807-931 of SOF2, indicating that these two domains are separate and distinct. Fibulin-1 bound to recombinant SOF from M types 2, 4, 28, and 75 of S. pyogenes, indicating that the fibulin-1-binding domain is likely conserved among SOF from different serotypes. Mixed binding experiments suggested that gelatin, fibronectin, fibulin-1, and SOF form a quaternary molecular complex that enhanced the binding of fibulin-1. These data indicate that S. pyogenes can interact with fibulin-1 and that SOF is a major streptococcal receptor for fibulin-1 but not the only receptor. Such interactions with fibulin-1 may be involved in the adhesion of S. pyogenes to extracellular matrices of the host.	[Courtney, Harry S.] Vet Adm Med Ctr, Res Serv 151, Memphis, TN 38104 USA; [Courtney, Harry S.; Li, Yi] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38104 USA; [Twal, Waleed O.; Argraves, W. Scott] Med Univ S Carolina, Dept Cell Biol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Medical University of South Carolina	Courtney, HS (corresponding author), Vet Adm Med Ctr, Res Serv 151, 1030 Jefferson Ave, Memphis, TN 38104 USA.	hcourtney@utmem.edu			National Institutes of Health [HL095067]; Department of Veterans Affairs; American Heart Association [0755346U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095067 (to W. S. A.). This work was also supported by the Department of Veterans Affairs (to H. S. C.) and American Heart Association Grant 0755346U (to W. S. A.).	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Cooley MA, 2008, DEV BIOL, V319, P336, DOI 10.1016/j.ydbio.2008.04.029; Courtney HS, 2006, J BIOL CHEM, V281, P5515, DOI 10.1074/jbc.M512538200; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; COURTNEY HS, 1994, INFECT IMMUN, V62, P3937, DOI 10.1128/IAI.62.9.3937-3946.1994; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; COURTNEY HS, 2004, BACTERIAL INVASION H, P239; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEVEGA S, 2009, CMLS CELL M IN PRESS; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gillen CM, 2008, J BIOL CHEM, V283, P6359, DOI 10.1074/jbc.M706739200; GODYNA S, 1995, MATRIX BIOL, V14, P467, DOI 10.1016/0945-053X(95)90004-7; Han M, 2009, BIOCHEMISTRY-US, V48, P1481, DOI 10.1021/bi802287q; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; Kim S, 2001, J CLIN MICROBIOL, V39, P1316, DOI 10.1128/JCM.39.4.1316-1318.2001; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 1999, FEMS MICROBIOL LETT, V178, P305, DOI 10.1016/S0378-1097(99)00373-0; Muriel JM, 2005, DEVELOPMENT, V132, P4223, DOI 10.1242/dev.02007; Oehmcke S, 2004, INFECT IMMUN, V72, P4302, DOI 10.1128/IAI.72.7.4302-4308.2004; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; Pownall HJ, 2008, CHEM PHYS LIPIDS, V156, P45, DOI 10.1016/j.chemphyslip.2008.09.001; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; RAKONJAC JV, 1995, INFECT IMMUN, V63, P622, DOI 10.1128/IAI.63.2.622-631.1995; Rivas JM, 2004, CURR OPIN DRUG DISC, V7, P223; Timmer AM, 2006, MOL MICROBIOL, V62, P15, DOI 10.1111/j.1365-2958.2006.05337.x; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458	34	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12966	12971		10.1074/jbc.M901143200	http://dx.doi.org/10.1074/jbc.M901143200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276078	Green Published, hybrid			2022-12-25	WOS:000265688300043
J	Domazet, I; Holleran, BJ; Martin, SS; Lavigne, P; Leduc, R; Escher, E; Guillemette, G				Domazet, Ivana; Holleran, Brian J.; Martin, Stephane S.; Lavigne, Pierre; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan			The Second Transmembrane Domain of the Human Type 1 Angiotensin II Receptor Participates in the Formation of the Ligand Binding Pocket and Undergoes Integral Pivoting Movement during the Process of Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CYSTEINE ACCESSIBILITY METHOD; MEMBRANE-SPANNING SEGMENT; HUMAN AT(1) RECEPTOR; CONSTITUTIVE ACTIVATION; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; CONTACT POINTS; SITE CREVICE; MECHANISM	The octapeptide hormone angiotensin II (AngII) exerts a wide variety of cardiovascular effects through the activation of the angiotensin II type-1 (AT1) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT1 receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand-binding pocket. In order to identify those residues in the second transmembrane domain (TMD2) that contribute to the formation of the binding pocket of the AT1 receptor, we used the substituted cysteine accessibility method. All of the residues within the Leu-70 to Trp-94 region were mutated one at a time to a cysteine, and, after expression in COS-7 cells, the mutant receptors were treated with the sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium (MTSEA). MTSEA reacts selectively with water-accessible, free sulfhydryl groups of endogenous or introduced point mutation cysteines. If a cysteine is found in the binding pocket, the covalent modification will affect the binding kinetics of the ligand. MTSEA substantially decreased the binding affinity of D74C-AT1, L81C-AT1, A85C-AT1, T88C-AT1, and A89C-AT1 mutant receptors, which suggests that these residues orient themselves within the water-accessible binding pocket of the AT1 receptor. Interestingly, this pattern of acquired MTSEA sensitivity was altered for TMD2 reporter cysteines engineered in a constitutively active N111G-AT1 receptor background. Indeed, mutant D74C-N111G-AT1 became insensitive to MTSEA, whereas mutant L81C-N111G-AT1 lost some sensitivity and mutant V86C-N111G-AT1 became sensitive to MTSEA. Our results suggest that constitutive activation of the AT1 receptor causes TMD2 to pivot, bringing the top of TMD2 closer to the binding pocket and pushing the bottom of TMD2 away from the binding pocket.	[Domazet, Ivana; Holleran, Brian J.; Martin, Stephane S.; Lavigne, Pierre; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Fac Med, Dept Pharmacol, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Gaetan.Guillemette@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. This article was submitted to fulfill the requirements of a Ph.D. thesis for I. D. at the Universite de Sherbrooke.	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; KOJIMA I, 1984, J BIOL CHEM, V259, P4448; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0	36	15	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11922	11929		10.1074/jbc.M808113200	http://dx.doi.org/10.1074/jbc.M808113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276075	Green Published, hybrid			2022-12-25	WOS:000265494600024
J	Brisse, S; Fevre, C; Passet, V; Issenhuth-Jeanjean, S; Tournebize, R; Diancourt, L; Grimont, P				Brisse, Sylvain; Fevre, Cindy; Passet, Virginie; Issenhuth-Jeanjean, Sylvie; Tournebize, Regis; Diancourt, Laure; Grimont, Patrick			Virulent Clones of Klebsiella pneumoniae: Identification and Evolutionary Scenario Based on Genomic and Phenotypic Characterization	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; ESCHERICHIA-COLI; BETA-LACTAMASE; CALYMMATOBACTERIUM-GRANULOMATIS; GENE-CLUSTER; SEROTYPE K1; STRAINS; RECOMBINATION; INFECTIONS; SEQUENCE	Klebsiella pneumoniae is found in the environment and as a harmless commensal, but is also a frequent nosocomial pathogen (causing urinary, respiratory and blood infections) and the agent of specific human infections including Friedlander's pneumonia, rhinoscleroma and the emerging disease pyogenic liver abscess (PLA). The identification and precise definition of virulent clones, i.e. groups of strains with a single ancestor that are associated with particular infections, is critical to understand the evolution of pathogenicity from commensalism and for a better control of infections. We analyzed 235 K. pneumoniae isolates of diverse environmental and clinical origins by multilocus sequence typing, virulence gene content, biochemical and capsular profiling and virulence to mice. Phylogenetic analysis of housekeeping genes clearly defined clones that differ sharply by their clinical source and biological features. First, two clones comprising isolates of capsular type K1, clone CC23(K1) and clone CC82(K1), were strongly associated with PLA and respiratory infection, respectively. Second, only one of the two major disclosed K2 clones was highly virulent to mice. Third, strains associated with the human infections ozena and rhinoscleroma each corresponded to one monomorphic clone. Therefore, K. pneumoniae subsp. ozaenae and K. pneumoniae subsp. rhinoscleromatis should be regarded as virulent clones derived from K. pneumoniae. The lack of strict association of virulent capsular types with clones was explained by horizontal transfer of the cps operon, responsible for the synthesis of the capsular polysaccharide. Finally, the reduction of metabolic versatility observed in clones Rhinoscleromatis, Ozaenae and CC82(K1) indicates an evolutionary process of specialization to a pathogenic lifestyle. In contrast, clone CC23(K1) remains metabolically versatile, suggesting recent acquisition of invasive potential. In conclusion, our results reveal the existence of important virulent clones associated with specific infections and provide an evolutionary framework for research into the links between clones, virulence and other genomic features in K. pneumoniae.	[Brisse, Sylvain; Fevre, Cindy; Passet, Virginie; Issenhuth-Jeanjean, Sylvie; Diancourt, Laure; Grimont, Patrick] Inst Pasteur, Paris, France; [Tournebize, Regis] Inst Pasteur, Unite Pathogen Microbienne Mol, Paris, France; [Tournebize, Regis] Inst Pasteur, INSERM, U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brisse, S (corresponding author), Inst Pasteur, Paris, France.	sylvain.brisse@pasteur.fr	Brisse, Sylvain/M-8723-2013; Tournebize, Regis/K-7847-2018	Brisse, Sylvain/0000-0002-2516-2108; Tournebize, Regis/0000-0003-3718-3130; Grimont, Patrick/0000-0002-6264-136X	Institut Pasteur; Conny-Maeva Charitable Foundation	Institut Pasteur(European Commission); Conny-Maeva Charitable Foundation	This work received financial support from Institut Pasteur and from a generous gift by the Conny-Maeva Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; BISERCIC M, 1991, J BACTERIOL, V173, P3894; BRENNER D J, 1972, International Journal of Systematic Bacteriology, V22, P193; Brisse S, 2005, VET MICROBIOL, V105, P307, DOI 10.1016/j.vetmic.2004.11.010; Brisse S, 2004, J CLIN MICROBIOL, V42, P3388, DOI 10.1128/JCM.42.8.3388-3398.2004; Brisse S, 2001, INT J SYST EVOL MICR, V51, P915, DOI 10.1099/00207713-51-3-915; Brisse S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P159, DOI 10.1007/0-387-30746-x_8; CARPENTER JL, 1990, REV INFECT DIS, V12, P672; Carter JS, 1999, INT J SYST BACTERIOL, V49, P1695, DOI 10.1099/00207713-49-4-1695; Chand MS, 1997, OTOLARYNG HEAD NECK, V116, P554, DOI 10.1016/S0194-5998(97)70311-5; CHENG DL, 1991, ARCH INTERN MED, V151, P1557; Cheng Hsiao-Pei, 2002, Journal of Microbiology Immunology and Infection, V35, P85; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; DARFEUILLE-MICHAUD A, 1992, INFECT IMMUN, V60, P44, DOI 10.1128/IAI.60.1.44-55.1992; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; DIMARTINO P, 1995, INFECT IMMUN, V63, P4336, DOI 10.1128/IAI.63.11.4336-4344.1995; EICKHOFF TC, 1966, ANN INTERN MED, V65, P1163, DOI 10.7326/0003-4819-65-6-1163; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Fang FC, 2005, J CLIN MICROBIOL, V43, P991, DOI 10.1128/JCM.43.2.991-992.2005; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P5149, DOI 10.1128/AAC.49.12.5149-5152.2005; GOLDSTEIN EJC, 1978, J CLIN MICROBIOL, V8, P413; Grimont P. A. D., 2005, BERGEYS MANUAL SYS B, P685; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hansen DS, 2002, CLIN MICROBIOL INFEC, V8, P397, DOI 10.1046/j.1469-0691.2002.00411.x; Hart CA, 2000, J MED MICROBIOL, V49, P395, DOI 10.1099/0022-1317-49-5-395; HORNICK DB, 1992, INFECT IMMUN, V60, P1577, DOI 10.1128/IAI.60.4.1577-1588.1992; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Kharsany ABM, 1999, J MED MICROBIOL, V48, P841, DOI 10.1099/00222615-48-9-841; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Kohler Jonathan E, 2007, Surg Infect (Larchmt), V8, P227, DOI 10.1089/sur.2006.007; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lai YC, 2003, FEMS MICROBIOL LETT, V218, P121, DOI 10.1016/S0378-1097(02)01120-5; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Lu CH, 2002, J CLIN NEUROSCI, V9, P533, DOI 10.1054/jocn.2001.1032; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; McVean G, 2002, GENETICS, V160, P1231; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; NELSON K, 1994, P NATL ACAD SCI USA, V91, P10227, DOI 10.1073/pnas.91.21.10227; NOUVELLON M, 1994, J CLIN MICROBIOL, V32, P2625, DOI 10.1128/JCM.32.10.2625-2627.1994; OFEK I, 1993, INFECT IMMUN, V61, P4208, DOI 10.1128/IAI.61.10.4208-4216.1993; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; ORSKOV I, 1974, BERGEYS MANUAL DETER, P321; Orskov I., 1984, BERGEYS MANUAL SYSTE, V1, P461; ORSKOV I, 1981, PROCARYOTES HDB HABI, P1160; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; RICHARD C, 1973, ANN BIOL CLIN-PARIS, V31, P295; RICHARD C, 1989, B SOC PATHOL EXOT, V82, P458; RICHENS J, 1985, PAPUA NEW GUINEA MED, V28, P67; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sarma PS, 2007, INT J INFECT DIS, V11, P86, DOI 10.1016/j.ijid.2005.11.003; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Seidler R. J., 1981, The prokaryotes. A handbook on habitats, isolation, and identification of bacteria. Volumes I and II, P1166; Shehata MA, 1996, AM J OTOLARYNG, V17, P81, DOI 10.1016/S0196-0709(96)90000-9; SIMOONSSMIT AM, 1984, J MED MICROBIOL, V17, P67, DOI 10.1099/00222615-17-1-67; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Struve C, 2005, J MED MICROBIOL, V54, P1111, DOI 10.1099/jmm.0.46165-0; TAINTURIER D, 1986, REV MED VET-TOULOUSE, V137, P49; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Turton JF, 2007, J MED MICROBIOL, V56, P593, DOI 10.1099/jmm.0.46964-0; van Westreenen M, 2003, J ANTIMICROB CHEMOTH, V52, P530, DOI 10.1093/jac/dkg382; VANKREGTEN E, 1984, J CLIN MICROBIOL, V20, P936, DOI 10.1128/JCM.20.5.936-941.1984; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Williams P., 1990, Reviews in Medical Microbiology, V1, P196; Wong CH, 2004, EUR J CLIN MICROBIOL, V23, P403, DOI 10.1007/s10096-004-1125-5; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; YU WL, 2008, DIAGN MICROBIOL INFE	92	299	322	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4982	10.1371/journal.pone.0004982	http://dx.doi.org/10.1371/journal.pone.0004982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319196	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499200013
J	Cheng, L; Pilder, S; Nairn, AC; Ramdas, S; Vijayaraghavan, S				Cheng, Lina; Pilder, Stephen; Nairn, Angus C.; Ramdas, Shandilya; Vijayaraghavan, Srinivasan			PP1 gamma 2 and PPP1R11 Are Parts of a Multimeric Complex in Developing Testicular Germ Cells in which their Steady State Levels Are Reciprocally Related	PLOS ONE			English	Article								Mice lacking the protein phosphatase 1 gamma isoforms, PP1 gamma 1 and PP1 gamma 2, are male-sterile due to defective germ cell morphogenesis and apoptosis. However, this deficiency causes no obvious abnormality in other tissues. A biochemical approach was employed to learn how expression versus deficiency of PP1 gamma 2, the predominant PP1 isoform in male germ cells, affects spermatogenesis. Methods used in this study include column chromatography, western blot and northern blot analyses, GST pull-down assays, immunoprecipitation, non-denaturing gel electrophoresis, phosphatase enzyme assays, protein sequencing, and immunohistochemistry. We report for the first time that in wild-type testis, PP1 gamma 2 forms an inactive complex with actin, protein phosphatase 1 regulatory subunit 7 (PPP1R7), and protein phosphatase 1 regulatory subunit 11 (PPP1R11), the latter, a potent PP1 inhibitor. Interestingly, PPP1R11 protein, but not its mRNA level, falls significantly in PP1 gamma-null testis where mature sperm are virtually absent. Conversely, both mature sperm numbers and the PPP1R11 level increase substantially in PP1 gamma-null testis expressing transgenic PP1 gamma 2. PPP1R11 also appears to be ubiquitinated in PP1 gamma-null testis. The levels of PP1 gamma 2 and PPP1R11 were increased in phenotypically normal PP1 alpha-null testis. However, in PP1 alpha-null spleen, where PP1 gamma 2 normally is not expressed, PPP1R11 levels remained unchanged. Our data clearly show a direct reciprocal relationship between the levels of the protein phosphatase isoform PP1 gamma 2 and its regulator PPP1R11, and suggest that complex formation between these polypeptides in testis may prevent proteolysis of PPP1R11 and thus, germ cell apoptosis.	[Cheng, Lina; Ramdas, Shandilya; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Pilder, Stephen] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Yale University	Cheng, L (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	svijayar@kent.edu		Nairn, Angus/0000-0002-7075-0195	NIH [R01 HD38520, HD31164, DA10044]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD031164, R01HD031164, R29HD031164, R01HD038520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 HD38520 (SV), HD31164 (SP), and DA10044 (ACN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Bennett D, 2006, J MOL BIOL, V364, P196, DOI 10.1016/j.jmb.2006.08.094; CEBRATHOMAS JA, 1991, NATURE, V349, P239, DOI 10.1038/349239a0; Ceulemans H, 1999, EUR J BIOCHEM, V262, P36, DOI 10.1046/j.1432-1327.1999.00344.x; Chakrabarti R, 2007, ASIAN J ANDROL, V9, P445, DOI 10.1111/j.1745-7262.2007.00307.x; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Cohen P, 1978, BIOCHEM SOC T, V6, P17, DOI 10.1042/bst0060017; Dinischiotu A, 1997, FEBS LETT, V402, P141, DOI 10.1016/S0014-5793(96)01514-1; Fardilha M, 2004, ANN NY ACAD SCI, V1030, P468, DOI 10.1196/annals.1329.059; Han YB, 2007, MOL REPROD DEV, V74, P1132, DOI 10.1002/mrd.20631; Helps NR, 1998, FEBS LETT, V438, P131, DOI 10.1016/S0014-5793(98)01286-1; Hrabchak C, 2004, J BIOL CHEM, V279, P37079, DOI 10.1074/jbc.M403710200; Hrabchak C, 2007, BIOCHEMISTRY-US, V46, P4635, DOI 10.1021/bi6025837; Huang HS, 2005, ARCH BIOCHEM BIOPHYS, V443, P33, DOI 10.1016/j.abb.2005.08.021; Huang HS, 2008, J BIOL CHEM, V283, P18135, DOI 10.1074/jbc.M709735200; Huang ZH, 2005, BIOL REPROD, V72, P384, DOI 10.1095/biolreprod.104.034140; Huang ZH, 2004, BIOL REPROD, V71, P177, DOI 10.1095/biolreprod.104.027284; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; Huang ZH, 2002, BIOL REPROD, V67, P1936, DOI 10.1095/biolreprod.102.004093; HUGO VV, 2002, JBC, V277, P47331; Hui L, 2006, BIOL REPROD, V74, P633, DOI 10.1095/biolreprod.105.045963; Kwon J, 2005, BIOL REPROD, V73, P29, DOI 10.1095/biolreprod.104.037077; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; NIMMO GA, 1978, EUR J BIOCHEM, V87, P341, DOI 10.1111/j.1432-1033.1978.tb12383.x; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Pilder S H, 2007, Soc Reprod Fertil Suppl, V63, P123; PILDER SH, 1993, DEV BIOL, V159, P631, DOI 10.1006/dbio.1993.1270; PILDER SH, 1991, GENETICS, V129, P237; Puntoni F, 1997, MOL CELL BIOCHEM, V171, P115, DOI 10.1023/A:1006892103306; RENOUF S, 1995, FEBS LETT, V375, P75, DOI 10.1016/0014-5793(95)01180-M; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Strack S, 1999, J COMP NEUROL, V413, P373; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayaraghavan S, 1997, BIOL REPROD, V57, P1517, DOI 10.1095/biolreprod57.6.1517; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan S, 1997, BIOL REPROD, V56, P1450, DOI 10.1095/biolreprod56.6.1450; Walsh Edmund P., 2007, V365, P235; Zhang J, 1998, BIOCHEMISTRY-US, V37, P16728, DOI 10.1021/bi981169g	42	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4861	10.1371/journal.pone.0004861	http://dx.doi.org/10.1371/journal.pone.0004861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300506	gold, Green Published			2022-12-25	WOS:000265496800002
J	Bond, CE; Zimmermann, M; Greenfield, SA				Bond, Cherie E.; Zimmermann, Martina; Greenfield, Susan A.			Upregulation of alpha 7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; READTHROUGH ACETYLCHOLINESTERASE; MOLECULAR-MECHANISMS; NEURITE GROWTH; T-PEPTIDE; IN-VITRO; CHOLINE; PROTEIN; NEURONS	Background: The alpha-7 nicotinic acetylcholine receptor (alpha 7-nAChR) is well known as a potent calcium ionophore that, in the brain, has been implicated in excitotoxicity and hence in the underlying mechanisms of neurodegenerative disorders such as Alzheimer's disease. Previous research implied that the activity of this receptor may be modified by exposure to a peptide fragment derived from the C-terminal region of the enzyme acetylcholinesterase. This investigation was undertaken to determine if the functional changes observed could be attributed to peptide binding interaction with the alpha 7-nAChR, or peptide modulation of receptor expression. Methodology/Principal Findings: This study provides evidence that two peptides derived from the C-terminus of acetylcholinesterase, not only selectively displace specific bungarotoxin binding at the alpha 7-nAChR, but also alter receptor binding properties for its familiar ligands, including the alternative endogenous agonist choline. Of more long-term significance, these peptides also induce upregulation of alpha 7-nAChR mRNA and protein expression, as well as enhancing receptor trafficking to the plasma membrane. Conclusions/Significance: The results reported here demonstrate a hitherto unknown relationship between the alpha 7-nAChR and the non-enzymatic functions of acetylcholinesterase, mediated independently by its C-terminal domain. Such an interaction may prove valuable as a pharmacological tool, prompting new approaches for understanding, and combating, the process of neurodegeneration.	[Bond, Cherie E.; Greenfield, Susan A.] Univ Oxford, Dept Pharmacol, Inst Future Mind, Oxford OX1 3QT, England; [Zimmermann, Martina] Goethe Univ Frankfurt, Dept Pharmacol, D-6000 Frankfurt, Germany	University of Oxford; Goethe University Frankfurt	Bond, CE (corresponding author), Univ Oxford, Dept Pharmacol, Inst Future Mind, S Parks Rd, Oxford OX1 3QT, England.	cherie.bond@pharm.ox.ac.uk		Zimmermann, Martina/0000-0003-4274-6145	James Martin 21st Century School Foundation	James Martin 21st Century School Foundation	This research was supported by a grant from the James Martin 21st Century School Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PR, 1984, J BIOL CHEM, V259, P5350; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Allen DD, 1997, NEUROSCI LETT, V234, P71; Alvarez A, 1998, J NEUROSCI, V18, P3213; Anderson AA, 2008, J CELL PHYSIOL, V215, P82, DOI 10.1002/jcp.21288; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Bednar I, 2002, MOL CELL NEUROSCI, V20, P354, DOI 10.1006/mcne.2002.1112; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; Bon CLM, 2003, EUR J NEUROSCI, V17, P1991, DOI 10.1046/j.1460-9568.2003.02648.x; Bond CE, 2007, GLIA, V55, P1348, DOI 10.1002/glia.20547; Bourin M, 2003, CURR MED RES OPIN, V19, P169, DOI 10.1185/030079903125001631; Broide RS, 1996, J NEUROSCI, V16, P2956; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chu LW, 2005, DEMENT GERIATR COGN, V19, P106, DOI 10.1159/000082661; Coleman BA, 1996, J BIOL CHEM, V271, P4410; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Day T, 2004, EXP BRAIN RES, V155, P500, DOI 10.1007/s00221-003-1757-1; Day T, 2003, EXP BRAIN RES, V153, P334, DOI 10.1007/s00221-003-1567-5; Day T, 2002, NEUROSCIENCE, V111, P649, DOI 10.1016/S0306-4522(02)00031-3; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dori A, 2006, J MOL NEUROSCI, V28, P247, DOI 10.1385/JMN:28:3:247; Dunckley T, 2006, BRAIN RES, V1116, P39, DOI 10.1016/j.brainres.2006.07.111; Emmett SR, 2004, NEUROSCI LETT, V358, P210, DOI 10.1016/j.neulet.2003.12.078; Evron T, 2007, TOXICOLOGY, V233, P97, DOI 10.1016/j.tox.2006.08.018; Fodero LR, 2004, J NEUROCHEM, V88, P1186, DOI 10.1046/j.1471-4159.2003.02296.x; FOSSIER P, 1983, NATURE, V301, P710, DOI 10.1038/301710a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; GREENFIELD S, 1984, TRENDS NEUROSCI, V7, P364, DOI 10.1016/S0166-2236(84)80055-7; Greenfield SA, 2004, J NEUROCHEM, V90, P325, DOI 10.1111/j.1471-4159.2004.02494.x; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; Hruska M, 2007, J NEUROSCI, V27, P11501, DOI 10.1523/JNEUROSCI.3057-07.2007; Inestrosa NC, 2008, FEBS J, V275, P625, DOI 10.1111/j.1742-4658.2007.06238.x; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jiang H, 2008, FEBS J, V275, P612, DOI 10.1111/j.1742-4658.2007.06236.x; Jin QH, 2004, ACTA PHARMACOL SIN, V25, P1013; Jones IW, 2006, J MOL NEUROSCI, V30, P83, DOI 10.1385/JMN:30:1:83; Jonnala RR, 2001, J NEUROSCI RES, V66, P565, DOI 10.1002/jnr.10022; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Liu Z, 2007, BIOCHEM PHARMACOL, V74, P1112, DOI 10.1016/j.bcp.2007.05.022; LUKAS RJ, 1980, J BIOL CHEM, V255, P5573; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Massoulie J, 2006, J MOL NEUROSCI, V30, P233, DOI 10.1385/JMN:30:1:233; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Mousavi M, 2004, INT J DEV NEUROSCI, V22, P545, DOI 10.1016/j.ijdevneu.2004.07.005; Novakova J, 2005, BRAIN RES, V1062, P101, DOI 10.1016/j.brainres.2005.09.021; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; Onganer PU, 2006, BBA-GEN SUBJECTS, V1760, P415, DOI 10.1016/j.bbagen.2005.12.016; Papke RL, 2000, EUR J PHARMACOL, V393, P179, DOI 10.1016/S0014-2999(00)00009-1; Papke RL, 1996, NEUROSCI LETT, V213, P201; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Paraoanu LE, 2006, J MOL NEUROSCI, V30, P201, DOI 10.1385/JMN:30:1:201; Park SE, 2008, CARCINOGENESIS, V29, P729, DOI 10.1093/carcin/bgn036; Payette DJ, 2007, BRAIN RES, V1135, P12, DOI 10.1016/j.brainres.2006.12.005; PEREIRA EFR, 1993, J PHARMACOL EXP THER, V265, P1474; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; Rozen S, 2000, Methods Mol Biol, V132, P365; Salinska E, 2005, FOLIA NEUROPATHOL, V43, P322; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Saxena A, 2003, BIOCHEMISTRY-US, V42, P15292, DOI 10.1021/bi030150x; SCHWARZ M, 1995, MOL BRAIN RES, V31, P101, DOI 10.1016/0169-328X(95)00040-Y; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sharma KV, 2001, J NEUROSCI RES, V63, P165, DOI 10.1002/1097-4547(20010115)63:2<165::AID-JNR1008>3.0.CO;2-O; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; Sternfeld M, 1998, J NEUROSCI, V18, P1240; Svedberg MM, 2002, J MOL NEUROSCI, V18, P211, DOI 10.1385/JMN:18:3:211; TAYLOR P, 1994, BIOCHEM SOC T, V22, P740, DOI 10.1042/bst0220740; Torrao AS, 2000, DEV BRAIN RES, V124, P81, DOI 10.1016/S0165-3806(00)00113-9; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; van Damme P, 2005, NEURODEGENER DIS, V2, P147, DOI 10.1159/000089620; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Yu WF, 2005, EXP NEUROL, V192, P215, DOI 10.1016/j.expneurol.2004.12.015; Zbarsky V, 2004, NEUROBIOL DIS, V16, P283, DOI 10.1016/j.nbd.2004.02.009; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zwart R, 2000, J NEUROCHEM, V75, P2492, DOI 10.1046/j.1471-4159.2000.0752492.x	92	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4846	10.1371/journal.pone.0004846	http://dx.doi.org/10.1371/journal.pone.0004846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287501	gold, Green Published			2022-12-25	WOS:000265496400008
J	Du, ZQ; Zhao, X; Vukasinovic, N; Rodriguez, F; Clutter, AC; Rothschild, MF				Du, Zhi-Qiang; Zhao, Xia; Vukasinovic, Natascha; Rodriguez, Fernanda; Clutter, Archie C.; Rothschild, Max F.			Association and Haplotype Analyses of Positional Candidate Genes in Five Genomic Regions Linked to Scrotal Hernia in Commercial Pig Lines	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; CREMASTER MUSCLES; INGUINAL-HERNIAS; EXPRESSION; ELF5; SUSCEPTIBILITY; SACS; TRAITS	Scrotal hernia in pigs is a complex trait likely affected by genetic and environmental factors. A large-scale association analysis of positional and functional candidate genes was conducted in four previously identified genomic regions linked to hernia susceptibility on Sus scrofa chromosomes 2 and 12, as well as the fifth region around 67 cM on chromosome 2, respectively. In total, 151 out of 416 SNPs discovered were genotyped successfully. Using a family-based analysis we found that four regions surrounding ELF5, KIF18A, COL23A1 on chromosome 2, and NPTX1 on chromosome 12, respectively, may contain the genetic variants important for the development of the scrotal hernia in pigs. These findings were replicated in another case-control dataset. The SNPs around the ELF5 region were in high linkage disequilibrium with each other, and a haplotype containing SNPs from ELF5 and CAT was highly significantly associated with hernia development. Extensive re-sequencing work focused on the KIF18A gene did not detect any further SNPs with extensive association signals. These genes may be involved in the estrogen receptor signaling pathway (KIF18A and NPTX1), the epithelial-mesenchymal transition (ELF5) and the collagen metabolism pathway (COL23A1), which are associated with the important molecular characteristics of hernia pathophysiology. Further investigation on the molecular mechanisms of these genes may provide more molecular clues on hernia development in pigs.	[Du, Zhi-Qiang; Zhao, Xia; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Du, Zhi-Qiang; Zhao, Xia; Rothschild, Max F.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA; [Vukasinovic, Natascha; Clutter, Archie C.] Newsham Choice Genet, Des Moines, IA USA; [Rodriguez, Fernanda] Monsanto Co, St Louis, MO USA	Iowa State University; Iowa State University; Monsanto	Rothschild, MF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu			Monsanto Choice Genetics and Newsham Choice Genetics; State of Iowa; Hatch Funds; College of Agriculture and Life Science in Iowa State University	Monsanto Choice Genetics and Newsham Choice Genetics; State of Iowa; Hatch Funds; College of Agriculture and Life Science in Iowa State University	We appreciate the financial support by Monsanto Choice Genetics and Newsham Choice Genetics, and the additional financial support provided by State of Iowa and Hatch Funds and the support from the College of Agriculture and Life Science in Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyard J, 2007, CLIN CANCER RES, V13, P2634, DOI 10.1158/1078-0432.CCR-06-2163; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellon JM, 2001, ANN SURG, V233, P287, DOI 10.1097/00000658-200102000-00020; Bendavid Robert, 2004, Hernia, V8, P171; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardini L, 2007, AM J MED GENET A, V143A, P2937, DOI 10.1002/ajmg.a.32092; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Dick DM, 2008, BIOL PSYCHIAT, V63, P1047, DOI 10.1016/j.biopsych.2007.11.005; Diniz G, 2004, PATHOL RES PRACT, V200, P531, DOI 10.1016/j.prp.2004.04.010; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; DU F, 2004, 29 INT C AN GEN ISAG, P123; Du FX, 2004, J DAIRY SCI, V87, P453; Du FX, 2004, J ANIM SCI, V82, P453; Du FX, 2004, POULTRY SCI, V83, P453; Du FX, 2007, INT J BIOL SCI, V3, P166; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Grindflek E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-25; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; Hutson JM, 2005, MED HYPOTHESES, V64, P37, DOI 10.1016/j.mehy.2003.11.046; Jansen PL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-36; Jansen PL, 2004, SURGERY, V136, P1, DOI 10.1016/j.surg.2004.01.004; Klinge U, 2006, Hernia, V10, P472, DOI 10.1007/s10029-006-0145-8; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Koskimies P, 2003, MOL CELL ENDOCRINOL, V206, P159, DOI 10.1016/S0303-7207(02)00425-2; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Luboshits G, 2007, J CELL BIOCHEM, V100, P693, DOI 10.1002/jcb.21000; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Metzger DE, 2008, DEV BIOL, V320, P149, DOI 10.1016/j.ydbio.2008.04.038; MIKAMI H, 1979, CAN J GENET CYTOL, V21, P9, DOI 10.1139/g79-002; Morrison AC, 2008, AM J HYPERTENS, V21, P117, DOI 10.1038/ajh.2007.17; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puri V, 2007, BIOL PSYCHIAT, V61, P873, DOI 10.1016/j.biopsych.2006.06.014; Skandalakis JE, 1997, HERNIA, V1, P45; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Szczesny W, 2006, Hernia, V10, P266, DOI 10.1007/s10029-006-0081-7; Tanyel FC, 2006, UROLOGY, V67, P855, DOI 10.1016/j.urology.2005.10.050; Tanyel FC, 2003, UROL INT, V70, P211, DOI 10.1159/000068765; Tanyel FC, 2001, BJU INT, V87, P251, DOI 10.1046/j.1464-410x.2001.02028.x; Tez M, 2006, MED HYPOTHESES, V66, P1042, DOI 10.1016/j.mehy.2005.12.016; Thaller G, 1996, GENETICS, V143, P1819; Tiranti IN, 2002, J AGR SCI, V138, P333, DOI 10.1017/S0021859602001958; Ulusu NN, 2007, CELL BIOCHEM FUNCT, V25, P515, DOI 10.1002/cbf.1341; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; VOGT DW, 1990, AM J VET RES, V51, P1501; Yasuhara F, 2008, BIOL REPROD, V79, P432, DOI 10.1095/biolreprod.107.067413; ZHAO X, 2008, AM J VET RE IN PRESS; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1; Zondervan KT, 2007, NAT PROTOC, V2, P2492, DOI 10.1038/nprot.2007.366	53	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4837	10.1371/journal.pone.0004837	http://dx.doi.org/10.1371/journal.pone.0004837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287495	Green Published, gold			2022-12-25	WOS:000265496400005
J	Gordo, I; Gomes, MGM; Reis, DG; Campos, PRA				Gordo, Isabel; Gomes, M. Gabriela M.; Reis, Daniel G.; Campos, Paulo R. A.			Genetic Diversity in the SIR Model of Pathogen Evolution	PLOS ONE			English	Article							POSITIVE SELECTION; VIRUS; SUBSTITUTIONS; REINFECTION; DYNAMICS; BURSTS	We introduce a model for assessing the levels and patterns of genetic diversity in pathogen populations, whose epidemiology follows a susceptible-infected-recovered model (SIR). We model the population of pathogens as a metapopulation composed of subpopulations (infected hosts), where pathogens replicate and mutate. Hosts transmit pathogens to uninfected hosts. We show that the level of pathogen variation is well predicted by analytical expressions, such that pathogen neutral molecular variation is bounded by the level of infection and increases with the duration of infection. We then introduce selection in the model and study the invasion probability of a new pathogenic strain whose fitness (R-0(1+s)) is higher than the fitness of the resident strain (R0). We show that this invasion probability is given by the relative increment in R-0 of the new pathogen (s). By analyzing the patterns of genetic diversity in this framework, we identify the molecular signatures during the replacement and compare these with those observed in sequences of influenza A.	[Gordo, Isabel; Gomes, M. Gabriela M.; Reis, Daniel G.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Gomes, M. Gabriela M.] Univ Lisbon, Ctr Mat Aplicacoes Fundament, P-1699 Lisbon, Portugal; [Campos, Paulo R. A.] Univ Fed Pernambuco, Dept Fis, Recife, PE, Brazil	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade Federal de Pernambuco	Gordo, I (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	igordo@igc.gulbenkian.pt	Gomes, Gabriela/H-7218-2014; Gordo, Isabel/D-6770-2013; Campos, Paulo/G-2459-2012; Campos, Paulo/AAC-7734-2019	Gomes, Gabriela/0000-0002-1454-4979; Gordo, Isabel/0000-0003-1622-5143; Campos, Paulo/0000-0002-7823-1998; Campos, Paulo/0000-0002-7823-1998	Portuguese Research Council (FCT) [PTDC/BIA-BDE/65276/2006]; Fundacao Calouste Gulbenkian; Instituto Gulbenkian de Ciencia, Oeiras; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); PRONEX/MCT-CNPq-FACEPE; European Commission [MEXT-CT-2004-14338]	Portuguese Research Council (FCT)(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); Instituto Gulbenkian de Ciencia, Oeiras; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); PRONEX/MCT-CNPq-FACEPE; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the Portuguese Research Council (FCT) for financial support through PTDC/BIA-BDE/65276/2006. We thank FCT of Portugal, grants PTDC/BIA-BDE/65276/2006, and, Fundacao Calouste Gulbenkian for the financial support of hermes, a High Performance Computing Centre, hosted in Instituto Gulbenkian de Ciencia, Oeiras. PRAC is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and program PRONEX/MCT-CNPq-FACEPE. MGG and DGR are supported by FCT and the European Commission grant MEXT-CT-2004-14338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bazykin GA, 2006, P NATL ACAD SCI USA, V103, P19396, DOI 10.1073/pnas.0609484103; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Campos PRA, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/12/L12003; Combadao J, 2007, GENET RES, V89, P7, DOI 10.1017/S0016672307008658; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Drake JW, 1998, GENETICS, V148, P1667; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Gokaydin D, 2007, J R SOC INTERFACE, V4, P137, DOI 10.1098/rsif.2006.0159; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Gordo I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-116; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kimura MA, 1985, NEUTRAL THEORY MOL E; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; ROUSSET F, 2004, GENETIC STRUCTURE SE; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SLATKIN M, 1981, EVOLUTION, V35, P477, DOI 10.1111/j.1558-5646.1981.tb04911.x; TAJIMA F, 1989, GENETICS, V123, P597; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Wilson DJ, 2005, TRENDS ECOL EVOL, V20, P39, DOI 10.1016/j.tree.2004.10.009; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34	31	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4876	10.1371/journal.pone.0004876	http://dx.doi.org/10.1371/journal.pone.0004876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287490	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400017
J	Kuczenski, B; Ruder, WC; Messner, WC; LeDuc, PR				Kuczenski, Brandon; Ruder, Warren C.; Messner, William C.; LeDuc, Philip R.			Probing Cellular Dynamics with a Chemical Signal Generator	PLOS ONE			English	Article								Observations of material and cellular systems in response to time-varying chemical stimuli can aid the analysis of dynamic processes. We describe a microfluidic "chemical signal generator,'' a technique to apply continuously varying chemical concentration waveforms to arbitrary locations in a microfluidic channel through feedback control of the interface between parallel laminar (co-flowing) streams. As the flow rates of the streams are adjusted, the channel walls are exposed to a chemical environment that shifts between the individual streams. This approach can be used to probe the dynamic behavior of objects or substances adherent to the interior of the channel. To demonstrate the technique, we exposed live fibroblast cells to ionomycin, a membrane-permeable calcium ionophore, while assaying cytosolic calcium concentration. Through the manipulation of the laminar flow interface, we exposed the cells' endogenous calcium handling machinery to spatially-contained discrete and oscillatory intracellular disturbances, which were observed to elicit a regulatory response. The spatiotemporal precision of the generated signals opens avenues to previously unapproachable areas for potential investigation of cell signaling and material behavior.	[Kuczenski, Brandon; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Ruder, Warren C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Messner, WC (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	bmessner@andrew.cmu.edu; prleduc@cmu.edu	LeDuc, Philip/M-1103-2014	LeDuc, Philip/0000-0001-6397-2905; Kuczenski, Brandon/0000-0003-1918-0825	National Institute of Health [T32-EB0003392]; Dowd-ICES [predoctoral fellowship]; National Science Foundation [CMS0555513]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dowd-ICES; National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the National Institute of Health (NIH-NIBIB T32-EB0003392 - WCR), the Dowd-ICES predoctoral fellowship (WCR), and the National Science Foundation (CMS0555513 - WCM and PRL, NSF Early Career faculty fellowship - PRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PR, 1986, AM J PHYSIOL, V251, pC887, DOI 10.1152/ajpcell.1986.251.6.C887; Araujo RP, 2006, CURR OPIN CHEM BIOL, V10, P81, DOI 10.1016/j.cbpa.2006.01.002; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Beta C, 2007, ANAL CHEM, V79, P3940, DOI 10.1021/ac070033y; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Gu W, 2004, P NATL ACAD SCI USA, V101, P15861, DOI 10.1073/pnas.0404353101; Hofer AM, 1998, EMBO J, V17, P1986, DOI 10.1093/emboj/17.7.1986; Ismagilov RF, 2000, APPL PHYS LETT, V76, P2376, DOI 10.1063/1.126351; Jimenez J, 2005, J FLUID MECH, V535, P245, DOI 10.1017/S0022112005004994; Kamholz AE, 1999, ANAL CHEM, V71, P5340, DOI 10.1021/ac990504j; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Korin N, 2007, LAB CHIP, V7, P611, DOI 10.1039/b702392h; Kuczenski B, 2007, LAB CHIP, V7, P647, DOI 10.1039/b617065j; Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Walker GM, 2002, BIOMED MICRODEVICES, V4, P161, DOI 10.1023/A:1016088128057; Wang F, 2008, BIOTECHNOL BIOENG, V100, P150, DOI 10.1002/bit.21737; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Yang MS, 2002, ANAL CHEM, V74, P3991, DOI 10.1021/ac025536c	33	52	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4847	10.1371/journal.pone.0004847	http://dx.doi.org/10.1371/journal.pone.0004847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287482	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496400009
J	Gillespie, JJ; Ammerman, NC; Dreher-Lesnick, SM; Rahman, MS; Worley, MJ; Setubal, JC; Sobral, BS; Azad, AF				Gillespie, Joseph J.; Ammerman, Nicole C.; Dreher-Lesnick, Sheila M.; Rahman, M. Sayeedur; Worley, Micah J.; Setubal, Joao C.; Sobral, Bruno S.; Azad, Abdu F.			An Anomalous Type IV Secretion System in Rickettsia Is Evolutionarily Conserved	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS VIRB7; ESSENTIAL VIRULENCE PROTEIN; T-DNA TRANSFER; COMPLEX TRANSPORT APPARATUS; MULTIPLE SEQUENCE ALIGNMENT; MEDIATED CONJUGAL TRANSFER; BRUCELLA-SUIS VIRB8; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASES	Background: Bacterial type IV secretion systems (T4SSs) comprise a diverse transporter family functioning in conjugation, competence, and effector molecule (DNA and/or protein) translocation. Thirteen genome sequences from Rickettsia, obligate intracellular symbionts/pathogens of a wide range of eukaryotes, have revealed a reduced T4SS relative to the Agrobacterium tumefaciens archetype ( vir). However, the Rickettsia T4SS has not been functionally characterized for its role in symbiosis/virulence, and none of its substrates are known. Results: Superimposition of T4SS structural/functional information over previously identified Rickettsia components implicate a functional Rickettsia T4SS. virB4, virB8 and virB9 are duplicated, yet only one copy of each has the conserved features of similar genes in other T4SSs. An extraordinarily duplicated VirB6 gene encodes five hydrophobic proteins conserved only in a short region known to be involved in DNA transfer in A. tumefaciens. virB1, virB2 and virB7 are newly identified, revealing a Rickettsia T4SS lacking only virB5 relative to the vir archetype. Phylogeny estimation suggests vertical inheritance of all components, despite gene rearrangements into an archipelago of five islets. Similarities of Rickettsia VirB7/VirB9 to ComB7/ComB9 proteins of e-proteobacteria, as well as phylogenetic affinities to the Legionella lvh T4SS, imply the Rickettsiales ancestor acquired a vir-like locus from distantly related bacteria, perhaps while residing in a protozoan host. Modern modifications of these systems likely reflect diversification with various eukaryotic host cells. Conclusion: We present the rvh (Rickettsiales vir homolog) T4SS, an evolutionary conserved transporter with an unknown role in rickettsial biology. This work lays the foundation for future laboratory characterization of this system, and also identifies the Legionella lvh T4SS as a suitable genetic model.	[Gillespie, Joseph J.; Setubal, Joao C.; Sobral, Bruno S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Gillespie, Joseph J.; Ammerman, Nicole C.; Dreher-Lesnick, Sheila M.; Rahman, M. Sayeedur; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA; [Worley, Micah J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Setubal, Joao C.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; University System of Maryland; University of Maryland Baltimore; University of Louisville; Virginia Polytechnic Institute & State University	Gillespie, JJ (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jgill@vbi.vt.edu	Setubal, Joao Carlos/C-7305-2012; Sobral, Bruno/GVU-7637-2022	Setubal, Joao Carlos/0000-0001-9174-2816; Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264; Ammerman, Nicole C./0000-0001-9359-9144	National Institute of Allergy And Infectious Diseases (NIAID) [R01AI017828, R01AI59118, HHSN266200400035C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017828, R01AI059118] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Numbers R01AI017828 and R01AI59118 from the National Institute of Allergy And Infectious Diseases (NIAID) to AFA, and through NIAID contract HHSN266200400035C to BSS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the National Institutes of Health.	Abajy MY, 2007, J BACTERIOL, V189, P2487, DOI 10.1128/JB.01491-06; Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; AMMERMAN NC, 2008, J BACTERIOL; Anderson LB, 1996, P NATL ACAD SCI USA, V93, P8889, DOI 10.1073/pnas.93.17.8889; ANDERSSON SGE, 1995, J BACTERIOL, V177, P4171, DOI 10.1128/jb.177.14.4171-4175.1995; Andersson SGE, 1995, BIOCHEM CELL BIOL, V73, P775, DOI 10.1139/o95-086; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andrzejewska J, 2006, J BACTERIOL, V188, P5865, DOI 10.1128/JB.00060-06; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; Azad AF, 2003, ANN NY ACAD SCI, V990, P734, DOI 10.1111/j.1749-6632.2003.tb07452.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Bandyopadhyay P, 2007, INFECT IMMUN, V75, P723, DOI 10.1128/IAI.00956-06; Baron C, 2005, FEMS MICROBIOL LETT, V253, P163, DOI 10.1016/j.femsle.2005.09.030; Baron C, 1997, J BACTERIOL, V179, P1203, DOI 10.1128/jb.179.4.1203-1210.1997; Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Bayer M, 2001, J BACTERIOL, V183, P3176, DOI 10.1128/JB.183.10.3176-3183.2001; BAYER M, 1995, J BACTERIOL, V177, P4279, DOI 10.1128/jb.177.15.4279-4288.1995; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Beaupre CE, 1997, J BACTERIOL, V179, P78, DOI 10.1128/jb.179.1.78-89.1997; BEIJERSBERGEN A, 1994, PLASMID, V32, P212, DOI 10.1006/plas.1994.1057; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; BETZNER AS, 1989, MOL GEN GENET, V219, P489, DOI 10.1007/BF00259625; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Bohne J, 1998, P NATL ACAD SCI USA, V95, P7057, DOI 10.1073/pnas.95.12.7057; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Carle A, 2006, INFECT IMMUN, V74, P108, DOI 10.1128/IAI.74.1.108-117.2006; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chao CC, 2004, PROTEOMICS, V4, P1280, DOI 10.1002/pmic.200300775; Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; CHRISTIE PJ, 1989, P NATL ACAD SCI USA, V86, P9677, DOI 10.1073/pnas.86.24.9677; Christie PJ, 1997, J BACTERIOL, V179, P3085, DOI 10.1128/jb.179.10.3085-3094.1997; Citovsky V, 2004, J BIOL CHEM, V279, P29528, DOI 10.1074/jbc.M403159200; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DALE EM, 1993, J BACTERIOL, V175, P887, DOI 10.1128/JB.175.3.887-891.1993; Dang TAT, 1997, J BACTERIOL, V179, P453, DOI 10.1128/jb.179.2.453-462.1997; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das A, 1997, J BACTERIOL, V179, P3404, DOI 10.1128/jb.179.11.3404-3409.1997; De Buck E, 2007, MICROBIOL-SGM, V153, P3948, DOI 10.1099/mic.0.2007/012039-0; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Dozot M, 2006, CELL MICROBIOL, V8, P1791, DOI 10.1111/j.1462-5822.2006.00749.x; Draper O, 2006, J BIOL CHEM, V281, P37628, DOI 10.1074/jbc.M606403200; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Duckely M, 2003, FEMS MICROBIOL LETT, V223, P1, DOI 10.1016/S0378-1097(03)00246-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; FINBERG KE, 1995, J BACTERIOL, V177, P4881, DOI 10.1128/jb.177.17.4881-4889.1995; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; FRITSCHE TR, 1993, J CLIN MICROBIOL, V31, P1122, DOI 10.1128/JCM.31.5.1122-1126.1993; Fullner KJ, 1998, J BACTERIOL, V180, P430, DOI 10.1128/JB.180.2.430-434.1998; FULLNER KJ, 1994, MOL GEN GENET, V245, P704, DOI 10.1007/BF00297277; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; Fuxelius HH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r42; Ge H, 2004, J BACTERIOL, V186, P556, DOI 10.1128/JB.186.2.556-565.2004; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GUYON P, 1980, P NATL ACAD SCI-BIOL, V77, P2693, DOI 10.1073/pnas.77.5.2693; HALL J, 1985, J PARASITOL, V71, P89, DOI 10.2307/3281982; Hapfelmeier S, 2000, J BACTERIOL, V182, P4505, DOI 10.1128/JB.182.16.4505-4511.2000; Hare S, 2007, EMBO J, V26, P4926, DOI 10.1038/sj.emboj.7601904; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Harris RL, 2001, MOL MICROBIOL, V42, P757, DOI 10.1046/j.1365-2958.2001.02667.x; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Hoppner C, 2005, MICROBIOL-SGM, V151, P3469, DOI 10.1099/mic.0.28326-0; Horn M, 1999, ENVIRON MICROBIOL, V1, P357, DOI 10.1046/j.1462-2920.1999.00045.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; JONES AL, 1994, J BACTERIOL, V176, P5255, DOI 10.1128/JB.176.17.5255-5261.1994; Jones AL, 1996, J BACTERIOL, V178, P5706, DOI 10.1128/jb.178.19.5706-5711.1996; Judd PK, 2005, MICROBIOL-SGM, V151, P3483, DOI 10.1099/mic.0.28337-0; Judd PK, 2005, MOL MICROBIOL, V55, P115, DOI 10.1111/j.1365-2958.2004.04378.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KADO CI, 1994, MOL MICROBIOL, V12, P17, DOI 10.1111/j.1365-2958.1994.tb00990.x; Kalkum M, 2004, CURR PROTEIN PEPT SC, V5, P417, DOI 10.2174/1389203043379639; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; KOCH AL, 1990, RES MICROBIOL, V141, P119, DOI 10.1016/0923-2508(90)90103-W; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P106; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KULDAU GA, 1990, MOL GEN GENET, V221, P256, DOI 10.1007/BF00261729; Kumpar RB, 2001, J BACTERIOL, V183, P3636, DOI 10.1128/JB.183.12.3636-3641.2001; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lehnherr H, 1998, MOL MICROBIOL, V30, P454, DOI 10.1046/j.1365-2958.1998.01069.x; LESSL M, 1994, CELL, V77, P321, DOI 10.1016/0092-8674(94)90146-5; LIN TS, 1993, MOL MICROBIOL, V9, P803, DOI 10.1111/j.1365-2958.1993.tb01739.x; Liu ZY, 2003, J BACTERIOL, V185, P3259, DOI 10.1128/JB.185.11.3259-3269.2003; Llosa M, 2000, J BACTERIOL, V182, P3437, DOI 10.1128/JB.182.12.3437-3445.2000; MAHER D, 1993, J BACTERIOL, V175, P2175, DOI 10.1128/JB.175.8.2175-2183.1993; Malek JA, 2004, NUCLEIC ACIDS RES, V32, P1059, DOI 10.1093/nar/gkh254; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Masui S, 2000, J BACTERIOL, V182, P6529, DOI 10.1128/JB.182.22.6529-6531.2000; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Medini D, 2006, PLOS COMPUT BIOL, V2, P1543, DOI 10.1371/journal.pcbi.0020173; METZGER S, 1989, J BIOL CHEM, V264, P9122; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P7321, DOI 10.1073/pnas.93.14.7321; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; NORRIS V, 1993, BIOPHYS J, V64, P1691, DOI 10.1016/S0006-3495(93)81541-8; Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; OKAMOTO S, 1991, MOL GEN GENET, V228, P24, DOI 10.1007/BF00282443; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Pansegrau W, 1996, PROG NUCLEIC ACID RE, V54, P197, DOI 10.1016/S0079-6603(08)60364-5; Paschos A, 2006, P NATL ACAD SCI USA, V103, P7252, DOI 10.1073/pnas.0600862103; Patey G, 2006, INFECT IMMUN, V74, P4945, DOI 10.1128/IAI.00584-06; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quebatte M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13068; Rambaut A., 2007, TRACER V1 4; RANCES E, 2008, J BACTERIOL; Rashkova S, 1997, J BACTERIOL, V179, P583, DOI 10.1128/jb.179.3.583-591.1997; Robertus JD, 1998, J EXP ZOOL, V282, P127, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;127::AID-JEZ14&gt;3.0.CO;2-R; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; Saga G, 1998, TRENDS MICROBIOL, V6, P253, DOI 10.1016/S0966-842X(98)01308-0; Sagulenko V, 2001, J BACTERIOL, V183, P3642, DOI 10.1128/JB.183.12.3642-3651.2001; SALMOND GPC, 1994, ANNU REV PHYTOPATHOL, V32, P181, DOI 10.1146/annurev.py.32.090194.001145; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Sexton JA, 2002, TRAFFIC, V3, P178, DOI 10.1034/j.1600-0854.2002.030303.x; Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; SHIRASU K, 1990, MOL MICROBIOL, V4, P1153, DOI 10.1111/j.1365-2958.1990.tb00690.x; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512; STACHEL SE, 1986, CELL, V46, P325, DOI 10.1016/0092-8674(86)90653-7; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; STOTHARD DR, 1995, SYST APPL MICROBIOL, V18, P52, DOI 10.1016/S0723-2020(11)80448-0; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; THOMPSON DV, 1988, NUCLEIC ACIDS RES, V16, P4621, DOI 10.1093/nar/16.10.4621; THORSTENSON YR, 1994, J BACTERIOL, V176, P1711, DOI 10.1128/jb.176.6.1711-1717.1994; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Tzfira T, 2004, NATURE, V431, P87, DOI 10.1038/nature02857; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Vogel JP, 1999, CURR OPIN MICROBIOL, V2, P30, DOI 10.1016/S1369-5274(99)80005-8; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Ward DV, 2002, TRENDS PLANT SCI, V7, P1, DOI 10.1016/S1360-1385(01)02175-6; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; WARD JE, 1990, J BACTERIOL, V172, P5187, DOI 10.1128/jb.172.9.5187-5199.1990; WARD JE, 1988, J BIOL CHEM, V263, P5804; WARD JE, 1990, J BACTERIOL, V172, P5200, DOI 10.1128/jb.172.9.5200-5210.1990; WARD JE, 1991, P NATL ACAD SCI USA, V88, P9350, DOI 10.1073/pnas.88.20.9350; WARD JE, 1990, J BIOL CHEM, V265, P4768; Watarai M, 2001, MOL MICROBIOL, V39, P313, DOI 10.1046/j.1365-2958.2001.02193.x; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; Winiecka-Krusnell J, 2002, SCAND J INFECT DIS, V34, P253, DOI 10.1080/00365540110080052; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; Winiecka-Krusnell J, 1999, SCAND J INFECT DIS, V31, P383, DOI 10.1080/00365549950163833; Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07	216	73	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4833	10.1371/journal.pone.0004833	http://dx.doi.org/10.1371/journal.pone.0004833			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279686	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496200010
J	Stengel, KR; Thangavel, C; Solomon, DA; Angus, SP; Zheng, Y; Knudsen, ES				Stengel, Kristy R.; Thangavel, Chellappagounder; Solomon, David A.; Angus, Steve P.; Zheng, Yi; Knudsen, Erik S.			Retinoblastoma/p107/p130 Pocket Proteins PROTEIN DYNAMICS AND INTERACTIONS WITH TARGET GENE PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; LIVING CELLS; TRANSCRIPTION FACTOR; FAMILY PROTEINS; RB FUNCTION; IN-VIVO; S-PHASE; E2F; REPRESSION	The retinoblastoma (RB) tumor suppressor and its family members, p107 and p130, function by repressing E2F transcription factor activity to limit the expression of genes required for cell cycle progression. Traditionally, it is thought that the RB family proteins repress E2F target gene expression through complexing with E2F at gene promoters. However, whereas chromatin immunoprecipitation experiments have demonstrated p107 and p130 at E2F-responsive promoters, RB chromatin association has not been reliably observed. Here we used green fluorescent protein-tagged proteins to rigorously explore the mechanism of RB-mediated transcriptional repression relative to its p107 and p130 family members. The use of live cell fluorescent imaging demonstrated that RB, p107, and p130 exhibit similar nuclear dynamics. Although these findings suggest a similar engagement with nuclear structures, chromatin immunoprecipitation approaches with multiple independent antibodies failed to detect the association of RB with target gene promoters. However, by employing antibodies directed against green fluorescent protein, we could utilize the same antibody to assess RB, p107, and p130 engagement. This approach demonstrated RB association with target gene promoters in a fashion analogous to p107 and p130. Extension of this technology demonstrated that direct RB phosphorylation disrupts promoter association to regulate transcription. Thus, RB is associated with promoters in a manner similar to p107/p130 and that association is modulated by phosphorylation during cell cycle progression.	[Thangavel, Chellappagounder; Knudsen, Erik S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Stengel, Kristy R.; Zheng, Yi] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45267 USA; [Angus, Steve P.] Duke Univ, Durham, NC 27710 USA; [Solomon, David A.] Georgetown Univ, Washington, DC 20007 USA	Jefferson University; Cincinnati Children's Hospital Medical Center; Duke University; Georgetown University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Stengel, Kristy/0000-0002-8330-5744; Angus, Steven/0000-0002-7655-657X				Angus SP, 2003, MOL CELL BIOL, V23, P8172, DOI 10.1128/MCB.23.22.8172-8188.2003; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gunawardena RW, 2007, J BIOL CHEM, V282, P20116, DOI 10.1074/jbc.M701406200; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; KATO J, 1993, GENE DEV, V7, P331; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Markey MP, 2002, CANCER RES, V62, P6587; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Takahashi Y, 2000, GENE DEV, V14, P804; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Vandromme M, 2008, MOL CANCER RES, V6, P418, DOI 10.1158/1541-7786.MCR-07-0381; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Young AP, 2004, ONCOGENE, V23, P2587, DOI 10.1038/sj.onc.1207330; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	37	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19265	19271		10.1074/jbc.M808740200	http://dx.doi.org/10.1074/jbc.M808740200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19279001	hybrid, Green Published			2022-12-25	WOS:000267908300017
J	Roda-Navarro, P; Reyburn, HT				Roda-Navarro, Pedro; Reyburn, Hugh T.			The Traffic of the NKG2D/Dap10 Receptor Complex during Natural Killer (NK) Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; TUMOR-CELLS; T-CELLS; SECRETORY LYSOSOMES; SURFACE EXPRESSION; DOWN-REGULATION; IMMUNE SYNAPSE; LYMPHOCYTES-T; FAS LIGAND	NKG2D is an important activating receptor for triggering the NK cell cytotoxic activity, although chronic engagement of specific ligands by NKG2D is also known to provoke decreased cell surface expression of the receptor and compromised NK cell function. We have studied the dynamics of surface NKG2D expression and how exposure to the specific ligand major histocompatibility complex class I chain-related molecule B (MICB) affects receptor traffic and fate. While in the NKL cell line and "resting" NK cells NKG2D was found principally at the cell surface, in activated primary NK cells an intracellular pool of receptor could also be found recycling to the plasma membrane. Exposure of NK cells to targets expressing MICB resulted in degradation of similar to 50% of total NKG2D protein and lysosomal degradation of the DAP10 adaptor molecule. Consistent with these observations, confocal microscopy experiments demonstrated that DAP10 trafficked to secretory lysosomes in both transfected NKL cells and in activated primary NK cells upon interaction with MICB-expressing target cells. Interestingly, polarization to the synapse of secretory lysosomes containing DAP10 was also observed. The implications of the intracellular traffic of the NKG2D/DAP10 receptor complex for NK cell activation are discussed. We propose that the rapid degradation of NKG2D/DAP10 observed coincident with recruitment of the receptor to the cytotoxic immune synapse may explain the loss of NKG2D receptor expression after chronic exposure to NKG2D ligands.	[Roda-Navarro, Pedro; Reyburn, Hugh T.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Reyburn, HT (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3,Campus Cantoblanco, E-28049 Madrid, Spain.	htreyburn@cnb.csic.es	Reyburn, Hugh T/B-4338-2009	Reyburn, Hugh T/0000-0003-2855-1595	Leukaemia Research Fund; Spanish Ministry of Education and Science; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Leukaemia Research Fund; Spanish Ministry of Education and Science(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Leukaemia Research Fund.; Supported by a fellowship from the Spanish Ministry of Education and Science.	Augugliaro R, 2003, EUR J IMMUNOL, V33, P1235, DOI 10.1002/eji.200323896; Batista A, 2004, J IMMUNOL, V172, P6709, DOI 10.4049/jimmunol.172.11.6709; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Maasho K, 2005, J IMMUNOL, V174, P4480, DOI 10.4049/jimmunol.174.8.4480; MANDERS EMM, 1992, J CELL SCI, V103, P857; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; PETERS PJ, 1990, IMMUNOL TODAY, V11, P28; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Roda-Navarro P, 2007, FASEB J, V21, P1636, DOI 10.1096/fj.06-7488rev; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Skepper JN, 2000, J MICROSC-OXFORD, V199, P1, DOI 10.1046/j.1365-2818.2000.00704.x; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zuccato E, 2007, J CELL SCI, V120, P191, DOI 10.1242/jcs.03315	39	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16463	16472		10.1074/jbc.M808561200	http://dx.doi.org/10.1074/jbc.M808561200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19329438	Green Published, hybrid			2022-12-25	WOS:000266730900043
J	Satpathy, M; Shao, MH; Emerson, R; Donner, DB; Matei, D				Satpathy, Minati; Shao, Minghai; Emerson, Robert; Donner, David B.; Matei, Daniela			Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CREB; MATRIX-METALLOPROTEINASE-9 MMP-9; PHOSPHORYLATED CREB; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; CELLS; KINASE; PROGRESSION; CHEMOSENSITIVITY	Tissue transglutaminase 2 (TG2) is overexpressed in epithelial ovarian cancer (EOC) and promotes intraperitoneal metastasis. How TG2 facilitates the spread of EOC is unknown. Here, we show that TG2 regulates the expression and function of matrix metalloproteinase-2 (MMP-2), a critical mediator of tissue invasiveness. TG2 knockdown down-regulates MMP-2 protein and mRNA expression in SKOV3, IGROV-1, MDA-MB436, and PC-3 cancer cells. TG2 knockdown or inhibition of TG2 activity using KCC009 decreases MMP-2 gelatinase activity in cancer cells. MMP-2expression and function are regulated by TG2 at transcriptional level, as demonstrated by quantitative PCR and reporter assays. We used bioinformatics and chromatin immunoprecipitation to identify a CREB binding site in the MMP-2 promoter. Binding of CREB to the MMP-2 promoter was diminished in cells that expressed decreased TG2 levels. TG2 knockdown decreased CREB phosphorylation, and CREB knockdown decreased MMP-2 expression. The effect of TG2 on CREB-activity and MMP-2 transcription is mediated by TG2-dependent degradation of protein phosphatase 2 (PP2A-alpha). We show that PP2A-alpha complexes with and is targeted for degradation by TG2. In addition to their related in vitro expression levels, TG2 and MMP-2 expression were significantly correlated in vivo, as shown by concordant immunostaining in peritoneal xenografts and in human ovarian tumors. The capacity of TG2 to regulate MMP-2 expression in vitro and in vivo identifies a mechanism that may facilitate tissue invasion and the spread of EOC. The demonstration that TG2 induced degradation of PP2A-alpha activates CREB, and thereby increases MMP-2 transcription, provides novel mechanistic insight into the prometastatic function of TG2.	[Matei, Daniela] Indiana Univ, Sch Med, Div Hematol Oncol, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Satpathy, Minati; Shao, Minghai; Matei, Daniela] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Emerson, Robert] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ, Sch Med, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Donner, David B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of California System; University of California San Francisco	Matei, D (corresponding author), Indiana Univ, Sch Med, Div Hematol Oncol, Dept Biochem & Mol Biol, 535 Barnhill Dr,Route 473, Indianapolis, IN 46202 USA.	dmatei@iupui.edu		Matei, Daniela/0000-0003-2169-5035	United States Department of Veterans Affairs	United States Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the United States Department of Veterans Affairs through a Veterans Affairs Merit Award ( to D. M.).	ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Davidson B., 2002, Arkhiv Patologii, V64, P47; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Hanahan Douglas, 2003, Cancer Research, V63, P3005; HIMELSTEIN BP, 1994, INVAS METAST, V14, P246; Huang H, 2001, J BIOL CHEM, V276, P38830, DOI 10.1074/jbc.M103632200; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Moran A, 2005, ONCOL REP, V13, P115; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Perigny M, 2008, AM J CLIN PATHOL, V129, P226, DOI 10.1309/49LA9XCBGWJ8F2KM; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Sillanpaa S, 2007, GYNECOL ONCOL, V104, P296, DOI 10.1016/j.ygyno.2006.09.004; Smolarz Beata, 2003, Pol J Pathol, V54, P233; Stadlmann S, 2003, EUR J CANCER, V39, P2499, DOI 10.1016/j.ejca.2003.08.011; Szyllol K, 2002, J EXP CLIN CANC RES, V21, P357; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Westerlund A, 1997, GYNECOL ONCOL, V67, P76, DOI 10.1006/gyno.1997.4808; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; Zakany R, 2002, EXP CELL RES, V275, P1, DOI 10.1006/excr.2002.5487; Zhao J, 2008, J NEUROSCI RES, V86, P2733, DOI 10.1002/jnr.21712	44	52	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15390	15399		10.1074/jbc.M808331200	http://dx.doi.org/10.1074/jbc.M808331200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19324884	hybrid, Green Published			2022-12-25	WOS:000266501000006
J	Kou, R; Sartoretto, J; Michel, T				Kou, Ruqin; Sartoretto, Juliano; Michel, Thomas			Regulation of Rac1 by Simvastatin in Endothelial Cells DIFFERENTIAL ROLES OF AMP-ACTIVATED PROTEIN KINASE AND CALMODULIN-DEPENDENT KINASE KINASE-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; STATIN-MEDIATED INHIBITION; GENE-EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; MECHANISMS; THROMBIN; SITE	These studies explore the connections between simvastatin, Rac1, and AMP-activated protein kinase (AMPK) pathways in cultured vascular endothelial cells and in arterial preparations isolated from statin-treated mice. In addition to their prominent effects on lipoprotein metabolism, statins can regulate the small GTPase Rac1, and may also affect the phosphorylation of the ubiquitous AMPK. We explored pathways of statin-modulated Rac1 and AMPK activation both in arterial preparations from statin-treated mice as well as in cultured endothelial cells. We treated adult mice with simvastatin daily for 2 weeks and then harvested and analyzed arterial preparations. Simvastatin treatment of mice led to a significant increase in AMPK and LKB1 phosphorylation and to a decrease in protein kinase A activity relative to control animals, associated with a marked increase in Rac1 activation. Exposure of bovine aortic endothelial cells to simvastatin for 24 h strikingly increased GTP-bound Rac1 and led to increased phosphorylation of AMPK as well as the AMPK kinase LKB1. These responses to simvastatin were blocked by mevalonate or geranylgeranyl pyrophosphate but not by farnesyl pyrophosphate. Small interfering RNA (siRNA)mediated knockdown of AMPK abrogated simvastatin-induced Rac1 activation and LKB1 phosphorylation. Importantly, siRNA-mediated knockdown of the key AMPK kinase, calcium/calmodulin-dependent protein kinase kinase beta, completely blocked simvastatin-induced endothelial cell migration and also abrogated statin-promoted phosphorylation of AMPK and LKB1, as did pharmacological inhibition with the specific calcium/calmodulin-dependent protein kinase beta, inhibitor STO-609. Moreover, siRNA-mediated knockdown of Rac1 completely blocked simvastatin-induced LKB1 phosphorylation, but without affecting simvastatin-induced AMPK phosphorylation. These findings establish a key role for simvastatin in activation of a novel Rac1-dependent signaling pathway in the vascular wall.	[Kou, Ruqin; Sartoretto, Juliano; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Thorn Bldg,Rm 1210A,75 Francis St, Boston, MA 02115 USA.	thomas_michel@harvard.edu		sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [HL46457, HL48743, GM36259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, HL48743, and GM36259.	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Brandes RP, 2005, CIRC RES, V96, P927, DOI 10.1161/01.RES.0000168040.70096.2a; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fleming I, 2003, THROMB HAEMOSTASIS, V90, P863, DOI 10.1160/TH03-04-0228; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Halcox JPJ, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000129500.29229.92; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hernandez-Perera O, 2000, CIRC RES, V87, P616, DOI 10.1161/01.RES.87.7.616; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Kou RQ, 2007, J BIOL CHEM, V282, P32719, DOI 10.1074/jbc.M706815200; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Lian LY, 2000, STRUCT FOLD DES, V8, P47, DOI 10.1016/S0969-2126(00)00080-0; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; Xenos ES, 2005, ANN VASC SURG, V19, P386, DOI 10.1007/s10016-005-0011-7; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	41	59	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14734	14743		10.1074/jbc.M808664200	http://dx.doi.org/10.1074/jbc.M808664200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332549	Green Published, hybrid			2022-12-25	WOS:000266288200009
J	Nagy, P; Kettle, AJ; Winterbourn, CC				Nagy, Peter; Kettle, Anthony J.; Winterbourn, Christine C.			Superoxide-mediated Formation of Tyrosine Hydroperoxides and Methionine Sulfoxide in Peptides through Radical Addition and Intramolecular Oxygen Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEINS AI; ELECTRON-TRANSFER; SINGLET OXYGEN; H-BOND; OXIDATION; ACID; GENERATION; TRYPTOPHAN; REDUCTION	The chemistry underlying superoxide toxicity is not fully understood. A potential mechanism for superoxide-mediated injury involves addition to tyrosyl radicals, to give peptide or protein hydroperoxides. The rate constant for the reaction of tyrosyl radicals with superoxide is higher than for dimerization, but the efficiency of superoxide addition to peptides depends on the position of the Tyr residue. We have examined the requirements for superoxide addition and structurally characterized the products for a range of tyrosyl peptides exposed to a peroxidase/O-2(radical anion) system. These included enkephalins as examples of the numerous proteins and physiological peptides with N-terminal tyrosines. The importance of amino groups in promoting hydroperoxide formation and effect of methionine residues on the reaction were investigated. When tyrosine was N-terminal, the major products were hydroperoxides that had undergone cyclization through conjugate addition of the terminal amine. With non-N-terminal tyrosine, electron transfer from O-2(radical anion) to the peptide radical prevailed. Peptides containing methionine revealed a novel and efficient intramolecular oxygen transfer mechanism from an initial tyrosine hydroperoxide to give a dioxygenated derivative with one oxygen on the tyrosine and the other forming methionine sulfoxide. Exogenous amines promoted hydroperoxide formation on tyrosyl peptides lacking a terminal amine, without forming an adduct. These findings, plus the high hydroperoxide yields with N-terminal tyrosine, can be explained by a mechanism in which hydrogen bonding of O-2(radical anion) to the amine increases is oxidizing potential and alters its reactivity. If this amine effect occurred more generally, it could increase the biological reactivity of O-2(radical anion) and have major implications.	[Nagy, Peter; Kettle, Anthony J.; Winterbourn, Christine C.] Univ Otago, Dept Pathol, Christchurch 8140, New Zealand	University of Otago	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, 2 Ricarton Ave,POB 4345, Christchurch 8140, New Zealand.	christine.winterbourn@otago.ac.nz	Nagy, Peter/C-6768-2008; Kettle, Anthony J/A-8520-2008	Nagy, Peter/0000-0003-3393-235X; Kettle, Anthony J/0000-0002-8218-7766	Marsden Fund; Health Research Council of New Zealand	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Marsden Fund and the Health Research Council of New Zealand and used equipment provided by the National Research Centre for Growth and Development.	Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BOBROWSKI K, 1990, INT J RADIAT BIOL, V57, P919, DOI 10.1080/09553009014551041; BRUICE TC, 1976, ANNU REV BIOCHEM, V45, P331, DOI 10.1146/annurev.bi.45.070176.001555; d'Alessandro N, 2000, J CHEM SOC PERK T 2, P1862, DOI 10.1039/b003346o; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dean RT, 1997, BIOCHEM J, V324, P1; Field SA, 2008, CHEM RES TOXICOL, V21, P1923, DOI 10.1021/tx8001687; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; GIESEG SP, 1993, BIOCHEMISTRY-US, V32, P4780, DOI 10.1021/bi00069a012; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jiang XY, 1996, J MASS SPECTROM, V31, P1309, DOI 10.1002/(SICI)1096-9888(199611)31:11<1309::AID-JMS423>3.0.CO;2-R; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; JONSSON M, 1993, J PHYS CHEM-US, V97, P8229, DOI 10.1021/j100133a018; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Mozziconacci O, 2007, FREE RADICAL BIO MED, V43, P229, DOI 10.1016/j.freeradbiomed.2007.04.006; Ohkubo K, 2006, J PHYS CHEM A, V110, P11613, DOI 10.1021/jp064115m; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; PRUTZ WA, 1982, BIOCHIM BIOPHYS ACTA, V705, P139, DOI 10.1016/0167-4838(82)90172-8; SAITO I, 1975, J AM CHEM SOC, V97, P5272, DOI 10.1021/ja00851a042; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Villamena FA, 2007, J AM CHEM SOC, V129, P8177, DOI 10.1021/ja0702622; Winterbourn CC, 1997, ARCH BIOCHEM BIOPHYS, V338, P15, DOI 10.1006/abbi.1996.9773; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wright A, 2002, PHOTOCHEM PHOTOBIOL, V76, P35, DOI 10.1562/0031-8655(2002)076<0035:SOMPOE>2.0.CO;2; Zhang H, 2009, ARCH BIOCHEM BIOPHYS, V484, P134, DOI 10.1016/j.abb.2008.11.018	36	40	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14723	14733		10.1074/jbc.M809396200	http://dx.doi.org/10.1074/jbc.M809396200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297319	Green Published, hybrid			2022-12-25	WOS:000266288200008
J	Hernandez, A; Mate, MJ; Sanchez-Diaz, PC; Romero, A; Rojo, F; Martinez, JL				Hernandez, Alvaro; Mate, Maria J.; Sanchez-Diaz, Patricia C.; Romero, Antonio; Rojo, Fernando; Martinez, Jose L.			Structural and Functional Analysis of SmeT, the Repressor of the Stenotrophomonas maltophilia Multidrug Efflux Pump SmeDEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; RECOMBINANT PROTEINS; TETR FAMILY; BINDING; RESISTANCE; EXPRESSION; COMPLEX; MODEL; OVEREXPRESSION; VISUALIZATION	Stenotrophomonas maltophilia is an opportunistic pathogen characterized for its intrinsic low susceptibility to several antibiotics. Part of this low susceptibility relies on the expression of chromosomally encoded multidrug efflux pumps, with SmeDEF being the most relevant antibiotic resistance efflux pump so far studied in this bacterial species. Expression of smeDEF is down-regulated by the SmeT repressor, encoded upstream smeDEF, in its complementary DNA strand. In the present article we present the crystal structure of SmeT and analyze its interactions with its cognate operator. Like other members of the TetR family of transcriptional repressors, SmeT behaves as a dimer and presents some common structural features with other TetR proteins like TtgR, QacR, and TetR. Differing from other TetR proteins for which the structure is available, SmeT turned out to have two extensions at the N and C termini that might be relevant for its function. Besides, SmeT presents the smallest binding pocket so far described in the TetR family of transcriptional repressors, which may correlate with a specific type and range of effectors. In vitro studies revealed that SmeT binds to a 28-bp pseudopalindromic region, forming two complexes. This operator region was found to overlap the promoters of smeT and smeDEF. This finding is consistent with a role for SmeT simultaneously down-regulating smeT and smeDEF transcription, likely by steric hindrance on RNA polymerase binding to DNA.	[Hernandez, Alvaro; Sanchez-Diaz, Patricia C.; Rojo, Fernando; Martinez, Jose L.] CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid 28049, Spain; [Martinez, Jose L.] CIBERESP, Madrid 28049, Spain; [Mate, Maria J.; Romero, Antonio] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid 28049, Spain.	maria.mate@afmb.univ-mrs.fr; jlmtnez@cnb.csic.es	Rojo, Fernando/A-7038-2008; Martinez, Jose L/C-4100-2008; Romero, Antonio/K-5754-2014; Martinez, Jose L/A-4725-2013	Rojo, Fernando/0000-0003-1848-7745; Romero, Antonio/0000-0002-6990-6973; Martinez, Jose L/0000-0001-8813-7607	Spanish Ministry of Science and Innovation [BIO2005-04278, BFU2005-05055, BFU2006-00767/BMC, BIO-2008-00090]; European Union [LSHM-CT-2005-518152, LSHM-CT-2005018705]; Spanish Ministry of Health [REIPIRD06/0008]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grants BIO2005-04278, BFU2005-05055, BFU2006-00767/BMC, and BIO-2008-00090 from the Spanish Ministry of Science and Innovation, LSHM-CT-2005-518152 and LSHM-CT-2005018705 from the European Union, and REIPIRD06/0008 from the Spanish Ministry of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 1997, ANTIMICROB AGENTS CH, V41, P1140, DOI 10.1128/AAC.41.5.1140; Alonso A, 2001, ANTIMICROB AGENTS CH, V45, P1879, DOI 10.1128/AAC.45.6.1879-1881.2001; [Anonymous], 2000, WHO REP INF DIS; ATLAS RM, 1993, HDB MICROBIOLOGICAL, P492; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brooks BE, 2007, J AM CHEM SOC, V129, P8389, DOI 10.1021/ja072576v; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176; Kamionka A, 2004, NUCLEIC ACIDS RES, V32, P842, DOI 10.1093/nar/gkh200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Linares JF, 2005, J BACTERIOL, V187, P1384, DOI 10.1128/JB.187.4.1384-1391.2005; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Orth P, 1998, J MOL BIOL, V279, P439, DOI 10.1006/jmbi.1998.1775; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reichheld SE, 2006, J MOL BIOL, V361, P382, DOI 10.1016/j.jmb.2006.06.035; Resch M, 2008, NUCLEIC ACIDS RES, V36, P4390, DOI 10.1093/nar/gkn400; Rockwell NC, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-123; ROJO F, 1995, NUCLEIC ACIDS RES, V23, P3181, DOI 10.1093/nar/23.16.3181; Sanchez P, 2002, J ANTIMICROB CHEMOTH, V50, P657, DOI 10.1093/jac/dkf185; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; Sanchez P, 2004, ANTIMICROB AGENTS CH, V48, P2274, DOI 10.1128/AAC.48.6.2274-2276.2004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1688, DOI 10.1107/S0907444903015142; Vila J, 2008, CURR DRUG TARGETS, V9, P797, DOI 10.2174/138945008785747806; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Zhang L, 2001, ANTIMICROB AGENTS CH, V45, P3497, DOI 10.1128/AAC.45.12.3497-3503.2001	66	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14428	14438		10.1074/jbc.M809221200	http://dx.doi.org/10.1074/jbc.M809221200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324881	Green Published, hybrid			2022-12-25	WOS:000266286100049
J	Tremblay, CS; Huard, CC; Huang, FF; Habi, O; Bourdages, V; Levesque, G; Carreau, M				Tremblay, Cedric S.; Huard, Caroline C.; Huang, Feng-Fei; Habi, Ouassila; Bourdages, Valerie; Levesque, Georges; Carreau, Madeleine			The Fanconi Anemia Core Complex Acts as a Transcriptional Co-regulator in Hairy Enhancer of Split 1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS FANCA; DNA-REPAIR; POSITIONAL CLONING; NUCLEAR-COMPLEX; HELICASE BRIP1; GENE; NOTCH; PATHWAY; COMPLEMENTATION; CELLS	Mutations in one of the 13 Fanconi anemia (FA) genes cause a progressive bone marrow failure disorder associated with developmental abnormalities and a predisposition to cancer. Although FA has been defined as a DNA repair disease based on the hypersensitivity of patient cells to DNA cross-linking agents, FA patients develop various developmental defects such as skeletal abnormalities, microphthalmia, and endocrine abnormalities that may be linked to transcriptional defects. Recently, we reported that the FA core complex interacts with the transcriptional repressor Hairy Enhancer of Split 1 (HES1) suggesting that the core complex plays a role in transcription. Here we show that the FA core complex contributes to transcriptional regulation of HES1-responsive genes, including HES1 and the cyclin-dependent kinase inhibitor p21cip1/waf1. Chromatin immunoprecipitation studies show that the FA core complex interacts with the HES1 promoter but not the p21cip1/waf1 promoter. Furthermore, we show that the FA core complex interferes with HES1 binding to the co-repressor transducin-like-Enhancer of Split, suggesting that the core complex affects transcription both directly and indirectly. Taken together these data suggest a novel function of the FA core complex in transcriptional regulation.	[Tremblay, Cedric S.; Huard, Caroline C.; Huang, Feng-Fei; Habi, Ouassila; Bourdages, Valerie; Levesque, Georges; Carreau, Madeleine] Univ Laval, CHU Laval, Quebec City, PQ G1V 4G2, Canada; [Carreau, Madeleine] Univ Laval, Dept Pediat, Quebec City, PQ G1V 4G2, Canada; [Levesque, Georges] Univ Laval, Dept Med Biol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University; Laval University	Carreau, M (corresponding author), Univ Laval, CHU Laval, 2705 Boul Laurier,RC-9800, Quebec City, PQ G1V 4G2, Canada.	Madeleine.Carreau@crchul.ulaval.ca		Huard, Caroline/0000-0001-9646-0500; Carreau, Madeleine/0000-0002-0582-6114	Sickkids Foundation/Institute for Human Development; Child and Youth Health of the Canadian Institutes of Health Research [XG 05-014R]; Roche Foundation for Anemia Research and the Canadian Blood Services; Fonds de la Recherche en Sante du Quebec Senior; La Fondation de la Recherche sur les Maladies Infantiles; FRSQ	Sickkids Foundation/Institute for Human Development; Child and Youth Health of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Roche Foundation for Anemia Research and the Canadian Blood Services; Fonds de la Recherche en Sante du Quebec Senior; La Fondation de la Recherche sur les Maladies Infantiles; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Sickkids Foundation/Institute for Human Development, Child and Youth Health of the Canadian Institutes of Health Research (CIHR, Grant XG 05-014R: Role of Fanconi anemia proteins in development), the Roche Foundation for Anemia Research and the Canadian Blood Services, and Fonds de la Recherche en Sante du Quebec Senior Investigator Awards (to G. L. and M. C.). Additional support was provided by training awards from La Fondation de la Recherche sur les Maladies Infantiles (to C. S. T.), the CIHR (to C. H.), and the FRSQ (to C. S. T.).	Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; Baia G, 2008, NEOPLASIA, V10, P604, DOI 10.1593/neo.08356; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brodeur I, 2004, J BIOL CHEM, V279, P4713, DOI 10.1074/jbc.M301291200; Carreau M, 1999, EXP HEMATOL, V27, P1667, DOI 10.1016/S0301-472X(99)00102-2; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Compe E, 2007, NAT NEUROSCI, V10, P1414, DOI 10.1038/nn1990; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; de Winter JP, 2000, AM J HUM GENET, V67, P1306, DOI 10.1016/S0002-9297(07)62959-0; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Dokal I, 2000, BEST PRACT RES CL HA, V13, P407, DOI 10.1053/beha.2000.0085; Dorsman JC, 2007, CELL ONCOL, V29, P211; Fagerlie SR, 2001, BLOOD, V97, P3017, DOI 10.1182/blood.V97.10.3017; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Godin C, 2003, NEUROREPORT, V14, P1613, DOI 10.1097/00001756-200308260-00014; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Haneline LS, 1999, BLOOD, V94, P1; Hebert SS, 2003, NEUROBIOL DIS, V13, P238, DOI 10.1016/S0969-9961(03)00035-4; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; Kruyt FAE, 1999, J BIOL CHEM, V274, P34212, DOI 10.1074/jbc.274.48.34212; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wajnrajch MP, 2001, PEDIATRICS, V107, P744, DOI 10.1542/peds.107.4.744; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	60	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13384	13395		10.1074/jbc.M807921200	http://dx.doi.org/10.1074/jbc.M807921200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19321451	hybrid, Green Published			2022-12-25	WOS:000265877300014
J	Lee, J; Moir, RD; Willis, IM				Lee, JaeHoon; Moir, Robyn D.; Willis, Ian M.			Regulation of RNA Polymerase III Transcription Involves SCH9-dependent and SCH9-independent Branches of the Target of Rapamycin (TOR) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; NUCLEAR-LOCALIZATION; NEGATIVE REGULATOR; MASS-SPECTROMETRY; MAF1; SCH9; REPRESSION; GENES	Maf1 is a conserved repressor of transcription that functions at the downstream end of multiple nutrient and stress signaling pathways. How these different signaling pathways converge on Maf1 is not known. Previous work in yeast indicates that protein kinase A (PKA) regulates RNA polymerase (pol) III transcription, in part, by phosphorylating multiple sites in Maf1. Here we present additional evidence for this view and show that a parallel nutrient and stress-sensing pathway involving Sch9, an homologous kinase to metazoan S6 kinase, targets Maf1 at a subset of PKA sites. Using ATP analog-sensitive alleles of PKA and Sch9, we find that these two kinases account for the bulk of the phosphorylation on consensus PKA sites in Maf1. Deletion of Sch9 reduces RNA pol III transcription in a Maf1-dependent manner, yet the cells remain susceptible to further repression by rapamycin and other treatments. Because the rapamycin-sensitive kinase activity of the TORC1 complex is necessary for Sch9 function in vivo and in vitro, our results show that transcriptional regulation of RNA pol III and the coordinate control of ribosomal protein genes can be achieved by Sch9-dependent and -independent branches of the target of rapamycin (TOR) signaling pathway.	[Lee, JaeHoon; Moir, Robyn D.; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	willis@aecom.yu.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [GM42728]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42728. This work was also supported by funds from the Albert Einstein College of Medicine.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Gregan J, 2007, NAT PROTOC, V2, P2996, DOI 10.1038/nprot.2007.447; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Shou WY, 2002, METHOD ENZYMOL, V351, P279; Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Willis IM, 2007, TRENDS BIOCHEM SCI, V32, P51, DOI 10.1016/j.tibs.2006.12.001; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	24	90	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12604	12608		10.1074/jbc.C900020200	http://dx.doi.org/10.1074/jbc.C900020200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19299514	hybrid, Green Published			2022-12-25	WOS:000265688300004
J	Li, GD; Chiara, DC; Cohen, JB; Olsen, RW				Li, Guo-Dong; Chiara, David C.; Cohen, Jonathan B.; Olsen, Richard W.			Neurosteroids Allosterically Modulate Binding of the Anesthetic Etomidate to gamma-Aminobutyric Acid Type A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GABA(A) RECEPTOR; SITES; SUBUNIT; IDENTIFICATION; PHARMACOLOGY; MECHANISMS; MUTATIONS; PROPOFOL; DISTINCT	Photoaffinity labeling of gamma-aminobutyric acid type A (GABA(A))-receptors (GABA(A)R) with an etomidate analog and mutational analyses of direct activation of GABA(A)R by neurosteroids have each led to the proposal that these structurally distinct general anesthetics bind to sites in GABA(A)Rs in the transmembrane domain at the interface between the beta and alpha subunits. We tested whether the two ligand binding sites might overlap by examining whether neuroactive steroids inhibited etomidate analog photolabeling. We previously identified (Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006) J. Neurosci. 26, 11599 - 11605) azietomidate photolabeling of GABA(A)R alpha 1Met-236 and beta Met-286 (in alpha M1 and beta M3). Positioning these two photolabeled amino acids in a single type of binding site at the interface of beta and alpha subunits (two copies per pentamer) is consistent with a GABA(A)R homology model based upon the structure of the nicotinic acetylcholine receptor and with recent alpha M1 to beta M3 cross-linking data. Biologically active neurosteroids enhance rather than inhibit azietomidate photolabeling, as assayed at the level of GABA(A)R subunits on analytical SDS-PAGE, and protein microsequencing establishes that the GABA(A)R-modulating neurosteroids do not inhibit photolabeling of GABA(A)R alpha 1Met-236 or beta Met-286 but enhance labeling of alpha 1Met-236. Thus modulatory steroids do not bind at the same site as etomidate, and neither of the amino acids identified as neurosteroid activation determinants (Hosie, A. M., Wilkins, M. E., da Silva, H. M., and Smart, T. G. (2006) Nature 444, 486 - 489) are located at the subunit interface defined by our etomidate site model.	[Li, Guo-Dong; Olsen, Richard W.] Univ Calif Los Angeles, Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School	Li, GD (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	guodongli@mednet.ucla.edu; ROlsen@mednet.ucla.edu			National Institutes of Health [GM58448]; Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58448 (to R.W.O., J.B.C., and Keith W. Miller). This work was also supported by an award to Harvard Medical School from the Howard Hughes Biomedical Research Support Program for Medical School.	Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liao M, 2005, ANESTH ANALG, V101, P131, DOI 10.1213/01.ANE.0000153011.64764.6F; MCCLELLAND RA, 2004, REACTIVE INTERMEDIAT, P3; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vodovozova EL, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1, DOI 10.1134/S0006297907010014; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	29	54	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11771	11775		10.1074/jbc.C900016200	http://dx.doi.org/10.1074/jbc.C900016200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19282280	hybrid, Green Published			2022-12-25	WOS:000265494600008
J	Krause, ET; Honarmand, M; Wetzel, J; Naguib, M				Krause, E. Tobias; Honarmand, Mariam; Wetzel, Jennifer; Naguib, Marc			Early Fasting Is Long Lasting: Differences in Early Nutritional Conditions Reappear under Stressful Conditions in Adult Female Zebra Finches	PLOS ONE			English	Article								Conditions experienced during early life can have profound effects on individual development and condition in adulthood. Differences in nutritional provisioning in birds during the first month of life can lead to differences in growth, reproductive success and survival. Yet, under natural conditions shorter periods of nutritional stress will be more prevalent. Individuals may respond differently, depending on the period of development during which nutritional stress was experienced. Such differences may surface specifically when poor environmental conditions challenge individuals again as adults. Here, we investigated long term consequences of differences in nutritional conditions experienced during different periods of early development by female zebra finches (Taeniopygia guttata) on measures of management and acquisition of body reserves. As nestlings or fledglings, subjects were raised under different nutritional conditions, a low or high quality diet. After subjects reached sexual maturity, we measured their sensitivity to periods of food restriction, their exploration and foraging behaviour as well as adult resting metabolic rate (RMR). During a short period of food restriction, subjects from the poor nutritional conditions had a higher body mass loss than those raised under qualitatively superior nutritional conditions. Moreover, subjects that were raised under poor nutritional conditions were faster to engage in exploratory and foraging behaviour. But RMR did not differ among treatments. These results reveal that early nutritional conditions affect adult exploratory behaviour, a representative personality trait, foraging and adult's physiological condition. As early nutritional conditions are reflected in adult phenotypic plasticity specifically when stressful situations reappear, the results suggest that costs for poor developmental conditions are paid when environmental conditions deteriorate.	[Krause, E. Tobias; Honarmand, Mariam; Wetzel, Jennifer; Naguib, Marc] Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany; [Naguib, Marc] Netherlands Inst Ecol, NIOO KNAW, Dept Anim Populat Biol, Heteren, Netherlands	University of Bielefeld; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Krause, ET (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany.	tobias.krause@uni-bielefeld.de	Krause, E. Tobias/A-9900-2009; Naguib, Marc/C-2650-2009	Krause, E. Tobias/0000-0002-8327-3711; Naguib, Marc/0000-0003-0494-4888	German Research Foundation [Na335/6]	German Research Foundation(German Research Foundation (DFG))	The research was funded by a grant from the German Research Foundation (Na335/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; ARNOLD KE, 2007, P ROY SOC LOND B BIO, V274, P2693; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; Blount JD, 2006, IBIS, V148, P509, DOI 10.1111/j.1474-919X.2006.00554.x; Carere C, 2005, BEHAVIOUR, V142, P1329, DOI 10.1163/156853905774539328; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; Cuthill Innes C., 1997, P97; Deerenberg C, 1996, J AVIAN BIOL, V27, P321, DOI 10.2307/3677263; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2006, J NEUROBIOL, V66, P1602, DOI 10.1002/neu.20312; Immelmann K., 1965, Journal fuer Ornithologie, V106, P415, DOI 10.1007/BF01673432; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; LEMON WC, 1991, NATURE, V352, P153, DOI 10.1038/352153a0; LEMON WC, 1993, PHYSIOL ZOOL, V66, P946, DOI 10.1086/physzool.66.6.30163748; LEMON WC, 1992, ANIM BEHAV, V44, P851, DOI 10.1016/S0003-3472(05)80581-0; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; MacLeod R, 2007, ECOL LETT, V10, P945, DOI 10.1111/j.1461-0248.2007.01088.x; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Mosseau TA, 1998, MATERNAL EFFECTS ADA; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Nilsson JA, 2001, OECOLOGIA, V128, P187, DOI 10.1007/s004420100653; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Pravosudov VV, 2005, BEHAV NEUROSCI, V119, P1368, DOI 10.1037/0735-7044.119.5.1368; R Core Team, 2022, R LANG ENV STAT COMP; Rickard IJ, 2007, TRENDS ENDOCRIN MET, V18, P94, DOI 10.1016/j.tem.2007.02.004; Roff Derek A., 1992; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Tobler M, 2007, BIOLOGY LETT, V3, P408, DOI 10.1098/rsbl.2007.0127; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walling CA, 2007, BEHAV ECOL SOCIOBIOL, V61, P1007, DOI 10.1007/s00265-006-0333-7; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; [No title captured]	41	88	88	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e5015	10.1371/journal.pone.0005015	http://dx.doi.org/10.1371/journal.pone.0005015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325706	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499400006
J	Wang, K; Yu, CS; Xu, LJ; Qin, W; Li, KC; Xu, L; Jiang, TZ				Wang, Kun; Yu, Chunshui; Xu, Lijuan; Qin, Wen; Li, Kuncheng; Xu, Lin; Jiang, Tianzi			Offline Memory Reprocessing: Involvement of the Brain's Default Network in Spontaneous Thought Processes	PLOS ONE			English	Article							STIMULUS-INDEPENDENT THOUGHT; RESTING HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; EPISODIC MEMORY; BASE-LINE; PREFRONTAL CORTEX; PARIETAL CORTEX; WORKING-MEMORY; VISUAL-CORTEX; STATE	Background: Spontaneous thought processes (STPs), also called daydreaming or mind-wandering, occur ubiquitously in daily life. However, the functional significance of STPs remains largely unknown. Methodology/Principal Finding: Using functional magnetic resonance imaging (fMRI), we first identified an STPs-network whose activity was positively correlated with the subjects' tendency of having STPs during a task-free state. The STPs-network was then found to be strongly associated with the default network, which has previously been established as being active during the task-free state. Interestingly, we found that offline reprocessing of previously memorized information further increased the activity of the STPs-network regions, although during a state with less STPs. In addition, we found that the STPs-network kept a dynamic balance between functional integration and functional separation among its component regions to execute offline memory reprocessing in STPs. Conclusion/Significance: These findings strengthen a view that offline memory reprocessing and STPs share the brain's default network, and thus implicate that offline memory reprocessing may be a predetermined function of STPs. This supports the perspective that memory can be consolidated and modified during STPs, and thus gives rise to a dynamic behavior dependent on both previous external and internal experiences.	[Wang, Kun; Xu, Lijuan; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Yu, Chunshui; Qin, Wen; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Lab Learning & Memory, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wang, K (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn	QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Xu, Lin/0000-0002-2710-3507; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [30425004, 60121302]; National Key Basic Research and Development Program (973) [2004CB318107]; Beijing Scientific and Technological New Star Program [2005B21]; CAS graduate science and social practice special funding innovative research projects	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); Beijing Scientific and Technological New Star Program; CAS graduate science and social practice special funding innovative research projects	This work was supported by the Natural Science Foundation of China, Grant Nos. 30425004, and 60121302, the National Key Basic Research and Development Program (973), Grant No. 2004CB318107, Beijing Scientific and Technological New Star Program Grant No. 2005B21, and CAS graduate science and social practice special funding innovative research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; ANTROBUS JS, 1970, T NEW YORK ACAD SCI, V32, P242, DOI 10.1111/j.2164-0947.1970.tb02056.x; ANTROBUS JS, 1968, BRIT J PSYCHOL, V59, P423, DOI 10.1111/j.2044-8295.1968.tb01157.x; ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dalla Barba G, 1998, CORTEX, V34, P547; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRIEDMAN HR, 1994, J NEUROSCI, V14, P2775; GIAMBRA LM, 1979, INT J AGING HUM DEV, V10, P1, DOI 10.2190/01BD-RFNE-W34G-9ECA; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jonides J, 1998, J NEUROSCI, V18, P5026; KEDALL M, 1990, CORRELAION METHODS; Klinger E., 1987, IMAG COGN PERS, V7, P105, DOI [DOI 10.2190/7K24-G343-MTQW-115V, 10.2190/7k24-g343-mtqw-115v]; KLINGER E, 1971, STRUCTURE FUNCTIONAL; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mellet E, 1996, J NEUROSCI, V16, P6504; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Miyamoto Hiroyuki, 2003, Mol Interv, V3, P404, DOI 10.1124/mi.3.7.404; Nadel L, 2001, HIPPOCAMPUS, V11, P56, DOI 10.1002/1098-1063(2001)11:1<56::AID-HIPO1020>3.0.CO;2-O; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; SHANK RC, 1982, DYNAMIC MEMORY; SINGER J L, 1963, Percept Mot Skills, V17, P187; Singer J. L., 1972, FUNCTION NATURE IMAG, P175; SINGER JL, 1961, J CONSULT PSYCHOL, V25, P1, DOI 10.1037/h0048906; Singer JL., 1966, DAYDREAMING; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Stein T, 2000, AM J NEURORADIOL, V21, P1397; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tulving E, 1972, ORG MEMORY; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	59	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4867	10.1371/journal.pone.0004867	http://dx.doi.org/10.1371/journal.pone.0004867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290044	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496500004
J	Stillwell, E; Vitale, J; Zhao, QS; Beck, A; Schneider, J; Khadim, F; Elson, G; Altaf, A; Yehia, G; Dong, JH; Liu, J; Mark, W; Bhaumik, M; Grange, R; Fraidenraich, D				Stillwell, Elizabeth; Vitale, Joseph; Zhao, Qingshi; Beck, Amanda; Schneider, Joel; Khadim, Farah; Elson, Genie; Altaf, Aneela; Yehia, Ghassan; Dong, Jia-hui; Liu, Jing; Mark, Willie; Bhaumik, Mantu; Grange, Robert; Fraidenraich, Diego			Blastocyst Injection of Wild Type Embryonic Stem Cells Induces Global Corrections in Mdx Mice	PLOS ONE			English	Article								Duchenne muscular dystrophy (DMD) is an incurable neuromuscular degenerative disease, caused by a mutation in the dystrophin gene. Mdx mice recapitulate DMD features. Here we show that injection of wild-type (WT) embryonic stem cells (ESCs) into mdx blastocysts produces mice with improved pathology and function. A small fraction of WT ESCs incorporates into the mdx mouse nonuniformly to upregulate protein levels of dystrophin in the skeletal muscle. The chimeric muscle shows reduced regeneration and restores dystrobrevin, a dystrophin-related protein, in areas with high and with low dystrophin content. WT ESC injection increases the amount of fat in the chimeras to reach WT levels. ESC injection without dystrophin does not prevent the appearance of phenotypes in the skeletal muscle or in the fat. Thus, dystrophin supplied by the ESCs reverses disease in mdx mice globally in a dose-dependent manner.	[Stillwell, Elizabeth; Vitale, Joseph; Zhao, Qingshi; Beck, Amanda; Schneider, Joel; Khadim, Farah; Elson, Genie; Altaf, Aneela; Yehia, Ghassan; Fraidenraich, Diego] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Dong, Jia-hui; Liu, Jing; Mark, Willie] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY USA; [Bhaumik, Mantu] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ USA; [Grange, Robert] Virginia Polytech Inst & State Univ, Dept Human Nutr, Foods & Exercise, Blacksburg, VA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Polytechnic Institute & State University	Stillwell, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA.	fraidedi@umdnj.edu	Zhao, Qingshi/H-9839-2013		Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was funded by the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2008, J CELL SCI, V121, P48, DOI 10.1242/jcs.020701; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; Chien KR, 2004, SCIENCE, V306, P239, DOI 10.1126/science.1104769; Colussi C, 2008, GENE THER, V15, P1075, DOI 10.1038/gt.2008.95; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Fraidenraich Diego, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS14, DOI 10.1038/ncpcardio0402; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ito K, 2006, HUM MOL GENET, V15, P2266, DOI 10.1093/hmg/ddl151; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; MATSUDA R, 1983, DEV BIOL, V100, P478, DOI 10.1016/0012-1606(83)90240-3; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nawrotzki R, 1998, J CELL SCI, V111, P2595; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Personius KE, 2005, MUSCLE NERVE, V32, P656, DOI 10.1002/mus.20405; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Satomura S, 2001, METABOLISM, V50, P1181, DOI 10.1053/meta.2001.26701; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straino S, 2004, CIRCULATION, V110, P3341, DOI 10.1161/01.CIR.0000147776.50787.74; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961; WATKINS SC, 1989, MUSCLE NERVE, V12, P861, DOI 10.1002/mus.880121013; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wolff AV, 2006, MUSCLE NERVE, V34, P304, DOI 10.1002/mus.20588; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4759	10.1371/journal.pone.0004759	http://dx.doi.org/10.1371/journal.pone.0004759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277212	Green Published, gold			2022-12-25	WOS:000265496100009
J	Sankar, N; Kadeppagari, RK; Thimmapaya, B				Sankar, Natesan; Kadeppagari, Ravi-Kumar; Thimmapaya, Bayar			c-Myc-induced Aberrant DNA Synthesis and Activation of DNA Damage Response in p300 Knockdown Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORMANT ORIGINS; EXCESS MCM2-7; G(1) EXIT; REPLICATION; CYCLE; ATM; APOPTOSIS; PROTEINS; TUMORIGENESIS; ACETYLATION	We previously showed that in quiescent cells, p300/CBP (CREB-binding protein) family coactivators repress c-myc and prevent premature induction of DNA synthesis. p300/CBP-depleted cells exit G(1) early and continue to accumulate in S phase but do not progress into G(2)/M, and eventually they die of apoptosis. Here, we show that the S-phase arrest in these cells is because of an intra-S-phase block. The inappropriate DNA synthesis that occurs as a result of forced expression of c-myc leads to the activation of the DNA damage response as evidenced by the phosphorylation of several checkpoint related proteins and the formation of foci containing gamma-H2AX. The activation of checkpoint response is related to the induction of c-myc, as the phosphorylation of checkpoint proteins can be reversed when cells are treated with a c-Myc inhibitor or when Myc synthesis is blocked by short hairpin RNA. Using the DNA fiber assay, we show that in p300-depleted cells initiation of replication occurs from multiple replication origins. Chromatin loading of the Cdc45 protein also indicates increased origin activity in p300 knockdown cells. Immunofluorescence experiments indicate that c-Myc colocalizes with replication foci, consistent with the recently reported direct role of c-Myc in the initiation of DNA synthesis. Thus, the inappropriate S-phase entry of p300 down-regulated cells is likely to be because of c-Myc-induced deregulated replication origin activity, which results in replicative stress, activation of a DNA damage response, and S-phase arrest. Our results point to an important role for p300 in maintaining genomic integrity by negatively regulating c-myc.	[Sankar, Natesan; Kadeppagari, Ravi-Kumar; Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Thimmapaya, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Olson 8-452, Chicago, IL 60611 USA.	b-thimmapaya@northwestern.edu	KADEPPAGARI, RAVI KUMAR/C-1682-2015; Natesan, Sankar/C-9866-2015	KADEPPAGARI, RAVI KUMAR/0000-0003-0576-9508; 	National Institutes of Health [CA74403]; NATIONAL CANCER INSTITUTE [R01CA074403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA74403 (USPHS).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Baluchamy S, 2007, ONCOGENE, V26, P781, DOI 10.1038/sj.onc.1209825; Baluchamy S, 2003, P NATL ACAD SCI USA, V100, P9524, DOI 10.1073/pnas.1633700100; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; Dang CV, 1999, MOL CELL BIOL, V19, P1; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Jaspers Nicolaas G J, 2006, Methods Mol Biol, V314, P51; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kolli S, 2001, P NATL ACAD SCI USA, V98, P4646, DOI 10.1073/pnas.081141998; Liao Y, 2007, ADV EXP MED BIOL, V608, P144; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Rajabi HN, 2005, J BIOL CHEM, V280, P361, DOI 10.1074/jbc.M408633200; Saha P, 1998, J BIOL CHEM, V273, P18205, DOI 10.1074/jbc.273.29.18205; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singhal G, 2008, VIROLOGY, V377, P227, DOI 10.1016/j.virol.2008.04.042; SOULE HD, 1990, CANCER RES, V50, P6075; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	45	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15193	15205		10.1074/jbc.M900776200	http://dx.doi.org/10.1074/jbc.M900776200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332536	Green Published, hybrid			2022-12-25	WOS:000266288200054
J	Kim, J; Wong, PKY				Kim, Jeesun; Wong, Paul K. Y.			Oxidative Stress Is Linked to ERK1/2-p16 Signaling-mediated Growth Defect in ATM-deficient Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL SELF-RENEWAL; ATAXIA-TELANGIECTASIA; CYCLE CONTROL; INK4A LOCUS; CANCER; MUTANT; GENE; NEURODEGENERATION; APOPTOSIS; NEURONS	The gene that encodes the ATM protein kinase is mutated in ataxia-telangiectasia (A-T). One of the prominent features of A-T is progressive neurodegeneration. We have previously reported that primary astrocytes isolated from Atm(-/-) mice grow slowly and die earlier than control cells in culture. However, the mechanisms for this remain unclear. We show here that intrinsic elevated intracellular levels of reactive oxygen species (ROS) are associated with the senescence-like growth defect of Atm(-/-) astrocytes. This condition is accompanied by constitutively higher levels of ERK1/2 phosphorylation and p16(Ink4a) in Atm(-/-) astrocytes. We also observe that ROS-induced up-regulation of p16(Ink4a) occurs correlatively with ERK1/2-dependent down-regulation and subsequent dissociation from chromatin of Bmi-1. Furthermore, both mitogen-activated protein kinase (MAPK)/ERK inhibitor PD98059 and antioxidant N-acetyl-L-cysteine restored normal proliferation of Atm(-/-) astrocytes. These results suggest that ATM is required for normal astrocyte growth through its ability to stabilize intracellular redox status and that the inability to control ROS is the molecular basis of limited cell growth of Atm(-/-) astrocytes. This defect may be mediated by a mechanism involving ERK1/2 activation and Bmi-1 derepression of p16Ink4a. These data identify new potential targets for therapeutic intervention in A-T neurodegeneration.	[Wong, Paul K. Y.] Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Dept Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Wong, PKY (corresponding author), Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Dept Carcinogenesis, 1808 Pk Rd,1C,POB 389, Smithville, TX 78957 USA.	pkwong@mdanderson.org			M. D. Anderson Cancer Center; Longevity Foundation; Ataxia-telanglectasia (A-T) Children's Project	M. D. Anderson Cancer Center; Longevity Foundation; Ataxia-telanglectasia (A-T) Children's Project	This work was supported by a fellowship from the Odyssey Program of M. D. Anderson Cancer Center (to J.K.) and by funds from the Longevity Foundation and Ataxia-telanglectasia (A-T) Children's Project.	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Browne SE, 2004, FREE RADICAL BIO MED, V36, P938, DOI 10.1016/j.freeradbiomed.2004.01.003; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; Chen P, 2003, J NEUROSCI, V23, P11453; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Crawford T O, 1998, Semin Pediatr Neurol, V5, P287, DOI 10.1016/S1071-9091(98)80007-7; Gamaley IA, 1999, INT REV CYTOL, V188, P203; Gosink EC, 1999, CANCER RES, V59, P5294; Gottfried C, 2002, MECH AGEING DEV, V123, P1333, DOI 10.1016/S0047-6374(02)00069-6; Gueven N, 2006, FREE RADICAL BIO MED, V41, P992, DOI 10.1016/j.freeradbiomed.2006.06.018; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Jiang YH, 2006, J VIROL, V80, P4557, DOI 10.1128/JVI.80.9.4557-4569.2006; Jorgensen TJ, 1996, INT J RADIAT BIOL, V69, P527, DOI 10.1080/095530096145535; Kamsler A, 2001, CANCER RES, V61, P1849; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Leutner S, 2005, PHARMACOPSYCHIATRY, V38, P312, DOI 10.1055/s-2005-916186; Lin YC, 1997, J NEUROVIROL, V3, P28, DOI 10.3109/13550289709015790; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Lucius R, 1996, BRAIN RES, V743, P56, DOI 10.1016/S0006-8993(96)01029-3; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Moors M, 2007, TOXICOL APPL PHARM, V221, P57, DOI 10.1016/j.taap.2007.02.018; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Pardo AC, 2006, EXP NEUROL, V201, P120, DOI 10.1016/j.expneurol.2006.03.028; Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rotman G, 1997, CANCER SURV, V29, P285; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHIKOVA E, 1993, J VIROL, V67, P1137, DOI 10.1128/JVI.67.3.1137-1147.1993; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Voncken JW, 1999, J CELL SCI, V112, P4627; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Watters DJ, 2003, REDOX REP, V8, P23, DOI 10.1179/135100003125001206; Wong P. K. Y., 1997, EOS-Rivista di Immunologia ed Immunofarmacologia, V17, P30; Yan MS, 2006, FREE RADICAL BIO MED, V41, P640, DOI 10.1016/j.freeradbiomed.2006.05.008; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	54	60	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14396	14404		10.1074/jbc.M808116200	http://dx.doi.org/10.1074/jbc.M808116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321450	Green Published, hybrid			2022-12-25	WOS:000266286100046
J	Maga, G; van Loon, B; Crespan, E; Villani, G; Hubscher, U				Maga, Giovanni; van Loon, Barbara; Crespan, Emmanuele; Villani, Giuseppe; Huebscher, Ulrich			The Block of DNA Polymerase delta Strand Displacement Activity by an Abasic Site Can Be Rescued by the Concerted Action of DNA Polymerase beta and Flap Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION PROTEIN-A; LAMBDA; BYPASS; REPAIR	Abasic (AP) sites are very frequent and dangerous DNA lesions. Their ability to block the advancement of a replication fork has been always viewed as a consequence of their inhibitory effect on the DNA synthetic activity of replicative DNA polymerases (DNA pols). Here we show that AP sites can also affect the strand displacement activity of the lagging strand DNA pol delta, thus preventing proper Okazaki fragment maturation. This block can be overcome through a polymerase switch, involving the combined physical and functional interaction of DNA pol beta and Flap endonuclease 1. Our data identify a previously unnoticed deleterious effect of the AP site lesion on normal cell metabolism and suggest the existence of a novel repair pathway that might be important in preventing replication fork stalling.	[Maga, Giovanni] CNR, IGM, Inst Mol Genet, I-27100 Pavia, Italy; [van Loon, Barbara; Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Villani, Giuseppe] Univ Toulouse 3, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Zurich; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Maga, G (corresponding author), CNR, IGM, Inst Mol Genet, Via Abbiategrasso 207, I-27100 Pavia, Italy.	maga@igm.cnr.it	Maga, Giovanni/C-5409-2009; van Loon, Barbara/E-6771-2014; Crespan, Emmanuele/F-3899-2018	Maga, Giovanni/0000-0001-8092-1552; van Loon, Barbara/0000-0002-7597-207X; Crespan, Emmanuele/0000-0003-0597-6929	Italiana per la Ricerca sul Cancro-AIRC Investigator Grant	Italiana per la Ricerca sul Cancro-AIRC Investigator Grant(Fondazione AIRC per la ricerca sul cancro)	Supported by an Associazione Italiana per la Ricerca sul Cancro-AIRC Investigator Grant. To whom correspondence should be addressed: Institute of Molecular Genetics IGM-CNR, via Abbiategrasso 207, I-27100 Pavia, Italy.	Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Cordeiro-Stone M, 2002, MUTAT RES-FUND MOL M, V510, P91, DOI 10.1016/S0027-5107(02)00255-5; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Maga G, 2008, P NATL ACAD SCI USA, V105, P20689, DOI 10.1073/pnas.0811241106; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MEZZINA M, 1988, J VIROL, V62, P4249, DOI 10.1128/JVI.62.11.4249-4258.1988; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Nikolaishvili-Feinberg N, 2001, BIOCHEMISTRY-US, V40, P15215, DOI 10.1021/bi011474t; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001	26	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14267	14275		10.1074/jbc.M900759200	http://dx.doi.org/10.1074/jbc.M900759200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329428	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000266286100033
J	Grimm, C; Jors, S; Heller, S				Grimm, Christian; Joers, Simone; Heller, Stefan			Life and Death of Sensory Hair Cells Expressing Constitutively Active TRPML3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARITINT-WADDLER VA; DEAFWADDLER MICE; DEAFNESS; MUTATIONS; MOUSE; CA2+; INCREASES; PHENOTYPE; RECEPTOR; BUNDLES	The varitint-waddler mutation A419P renders TRPML3 constitutively active, resulting in cationic overload, particularly in sustained influx of Ca2+. TRPML3 is expressed by inner ear sensory hair cells, and we were intrigued by the fact that hair cells are able to cope with expressing the TRPML3(A419P) isoform for weeks before they ultimately die. We hypothesized that the survival of varitint-waddler hair cells is linked to their ability to deal with Ca2+ loads due to the abundance of plasma membrane calcium ATPases (PMCAs). Here, we show that PMCA2 significantly reduced [Ca2+](i) increase and apoptosis in HEK293 cells expressing TRPML3(A419P). The deaf-waddler isoform of PMCA2, operating at 30% efficacy, showed a significantly decreased ability to rescue the Ca2+ loading of cells expressing TRPML3(A419P). When we combined mice heterozygous for the varitint-waddler mutant allele with mice heterozygous for the deaf-waddler mutant allele, we found severe hair bundle defects as well as increased hair cell loss compared with mice heterozygous for each mutant allele alone. Furthermore, 3-week-old double mutant mice lacked auditory brainstem responses, which were present in their respective littermates containing single mutant alleles. Likewise, heterozygous double mutant mice exhibited severe circling behavior, which was not observed in mice heterozygous for TRPML3(A419P) or PMCA2(G283S) alone. Our results provide a molecular rationale for the delayed hair cell loss in varitint-waddler mice. They also show that hair cells are able to survive for weeks with sustained Ca2+ loading, which implies that Ca2+ loading is an unlikely primary cause of hair cell death in ototoxic stress situations.	Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol, 801 Welch Rd, Stanford, CA 94305 USA.	hellers@stanford.edu	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559	National Institutes of Health [DC04563]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC04563.	Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; De Luisi A, 2003, J CELL SCI, V116, P1527, DOI 10.1242/jcs.00368; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Duncan RK, 2000, J COMP PHYSIOL A, V186, P1095, DOI 10.1007/s003590000164; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Kim HJ, 2003, JARO-J ASSOC RES OTO, V4, P83, DOI 10.1007/s10162-002-3011-0; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Penheiter AR, 2001, HEARING RES, V162, P19, DOI 10.1016/S0378-5955(01)00356-2; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yamoah EN, 1998, J NEUROSCI, V18, P610	20	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13823	13831		10.1074/jbc.M809045200	http://dx.doi.org/10.1074/jbc.M809045200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299509	hybrid, Green Published			2022-12-25	WOS:000265877300059
J	Harrington, JM; Howell, S; Hajduk, SL				Harrington, John M.; Howell, Sawyer; Hajduk, Stephen L.			Membrane Permeabilization by Trypanosome Lytic Factor, a Cytolytic Human High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAPTOGLOBIN-RELATED PROTEIN; APOLIPOPROTEIN-L GENE; NORMAL HUMAN-SERUM; A-I; PHOSPHOLIPID-MEMBRANES; BRUCEI; HEMOGLOBIN; PLASMA; LYSIS; IDENTIFICATION	Trypanosome lytic factor (TLF) is a subclass of human high density lipoprotein (HDL) that mediates an innate immune killing of certain mammalian trypanosomes, most notably Trypanosoma brucei brucei, the causative agent of a wasting disease in cattle. Mechanistically, killing is initiated in the lysosome of the target trypanosome where the acidic pH facilitates a membrane-disrupting activity by TLF. Here we utilize a model liposome system to characterize the membrane binding and permeabilizing activity of TLF and its protein constituents, haptoglobin-related protein (Hpr), apolipoprotein L-1 (apoL-1), and apolipoprotein A-1 (apoA-1). We show that TLF efficiently binds and permeabilizes unilamellar liposomes at lysosomal pH, whereas non-lytic human HDL exhibits inefficient permeabilizing activity. Purified, delipidated Hpr and apoL-1 both efficiently permeabilize lipid bilayers at low pH. Trypanosome lytic factor, apoL-1, and apoA-1 exhibit specificity for anionic membranes, whereas Hpr permeabilizes both anionic and zwitterionic membranes. Analysis of the relative particle sizes of susceptible liposomes reveals distinctly different membrane-active behavior for native TLF and the delipidated protein components. We propose that lysosomal membrane damage in TLF-susceptible trypanosomes is initiated by the stable association of the TLF particle with the lysosomal membrane and that this is a property unique to this subclass of human HDL.	[Harrington, John M.; Howell, Sawyer; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hajduk, SL (corresponding author), 120 Green St,B129 Life Sci Bldg, Athens, GA 30602 USA.	shajduk@bmb.uga.edu			National Institutes of Health [AI39033]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039033, R21AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI39033 (to S. L. H.).	Andra J, 2003, DEV COMP IMMUNOL, V27, P291, DOI 10.1016/S0145-305X(02)00106-4; BAUMBERGER C, 1991, PATHOBIOLOGY, V59, P378, DOI 10.1159/000163681; Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 2001, J LIPID RES, V42, P620; Fedders H, 2008, BIOCHEM J, V416, P65, DOI 10.1042/BJ20080398; Fukuda M, 2007, J LIPID RES, V48, P882, DOI 10.1194/jlr.M600495-JLR200; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; HAJDUK SL, 1992, PARASITOL TODAY, V8, P95, DOI 10.1016/0169-4758(92)90247-Y; Harrington JM, 2008, BIOCHEM J, V413, P305, DOI 10.1042/BJ20071357; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; LORENZ P, 1994, T ROY SOC TROP MED H, V88, P487, DOI 10.1016/0035-9203(94)90443-X; MAEDA N, 1985, J BIOL CHEM, V260, P6698; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; MCEVOY SM, 1988, J BIOL CHEM, V263, P15740; Molina-Portela MP, 2008, J EXP MED, V205, P1721, DOI 10.1084/jem.20071463; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oli MW, 2006, EUKARYOT CELL, V5, P132, DOI 10.1128/EC.5.1.132-139.2006; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; RIFKIN MR, 1978, P NATL ACAD SCI USA, V75, P3450, DOI 10.1073/pnas.75.7.3450; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; SEGREST JP, 1992, J LIPID RES, V33, P141; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; TALL AR, 1977, NATURE, V265, P163, DOI 10.1038/265163a0; Thaveeratitham P, 2007, J ENDOTOXIN RES, V13, P58, DOI 10.1177/0968051907078611; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2006, CELL MOL LIFE SCI, V63, P1937, DOI 10.1007/s00018-006-6091-x; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2007, J EUKARYOT MICROBIOL, V54, P448, DOI 10.1111/j.1550-7408.2007.00285.x; VANZWIETEN R, 1981, J CLIN INVEST, V68, P310, DOI 10.1172/JCI110250; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Winkelmann J, 2006, MOL BIOCHEM PARASIT, V147, P85, DOI 10.1016/j.molbiopara.2006.01.010; WRIGHT J, 1986, J CLIN INVEST, V77, P782, DOI 10.1172/JCI112375; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	50	32	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13505	13512		10.1074/jbc.M900151200	http://dx.doi.org/10.1074/jbc.M900151200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324878	Green Published, hybrid			2022-12-25	WOS:000265877300027
J	Kuang, E; Wu, FY; Zhu, FX				Kuang, Ersheng; Wu, Fayi; Zhu, Fanxiu			Mechanism of Sustained Activation of Ribosomal S6 Kinase (RSK) and ERK by Kaposi Sarcoma-associated Herpesvirus ORF45 MULTIPROTEIN COMPLEXES RETAIN ACTIVE PHOSPHORYLATED ERK AND RSK AND PROTECT THEM FROM DEPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; HUMAN CYTOMEGALOVIRUS-INFECTION; CANCER-CELL-PROLIFERATION; MAP KINASE; IN-VIVO; DOCKING SITE; PATHWAY; SPECIFICITY; INHIBITION; IDENTIFICATION	As obligate intracellular parasites, viruses exploit diverse cellular signaling machineries, including the mitogen-activated protein-kinase pathway, during their infections. We have demonstrated previously that the open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus interacts with p90 ribosomal S6 kinases (RSKs) and strongly stimulates their kinase activities (Kuang, E., Tang, Q., Maul, G. G., and Zhu, F. (2008) J. Virol. 82, 1838-1850). Here, we define the mechanism by which ORF45 activates RSKs. We demonstrated that binding of ORF45 to RSK increases the association of extracellular signal-regulated kinase (ERK) with RSK, such that ORF45, RSK, and ERK formed high molecular mass protein complexes. We further demonstrated that the complexes shielded active pERK and pRSK from dephosphorylation. As a result, the complex-associated RSK and ERK were activated and sustained at high levels. Finally, we provide evidence that this mechanism contributes to the sustained activation of ERK and RSK in Kaposi sarcoma-associated herpesvirus lytic replication.	[Kuang, Ersheng; Wu, Fayi; Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Zhu, FX (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.	fzhu@bio.fsu.edu			National Institutes of Health [R01DE016680]; Bankhead-Coley bridge grant; Florida State University set-up funds; a planning grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley bridge grant; Florida State University set-up funds; a planning grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE016680. This work was also supported by a Bankhead-Coley bridge grant, Florida State University set-up funds, and a planning grant ( to F. Z.).	Abada R, 2008, J VIROL, V82, P2230, DOI 10.1128/JVI.02285-07; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clark DE, 2005, CANCER RES, V65, P3108; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuadrado A, 2007, CANCER CELL, V12, P187, DOI 10.1016/j.ccr.2007.08.017; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; GANEM D, 2007, FIELDS VIROLOGY, P2847; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kim MJ, 2006, EMBO J, V25, P3056, DOI 10.1038/sj.emboj.7601180; Kong XY, 2004, FEBS LETT, V559, P33, DOI 10.1016/S0014-5793(04)00002-X; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Xie JP, 2005, J VIROL, V79, P15027, DOI 10.1128/JVI.79.24.15027-15037.2005; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	60	40	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13958	13968		10.1074/jbc.M900025200	http://dx.doi.org/10.1074/jbc.M900025200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304659	Green Published, hybrid			2022-12-25	WOS:000265877300071
J	Lilla, JN; Joshi, RV; Craik, CS; Werb, Z				Lilla, Jennifer N.; Joshi, Ravi V.; Craik, Charles S.; Werb, Zena			Active Plasma Kallikrein Localizes to Mast Cells and Regulates Epithelial Cell Apoptosis, Adipocyte Differentiation, and Stromal Remodeling during Mammary Gland Involution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-I; PLASMINOGEN ACTIVATION; CONTACT ACTIVATION; PREKALLIKREIN GENE; EXPRESSION; KININOGEN; SYSTEM; TRANSCRIPTION; ADIPOGENESIS; INHIBITION	The plasminogen cascade of serine proteases directs both development and tumorigenesis in the mammary gland. Plasminogen can be activated to plasmin by urokinase-type plasminogen activator (uPA), tissue-type plasminogen activator (tPA), and plasma kallikrein (PKal). The dominant plasminogen activator for mammary involution is PKal, a serine protease that participates in the contact activation system of blood coagulation. We observed that the prekallikrein gene (Klkb1) is expressed highly in the mammary gland during stromal remodeling periods including puberty and postlactational involution. We used a variant of ecotin (ecotin-PKal), a macromolecular inhibitor of serine proteases engineered to be highly specific for active PKal, to demonstrate that inhibition of PKal with ecotin-PKal delays alveolar apoptosis, adipocyte replenishment, and stromal remodeling in the involuting mammary gland, producing a phenotype resembling that resulting from plasminogen deficiency. Using biotinylated ecotin-PKal, we localized active PKal to connective tissue-type mast cells in the mammary gland. Taken together, these results implicate PKal as an effector of the plasminogen cascade during mammary development.	[Lilla, Jennifer N.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Joshi, Ravi V.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, HSW 1323, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			National Institutes of Health [CA057621]; NCI [CA072006]; Department of Defense DOD-CMDRP Breast Cancer Research Program [W81XW-05-0272]; NATIONAL CANCER INSTITUTE [P01CA072006, R01CA057621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense DOD-CMDRP Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA057621 and CA072006 from the NCI. This work was also supported by a Predoctoral Fellowship from the Department of Defense DOD-CMDRP Breast Cancer Research Program (W81XW-05-0272) ( to J. N. L.).	Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; BAUMGARTEN CR, 1986, J IMMUNOL, V137, P977; Cerf ME, 2000, METAB BRAIN DIS, V15, P315, DOI 10.1023/A:1011179426420; CIECHANOWICZ A, 1993, BIOCHEM BIOPH RES CO, V197, P1370, DOI 10.1006/bbrc.1993.2628; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; ICHINOSE A, 1984, FEBS LETT, V175, P412, DOI 10.1016/0014-5793(84)80779-6; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Lima AR, 2008, BIOL CHEM, V389, P1487, DOI 10.1515/BC.2008.166; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1996, DEVELOPMENT, V122, P181; Lund LR, 2000, DEVELOPMENT, V127, P4481; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; MCINTYRE JA, 1981, INT ARCH ALLER A IMM, V66, P244, DOI 10.1159/000232827; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; MOLONEY WC, 1960, J HISTOCHEM CYTOCHEM, V8, P200, DOI 10.1177/8.3.200; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Neth P, 2005, BIOL CHEM, V386, P101, DOI 10.1515/BC.2005.013; Neth P, 2001, THROMB HAEMOSTASIS, V85, P1043, DOI 10.1055/s-0037-1615961; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; RAZIN E, 1984, J IMMUNOL, V132, P1479; Rojkjaer R, 1999, IMMUNOPHARMACOLOGY, V43, P109, DOI 10.1016/S0162-3109(99)00069-7; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Schmaier AH, 1999, THROMB HAEMOSTASIS, V82, P226; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; STRANGE R, 1992, DEVELOPMENT, V115, P49; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Yang SQ, 1998, J MOL BIOL, V279, P1001, DOI 10.1006/jmbi.1998.1749	35	36	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13792	13803		10.1074/jbc.M900508200	http://dx.doi.org/10.1074/jbc.M900508200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297327	hybrid, Green Published			2022-12-25	WOS:000265877300056
J	Kampf, M; Absmanner, B; Schwarz, M; Lehle, L				Kaempf, Michael; Absmanner, Birgit; Schwarz, Markus; Lehle, Ludwig			Biochemical Characterization and Membrane Topology of Alg2 from Saccharomyces cerevisiae as a Bifunctional alpha 1,3-and 1,6-Mannosyltransferase Involved in Lipid-linked Oligosaccharide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; FUNGUS RHIZOMUCOR-PUSILLUS; YEAST MUTANTS DEFICIENT; 2 ACTIVE-SITES; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MOLECULAR-CLONING; PROTEIN TOPOLOGY; OLIGOSACCHARYLTRANSFERASE COMPLEX; TRANSMEMBRANE TOPOLOGY	N-Linked glycosylation involves the ordered, stepwise synthesis of the unique lipid-linked oligosaccharide precursor Glc(3)Man(9) GlcNAc(2)-PP-Dol on the endoplasmic reticulum (ER), catalyzed by a series of glycosyltransferases. Here we characterize Alg2 as a bifunctional enzyme that is required for both the transfer of the alpha 1,3- and the alpha 1,6-mannose-linked residue from GDP-mannose to Man(1)GlcNAc(2)-PP-Dol forming the Man(3)GlcNAc(2)-PP-Dol intermediate on the cytosolic side of the ER. Alg2 has a calculated mass of 58 kDa and is predicted to contain four transmembrane-spanning helices, two at the N-terminus and two at the C terminus. Contradictory to topology predictions, we prove that only the two N-terminal domains ful-fill this criterion, whereas the C-terminal hydrophobic sequences contribute to ER localization in a nontransmembrane manner. Surprisingly, none of the four domains is essential for transferase activity because truncated Alg2 variants can exert their function as long as Alg2 is associated with the ER by either its N- or C-terminal hydrophobic regions. By site-directed mutagenesis we demonstrate that an EX7E motif, conserved in a variety of glycosyltransferases, is not important for Alg2 function in vivo and in vitro. Instead, we identify a conserved lysine residue, Lys(230), as being essential for activity, which could be involved in the binding of the phosphate of the glycosyl donor.	[Kaempf, Michael; Absmanner, Birgit; Schwarz, Markus; Lehle, Ludwig] Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93053 Regensburg, Germany	University of Regensburg	Lehle, L (corresponding author), Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, Univ Str 31, D-93053 Regensburg, Germany.	ludwig.lehle@biologie.uni-regensburg.de			Deutsche Forschungsgemeinschaft; Korber-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Korber-Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Korber-Stiftung.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; BECK PJ, 1990, SOMAT CELL MOLEC GEN, V16, P539, DOI 10.1007/BF01233094; Bickel T, 2005, J BIOL CHEM, V280, P34500, DOI 10.1074/jbc.M506358200; Blobel G, 2000, CHEMBIOCHEM, V1, P87; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CHAPMAN A, 1979, J BIOL CHEM, V254, P243; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Frank CG, 2005, GLYCOBIOLOGY, V15, P1156, DOI 10.1093/glycob/cwj002; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hall CW, 1997, J CELL BIOCHEM, V67, P201, DOI 10.1002/(SICI)1097-4644(19971101)67:2<201::AID-JCB5>3.3.CO;2-Q; HEIFETZ A, 1977, J BIOL CHEM, V252, P3057; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; KEAN EL, 1983, BIOCHIM BIOPHYS ACTA, V750, P268, DOI 10.1016/0005-2760(83)90028-0; Kean EL, 1999, J BIOL CHEM, V274, P34072, DOI 10.1074/jbc.274.48.34072; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; RUNGE KW, 1984, J BIOL CHEM, V259, P412; RUNGE KW, 1986, J BIOL CHEM, V261, P5582; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; SENGSTAG C, 1990, MOL CELL BIOL, V10, P672, DOI 10.1128/MCB.10.2.672; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; Sharma CB, 2001, BIOL CHEM, V382, P321, DOI 10.1515/BC.2001.039; SILBERSTEIN S, 1995, J CELL BIOL, V131, P371, DOI 10.1083/jcb.131.2.371; Stolz J, 1998, FEBS LETT, V440, P213, DOI 10.1016/S0014-5793(98)01454-9; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Takeuchi K, 1999, GLYCOBIOLOGY, V9, P1287, DOI 10.1093/glycob/9.12.1287; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; VIJAY IK, 1982, EUR J BIOCHEM, V126, P167, DOI 10.1111/j.1432-1033.1982.tb06762.x; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; Yamazaki H, 1998, GENE, V221, P179, DOI 10.1016/S0378-1119(98)00456-9; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0; ZENG Y, 1991, ANAL BIOCHEM, V193, P266, DOI 10.1016/0003-2697(91)90020-T; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103	69	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11900	11912		10.1074/jbc.M806416200	http://dx.doi.org/10.1074/jbc.M806416200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19282279	hybrid, Green Published			2022-12-25	WOS:000265494600022
J	Ciarapica, R; Annibali, D; Raimondi, L; Savino, M; Nasi, S; Rota, R				Ciarapica, R.; Annibali, D.; Raimondi, L.; Savino, M.; Nasi, S.; Rota, R.			Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation	ONCOGENE			English	Article						HLH domain; Id proteins; neuroblastoma; differentiation	HELIX-LOOP-HELIX; NEGATIVE AUTOREGULATION; RETINOBLASTOMA PROTEIN; SELF-RENEWAL; CYCLE ARREST; EXPRESSION; CANCER; PROLIFERATION; TRANSCRIPTION; TUMORS	Inhibitor of DNA-binding (Id) proteins prevent cell differentiation, promote growth and sustain tumour development. They do so by binding to E proteins and other transcription factors through the helix-loop-helix (HLH) domain, and inhibiting transcription. This makes HLH-mediated Id protein interactions an appealing therapeutic target. We have used the dominant interfering HLH dimerization mutant 13I to model the impact of Id inhibition in two human neuroblastoma cell lines: LA-N-5, similar to immature neuroblasts, and SH-EP, resembling more immature precursor cells. We have validated 13I as an Id inhibitor by showing that it selectively binds to Ids, impairs complex formation with RB, and relieves repression of E protein-activated transcription. Id inactivation by 13I enhances LA-N-5 neural features and causes SH-EP cells to acquire neuronal morphology, express neuronal proteins such as N-CAMand NF-160, proliferate more slowly, and become responsive to retinoic acid. Concomitantly, 13I augments the cell-cycle inhibitor p27(Kip1) and reduces the angiogenic factor vascular endothelial growth factor. These effects are Id specific, being counteracted by Id overexpression. Furthermore, 13I strongly impairs tumorigenic properties in agar colony formation and cell invasion assays. Targeting Id dimerization may therefore be effective for triggering differentiation and restraining neuroblastoma cell tumorigenicity.	[Ciarapica, R.; Raimondi, L.; Rota, R.] Osped Pediat Bambino Gesu, Angiogenesis Lab, I-00165 Rome, Italy; [Annibali, D.; Savino, M.; Nasi, S.] CNR, Ist Biol & Patol Mol, Rome, Italy	IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Rota, R (corresponding author), Osped Pediat Bambino Gesu, Angiogenesis Lab, Piazza S Onofrio 4, I-00165 Rome, Italy.	sergio.nasi@uniroma1.it; rota@opbg.net	Raimondi, Lavinia/K-4085-2016; Annibali, Daniela/AAE-3004-2019; Rota, Rossella/AAB-2497-2019; Annibali, Daniela/AAC-5270-2019	Raimondi, Lavinia/0000-0001-9394-2002; Rota, Rossella/0000-0002-9408-7711; Annibali, Daniela/0000-0001-8413-7669				Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bergmann E, 2001, INT J CANCER, V95, P176, DOI 10.1002/1097-0215(20010520)95:3<176::AID-IJC1030>3.3.CO;2-Q; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chassot AA, 2007, ONCOGENE, V26, P5772, DOI 10.1038/sj.onc.1210386; Ciarapica R, 2003, J BIOL CHEM, V278, P12182, DOI 10.1074/jbc.M211991200; CICCARONE V, 1989, CANCER RES, V49, P219; COHEN PS, 1988, AM J PATHOL, V131, P391; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; Farah MH, 2000, DEVELOPMENT, V127, P693; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Toschi E, 2000, J INVEST DERMATOL, V114, P1188, DOI 10.1046/j.1523-1747.2000.00000.x; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Vandesompele J, 2003, ONCOGENE, V22, P456, DOI 10.1038/sj.onc.1206148; Voigt A, 2000, CELL ADHES COMMUN, V7, P423, DOI 10.3109/15419060009109023; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	41	31	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2009	28	17					1881	1891		10.1038/onc.2009.56	http://dx.doi.org/10.1038/onc.2009.56			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PX	19330020				2022-12-25	WOS:000265640600001
J	Richards, KL; Zhang, B; Baggerly, KA; Colella, S; Lang, JC; Schuller, DE; Krahe, R				Richards, Kristy L.; Zhang, Baili; Baggerly, Keith A.; Colella, Stefano; Lang, James C.; Schuller, David E.; Krahe, Ralf			Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability	PLOS ONE			English	Article							DNA METHYLATION; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; HUMAN-PAPILLOMAVIRUS; COLORECTAL-CANCER; LEVEL; ALU; CARCINOMA; BIOMARKER; ELEMENTS	Loss of genome-wide methylation is a common feature of cancer, and the degree of hypomethylation has been correlated with genomic instability. Global methylation of repetitive elements possibly arose as a defense mechanism against parasitic DNA elements, including retrotransposons and viral pathogens. Given the alterations of global methylation in both viral infection and cancer, we examined genome-wide methylation levels in head and neck squamous cell carcinoma (HNSCC), a cancer causally associated with human papilloma virus (HPV). We assayed global hypomethylation levels in 26 HNSCC samples, compared with their matched normal adjacent tissue, using Pyrosequencing-based methylation assays for LINE repeats. In addition, we examined cell lines derived from a variety of solid tumors for LINE and SINE (Alu) repeats. The degree of LINE and Alu hypomethylation varied among different cancer cell lines. There was only moderate correlation between LINE and Alu methylation levels, with the range of variation in methylation levels being greater for the LINE elements. LINE hypomethylation was more pronounced in HPV-negative than in HPV-positive tumors. Moreover, genomic instability, as measured by genome-wide loss-of-heterozygosity (LOH) single nucleotide polymorphism (SNP) analysis, was greater in HNSCC samples with more pronounced LINE hypomethylation. Global hypomethylation was variable in HNSCC. Its correlation with both HPV status and degree of LOH as a surrogate for genomic instability may reflect alternative oncogenic pathways in HPV-positive versus HPV-negative tumors.	[Richards, Kristy L.; Zhang, Baili; Colella, Stefano; Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX USA; [Baggerly, Keith A.] Univ Texas M. D. Anderson Canc Ctr, Dept Bioinformat & Comput Biol, Houston, TX USA; [Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA; [Richards, Kristy L.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA; [Baggerly, Keith A.; Krahe, Ralf] Univ Texas, Houston Grad Sch Biomed Sci, Grad Program Human & Mol Genet, Houston, TX USA; [Krahe, Ralf] Univ Texas, Houston Grad Sch Biomed Sci, Grad Program Genes & Dev, Houston, TX USA; [Lang, James C.; Schuller, David E.] Ohio State Univ, Comprehensive Canc Ctr, Mol Biol & Canc Genet Programs, Columbus, OH 43210 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas System; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Richards, KL (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, Chapel Hill, NC 27599 USA.	rkrahe@mdanderson.org	Colella, Stefano/A-7040-2008	Colella, Stefano/0000-0003-3139-6055	Kleberg Foundation; State of Texas Tobacco Research Funds; Texas Tobacco Settlement Funds; University of Texas M. D. Anderson Cancer Center; DoD [W81XWH-05-2-0027]	Kleberg Foundation; State of Texas Tobacco Research Funds; Texas Tobacco Settlement Funds; University of Texas M. D. Anderson Cancer Center; DoD(United States Department of Defense)	This work was supported in part by the Kleberg Foundation, State of Texas Tobacco Research Funds, an institutional research grant from the Texas Tobacco Settlement Funds (University of Texas M. D. Anderson Cancer Center), and DoD W81XWH-05-2-0027 to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AP, 1993, COLD SPRING HARB SYM, V58, P281, DOI 10.1101/SQB.1993.058.01.033; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; COLELLA S, 2008, HEAD NECK IN PRESS; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; PATTAMADILOK J, 2007, INT J GYNECOL CANC; Price AL, 2004, GENOME RES, V14, P2245, DOI 10.1101/gr.2693004; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; ROSL F, 1993, J GEN VIROL, V74, P791, DOI 10.1099/0022-1317-74-5-791; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	27	95	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4941	10.1371/journal.pone.0004941	http://dx.doi.org/10.1371/journal.pone.0004941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293934	Green Submitted, gold, Green Published			2022-12-25	WOS:000265496600016
J	Alsop, GB; Chen, W; Foss, M; Tseng, KF; Zhang, DH				Alsop, G. Bradley; Chen, Wei; Foss, Margit; Tseng, Kuo-Fu; Zhang, Dahong			Redistribution of Actin during Assembly and Reassembly of the Contractile Ring in Grasshopper Spermatocytes	PLOS ONE			English	Article								Cytokinesis in animal cells requires the assembly of an actomyosin contractile ring to cleave the cell. The ring is highly dynamic; it assembles and disassembles during each cell cleavage, resulting in the recurrent redistribution of actin. To investigate this process in grasshopper spermatocytes, we mechanically manipulated the spindle to induce actin redistribution into ectopic contractile rings, around reassembled lateral spindles. To enhance visualization of actin, we folded the spindle at its equator to convert the remnants of the partially assembled ring into a concentrated source of actin. Filaments from the disintegrating ring aligned along reorganizing spindle microtubules, suggesting that their incorporation into the new ring was mediated by microtubules. We tracked incorporation by speckling actin filaments with Qdots and/or labeling them with Alexa 488-phalloidin. The pattern of movement implied that actin was transported along spindle microtubules, before entering the ring. By double-labeling dividing cells, we imaged actin filaments moving along microtubules near the contractile ring. Together, our findings indicate that in one mechanism of actin redistribution, actin filaments are transported along spindle microtubule tracks in a plus-end-directed fashion. After reaching the spindle midzone, the filaments could be transported laterally to the ring. Notably, actin filaments undergo a dramatic trajectory change as they enter the ring, implying the existence of a pulling force. Two other mechanisms of actin redistribution, cortical flow and de novo assembly, are also present in grasshopper, suggesting that actin converges at the nascent contractile ring from diffuse sources within the cytoplasm and cortex, mediated by spindle microtubules.	[Alsop, G. Bradley; Chen, Wei; Foss, Margit; Tseng, Kuo-Fu; Zhang, Dahong] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Alsop, G. Bradley; Chen, Wei; Tseng, Kuo-Fu] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Zhang, Dahong] Oregon State Univ, CGRB, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Zhang, DH (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	zhangd@science.oregonstate.edu			National Science Foundation (NSF) [GK-12 Program fellowship, MCB-0090725, MCB-0424897]; American Heart Association [0510084Z]	National Science Foundation (NSF)(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by a National Science Foundation (NSF) GK-12 Program fellowship to GBA, an American Heart Association predoctoral fellowship 0510084Z to WC and NSF grants to DZ (MCB-0090725 and MCB-0424897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2008, J CELL BIOL, V181, P777, DOI 10.1083/jcb.200803096; Alsop GB, 2004, J CELL SCI, V117, P1591, DOI 10.1242/jcs.01007; Alsop GB, 2003, J CELL BIOL, V162, P383, DOI 10.1083/jcb.200301073; Arai R, 2002, J CELL SCI, V115, P887; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; CAO LG, 1990, J CELL BIOL, V111, P1905, DOI 10.1083/jcb.111.5.1905; CAO LG, 1990, J CELL BIOL, V110, P1089, DOI 10.1083/jcb.110.4.1089; Chen W, 2008, PLOS BIOL, V6, P1927, DOI 10.1371/journal.pbio.0060209; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Foe VE, 2000, DEVELOPMENT, V127, P1767; FUKUI Y, 1991, CELL MOTIL CYTOSKEL, V18, P41, DOI 10.1002/cm.970180105; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hirata H, 2007, BBA-GEN SUBJECTS, V1770, P1115, DOI 10.1016/j.bbagen.2007.03.010; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Huang YY, 2008, J CELL BIOL, V183, P979, DOI 10.1083/jcb.200806151; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; NICKLAS RB, 1979, J CELL SCI, V35, P87; Noguchi T, 2001, J CELL SCI, V114, P401; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Rappaport R., 1996, CYTOKINESIS ANIMAL C; RIS H, 1949, BIOL BULL, V96, P90, DOI 10.2307/1538001; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SATTERWHITE L L, 1992, Current Opinion in Cell Biology, V4, P43, DOI 10.1016/0955-0674(92)90057-J; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wolfe BA, 2005, TRENDS CELL BIOL, V15, P10, DOI 10.1016/j.tcb.2004.11.006; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Ybo J, 2008, EXP CELL RES, V314, P3563, DOI 10.1016/j.yexcr.2008.09.014; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhang DH, 1999, METHOD CELL BIOL, V61, P209; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4892	10.1371/journal.pone.0004892	http://dx.doi.org/10.1371/journal.pone.0004892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287500	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496400022
J	Pechhold, K; Koczwara, K; Zhu, XL; Harrison, VS; Walker, G; Lee, J; Harlan, DM				Pechhold, Klaus; Koczwara, Kerstin; Zhu, Xiaolong; Harrison, Victor S.; Walker, Greg; Lee, Janet; Harlan, David M.			Blood Glucose Levels Regulate Pancreatic beta-Cell Proliferation during Experimentally-Induced and Spontaneous Autoimmune Diabetes in Mice	PLOS ONE			English	Article							ISLET NEOGENESIS; MASS; INSULIN; REGENERATION; GROWTH; PROTEIN; MOUSE; REPLICATION; PROGENITORS; HYPERPLASIA	Background: Type 1 diabetes mellitus is caused by immune-mediated destruction of pancreatic beta-cells leading to insulin deficiency, impaired intermediary metabolism, and elevated blood glucose concentrations. While at autoimmune diabetes onset a limited number of beta-cells persist, the cells' regenerative potential and its regulation have remained largely unexplored. Using two mouse autoimmune diabetes models, this study examined the proliferation of pancreatic islet beta-cells and other endocrine and non-endocrine subsets, and the factors regulating that proliferation. Methodology and Principal Findings: We adapted multi-parameter flow cytometry techniques (including DNA-content measurements and 5'-bromo-2'-deoxyuridine [BrdU] incorporation) to study pancreatic islet single cell suspensions. These studies demonstrate that beta-cell proliferation rapidly increases at diabetes onset, and that this proliferation is closely correlated with the diabetic animals' elevated blood glucose levels. For instance, we show that when normoglycemia is restored by exogenous insulin or islet transplantation, the beta-cell proliferation rate returns towards low levels found in control animals, yet surges when hyperglycemia recurs. In contrast, other-than-beta endocrine islet cells did not exhibit the same glucose-dependent proliferative responses. Rather, disease-associated alterations of BrdU-incorporation rates of delta-ells (minor decrease), and non-endocrine islet cells (slight increase) were not affected by blood glucose levels, or were inversely related to glycemia control after diabetes onset (alpha-cells). Conclusion: We conclude that murine beta-cells' ability to proliferate in response to metabolic need (i. e. rising blood glucose concentrations) is remarkably well preserved during severe, chronic beta-cell autoimmunity. These data suggest that timely control of the destructive immune response after disease manifestation could allow spontaneous regeneration of sufficient beta-cell mass to restore normal glucose homeostasis.	[Pechhold, Klaus; Koczwara, Kerstin; Zhu, Xiaolong; Harrison, Victor S.; Walker, Greg; Lee, Janet; Harlan, David M.] NIDDK, NIH, Diabetes Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pechhold, K (corresponding author), NIDDK, NIH, Diabetes Branch, Bethesda, MD USA.	KlausP@intra.NIDDK.NIH.gov		Harrison, Victor/0000-0003-3397-6045	Intramural Research Program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055113, ZIADK062002, Z01DK062002, ZIADK055113] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bouwens L, 2006, CURR DIABETES REV, V2, P3, DOI 10.2174/157339906775473644; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; COBBOLD S, 1986, TRANSPLANTATION, V41, P634, DOI 10.1097/00007890-198605000-00016; COOPER GJS, 1991, MED HYPOTHESES, V36, P284, DOI 10.1016/0306-9877(91)90150-W; Del Zotto H, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740225; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Hardikar AA, 1999, J ENDOCRINOL, V162, P189, DOI 10.1677/joe.0.1620189; HARLAN DM, 1995, DIABETES, V44, P816, DOI 10.2337/diabetes.44.7.816; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Juan G, 2001, METHOD CELL BIOL, V63, P343; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; KRISS JP, 1962, CANCER RES, V22, P254; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Lipsett M, 2007, CELL BIOCHEM BIOPHYS, V48, P127, DOI 10.1007/s12013-007-0028-3; Lombardo F, 2002, DIABETES NUTR METAB, V15, P246; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; Paris M, 2004, EXP DIABESITY RES, V5, P111, DOI 10.1080/15438600490455079; Pechhold K, 2003, J AUTOIMMUN, V20, P1, DOI 10.1016/S0896-8411(02)00105-1; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Ramiya V, 2004, PEDIATR DIABETES, V5, P45, DOI 10.1111/j.1399-543X.2004.00079.x; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHAPIRO H, 2003, PRACTICAL FLOW CYTOM, P285; SHAPIRO HM, 2003, PRACTICAL FLOW CYTOM, P448; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Stoffers DA, 2004, HORM METAB RES, V36, P811, DOI 10.1055/s-2004-826168; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2002, ENDOCRINOLOGY, V143, P3540, DOI 10.1210/en.2002-220089	62	28	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4827	10.1371/journal.pone.0004827	http://dx.doi.org/10.1371/journal.pone.0004827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287497	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400003
J	Johannesson, M; Stahlberg, A; Ameri, J; Sand, FW; Norrman, K; Semb, H				Johannesson, Martina; Stahlberg, Anders; Ameri, Jacqueline; Sand, Fredrik Wolfhagen; Norrman, Karin; Semb, Henrik			FGF4 and Retinoic Acid Direct Differentiation of hESCs into PDX1-Expressing Foregut Endoderm in a Time- and Concentration-Dependent Manner	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PANCREAS DEVELOPMENT; TRANSCRIPTION FACTOR; SONIC-HEDGEHOG; DEFINITIVE ENDODERM; HUMAN BLASTOCYSTS; ENDOCRINE-CELLS; SPINAL-CORD; SOX9; GENES	Background: Retinoic acid (RA) and fibroblast growth factor 4 (FGF4) signaling control endoderm patterning and pancreas induction/expansion. Based on these findings, RA and FGFs, excluding FGF4, have frequently been used in differentiation protocols to direct differentiation of hESCs into endodermal and pancreatic cell types. In vivo, these signaling pathways act in a temporal and concentration-dependent manner. However, in vitro, the underlying basis for the time of addition of growth and differentiation factors (GDFs), including RA and FGFs, as well as the concentration is lacking. Thus, in order to develop robust and reliable differentiation protocols of ESCs into mature pancreatic cell types, including insulin-producing beta cells, it will be important to mechanistically understand each specification step. This includes differentiation of mesendoderm/definitive endoderm into foregut endoderm-the origin of pancreatic endoderm. Methodology/Principal Findings: Here, we provide data on the individual and combinatorial role of RA and FGF4 in directing differentiation of ActivinA (AA)-induced hESCs into PDX1-expressing cells. FGF4's ability to affect endoderm patterning and specification in vitro has so far not been tested. By testing out the optimal concentration and timing of addition of FGF4 and RA, we present a robust differentiation protocol that on average generates 32% PDX1(+) cells. Furthermore, we show that RA is required for converting AA-induced hESCs into PDX1(+) cells, and that part of the underlying mechanism involves FGF receptor signaling. Finally, further characterization of the PDX1(+) cells suggests that they represent foregut endoderm not yet committed to pancreatic, posterior stomach, or duodenal endoderm. Conclusion/Significance: In conclusion, we show that RA and FGF4 jointly direct differentiation of PDX1(+) foregut endoderm in a robust and efficient manner. RA signaling mediated by the early induction of RAR beta through AA/Wnt3a is required for PDX1 expression. Part of RA's activity is mediated by FGF signaling.	[Johannesson, Martina; Stahlberg, Anders; Ameri, Jacqueline; Sand, Fredrik Wolfhagen; Norrman, Karin; Semb, Henrik] Lund Univ, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Stahlberg, Anders] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehab, S-41124 Gothenburg, Sweden	Lund University; University of Gothenburg	Johannesson, M (corresponding author), Lund Univ, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden.	henrik.semb@med.lu.se		Stahlberg, Anders/0000-0003-4243-0191; Ameri, Jacqueline/0000-0002-6146-3944; Semb, Henrik/0000-0002-6747-787X	Juvenile Diabetes Research Foundation (JDRF); Swedish Research Council; Swedish Diabetes Association Research Foundation; Stem Cell Center; Lund University; JDRF-Center for Beta cell Therapy in Europe; Medical Faculty of Lund University	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association Research Foundation; Stem Cell Center; Lund University; JDRF-Center for Beta cell Therapy in Europe; Medical Faculty of Lund University	The work has been supported by Juvenile Diabetes Research Foundation (JDRF), Swedish Research Council, Swedish Diabetes Association Research Foundation, Stem Cell Center, Lund University and JDRF-Center for Beta cell Therapy in Europe (supported by JDRF&EU). MJ was supported by the Medical Faculty of Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Deutsch G, 2001, DEVELOPMENT, V128, P871; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Frandsen U, 2007, BIOCHEM BIOPH RES CO, V362, P568, DOI 10.1016/j.bbrc.2007.07.200; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Grand EK, 2004, LEUKEMIA, V18, P962, DOI 10.1038/sj.leu.2403347; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hoffman L, 2002, INT J DEV BIOL, V46, P949; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Offield MF, 1996, DEVELOPMENT, V122, P983; Pedersen JK, 2005, DEV BIOL, V288, P487, DOI 10.1016/j.ydbio.2005.10.001; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Shiotsugu J, 2004, DEVELOPMENT, V131, P2653, DOI 10.1242/dev.01129; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wilding L, 2004, DIABETES-METAB RES, V20, P114, DOI 10.1002/dmrr.429; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	60	85	104	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4794	10.1371/journal.pone.0004794	http://dx.doi.org/10.1371/journal.pone.0004794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277121	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496100016
J	Strijbis, K; van Roermund, CWT; Hardy, GP; van den Burg, J; Bloem, K; de Haan, J; van Vlies, N; Wanders, RJA; Vaz, FM; Distel, B				Strijbis, Karin; van Roermund, Carlo W. T.; Hardy, Guy P.; van den Burg, Janny; Bloem, Karien; de Haan, Jolanda; van Vlies, Naomi; Wanders, Ronald J. A.; Vaz, Frederic M.; Distel, Ben			Identification and characterization of a complete carnitine biosynthesis pathway in Candida albicans	FASEB JOURNAL			English	Article						hydroxytrimethyllysine aldolase; threonine aldolase; nonfermentable carbon source; acetyl unit transport; carnitine acetyltransferase	EPSILON-N-TRIMETHYLLYSINE; THREONINE ALDOLASE; SERINE HYDROXYMETHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; DEPENDENT TRANSPORT; CARBON-SOURCES; RAT-LIVER; GENE; METABOLISM	Carnitine is an essential metabolite that enables intracellular transport of fatty acids and acetyl units. Here we show that the yeast Candida albicans can synthesize carnitine de novo, and we identify the 4 genes of the pathway. Null mutants of orf19.4316 (trimethyllysine dioxygenase), orf19.6306 (trimethylaminobutyraldehyde dehydrogenase), and orf19.7131 (butyrobetaine dioxygenase) lacked their respective enzymatic activities and were unable to utilize fatty acids, acetate, or ethanol as a sole carbon source, in accordance with the strict requirement for carnitine-mediated transport under these growth conditions. The second enzyme of carnitine biosynthesis, hydroxytrimethyllysine aldolase, is encoded by orf19.6305, a member of the threonine aldolase (TA) family in C. albicans. A strain lacking orf19.6305 showed strongly reduced growth on fatty acids and was unable to utilize either acetate or ethanol, but TA activity was unaffected. Growth of the null mutants on nonfermentable carbon sources is restored only by carnitine biosynthesis intermediates after the predicted enzymatic block in the pathway, which provides independent evidence for a specific defect in carnitine biosynthesis for each of the mutants. In conclusion, we have genetically characterized a complete carnitine biosynthesis pathway in C. albicans and show that a TA family member is mainly involved in the aldolytic cleavage of hydroxytrimethyllysine in vivo.-Strijbis, K., van Roermund, C. W. T., Hardy, G. P., van den Burg, J., Bloem, K., de Haan, J., van Vlies, N., Wanders, R. J. A., Vaz, F. M., Distel, B. Identification and characterization of a complete carnitine biosynthesis pathway in Candida albicans. FASEB J. 23, 2349-2359 (2009)	[Strijbis, Karin; Hardy, Guy P.; van den Burg, Janny; Bloem, Karien; de Haan, Jolanda; Distel, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W. T.; van Vlies, Naomi; Wanders, Ronald J. A.; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Dept Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Distel, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	b.distel@amc.uva.nl		Strijbis, Karin/0000-0001-9167-7137; Vaz, Frederic/0000-0002-9048-1041				BALLEVRE O, 1991, AM J PHYSIOL, V261, pE748, DOI 10.1152/ajpendo.1991.261.6.E748; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; BREMER J, 1962, BIOCHIM BIOPHYS ACTA, V57, P327, DOI 10.1016/0006-3002(62)91126-5; Contestabile R, 2001, EUR J BIOCHEM, V268, P6508, DOI 10.1046/j.0014-2956.2001.02606.x; DAVIS AJ, 1994, J NUTR, V124, P1667, DOI 10.1093/jn/124.9.1667; DUNN WA, 1982, J BIOL CHEM, V257, P7948; Edgar AJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-32; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; HENDERSON LM, 1982, FED PROC, V41, P2843; HENDERSON LM, 1980, CARNITINE BIOSYNTHES, P35; HOCHALTER JB, 1976, BIOCHEM BIOPH RES CO, V70, P364, DOI 10.1016/0006-291X(76)91054-8; HULSE JD, 1978, J BIOL CHEM, V253, P1654; KAUFMAN RA, 1977, J BIOL CHEM, V252, P7437; McNeil JB, 2000, YEAST, V16, P167, DOI 10.1002/(SICI)1097-0061(20000130)16:2&lt;167::AID-YEA519&gt;3.0.CO;2-1; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Ogawa A, 2000, BIOSCI BIOTECH BIOCH, V64, P1133, DOI 10.1271/bbb.64.1133; OGAWA H, 1981, J BIOCHEM, V90, P381, DOI 10.1093/oxfordjournals.jbchem.a133484; Ogawa H, 2000, INT J BIOCHEM CELL B, V32, P289, DOI 10.1016/S1357-2725(99)00113-2; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054; PULLMAN ME, 1963, METHOD ENZYMOL, V6, P277, DOI 10.1016/0076-6879(63)06174-7; Ramon AM, 2003, EUKARYOT CELL, V2, P718, DOI 10.1128/EC.2.4.718-728.2003; REBOUCHE CJ, 1984, J CLIN INVEST, V73, P857, DOI 10.1172/JCI111281; REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6; REBOUCHE CJ, 1986, J NUTR, V116, P751; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Staib P, 2001, INT J MED MICROBIOL, V291, P183, DOI 10.1078/1438-4221-00114; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Swiegers JH, 2001, YEAST, V18, P585, DOI 10.1002/yea.712; TANPHAIC.V, 1973, J BIOL CHEM, V248, P2176; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; van Vlies N, 2006, ANAL BIOCHEM, V354, P132, DOI 10.1016/j.ab.2006.04.007; Vaz FM, 1998, BIOCHEM BIOPH RES CO, V250, P506, DOI 10.1006/bbrc.1998.9343; Vaz FM, 2000, J BIOL CHEM, V275, P7390, DOI 10.1074/jbc.275.10.7390; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vaz FM, 2001, J BIOL CHEM, V276, P33512, DOI 10.1074/jbc.M105929200; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Zhou H, 2008, MICROBIOL-SGM, V154, P500, DOI 10.1099/mic.0.2007/014555-0	41	28	33	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2349	2359		10.1096/fj.08-127985	http://dx.doi.org/10.1096/fj.08-127985			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19289605				2022-12-25	WOS:000268836700003
J	Vizlin-Hodzic, D; Ryme, J; Simonsson, S; Simonsson, T				Vizlin-Hodzic, Dzeneta; Ryme, Jessica; Simonsson, Stina; Simonsson, Tomas			Developmental studies of Xenopus shelterin complexes: the message to reset telomere length is already present in the egg	FASEB JOURNAL			English	Article						telosome; differentiation; ES cell; iPS cell; quadruplex; cellular senescence	SINGLE-STRANDED-DNA; CELLULAR SENESCENCE; MAMMALIAN TELOMERES; CLONED CATTLE; STEM-CELLS; POT1; PROTEINS; TRF2; PROTECTION; REGULATOR	The 6-protein complex shelterin protects the telomeres of human chromosomes. The recent discovery that telomeres are important for epigenetic gene regulation and vertebrate embryonic development calls for the establishment of model organisms to study shelterin and telomere function under normal developmental conditions. Here, we report the sequences of the shelterin-encoding genes in Xenopus laevis and its close relation Xenopus tropicalis. In vitro expression and biochemical characterization of the Xenopus shelterin proteins TRF1, TRF2, POT1, TIN2, RAP1, TPP1, and the shelterin accessory factor PINX1 indicate that all main functions of their human orthologs are conserved in Xenopus. The X1TRF1 and XtTRF1 proteins bind double-stranded telomeric DNA sequence specifically and interact with X1TIN2 and XtTIN2, respectively. Similarly, the X1TRF2 and XtTRF2 proteins bind double-stranded telomeric DNA and interact with X1RAP1 and XtRAP1, respectively, whereas the X1POT1 and XtPOT1 proteins bind single-stranded telomeric DNA. Real-time PCR further reveals the gene expression profiles for telomerase and the shelterin genes during embryogenesis. Notably, the composition of shelterin and the formation of its subcomplexes appear to be temporally regulated during embryonic development. Moreover, unexpectedly high telomerase and shelterin gene expression during early embryogenesis may reflect a telomere length-resetting mechanism, similar to that reported for induced pluripotent stem cells and for animals cloned through somatic nuclear transfer.-Vizlin-Hodzic, D., Ryme, J., Simonsson, S., Simonsson, T. Developmental studies of Xenopus shelterin complexes: the message to reset telomere length is already present in the egg. FASEB J. 23, 2587-2594 ( 2009)	[Vizlin-Hodzic, Dzeneta; Ryme, Jessica; Simonsson, Stina; Simonsson, Tomas] Univ Gothenburg, Dept Biomed, Med Biochem & Cell Biol Div, SE-40530 Gothenburg, Sweden	University of Gothenburg	Simonsson, T (corresponding author), Univ Gothenburg, Dept Biomed, Med Biochem & Cell Biol Div, POB 440, SE-40530 Gothenburg, Sweden.	tomas.simonsson@gu.se	Simonsson, Stina/R-2699-2016	Simonsson, Stina/0000-0001-9020-3714	Wellcome Trust/Cancer Research UK Gurdon Institute; Swedish Research Council; Swedish Cancer Society; Assar Gabrielsson cancer research foundation; Johan Jansson foundation; Magn. Bergvall Research Foundation [x1TRF1 EU422974, x1TRF2 EU422975, x1POT1 EU422976, x1TIN2 EU422981, x1RAP1 EU422979, x1TPP1 AY673986, x1PINX1 EU520258, xtTRF1 EU422977, xtTRF2 EU422978, xtPOT1 AY535401, xtTIN2 EU422982, xtRAP1 EU422980, xtTPP1 AY673987, xtPINX1 EU520259]	Wellcome Trust/Cancer Research UK Gurdon Institute(Wellcome Trust); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielsson cancer research foundation; Johan Jansson foundation; Magn. Bergvall Research Foundation	We thank John Gurdon and Nigel Garett at the Wellcome Trust/Cancer Research UK Gurdon Institute for embryo staging and X. laevis cDNA. This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Assar Gabrielsson cancer research foundation, the Johan Jansson foundation, and the Magn. Bergvall Research Foundation. Nucleotide sequences have been deposited to GenBank under the following accession numbers: x1TRF1 EU422974, x1TRF2 EU422975, x1POT1 EU422976, x1TIN2 EU422981, x1RAP1 EU422979, x1TPP1 AY673986, x1PINX1 EU520258, xtTRF1 EU422977, xtTRF2 EU422978, xtPOT1 AY535401, xtTIN2 EU422982, xtRAP1 EU422980, xtTPP1 AY673987, and xtPINX1 EU520259.	Azzalin CM, 2007, NATURE, V448, P1001, DOI 10.1038/4481001a; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Betts DH, 2001, P NATL ACAD SCI USA, V98, P1077, DOI 10.1073/pnas.031559298; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; CARDENAS ME, 1993, GENE DEV, V7, P883, DOI 10.1101/gad.7.5.883; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Crumet N, 2006, GENE, V369, P20, DOI 10.1016/j.gene.2005.10.006; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Greider C W, 2000, Harvey Lect, V96, P33; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Ly H, 2003, GENE DEV, V17, P1078, DOI 10.1101/gad.1060803; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; MCCLINTOCK B, 1938, GENETICS, V23, P403; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; O'Reilly Marc, 1999, Current Opinion in Structural Biology, V9, P56, DOI 10.1016/S0959-440X(99)80008-6; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Simonsson T, 2003, TRENDS BIOCHEM SCI, V28, P632, DOI 10.1016/j.tibs.2003.10.005; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Sindelka R, 2008, NUCLEIC ACIDS RES, V36, P387, DOI 10.1093/nar/gkm1024; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tian XC, 2000, NAT GENET, V26, P272, DOI 10.1038/81559; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	58	11	13	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2587	2594		10.1096/fj.09-129619	http://dx.doi.org/10.1096/fj.09-129619			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19329760				2022-12-25	WOS:000268836700027
J	Farias, GG; Alfaro, IE; Cerpa, W; Grabowski, CP; Godoy, JA; Bonansco, C; Inestrosa, NC				Farias, Ginny G.; Alfaro, Ivan E.; Cerpa, Waldo; Grabowski, Catalina P.; Godoy, Juan A.; Bonansco, Christian; Inestrosa, Nibaldo C.			Wnt-5a/JNK Signaling Promotes the Clustering of PSD-95 in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY-95; WNT; SYNAPSE; PROTEINS; PATHWAY; COLOCALIZATION; TRANSMISSION; ACCUMULATION; MECHANISMS; INHIBITOR	During the formation of synapses, specific regions of pre- and postsynaptic cells associate to form a single functional transmission unit. In this process, synaptogenic factors are necessary to modulate pre- and postsynaptic differentiation. In mammals, different Wnt ligands operate through canonical and non-canonical Wnt pathways, and their precise functions to coordinate synapse structure and function in the mature central nervous system are still largely unknown. Here, we studied the effect of different Wnt ligands on postsynaptic organization. We found that Wnt-5a induces short term changes in the clustering of PSD-95, without affecting its total levels. Wnt-5a promotes the recruitment of PSD-95 from a diffuse dendritic cytoplasmic pool to form new PSD-95 clusters in dendritic spines. Moreover, Wnt-5a acting as a non-canonical ligand regulates PSD-95 distribution through a JNK-dependent signaling pathway, as demonstrated by using the TAT-TI-JIP peptide in mature hippocampal neurons. Finally, using adult rat hippocampal slices, we found that Wnt-5a modulates glutamatergic synaptic transmission through a postsynaptic mechanism. Our studies indicate that the Wnt-5a/JNK pathway modulates the postsynaptic region of mammalian synapse directing the clustering and distribution of the physiologically relevant scaffold protein, PSD-95.	[Farias, Ginny G.; Alfaro, Ivan E.; Cerpa, Waldo; Grabowski, Catalina P.; Godoy, Juan A.; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Inst Milenio,Ctr Regulac Celular & Patol Joaquin, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Cerpa, Waldo; Bonansco, Christian] Univ Valparaiso, Fac Ciencias, Dept Fisiol, Ctr Neurobiol & Plast Desarrollo, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; Universidad de Valparaiso	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Inst Milenio,Ctr Regulac Celular & Patol Joaquin, Ctr Envejecimiento & Regenerac, Alameda 340,POB 8331150, Santiago, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018; Cerpa, Waldo/GSI-5204-2022	Godoy, Juan A/0000-0001-9920-6698; Cerpa, Waldo/0000-0001-7344-0144	Fondo de Financiamiento de Centros de Excelencia en Investigacion; Comision Nacional de Investigacion Cientifica y Tecnologica; Millennium Institute; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1061074]; DIPUV [CID/1/2006]; FONDECYT	Fondo de Financiamiento de Centros de Excelencia en Investigacion; Comision Nacional de Investigacion Cientifica y Tecnologica; Millennium Institute(Takeda Pharmaceutical Company Ltd); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DIPUV; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo de Financiamiento de Centros de Excelencia en Investigacion, Comision Nacional de Investigacion Cientifica y Tecnologica, and the Millennium Institute ( to N.C.I.); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1061074 and DIPUV Grant CID/1/2006 ( to C. B.); and predoctoral fellowships from FONDECYT ( to G. G. F., I. E. A., W. C., and C. P. G.).	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Beaumont V, 2007, MOL CELL NEUROSCI, V35, P513, DOI 10.1016/j.mcn.2007.03.004; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Stein V, 2003, J NEUROSCI, V23, P5503; Tang SJ, 2007, SYNAPSE, V61, P866, DOI 10.1002/syn.20434; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010	54	160	166	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15857	15866		10.1074/jbc.M808986200	http://dx.doi.org/10.1074/jbc.M808986200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19332546	Green Published, hybrid			2022-12-25	WOS:000266501000054
J	Rawlinson, SM; Pryor, MJ; Wright, PJ; Jans, DA				Rawlinson, Stephen M.; Pryor, Melinda J.; Wright, Peter J.; Jans, David A.			CRM1-mediated Nuclear Export of Dengue Virus RNA Polymerase NS5 Modulates Interleukin-8 Induction and Virus Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PROTEIN; IN-VITRO; LOCALIZATION SEQUENCE; IMPORTIN BETA-1; VIRAL HELICASE; CK2 SITE; SIGNALS; TRANSPORT; IDENTIFICATION; REPLICATION	Although all established functions of dengue virus NS5 (nonstructural protein 5) occur in the cytoplasm, its nuclear localization, mediated by dual nuclear localization sequences, is essential for virus replication. Here, we have determined the mechanism by which NS5 can localize in the cytoplasm to perform its role in replication, establishing for the first time that it is able to be exported from the nucleus by the exportin CRM1 and hence can shuttle between the nucleus and cytoplasm. We define the nuclear export sequence responsible to be residues 327-343 and confirm interaction of NS5 and CRM1 by pull-down assay. Significantly, greater nuclear accumulation of NS5 during infection due to CRM1 inhibition coincided with altered kinetics of virus production and decreased induction of the antiviral chemokine interleukin-8. This is the first report of a nuclear export sequence within NS5 for any member of the Flavivirus genus; because of its high conservation within the genus, it may represent a target for the treatment of diseases caused by several medically important flaviviruses.	[Rawlinson, Stephen M.; Pryor, Melinda J.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Wright, Peter J.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Monash University; Monash University	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	david.jans@med.monash.edu.au		Rawlinson, Stephen/0000-0003-2602-7650; Jans, David/0000-0001-5115-4745	National Health and Medical Research Council Fellowship (Australia) [384109]	National Health and Medical Research Council Fellowship (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Fellowship 384109 (Australia).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Alvisi G, 2008, BBA-PROTEINS PROTEOM, V1784, P213, DOI 10.1016/j.bbapap.2007.08.021; BARTHOLOMEUSZ AI, 1993, ARCH VIROL, V128, P111, DOI 10.1007/BF01309792; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Koo BCA, 2006, J VIROL, V80, P7885, DOI 10.1128/JVI.00519-06; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindenbach B.D., 2001, FLAVIVIRIDAE VIRUSES; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Moseley GW, 2007, BIOCHEMISTRY-US, V46, P12053, DOI 10.1021/bi700521m; Murai N, 2003, J BIOL CHEM, V278, P44791, DOI 10.1074/jbc.M308059200; NISHI K, 1994, J BIOL CHEM, V269, P6320; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Scheifele LZ, 2005, J VIROL, V79, P8732, DOI 10.1128/JVI.79.14.8732-8741.2005; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; Strunze S, 2005, MOL BIOL CELL, V16, P2999, DOI 10.1091/mbc.E05-02-0121; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Uchil PD, 2003, VIROLOGY, V307, P358, DOI 10.1016/S0042-6822(02)00130-7; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191	51	87	118	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15589	15597		10.1074/jbc.M808271200	http://dx.doi.org/10.1074/jbc.M808271200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19297323	hybrid, Green Published			2022-12-25	WOS:000266501000027
J	Kurella, VB; Richard, JM; Parke, CL; LeCour, LF; Bellamy, HD; Worthylake, DK				Kurella, Vinodh B.; Richard, Jessica M.; Parke, Courtney L.; LeCour, Louis F., Jr.; Bellamy, Henry D.; Worthylake, David K.			Crystal Structure of the GTPase-activating Protein-related Domain from IQGAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; COMPLEX; BINDING; RASGAP; ALIGNMENT; CDC42; GAP; OVEREXPRESSION; STIMULATION; ASSOCIATION	IQGAP1 is a 190-kDa molecular scaffold containing several domains required for interaction with numerous proteins. One domain is homologous to Ras GTPase-activating protein (GAP) domains. However, instead of accelerating hydrolysis of bound GTP on Ras IQGAP1, using its GAP-related domain (GRD) binds to Cdc42 and Rac1 and stabilizes their GTP-bound states. We report here the crystal structure of the isolated IQGAP1 GRD. Despite low sequence conservation, the overall structure of the GRD is very similar to the GAP domains from p120 RasGAP, neurofibromin, and SynGAP. However, instead of the catalytic "arginine finger" seen in functional Ras GAPs, the GRD has a conserved threonine residue. GRD residues 1099-1129 have no structural equivalent in RasGAP and are seen to form an extension at one end of the molecule. Because the sequence of these residues is highly conserved, this region likely confers a functionality particular to IQGAP family GRDs. We have used isothermal titration calorimetry to demonstrate that the isolated GRD binds to active Cdc42. Assuming a mode of interaction similar to that displayed in the Ras-RasGAP complex, we created an energy-minimized model of Cdc42 center dot GTP bound to the GRD. Residues of the GRD that contact Cdc42 map to the surface of the GRD that displays the highest level of sequence conservation. The model indicates that steric clash between threonine 1046 with the phosphate-binding loop and other subtle changes would likely disrupt the proper geometry required for GTP hydrolysis.	[Worthylake, David K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Bellamy, Henry D.] Louisiana State Univ, Ctr Adv Microstruct & Devices, Baton Rouge, LA 70806 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University	Worthylake, DK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	dworth@lsuhsc.edu						Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; Ahmadian MR, 1999, P NATL ACAD SCI USA, V96, P7065, DOI 10.1073/pnas.96.12.7065; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Bax B, 1998, NATURE, V392, P447, DOI 10.1038/33040; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; Morris LE, 2005, GENE CHROMOSOME CANC, V42, P280, DOI 10.1002/gcc.20150; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SKINNER RH, 1991, J BIOL CHEM, V266, P14163; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517	46	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14857	14865		10.1074/jbc.M808974200	http://dx.doi.org/10.1074/jbc.M808974200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321438	Green Published, hybrid			2022-12-25	WOS:000266288200021
J	Partch, CL; Card, PB; Amezcua, CA; Gardner, KH				Partch, Carrie L.; Card, Paul B.; Amezcua, Carlos A.; Gardner, Kevin H.			Molecular Basis of Coiled Coil Coactivator Recruitment by the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS-B DOMAIN; STRUCTURAL BASIS; GENE-EXPRESSION; CHEMICAL-SHIFT; DNA-BINDING; HYPOXIA; PROTEIN; DIOXIN; MOTIF; HETERODIMERIZATION	The aryl hydrocarbon receptor nuclear translocator ( ARNT) serves as the obligate heterodimeric partner for bHLH-PAS proteins involved in sensing and coordinating transcriptional responses to xenobiotics, hypoxia, and developmental pathways. Although its C-terminal transactivation domain is dispensable for transcriptional activation in vivo, ARNT has recently been shown to use its N-terminal bHLH and/or PAS domains to interact with several transcriptional coactivators that are required for transcriptional initiation after xenobiotic or hypoxic cues. Here we show that ARNT uses a single PAS domain to interact with two coiled coil coactivators, TRIP230 and CoCoA. Both coactivators interact with the same interface on the ARNT PAS-B domain, located on the opposite side of the domain used to associate with the analogous PAS domain on its heterodimeric bHLH-PAS partner HIF-2 alpha. Using NMR and biochemical studies, we identified the ARNT-interacting motif of one coactivator, TRIP230 as an LXXLL-like nuclear receptor box. Mutation of this motif and proximal sequences disrupts the interaction with ARNT PAS-B. Identification of this ARNT-coactivator interface illustrates how ARNT PAS-B is used to form critical interactions with both bHLH-PAS partners and coactivators that are required for transcriptional responses.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gardner, KH (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kevin.Gardner@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019	Gardner, Kevin H./0000-0002-8671-2556; 	National Institutes of Health [GM081875];  [CA130441]; NATIONAL CANCER INSTITUTE [F32CA130441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081875 (to K.H.G.) and CA130441 (to C.L.P.).	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; Chapman-Smith A, 2006, J BIOL CHEM, V281, P12535, DOI 10.1074/jbc.M512145200; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; Chen YH, 2005, MOL CELL BIOL, V25, P5965, DOI 10.1128/MCB.25.14.5965-5972.2005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim JH, 2004, J BIOL CHEM, V279, P49842, DOI 10.1074/jbc.M408535200; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Lodrini M, 2008, NUCLEIC ACIDS RES, V36, P1847, DOI 10.1093/nar/gkn029; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MA Q, 1995, J BIOL CHEM, V270, P12697, DOI 10.1074/jbc.270.21.12697; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	49	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15184	15192		10.1074/jbc.M808479200	http://dx.doi.org/10.1074/jbc.M808479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324882	Green Published, hybrid			2022-12-25	WOS:000266288200053
J	Paul, DM; Morris, EP; Kensler, RW; Squire, JM				Paul, Danielle M.; Morris, Edward P.; Kensler, Robert W.; Squire, John M.			Structure and Orientation of Troponin in the Thin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-PARTICLE ANALYSIS; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; MUSCLE-CONTRACTION; ACTIN-FILAMENT; ATOMIC MODEL; F-ACTIN; SKELETAL-MUSCLE; CO-CRYSTALS; TROPOMYOSIN	The troponin complex on the thin filament plays a crucial role in the regulation of muscle contraction. However, the precise location of troponin relative to actin and tropomyosin remains uncertain. We have developed a method of reconstructing thin filaments using single particle analysis that does not impose the helical symmetry of actin and is independent of a starting model. We present a single particle three-dimensional reconstruction of the thin filament. Atomic models of the F-actin filament were fitted into the electron density maps and troponin and tropomyosin located. The structure provides evidence that the globular head region of troponin labels the two strands of actin with a 27.5-angstrom axial stagger. The density attributed to troponin appears tapered with the widest point toward the barbed end. This leads us to interpret the polarity of the troponin complex in the thin filament as reversed with respect to the widely accepted model.	[Paul, Danielle M.; Morris, Edward P.] Chester Beatty Labs, Inst Canc Res, London SW3 6JB, England; [Kensler, Robert W.] Univ Puerto Rico, Dept Anat, Sch Med, San Juan, PR 00936 USA; [Squire, John M.] Univ Bristol, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Bristol	Morris, EP (corresponding author), Chester Beatty Labs, Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England.	edward.morris@icr.ac.uk		Squire, John/0000-0001-5731-253X; Squire, John/0000-0001-6656-7390; Morris, Edward/0000-0003-3544-0041	National Institutes of Health Minorities Basic Research [S06 GM08224]; Research Centers in Minority Institutions Award [G12RR-03051]; BHF [13962, 23480]; Wellcome Trust [066418]; European MYORES Network on Muscle Development; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health Minorities Basic Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BHF(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European MYORES Network on Muscle Development; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Minorities Basic Research Support Grant S06 GM08224 (to R. W. K.) and a Research Centers in Minority Institutions Award G12RR-03051 from the NCRR. This work was also supported by a BHF studentship (13962, to D. P.), a BHF Project Grant 23480 (to E. P. M. and J.M.S.), a Wellcome Trust Grant 066418 (to E. P. M.), and the European MYORES Network on Muscle Development (to J.M.S.).	Al-Khayat HA, 2006, J STRUCT BIOL, V155, P202, DOI 10.1016/j.jsb.2006.01.014; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Burgess S, 2004, J MOL BIOL, V341, P1161, DOI 10.1016/j.jmb.2004.06.077; CabralLilly D, 1997, BIOPHYS J, V73, P1763, DOI 10.1016/S0006-3495(97)78206-7; CARR HJ, 1988, J MUSCLE RES CELL M, V9, P384, DOI 10.1007/BF01774065; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EBASHI S, 1972, NATURE, V240, P217, DOI 10.1038/240217a0; EBASHI S, 1972, COLD SPRING HARB SYM, V37, P215; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; EGELMAN EH, 1992, BIOPHYS J, V63, P1299, DOI 10.1016/S0006-3495(92)81716-2; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 1998, BIOPHYS J, V74, P589, DOI 10.1016/S0006-3495(98)77817-8; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; GONCHAROV AB, 1988, ULTRAMICROSCOPY, V25, P317, DOI 10.1016/0304-3991(88)90006-X; GREASER ML, 1973, J BIOL CHEM, V248, P2125; Greenfield NJ, 2002, BIOPHYS J, V82, P2580, DOI 10.1016/S0006-3495(02)75600-2; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; HARAUZ G, 1986, OPTIK, V73, P146; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; KENSLER RW, 1989, J CELL SCI, V94, P391; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Liu J, 2004, J STRUCT BIOL, V147, P268, DOI 10.1016/j.jsb.2004.03.008; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; MENDELSON RA, 1994, J MOL BIOL, V240, P138, DOI 10.1006/jmbi.1994.1428; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Mouche F, 2003, J STRUCT BIOL, V144, P301, DOI 10.1016/j.jsb.2003.09.001; Narita A, 2001, J MOL BIOL, V308, P241, DOI 10.1006/jmbi.2001.4598; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; OHTSUKI I, 1988, J BIOCHEM-TOKYO, V103, P913, DOI 10.1093/oxfordjournals.jbchem.a122387; OHTSUKI I, 1974, J BIOCHEM-TOKYO, V75, P753, DOI 10.1093/oxfordjournals.jbchem.a130448; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; Patwardhan A, 2004, J MOL BIOL, V344, P707, DOI 10.1016/j.jmb.2004.09.068; Paul D, 2004, J STRUCT BIOL, V148, P236, DOI 10.1016/j.jsb.2004.05.004; PEARLSTONE JR, 1982, J BIOL CHEM, V257, P587; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; RADERMACHER M, 1994, ULTRAMICROSCOPY, V53, P121, DOI 10.1016/0304-3991(94)90003-5; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; STOKES DL, 1987, J CELL BIOL, V104, P1005, DOI 10.1083/jcb.104.4.1005; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1989, OPTIK, V82, P114; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Whitby FG, 2000, PROTEINS, V38, P49; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	61	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15007	15015		10.1074/jbc.M808615200	http://dx.doi.org/10.1074/jbc.M808615200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321455	hybrid, Green Published			2022-12-25	WOS:000266288200037
J	Resman, N; Vasl, J; Oblak, A; Pristovsek, P; Gioannini, TL; Weiss, JP; Jerala, R				Resman, Nusa; Vasl, Jozica; Oblak, Alja; Pristovsek, Primoz; Gioannini, Theresa L.; Weiss, Jerrold P.; Jerala, Roman			Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; LIPID-IVA; LIPOPOLYSACCHARIDE RESPONSIVENESS; SIGNAL-TRANSDUCTION; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; NMR SYSTEM; BINDING; TLR4; LPS	Gram-negative bacterial endotoxin (i.e. lipopolysaccharide (LPS)) is one of the most potent stimulants of the innate immune system, recognized by the TLR4.MD-2 complex. Direct binding to MD-2 of LPS and LPS analogues that act as TLR4 agonists or antagonists is well established, but the role of MD-2 and TLR4 in receptor activation is much less clear. We have identified residues within the hairpin of MD-2 between strands five and six that, although not contacting acyl chains of tetraacylated lipid IVa (a TLR4 antagonist), influence activation of TLR4 by hexaacylated lipid A. We show that hydrophobic residues at positions 82, 85, and 87 of MD-2 are essential both for transfer of endotoxin from CD14 to monomeric MD-2 and for TLR4 activation. We also identified a pair of conserved hydrophobic residues (Phe-440 and Phe-463) in leucine-rich repeats 16 and 17 of the TLR4 ectodomain, which are essential for activation of TLR4 by LPS. F440A or F463A mutants of TLR4 were inactive, whereas the F440W mutant retained full activity. Charge reversal of neighboring cationic groups in the TLR4 ectodomain (Lys-388 and Lys-435), in contrast, did not affect cell activation. Our mutagenesis studies are consistent with a molecular model in which Val-82, Met-85, and Leu-87 in MD-2 and distal portions of a secondary acyl chain of hexaacylated lipid A that do not fit into the hydrophobic binding pocket of MD-2 form a hydrophobic surface that interacts with Phe-440 and Phe-463 on a neighboring TLR4.MD-2.LPS complex, driving TLR4 activation.	[Resman, Nusa; Vasl, Jozica; Oblak, Alja; Pristovsek, Primoz; Jerala, Roman] Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Inflammat Program, Dept Microbiol, Iowa City, IA 52242 USA; [Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Jerala, R (corresponding author), Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si	; Jerala, Roman/H-9850-2015	Pristovsek, Primoz/0000-0002-2304-1791; Weiss, Jerrold/0000-0003-1476-4485; Jerala, Roman/0000-0002-6337-5251	National Institutes of Health [AI05732]; Slovenian research agency; Slovenian-United States of America; Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian research agency(Slovenian Research Agency - Slovenia); Slovenian-United States of America; Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI05732 (NIAID, to J.W.). This work was also supported by grants from the Slovenian research agency, a bilateral Slovenian-United States of America collaborative grant, and by Veterans Affairs (to T. L. G.).	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MEDZHITOV R, 1997, NATURE, V388, P397; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park BS, 2009, NATURE IN PRESS; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Resman N, 2008, FEBS LETT, V582, P3929, DOI 10.1016/j.febslet.2008.10.037; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Vasl J, 2008, J IMMUNOL, V180, P6107, DOI 10.4049/jimmunol.180.9.6107; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	43	85	95	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15052	15060		10.1074/jbc.M901429200	http://dx.doi.org/10.1074/jbc.M901429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321453	Green Published, hybrid			2022-12-25	WOS:000266288200041
J	Kataoka, K; Sugiyama, R; Hirota, S; Inoue, M; Urata, K; Minagawa, Y; Seo, D; Sakurai, T				Kataoka, Kunishige; Sugiyama, Ryosuke; Hirota, Shun; Inoue, Megumi; Urata, Kanae; Minagawa, Yoichi; Seo, Daisuke; Sakurai, Takeshi			Four-electron Reduction of Dioxygen by a Multicopper Oxidase, CueO, and Roles of Asp(112) and Glu(506) Located Adjacent to the Trinuclear Copper Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PEROXIDE INTERMEDIATE; BILIRUBIN-OXIDASE; CUPROUS OXIDASE; PROTON DONOR; BINDING; LACCASE; O-2; HOMEOSTASIS	The mechanism of the four-electron reduction of dioxygen by a multicopper oxidase, CueO, was studied based on reactions of single and double mutants with Cys(500), a type I copper ligand, and the noncoordinating Asp(112) and Glu(506), which form hydrogen bonds with the trinuclear copper center directly and indirectly via a water molecule. The reaction of C500S containing a vacant type I copper center produced intermediate I in an EPR-silent peroxide-bound form. The formation of intermediate I from C500S/D112N was restricted due to a reduction in the affinity of the trinuclear copper center for dioxygen. The state of intermediate I was realized to be the resting form of C500S/E506Q and C500S of the truncated mutant Delta alpha 5-7CueO, in which the 50 amino acids covering the substrate-binding site were removed. Reactions of the recombinant CueO and E506Q afforded intermediate II, a fully oxidized form different from the resting one, with a very broad EPR signal, g < 2, detectable only at cryogenic temperatures and unsaturated with high power microwaves. The lifetime of intermediate II was prolonged by the mutation at Glu(506) involved in the donation of protons. The structure of intermediates I and II and the mechanism of the four-electron reduction of dioxygen driven by Asp(112) and Glu(506) are discussed.	[Kataoka, Kunishige; Sugiyama, Ryosuke; Inoue, Megumi; Urata, Kanae; Minagawa, Yoichi; Seo, Daisuke; Sakurai, Takeshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan	Kanazawa University; Nara Institute of Science & Technology	Sakurai, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	ts0513@kenroku.kanazawa-u.ac.jp	SEO, Daisuke/L-3520-2015; Sakurai, Takeshi/C-3335-2015; Hirota, Shun/AAD-2651-2021; KATAOKA, Kunishige/J-8457-2015	SEO, Daisuke/0000-0001-9596-6569; Sakurai, Takeshi/0000-0002-7989-8882; Hirota, Shun/0000-0003-3227-8376; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [19350081]; NEDO; Mandom Corp; Toyota Motor Corp	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEDO(New Energy and Industrial Technology Development Organization (NEDO)); Mandom Corp; Toyota Motor Corp	This work was supported by Grant-in-aid for Scientific Research 19350081 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. S.), NEDO, Mandom Corp., and Toyota Motor Corp.	Augustine AJ, 2007, J AM CHEM SOC, V129, P13118, DOI 10.1021/ja073905m; BENTO I, 2005, J CHEM SOC DA, P3507; Bento I, 2007, ACTA CRYSTALLOGR D, V63, P240, DOI 10.1107/S090744490604947X; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Huang HW, 1999, J BIOL CHEM, V274, P32718, DOI 10.1074/jbc.274.46.32718; Kataoka K, 2005, BIOCHEMISTRY-US, V44, P7004, DOI 10.1021/bi0476836; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; Kurose S, 2007, CHEM LETT, V36, P232, DOI 10.1246/cl.2007.232; Lee SK, 2002, J AM CHEM SOC, V124, P6180, DOI 10.1021/ja0114052; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Messerschmidt A., 1997, MULTICOPPER OXIDASES; Miura Y, 2009, FUEL CELLS, V9, P70, DOI 10.1002/fuce.200800027; Miura Y, 2007, CHEM LETT, V36, P132, DOI 10.1246/cl.2007.132; Nitta K, 2002, J INORG BIOCHEM, V91, P125, DOI 10.1016/S0162-0134(02)00440-3; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Palmer AE, 2002, BIOCHEMISTRY-US, V41, P6438, DOI 10.1021/bi011979j; Quintanar L, 2005, BIOCHEMISTRY-US, V44, P6081, DOI 10.1021/bi047379c; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Shin W, 1996, J AM CHEM SOC, V118, P3202, DOI 10.1021/ja953621e; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tsujimura S, 2008, ELECTROCHIM ACTA, V53, P5716, DOI 10.1016/j.electacta.2008.03.037; Ueki Y, 2006, FEBS LETT, V580, P4069, DOI 10.1016/j.febslet.2006.06.049; Yoon JJ, 2007, J AM CHEM SOC, V129, P13127, DOI 10.1021/ja073947a; Zoppellaro G, 2001, J BIOCHEM-TOKYO, V129, P949, DOI 10.1093/oxfordjournals.jbchem.a002942	35	61	62	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14405	14413		10.1074/jbc.M808468200	http://dx.doi.org/10.1074/jbc.M808468200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297322	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000266286100047
J	Ogawa, C; Usui, K; Ito, F; Itoh, M; Hayashizaki, Y; Suzuki, H				Ogawa, Chihiro; Usui, Kengo; Ito, Fuyu; Itoh, Masayoshi; Hayashizaki, Yoshihide; Suzuki, Harukazu			Role of Survival Motor Neuron Complex Components in Small Nuclear Ribonucleoprotein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SMN COMPLEX; IN-VITRO; U SNRNPS; PROTEIN; IDENTIFICATION; GENE; BIOGENESIS; EXPRESSION; GEMIN8	Survival motor neuron (SMN) complex is essential for the biogenesis of the small nuclear ribonucleoprotein (snRNP) complex, although the complete role of each SMN complex component for the snRNP synthesis is largely unclear. We have identified an interaction between the two components Gemin2-Gemin7 using the mammalian two-hybrid system. In vitro stability assay revealed that the known SMN-Gemin7 interaction becomes stable in the presence of Gemin2 possibly via the identified Gemin2-Gemin7 interaction. Gemin7 knockdown revealed a decrease in snRNP assembly activity and a decrease in SmE protein, a component of snRNP, in the SMN complex, which was consistent with a previous discussion that the Gemin6-Gemin7 heterodimer may serve as a surrogate for the SmD3-SmB particle in forming a subcore, the intermediate complex for snRNP. Interestingly, we found that Unrip, but not Gemin8, can remove Gemin7 from the stable SMN-Gemin2-Gemin7 ternary complex. In an in vitro snRNP assembly assay using the Unrip knockdown and the untreated cell lysates, we revealed that there was a decrease in Gemin7 and increase in SmB/B' in the SMN complex observed in untreated cells during the assay, suggesting that the Gemin6-Gemin7 heterodimer in the subcore is exchanged by the SmD3-SmB particle to form snRNP. Surprisingly, these changes were not observed in the assay using the Unrip knockdown cell extracts, indicating the importance of Unrip in the formation of snRNP likely via removal of the Gemin6-Gemin7 from the SMN complex. Taken together, these results indicate that snRNP is synthesized by harmonization of the SMN complex components.	[Ogawa, Chihiro; Usui, Kengo; Ito, Fuyu; Itoh, Masayoshi; Hayashizaki, Yoshihide; Suzuki, Harukazu] RIKEN, Yokohama Inst, RIKEN Om Sci Ctr OSC, Tsurumi Ku, Kanagawa 2300045, Japan; [Usui, Kengo; Ito, Fuyu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST)	Suzuki, H (corresponding author), RIKEN, Yokohama Inst, RIKEN Om Sci Ctr OSC, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	rgscerg@gsc.riken.jp	Hayashizaki, Yoshihide/N-6590-2015; Itoh, Masayoshi/N-5363-2015; Suzuki, Harukazu/N-9553-2015; Usui, Kengo/A-7203-2016	Itoh, Masayoshi/0000-0002-1772-318X; Suzuki, Harukazu/0000-0002-8087-0836; 	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation (JST); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation (JST) (to Y. H.) and a research grant for the RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (to Y. H.).	Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Ma YL, 2005, STRUCTURE, V13, P883, DOI 10.1016/j.str.2005.03.014; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Suzuki H, 2004, BIOTECHNIQUES, V37, P918, DOI 10.2144/04376BM06; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Yong JS, 2002, EMBO J, V21, P1188, DOI 10.1093/emboj/21.5.1188; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	28	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14609	14617		10.1074/jbc.M809031200	http://dx.doi.org/10.1074/jbc.M809031200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321448	Green Published, hybrid			2022-12-25	WOS:000266286100066
J	Wang, GH; Krishnamurthy, K; Umapathy, NS; Verin, AD; Bieberich, E				Wang, Guanghu; Krishnamurthy, Kannan; Umapathy, Nagavedi S.; Verin, Alexander D.; Bieberich, Erhard			The Carboxyl-terminal Domain of Atypical Protein Kinase C zeta Binds to Ceramide and Regulates Junction Formation in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; PKC-LAMBDA; NEURONAL MIGRATION; ADHERENS JUNCTIONS; CANCER-CELLS; STEM-CELLS; APOPTOSIS; POLARITY; MOUSE; COMPLEX	Atypical protein kinase Cs (PKCs) (aPKC zeta and lambda/iota) have emerged as important binding partners for ceramide, a membrane-resident cell signaling lipid that is involved in the regulation of apoptosis as well as cell polarity. Using ceramide overlay assays with proteolytic fragments of PKC zeta and vesicle binding assays with ectopically expressed protein, we show that a protein fragment comprising the carboxyl-terminal 20-kDa sequence of PKC zeta (C20 zeta, amino acids 405-592) bound to C16:0 ceramide. This sequence is not identical to the C1 domain (amino acids 131-180), which has been suggested to serve as a potential ceramide binding domain. Using immunocytochemistry, we found that a C20 zeta protein fragment ectopically expressed in two epithelial cell types (neural progenitors and Madin-Darby canine kidney cells) co-distributed with ceramide. Stable expression of C20 zeta-EGFP in Madin-Darby canine kidney cells disrupted the formation of adherens and tight junctions and impaired the epithelium integrity by reducing transepithelial electrical resistance. Disruption of cell adhesion and loss of transepithelial electrical resistance was prevented by incubation with C16: 0 ceramide. Our results show, for the first time, that there is a novel ceramide binding domain (C20 zeta) in the carboxyl terminus of aPKC. Our results also show that the interaction of ceramide with this binding domain is essential for cell-to-cell contacts in epithelia. Therefore, ceramide interaction with the C20 zeta binding domain is a potential mechanism by which ceramide and aPKC regulate the formation of junctional complexes in epithelial cells.	[Wang, Guanghu; Krishnamurthy, Kannan; Bieberich, Erhard] Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, Sch Med, Augusta, GA 30912 USA; [Umapathy, Nagavedi S.; Verin, Alexander D.] Med Coll Georgia, Sch Med, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bieberich, E (corresponding author), 1120 15th St,Rm CB-2803, Augusta, GA 30912 USA.	ebieberich@mcg.edu			National Institutes of Health [R01NS046835]; March of Dimes [6FY08-322]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS046835. This work was also supported by March of Dimes Grant 6FY08-322.	AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bieberich E, 2000, J BIOL CHEM, V275, P177, DOI 10.1074/jbc.275.1.177; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bieberich E, 2002, CANCER LETT, V181, P55, DOI 10.1016/S0304-3835(02)00049-6; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Bourbon NA, 2000, J BIOL CHEM, V275, P35617, DOI 10.1074/jbc.M007346200; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Frutos S, 1999, J BIOL CHEM, V274, P10765, DOI 10.1074/jbc.274.16.10765; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kitchens KM, 2005, ADV DRUG DELIVER REV, V57, P2163, DOI 10.1016/j.addr.2005.09.013; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Krishnamurthy K, 2007, J BIOL CHEM, V282, P3379, DOI 10.1074/jbc.M607779200; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; van Blitterswijk WJ, 1998, BIOCHEM J, V331, P679; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wooten MW, 1999, CELL DEATH DIFFER, V6, P753, DOI 10.1038/sj.cdd.4400548; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	49	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14469	14475		10.1074/jbc.M808909200	http://dx.doi.org/10.1074/jbc.M808909200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19304661	Green Published, hybrid			2022-12-25	WOS:000266286100053
J	Kurada, BRVVSN; Li, LC; Mulherkar, N; Subramanian, M; Prasad, KV; Prabhakar, BS				Kurada, Bapi Raju V. V. S. N.; Li, Liang Cheng; Mulherkar, Nirupama; Subramanian, Mahesh; Prasad, Kanteti V.; Prabhakar, Bellur S.			MADD, a Splice Variant of IG20, Is Indispensable for MAPK Activation and Protection against Apoptosis upon Tumor Necrosis Factor-alpha Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP/GTP EXCHANGE PROTEIN; TRAIL-INDUCED APOPTOSIS; DEATH DOMAIN PROTEIN; TNF RECEPTOR-I; NF-KAPPA-B; SIGNAL-TRANSDUCTION; NEOPLASTIC-CELLS; DENN-SV; CANCER; KINASE	We investigated the physiological role of endogenous MAPK-activating death domain-containing protein (MADD), a splice variant of the IG20 gene, that can interact with TNFR1 in tumor necrosis factor-alpha (TNF alpha)-induced activation of NF-kappa B, MAPK, ERK1/2, JNK, and p38. Using exon-specific short hairpin RNAs expressing lentiviruses, we knocked down the expression of all IG20 splice variants or MADD, which is overexpressed in cancer cells. Abrogation of MADD expression rendered cells highly susceptible to TNF alpha-induced apoptosis in the absence of cycloheximide. It also resulted in a dramatic loss in TNF alpha-induced activation of MAPK without any apparent effect on NF-kappa B activation. This observation was substantiated by an accompanying loss in the activation of p90RSK, a key downstream target of MAPK, whereas the NF-kappa B-regulated interleukin 6 levels remained unaffected. Endogenous MADD knockdown, however, did not affect epidermal growth factor-induced MAPK activation thereby demonstrating the specific requirement of MADD for TNF receptor-mediated MAPK activation. Re-expression of short hairpin RNA-resistant MADD in the absence of endogenous IG20 expression rescued the cells from TNF alpha-induced apoptosis. The requirement for MADD was highly specific for TNF alpha-induced activation of MAPK but not the related JNK and p38 kinases. Loss of MADD expression resulted in reduced Grb2 and Sos1/2 recruitment to the TNFR1 complex and decreased Ras and MEKK1/2 activation. These results demonstrate the essential role of MADD in protecting cancer cells from TNF alpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.	[Kurada, Bapi Raju V. V. S. N.; Li, Liang Cheng; Mulherkar, Nirupama; Subramanian, Mahesh; Prasad, Kanteti V.; Prabhakar, Bellur S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prabhakar, BS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Rm E-705,835 S Wolcott Ave M-C 790, Chicago, IL 60612 USA.	bprabhak@uic.edu			National Institutes of Health [R01 CA107506]; NATIONAL CANCER INSTITUTE [R01CA107506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA107506 (to B. S. P.).	Al-Zoubi AM, 2001, J BIOL CHEM, V276, P47202, DOI 10.1074/jbc.M104835200; Bachmann R, 1999, AM J PATHOL, V154, P1417, DOI 10.1016/S0002-9440(10)65395-3; BARKER PE, 1984, P NATL ACAD SCI-BIOL, V81, P5826, DOI 10.1073/pnas.81.18.5826; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brown TL, 1998, CURR BIOL, V8, pR191; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chow VTK, 1998, GENOME, V41, P543, DOI 10.1139/gen-41-4-543; Chow VTK, 1996, DNA SEQUENCE, V6, P263, DOI 10.3109/10425179609020873; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Goeddel DV, 1999, CHEST, V116, p69S, DOI 10.1378/chest.116.suppl_1.69S; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Ostrowski J, 2000, BRIT J CANCER, V82, P1041; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; SASAOKA T, 1994, J BIOL CHEM, V269, P32621; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; SUBRAMANIAN M, 2009, J CLIN ENDO IN PRESS; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Xiao CW, 2002, BIOL REPROD, V67, P436, DOI 10.1095/biolreprod67.2.436; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yang Y, 2007, EUR J PHARMACOL, V576, P26, DOI 10.1016/j.ejphar.2007.07.067; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225; Zhou T, 1996, J IMMUNOL, V156, P2661	46	34	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13533	13541		10.1074/jbc.M808554200	http://dx.doi.org/10.1074/jbc.M808554200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289468	Green Published, hybrid			2022-12-25	WOS:000265877300030
J	Kleinschmidt, MA; Wagner, TU; Liedtke, D; Spahr, S; Samans, B; Gaubatz, S				Kleinschmidt, Markus A.; Wagner, Toni U.; Liedtke, Daniel; Spahr, Susi; Samans, Birgit; Gaubatz, Stefan			lin9 Is Required for Mitosis and Cell Survival during Early Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-MYB; REPRESSOR COMPLEX; PROTEIN; GENES; CYCLE; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; PROLIFERATION; CYTOKINESIS	LIN9 has been described as a regulator of G(1)/S and G(2)/M progression of the cell cycle in invertebrates and human cell lines. To elucidate the in vivo function of LIN9 during vertebrate development, we took advantage of the teleost zebrafish (Danio rerio). By means of antisense morpholinos we show here that Lin9-depleted embryonic cells accumulate in mitosis. Flow cytometry and confocal microscopy data demonstrate that the delay in mitotic progression is followed by apoptosis, which strongly manifests in the developing central nervous system. In accordance with these findings, we identified a cohort of Lin9-regulated genes required for different mitotic processes, including mitotic entry, metaphase/anaphase transition, and cytokinesis. Our data establish LIN9 as an essential regulator of mitosis in vertebrate development.	[Kleinschmidt, Markus A.; Wagner, Toni U.; Liedtke, Daniel; Spahr, Susi; Gaubatz, Stefan] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany; [Samans, Birgit] Univ Marburg, Inst Mol Biol & Tumor Res, D-35032 Marburg, Germany	University of Wurzburg; Philipps University Marburg	Gaubatz, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de	Wagner, Toni/A-5387-2011; Pillay, Nischalan/F-9536-2012; Liedtke, Daniel/A-7804-2010	Liedtke, Daniel/0000-0003-0934-7169; Gaubatz, Stefan/0000-0001-8751-4191	Deutsche Forschungsgemeinschaft [TR 17]; European Union [018673]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant TR 17 (to S. G. and D. L.) and a European Union grant (Plurigenes FP6 project 018673) (to T. W.).	Abaza A, 2003, J BIOL CHEM, V278, P27844, DOI 10.1074/jbc.M304522200; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Coelho PA, 2008, PLOS BIOL, V6, P1758, DOI 10.1371/journal.pbio.0060207; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-99; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li L, 2007, CELL SIGNAL, V19, P2046, DOI 10.1016/j.cellsig.2007.05.017; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Sandoval R, 2006, EXP CELL RES, V312, P2465, DOI 10.1016/j.yexcr.2006.04.002; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitehead CM, 1998, J CELL SCI, V111, P2551; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Zhu CJ, 2005, BIOCHEM J, V389, P373, DOI 10.1042/BJ20050097; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	39	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13119	13127		10.1074/jbc.M809635200	http://dx.doi.org/10.1074/jbc.M809635200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19278998	Green Published, hybrid			2022-12-25	WOS:000265688300059
J	Mitchell, DA; Lee, SW; Pence, MA; Markley, AL; Limm, JD; Nizet, V; Dixon, JE				Mitchell, Douglas A.; Lee, Shaun W.; Pence, Morgan A.; Markley, Andrew L.; Limm, Joyce D.; Nizet, Victor; Dixon, Jack E.			Structural and Functional Dissection of the Heterocyclic Peptide Cytotoxin Streptolysin S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-STABLE HEMOLYSINS; ANTIBIOTIC MICROCIN B17; PROMOTES SECONDARY METABOLISM; DNA-GYRASE INHIBITOR; MUTATIONAL ANALYSIS; CHEMICAL-SUBSTANCE; NISIN BIOSYNTHESIS; MATURATION PATHWAY; GENE-CLUSTER; STREPTOCOCCUS	The human pathogen Streptococcus pyogenes secretes a highly cytolytic toxin known as streptolysin S (SLS). SLS is a key virulence determinant and responsible for the beta-hemolytic phenotype of these bacteria. Despite over a century of research, the chemical structure of SLS remains unknown. Recent experiments have revealed that SLS is generated from an inactive precursor peptide that undergoes extensive post-translational modification to an active form. In this work, we address outstanding questions regarding the SLS biosynthetic process, elucidating the features of substrate recognition and sites of post-translational modification to the SLS precursor peptide. Further, we exploit these findings to guide the design of artificial cytolytic toxins that are recognized by the SLS biosynthetic enzymes and others that are intrinsically cytolytic. This new structural information has ramifications for future antimicrobial therapies.	[Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Mitchell, Douglas A.; Lee, Shaun W.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Mitchell, Douglas A.; Lee, Shaun W.; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Mitchell, Douglas A.; Lee, Shaun W.; Markley, Andrew L.; Limm, Joyce D.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pence, Morgan A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	jedixon@ucsd.edu	Nizet, Victor/AAF-3190-2019; Mitchell, Doug/B-6349-2012; Pence, Morgan A./N-1620-2019; Mitchell, Douglas/C-4400-2011	Mitchell, Doug/0000-0002-9564-0953; Pence, Morgan A./0000-0003-0239-0228; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health; Walther Cancer Institute, the Ellison Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walther Cancer Institute, the Ellison Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by grants from the Walther Cancer Institute, the Ellison Foundation, and the Howard Hughes Medical Institute (to J.E.D.).	BERNHEIM.AW, 1967, J BACTERIOL, V93, P2024, DOI 10.1128/JB.93.6.2024-2025.1967; BERNHEIM.AW, 1965, J BACTERIOL, V89, P1387, DOI 10.1128/JB.89.5.1387-1392.1965; BERNHEIMER AW, 1949, J EXP MED, V90, P373, DOI 10.1084/jem.90.5.373; BERNHEIMER AW, 1950, J EXP MED, V92, P129, DOI 10.1084/jem.92.2.129; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; GINSBURG I, 1963, J EXP MED, V118, P905, DOI 10.1084/jem.118.6.905; GINSBURG I, 1965, J EXP MED, V121, P633, DOI 10.1084/jem.121.4.633; HRYNIEWICZ W, 1977, INFECT IMMUN, V16, P730, DOI 10.1128/IAI.16.3.730-733.1977; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Igarashi Y, 2001, J ANTIBIOT, V54, P1045, DOI 10.7164/antibiotics.54.1045; Kelleher NL, 1999, BIOCHEMISTRY-US, V38, P15623, DOI 10.1021/bi9913698; KOYAMA J, 1963, J BIOCHEM-TOKYO, V53, P147, DOI 10.1093/oxfordjournals.jbchem.a127670; KOYAMA J, 1963, J BIOCHEM-TOKYO, V54, P146; KOYAMA J, 1963, J BIOCHEM-TOKYO, V56, P355; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Locke JB, 2007, DIS AQUAT ORGAN, V76, P17, DOI 10.3354/dao076017; Madison LL, 1997, MOL MICROBIOL, V23, P161, DOI 10.1046/j.1365-2958.1997.2041565.x; Marmorek A., 1895, ANN I PASTEUR, V9, P593; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OFEK I, 1972, INFECT IMMUN, V6, P459, DOI 10.1128/IAI.6.4.459-464.1972; Okeley NM, 2003, BIOCHEMISTRY-US, V42, P13613, DOI 10.1021/bi0354942; Onaka H, 2001, J ANTIBIOT, V54, P1036, DOI 10.7164/antibiotics.54.1036; ROBINSON JJ, 1951, J IMMUNOL, V66, P661; Roy RS, 1999, CHEM BIOL, V6, P789, DOI 10.1016/S1074-5521(99)80126-4; Roy RS, 1999, NAT PROD REP, V16, P249, DOI 10.1039/a806930a; Roy RS, 1998, CHEM BIOL, V5, P217, DOI 10.1016/S1074-5521(98)90635-4; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; WILLIAMS AB, 1993, CANCER LETT, V71, P97, DOI 10.1016/0304-3835(93)90103-G; YORGEY P, 1993, MOL MICROBIOL, V9, P897, DOI 10.1111/j.1365-2958.1993.tb01747.x; YORGEY P, 1994, P NATL ACAD SCI USA, V91, P4519, DOI 10.1073/pnas.91.10.4519	39	61	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13004	13012		10.1074/jbc.M900802200	http://dx.doi.org/10.1074/jbc.M900802200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286651	hybrid, Green Published			2022-12-25	WOS:000265688300048
J	Park, E; Lee, MS; Baik, SM; Cho, EB; Son, GH; Seong, JY; Lee, KH; Kim, K				Park, Eonyoung; Lee, Mi Sun; Baik, Sun Mi; Cho, Eun Bee; Son, Gi Hoon; Seong, Jae Young; Lee, Kun Ho; Kim, Kyungjin			Nova-1 Mediates Glucocorticoid-induced Inhibition of Pre-mRNA Splicing of Gonadotropin-releasing Hormone Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; 1ST INTRON; FEMALE REPRODUCTION; LHRH NEURONS; STRESS; GNRH; PITUITARY; ENHANCER; REPRESSION; RECEPTOR	Glucocorticoid (GC) is known to affect the reproductive system by suppressing the gonadotropin-releasing hormone (GnRH) gene expression in the hypothalamus. However, the mechanism of this effect is poorly understood. We show here that the GC-induced reduction of GnRH mRNA is due to attenuation of a post-transcriptional process i.e. splicing of intron A. Treatment of dexamethasone (DEX), a synthetic GC, lowered GnRH mRNA transcripts and was accompanied by reduced excision of the first intron (intron A) from the GnRH pre-mRNA both in vitro and in vivo. While seeking to identify the splicing factors involved in GC-inhibited GnRH pre-mRNA splicing, we found that DEX down-regulated neuro-oncological ventral antigen-1 (Nova-1) mRNA and protein and that knockdown of Nova-1 reduced intron A excision from GnRH pre-mRNA. Nova-1 overexpression reversed the DEX-induced reduction of intron A excision. Nova-1 appears to promote intron A excision by binding to the distal region of exon 1 of the GnRH pre-mRNA. Taken together, our findings indicate that the intron A excision by Nova-1 is a target of GC for down-regulation of GnRH gene expression, and more importantly, we characterized Nova-1, a brain-enriched splicing regulator responsible for GnRH pre-mRNA splicing.	[Park, Eonyoung; Lee, Mi Sun; Baik, Sun Mi; Cho, Eun Bee; Son, Gi Hoon; Lee, Kun Ho; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Seong, Jae Young] Korea Univ, Coll Med, Lab G Protein Coupled Receptors, Seoul 136705, South Korea	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Kim, K (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	kyungjin@snu.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924	Ministry of Science and Technology, Republic of Korea	Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program in Neuroscience funded by the Ministry of Science and Technology, Republic of Korea.	AHIMA RS, 1992, NEUROENDOCRINOLOGY, V56, P845, DOI 10.1159/000126315; Breen KM, 2004, ENDOCRINOLOGY, V145, P692, DOI 10.1210/en.2003-1114; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; CHANDRAN UR, 1994, ENDOCRINOLOGY, V134, P1467, DOI 10.1210/en.134.3.1467; CHATTERTON RT, 1990, INT J FERTIL, V35, P8; Chou MY, 1999, MOL CELL BIOL, V19, P69; Dobson H, 2003, REPRODUCTION, V125, P151, DOI 10.1530/rep.0.1250151; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; Genazzani Alessandro D, 2005, Pediatr Endocrinol Rev, V2, P661; Gore AC, 2006, MOL CELL ENDOCRINOL, V256, P40, DOI 10.1016/j.mce.2006.06.002; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Lai GJ, 2006, ENDOCRINOLOGY, V147, P3961, DOI 10.1210/en.2005-1551; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Mastorakos George, 2006, Pediatr Endocrinol Rev, V3 Suppl 1, P172; MCEWEN BS, 1994, ANN NY ACAD SCI, V743, P1, DOI 10.1111/j.1749-6632.1994.tb55784.x; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Nijholt I, 2004, MOL PSYCHIATR, V9, P174, DOI 10.1038/sj.mp.4001446; Park E, 2006, J BIOL CHEM, V281, P401, DOI 10.1074/jbc.M505814200; RIVIER JE, 1986, J MED CHEM, V29, P1846, DOI 10.1021/jm00160a008; Seong JY, 1999, MOL ENDOCRINOL, V13, P1882, DOI 10.1210/me.13.11.1882; Seong JY, 2002, MOL ENDOCRINOL, V16, P2426, DOI 10.1210/me.2001-0297; Seong JY, 2001, ENDOCRINOLOGY, V142, P4454, DOI 10.1210/en.142.10.4454; Son GH, 2003, J BIOL CHEM, V278, P18037, DOI 10.1074/jbc.M209850200; Tanebe K, 2000, J NEUROENDOCRINOL, V12, P13; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; WRAY S, 1988, PEPTIDES, V9, P1151, DOI 10.1016/0196-9781(88)90103-9; Zhang WQ, 2002, RNA, V8, P671, DOI 10.1017/S1355838202027036; Zhen SJ, 1997, J BIOL CHEM, V272, P12620, DOI 10.1074/jbc.272.19.12620	38	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12792	12800		10.1074/jbc.M807386200	http://dx.doi.org/10.1074/jbc.M807386200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282286	Green Published, hybrid			2022-12-25	WOS:000265688300024
J	Glozak, MA; Seto, E				Glozak, Michele A.; Seto, Edward			Acetylation/Deacetylation Modulates the Stability of DNA Replication Licensing Factor Cdt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE FAMILY; S-PHASE; GEMININ BINDING; ORIGIN ACTIVITY; ACETYLATION; ACETYLTRANSFERASE; DEGRADATION; CHROMATIN; PROTEIN; CELLS	Proper expression of the replication licensing factor Cdt1 is primarily regulated post-translationally by ubiquitylation and proteasome degradation. In a screen to identify novel non-histone targets of histone deacetylases (HDACs), we found Cdt1 as a binding partner for HDAC11. Cdt1 associates specifically and directly with HDAC11. We show that Cdt1 undergoes acetylation and is reversibly deacetylated by HDAC11. In vitro, Cdt1 can be acetylated at its N terminus by the lysine acetyltransferases KAT2B and KAT3B. Acetylation protects Cdt1 from ubiquitylation and subsequent proteasomal degradation. These results extend the list of non-histone acetylated proteins to include a critical DNA replication factor and provide an additional level of complexity to the regulation of Cdt1.	[Glozak, Michele A.; Seto, Edward] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, SRB 23011,12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org			National Institutes of Health [CA109699]; American Heart Association [0755298B]; Kaul Foundation; NATIONAL CANCER INSTITUTE [R01CA109699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Kaul Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109699 (to E. S.). This work was also supported by American Heart Association Grant 0755298B and the Kaul Foundation (to E. S.).	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu HD, 2008, J NEUROSCI RES, V86, P537, DOI 10.1002/jnr.21521; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Polesskaya A, 2001, J BIOL CHEM, V276, P44502, DOI 10.1074/jbc.M106501200; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	30	54	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11446	11453		10.1074/jbc.M809394200	http://dx.doi.org/10.1074/jbc.M809394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19276081	hybrid, Green Published			2022-12-25	WOS:000265494500049
J	Schmuckli-Maurer, J; Casanova, C; Schmied, S; Affentranger, S; Parvanova, I; Kang'a, S; Nene, V; Katzer, F; McKeever, D; Muller, J; Bishop, R; Pain, A; Dobbelaere, DAE				Schmuckli-Maurer, Jacqueline; Casanova, Carlo; Schmied, Stefanie; Affentranger, Sarah; Parvanova, Iana; Kang'a, Simon; Nene, Vishvanath; Katzer, Frank; McKeever, Declan; Mueller, Joachim; Bishop, Richard; Pain, Arnab; Dobbelaere, Dirk A. E.			Expression Analysis of the Theileria parva Subtelomere-Encoded Variable Secreted Protein Gene Family	PLOS ONE			English	Article								Background: The intracellular protozoan parasite Theileria parva transforms bovine lymphocytes inducing uncontrolled proliferation. Proteins released from the parasite are assumed to contribute to phenotypic changes of the host cell and parasite persistence. With 85 members, genes encoding subtelomeric variable secreted proteins (SVSPs) form the largest gene family in T. parva. The majority of SVSPs contain predicted signal peptides, suggesting secretion into the host cell cytoplasm. Methodology/Principal Findings: We analysed SVSP expression in T. parva-transformed cell lines established in vitro by infection of T or B lymphocytes with cloned T. parva parasites. Microarray and quantitative real-time PCR analysis revealed mRNA expression for a wide range of SVSP genes. The pattern of mRNA expression was largely defined by the parasite genotype and not by host background or cell type, and found to be relatively stable in vitro over a period of two months. Interestingly, immunofluorescence analysis carried out on cell lines established from a cloned parasite showed that expression of a single SVSP encoded by TP03_0882 is limited to only a small percentage of parasites. Epitope-tagged TP03_0882 expressed in mammalian cells was found to translocate into the nucleus, a process that could be attributed to two different nuclear localisation signals. Conclusions: Our analysis reveals a complex pattern of Theileria SVSP mRNA expression, which depends on the parasite genotype. Whereas in cell lines established from a cloned parasite transcripts can be found corresponding to a wide range of SVSP genes, only a minority of parasites appear to express a particular SVSP protein. The fact that a number of SVSPs contain functional nuclear localisation signals suggests that proteins released from the parasite could contribute to phenotypic changes of the host cell. This initial characterisation will facilitate future studies on the regulation of SVSP gene expression and the potential biological role of these enigmatic proteins.	[Schmuckli-Maurer, Jacqueline; Casanova, Carlo; Schmied, Stefanie; Affentranger, Sarah; Parvanova, Iana; Dobbelaere, Dirk A. E.] Univ Bern, Vetsuisse Fac, Bern, Switzerland; [Kang'a, Simon; Nene, Vishvanath] The Inst Genom Res TIGR, Rockville, MD USA; [Katzer, Frank; McKeever, Declan] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Vet Ctr, Ctr Trop Vet Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Mueller, Joachim] Univ Bern, Inst Parasitol, CH-3012 Bern, Switzerland; [Bishop, Richard] Int Livestock Res Inst, Nairobi, Kenya; [Pain, Arnab] Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England	University of Bern; J. Craig Venter Institute; University of Edinburgh; University of Bern; CGIAR; International Livestock Research Institute (ILRI); Wellcome Trust Sanger Institute	Schmuckli-Maurer, J (corresponding author), Univ Bern, Vetsuisse Fac, Bern, Switzerland.	dirk.dobbelaere@mopa.unibe.ch	Katzer, Frank/AAG-2042-2020; Pain, Arnab/L-5766-2015; Dobbelaere, Dirk/A-3885-2013	Katzer, Frank/0000-0001-5902-4136; Pain, Arnab/0000-0002-1755-2819; Dobbelaere, Dirk/0000-0003-0672-8468; Muller, Joachim/0000-0001-8189-9270; Nene, Vishvanath/0000-0001-7066-4169; Casanova, Carlo/0000-0002-7888-6329; Schmuckli-Maurer, Jacqueline/0000-0002-8721-1163	Wellcome Trust [GR075820MA, 064654, 077431] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Baydoun H, 2007, GENE, V386, P191, DOI 10.1016/j.gene.2006.09.008; BAYLIS HA, 1993, MOL BIOCHEM PARASIT, V61, P171, DOI 10.1016/0166-6851(93)90063-4; Bevington JM, 2007, VIROLOGY, V357, P102, DOI 10.1016/j.virol.2006.07.050; Bishop R, 2005, NUCLEIC ACIDS RES, V33, P5503, DOI 10.1093/nar/gki818; Bishop R, 2000, MOL BIOCHEM PARASIT, V110, P359, DOI 10.1016/S0166-6851(00)00291-7; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; BROWN CGD, 1973, NATURE, V245, P101, DOI 10.1038/245101a0; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; DOBBELAERE DAE, 1990, INFECT IMMUN, V58, P3847, DOI 10.1128/IAI.58.12.3847-3855.1990; Dobbelaere DAE, 2004, CURR OPIN IMMUNOL, V16, P524, DOI 10.1016/j.coi.2004.05.009; Dobbelaere DAE, 2003, CURR OPIN MICROBIOL, V6, P377, DOI 10.1016/S1369-5274(03)00085-7; Dudoit S, 2003, BIOTECHNIQUES, P45; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Graham Simon P, 2007, Immunome Res, V3, P2, DOI 10.1186/1745-7580-3-2; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; HEUSSLER V, 2006, PARASITOLOGY S, V132, pS429; Heussler VT, 2008, PARASITE, V15, P211, DOI 10.1051/parasite/2008153211; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Katzer F, 2007, INFECT IMMUN, V75, P4909, DOI 10.1128/IAI.00710-07; Katzer F, 2006, INFECT IMMUN, V74, P5456, DOI 10.1128/IAI.00472-06; Mckeever DJ, 2006, PARASITE IMMUNOL, V28, P339, DOI 10.1111/j.1365-3024.2006.00824.x; MCKEEVER DJ, 1994, CURR OPIN IMMUNOL, V6, P564, DOI 10.1016/0952-7915(94)90142-2; Merrick CJ, 2006, MOL MICROBIOL, V62, P612, DOI 10.1111/j.1365-2958.2006.05397.x; Morrison WI, 2006, PARASITOLOGY, V133, pS169, DOI 10.1017/S0031182006001867; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oura CAL, 2003, INT J PARASITOL, V33, P1641, DOI 10.1016/S0020-7519(03)00280-7; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Shaw MK, 2002, WORLD CL PARASITES, V3, P1; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; Shiels BR, 2004, EUKARYOT CELL, V3, P495, DOI 10.1128/EC.3.2.495-505.2004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Swan DG, 1999, MOL BIOCHEM PARASIT, V101, P117, DOI 10.1016/S0166-6851(99)00064-X; Swan DG, 2003, CELL MICROBIOL, V5, P947, DOI 10.1046/j.1462-5822.2003.00340.x; Swan DG, 2001, J CELL SCI, V114, P2747; TOYE P, 1995, MOL BIOCHEM PARASIT, V73, P165, DOI 10.1016/0166-6851(95)00110-M; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642	50	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4839	10.1371/journal.pone.0004839	http://dx.doi.org/10.1371/journal.pone.0004839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325907	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499600001
J	Sellin, CI; Jegou, JF; Renneson, J; Druelle, J; Wild, TF; Marie, JC; Horvat, B				Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka			Interplay between Virus-Specific Effector Response and Foxp3(+) Regulatory T Cells in Measles Virus Immunopathogenesis	PLOS ONE			English	Article								Measles is a highly contagious childhood disease associated with an immunological paradox: although a strong virus-specific immune response results in virus clearance and the establishment of a life-long immunity, measles infection is followed by an acute and profound immunosuppression leading to an increased susceptibility to secondary infections and high infant mortality. In certain cases, measles is followed by fatal neurological complications. To elucidate measles immunopathology, we have analyzed the immune response to measles virus in mice transgenic for the measles virus receptor, human CD150. These animals are highly susceptible to intranasal infection with wild-type measles strains. Similarly to what has been observed in children with measles, infection of suckling transgenic mice leads to a robust activation of both T and B lymphocytes, generation of virus-specific cytotoxic T cells and antibody responses. Interestingly, Foxp3(+)CD25(+)CD4(+) regulatory T cells are highly enriched following infection, both in the periphery and in the brain, where the virus intensively replicates. Although specific anti-viral responses develop in spite of increased frequency of regulatory T cells, the capability of T lymphocytes to respond to virus-unrelated antigens was strongly suppressed. Infected adult CD150 transgenic mice crossed in an interferon receptor type I-deficient background develop generalized immunosuppression with an increased frequency of CD4(+)CD25(+)Foxp3(+) T cells and strong reduction of the hypersensitivity response. These results show that measles virus affects regulatory T-cell homeostasis and suggest that an interplay between virus-specific effector responses and regulatory T cells plays an important role in measles immunopathogenesis. A better understanding of the balance between measles-induced effector and regulatory T cells, both in the periphery and in the brain, may be of critical importance in the design of novel approaches for the prevention and treatment of measles pathology.	[Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] INSERM, U758, F-69008 Lyon, France; [Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] Ecole Normale Superieure Lyon, Lyon, France; [Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] IFR128 BioSci Lyon Gerland Lyon Sud, Lyon, France; [Sellin, Caroline I.; Jegou, Jean-Francois; Renneson, Joelle; Druelle, Johan; Wild, T. Fabian; Marie, Julien C.; Horvat, Branka] Univ Lyon 1, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sellin, CI (corresponding author), INSERM, U758, F-69008 Lyon, France.	branka.horvat@inserm.fr	Marie, Julien/I-5084-2016; Horvat, Branka/M-3504-2014	Horvat, Branka/0000-0003-0578-7765; Marie, Julien/0000-0001-6713-7923; Jegou, Jean-Francois/0000-0002-9703-5976	INSERM; Fondation pour la Recherche Medicale (FRM); MRT; ARSEP	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MRT; ARSEP	This work was supported by institutional grant from INSERM and by Fondation pour la Recherche Medicale (FRM). Coauthors were supported by FRM (CIS, JR), MRT (JD) and ARSEP (JFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2007, CIRCULATION, V116, P1707, DOI 10.1161/CIRCULATIONAHA.107.699470; ARNEBORN P, 1983, CLIN EXP IMMUNOL, V51, P165; ARNEBORN P, 1983, INFECT IMMUN, V39, P29, DOI 10.1128/IAI.39.1.29-37.1983; Atabani SF, 2001, J INFECT DIS, V184, P1, DOI 10.1086/321009; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; BEAUVERGER P, 1993, J VIROL METHODS, V44, P199, DOI 10.1016/0166-0934(93)90055-V; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Beloeil L, 2003, J IMMUNOL, V171, P2995, DOI 10.4049/jimmunol.171.6.2995; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Coquerelle C, 2008, IMMUNOL LETT, V119, P12, DOI 10.1016/j.imlet.2008.05.005; Druelle J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-22; Evlashev A, 2001, J GEN VIROL, V82, P2125, DOI 10.1099/0022-1317-82-9-2125; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GALAMA JMD, 1980, CELL IMMUNOL, V50, P405, DOI 10.1016/0008-8749(80)90294-4; GIRAUDON P, 1985, VIROLOGY, V144, P46, DOI 10.1016/0042-6822(85)90303-4; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; GRIFFIN DE, 1989, NEW ENGL J MED, V320, P1667, DOI 10.1056/NEJM198906223202506; GRIFFIN DE, 1986, CLIN IMMUNOL IMMUNOP, V40, P305, DOI 10.1016/0090-1229(86)90035-8; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275; GRIFFIN DE, 1994, J INFECT DIS, V170, pS24, DOI 10.1093/infdis/170.Supplement_1.S24; Grosjean I, 1997, J EXP MED, V186, P801, DOI 10.1084/jem.186.6.801; Hahm B, 2004, VIROLOGY, V323, P292, DOI 10.1016/j.virol.2004.03.011; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Kerdiles YM, 2006, VIRAL IMMUNOL, V19, P324, DOI 10.1089/vim.2006.19.324; Kerdiles YM, 2006, REV MED VIROL, V16, P49, DOI 10.1002/rmv.486; Li Mei-Zhong, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P211; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; Marie JC, 2004, J VIROL, V78, P11952, DOI 10.1128/JVI.78.21.11952-11961.2004; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Okada H, 2000, ARCH VIROL, V145, P905, DOI 10.1007/s007050050683; Oldstone MBA, 2005, J EXP MED, V202, P1185, DOI 10.1084/jem.20051376; Patterson CE, 2003, J IMMUNOL, V171, P3102, DOI 10.4049/jimmunol.171.6.3102; Sato H, 2008, COMP IMMUNOL MICROB, V31, P25, DOI 10.1016/j.cimid.2007.03.003; Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194; Schneider-Schaulies S, 2006, J GEN VIROL, V87, P1423, DOI 10.1099/vir.0.81713-0; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; Sellin CI, 2009, CURR TOP MICROBIOL, V330, P111; Sellin CI, 2006, J VIROL, V80, P6420, DOI 10.1128/JVI.00209-06; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Yu XL, 2008, J IMMUNOL, V181, P7356, DOI 10.4049/jimmunol.181.10.7356	48	28	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4948	10.1371/journal.pone.0004948	http://dx.doi.org/10.1371/journal.pone.0004948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319188	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499200007
J	Viaud, S; Terme, M; Flament, C; Taieb, J; Andre, F; Novault, S; Escudier, B; Robert, C; Caillat-Zucman, S; Tursz, T; Zitvogel, L; Chaput, N				Viaud, Sophie; Terme, Magali; Flament, Caroline; Taieb, Julien; Andre, Fabrice; Novault, Sophie; Escudier, Bernard; Robert, Caroline; Caillat-Zucman, Sophie; Tursz, Thomas; Zitvogel, Laurence; Chaput, Nathalie			Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15R alpha	PLOS ONE			English	Article							PEPTIDE-BASED VACCINE; REGULATORY T-CELLS; METASTATIC MELANOMA; CANCER REGRESSION; NK CELLS; IN-VIVO; CUTTING EDGE; RECEPTOR; TUMORS; RESPONSES	Dendritic cell (DC) derived-exosomes (Dex) are nanomeric vesicles harboring functional MHC/peptide complexes promoting T cell-dependent tumor rejection. In the first Phase I trial using peptide-pulsed Dex, the observation of clinical regressions in the absence of T cell responses prompted the search for alternate effector mechanisms. Mouse studies unraveled the bioactivity of Dex on NK cells. Indeed, Dex promoted an IL-15R alpha-and NKG2D-dependent NK cell proliferation and activation respectively, resulting in anti-metastatic effects mediated by NK1.1(+) cells. In humans, Dex express functional IL-15R alpha which allow proliferation and IFN gamma secretion by NK cells. In contrast to immature DC, human Dex harbor NKG2D ligands on their surface leading to a direct engagement of NKG2D and NK cell activation ex vivo. In our phase I clinical trial, we highlight the capacity of Dex based-vaccines to restore the number and NKG2D-dependent function of NK cells in 7/14 patients. Altogether, these data provide a mechanistic explanation on how Dex may stimulate non MHC restricted-anti-tumor effectors and induce tumor regression in vivo.	[Viaud, Sophie; Terme, Magali; Flament, Caroline; Taieb, Julien; Andre, Fabrice; Novault, Sophie; Zitvogel, Laurence; Chaput, Nathalie] Inst Natl Sante & Rech Med, Unite 805, Villejuif, France; [Viaud, Sophie; Terme, Magali; Flament, Caroline; Taieb, Julien; Andre, Fabrice; Novault, Sophie; Tursz, Thomas; Zitvogel, Laurence; Chaput, Nathalie] Inst Gustave Roussy, Villejuif, France; [Flament, Caroline; Zitvogel, Laurence; Chaput, Nathalie] Inst Gustave Roussy, Ctr Clin Investigat Biotherap, CICBT507, Villejuif, France; [Taieb, Julien] APHP, Hop Europeen Georges Pompidou, Dept Hepatogastroenterol, Paris, France; [Escudier, Bernard] Inst Gustave Roussy, Dept Immunother, Villejuif, France; [Robert, Caroline] Inst Gustave Roussy, Dept Dermatol, Villejuif, France; [Caillat-Zucman, Sophie] Hop St Vincent De Paul, Inst Natl Sante Rech Med, Unite 561, Paris, France; [Zitvogel, Laurence] Univ Paris Sud XI, Fac Med, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Viaud, S (corresponding author), Inst Natl Sante & Rech Med, Unite 805, Villejuif, France.	nathalie.chaput@igr.fr	TERME, Magali/GZK-9661-2022; Robert, Caroline/G-6157-2018; ANDRE, Fabrice/AAL-2683-2020	TERME, Magali/0000-0003-0857-7237; Robert, Caroline/0000-0002-9493-0238; ANDRE, Fabrice/0000-0001-5795-8357; Caillat-Zucman, Sophie/0000-0002-4535-3550; ZITVOGEL, laurence/0000-0003-1596-0998	AP-HP; ARC Institut Gustave Roussy; Young Investigator Award; ASCO 2002; EC Cell factory program project; ALLOSTEM European; Ligue labellisee contre le cancer; Canceropcle Ile de France;  [QLRT-2001-00093]	AP-HP; ARC Institut Gustave Roussy; Young Investigator Award; ASCO 2002; EC Cell factory program project; ALLOSTEM European; Ligue labellisee contre le cancer; Canceropcle Ile de France; 	QLRT-2001-00093, AP-HP, ARC Institut Gustave Roussy, the Young Investigator Award, ASCO 2002, the EC Cell factory program project, ALLOSTEM European grant, the Ligue labellisee contre le cancer and Canceropcle Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boon T, 2003, NEW ENGL J MED, V348, P252, DOI 10.1056/NEJMe020165; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Chaput N, 2004, J IMMUNOL, V172, P2137, DOI 10.4049/jimmunol.172.4.2137; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Chiong B, 2004, J IMMUNOTHER, V27, P368, DOI 10.1097/00002371-200409000-00005; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Coulie PG, 2001, P NATL ACAD SCI USA, V98, P10290, DOI 10.1073/pnas.161260098; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; Jager E, 2000, INT J CANCER, V86, P538; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kruit WHJ, 2005, INT J CANCER, V117, P596, DOI 10.1002/ijc.21264; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Osada T, 2006, CANCER IMMUNOL IMMUN, V55, P1122, DOI 10.1007/s00262-005-0089-3; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Palucka AK, 2003, J IMMUNOTHER, V26, P432, DOI 10.1097/00002371-200309000-00006; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pilla L, 2006, CANCER IMMUNOL IMMUN, V55, P958, DOI 10.1007/s00262-005-0084-8; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Segura E, 2005, BLOOD CELL MOL DIS, V35, P89, DOI 10.1016/j.bcmd.2005.05.003; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sprent J, 2005, BLOOD CELL MOL DIS, V35, P17, DOI 10.1016/j.bcmd.2005.04.004; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Taieb J, 2006, J IMMUNOL, V176, P2722, DOI 10.4049/jimmunol.176.5.2722; Terme M, 2004, J IMMUNOL, V172, P5957, DOI 10.4049/jimmunol.172.10.5957; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Theoret MR, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3032; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Viaud S, 2008, HORM METAB RES, V40, P82, DOI 10.1055/s-2007-1022548; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Watzl C, 2003, MICROBES INFECT, V5, P31, DOI 10.1016/S1286-4579(02)00057-6; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	79	296	309	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4942	10.1371/journal.pone.0004942	http://dx.doi.org/10.1371/journal.pone.0004942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319200	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200006
J	Bachar, E; Ariav, Y; Ketzinel-Gilad, M; Cerasi, E; Kaiser, N; Leibowitz, G				Bachar, Etti; Ariav, Yafa; Ketzinel-Gilad, Mali; Cerasi, Erol; Kaiser, Nurit; Leibowitz, Gil			Glucose Amplifies Fatty Acid- Induced Endoplasmic Reticulum Stress in Pancreatic beta-Cells via Activation of mTORC1	PLOS ONE			English	Article								Background: Palmitate is a potent inducer of endoplasmic reticulum ( ER) stress in beta-cells. In type 2 diabetes, glucose amplifies fatty-acid toxicity for pancreatic beta-cells, leading to beta-cell dysfunction and death. Why glucose exacerbates beta-cell lipotoxicity is largely unknown. Glucose stimulates mTORC1, an important nutrient sensor involved in the regulation of cellular stress. Our study tested the hypothesis that glucose augments lipotoxicity by stimulating mTORC1 leading to increased beta-cell ER stress. Principal Findings: We found that glucose amplifies palmitate-induced ER stress by increasing IRE1 alpha protein levels and activating the JNK pathway, leading to increased beta-cell apoptosis. Moreover, glucose increased mTORC1 activity and its inhibition by rapamycin decreased beta-cell apoptosis under conditions of glucolipotoxicity. Inhibition of mTORC1 by rapamycin did not affect proinsulin and total protein synthesis in b-cells incubated at high glucose with palmitate. However, it decreased IRE1 alpha expression and signaling and inhibited JNK pathway activation. In TSC2-deficient mouse embryonic fibroblasts, in which mTORC1 is constitutively active, mTORC1 regulated the stimulation of JNK by ER stressors, but not in response to anisomycin, which activates JNK independent of ER stress. Finally, we found that JNK inhibition decreased beta-cell apoptosis under conditions of glucolipotoxicity. Conclusions/Significance: Collectively, our findings suggest that mTORC1 mediates glucose amplification of lipotoxicity, acting through activation of ER stress and JNK. Thus, mTORC1 is an important transducer of ER stress in beta-cell glucolipotoxicity. Moreover, in stressed beta-cells mTORC1 inhibition decreases IRE1 alpha protein expression and JNK activity without affecting ER protein load, suggesting that mTORC1 regulates the beta-cell stress response to glucose and fatty acids by modulating the synthesis and activity of specific proteins involved in the execution of the ER stress response. This novel paradigm may have important implications for understanding beta-cell failure in type 2 diabetes.	[Bachar, Etti; Ariav, Yafa; Ketzinel-Gilad, Mali; Cerasi, Erol; Kaiser, Nurit; Leibowitz, Gil] Hadassah Hebrew Univ, Endocrinol & Metab Serv, Dept Med, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Leibowitz, G (corresponding author), Hadassah Hebrew Univ, Endocrinol & Metab Serv, Dept Med, Med Ctr, Jerusalem, Israel.	gleib@hadassah.org.il	Bachar-Wikström, Etty/AAJ-1147-2020	Bachar-Wikstrom, Etty/0000-0002-3283-6721	Israel Science foundation	Israel Science foundation(Israel Science Foundation)	This study was supported by a grant from the Israel Science foundation to Gil Leibowitz and Nurit Kaiser. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON C, 1993, J BIOL CHEM, V268, P4276; Attali V, 2006, ENDOCRINOLOGY, V147, P5110, DOI 10.1210/en.2006-0496; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Fonseca SG, 2007, ANTIOXID REDOX SIGN, V9, P2335, DOI 10.1089/ars.2007.1790; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goh TT, 2007, AM J PHYSIOL-ENDOC M, V292, pE549, DOI 10.1152/ajpendo.00255.2006; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Serizawa M, 2008, ATHEROSCLEROSIS, V199, P340, DOI 10.1016/j.atherosclerosis.2007.11.009; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Trusina A, 2008, P NATL ACAD SCI USA, V105, P20280, DOI 10.1073/pnas.0803476105; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	53	110	113	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4954	10.1371/journal.pone.0004954	http://dx.doi.org/10.1371/journal.pone.0004954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305497	Green Published, Green Submitted, gold			2022-12-25	WOS:000265498800007
J	Resendis-Antonio, O				Resendis-Antonio, Osbaldo			Filling Kinetic Gaps: Dynamic Modeling of Metabolism Where Detailed Kinetic Information Is Lacking	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH-THROUGHPUT; ROBUSTNESS; SIMULATION; RECONSTRUCTION; METABOLOMICS; CELLS	Background: Integrative analysis between dynamical modeling of metabolic networks and data obtained from high throughput technology represents a worthy effort toward a holistic understanding of the link among phenotype and dynamical response. Even though the theoretical foundation for modeling metabolic network has been extensively treated elsewhere, the lack of kinetic information has limited the analysis in most of the cases. To overcome this constraint, we present and illustrate a new statistical approach that has two purposes: integrate high throughput data and survey the general dynamical mechanisms emerging for a slightly perturbed metabolic network. Methodology/Principal Findings: This paper presents a statistic framework capable to study how and how fast the metabolites participating in a perturbed metabolic network reach a steady-state. Instead of requiring accurate kinetic information, this approach uses high throughput metabolome technology to define a feasible kinetic library, which constitutes the base for identifying, statistical and dynamical properties during the relaxation. For the sake of illustration we have applied this approach to the human Red blood cell metabolism (hRBC) and its capacity to predict temporal phenomena was evaluated. Remarkable, the main dynamical properties obtained from a detailed kinetic model in hRBC were recovered by our statistical approach. Furthermore, robust properties in time scale and metabolite organization were identify and one concluded that they are a consequence of the combined performance of redundancies and variability in metabolite participation. Conclusions/Significance: In this work we present an approach that integrates high throughput metabolome data to define the dynamic behavior of a slightly perturbed metabolic network where kinetic information is lacking. Having information of metabolite concentrations at steady-state, this method has significant relevance due its potential scope to analyze others genome scale metabolic reconstructions. Thus, I expect this approach will significantly contribute to explore the relationship between dynamic and physiology in other metabolic reconstructions, particularly those whose kinetic information is practically nulls. For instances, I envisage that this approach can be useful in genomic medicine or pharmacogenomics, where the estimation of time scales and the identification of metabolite organization may be crucial to characterize and identify (dis)functional stages.	UNAM, Ctr Genom Sci, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Resendis-Antonio, O (corresponding author), UNAM, Ctr Genom Sci, Cuernavaca, Morelos, Mexico.	resendis@ccg.unam.mx	RESENDIS, OSBALDO/ADE-5280-2022	RESENDIS, OSBALDO/0000-0001-5220-541X	National Institute of Health [GM68837]; PAPITT-UNAM [IN203809]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068837] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PAPITT-UNAM(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institute of Health Grant GM68837 and PAPITT-UNAM grant IN203809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Famili I, 2005, BIOPHYS J, V88, P1616, DOI 10.1529/biophysj.104.050385; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Hardy BJ, 2008, NAT REV GENET, V9, pS23, DOI 10.1038/nrg2444; Heinrich R., 1996, REGULATION CELLULAR; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Jamshidi N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000177; Jollife I. T., 2002, PRINCIPAL COMPONENT; Kauffman KJ, 2002, BIOPHYS J, V83, P646, DOI 10.1016/S0006-3495(02)75198-9; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kinoshita A, 2007, J BIOL CHEM, V282, P10731, DOI 10.1074/jbc.M610717200; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Nakayama Y, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-18; Ni TC, 1996, J BIOL CHEM, V271, P7927, DOI 10.1074/jbc.271.14.7927; Palsson BO, 2004, CURR OPIN BIOTECH, V15, P50, DOI 10.1016/j.copbio.2004.01.006; PALSSON BO, 1987, CHEM ENG SCI, V42, P447, DOI 10.1016/0009-2509(87)80007-6; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; PRIGOGINE ISA, 1980, ADV CHEM PHYS, V43; REICH JG, 1981, ENERGY METABOLISM CE; Resendis-Antonio O, 2007, PLOS COMPUT BIOL, V3, P1887, DOI 10.1371/journal.pcbi.0030192; Rojas I, 2007, BMC SYST BIOL, DOI [DOI 10.1186/1752-0509-1-51-56, 10.1186/1752-0509-1-S1-S6, DOI 10.1186/1752-0509-1-S1-S6]; Rojas Isabel, 2007, In Silico Biology, V7, pS37; Santillan M, 2008, BIOPHYS J, V94, P2065, DOI 10.1529/biophysj.107.118026; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4967	10.1371/journal.pone.0004967	http://dx.doi.org/10.1371/journal.pone.0004967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305506	Green Published, gold, Green Submitted			2022-12-25	WOS:000265498800015
J	Lovegrove, FE; Tangpukdee, N; Opoka, RO; Lafferty, EI; Rajwans, N; Hawkes, M; Krudsood, S; Looareesuwan, S; John, CC; Liles, WC; Kain, KC				Lovegrove, Fiona E.; Tangpukdee, Noppadon; Opoka, Robert O.; Lafferty, Erin I.; Rajwans, Nimerta; Hawkes, Michael; Krudsood, Srivicha; Looareesuwan, Sornchai; John, Chandy C.; Liles, W. Conrad; Kain, Kevin C.			Serum Angiopoietin-1 and-2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SEVERE FALCIPARUM-MALARIA; VON-WILLEBRAND-FACTOR; PLASMODIUM-FALCIPARUM; FACTOR-ALPHA; ENDOTHELIAL ACTIVATION; BRAIN; BARRIER; SEVERITY	Background: Limited tools exist to identify which individuals infected with Plasmodium falciparum are at risk of developing serious complications such as cerebral malaria (CM). The objective of this study was to assess serum biomarkers that differentiate between CM and non-CM, with the long-term goal of developing a clinically informative prognostic test for severe malaria. Methodology/Principal Findings: Based on the hypothesis that endothelial activation and blood-brain-barrier dysfunction contribute to CM pathogenesis, we examined the endothelial regulators, angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2), in serum samples from P. falciparum-infected patients with uncomplicated malaria (UM) or CM, from two diverse populations - Thai adults and Ugandan children. Angiopoietin levels were compared to tumour necrosis factor (TNF). In both populations, ANG-1 levels were significantly decreased and ANG-2 levels were significantly increased in CM versus UM and healthy controls (p < 0.001). TNF was significantly elevated in CM in the Thai adult population (p < 0.001), but did not discriminate well between CM and UM in African children. Receiver operating characteristic curve analysis showed that ANG-1 and the ratio of ANG-2: ANG-1 accurately discriminated CM patients from UM in both populations. Applied as a diagnostic test, ANG-1 had a sensitivity and specificity of 100% for distinguishing CM from UM in Thai adults and 70% and 75%, respectively, for Ugandan children. Across both populations the likelihood ratio of CM given a positive test (ANG-1<15 ng/mL) was 4.1 (2.7-6.5) and the likelihood ratio of CM given a negative test was 0.29 (0.20-0.42). Moreover, low ANG-1 levels at presentation predicted subsequent mortality in children with CM (p=0.027). Conclusions/Significance: ANG-1 and the ANG-2/1 ratio are promising clinically informative biomarkers for CM. Additional studies should address their utility as prognostic biomarkers and potential therapeutic targets in severe malaria.	[Lovegrove, Fiona E.; Lafferty, Erin I.; Rajwans, Nimerta; Hawkes, Michael; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Univ Hlth Network, Toronto, ON, Canada; [Tangpukdee, Noppadon; Krudsood, Srivicha; Looareesuwan, Sornchai] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Opoka, Robert O.] Makerere Univ, Dept Paediat & Child Hlth, Kampala, Uganda; [John, Chandy C.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mahidol University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto	Lovegrove, FE (corresponding author), Univ Toronto, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Univ Hlth Network, Toronto, ON, Canada.	kevin.kain@uhn.on.ca	John, Chandy/GNP-8431-2022; , Michael/AAP-3049-2020	John, Chandy/0000-0002-1634-1411; Kain, Kevin/0000-0001-6068-1272; Tangpukdee, Noppadon/0000-0002-4551-6268	CIHR [MT-13721, Canada Research Chairs]; Ontario Genomics Institute; NIH Fogarty International Center [R21 TW-006794]; The McLaughlin Centre for Molecular Medicine; FOGARTY INTERNATIONAL CENTER [R21TW006794] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); The McLaughlin Centre for Molecular Medicine; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a CIHR Team Grant in Malaria (KCK), operating grant MT-13721(KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK, WCL), the NIH Fogarty International Center (grant R21 TW-006794, CCJ), and The McLaughlin Centre for Molecular Medicine (KCK, WCL). The funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Idro R, 2004, ANN TROP PAEDIATR, V24, P17, DOI 10.1179/027249304225013240; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kochar D K, 2000, J Assoc Physicians India, V48, P1222; Kochar DK, 1998, QJM-INT J MED, V91, P845, DOI 10.1093/qjmed/91.12.845; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LOOAREESUWAN S, 1995, CLIN INFECT DIS, V21, P300, DOI 10.1093/clinids/21.2.300; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marty AM, 2006, CLIN LAB MED, V26, P345, DOI 10.1016/j.cll.2006.05.001; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Orfanos SE, 2007, CRIT CARE MED, V35, P1224, DOI 10.1097/01.ccm.0000264153.90247.11; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tripathi AK, 2007, J INFECT DIS, V195, P942, DOI 10.1086/512083; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; WARRELL DA, 1986, AM J TROP MED HYG, V35, P882, DOI 10.4269/ajtmh.1986.35.882; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	44	156	159	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4912	10.1371/journal.pone.0004912	http://dx.doi.org/10.1371/journal.pone.0004912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300530	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000265496800009
J	Passalacqua, KD; Varadarajan, A; Byrd, B; Bergman, NH				Passalacqua, Karla D.; Varadarajan, Anjana; Byrd, Benjamin; Bergman, Nicholas H.			Comparative Transcriptional Profiling of Bacillus cereus Sensu Lato Strains during Growth in CO2-Bicarbonate and Aerobic Atmospheres	PLOS ONE			English	Article								Background: Bacillus species are spore-forming bacteria that are ubiquitous in the environment and display a range of virulent and avirulent phenotypes. This range is particularly evident in the Bacillus cereus sensu lato group; where closely related strains cause anthrax, food-borne illnesses, and pneumonia, but can also be non-pathogenic. Although much of this phenotypic range can be attributed to the presence or absence of a few key virulence factors, there are other virulence-associated loci that are conserved throughout the B. cereus group, and we hypothesized that these genes may be regulated differently in pathogenic and non-pathogenic strains. Methodology/Principal Findings: Here we report transcriptional profiles of three closely related but phenotypically unique members of the Bacillus cereus group-a pneumonia-causing B. cereus strain (G9241), an attenuated strain of B. anthracis (Sterne 34F(2)), and an avirulent B. cereus strain (10987)-during exponential growth in two distinct atmospheric environments: 14% CO2/bicarbonate and ambient air. We show that the disease-causing Bacillus strains undergo more distinctive transcriptional changes between the two environments, and that the expression of plasmid-encoded virulence genes was increased exclusively in the CO2 environment. We observed a core of conserved metabolic genes that were differentially expressed in all three strains in both conditions. Additionally, the expression profiles of putative virulence genes in G9241 suggest that this strain, unlike Bacillus anthracis, may regulate gene expression with both PlcR and AtxA transcriptional regulators, each acting in a different environment. Conclusions/Significance: We have shown that homologous and even identical genes within the genomes of three closely related members of the B. cereus sensu lato group are in some instances regulated very differently, and that these differences can have important implications for virulence. This study provides insights into the evolution of the B. cereus group, and highlights the importance of looking beyond differences in gene content in comparative genomics studies.	[Passalacqua, Karla D.; Varadarajan, Anjana; Byrd, Benjamin; Bergman, Nicholas H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bergman, Nicholas H.] Georgia Tech Res Inst, Electro Opt Syst Lab, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Passalacqua, KD (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	nickbergman@gatech.edu	Passalacqua, Karla/AAU-8156-2021	Passalacqua, Karla/0000-0002-2672-3261	DHHS [N266200400059C, N01-AI-40059]; Southeast RCE for Biodefense and Emerging Infectious Diseases [New Opportunities award]	DHHS; Southeast RCE for Biodefense and Emerging Infectious Diseases	This work was supported by DHHS contract N266200400059C/N01-AI-40059 and by a New Opportunities award from the Southeast RCE for Biodefense and Emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; Casey JR, 2006, BIOCHEM CELL BIOL, V84, P930, DOI 10.1139/O06-184; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; Duport C, 2006, J BACTERIOL, V188, P6640, DOI 10.1128/JB.00702-06; Ehling-Schulz M, 2006, FEMS MICROBIOL LETT, V260, P232, DOI 10.1111/j.1574-6968.2006.00320.x; ELIASSON R, 1995, BIOCHEM BIOPH RES CO, V214, P28, DOI 10.1006/bbrc.1995.2252; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 1999, J APPL MICROBIOL, V87, P279, DOI 10.1046/j.1365-2672.1999.00887.x; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoffmaster AR, 1997, INFECT IMMUN, V65, P3091, DOI 10.1128/IAI.65.8.3091-3099.1997; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaaskelainen EL, 2004, INT J FOOD MICROBIOL, V96, P75, DOI 10.1016/j.ijfoodmicro.2004.03.011; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mignot T, 2004, INT J MED MICROBIOL, V293, P619, DOI 10.1078/1438-4221-00306; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Moat A.G., 2002, MICROBIAL PHYSL; Ngamwongsatit P, 2008, INT J FOOD MICROBIOL, V121, P352, DOI 10.1016/j.ijfoodmicro.2007.11.013; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Ouhib O, 2006, CURR MICROBIOL, V53, P222, DOI 10.1007/s00284-006-0094-6; Passalacqua KD, 2006, FUTURE MICROBIOL, V1, P397, DOI 10.2217/17460913.1.4.397; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Pruss BM, 1999, APPL ENVIRON MICROB, V65, P5436; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; RAVEL J, 2008, J BACTERIOL; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Rivera AMG, 2000, FEMS MICROBIOL LETT, V190, P151, DOI 10.1111/j.1574-6968.2000.tb09278.x; Rowland BM, 1996, GENE, V178, P119, DOI 10.1016/0378-1119(96)00349-6; Ruzicka FJ, 2000, J BACTERIOL, V182, P469, DOI 10.1128/JB.182.2.469-476.2000; Sirard JC, 1995, RES MICROBIOL, V146, P729, DOI 10.1016/0923-2508(96)81069-2; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; STERNE M, 1957, J BACTERIOL, V74, P541, DOI 10.1128/JB.74.4.541-542.1957; Sue D, 2006, J CLIN MICROBIOL, V44, P3426, DOI 10.1128/JCM.00873-06; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Wilson AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000210; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Zwick ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002513	58	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4904	10.1371/journal.pone.0004904	http://dx.doi.org/10.1371/journal.pone.0004904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295911	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496700006
J	Bourjade, M; des Roches, AD; Hausberger, M				Bourjade, Marie; des Roches, Alice de Boyer; Hausberger, Martine			Adult-Young Ratio, a Major Factor Regulating Social Behaviour of Young: A Horse Study	PLOS ONE			English	Article							CAPTIVE GROUP; DAY-CARE; QUALITY; COMMUNICATION; CONTACT; FOALS	Background: Adults play an important role in regulating the social behaviour of young individuals. However, a few pioneer studies suggest that, more than the mere presence of adults, their proportions in social groups affect the social development of young. Here, we hypothesized that aggression rates and social cohesion were correlated to adult-young ratios. Our biological model was naturally-formed groups of Przewalski horses, Equus f. przewalskii, varying in composition. Methodology/Principal Findings: We investigated the social interactions and spatial relationships of 12 one-and two-year-old Przewalski horses belonging to five families with adult-young ratios (AYR) ranging from 0.67 to 1.33. We found striking variations of aggression rates and spatial relationships related to the adult-young ratio: the lower this ratio, the more the young were aggressive, the more young and adults segregated and the tighter the young bonded to other young. Conclusion/Significance: This is the first study demonstrating a correlation between adult-young ratios and aggression rates and social cohesion of young individuals in a naturalistic setting. The increase of aggression and the emergence of social segregation in groups with lower proportions of adults could reflect a related decrease of the influence of adults as regulators of the behaviour of young. This social regulation has both theoretical and practical implications for understanding the modalities of the influence of adults during ontogeny and for recommending optimal settings, as for instance, for schooling or animal group management.	[Bourjade, Marie; des Roches, Alice de Boyer; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, Rennes, France; [Bourjade, Marie] Assoc Takh Pour Cheval Przewalski, Stn Biol Tour Valat, Arles, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Bourjade, M (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, Rennes, France.	marie.bourjade@gmail.com		de Boyer des Roches, Alice/0000-0002-6903-7456	MAVA foundation	MAVA foundation	The Association Takh was supported financially by the MAVA foundation but this work did not receive specific funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Bourjade M, 2008, DEV PSYCHOBIOL, V50, P408, DOI 10.1002/dev.20301; Boyd L, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P55; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Burchinal MR, 2000, CHILD DEV, V71, P339, DOI 10.1111/1467-8624.00149; Burchinal MR, 1997, CHILD DEV, V68, P935, DOI 10.1111/j.1467-8624.1997.tb01972.x; Castellan NJ, 1988, NONPARAMETRIC STAT B; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cousillas H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002194; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Henry S, 2007, DEV PSYCHOBIOL, V49, P514, DOI 10.1002/dev.20225; Henry S, 2005, APPL ANIM BEHAV SCI, V93, P341, DOI 10.1016/j.applanim.2005.01.008; HOWES C, 1985, CHILD YOUTH CARE Q, V14, P140, DOI 10.1007/BF01113407; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; MCCARTNEY K, 1984, DEV PSYCHOL, V20, P244, DOI 10.1037/0012-1649.20.2.244; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Monfort S.L., 1994, P173; Pettit GS, 1999, CHILD DEV, V70, P768, DOI 10.1111/1467-8624.00055; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; RUBENSTEIN J, 1976, CHILD DEV, V47, P597; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; THORHALLSDOTTIR AG, 1990, APPL ANIM BEHAV SCI, V25, P25, DOI 10.1016/0168-1591(90)90066-M; Vandell DL, 1996, EARLY CHILD RES Q, V11, P269, DOI 10.1016/S0885-2006(96)90009-5; Voelkl B, 2006, ANIM BEHAV, V72, P365, DOI 10.1016/j.anbehav.2005.10.013; West MJ, 2003, ANIM BEHAV, V66, P617, DOI 10.1006/anbe.2003.2221; White DJ, 2002, ETHOLOGY, V108, P23, DOI 10.1046/j.1439-0310.2002.00755.x; White DJ, 2002, BEHAV ECOL, V13, P487, DOI 10.1093/beheco/13.4.487; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	23	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4888	10.1371/journal.pone.0004888	http://dx.doi.org/10.1371/journal.pone.0004888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293930	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496600008
J	Gavara, N; Chadwick, RS				Gavara, Nuria; Chadwick, Richard S.			Collagen-Based Mechanical Anisotropy of the Tectorial Membrane: Implications for Inter-Row Coupling of Outer Hair Cell Bundles	PLOS ONE			English	Article								Background: The tectorial membrane (TM) in the mammalian cochlea displays anisotropy, where mechanical or structural properties differ along varying directions. The anisotropy arises from the presence of collagen fibrils organized in fibers of,1 mm diameter that run radially across the TM. Mechanical coupling between the TM and the sensory epithelia is required for normal hearing. However, the lack of a suitable technique to measure mechanical anisotropy at the microscale level has hindered understanding of the TM's precise role. Methodology/Principal Findings: Here we report values of the three elastic moduli that characterize the anisotropic mechanical properties of the TM. Our novel technique combined Atomic Force Microscopy (AFM), modeling, and optical tracking of microspheres to determine the elastic moduli. We found that the TM's large mechanical anisotropy results in a marked transmission of deformations along the direction that maximizes sensory cell excitation, whereas in the perpendicular direction the transmission is greatly reduced. Conclusions/Significance: Computational results, based on our values of elastic moduli, suggest that the TM facilitates the directional cooperativity of sensory cells in the cochlea, and that mechanical properties of the TM are tuned to guarantee that the magnitude of sound-induced tip-link stretching remains similar along the length of the cochlea. Furthermore, we anticipate our assay to be a starting point for other studies of biological tissues that require directional functionality.	[Gavara, Nuria; Chadwick, Richard S.] Natl Inst Deafness & Other Commun Disorders, Auditory Mech Sect, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Gavara, N (corresponding author), Natl Inst Deafness & Other Commun Disorders, Auditory Mech Sect, NIH, Bethesda, MD USA.	chadwick@helix.nih.gov	Gavara, Núria/AAI-2448-2020	Gavara, Núria/0000-0002-7666-110X	NIDCD Intramural Program [Z01-DC000033-10]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000033, ZIADC000033] Funding Source: NIH RePORTER	NIDCD Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The NIDCD Intramural Program Project Z01-DC000033-10 supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2000, HEARING RES, V144, P29, DOI 10.1016/S0378-5955(00)00041-1; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cai HX, 2004, P NATL ACAD SCI USA, V101, P6243, DOI 10.1073/pnas.0401395101; Chadwick RS, 2004, SIAM J APPL MATH, V64, P1186, DOI 10.1137/S0036139903425338; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Dierkes K, 2008, P NATL ACAD SCI USA, V105, P18669, DOI 10.1073/pnas.0805752105; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; FURNESS DN, 1990, ACTA OTO-LARYNGOL, V109, P66, DOI 10.3109/00016489009107416; Ghaffari R, 2007, P NATL ACAD SCI USA, V104, P16510, DOI 10.1073/pnas.0703665104; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gueta R, 2008, BIOPHYS J, V94, P4570, DOI 10.1529/biophysj.107.125203; Gueta R, 2007, J STRUCT BIOL, V159, P103, DOI 10.1016/j.jsb.2007.03.002; Gueta R, 2006, P NATL ACAD SCI USA, V103, P14790, DOI 10.1073/pnas.0603429103; KROS CJ, 1996, COCHLEA, P319; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; LIM DJ, 1972, ARCHIV OTOLARYNGOL, V96, P199; Masaki K, 2006, BIOPHYS J, V91, P2356, DOI 10.1529/biophysj.105.078121; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; SAITO K, 1979, J ELECTRON MICROSC, V28, P36; SHAH DM, 1995, HEARING RES, V87, P187, DOI 10.1016/0378-5955(95)00089-M; Shoelson B, 2004, BIOPHYS J, V87, P2768, DOI 10.1529/biophysj.104.040774; SPENCER JM, 1984, CONTINUM THEORY MECH, P1; STEEL KP, 1983, HEARING RES, V9, P327, DOI 10.1016/0378-5955(83)90035-7; Teudt IU, 2007, J NEUROSCI METH, V162, P187, DOI 10.1016/j.jneumeth.2007.01.012; Thiers FA, 2002, JARO-J ASSOC RES OTO, V3, P269, DOI 10.1007/s101620020024; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tsuprun V, 1998, J NEUROCYTOL, V27, P517, DOI 10.1023/A:1006903926571	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4877	10.1371/journal.pone.0004877	http://dx.doi.org/10.1371/journal.pone.0004877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293929	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496600006
J	Mortaz, E; Kraneveld, AD; Smit, JJ; Kool, M; Lambrecht, BN; Kunkel, SL; Lukacs, NW; Nijkamp, FP; Folkerts, G				Mortaz, Esmaeil; Kraneveld, Aletta D.; Smit, Joost J.; Kool, Mirjam; Lambrecht, Bart N.; Kunkel, Steven L.; Lukacs, Nicholas W.; Nijkamp, Frans P.; Folkerts, Gert			Effect of Cigarette Smoke Extract on Dendritic Cells and Their Impact on T-Cell Proliferation	PLOS ONE			English	Article								Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation. Cigarette smoke has been considered a major player in the pathogenesis of COPD. The inflamed airways of COPD patients contain several inflammatory cells including neutrophils, macrophages, T lymphocytes, and dendritic cells (DCs). The relative contributions of these various inflammatory cells to airway injury and remodeling are not well documented. In particular, the potential role of DCs as mediators of inflammation in the smoker's airways and COPD patients is poorly understood. In the current study we analyzed the effects of cigarette smoke extract on mouse bone marrow derived DC and the production of chemokines and cytokines were studied. In addition, we assessed CSE-induced changes in cDC function in the mixed lymphocyte reaction (MLR) examining CD4+ and CD8+ T cell proliferation. Cigarette smoke extract induces the release of the chemokines CCL3 and CXCL2 (but not cytokines), via the generation of reactive oxygen species (ROS). In a mixed-leukocyte reaction assay, cigarette smoke-primed DCs potentiate CD8+ T cell proliferation via CCL3. In contrast, proliferation of CD4+ T cells is suppressed via an unknown mechanism. The cigarette smoke-induced release of CCL3 and CXCL2 by DCs may contribute to the influx of CD8+ T cells and neutrophils into the airways, respectively.	[Mortaz, Esmaeil; Kraneveld, Aletta D.; Nijkamp, Frans P.; Folkerts, Gert] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands; [Mortaz, Esmaeil] Tarbiat Modares Univ, Fac Med Sci, Dept Biochem, Tehran, Iran; [Mortaz, Esmaeil] Urmia Univ, Fac Vet Med, Dept Basic Sci, Sect Biochem, Orumiyeh, Iran; [Smit, Joost J.] Univ Utrecht, IRAS, Utrecht, Netherlands; [Kool, Mirjam; Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulmonary Med, NL-3000 DR Rotterdam, Netherlands; [Kool, Mirjam; Lambrecht, Bart N.] Univ Ghent, Dept Pulm Med, Lab Immunoreg & Mucosal Immun, Ghent, Belgium; [Kunkel, Steven L.; Lukacs, Nicholas W.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	Utrecht University; Tarbiat Modares University; Urmia University; Utrecht University; Erasmus University Rotterdam; Erasmus MC; Ghent University; University of Michigan System; University of Michigan	Mortaz, E (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands.	e.mortaz@uu.nl	Lambrecht, Bart N/K-2484-2014; Kraneveld, Aletta D/J-3351-2016; Lukacs, Nicholas W/ABH-5583-2020	Lambrecht, Bart N/0000-0003-4376-6834; Kraneveld, Aletta D/0000-0001-9819-383X; Smit, Joost/0000-0003-4612-4036; Mortaz, Esmaeil/0000-0003-0250-087X; Adcock, Ian/0000-0003-2101-8843	Dutch Top Institute Pharma [T1-103, D1.101]	Dutch Top Institute Pharma	This study was performed within the framework of Dutch Top Institute Pharma (project numbers T1-103 and D1.101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Beaudeux J. -L., 2006, ANNALES PHARMACEUTIQUES FRANCAISES, V64, P373, DOI 10.1016/S0003-4509(06)75332-9; Bell D, 1999, ADV IMMUNOL, V72, P255, DOI 10.1016/S0065-2776(08)60023-1; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; CHANG JCC, 1990, TOXICOL APPL PHARM, V102, P514, DOI 10.1016/0041-008X(90)90046-W; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Folkerts G, 2008, TRENDS PHARMACOL SCI, V29, P181, DOI 10.1016/j.tips.2008.01.005; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Karimi K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-66; Kim HY, 2007, IMMUNOL CELL BIOL, V85, P60, DOI 10.1038/sj.icb.7100001; Kinnula Vuokko L., 2005, Current Drug Targets - Inflammation and Allergy, V4, P465, DOI 10.2174/1568010054526368; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lambrecht BN, 2002, CLIN EXP ALLERGY, V32, P805, DOI 10.1046/j.1365-2745.2002.01434.x; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Liu XD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-66; Lukacs NW, 1999, J CLIN INVEST, V104, P995, DOI 10.1172/JCI8125; Ma B, 2004, J IMMUNOL, V172, P1872, DOI 10.4049/jimmunol.172.3.1872; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Mortaz E, 2005, BIOCHEM PHARMACOL, V69, P1049, DOI 10.1016/j.bcp.2004.12.018; Nouri-Shirazi M, 2006, IMMUNOL LETT, V103, P167, DOI 10.1016/j.imlet.2005.10.024; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Robbins CS, 2008, J IMMUNOL, V180, P6623, DOI 10.4049/jimmunol.180.10.6623; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Spurzem JR, 2005, SEMIN RESP CRIT CARE, V26, P142, DOI 10.1055/s-2005-869535; Stevenson CS, 2005, AM J PHYSIOL-LUNG C, V288, pL514, DOI 10.1152/ajplung.00317.2004; Taub DD, 1996, J IMMUNOL, V156, P2095; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Tsoumakidou M, 2008, AM J RESP CRIT CARE, V177, P1180, DOI 10.1164/rccm.200711-1727PP; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006	43	54	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4946	10.1371/journal.pone.0004946	http://dx.doi.org/10.1371/journal.pone.0004946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293939	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496600017
J	Srivastava, B; Blazejewska, P; Hessmann, M; Bruder, D; Geffers, R; Mauel, S; Gruber, AD; Schughart, K				Srivastava, Barkha; Blazejewska, Paulina; Hessmann, Manuela; Bruder, Dunja; Geffers, Robert; Mauel, Susanne; Gruber, Achim D.; Schughart, Klaus			Host Genetic Background Strongly Influences the Response to Influenza A Virus Infections	PLOS ONE			English	Article								The genetic make-up of the host has a major influence on its response to combat pathogens. For influenza A virus, several single gene mutations have been described which contribute to survival, the immune response and clearance of the pathogen by the host organism. Here, we have studied the influence of the genetic background to influenza A H1N1 (PR8) and H7N7 (SC35M) viruses. The seven inbred laboratory strains of mice analyzed exhibited different weight loss kinetics and survival rates after infection with PR8. Two strains in particular, DBA/2J and A/J, showed very high susceptibility to viral infections compared to all other strains. The LD50 to the influenza virus PR8 in DBA/2J mice was more than 1000-fold lower than in C57BL/6J mice. High susceptibility in DBA/2J mice was also observed after infection with influenza strain SC35M. In addition, infected DBA/2J mice showed a higher viral load in their lungs, elevated expression of cytokines and chemokines, and a more severe and extended lung pathology compared to infected C57BL/6J mice. These findings indicate a major contribution of the genetic background of the host to influenza A virus infections. The overall response in highly susceptible DBA/2J mice resembled the pathology described for infections with the highly virulent influenza H1N1-1918 and newly emerged H5N1 viruses.	[Srivastava, Barkha; Blazejewska, Paulina; Hessmann, Manuela; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany; [Srivastava, Barkha; Blazejewska, Paulina; Hessmann, Manuela; Schughart, Klaus] Univ Vet Med Hannover, Braunschweig, Germany; [Bruder, Dunja] Helmholtz Ctr Infect Res, Res Grp Immunoregulat, Braunschweig, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany; [Mauel, Susanne; Gruber, Achim D.] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, D-1000 Berlin, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Free University of Berlin	Srivastava, B (corresponding author), Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, Braunschweig, Germany.	kls@helmholtz-hzi.de	Gruber, Achim D./ABA-4514-2021	Schughart, Klaus/0000-0002-6824-7523	Helmholtz-Association (Program Infection and Immunity); FluResearchNet [01KI07137]; German Ministry of Education and Research; Georg-Christoph-Lichtenberg Foundation [PhD fellowship]	Helmholtz-Association (Program Infection and Immunity)(Helmholtz Association); FluResearchNet; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Georg-Christoph-Lichtenberg Foundation	This work was supported by intra-mural grants from the Helmholtz-Association (Program Infection and Immunity) and a research grant FluResearchNet (No. 01KI07137) from the German Ministry of Education and Research to KS. PB has obtained a PhD fellowship from the Georg-Christoph-Lichtenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Buer J, 2003, NAT REV GENET, V4, P195, DOI 10.1038/nrg1019; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Ding M, 2008, GENES BRAIN BEHAV, V7, P173, DOI 10.1111/j.1601-183X.2007.00335.x; DROEBNER K, 2008, J VIROL; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gottfredsson M, 2008, P NATL ACAD SCI USA, V105, P1303, DOI 10.1073/pnas.0707659105; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; HALLER O, 1976, INFECT IMMUN, V13, P844, DOI 10.1128/IAI.13.3.844-854.1976; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hollingsworth JW, 2007, IMMUNOGENETICS, V59, P713, DOI 10.1007/s00251-007-0242-6; JANEWAY GA, 2001, IMMUNOBIOLOGY; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lengeling A, 2001, MAMM GENOME, V12, P261, DOI 10.1007/s003350040001; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Marquis JF, 2008, CURR TOP MICROBIOL, V321, P27; Marquis JF, 2008, INFECT IMMUN, V76, P78, DOI 10.1128/IAI.00369-07; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Medina E, 2001, J INFECT DIS, V184, P846, DOI 10.1086/323292; Mitsos LM, 2000, GENES IMMUN, V1, P467, DOI 10.1038/sj.gene.6363712; Mitsos LM, 2003, P NATL ACAD SCI USA, V100, P6610, DOI 10.1073/pnas.1031727100; Murphy PM, 2000, PHARMACOL REV, V52, P145; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Rajagopal S, 2007, SEMIN RESP CRIT CARE, V28, P159, DOI 10.1055/s-2007-976488; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STAMBAS J, 2008, PHARM THER; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Vanlaere I, 2008, CYTOKINE, V42, P62, DOI 10.1016/j.cyto.2008.01.013; Vidal SM, 2008, ANNU REV IMMUNOL, V26, P81, DOI 10.1146/annurev.immunol.26.021607.090304; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	59	143	148	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4857	10.1371/journal.pone.0004857	http://dx.doi.org/10.1371/journal.pone.0004857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293935	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496600005
J	Awan, A; Bell, AJ; Satir, P				Awan, Aashir; Bell, Aaron J.; Satir, Peter			Kin5 Knockdown in Tetrahymena thermophila Using RNAi Blocks Cargo Transport of Gef1	PLOS ONE			English	Article								A critical process that builds and maintains the eukaryotic cilium is intraflagellar transport (IFT). This process utilizes members of the kinesin-2 superfamily to transport cargo into the cilium (anterograde transport) and a dynein motor for the retrograde traffic. Using a novel RNAi knockdown method, we have analyzed the function of the homodimeric IFT kinesin-2, Kin5, in Tetrahymena ciliary transport. In RNAi transformants, Kin5 was severely downregulated and disappeared from the cilia, but cilia did not resorb, although tip structure was affected. After deciliation of the knockdown cell, cilia regrew and cells swam, which suggested that Kin5 is not responsible for the trafficking of axonemal precursors to build the cilium, but could be transporting molecules that act in ciliary signal transduction, such as guanine nucleotide exchange proteins (GEFs). Gef1 is a Tetrahymena ciliary protein, and current coimmunoprecipitation and immunofluorescence studies showed that it is absent in regrowing cilia of the knockdown cells lacking ciliary Kin5. We suggest that one important cargo of Kin5 is Gef1 and knockdown of Kin5 results in cell lethality.	[Awan, Aashir; Bell, Aaron J.; Satir, Peter] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Awan, A (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	satir@aecom.yu.edu		Awan, Aashir/0000-0002-8726-2921				Awan A, 2004, CELL MOTIL CYTOSKEL, V58, P1, DOI 10.1002/cm.10170; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; CassidyHanley D, 1997, GENETICS, V146, P135; Christensen ST, 2003, CURR BIOL, V13, pR50, DOI 10.1016/S0960-9822(02)01425-2; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Dondero F, 2004, PROTIST, V155, P157, DOI 10.1078/143446104774199565; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Flannery RJ, 2006, BIOPHYS J, V91, P179, DOI 10.1529/biophysj.105.079046; GAERTIG J, 1994, P NATL ACAD SCI USA, V91, P4549, DOI 10.1073/pnas.91.10.4549; Hai B, 2000, METHOD CELL BIOL, V62, P513; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; Howard-Till RA, 2006, MOL CELL BIOL, V26, P8731, DOI 10.1128/MCB.01430-06; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Linder JU, 1999, EMBO J, V18, P4222, DOI 10.1093/emboj/18.15.4222; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nair S, 1999, FASEB J, V13, P1249, DOI 10.1096/fasebj.13.10.1249; NILSSON JR, 1989, EUR J PROTISTOL, V25, P2, DOI 10.1016/S0932-4739(89)80074-4; ORIAS E, 1975, GENETICS, V79, P187; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Piperno G, 1996, J CELL BIOL, V133, P371, DOI 10.1083/jcb.133.2.371; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; VELAND IR, 2009, J NEPHROLOG IN PRESS	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4873	10.1371/journal.pone.0004873	http://dx.doi.org/10.1371/journal.pone.0004873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290045	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496500007
J	Konig, P; Krain, B; Krasteva, G; Kummer, W				Koenig, Peter; Krain, Benjamin; Krasteva, Gabriela; Kummer, Wolfgang			Serotonin Increases Cilia-Driven Particle Transport via an Acetylcholine-Independent Pathway in the Mouse Trachea	PLOS ONE			English	Article								Background: Mucociliary clearance in the airways is driven by the coordinated beating of ciliated cells. Classical neuromediators such as noradrenalin and acetylcholine increase ciliary beat frequency and thus cilia-driven transport. Despite the fact that the neuromediator serotonin is ciliostimulatory in invertebrates and has been implied in releasing acetylcholine from the airway epithelium, its role in regulating cilia function in vertebrate airways is not established. Methodology/Principal Findings: We examined the effects of serotonin on ciliary beat frequency and cilia-driven particle transport in the acutely excised submerged mouse trachea and determined the sources of serotonin in this tissue by immunohistochemistry. Serotonin (100 mu M) increased cilary beat frequency (8.9+/-1.2 Hz to 17.0+/-2.7 Hz) and particle transport speed (38.9+/-4.6 mu m/s to 83.4+/-8.3 mu m/s) to an extent that was comparable to a supramaximal dose of ATP. The increase in particle transport speed was totally prevented by methysergide (100 mu M). Blockade of muscarinic receptors by atropine (1 mu M) did not reduce the effect of serotonin, although it was effective in preventing the increase in particle transport speed mediated by muscarine (100 mu M). Immunohistochemistry demonstrated serotonin in mast cells pointing towards mast cells and platelets as possible endogenous sources of serotonin. Conclusions/Significance: These results indicate that serotonin is a likely endogenous mediator that can increase cilia-driven transport independent from acetylcholine during activation of mast cells and platelets.	[Koenig, Peter] Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany; [Krain, Benjamin; Krasteva, Gabriela; Kummer, Wolfgang] Univ Giessen, Univ Giessen Lung Ctr, Inst Anat & Zellbiol, D-35390 Giessen, Germany	University of Lubeck; Justus Liebig University Giessen	Konig, P (corresponding author), Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany.	koenig@anat.uni-luebeck.de	Krasteva-Christ, Gabriela/K-7253-2015; Krasteva-Christ, Gabriela/CAI-9036-2022; König, Peter/AAK-2021-2020	Krasteva-Christ, Gabriela/0000-0002-0113-521X; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Kummer, Wolfgang/0000-0002-3946-0683	Medizinische Fakultat der Universitat zu Lubeck [A31-2007, E21-2008]; Fachbereich Medizin der Justus-Liebig-Universitat Giessen; DFG, Excellence Cluster Cardiopulmonary System	Medizinische Fakultat der Universitat zu Lubeck; Fachbereich Medizin der Justus-Liebig-Universitat Giessen; DFG, Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG))	This work was supported by grants to PK from the Medizinische Fakultat der Universitat zu Lubeck (A31-2007; E21-2008), to GK from the Fachbereich Medizin der Justus-Liebig-Universitat Giessen, and by the DFG, Excellence Cluster Cardiopulmonary System (GK, WK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; ASKENASE PW, 1995, INT ARCH ALLERGY IMM, V107, P145, DOI 10.1159/000236958; Bai Y, 2007, AM J RESP CELL MOL, V36, P122, DOI 10.1165/rcmb.2006-0036OC; Christopher KJ, 1996, J EXP BIOL, V199, P1105; DOELLER JE, 1993, J EXP ZOOL, V265, P1, DOI 10.1002/jez.1402650102; Fernandez-Gonzalez A, 2009, AM J RESP CELL MOL, V40, P305, DOI 10.1165/rcmb.2008-0102OC; FORSSMANN WG, 1977, ANAT RECORD, V188, P307, DOI 10.1002/ar.1091880304; GOLDBERG JI, 1994, J NEUROBIOL, V25, P1545, DOI 10.1002/neu.480251207; GOSSELIN RE, 1961, J CELL COMPAR PHYSL, V58, P17, DOI 10.1002/jcp.1030580104; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Ikawati Z, 2000, EUR J PHARMACOL, V402, P297, DOI 10.1016/S0014-2999(00)00482-9; JOHNSON DE, 1989, AM REV RESPIR DIS, V140, P1807, DOI 10.1164/ajrccm/140.6.1807; KIMURA ET, 1959, ARCHIV OTOLARYNGOL, V69, P674; KLEIN MK, 2009, EUR RESP J IN PRESS; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KRUEGER AP, 1960, J GEN PHYSIOL, V43, P533, DOI 10.1085/jgp.43.3.533; Kummer W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-65; Kushnir-Sukhov NM, 2007, J ALLERGY CLIN IMMUN, V119, P498, DOI 10.1016/j.jaci.2006.09.003; Lima C, 2007, CLIN EXP ALLERGY, V37, P723, DOI 10.1111/j.1365-2222.2007.02700.x; MacLean MR, 2000, BRIT J PHARMACOL, V131, P161, DOI 10.1038/sj.bjp.0703570; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Moffatt JD, 2004, BRIT J PHARMACOL, V141, P1159, DOI 10.1038/sj.bjp.0705720; Nagase T, 1996, J APPL PHYSIOL, V80, P583, DOI 10.1152/jappl.1996.80.2.583; Nam BD, 2006, PHYSIOL RES, V55, P397, DOI 10.33549/physiolres.930553; Nguyen T, 2001, J PHYSIOL-LONDON, V531, P131, DOI 10.1111/j.1469-7793.2001.0131j.x; Olivenstein R, 1997, PULM PHARMACOL THER, V10, P223, DOI 10.1006/pupt.1997.0095; Pitchford SC, 2006, CLIN EXP ALLERGY, V36, P399, DOI 10.1111/j.1365-2222.2006.02462.x; Ricciardolo FLM, 2000, AM J RESP CELL MOL, V22, P97, DOI 10.1165/ajrcmb.22.1.3706; Salathe M, 1997, AM J PHYSIOL-LUNG C, V272, pL301, DOI 10.1152/ajplung.1997.272.2.L301; TSUCHIYA M, 1959, FED PROC, V18, P453; Wada Y, 1997, J EXP BIOL, V200, P9; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WASSERMAN SI, 1980, ENVIRON HEALTH PERSP, V35, P153, DOI 10.2307/3428985	33	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4938	10.1371/journal.pone.0004938	http://dx.doi.org/10.1371/journal.pone.0004938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290057	Green Submitted, gold, Green Published			2022-12-25	WOS:000265496500021
J	Werner, M; Semsey, S; Sneppen, K; Krishna, S				Werner, Maria; Semsey, Szabolcs; Sneppen, Kim; Krishna, Sandeep			Dynamics of Uptake and Metabolism of Small Molecules in Cellular Response Systems	PLOS ONE			English	Article							MECHANISMS; HOMEOSTASIS; EXPRESSION	Background: Proper cellular function requires uptake of small molecules from the environment. In response to changes in extracellular conditions cells alter the import and utilization of small molecules. For a wide variety of small molecules the cellular response is regulated by a network motif that combines two feedback loops, one which regulates the transport and the other which regulates the subsequent metabolism. Results: We analyze the dynamic behavior of two widespread but logically distinct two-loop motifs. These motifs differ in the logic of the feedback loop regulating the uptake of the small molecule. Our aim is to examine the qualitative features of the dynamics of these two classes of feedback motifs. We find that the negative feedback to transport is accompanied by overshoot in the intracellular amount of small molecules, whereas a positive feedback to transport removes overshoot by boosting the final steady state level. On the other hand, the negative feedback allows for a rapid initial response, whereas the positive feedback is slower. We also illustrate how the dynamical deficiencies of one feedback motif can be mitigated by an additional loop, while maintaining the original steady-state properties. Conclusions: Our analysis emphasizes the core of the regulation found in many motifs at the interface between the metabolic network and the environment of the cell. By simplifying the regulation into uptake and the first metabolic step, we provide a basis for elaborate studies of more realistic network structures. Particularly, this theoretical analysis predicts that FeS cluster formation plays an important role in the dynamics of iron homeostasis.	[Werner, Maria] Albanova Univ Ctr, Royal Inst Technol, Dept Computat Biol, Stockholm, Sweden; [Semsey, Szabolcs] Eotvos Lorand Univ, Dept Genet, H-1364 Budapest, Hungary; [Sneppen, Kim; Krishna, Sandeep] Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, DK-1168 Copenhagen, Denmark	Royal Institute of Technology; Eotvos Lorand University; University of Copenhagen; Niels Bohr Institute	Werner, M (corresponding author), Albanova Univ Ctr, Royal Inst Technol, Dept Computat Biol, Stockholm, Sweden.	mariawer@kth.se	Semsey, Szabolcs/L-6329-2013	Sneppen, Kim/0000-0001-9820-3567; Semsey, Szabolcs/0000-0002-4522-5495; krishna, sandeep/0000-0002-0581-173X	Danish National Research Foundation; Swedish Research Council;  [OTKA PD75496]	Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); 	This work was funded by Danish National Research Foundation, the Swedish Research Council and by the grant OTKA PD75496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; ONG IM, 2006, BIOINFORMATICS, V18, pS241; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pruteanu M, 2007, J BACTERIOL, V189, P3017, DOI 10.1128/JB.01531-06; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o	15	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4923	10.1371/journal.pone.0004923	http://dx.doi.org/10.1371/journal.pone.0004923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290058	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496500017
J	Bren, GD; Trushin, SA; Whitman, J; Shepard, B; Badley, AD				Bren, Gary D.; Trushin, Sergey A.; Whitman, Joe; Shepard, Brett; Badley, Andrew D.			HIV gp120 Induces, NF-kappa B Dependent, HIV Replication that Requires Procaspase 8	PLOS ONE			English	Article								Background: HIV envelope glycoprotein gp120 causes cellular activation resulting in anergy, apoptosis, proinflammatory cytokine production, and through an unknown mechanism, enhanced HIV replication. Methodology/Principal Findings: We describe that the signals which promote apoptosis are also responsible for the enhanced HIV replication. Specifically, we demonstrate that the caspase 8 cleavage fragment Caspase8p43, activates p50/p65 Nuclear Factor kappa B (NF-kappa B), in a manner which is inhibited by dominant negative IkB alpha. This caspase 8 dependent NF-kappa B activation occurs following stimulation with gp120, TNF, or CD3/CD28 crosslinking, but these treatments do not activate NFkB in cells deficient in caspase 8. The Casp8p43 cleavage fragment also transactivates the HIV LTR through NF-kappa B, and the absence of caspase 8 following HIV infection greatly inhibits HIV replication. Conclusion/Significance: Gp120 induced caspase 8 dependent NF-kappa B activation is a novel pathway of HIV replication which increases understanding of the biology of T-cell death, as well as having implications for understanding treatment and prevention of HIV infection.	[Bren, Gary D.; Trushin, Sergey A.; Whitman, Joe; Shepard, Brett; Badley, Andrew D.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Trushin, Sergey A.; Badley, Andrew D.] Mayo Clin, Program Translat Immunovirol & Biodefense, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Badley, AD (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014	Badley, Andrew/0000-0001-7796-7680	NIH [R01 AI62261, R01 AI40384]; Burroughs Wellcome Award [1005160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261, R01AI040384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: Dr. Andrew Badley is supported by the following grants: NIH R01 AI62261, R01 AI40384 and a Burroughs Wellcome Award ID #1005160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich Alicia, 2007, Open Virol J, V1, P39, DOI 10.2174/1874357900701010039; Asin S, 1999, J VIROL, V73, P3893, DOI 10.1128/JVI.73.5.3893-3903.1999; BADLEY AD, 2006, CELL DEATH HIV INFEC; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cicala C, 2006, VIROLOGY, V345, P105, DOI 10.1016/j.virol.2005.09.052; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Lee S, 2002, MOL CELLS, V14, P348; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; MCELHINNY JA, 1995, J VIROL, V69, P1500, DOI 10.1128/JVI.69.3.1500-1509.1995; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Oakley JD, 2003, IUBMB LIFE, V55, P415, DOI 10.1080/1521654031000146768; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Roggero R, 2001, J VIROL, V75, P7637, DOI 10.1128/JVI.75.16.7637-7650.2001; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takasawa R, 2005, APOPTOSIS, V10, P1121, DOI 10.1007/s10495-005-0901-8; Trushin SA, 2007, J IMMUNOL, V178, P4846, DOI 10.4049/jimmunol.178.8.4846; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4875	10.1371/journal.pone.0004875	http://dx.doi.org/10.1371/journal.pone.0004875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287489	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400016
J	Xing, LJ; Li, J; Xu, YY; Xu, ZH; Chong, K				Xing, Lijing; Li, Juan; Xu, Yunyuan; Xu, Zhihong; Chong, Kang			Phosphorylation Modification of Wheat Lectin VER2 Is Associated with Vernalization-Induced O-GlcNAc Signaling and Intracellular Motility	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINE; JACALIN-RELATED LECTINS; ARABIDOPSIS-THALIANA; NUCLEAR MIGRATION; NUCLEOCYTOPLASMIC PROTEINS; PREVACUOLAR COMPARTMENT; MOLECULAR-BASIS; BINDING LECTIN; ROOT HAIRS; POST-GOLGI	Background: O-linked b-N-acetylglucosamine (O-GlcNAc) modification of proteins mediates stress response and cellular motility in animal cells. The plant lectin concanavalin A can increase nuclear O-GlcNAc levels and decrease cytoplasmic O-GlcNAc levels in T lymphocytes. However, the functions of O-GlcNAc signaling in plants, as well as the relation between plant lectins and O-GlcNAc in response to environmental stimuli are largely undefined. Methodology/Principal Findings: We describe a jacalin-like lectin VER2 in wheat that shows N-acetylglucosamine and galactose specificity. Immunocytochemical localization showed VER2 expression induced predominantly at potential nuclear structures in shoot tips and young leaves and weakly in cytoplasm in response to vernalization. In contrast, under devernalization (continuous stimulation with a higher temperature after vernalization), VER2 signals appeared predominantly in cytoplasm. 2-D electrophoresis, together with western blot analysis, showed phosphorylation modification of VER2 under vernalization. Immunoblot assay with O-GlcNAc-specific antibody revealed that vernalization increased O-GlcNAc modification of proteins at the global level. An O-GlcNAc-modified protein co-immunoprecipitated with VER2 in vernalized wheat plants but not in devernalized materials. The dynamic of VER2 was observed in transgenic Arabidopsis overexpressing the VER2-GFP fusion protein. Overexpressed VER2 accelerated nuclear migration. Immunogold labeling and indirect immunofluoresence colocalization assay indicated that VER2-GFP was targeted to the secretory pathway. Conclusions/Significance: O-GlcNAc signaling is involved in the vernalization response in wheat, and phosphorylation is necessary for the lectin VER2 involving O-GlcNAc signaling during vernalization. Our findings open the way to studies of O-GlcNAc protein modification in response to environmental signals in plants.	[Xing, Lijing; Li, Juan; Xu, Yunyuan; Chong, Kang] Chinese Acad Sci, Inst Bot, Res Ctr Mol Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China; [Xu, Zhihong; Chong, Kang] Natl Ctr Plant Gene Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences	Chong, K (corresponding author), Chinese Acad Sci, Inst Bot, Res Ctr Mol Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China.	chongk@ibcas.ac.cn			National Natural Science Foundation of China NSFC [30470167]; National Science Foundation for Distinguished Young Scholars of China [30525026]; Major State Basic Research Program of the People's Republic of China [2007CB108700]	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Major State Basic Research Program of the People's Republic of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NSFC 30470167); the National Science Foundation for Distinguished Young Scholars of China (30525026); and the Major State Basic Research Program of the People's Republic of China (2007CB108700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmed SU, 2000, J CELL BIOL, V149, P1335, DOI 10.1083/jcb.149.7.1335; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BEDNAREK SY, 1990, PLANT CELL, V2, P1145, DOI 10.1105/tpc.2.12.1145; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Chen Y, 2002, FASEB J, V16, P905, DOI 10.1096/fj.01-0598fje; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Foresti O, 2006, PLANT CELL, V18, P2275, DOI 10.1105/tpc.105.040279; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Grunwald I, 2007, PLANTA, V226, P225, DOI 10.1007/s00425-006-0467-x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartweck LM, 2006, J EXP BOT, V57, P865, DOI 10.1093/jxb/erj071; Hartweck LM, 2002, GENETICS, V161, P1279; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; Holzinger A, 2002, CELL BIOL INT, V26, P689, DOI 10.1006/cbir.2002.0920; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Jiang JF, 2006, TOXICON, V47, P133, DOI 10.1016/j.toxicon.2005.10.010; KAMINSKYJ SGW, 1989, J CELL SCI, V94, P663; Kennard JL, 1997, CELL MOTIL CYTOSKEL, V36, P55; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Kneass ZT, 2004, J BIOL CHEM, V279, P45759, DOI 10.1074/jbc.M407911200; Lannoo N, 2006, FEBS LETT, V580, P6329, DOI 10.1016/j.febslet.2006.10.044; Lefebvre T, 2001, BIOCHEM J, V360, P179, DOI 10.1042/0264-6021:3600179; Li YB, 2002, PLANT CELL PHYSIOL, V43, P726, DOI 10.1093/pcp/pcf085; Liu TY, 2002, J CELL SCI, V115, P1907; MADRID JF, 1994, HISTOCHEMISTRY, V101, P195, DOI 10.1007/BF00269544; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Peumans WJ, 2000, FEBS LETT, V477, P186, DOI 10.1016/S0014-5793(00)01801-9; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; RUHLAND W, 1965, HDB PFLANZENPHYSIOLO, P1479; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Van Bruaene N, 2003, J MICROSC-OXFORD, V211, P167, DOI 10.1046/j.1365-2818.2003.01217.x; Van Damme EJM, 1999, EUR J BIOCHEM, V259, P135, DOI 10.1046/j.1432-1327.1999.00013.x; Van Damme EJM, 2004, TRENDS PLANT SCI, V9, P484, DOI 10.1016/j.tplants.2004.08.003; Van Damme EJM, 2003, GLYCOCONJUGATE J, V20, P449, DOI 10.1023/B:GLYC.0000038291.67527.a5; Van Damme EJM, 2002, PLANT PHYSIOL, V130, P757, DOI 10.1104/pp.005892; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Xing LJ, 2004, PROG BIOCHEM BIOPHYS, V31, P150; Yong WD, 2003, PLANTA, V217, P261, DOI 10.1007/s00425-003-0994-7; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705	69	37	44	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4854	10.1371/journal.pone.0004854	http://dx.doi.org/10.1371/journal.pone.0004854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287503	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400011
J	Kim, SHJ; Yu, W; Mostov, K; Matthay, MA; Hunt, CA				Kim, Sean H. J.; Yu, Wei; Mostov, Keith; Matthay, Michael A.; Hunt, C. Anthony			A Computational Approach to Understand In Vitro Alveolar Morphogenesis	PLOS ONE			English	Article								Primary human alveolar type II (AT II) epithelial cells maintained in Matrigel cultures form alveolar-like cysts (ALCs) using a cytogenesis mechanism that is different from that of other studied epithelial cell types: neither proliferation nor death is involved. During ALC formation, AT II cells engage simultaneously in fundamentally different, but not fully characterized activities. Mechanisms enabling these activities and the roles they play during different process stages are virtually unknown. Identifying, characterizing, and understanding the activities and mechanisms are essential to achieving deeper insight into this fundamental feature of morphogenesis. That deeper insight is needed to answer important questions. When and how does an AT cell choose to switch from one activity to another? Why does it choose one action rather than another? We report obtaining plausible answers using a rigorous, multi-attribute modeling and simulation approach that leveraged earlier efforts by using new, agent and object-oriented capabilities. We discovered a set of cell-level operating principles that enabled in silico cells to self-organize and generate systemic cystogenesis phenomena that are quantitatively indistinguishable from those observed in vitro. Success required that the cell components be quasi-autonomous. As simulation time advances, each in silico cell autonomously updates its environment information to reclassify its condition. It then uses the axiomatic operating principles to execute just one action for each possible condition. The quasi-autonomous actions of individual in silico cells were sufficient for developing stable cyst-like structures. The results strengthen in silico to in vitro mappings at three levels: mechanisms, behaviors, and operating principles, thereby achieving a degree of validation and enabling answering the questions posed. We suggest that the in silico operating principles presented may have a biological counterpart and that a semiquantitative mapping exists between in silico causal events and in vitro causal events.	[Kim, Sean H. J.; Hunt, C. Anthony] Univ Calif Berkeley, UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; [Yu, Wei; Mostov, Keith] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Hunt, C. Anthony] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kim, SHJ (corresponding author), Univ Calif Berkeley, UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA 94720 USA.	a.hunt@ucsf.edu		mostov, keith/0000-0002-8123-6247; Hunt, C. Anthony/0000-0001-9372-6860	CDH Research Foundation [08-0023]; International Foundation for Ethical Research [graduate student fellowship]; National Kidney Foundation [fellowship]; NIH [R01 DK074398, R01 DK067153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, R01DK067153] Funding Source: NIH RePORTER	CDH Research Foundation; International Foundation for Ethical Research; National Kidney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the CDH Research Foundation grant 08-0023, and a graduate student fellowship from the International Foundation for Ethical Research, a fellowship from the National Kidney Foundation to WY, and NIH grants R01 DK074398 and R01 DK067153 to KM. CAH is a trustee of the CDH Research Foundation. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Christley S, 2007, PLOS COMPUT BIOL, V3, P743, DOI 10.1371/journal.pcbi.0030076.eor; Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Grant MR, 2006, PLOS COMPUT BIOL, V2, P1193, DOI 10.1371/journal.pcbi.0020129; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hunt CA, 2008, NAT BIOTECHNOL, V26, P737, DOI 10.1038/nbt0708-737; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; KIM SH, 2007, P ISCA 20 INT C COMP; Law A. M., 2000, SIMULATION MODELING; Longo D, 2004, DEV BIOL, V271, P210, DOI 10.1016/j.ydbio.2004.03.021; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Newman SA, 2008, CURR TOP DEV BIOL, V81, P311, DOI 10.1016/S0070-2153(07)81011-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Peirce SM, 2004, FASEB J, V18, P731, DOI 10.1096/fj.03-0933fje; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Robertson SH, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-46; Rorth P, 2003, CELL, V112, P595, DOI 10.1016/S0092-8674(03)00156-9; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Tang J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-14; Thorne BC, 2007, BRIEF BIOINFORM, V8, P245, DOI 10.1093/bib/bbm024; Walker D, 2006, J THEOR BIOL, V242, P774, DOI 10.1016/j.jtbi.2006.04.020; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zeigler B., 2000, THEORY MODELING SIMU	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4819	10.1371/journal.pone.0004819	http://dx.doi.org/10.1371/journal.pone.0004819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283073	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496300005
J	Sunagawa, S; DeSalvo, MK; Voolstra, CR; Reyes-Bermudez, A; Medina, M				Sunagawa, Shinichi; DeSalvo, Michael K.; Voolstra, Christian R.; Reyes-Bermudez, Alejandro; Medina, Monica			Identification and Gene Expression Analysis of a Taxonomically Restricted Cysteine-Rich Protein Family in Reef-Building Corals	PLOS ONE			English	Article							ANCESTRAL COMPLEXITY; GENOME REVEALS; SEQUENCE; EVOLUTION; REPERTOIRE; COMPONENTS; SITES	The amount of genomic sequence information continues to grow at an exponential rate, while the identification and characterization of genes without known homologs remains a major challenge. For non-model organisms with limited resources for manipulative studies, high-throughput transcriptomic data combined with bioinformatics methods provide a powerful approach to obtain initial insights into the function of unknown genes. In this study, we report the identification and characterization of a novel family of putatively secreted, small, cysteine-rich proteins herein named Small Cysteine-Rich Proteins (SCRiPs). Their discovery in expressed sequence tag (EST) libraries from the coral Montastraea faveolata required the performance of an iterative search strategy based on BLAST and Hidden-Markov-Model algorithms. While a discernible homolog could neither be identified in the genome of the sea anemone Nematostella vectensis, nor in a large EST dataset from the symbiotic sea anemone Aiptasia pallida, we identified SCRiP sequences in multiple scleractinian coral species. Therefore, we postulate that this gene family is an example of lineage-specific gene expansion in reef-building corals. Previously published gene expression microarray data suggest that a sub-group of SCRiPs is highly responsive to thermal stress. Furthermore, data from microarray experiments investigating developmental gene expression in the coral Acropora millepora suggest that different SCRiPs may play distinct roles in the development of corals. The function of these proteins remains to be elucidated, but our results from in silico, transcriptomic, and phylogenetic analyses provide initial insights into the evolution of SCRiPs, a novel, taxonomically restricted gene family that may be responsible for a lineage-specific trait in scleractinian corals.	[Sunagawa, Shinichi; DeSalvo, Michael K.; Voolstra, Christian R.; Reyes-Bermudez, Alejandro; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced	Sunagawa, S (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	mmedina@ucmerced.edu	Sunagawa, Shinichi/Q-5950-2019; Voolstra, Christian R/H-7158-2014	Sunagawa, Shinichi/0000-0003-3065-0314; Voolstra, Christian R/0000-0003-4555-3795; Reyes-Bermudez, Alejandro/0000-0002-4588-3770	NSF [BE-GEN 0313708, IOS 0644438]; Division Of Integrative Organismal Systems [1402065] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported through NSF awards BE-GEN 0313708 and IOS 0644438 funded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lynch M, 2000, GENETICS, V154, P459; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Miller DJ, 2008, TRENDS GENET, V24, P1, DOI 10.1016/j.tig.2007.10.002; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; NAKAYAMA K, 1992, J BIOL CHEM, V267, P16335; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, EVOLUTION GENE DUPLI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RHOLAM M, 1995, EUR J BIOCHEM, V227, P707, DOI 10.1111/j.1432-1033.1995.tb20192.x; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Steele RE, 2005, INTEGR COMP BIOL, V45, P639, DOI 10.1093/icb/45.4.639; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; SYMBIOSYS; AIPTASIABASE	40	54	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4865	10.1371/journal.pone.0004865	http://dx.doi.org/10.1371/journal.pone.0004865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283069	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496300009
J	Pages, JM; Lavigne, JP; Leflon-Guibout, V; Marcon, E; Bert, F; Noussair, L; Nicolas-Chanoine, MH				Pages, Jean-Marie; Lavigne, Jean-Philippe; Leflon-Guibout, Veronique; Marcon, Estelle; Bert, Frederic; Noussair, Latifa; Nicolas-Chanoine, Marie-Helene			Efflux Pump, the Masked Side of beta-Lactam Resistance in Klebsiella pneumoniae Clinical Isolates	PLOS ONE			English	Article								Background: beta-lactamase production and porin decrease are the well-recognized mechanisms of acquired beta-lactam resistance in Klebsiella pneumoniae isolates. However, such mechanisms proved to be absent in K. pneumoniae isolates that are non susceptible to cefoxitin (FOX) and succeptible to amoxicillin+clavulanic acid in our hospital. Assessing the role of efflux pumps in this b-lactam phenotype was the aim of this study. Methodology/Findings: MICs of 9 beta-lactams, including cloxacillin (CLX), and other antibiotic families were tested alone and with an efflux pump inhibitor (EPI), then with both CLX (subinhibitory concentrations) and EPI against 11 unique bacteremia K. pneumoniae isolates displaying the unusual phenotype, and 2 ATCC strains. CLX and EPI-dose dependent effects were studied on 4 representatives strains. CLX MICs significantly decreased when tested with EPI. A similar phenomenon was observed with piperacillin+tazobactam whereas MICs of the other b-lactams significantly decreased only in the presence of both EPI and CLX. Thus, FOX MICs decreased 128 fold in the K. pneumoniae isolates but also16 fold in ATCC strain. Restoration of FOX activity was CLX dose-dependent suggesting a competitive relationship between CLX and the other beta-lactams with regard to their efflux. For chloramphenicol, erythromycin and nalidixic acid whose resistance was also due to efflux, adding CLX to EPI did not increase their activity suggesting differences between the efflux process of these molecules and that of beta-lactams. Conclusion: This is the first study demonstrating that efflux mechanism plays a key role in the beta-lactam susceptibility of clinical isolates of K. pneumoniae. Such data clearly evidence that the involvement of efflux pumps in beta-lactam resistance is specially underestimated in clinical isolates.	[Pages, Jean-Marie; Lavigne, Jean-Philippe] Univ Aix Marseille 2, Fac Med & Pharm, UMR MD 1, IFR88, Marseille, France; [Leflon-Guibout, Veronique; Marcon, Estelle; Bert, Frederic; Noussair, Latifa; Nicolas-Chanoine, Marie-Helene] AP HP, Hop Beaujon, Serv Microbiol, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Univ D Diderot, CRB3, INSERM, U 773, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pages, JM (corresponding author), Univ Aix Marseille 2, Fac Med & Pharm, UMR MD 1, IFR88, Marseille, France.	Jean-Marie.PAGES@univmed.fr	Lavigne, Jean-Philippe/E-1756-2014; PAGES, jean-marie/F-2555-2013	Lavigne, Jean-Philippe/0000-0002-9484-0304; PAGES, jean-marie/0000-0001-7092-7977	Service de Sante des Armees [2004RC16]; Universite de la Mediterranee	Service de Sante des Armees; Universite de la Mediterranee	This study was supported by the Service de Sante des Armees (contrat recherche clinique 2004RC16 and livre rouge operation 23e) and by the Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2003, ANTIMICROB AGENTS CH, V47, P1165, DOI 10.1128/AAC.47.3.1165-1168.2003; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Chevalier J, 2000, BIOCHEM BIOPH RES CO, V274, P496, DOI 10.1006/bbrc.2000.3159; Chevalier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003203; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P3621, DOI 10.1128/AAC.48.9.3621-3624.2004; Dastidar V, 2007, J BACTERIOL, V189, P5550, DOI 10.1128/JB.00471-07; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Elkins CA, 2003, DRUG RESIST UPDATE, V6, P9, DOI 10.1016/S1368-7646(03)00004-9; Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Gori A, 1996, J CLIN MICROBIOL, V34, P2448, DOI 10.1128/JCM.34.10.2448-2453.1996; Gruteke P, 2003, J CLIN MICROBIOL, V41, P1161, DOI 10.1128/JCM.41.3.1161-1166.2003; Haeggman S, 2004, ANTIMICROB AGENTS CH, V48, P2400, DOI 10.1128/AAC.48.7.2400-2408.2004; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2005, J BACTERIOL, V187, P1879, DOI 10.1128/JB.187.6.1879-1883.2005; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; PAGES JM, 2009, BIOCH BIOPH IN PRESS; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Simonet V, 1996, FEMS MICROBIOL LETT, V136, P91; Su CC, 2007, FEBS LETT, V581, P4972, DOI 10.1016/j.febslet.2007.09.035; Su SC, 2008, ANTIMICROB AGENTS CH, V52, P804, DOI 10.1128/AAC.01269-07; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412	38	77	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4817	10.1371/journal.pone.0004817	http://dx.doi.org/10.1371/journal.pone.0004817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279676	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496200004
J	Ishizuya-Oka, A; Hasebe, T; Buchholz, DR; Kajita, M; Fu, LZ; Shi, YB				Ishizuya-Oka, Atsuko; Hasebe, Takashi; Buchholz, Daniel R.; Kajita, Mitsuko; Fu, Liezhen; Shi, Yun-Bo			Origin of the adult intestinal stem cells induced by thyroid hormone in Xenopus laevis	FASEB JOURNAL			English	Article						transgenic frog; organ culture; tissue recombination; gut remodeling; metamorphosis	MATRIX-METALLOPROTEINASE STROMELYSIN-3; ACID-BINDING PROTEIN; AMPHIBIAN METAMORPHOSIS; GENE-EXPRESSION; POSTEMBRYONIC DEVELOPMENT; EPITHELIAL DEVELOPMENT; EXTRACELLULAR-MATRIX; CONNECTIVE-TISSUE; TADPOLE INTESTINE; PROGENITOR CELLS	In the amphibian intestine during metamorphosis, de novo stem cells generate the adult epithelium analogous to the mammalian counterpart. Interestingly, to date the exact origin of these stem cells remains to be determined, making intestinal metamorphosis a unique model to study development of adult organ-specific stem cells. Here, to determine their origin, we made use of transgenic Xenopus tadpoles expressing green fluorescent protein (GFP) for recombinant organ cultures. The larval epithelium separated from the wild-type (Wt) or GFP transgenic (Tg) intestine before metamorphic climax was recombined with homologous and heterologous nonepithelial tissues and was cultivated in the presence of thyroid hormone, the causative agent of metamorphosis. In all kinds of recombinant intestine, adult progenitor cells expressing markers for intestinal stem cells such as sonic hedgehog became detectable and then differentiated into the adult epithelium expressing intestinal fatty acid binding-protein, a marker for absorptive cells. Notably, whenever the epithelium was derived from Tg intestine, both the adult progenitor/stem cells and their differentiated cells expressed GFP, whereas neither of them expressed GFP in the Wt-derived epithelium. Our results provide direct evidence that stem cells that generate the adult intestinal epithelium originate from the larval epithelium, through thyroid hormone-induced dedifferentiation.-Ishizuya-Oka, A., Hasebe, T., Buchholz, D. R., Kajita, M., Fu, L., Shi, Y.-B. The origin of the adult intestinal stem cells induced by thyroid hormone in Xenopus laevis. FASEB J. 23, 2568-2575 (2009)	[Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Nakahara Ku, Kanagawa 2210063, Japan; [Ishizuya-Oka, Atsuko; Kajita, Mitsuko] Nippon Med Sch, Inst Dev & Aging Sci, Kanagawa 2210063, Japan; [Buchholz, Daniel R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Fu, Liezhen; Shi, Yun-Bo] NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Nippon Medical School; Nippon Medical School; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ishizuya-Oka, A (corresponding author), Nippon Med Sch, Dept Biol, Nakahara Ku, 2-297-2 Kosugi Cho, Kanagawa 2210063, Japan.	a-oka@nms.ac.jp		Hasebe, Takashi/0000-0001-7200-8173; Shi, Yun-Bo/0000-0002-6330-0639	Japan Society for the Promotion of Science [20570060]; National Institute of Child Health and Human Development, U.S. National Institutes of Health; Grants-in-Aid for Scientific Research [20570060] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008858] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Child Health and Human Development, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Dave Turner (University of Michigan, Ann Arbor, MI, USA) and Dr. Gert Jan C. Veenstra (University of Nijmegen, Nijmegen, The Netherlands) for kind gifts of plasmids. This work was supported in part by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (C) (grant 20570060 to A.I.-O.) and in part by the Intramural Research Program of the National Institute of Child Health and Human Development, U.S. National Institutes of Health (to Y.-B.S.).	Amano T, 1998, Wound Repair Regen, V6, P302, DOI 10.1046/j.1524-475X.1998.60406.x; Amano T, 1998, DEV GROWTH DIFFER, V40, P177; [Anonymous], 1977, INT REV CYTOL; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; DODD MHI, 1977, PHYSL AMPHIBIA, V3, P467; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Hasebe T, 2008, DEV DYNAM, V237, P3006, DOI 10.1002/dvdy.21698; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ishizuya-Oka A, 2003, J CELL SCI, V116, P3157, DOI 10.1242/jcs.00616; Ishizuya-Oka A, 2001, DIFFERENTIATION, V69, P27, DOI 10.1046/j.1432-0436.2001.690103.x; Ishizuya-Oka A, 2007, DEV DYNAM, V236, P3358, DOI 10.1002/dvdy.21291; IshizuyaOka A, 1996, CELL TISSUE RES, V286, P467, DOI 10.1007/s004410050716; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; ISHIZUYAOKA A, 1992, ROUX ARCH DEV BIOL, V201, P322, DOI 10.1007/BF00592113; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kroll KL, 1996, DEVELOPMENT, V122, P3173; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; MARSHALL JA, 1978, J ANAT, V126, P133; MARSHALL JA, 1978, J EXP ZOOL, V203, P31, DOI 10.1002/jez.1402030104; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; MCAVOY JW, 1978, J ANAT, V125, P155; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Mukhi S, 2008, P NATL ACAD SCI USA, V105, P8962, DOI 10.1073/pnas.0803569105; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Offield MF, 2000, DEVELOPMENT, V127, P1789; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; SHI YB, 1993, J BIOL CHEM, V268, P20312; Shi YB, 2007, PHARMACOL THERAPEUT, V116, P391, DOI 10.1016/j.pharmthera.2007.07.005; Shimizu K, 2002, DEV GENES EVOL, V212, P357, DOI 10.1007/s00427-002-0250-3; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Su Y, 1997, J CELL BIOL, V139, P1533, DOI 10.1083/jcb.139.6.1533; Suzuki K, 2002, DEV GROWTH DIFFER, V44, P225; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Utoh R, 2003, DEV DYNAM, V227, P157, DOI 10.1002/dvdy.10302; YOSHIZATO K, 1989, INT REV CYTOL, V119, P97; Yoshizato K, 2007, INT REV CYTOL, V260, P213, DOI 10.1016/S0074-7696(06)60005-3	52	59	61	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2568	2575		10.1096/fj.08-128124	http://dx.doi.org/10.1096/fj.08-128124			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19299481	Green Published			2022-12-25	WOS:000268836700025
J	Lohner, S; Walev, I; Boukhallouk, F; Palmer, M; Bhakdi, S; Valeva, A				Loehner, Sabine; Walev, Iwan; Boukhallouk, Fatima; Palmer, Michael; Bhakdi, Sucharit; Valeva, Angela			Pore formation by Vibrio cholerae cytolysin follows the same archetypical mode as beta-barrel toxins from gram-positive organisms	FASEB JOURNAL			English	Article						prepore; assembly intermediate; membrane perforation; microbial pathogenicity	STAPHYLOCOCCAL ALPHA-HEMOLYSIN; CHOLESTEROL-DEPENDENT CYTOLYSIN; HEPTAMERIC TRANSMEMBRANE PORE; EL-TOR CYTOLYSIN; NUCLEOTIDE-SEQUENCE; INTERMEDIATE STAGES; GAMMA-HEMOLYSIN; FORMING TOXIN; MEMBRANE; INSERTION	Vibrio cholerae cytolysin (VCC) forms SDS- stable heptameric beta-barrel transmembrane pores in mammalian cell membranes. In contrast to structurally related pore formers of gram-positive organisms, no oligomeric prepore stage of assembly has been detected to date. In the present study, disulfide bonds were engineered to tie the pore-forming amino acid sequence to adjacent domains. In their nonreduced form, mutants were able to bind to rabbit erythrocytes and to native erythrocyte membranes suspended in PBS solution and form SDS-labile oligomers. These remained nonfunctional and represented the long-sought VCC prepores. Disulfide bond reduction in these oligomers released the pore-forming sequence from its locked position, and subsequent membrane insertion led to formation of SDS-stable pores and hemolysis. Addition of increasing amounts of an inactive mutant to wild-type toxin resulted in the formation of mixed oligomers with progressively reduced SDS stability on membranes. Membrane insertion of active monomers in these hybrid oligomers was still observed, but the functional pore diameter was reduced. These findings indicate that formation of an oligomeric prepore precedes membrane insertion of the pore-forming amino acid sequence and demonstrate that pore formation by VCC follows the same archetypical pathway as beta-barrel cytolysins of gram-positive organisms such as staphylococcal alpha-toxin.-Lohner, S., Walev, I., Boukhallouk, F., Palmer, M., Bhakdi, S., Valeva, A. Pore formation by Vibrio cholerae cytolysin follows the same archetypical mode as beta-barrel toxins from gram-positive organisms. FASEB J. 23, 2521-2528 (2009)	[Loehner, Sabine; Walev, Iwan; Boukhallouk, Fatima; Bhakdi, Sucharit; Valeva, Angela] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Palmer, Michael] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	Johannes Gutenberg University of Mainz; University of Waterloo	Bhakdi, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Augustuspl, D-55131 Mainz, Germany.	sbhakdi@uni-mainz.de			Deutsche Forschungsgemeinschaft [SFB 490]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft, grant SFB 490, Project D3.	Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Cormack B., 2001, CURR PROTOC MOL BIOL; Furini S, 2008, BIOPHYS J, V95, P2265, DOI 10.1529/biophysj.107.127019; Gouaux E, 1997, PROTEIN SCI, V6, P2631; HIRONO I, 1993, MICROB PATHOGENESIS, V15, P269, DOI 10.1006/mpat.1993.1077; HIRONO I, 1991, MICROB PATHOGENESIS, V11, P189, DOI 10.1016/0882-4010(91)90049-G; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Kawate T, 2003, PROTEIN SCI, V12, P997, DOI 10.1110/ps.0231203; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; Nagamune K, 1996, INFECT IMMUN, V64, P4655, DOI 10.1128/IAI.64.11.4655-4658.1996; Nagamune K, 1997, J BIOL CHEM, V272, P1338, DOI 10.1074/jbc.272.2.1338; Nguyen VT, 2002, MOL MICROBIOL, V45, P1485, DOI 10.1046/j.1365-2958.2002.03125.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 2003, PROTEIN SCI, V12, P379, DOI 10.1110/ps.0231703; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Valeva A, 2005, MOL MICROBIOL, V57, P124, DOI 10.1111/j.1365-2958.2005.04684.x; Valeva A, 2004, J BIOL CHEM, V279, P25143, DOI 10.1074/jbc.M313913200; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; Valeva A, 2001, J BIOL CHEM, V276, P14835, DOI 10.1074/jbc.M100301200; VANDERGOOT FG, 1992, BIOCHEMISTRY-US, V31, P8566, DOI 10.1021/bi00151a026; WALKER B, 1992, J BIOL CHEM, V267, P21782; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; YAMAMOTO K, 1990, INFECT IMMUN, V58, P2706, DOI 10.1128/IAI.58.8.2706-2709.1990; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x; Zitzer A, 2000, BBA-BIOMEMBRANES, V1509, P264, DOI 10.1016/S0005-2736(00)00303-5; ZITZER AO, 1993, ZBL BAKT-INT J MED M, V279, P494, DOI 10.1016/S0934-8840(11)80421-4	32	18	18	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2521	2528		10.1096/fj.08-127688	http://dx.doi.org/10.1096/fj.08-127688			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19276173				2022-12-25	WOS:000268836700020
J	Planel, E; Bretteville, A; Liu, L; Virag, L; Du, AL; Yu, WH; Dickson, DW; Whittington, RA; Duff, KE				Planel, Emmanuel; Bretteville, Alexis; Liu, Li; Virag, Laszlo; Du, Angela L.; Yu, Wai Haung; Dickson, Dennis W.; Whittington, Robert A.; Duff, Karen E.			Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia	FASEB JOURNAL			English	Article						Alzheimer's disease; hypothermia; tau hyperphosphorylation; microtubules	GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; TAU-PROTEIN; IN-VIVO; STABLE MICROTUBULES; P301L TAU; PHOSPHORYLATION; KINASE	Alzheimer's disease and other tauopathies are characterized by the presence of intracellular neurofibrillary tangles composed of hyperphosphorylated, insoluble tau. General anesthesia has been shown to be associated with increased risk of Alzheimer's disease, and we have previously demonstrated that anesthesia induces hypothermia, which leads to overt tau hyperphosphorylation in the brain of mice regardless of the anesthetic used. To investigate whether anesthesia enhances the long-term risk of developing pathological forms of tau, we exposed a mouse model with tauopathy to anesthesia and monitored the outcome at two time points-during anesthesia, or 1 wk after exposure. We found that exposure to isoflurane at clinically relevant doses led to increased levels of phospho-tau, increased insoluble, aggregated forms of tau, and detachment of tau from microtubules. Furthermore, levels of phospho-tau distributed in the neuropil, as well as in cell bodies increased. Interestingly, the level of insoluble tau was increased 1 wk following anesthesia, suggesting that anesthesia precipitates changes in the brain that provoke the later development of tauopathy. Overall, our results suggest that anesthesia-induced hypothermia could lead to an acceleration of tau pathology in vivo that could have significant clinical implications for patients with early stage, or overt neurofibrillary tangle pathology.-Planel, E., Bretteville, A., Liu, L., Virag, L., Du, A. L., Yu, W. Y., Dickson, D. W., Whittington, R. A., Duff, K. E. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J. 23, 2595-2604 ( 2009)	[Planel, Emmanuel; Bretteville, Alexis; Liu, Li; Du, Angela L.; Yu, Wai Haung; Duff, Karen E.] Columbia Univ, Med Ctr, Dept Pathol, Taub Inst Alzheimers Dis Res, New York, NY 10032 USA; [Planel, Emmanuel] Univ Laval, Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Quebec City, PQ, Canada; [Virag, Laszlo; Whittington, Robert A.] Columbia Univ, Med Ctr, Dept Anesthesiol, New York, NY 10032 USA; [Planel, Emmanuel; Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Integrat Neurosci, New York, NY 10032 USA; [Dickson, Dennis W.] Mayo Clin Jacksonville, Dept Pathol & Neurosci, Jacksonville, FL 32224 USA	Columbia University; Laval University; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Duff, KE (corresponding author), Columbia Univ, Med Ctr, Dept Pathol, Taub Inst Alzheimers Dis Res, P&S Bldg 12-461,630 W 168th St, New York, NY 10032 USA.	ked2115@columbia.edu	Duff, Karen EK/C-2510-2009	Dickson, Dennis W/0000-0001-7189-7917; Yu, Wai Haung/0000-0001-7186-6731; Duff, Karen/0000-0002-6177-868X; Planel, Emmanuel/0000-0001-5128-0565	Institute for the Study of Aging/Alzheimer's Drug Discovery Foundation; National Institute of Neurological Disorders and Stroke [NS048447]; National Institute on Aging [AG017216]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216] Funding Source: NIH RePORTER	Institute for the Study of Aging/Alzheimer's Drug Discovery Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Dr. Jada Lewis ( Mayo Clinic, Jacksonville, FL, USA) for help with the motor function analysis. We thank Dr. Peter Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for the generous gift of antibodies. We are also grateful to Helen Y. Figueroa and Mathieu Herman for technical help. This work was supported by an Institute for the Study of Aging/Alzheimer's Drug Discovery Foundation grant ( to E. P.), a National Institute of Neurological Disorders and Stroke grant (NS048447), and a National Institute on Aging grant (AG017216; to K. E. D.).	Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360; Avila J, 2004, NAT MED, V10, P460, DOI 10.1038/nm0504-460; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; BOHNEN N, 1994, INT J NEUROSCI, V77, P181, DOI 10.3109/00207459408986029; Bone I, 2000, ANAESTHESIA, V55, P592, DOI 10.1046/j.1365-2044.2000.01479-5.x; Bretteville A, 2008, J ALZHEIMERS DIS, V14, P431; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; ECKENHOFF RG, 2007, CELL SCI REV, V4, P78; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P17, DOI 10.1007/s00401-008-0383-1; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GURLAND G, 1993, P NATL ACAD SCI USA, V90, P8827, DOI 10.1073/pnas.90.19.8827; Holtzmam A, 2000, MED HYPOTHESES, V55, P440, DOI 10.1054/mehy.2000.1085; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Johansson C, 1996, AGING CLIN EXP RES, V8, P189, DOI 10.1007/BF03339676; Kim D, 1999, BRAIN RES, V839, P253, DOI 10.1016/S0006-8993(99)01724-2; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; LAMY C, 1989, NEUROPATH APPL NEURO, V15, P563, DOI 10.1111/j.1365-2990.1989.tb01255.x; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Merrick SE, 1997, J NEUROSCI, V17, P5726; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Planel E, 2002, DRUG DEVELOP RES, V56, P491, DOI 10.1002/ddr.10100; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; REES DI, 1985, TEX MED, V81, P45; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Ritchie K, 1997, Int Psychogeriatr, V9, P309, DOI 10.1017/S1041610297004468; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; Sironi JJ, 1998, FEBS LETT, V436, P471, DOI 10.1016/S0014-5793(98)01185-5; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43; TROJANOWSKI JQ, 1994, AM J PATHOL, V144, P449; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	52	99	104	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2595	2604		10.1096/fj.08-122424	http://dx.doi.org/10.1096/fj.08-122424			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19279139	Green Published			2022-12-25	WOS:000268836700028
J	Wang, XX; Wu, YT; Zhou, B				Wang, Xiaoxi; Wu, Yuantai; Zhou, Bing			Dietary zinc absorption is mediated by ZnT1 in Drosophila melanogaster	FASEB JOURNAL			English	Article						dZnT1, metallothionein; midgut constriction; basolateral membrane	TRANSCRIPTION FACTOR MTF-1; OF-INTIMACY ENCODES; MAMMALIAN ZINC; CONFERS RESISTANCE; FUNCTIONAL-CHARACTERIZATION; GONAD MORPHOGENESIS; COPPER HOMEOSTASIS; MENKES PROTEIN; TRANSPORTER; GENE	Zinc is an essential nutritional factor involved in many key biological processes. However, the physiological function of zinc transporters at the organismal level is not well characterized. Early embryonic lethality of Znt1 knockout mice precludes functional analysis of the role of ZnT1 in dietary zinc absorption. Here, we report the identification and characterization of the Drosophila ZnT1 orthologue, dZnT1, for its role in Drosophila dietary zinc absorption. In cell culture, dZnT1 promoted zinc transport to reduce cytoplasmic zinc levels. Ubiquitous RNA interference of dZnT1 in Drosophila resulted in developmental arrest under restriction of dietary zinc, while dZnT1-overexpressing flies exhibited hypersensitivity to zinc. dZnT1 was prominently expressed in restricted regions of the midgut and exhibited a distribution on the basolateral membrane of the enterocytes. Gut-specific silencing of dZnT1 was sufficient to evoke lethality under zinc scarcity. Human ZnT1, but not ZnT7 or ZnT4, could rescue the zinc-acquiring defects caused by dZnT1 silencing. Taken together, our results proved that dZnT1 is a key zinc transporter in dietary zinc absorption, functioning by pumping zinc out of the enterocytes across the basolateral membrane. This study will be helpful in understanding the fundamental process of acquiring dietary zinc in higher eukaryotes.-Wang, X., Wu, Y., Zhou, B. Dietary zinc absorption is mediated by ZnT1 in Drosophila melanogaster. FASEB J. 23, 2650-2661 (2009)	[Wang, Xiaoxi; Wu, Yuantai; Zhou, Bing] Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Zhou, B (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	zhoubing@mail.tsinghua.edu.cn	Wang, Xiaoxi/C-7178-2015	Wang, Xiaoxi/0000-0002-2232-8504	National Basic Research Program of China [2005CB522503]; National Scientific Foundation of China [30688001]	National Basic Research Program of China(National Basic Research Program of China); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	We greatly appreciate the kind gifts of fly stocks from Dr. Walter Schaffner ( University of Zurich, Zurich, Switzerland) and Dr. Craig Montell ( Johns Hopkins University School of Medicine, Baltimore, MD, USA); Drosophila S2 cells and expression vector pPac5c-PL from Dr. Hong Luo (Tsinghua University, Beijing, China). We are also grateful to the Bloomington Stock Center, the Drosophila Genetic Resource Center at the Kyoto Institute of Technology, Flytrap, and the Vienna Drosophila RNAi Center for fly stocks. This work was supported by the National Basic Research Program of China (2005CB522503) and by the National Scientific Foundation of China (30688001). We thank Sumin Guo for assistance in Drosophila microinjection and Wen Lu for help in antibody preparation.	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Andrews GK, 2004, GENESIS, V40, P74, DOI 10.1002/gene.20067; BAER MT, 1984, AM J CLIN NUTR, V39, P556, DOI 10.1093/ajcn/39.4.556; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Brenner R, 1997, COMP BIOCHEM PHYS B, V118, P411, DOI 10.1016/S0305-0491(97)00167-3; BREWER GJ, 1990, J AM COLL NUTR, V9, P487, DOI 10.1080/07315724.1990.10720405; BRUGGER C, 1974, J INSECT PHYSIOL, V20, P121, DOI 10.1016/0022-1910(74)90128-0; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; Carstens J, 1997, CLIN CHEM, V43, P638; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; DURLIAT M, 1995, BIOMETALS, V8, P339; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Egli D, 2006, GENES CELLS, V11, P647, DOI 10.1111/j.1365-2443.2006.00971.x; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; JARIAL MS, 1987, TISSUE CELL, V19, P559, DOI 10.1016/0040-8166(87)90048-6; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kim AH, 2000, BRAIN RES, V886, P99, DOI 10.1016/S0006-8993(00)02944-9; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Mathews WR, 2006, DEVELOPMENT, V133, P1143, DOI 10.1242/dev.02256; Mathews WR, 2005, J BIOL CHEM, V280, P787, DOI 10.1074/jbc.M411308200; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; McNulty M, 2001, CELL TISSUE RES, V304, P383, DOI 10.1007/s004410100371; Mehta A, 2008, BIOCHEM SOC T, V36, P1313, DOI 10.1042/BST0361313; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Pielage J, 2004, DEV BIOL, V275, P245, DOI 10.1016/j.ydbio.2004.07.039; Poulsen D. F., 1952, Experimental Cell Research New York Supplement, VNo. 2, P161; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; VANCAMPEN DR, 1965, J NUTR, V86, P120, DOI 10.1093/jn/86.2.120; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	66	64	66	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2650	2661		10.1096/fj.08-126649	http://dx.doi.org/10.1096/fj.08-126649			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19325039				2022-12-25	WOS:000268836700033
J	Magnone, M; Bruzzone, S; Guida, L; Damonte, G; Millo, E; Scarft, S; Usai, C; Sturla, L; Palombo, D; De Flora, A; Zocchi, E				Magnone, Mirko; Bruzzone, Santina; Guida, Lucrezia; Damonte, Gianluca; Millo, Enrico; Scarft, Sonia; Usai, Cesare; Sturla, Laura; Palombo, Domenico; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Released by Human Monocytes Activates Monocytes and Vascular Smooth Muscle Cell Responses Involved in Atherogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; CHEMOATTRACTANT PROTEIN-1 GENE; NF-KAPPA-B; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; C-DEPENDENT PROCESSES; POLYMORPHONUCLEAR NEUTROPHILS; HUMAN GRANULOCYTES; EXPRESSION; ATHEROSCLEROSIS; PROLIFERATION	Abscisic acid (ABA) is a phytohormone recently identified as a new endogenous pro-inflammatory hormone in human granulocytes. Here we report the functional activation of human monocytes and vascular smooth muscle cells by ABA. Incubation of monocytes with ABA evokes an intracellular Ca2+ rise through the second messenger cyclic ADP-ribose, leading to NF-kappa B activation and consequent increase of cyclooxygenase-2 expression and prostaglandin E-2 production and enhanced release of MCP-1 (monocyte chemoattractant protein-1) and of metalloprotease-9, all events reportedly involved in atherogenesis. Moreover, monocytes release ABA when exposed to thrombin-activated platelets, a condition occurring at the injured vascular endothelium; monocyte-derived ABA behaves as an autocrine and paracrine pro-inflammatory hormone-stimulating monocyte migration and MCP-1 release, as well as vascular smooth muscle cells migration and proliferation. These results, and the presence of ABA in human arterial plaques at a 10-fold higher concentration compared with normal arterial tissue, identify ABA as a new signal molecule involved in the development of atherosclerosis and suggest a possible new target for anti-atherosclerotic therapy.	[Magnone, Mirko; Bruzzone, Santina; Guida, Lucrezia; Damonte, Gianluca; Millo, Enrico; Scarft, Sonia; Sturla, Laura; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Scarft, Sonia; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Palombo, Domenico] San Martino Hosp, Vasc & Endovasc Surg Unit, I-16132 Genoa, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Genoa; IRCCS AOU San Martino IST	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15 1, I-16132 Genoa, Italy.	ezocchi@unige.it	Bruzzone, Santina/A-4264-2015; Millo, Enrico/K-3218-2018; Scarfi, Sonia/AAJ-2387-2020	Bruzzone, Santina/0000-0003-2034-3716; Millo, Enrico/0000-0002-4019-0051; Scarfi, Sonia/0000-0002-7079-6919; Usai, Cesare/0000-0001-8863-7759	Regione Liguria; Italian Ministry for University and Research; University of Genova; Fondazione CARIGE	Regione Liguria(Regione Liguria); Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione CARIGE(Fondazione Carige)	This work was supported in part by grants from Regione Liguria, Italian Ministry for University and Research, University of Genova, and Fondazione CARIGE.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Chazov EI, 2007, CAN J PHYSIOL PHARM, V85, P332, DOI 10.1139/Y07-008; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; De Simone R, 2007, J NEUROIMMUNOL, V190, P53, DOI 10.1016/j.jneuroim.2007.07.020; De Smet P, 1999, CELL CALCIUM, V26, P9; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Han B, 2000, AM J PHYSIOL-CELL PH, V278, pC344, DOI 10.1152/ajpcell.2000.278.2.C344; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Imhof A, 2008, DIABETES VASC DIS RE, V5, P48, DOI 10.3132/dvdr.2008.009; Kim MP, 2007, ATHEROSCLEROSIS, V193, P366, DOI 10.1016/j.atherosclerosis.2006.06.029; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; LEE HC, 2002, CYCLIC ADP RIBOSE NA; LEONCINI G, 1990, EUR J HAEMATOL, V44, P115; Lutgens E, 2005, CIRCULATION, V111, P3443, DOI 10.1161/CIRCULATIONAHA.104.510073; Martineau I, 2004, BIOMATERIALS, V25, P4489, DOI 10.1016/j.biomaterials.2003.11.013; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Ogawa K, 2004, BIOCHEM J, V381, P413, DOI 10.1042/BJ20040058; Ohtani K, 2004, GENE THER, V11, P1273, DOI 10.1038/sj.gt.3302288; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Scarfi S, 2007, FEBS J, V274, P60, DOI 10.1111/j.1742-4658.2006.05564.x; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Soler C, 2001, FASEB J, V15, P1979, DOI 10.1096/fj.01-0022com; Sussmann M, 2004, CIRC RES, V94, P592, DOI 10.1161/01.RES.0000119169.87429.A0; Takeshita H, 1999, J VIROL, V73, P5548, DOI 10.1128/JVI.73.7.5548-5555.1999; UEDA A, 1994, J IMMUNOL, V153, P2052; Verstraete M, 1996, HAEMOSTASIS, V26, P70; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Willis A I, 2004, Vasc Endovascular Surg, V38, P11, DOI 10.1177/153857440403800102; Yamazaki D, 2003, PLANT J, V35, P129, DOI 10.1046/j.1365-313X.2003.01782.x; Zilber MT, 2000, P NATL ACAD SCI USA, V97, P2840, DOI 10.1073/pnas.050583197; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277	51	63	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17808	17818		10.1074/jbc.M809546200	http://dx.doi.org/10.1074/jbc.M809546200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19332545	hybrid, Green Published			2022-12-25	WOS:000267202500046
J	Li, GY; Zhang, YL; Inouye, M; Ikura, M				Li, Guang-Yao; Zhang, Yonglong; Inouye, Masayori; Ikura, Mitsuhiko			Inhibitory Mechanism of Escherichia coli RelE-RelB Toxin-Antitoxin Module Involves a Helix Displacement Near an mRNA Interferase Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; CHEMICAL-SHIFT; PROTEIN; SYSTEM; PLASMID; COMPLEX; DECAY; 30S	In Escherichia coli, RelE toxin participates in growth arrest and cell death by inducing mRNA degradation at the ribosomal A-site under stress conditions. The NMR structures of a mutant of E. coli RelE toxin, RelE(R81A/R83A), with reduced toxicity and its complex with an inhibitory peptide from RelB antitoxin, RelBC (Lys(47)-Leu(79)), have been determined. In the free RelE(R81A/R83A) structure, helix alpha 4 at the C terminus adopts a closed conformation contacting with the beta-sheet core and adjacent loops. In the RelE(R81A/R83A)-RelB(C) complex, helix alpha 3* of RelBC displaces alpha 4 of RelE(R81A/R83A) from the binding site on the beta-sheet core. This helix replacement results in neutralization of a conserved positively charged cluster of RelE by acidic residues from alpha 3* of RelB. The released helix alpha 4 becomes unfolded, adopting an open conformation with increased mobility. The displacement of alpha 4 disrupts the geometry of critical residues, including Arg(81) and Tyr(87), in a putative active site of RelE toxin. Our structures indicate that RelB counteracts the toxic activity of RelE by displacing alpha 4 helix from the catalytically competent position found in the free RelE structure.	[Li, Guang-Yao; Ikura, Mitsuhiko] Univ Toronto, Div Signaling Biol, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Li, Guang-Yao; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Zhang, Yonglong; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ikura, M (corresponding author), MaRS Toronto Med Discovery Tower,Rm 4-804,101 C, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca			National Institutes of Health [RO1GM081567]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM081567 (to M. Inouye). This work was also supported by a grant from Canadian Institutes of Health Research (to M. Ikura) and a Canadian Institutes of Health Research operating grant.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Aoki H, 2002, ANTIMICROB AGENTS CH, V46, P1080, DOI 10.1128/AAC.46.4.1080-1085.2002; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 1997, Genet Eng (N Y), V19, P49; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Mal TK, 2004, J MOL BIOL, V339, P681, DOI 10.1016/j.jmb.2004.04.020; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; ORENGO CA, 1993, STRUCTURE, V1, P105, DOI 10.1016/0969-2126(93)90026-D; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Sevcik J, 2002, ACTA CRYSTALLOGR D, V58, P1307, DOI 10.1107/S0907444902010090; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yajima S, 2006, NUCLEIC ACIDS RES, V34, P6074, DOI 10.1093/nar/gkl729; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	36	57	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14628	14636		10.1074/jbc.M809656200	http://dx.doi.org/10.1074/jbc.M809656200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297318	hybrid, Green Published			2022-12-25	WOS:000266286100068
J	Simon, N; Scholz, SM; Moreira, CK; Templeton, TJ; Kuehn, A; Dude, MA; Pradel, G				Simon, Nina; Scholz, Sabrina M.; Moreira, Cristina K.; Templeton, Thomas J.; Kuehn, Andrea; Dude, Marie-Adrienne; Pradel, Gabriele			Sexual Stage Adhesion Proteins Form Multi-protein Complexes in the Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; DEAFNESS DISORDER; XANTHURENIC ACID; TRANSMISSION; EXPRESSION; DOMAIN; MOSQUITO; GENE; RECEPTOR; BINDING	The sexual phase of the malaria parasite Plasmodium falciparum is accompanied by the coordinated expression of stage-specific adhesive proteins. Among these are six secreted proteins with multiple adhesion domains, termed P. falciparum LCCL domain-containing protein (PfCCp) proteins, which are expressed in the parasitophorous vacuole of the differentiating gametocytes and which are later associated with macrogametes. Although the majority of the PfCCp proteins are implicated in parasite development in the mosquito vector, their functions remain unknown. In the present study we investigated the molecular interactions between the PfCCp proteins during gametocyte development and emergence. Using five different gene-disruptant parasite lines, we show that the lack of one PfCCp protein leads to the loss of other PfCCp family members. Co-immunoprecipitation assays on gametocyte lysates revealed formation of complexes involving all PfCCp proteins, and affinity chromatography co-elution binding assays with recombinant PfCCp domains further indicated direct binding between distinct adhesion domains. PfCCp-coated latex beads bind to newly formed macrogametes but not to gametocytes or older macrogametes 6 or 24 h post-activation. In view of these data, we propose that the PfCCp proteins form multi-protein complexes that are exposed during gametogenesis, thereby mediating cell contacts of macrogametes.	[Simon, Nina; Scholz, Sabrina M.; Kuehn, Andrea; Dude, Marie-Adrienne; Pradel, Gabriele] Univ Wurzburg, Res Ctr Infect Dis, D-97070 Wurzburg, Germany; [Moreira, Cristina K.; Templeton, Thomas J.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Wurzburg; Cornell University	Pradel, G (corresponding author), Univ Wurzburg, Res Ctr Infect Dis, Rontgenring 11, D-97070 Wurzburg, Germany.	gabriele.pradel@mail.uni-wuerzburg.de			National Institutes of Health [RO1 A1054580-01A1]; Deutsche Forschungsgemeinschaft [SFB479]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 A1054580-01A1 (to T.J.T.). This work was also supported by an Emmy Noether grant and an SFB479 grant from the Deutsche Forschungsgemeinschaft (to G. P.).	Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Dessens JT, 2004, TRENDS PARASITOL, V20, P102, DOI 10.1016/j.pt.2004.01.002; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; GOLDBERGER G, 1987, J BIOL CHEM, V262, P10065; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; KAPLAN F, 1999, AM J PHYSIOL, V276, P1027; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; KUMAR N, 1992, MOL BIOCHEM PARASIT, V53, P113, DOI 10.1016/0166-6851(92)90013-A; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lavazec C, 2009, MOL BIOCHEM PARASIT, V163, P1, DOI 10.1016/j.molbiopara.2008.09.002; Liepinsh E, 2001, EMBO J, V20, P5347, DOI 10.1093/emboj/20.19.5347; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; MUTA T, 1991, J BIOL CHEM, V266, P6554; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Pradel G, 2006, EXP PARASITOL, V112, P263, DOI 10.1016/j.exppara.2005.11.010; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; Raine JD, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030030; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; Scholz SM, 2008, INT J PARASITOL, V38, P327, DOI 10.1016/j.ijpara.2007.08.009; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Templeton TJ, 1997, MOL BIOCHEM PARASIT, V90, P359, DOI 10.1016/S0166-6851(97)00164-3; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Trexler M, 2000, EUR J BIOCHEM, V267, P5751, DOI 10.1046/j.1432-1327.2000.01641.x; Trueman HE, 2004, J PARASITOL, V90, P1062, DOI 10.1645/GE-3368; WHITNEY GS, 1995, J BIOL CHEM, V270, P18187, DOI 10.1074/jbc.270.31.18187; YU Q, 1990, NUCLEIC ACIDS RES, V18, P5296, DOI 10.1093/nar/18.17.5296	39	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14537	14546		10.1074/jbc.M808472200	http://dx.doi.org/10.1074/jbc.M808472200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19304662	Green Published, hybrid			2022-12-25	WOS:000266286100060
J	Hanoulle, X; Badillo, A; Wieruszeski, JM; Verdegem, D; Landrieu, I; Bartenschlager, R; Penin, F; Lippens, G				Hanoulle, Xavier; Badillo, Aurelie; Wieruszeski, Jean-Michel; Verdegem, Dries; Landrieu, Isabelle; Bartenschlager, Ralf; Penin, Francois; Lippens, Guy			Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS; NONSTRUCTURAL PROTEIN; CYCLOSPORINE-A; BINDING-PROTEIN; REPLICATION; SENSITIVITY; RESISTANCE; CATALYSIS; DOMAIN; IDENTIFICATION	We report here a biochemical and structural characterization of domain 2 of the nonstructural 5A protein (NS5A) from the JFH1 Hepatitis C virus strain and its interactions with cyclophilins A and B (CypA and CypB). Gel filtration chromatography, circular dichroism spectroscopy, and finally NMR spectroscopy all indicate the natively unfolded nature of this NS5A-D2 domain. Because mutations in this domain have been linked to cyclosporin A resistance, we used NMR spectroscopy to investigate potential interactions between NS5A-D2 and cellular CypA and CypB. We observed a direct molecular interaction between NS5A-D2 and both cyclophilins. The interaction surface on the cyclophilins corresponds to their active site, whereas on NS5A-D2, it proved to be distributed over the many proline residues of the domain. NMR heteronuclear exchange spectroscopy yielded direct evidence that many proline residues in NS5A-D2 form a valid substrate for the enzymatic peptidyl-prolyl cis/trans isomerase (PPIase) activity of CypA and CypB.	[Hanoulle, Xavier; Wieruszeski, Jean-Michel; Verdegem, Dries; Landrieu, Isabelle; Lippens, Guy] Univ Sci & Technol Lille, CNRS, IFR 147, Unite Glycobiol Struct & Fonctionnelle,UMR 8576, F-59655 Villeneuve Dascq, France; [Badillo, Aurelie; Penin, Francois] Univ Lyon, Inst Biol & Chim Prot, UMR 5086, CNRS,IFR 128, F-69397 Lyon, France; [Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ruprecht Karls University Heidelberg	Lippens, G (corresponding author), Univ Sci & Technol Lille, CNRS, IFR 147, Unite Glycobiol Struct & Fonctionnelle,UMR 8576, F-59655 Villeneuve Dascq, France.	guy.lippens@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Hanoulle, Xavier/AAK-7236-2021; Landrieu, Isabelle/AAF-8495-2019; Bartenschlager, Ralf/L-2582-2015	Hanoulle, Xavier/0000-0002-3755-2680; Landrieu, Isabelle/0000-0002-4883-2637; Bartenschlager, Ralf/0000-0001-5601-9307; Lippens, Guy/0000-0002-8236-0901	French Centre National de la Recherche Scientifique (CNRS); Universities of Lille and Lyon; French National Agency for Research on AIDS; European Commission	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universities of Lille and Lyon; French National Agency for Research on AIDS(ANRS); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the French Centre National de la Recherche Scientifique (CNRS) and the Universities of Lille and Lyon and by grants from the French National Agency for Research on AIDS and Viral Hepatitis and the European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance).	Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; BERGSMA DJ, 1991, J BIOL CHEM, V266, P23204; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Bukovsky AA, 1997, P NATL ACAD SCI USA, V94, P10943, DOI 10.1073/pnas.94.20.10943; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Golovanov AP, 2007, J AM CHEM SOC, V129, P6528, DOI 10.1021/ja070505q; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2007, J BIOL CHEM, V282, P34148, DOI 10.1074/jbc.M706353200; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kaplan J.I., 1980, NMR CHEM EXCHANGING; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; KERN D, 1993, FEBS LETT, V323, P198, DOI 10.1016/0014-5793(93)81338-Z; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Liang Y, 2006, MOL CELLS, V22, P13; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; *NIH, 2002, HEPATOLOGY S1, V36, pS2; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Tanabe Y, 2004, J INFECT DIS, V189, P1129, DOI 10.1086/382595; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Watashi K, 2007, DRUG TARGET INSIGHT, V2, P9; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7362, DOI 10.1021/bi960278x; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	71	131	144	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13589	13601		10.1074/jbc.M809244200	http://dx.doi.org/10.1074/jbc.M809244200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297321	Green Published, hybrid			2022-12-25	WOS:000265877300036
J	Uvarov, P; Ludwig, A; Markkanen, M; Soni, S; Hubner, CA; Rivera, C; Airaksinen, MS				Uvarov, Pavel; Ludwig, Anastasia; Markkanen, Marika; Soni, Shetal; Hubner, Christian A.; Rivera, Claudio; Airaksinen, Matti S.			Coexpression and Heteromerization of Two Neuronal K-Cl Cotransporter Isoforms in Neonatal Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; INHIBITORY NEUROTRANSMISSION; MEMBRANE-PROTEINS; KCC2; EXPRESSION; NKCC1; DISRUPTION; KINASE	The neuron-specific K-Cl cotransporter KCC2 maintains the low intracellular chloride concentration required for the fast hyperpolarizing actions of inhibitory neurotransmitters. The KCC2 gene codes for two isoforms, KCC2a and KCC2b, which differ in their N termini. The relative expression and cellular distribution of the two KCC2 protein isoforms are unknown. Here, we characterize an antibody against the KCC2a isoform and show that a previously described antibody against KCC2 is specific for the KCC2b isoform (Hubner, C. A., Stein, V., Hermans-Borgmeyer, I., Meyer, T., Ballanyi, K., and Jentsch, T. J. (2001) Neuron 30, 515-524). Immunostaining of dissociated hippocampal cultures confirms that both KCC2 isoforms are neuron-specific. Immunoblot analysis indicates that KCC2b is the major KCC2 isoform in the adult brain, whereas in the neonatal mouse central nervous system, half of total KCC2 protein is KCC2a. At this stage, the two KCC2 isoforms are largely colocalized and show similar patterns of distribution in the brain. When coexpressed in HEK293 cells, KCC2a and KCC2b proteins form heteromeric complexes. Moreover, the two isoforms can be coimmunoprecipitated from the neonatal brain, suggesting the presence of endogenous KCC2a-KCC2b heteromers. Consistent with this, native gel analysis shows that a substantial part of endogenous KCC2 isoforms in the neonatal brain constitute dimers.	[Uvarov, Pavel; Markkanen, Marika; Airaksinen, Matti S.] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Ludwig, Anastasia; Soni, Shetal; Rivera, Claudio] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Hubner, Christian A.] Univ Jena, Dept Clin Chem, D-07747 Jena, Germany	University of Helsinki; University of Helsinki; Friedrich Schiller University of Jena	Uvarov, P (corresponding author), Univ Helsinki, Ctr Neurosci, Viikinkaari 4, FIN-00014 Helsinki, Finland.	pavel.uvarov@helsinki.fi; matti.airaksinen@helsinki.fi	Ludwig, Anastasia/N-1837-2016; Hübner, Christian/A-2950-2017; Rivera, Claudio/ABE-2499-2021; Uvarov, Pavel/AGR-2614-2022	Ludwig, Anastasia/0000-0003-4849-8074; Hübner, Christian/0000-0002-1030-4943; Rivera, Claudio/0000-0003-2462-6561; Uvarov, Pavel/0000-0001-8439-6150; Airaksinen, Matti/0000-0002-7199-4984; Soni, Shetal/0000-0003-1006-8511	Academy of Finland; University of Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Academy of Finland, the University of Helsinki, and the Sigrid Juselius Foundation (to M. S. A. and C. R.).	Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Goslin K., 1998, CULTURING NERVE CELL, P339; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100	28	60	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13696	13704		10.1074/jbc.M807366200	http://dx.doi.org/10.1074/jbc.M807366200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307176	hybrid, Green Published			2022-12-25	WOS:000265877300047
J	Bauer, PO; Wong, HK; Oyama, F; Goswami, A; Okuno, M; Kino, Y; Miyazaki, H; Nukina, N				Bauer, Peter O.; Wong, Hon Kit; Oyama, Fumitaka; Goswami, Anand; Okuno, Misako; Kino, Yoshihiro; Miyazaki, Haruko; Nukina, Nobuyuki			Inhibition of Rho Kinases Enhances the Degradation of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE; BINDING-PROTEIN; CASPASE ACTIVATION; CELL-DEATH; DISEASE; AUTOPHAGY; PHOSPHORYLATION; EXPRESSION	Huntington disease (HD) is a fatal hereditary neurodegenerative disease caused by an expansion of the polyglutamine (polyQ) stretch in huntingtin (htt). Whereas the pathological significance of the expanded polyQ has been clearly established and a tremendous effort to develop therapeutic tools for HD has been exerted, there is yet no effective cure. Whereas many molecules able to reduce the polyQ accumulation and aggregation have been identified, including several Rho kinase (ROCK) inhibitors, it remains very important to determine the mechanism of action of the potential drugs. ROCK inhibitors, including Y-27632 were reported to decrease aggregation of htt and androgen receptor (AR) through ROCK1 and protein kinase C-related protein kinase-2 (PRK-2). A downstream effector of ROCK1, actin-binding factor profilin, was shown to inhibit the mutant htt aggregation but not AR by direct interaction. We found that the anti-aggregation effect of ROCK inhibitors was not limited to the mutant htt and AR and that Y-27632 was also able to reduce the aggregation of ataxin-3 and atrophin-1 with expanded polyQ. These results suggested that in addition to the mechanism reported for htt and AR, there might also be other common mediators involved in the reduced aggregation of different polyQ proteins. In this study, we show that Y-27632 not only reduced the mutant htt aggregation by enhancing its degradation, but surprisingly was able to activate the main cellular degradation pathways, proteasome, and macroautophagy. We also show that this unique effect was mediated by ROCK1 and ROCK2.	[Bauer, Peter O.; Wong, Hon Kit; Oyama, Fumitaka; Goswami, Anand; Okuno, Misako; Kino, Yoshihiro; Miyazaki, Haruko; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	RIKEN	Nukina, N (corresponding author), RIKEN, Brain Sci Inst, Lab Struct Neuropathol, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nukina@brain.riken.jp	Oyama, Fumitaka/Q-4268-2019; Nukina, Nobuyuki/GPP-6265-2022; Bauer, Peter O./AAD-6502-2022; Wong, Hon-Kit/G-3944-2014	Oyama, Fumitaka/0000-0002-1095-8306; Bauer, Peter O./0000-0003-2811-1354; Wong, Hon-Kit/0000-0003-0049-8454	Ministry of Education, Culture, Sport, Science, and Technology of Japan [17025044]; Ministry of Health, Welfare and Labor of Japan; JSPS (Japan Society for the Promotion of Science)	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (17025044) and by a Grant-in-Aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Welfare and Labor of Japan. This work was also supported in part by a grant from the JSPS (Japan Society for the Promotion of Science).	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Brown ME, 2004, J NEUROBIOL, V58, P118, DOI 10.1002/neu.10285; Davies JE, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S2; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Evert BO, 2000, CELL TISSUE RES, V301, P189, DOI 10.1007/s004410000228; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Machida Y, 2006, BIOCHEM BIOPH RES CO, V343, P190, DOI 10.1016/j.bbrc.2006.02.141; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nishimura Y, 2000, CELL TISSUE RES, V301, P341, DOI 10.1007/s004410000243; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Peters MF, 1999, NEUROSCI LETT, V275, P129, DOI 10.1016/S0304-3940(99)00758-2; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Satoh SI, 2008, BRAIN RES, V1193, P102, DOI 10.1016/j.brainres.2007.11.050; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Zemskov EA, 2003, J NEUROCHEM, V87, P395, DOI 10.1046/j.1471-4159.2003.02002.x; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	64	74	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13153	13164		10.1074/jbc.M809229200	http://dx.doi.org/10.1074/jbc.M809229200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19278999	Green Published, hybrid			2022-12-25	WOS:000265688300062
J	Boshuizen, RS; Schulz, V; Morbin, M; Mazzoleni, G; Meloen, RH; Langedijk, JPM				Boshuizen, Ronald S.; Schulz, Veronica; Morbin, Michela; Mazzoleni, Giulia; Meloen, Rob H.; Langedijk, Johannes P. M.			Heterologous Stacking of Prion Protein Peptides Reveals Structural Details of Fibrils and Facilitates Complete Inhibition of Fibril Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARALLEL BETA-HELICES; AMYLOID FIBRILS; RESIDUES; SEQUENCE; SCRAPIE; DISEASE; FORM; NEURODEGENERATION; NEUROTOXICITY; DYNAMICS	Fibrils play an important role in the pathogenesis of amyloidosis; however, the underlying mechanisms of the growth process and the structural details of fibrils are poorly understood. Crucial in the fibril formation of prion proteins is the stacking of PrP monomers. We previously proposed that the structure of the prion protein fibril may be similar as a parallel left-handed beta-helix. The beta-helix is composed of spiraling rungs of parallel beta-strands, and in the PrP model residues 105-143 of each PrP monomer can contribute two beta-helical rungs to the growing fibril. Here we report data to support this model. We show that two cyclized human PrP peptides corresponding to residues 105-124 and 125-143, based on two single rungs of the left-handed beta-helical core of the human PrPSc fibril, show spontaneous cooperative fibril growth in vitro by heterologous stacking. Because the structural model must have predictive value, peptides were designed based on the structure rules of the left-handed beta-helical fold that could stack with prion protein peptides to stimulate or to block fibril growth. The stimulator peptide was designed as an optimal left-handed beta-helical fold that can serve as a template for fibril growth initiation. The inhibiting peptide was designed to bind to the exposed rung but frustrate the propagation of the fibril growth. The single inhibitory peptide hardly shows inhibition, but the combination of the inhibitory with the stimulatory peptide showed complete inhibition of the fibril growth of peptide huPrP-(106-126). Moreover, the unique strategy based on stimulatory and inhibitory peptides seems a powerful new approach to study amyloidogenic fibril structures in general and could prove useful for the development of therapeutics.	[Boshuizen, Ronald S.; Schulz, Veronica; Meloen, Rob H.; Langedijk, Johannes P. M.] Pepscan Therapeut BV, NL-8243 RC AB Lelystad, Netherlands; [Morbin, Michela; Mazzoleni, Giulia] Carattere Sci Inst Neurol Carlo Besta, Fdn Ist Di Ricovero & Cura, I-20133 Milan, Italy; [Meloen, Rob H.] Univ Utrecht, Acad Biomed Ctr, Utrecht, Netherlands	Pepscan Therapeutics B.V.; IRCCS Istituto Neurologico Besta; Utrecht University	Boshuizen, RS (corresponding author), Pepscan Therapeut BV, Zuidersluisweg 2, NL-8243 RC AB Lelystad, Netherlands.	r.boshuizen@pepscan.com		Morbin, Michela/0000-0001-8034-3123				Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Boshuizen RS, 2007, AMYLOID, V14, P205, DOI 10.1080/13506120701464628; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Choi JH, 2008, PROTEINS, V73, P150, DOI 10.1002/prot.22051; FIELDS C G, 1991, Peptide Research, V4, P95; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Gray F, 1999, J NEUROPATH EXP NEUR, V58, P321, DOI 10.1097/00005072-199904000-00002; Haik S, 2000, NEUROBIOL DIS, V7, P644, DOI 10.1006/nbdi.2000.0316; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Laws DD, 2001, P NATL ACAD SCI USA, V98, P11686, DOI 10.1073/pnas.201404298; Lim KH, 2006, SOLID STATE NUCL MAG, V29, P183, DOI 10.1016/j.ssnmr.2005.09.017; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Salmona M, 2003, J BIOL CHEM, V278, P48146, DOI 10.1074/jbc.M307295200; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839	34	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12809	12820		10.1074/jbc.M809151200	http://dx.doi.org/10.1074/jbc.M809151200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19304665	Green Published, hybrid			2022-12-25	WOS:000265688300026
J	Ramirez, OA; Vidal, RL; Tello, JA; Vargas, KJ; Kindler, S; Haertel, S; Couve, A				Ramirez, Omar A.; Vidal, Rene L.; Tello, Judith A.; Vargas, Karina J.; Kindler, Stefan; Haertel, Steffen; Couve, Andres			Dendritic Assembly of Heteromeric gamma-Aminobutyric Acid Type B Receptor Subunits in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERODIMERIC GABA(B) RECEPTOR; DEPENDENT PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; TRAFFICKING; ACTIVATION; TRANSPORT; CELLS; PHOSPHORYLATION; OLIGOMERIZATION	Understanding the mechanisms that control synaptic efficacy through the availability of neurotransmitter receptors depends on uncovering their specific intracellular trafficking routes. gamma-Aminobutyric acid type B (GABA(B)) receptors (GABA(B)Rs) are obligatory heteromers present at dendritic excitatory and inhibitory postsynaptic sites. It is unknown whether synthesis and assembly of GABA(B)Rs occur in the somatic endoplasmic reticulum (ER) followed by vesicular transport to dendrites or whether somatic synthesis is followed by independent transport of the subunits for assembly and ER export throughout the somatodendritic compartment. To discriminate between these possibilities we studied the association of GABA(B)R subunits in dendrites of hippocampal neurons combining live fluorescence microscopy, biochemistry, quantitative colocalization, and bimolecular fluorescent complementation. We demonstrate that GABA(B)R subunits are segregated and differentially mobile in dendritic intracellular compartments and that a high proportion of non-associated intracellular subunits exist in the brain. Assembled heteromers are preferentially located at the plasma membrane, but blockade of ER exit results in their intracellular accumulation in the cell body and dendrites. We propose that GABA(B)R subunits assemble in the ER and are exported from the ER throughout the neuron prior to insertion at the plasmamembrane. Our results are consistent with a bulk flow of segregated subunits through the ER and rule out a post-Golgi vesicular transport of preassembled GABA(B)Rs.	[Couve, Andres] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Santiago 8380000, Chile; [Kindler, Stefan] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Vidal, Rene L.; Vargas, Karina J.] Univ Austral Chile, Valdivia 5090000, Chile	Universidad de Chile; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidad Austral de Chile	Couve, A (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Independencia 1027, Santiago 8380000, Chile.	andres@neuro.med.uchile.cl	Vidal, Rene Luis/S-7154-2019; Härtel, Steffen/AAA-2336-2020; couve, andres/I-2249-2013	Härtel, Steffen/0000-0002-8913-1757; couve, andres/0000-0003-4216-8672	Mejoramiento de la Calidad y Equidad de la Educacio n Superior (MECESUP); Comisio n Nacional de Investigacio n Cientifica y Tecnologica (CONICYT); Fondo Nacional de Desanollo Cientifico y Tecnologico (FONDECYT) [1060890]; FONDECYT [1071001]; Iniciativa Cientifico Milenio (ICM) [P07-048-F]; Human Frontiers Science Program Organization (HFSPO) [ST00105/2005-C]; Deutsche Forschungsgemeinschaft Forschergruppe 885;  [Ki488/2-6];  [KR 1321/4-1]	Mejoramiento de la Calidad y Equidad de la Educacio n Superior (MECESUP); Comisio n Nacional de Investigacio n Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desanollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifico Milenio (ICM); Human Frontiers Science Program Organization (HFSPO)(Human Frontier Science Program); Deutsche Forschungsgemeinschaft Forschergruppe 885(German Research Foundation (DFG)); ; 	Supported by Mejoramiento de la Calidad y Equidad de la Educacio n Superior (MECESUP).; 2 Supported by Comisio n Nacional de Investigacio n Cientifica y Tecnologica (CONICYT).; 3 Supported by Grants Ki488/2-6 and KR 1321/4-1.; 4 Supported by Fondo Nacional de Desanollo Cientifico y Tecnologico (FONDECYT) Grant 1060890.; 5 Supported by FONDECYT Grant 1071001, Iniciativa Cientifico Milenio (ICM) Grant P07-048-F, Human Frontiers Science Program Organization (HFSPO) Grant ST00105/2005-C, and Deutsche Forschungsgemeinschaft Forschergruppe 885.	Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Calver AR, 2001, J NEUROSCI, V21, P1203; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; COSTES SV, BIOPHYS J, V86, P3993; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Filippov AK, 2000, J NEUROSCI, V20, P2867; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Goslin K., 1991, CULTURING NERVE CELL, P251; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Horton AC, 2003, J NEUROSCI, V23, P6188; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kulik A, 2003, J NEUROSCI, V23, P11026; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Rubio ME, 1999, J NEUROSCI, V19, P5549; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; SEGUCHI T, 1992, J BIOL CHEM, V267, P11626; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Vidal RL, 2007, MOL CELL NEUROSCI, V35, P501, DOI 10.1016/j.mcn.2007.04.008; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045	48	32	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13077	13085		10.1074/jbc.M900575200	http://dx.doi.org/10.1074/jbc.M900575200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276079	Green Published, hybrid			2022-12-25	WOS:000265688300055
J	Qin, J; Xie, Y; Wang, B; Hoshino, M; Wolff, DW; Zhao, J; Scofield, MA; Dowd, FJ; Lin, MF; Tu, Y				Qin, J.; Xie, Y.; Wang, B.; Hoshino, M.; Wolff, D. W.; Zhao, J.; Scofield, M. A.; Dowd, F. J.; Lin, M-F; Tu, Y.			Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis	ONCOGENE			English	Article						prostate cancer metastasis; P-Rex1; Rac-selective guanine nucleotide exchange factor; G-protein-coupled receptors; receptor tyrosine kinases	PROTEIN-COUPLED RECEPTORS; BETA-GAMMA-SUBUNITS; PHOSPHOINOSITIDE 3-KINASE; CELL-MIGRATION; GROWTH-FACTOR; RHO GTPASES; ACTIVATION; PROGRESSION; EXPRESSION; INVASION	Excessive activation of G-protein-coupled receptor (GPCR) and receptor tyrosine kinase (RTK) pathways has been linked to prostate cancer metastasis. Rac activation by guanine nucleotide exchange factors (GEFs) plays an important role in directional cell migration, a critical step of tumor metastasis cascades. We found that the upregulation of P-Rex1, a Rac-selective GEF synergistically activated by Gb gamma freed during GPCR signaling, and PIP3, generated during either RTK or GPCR signaling, strongly correlates with metastatic phenotypes in both prostate cancer cell lines and human prostate cancer specimens. Silencing endogenous P-Rex1 in metastatic prostate cancer PC-3 cells selectively inhibited Rac activity and reduced cell migration and invasion in response to ligands of both epidermal growth factor receptor and G-protein-coupled CXC chemokine receptor 4. Conversely, expression of recombinant P-Rex1, but not its 'GEF-dead' mutant, in non-metastatic prostate cancer cells, such as CWR22Rv1, increased cell migration and invasion through Rac-dependent lamellipodia formation. More importantly, using a mouse xenograft model, we showed that the expression of P-Rex1, but not its mutant, induced lymph node metastasis of CWR22Rv1 cells without an effect on primary tumor growth. Thus, by functioning as a coincidence detector of chemotactic signals from both GPCRs and RTKs, P-Rex1-dependent activation of Rac promotes prostate cancer metastasis.	[Qin, J.; Xie, Y.; Wolff, D. W.; Zhao, J.; Scofield, M. A.; Dowd, F. J.; Tu, Y.] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA; [Wang, B.] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE 68178 USA; [Hoshino, M.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Kyoto, Japan; [Zhao, J.; Tu, Y.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Lin, M-F] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	Creighton University; Creighton University; National Center for Neurology & Psychiatry - Japan; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Nebraska System; University of Nebraska Medical Center	Tu, Y (corresponding author), Creighton Univ, Sch Med, Dept Pharmacol, 2500 Calif Plaza,Crsis 3, Omaha, NE 68178 USA.	yapingtu@creighton.edu			Nebraska State Grant [LB595]; NIH [1R011CA125661]; Department of Defense Prostate Cancer Research Program [W81XWH-07-1-0189]; National Center for Research Resources [G20RR024001]; NATIONAL CANCER INSTITUTE [R01CA125661] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER	Nebraska State Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer Research Program(United States Department of Defense); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by Nebraska State Grant LB595, NIH 1R011CA125661 and by the Department of Defense Prostate Cancer Research Program W81XWH-07-1-0189 (YT). We thank Dr Laura Hansen for helpful comments and discussions; Dr Haihong Jiang, Lyudmila Batalkina, Dr Greg Perry and Lisa Linder-Stephenson for their technical assistance. The project described was also supported by Grant G20RR024001 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Arya Manit, 2004, J Exp Ther Oncol, V4, P291; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bex A, 1999, PROSTATE CANCER P D, V2, P36, DOI 10.1038/sj.pcan.4500286; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; CHING KZ, 1993, MOL CELL BIOCHEM, V126, P151, DOI 10.1007/BF00925693; DAAKA Y, 2004, SCI STKE, pRE2; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gao XH, 2005, ENDOCRINOLOGY, V146, P1707, DOI 10.1210/en.2004-1198; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; MENSING H, 1983, EUR J CELL BIOL, V29, P268; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Wang ZL, 2008, PROSTAG OTH LIPID M, V87, P9, DOI 10.1016/j.prostaglandins.2008.04.001; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	44	103	105	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2009	28	16					1853	1863		10.1038/onc.2009.30	http://dx.doi.org/10.1038/onc.2009.30			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PW	19305425	Green Accepted, Green Submitted			2022-12-25	WOS:000265640500004
J	Durer, ZAO; Cohlberg, JA; Dinh, P; Padua, S; Ehrenclou, K; Downes, S; Tan, JK; Nakano, Y; Bowman, CJ; Hoskins, JL; Kwon, CH; Mason, AZ; Rodriguez, JA; Doucette, PA; Shaw, BF; Valentine, JS				Durer, Zeynep A. Oztug; Cohlberg, Jeffrey A.; Dinh, Phong; Padua, Shelby; Ehrenclou, Krista; Downes, Sean; Tan, James K.; Nakano, Yoko; Bowman, Christopher J.; Hoskins, Jessica L.; Kwon, Chuhee; Mason, Andrew Z.; Rodriguez, Jorge A.; Doucette, Peter A.; Shaw, Bryan F.; Valentine, Joan Selverstone			Loss of Metal Ions, Disulfide Reduction and Mutations Related to Familial ALS Promote Formation of Amyloid-Like Aggregates from Superoxide Dismutase	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN-SUPEROXIDE DISMUTASE; ALPHA-SYNUCLEIN; FIBRIL FORMATION; TRANSGENIC MICE; MUTANT SOD1; BETA-SHEET; POSTTRANSLATIONAL MODIFICATIONS; SOLUBLE OLIGOMERS; RECOMBINANT HUMAN	Mutations in the gene encoding Cu-Zn superoxide dismutase (SOD1) are one of the causes of familial amyotrophic lateral sclerosis (FALS). Fibrillar inclusions containing SOD1 and SOD1 inclusions that bind the amyloid-specific dye thioflavin S have been found in neurons of transgenic mice expressing mutant SOD1. Therefore, the formation of amyloid fibrils from human SOD1 was investigated. When agitated at acidic pH in the presence of low concentrations of guanidine or acetonitrile, metalated SOD1 formed fibrillar material which bound both thioflavin T and Congo red and had circular dichroism and infrared spectra characteristic of amyloid. While metalated SOD1 did not form amyloid-like aggregates at neutral pH, either removing metals from SOD1 with its intramolecular disulfide bond intact or reducing the intramolecular disulfide bond of metalated SOD1 was sufficient to promote formation of these aggregates. SOD1 formed amyloid-like aggregates both with and without intermolecular disulfide bonds, depending on the incubation conditions, and a mutant SOD1 lacking free sulfhydryl groups (AS-SOD1) formed amyloid-like aggregates at neutral pH under reducing conditions. ALS mutations enhanced the ability of disulfide-reduced SOD1 to form amyloid-like aggregates, and apo-AS-SOD1 formed amyloid-like aggregates at pH 7 only when an ALS mutation was also present. These results indicate that some mutations related to ALS promote formation of amyloid-like aggregates by facilitating the loss of metals and/or by making the intramolecular disulfide bond more susceptible to reduction, thus allowing the conversion of SOD1 to a form that aggregates to form resembling amyloid. Furthermore, the occurrence of amyloid-like aggregates per se does not depend on forming intermolecular disulfide bonds, and multiple forms of such aggregates can be produced from SOD1.	[Durer, Zeynep A. Oztug; Cohlberg, Jeffrey A.; Dinh, Phong; Padua, Shelby; Ehrenclou, Krista; Downes, Sean; Tan, James K.; Nakano, Yoko; Bowman, Christopher J.] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Hoskins, Jessica L.; Kwon, Chuhee] Calif State Univ Long Beach, Dept Phys & Astron, Long Beach, CA 90840 USA; [Mason, Andrew Z.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Rodriguez, Jorge A.; Doucette, Peter A.; Shaw, Bryan F.; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of California System; University of California Los Angeles	Durer, ZAO (corresponding author), Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA.	cohlberg@csulb.edu	Valentine, Joan S/B-6665-2008; Shaw, Bryan/A-7001-2008; durer, zeynep/G-5626-2019	Valentine, Joan S/0000-0002-7174-925X; Durer, Zeynep/0000-0001-9912-510X	Research Corporation [CC5571]; ALS Association [3Q1Y]; NIH [GM28222]; California State University, Long Beach; NSF [OCE-9977564]; Beckman Scholars Program; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222] Funding Source: NIH RePORTER	Research Corporation(Research Corporation for Science Advancement); ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California State University, Long Beach; NSF(National Science Foundation (NSF)); Beckman Scholars Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Research Corporation grant CC5571 and ALS Association grant 3Q1Y to JAC, NIH grant GM28222 and a grant from the ALS Association to JSV, and California State University, Long Beach. The ICP-MS was purchased with support from NSF grant OCE-9977564. PD and CJB were supported by the Beckman Scholars Program and JKT by a grant to CSULB from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtoniemi T, 2008, NEUROBIOL DIS, V32, P479, DOI 10.1016/j.nbd.2008.08.010; Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Bartnikas TB, 2003, J BIOL CHEM, V278, P33602, DOI 10.1074/jbc.M305435200; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Boissinot M, 1997, EMBO J, V16, P2171, DOI 10.1093/emboj/16.9.2171; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Crow JP, 1997, J NEUROCHEM, V69, P1936; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dennison SM, 2002, BIOCHEMISTRY-US, V41, P14925, DOI 10.1021/bi0203233; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; DIVRY PAUL, 1927, JOUR NEUROL ET PSYCHIATR, V27, P643; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; FEE JA, 1975, BIOCHIM BIOPHYS ACTA, V412, P26, DOI 10.1016/0005-2795(75)90336-0; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Giacomelli CE, 2003, BIOMACROMOLECULES, V4, P1719, DOI 10.1021/bm034151g; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gross M, 1999, PROTEIN SCI, V8, P1350, DOI 10.1110/ps.8.6.1350; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; HARTZ JW, 1972, J BIOL CHEM, V247, P7043; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heller J, 1996, PROTEIN SCI, V5, P1655, DOI 10.1002/pro.5560050819; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hough MA, 2003, STRUCTURE, V11, P937, DOI 10.1016/S0969-2126(03)00155-2; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; JARVIS JA, 1994, INT J PEPT PROT RES, V44, P388; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1293, DOI 10.1177/37.8.2666512; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Koide T, 1998, NEUROSCI LETT, V257, P29, DOI 10.1016/S0304-3940(98)00800-3; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; McDuff FO, 2004, BIOCHEM CELL BIOL, V82, P305, DOI 10.1139/o03-072; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; OZTUG ZA, 2005, THESIS CALIFORNIA ST; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Petrovic N, 1996, J BIOL CHEM, V271, P28335, DOI 10.1074/jbc.271.45.28335; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2006, BBA-MOL BASIS DIS, V1762, P1025, DOI 10.1016/j.bbadis.2006.05.004; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Sasaki S, 2005, ACTA NEUROPATHOL, V109, P247, DOI 10.1007/s00401-004-0939-7; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Stieber A, 2000, J NEUROL SCI, V177, P114, DOI 10.1016/S0022-510X(00)00351-8; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Tcherkasskaya O, 2003, J BIOMOL STRUCT DYN, V21, P353, DOI 10.1080/07391102.2003.10506931; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yamagishi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001030; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	91	100	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5004	10.1371/journal.pone.0005004	http://dx.doi.org/10.1371/journal.pone.0005004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325915	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499600004
J	Day, CJ; Tiralongo, J; Hartnell, RD; Logue, CA; Wilson, JC; von Itzstein, M; Korolik, V				Day, Christopher J.; Tiralongo, Joe; Hartnell, Regan D.; Logue, Carie-Anne; Wilson, Jennifer C.; von Itzstein, Mark; Korolik, Victoria			Differential Carbohydrate Recognition by Campylobacter jejuni Strain 11168: Influences of Temperature and Growth Conditions	PLOS ONE			English	Article								The pathogenic clinical strain NCTC11168 was the first Campylobacter jejuni strain to be sequenced and has been a widely used laboratory model for studying C. jejuni pathogenesis. However, continuous passaging of C. jejuni NCTC11168 has been shown to dramatically affect its colonisation potential. Glycan array analysis was performed on C. jejuni NCTC11168 using the frequently passaged, non-colonising, genome sequenced (11168-GS) and the infrequently passaged, original, virulent (11168-O) isolates grown or maintained under various conditions. Glycan structures recognised and bound by C. jejuni included terminal mannose, N-acetylneuraminic acid, galactose and fucose. Significantly, it was found that only when challenged with normal oxygen at room temperature did 11168-O consistently bind to sialic acid or terminal mannose structures, while 11168-GS bound these structures regardless of growth/maintenance conditions. Further, binding of uncapped galactose and fucosylated structures was significantly reduced when C. jejuni was maintained at 25 degrees C under atmospheric oxygen conditions. These binding differences identified through glycan array analysis were confirmed by the ability of specific lectins to competitively inhibit the adherence of C. jejuni to a Caco-2 intestinal cell line. Our data suggests that the binding of mannose and/or N-acetylneuraminic acid may provide the initial interactions important for colonisation following environmental exposure.	[Day, Christopher J.; Tiralongo, Joe; Hartnell, Regan D.; Logue, Carie-Anne; Wilson, Jennifer C.; von Itzstein, Mark; Korolik, Victoria] Griffith Univ, Inst Glyc, Nathan, Qld 4111, Australia	Griffith University	Day, CJ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Nathan, Qld 4111, Australia.	j.tiralongo@griffith.edu.au; v.korolik@griffith.edu.au	von Itzstein, Mark/E-4823-2010; Wilson, Jennifer/H-5297-2013	Day, Christopher/0000-0001-7953-4408; Tiralongo, Joe/0000-0002-3529-6310; Korolik, Victoria/0000-0002-5535-4151	Queensland State Government [Smart State Research Fellowship]; Rural Industries Research and Development Corporation; Griffith University; Australian Research Council [Australian Postdoctoral Fellowship, Federation Fellowship]	Queensland State Government; Rural Industries Research and Development Corporation; Griffith University(Griffith University); Australian Research Council(Australian Research Council)	This work was supported by a Queensland State Government Smart State Research Fellowship (CJD) in conjunction with the Rural Industries Research and Development Corporation and Griffith University. JT and MvI were supported by the Australian Research Council through the awarding of an Australian Postdoctoral Fellowship and a Federation Fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 2001, ARCH BIOCHEM BIOPHYS, V395, P191, DOI 10.1006/abbi.2001.2572; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bradner JE, 2006, NAT PROTOC, V1, P2344, DOI 10.1038/nprot.2006.282; Cheng JS, 2008, GLYCOBIOLOGY, V18, P686, DOI 10.1093/glycob/cwn047; Cioci G, 2003, FEBS LETT, V555, P297, DOI 10.1016/S0014-5793(03)01249-3; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; Demetter P, 2008, J PATHOL, V215, P1, DOI 10.1002/path.2334; Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gaynor EC, 2001, MOL MICROBIOL, V39, P1546, DOI 10.1046/j.1365-2958.2001.02341.x; Gilboa-Garber N, 1999, FEMS IMMUNOL MED MIC, V25, P365, DOI 10.1111/j.1574-695X.1999.tb01361.x; Gouyer V, 2001, J CELL SCI, V114, P1455; Grover V, 2001, ARCH BIOCHEM BIOPHYS, V390, P109, DOI 10.1006/abbi.2001.2355; Grover V, 2007, CURR MICROBIOL, V54, P175, DOI 10.1007/s00284-005-0366-6; GUCCIONE E, 2008, MOL MICROBIOL; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Hyland RM, 2008, CELL MICROBIOL, V10, P177, DOI 10.1111/j.1462-5822.2007.01028.x; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Isshiki S, 2003, J BIOL CHEM, V278, P36611, DOI 10.1074/jbc.M302681200; Kakiuchi Y, 2002, CANCER RES, V62, P1567; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Linden SK, 2007, HELICOBACTER, V12, P341, DOI 10.1111/j.1523-5378.2007.00509.x; Logan RPH, 1998, J IMMUNOL METHODS, V213, P19, DOI 10.1016/S0022-1759(98)00018-0; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Malagolini N, 2007, GLYCOBIOLOGY, V17, P688, DOI 10.1093/glycob/cwm040; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Morrow AL, 2004, ADV EXP MED BIOL, V554, P443; Morrow AL, 2005, J NUTR, V135, P1304, DOI 10.1093/jn/135.5.1304; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parry S, 2006, GLYCOBIOLOGY, V16, P623, DOI 10.1093/glycob/cwj110; Rhim AD, 2001, GLYCOCONJUGATE J, V18, P649, DOI 10.1023/A:1020815205022; Rhim AD, 2000, GLYCOCONJUGATE J, V17, P385, DOI 10.1023/A:1007156014384; Ringoir DD, 2003, VET MICROBIOL, V92, P225, DOI 10.1016/S0378-1135(02)00378-4; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; RUSSELL RG, 1994, INFECT IMMUN, V62, P3773, DOI 10.1128/IAI.62.9.3773-3779.1994; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Sharon N, 1996, ADV EXP MED BIOL, V408, P1; Siebert HC, 2003, BIOCHEMISTRY-US, V42, P14762, DOI 10.1021/bi035477c; SKIRROW MB, 1991, INT J FOOD MICROBIOL, V12, P9, DOI 10.1016/0168-1605(91)90044-P; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Sung MA, 2001, J BIOMOL NMR, V19, P197, DOI 10.1023/A:1008330323188; Sung MA, 2001, EMBO REP, V2, P621, DOI 10.1093/embo-reports/kve133; Thomas CJ, 2002, J AM CHEM SOC, V124, P12926, DOI 10.1021/ja0208916; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VETTER D, 1995, BIOCONJUGATE CHEM, V6, P316, DOI 10.1021/bc00033a013; Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049; Wu AM, 2006, BIOCHIMIE, V88, P1479, DOI 10.1016/j.biochi.2006.05.004	59	78	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4927	10.1371/journal.pone.0004927	http://dx.doi.org/10.1371/journal.pone.0004927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290056	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496500020
J	Schillace, RV; Miller, CL; Pisenti, N; Grotzke, JE; Swarbrick, GM; Lewinsohn, DM; Carr, DW				Schillace, Robynn V.; Miller, Casey L.; Pisenti, Neal; Grotzke, Jeff E.; Swarbrick, Gwendolyn M.; Lewinsohn, David M.; Carr, Daniel W.			A-Kinase Anchoring in Dendritic Cells Is Required for Antigen Presentation	PLOS ONE			English	Article								Background: Dendritic cells (DC) are the most potent antigen presenting cells (APC) of the immune system. Prostaglandin E-2, cyclic AMP, and protein kinase A (PKA) have all been shown to regulate DC maturation and activity. In other cells, the ability of these molecules to convey their signals has been shown to be dependent on A-kinase anchoring proteins (AKAPs). Here we present evidence for the existence and functional importance of AKAPs in human DC. Methodology/Principal Findings: Using immunofluorescence and/or western analyses we identify AKAP79, AKAP149, AKAP95, AKAP LBC and Ezrin. We also demonstrate by western analysis that expression of AKAP79, AKAP149 and RII are upregulated with DC differentiation and maturation. We establish the functional importance of PKA anchoring in multiple aspects of DC biology using the anchoring inhibitor peptides Ht31 and AKAP-IS. Incubation of protein or peptide antigen loaded DC with Ht31 or AKAP-IS results in a 30-50% decrease in antigen presentation as measured by IFN-gamma production from antigen specific CD4(+) T cells. Incubation of LPS treated DC with Ht31 results in 80% inhibition of TNF-alpha and IL-10 production. Ht31 slightly decreases the expression of CD18 and CD11a and CD11b, slightly increases the basal expression of CD83, dramatically decreases the LPS stimulated expression of CD40, CD80 and CD83, and significantly increases the expression of the chemokine receptor CCR7. Conclusions: These experiments represent the first evidence for the functional importance of PKA anchoring in multiple aspects of DC biology.	[Schillace, Robynn V.; Miller, Casey L.; Pisenti, Neal; Lewinsohn, David M.; Carr, Daniel W.] Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA; [Schillace, Robynn V.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Grotzke, Jeff E.] Oregon Hlth & Sci Univ, Dept Microbiol & Mol Immunol, Portland, OR 97201 USA; [Swarbrick, Gwendolyn M.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulmonary Med, Portland, OR 97201 USA; [Carr, Daniel W.] Oregon Hlth & Sci Univ, Dept Endocrinol, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Schillace, RV (corresponding author), Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA.	carrd@ohsu.edu	Lewinsohn, David/I-4936-2013	Lewinsohn, David/0000-0001-9906-9494	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development Service	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development Service(US Department of Veterans Affairs)	This research was supported by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development Service (DWC). VA Merit Review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dodge KL, 1999, ENDOCRINOLOGY, V140, P5165, DOI 10.1210/en.140.11.5165; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Eun SY, 2006, J IMMUNOL, V177, P4271, DOI 10.4049/jimmunol.177.7.4271; Furusawa M, 2002, J BIOL CHEM, V277, P50885, DOI 10.1074/jbc.M206387200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; GONZALEZ AM, 2008, J BIOL CHEM; Grunig G, 2005, PHARMACOL THERAPEUT, V106, P75, DOI 10.1016/j.pharmthera.2004.11.004; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Harizi H, 2001, CELL IMMUNOL, V209, P19, DOI 10.1006/cimm.2001.1785; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Jones SL, 2005, J LEUKOCYTE BIOL, V78, P248, DOI 10.1189/jlb.0804459; Jones SL, 2002, J LEUKOCYTE BIOL, V71, P1042; Kambayashi T, 2001, J LEUKOCYTE BIOL, V70, P903; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; LIM CJ, 2008, MOL BIOL CELL; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; MCCONNELL BK, 2008, J BIOL CHEM; Meja KK, 2004, J PHARMACOL EXP THER, V309, P833, DOI 10.1124/jpet.103.060020; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Rodriguez-Fernandez Jose Luis, 2005, Curr Opin Investig Drugs, V6, P1103; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Smith CW, 2008, J ALLERGY CLIN IMMUN, V121, pS375, DOI 10.1016/j.jaci.2007.07.030; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Williams RO, 2002, J IMMUNOL, V168, P5392, DOI 10.4049/jimmunol.168.11.5392; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447	50	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4807	10.1371/journal.pone.0004807	http://dx.doi.org/10.1371/journal.pone.0004807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277197	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496100024
J	Wang, ZY; Ma, W; Chabot, JG; Quirion, R				Wang, Zhiyong; Ma, Weiya; Chabot, Jean-Guy; Quirion, Remi			Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia	FASEB JOURNAL			English	Article						neuropeptide; astrocyte; microglia; cytokine; kinase	PRIMARY SENSORY NEURONS; SPINAL NERVE LIGATION; PROTEIN-KINASE; NEUROPATHIC PAIN; PROINFLAMMATORY CYTOKINES; CENTRAL SENSITIZATION; MECHANICAL ALLODYNIA; SIGNAL-TRANSDUCTION; SUBSTANCE-P; EXPRESSION	Tolerance to morphine-induced analgesia is a well-established phenomenon, often limiting its usefulness in the long-term treatment of pain. The mechanisms underlying tolerance are not well understood. We previously suggested a possible role for spinal calcitonin gene-related peptide ( CGRP) in the development of tolerance to morphine-induced analgesia. In the present study, we demonstrate that CGRP is involved in morphine tolerance by differentially regulating the ERK-dependent up-regulation of IL-1 beta, TNF-alpha, and microsomal prostaglandin E synthase-1 (mPGES-1) in astrocytes and p38-dependent up-regulation of IL-6 in microglia in the rat spinal cord. A 7-d treatment with morphine induced tolerance to the antinociceptive effect and increased phosphorylated ERK localized in astrocytes and phosphorylated p38 enriched in microglia, both effects being inhibited by blocking CGRP receptors. Interestingly, the inhibition of the ERK pathway suppressed the development of tolerance and morphine-induced up-regulation of IL1 beta, TNF-alpha, and mPGES-1. Blockade of p38 activity also inhibited the development of tolerance and morphine-induced IL-6 up-regulation. Taken together, these data suggest that chronic morphine induces the synthesis of CGRP, which in turn acts on CGRP receptors located on astrocytes and microglia to stimulate ERK and p38, respectively, leading to increased synthesis and release of proinflammatory mediators resulting in tolerance to morphine-induced analgesia.-Wang, Z., Ma, W., Chabot, J.-G., Quirion, R. Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J. 23, 2576-2586 ( 2009)	[Wang, Zhiyong; Ma, Weiya; Chabot, Jean-Guy; Quirion, Remi] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada	McGill University	Quirion, R (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, 6875 Blvd LaSalle, Montreal, PQ H4H 1R3, Canada.	remi.quirion@douglas.mcgill.ca			Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research to R. Q.	Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Bird GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-31; Chen Y, 2008, J NEUROSCI, V28, P5836, DOI 10.1523/JNEUROSCI.4170-07.2008; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; CRIDLAND RA, 1988, NEUROPEPTIDES, V11, P23, DOI 10.1016/0143-4179(88)90024-8; Cui Y, 2006, BRAIN RES, V1069, P235, DOI 10.1016/j.brainres.2005.11.066; Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014; De Oliveira ACP, 2008, GLIA, V56, P844, DOI 10.1002/glia.20658; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Fan XL, 2003, NEUROSCIENCE, V122, P997, DOI 10.1016/j.neuroscience.2003.08.062; Gardell LR, 2002, J NEUROSCI, V22, P6747; HAAS CA, 1991, EUR J NEUROSCI, V3, P708, DOI 10.1111/j.1460-9568.1991.tb00856.x; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; HOKFELT T, 1992, ANN NY ACAD SCI, V657, P119; Houghton AK, 1999, PAIN, V82, P73, DOI 10.1016/S0304-3959(99)00034-2; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Johnston IN, 2004, J NEUROSCI, V24, P7353, DOI 10.1523/JNEUROSCI.1850-04.2004; KANGRGA I, 1990, NEUROSCI LETT, V108, P155, DOI 10.1016/0304-3940(90)90723-M; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; King T, 2005, NEUROSIGNALS, V14, P194, DOI 10.1159/000087658; LEGREVES P, 1985, EUR J PHARMACOL, V115, P309, DOI 10.1016/0014-2999(85)90706-X; Lofgren O, 1997, NEUROPEPTIDES, V31, P601, DOI 10.1016/S0143-4179(97)90006-8; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; MAO J, 1994, J NEUROSCI, V14, P2301; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; MENARD DP, 1995, J PHARMACOL EXP THER, V273, P887; Menard DP, 1996, J NEUROSCI, V16, P2342; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Parameswaran N, 2000, EUR J PHARMACOL, V389, P125, DOI 10.1016/S0014-2999(99)00874-2; Powell KJ, 1999, BRIT J PHARMACOL, V127, P631, DOI 10.1038/sj.bjp.0702587; Powell KJ, 2000, BRIT J PHARMACOL, V131, P875, DOI 10.1038/sj.bjp.0703655; Powell KJ, 2003, EUR J NEUROSCI, V18, P1572, DOI 10.1046/j.1460-9568.2003.02887.x; Poyner D, 1995, TRENDS PHARMACOL SCI, V16, P424, DOI 10.1016/S0165-6147(00)89093-8; Priller J, 1995, GLIA, V15, P447, DOI 10.1002/glia.440150408; Raghavendra V, 2004, NEUROPSYCHOPHARMACOL, V29, P327, DOI 10.1038/sj.npp.1300315; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; REDDINGTON M, 1995, CAN J PHYSIOL PHARM, V73, P1047, DOI 10.1139/y95-148; ROSENFELD MG, 1984, SCIENCE, V225, P1315, DOI 10.1126/science.6089345; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Schaible HG, 1996, PROG BRAIN RES, V113, P423, DOI 10.1016/S0079-6123(08)61102-4; Tepper SJ, 2008, HEADACHE, V48, P1259, DOI 10.1111/j.1526-4610.2008.01214.x; Trang T, 2002, BRIT J PHARMACOL, V136, P37, DOI 10.1038/sj.bjp.0704681; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; VAN RD, 1997, NEUROSCI BIOBEHAV R, V21, P649; Wang ZY, 2006, NEUROPHARMACOLOGY, V51, P764, DOI 10.1016/j.neuropharm.2006.05.024; Watkins LR, 2007, BRAIN BEHAV IMMUN, V21, P131, DOI 10.1016/j.bbi.2006.10.011; Watkins LR, 2005, TRENDS NEUROSCI, V28, P661, DOI 10.1016/j.tins.2005.10.001; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Wimalawansa SJ, 1996, ENDOCR REV, V17, P533, DOI 10.1210/er.17.5.533; Ye Z, 1999, NEUROSCIENCE, V92, P1389, DOI 10.1016/S0306-4522(99)00088-3; Yue X, 2008, EUR J PHARMACOL, V584, P272, DOI 10.1016/j.ejphar.2008.02.013; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	59	80	94	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2576	2586		10.1096/fj.08-128348	http://dx.doi.org/10.1096/fj.08-128348			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19299480				2022-12-25	WOS:000268836700026
J	Mushinski, JF; Nguyen, P; Stevens, LM; Khanna, C; Lee, S; Chung, EJ; Lee, MJ; Kim, YS; Linehan, WM; Horisberger, MA; Trepel, JB				Mushinski, J. Frederic; Nguyen, PhuongMai; Stevens, Lisa M.; Khanna, Chand; Lee, Sunmin; Chung, Eun Joo; Lee, Min-Jung; Kim, Yeong Sang; Linehan, W. Marston; Horisberger, Michel A.; Trepel, Jane B.			Inhibition of Tumor Cell Motility by the Interferon-inducible GTPase MxA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTATE-CANCER; GENE-EXPRESSION; ANTIVIRAL ACTIVITY; CARCINOMA-CELLS; DYNAMIN FAMILY; MESSENGER-RNA; PROTEIN MXA; METASTASIS; GROWTH; INVOLVEMENT	To identify pathways controlling prostate cancer metastasis we performed differential display analysis of the human prostate carcinoma cell line PC-3 and its highly metastatic derivative PC-3M. This revealed that a 78-kDa interferon-inducible GTPase, MxA, was expressed in PC-3 but not in PC-3M cells. The gene encoding MxA, MX1, is located in the region of chromosome 21 deleted as a consequence of fusion of TMPRSS2 and ERG, which has been associated with aggressive, invasive prostate cancer. Stable exogenous MxA expression inhibited in vitro motility and invasiveness of PC-3M cells. In vivo exogenous MxA expression decreased the number of hepatic metastases following intrasplenic injection. Exogenous MxA also reduced motility and invasiveness of highly metastatic LOX melanoma cells. A mutation in MxA that inactivated its GTPase reversed inhibition of motility and invasion in both tumor cell lines. Co-immunoprecipitation studies demonstrated that MxA associated with tubulin, but the GTPase-inactivating mutation blocked this association. Because MxA is a highly inducible gene, an MxA-targeted drug discovery screen was initiated by placing the MxA promoter upstream of a luciferase reporter. Examination of the NCI diversity set of small molecules revealed three hits that activated the promoter. In PC-3M cells, these drugs induced MxA protein and inhibited motility. These data demonstrate that MxA inhibits tumor cell motility and invasion, and that MxA expression can be induced by small molecules, potentially offering a new approach to the prevention and treatment of metastasis.	[Nguyen, PhuongMai; Lee, Sunmin; Chung, Eun Joo; Lee, Min-Jung; Kim, Yeong Sang; Trepel, Jane B.] NCI, NIH, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; NCI, NIH, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Khanna, Chand] NCI, NIH, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Linehan, W. Marston] NCI, NIH, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Horisberger, Michel A.] Aivogen AG, CH-4052 Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Trepel, JB (corresponding author), NCI, NIH, Med Oncol Branch, Ctr Canc Res, Bldg 10,Rm 12N230,10 Ctr Dr, Bethesda, MD 20892 USA.	trepel@helix.nih.gov			National Institutes of Health NCI Intramural Program; NATIONAL CANCER INSTITUTE [Z01BC011028, ZIABC011024, ZIABC011028, ZICSC006743, Z01SC006743, ZIABC010566, Z01BC011024, Z01BC010566] Funding Source: NIH RePORTER	National Institutes of Health NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Program.	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AlMasri AN, 1997, J CLIN PATHOL-MOL PA, V50, P9, DOI 10.1136/mp.50.1.9; Amara N, 2001, CANCER RES, V61, P4660; Argani P, 2001, CANCER RES, V61, P4320; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; BROUTYBOYE D, 1980, SCIENCE, V208, P516, DOI 10.1126/science.6154315; Cascinelli N, 2001, LANCET, V358, P866, DOI 10.1016/S0140-6736(01)06068-8; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Dolle L, 2006, CURR CANCER DRUG TAR, V6, P729, DOI 10.2174/156800906779010263; Dong ZY, 1999, CANCER RES, V59, P872; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOETSCHY JF, 1989, J VIROL, V63, P2616, DOI 10.1128/JVI.63.6.2616-2622.1989; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; HORISBERGER MA, 1990, J VIROL, V64, P1171, DOI 10.1128/JVI.64.3.1171-1181.1990; HORISBERGER MA, 1995, AM J RESP CRIT CARE, V152, pS67, DOI 10.1164/ajrccm/152.4_Pt_2.S67; HORISBERGER MA, 1987, J INTERFERON RES, V7, P331, DOI 10.1089/jir.1987.7.331; Jatiani SS, 2004, BIOCHEM BIOPH RES CO, V323, P541, DOI 10.1016/j.bbrc.2004.08.134; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kauffman EC, 2003, J UROLOGY, V169, P1122, DOI 10.1097/01.ju.0000051580.89109.4b; Kawamoto S, 2004, EXP HEMATOL, V32, P797, DOI 10.1016/j.exphem.2004.06.008; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kuratsukuri K, 2000, UROL ONCOL, V5, P265, DOI 10.1016/S1078-1439(00)00086-7; LAFONT F, 1994, NATURE, V372, P801; Lee SJ, 1998, J BIOL CHEM, V273, P10618, DOI 10.1074/jbc.273.17.10618; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Nagano K, 2004, ONCOGENE, V23, P1693, DOI 10.1038/sj.onc.1207297; Nanus D M, 2000, Curr Oncol Rep, V2, P417, DOI 10.1007/s11912-000-0061-5; Oh WK, 1999, J CLIN ONCOL, V17, P3664, DOI 10.1200/JCO.1999.17.11.3664; Pastore RD, 2001, CANCER INVEST, V19, P281, DOI 10.1081/CNV-100102556; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Ratner S, 1997, J IMMUNOL, V159, P1063; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schulz WA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-14; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tazi-Ahnini R, 2000, HUM GENET, V106, P639, DOI 10.1007/s004390050037; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wittmann T, 2001, J CELL SCI, V114, P3795; YAMADA T, 1994, NEUROSCI LETT, V181, P61, DOI 10.1016/0304-3940(94)90560-6; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5	59	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15206	15214		10.1074/jbc.M806324200	http://dx.doi.org/10.1074/jbc.M806324200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297326	Green Published, hybrid			2022-12-25	WOS:000266288200055
J	Xu, J; Liao, L; Qin, J; Xu, JM; Liu, D; Songyang, Z				Xu, Jun; Liao, Lan; Qin, Jun; Xu, Jianming; Liu, Dan; Songyang, Zhou			Identification of Flightless-I as a Substrate of the Cytokine-independent Survival Kinase CISK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTOR; UBIQUITIN LIGASE NEDD4-2; SERINE-THREONINE KINASE; PROTEIN-KINASE; ESTROGEN-RECEPTOR; TARGETED DISRUPTION; HAIR FOLLICLE; MAMMARY-GLAND; BREAST-CANCER	Phosphatidylinositol (PI) 3-kinase mediates multiple pathways that regulate many aspects of the cell including metabolism, survival, migration, and proliferation. Both Akt and cytokine-independent survival kinase (CISK)/SGK3 are known AGC family protein kinases that function downstream of PI 3-kinase. Although the Akt signaling pathway has been studied extensively, the specific signaling cascades that are modulated by CISK remain to be elucidated. To understand CISK function, we affinity-purified the CISK protein complex and identified Flightless-I (FLII) as a novel downstream target of CISK. Here we show that FLII is an in vivo substrate of CISK that functions downstream of PI 3-kinase. CISK can associate with FLII and phosphorylate FLII at residues Ser(436) and Thr(818). FLII has been shown to act as a co-activator for nuclear hormone receptors such as estrogen receptor (ER). We demonstrate here that CISK can enhance ER transcription, which is dependent on its kinase activity, and mutation of CISK phosphorylation sites on FLII attenuates its activity as an ER co-activator. Furthermore, FLII knockdown by RNA interference renders 32D cells more sensitive to interleukin-3 withdrawal-induced apoptosis, suggesting that FLII itself is also a survival factor. These findings support the model that CISK phosphorylates FLII and activates nuclear receptor transcription and suggest a new cell survival signaling pathway mediated by PI 3-kinase and CISK.	[Xu, Jun; Qin, Jun; Liu, Dan; Songyang, Zhou] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Liao, Lan; Qin, Jun; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Songyang, Z (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	songyang@bcm.tmc.edu			National Institutes of Health [CA84208, GM069572, CA119689]; Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA084208, R01CA119689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA84208 and GM069572 (to Z.S.) and CA119689 (to J.M.X.). This work was also supported by funds from the Welch Foundation (to Z.S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alonso L, 2005, J CELL BIOL, V170, P559, DOI 10.1083/jcb.200504131; Archer SK, 2004, BIOCHEM SOC T, V32, P940, DOI 10.1042/BST0320940; Baltaev R, 2005, PFLUG ARCH EUR J PHY, V450, P26, DOI 10.1007/s00424-004-1369-z; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Campbell HD, 1997, GENOMICS, V42, P46, DOI 10.1006/geno.1997.4709; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Castagnetta L, 2004, ANN NY ACAD SCI, V1028, P233, DOI 10.1196/annals.1321.028; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davy DA, 2001, J CELL SCI, V114, P549; DEL PL, 1997, SCIENCE, V278, P687; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Grahammer F, 2006, AM J PHYSIOL-REG I, V290, pR945, DOI 10.1152/ajpregu.00484.2005; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Herynk MH, 2007, ADV EXP MED BIOL, V608, P130; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Kucharova Silvia, 2002, Endocr Regul, V36, P37; Lang UE, 2006, BEHAV BRAIN RES, V167, P75, DOI 10.1016/j.bbr.2005.08.017; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Li QT, 2007, MOL CELL BIOL, V27, P8073, DOI 10.1128/MCB.00451-07; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCormick JA, 2004, MOL BIOL CELL, V15, P4278, DOI 10.1091/mbc.E04-01-0027; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Mussi P, 2006, P NATL ACAD SCI USA, V103, P16716, DOI 10.1073/pnas.0607768103; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ozes ON, 1999, NATURE, V401, P82; Peri A, 2005, J ENDOCRINOL INVEST, V28, P285, DOI 10.1007/BF03345387; Sandu C, 2005, PFLUG ARCH EUR J PHY, V451, P437, DOI 10.1007/s00424-005-1474-7; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; WANG TTY, 1995, CANCER RES, V55, P2487; Wyllie AH, 1997, EUR J CELL BIOL, V73, P189; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111	66	18	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14377	14385		10.1074/jbc.M807770200	http://dx.doi.org/10.1074/jbc.M807770200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19293151	Green Published, hybrid			2022-12-25	WOS:000266286100044
J	Senthivinayagam, S; Mishra, P; Paramasivam, SK; Yallapragada, S; Chatterjee, M; Wong, L; Rana, A; Rana, B				Senthivinayagam, Subramanian; Mishra, Prajna; Paramasivam, Suresh Kanna; Yallapragada, Srinivas; Chatterjee, Malay; Wong, Lucas; Rana, Ajay; Rana, Basabi			Caspase-mediated Cleavage of beta-Catenin Precedes Drug-induced Apoptosis in Resistant Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; RECEPTOR-GAMMA ACTIVATION; SENSITIZES TUMOR-CELLS; HUMAN COLON-CANCER; COLORECTAL-CANCER; IN-VITRO; HEPATOCELLULAR CARCINOMAS; DEATH RECEPTORS; GENE-EXPRESSION; TARGETING DEATH	A delicate balance between cell death and survival pathways maintains normal physiology, which is altered in many cancers, shifting the balance toward increased survival. Several studies have established a close connection between the Wnt/beta-catenin pathway and tumorigenesis, aberrant activation of which might contribute toward increased cancer cell growth and survival. Extensive research is underway to identify therapeutic agents that can induce apoptosis specifically in cancer cells with minimal collateral damage to normal cells. Although tumor necrosis factor-related apoptosis-inducing ligand( TRAIL) can induce apoptosis specifically in tumor cells, many cancer cells develop resistance, which can be overcome by combinatorial treatment with other agents: for example, peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands. To identify the molecular target mediating combinatorial drug-induced apoptosis, we focused on beta-catenin, a protein implicated in oncogenesis. Our results show that co-treatment of TRAIL-resistant cancer cells with TRAIL and the PPAR gamma ligand troglitazone leads to a reduction of beta-catenin expression, coinciding with maximal apoptosis. Modulation of beta-catenin levels via ectopic overexpression or small interference RNA-mediated gene silencing modulates drug-induced apoptosis, indicating involvement of beta-catenin in regulating this pathway. More in-depth studies indicated a post-translational mechanism, independent of glycogen synthase kinase-3 beta activity regulating beta-catenin expression following combinatorial drug treatment. Furthermore, TRAIL- and troglitazone-induced apoptosis was preceded by a cleavage of beta-catenin, which was complete in a fully apoptotic population, and was mediated by caspases-3 and -8. These results demonstrate beta-catenin as a promising new target of drug-induced apoptosis, which can be targeted to sensitize apoptosis-resistant cancer cells.	[Senthivinayagam, Subramanian; Mishra, Prajna; Paramasivam, Suresh Kanna; Rana, Basabi] Loyola Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Maywood, IL 60153 USA; [Rana, Ajay; Rana, Basabi] Loyola Univ, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Yallapragada, Srinivas] Texas A&M Univ, Hlth Sci Ctr, Dept Internal Med, Coll Med, Temple, TX 76504 USA; [Rana, Ajay; Rana, Basabi] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA; [Chatterjee, Malay] Jadavpur Univ, Dept Pharmaceut Technol, Div Biochem, Kolkata 700032, India; [Wong, Lucas] Scott & White Hosp, Div Hematol Oncol, Temple, TX 76504 USA	Loyola University Chicago; Loyola University Chicago; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Jadavpur University	Rana, B (corresponding author), Loyola Univ Chicago, Bldg 101,Rm 2729,2160 S 1st Ave, Maywood, IL 60153 USA.	brana@lumc.edu	Senthivinayagam, Subramanian/E-3141-2012; Rana, Ajay/ABE-3739-2020	Senthivinayagam, Subramanian/0000-0001-8796-3640; Rana, Ajay/0000-0003-0951-2566; Mishra, Prajna/0000-0002-1906-0244	National Institutes of Health [CA121221, GM55835]; Veterans Affairs Merit and VISN 17; Susan Komen Breast Cancer Foundation; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R21CA121221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit and VISN 17(US Department of Veterans Affairs); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121221 (to B. R.) and GM55835 (to A. R.). This work was also supported by Veterans Affairs Merit and VISN 17 awards (to B. R.), the Susan Komen Breast Cancer Foundation, and a Veterans Affairs Merit award (to A. R.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bonavida B, 1999, INT J ONCOL, V15, P793; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fukuda K, 1999, INT J BIOCHEM CELL B, V31, P519, DOI 10.1016/S1357-2725(98)00119-8; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Goke R, 2000, CELL IMMUNOL, V201, P77, DOI 10.1006/cimm.2000.1650; He Q, 2002, ONCOGENE, V21, P6032, DOI 10.1038/sj.onc.1205897; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Keane MM, 1999, CANCER RES, V59, P734; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Ling YH, 2001, MOL PHARMACOL, V59, P593, DOI 10.1124/mol.59.3.593; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Miyoshi Y, 1998, CANCER RES, V58, P2524; Nayak TK, 2007, NUCL MED BIOL, V34, P185, DOI 10.1016/j.nucmedbio.2006.11.006; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; SUREAU C, 1992, J VIROL, V66, P1241, DOI 10.1128/JVI.66.2.1241-1245.1992; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Nhieu JT, 1999, AM J PATHOL, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang HY, 2005, CANCER RES, V65, P8604, DOI 10.1158/0008-5472.CAN-05-1169; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266; Yu J, 2006, HEPATOLOGY, V43, P134, DOI 10.1002/hep.20994; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555	53	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13577	13588		10.1074/jbc.M900248200	http://dx.doi.org/10.1074/jbc.M900248200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289465	hybrid, Green Published			2022-12-25	WOS:000265877300035
J	Kamata, Y; Taniguchi, A; Yamamoto, M; Nomura, J; Ishihara, K; Takahara, H; Hibino, T; Takeda, A				Kamata, Yayoi; Taniguchi, Aya; Yamamoto, Mami; Nomura, Junko; Ishihara, Kazuhiko; Takahara, Hidenari; Hibino, Toshihiko; Takeda, Atsushi			Neutral Cysteine Protease Bleomycin Hydrolase Is Essential for the Breakdown of Deiminated Filaggrin into Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYLARGININE DEIMINASE; IMMUNOHISTOCHEMICAL LOCALIZATION; TERMINAL DIFFERENTIATION; PROTEOLYTIC CLEAVAGE; HUMAN PROFILAGGRIN; STRATUM-CORNEUM; MULTIPLE ROLES; ENVELOPE; SKIN; CALCIUM	Filaggrin is a component of the cornified cell envelope and the precursor of free amino acids acting as a natural moisturizing factor in the stratum corneum. Deimination is critical for the degradation of filaggrin into free amino acids. In this study, we tried to identify the enzyme(s) responsible for the cleavage of deiminated filaggrin in vitro. First, we investigated citrulline aminopeptidase activity in the extract of newborn rat epidermis by double layer fluorescent zymography and detected strong activity at neutral pH. Monitoring the citrulline-releasing activity, we purified an enzyme of 280 kDa, comprised of six identical subunits of 48 kDa. The NH2 terminus of representative tryptic peptides perfectly matched the sequence of rat bleomycin hydrolase (BH). The enzyme released various amino acids except Pro from beta-naphthylamide derivatives and hydrolyzed citrulline-beta-naphthylamide most effectively. Thus, to break down deiminated filaggrin, another protease would be required. Among proteases tested, calpain I degraded the deiminated filaggrin effectively into many peptides of different mass on the matrix-assisted laser desorption/ionization-time of flight mass spectrum. We confirmed that various amino acids including citrulline were released by BH from those peptides. On the other hand, caspase 14 degraded deiminated filaggrin into a few peptides of limited mass. Immunohistochemical analysis of normal human skin revealed co-localization of BH and filaggrin in the granular layer. Collectively, our results suggest that BH is essential for the synthesis of natural moisturizing factors and that calpain I would play a role as an upstream protease in the degradation of filaggrin.	[Kamata, Yayoi; Taniguchi, Aya; Takeda, Atsushi] Sagami Womens Univ, Grad Sch Nutr Sci, Biochem Lab, Kanagawa 2288533, Japan; [Kamata, Yayoi; Ishihara, Kazuhiko] Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Kanagawa 2288555, Japan; [Yamamoto, Mami; Nomura, Junko; Hibino, Toshihiko] Shiseido Res Ctr, Kanagawa 2388643, Japan; [Takahara, Hidenari] Ibaraki Univ, Sch Agr, Dept Appl Biol Resource Sci, Ami, Ibaraki 30003, Japan	Kitasato University; Shiseido Company, Limited; Ibaraki University	Takeda, A (corresponding author), Sagami Womens Univ, Grad Sch Nutr Sci, Biochem Lab, Kanagawa 2288533, Japan.	takeda.a.ns@star.sagami-wu.ac.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; Takahara, Hidenari/0000-0003-2373-8588	Sagami Women's University	Sagami Women's University	This work was supported by research grants from Sagami Women's University.	BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BIKLE DD, 1993, ENDOCR REV, V14, P3, DOI 10.1210/er.14.1.3; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; CLAR EJ, 1981, INT J COSMETIC SCI, V3, P101, DOI 10.1111/j.1467-2494.1981.tb00275.x; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; HARDING CR, 1983, J MOL BIOL, V170, P651, DOI 10.1016/S0022-2836(83)80126-0; HOHL D, 1991, J BIOL CHEM, V266, P6626; JOSHUATOR L, 2004, HDB PROTEOLYTIC ENZY, P1197; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kamata Y, 2007, J BIOCHEM, V141, P69, DOI 10.1093/jb/mvm005; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Katunuma N, 2005, ANAL BIOCHEM, V347, P208, DOI 10.1016/j.ab.2005.09.024; Koldamova RP, 1998, MOL PHARMACOL, V54, P954, DOI 10.1124/mol.54.6.954; Koldamova RP, 1999, BIOCHEMISTRY-US, V38, P7111, DOI 10.1021/bi990135l; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SC, 1993, J BIOL CHEM, V268, P12164; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Niemer I, 1997, CURR GENET, V32, P41, DOI 10.1007/s002940050246; OHSUGI I, 1995, ARCH BIOCHEM BIOPHYS, V317, P62, DOI 10.1006/abbi.1995.1136; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; RESING KA, 1989, J BIOL CHEM, V264, P1837; RESING KA, 1993, J BIOL CHEM, V268, P25139; RESING KA, 1995, J BIOL CHEM, V270, P28193; Schwartz DR, 1999, P NATL ACAD SCI USA, V96, P4680, DOI 10.1073/pnas.96.8.4680; SCOTT IR, 1982, BIOCHIM BIOPHYS ACTA, V719, P110, DOI 10.1016/0304-4165(82)90314-2; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Takahashi M, 1996, ARCH BIOCHEM BIOPHYS, V329, P123, DOI 10.1006/abbi.1996.0199; Takeda A, 1999, ARCH DERMATOL RES, V291, P238, DOI 10.1007/s004030050400; Takeda A, 1996, J BIOCHEM-TOKYO, V119, P29; Takeda A, 1996, J BIOCHEM-TOKYO, V120, P353; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Trianse S., 1974, COSMET PERFUM, V89, P57; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Yamazaki M, 1997, BIOCHEM BIOPH RES CO, V235, P652, DOI 10.1006/bbrc.1997.6809; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	55	112	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12829	12836		10.1074/jbc.M807908200	http://dx.doi.org/10.1074/jbc.M807908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286660	Green Published, hybrid			2022-12-25	WOS:000265688300028
J	Mei, J; Li, Z; Gui, JF				Mei, Jie; Li, Zhi; Gui, Jian-Fang			Cooperation of Mtmr8 with PI3K Regulates Actin Filament Modeling and Muscle Development in Zebrafish	PLOS ONE			English	Article							PROTEIN-KINASE-A; SONIC-HEDGEHOG; TYROSINE PHOSPHATASES; MYOTUBULAR MYOPATHY; MUSCULAR-DYSTROPHY; CELL MIGRATION; GRAM DOMAIN; GENE; DISEASE; FAMILY	Background: It has been shown that mutations in at least four myotubularin family genes (MTM1, MTMR1, 2 and 13) are causative for human neuromuscular disorders. However, the pathway and regulative mechanism remain unknown. Methodology/Principal Findings: Here, we reported a new role for Mtmr8 in neuromuscular development of zebrafish. Firstly, we cloned and characterized zebrafish Mtmr8, and revealed the expression pattern predominantly in the eye field and somites during early somitogenesis. Using morpholino knockdown, then, we observed that loss-of-function of Mtmr8 led to defects in somitogenesis. Subsequently, the possible underlying mechanism and signal pathway were examined. We first checked the Akt phosphorylation, and observed an increase of Akt phosphorylation in the morphant embryos. Furthermore, we studied the PH/G domain function within Mtmr8. Although the PH/G domain deletion by itself did not result in embryonic defect, addition of PI3K inhibitor LY294002 did give a defective phenotype in the PH/G deletion morphants, indicating that the PH/G domain was essential for Mtmr8's function. Moreover, we investigated the cooperation of Mtmr8 with PI3K in actin filament modeling and muscle development, and found that both Mtmr8-MO1 and Mtmr8-MO2+LY294002 led to the disorganization of the actin cytoskeleton. In addition, we revealed a possible participation of Mtmr8 in the Hedgehog pathway, and cell transplantation experiments showed that Mtmr8 worked in a non-cell autonomous manner in actin modeling. Conclusion/Significance: The above data indicate that a conserved functional cooperation of Mtmr8 with PI3K regulates actin filament modeling and muscle development in zebrafish, and reveal a possible participation of Mtmr8 in the Hedgehog pathway. Therefore, this work provides a new clue to study the physiological function of MTM family members.	[Mei, Jie; Li, Zhi; Gui, Jian-Fang] Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Mei, J (corresponding author), Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn	Mei, Jie/C-5261-2012		National Major Basic Research Program [6462004CB117401]; Innovation Project of Chinese Academy of Sciences [KSCX2-YW-N-020]; Innovation Project of IHB, CAS [075A01-1-301]	National Major Basic Research Program(National Basic Research Program of China); Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Innovation Project of IHB, CAS(Chinese Academy of Sciences)	This work was supported by the National Major Basic Research Program (grant No. 6462004CB117401), the Innovation Project of Chinese Academy of Sciences (grant No.KSCX2-YW-N-020), and the Innovation Project of IHB, CAS (grant No. 075A01-1-301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Carricaburu V, 2003, P NATL ACAD SCI USA, V100, P9867, DOI 10.1073/pnas.1734038100; Chodniewicz D, 2003, BLOOD, V101, P1181, DOI 10.1182/blood-2002-05-1435; Chojnowski A, 2007, NEUROBIOL DIS, V26, P323, DOI 10.1016/j.nbd.2006.12.018; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Hunter T, 1998, NAT GENET, V18, P303; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; Mei J, 2008, MOL CELL ENDOCRINOL, V289, P67, DOI 10.1016/j.mce.2008.02.016; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Wang W, 2005, BIOCHEM BIOPH RES CO, V330, P1127, DOI 10.1016/j.bbrc.2005.03.082; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whittard JD, 2001, J CELL SCI, V114, P3265; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07	63	23	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4979	10.1371/journal.pone.0004979	http://dx.doi.org/10.1371/journal.pone.0004979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325702	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499400003
J	Bortolotti, GR; Mougeot, F; Martinez-Padilla, J; Webster, LMI; Piertney, SB				Bortolotti, Gary R.; Mougeot, Francois; Martinez-Padilla, Jesus; Webster, Lucy M. I.; Piertney, Stuart B.			Physiological Stress Mediates the Honesty of Social Signals	PLOS ONE			English	Article							IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; AUTUMN TERRITORIAL BEHAVIOR; LAGOPUS-LAGOPUS-SCOTICUS; RED GROUSE; TRICHOSTRONGYLUS-TENUIS; PLUMAGE COLORATION; IMMUNE FUNCTION; ZEBRA FINCHES; TESTOSTERONE; CORTICOSTERONE	Background: Extravagant ornaments used as social signals evolved to advertise their bearers' quality. The Immunocompetence Handicap Hypothesis proposes that testosterone-dependent ornaments reliably signal health and parasite resistance; however, empirical studies have shown mixed support. Alternatively, immune function and parasite resistance may be indirectly or directly related to glucocorticoid stress hormones. We propose that an understanding of the interplay between the individual and its environment, particularly how they cope with stressors, is crucial for understanding the honesty of social signals. Methodology/Principal Findings: We analyzed corticosterone deposited in growing feathers as an integrated measure of hypothalamic-pituitary-adrenal activity in a wild territorial bird, the red grouse Lagopus lagopus scoticus. We manipulated two key, interrelated components, parasites and testosterone, which influence both ornamentation and fitness. Birds were initially purged of parasites, and later challenged with parasites or not, while at the same time being given testosterone or control implants, using a factorial experimental design. At the treatment level, testosterone enhanced ornamentation, while parasites reduced it, but only in males not implanted with testosterone. Among individuals, the degree to which both parasites and testosterone had an effect was strongly dependent on the amount of corticosterone in the feather grown during the experiment. The more stressors birds had experienced (i.e., higher corticosterone), the more parasites developed, and the less testosterone enhanced ornamentation. Conclusions/Significance: With this unique focus on the individual, and a novel, integrative, measure of response to stressors, we show that ornamentation is ultimately a product of the cumulative physiological response to environmental challenges. These findings lead toward a more realistic concept of honesty in signaling as well as a broader discussion of the concept of stress.	[Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Mougeot, Francois] CSIC, Estac Experiment Zonas Aridas, Almeria, Spain; [Mougeot, Francois] IREC, CSIC, UCLM, JCCM, Ciudad Real, Spain; [Martinez-Padilla, Jesus; Webster, Lucy M. I.; Piertney, Stuart B.] Univ Aberdeen, Sch Biol Sci, Aberdeen AB9 1FX, Scotland	University of Saskatchewan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Aberdeen	Bortolotti, GR (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	gary.bortolotti@usask.ca	Mougeot, Francois/B-1894-2009; Mougeot, Francois/Y-9569-2019; Martinez-Padilla, Jesus/C-6446-2008; Piertney, Stuart/I-3144-2012	Mougeot, Francois/0000-0002-5819-6275; Mougeot, Francois/0000-0002-5819-6275; Martinez-Padilla, Jesus/0000-0003-2956-5163; Piertney, Stuart/0000-0001-6654-0569	NERC [NE/D000602/1, Advanced Fellowship, Discovery Grant]; Stuart and Mary Houston Professorship in Ornithology; Natural Environment Research Council [NE/D000602/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Stuart and Mary Houston Professorship in Ornithology; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	NERC Advanced Fellowship to FM; NERC grant (NE/D000602/1) to SP and LW; NSERC Discovery Grant to GRB; Stuart and Mary Houston Professorship in Ornithology to GRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; BORTOLOTTI GR, 2009, J EXPT BIOL IN PRESS; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; DELAHAY RJ, 1995, PARASITOLOGY, V110, P473, DOI 10.1017/S0031182000064817; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hudson PJ, 1986, RED GROUSE BIOL MANA; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Maney DL, 2008, ETHOLOGY, V114, P369, DOI 10.1111/j.1439-0310.2008.01476.x; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McNamara JM, 2005, BEHAV ECOL, V16, P1008, DOI 10.1093/beheco/ari087; MOSS R, 1979, AGGRESSIVE BEHAV, V5, P59, DOI 10.1002/1098-2337(1979)5:1<59::AID-AB2480050108>3.0.CO;2-S; MOSS R, 1985, AGGRESSIVE BEHAV, V11, P253, DOI 10.1002/1098-2337(1985)11:3<253::AID-AB2480110308>3.0.CO;2-Z; Mougeot F, 2006, BEHAV ECOL, V17, P117, DOI 10.1093/beheco/arj005; Mougeot F, 2005, AM NAT, V166, P158, DOI 10.1086/431256; Mougeot F, 2005, OECOLOGIA, V144, P289, DOI 10.1007/s00442-005-0080-x; Mougeot F, 2005, HORM BEHAV, V47, P576, DOI 10.1016/j.yhbeh.2004.11.021; Mougeot F, 2004, J AVIAN BIOL, V35, P425, DOI 10.1111/j.0908-8857.2004.03256.x; Mougeot F, 2003, J ANIM ECOL, V72, P1073, DOI 10.1046/j.1365-2656.2003.00781.x; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Perez-Rodriguez L, 2006, ANIM BEHAV, V72, P97, DOI 10.1016/j.anbehav.2005.09.021; Redpath SM, 2006, ANIM BEHAV, V71, P1297, DOI 10.1016/j.anbehav.2005.08.012; Roberts ML, 2007, J EXP BIOL, V210, P4368, DOI 10.1242/jeb.007104; Roberts ML, 2007, ANIM BEHAV, V74, P921, DOI 10.1016/j.anbehav.2006.12.021; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Rubenstein DR, 2007, P ROY SOC B-BIOL SCI, V274, P967, DOI 10.1098/rspb.2006.0051; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seivwright LJ, 2005, P ROY SOC B-BIOL SCI, V272, P2299, DOI 10.1098/rspb.2005.3233; SEIVWRIGHT LJ, 2004, PATTERN TRICHOSTRONG; SHAW JL, 1988, RES VET SCI, V45, P256, DOI 10.1016/S0034-5288(18)30943-3; SHAW JL, 1989, PARASITOLOGY, V99, P259, DOI 10.1017/S0031182000058716; Washburn BE, 2007, CONDOR, V109, P181, DOI 10.1650/0010-5422(2007)109[181:UACAEI]2.0.CO;2; WATSON A, 1985, OECOLOGIA, V67, P493, DOI 10.1007/BF00790019; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Zahavi A., 1997, HANDICAP PRINCIPLE	44	79	80	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4983	10.1371/journal.pone.0004983	http://dx.doi.org/10.1371/journal.pone.0004983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PK	19319197	Green Published, gold			2022-12-25	WOS:000265499200014
J	Craig, M; Slauch, JM				Craig, Maureen; Slauch, James M.			Phagocytic Superoxide Specifically Damages an Extracytoplasmic Target to Inhibit or Kill Salmonella	PLOS ONE			English	Article								Background: The phagocytic oxidative burst is a primary effector of innate immunity that protects against bacterial infection. However, the mechanism by which reactive oxygen species (ROS) kill or inhibit bacteria is not known. It is often assumed that DNA is a primary target of oxidative damage, consistent with known effects of endogenously produced ROS in the bacterial cytoplasm. But most studies fail to distinguish between effects of host derived ROS versus damage caused by endogenous bacterial sources. We took advantage of both the ability of Salmonella enterica serovar Typhimurium to survive in macrophages and the genetic tractability of the system to test the hypothesis that phagocytic superoxide damages cytoplasmic targets including DNA. Methodology/Principal Findings: SodCI is a periplasmic Cu-Zn superoxide dismutase ( SOD) that contributes to the survival of Salmonella Typhimurium in macrophages. Through competitive virulence assays, we asked if sodCI has a genetic interaction with various cytoplasmic systems. We found that SodCI acts independently of cytoplasmic SODs, SodA and SodB. In addition, SodCI acts independently of the base excision repair system and RuvAB, involved in DNA repair. Although sodCI did show genetic interaction with recA, this was apparently independent of recombination and is presumably due to the pleiotropic effects of a recA mutation. Conclusions/Significance: Taken together, these results suggest that bacterial inhibition by phagocytic superoxide is primarily the result of damage to an extracytoplasmic target.	[Craig, Maureen; Slauch, James M.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Slauch, James M.] Univ Illinois, Coll Med, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Slauch, JM (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	slauch@illinois.edu			Public Health Service [AI63230]; NIH [GM007283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063230] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI63230 to JMS. MC was partially supported by NIH training grant GM007283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola S, 2008, J BIOL CHEM, V283, P13688, DOI 10.1074/jbc.M710499200; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; BIELSKI BHJ, 1977, J PHYS CHEM-US, V81, P1048, DOI 10.1021/j100526a005; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Bunny K, 2002, J BACTERIOL, V184, P6235, DOI 10.1128/JB.184.22.6235-6249.2002; Cano DA, 2002, J BACTERIOL, V184, P592, DOI 10.1128/JB.184.2.592-595.2002; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CAYROL C, 1995, P NATL ACAD SCI USA, V92, P11806, DOI 10.1073/pnas.92.25.11806; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DEMPLE B, 1983, J BACTERIOL, V153, P1079, DOI 10.1128/JB.153.2.1079-1082.1983; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Fang FC, 1997, INFECT IMMUN, V65, P5371, DOI 10.1128/IAI.65.12.5371-5375.1997; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Ho TD, 2001, J BACTERIOL, V183, P611, DOI 10.1128/JB.183.2.611-620.2001; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; Krishnakumar R, 2004, J BACTERIOL, V186, P5230, DOI 10.1128/JB.186.16.5230-5238.2004; Krishnakumar R, 2007, J BACTERIOL, V189, P4343, DOI 10.1128/JB.00010-07; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; LESCA C, 1991, BIOCHIMIE, V73, P407, DOI 10.1016/0300-9084(91)90107-C; Linehan SA, 2003, IMMUNOL LETT, V85, P183, DOI 10.1016/S0165-2478(02)00227-4; Maloy SR., 1996, GENETIC ANAL PATHOGE; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; PETIT C, 1993, J BACTERIOL, V175, P642, DOI 10.1128/JB.175.3.642-646.1993; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Reeves EP, 2003, J MED MICROBIOL, V52, P643, DOI 10.1099/jmm.0.05181-0; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Sansone A, 2002, MICROBIOL-SGM, V148, P719, DOI 10.1099/00221287-148-3-719; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Suvarnapunya AE, 2003, MOL MICROBIOL, V48, P549, DOI 10.1046/j.1365-2958.2003.03460.x; Suvarnapunya AE, 2005, MICROBIOL-SGM, V151, P557, DOI 10.1099/mic.0.27555-0; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; TSOLIS RM, 1995, INFECT IMMUN, V63, P1739, DOI 10.1128/IAI.63.5.1739-1744.1995; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Uzzau S, 2002, MOL MICROBIOL, V46, P147, DOI 10.1046/j.1365-2958.2002.03145.x; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; WANG TCV, 1991, BIOCHEM BIOPH RES CO, V180, P774, DOI 10.1016/S0006-291X(05)81132-5; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	68	63	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4975	10.1371/journal.pone.0004975	http://dx.doi.org/10.1371/journal.pone.0004975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305502	gold, Green Published, Green Submitted			2022-12-25	WOS:000265498800017
J	Guillon, N; Tirode, F; Boeva, V; Zynovyev, A; Barillot, E; Delattre, O				Guillon, Noelle; Tirode, Franck; Boeva, Valentina; Zynovyev, Andrei; Barillot, Emmanuel; Delattre, Olivier			The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							EWINGS-SARCOMA TRANSLOCATION; DNA-BINDING; TARGET GENE; EWS GENE; FUSION; GENOME; EWS/FLI; IDENTIFICATION; ONCOPROTEINS; ENRICHMENT	The fusion between EWS and ETS family members is a key oncogenic event in Ewing tumors and important EWS-FLI1 target genes have been identified. However, until now, the search for EWS-FLI1 targets has been limited to promoter regions and no genome-wide comprehensive analysis of in vivo EWS-FLI1 binding sites has been undertaken. Using a ChIP-Seq approach to investigate EWS-FLI1-bound DNA sequences in two Ewing cell lines, we show that this chimeric transcription factor preferentially binds two types of sequences including consensus ETS motifs and microsatellite sequences. Most bound sites are found outside promoter regions. Microsatellites containing more than 9 GGAA repeats are very significantly enriched in EWS-FLI1 immunoprecipitates. Moreover, in reporter gene experiments, the transcription activation is highly dependent upon the number of repeats that are included in the construct. Importantly, in vivo EWS-FLI1-bound microsatellites are significantly associated with EWS-FLI1-driven gene activation. Put together, these results point out the likely contribution of microsatellite elements to long-distance transcription regulation and to oncogenesis.	[Guillon, Noelle; Tirode, Franck; Boeva, Valentina; Zynovyev, Andrei; Barillot, Emmanuel; Delattre, Olivier] Inst Curie, Paris, France; [Guillon, Noelle; Tirode, Franck; Boeva, Valentina; Delattre, Olivier] INSERM, U830, Paris, France; [Boeva, Valentina; Zynovyev, Andrei; Barillot, Emmanuel] INSERM, U900, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Delattre, O (corresponding author), Inst Curie, Paris, France.	olivier.delattre@curie.fr	TIRODE, Franck/HHS-7070-2022; Boeva, Valentina/C-2855-2017; Zinovyev, Andrei/B-4715-2010; Tirode, Franck/B-4586-2009	Boeva, Valentina/0000-0002-4382-7185; Zinovyev, Andrei/0000-0002-9517-7284; BARILLOT, Emmanuel/0000-0003-2724-2002; Tirode, Franck/0000-0003-4731-7817; delattre, olivier/0000-0002-8730-2276	Institut National de la Sante et de la Recherche Medicale; Institut Curie; Ligue Nationale contre le Cancer; Agence Nationale de la Recherche	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Institut Curie, the Ligue Nationale contre le Cancer (Equipe labellise and CIT program) and the Agence Nationale de la Recherche (SITCON project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Caramel J, 2008, CANCER RES, V68, P6154, DOI 10.1158/0008-5472.CAN-08-0115; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, CANCER RES, V63, P4268; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; GARCIAARAGONCIL.E, 2008, ONCOGENE; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; JEON IS, 1995, ONCOGENE, V10, P1229; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; KIKUCHI R, 2006, ONCOGENE; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Li X, 2005, INT J CANCER, V116, P385, DOI 10.1002/ijc.21010; MagnaghiJaulin L, 1996, NUCLEIC ACIDS RES, V24, P1052, DOI 10.1093/nar/24.6.1052; MAO XH, 1994, J BIOL CHEM, V269, P18216; May WA, 1997, CURR TOP MICROBIOL, V220, P143; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Potikyan G, 2007, CANCER RES, V67, P6675, DOI 10.1158/0008-5472.CAN-06-4140; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; RAYGALLET D, 1995, ONCOGENE, V11, P303; SHORE P, 1995, NUCLEIC ACIDS RES, V23, P4698, DOI 10.1093/nar/23.22.4698; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Urano F, 1996, BIOCHEM BIOPH RES CO, V219, P608, DOI 10.1006/bbrc.1996.0281; Valbuena Alberto, 2008, PLoS One, V3, pe1642, DOI 10.1371/journal.pone.0001642; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wai DH, 2002, INT J ONCOL, V20, P441; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104	52	114	118	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4932	10.1371/journal.pone.0004932	http://dx.doi.org/10.1371/journal.pone.0004932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305498	Green Published, gold, Green Submitted			2022-12-25	WOS:000265498800004
J	Lickwar, CR; Rao, B; Shabalin, AA; Nobel, AB; Strahl, BD; Lieb, JD				Lickwar, Colin R.; Rao, Bhargavi; Shabalin, Andrey A.; Nobel, Andrew B.; Strahl, Brian D.; Lieb, Jason D.			The Set2/Rpd3S Pathway Suppresses Cryptic Transcription without Regard to Gene Length or Transcription Frequency	PLOS ONE			English	Article								In cells lacking the histone methyltransferase Set2, initiation of RNA polymerase II transcription occurs inappropriately within the protein-coding regions of genes, rather than being restricted to the proximal promoter. It was previously reported that this "cryptic'' transcription occurs preferentially in long genes, and in genes that are infrequently transcribed. Here, we mapped the transcripts produced in an S. cerevisiae strain lacking Set2, and applied rigorous statistical methods to identify sites of cryptic transcription at high resolution. We find that suppression of cryptic transcription occurs independent of gene length or transcriptional frequency. Our conclusions differ with those reported previously because we obtained a higher-resolution dataset, we accounted for the fact that gene length and transcriptional frequency are not independent variables, and we accounted for several ascertainment biases that make cryptic transcription easier to detect in long, infrequently transcribed genes. These new results and conclusions have implications for many commonly used genomic analysis approaches, and for the evolution of high-fidelity RNA polymerase II transcriptional initiation in eukaryotes.	[Lickwar, Colin R.; Rao, Bhargavi; Strahl, Brian D.; Lieb, Jason D.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Shabalin, Andrey A.; Nobel, Andrew B.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA; [Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Lickwar, Colin R.; Rao, Bhargavi; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Dept Biol, Chapel Hill, NC 27515 USA; [Lickwar, Colin R.; Rao, Bhargavi; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehensive Canc Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lickwar, CR (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	jlieb@bio.unc.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Shabalin, Andrey/0000-0003-0309-6821	NIH [GM072518, GM68088]; Pew Scholar in the Biomedical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518, R01GM068088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in the Biomedical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH grants GM072518 (JDL) and GM68088 (BDS). BDS is a Pew Scholar in the Biomedical Sciences. The funding agencies played no active role in the study design or publication of this work.	Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; ANDREWS DWK, 1993, ECONOMETRICA, V61, P821, DOI 10.2307/2951764; Bai JS, 1998, ECONOMETRICA, V66, P47, DOI 10.2307/2998540; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; CEDAR H, 1973, J MOL BIOL, V77, P237, DOI 10.1016/0022-2836(73)90334-3; CHEUNG V, 2008, GENOME PLOS BIOL, V6, pE277; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huarte M, 2007, J BIOL CHEM, V282, P21662, DOI 10.1074/jbc.M703897200; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lieb JD, 2005, CELL, V123, P1187, DOI 10.1016/j.cell.2005.12.010; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	32	46	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4886	10.1371/journal.pone.0004886	http://dx.doi.org/10.1371/journal.pone.0004886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295910	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496700003
J	Kuipers, SD; Tiron, A; Soule, J; Messaoudi, E; Trentani, A; Bramham, CR				Kuipers, Sjoukje D.; Tiron, Adrian; Soule, Jonathan; Messaoudi, Elhoucine; Trentani, Andrea; Bramham, Clive R.			Selective Survival and Maturation of Adult-Born Dentate Granule Cells Expressing the Immediate Early Gene Arc/Arg3.1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; ENHANCED SYNAPTIC PLASTICITY; NEWLY GENERATED NEURONS; RAT HIPPOCAMPUS; NEUROGENESIS; GYRUS; CONSOLIDATION; PML; ARC	Progenitor cells in the adult dentate gyrus provide a constant supply of neuronal precursors, yet only a small fraction of these cells survive and develop into mature dentate granule cells (DGCs). A major challenge of current research is thus to understand the stringent selection process that governs the maturation and functional integration of adult-born DGCs. In mature DGCs, high-frequency stimulation (HFS) of the perforant path input elicits robust expression of the immediate early gene Arc/Arg3.1, trafficking of its mRNA to dendrites, and local synthesis of the protein necessary for consolidation of long-term potentiation (LTP). Given the synaptic commitment inherent in LTP consolidation, we considered that HFS-evoked expression of Arc could be used to timemap the functional integration of newborn DGCs. Dividing cells were birthmarked by BrdU-labeling at 1, 7, 14, 21, or 28 days prior to induction of LTP and expression of Arc was examined by confocal microscopy. Contrary to expectation, LTP did not induce Arc expression in newborn cells at any age, suggesting they might be refractory to synaptically-evoked Arc expression for at least one month. Importantly, however, spontaneous expression of Arc was detected in BrdU-labeled cells and strongly associated with the survival and maturation of NeuN-positive DGCs. Moreover, Arc expression at the earliest ages (1 and 7 days), clearly precedes the formation of glutamatergic synapses on new neurons. These results suggest an unexpected early role for Arc in adult-born DGCs, distinct from its functions in LTP, LTD, and homeostatic synaptic plasticity.	[Kuipers, Sjoukje D.; Tiron, Adrian; Soule, Jonathan; Messaoudi, Elhoucine; Trentani, Andrea; Bramham, Clive R.] Univ Bergen, Dept Biomed, Bergen, Norway; [Kuipers, Sjoukje D.; Tiron, Adrian; Soule, Jonathan; Messaoudi, Elhoucine; Trentani, Andrea; Bramham, Clive R.] Univ Bergen, Bergen Mental Hlth Res Ctr, Bergen, Norway	University of Bergen; University of Bergen	Kuipers, SD (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	clive.bramham@biomed.uib.no	Tiron, Adrian/AAQ-4002-2020; Trentani, Andrea/AAF-7273-2021; Bramham, Clive/Q-1854-2018	Tiron, Adrian/0000-0002-7006-5884; Trentani, Andrea/0000-0003-3304-2066; Bramham, Clive/0000-0001-5958-7115	Norwegian Research Council (NFR); Netherlands Organisation for Scientific Research (NWO)	Norwegian Research Council (NFR)(Research Council of Norway); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by research grants from the the Norwegian Research Council (NFR) and the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bloomer WAC, 2007, BRAIN RES, V1153, P20, DOI 10.1016/j.brainres.2007.03.079; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Bramham CR, 2007, PROG BRAIN RES, V163, P453, DOI 10.1016/S0079-6123(07)63025-8; BRAMHAM CR, 2008, CURR OPIN NEUROBIOL; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuipers SD, 2006, NEUROPHARMACOLOGY, V50, P428, DOI 10.1016/j.neuropharm.2005.10.006; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Matsuzaki M, 2007, NEUROSCI RES, V57, P1, DOI 10.1016/j.neures.2006.09.017; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; RAJEEVKUMAR R, 2007, NUCL TRANSLOCATION S; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; ROSS HH, 2008, STEM CELLS; Sanchez-Pulido L, 2007, TRENDS BIOCHEM SCI, V32, P400, DOI 10.1016/j.tibs.2007.08.001; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	62	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4885	10.1371/journal.pone.0004885	http://dx.doi.org/10.1371/journal.pone.0004885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290048	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496500008
J	Tian, J; Li, X; Liang, M; Liu, LJ; Xie, JX; Ye, QQ; Kometiani, P; Tillekeratne, M; Jin, RM; Xie, ZJ				Tian, Jiang; Li, Xin; Liang, Man; Liu, Lijun; Xie, Joe X.; Ye, Qiqi; Kometiani, Peter; Tillekeratne, Manoranjani; Jin, Runming; Xie, Zijian			Changes in Sodium Pump Expression Dictate the Effects of Ouabain on Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMALEMMAL NA/K-ATPASE; HUMAN SKELETAL-MUSCLE; CARDIAC-GLYCOSIDES; NA+/K+-ATPASE; BREAST-CANCER; LLC-PK1 CELLS; CARDIOTONIC STEROIDS; MESSENGER-RNA; BETA-SUBUNIT; NA,K-ATPASE	Here we show that ouabain-induced cell growth regulation is intrinsically coupled to changes in the cellular amount of Na/K-ATPase via the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway. Ouabain increases the endocytosis and degradation of Na/K-ATPase in LLC-PK1, human breast (BT20), and prostate (DU145) cancer cells. However, ouabain stimulates the PI3K/Akt/mTOR pathway and consequently up-regulates the expression of Na/K-ATPase in LLC-PK1 but not BT20 and DU145 cells. This up-regulation is sufficient to replete the plasma membrane pool of Na/K-ATPase and to stimulate cell proliferation in LLC-PK1 cells. On the other hand, ouabain causes a gradual depletion of Na/K-ATPase and an increased expression of cell cycle inhibitor p21(cip), which consequently inhibits cell proliferation in BT20 and DU145 cells. Consistently, we observe that small interfering RNA-mediated knockdown of Na/K-ATPase is sufficient to induce the expression of p21cip and slow the proliferation of LLC-PK1 cells. Moreover, this knockdown converts the growth stimulatory effect of ouabain to growth inhibition in LLC-PK1 cells. Mechanistically, both Src and caveolin-1 are required for ouabain-induced activation of Akt and up-regulation of Na/K-ATPase. Furthermore, inhibition of the PI3K/Akt/mTOR pathway by rapamycin completely blocks ouabain-induced expression of Na/K-ATPase and converts ouabain-induced growth stimulation to growth inhibition in LLC-PK1 cells. Taken together, we conclude that changes in the expression of Na/K-ATPase dictate the growth regulatory effects of ouabain on cells.	[Tian, Jiang; Liang, Man; Liu, Lijun; Xie, Joe X.; Ye, Qiqi; Kometiani, Peter; Tillekeratne, Manoranjani; Xie, Zijian] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43614 USA; [Li, Xin; Jin, Runming] Huazhong Univ Sci & Technol, Dept Pediat, Union Hosp, Wuhan 430074, Hubei, Peoples R China	University System of Ohio; University of Toledo; Huazhong University of Science & Technology	Xie, ZJ (corresponding author), 3000 Arlington Ave, Toledo, OH 43614 USA.	zi-jian.xie@utoledo.edu			National Institutes of Health [HL-36573, HL-67963, GM 78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067963, P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573, HL-67963, and GM 78565.	ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Bagrov AY, 1996, CARDIOVASC RES, V31, P296; BAKER PF, 1972, J PHYSIOL-LONDON, V224, P441, DOI 10.1113/jphysiol.1972.sp009904; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; CAYANIS E, 1992, J MEMBRANE BIOL, V125, P163; Chueh SC, 2001, J UROLOGY, V166, P347, DOI 10.1016/S0022-5347(05)66157-5; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Cook J S, 1985, Soc Gen Physiol Ser, V39, P3; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Elkareh J, 2007, HYPERTENSION, V49, P215, DOI 10.1161/01.HYP.0000252409.36927.05; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; Haux J, 1999, MED HYPOTHESES, V53, P543, DOI 10.1054/mehy.1999.0985; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; JING YK, 1994, JPN J CANCER RES, V85, P645, DOI 10.1111/j.1349-7006.1994.tb02408.x; KAPLAN JG, 1978, ANNU REV PHYSIOL, V40, P19, DOI 10.1146/annurev.ph.40.030178.000315; Khundmiri SJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1247, DOI 10.1152/ajpcell.00593.2005; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; KONSKI AA, 1991, INT J RADIAT ONCOL, V21, P1033; Kotova O, 2006, J BIOL CHEM, V281, P20085, DOI 10.1074/jbc.M601577200; LESCALEMATYS L, 1990, J BIOL CHEM, V265, P17935; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; LIANG M, 2006, J BIOL CHEM; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Maeshima A, 2002, KIDNEY INT, V62, P446, DOI 10.1046/j.1523-1755.2002.00463.x; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Murata Y, 1996, JPN J PHARMACOL, V72, P347, DOI 10.1254/jjp.72.347; Murphy KT, 2004, J PHYSIOL-LONDON, V556, P507, DOI 10.1113/jphysiol.2003.054981; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Nguyen ANT, 2007, J AM SOC NEPHROL, V18, P46, DOI 10.1681/ASN.2006010086; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Pollack L R, 1982, Prog Clin Biol Res, V91, P71; POLLACK LR, 1981, AM J PHYSIOL, V241, pC173, DOI 10.1152/ajpcell.1981.241.5.C173; POLLACK LR, 1981, J CELL PHYSIOL, V106, P85, DOI 10.1002/jcp.1041060110; QIN X, 1994, AM J HYPERTENS, V7, P96, DOI 10.1093/ajh/7.1.96; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Schoner W, 2008, NAT MED, V14, P16, DOI 10.1038/nm0108-16; SKOU JC, 1965, PHYSIOL REV, V45, P596, DOI 10.1152/physrev.1965.45.3.596; Stenkvist B, 1999, ONCOL REP, V6, P493; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; STENKVIST B, 1980, ANAL QUANT CYTOL, V2, P49; Taguchi K, 2007, NEUROSCI LETT, V413, P42, DOI 10.1016/j.neulet.2006.11.061; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Watabe M, 1998, ONCOGENE, V16, P779, DOI 10.1038/sj.onc.1201592; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Ye M, 2004, J STEROID BIOCHEM, V91, P87, DOI 10.1016/j.jsbmb.2004.01.010; Yeh JY, 2001, J UROLOGY, V166, P1937, DOI 10.1016/S0022-5347(05)65724-2; Zhou XM, 2001, BIOCHEM BIOPH RES CO, V285, P46, DOI 10.1006/bbrc.2001.5126	64	101	108	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14921	14929		10.1074/jbc.M808355200	http://dx.doi.org/10.1074/jbc.M808355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329430	hybrid, Green Published			2022-12-25	WOS:000266288200028
J	Takaku, M; Machida, S; Hosoya, N; Nakayama, S; Takizawa, Y; Sakane, I; Shibata, T; Miyagawa, K; Kurumizaka, H				Takaku, Motoki; Machida, Shinichi; Hosoya, Noriko; Nakayama, Shugo; Takizawa, Yoshimasa; Sakane, Isao; Shibata, Takehiko; Miyagawa, Kiyoshi; Kurumizaka, Hitoshi			Recombination Activator Function of the Novel RAD51-and RAD51B-binding Protein, Human EVL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; HUMAN RAD52 PROTEIN; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; EXCHANGE ACTIVITY; COMPLEX-FORMATION; VERTEBRATE CELLS; BINDING PROTEIN; USTILAGO-MAYDIS; MOUSE GENES	The RAD51 protein is a central player in homologous recombinational repair. The RAD51B protein is one of five RAD51 paralogs that function in the homologous recombinational repair pathway in higher eukaryotes. In the present study, we found that the human EVL (Ena/Vasp-like) protein, which is suggested to be involved in actin-remodeling processes, unexpectedly binds to the RAD51 and RAD51B proteins and stimulates the RAD51-mediated homologous pairing and strand exchange. The EVL knockdown cells impaired RAD51 assembly onto damaged DNA after ionizing radiation or mitomycin C treatment. The EVL protein alone promotes single-stranded DNA annealing, and the recombination activities of the EVL protein are further enhanced by the RAD51B protein. The expression of the EVL protein is not ubiquitous, but it is significantly expressed in breast cancer-derived MCF7 cells. These results suggest that the EVL protein is a novel recombination factor that may be required for repairing specific DNA lesions, and that may cause tumor malignancy by its inappropriate expression.	[Takaku, Motoki; Machida, Shinichi; Nakayama, Shugo; Takizawa, Yoshimasa; Sakane, Isao; Kurumizaka, Hitoshi] Waseda Univ, Inst Adv Sci & Med Care, Grad Sch Adv Sci & Engn & Consolidated Res, Struct Biol Lab,Shinjuku Ku, Tokyo 1628480, Japan; [Hosoya, Noriko; Miyagawa, Kiyoshi] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Mol Radiol,Bunkyo ku, Tokyo 1130033, Japan; [Shibata, Takehiko] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan	Waseda University; University of Tokyo; RIKEN	Kurumizaka, H (corresponding author), Waseda Univ, Inst Adv Sci & Med Care, Grad Sch Adv Sci & Engn & Consolidated Res, Struct Biol Lab,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp	Takaku, Motoki/AAT-7972-2020; Hosoya, Noriko/AAA-1447-2022; Takizawa, Yoshimasa/G-2956-2015	Takaku, Motoki/0000-0002-8652-2541; Hosoya, Noriko/0000-0002-1418-0677; Takizawa, Yoshimasa/0000-0002-6265-4830; Kurumizaka, Hitoshi/0000-0001-7412-3722	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21310034] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bleuyard JY, 2005, PLANT J, V41, P533, DOI 10.1111/j.1365-313X.2004.02318.x; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Date O, 2006, CANCER RES, V66, P6018, DOI 10.1158/0008-5472.CAN-05-2803; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu LD, 2008, ONCOL REP, V19, P1015; Ishida T, 2008, GENES CELLS, V13, P91, DOI 10.1111/j.1365-2443.2007.01143.x; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Maeshima K, 1996, GENES CELLS, V1, P1057, DOI 10.1046/j.1365-2443.1996.d01-224.x; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ohta S, 1997, BIOCHEM BIOPH RES CO, V237, P307, DOI 10.1006/bbrc.1997.7113; Osakabe K, 2005, PLANT MOL BIOL, V57, P819, DOI 10.1007/s11103-005-2187-1; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Reddy G, 1997, MUTAT RES-FUND MOL M, V377, P53, DOI 10.1016/S0027-5107(97)00057-2; Rice MC, 1997, P NATL ACAD SCI USA, V94, P7417, DOI 10.1073/pnas.94.14.7417; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; SHIVJI MK, NUCL ACIDS RES, V34, P4000; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Tanaka K, 2000, J BIOL CHEM, V275, P26316, DOI 10.1074/jbc.M910306199; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yokoyama H, 2004, NUCLEIC ACIDS RES, V32, P2556, DOI 10.1093/nar/gkh578; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Yonetani Y, 2005, NUCLEIC ACIDS RES, V33, P4544, DOI 10.1093/nar/gki766	66	16	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14326	14336		10.1074/jbc.M807715200	http://dx.doi.org/10.1074/jbc.M807715200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329439	Green Published, hybrid			2022-12-25	WOS:000266286100039
J	Aimanianda, V; Clavaud, C; Simenel, C; Fontaine, T; Delepierre, M; Latge, JP				Aimanianda, Vishukumar; Clavaud, Cecile; Simenel, Catherine; Fontaine, Thierry; Delepierre, Muriel; Latge, Jean-Paul			Cell Wall beta-(1,6)-Glucan of Saccharomyces cerevisiae STRUCTURAL CHARACTERIZATION AND IN SITU SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,6-GLUCAN SYNTHESIS; CANDIDA-ALBICANS; GENE ENCODES; MEMBRANE-PROTEIN; GLUCAN SYNTHESIS; OSMOTIC SHOCK; BETA-GLUCANS; YEAST; GROWTH; SPECTROSCOPY	Despite its essential role in the yeast cell wall, the exact composition of the beta-(1,6)-glucan component is not well characterized. While solubilizing the cell wall alkali-insoluble fraction from a wild type strain of Saccharomyces cerevisiae using a recombinant beta-(1,3)-glucanase followed by chromatographic characterization of the digest on an anion exchange column, we observed a soluble polymer that eluted at the end of the solvent gradient run. Further characterization indicated this soluble polymer to have a molecular mass of similar to 38 kDa and could be hydrolyzed only by beta-(1,6)-glucanase. Gas chromatography-mass spectrometry and NMR(H-1 and C-13) analyses confirmed it to be a beta-(1,6)-glucan polymer with, on average, branching at every fifth residue with one or two beta-(1,3)-linked glucose units in the side chain. This polymer peak was significantly reduced in the corresponding digests from mutants of the kre genes (kre9 and kre5) that are known to play a crucial role in the beta-(1,6)glucan biosynthesis. In the current study, we have developed a biochemical assay wherein incubation of UDP-[C-14] glucose with permeabilized S. cerevisiae yeasts resulted in the synthesis of a polymer chemically identical to the branched beta-(1,6)-glucan isolated from the cell wall. Using this assay, parameters essential for beta-(1,6)-glucan synthetic activity were defined.	[Aimanianda, Vishukumar; Clavaud, Cecile; Fontaine, Thierry; Latge, Jean-Paul] Inst Pasteur, CNRS, URA 2185, Unite Aspergillus, F-75724 Paris 15, France; [Simenel, Catherine; Delepierre, Muriel] Inst Pasteur, CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Latge, JP (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Aspergillus, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	jplatge@pasteur.fr	Fontaine, Thierry/F-8227-2011; Aimanianda, Vishukumar/E-9204-2011; Fontaine, thierry/Q-2201-2018; Latge, Jean Paul/C-9846-2014	Aimanianda, Vishukumar/0000-0001-5813-7497; Fontaine, thierry/0000-0002-8184-789X; 	European Union [LSHB CT 2004-511952]	European Union(European Commission)	This work was supported in part by European Union STREP Fungwall Grant LSHB CT 2004-511952.	BATRA KK, 1969, CARBOHYD RES, V9, P221, DOI 10.1016/S0008-6215(00)82137-0; BOCK K, 1974, J CHEM SOC PERK T 2, P293, DOI 10.1039/p29740000293; BROWN JL, 1993, MOL CELL BIOL, V13, P6346, DOI 10.1128/MCB.13.10.6346; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Chelico L, 2003, MYCOLOGIA, V95, P976, DOI 10.2307/3762025; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crotti LB, 2001, ANAL BIOCHEM, V292, P8, DOI 10.1006/abio.2001.5051; DELACRUZ J, 1995, J BACTERIOL, V177, P1864, DOI 10.1128/jb.177.7.1864-1871.1995; Dijkgraaf GJP, 1996, YEAST, V12, P683, DOI 10.1002/(SICI)1097-0061(19960615)12:7<683::AID-YEA959>3.0.CO;2-8; Feldmesser M, 2000, J INFECT DIS, V182, P1791, DOI 10.1086/317614; FELIX H, 1982, ANAL BIOCHEM, V120, P211, DOI 10.1016/0003-2697(82)90340-2; FONTAINE T, 1991, ANAL BIOCHEM, V199, P154, DOI 10.1016/0003-2697(91)90083-6; Fontaine T, 2000, J BIOL CHEM, V275, P27594; GOLDSTEIN I. J., 1965, METHOD CARBOHYD CHEM, V5, P361; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Iorio E, 2008, CARBOHYD RES, V343, P1050, DOI 10.1016/j.carres.2008.02.020; KANG MS, 1986, P NATL ACAD SCI USA, V83, P5808, DOI 10.1073/pnas.83.16.5808; KAPTEYN JC, 1995, J BACTERIOL, V177, P3788, DOI 10.1128/jb.177.13.3788-3792.1995; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Lequette Y, 2007, MICROBIOL-SGM, V153, P3255, DOI 10.1099/mic.0.2007/008953-0; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Llull D, 2001, J BIOL CHEM, V276, P21053, DOI 10.1074/jbc.M010287200; LOPEZROMERO E, 1977, BIOCHIM BIOPHYS ACTA, V500, P372, DOI 10.1016/0304-4165(77)90028-9; Lussier M, 1998, P NATL ACAD SCI USA, V95, P9825, DOI 10.1073/pnas.95.17.9825; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; Magnelli P, 2002, ANAL BIOCHEM, V301, P136, DOI 10.1006/abio.2001.5473; MANNERS DJ, 1973, BIOCHEM J, V135, P31, DOI 10.1042/bj1350031; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Mio T, 1997, J BACTERIOL, V179, P2363, DOI 10.1128/jb.179.7.2363-2372.1997; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Mrsa V, 1997, YEAST, V13, P1145; Mukerjea R, 1996, CARBOHYD RES, V292, P11; Nagahashi S, 1998, J BACTERIOL, V180, P5020, DOI 10.1128/JB.180.19.5020-5029.1998; PARENTE JP, 1985, CARBOHYD RES, V141, P41, DOI 10.1016/S0008-6215(00)90753-5; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROEMER T, 1994, J CELL BIOL, V127, P567, DOI 10.1083/jcb.127.2.567; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Rubio MC, 2006, ENZYME MICROB TECH, V39, P601, DOI 10.1016/j.enzmictec.2005.11.011; SAWARDEKAR JS, 1967, ANAL CHEM, V37, P1602; Schmid F, 2006, CARBOHYD RES, V341, P365, DOI 10.1016/j.carres.2005.10.013; Sestak S, 2001, ANAL BIOCHEM, V292, P34; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Stevens DA, 2006, ANTIMICROB AGENTS CH, V50, P3160, DOI 10.1128/AAC.00563-06; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Vink E, 2004, YEAST, V21, P1121, DOI 10.1002/yea.1156; WAGNER G, 1983, J MAGN RESON, V55, P151, DOI 10.1016/0022-2364(83)90284-6; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zverlov VV, 1997, MICROBIOL-SGM, V143, P3537, DOI 10.1099/00221287-143-11-3537	58	87	90	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13401	13412		10.1074/jbc.M807667200	http://dx.doi.org/10.1074/jbc.M807667200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19279004	hybrid, Green Published			2022-12-25	WOS:000265877300016
J	Han, D; Qureshi, HY; Lu, YF; Paudel, HK				Han, Dong; Qureshi, Hamid Y.; Lu, Yifan; Paudel, Hemant K.			Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser(202) in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3-BETA; CDC2-LIKE PROTEIN-KINASE; CYCLIN-DEPENDENT PROTEIN-KINASE-5; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; ABNORMAL PHOSPHORYLATION; MASS-SPECTROMETRY; BRAIN; PATHOLOGY	In Alzheimer disease (AD), frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) and other tauopathies, tau accumulates and forms paired helical filaments (PHFs) in the brain. Tau isolated from PHFs is phosphorylated at a number of sites, migrates as similar to 60-, 64-, and 68-kDa bands on SDS-gel, and does not promote microtubule assembly. Upon dephosphorylation, the PHF-tau migrates as similar to 50-60-kDa bands on SDS-gels in a manner similar to tau that is isolated from normal brain and promotes microtubule assembly. The site(s) that inhibits microtubule assembly-promoting activity when phosphorylated in the diseased brain is not known. In this study, when tau was phosphorylated by Cdk5 in vitro, its mobility shifted from similar to 60-kDa bands to similar to 64- and 68-kDa bands in a time-dependent manner. This mobility shift correlated with phosphorylation at Ser(202), and Ser(202) phosphorylation inhibited tau microtubule-assembly promoting activity. When several tau point mutants were analyzed, G272V, P301L, V337M, and R406W mutations associated with FTDP-17, but not nonspecific mutations S214A and S262A, promoted Ser(202) phosphorylation and mobility shift to a similar to 68-kDa band. Furthermore, Ser(202) phosphorylation inhibited the microtubule assembly-promoting activity of FTDP-17 mutants more than of WT. Our data indicate that FTDP-17 missense mutations, by promoting phosphorylation at Ser(202), inhibit the microtubule assembly-promoting activity of tau in vitro, suggesting that Ser(202) phosphorylation plays a major role in the development of NFT pathology in AD and related tauopathies.	[Han, Dong; Qureshi, Hamid Y.; Lu, Yifan; Paudel, Hemant K.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer Society of Canada; National Science and Engineering Research Council of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institute for Health Research, the Alzheimer Society of Canada, and the National Science and Engineering Research Council of Canada.	Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Arima K, 2000, NEUROLOGY, V54, P1787, DOI 10.1212/WNL.54.9.1787; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; FLAMENT S, 1990, ACTA NEUROPATHOL, V80, P212, DOI 10.1007/BF00308927; FLAMENT S, 1989, FEBS LETT, V247, P213, DOI 10.1016/0014-5793(89)81337-7; GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lu PJ, 1999, NATURE, V399, P784; Mack TGA, 2001, NEUROSCIENCE, V108, P701, DOI 10.1016/S0306-4522(01)00434-1; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Mesulam M, 2004, ANN NEUROL, V55, P815, DOI 10.1002/ana.20100; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Paudel HK, 1997, J BIOL CHEM, V272, P28328, DOI 10.1074/jbc.272.45.28328; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Sahara N, 2000, J NEUROSCI RES, V60, P380, DOI 10.1002/(SICI)1097-4547(20000501)60:3<380::AID-JNR13>3.0.CO;2-5; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; Spillantini MG, 1996, ACTA NEUROPATHOL, V92, P42, DOI 10.1007/s004010050487; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Yang LS, 1997, J NEUROCHEM, V69, P1548; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200	53	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13422	13433		10.1074/jbc.M901095200	http://dx.doi.org/10.1074/jbc.M901095200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304664	Green Published, hybrid			2022-12-25	WOS:000265877300018
J	Chernov, AV; Sounni, NE; Remacle, AG; Strongin, AY				Chernov, Andrei V.; Sounni, Nor Eddine; Remacle, Albert G.; Strongin, Alex Y.			Epigenetic Control of the Invasion-promoting MT1-MMP/MMP-2/TIMP-2 Axis in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; EMBRYONIC STEM-CELLS; INTEGRIN ALPHA(V) SUBUNIT; BREAST-CARCINOMA CELLS; HISTONE H3; DEVELOPMENTAL REGULATORS; LYSINE-9 METHYLATION; TISSUE INHIBITOR; GENE-EXPRESSION; MEMBRANE	Membrane type-1 matrix metalloproteinase (MT1-MMP) is an activator of soluble MMP-2. The activity of both MMPs is regulated by their physiological inhibitor TIMP-2. An MT1-MMP/MMP-2/TIMP-2 axis plays a key role in the invasive behavior of many cell types. Despite its importance, epigenetic control of this pro-invasive axis is insufficiently studied, and, as a result, its modification in a rational and clinically beneficial manner is exceedingly difficult. Therefore, we performed an epigenetic analysis of the MT1-MMP, MMP-2, and TIMP-2 gene promoters in highly migratory glioblastoma cells and in low migratory breast carcinoma MCF-7 cells. We determined, for the first time, that the epigenetic control leading to the transcriptional silencing of both MMPs includes hypermethylation of the corresponding CpG regions and histone H3 lysine-27 trimethylation (H3K27me3). In turn, undermethylation of the CpG islands and low levels of histone H3 lysine-27 trimethylation are features of transcriptionally active MT1-MMP and MMP-2 genes in invasive cancer cells. Additional histone modifications we have analyzed, including H3ac and H3K4me2, are present in both transcriptionally active and inactive promoters of both MMPs. Histone H3 lysine-4 trimethylation is likely to play no significant role in regulating MT1-MMP and MMP-2. The pattern of epigenetic regulation of TIMP-2 was clearly distinct from that of MMPs and included the coordinated methylation and demethylation of the two CpG regions in the promoter. Our results suggest that the epigenetic control plays an important role in both the balanced regulation of the MT1-MMP/MMP-2/TIMP-2 axis and the invasive behavior in cancer cells.	[Chernov, Andrei V.; Sounni, Nor Eddine; Remacle, Albert G.; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019; Sounni, Nor Eddine/AAY-8766-2021	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418; Sounni, Nor Eddine/0000-0001-9962-9236	National Institutes of Health [CA83017, CA77470, RR020843]; Susan G. Komen Breast Cancer Foundation [BCTR123106]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017, CA77470, and RR020843. This work was also supported by Susan G. Komen Breast Cancer Foundation Grant BCTR123106 (to A. Y. S.).	Atkinson SJ, 2006, BIOCHEM J, V398, P15, DOI 10.1042/BJ20060243; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Clark IM, 2007, FRONT BIOSCI, V12, P528, DOI 10.2741/2079; Curtin M, 2003, CURR MED CHEM, V10, P2373, DOI 10.2174/0929867033456576; Deryugina EI, 1997, J CELL SCI, V110, P2473; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Aziz SHA, 2007, CANCER SCI, V98, P1330, DOI 10.1111/j.1349-7006.2007.00547.x; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Golubkov VS, 2005, J BIOL CHEM, V280, P42237, DOI 10.1074/jbc.M510139200; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noel A, 2004, J CLIN PATHOL, V57, P577, DOI 10.1136/jcp.2003.014472; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Rozen S, 2000, Methods Mol Biol, V132, P365; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	45	90	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12727	12734		10.1074/jbc.M900273200	http://dx.doi.org/10.1074/jbc.M900273200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286653	Green Published, hybrid			2022-12-25	WOS:000265688300017
J	LaChapelle, S; Tweten, RK; Hotze, EM				LaChapelle, Stephanie; Tweten, Rodney K.; Hotze, Eileen M.			Intermedilysin-Receptor Interactions during Assembly of the Pore Complex ASSEMBLY INTERMEDIATES INCREASE HOST CELL SUSCEPTIBILITY TO COMPLEMENT-MEDIATED LYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; STREPTOCOCCUS-INTERMEDIUS; PERFRINGOLYSIN-O; CONFORMATIONAL-CHANGES; HUMAN CD59; MEMBRANE; TOXIN; BINDING; C5B-9; MECHANISM	Intermedilysin (ILY) is an unusual member of the family of cholesterol-dependent cytolysins because it binds to human CD59 (hCD59) rather than directly to cholesterol-rich membranes. Binding of ILY to hCD59 initiates a series of conformational changes within the toxin that result in the conversion of the soluble monomer into an oligomeric membrane-embedded pore complex. In this study the association of ILY with its membrane receptor has been examined throughout the assembly and formation of the pore complex. Using ILY mutants trapped at various stages of pore assembly, we show ILY remains engaged with hCD59 throughout the assembly of the prepore oligomer, but it disengages from the receptor upon the conversion to the pore complex. We further show that the assembly intermediates increase the sensitivity of the host cell to lysis by its complement membrane attack complex, apparently by blocking the hCD59-binding site for complement proteins C8 alpha and C9.	[LaChapelle, Stephanie; Tweten, Rodney K.; Hotze, Eileen M.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Hotze, EM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, 940 Stanton L Young Blvd,BMSB 1053, Oklahoma City, OK 73190 USA.	eileen-hotze@ouhsc.edu			National Institutes of Health [P20 RR015564-08, AI063444]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015564-08 (to E. M. H.) and AI063444 (to R. K. T.) from NIAID.	BOULNOIS GJ, 1992, J GEN MICROBIOL, V138, P249, DOI 10.1099/00221287-138-2-249; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; Brooke JS, 1998, BIOCHEM BIOPH RES CO, V248, P297, DOI 10.1006/bbrc.1998.8953; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Farkas I, 2002, J PHYSIOL-LONDON, V539, P537, DOI 10.1113/jphysiol.2001.013381; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; HAMILTON KK, 1990, BLOOD, V76, P2572; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hotze E, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P23; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Huang YX, 2005, J BIOL CHEM, V280, P34073, DOI 10.1074/jbc.M504922200; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Macey MG, 2001, INFECT IMMUN, V69, P6102, DOI 10.1128/IAI.69.10.6102-6109.2001; Nagamune H, 1996, INFECT IMMUN, V64, P3093, DOI 10.1128/IAI.64.8.3093-3100.1996; Nagamune H, 2000, J CLIN MICROBIOL, V38, P220; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Otabor I, 2004, MOL IMMUNOL, V41, P185, DOI 10.1016/j.molimm.2004.03.029; Pecharki D, 2008, ORAL MICROBIOL IMMUN, V23, P79, DOI 10.1111/j.1399-302X.2007.00395.x; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; ZHAO J, 1991, J BIOL CHEM, V266, P13418	36	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12719	12726		10.1074/jbc.M900772200	http://dx.doi.org/10.1074/jbc.M900772200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19293153	Green Published, hybrid			2022-12-25	WOS:000265688300016
J	Holdensen, AN; Andersen, JP				Holdensen, Anne Nyholm; Andersen, Jens Peter			The Length of the A-M3 Linker Is a Crucial Determinant of the Rate of the Ca2+ Transport Cycle of Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL CONSEQUENCES; STRUCTURAL BASIS; CALCIUM-TRANSPORT; DOMAIN; CA-2+-ATPASE; SITE; DEPHOSPHORYLATION; GLUTAMATE-183; EFFICIENCY; MUTATIONS	Ion translocation by the sarcoplasmic reticulum Ca2+-ATPase depends on large movements of the A-domain, but the driving forces have yet to be defined. The A-domain is connected to the ion-binding membranous part of the protein through linker regions. We have determined the functional consequences of changing the length of the linker between the A-domain and transmembrane helix M3 ("A-M3 linker") by insertion and deletion mutagenesis at two sites. It was feasible to insert as many as 41 residues (polyglycine and glycine-proline loops) in the flexible region of the linker without loss of the ability to react with Ca2+ and ATP and to form the phosphorylated Ca(2)E1P intermediate, but the rate of the energy-transducing conformational transition to E2P was reduced by >80%. Insertion of a smaller number of residues gave effects gradually increasing with the length of the insertion. Deletion of two residues at the same site, but not replacement with glycine, gave a similar reduction as the longest insertion. Insertion of one or three residues in another part of the A-M3 linker that forms an alpha-helix ("A3 helix") in E2/E2P conformations had even more profound effects on the ability of the enzyme to form E2P. These results demonstrate the importance of the length of the A-M3 linker and of the position and integrity of the A3 helix for stabilization of E2P and suggest that, during the normal enzyme cycle, strain of the A-M3 linker could contribute to destabilize the Ca(2)E1P state and thereby to drive the transition to E2P.	[Holdensen, Anne Nyholm; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark	Aarhus University; Danmarks Grundforskningsfond	Andersen, JP (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Bldg 1180,Ole Worms Alle 6, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Danish National Research Foundation-PUMPKIN	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation-PUMPKIN(Danmarks Grundforskningsfond)	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Denmark), the Lundbeck Foundation (Denmark) ( to A. N. H.), and the Danish National Research Foundation- PUMPKIN.	Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FORGE V, 1993, J BIOL CHEM, V268, P10953; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HASSELBACH W, 1963, BIOCHEM Z, V339, P94; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 2009, BIOCH BIOPH IN PRESS; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WEBER K, 1969, J BIOL CHEM, V244, P4406	32	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12258	12265		10.1074/jbc.M900977200	http://dx.doi.org/10.1074/jbc.M900977200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19278994	Green Published, hybrid			2022-12-25	WOS:000265494600057
J	Chen, LC; Liu, HP; Li, HP; Hsueh, C; Yu, JS; Liang, CL; Chang, YS				Chen, L-C; Liu, H-P; Li, H-P; Hsueh, C.; Yu, J-S; Liang, C-L; Chang, Y-S			Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells	ONCOGENE			English	Article						hnRNP K; thymidine phosphorylase; ERK signaling; nasopharyngeal carcinoma	NUCLEAR RIBONUCLEOPROTEIN-K; HYPOXIA-INDUCED APOPTOSIS; ENDOTHELIAL GROWTH-FACTOR; BINDING-PROTEIN; IN-VITRO; TRANSLATION; EXPRESSION; CANCER; METASTASIS; ACTIVATION	The cytoplasmic level of heterogeneous nuclear ribonucleoprotein K (hnRNP K) is significantly correlated with the elevated expression of thymidine phosphorylase (TP), and high levels of both proteins are predictive of a poor prognosis in nasopharyngeal carcinoma (NPC). We herein show that TP is highly induced by serum deprivation in NPC cells, and that this is due to an increase in the half-life of the TP mRNA, as shown by nuclear run-on and actinomycin D assays. We further show that the CU-rich element of the TP mRNA directly interacts with hnRNP K, as demonstrated by immunoprecipitation RT-PCR assays, and the nucleus-to-cytoplasm translocation of hnRNP K. Blockade of hnRNP K expression reduces TP expression, suggesting that hnRNP K acts in the upregulation of TP. Mechanistically, both MEK inhibitor and the hnRNP K ERK-phosphoacceptor-site mutant decrease cytoplasmic accumulation of hnRNP K, suggesting that ERK-dependent phosphorylation is critical for TP induction. Furthermore, we found that hnRNP K-mediated TP induction allows NPC cells to resist hypoxia-induced apoptosis. Our results collectively establish the regulation and role of ERK-mediated cytoplasmic accumulation of hnRNP K as an upstream modulator of TP, suggesting that hnRNP K may be an attractive candidate as a future therapeutic target for cancer.	[Chen, L-C; Liu, H-P; Hsueh, C.; Yu, J-S; Chang, Y-S] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan 333, Taiwan; [Li, H-P; Yu, J-S; Chang, Y-S] Chang Gung Univ, Grad Inst Basic Med Sci, Tao Yuan 333, Taiwan; [Hsueh, C.] Chang Gung Mem Hosp Lin Kou, Dept Pathol, Tao Yuan, Taiwan; [Liang, C-L] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chung Shan Medical University	Chang, YS (corresponding author), Chang Gung Univ, Chang Gung Mol Med Res Ctr, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	ysc@mail.cgu.edu.tw	Liu, Hao-Ping/AAJ-3038-2020; Li, Hsin-Pai/C-7305-2014	Liu, Hao-Ping/0000-0001-5915-5128; Hsueh, Chuen/0000-0001-7860-5964; Chang, Yu-Sun/0000-0002-6457-3890; Yu, Jau-Song/0000-0002-4295-983X	Ministry of Education, Taiwan (to Chang Gung University); National Science Council, Taiwan [NSC 94-2314-B-182A-188, 94-3112-B-182-005, 95-2320-B-182-001]; Chang Gung Memorial Hospital, Taiwan [CMRPD150961, CMRPG360221]	Ministry of Education, Taiwan (to Chang Gung University)(Ministry of Education, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	Grant support was provided by the Ministry of Education, Taiwan (to Chang Gung University), the National Science Council, Taiwan (grants NSC 94-2314-B-182A-188, 94-3112-B-182-005 and 95-2320-B-182-001 to Y-S Chang) and Chang Gung Memorial Hospital, Taiwan (grants CMRPD150961 and CMRPG360221 to Y-S Chang). Special thanks to Chung Shan Medical University for supporting CL Liang to attend the 12th International EBV Symposium.	Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Goto H, 2001, CANCER RES, V61, P469; Griffiths L, 1997, CANCER RES, V57, P570; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hatakeyama H, 2006, PROTEOMICS, V6, P6300, DOI 10.1002/pmic.200600488; Ikeda R, 2006, BIOCHEM BIOPH RES CO, V342, P280, DOI 10.1016/j.bbrc.2006.01.142; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kim E, 2006, FEBS J, V273, P793, DOI 10.1111/j.1742-4658.2006.05112.x; Kitazono M, 1998, BIOCHEM BIOPH RES CO, V253, P797, DOI 10.1006/bbrc.1998.9852; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Liekens S, 2007, BIOCHEM PHARMACOL, V74, P1555, DOI 10.1016/j.bcp.2007.05.008; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Schwartz EL, 1998, CANCER RES, V58, P1551; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Tse KP, 2007, CLIN CANCER RES, V13, P6320, DOI 10.1158/1078-0432.CCR-07-1029; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Wang SB, 2006, NUCLEIC ACIDS RES, V34, P3044, DOI 10.1093/nar/gkl386; Yao YX, 2005, J NEURO-ONCOL, V72, P217, DOI 10.1007/s11060-004-3012-4; Zhu GH, 2002, ONCOGENE, V21, P8477, DOI 10.1038/sj.onc.1206030	35	46	47	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2009	28	17					1904	1915		10.1038/onc.2009.55	http://dx.doi.org/10.1038/onc.2009.55			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PX	19330019				2022-12-25	WOS:000265640600003
J	Di Pasquale, E; Chahinian, H; Sanchez, P; Fantini, J				Di Pasquale, Eric; Chahinian, Henri; Sanchez, Patrick; Fantini, Jacques			The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol-Dependent	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CANNABINOID RECEPTORS; RAFTS; ACID; SPHINGOSINE; HYDROLYSIS; MONOLAYERS; CELLS	Background: Anandamide is a lipid neurotransmitter which belongs to a class of molecules termed the endocannabinoids involved in multiple physiological functions. Anandamide is readily taken up into cells, but there is considerable controversy as to the nature of this transport process (passive diffusion through the lipid bilayer vs. involvement of putative proteic transporters). This issue is of major importance since anandamide transport through the plasma membrane is crucial for its biological activity and intracellular degradation. The aim of the present study was to evaluate the involvement of cholesterol in membrane uptake and transport of anandamide. Methodology/Principal Findings: Molecular modeling simulations suggested that anandamide can adopt a shape that is remarkably complementary to cholesterol. Physicochemical studies showed that in the nanomolar concentration range, anandamide strongly interacted with cholesterol monolayers at the air-water interface. The specificity of this interaction was assessed by: i) the lack of activity of structurally related unsaturated fatty acids (oleic acid and arachidonic acid at 50 nM) on cholesterol monolayers, and ii) the weak insertion of anandamide into phosphatidylcholine or sphingomyelin monolayers. In agreement with these data, the presence of cholesterol in reconstituted planar lipid bilayers triggered the stable insertion of anandamide detected as an increase in bilayer capacitance. Kinetics transport studies showed that pure phosphatidylcholine bilayers were weakly permeable to anandamide. The incorporation of cholesterol in phosphatidylcholine bilayers dose-dependently stimulated the translocation of anandamide. Conclusions/Significance: Our results demonstrate that cholesterol stimulates both the insertion of anandamide into synthetic lipid monolayers and bilayers, and its transport across bilayer membranes. In this respect, we suggest that besides putative anandamide protein-transporters, cholesterol could be an important component of the anandamide transport machinery. Finally, this study provides a mechanistic explanation for the key regulatory activity played by membrane cholesterol in the responsiveness of cells to anandamide.	[Di Pasquale, Eric; Chahinian, Henri; Sanchez, Patrick; Fantini, Jacques] Univ Aix Marseille 2, Ctr Rech Neurobiol & Neurophysiol Marseille,CNRS, Fac Sci St Jerome, Univ Aix Marseille 3,UMR 6231,INRA,USC 2027, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Aix-Marseille Universite	Di Pasquale, E (corresponding author), Univ Aix Marseille 2, Ctr Rech Neurobiol & Neurophysiol Marseille,CNRS, Fac Sci St Jerome, Univ Aix Marseille 3,UMR 6231,INRA,USC 2027, F-13284 Marseille 07, France.	jacques.fantini@univ-cezanne.fr		Fantini, Jacques/0000-0001-8653-5521	University Paul Cezanne; Centre National de la Recherche Scientifique (CNRS); Institut National du Cancer (INCA)	University Paul Cezanne; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France)	This work has been supported by academic funds from University Paul Cezanne, the Centre National de la Recherche Scientifique (CNRS) and a grant (FAN-BCL) from the Institut National du Cancer (INCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Ambrosi S, 2005, J LIPID RES, V46, P1953, DOI 10.1194/jlr.M500121-JLR200; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Biswas KK, 2003, HEPATOLOGY, V38, P1167, DOI 10.1053/jhep.2003.50459; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Garmy N, 2005, ARCH BIOCHEM BIOPHYS, V440, P91, DOI 10.1016/j.abb.2005.06.001; Garmy N, 2005, J LIPID RES, V46, P36, DOI 10.1194/jlr.M400199-JLR200; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; HARRIS JS, 1995, BIOCHEMISTRY-US, V34, P3851, DOI 10.1021/bi00011a043; Jarho P, 1996, LIFE SCI, V58, pPL181; MAKRIYANNIS A, 1995, CANNABINOID RECEPTOR, P87; McFarland MJ, 2004, J BIOL CHEM, V279, P41991, DOI 10.1074/jbc.M407250200; Mechoulam R, 2005, P NATL ACAD SCI USA, V102, P17541, DOI 10.1073/pnas.0508644102; NAKANISHI K, 1989, CHEM PHARM BULL, V37, P211; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; ROSE IA, 1980, P NATL ACAD SCI-BIOL, V77, P2439, DOI 10.1073/pnas.77.5.2439; Sarker KP, 2003, CELL MOL LIFE SCI, V60, P1200, DOI 10.1007/s00018-003-3055-2; Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667; Song ZH, 1996, MOL PHARMACOL, V49, P891; Tian X., 2000, J BIOL CHEM, V280, P29788; Tien H.T., 1974, BILAYER LIPID MEMBRA; van Zadelhoff G, 1998, BIOCHEM BIOPH RES CO, V248, P33, DOI 10.1006/bbrc.1998.8910; Vargas J, 2000, BIOPHYS J, V79, P934, DOI 10.1016/S0006-3495(00)76348-X	34	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e4989	10.1371/journal.pone.0004989	http://dx.doi.org/10.1371/journal.pone.0004989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330032	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499700002
J	Bretteville, A; Ando, K; Ghestem, A; Loyens, A; Begard, S; Beauvillain, JC; Sergeant, N; Hamdane, M; Buee, L				Bretteville, Alexis; Ando, Kunie; Ghestem, Antoine; Loyens, Anne; Begard, Severine; Beauvillain, Jean-Claude; Sergeant, Nicolas; Hamdane, Malika; Buee, Luc			Two-Dimensional Electrophoresis of Tau Mutants Reveals Specific Phosphorylation Pattern Likely Linked to Early Tau Conformational Changes	PLOS ONE			English	Article								The role of Tau phosphorylation in neurofibrillary degeneration linked to Alzheimer's disease remains to be established. While transgenic mice based on FTDP-17 Tau mutations recapitulate hallmarks of neurofibrillary degeneration, cell models could be helpful for exploratory studies on molecular mechanisms underlying Tau pathology. Here, "human neuronal cell lines'' overexpressing Wild Type or mutated Tau were established. Two-dimensional electrophoresis highlights that mutated Tau displayed a specific phosphorylation pattern, which occurs in parallel to the formation of Tau clusters as visualized by electron microscopy. In fact, this pattern is also displayed before Tau pathology onset in a well established mouse model relevant to Tau aggregation in Alzheimer's disease. This study suggests first that pathological Tau mutations may change the distribution of phosphate groups. Secondly, it is possible that this molecular event could be one of the first Tau modifications in the neurofibrillary degenerative process, as this phenomenon appears prior to Tau pathology in an in vivo model and is linked to early steps of Tau nucleation in Tau mutants cell lines. Such cell lines consist in suitable and evolving models to investigate additional factors involved in molecular pathways leading to whole Tau aggregation.	[Bretteville, Alexis; Ando, Kunie; Ghestem, Antoine; Loyens, Anne; Begard, Severine; Beauvillain, Jean-Claude; Sergeant, Nicolas; Hamdane, Malika; Buee, Luc] INSERM, U837, F-59045 Lille, France; [Bretteville, Alexis; Ando, Kunie; Ghestem, Antoine; Loyens, Anne; Begard, Severine; Beauvillain, Jean-Claude; Sergeant, Nicolas; Hamdane, Malika; Buee, Luc] Univ Lille 2, Fac Med, Jean Pierre Aubert Res Ctr, Inst Med Predict Rech Therapeut, F-59800 Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bretteville, A (corresponding author), INSERM, U837, F-59045 Lille, France.	luc.buee@inserm.fr	BUEE, Luc/B-3126-2010; Sergeant, Nicolas/O-5467-2017	BUEE, Luc/0000-0002-6261-4230; Sergeant, Nicolas/0000-0003-1448-124X; Hamdane, Malika/0000-0001-7971-8696; Ando, Kunie/0000-0003-3822-175X	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante Et de la Recherche Medicale (Inserm); University of Lille 2; European Community [LSHM-CT-2003-503330, LSHM-CT-2007-037950, 200611]; Federation pour la Recherche sur le Cerveau (FRC); Gis Longevite; F.E.D.E.R; Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais; French Foreign Affairs Ministry	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante Et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Lille 2; European Community(European Commission); Federation pour la Recherche sur le Cerveau (FRC); Gis Longevite; F.E.D.E.R(European Commission); Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais(Region Hauts-de-France); French Foreign Affairs Ministry	These studies were supported by Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante Et de la Recherche Medicale (Inserm), University of Lille 2, the European Community (APOPIS LSHM-CT-2003-503330, and cNEUPRO LSHM-CT-2007-037950 and MEMOSAD FP7 grant agreement 200611), Federation pour la Recherche sur le Cerveau (FRC), the Gis Longevite and the F.E.D.E.R.. A. Bretteville and K. Ando are recipients of a scholarship from Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais and French Foreign Affairs Ministry respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BILLINGS PC, 1979, NUCLEIC ACIDS RES, V6, P2151, DOI 10.1093/nar/6.6.2151; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; Delobel P, 2003, ANN NY ACAD SCI, V1010, P623, DOI 10.1196/annals.1299.115; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Gotz J, 2006, MED J AUSTRALIA, V185, P381, DOI 10.5694/j.1326-5377.2006.tb00615.x; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Hamdane M, 2006, MOL CELL NEUROSCI, V32, P155, DOI 10.1016/j.mcn.2006.03.006; Hanger DP, 2002, FEBS LETT, V531, P538, DOI 10.1016/S0014-5793(02)03611-6; Iliev AI, 2006, J BIOL CHEM, V281, P37195, DOI 10.1074/jbc.M604863200; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Ko LW, 2005, BBA-MOL BASIS DIS, V1739, P125, DOI 10.1016/j.bbadis.2004.09.004; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; Mailliot C, 2000, J CEREBR BLOOD F MET, V20, P543, DOI 10.1097/00004647-200003000-00013; Perez M, 2002, EUR J BIOCHEM, V269, P1484, DOI 10.1046/j.1432-1033.2002.02794.x; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200	25	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4843	10.1371/journal.pone.0004843	http://dx.doi.org/10.1371/journal.pone.0004843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290042	Green Submitted, gold, Green Published			2022-12-25	WOS:000265496500003
J	Tsuji, T; Miyoshi, T; Higashida, C; Narumiya, S; Watanabe, N				Tsuji, Takahiro; Miyoshi, Takushi; Higashida, Chiharu; Narumiya, Shuh; Watanabe, Naoki			An Order of Magnitude Faster AIP1-Associated Actin Disruption than Nucleation by the Arp2/3 Complex in Lamellipodia	PLOS ONE			English	Article								The mechanism of lamellipod actin turnover is still under debate. To clarify the intracellular behavior of the recently-identified actin disruption mechanism, we examined kinetics of AIP1 using fluorescent single-molecule speckle microscopy. AIP1 is thought to cap cofilin-generated actin barbed ends. Here we demonstrate a reduction in actin-associated AIP1 in lamellipodia of cells overexpressing LIM-kinase. Moreover, actin-associated AIP1 was rapidly abolished by jasplakinolide, which concurrently blocked the F-actin-cofilin interaction. Jasplakinolide also slowed dissociation of AIP1, which is analogous to the effect of this drug on capping protein. These findings provide in vivo evidence of the association of AIP1 with barbed ends generated by cofilin-catalyzed filament disruption. Single-molecule observation found distribution of F-actin-associated AIP1 throughout lamellipodia, and revealed even faster dissociation of AIP1 than capping protein. The estimated overall AIP1-associated actin disruption rate, 1.8 mu M/s, was one order of magnitude faster than Arp2/3 complex-catalyzed actin nucleation in lamellipodia. This rate does not suffice the filament severing rate predicted in our previous high frequency filament severing-annealing hypothesis. Our data together with recent biochemical studies imply barbed end-preferred frequent filament disruption. Frequent generation of AIP1-associated barbed ends and subsequent release of AIP1 may be the mechanism that facilitates previously observed ubiquitous actin polymerization throughout lamellipodia.	[Tsuji, Takahiro; Miyoshi, Takushi; Higashida, Chiharu; Narumiya, Shuh; Watanabe, Naoki] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan	Kyoto University	Tsuji, T (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	naoki-w@mfour.med.kyoto-u.ac.jp	TSUJI, Takahiro/AAP-7549-2020	Tsuji, Takahiro/0000-0002-5706-8300	Ministry of Education, Culture, Sport, Science and Technology of Japan [19390075]; Uehara Memorial Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work is supported in part by a Grant-in-Aid for Scientific Research (19390075) from the Ministry of Education, Culture, Sport, Science and Technology of Japan and by Special Project Research Grant (Systems biology) from Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Aizawa H, 1999, GENES CELLS, V4, P311, DOI 10.1046/j.1365-2443.1999.00262.x; Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Carlsson AE, 2004, BIOPHYS J, V86, P1074, DOI 10.1016/S0006-3495(04)74182-X; CASEY P, 1994, PROG PALLIAT CARE, V2, P1; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Clark MG, 2007, GENETICS, V176, P1527, DOI 10.1534/genetics.107.072066; Dawes AT, 2006, J THEOR BIOL, V242, P265, DOI 10.1016/j.jtbi.2006.02.017; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Iida K, 1999, GENES CELLS, V4, P21, DOI 10.1046/j.1365-2443.1999.00235.x; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Liu HX, 2008, NEUROSCI LETT, V448, P67, DOI 10.1016/j.neulet.2008.09.084; Maciver SK, 1998, CURR OPIN CELL BIOL, V10, P140, DOI 10.1016/S0955-0674(98)80097-5; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mohri K, 2003, J CELL SCI, V116, P4107, DOI 10.1242/jcs.00717; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 2001, J CELL BIOL, V152, P1313, DOI 10.1083/jcb.152.6.1313; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tardy Y, 1995, BIOPHYS J, V69, P1674, DOI 10.1016/S0006-3495(95)80085-8; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; TILNEY LG, 1992, J CELL BIOL, V118, P71, DOI 10.1083/jcb.118.1.71; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	55	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4921	10.1371/journal.pone.0004921	http://dx.doi.org/10.1371/journal.pone.0004921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290054	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496500015
J	Matsumoto, K; Isagawa, T; Nishimura, T; Ogaeri, T; Eto, K; Miyazaki, S; Miyazaki, J; Aburatani, H; Nakauchi, H; Ema, H				Matsumoto, Kenji; Isagawa, Takayuki; Nishimura, Toshinobu; Ogaeri, Takunori; Eto, Koji; Miyazaki, Satsuki; Miyazaki, Jun-ichi; Aburatani, Hiroyuki; Nakauchi, Hiromitsu; Ema, Hideo			Stepwise Development of Hematopoietic Stem Cells from Embryonic Stem Cells	PLOS ONE			English	Article							YOLK-SAC; DEFINITIVE HEMATOPOIESIS; COMMON PRECURSOR; CD34 EXPRESSION; IN-VITRO; LIVER; FETAL; DIFFERENTIATION; HEMANGIOBLAST; PURIFICATION	The cellular ontogeny of hematopoietic stem cells (HSCs) remains poorly understood because their isolation from and their identification in early developing small embryos are difficult. We attempted to dissect early developmental stages of HSCs using an in vitro mouse embryonic stem cell (ESC) differentiation system combined with inducible HOXB4 expression. Here we report the identification of pre-HSCs and an embryonic type of HSCs (embryonic HSCs) as intermediate cells between ESCs and HSCs. Both pre-HSCs and embryonic HSCs were isolated by their c-Kit+ CD41+ CD45 2 phenotype. Pre-HSCs did not engraft in irradiated adult mice. After co-culture with OP9 stromal cells and conditional expression of HOXB4, pre-HSCs gave rise to embryonic HSCs capable of engraftment and long-term reconstitution in irradiated adult mice. Blast colony assays revealed that most hemangioblast activity was detected apart from the pre-HSC population, implying the early divergence of pre-HSCs from hemangioblasts. Gene expression profiling suggests that a particular set of transcripts closely associated with adult HSCs is involved in the transition of pre-HSC to embryonic HSCs. We propose an HSC developmental model in which pre-HSCs and embryonic HSCs sequentially give rise to adult types of HSCs in a stepwise manner.	[Matsumoto, Kenji; Nishimura, Toshinobu; Ogaeri, Takunori; Eto, Koji; Nakauchi, Hiromitsu; Ema, Hideo] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan; [Isagawa, Takayuki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Advanced Sci & Technol, Genome Sci Div, Tokyo, Japan; [Miyazaki, Satsuki; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 565, Japan	University of Tokyo; University of Tokyo; Osaka University	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan.	nakauchi@ims.u-tokyo.ac.jp; hema@ims.u-tokyo.ac.jp	Nishimura, Toshinobu/AAZ-7675-2021; Miyazaki, Jun-ichi/N-1976-2015	Nishimura, Toshinobu/0000-0002-5425-1708; Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590	Ministry of Education, Culture, Sport, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21390321] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sport, Science, and Technology, Japan. These grants have no financial interests, and played no role in study and preparation of the manuscript.	Abkowitz JL, 2007, BLOOD, V109, P5186, DOI 10.1182/blood-2006-08-044503; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fujimoto T, 2001, GENES CELLS, V6, P1113, DOI 10.1046/j.1365-2443.2001.00490.x; Furuta C, 2006, DEVELOPMENT, V133, P2771, DOI 10.1242/dev.02440; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacaud G, 2001, ANN NY ACAD SCI, V938, P96; LACAUD G, 2001, ANN NY ACAD SCI, V938, P108; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; McKinney-Freeman SL, 2008, BLOOD, V111, P4944, DOI 10.1182/blood-2007-11-124644; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Mizuguchi H, 2002, J GENE MED, V4, P240, DOI 10.1002/jgm.261; MOORE MAS, 2004, HDB STEM CELLS, P159; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nobuhisa I, 2007, EXP CELL RES, V313, P965, DOI 10.1016/j.yexcr.2006.12.024; OKADA S, 1991, BLOOD, V78, P1706; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; SMITH RA, 1982, DEV COMP IMMUNOL, V6, P359, DOI 10.1016/S0145-305X(82)80019-0; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	47	35	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4820	10.1371/journal.pone.0004820	http://dx.doi.org/10.1371/journal.pone.0004820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287487	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496400002
J	Opresko, PL; Sowd, G; Wang, H				Opresko, Patricia L.; Sowd, Gregory; Wang, Hong			The Werner Syndrome Helicase/Exonuclease Processes Mobile D-Loops through Branch Migration and Degradation	PLOS ONE			English	Article							SYNDROME PROTEIN WRN; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; RECQ HELICASES; SUBSTRATE-SPECIFICITY; MAMMALIAN TELOMERES; HOLLIDAY JUNCTIONS; DNA; MECHANISM; BLM	RecQ DNA helicases are critical for preserving genome integrity. Of the five RecQ family members identified in humans, only the Werner syndrome protein (WRN) possesses exonuclease activity. Loss of WRN causes the progeroid disorder Werner syndrome which is marked by cancer predisposition. Cellular evidence indicates that WRN disrupts potentially deleterious intermediates in homologous recombination (HR) that arise in genomic and telomeric regions during DNA replication and repair. Precisely how the WRN biochemical activities process these structures is unknown, especially since the DNA unwinding activity is poorly processive. We generated biologically relevant mobile D-loops which mimic the initial DNA strand invasion step in HR to investigate whether WRN biochemical activities can disrupt this joint molecule. We show that WRN helicase alone can promote branch migration through an 84 base pair duplex region to completely displace the invading strand from the D-loop. However, substrate processing is altered in the presence of the WRN exonuclease activity which degrades the invading strand both prior to and after release from the D-loop. Furthermore, telomeric D-loops are more refractory to disruption by WRN, which has implications for tighter regulation of D-loop processing at telomeres. Finally, we show that WRN can recognize and initiate branch migration from both the 59 and 39 ends of the invading strand in the D-loops. These findings led us to propose a novel model for WRN D-loop disruption. Our biochemical results offer an explanation for the cellular studies that indicate both WRN activities function in processing HR intermediates.	[Opresko, Patricia L.; Sowd, Gregory] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Wang, Hong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wang, Hong] Univ Pittsburgh, Canc Inst, Hillman Canc Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Opresko, PL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	plo4@pitt.edu	Wang, Hong/F-3164-2014	Wang, Hong/0000-0003-0165-3559; Opresko, Patricia/0000-0002-6470-2189	NIH [ES0515052]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015052, R00ES016758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH grant ES0515052 (P.L.O.) and the Ellison Medical Foundation (P.L.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Choi JM, 2007, J BIOL CHEM, V282, P9941, DOI 10.1074/jbc.M609657200; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Driscoll HC, 2003, J BIOL CHEM, V278, P41126, DOI 10.1074/jbc.M304798200; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hile SE, 2000, CANCER RES, V60, P1698; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-6; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Ozsoy AZ, 2003, NUCLEIC ACIDS RES, V31, P1554, DOI 10.1093/nar/gkg243; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Tarsounas M, 2005, CELL CYCLE, V4, P672, DOI 10.4161/cc.4.5.1689; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	62	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4825	10.1371/journal.pone.0004825	http://dx.doi.org/10.1371/journal.pone.0004825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283071	Green Published, gold, Green Accepted			2022-12-25	WOS:000265496300007
J	Butcher, AJ; Torrecilla, I; Young, KW; Kong, KC; Mistry, SC; Bottrill, AR; Tobin, AB				Butcher, Adrian J.; Torrecilla, Ignacio; Young, Kenneth W.; Kong, Kok Choi; Mistry, Sharad C.; Bottrill, Andrew R.; Tobin, Andrew B.			N-Methyl-D-aspartate Receptors Mediate the Phosphorylation and Desensitization of Muscarinic Receptors in Cerebellar Granule Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; SH-SY5Y NEUROBLASTOMA-CELLS; INOSITOL 1,4,5-TRISPHOSPHATE; COUPLED RECEPTORS; RAPID DESENSITIZATION; SYNAPTIC PLASTICITY; NMDA RECEPTORS; CA1 REGION; HIPPOCAMPUS	Changes in synaptic strength mediated by ionotropic glutamate N-methyl-D-asparate (NMDA) receptors is generally considered to be the molecular mechanism underlying memory and learning. NMDA receptors themselves are subject to regulation through signaling pathways that are activated by G-proteincoupled receptors (GPCRs). In this study we investigate the ability of NMDA receptors to regulate the signaling of GPCRs by focusing on the G(q/11)-coupled M-3-muscarinic receptor expressed endogenously in mouse cerebellar granule neurons. We show that NMDA receptor activation results in the phosphorylation and desensitization of M-3-muscarinic receptors through a mechanism dependent on NMDA-mediated calcium influx and the activity of calcium-calmodulin-dependent protein kinase II. Our study reveals a complex pattern of regulation where GPCRs (M-3-muscarinic) and NMDA receptors can feedback on each other in a process that is likely to influence the threshold value of signaling networks involved in synaptic plasticity.	[Butcher, Adrian J.; Torrecilla, Ignacio; Kong, Kok Choi; Tobin, Andrew B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Mistry, Sharad C.; Bottrill, Andrew R.] Univ Leicester, Prot & Nucle Acid Chem Lab, Leicester LE1 9HN, Leics, England; [Young, Kenneth W.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@le.ac.uk	Bottrill, Andrew/ABD-1459-2021; Bottrill, Andrew/C-6367-2013	Bottrill, Andrew/0000-0002-5182-3643; Bottrill, Andrew/0000-0002-5182-3643; Torrecilla, Ignacio/0000-0003-4283-0283	Wellcome Trust [047600]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by Wellcome Trust Grant 047600.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Budd DC, 2001, J BIOL CHEM, V276, P4581, DOI 10.1074/jbc.M008827200; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; DeBock F, 2003, EUR J NEUROSCI, V17, P1411, DOI 10.1046/j.1460-9568.2003.02544.x; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Grishin AA, 2005, NEUROPHARMACOLOGY, V49, P328, DOI 10.1016/j.neuropharm.2005.03.019; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Leist M, 1997, MOL MED, V3, P750, DOI 10.1007/BF03401713; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; MacDonald JF, 2007, BBA-BIOMEMBRANES, V1768, P941, DOI 10.1016/j.bbamem.2006.12.006; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McCutchen E, 2006, J NEUROPHYSIOL, V96, P3114, DOI 10.1152/jn.00144.2006; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nguyen PV, 2001, TRENDS NEUROSCI, V24, P314, DOI 10.1016/S0166-2236(00)01872-5; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Okubo Y, 2001, NEURON, V32, P113, DOI 10.1016/S0896-6273(01)00464-0; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Semba K, 1997, J NEUROCHEM, V69, P1066; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; TOBIN AB, 1993, FEBS LETT, V335, P353, DOI 10.1016/0014-5793(93)80418-T; TOBIN AB, 1992, MOL PHARMACOL, V42, P1042; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; van Koppen CJ, 2003, PHARMACOL THERAPEUT, V98, P197, DOI 10.1016/S0163-7258(03)00032-9; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; Willets JM, 2002, J BIOL CHEM, V277, P15523, DOI 10.1074/jbc.M111217200; WOJCIKIEWICZ RJH, 1994, J NEUROCHEM, V63, P177; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Young KW, 2004, J NEUROCHEM, V89, P1537, DOI 10.1111/j.1471-4159.2004.02458.x	47	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17147	17156		10.1074/jbc.M901031200	http://dx.doi.org/10.1074/jbc.M901031200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19332541	hybrid, Green Published			2022-12-25	WOS:000266962400053
J	Garza, RM; Sato, BK; Hampton, RY				Garza, Renee M.; Sato, Brian K.; Hampton, Randolph Y.			In Vitro Analysis of Hrd1p-mediated Retrotranslocation of Its Multispanning Membrane Substrate 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM MEMBRANE; HMG-COA REDUCTASE; UBIQUITIN-PROTEASOME PATHWAY; PROTEIN-DEGRADATION; MISFOLDED PROTEINS; QUALITY-CONTROL; REGULATED DEGRADATION; RETRO-TRANSLOCATION; STEROL REGULATION	Endoplasmic reticulum (ER)-associated degradation (ERAD) is responsible for the ubiquitin-mediated destruction of both misfolded and normal ER-resident proteins. ERAD substrates must be moved from the ER to the cytoplasm for ubiquitination and proteasomal destruction by a process called retrotranslocation. Many aspects of retrotranslocation are poorly understood, including its generality, the cellular components required, the energetics, and the mechanism of transfer through the ER membrane. To address these questions, we have developed an in vitro assay, using the 8-transmembrane span ER-resident Hmg2p isozyme of HMG-CoA reductase fused to GFP, which undergoes regulated ERAD mediated by the Hrd1p ubiquitin ligase. We have now directly demonstrated in vitro retrotranslocation of full-length, ubiquitinated Hmg2p-GFP to the aqueous phase. Hrd1p was rate-limiting for Hmg2p-GFP retrotranslocation, which required ATP, the AAA-ATPase Cdc48p, and its receptor Ubx2p. In addition, the adaptors Dsk2p and Rad23p, normally implicated in later parts of the pathway, were required. Hmg2p-GFP retrotranslocation did not depend on any of the proposed ER channel candidates. To examine the role of the Hrd1p transmembrane domain as a retrotranslocon, we devised a self-ubiquitinating polytopic substrate (Hmg1-Hrd1p) that undergoes ERAD in the absence of Hrd1p. In vitro retrotranslocation of full-length Hmg1-Hrd1p occurred in the absence of the Hrd1p transmembrane domain, indicating that it did not serve a required channel function. These studies directly demonstrate polytopic membrane protein retrotranslocation during ERAD and delineate avenues for mechanistic understanding of this general process.	[Garza, Renee M.; Sato, Brian K.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5 R01 DK051996-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R01 DK051996-15 (to R.Y.H.) with an additional Minority Supplement (to R.M.G.).	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bazirgan OA, 2006, J BIOL CHEM, V281, P38989, DOI 10.1074/jbc.M608174200; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JOHNSTON NL, 1991, BIOCHEMISTRY-US, V30, P7514, DOI 10.1021/bi00244a021; Kang Y, 2006, J MOL BIOL, V356, P1027, DOI 10.1016/j.jmb.2005.12.001; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, MOL BIOL REP, V26, P125, DOI 10.1023/A:1006913215484; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	63	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14710	14722		10.1074/jbc.M809607200	http://dx.doi.org/10.1074/jbc.M809607200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324879	hybrid, Green Published			2022-12-25	WOS:000266288200007
J	Satapathy, AK; Crampton, DJ; Beauchamp, BB; Richardson, CC				Satapathy, Ajit K.; Crampton, Donald J.; Beauchamp, Benjamin B.; Richardson, Charles C.			Promiscuous Usage of Nucleotides by the DNA Helicase of Bacteriophage T7 DETERMINANTS OF NUCLEOTIDE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GENE 4 PROTEIN; DEOXYRIBONUCLEIC-ACID; CRYSTAL-STRUCTURE; HEXAMERIC HELICASES; REPLICATION FORK; PRIMASE; BINDING; HYDROLYSIS; POLYMERASE	The multifunctional protein encoded by gene 4 of bacteriophage T7 (gp4) provides both helicase and primase activity at the replication fork. T7 DNA helicase preferentially utilizes dTTP to unwind duplex DNA in vitro but also hydrolyzes other nucleotides, some of which do not support helicase activity. Very little is known regarding the architecture of the nucleotide binding site in determining nucleotide specificity. Crystal structures of the T7 helicase domain with bound dATP or dTTP identified Arg-363 and Arg-504 as potential determinants of the specificity for dATP and dTTP. Arg-363 is in close proximity to the sugar of the bound dATP, whereas Arg-504 makes a hydrogen bridge with the base of bound dTTP. T7 helicase has a serine at position 319, whereas bacterial helicases that use rATP have a threonine in the comparable position. Therefore, in the present study we have examined the role of these residues (Arg-363, Arg-504, and Ser-319) in determining nucleotide specificity. Our results show that Arg-363 is responsible for dATP, dCTP, and dGTP hydrolysis, whereas Arg-504 and Ser-319 confer dTTP specificity. Helicase-R504A hydrolyzes dCTP far better than wild-type helicase, and the hydrolysis of dCTP fuels unwinding of DNA. Substitution of threonine for serine 319 reduces the rate of hydrolysis of dTTP without affecting the rate of dATP hydrolysis. We propose that different nucleotides bind to the nucleotide binding site of T7 helicase by an induced fit mechanism. We also present evidence that T7 helicase uses the energy derived from the hydrolysis of dATP in addition to dTTP for mediating DNA unwinding.	[Satapathy, Ajit K.; Crampton, Donald J.; Beauchamp, Benjamin B.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,Bldg C2,Rm 219, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; PATEL SS, 1992, J BIOL CHEM, V267, P15013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825	32	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14286	14295		10.1074/jbc.M900557200	http://dx.doi.org/10.1074/jbc.M900557200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297330	Green Published, hybrid			2022-12-25	WOS:000266286100035
J	Zhu, YWT; Hu, LP; Qi, C; Zhu, YJ				Zhu, Yiwei Tony; Hu, Liping; Qi, Chao; Zhu, Yi-Jun			PRIP Promotes Tumor Formation through Enhancing Serum-responsive Factor-mediated FOS Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN; ACTIVATING PROTEIN-1; MOLECULAR-CLONING; COACTIVATOR PRIP; NUCLEAR-FACTOR; IDENTIFICATION; MODULATOR; RAP250; GROWTH; DOMAIN	PRIP (peroxisome proliferator-activator receptor interacting protein) is a nuclear receptor coactivator required for mammary gland development. To understand the function of PRIP in breast tumorigenesis, we established a mammary tumor cell line with the PRIPLoxp/Loxp genotype. By knocking out the PRIP gene in the tumor cell line, we demonstrated that PRIP deficiency led to inhibited tumor formation without affecting tumor cell proliferation. The PRIP deficiency was associated with decreased cell invasion and migration capabilities. We found that PRIP deficiency substantially reduced FOS gene expression. A chromatin immunoprecipitation assay revealed that PRIP was recruited to the FOS promoter. In addition, we demonstrated that PRIP also directly up-regulated the FOS gene expression in human breast cancer cells. Promoter analysis showed that PRIP acted through serum-responsive factor to regulate FOS gene expression. Finally, by re-expressing the FOS gene, we confirmed that the inhibited tumor formation of PRIP-deficient tumor cells was due to reduced expression of the FOS gene.	[Zhu, Yiwei Tony; Hu, Liping; Qi, Chao; Zhu, Yi-Jun] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Zhu, YJ (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-zhu2@northwestern.edu			National Institutes of Health [CA 88898]; NATIONAL CANCER INSTITUTE [R01CA088898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 88898 (to Y. J. Z.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kuang SQ, 2002, J BIOL CHEM, V277, P45356, DOI 10.1074/jbc.C200509200; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Marzluff WF, 2005, CURR OPIN CELL BIOL, V17, P274, DOI 10.1016/j.ceb.2005.04.010; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Qi C, 2004, J BIOL CHEM, V279, P33696, DOI 10.1074/jbc.M401266200; ROSKAM WG, 1979, NUCLEIC ACIDS RES, V7, P305, DOI 10.1093/nar/7.2.305; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sng JCG, 2004, BIOL PHARM BULL, V27, P606, DOI 10.1248/bpb.27.606; YANG J, 1980, P NATL ACAD SCI-BIOL, V77, P2088, DOI 10.1073/pnas.77.4.2088; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510; Zhu YJ, 2003, J BIOL CHEM, V278, P1986, DOI 10.1074/jbc.C200634200; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	30	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14485	14492		10.1074/jbc.M900935200	http://dx.doi.org/10.1074/jbc.M900935200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329434	hybrid, Green Published			2022-12-25	WOS:000266286100055
J	Garscha, U; Oliw, EH				Garscha, Ulrike; Oliw, Ernst H.			Leucine/Valine Residues Direct Oxygenation of Linoleic Acid by (10R)- and (8R)-Dioxygenases EXPRESSION AND SITE-DIRECTED MUTAGENESIS OF (10R)-DIOXYGENASE WITH EPOXYALCOHOL SYNTHASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; CYCLOOXYGENASE ACTIVE-SITE; TANDEM MASS-SPECTROMETRY; ARACHIDONIC-ACID; ASPERGILLUS-NIDULANS; DIOL SYNTHASE; LIQUID-CHROMATOGRAPHY; STEREOCHEMISTRY; PRODUCTS; REARRANGEMENT	Linoleate (10R)-dioxygenase (10R-DOX) of Aspergillus fumigatus was cloned and expressed in insect cells. Recombinant 10R-DOX oxidized 18:2n-6 to (10R)-hydroperoxy8(E), 12(Z)-octadecadienoic acid (10R-HPODE; similar to 90%), (8R)-hydroperoxylinoleic acid (8R-HPODE; similar to 10%), and small amounts of 12S(13R)-epoxy-(10R)-hydroxy-(8E)-octadecenoic acid. We investigated the oxygenation of 18: 2n-6 at C-10 and C-8 by site-directed mutagenesis of 10R-DOX and 7,8-linoleate diol synthase (7,8-LDS), which forms similar to 98% 8R-HPODE and similar to 2% 10R-HPODE. The 10R-DOX and 7,8-LDS sequences differ in homologous positions of the presumed dioxygenation sites (Leu-384/Val-330 and Val-388/Leu-334, respectively) and at the distal site of the heme (Leu-306/Val-256). Leu-384/Val-330 influenced oxygenation, as L384V and L384A of 10R-DOX elevated the biosynthesis of 8-HPODE to 22 and 54%, respectively, as measured by liquid chromatography-tandem mass spectrometry analysis. The stereospecificity was also decreased, as L384A formed the R and S isomers of 10-HPODE and 8-HPODE in a 3: 2 ratio. Residues in this position also influenced oxygenation by 7,8-LDS, as its V330L mutant augmented the formation of 10R-HPODE 3-fold. Replacement of Val-388 in 10R-DOX with leucine and phenylalanine increased the formation of 8R-HPODE to 16 and 36%, respectively, whereas L334V of 7,8-LDS was inactive. Mutation of Leu-306 with valine or alanine had little influence on the epoxyalcohol synthase activity. Our results suggest that Leu-384 and Val-388 of 10R-DOX control oxygenation of 18: 2n-6 at C-10 and C-8, respectively. The two homologous positions of prostaglandin H synthase-1, Val-349 and Ser-353, are also critical for the position and stereospecificity of the cyclooxygenase reaction.	[Oliw, Ernst H.] Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut Biosci, Div Biochem Pharmacol, SE-75124 Uppsala, Sweden	Uppsala University	Oliw, EH (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut Biosci, Div Biochem Pharmacol, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	; Garscha, Ulrike/G-3559-2018	Oliw, Ernst/0000-0002-7986-8130; Garscha, Ulrike/0000-0002-3645-7833	VR Medicine [03X-06523]; FORMAS [222-2005-1733]; Knut and Alice Wallenberg Foundation [2004.0123]	VR Medicine; FORMAS(Swedish Research Council Formas); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by VR Medicine Grant 03X-06523, FORMAS Grant 222-2005-1733, and by Knut and Alice Wallenberg Foundation Grant 2004.0123.	Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; BRASH AR, 1995, ARCH BIOCHEM BIOPHYS, V321, P485, DOI 10.1006/abbi.1995.1421; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea M, 2003, LIPIDS, V38, P1275, DOI 10.1007/s11745-003-1189-3; Cristea N, 2007, J LIPID RES, V48, P890, DOI 10.1194/jlr.M600505-JLR200; Dagenais TRT, 2008, INFECT IMMUN, V76, P3214, DOI 10.1128/IAI.00009-08; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Koszelak-Rosenblum M, 2008, J BIOL CHEM, V283, P24962, DOI 10.1074/jbc.M804358200; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Noverr MC, 2002, INFECT IMMUN, V70, P400, DOI 10.1128/IAI.70.1.400-402.2002; Oliw EH, 2006, ANAL BIOCHEM, V354, P111, DOI 10.1016/j.ab.2006.04.010; OLIW EH, 1983, J CHROMATOGR, V275, P245, DOI 10.1016/S0378-4347(00)84372-8; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; TSAI AL, 1994, J BIOL CHEM, V269, P5085; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Valmsen K, 2004, EUR J BIOCHEM, V271, P3533, DOI 10.1111/j.0014-2956.2004.04289.x; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P18, DOI 10.1016/0005-2760(84)90292-3	45	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13755	13765		10.1074/jbc.M808665200	http://dx.doi.org/10.1074/jbc.M808665200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289462	Green Published, hybrid			2022-12-25	WOS:000265877300053
J	Sesma, JI; Esther, CR; Kreda, SM; Jones, L; O'Neal, W; Nishihara, S; Nicholas, RA; Lazarowski, ER				Sesma, Juliana I.; Esther, Charles R., Jr.; Kreda, Silvia M.; Jones, Lisa; O'Neal, Wanda; Nishihara, Shoko; Nicholas, Robert A.; Lazarowski, Eduardo R.			Endoplasmic Reticulum/Golgi Nucleotide Sugar Transporters Contribute to the Cellular Release of UDP-sugar Signaling Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AIRWAY EPITHELIAL-CELLS; ATP RELEASE; P2Y(14) RECEPTOR; ADENOSINE-TRIPHOSPHATE; FUNCTIONAL EXPRESSION; INTRACELLULAR CALCIUM; PURINERGIC RECEPTORS; FRINGE CONNECTION; GOLGI-APPARATUS	Extracellular UDP-sugars promote cellular responses by interacting with widely distributed P2Y(14) receptors, but the mechanisms by which these molecules are released from cells are poorly understood. Given the active role of UDP-sugars in glycosylation reactions within the secretory pathway, we hypothesized that UDP-sugar release includes an exocytotic component. This hypothesis was tested by assessing the contribution of endoplasmic reticulum (ER)/Golgi-resident UDPGlcNAc transporters to the cellular release of their cognate substrates. A sensitive and highly selective assay for UDP-GlcNAc mass was developed using purified AGX2, an isoenzyme of human UDP-GlcNAc pyrophosphorylase. Robust constitutive release of UDP-GlcNAc was observed in yeast as well as in well differentiated human airway epithelial cells. The human UDPGlcNAc transporter HFRC1 was overexpressed in human bronchial epithelial cells and was shown to localize in the Golgi and to enhance the surface expression of N-acetylglucosamine-rich glycans. HFRC1-overexpressing cells also displayed increased constitutive and hypotonic stress-stimulated release of UDPGlcNAc. Yeast mutants lacking Yea4 (the ER UDP-GlcNAc transporter endogenously expressed in Saccharomyces cerevisiae) showed reduced UDP-GlcNAc release. Yea4-deficient cells complemented with Yea4 showed UDP-GlcNAc release rates at levels similar to or higher than wild type cells. Our results illustrate that ER/Golgi lumen constitutes a significant source of extracellular UDP-sugars and therefore plays a critical role in nucleotide sugar-promoted cell signaling.	[Lazarowski, Eduardo R.] Univ N Carolina, Dept Med, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Esther, Charles R., Jr.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Tokyo, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Soka University	Lazarowski, ER (corresponding author), Univ N Carolina, Dept Med, Cyst Fibrosis Pulm Res & Treatment Ctr, 7017 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	eduardo_lazarowski@med.unc.edu		Nishihara, Shoko/0000-0002-1668-2603	National Institutes of Health [P01-HL034322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL034322.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Boudreault F, 2004, J MICROSC-OXFORD, V215, P302, DOI 10.1111/j.0022-2720.2004.01378.x; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Esther CR, 2008, EUR RESPIR J, V31, P949, DOI 10.1183/09031936.00089807; Esther CR, 2008, BIOCHEMISTRY-US, V47, P9269, DOI 10.1021/bi800855k; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; GUILLEN E, 1995, BIOCHEMISTRY-US, V34, P5472, DOI 10.1021/bi00016a018; Guyot A, 2002, J PHYSIOL-LONDON, V545, P199, DOI 10.1113/jphysiol.2002.030148; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Johnson LG, 1998, J VIROL, V72, P8861, DOI 10.1128/JVI.72.11.8861-8872.1998; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Joseph SM, 2004, BRIT J PHARMACOL, V142, P1002, DOI 10.1038/sj.bjp.0705865; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kreda SM, 2000, NAT BIOTECHNOL, V18, P635, DOI 10.1038/76479; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; PEREZ M, 1986, J BIOL CHEM, V261, P6822; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Roy SK, 2000, J BIOL CHEM, V275, P13580, DOI 10.1074/jbc.275.18.13580; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Scrivens M, 2005, BRIT J PHARMACOL, V146, P435, DOI 10.1038/sj.bjp.0706322; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Shin A, 2008, BLOOD, V111, P3062, DOI 10.1182/blood-2007-02-071910; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Tatur S, 2008, PURINERG SIGNAL, V4, P139, DOI 10.1007/s11302-007-9059-x; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van der Wijk T, 2003, J BIOL CHEM, V278, P40020, DOI 10.1074/jbc.M307603200; Wang-Gillam A, 1998, J BIOL CHEM, V273, P27055, DOI 10.1074/jbc.273.42.27055; Yi SMP, 2001, GENE THER, V8, P1826, DOI 10.1038/sj.gt.3301598; Zhong XT, 2003, J BIOL CHEM, V278, P33436, DOI 10.1074/jbc.M305785200	59	51	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12572	12583		10.1074/jbc.M806759200	http://dx.doi.org/10.1074/jbc.M806759200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276090	Green Published, hybrid			2022-12-25	WOS:000265494600086
J	Piccirillo, SGM; Combi, R; Cajola, L; Patrizi, A; Redaelli, S; Bentivegna, A; Baronchelli, S; Maira, G; Pollo, B; Mangiola, A; DiMeco, F; Dalpra, L; Vescovi, AL				Piccirillo, S. G. M.; Combi, R.; Cajola, L.; Patrizi, A.; Redaelli, S.; Bentivegna, A.; Baronchelli, S.; Maira, G.; Pollo, B.; Mangiola, A.; DiMeco, F.; Dalpra, L.; Vescovi, A. L.			Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution	ONCOGENE			English	Article						brain tumours; cancer stem-like cells; tumorigenicity	IDENTIFICATION	Glioblastomas (GBMs) contain transformed, self-maintaining, multipotent, tumour-initiating cancer stem cells, whose identification has radically changed our perspective on the physiology of these tumours. Currently, it is unknown whether multiple types of transformed precursors, which display alternative sets of the complement of properties of true cancer stem cells, can be found in a GBM. If different subsets of such cancer stem-like cells (CSCs) do exist, they might represent distinct cell targets, with a differential therapeutic importance, also depending on their characteristics and lineage relationship. Here, we report the presence of two types of CSCs within different regions of the same human GBM. Cytogenetic and molecular analysis shows that the two types of CSCs bear quite diverse tumorigenic potential and distinct genetic anomalies, and, yet, derive from common ancestor cells. This provides critical information to unravel the development of CSCs and the key molecular/genetic components underpinning tumorigenicity in human GBMs.	[Patrizi, A.; Redaelli, S.; Bentivegna, A.; Baronchelli, S.; Dalpra, L.] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, I-20052 Monza, Mi, Italy; [Piccirillo, S. G. M.; Combi, R.; Vescovi, A. L.] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Piccirillo, S. G. M.; Cajola, L.; Vescovi, A. L.] Univ Milano Bicocca, Unit Canc Stem Cell Biol, I-20126 Milan, Italy; [Maira, G.; Mangiola, A.] Univ Cattolica Sacro Cuore, Dept Neurol Sci, Inst Neurosurg, I-00168 Rome, Italy; [Pollo, B.; DiMeco, F.] Natl Neurol Inst C Besta, Dept Neurosurg, Milan, Italy; [Pollo, B.; DiMeco, F.] Johns Hopkins Med Sch, Dept Neurol Surg, Baltimore, MD USA	University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Neurologico Besta; Johns Hopkins University; Johns Hopkins Medicine	Dalpra, L (corresponding author), Univ Milano Bicocca, Dept Neurosci & Biomed Technol, I-20052 Monza, Mi, Italy.	leda.dalpra@unimib.it; vescovi@tin.it	Combi, Romina/AAC-2944-2020; DiMeco, Francesco/Z-5431-2019; Bentivegna, Angela/J-3478-2018; Vescovi, Angelo Luigi/A-4919-2015; Baronchelli, Simona/G-6771-2016; Pollo, Bianca/K-5347-2018; DiMeco, Francesco/Q-3785-2016	Combi, Romina/0000-0003-1742-6078; Bentivegna, Angela/0000-0001-7535-846X; Vescovi, Angelo Luigi/0000-0002-1742-4112; Baronchelli, Simona/0000-0002-1857-1472; Pollo, Bianca/0000-0002-5523-4256; DiMeco, Francesco/0000-0001-6213-5793; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992	'Associazione Italiana per la Ricerca Sul Cancro' AIRC, Italy; Brain Tumor Funders Collaborative Initiative, USA	'Associazione Italiana per la Ricerca Sul Cancro' AIRC, Italy(Fondazione AIRC per la ricerca sul cancro); Brain Tumor Funders Collaborative Initiative, USA	This work was supported by grants of the 'Associazione Italiana per la Ricerca Sul Cancro' AIRC, Italy and the Brain Tumor Funders Collaborative Initiative, USA.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Piccirillo SGM, 2007, EXPERT OPIN BIOL TH, V7, P1129, DOI 10.1517/14712598.7.8.1129; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Trent S, 2002, J NEURO-ONCOL, V57, P247, DOI 10.1023/A:1015788814667; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130	14	144	150	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1807	1811		10.1038/onc.2009.27	http://dx.doi.org/10.1038/onc.2009.27			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19287454	Bronze			2022-12-25	WOS:000265640400007
J	Baral, S; Trapence, G; Motimedi, F; Umar, E; Iipinge, S; Dausab, F; Beyrer, C				Baral, Stefan; Trapence, Gift; Motimedi, Felistus; Umar, Eric; Iipinge, Scholastika; Dausab, Friedel; Beyrer, Chris			HIV Prevalence, Risks for HIV Infection, and Human Rights among Men Who Have Sex with Men (MSM) in Malawi, Namibia, and Botswana	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PREVENTION; BEHAVIOR; EPIDEMIOLOGY; MOMBASA	Background: In the generalized epidemics of HIV in southern Sub-Saharan Africa, men who have sex with men have been largely excluded from HIV surveillance and research. Epidemiologic data for MSM in southern Africa are among the sparsest globally, and HIV risk among these men has yet to be characterized in the majority of countries. Methodology: A cross-sectional anonymous probe of 537 men recruited with non-probability sampling among men who reported ever having had sex with another man in Malawi, Namibia, and Botswana using a structured survey instrument and HIV screening with the OraQuick (c) rapid test kit. Principal Findings: The HIV prevalence among those between the ages of 18 and 23 was 8.3% (20/241); 20.0% (42/210) among those 24-29; and 35.7% (30/84) among those older than 30 for an overall prevalence of 17.4% (95% CI 14.4-20.8). In multivariate logistic regressions, being older than 25 (aOR 4.0, 95% CI 2.0-8.0), and not always wearing condoms during sex (aOR 2.6, 95% CI 1.3-4.9) were significantly associated with being HIV-positive. Sexual concurrency was common with 16.6% having ongoing concurrent stable relationships with a man and a woman and 53.7% had both male and female sexual partners in proceeding 6 months. Unprotected anal intercourse was common and the use of petroleum-based lubricants was also common when using condoms. Human rights abuses, including blackmail and denial of housing and health care was prevalent with 42.1% (222/527) reporting at least one abuse. Conclusions: MSM are a high-risk group for HIV infection and human rights abuses in Malawi, Namibia, and Botswana. Concurrency of sexual partnerships with partners of both genders may play important roles in HIV spread in these populations. Further epidemiologic and evaluative research is needed to assess the contribution of MSM to southern Africa's HIV epidemics and how best to mitigate this. These countries should initiate and adequately fund evidence-based and targeted HIV prevention programs for MSM.	[Baral, Stefan; Beyrer, Chris] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Trapence, Gift] Ctr Dev People, Blantyre, Malawi; [Motimedi, Felistus] Botswana Network Ethics Law & HIV AIDS, Gaborone, Botswana; [Umar, Eric] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Iipinge, Scholastika] Univ Namibia, Windhoek, Namibia; [Dausab, Friedel] Rainbow Project, Windhoek, Namibia; [Baral, Stefan] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Malawi; University of Namibia; University of Toronto	Baral, S (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD USA.	sbaral@jhsph.edu	Baral, Stefan/D-2930-2013; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419	Sexual Health and Rights Project (SHARP) of the Open Society Institute; Open Society Initiative for Southern Africa (OSISA)	Sexual Health and Rights Project (SHARP) of the Open Society Institute; Open Society Initiative for Southern Africa (OSISA)	This study was supported by the Sexual Health and Rights Project (SHARP) of the Open Society Institute and the Open Society Initiative for Southern Africa (OSISA). The decision to publish was made by the community partners and not the funders. Publication costs were offset by a grant from The Himmelfarb Family Foundation to the Center for Public Health and Human Rights.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Brody S, 2003, INT J STD AIDS, V14, P431, DOI 10.1258/095646203322025704; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; GRIJSEN ML, 2008, SEX TRANSM INFECT; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; IGLHRC, 2007, MAP HIV AIDS PROGR F; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Johnson WD, 2005, AIDS EDUC PREV, V17, P568, DOI 10.1521/aeap.2005.17.6.568; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; MAH TL, 2008, AIDS BEHAV; Ntata P R T, 2008, Tanzan J Health Res, V10, P124; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sharma A, 2008, SEX TRANSM DIS, V35, P352, DOI 10.1097/OLQ.0b013e31815e6320; Siegel K, 2008, ARCH SEX BEHAV, V37, P720, DOI 10.1007/s10508-008-9357-6; SIFAKIS F, 2008, RAPID ASSESSMENT HIV; Spitzberg B H, 1999, Violence Vict, V14, P241; StataCorp L, 2007, STAT DAT AN STAT SOF; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07	28	257	264	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4997	10.1371/journal.pone.0004997	http://dx.doi.org/10.1371/journal.pone.0004997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PM	19325707	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499400005
J	Gomez, GA; Veldman, MB; Zhao, Y; Burgess, S; Lin, S				Gomez, Gustavo A.; Veldman, Matthew B.; Zhao, Yan; Burgess, Shawn; Lin, Shuo			Discovery and Characterization of Novel Vascular and Hematopoietic Genes Downstream of Etsrp in Zebrafish	PLOS ONE			English	Article							MICROARRAY ANALYSIS; EMBRYONIC BLOOD; EXPRESSION; RECEPTOR; PROTEIN; FAMILY; IDENTIFICATION; CLOCHE; DIFFERENTIATION; PRECURSOR	The transcription factor Etsrp is required for vasculogenesis and primitive myelopoiesis in zebrafish. When ectopically expressed, etsrp is sufficient to induce the expression of many vascular and myeloid genes in zebrafish. The mammalian homolog of etsrp, ER71/Etv2, is also essential for vascular and hematopoietic development. To identify genes downstream of etsrp, gain-of-function experiments were performed for etsrp in zebrafish embryos followed by transcription profile analysis by microarray. Subsequent in vivo expression studies resulted in the identification of fourteen genes with blood and/or vascular expression, six of these being completely novel. Regulation of these genes by etsrp was confirmed by ectopic induction in etsrp overexpressing embryos and decreased expression in etsrp deficient embryos. Additional functional analysis of two newly discovered genes, hapln1b and sh3gl3, demonstrates their importance in embryonic vascular development. The results described here identify a group of genes downstream of etsrp likely to be critical for vascular and/or myeloid development.	[Gomez, Gustavo A.; Veldman, Matthew B.; Zhao, Yan; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Burgess, Shawn] Natl Human Genome Res Inst, NIH, Genome Technol Branch, Bethesda, MD USA	University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Gomez, GA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	shuolin@ucla.edu		Burgess, Shawn/0000-0003-1147-0596; Gomez, Gustavo/0000-0001-9294-4276	HIN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000183, Z01HG000183] Funding Source: NIH RePORTER	HIN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	HIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Choi K, 1998, DEVELOPMENT, V125, P725; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Coolen M, 2005, DEV GENES EVOL, V215, P327, DOI 10.1007/s00427-005-0476-y; Dieterlen-Lievre F, 2004, MECH DEVELOP, V121, P1117, DOI 10.1016/j.mod.2004.06.008; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liao W, 1997, DEVELOPMENT, V124, P381; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Manzanares M, 1997, NATURE, V387, P191, DOI 10.1038/387191a0; Martins-Green M, 2000, INT J BIOCHEM CELL B, V32, P351, DOI 10.1016/S1357-2725(99)00118-1; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Moens CB, 1998, DEVELOPMENT, V125, P381; Narumiya H, 2007, BIOCHEM BIOPH RES CO, V357, P896, DOI 10.1016/j.bbrc.2007.04.030; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Palis J, 1999, DEVELOPMENT, V126, P5073; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Schvarzstein M, 1999, MECH DEVELOP, V80, P223, DOI 10.1016/S0925-4773(98)00220-2; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; So CW, 2000, BIOCHEM J, V348, P447, DOI 10.1042/0264-6021:3480447; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; St Croix B, 2000, SCIENCE, V289, P1197; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; Vogel BE, 2001, DEVELOPMENT, V128, P883; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Xu XH, 2007, J HISTOCHEM CYTOCHEM, V55, P119, DOI 10.1369/jhc.6A6975.2006; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yang SY, 2002, ARTERIOSCL THROM VAS, V22, P1797, DOI 10.1161/01.ATV.0000038995.31179.24; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	66	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4994	10.1371/journal.pone.0004994	http://dx.doi.org/10.1371/journal.pone.0004994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308258	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499000011
J	Qi, XP; Bao, FS; Xie, ZX				Qi, Xiaopeng; Bao, Forrest Sheng; Xie, Zhixin			Small RNA Deep Sequencing Reveals Role for Arabidopsis thaliana RNA-Dependent RNA Polymerases in Viral siRNA Biogenesis	PLOS ONE			English	Article								RNA silencing functions as an important antiviral defense mechanism in a broad range of eukaryotes. In plants, biogenesis of several classes of endogenous small interfering RNAs (siRNAs) requires RNA-dependent RNA Polymerase (RDR) activities. Members of the RDR family proteins, including RDR1 and RDR6, have also been implicated in antiviral defense, although a direct role for RDRs in viral siRNA biogenesis has yet to be demonstrated. Using a crucifer-infecting strain of Tobacco Mosaic Virus (TMV-Cg) and Arabidopsis thaliana as a model system, we analyzed the viral small RNA profile in wild-type plants as well as rdr mutants by applying small RNA deep sequencing technology. Over 100,000 TMV-Cg-specific small RNA reads, mostly of 21- (78.4%) and 22-nucleotide (12.9%) in size and originating predominately (79.9%) from the genomic sense RNA strand, were captured at an early infection stage, yielding the first high-resolution small RNA map for a plant virus. The TMV-Cg genome harbored multiple, highly reproducible small RNA-generating hot spots that corresponded to regions with no apparent local hairpin-forming capacity. Significantly, both the rdr1 and rdr6 mutants exhibited globally reduced levels of viral small RNA production as well as reduced strand bias in viral small RNA population, revealing an important role for these host RDRs in viral siRNA biogenesis. In addition, an informatics analysis showed that a large set of host genes could be potentially targeted by TMV-Cg-derived siRNAs for posttranscriptional silencing. Two of such predicted host targets, which encode a cleavage and polyadenylation specificity factor (CPSF30) and an unknown protein similar to translocon-associated protein alpha (TRAP alpha), respectively, yielded a positive result in cleavage validation by 5'RACE assays. Our data raised the interesting possibility for viral siRNA-mediated virus-host interactions that may contribute to viral pathogenicity and host specificity.	[Qi, Xiaopeng; Xie, Zhixin] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Bao, Forrest Sheng] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Qi, XP (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	zhixin.xie@ttu.edu	Bao, Forrest/C-6464-2011	Xie, Zhixin/0000-0002-6191-5170	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2006-35319-17438]	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service grant 2006-35319-17438 (to Z.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Buck KW, 1999, PHILOS T R SOC B, V354, P613, DOI 10.1098/rstb.1999.0413; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; ISHIKAWA M, 1991, MOL GEN GENET, V230, P33, DOI 10.1007/BF00290647; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	198	210	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4971	10.1371/journal.pone.0004971	http://dx.doi.org/10.1371/journal.pone.0004971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308254	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499000009
J	Nakamura, F; Heikkinen, O; Pentikainen, OT; Osborn, TM; Kasza, KE; Weitz, DA; Kupiainen, O; Permi, P; Kilpelainen, I; Ylanne, J; Hartwig, JH; Stossel, TP				Nakamura, Fumihiko; Heikkinen, Outi; Pentikaeinen, Olli T.; Osborn, Teresia M.; Kasza, Karen E.; Weitz, David A.; Kupiainen, Olga; Permi, Perttu; Kilpelaeinen, Ilkka; Ylaenne, Jari; Hartwig, John H.; Stossel, Thomas P.			Molecular Basis of Filamin A-FilGAP Interaction and Its Impairment in Congenital Disorders Associated with Filamin A Mutations	PLOS ONE			English	Article								Background: Mutations in filamin A (FLNa), an essential cytoskeletal protein with multiple binding partners, cause developmental anomalies in humans. Methodology/Principal Findings: We determined the structure of the 23(rd) Ig repeat of FLNa (IgFLNa23) that interacts with FilGAP, a Rac-specific GTPase-activating protein and regulator of cell polarity and movement, and the effect of the three disease-related mutations on this interaction. A combination of NMR structural analysis and in silico modeling revealed the structural interface details between the C and D beta-strands of the IgFLNa23 and the C-terminal 32 residues of FilGAP. Mutagenesis of the predicted key interface residues confirmed the binding constraints between the two proteins. Specific loss-of-function FLNa constructs were generated and used to analyze the importance of the FLNa-FilGAP interaction in vivo. Point mutagenesis revealed that disruption of the FLNa-FilGAP interface perturbs cell spreading. FilGAP does not bind FLNa homologs FLNb or FLNc establishing the importance of this interaction to the human FLNa mutations. Tight complex formation requires dimerization of both partners and the correct alignment of the binding surfaces, which is promoted by a flexible hinge domain between repeats 23 and 24 of FLNa. FLNa mutations associated with human developmental anomalies disrupt the binding interaction and weaken the elasticity of FLNa/F-actin network under high mechanical stress. Conclusions/Significance: Mutational analysis informed by structure can generate reagents for probing specific cellular interactions of FLNa. Disease-related FLNa mutations have demonstrable effects on FLNa function.	[Nakamura, Fumihiko; Osborn, Teresia M.; Hartwig, John H.; Stossel, Thomas P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Translat Med Div, Boston, MA 02115 USA; [Heikkinen, Outi; Kupiainen, Olga; Kilpelaeinen, Ilkka] Univ Helsinki, Dept Chem, Lab Organ Chem, FIN-00014 Helsinki, Finland; [Pentikaeinen, Olli T.; Ylaenne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, SF-40351 Jyvaskyla, Finland; [Kasza, Karen E.; Weitz, David A.] Harvard Univ, Dept Phys, SEAS, Cambridge, MA USA; [Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FIN-00014 Helsinki, Finland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Helsinki; University of Jyvaskyla; Harvard University; University of Helsinki	Nakamura, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Translat Med Div, Boston, MA 02115 USA.	fnakamura@rics.bwh.harvard.edu	Nakamura, Fumihiko/N-5476-2016; Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Ylanne, Jari/0000-0003-4627-021X; Kasza, Karen/0000-0002-0888-3579; Nakamura, Fumihiko/0000-0002-6872-4246	National Institutes of Health [HL-19429, HL-56252]; HUSEC Seed Fund for Interdisciplinary Science; National Science Foundation's Graduate Research Fellowship Program; Academy of Finland [114713, 122170]; Finnish IT Center for Science [jyy2516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056252, R01HL019429, R37HL019429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HUSEC Seed Fund for Interdisciplinary Science; National Science Foundation's Graduate Research Fellowship Program(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Finnish IT Center for Science(Finnish IT center for science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health Grants HL-19429 (TPS) and HL-56252 (JHH), the HUSEC Seed Fund for Interdisciplinary Science (DAW and TPS), the National Science Foundation's Graduate Research Fellowship Program (KEK), Academy of Finland (114713, JY, 122170, PP), and the Finnish IT Center for Science (computational grant for project jyy2516, OTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASE DA, 2004, AMBER, V8; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Goddard T., 2008, SPARKY, V3; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; MORRIS RJ, 1995, MONOCLONAL ANTIBODIE, P34; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Permi P, 2004, PROG NUCL MAG RES SP, V44, P97, DOI 10.1016/j.pnmrs.2003.12.001; Permi P, 2002, J BIOMOL NMR, V23, P201, DOI 10.1023/A:1019819514298; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Robertson SP, 2006, AM J MED GENET A, V140A, P1726, DOI 10.1002/ajmg.a.31322; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TAKALA H, 2008, BLOOD; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	44	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4928	10.1371/journal.pone.0004928	http://dx.doi.org/10.1371/journal.pone.0004928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293932	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496600014
J	Rollins, B; Martin, MV; Sequeira, PA; Moon, EA; Morgan, LZ; Watson, SJ; Schatzberg, A; Akil, H; Myers, RM; Jones, EG; Wallace, DC; Bunney, WE; Vawter, MP				Rollins, Brandi; Martin, Maureen V.; Sequeira, P. Adolfo; Moon, Emily A.; Morgan, Ling Z.; Watson, Stanley J.; Schatzberg, Alan; Akil, Huda; Myers, Richard M.; Jones, Edward G.; Wallace, Douglas C.; Bunney, William E.; Vawter, Marquis P.			Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MTDNA POINT MUTATIONS; SUBUNIT GENE NDUFV2; DNA DELETION LEVELS; COMPLEX-I; PARENTAL TRANSMISSION; RAPID IDENTIFICATION; MATERNAL INHERITANCE; GLUCOSE-METABOLISM; BAYESIAN-INFERENCE	Backgroud: Mitochondria provide most of the energy for brain cells by the process of oxidative phosphorylation. Mitochondrial abnormalities and deficiencies in oxidative phosphorylation have been reported in individuals with schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD) in transcriptomic, proteomic, and metabolomic studies. Several mutations in mitochondrial DNA (mtDNA) sequence have been reported in SZ and BD patients. Methodology/Principal Findings: Dorsolateral prefrontal cortex (DLPFC) from a cohort of 77 SZ, BD, and MDD subjects and age-matched controls (C) was studied for mtDNA sequence variations and heteroplasmy levels using Affymetrix mtDNA resequencing arrays. Heteroplasmy levels by microarray were compared to levels obtained with SNaPshot and allele specific real-time PCR. This study examined the association between brain pH and mtDNA alleles. The microarray resequencing of mtDNA was 100% concordant with conventional sequencing results for 103 mtDNA variants. The rate of synonymous base pair substitutions in the coding regions of the mtDNA genome was 22% higher (p = 0.0017) in DLPFC of individuals with SZ compared to controls. The association of brain pH and super haplogroup (U, K, UK) was significant (p = 0.004) and independent of postmortem interval time. Conclusions: Focusing on haplogroup and individual susceptibility factors in psychiatric disorders by considering mtDNA variants may lead to innovative treatments to improve mitochondrial health and brain function.	[Rollins, Brandi; Martin, Maureen V.; Sequeira, P. Adolfo; Moon, Emily A.; Morgan, Ling Z.; Bunney, William E.; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Schatzberg, Alan] Stanford Univ, Dept Psychiat, Palo Alto, CA USA; [Myers, Richard M.] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Jones, Edward G.] Univ Calif Davis, Neurosci Ctr, Davis, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of Michigan System; University of Michigan; Stanford University; University of California System; University of California Davis; University of California System; University of California Irvine	Rollins, B (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	mvawter@uci.edu	Sequeira, Adolfo/K-7278-2015	Sequeira, Adolfo/0000-0003-3040-1190	NIMH Conte Center [P50 MH60398, MH54844, MH42251]; Pritzker Family Philanthropic Fund; William Lion Penzner Foundation; Della Martin Foundation; W.M. Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054844, P50MH060398] Funding Source: NIH RePORTER	NIMH Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pritzker Family Philanthropic Fund; William Lion Penzner Foundation; Della Martin Foundation; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project is supported by the NIMH Conte Center Grant P50 MH60398, Pritzker Family Philanthropic Fund, William Lion Penzner Foundation (UCI), Della Martin Foundation (UCI), NIMH Grant #MH54844 (EGJ), W.M. Keck Foundation (EGJ), and the NIMH Program Project MH42251 (SJW and HA). The authors are members of a Conte Center supported by the NIMH and members of the Pritzker Neuropsychiatric Disorders Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balijepalli S, 1999, NEUROPHARMACOLOGY, V38, P567, DOI 10.1016/S0028-3908(98)00215-9; Bamne MN, 2008, SCHIZOPHRENIA BULL, V34, P458, DOI 10.1093/schbul/sbm100; Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177; Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318; BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009; Cavelier L, 2000, HUM GENET, V107, P45, DOI 10.1007/s004390050009; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; DEICKEN RF, 1995, AM J PSYCHIAT, V152, P915; DeLisi LE, 2000, BIOL PSYCHIAT, V48, P706, DOI 10.1016/S0006-3223(00)00939-2; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Fan HX, 2006, J MOL DIAGN, V8, P277, DOI 10.2353/jmoldx.2006.050066; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1; Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Gardner A, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-7; Gardner A, 2008, PSYCHOTHER PSYCHOSOM, V77, P127, DOI 10.1159/000112891; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; Gibson GE, 2008, ANN NY ACAD SCI, V1147, pXI, DOI 10.1196/annals.1427.039; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOLDSTEIN JM, 1992, SCHIZOPHR RES, V7, P135, DOI 10.1016/0920-9964(92)90043-5; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; Grigoroiu-Serbanescu M, 1998, AM J MED GENET, V81, P397, DOI 10.1002/(SICI)1096-8628(19980907)81:5<397::AID-AJMG8>3.0.CO;2-Q; Grigoroiu-Serbanescu M, 2001, AM J MED GENET, V105, P765, DOI 10.1002/ajmg.10047; Hamakawa H, 1999, PSYCHOL MED, V29, P639, DOI 10.1017/S0033291799008442; HARRISON PJ, 1991, MOL BRAIN RES, V9, P161, DOI 10.1016/0169-328X(91)90143-L; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112; Jakupciak JP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-95; Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Johnston NL, 1997, J NEUROSCI METH, V77, P83, DOI 10.1016/S0165-0270(97)00115-5; Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213; Kato T, 1996, J AFFECT DISORDERS, V37, P67, DOI 10.1016/0165-0327(95)00050-X; Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7; Kato T, 1998, J AFFECT DISORDERS, V50, P135, DOI 10.1016/S0165-0327(97)00102-X; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926; Kato T, 2008, CELL CALCIUM, V44, P92, DOI 10.1016/j.ceca.2007.11.005; Kato T, 2007, CAN J PSYCHIAT, V52, P763; Kato T, 2006, DRUG NEWS PERSPECT, V19, P597, DOI 10.1358/dnp.2006.19.10.1068006; Kazuno AA, 2005, PSYCHIAT CLIN NEUROS, V59, P497, DOI 10.1111/j.1440-1819.2005.01404.x; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kegeles LS, 1998, BIOL PSYCHIAT, V44, P382, DOI 10.1016/S0006-3223(97)00425-3; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kornberg JR, 2000, J AFFECT DISORDERS, V59, P183, DOI 10.1016/S0165-0327(99)00151-2; Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891; Lin JP, 1997, GENET EPIDEMIOL, V14, P665, DOI 10.1002/(SICI)1098-2272(1997)14:6<665::AID-GEPI19>3.0.CO;2-O; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Lindholm E, 1997, EUR J HUM GENET, V5, P406, DOI 10.1159/000484799; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Maragh S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-7; Marchbanks RM, 2003, SCHIZOPHR RES, V65, P33, DOI 10.1016/S0920-9964(03)00011-2; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041; Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015; Munakata K, 2007, MUTAT RES-FUND MOL M, V617, P119, DOI 10.1016/j.mrfmmm.2007.01.006; NEI M, 1986, MOL BIOL EVOL, V3, P418; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; SHIMIZU A, 1987, JPN J PSYCHIAT NEUR, V41, P65; SHOFFNER JM, 1995, METABOLIC MOL BASIS, V1, P1535; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Strakowski SM, 2000, BIPOLAR DISORD, V2, P148, DOI 10.1034/j.1399-5618.2000.020302.x; Strand H, 2008, CLIN CHIM ACTA, V390, P126, DOI 10.1016/j.cca.2008.01.010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Volz HP, 1997, BIOL PSYCHIAT, V41, P644, DOI 10.1016/S0006-3223(96)00062-5; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Washizuka S, 2006, AM J MED GENET B, V141B, P301, DOI 10.1002/ajmg.b.30285; Washizuka S, 2005, BIPOLAR DISORD, V7, P146, DOI 10.1111/j.1399-5618.2005.00184.x; Washizuka S, 2003, INT J NEUROPSYCHOPH, V6, P421, DOI 10.1017/S1461145703003778; Washizuka S, 2003, AM J MED GENET B, V120B, P72, DOI 10.1002/ajmg.b.20041; WESTER P, 1985, NEUROCHEM PATHOL, V3, P169, DOI 10.1007/BF02834269; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; WOLYNIEC PS, 1992, J PSYCHIAT RES, V26, P17, DOI 10.1016/0022-3956(92)90012-D; Yildiz-Yesiloglu A, 2006, PROG NEURO-PSYCHOPH, V30, P969, DOI 10.1016/j.pnpbp.2006.03.012; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008	109	160	165	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4913	10.1371/journal.pone.0004913	http://dx.doi.org/10.1371/journal.pone.0004913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290059	Green Published, gold			2022-12-25	WOS:000265496500012
J	Aicher, A; Heeschen, C; Feil, S; Hofmann, F; Mendelsohn, ME; Feil, R; Dimmeler, S				Aicher, Alexandra; Heeschen, Christopher; Feil, Susanne; Hofmann, Franz; Mendelsohn, Michael E.; Feil, Robert; Dimmeler, Stefanie			cGMP-Dependent Protein Kinase I Is Crucial for Angiogenesis and Postnatal Vasculogenesis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; MARROW MONONUCLEAR-CELLS; STIMULATES ANGIOGENESIS; INDUCED MOBILIZATION; NO; NEOVASCULARIZATION; ACTIVATION; CAPACITY; PATHWAY	Background: Endothelium-derived nitric oxide plays an important role for the bone marrow microenvironment. Since several important effects of nitric oxide are mediated by cGMP-dependent pathways, we investigated the role of the cGMP downstream effector cGMP-dependent protein kinase I (cGKI) on postnatal neovascularization. Methodology/Principal Findings: In a disc neovascularization model, cGKI(-/-) mice showed an impaired neovascularization as compared to their wild-type (WT) littermates. Infusion of WT, but not cGKI(-/-) bone marrow progenitors rescued the impaired ingrowth of new vessels in cGKI-deficient mice. Bone marrow progenitors from cGKI(-/-) mice showed reduced proliferation and survival rates. In addition, we used cGKI alpha leucine zipper mutant (LZM) mice as model for cGKI deficiency. LZM mice harbor a mutation in the cGKIa leucine zipper that prevents interaction with downstream signaling molecules. Consistently, LZM mice exhibited reduced numbers of vasculogenic progenitors and impaired neovascularization following hindlimb ischemia compared to WT mice. Conclusions/Significance: Our findings demonstrate that the cGMP-cGKI pathway is critical for postnatal neovascularization and establish a new role for cGKI in vasculogenesis, which is mediated by bone marrow-derived progenitors.	[Aicher, Alexandra; Heeschen, Christopher; Dimmeler, Stefanie] Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Feil, Susanne; Feil, Robert] Univ Tubingen, Interfakult Inst Biochem, D-72074 Tubingen, Germany; [Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, D-8000 Munich, Germany; [Mendelsohn, Michael E.] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Medford, MA 02155 USA	Goethe University Frankfurt; Eberhard Karls University of Tubingen; Technical University of Munich; Tufts University	Aicher, A (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	aicher_a@yahoo.com; dimmeler@em.uni-frankfurt.de	Aicher, Alexandra/GZK-8031-2022; Feil, Robert/B-8918-2014; Feil, Susanne/AAF-7032-2019; Guba, Markus/M-4309-2019	Feil, Robert/0000-0002-7335-4841; Dimmeler, Stefanie/0000-0002-1045-2436; Aicher, Alexandra/0000-0002-8920-9577; Heeschen, Christopher/0000-0002-1158-8554	SFB [553 B6]	SFB(Austrian Science Fund (FWF))	This work was supported by SFB 553 B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Chan SL, 2003, MOL HUM REPROD, V9, P775, DOI 10.1093/molehr/gag094; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; DRAIJER R, 1995, CIRC RES, V77, P897, DOI 10.1161/01.RES.77.5.897; FAJARDO LF, 1988, LAB INVEST, V58, P718; Feil R, 2005, TRENDS MOL MED, V11, P71, DOI 10.1016/j.molmed.2004.12.001; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hornig B, 1998, CIRCULATION, V97, P363; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Massberg S, 1999, J EXP MED, V189, P1255, DOI 10.1084/jem.189.8.1255; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; OSHITA AK, 1977, BLOOD, V49, P585; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Santhanam AVR, 2008, PEPTIDES, V29, P1451, DOI 10.1016/j.peptides.2008.03.016; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Senthilkumar A, 2007, ARTERIOSCL THROM VAS, V27, P1947, DOI 10.1161/ATVBAHA.107.147421; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4879	10.1371/journal.pone.0004879	http://dx.doi.org/10.1371/journal.pone.0004879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287493	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496400019
J	Rambert, J; Mamani-Matsuda, M; Moynet, D; Dubus, P; Desplat, V; Kauss, T; Dehais, J; Schaeverbeke, T; Ezzedine, K; Malvy, D; Vincendeau, P; Mossalayi, MD				Rambert, Jerome; Mamani-Matsuda, Maria; Moynet, Daniel; Dubus, Pierre; Desplat, Vanessa; Kauss, Tina; Dehais, Joel; Schaeverbeke, Thierry; Ezzedine, Khaled; Malvy, Denis; Vincendeau, Philippe; Mossalayi, M. Djavad			Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis	PLOS ONE			English	Article								Background: CD23 is a differentiation/activation antigen expressed by a variety of hematopoietic and epithelial cells. It can also be detected in soluble forms in biological fluids. Initially known as the low-affinity receptor for immunoglobulin E (Fc epsilon RII), CD23 displays various other physiologic ligands such as CD21, CD11b/c, CD47-vitronectin, and mannose-containing proteins. CD23 mediates numerous immune responses by enhancing IgE-specific antigen presentation, regulating IgE synthesis, influencing cell differentiation and growth of both B- and T-cells. CD23-crosslinking promotes the secretion of pro-inflammatory mediators from human monocytes/macrophages, eosinophils and epithelial cells. Increased CD23 expression is found in patients during allergic reactions and rheumatoid arthritis while its physiopathologic role in these diseases remains to be clarified. Methodology/Principal Findings: We previously generated heptapeptidic countrestructures of human CD23. Based on in vitro studies on healthy and arthritic patients' cells, we showed that CD23-specific peptide addition to human macrophages greatly diminished the transcription of genes encoding inflammatory cytokines. This was also confirmed by significant reduction of mediator levels in cell supernatants. We also show that CD23 peptide decreased IgE-mediated activation of both human and rat CD23(+) macrophages. In vivo studies in rat model of arthritis showed that CD23-blocking peptide ameliorates clinical scores and prevent bone destruction in a dose dependent manner. Ex-vivo analysis of rat macrophages further confirmed the inhibitory effect of peptides on their activation. Taken together our results support the role of CD23 activation and subsequent inflammatory response in arthritis. Conclusion: CD23-blocking peptide (p30A) prevents the activation of monocytes/macrophages without cell toxicity. Thus, targeting CD23 by antagonistic peptide decreases inflammatory markers and may have clinical value in the treatment of human arthritis and allergic reactions involving CD23.	[Rambert, Jerome; Mamani-Matsuda, Maria; Moynet, Daniel; Desplat, Vanessa; Kauss, Tina; Ezzedine, Khaled; Malvy, Denis; Vincendeau, Philippe; Mossalayi, M. Djavad] Univ Bordeaux 2, UFR Sci Pharmaceut, Lab Immunol & Parasitol, Grp Therapeut Inflammat & Infect, F-33076 Bordeaux, France; [Dubus, Pierre] Univ Bordeaux 2, EA 2406, F-33076 Bordeaux, France; [Dehais, Joel; Schaeverbeke, Thierry] Univ Pellegrin, Ctr Hosp, Serv Rhumatol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Rambert, J (corresponding author), Univ Bordeaux 2, UFR Sci Pharmaceut, Lab Immunol & Parasitol, Grp Therapeut Inflammat & Infect, F-33076 Bordeaux, France.	djavad.mossalayi@u-bordeaux2.fr	Ezzedine, Khaled/A-3072-2009; MALVY, Denis/T-7930-2019; Ezzedine, Khaled/F-2716-2017; Kauss, Tina/ABC-4020-2020	Ezzedine, Khaled/0000-0002-5468-4589; Kauss, Tina/0000-0002-0541-6684; Dubus, Pierre/0000-0003-1803-4711	Association pour la recherche sur la polyarthrite [pre-doctoral fellowship]; Bordeaux 2 University	Association pour la recherche sur la polyarthrite; Bordeaux 2 University	J.R. was supported by a pre-doctoral fellowship of the Association pour la recherche sur la polyarthrite. This work was supported by the intramural program of the Bordeaux 2 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1995, J IMMUNOL, V154, P6475; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Aubry JP, 1997, J IMMUNOL, V159, P614; Becherel PA, 1997, J IMMUNOL, V159, P5761; Becherel PA, 1997, MOL MED, V3, P686, DOI 10.1007/BF03401707; BECHEREL PA, 1994, J CLIN INVEST, V93, P2275, DOI 10.1172/JCI117227; BECKER H, 1991, CLIN EXP IMMUNOL, V85, P61; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; DUGAS B, 1995, IMMUNOL TODAY, V16, P574, DOI 10.1016/0167-5699(95)80080-8; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hermann P, 1999, J CELL BIOL, V144, P767, DOI 10.1083/jcb.144.4.767; KAISERLIAN D, 1993, IMMUNOLOGY, V80, P90; Karagiannis SN, 2007, J IMMUNOL, V179, P2832, DOI 10.4049/jimmunol.179.5.2832; Kleinau S, 1999, J IMMUNOL, V162, P4266; KOGA T, 1973, J IMMUNOL, V111, P599; KOLB JP, 1994, J BIOL CHEM, V269, P9811; LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7; Loza E, 1999, RHEUMATOLOGY, V38, P325, DOI 10.1093/rheumatology/38.4.325; LUDIN C, 1987, EMBO J, V6, P109, DOI 10.1002/j.1460-2075.1987.tb04726.x; Massa M, 1998, CLIN EXP RHEUMATOL, V16, P611; Montagnac G, 2005, J IMMUNOL, V174, P5562, DOI 10.4049/jimmunol.174.9.5562; Mossalayi M D, 1997, Int Rev Immunol, V16, P129, DOI 10.3109/08830189709045706; MOSSALAYI MD, 1992, EMBO J, V11, P4323, DOI 10.1002/j.1460-2075.1992.tb05531.x; OUAAZ F, 1994, BLOOD, V84, P3095; Pathan NI, 2008, BLOOD, V111, P1594, DOI 10.1182/blood-2007-03-082024; PLATERZYBERK C, 1995, NAT MED, V1, P781, DOI 10.1038/nm0895-781; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Riffo-Vasquez Y, 2000, CLIN EXP ALLERGY, V30, P728; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; So EY, 2002, FEBS LETT, V518, P53, DOI 10.1016/S0014-5793(02)02635-2; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Sukumar S, 2006, J IMMUNOL, V176, P4811, DOI 10.4049/jimmunol.176.8.4811; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; YOKOTA A, 1992, P NATL ACAD SCI USA, V89, P5030, DOI 10.1073/pnas.89.11.5030	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4834	10.1371/journal.pone.0004834	http://dx.doi.org/10.1371/journal.pone.0004834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279679	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496200011
J	Lie, PPY; Mruk, DD; Lee, WM; Cheng, CY				Lie, Pearl P. Y.; Mruk, Dolores D.; Lee, Will M.; Cheng, C. Yan			Epidermal growth factor receptor pathway substrate 8 (Eps8) is a novel regulator of cell adhesion and the blood-testis barrier integrity in the seminiferous epithelium	FASEB JOURNAL			English	Article						spermatogenesis; Sertoli cells; germ cells; actin; actin dynamics	SERTOLI-CELL; ECTOPLASMIC SPECIALIZATION; RAT TESTIS; JUNCTION DYNAMICS; ADHERENS JUNCTIONS; TISSUE INHIBITOR; KINASE PATHWAY; MOUSE TESTES; IN-VIVO; SPERMATOGENESIS	In the seminiferous epithelium, Eps8 is localized to actin-based cell junctions at the blood-testis barrier (BTB) and the apical ectoplasmic specialization (ES) in stage V-VI tubules but is considerably diminished in stage VIII tubules. Eps8 down-regulation coincides with the time of BTB restructuring and apical ES disassembly, implicating the role of Eps8 in cell adhesion. Its involvement in Sertoli-germ cell adhesion was substantiated in studies using an in vivo animal model by treating rats with 1-(2,4-dichlorobenzy)-1H-indazole-3-carbohydrazide (adjudin) to induce anchoring junction restructuring, during which Eps8 disappeared at the apical ES before germ cell departure. In Sertoli cell cultures with established permeability barrier mimicking the BTB in vivo, the knockdown of Eps8 by RNAi led to F-actin disorganization and the mislocalization of the tight junction proteins occludin and ZO-1, suggesting the function of Eps8 in maintaining BTB integrity. In vivo knockdown of Eps8 in the testis caused germ cell sloughing and BTB damage, concomitant with occludin mislocalization, further validating that Eps8 is a novel regulator of cell adhesion and BTB integrity in the seminiferous epithelium.-Lie, P. P. Y., Mruk, D. D., Lee, W. M., Cheng, C. Y. Epidermal growth factor receptor pathway substrate 8 ( Eps8) is a novel regulator of cell adhesion and the blood-testis barrier integrity in the seminiferous epithelium. FASEB J. 23, 2555-2567 (2009)	[Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA; [Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Population Council; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009	Cheng, C Yan/0000-0003-3117-3791	NIH (NICHD) [R01HD056034, R03HD051512]; Hong Kong Research Grants Council [HKU7599/06M]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD051512] Funding Source: NIH RePORTER	NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grants (NICHD, R01HD056034, R03HD051512 to C.Y.C.) and a Hong Kong Research Grants Council grant (HKU7599/06M to W. M. L.).	Aravindan GR, 1996, J CELL PHYSIOL, V168, P123; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CHENG CY, 1986, ENDOCRINOLOGY, V118, P480, DOI 10.1210/endo-118-2-480; Cheng CY, 2001, BIOL REPROD, V65, P449, DOI 10.1095/biolreprod65.2.449; Chung NPY, 2001, BIOL REPROD, V65, P1340, DOI 10.1095/biolreprod65.5.1340; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; D'Souza R, 2009, ENDOCRINOLOGY, V150, P1861, DOI 10.1210/en.2008-1232; de Kretser D.M., 1988, P837; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Galdieri M, 1981, J ANDROL, V5, P249; Guttman JA, 2000, J CELL SCI, V113, P2167; Higgs HN, 2004, NAT CELL BIOL, V6, P1147, DOI 10.1038/ncb1204-1147; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee NPY, 2004, J ANDROL, V25, P200; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lui WY, 2003, ENDOCRINOLOGY, V144, P1139, DOI 10.1210/en.2002-0211; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; Maa MC, 2007, J BIOL CHEM, V282, P19399, DOI 10.1074/jbc.M610280200; MacCalman CD, 1997, ENDOCRINOLOGY, V138, P41, DOI 10.1210/en.138.1.41; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk DD, 2003, J ANDROL, V24, P510; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; PARVINEN M, 1982, ENDOCR REV, V3, P404, DOI 10.1210/edrv-3-4-404; PELLETIER RM, 1992, MICROSC RES TECHNIQ, V20, P3, DOI 10.1002/jemt.1070200104; PINEAU C, 1993, J ANDROL, V14, P87; POLLARD TD, 1999, GUIDEBOOK CYTOSKELET, P3; RUSSELL LD, 1988, BIOL REPROD, V39, P105, DOI 10.1095/biolreprod39.1.105; RUSSELL LD, 1987, GAMETE RES, V17, P43, DOI 10.1002/mrd.1120170106; RUSSELL LD, 1989, TISSUE CELL, V21, P361, DOI 10.1016/0040-8166(89)90051-7; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Toyama Yoshiro, 2003, Anatomical Science International, V78, P1, DOI 10.1046/j.0022-7722.2003.00034.x; Vaid KS, 2007, BIOL REPROD, V77, P1037, DOI 10.1095/biolreprod.107.063735; Velichkova M, 2002, CELL MOTIL CYTOSKEL, V51, P147, DOI 10.1002/cm.10025; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Vogl AW, 2000, ARCH HISTOL CYTOL, V63, P1, DOI 10.1679/aohc.63.1; Vogl AW, 1993, SERTOLI CELL, P39; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Wiebe JP, 2000, J ANDROL, V21, P625; WIEBE JP, 1989, CONTRACEPTION, V39, P447, DOI 10.1016/0010-7824(89)90122-4; WIEBE JP, 1984, LIFE SCI, V34, P1747, DOI 10.1016/0024-3205(84)90574-5; Wong CH, 2005, ENDOCRINOLOGY, V146, P1893, DOI 10.1210/en.2004-1464; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200	59	112	117	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2555	2567		10.1096/fj.06-070573	http://dx.doi.org/10.1096/fj.06-070573			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19293393	Green Published			2022-12-25	WOS:000268836700024
J	Schroeder, MA; Atherton, HJ; Ball, DR; Cole, MA; Heather, LC; Griffin, JL; Clarke, K; Radda, GK; Tyler, DJ				Schroeder, Marie A.; Atherton, Helen J.; Ball, Daniel R.; Cole, Mark A.; Heather, Lisa C.; Griffin, Julian L.; Clarke, Kieran; Radda, George K.; Tyler, Damian J.			Real-time assessment of Krebs cycle metabolism using hyperpolarized C-13 magnetic resonance spectroscopy	FASEB JOURNAL			English	Article						dynamic nuclear polarization; ischemia; pyruvate dehydrogenase; TCA cycle	ACETYL-COENZYME-A; RAT-HEART; PYRUVATE-DEHYDROGENASE; ENERGY-METABOLISM; FAILING HEART; KETONE-BODIES; FATTY-ACIDS; NMR; OXIDATION; ENZYME	The Krebs cycle plays a fundamental role in cardiac energy production and is often implicated in the energetic imbalance characteristic of heart disease. In this study, we measured Krebs cycle flux in real time in perfused rat hearts using hyperpolarized magnetic resonance spectroscopy (MRS). [2-C-13] Pyruvate was hyperpolarized and infused into isolated perfused hearts in both healthy and postischemic metabolic states. We followed the enzymatic conversion of pyruvate to lactate, acetylcarnitine, citrate, and glutamate with 1 s temporal resolution. The appearance of C-13-labeled glutamate was delayed compared with that of other metabolites, indicating that Krebs cycle flux can be measured directly. The production of C-13-labeled citrate and glutamate was decreased postischemia, as opposed to lactate, which was significantly elevated. These results showed that the control and fluxes of the Krebs cycle in heart disease can be studied using hyperpolarized [2-C-13]pyruvate.-Schroeder, M. A., Atherton, H. J., Ball, D. R., Cole, M. A., Heather, L. C., Griffin, J. L., Clarke, K., Radda, G. K. Tyler, D. J. Real-time assessment of Krebs cycle metabolism using hyperpolarized C-13 magnetic resonance spectroscopy. FASEB J. 23, 2529-2538 (2009)	[Schroeder, Marie A.; Atherton, Helen J.; Ball, Daniel R.; Cole, Mark A.; Heather, Lisa C.; Clarke, Kieran; Radda, George K.; Tyler, Damian J.] Univ Oxford, Cardiac Metab Res Grp, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Oxford; University of Cambridge	Tyler, DJ (corresponding author), Univ Oxford, Cardiac Metab Res Grp, Dept Physiol Anat & Genet, Sherrington Bldg,Pk Rd, Oxford OX1 3PT, England.	damian.tyler@dpag.ox.ac.uk	Tyler, Damian/E-6296-2011	Tyler, Damian/0000-0002-0780-8905; Heather, Lisa/0000-0002-7246-1338; Cole, Mark/0000-0002-0727-7833	Newton Abraham Scholarship Foundation; NIH [1-F31-EB006692-01A1]; Medical Research Council (MRC) [G0601490]; British Heart Foundation (BHF) [PG/07/070/23365]; GE-Healthcare and Oxford Instruments Molecular Biotools; MRC [G0601490] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB006692] Funding Source: NIH RePORTER; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish; Medical Research Council [G0601490] Funding Source: researchfish	Newton Abraham Scholarship Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); GE-Healthcare and Oxford Instruments Molecular Biotools; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge previous work from scientists at Imagnia AB (Malmo, Sweden), which aided peak assignment in this study. We also thank Dr. Matthew Merritt and Professor Craig Malloy for helpful discussions regarding perfused heart techniques. M. S. gratefully acknowledges the Newton Abraham Scholarship Foundation for her D. Phil. studentship, and NIH grant 1-F31-EB006692-01A1. This work was funded by research grants from the Medical Research Council (MRC grant G0601490) and the British Heart Foundation (BHF grant PG/07/070/23365) and through equipment support from GE-Healthcare and Oxford Instruments Molecular Biotools.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Atherton HJ, 2006, PHYSIOL GENOMICS, V27, P178, DOI 10.1152/physiolgenomics.00060.2006; BAILEY IA, 1981, FEBS LETT, V123, P315, DOI 10.1016/0014-5793(81)80317-1; BRINDLE KM, 1986, EUR J BIOCHEM, V158, P299, DOI 10.1111/j.1432-1033.1986.tb09751.x; Chen AP, 2007, MAGN RESON MED, V58, P1099, DOI 10.1002/mrm.21256; CLARKE K, 1993, NMR BIOMED, V6, P278, DOI 10.1002/nbm.1940060407; CLARKE K, 1987, J MOL CELL CARDIOL, V19, P1153, DOI 10.1016/S0022-2828(87)80525-4; CROSS HR, 1995, J MOL CELL CARDIOL, V27, P1369, DOI 10.1006/jmcc.1995.0130; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; DEVILLALOBOS DH, 1995, LANCET, V345, P1552; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Jensen P.R., 2008, P INT SOC MAGN RES M; KERBEY AL, 1976, BIOCHEM J, V154, P327, DOI 10.1042/bj1540327; KURHANEWICZ J, 1995, UROLOGY, V45, P459, DOI 10.1016/S0090-4295(99)80016-8; LAUGHLIN MR, 1994, AM J PHYSIOL, V267, pH217, DOI 10.1152/ajpheart.1994.267.1.H217; Lopaschuk GD, 1997, CIRCULATION, V95, P313; Lydell CP, 2002, CARDIOVASC RES, V53, P841, DOI 10.1016/S0008-6363(01)00560-0; LYSIAK W, 1986, J BIOL CHEM, V261, P3698; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; NEELY JR, 1984, CIRC RES, V55, P816, DOI 10.1161/01.RES.55.6.816; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Opie L.H., 2004, HEART PHYSL CELL CIR, DOI 10.1161/01.CIR.0000143724.99618.; Opie LH, 1998, HEART PHYSL CELL CIR; RANDLE PJ, 1963, LANCET, V1, P785; RENSTROM B, 1990, AM J PHYSIOL, V259, pH317, DOI 10.1152/ajpheart.1990.259.2.H317; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Sorokina N, 2007, CIRCULATION, V115, P2033, DOI 10.1161/CIRCULATIONAHA.106.668665; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; Tyler DJ, 2008, APPL MAGN RESON, V34, P523, DOI 10.1007/s00723-008-0115-7	40	167	167	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2529	2538		10.1096/fj.09-129171	http://dx.doi.org/10.1096/fj.09-129171			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19329759	Green Published			2022-12-25	WOS:000268836700021
J	Tan, KM; Duquette, M; Joachimiak, A; Lawler, J				Tan, Kemin; Duquette, Mark; Joachimiak, Andrzej; Lawler, Jack			The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding	FASEB JOURNAL			English	Article						thrombospondins; pseudoachondroplasia; multiple epiphyseal dysplasia	MULTIPLE EPIPHYSEAL DYSPLASIA; EXTRACELLULAR-MATRIX; CELL-DEATH; LIGAND RECOGNITION; COMP MUTATIONS; IX COLLAGEN; A-DOMAIN; PSEUDOACHONDROPLASIA; CALCIUM; THROMBOSPONDIN-1	Cartilage oligomeric matrix protein (COMP), or thrombospondin-5 (TSP-5), is a secreted glycoprotein that is important for growth plate organization and function. Mutations in COMP cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1). In this study, we determined the structure of a recombinant protein that contains the last epidermal growth factor repeat, the type 3 repeats and the C-terminal domain (CTD) of COMP to 3.15-angstrom resolution limit by X-ray crystallography. The CTD is a beta-sandwich that is composed of 15 antiparallel beta-strands, and the type 3 repeats are a contiguous series of calcium binding sites that associate with the CTD at multiple points. The crystal packing reveals an exposed potential metal-ion-dependent adhesion site (MIDAS) on one edge of the beta-sandwich that is common to all TSPs and may serve as a binding site for collagens and other ligands. Disease-causing mutations in COMP disrupt calcium binding, disulfide bond formation, intramolecular interactions, or sites for potential ligand binding. The structure presented here and its unique molecular packing in the crystal identify potential interactive sites for glycosaminoglycans, integrins, and collagens, which are key to cartilage structure and function.-Tan, K., Duquette, M., Joachimiak, A., Lawler, J. The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding. FASEB J. 23, 2490-2501 (2009)	[Duquette, Mark; Lawler, Jack] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Harvard University; Beth Israel Deaconess Medical Center; United States Department of Energy (DOE); Argonne National Laboratory	Lawler, J (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, 330 Brookline Ave,EC CLS 503, Boston, MA 02215 USA.	jlawler@bidmc.harvard.edu	Lawler, Jack/AAJ-1379-2020		National Institutes of Health [HL49081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jacqui Hecht and Dr. Karen Posey for insightful comments and suggestions, and Sami Lawler and Raji Bhat for expert assistance in the preparation of the manuscript. This work was funded by grant HL49081 from the National Institutes of Health. The coordinates and structural factors of E4T3C5 structure have been deposited in the PDB databank under the access code of 3FBY.	Adams JC, 2004, INT J BIOCHEM CELL B, V36, P1102, DOI 10.1016/j.biocel.2004.01.022; Adams JC, 2003, J MOL BIOL, V328, P479, DOI 10.1016/S0022-2836(03)00248-1; Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carlson CB, 2008, J BIOL CHEM, V283, P27089, DOI 10.1074/jbc.M803842200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen TLL, 2008, J CELL BIOCHEM, V103, P778, DOI 10.1002/jcb.21445; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; Dinser R, 2002, J CLIN INVEST, V110, P505, DOI 10.1172/JCI200214386; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giannoni P, 2003, BIORHEOLOGY, V40, P101; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kawaji H, 2002, SKELETAL RADIOL, V31, P730, DOI 10.1007/s00256-002-0553-5; Kawaji H, 2002, GENOME RES, V12, P367, DOI 10.1101/gr.193702; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Weirich C, 2007, MATRIX BIOL, V26, P314, DOI 10.1016/j.matbio.2007.01.004; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200	57	51	55	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2490	2501		10.1096/fj.08-128090	http://dx.doi.org/10.1096/fj.08-128090			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19276170	Green Published			2022-12-25	WOS:000268836700017
J	Nakamura, S; Takamura, T; Matsuzawa-Nagata, N; Takayama, H; Misu, H; Noda, H; Nabemoto, S; Kurita, S; Ota, T; Ando, H; Miyamoto, K; Kaneko, S				Nakamura, Seiji; Takamura, Toshinari; Matsuzawa-Nagata, Naoto; Takayama, Hiroaki; Misu, Hirofumi; Noda, Hiroyo; Nabemoto, Satoko; Kurita, Seiichiro; Ota, Tsuguhito; Ando, Hitoshi; Miyamoto, Ken-ichi; Kaneko, Shuichi			Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SATURATED FATTY-ACIDS; INCREASED OXIDATIVE STRESS; SKELETAL-MUSCLE CELLS; SIGNAL-TRANSDUCTION; JNK PATHWAY; LIVER; CERAMIDE; OBESITY; KINASE	Visceral adiposity in obesity causes excessive free fatty acid (FFA) flux into the liver via the portal vein and may cause fatty liver disease and hepatic insulin resistance. However, because animal models of insulin resistance induced by lipid infusion or a high fat diet are complex and may be accompanied by alterations not restricted to the liver, it is difficult to determine the contribution of FFAs to hepatic insulin resistance. Therefore, we treated H4IIEC3 cells, a rat hepatocyte cell line, with a monounsaturated fatty acid (oleate) and a saturated fatty acid (palmitate) to investigate the direct and initial effects of FFAs on hepatocytes. We show that palmitate, but not oleate, inhibited insulin-stimulated tyrosine phosphorylation of insulin receptor substrate 2 and serine phosphorylation of Akt, through c-Jun NH2-terminal kinase (JNK) activation. Among the well established stimuli for JNK activation, reactive oxygen species (ROS) played a causal role in palmitate-induced JNK activation. In addition, etomoxir, an inhibitor of carnitine palmitoyltransferase-1, which is the rate-limiting enzyme in mitochondrial fatty acid beta-oxidation, as well as inhibitors of the mitochondrial respiratory chain complex (thenoyltrifluoroacetone and carbonyl cyanide m-chlorophenylhydrazone) decreased palmitate-induced ROS production. Together, our findings in hepatocytes indicate that palmitate inhibited insulin signal transduction through JNK activation and that accelerated beta-oxidation of palmitate caused excess electron flux in the mitochondrial respiratory chain, resulting in increased ROS generation. Thus, mitochondria-derived ROS induced by palmitate may be major contributors to JNK activation and cellular insulin resistance.	[Nakamura, Seiji; Takamura, Toshinari; Takayama, Hiroaki; Misu, Hirofumi; Noda, Hiroyo; Nabemoto, Satoko; Kurita, Seiichiro; Ota, Tsuguhito; Ando, Hitoshi; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Matsuzawa-Nagata, Naoto; Miyamoto, Ken-ichi] Kanazawa Univ Hosp, Dept Med Informat, Kanazawa, Ishikawa 9208641, Japan	Kanazawa University; Kanazawa University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan.	ttakamura@m-kanazawa.jp	Takayama, Hiroaki/C-4694-2015; NAGATA, Naoto/D-9261-2012; ANDO, Hitoshi/O-8199-2016; Nagata, Naoto/C-8498-2009	Takayama, Hiroaki/0000-0003-4792-3868; NAGATA, Naoto/0000-0002-2389-2334; ANDO, Hitoshi/0000-0001-6179-9993; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bruce CR, 2007, NAT MED, V13, P1137, DOI 10.1038/nm1007-1137; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Minicis S, 2006, GASTROENTEROLOGY, V131, P272, DOI 10.1053/j.gastro.2006.05.048; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Kaneto H, 2004, DRUG NEWS PERSPECT, V17, P447, DOI 10.1358/dnp.2004.17.7.863704; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Sakurai M, 2007, J GASTROENTEROL, V42, P312, DOI 10.1007/s00535-006-1948; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; TURINSKY J, 1990, J BIOL CHEM, V265, P16880	38	315	325	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14809	14818		10.1074/jbc.M901488200	http://dx.doi.org/10.1074/jbc.M901488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332540	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000266288200016
J	Gong, R; Vu, BK; Feng, Y; Prieto, DA; Dyba, MA; Walsh, JD; Prabakaran, P; Veenstra, TD; Tarasov, SG; Ishima, R; Dimitrov, DS				Gong, Rui; Vu, Bang K.; Feng, Yang; Prieto, DaRue A.; Dyba, Marzena A.; Walsh, Joseph D.; Prabakaran, Ponraj; Veenstra, Timothy D.; Tarasov, Sergey G.; Ishima, Rieko; Dimitrov, Dimiter S.			Engineered Human Antibody Constant Domains with Increased Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; DISULFIDE BOND; CRYSTAL-STRUCTURE; VARIABLE DOMAINS; NMR; STABILIZATION; RECOGNITION; SENSITIVITY; SCAFFOLDS; FRAGMENTS	The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH2 domains are promising as scaffolds for construction of libraries containing diverse binders that could also confer some effector functions. However, previous work has shown that an isolated murine CH2 domain is relatively unstable to thermally induced unfolding. To explore unfolding mechanisms of isolated human CH2 and increase its stability gamma 1 CH2 was cloned and a panel of cysteine mutants was constructed. Human gamma 1 CH2 unfolded at a higher temperature (T-m = 54.1 degrees C, as measured by circular dichroism) than that previously reported for a mouse CH2 (41 degrees C). One mutant (m01) was remarkably stable (T-m = 73.8 degrees C). Similar results were obtained by differential scanning calorimetry. This mutant was also significantly more stable than the wild-type CH2 against urea induced unfolding (50% unfolding at urea concentration of 6.8 M versus 4.2 M). The m01 was highly soluble and monomeric. The existence of the second disulfide bond in m01 and its correct position were demonstrated by mass spectrometry and nuclear magnetic resonance spectroscopy, respectively. The loops were on average more flexible than the framework in both CH2 and m01, and the overall secondary structure was not affected by the additional disulfide bond. These data suggest that a human CH2 domain is relatively stable to unfolding at physiological temperature, and that both CH2 and the highly stable mutant m01 are promising new scaffolds for the development of therapeutics against human diseases.	[Gong, Rui; Vu, Bang K.; Feng, Yang; Prabakaran, Ponraj; Dimitrov, Dimiter S.] NCI Frederick, Prot Interact Grp, CCRNP, CCR,NIH, Frederick, MD 21702 USA; [Tarasov, Sergey G.] NCI Frederick, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Prieto, DaRue A.; Veenstra, Timothy D.] NCI Frederick, Lab Prote & Analyt Technol, SAIC Frederick Inc, Frederick, MD 21702 USA; [Dyba, Marzena A.] NCI Frederick, Struct Biophys Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Walsh, Joseph D.; Ishima, Rieko] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dimitrov, DS (corresponding author), NCI Frederick, Prot Interact Grp, CCRNP, CCR,NIH, Bldg 469,Rm 150B, Frederick, MD 21702 USA.	dimitrov@ncifcrf.gov	Ponraj, Prabakaran/D-6325-2011	Ponraj, Prabakaran/0000-0002-4049-4813	National Institutes of Health; NCI [N01-CO-12400]; Center for Cancer Research Intramural Research Program; Gates Foundation; NATIONAL CANCER INSTITUTE [ZICBC010965, ZIABC010701, ZIABC011155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants from the Intramural AIDS Targeted Antiviral Program (IATAP), the NIAID Intramural Biodefense Program, the NCI, Center for Cancer Research Intramural Research Program (to D. S. D.) and Contract N01-CO-12400 from the NCI. This work was also supported by the Gates Foundation.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Gong QG, 2007, J BIOMOL NMR, V37, P147, DOI 10.1007/s10858-006-9125-7; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Kolmar H, 2008, FEBS J, V275, P2667, DOI 10.1111/j.1742-4658.2008.06437.x; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pellequer JL, 2006, PROTEINS, V65, P192, DOI 10.1002/prot.21059; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0	29	80	96	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14203	14210		10.1074/jbc.M900769200	http://dx.doi.org/10.1074/jbc.M900769200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307178	Green Published, hybrid			2022-12-25	WOS:000266286100026
J	Heinrich, B; Zhang, ZY; Raitskin, O; Hiller, M; Benderska, N; Hartmann, AM; Bracco, L; Elliott, D; Ben-Ari, S; Soreq, H; Sperling, J; Sperling, R; Stamm, S				Heinrich, Bettina; Zhang, Zhaiyi; Raitskin, Oleg; Hiller, Michael; Benderska, Natalya; Hartmann, Annette M.; Bracco, Laurent; Elliott, David; Ben-Ari, Shani; Soreq, Hermona; Sperling, Joseph; Sperling, Ruth; Stamm, Stefan			Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-G; ELECTRON-MICROSCOPY; CARCINOMA-CELLS; INRNP PARTICLES; TAU EXON-10; SR PROTEINS; PHOSPHORYLATION; HTRA2-BETA-1; EXPRESSION; TRA2-BETA	Almost every protein-coding gene undergoes pre-mRNA splicing, and the majority of these pre-mRNAs are alternatively spliced. Alternative exon usage is regulated by the transient formation of protein complexes on the pre-mRNA that typically contain heterogeneous nuclear ribonucleoproteins (hnRNPs). Here we characterize hnRNP G, a member of the hnRNP class of proteins. We show that hnRNP G is a nuclear protein that is expressed in different concentrations in various tissues and that interacts with other splicing regulatory proteins. hnRNP G is part of the supraspliceosome, where it regulates alternative splice site selection in a concentration-dependent manner. Its action on alternative exons can occur without a functional RNA-recognition motif by binding to other splicing regulatory proteins. The RNA-recognition motif of hnRNP G binds to a loose consensus sequence containing a CC(A/C) motif, and hnRNP G preferentially regulates alternative exons where this motif is clustered in close proximity. The X-chromosomally encoded hnRNP G regulates different RNAs than its Y-chromosomal paralogue RNA-binding motif protein, Y-linked (RBMY), suggesting that differences in alternative splicing, evoked by the sex-specific expression of hnRNP G and RBMY, could contribute to molecular sex differences in mammals.	[Heinrich, Bettina; Zhang, Zhaiyi; Benderska, Natalya; Hartmann, Annette M.; Stamm, Stefan] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Raitskin, Oleg; Ben-Ari, Shani; Soreq, Hermona; Sperling, Ruth] Hebrew Univ Jerusalem, IL-91904 Jerusalem, Israel; [Hiller, Michael] Univ Freiburg, Bioinformat Grp, Inst Comp Sci, D-79110 Freiburg, Germany; [Bracco, Laurent] ExonHit Therapeut, Exonhit, F-75013 Paris, France; [Sperling, Joseph] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Elliott, David] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Zhang, Zhaiyi; Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Erlangen Nuremberg; Hebrew University of Jerusalem; University of Freiburg; Weizmann Institute of Science; Newcastle University - UK; University of Kentucky	Stamm, S (corresponding author), B283 Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net	Hartmann, Annette/AAS-6331-2021	Soreq, Hermona/0000-0002-0955-526X	National Institutes of Health [GM079549, P20 RR020171, R21HD056195-01]; German Research Council; Families of SMA, EURASNET; Bundesministerium fur Bildung und Forschung; Weizmann Institute of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); Families of SMA, EURASNET; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Weizmann Institute of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079549 (to R. S. and J.S.), P20 RR020171, and R21HD056195-01 (to S. S.). This work was also supported by the German Research Council, the Families of SMA, EURASNET, the Bundesministerium fur Bildung und Forschung, and a grant from the Helen and Milton Kimmelman Center for Biomolecular Structure and Assembly at the Weizmann Institute of Science (to J.S.).	Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022; Azubel M, 2006, J MOL BIOL, V356, P955, DOI 10.1016/j.jmb.2005.11.078; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cohen-Krausz S, 2007, J MOL BIOL, V368, P319, DOI 10.1016/j.jmb.2007.01.090; Elliott DJ, 2004, INT J ANDROL, V27, P328, DOI 10.1111/j.1365-2605.2004.00496.x; Fehlbaum P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni047; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Lalli E, 2003, J CELL SCI, V116, P441, DOI 10.1242/jcs.00249; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MIRIAMI E, 1995, J MOL BIOL, V246, P254, DOI 10.1006/jmbi.1994.0081; MIRIAMI E, 1994, NUCLEIC ACIDS RES, V22, P3084, DOI 10.1093/nar/22.15.3084; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078; Nadano D, 2001, BIOCHEMISTRY-US, V40, P15184, DOI 10.1021/bi0108397; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Raitskin O, 2002, J STRUCT BIOL, V140, P123, DOI 10.1016/S1047-8477(02)00541-5; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; Sambrook J, 2001, MOL CLONING LAB MANU; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Skrisovska L, 2007, EMBO REP, V8, P372, DOI 10.1038/sj.embor.7400910; SOULARD M, 1991, EXP CELL RES, V193, P59, DOI 10.1016/0014-4827(91)90538-6; SOULARD M, 1993, NUCLEIC ACIDS RES, V21, P4210, DOI 10.1093/nar/21.18.4210; SPANN P, 1989, P NATL ACAD SCI USA, V86, P466, DOI 10.1073/pnas.86.2.466; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; SPERLING R, 1985, MOL CELL BIOL, V5, P569, DOI 10.1128/MCB.5.3.569; Stamm S, 1999, MOL BRAIN RES, V64, P108, DOI 10.1016/S0169-328X(98)00313-1; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Stoss O, 2004, MOL CELL NEUROSCI, V27, P8, DOI 10.1016/j.mcn.2004.04.011; Venables JP, 2000, HUM MOL GENET, V9, P685, DOI 10.1093/hmg/9.5.685; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Yitzhaki S, 1996, P NATL ACAD SCI USA, V93, P8830, DOI 10.1073/pnas.93.17.8830	51	67	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14303	14315		10.1074/jbc.M901026200	http://dx.doi.org/10.1074/jbc.M901026200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19282290	hybrid, Green Published			2022-12-25	WOS:000266286100037
J	Lehmann, M; Milev, MP; Abrahamyan, L; Yao, XJ; Pante, N; Mouland, AJ				Lehmann, Martin; Milev, Miroslav P.; Abrahamyan, Levon; Yao, Xiao-Jian; Pante, Nelly; Mouland, Andrew J.			Intracellular Transport of Human Immunodeficiency Virus Type 1 Genomic RNA and Viral Production Are Dependent on Dynein Motor Function and Late Endosome Positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 AUXILIARY PROTEINS; MEMBRANE-BINDING; PLASMA-MEMBRANE; NUCLEAR EXPORT; NUCLEOCAPSID PROTEIN; GAG MULTIMERIZATION; CYTOPLASMIC DYNEIN; QUALITY-CONTROL; RILP INTERACTS; MATRIX PROTEIN	Our earlier work indicated that the human immunodeficiency virus type 1 (HIV-1) genomic RNA (vRNA) is trafficked to the microtubule-organizing center (MTOC) when heterogeneous nuclear ribonucleoprotein A2/B1 is depleted from cells. Also, Rab7-interacting lysosomal protein promoted dynein motor complex, late endosome and vRNA clustering at the MTOC suggesting that the dynein motor and late endosomes were involved in vRNA trafficking. To investigate the role of the dynein motor in vRNA trafficking, dynein motor function was disrupted by small interference RNA-mediated depletion of the dynein heavy chain or by p50/dynamitin overexpression. These treatments led to a marked relocalization of vRNA and viral structural protein Gag to the cell periphery with late endosomes and a several-fold increase in HIV-1 production. In contrast, rerouting vRNA to the MTOC reduced virus production. vRNA localization depended on Gag membrane association as shown using both myristoylation and Gag nucleocapsid domain proviral mutants. Furthermore, the cytoplasmic localization of vRNA and Gag was not attributable to intracellular or internalized endocytosed virus particles. Our results demonstrate that dynein motor function is important for regulating Gag and vRNA egress on endosomal membranes in the cytoplasm to directly impact on viral production.	[Lehmann, Martin; Milev, Miroslav P.; Abrahamyan, Levon; Mouland, Andrew J.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, RNA Trafficking Lab HIV 1, Montreal, PQ H3T 1E2, Canada; [Milev, Miroslav P.; Mouland, Andrew J.] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Yao, Xiao-Jian] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada; [Pante, Nelly] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Lady Davis Institute; McGill University; McGill University; University of Manitoba; University of British Columbia	Mouland, AJ (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	andrew.mouland@mcgill.ca	Pante, Nelly/GVR-8478-2022; Abrahamyan, Levon/E-1982-2013	Abrahamyan, Levon/0000-0002-0849-0134; Milev, Miroslav/0000-0002-3354-1634; Yao, Xiaojian/0000-0002-5022-1309	Canadian Institutes of Health Research (CIHR) [MOP-56794, MOP-38111]; Canadian Foundation for Innovation [6848]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported in part by the Canadian Institutes of Health Research (CIHR) (Grants MOP-56794 and MOP-38111) and the Canadian Foundation for Innovation (Grant 6848) (to A.J.M.).	Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Benmerah A, 1999, J CELL SCI, V112, P1303; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Butsch M, 2002, J VIROL, V76, P3089, DOI 10.1128/jvi.76.7.3089-3094.2002; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Carson JH, 2005, BIOL CELL, V97, P51; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Cimarelli A, 1999, J VIROL, V73, P5388, DOI 10.1128/JVI.73.7.5388-5401.1999; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Cohen RS, 2005, BIOL CELL, V97, P5; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Dupont S, 1999, NATURE, V402, P681, DOI 10.1038/45272; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; Grigorov B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-54; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kjems J, 2000, Adv Pharmacol, V48, P251; Klein KC, 2007, AIDS REV, V9, P150; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lee YM, 1998, J VIROL, V72, P9061, DOI 10.1128/JVI.72.11.9061-9068.1998; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Li L, 2005, CELL RES, V15, P923, DOI 10.1038/sj.cr.7290370; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Ma S, 2002, J CELL SCI, V115, P1453; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; MOULAND AJ, 2003, CURR GENOMICS, V4, P196; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2005, J VIROL, V79, P14131, DOI 10.1128/JVI.79.22.14131-14140.2005; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; Progida C, 2006, BIOCHEM BIOPH RES CO, V347, P1074, DOI 10.1016/j.bbrc.2006.07.007; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Resh MD, 2005, AIDS REV, V7, P84; Resh MD, 2004, P NATL ACAD SCI USA, V101, P417, DOI 10.1073/pnas.0308043101; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sandefur S, 1998, J VIROL, V72, P2723, DOI 10.1128/JVI.72.4.2723-2732.1998; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schrader M, 2000, J CELL SCI, V113, P3663; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Seelamgari A, 2004, FRONT BIOSCI-LANDMRK, V9, P2388, DOI 10.2741/1403; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Varthakavi V, 2006, TRAFFIC, V7, P298, DOI 10.1111/j.1600-0854.2005.00380.x; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; Yu Z, 2005, P NATL ACAD SCI USA, V102, P4027, DOI 10.1073/pnas.0408889102; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	95	59	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14572	14585		10.1074/jbc.M808531200	http://dx.doi.org/10.1074/jbc.M808531200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19286658	Green Published, hybrid			2022-12-25	WOS:000266286100063
J	Waak, J; Weber, SS; Gorner, K; Schall, C; Ichijo, H; Stehle, T; Kahle, PJ				Waak, Jens; Weber, Stephanie S.; Goerner, Karin; Schall, Christoph; Ichijo, Hidenori; Stehle, Thilo; Kahle, Philipp J.			Oxidizable Residues Mediating Protein Stability and Cytoprotective Interaction of DJ-1 with Apoptosis Signal-regulating Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; DEATH-ASSOCIATED PROTEIN; CYSTEINE-SULFINIC ACID; CELL-DEATH; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; ANTIOXIDATIVE STRESS; ALPHA-SYNUCLEIN; MUTATIONS; DAXX	Parkinson disease (PD)-associated genomic deletions and the destabilizing L166P point mutation lead to loss of the cytoprotective DJ-1 protein. The effects of other PD-associated point mutations are less clear. Here we demonstrate that the M26I mutation reduces DJ-1 expression, particularly in a null background (knockout mouse embryonic fibroblasts). Thus, homozygous M26I mutation causes loss of DJ-1 protein. To determine the cellular consequences, we measured suppression of apoptosis signal-regulating kinase 1 (ASK1) and cytotoxicity for [M26I] DJ-1, and systematically all other DJ-1 methionine and cysteine mutants. C106A mutation of the central redox site specifically abolished binding to ASK1 and the cytoprotective activity of DJ-1. DJ-1 was apparently recruited into the ASK1 signalosome via Cys-106-linked mixed disulfides. The designed higher order oxidation mimicking [C106DD]DJ-1 non-covalently bound to ASK1 even in the absence of hydrogen peroxide and conferred partial cytoprotection. Interestingly, mutations of peripheral redox sites (C46A and C53A) and M26I also led to constitutive ASK1 binding. Cytoprotective [wt] DJ-1 bound to the ASK1 N terminus (which is known to bind another negative regulator, thioredoxin 1), whereas [M26I] DJ-1 bound to aberrant C-terminal site(s). Consequently, the peripheral cysteine mutants retained cytoprotective activity, whereas the PD-associated mutant [M26I] DJ-1 failed to suppress ASK1 activity and nuclear export of the death domain-associated protein Daxx and did not promote cytoprotection. Thus, cytoprotective binding of DJ-1 to ASK1 depends on the central redox-sensitive Cys-106 and may be modulated by peripheral cysteine residues. We suggest that impairments in oxidative conformation changes of DJ-1 might contribute to PD neurodegeneration.	[Waak, Jens; Weber, Stephanie S.; Kahle, Philipp J.] Univ Clin Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, D-72076 Tubingen, Germany; [Goerner, Karin; Kahle, Philipp J.] Univ Munich, Dept Metab Biochem, D-80336 Munich, Germany; [Goerner, Karin] Advalytix Prod, Bio Business Div, Olympus Life Sci Res Europe, D-81377 Munich, Germany; [Schall, Christoph; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo 1130033, Japan; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Olympus Corporation; Eberhard Karls University of Tubingen; University of Tokyo; Vanderbilt University	Kahle, PJ (corresponding author), Univ Clin Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Otfried Muller Str 27, D-72076 Tubingen, Germany.	Philipp.Kahle@Uni-Tuebingen.de		Ichijo, Hidenori/0000-0002-5005-6438	German National Genome Research Network [01GS0466]; Deutsche Forschungsgemeinschaft [SFB596 A12]; Novartis Pharma Ltd; Hertie Foundation	German National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novartis Pharma Ltd; Hertie Foundation	This work was supported by the German National Genome Research Network (NGFN-2 Grant 01GS0466), the Deutsche Forschungsgemeinschaft (Program Project Grant SFB596 A12), a collaborative research contract with Novartis Pharma Ltd., and the Hertie Foundation.	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Abou-Sleiman PM, 2004, CELL TISSUE RES, V318, P185, DOI 10.1007/s00441-004-0922-6; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Gorner K, 2004, J BIOL CHEM, V279, P6943, DOI 10.1074/jbc.M309204200; Hering R, 2004, HUM MUTAT, V24, P321, DOI 10.1002/humu.20089; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; LIU F, 2008, J NEUROCHEM; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	51	113	117	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14245	14257		10.1074/jbc.M806902200	http://dx.doi.org/10.1074/jbc.M806902200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19293155	hybrid, Green Published			2022-12-25	WOS:000266286100031
J	Zhang, ZR; Perrett, S				Zhang, Zai-Rong; Perrett, Sarah			Novel Glutaredoxin Activity of the Yeast Prion Protein Ure2 Reveals a Native-like Dimer within Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; HEAVY-METAL ION; SACCHAROMYCES-CEREVISIAE; DISULFIDE-ISOMERASE; ESCHERICHIA-COLI; OMEGA CLASS; IN-VITRO; THIOLTRANSFERASE GLUTAREDOXIN; MONOTHIOL GLUTAREDOXINS; INSULIN DISULFIDES	Ure2 is the protein determinant of the Saccharomyces cerevisiae prion [URE3]. Ure2 has structural similarity to glutathione transferases, protects cells against heavy metal and oxidant toxicity in vivo, and shows glutathione-dependent peroxidase activity in vitro. Here we report that Ure2 (which has no cysteine residues) also shows thiol-disulfide oxidoreductase activity similar to that of glutaredoxin enzymes. This demonstrates that disulfide reductase activity can be independent of the classical glutaredoxin CXXC/CXXS motif or indeed an intrinsic catalytic cysteine residue. The kinetics of the glutaredoxin activity of Ure2 showed positive cooperativity for the substrate glutathione in both the soluble native state and in amyloid-like fibrils, indicating native-like dimeric structure within Ure2 fibrils. Characterization of the glutaredoxin activity of Ure2 sheds light on its ability to protect yeast from heavy metal ion and oxidant toxicity and suggests a role in reversible protein glutathionylation signal transduction. Observation of allosteric enzyme behavior within amyloid-like Ure2 fibrils not only provides insight into the molecular structure of the fibrils but also has implications for the mechanism of [URE3] prion formation.	[Zhang, Zai-Rong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhang, Zai-Rong] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@iname.com	Zhang, Zairong/G-1030-2013; Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; ZHANG, ZAIRONG/0000-0001-9768-0548	National Natural Science Foundation of China [30620130109, 30670428, 30870482]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences [KSCX2-YW-R-119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30620130109, 30670428, and 30870482; Chinese Ministry of Science and Technology Grants 2006CB500703 and 2006CB910903; and Chinese Academy of Sciences Grant KSCX2-YW-R-119.	Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Collinson EJ, 2003, J BIOL CHEM, V278, P22492, DOI 10.1074/jbc.M301387200; Collinson EJ, 2002, J BIOL CHEM, V277, P16712, DOI 10.1074/jbc.M111686200; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Lillig CH, 2003, J BIOL CHEM, V278, P22325, DOI 10.1074/jbc.M302304200; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Rai R, 2005, YEAST, V22, P343, DOI 10.1002/yea.1215; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Speransky VV, 2001, J CELL BIOL, V153, P1327, DOI 10.1083/jcb.153.6.1327; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Wang XY, 2009, BIOCHEM J, V417, P55, DOI 10.1042/BJ20071702; WANG ZX, 1994, ANAL BIOCHEM, V216, P15, DOI 10.1006/abio.1994.1002; WELLS WW, 1995, METHOD ENZYMOL, V252, P30; WELLS WW, 1990, J BIOL CHEM, V265, P15361; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	45	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14058	14067		10.1074/jbc.M901189200	http://dx.doi.org/10.1074/jbc.M901189200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321443	Green Published, hybrid			2022-12-25	WOS:000266286100012
J	Zhu, YJ; Wu, YJ; Kim, JI; Wang, ZM; Daaka, Y; Nie, ZZ				Zhu, Yunjuan; Wu, Yuanjun; Kim, Jae I.; Wang, Zhimin; Daaka, Yehia; Nie, Zhongzhen			Arf GTPase-activating Protein AGAP2 Regulates Focal Adhesion Kinase Activity and Focal Adhesion Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; CELL-MIGRATION; HUMAN CANCERS; PIKE-A; ASAP1; INVASION; GAPS; DYNAMICS; REGION; MOTILE	Focal adhesions are specialized sites of cell attachment to the extracellular matrix where integrin receptors link extracellular matrix to the actin cytoskeleton, and they are constantly remodeled during cell migration. Focal adhesion kinase (FAK) is an important regulator of focal adhesion remodeling. AGAP2 is an Arf GTPase-activating protein that regulates endosomal trafficking and is overexpressed in different human cancers. Here we examined the regulation of the FAK activity and the focal adhesion remodeling by AGAP2. Our results show that FAK binds the pleckstrin homology domain of AGAP2, and the binding is independent of FAK activation following epidermal growth factor receptor stimulation. Overexpression of AGAP2 augments the activity of FAK, and concordantly, the knockdown of AGAP2 expression with RNA interference attenuates the FAK activity stimulated by epidermal growth factor or platelet-derived growth factor receptors. AGAP2 is localized to the focal adhesions, and its overexpression results in dissolution of the focal adhesions, whereas knockdown of its expression stabilizes them. The AGAP2-induced dissolution of the focal adhesions is independent of its GTPase-activating protein activity but may involve its N-terminal G protein-like domain. Our results indicate that AGAP2 regulates the FAK activity and the focal adhesion disassembly during cell migration.	[Zhu, Yunjuan; Wu, Yuanjun; Kim, Jae I.; Wang, Zhimin; Daaka, Yehia; Nie, Zhongzhen] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Nie, ZZ (corresponding author), Med Coll Georgia, Dept Pathol, 1410 Laney Walker Blvd,CN-3112, Augusta, GA 30912 USA.	znie@mcg.edu		Kim, Jae/0000-0003-1668-3910	National Institutes of Health [CA129155, CA131988]; Department of Pathology at the Medical College of Georgia; NATIONAL CANCER INSTITUTE [R21CA131988, R01CA129155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology at the Medical College of Georgia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129155 and CA131988 (to Y. D.). This work was also supported by start-up funds from the Department of Pathology at the Medical College of Georgia (to Z. N.).	Ahn JY, 2004, P NATL ACAD SCI USA, V101, P6993, DOI 10.1073/pnas.0400921101; Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Ehlers JP, 2005, CLIN CANCER RES, V11, P3609, DOI 10.1158/1078-0432.CCR-04-1941; Elkahloun AG, 1997, GENOMICS, V42, P295, DOI 10.1006/geno.1997.4727; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Okabe H, 2004, INT J ONCOL, V24, P43; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237	33	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13489	13496		10.1074/jbc.M900469200	http://dx.doi.org/10.1074/jbc.M900469200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318351	Green Published, hybrid			2022-12-25	WOS:000265877300025
J	Erales, J; Lignon, S; Gontero, B				Erales, Jenny; Lignon, Sabrina; Gontero, Brigitte			CP12 from Chlamydomonas reinhardtii, a Permanent Specific "Chaperone-like" Protein of Glyceraldehyde-3-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CALVIN CYCLE ACTIVITY; FRESH-WATER DIATOM; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; REDOX-SWITCH; SUPRAMOLECULAR COMPLEX; ASTERIONELLA-FORMOSA; THERMAL AGGREGATION; STRUCTURAL DISORDER; LIGHT REGULATION	Anew role is reported for CP12, a highly unfolded and flexible protein, mainly known for its redox function with A(4) glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Both reduced and oxidized CP12 can prevent the in vitro thermal inactivation and aggregation of GAPDH from Chlamydomonas reinhardtii. This mechanism is thus not redox-dependent. The protection is specific to CP12, because other proteins, such as bovine serum albumin, thioredoxin, and a general chaperone, Hsp33, do not fully prevent denaturation of GAPDH. Furthermore, CP12 acts as a specific chaperone, since it does not protect other proteins, such as catalase, alcohol dehydrogenase, or lysozyme. The interaction between CP12 and GAPDH is necessary to prevent the aggregation and inactivation, since the mutant C66S that does not form any complex with GAPDH cannot accomplish this protection. Unlike the C66S mutant, the C23S mutant that lacks the N-terminal bridge is partially able to protect and to slow down the inactivation and aggregation. Tryptic digestion coupled to mass spectrometry confirmed that the S-loop of GAPDH is the interaction site with CP12. Thus, CP12 not only has a redox function but also behaves as a specific "chaperone-like protein" for GAPDH, although a stable and not transitory interaction is observed. This new function of CP12 may explain why it is also present in complexes involving A(2)B(2) GAPDHs that possess a regulatory C-terminal extension (GapB subunit) and therefore do not require CP12 to be redox-regulated.	[Erales, Jenny; Gontero, Brigitte] CNRS, Lab Enzymol Complexes Supramol, UPR 9036, F-13402 Marseille 20, France; [Lignon, Sabrina] CNRS, Inst Microbiol Mediterranee, IFR88, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Gontero, B (corresponding author), CNRS, Lab Enzymol Complexes Supramol, UPR 9036, 31 Chemin J Aiguier, F-13402 Marseille 20, France.	bmeunier@ifr88.cnrs-mrs.fr			French Ministry of Research (fellowship from the Universite Pierre et Marie Curie, Paris VI, France)	French Ministry of Research (fellowship from the Universite Pierre et Marie Curie, Paris VI, France)(Ministry of Research, France)	Supported by Ph.D. funding from the French Ministry of Research (fellowship from the Universite Pierre et Marie Curie, Paris VI, France).	Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; Bhattacharyya J, 1999, J BIOL CHEM, V274, P15505, DOI 10.1074/jbc.274.22.15505; Boggetto N, 2007, J PHYCOL, V43, P1227, DOI 10.1111/j.1529-8817.2007.00409.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINKMANN H, 1989, PLANT MOL BIOL, V13, P81, DOI 10.1007/BF00027337; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Caldas T, 2006, BIOCHEM BIOPH RES CO, V343, P780, DOI 10.1016/j.bbrc.2006.03.028; CERFF R, 1979, J BIOL CHEM, V254, P6094; Clark JI, 1996, P NATL ACAD SCI USA, V93, P15185, DOI 10.1073/pnas.93.26.15185; Csizmok V, 2007, CURR PROTEIN PEPT SC, V8, P173, DOI 10.2174/138920307780363479; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Delobel A, 2005, RAPID COMMUN MASS SP, V19, P3379, DOI 10.1002/rcm.2192; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker AK, 2007, STRUCTURE, V15, P1026, DOI 10.1016/j.str.2007.08.001; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Erales J, 2008, FEBS J, V275, P1248, DOI 10.1111/j.1742-4658.2008.06284.x; Erales J, 2009, BIOCHEM J, V419, P75, DOI 10.1042/BJ20082004; Erales J, 2008, J PHYCOL, V44, P1455, DOI 10.1111/j.1529-8817.2008.00600.x; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2001, J MOL BIOL, V314, P527, DOI 10.1006/jmbi.2001.5172; Gardebien F, 2006, J MOL GRAPH MODEL, V25, P186, DOI 10.1016/j.jmgm.2005.12.003; Graciet E, 2004, EUR J BIOCHEM, V271, P4737, DOI 10.1111/j.1432-1033.2004.04437.x; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Graciet E, 2003, BIOCHEMISTRY-US, V42, P8163, DOI 10.1021/bi034474x; Graciet E, 2003, EUR J BIOCHEM, V270, P129, DOI 10.1046/j.1432-1033.2003.03372.x; Guha S, 1998, J BIOL CHEM, V273, P30077, DOI 10.1074/jbc.273.46.30077; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebreton S, 2006, FEBS J, V273, P3358, DOI 10.1111/j.1742-4658.2006.05342.x; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Li AD, 1997, PLANT PHYSIOL, V115, P1201, DOI 10.1104/pp.115.3.1201; LIANG SJ, 1990, BIOCHIM BIOPHYS ACTA, V1038, P240, DOI 10.1016/0167-4838(90)90211-W; LIN YZ, 1990, BIOCHIM BIOPHYS ACTA, V1038, P247, DOI 10.1016/0167-4838(90)90212-X; Manna T, 2001, J BIOL CHEM, V276, P39742, DOI 10.1074/jbc.M104061200; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Marri L, 2005, PLANT PHYSIOL, V139, P1433, DOI 10.1104/pp.105.068445; Marri L, 2008, J BIOL CHEM, V283, P1831, DOI 10.1074/jbc.M705650200; Oesterhelt C, 2007, PLANT CELL PHYSIOL, V48, P1359, DOI 10.1093/pcp/pcm108; Pohlmeyer K, 1996, PLANT MOL BIOL, V32, P969, DOI 10.1007/BF00020493; Potters G, 2002, PLANT PHYSIOL BIOCH, V40, P537, DOI 10.1016/S0981-9428(02)01414-6; Robbens S, 2007, J MOL EVOL, V64, P601, DOI 10.1007/s00239-006-0159-y; Scagliarini S, 1998, J EXP BOT, V49, P1307, DOI 10.1093/jexbot/49.325.1307; Scheibe R, 2002, EUR J BIOCHEM, V269, P5617, DOI 10.1046/j.1432-1033.2002.03269.x; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sparla F, 2005, PLANT PHYSIOL, V138, P2210, DOI 10.1104/pp.105.062117; Sparla F, 2002, J BIOL CHEM, V277, P44946, DOI 10.1074/jbc.M206873200; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yoon MK, 2006, PROTEINS, V65, P856, DOI 10.1002/prot.21089; Zhang XF, 2005, INT J BIOCHEM CELL B, V37, P1232, DOI 10.1016/j.biocel.2004.12.004	73	35	35	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12735	12744		10.1074/jbc.M808254200	http://dx.doi.org/10.1074/jbc.M808254200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19287002	Green Published, hybrid			2022-12-25	WOS:000265688300018
J	Hatzios, SK; Schelle, MW; Holsclaw, CM; Behrens, CR; Botyanszki, Z; Lin, FL; Carlson, BL; Kumar, P; Leary, JA; Bertozzi, CR				Hatzios, Stavroula K.; Schelle, Michael W.; Holsclaw, Cynthia M.; Behrens, Christopher R.; Botyanszki, Zsofia; Lin, Fiona L.; Carlson, Brian L.; Kumar, Pawan; Leary, Julie A.; Bertozzi, Carolyn R.			PapA3 Is an Acyltransferase Required for Polyacyltrehalose Biosynthesis in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKAGE POSITION DETERMINATION; SULFOLIPID-1 BIOSYNTHESIS; GENE-EXPRESSION; VIRULENCE; ACYLTREHALOSES; ANTIGENS; MMPL8; ACIDS	Mycobacterium tuberculosis possesses an unusual cell wall that is replete with virulence-enhancing lipids. One cell wall molecule unique to pathogenic M. tuberculosis is polyacyltrehalose (PAT), a pentaacylated, trehalose-based glycolipid. Little is known about the biosynthesis of PAT, although its biosynthetic gene cluster has been identified and found to resemble that of the better studied M. tuberculosis cell wall component sulfolipid-1. In this study, we sought to elucidate the function of papA3, a gene from the PAT locus encoding a putative acyltransferase. To determine whether PapA3 participates in PAT assembly, we expressed the protein heterologously and evaluated its acyltransferase activity in vitro. The purified enzyme catalyzed the sequential esterification of trehalose with two palmitoyl groups, generating a diacylated product similar to the 2,3-diacyltrehalose glycolipids of M. tuberculosis. Notably, PapA3 was selective for trehalose; no activity was observed with other structurally related disaccharides. Disruption of the papA3 gene from M. tuberculosis resulted in the loss of PAT from bacterial lipid extracts. Complementation of the mutant strain restored PAT production, demonstrating that PapA3 is essential for the biosynthesis of this glycolipid in vivo. Furthermore, we determined that the PAT biosynthetic machinery has no cross-talk with that for sulfolipid-1 despite their related structures.	[Hatzios, Stavroula K.; Schelle, Michael W.; Behrens, Christopher R.; Botyanszki, Zsofia; Lin, Fiona L.; Kumar, Pawan; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Carlson, Brian L.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hatzios, Stavroula K.; Schelle, Michael W.; Botyanszki, Zsofia; Lin, Fiona L.; Carlson, Brian L.; Kumar, Pawan; Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Holsclaw, Cynthia M.; Leary, Julie A.] Univ Calif Davis, Sect Mol & Cell Biol, Davis, CA 95616 USA; [Leary, Julie A.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, B84 Hildebrand Hall, Berkeley, CA 94720 USA.	crb@berkeley.edu		Hatzios, Stavroula/0000-0001-8658-8949	National Institutes of Health [AI51622]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051622, R01AI051622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51622 (to C. R. B.).	Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; DAFFE M, 1988, EUR J BIOCHEM, V172, P579, DOI 10.1111/j.1432-1033.1988.tb13928.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; HOFMEISTER GE, 1991, J AM CHEM SOC, V113, P5964, DOI 10.1021/ja00016a007; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; LANGSTON S, 1994, HELV CHIM ACTA, V77, P2341, DOI 10.1002/hlca.19940770821; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; WALLACE PA, 1994, J CHEM SOC CHEM COMM, P329, DOI 10.1039/c39940000329; WALLACE PA, 1994, CARBOHYD RES, V263, P43, DOI 10.1016/0008-6215(94)00164-2; ZHOU ZR, 1990, J ORG CHEM, V55, P5444, DOI 10.1021/jo00307a011	29	53	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12745	12751		10.1074/jbc.M809088200	http://dx.doi.org/10.1074/jbc.M809088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276083	hybrid, Green Published			2022-12-25	WOS:000265688300019
J	Lefevre-Colau, MM; Fayad, F; Rannou, F; Fermanian, J; Coriat, F; Mace, Y; Revel, M; Poiraudeau, S				Lefevre-Colau, Marie-Martine; Fayad, Fouad; Rannou, Francois; Fermanian, Jacques; Coriat, Fernand; Mace, Yann; Revel, Michel; Poiraudeau, Serge			Frequency and Interrelations of Risk Factors for Chronic Low Back Pain in a Primary Care Setting	PLOS ONE			English	Article								Introduction: Many risk factors have been identified for chronic low back pain (cLBP), but only one study evaluated their interrelations. We aimed to investigate the frequency of cLBP risk factors and their interrelations in patients consulting their general practitioners (GPs) for cLBP. Methods: A cross-sectional, descriptive, national survey was performed. 3000 GPs randomly selected were asked to include at least one patient consulting for cLBP. Demographic, clinical characteristics and the presence of cLBP risk factors were recorded. The frequency of each cLBP risk factor was calculated and multiple correspondence analysis (MCA) was performed to study their interrelations. Results: A total of 2068 GPs (68.9%) included at least 1 patient, for 4522 questionnaires analyzed. In the whole sample of patients, the 2 risk factors most commonly observed were history of recurrent LBP (72.1%) and initial limitation of activities of daily living (66.4%). For working patients, common professional risk factors were beliefs, that LBP was due to maintaining a specific posture at work (79.0%) and frequent heavy lifting at work (65.5%). On MCA, we identified 3 risk-factor dimensions (axes) for working and nonworking patients. The main dimension for working patients involved professional risk factors and among these factors, patients' job satisfaction and job recognition largely contribute to this dimension. Discussion: Our results shed in light for the first time the interrelation and the respective contribution of several previously identified cLBP risk factors. They suggest that risk factors representing a "work-related'' dimension are the most important cLBP risk factors in the working population.			Lefevre-Colau, MM (corresponding author), Paris Descartes Univ, Corentin Celton Hosp, AP HP, Dept Phys Med & Rehabil, Issy Les Moulineaux, France.	marie-martine.lefevre-colau@ccl.aphp.fr		Poiraudeau, Serge/0000-0002-1988-9124; lefevre-colau, marie-martine/0000-0002-7493-1225				Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Atlas SJ, 2003, MUSCLE NERVE, V27, P265, DOI 10.1002/mus.10311; Atlas SJ, 2000, J BONE JOINT SURG AM, V82A, P4, DOI 10.2106/00004623-200001000-00002; Bildt C, 2000, INT J BEHAV MED, V7, P372, DOI 10.1207/S15327558IJBM0704_07; Cedraschi C, 2005, BEST PRACT RES CL RH, V19, P577, DOI 10.1016/j.berh.2005.03.002; Clauw DJ, 1999, SPINE, V24, P2035, DOI 10.1097/00007632-199910010-00013; Ekman M, 2005, SPINE, V30, P1777, DOI 10.1097/01.brs.0000171911.99348.90; Fayad F., 2004, Annales de Readaptation et de Medecine Physique, V47, P179, DOI 10.1016/j.annrmp.2004.01.005; Fishbain DA, 1997, CLIN J PAIN, V13, P197, DOI 10.1097/00002508-199709000-00004; Fransen M, 2002, SPINE, V27, P92, DOI 10.1097/00007632-200201010-00022; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Gatchel RJ, 1995, SPINE, V20, P2702, DOI 10.1097/00007632-199512150-00011; George SZ, 2003, SPINE, V28, P2551, DOI 10.1097/01.BRS.0000096677.84605.A2; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Henrotin Y., 2006, REV RHUM, V73, ps33; Hoogendoorn WE, 2002, OCCUP ENVIRON MED, V59, P323, DOI 10.1136/oem.59.5.323; Linton SJ, 2000, SPINE, V25, P2825, DOI 10.1097/00007632-200011010-00017; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Macfarlane GJ, 1999, PAIN, V80, P113, DOI 10.1016/S0304-3959(98)00209-7; Muller CF, 1999, SPINE, V24, P1562, DOI 10.1097/00007632-199908010-00010; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; POLATIN PB, 1993, SPINE, V18, P66, DOI 10.1097/00007632-199301000-00011; *SBU, 2000, 145 SBU; Schiottz-Christensen B, 1999, FAM PRACT, V16, P223, DOI 10.1093/fampra/16.3.223; Seferlis T, 2000, J SPINAL DISORD, V13, P470, DOI 10.1097/00002517-200012000-00002; Swinkels-Meewisse IEJ, 2006, CLIN J PAIN, V22, P45, DOI 10.1097/01.ajp.0000148626.84874.93; Tabachnick BG., USING MULTIVARIATE S; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; Valat JP, 2000, JOINT BONE SPINE, V67, P456; van der Weide WE, 1999, SCAND J WORK ENV HEA, V25, P50, DOI 10.5271/sjweh.383; vandenHoogen H, 1997, SPINE, V22, P1515, DOI 10.1097/00007632-199707010-00019; VOLINN E, 1991, SPINE, V16, P542, DOI 10.1097/00007632-199105000-00010; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Williams RA, 1998, ARCH PHYS MED REHAB, V79, P366, DOI 10.1016/S0003-9993(98)90135-6; 1987, SPINE S, V12, P1	38	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4874	10.1371/journal.pone.0004874	http://dx.doi.org/10.1371/journal.pone.0004874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287499	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400015
J	Valin, A; Barnay-Verdier, S; Robert, T; Ripoche, H; Brellier, F; Chevallier-Lagente, O; Avril, MF; Magnaldo, T				Valin, Alexandre; Barnay-Verdier, Stephanie; Robert, Thomas; Ripoche, Hugues; Brellier, Florence; Chevallier-Lagente, Odile; Avril, Marie-Francoise; Magnaldo, Thierry			PTCH1(+/-) Dermal Fibroblasts Isolated from Healthy Skin of Gorlin Syndrome Patients Exhibit Features of Carcinoma Associated Fibroblasts	PLOS ONE			English	Article								Gorlin's or nevoid basal cell carcinoma syndrome (NBCCS) causes predisposition to basal cell carcinoma (BCC), the commonest cancer in adult human. Mutations in the tumor suppressor gene PTCH1 are responsible for this autosomal dominant syndrome. In NBCCS patients, as in the general population, ultraviolet exposure is a major risk factor for BCC development. However these patients also develop BCCs in sun-protected areas of the skin, suggesting the existence of other mechanisms for BCC predisposition in NBCCS patients. As increasing evidence supports the idea that the stroma influences carcinoma development, we hypothesized that NBCCS fibroblasts could facilitate BCC occurence of the patients. WT (n = 3) and NBCCS fibroblasts bearing either nonsense (n = 3) or missense (n = 3) PTCH1 mutations were cultured in dermal equivalents made of a collagen matrix and their transcriptomes were compared by whole genome microarray analyses. Strikingly, NBCCS fibroblasts over-expressed mRNAs encoding pro-tumoral factors such as Matrix Metalloproteinases 1 and 3 and tenascin C. They also over-expressed mRNA of pro-proliferative diffusible factors such as fibroblast growth factor 7 and the stromal cell-derived factor 1 alpha, known for its expression in carcinoma associated fibroblasts. These data indicate that the PTCH1(+/-) genotype of healthy NBCCS fibroblasts results in phenotypic traits highly reminiscent of those of BCC associated fibroblasts, a clue to the yet mysterious proneness to non photo-exposed BCCs in NBCCS patients.	[Valin, Alexandre; Ripoche, Hugues; Chevallier-Lagente, Odile; Magnaldo, Thierry] Univ Paris 11, Inst Gustave Roussy, CNRS, FRE2939, Villejuif, France; [Barnay-Verdier, Stephanie] Univ Paris 05, Ctr Rech Cordeliers, INSERM, UMRS872, F-75270 Paris, France; [Robert, Thomas] Univ Paris Sud, Inst Gustave Roussy, CNRS, Unite Genom Fonct, Villejuif, France; [Brellier, Florence] Friedrich Miescher Inst, Basel, Switzerland; [Avril, Marie-Francoise] Univ Paris 05, APHP, Serv Dermatol, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Friedrich Miescher Institute for Biomedical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite	Magnaldo, T (corresponding author), Univ Paris 11, Inst Gustave Roussy, CNRS, FRE2939, Villejuif, France.	tmagnaldo@unice.fr		Thierry, Magnaldo/0000-0001-9174-8599; Ripoche, Hugues/0000-0003-0433-1125; Barnay-Verdier, Stephanie/0000-0002-4615-3059; Brellier, Florence/0000-0002-0143-472X	Universite Paris Diderot-Paris 7 [PhD fellowship]; IGR [post-doctoral]; CNRS; Association pour la Recherche sur le Cancer [9500]; Fondation de l'Avenir; Societe Francaise de Dermatologie; Association Francaise contre les Myopathies	Universite Paris Diderot-Paris 7; IGR; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation de l'Avenir; Societe Francaise de Dermatologie; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	AV is recipient of a PhD fellowship from the Universite Paris Diderot-Paris 7. SB was recipient of post-doctoral grant from the IGR. TR is recipient of a grant from the CNRS. This work was performed in the frame of fund for the taxe d'apprentissage from the Institut Gustave Roussy. This work was supported by the CNRS, the Association pour la Recherche sur le Cancer (# 9500), the Fondation de l'Avenir, the Societe Francaise de Dermatologie, the Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Basler K, 2000, EMBO J, V19, P1169, DOI 10.1093/emboj/19.6.1169; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Brellier F, 2008, ONCOGENE, V27, P6601, DOI 10.1038/onc.2008.260; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Chin CWS, 2003, J PATHOL, V200, P308, DOI 10.1002/path.1363; Chu CY, 2007, ONCOGENE, V26, P2491, DOI 10.1038/sj.onc.1210040; COOPER M, 1977, CANCER RES, V37, P2544; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; DARMIENTO J, 1995, MOL CELL BIOL, V15, P5732; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Fischer H, 2001, CARCINOGENESIS, V22, P875, DOI 10.1093/carcin/22.6.875; FRECHET M, 2008, ONCOGENE; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Green J, 1998, BRIT J DERMATOL, V139, P911; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Heitzer E, 2007, J INVEST DERMATOL, V127, P2872, DOI 10.1038/sj.jid.5700923; Howell BG, 2005, J DERMATOL SCI, V39, P39, DOI 10.1016/j.jdermsci.2005.02.004; IMAI K, 1994, FEBS LETT, V352, P216, DOI 10.1016/0014-5793(94)00960-0; Ito Y, 2003, CANCER RES, V63, P6651; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; MAJMUDAR G, 1994, MOL CARCINOGEN, V11, P29, DOI 10.1002/mc.2940110106; MAJMUDAR G, 1994, MOL CARCINOGEN, V9, P17, DOI 10.1002/mc.2940090105; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Monhian N, 2005, ARCH FACIAL PLAST S, V7, P238, DOI 10.1001/archfaci.7.4.238; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Nishiura R, 2005, GYNECOL ENDOCRINOL, V21, P111, DOI 10.1080/09513590500168399; O'Driscoll L, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-74; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Robinson JK, 2003, ARCH DERMATOL, V139, P643, DOI 10.1001/archderm.139.5.643; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Slavik MA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-9; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; STAMP GWH, 1989, J PATHOL, V159, P225, DOI 10.1002/path.1711590309; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Unden AB, 1996, CANCER RES, V56, P4562; Unden AB, 1997, CANCER RES, V57, P2336; VANSCOTT EJ, 1961, J INVEST DERMATOL, V36, P109, DOI 10.1038/jid.1961.21; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wong CSM, 2003, BMJ-BRIT MED J, V327, P794, DOI 10.1136/bmj.327.7418.794; Yamazaki F, 2001, BRIT J DERMATOL, V145, P771, DOI 10.1046/j.1365-2133.2001.04468.x; Zedan W, 2001, J PATHOL, V194, P473, DOI 10.1002/path.940	70	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4818	10.1371/journal.pone.0004818	http://dx.doi.org/10.1371/journal.pone.0004818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287498	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496400001
J	Schilling, D; Gehrmann, M; Steinem, C; De Maio, A; Pockley, AG; Abend, M; Molls, M; Multhoff, G				Schilling, Daniela; Gehrmann, Mathias; Steinem, Claudia; De Maio, Antonio; Pockley, Alan G.; Abend, Michael; Molls, Michael; Multhoff, Gabriele			Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells	FASEB JOURNAL			English	Article						nonapoptotic tumor cell death; stress proteins; ionizing radiation; cancer therapy	HEAT-SHOCK PROTEINS; NATURAL-KILLER-CELLS; IMMUNE-RESPONSE; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; STRESS-PROTEINS; IN-VITRO; HSP70; CANCER	Hypoxia is well known to limit curability of tumors by ionizing radiation. Here, we show that hypoxia treatment of tumor cells causes coexpression of heat shock protein 70 (Hsp70) and phosphatidylserine ( PS) on the cell surface. Colocalization of Hsp70 and PS, as determined by confocal microscopy, also occurs when exogenous FITC-labeled Hsp70 protein is added to normoxic and hypoxic tumor cells. Moreover, the interaction of Hsp70 with PS was demonstrated in artificial unilamellar phosphatidylcholine/phosphatidylserine (PC/PS) liposomes at the physiological ratio of 8/2. Indeed, the Hsp70-liposome interaction gradually increased with elevating PS molar ratios (8/(2) under bar >= 7/3<5/5<4/6<3/7<(2) under bar /8). In contrast, only a weak Hsp70 interaction was detected in phosphatidylcholine/phosphatidylglycerol (PC/PG) liposomes, thus demonstrating that the interaction was not a charge-related effect. The interaction of Hsp70 with surface PS significantly reduces clonogenic cell survival in normoxic (EC50 of Hsp70 = 85 mu g/ml) and hypoxic (EC50 of Hsp70 = 55 mu g/ml) tumor cells. The radiationinduced tumor cell killing was significantly enhanced by the addition of Hsp70 protein (50 mu g/ml). Since apoptosis was not significantly enhanced in normoxic and hypoxic tumor cells by the addition of Hsp70, we hypothesize that the Hsp70 protein-induced reduction in clonogenic cell survival might be through necrosis rather than apoptosis.-Schilling, D., Gehrmann, M., Steinem, C., De Maio, A., Pockley, A. G., Abend, M., Molls, M., Multhoff, G. Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells. FASEB J. 23, 2467-2477 (2009)	[Schilling, Daniela; Gehrmann, Mathias; Molls, Michael; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-81675 Munich, Germany; [Schilling, Daniela; Gehrmann, Mathias; Molls, Michael; Multhoff, Gabriele] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Pathol, Munich, Germany; [Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, Gottingen, Germany; [De Maio, Antonio] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Pockley, Alan G.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Abend, Michael] Fed Armed Forces Med Acad, Inst Radiobiol, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen; University of California System; University of California San Diego; University of Sheffield	Multhoff, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, Ismaningerstr 22, D-81675 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Pockley, Alan G/I-4704-2015; Steinem, Claudia/O-4801-2019; Steinem, Claudia/K-7534-2018	Pockley, Alan G/0000-0001-9593-6431; Steinem, Claudia/0000-0001-8778-9283; Multhoff, Gabriele/0000-0002-2616-3137	Deutsche Forschungsgemeinschaft (DFG) [MU1238 7/2]; Bundesministerium fur Forschung und Technologie (BMBF BioChance plus) [0313686A]; European Union [Transnet 512253, Stemdiagnostics LSHB CT 2007 037703, Cardiorisk 211404]; U.S. National Institutes of Health (NIH) [GM 050878]; Multimmune GmbH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050878] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Forschung und Technologie (BMBF BioChance plus)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multimmune GmbH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG MU1238 7/2 to G. M.), the Bundesministerium fur Forschung und Technologie (BMBF BioChance plus, 0313686A to G. M.), the European Union (Transnet 512253; Stemdiagnostics LSHB CT 2007 037703; Cardiorisk 211404 to G. M.), the U.S. National Institutes of Health (NIH GM 050878 to A. D.), and Multimmune GmbH.	Arispe N, 2004, FASEB J, V18, P1636, DOI 10.1096/fj.04-2088com; Arispe N, 2002, CELL STRESS CHAPERON, V7, P330, DOI 10.1379/1466-1268(2002)007<0330:LIDTCA>2.0.CO;2; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Asea A, 2001, INT J HYPERTHER, V17, P347, DOI 10.1080/02656730110053146; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; BENJAMIN IJ, 1990, P NATL ACAD SCI USA, V87, P6263, DOI 10.1073/pnas.87.16.6263; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Campisi J, 2003, CELL STRESS CHAPERON, V8, P272, DOI 10.1379/1466-1268(2003)008<0272:SEHIAF>2.0.CO;2; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Fouchaq B, 1999, EUR J BIOCHEM, V259, P379, DOI 10.1046/j.1432-1327.1999.00053.x; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; GIACCIA AJ, 1992, INT J RADIAT ONCOL, V23, P891, DOI 10.1016/0360-3016(92)90667-7; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; GRENMAN R, 1989, INT J CANCER, V44, P131, DOI 10.1002/ijc.2910440123; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moseley P, 2000, IMMUNOPHARMACOLOGY, V48, P299, DOI 10.1016/S0162-3109(00)00227-7; Multhoff G, 1997, J IMMUNOL, V158, P4341; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; PRICE BD, 1992, CANCER RES, V52, P3814; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Sovik A, 2007, INT J RADIAT ONCOL, V68, P1496, DOI 10.1016/j.ijrobp.2007.04.027; SRIVASTAVA PK, 1994, EXPERIENTIA, V50, P1054, DOI 10.1007/BF01923461; Terui K, 2004, BIOCHEM J, V380, P203, DOI 10.1042/BJ20031891; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P350; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Walton M, 1997, NEUROREPORT, V8, P3871, DOI 10.1097/00001756-199712220-00007; Wang MH, 2004, BRIT J CANCER, V90, P926, DOI 10.1038/sj.bjc.6601583	43	80	82	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2467	2477		10.1096/fj.08-125229	http://dx.doi.org/10.1096/fj.08-125229			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19289606	Green Published			2022-12-25	WOS:000268836700015
J	Balakrishnan, L; Brandt, PD; Lindsey-Boltz, LA; Sancar, A; Bambara, RA				Balakrishnan, Lata; Brandt, Patrick D.; Lindsey-Boltz, Laura A.; Sancar, Aziz; Bambara, Robert A.			Long Patch Base Excision Repair Proceeds via Coordinated Stimulation of the Multienzyme DNA Repair Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAD9-RAD1-HUS1 CHECKPOINT COMPLEX; POLYMERASE-BETA; FLAP ENDONUCLEASE-1; LIGASE-I; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; FISSION YEAST; CLAMP; SUBSTRATE; PROTEINS; CLEAVAGE	Base excision repair, a major repair pathway in mammalian cells, is responsible for correcting DNA base damage and maintaining genomic integrity. Recent reports show that the Rad9-Rad1-Hus1 complex (9-1-1) stimulates enzymes proposed to perform a long patch-base excision repair sub-pathway (LP-BER), including DNA glycosylases, apurinic/apyrimidinic endonuclease 1 (APE1), DNA polymerase beta (pol beta), flap endonuclease 1 (FEN1), and DNA ligase I (LigI). However, 9-1-1 was found to produce minimal stimulation of FEN1 and LigI in the context of a complete reconstitution of LP-BER. We show here that pol beta is a robust stimulator of FEN1 and a moderate stimulator of LigI. Apparently, there is a maximum possible stimulation of these two proteins such that after responding to pol beta or another protein in the repair complex, only a small additional response to 9-1-1 is allowed. The 9-1-1 sliding clamp structure must serve primarily to coordinate enzyme actions rather than enhancing rate. Significantly, stimulation by the polymerase involves interaction of primer terminus-bound pol beta with FEN1 and LigI. This observation provides compelling evidence that the proposed LP-BER pathway is actually employed in cells. Moreover, this pathway has been proposed to function by sequential enzyme actions in a "hit and run" mechanism. Our results imply that this mechanism is still carried out, but in the context of a multienzyme complex that remains structurally intact during the repair process.	[Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of Rochester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_bambara@urmc.rochester.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194	National Institutes of Health [GM024441, GM032833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 (to R.A.B.), with additional support from Grant GM032833 (to A.S.).	Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; CASASFINET JR, 1991, J BIOL CHEM, V266, P19618; Chang DY, 2005, J BIOL CHEM, V280, P408, DOI 10.1074/jbc.M406800200; Dahm K, 2002, ONCOGENE, V21, P7710, DOI 10.1038/sj.onc.1205872; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Jaiswal AS, 2002, ONCOGENE, V21, P5912, DOI 10.1038/sj.onc.1205789; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Petermann E, 2003, DNA REPAIR, V2, P1101, DOI 10.1016/S1568-7864(03)00117-4; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Rajendran S, 1998, J BIOL CHEM, V273, P31021, DOI 10.1074/jbc.273.47.31021; Ranalli TA, 2002, J BIOL CHEM, V277, P41715, DOI 10.1074/jbc.M207207200; REIN DC, 1990, EUKARYOTIC NUCLEUS M, V1, P95; Sattler U, 2003, EMBO REP, V4, P363, DOI 10.1038/sj.embor.embor796; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Tom S, 2001, J BIOL CHEM, V276, P48781, DOI 10.1074/jbc.M109626200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	49	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15158	15172		10.1074/jbc.M109.000505	http://dx.doi.org/10.1074/jbc.M109.000505			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329425	hybrid, Green Published			2022-12-25	WOS:000266288200051
J	Bhattacharyya, S; Keirsey, J; Russell, B; Kavecansky, J; Lillard-Wetherell, K; Tahmaseb, K; Turchi, JJ; Groden, J				Bhattacharyya, Saumitri; Keirsey, Jeremy; Russell, Beatriz; Kavecansky, Juraj; Lillard-Wetherell, Kate; Tahmaseb, Kambiz; Turchi, John J.; Groden, Joanna			Telomerase-associated Protein 1, HSP90, and Topoisomerase II alpha Associate Directly with the BLM Helicase in Immortalized Cells Using ALT and Modulate Its Helicase Activity Using Telomeric DNA Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNERS-SYNDROME GENES; REPLICATION FORK; BLOOMS; SGS1; MAINTENANCE; TRF2; RECOMBINATION; INTERACTS; RAD50/MRE11/NBS1; INSTABILITY	The BLM helicase associates with the telomere structural proteins TRF1 and TRF2 in immortalized cells using the alternative lengthening of telomere (ALT) pathways. This work focuses on identifying protein partners of BLM in cells using ALT. Mass spectrometry and immunoprecipitation techniques have identified three proteins that bind directly to BLM and TRF2 in ALT cells: telomerase-associated protein 1 (TEP1), heat shock protein 90 (HSP90), and topoisomerase II alpha (TOPOII alpha). BLM predominantly co-localizes with these proteins in foci actively synthesizing DNA during late S and G(2)/M phases of the cell cycle when ALT is thought to occur. Immunoprecipitation studies also indicate that only HSP90 and TOPOII alpha are components of a specific complex containing BLM, TRF1, and TRF2 but that this complex does not include TEP1. TEP1, TOPOII alpha, and HSP90 interact directly with BLM in vitro and modulate its helicase activity on telomere-like DNA substrates but not on non-telomeric substrates. Initial studies suggest that knockdown of BLM in ALT cells reduces average telomere length but does not do so in cells using telomerase.	[Bhattacharyya, Saumitri; Keirsey, Jeremy; Russell, Beatriz; Kavecansky, Juraj; Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Lillard-Wetherell, Kate] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Howard Hughes Med Inst, Coll Med, Cincinnati, OH 43267 USA; [Tahmaseb, Kambiz] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA; [Turchi, John J.] Indiana Univ, Dept Biochem & Mol Biol, Sch Med, Indianapolis, IN 46220 USA; [Turchi, John J.] Indiana Univ, Dept Med, Sch Med, Indianapolis, IN 46220 USA	University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Groden, J (corresponding author), 460 W 12th Ave,986 Biomed Res Tower, Columbus, OH 43210 USA.	groden.2@osu.edu	Turchi, John J/B-5807-2015	Turchi, John J/0000-0001-5375-2992	National Institutes of Health [CA-117898]; Bloom's Syndrome Foundation; NATIONAL CANCER INSTITUTE [R01CA117898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloom's Syndrome Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-117898. This work was also supported by The Bloom's Syndrome Foundation.	BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Franchitto A, 2002, J CELL BIOL, V157, P19, DOI 10.1083/jcb.200110009; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; GERMAN J, 1966, ANN GENET-PARIS, V9, pG143; Grobelny JV, 2000, J CELL SCI, V113, P4577; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Igel H, 1998, RNA, V4, P1; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Laine JP, 2003, CANCER RES, V63, P7136; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; Lillard-Wetherell K, 2005, CANCER RES, V65, P5520, DOI 10.1158/0008-5472.CAN-05-0632; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Shor E, 2002, GENETICS, V162, P647; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Ui A, 2005, DNA REPAIR, V4, P191, DOI 10.1016/j.dnarep.2004.09.002; Ui A, 2001, MOL GENET GENOMICS, V265, P837, DOI 10.1007/s004380100479; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Watt PM, 1996, GENETICS, V144, P935; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yeager TR, 1999, CANCER RES, V59, P4175; Yoon HJ, 1998, BBA-GENE STRUCT EXPR, V1395, P110, DOI 10.1016/S0167-4781(97)00139-5; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	40	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14966	14977		10.1074/jbc.M900195200	http://dx.doi.org/10.1074/jbc.M900195200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329795	Green Published, hybrid			2022-12-25	WOS:000266288200033
J	Hernandez, A; Jiang, XY; Cubero, B; Nieto, PM; Bressan, RA; Hasegawa, PM; Pardo, JM				Hernandez, Agustin; Jiang, Xingyu; Cubero, Beatriz; Nieto, Pedro M.; Bressan, Ray A.; Hasegawa, Paul M.; Pardo, Jose M.			Mutants of the Arabidopsis thaliana Cation/H+ Antiporter AtNHX1 Conferring Increased Salt Tolerance in Yeast THE ENDOSOME/PREVACUOLAR COMPARTMENT IS A TARGET FOR SALT TOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; NA+/H+ EXCHANGER; SACCHAROMYCES-CEREVISIAE; POTASSIUM UPTAKE; ION HOMEOSTASIS; TOPOLOGY MODEL; PH; PROTEIN; GOLGI; VACUOLE	Mutants of the plant cation/H+ antiporter AtNHX1 that confer greater halotolerance were generated by random mutagenesis and selected in yeast by phenotypic complementation. The amino acid substitutions that were selected were conservative and occurred in the second half of the membrane-associated N terminus. AtNHX1 complemented the lack of endogenous ScNHX1 in endosomal protein trafficking assays. Growth enhancement on hygromycin B and vanadate media agreed with a generally improved endosomal/prevacuolar function of the mutated proteins. In vivo measurements by P-31 NMR revealed that wild-type and mutant AtNHX1 transporters did not affect cytosolic or vacuolar pH. Surprisingly, when yeast cells were challenged with lithium, a tracer for sodium, the main effect of the mutations in AtNHX1 was a reduction in the amount of compartmentalized lithium. When purified and reconstituted into proteoliposomes or assayed in intact vacuoles isolated from yeast cells, a representative mutant transporter (V318I) showed a greater cation discrimination favoring potassium transport over that of sodium or lithium. Together, our data suggest that the endosome/prevacuolar compartment is a target for salt toxicity. Poisoning by toxic cations in the endosome/prevacuolar compartment is detrimental for cell functions, but it can be alleviated by improving the discrimination of transported alkali cations by the resident cation/H+ antiporter.	[Hernandez, Agustin; Jiang, Xingyu; Cubero, Beatriz; Pardo, Jose M.] CSIC, Inst Recursos Nat & Agrobiol, IRNASE, Seville 41012, Spain; [Nieto, Pedro M.] CSIC, IIQ, Seville 41092, Spain; [Bressan, Ray A.; Hasegawa, Paul M.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pardo, JM (corresponding author), CSIC, Inst Recursos Nat & Agrobiol, IRNASE, Avda Reina Mercedes 10, Seville 41012, Spain.	pardo@cica.es	Nieto, Pedro M/B-7869-2008; Pardo, Jose M/AAB-5866-2022; Hernandez, Agustin/E-4544-2010; Pardo, Jose M./B-4652-2009	Nieto, Pedro M/0000-0002-4074-9011; Pardo, Jose M/0000-0003-4510-8624; Hernandez, Agustin/0000-0002-7884-8023; Pardo, Jose M./0000-0003-4510-8624; Bressan, Ray/0000-0002-8754-606X	Ministry of Science and Innovation in Spain [BFU2006-06968]	Ministry of Science and Innovation in Spain(Ministry of Science and Innovation, Spain (MICINN))	This work was supported by Ministry of Science and Innovation in Spain Grant BFU2006-06968.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bachert C, 2001, MOL BIOL CELL, V12, P3152, DOI 10.1091/mbc.12.10.3152; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Carmelo V, 1997, BBA-BIOMEMBRANES, V1325, P63, DOI 10.1016/S0005-2736(96)00245-3; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILLIES R J, 1992, Cellular Physiology and Biochemistry, V2, P159, DOI 10.1159/000154638; Hernandez A, 1998, BIOINFORMATICS, V14, P227, DOI 10.1093/bioinformatics/14.2.227; JIA ZP, 1992, EMBO J, V11, P1631, DOI 10.1002/j.1460-2075.1992.tb05209.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Miseta A, 1999, J BIOL CHEM, V274, P5939, DOI 10.1074/jbc.274.9.5939; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; MURGUIA JR, 1995, SCIENCE, V267, P232; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Navarre C, 2000, EMBO J, V19, P2515, DOI 10.1093/emboj/19.11.2515; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pouyssegur J, 2001, Novartis Found Symp, V240, P186; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Ritter M, 2001, CELL PHYSIOL BIOCHEM, V11, P1, DOI 10.1159/000047787; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Rockwell NC, 2002, J BIOL CHEM, V277, P17531, DOI 10.1074/jbc.M111909200; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Roos W, 1997, J BIOL CHEM, V272, P15849, DOI 10.1074/jbc.272.25.15849; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Sato Y, 2005, J BIOCHEM, V138, P425, DOI 10.1093/jb/mvi132; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Shaw JD, 2001, EXP CELL RES, V271, P1, DOI 10.1006/excr.2001.5373; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sychrova H, 1999, FEMS MICROBIOL LETT, V171, P167, DOI 10.1111/j.1574-6968.1999.tb13428.x; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoshida S, 2000, MOL GEN GENET, V263, P877, DOI 10.1007/s004380000255; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257; Zizak M, 2000, BIOCHEMISTRY-US, V39, P8102, DOI 10.1021/bi000870t	63	62	64	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14276	14285		10.1074/jbc.M806203200	http://dx.doi.org/10.1074/jbc.M806203200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307188	Green Published, hybrid			2022-12-25	WOS:000266286100034
J	Hua, QX; Xu, B; Huang, K; Hu, SQ; Nakagawa, S; Jia, WH; Wang, S; Whittaker, J; Katsoyannis, PG; Weiss, MA				Hua, Qing-xin; Xu, Bin; Huang, Kun; Hu, Shi-Quan; Nakagawa, Satoe; Jia, Wenhua; Wang, Shuhua; Whittaker, Jonathan; Katsoyannis, Panayotis G.; Weiss, Michael A.			Enhancing the Activity of a Protein by Stereospecific Unfolding CONFORMATIONAL LIFE CYCLE OF INSULIN AND ITS EVOLUTIONARY ORIGINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-ASSOCIATED MUTATIONS; RECEPTOR-BINDING SURFACE; SINGLE-CHAIN INSULIN; MUTANT HUMAN INSULIN; PHOTO-CROSS-LINKING; B-CHAIN; A-CHAIN; CHIRAL MUTAGENESIS; STRUCTURAL SWITCH; CRYSTAL-STRUCTURE	A central tenet of molecular biology holds that the function of a protein is mediated by its structure. An inactive ground-state conformation may nonetheless be enjoined by the interplay of competing biological constraints. A model is provided by insulin, well characterized at atomic resolution by x-ray crystallography. Here, we demonstrate that the activity of the hormone is enhanced by stereospecific unfolding of a conserved structural element. A bifunctional beta-strand mediates both self-assembly (within beta-cell storage vesicles) and receptor binding (in the bloodstream). This strand is anchored by an invariant side chain (Phe(B24)); its substitution by Ala leads to an unstable but native-like analog of low activity. Substitution by D-Ala is equally destabilizing, and yet the protein diastereomer exhibits enhanced activity with segmental unfolding of the beta-strand. Corresponding photoactivable derivatives (containing L- or D-para-azido-Phe) cross-link to the insulin receptor with higher D-specific efficiency. Aberrant exposure of hydrophobic surfaces in the analogs is associated with accelerated fibrillation, a form of aggregation-coupled misfolding associated with cellular toxicity. Conservation of Phe(B24), enforced by its dual role in native self-assembly and induced fit, thus highlights the implicit role of misfolding as an evolutionary constraint. Whereas classical crystal structures of insulin depict its storage form, signaling requires engagement of a detachable arm at an extended receptor interface. Because this active conformation resembles an amyloidogenic intermediate, we envisage that induced fit and self-assembly represent complementary molecular adaptations to potential proteotoxicity. The cryptic threat of misfolding poses a universal constraint in the evolution of polypeptide sequences.	[Hua, Qing-xin; Xu, Bin; Huang, Kun; Hu, Shi-Quan; Jia, Wenhua; Wang, Shuhua; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Nakagawa, Satoe] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Katsoyannis, Panayotis G.] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Case Western Reserve University; University of Chicago; Icahn School of Medicine at Mount Sinai	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012	Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK040949, DK069764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK040949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK040949 and DK069764 (to M.A.W.). This is a contribution from the Cleveland Center for Membrane and Structural Biology.	Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; ASSOIAN RK, 1982, P NATL ACAD SCI-BIOL, V79, P5147, DOI 10.1073/pnas.79.17.5147; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; COSMATOS A, 1979, INT J PEPT PROT RES, V14, P457; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; HUA QX, 1993, P NATL ACAD SCI USA, V90, P582, DOI 10.1073/pnas.90.2.582; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KOBAYASHI M, 1989, DIABETES RES CLIN PR, V7, P25, DOI 10.1016/0168-8227(89)90040-5; KOBAYASHI M, 1984, BIOCHEM BIOPH RES CO, V119, P49, DOI 10.1016/0006-291X(84)91616-4; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Kurapkat G, 1999, PROTEIN SCI, V8, P499; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200	79	37	38	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14586	14596		10.1074/jbc.M900085200	http://dx.doi.org/10.1074/jbc.M900085200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321436	Green Published, hybrid			2022-12-25	WOS:000266286100064
J	Wang, ZH; Treder, K; Miller, WA				Wang, Zhaohui; Treder, Krzysztof; Miller, W. Allen			Structure of a Viral Cap-independent Translation Element That Functions via High Affinity Binding to the eIF4E Subunit of eIF4F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO NECROSIS VIRUS; INITIATION-FACTOR 4E; MESSENGER-RNA-CAP; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; YEAST 2-HYBRID SYSTEM; ENATION MOSAIC-VIRUS; FACTOR ISO 4E; 3'-UNTRANSLATED REGION	RNAs of many positive strand RNA viruses lack a 5' cap structure and instead rely on cap-independent translation elements (CITEs) to facilitate efficient translation initiation. The mechanisms by which these RNAs recruit ribosomes are poorly understood, and for many viruses the CITE is unknown. Here we identify the first CITE of an umbravirus in the 3'-untranslated region of pea enation mosaic virus RNA 2. Chemical and enzymatic probing of the similar to 100-nucleotide PEMV RNA 2 CITE (PTE), and mutagenesis revealed that it forms a long, bulged helix that branches into two short stem-loops, with a possible pseudoknot interaction between a C-rich bulge at the branch point and a G-rich bulge in the main helix. The PTE inhibited translation in trans, and addition of eIF4F, but not eIFiso4F, restored translation. Filter binding assays revealed that the PTE binds eIF4F and its eIF4E subunit with high affinity. Tight binding required an intact cap-binding pocket in eIF4E. Among many PTE mutants, there was a strong correlation between PTE-eIF4E binding affinity and ability to stimulate cap-independent translation. We conclude that the PTE recruits eIF4F by binding eIF4E. The PTE represents a different class of translation enhancer element, as defined by its structure and ability to bind eIF4E in the absence of an m(7)G cap.	[Wang, Zhaohui; Treder, Krzysztof; Miller, W. Allen] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA; [Miller, W. Allen] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University; Iowa State University	Miller, WA (corresponding author), Iowa State Univ, Dept Plant Pathol, 351 Bessey Hall, Ames, IA 50011 USA.	wamiller@iastate.edu	Wang, Zhaohui/E-8139-2013; Treder, Krzysztof/L-3856-2014	Treder, Krzysztof/0000-0002-8764-0574	National Institutes of Health [2R01 GM067104]; Hatch Act and State of Iowa funds [3608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act and State of Iowa funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 GM067104. This is journal paper of the Iowa Agriculture and Home Economics Experiment Station, Ames, IA, Project No. 3608 was supported by Hatch Act and State of Iowa funds.	ALLEN ML, 1992, J BIOL CHEM, V267, P23232; Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Barry JK, 2002, P NATL ACAD SCI USA, V99, P11133, DOI 10.1073/pnas.162223099; Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Demler SA, 1997, J GEN VIROL, V78, P511, DOI 10.1099/0022-1317-78-3-511; DEMLER SA, 1993, J GEN VIROL, V74, P1, DOI 10.1099/0022-1317-74-1-1; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; German-Retana S, 2008, J VIROL, V82, P7601, DOI 10.1128/JVI.00209-08; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOSS DJ, 1990, BIOCHEMISTRY-US, V29, P5008, DOI 10.1021/bi00473a002; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Guo L, 2000, RNA, V6, P1808, DOI 10.1017/S1355838200001539; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; JEFFREY SB, 2006, FEBS LETT, V580, P2591; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Meulewaeter F, 1998, RNA, V4, P1347, DOI 10.1017/S135583829898092X; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Miller WA, 2006, ANNU REV PHYTOPATHOL, V44, P447, DOI 10.1146/annurev.phyto.44.070505.143353; MILLER WA, 2009, RECODING EX IN PRESS; Mizumoto H, 2003, J VIROL, V77, P12113, DOI 10.1128/JVI.77.22.12113-12121.2003; Mochizuki K, 2005, RNA, V11, P77, DOI 10.1261/rna.7108205; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Morino S, 1996, EUR J BIOCHEM, V239, P597, DOI 10.1111/j.1432-1033.1996.0597u.x; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Niepel M, 1999, FEBS LETT, V462, P79, DOI 10.1016/S0014-5793(99)01514-8; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.02885.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Qu F, 2000, J VIROL, V74, P1085, DOI 10.1128/JVI.74.3.1085-1093.2000; RAKOTONDRAFARA AM, 2007, CURRENT PROTOCOLS MI; Rakotondrafara AM, 2006, RNA, V12, P1893, DOI 10.1261/rna.115606; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Scheets K, 2006, VIROLOGY, V350, P171, DOI 10.1016/j.virol.2006.02.004; Shen RZ, 2004, J VIROL, V78, P4655, DOI 10.1128/JVI.78.9.4655-4664.2004; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Stupina VA, 2008, RNA, V14, P2379, DOI 10.1261/rna.1227808; Taliansky ME, 2003, J GEN VIROL, V84, P1951, DOI 10.1099/vir.0.19219-0; TIMMER RT, 1993, J BIOL CHEM, V268, P9504; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Van Lipzig R, 2002, RNA, V8, P229, DOI 10.1017/S1355838202018071; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; WANG SP, 1995, J BIOL CHEM, V270, P13446, DOI 10.1074/jbc.270.22.13446; Wang SP, 1997, EMBO J, V16, P4107, DOI 10.1093/emboj/16.13.4107; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	60	63	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14189	14202		10.1074/jbc.M808841200	http://dx.doi.org/10.1074/jbc.M808841200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19276085	hybrid, Green Published			2022-12-25	WOS:000266286100025
J	Diab, H; Ohira, M; Liu, ML; Cobb, E; Kane, PM				Diab, Heba; Ohira, Masashi; Liu, Mali; Cobb, Ester; Kane, Patricia M.			Subunit Interactions and Requirements for Inhibition of the Yeast V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; N-TERMINAL DOMAIN; V-ATPASE; REGULATORY PROTEIN; CRYSTAL-STRUCTURE; PERIPHERAL STALK; STATOR; F-1-ATPASE; COMPLEX; VMA13P	Disassembly of the yeast V-ATPase into cytosolic V-1 and membrane V-0 sectors inactivates MgATPase activity of the V-1-ATPase. This inactivation requires the V-1 H subunit (Parra, K. J., Keenan, K. L., and Kane, P. M. (2000) J. Biol. Chem. 275, 21761-21767), but its mechanism is not fully understood. The H subunit has two domains. Interactions of each domain with V-1 and V-0 subunits were identified by two-hybrid assay. The B subunit of the V-1 catalytic headgroup interacted with the H sub unit N-terminal domain (H-NT), and the C-terminal domain (H-CT) interacted with V-1 subunits B, E (peripheral stalk), and D (central stalk), and the cytosolic N-terminal domain of V-0 subunit Vph1p. V-1-ATPase complexes from yeast expressing H-NT are partially inhibited, exhibiting 26% the MgATPase activity of complexes with no H subunit. The H-CT domain does not copurify with V-1 when expressed in yeast, but the bacterially expressed and purified H-CT domain inhibits MgATPase activity in V-1 lacking H almost as well as the full-length H subunit. Binding of full-length H subunit to V-1 was more stable than binding of either H-NT or H-CT, suggesting that both domains contribute to binding and inhibition. Intact H and H-CT can bind to the expressed N-terminal domain of Vph1p, but this fragment of Vph1p does not bind to V-1 complexes containing subunit H. We propose that upon disassembly, the H subunit undergoes a conformational change that inhibits V-1-ATPase activity and precludes V-0 interactions.	[Diab, Heba; Ohira, Masashi; Liu, Mali; Cobb, Ester; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	kanepm@upstate.edu			National Institutes of Health [R01-GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM50322 ( to P. M. K.).	Bai C, 1997, METHOD ENZYMOL, V283, P141; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Flannery AR, 2008, J BIOL CHEM, V283, P29099, DOI 10.1074/jbc.M803280200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Gledhill JR, 2005, BIOCHEM J, V386, P591, DOI 10.1042/BJ20041513; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; James P, 1996, GENETICS, V144, P1425; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1992, J BIOL CHEM, V267, P447; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4128, DOI 10.1021/bi00313a018; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rizzo JM, 2007, J BIOL CHEM, V282, P8521, DOI 10.1074/jbc.M607092200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Tucker WC, 2004, J BIOL CHEM, V279, P47415, DOI 10.1074/jbc.C400269200; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	46	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13316	13325		10.1074/jbc.M900475200	http://dx.doi.org/10.1074/jbc.M900475200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299516	hybrid, Green Published			2022-12-25	WOS:000265877300007
J	Lee, JH; Kim, HN; Yang, D; Jung, K; Kim, HM; Kim, HH; Ha, H; Lee, ZH				Lee, Jong-Ho; Kim, Ha-Neui; Yang, Daum; Jung, Kyoungsuk; Kim, Hyun-Man; Kim, Hong-Hee; Ha, Hyunil; Lee, Zang Hee			Trolox Prevents Osteoclastogenesis by Suppressing RANKL Expression and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; LACKING C-FOS; BONE-RESORPTION; RECEPTOR ACTIVATOR; MICE LACKING; CRUCIAL ROLE; OSTEOPROTEGERIN LIGAND; OXIDATIVE STRESS; GENE-EXPRESSION	Excessive receptor activator of NF-kappa B ligand (RANKL) signaling causes enhanced osteoclast formation and bone resorption. Thus, down-regulation of RANKL expression or its downstream signals may be a therapeutic approach to the treatment of pathological bone loss. In this study, we investigated the effects of Trolox, a water-soluble vitamin E analogue, on osteoclastogenesis and RANKL signaling. Trolox potently inhibited interleukin-1-induced osteoclast formation in bone marrow cell-osteoblast coculture by abrogating RANKL induction in osteoblasts. This RANKL reduction was attributed to the reduced production of prostaglandin E-2 via a down-regulation of cyclooxygenase-2 activity. We also found that Trolox inhibited osteoclast formation from bone marrow macrophages induced by macrophage colony-stimulating factor plus RANKL in a reversible manner. Trolox was effective only when present during the early stage of culture, which implies that it targets early osteoclast precursors. Pretreatment with Trolox did not affect RANKL-induced early signaling pathways, including MAPKs, NF-kappa B, and Akt. We found that Trolox down-regulated the induction by RANKL of c-Fos protein by suppressing its translation. Ectopic overexpression of c-Fos rescued the inhibition of osteoclastogenesis by Trolox in bone marrow macrophages. Trolox also suppressed interleukin-1-induced osteoclast formation and bone loss in mouse calvarial bone. Taken together, our findings indicate that Trolox prevents osteoclast formation and bone loss by inhibiting both RANKL induction in osteoblasts and c-Fos expression in osteoclast precursors.	[Lee, Jong-Ho; Kim, Ha-Neui; Yang, Daum; Jung, Kyoungsuk; Kim, Hyun-Man; Kim, Hong-Hee; Ha, Hyunil; Lee, Zang Hee] Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Dent Res Inst, Seoul 110749, South Korea	Seoul National University (SNU)	Ha, H (corresponding author), Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Dent Res Inst, 28 Yeongon Dong, Seoul 110749, South Korea.	hyunil74@hotmail.com; zang1959@snu.ac.kr			21st Century Frontier R D Program; Korea Science and Engineering Foundation Science Research Center; Korean Ministry of Education, Science, and Technology	21st Century Frontier R D Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation Science Research Center(Korea Science and Engineering Foundation); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Center for Biological Modulators of the 21st Century Frontier R & D Program and the Korea Science and Engineering Foundation Science Research Center through Bone Metabolism Research Center, the Korean Ministry of Education, Science, and Technology.	Abramson SB, 2002, RHEUMATOLOGY, V41, P972, DOI 10.1093/rheumatology/41.9.972; Besselink GAJ, 2003, VOX SANG, V85, P25, DOI 10.1046/j.1423-0410.2003.00318.x; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Diaz Z, 2005, BLOOD, V105, P1237, DOI 10.1182/blood-200405-1772; Eum HA, 2004, BRIT J PHARMACOL, V142, P35, DOI 10.1038/sj.bjp.0705758; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Ha H, 2006, J IMMUNOL, V176, P111, DOI 10.4049/jimmunol.176.1.111; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lorenzo JA, 1998, ENDOCRINOLOGY, V139, P3022, DOI 10.1210/en.139.6.3022; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Ouedraogo GD, 2003, PHOTOCHEM PHOTOBIOL, V77, P192, DOI 10.1562/0031-8655(2003)077<0192:SROSET>2.0.CO;2; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Xiao T, 2003, J TOXICOL ENV HEAL A, V66, P469, DOI 10.1080/15287390306449; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	43	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13725	13734		10.1074/jbc.M806941200	http://dx.doi.org/10.1074/jbc.M806941200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299513	hybrid, Green Published			2022-12-25	WOS:000265877300050
J	Saitoh, A; Shin, HW; Yamada, A; Waguri, S; Nakayama, K				Saitoh, Akina; Shin, Hye-Won; Yamada, Akane; Waguri, Satoshi; Nakayama, Kazuhisa			Three Homologous ArfGAPs Participate in Coat Protein I-mediated Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; COPI VESICLES; GOLGI MEMBRANES; ARF GAPS; COMPLEX; LOCALIZATION; HYDROLYSIS; CARGO; BIG2	ArfGAP1 is a prototype of GTPase-activating proteins for ADP-ribosylation factors (ARFs) and has been proposed to be involved in retrograde transport from the Golgi apparatus to the endoplasmic reticulum (ER) by regulating the uncoating of coat protein I (COPI)-coated vesicles. Depletion of ArfGAP1 by RNA interference, however, causes neither a discernible phenotypic change in the COPI localization nor a change in the Golgi-to-ER retrograde transport. Therefore, we also examined ArfGAP2 and ArfGAP3, closely related homologues of ArfGAP1. Cells in which ArfGAP1, ArfGAP2, and ArfGAP3 are simultaneously knocked down show an increase in the GTP-bound ARF level. Furthermore, in these cells proteins resident in or cycling through the cis-Golgi, including ERGIC-53, beta-COP, and GM130, accumulate in the ER-Golgi intermediate compartment, and Golgi-to-ER retrograde transport is blocked. The phenotypes observed in the triple ArfGAP knockdown cells are similar to those seen in beta-COP-depleted cells. Both the triple ArfGAP- and beta-COP-depleted cells accumulate characteristic vacuolar structures that are visible under electron microscope. Furthermore, COPI is concentrated at rims of the vacuolar structures in the ArfGAP-depleted cells. On the basis of these observations, we conclude that ArfGAP1, ArfGAP2, and ArfGAP3 have overlapping roles in regulating COPI function in Golgi-to-ER retrograde transport.	[Saitoh, Akina; Shin, Hye-Won; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Sci, Sakyo Ku, Kyoto 6068501, Japan; [Yamada, Akane; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan	Kyoto University; Kyoto University; Fukushima Medical University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Nakayama, Kazuhisa/ABF-2924-2020; Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science; Targeted Proteins Research Program; International Young Scientists Career Development Organization ( ICDO) of Kyoto University; Uehara Memorial Foundation; NOVARTIS Foundation ( Japan) for the Promotion of Science; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Young Scientists Career Development Organization ( ICDO) of Kyoto University; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation ( Japan) for the Promotion of Science(Novartis); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for Promotion of Science, the Targeted Proteins Research Program, the International Young Scientists Career Development Organization ( ICDO) of Kyoto University, the Uehara Memorial Foundation, the NOVARTIS Foundation ( Japan) for the Promotion of Science, and the Hayashi Memorial Foundation for Female Natural Scientists.	Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Futatsumori M, 2000, J BIOCHEM-TOKYO, V128, P793, DOI 10.1093/oxfordjournals.jbchem.a022817; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson PA, 1996, J CELL SCI, V109, P2811; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.e04-04-0316; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Nickel W, 1998, J CELL SCI, V111, P3081; Nickel W, 1998, HISTOCHEM CELL BIOL, V109, P477, DOI 10.1007/s004180050249; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Pepperkok R, 2000, J CELL SCI, V113, P135; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Shin HW, 2005, METHOD ENZYMOL, V404, P206, DOI 10.1016/S0076-6879(05)04020-6; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Waguri S, 1999, ARCH HISTOL CYTOL, V62, P423, DOI 10.1679/aohc.62.423; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Zhang CG, 2000, GENOMICS, V63, P400, DOI 10.1006/geno.1999.6095	58	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13948	13957		10.1074/jbc.M900749200	http://dx.doi.org/10.1074/jbc.M900749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299515	Green Published, hybrid			2022-12-25	WOS:000265877300070
J	Zhang, H; Liu, CY; Zha, ZY; Zhao, B; Yao, J; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Zhang, Heng; Liu, Chen-Ying; Zha, Zheng-Yu; Zhao, Bin; Yao, Jun; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; FACTOR CTGF; PROLIFERATION; TUMORIGENESIS; COACTIVATOR; EXPRESSION; APOPTOSIS; PROMOTES	The TAZ transcription co-activator has been shown to promote cell proliferation and to induce epithelial-mesenchymal transition. Recently we have demonstrated that TAZ is phosphorylated and inhibited by the Hippo tumor suppressor pathway, which is altered in human cancer. The mechanism of TAZ-mediated transcription is unclear. We demonstrate here that TEAD is a key downstream transcription factor mediating the function of TAZ. Disruption of TEAD-TAZ binding or silencing of TEAD expression blocked the function of TAZ to promote cell proliferation and to induce epithelial-mesenchymal transition, demonstrating TEAD as a key downstream effector of TAZ. We also identified CTGF, a gene that regulates cell adhesion, proliferation, and migration, as a direct target of TAZ and TEAD. Our study establishes a functional partnership between TAZ and TEAD under negative regulation by the Hippo signaling pathway.	[Zhang, Heng; Liu, Chen-Ying; Zha, Zheng-Yu; Yao, Jun; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhang, Heng; Liu, Chen-Ying; Zhao, Shimin] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Zhao, Bin; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhao, Bin; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Lei, QY (corresponding author), Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; zha, zhengyu/0000-0002-8619-3661; Liu, Chen-Ying/0000-0002-8930-6182	National Institutes of Health [RO1CA65572, RO1CA132809]; Chinese Ministry of Education, National High Technology Research and Development Program of China [2004BA711A18, 2006AA02A308]; State Key Development Program for Basic Research of China [2006CB806700, 2009CB918401]; National Natural Science Foundation of China [30600112, 30871255]; Shanghai Key Project [06JC14086]; Pufa Talent [07pj14011]; Shanghai Leading Academic Discipline [B110]; University of Michigan; NATIONAL CANCER INSTITUTE [R01CA065572, R01CA132809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Education, National High Technology Research and Development Program of China(Ministry of Education, China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Project; Pufa Talent; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants RO1CA65572 and RO1CA132809 (to Y. X. and K.-L. G.). This work was also supported by 985 Program from the Chinese Ministry of Education, National High Technology Research and Development Program of China Grants 2004BA711A18 and 2006AA02A308, State Key Development Program for Basic Research of China Grants 2006CB806700 and 2009CB918401, National Natural Science Foundation of China Grants 30600112 and 30871255, Shanghai Key Project Grant 06JC14086, Pufa Talent Grant 07pj14011, Shanghai Leading Academic Discipline Project, project number B110, and a University of Michigan Rackham predoctoral fellowship (to B. Z.).	Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	23	387	404	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13355	13362		10.1074/jbc.M900843200	http://dx.doi.org/10.1074/jbc.M900843200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324877	hybrid, Green Published			2022-12-25	WOS:000265877300011
J	Funakoshi-Tago, M; Tago, K; Sumi, K; Abe, M; Aizu-Yokota, E; Oshio, T; Sonoda, Y; Kasahara, T				Funakoshi-Tago, Megumi; Tago, Kenji; Sumi, Kazuya; Abe, Miyuki; Aizu-Yokota, Eriko; Oshio, Tomoyuki; Sonoda, Yoshiko; Kasahara, Tadashi			The Acute Lymphoblastic Leukemia-associated JAK2 L611S Mutant Induces Tumorigenesis in Nude Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; PSEUDOKINASE DOMAIN; POLYCYTHEMIA-VERA; INDUCED APOPTOSIS; GENE-EXPRESSION; CELL-DEATH; LINKED IAP; BCL-X; ACTIVATION; RECEPTOR	JAK2 plays important roles in the regulation of a variety of cellular processes including cell migration, proliferation, and protection from apoptosis. Recently the L611S point mutation in JAK2 has been identified in a child with acute lymphoblastic leukemia. Here we analyzed the mechanism by which JAK2 exhibits its oncogenicity. In BaF3 murine hematopoietic cells, L611S mutant increased the expression of antiapoptotic proteins including X chromosome-linked inhibitor of apoptosis protein, inhibitor of apoptosis protein, and Bcl-XL. We also showed that JAK2 L611S mutant protects BaF3 cells from cytokine withdrawal-induced apoptotic cell death and leads to cytokine-independent cell growth. Furthermore BaF3 cells expressing JAK2 L611S mutant gained the ability to induce tumorigenesis in nude mice. The L611S mutant also exhibited malignancy, including prompt invasion and spreading into various organs, leading to rapid lethality of the mice. Finally we showed that a specific JAK2 inhibitor, AG490, potently inhibited cytokine-independent cell growth induced by JAK2 L611S mutant via the induction of apoptotic cell death. In addition, treatment with AG490 significantly inhibited the JAK2 L611S mutant-induced tumorigenesis in nude mice. Thus, our results both in vitro and in vivo strongly suggest that L611S mutant of JAK2 harbors potent oncogenic activity, and this probably requires the antiapoptotic signaling pathway.	[Funakoshi-Tago, Megumi; Sumi, Kazuya; Abe, Miyuki; Aizu-Yokota, Eriko; Oshio, Tomoyuki; Sonoda, Yoshiko; Kasahara, Tadashi] Keio Univ, Dept Biochem, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Tago, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Nara 6300101, Japan	Keio University; Nara Institute of Science & Technology	Funakoshi-Tago, M (corresponding author), Keio Univ, Dept Biochem, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp	Aizu-Yokota, Eriko/AAH-1318-2020		Ministry of Education, Culture, Sports, Science and Technology [G19790071]; Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	This work was supported in part by Ministry of Education, Culture, Sports, Science and Technology Grant G19790071 and grants from the Research Foundation for Pharmaceutical Sciences and the Hi-Tech Research Center Project for Private Universities in Japan.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P1681, DOI 10.1016/j.bcp.2008.09.012; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; GOTTSCHALK AR, 1994, P NATL ACAD SCI USA, V91, P7350, DOI 10.1073/pnas.91.15.7350; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kratz CP, 2006, LEUKEMIA, V20, P381, DOI 10.1038/sj.leu.2404060; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328	32	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12680	12690		10.1074/jbc.M808879200	http://dx.doi.org/10.1074/jbc.M808879200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19289461	Green Published, hybrid			2022-12-25	WOS:000265688300012
J	Meyer, PA; Ye, P; Suh, MH; Zhang, M; Fu, J				Meyer, Peter A.; Ye, Ping; Suh, Man-Hee; Zhang, Mincheng; Fu, Jianhua			Structure of the 12-Subunit RNA Polymerase II Refined with the Aid of Anomalous Diffraction Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION COMPLEX; MOLECULAR-BASIS; TRANSCRIPTION; INITIATION; RESOLUTION; ARCHITECTURE; TEMPERATURE; SUBUNIT; RPB4; DNA	RNApolymerase II (Pol II) is the central enzyme of eukaryotic gene expression machinery. Complete definition of the three-dimensional structure of Pol II is essential for understanding the mechanisms that regulate transcription via protein-protein interactions within the Pol II apparatus. To date a series of Pol II-related crystal structures have been reported. However, certain peptide regions, including several that are implicated to interact with regulatory factors, remain obscure. Here we describe conformations for two such regions that are close to the Pol II surface and assume seemingly flexible loop structures. One is located in the TFIIF-interacting Protrusion domain, whereas the other is in the TFIIE-interacting Clamp domain. This structural definition was aided by the application of an advanced crystallographic refinement approach that utilizes the single anomalous diffraction (SAD) from zinc ions bound intrinsically in Pol II. The SAD-based strategy allowed the 12-subunit Pol II model to be fully refined up to 3.8 A with excellent stereochemical properties, demonstrating the effectiveness of the SAD approach for the refinement of large structures at low-tomoderate resolutions. Our results also define additional components of the free Pol II, including the functionally critical Fork Loop-1 and Fork Loop-2 elements. As such, this refined Pol II model provides the most complete structural reference for future analyses of complex structures formed between Pol II and its regulatory factors.	[Meyer, Peter A.; Ye, Ping; Suh, Man-Hee; Zhang, Mincheng; Fu, Jianhua] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Meyer, Peter A.; Suh, Man-Hee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Medical College of Wisconsin; Cornell University	Fu, J (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	jfu@mcw.edu			National Institutes of Health [GM064651]; American Cancer Society [IRG-01-231-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM064651 (to J.F.). This work was also supported by American Cancer Society Grant IRG-01-231-01 (to J.F.).	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Arrahams JP, 2003, METHOD ENZYMOL, V374, P163; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EYCK LFT, 2001, INT TABLES CRYSTALLO, P369; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HOWLIN B, 1989, ACTA CRYSTALLOGR A, V45, P851, DOI 10.1107/S0108767389009177; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meyer PA, 2006, STRUCTURE, V14, P973, DOI 10.1016/j.str.2006.04.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pannu NS, 2004, ACTA CRYSTALLOGR D, V60, P22, DOI 10.1107/S0907444903020808; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rosenheck S, 1998, J BACTERIOL, V180, P6187; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Skubak P, 2005, ACTA CRYSTALLOGR D, V61, P1626, DOI 10.1107/S0907444905032233; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	45	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12933	12939		10.1074/jbc.M809199200	http://dx.doi.org/10.1074/jbc.M809199200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19289466	hybrid, Green Published			2022-12-25	WOS:000265688300039
J	Sakoh-Nakatogawa, M; Nishikawa, S; Endo, T				Sakoh-Nakatogawa, Machiko; Nishikawa, Shuh-ichi; Endo, Toshiya			Roles of Protein-disulfide Isomerase-mediated Disulfide Bond Formation of Yeast Mnl1p in Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; MOLECULAR CHAPERONES; QUALITY-CONTROL; SIGNAL; RETROTRANSLOCATION; MUTATIONS; CALNEXIN	The endoplasmic reticulum (ER) has a strict protein quality control system. Misfolded proteins generated in the ER are degraded by the ER-associated degradation (ERAD). Yeast Mnl1p consists of an N-terminal mannosidase homology domain and a less conserved C-terminal domain and facilitates the ERAD of glycoproteins. We found that Mnl1p is an ER luminal protein with a cleavable signal sequence and stably interacts with a protein-disulfide isomerase (PDI). Analyses of a series of Mnl1p mutants revealed that interactions between the C-terminal domain of Mnl1p and PDI, which include an intermolecular disulfide bond, are essential for subsequent introduction of a disulfide bond into the mannosidase homology domain of Mnl1p by PDI. This disulfide bond is essential for the ERAD activity of Mnl1p and in turn stabilizes the prolonged association of PDI with Mnl1p. Close interdependence between Mnl1p and PDI suggests that these two proteins form a functional unit in the ERAD pathway.	[Sakoh-Nakatogawa, Machiko; Nishikawa, Shuh-ichi; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp						Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; CREIGHTON TE, 1995, TRENDS BIOTECHNOL, V13, P18, DOI 10.1016/S0167-7799(00)88896-4; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; QADOTA H, 1992, YEAST, V8, P735, DOI 10.1002/yea.320080906; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; SIKORSKI RS, 1989, GENETICS, V122, P19; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; YAFFE MP, P NATL ACAD SCI US, V81, P4819; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	41	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11815	11825		10.1074/jbc.M900813200	http://dx.doi.org/10.1074/jbc.M900813200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19279007	hybrid, Green Published			2022-12-25	WOS:000265494600013
J	Daprati, E; Iosa, M; Haggard, P				Daprati, Elena; Iosa, Marco; Haggard, Patrick			A Dance to the Music of Time: Aesthetically-Relevant Changes in Body Posture in Performing Art	PLOS ONE			English	Article							BALLET DANCERS; HIP; PREFERENCE; MOTION; RANGE	In performing arts, body postures are both means for expressing an artist's intentions, and also artistic objects, appealing to the audience. The postures of classical ballet obey the body's biomechanical limits, but also follow strict rules established by tradition. This combination offers a perfect milieu for assessing scientifically how the execution of this particular artistic activity has changed over time, and evaluating what factors may induce such changes. We quantified angles between body segments in archive material showing dancers from a leading company over a 60-year period. The data showed that body positions supposedly fixed by codified choreography were in fact implemented by very different elevation angles, according to the year of ballet production. Progressive changes lead to increasingly vertical positions of the dancer's body over the period studied. Experimental data showed that these change reflected aesthetic choices of naive modern observers. Even when reduced to stick figures and unrecognisable shapes, the more vertical postures drawn from later productions were systematically preferred to less vertical postures from earlier productions. This gradual change within a conservative art form provides scientific evidence that aesthetic change may arise from continuous interaction between artistic tradition, individual artists' creativity, and a wider environmental context. This context may include social aesthetic pressure from audiences.	[Daprati, Elena] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Daprati, Elena] IRCCS Fdn Santa Lucia, Dipartimento Fisiol Neuromotor, Rome, Italy; [Iosa, Marco] Ist Univ Sci Motor, Dipartimento Sci Movimento Umano Sport, Rome, Italy; [Haggard, Patrick] UCL, Inst Cognitive Neurosci, London WC1E 6BT, England	University of Rome Tor Vergata; IRCCS Santa Lucia; University of London; University College London	Daprati, E (corresponding author), Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy.	p.haggard@ucl.ac.uk	Iosa, Marco/B-9531-2012; Haggard, Patrick/A-5081-2010; Iosa, Marco/AAC-1693-2022; daprati, elena/AAA-2224-2019	Iosa, Marco/0000-0003-2434-3887; Haggard, Patrick/0000-0001-7798-793X	Leverhulme Trust; BBSRC ISIS	Leverhulme Trust(Leverhulme Trust); BBSRC ISIS(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by a Leverhulme Trust project grant, and a BBSRC ISIS grant awarded to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor W., 1970, AESTHETISCHE THEORIE; Gallego MAA, 2007, REV DERECHO COMUNITA, V11, P203; Austin TR, 1951, J APPL PSYCHOL, V35, P430, DOI 10.1037/h0058574; Bandura A., 1971, SOCIAL LEARNING THEO; Birkhoff GD, 1933, AESTHETIC MEASURE; BOSELIE F, 1992, EMPIR STUD ARTS, V10, P1, DOI DOI 10.2190/QB14-NK7B-ARYT-W5QT; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Cohn J., 1894, PHILOS STUD, V10, P562; Cutting J., 2006, NEW DIRECTIONS AESTH, P33, DOI [10.4324/9781315224084-4, DOI 10.4324/9781315224084-4]; Dawkins R, 1976, SELFISH GENE; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; EYSENCK HJ, 1968, J GEN PSYCHOL, V79, P3, DOI 10.1080/00221309.1968.9710447; Fechner G.T., 1876, VORSCHULE STHETIK; FECHNER GT, 1897, VORSCHULE ASTHETIK; Funch BjarneS., 1997, PSYCHOL ART APPRECIA; Gombrich Ernst., 1972, STORY ART, V13; Gupta A, 2004, BRIT J SPORT MED, V38, P778, DOI 10.1136/bjsm.2003.010827; Khan K, 1997, CLIN J SPORT MED, V7, P174, DOI 10.1097/00042752-199707000-00004; KUSHNER S, 1990, AM J SPORT MED, V18, P286, DOI 10.1177/036354659001800312; LABAN R, 1928, KINETOGRAPHIE; Noverre J.G, 2009, LETT DANSE BALLETS, V2; RAMACHANDRAN VS, 1999, J CONSCIOUSNESS STUD, V6; Schama S., 2006, POWER ART; Stepanov Vladimir Ivanovich, 1892, ALPHABET MOUVEMENTS; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P2	29	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e5023	10.1371/journal.pone.0005023	http://dx.doi.org/10.1371/journal.pone.0005023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PM	19325705	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499400008
J	Santos, LO; Marinho, FA; Altoe, EF; Vitorio, BS; Alves, CR; Britto, C; Motta, MCM; Branquinha, MH; Santos, ALS; d'Avila-Levy, CM				Santos, Livia O.; Marinho, Fernanda A.; Altoe, Ellen F.; Vitorio, Bianca S.; Alves, Carlos R.; Britto, Constanca; Motta, Maria Cristina M.; Branquinha, Marta H.; Santos, Andre L. S.; d'Avila-Levy, Claudia M.			HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTILEISHMANIAL ACTIVITY; VISCERAL LEISHMANIASIS; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; CYSTEINE PEPTIDASES; AUTOPHAGY; REPLICATION; EXPRESSION; VIRULENCE	Background: Leishmania is the etiologic agent of leishmanisais, a protozoan disease whose pathogenic events are not well understood. Current therapy is suboptimal due to toxicity of the available therapeutic agents and the emergence of drug resistance. Compounding these problems is the increase in the number of cases of Leishmania-HIV coinfection, due to the overlap between the AIDS epidemic and leishmaniasis. Methodology/Principal Findings: In the present report, we have investigated the effect of HIV aspartyl peptidase inhibitors (PIs) on the Leishmania amazonensis proliferation, ultrastructure, interaction with macrophage cells and expression of classical peptidases which are directly involved in the Leishmania pathogenesis. All the HIV PIs impaired parasite growth in a dose-dependent fashion, especially nelfinavir and lopinavir. HIV PIs treatment caused profound changes in the leishmania ultrastructure as shown by transmission electron microscopy, including cytoplasm shrinking, increase in the number of lipid inclusions and some cells presenting the nucleus closely wrapped by endoplasmic reticulum resembling an autophagic process, as well as chromatin condensation which is suggestive of apoptotic death. The hydrolysis of HIV peptidase substrate by L. amazonensis extract was inhibited by pepstatin and HIV PIs, suggesting that an aspartyl peptidase may be the intracellular target of the inhibitors. The treatment with HIV PIs of either the promastigote forms preceding the interaction with macrophage cells or the amastigote forms inside macrophages drastically reduced the association indexes. Despite all these beneficial effects, the HIV PIs induced an increase in the expression of cysteine peptidase b (cpb) and the metallopeptidase gp63, two well-known virulence factors expressed by Leishmania spp. Conclusions/Significance: In the face of leishmaniasis/HIV overlap, it is critical to further comprehend the sophisticated interplays among Leishmania, HIV and macrophages. In addition, there are many unresolved questions related to the management of Leishmania-HIV-coinfected patients. For instance, the efficacy of therapy aimed at controlling each pathogen in coinfected individuals remains largely undefined. The results presented herein add new in vitro insight into the wide spectrum efficacy of HIV PIs and suggest that additional studies about the synergistic effects of classical antileishmanial compounds and HIV PIs in macrophages coinfected with Leishmania and HIV-1 should be performed.	[Santos, Livia O.; Altoe, Ellen F.; Vitorio, Bianca S.; Alves, Carlos R.; Britto, Constanca; d'Avila-Levy, Claudia M.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Marinho, Fernanda A.; Branquinha, Marta H.; Santos, Andre L. S.] Univ Fed Rio de Janeiro UFRJ, CCS, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Geral, BR-21941 Rio De Janeiro, Brazil; [Motta, Maria Cristina M.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude CCS, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Santos, LO (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil.	davila.levy@ioc.fiocruz.br	Alves, Carlos Roberto/AAA-2071-2020; Santos, André/Z-5853-2019; Motta, Maria Cristina M/I-3140-2014; Branquinha, Marta/AAA-3084-2019; Santos, Livia/H-1027-2013; d'Avila-Levy, Claudia M/O-7192-2014; Britto, Constanca/L-7658-2016	Alves, Carlos Roberto/0000-0001-8703-426X; Santos, André/0000-0003-0821-8592; d'Avila-Levy, Claudia M/0000-0001-8042-4695; Britto, Constanca/0000-0003-0788-7030; Motta, Maria Cristina/0000-0002-0947-4830	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FIOCRUZ (Fundacao Oswaldo Cruz)	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ (Fundacao Oswaldo Cruz)	This study was supported by the Brazilian agencies: MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), FUJB (Fundacao Universitaria Jose Bonifacio), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and FIOCRUZ (Fundacao Oswaldo Cruz). A.L.S.S, C.M.D., C.R.A., C.B., M.C.M.M., M.H.B. are CNPq research fellows.	Alexander J, 1999, J CELL SCI, V112, P2993; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alves CR, 2005, EXP PARASITOL, V109, P38, DOI 10.1016/j.exppara.2004.10.005; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Andrews L, 2000, INFECT DIS CLIN N AM, V14, P901, DOI 10.1016/S0891-5520(05)70139-2; Barat C, 2007, J INFECT DIS, V195, P236, DOI 10.1086/510398; Barreto-de-Souza V, 2008, MICROBES INFECT, V10, P642, DOI 10.1016/j.micinf.2008.02.014; Bektic J, 2001, FEMS IMMUNOL MED MIC, V31, P65, DOI 10.1111/j.1574-695X.2001.tb01588.x; Blasi E, 2004, FEMS IMMUNOL MED MIC, V42, P187, DOI 10.1016/j.femsim.2004.05.001; Chang KP, 1999, CLIN DERMATOL, V17, P269, DOI 10.1016/S0738-081X(99)00055-3; Cruz I, 2006, INDIAN J MED RES, V123, P357; Cupolillo E, 2001, MED MICROBIOL IMMUN, V190, P57, DOI 10.1007/s004300100080; d'Avila-Levy CM, 2006, INT J ANTIMICROB AG, V28, P138, DOI 10.1016/j.ijantimicag.2006.03.021; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Dutta A, 2005, PARASITOL INT, V54, P119, DOI 10.1016/j.parint.2005.01.001; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Garg R, 2008, J INFECT DIS, V197, P1701, DOI 10.1086/588146; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gradoni L, 1996, AIDS, V10, P785, DOI 10.1097/00002030-199606001-00014; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Marques Nuno, 2007, Acta Med Port, V20, P291; Mastroianni CM, 1999, AIDS, V13, P883, DOI 10.1097/00002030-199905280-00003; Mezzaroma I, 1999, AIDS, V13, P1187, DOI 10.1097/00002030-199907090-00006; Monari C, 2005, J INFECT DIS, V191, P307, DOI 10.1086/426828; Mottram JC, 2004, CURR OPIN MICROBIOL, V7, P375, DOI 10.1016/j.mib.2004.06.010; Palmeira VF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003382; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Pereira FM, 2009, PARASITOLOGY, V136, P45, DOI 10.1017/S0031182008005209; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; Pintado V, 2001, MEDICINE, V80, P54, DOI 10.1097/00005792-200101000-00006; Powderly WG, 1998, JAMA-J AM MED ASSOC, V280, P72, DOI 10.1001/jama.280.1.72; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; Rabello A, 2003, Ann Trop Med Parasitol, V97 Suppl 1, P17; Robertson CD, 1999, MOL BIOCHEM PARASIT, V103, P49, DOI 10.1016/S0166-6851(99)00110-3; RUCHEL R, 1990, ZBL BAKT-INT J MED M, V273, P391; Saag MS, 1998, CURR CLIN TOPICS INF, V18, P154; Pereira BAS, 2008, VET PARASITOL, V158, P239, DOI 10.1016/j.vetpar.2008.09.015; Savoia D, 2005, INT J ANTIMICROB AG, V26, P92, DOI 10.1016/j.ijantimicag.2005.04.003; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Soares RMD, 2003, EXP PARASITOL, V104, P104, DOI 10.1016/S0014-4894(03)00135-8; Tiuman TS, 2005, ANTIMICROB AGENTS CH, V49, P176, DOI 10.1128/AAC.49.11.176-182.2005; Trudel N, 2008, J INFECT DIS, V198, P1292, DOI 10.1086/592280; Valdivieso E, 2007, EXP PARASITOL, V116, P77, DOI 10.1016/j.exppara.2006.10.006; Vermelrio A.B., 2007, CURR ENZYME INHIB, V3, P19; *WHO, 2007, 5 CONS M LEISHM HIV, P1; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zhao CQ, 2006, J GEN VIROL, V87, P1295, DOI 10.1099/vir.0.81647-0; Zhao CQ, 2004, CLIN IMMUNOL, V113, P81, DOI 10.1016/j.clim.2004.06.003	55	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4918	10.1371/journal.pone.0004918	http://dx.doi.org/10.1371/journal.pone.0004918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325703	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499400002
J	Shiryaev, SA; Savinov, AY; Cieplak, P; Ratnikov, BI; Motamedchaboki, K; Smith, JW; Strongin, AY				Shiryaev, Sergey A.; Savinov, Alexei Y.; Cieplak, Piotr; Ratnikov, Boris I.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.			Matrix Metalloproteinase Proteolysis of the Myelin Basic Protein Isoforms Is a Source of Immunogenic Peptides in Autoimmune Multiple Sclerosis	PLOS ONE			English	Article								Background: Matrix metalloproteinases (MMPs) play a significant role in the fragmentation of myelin basic protein (MBP) and demyelination leading to autoimmune multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The classic MBP isoforms are predominantly expressed in the oligodendrocytes of the CNS. The splice variants of the single MBP gene (Golli-MBP BG21 and J37) are widely expressed in the neurons and also in the immune cells. The relative contribution of the individual MMPs to the MBP cleavage is not known. Methodology/Principal Findings: To elucidate which MMP plays the primary role in cleaving MBP, we determined the efficiency of MMP-2, MMP-8, MMP-9, MMP-10, MMP-12, MT1-MMP, MT2-MMP, MT3-MMP, MT4-MMP, MT5-MMP and MT6-MMP in the cleavage of the MBP, BG21 and J37 isoforms in the in vitro cleavage reactions followed by mass-spectroscopy analysis of the cleavage fragments. As a result, we identified the MMP cleavage sites and the sequence of the resulting fragments. We determined that MBP, BG21 and J37 are highly sensitive to redundant MMP proteolysis. MT6-MMP (initially called leukolysin), however, was superior over all of the other MMPs in cleaving the MBP isoforms. Using the mixed lymphocyte culture assay, we demonstrated that MT6-MMP proteolysis of the MBP isoforms readily generated, with a near quantitative yield, the immunogenic N-terminal 1-15 MBP peptide. This peptide selectively stimulated the proliferation of the PGPR7.5 T cell clone isolated from mice with EAE and specific for the 1-15 MBP fragment presented in the MHC H-2(U) context. Conclusions/Significance: In sum, our biochemical observations led us to hypothesize that MT6-MMP, which is activated by furin and associated with the lipid rafts, plays an important role in MS pathology and that MT6-MMP is a novel and promising drug target in MS especially when compared with other individual MMPs.	[Shiryaev, Sergey A.; Savinov, Alexei Y.; Cieplak, Piotr; Ratnikov, Boris I.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.] Burnham Inst Med Res, Inflammatory & Infect Dis Ctr, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Burnham Inst Med Res, Inflammatory & Infect Dis Ctr, La Jolla, CA USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Messier, Claude/A-2322-2008	Strongin, Alex/0000-0003-3765-3016; Messier, Claude/0000-0002-4791-1763	NIH [CA83017, CA77470, RR020843]; Susan G. Komen Breast Cancer Foundation [BCTR0601231]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470, R01CA108959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work reported here was supported by NIH Grants CA83017, CA77470 and the Susan G. Komen Breast Cancer Foundation Grant BCTR0601231 (to AYStr), and NIH Grant RR020843 (to JWS and AYStr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; DaSliva AG, 2008, J NEUROIMMUNOL, V199, P24, DOI 10.1016/j.jneuroim.2008.04.034; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Feng JM, 2004, J NEUROIMMUNOL, V152, P57, DOI 10.1016/j.jneuroim.2004.03.021; Filipovic R, 2002, J NEUROIMMUNOL, V127, P1, DOI 10.1016/S0165-5728(02)00070-X; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; Hellings N, 2001, J NEUROSCI RES, V63, P290, DOI 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Jacobs EC, 2005, J NEUROSCI, V25, P7004, DOI 10.1523/JNEUROSCI.0288-05.2005; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Katsara M, 2008, J MED CHEM, V51, P3971, DOI 10.1021/jm8000554; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Landry CF, 1998, J NEUROSCI, V18, P7315; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; PitchekianHalabi H, 1996, J NEUROIMMUNOL, V68, P121, DOI 10.1016/0165-5728(96)00084-7; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2001, J CLIN IMMUNOL, V21, P93, DOI 10.1023/A:1011020225433; STEINMAN L, 1995, MOL MED TODAY, V1, P79, DOI 10.1016/S1357-4310(95)92366-7; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Tosic M, 2002, GLIA, V37, P219, DOI 10.1002/glia.10028; Tranquill LR, 1996, J NEUROSCI RES, V45, P820, DOI 10.1002/(SICI)1097-4547(19960915)45:6<820::AID-JNR19>3.0.CO;2-Z; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tselios T, 2002, J MED CHEM, V45, P275, DOI 10.1021/jm0102147; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; Velasco G, 2000, CANCER RES, V60, P877; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Voskuhl RR, 1996, J NEUROIMMUNOL, V70, P103, DOI 10.1016/S0165-5728(96)00054-9; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Werner SR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-83; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	49	69	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4952	10.1371/journal.pone.0004952	http://dx.doi.org/10.1371/journal.pone.0004952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300513	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496800013
J	Garcia-Lavandeira, M; Quereda, V; Flores, I; Saez, C; Diaz-Rodriguez, E; Japon, MA; Ryan, AK; Blasco, MA; Dieguez, C; Malumbres, M; Alvarez, CV				Garcia-Lavandeira, Montse; Quereda, Victor; Flores, Ignacio; Saez, Carmen; Diaz-Rodriguez, Esther; Japon, Miguel A.; Ryan, Aymee K.; Blasco, Maria A.; Dieguez, Carlos; Malumbres, Marcos; Alvarez, Clara V.			A GRFa2/Prop1/Stem (GPS) Cell Niche in the Pituitary	PLOS ONE			English	Article								Background: The adult endocrine pituitary is known to host several hormone-producing cells regulating major physiological processes during life. Some candidates to progenitor/stem cells have been proposed. However, not much is known about pituitary cell renewal throughout life and its homeostatic regulation during specific physiological changes, such as puberty or pregnancy, or in pathological conditions such as tumor development. Principal Findings: We have identified in rodents and humans a niche of non-endocrine cells characterized by the expression of GFRa2, a Ret co-receptor for Neurturin. These cells also express b-Catenin and E-cadherin in an oriented manner suggesting a planar polarity organization for the niche. In addition, cells in the niche uniquely express the pituitary-specific transcription factor Prop1, as well as known progenitor/stem markers such as Sox2, Sox9 and Oct4. Half of these GPS (GFRa2/Prop1/Stem) cells express S-100 whereas surrounding elongated cells in contact with GPS cells express Vimentin. GFRa2+-cells form non-endocrine spheroids in culture. These spheroids can be differentiated to hormone-producing cells or neurons outlining the neuroectoderm potential of these progenitors. In vivo, GPSs cells display slow proliferation after birth, retain BrdU label and show long telomeres in its nuclei, indicating progenitor/stem cell properties in vivo. Significance: Our results suggest the presence in the adult pituitary of a specific niche of cells characterized by the expression of GFRa2, the pituitary-specific protein Prop1 and stem cell markers. These GPS cells are able to produce different hormone-producing and neuron-like cells and they may therefore contribute to postnatal pituitary homeostasis. Indeed, the relative abundance of GPS numbers is altered in Cdk4-deficient mice, a model of hypopituitarism induced by the lack of this cyclin-dependent kinase. Thus, GPS cells may display functional relevance in the physiological expansion of the pituitary gland throughout life as well as protection from pituitary disease.	[Garcia-Lavandeira, Montse; Diaz-Rodriguez, Esther; Dieguez, Carlos; Alvarez, Clara V.] Univ Santiago de Compostela, Sch Med, Dept Physiol, Santiago De Compostela, Spain; [Quereda, Victor; Malumbres, Marcos] CNIO, Cell Div, Madrid, Spain; [Quereda, Victor; Flores, Ignacio; Malumbres, Marcos] CNIO, Canc Grp, Madrid, Spain; [Blasco, Maria A.] CNIO, Telomeres & Telomerase Grp, Madrid, Spain; [Saez, Carmen; Japon, Miguel A.] Hosp Univ Virgen Rocio, Dept Pathol, Seville, Spain; [Ryan, Aymee K.] McGill Univ, Dept Human Geneti, Montreal, PQ H3A 2T5, Canada; [Dieguez, Carlos] CIBER Obesity & Nutr ISCIII, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Virgen del Rocio University Hospital; McGill University	Garcia-Lavandeira, M (corresponding author), Univ Santiago de Compostela, Sch Med, Dept Physiol, Santiago De Compostela, Spain.	malumbres@cnio.es; clara.alvarez@usc.es	Malumbres, Marcos/E-8834-2011; Sáez, Carmen/B-9468-2015; Quereda, Victor/J-8120-2019; IBIS, TUMORIGENESIS/P-3506-2015; Flores, Ignacio/E-8304-2016; Holt, Janet E/B-2415-2013; Blasco, Maria A./M-1694-2014; Lavandeira, Montserrat García/R-4708-2019; Japón, Miguel A/L-2555-2017; Alvarez, Clara V/AAN-4173-2020	Malumbres, Marcos/0000-0002-0829-6315; Sáez, Carmen/0000-0002-8600-0508; Quereda, Victor/0000-0002-9966-9104; Flores, Ignacio/0000-0001-8789-6396; Blasco, Maria A./0000-0002-4211-233X; Lavandeira, Montserrat García/0000-0001-9208-2418; Japón, Miguel A/0000-0002-5980-5044; Alvarez, Clara V/0000-0003-1500-4058; dieguez, carlos/0000-0002-0919-4337	Spanish Ministry of Education and Science [fellowship]; Foundation of the Asociacion Espanola contra el Cancer; Foundation Mutua Madrilena Automovilista; Xunta de Galicia [PGIDIT05BTF20803PR]; Ministry of Education and Science [SAF2004-03131, BFU2007-60571, SAF2006-05186]; OncoCycle programme from the Comunidad de Madrid [S-BIO-0283-2006]; Consolider-Ingenio, MICINN [CSD2007-00017]	Spanish Ministry of Education and Science(Spanish Government); Foundation of the Asociacion Espanola contra el Cancer; Foundation Mutua Madrilena Automovilista; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OncoCycle programme from the Comunidad de Madrid; Consolider-Ingenio, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	V.Q. was supported by a fellowship from the Spanish Ministry of Education and Science. This work was funded by grants from the Foundation of the Asociacion Espanola contra el Cancer (AECC; to M.M.), Foundation Mutua Madrilena Automovilista (to M.M.), Xunta de Galicia PGIDIT05BTF20803PR (to C.V.A. and C.D.) and the Ministry of Education and Science (MICINN; SAF2004-03131 and BFU2007-60571 to C.V.A. and SAF2006-05186, to M.M.). The Cell Division and Cancer Group of the CNIO is supported by the OncoCycle programme from the Comunidad de Madrid (S-BIO-0283-2006) and the Consolider-Ingenio (CSD2007-00017) program from the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P5256, DOI 10.1210/jc.2004-0661; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Cushman LJ, 2001, HUM MOL GENET, V10, P1141, DOI 10.1093/hmg/10.11.1141; DESAI B, 1995, EUR J ENDOCRINOL, V133, P25, DOI 10.1530/eje.0.1330025; DODD J, 1984, NATURE, V311, P469, DOI 10.1038/311469a0; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Fofanova O, 1998, J CLIN ENDOCR METAB, V83, P2601; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Garcia A, 2001, MOL ENDOCRINOL, V15, P1484, DOI 10.1210/me.15.9.1484; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horvath E, 2002, ULTRASTRUCT PATHOL, V26, P219, DOI 10.1080/01913120290104476; ISLAM O, 2007, RATHKE CLEFTT CYSTS; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Japon MA, 2002, J CLIN ENDOCR METAB, V87, P1879, DOI 10.1210/jc.87.4.1879; Johnson MD, 2007, J HISTOCHEM CYTOCHEM, V55, P1265, DOI 10.1369/jhc.7A7311.2007; KASPER M, 1988, CELL TISSUE RES, V253, P419; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kovacs K, 1998, J NEUROSURG, V88, P1111, DOI 10.3171/jns.1998.88.6.1111; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lepore DA, 2005, EXP CELL RES, V308, P166, DOI 10.1016/j.yexcr.2005.04.023; Lepore DA, 2006, STEM CELLS, V24, P2382, DOI 10.1634/stemcells.2006-0085; Li HY, 2007, STEM CELLS, V25, P2053, DOI 10.1634/stemcells.2007-0080; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MARIN F, 1989, ANAT EMBRYOL, V179, P491, DOI 10.1007/BF00319592; MARIN F, 1989, ARCH HISTOL CYTOL, V52, P241, DOI 10.1679/aohc.52.241; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; Matsuno A, 1996, ACTA NEUROCHIR, V138, P1002, DOI 10.1007/BF01411291; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; NAKAJIMA T, 1980, BRAIN RES, V191, P523, DOI 10.1016/0006-8993(80)91300-1; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SHANKLIN WM, 1951, ACTA ANAT, V11, P361; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Suh H, 2002, DEVELOPMENT, V129, P329; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; U HS, 2002, MOL ENDOCRINOL, V16, P2645, DOI 10.1210/me.2002-0094; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Urbano AG, 2000, ENDOCRINOLOGY, V141, P1893, DOI 10.1210/en.141.5.1893; Vallette-Kasic S, 2001, J CLIN ENDOCR METAB, V86, P4529, DOI 10.1210/jc.86.9.4529; Vankelecom H, 2007, NEUROENDOCRINOLOGY, V85, P110, DOI 10.1159/000100278; Vankelecom H, 2007, SEMIN CELL DEV BIOL, V18, P559, DOI 10.1016/j.semcdb.2007.04.006; Vesper AH, 2006, ENDOCRINOLOGY, V147, P1654, DOI 10.1210/en.2005-1080; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Ward RD, 2006, MOL ENDOCRINOL, V20, P1378, DOI 10.1210/me.2005-0409; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Widenfalk J, 2000, CELL TISSUE RES, V299, P409, DOI 10.1007/s004410050039; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Xie T, 2007, DEVELOPMENT, V134, P2001, DOI 10.1242/dev.002022; YOSHIMURA F, 1977, ENDOCRINOL JAPON, V24, P301; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	81	130	132	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4815	10.1371/journal.pone.0004815	http://dx.doi.org/10.1371/journal.pone.0004815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283075	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496300004
J	Martinez-Mekler, G; Martinez, RA; del Rio, MB; Mansilla, R; Miramontes, P; Cocho, G				Martinez-Mekler, Gustavo; Alvarez Martinez, Roberto; Beltran del Rio, Manuel; Mansilla, Ricardo; Miramontes, Pedro; Cocho, Germinal			Universality of Rank-Ordering Distributions in the Arts and Sciences	PLOS ONE			English	Article								Searching for generic behaviors has been one of the driving forces leading to a deep understanding and classification of diverse phenomena. Usually a starting point is the development of a phenomenology based on observations. Such is the case for power law distributions encountered in a wealth of situations coming from physics, geophysics, biology, lexicography as well as social and financial networks. This finding is however restricted to a range of values outside of which finite size corrections are often invoked. Here we uncover a universal behavior of the way in which elements of a system are distributed according to their rank with respect to a given property, valid for the full range of values, regardless of whether or not a power law has previously been suggested. We propose a two parameter functional form for these rank-ordered distributions that gives excellent fits to an impressive amount of very diverse phenomena, coming from the arts, social and natural sciences. It is a discrete version of a generalized beta distribution, given by f(r) = A(N+1-r)(b)/r(a), where r is the rank, N its maximum value, A the normalization constant and (a, b) two fitting exponents. Prompted by our genetic sequence observations we present a growth probabilistic model incorporating mutation-duplication features that generates data complying with this distribution. The competition between permanence and change appears to be a relevant, though not necessary feature. Additionally, our observations mainly of social phenomena suggest that a multifactorial quality resulting from the convergence of several heterogeneous underlying processes is an important feature. We also explore the significance of the distribution parameters and their classifying potential. The ubiquity of our findings suggests that there must be a fundamental underlying explanation, most probably of a statistical nature, such as an appropriate central limit theorem formulation.	[Martinez-Mekler, Gustavo] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Martinez-Mekler, Gustavo; Alvarez Martinez, Roberto; Cocho, Germinal] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Cuernavaca 62191, Morelos, Mexico; [Alvarez Martinez, Roberto; Beltran del Rio, Manuel; Cocho, Germinal] Univ Nacl Autonoma Mexico, Inst Fis, Cuernavaca 62191, Morelos, Mexico; [Mansilla, Ricardo] Univ Nacl Autonoma Mexico, Ctr Investigac Interdisciplin Ciencias Humanidades, Cuernavaca 62191, Morelos, Mexico; [Miramontes, Pedro] Univ Nacl Autonoma Mexico, Fac Ciencias, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Mekler, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	mekler@fis.unam.mx		Martinez-Mekler, Gustavo/0000-0002-1192-9769; Mansilla, Ricardo/0000-0002-1248-0959	CONACyT [47836-F, DGAPA-UNAM-IN115908, DGAPA-UNAM-IN112407-3, scholarship]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Support from CONACyT 47836-F, DGAPA-UNAM-IN115908 and DGAPA-UNAM-IN112407-3 grants are acknowledged. R. Alvarez thanks CONACyT for a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; AMARAL LAN, PNAS, V97, P11149; [Anonymous], ACAD RANKING WORLD U; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Bury K., 1999, STAT DISTRIBUTIONS E; CANCHO FFI, 2001, QUANTITATIVE LINGUIS, V8, P165; CZIROK A, 1995, CORRELATIONS BINARY; del Rio MB, 2008, PHYSICA A, V387, P5552, DOI 10.1016/j.physa.2008.05.031; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Frisch U., 1995, TURBULENCE LEGACY AN; Hong HS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258701; Kadanoff L. P., 2000, STAT PHYS STATICS DY; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; LI WT, 1991, PHYS REV A, V43, P5240, DOI 10.1103/PhysRevA.43.5240; Mansilla R, 2007, J INFORMETR, V1, P155, DOI 10.1016/j.joi.2007.01.001; MCDONALD JB, 1984, ECONOMETRICA, V52, P647, DOI 10.2307/1913469; *MEX NAT I STAT, 2003, GEOGR INF; MONTROLL EW, 1983, J STAT PHYS, V32, P209, DOI 10.1007/BF01012708; Naumis GG, 2008, PHYSICA A, V387, P84, DOI 10.1016/j.physa.2007.08.002; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Popescu I., 2003, GLOTTOMETRICS, V6, P83; QUAN HL, 2000, P 17 INT C COMPUTERL; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sornette D, 2003, PHYS REP, V378, P1, DOI 10.1016/S0370-1573(02)00634-8; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; CONCISE OXFORD DICT; 2001, MAJOR FIGURES 2000 P	31	95	96	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4791	10.1371/journal.pone.0004791	http://dx.doi.org/10.1371/journal.pone.0004791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277122	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496100014
J	Jaeger, MA; Sonnemann, KJ; Fitzsimons, DP; Prins, KW; Ervasti, JM				Jaeger, Michele A.; Sonnemann, Kevin J.; Fitzsimons, Daniel P.; Prins, Kurt W.; Ervasti, James M.			Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin	FASEB JOURNAL			English	Article						isoforms; isoform substitution; myofibril; sarcomere; thin filament; nemaline myopathy	CARDIAC ACTIN; BETA-ACTIN; MDX MICE; MUSCLE; DYSTROPHIN; ISOFORMS; EXPRESSION; SARCOLEMMA; OVEREXPRESSION; IDENTIFICATION	We generated transgenic mice that over-expressed gamma-(cyto) actin 2000-fold above wild-type levels in skeletal muscle. gamma-(cyto) actin comprised 40% of total actin in transgenic skeletal muscle, with a concomitant 40% decrease in alpha-actin. Surprisingly, transgenic muscle was histologically and ultrastructurally identical to wild-type muscle despite near-stoichiometric incorporation of gamma-(cyto) actin into sarcomeric thin filaments. Furthermore, several parameters of muscle physiological performance in the transgenic animals were not different from wild type. Given these surprising results, we tested whether overexpression of gamma-(cyto) actin could rescue the early postnatal lethality in alpha-(sk) actin-null mice (Acta1(-/-)). By quantitative Western blot analysis, we found total actin levels were decreased by 35% in Acta1(-/-) muscle. Although transgenic overexpression of gamma-(cyto) actin on the Acta1(-/-) background restored total actin levels to wild type, resulting in thin filaments composed of 60% gamma-cyto actin and a 40% mixture of cardiac and vascular actin, the life span of transgenic Acta1(-/-) mice was not extended. These results indicate that sarcomeric thin filaments can accommodate substantial incorporation of gamma-(cyto) actin without functional consequences, yet gamma-(cyto) actin cannot fully substitute for alpha-(sk) actin.-Jaeger, M. A., Sonnemann, K. J., Fitzsimons, D. P., Prins, K. W., Ervasti, J. M. Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin. FASEB J. 23, 2205-2214 (2009)	[Jaeger, Michele A.; Sonnemann, Kevin J.; Prins, Kurt W.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Fitzsimons, Daniel P.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Ervasti, JM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020	Prins, Kurt/0000-0002-0364-6742	American Heart Association Predoctoral Fellowships; NIH [AR049899]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049899] Funding Source: NIH RePORTER	American Heart Association Predoctoral Fellowships(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Nigel Laing and Dr. Kristen Nowak ( University of Western Australia, Perth, Australia) for generously providing Acta1<SUP>+/-</SUP> mice and for sharing their data prior to publication, and Dr. Richard L. Moss for helpful comments and suggestions. This study was supported by American Heart Association Predoctoral Fellowships to M.A.J and K.J.S., and NIH grant AR049899 to J.M.E.	BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131; BRAVO R, 1981, CELL, V25, P195, DOI 10.1016/0092-8674(81)90244-0; CARLSON CG, 1990, MUSCLE NERVE, V13, P480, DOI 10.1002/mus.880130603; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DENOFRIO D, 1989, J CELL BIOL, V109, P191, DOI 10.1083/jcb.109.1.191; ERBA HP, 1988, MOL CELL BIOL, V8, P1775, DOI 10.1128/MCB.8.4.1775; FIRTEL RA, 1981, CELL, V24, P6, DOI 10.1016/0092-8674(81)90494-3; Fyrberg EA, 1998, BIOCHEM GENET, V36, P271, DOI 10.1023/A:1018785127079; GORDON DJ, 1977, J BIOL CHEM, V252, P8300; GUNNING P, 1987, MOL CELL BIOL, V7, P4100, DOI 10.1128/MCB.7.11.4100; Hack AA, 2000, J CELL SCI, V113, P2535; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Kumar A, 2004, TRANSGENIC RES, V13, P531, DOI 10.1007/s11248-004-2823-6; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Lloyd CM, 2004, EXP CELL RES, V297, P82, DOI 10.1016/j.yexcr.2004.02.012; Marco-Ferreres R, 2005, BIOCHEM J, V386, P145, DOI 10.1042/BJ20041240; Martiny AC, 2002, WA SCI TECHNOL, V2, P283, DOI 10.2166/ws.2002.0114; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; MCKENNA N, 1985, J CELL BIOL, V100, P292, DOI 10.1083/jcb.100.1.292; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; MOSSAKOWSKA M, 1985, EUR J BIOCHEM, V153, P373, DOI 10.1111/j.1432-1033.1985.tb09313.x; NOWAK K, 2007, NEUROMUSCUL DISORD, V17; Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035; OTEY CA, 1988, CELL MOTIL CYTOSKEL, V9, P337, DOI 10.1002/cm.970090406; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; PARDO JV, 1983, CELL, V32, P1093, DOI 10.1016/0092-8674(83)90293-3; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PROCHNIEWICZ E, 1980, EUR J BIOCHEM, V106, P305; Prochniewicz E, 1999, BIOCHEMISTRY-US, V38, P14860, DOI 10.1021/bi991343g; Renley BA, 1998, CELL MOTIL CYTOSKEL, V41, P264, DOI 10.1002/(SICI)1097-0169(1998)41:3<264::AID-CM7>3.3.CO;2-Q; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Suzuki H, 1998, TISSUE CELL, V30, P274, DOI 10.1016/S0040-8166(98)80076-1; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; vonArx P, 1995, J CELL BIOL, V131, P1759, DOI 10.1083/jcb.131.6.1759	42	27	28	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2205	2214		10.1096/fj.09-129783	http://dx.doi.org/10.1096/fj.09-129783			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19279140	Green Published			2022-12-25	WOS:000268836500020
J	Dixon, RM; Mellor, JR; Hanley, JG				Dixon, Rebecca M.; Mellor, Jack R.; Hanley, Jonathan G.			PICK1-mediated Glutamate Receptor Subunit 2 (GluR2) Trafficking Contributes to Cell Death in Oxygen/Glucose-deprived Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE AMPA RECEPTORS; GLOBAL-ISCHEMIA; SYNAPTIC PLASTICITY; CA2+ PERMEABILITY; DOWN-REGULATION; PICK1; EXPRESSION; CALCIUM; BLOCKADE	Oxygen and glucose deprivation (OGD) induces delayed cell death in hippocampal CA1 neurons via Ca2+/Zn2+-permeable, GluR2-lacking AMPA receptors (AMPARs). Following OGD, synaptic AMPAR currents in hippocampal neurons show marked inward rectification and increased sensitivity to channel blockers selective for GluR2-lacking AMPARs. This occurs via two mechanisms: a delayed down-regulation of GluR2 mRNA expression and a rapid internalization of GluR2-containing AMPARs during the OGD insult, which are replaced by GluR2-lacking receptors. The mechanisms that underlie this rapid change in subunit composition are unknown. Here, we demonstrate that this trafficking event shares features in common with events that mediate long term depression and long term potentiation and is initiated by the activation of N-methyl-D-aspartic acid receptors. Using biochemical and electrophysiological approaches, we show that peptides that interfere with PICK1 PDZ domain interactions block the OGD-induced switch in subunit composition, implicating PICK1 in restricting GluR2 from synapses during OGD. Furthermore, we show that GluR2-lacking AMPARs that arise at synapses during OGD as a result of PICK1 PDZ interactions are involved in OGD-induced delayed cell death. This work demonstrates that PICK1 plays a crucial role in the response to OGD that results in altered synaptic transmission and neuronal death and has implications for our understanding of the molecular mechanisms that underlie cell death during stroke.	[Dixon, Rebecca M.; Mellor, Jack R.; Hanley, Jonathan G.] Univ Bristol, Dept Anat, Ctr Synapt Plast, MRC, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Dept Anat, Ctr Synapt Plast, MRC, Univ Walk, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk	MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Hanley, Jonathan/0000-0003-1704-4707	The Wellcome Trust; Medical Research Council; European Neuroscience Institutes Network (ENI-NET); Medical Research Council [G120/838, G0601841B] Funding Source: researchfish; MRC [G120/838] Funding Source: UKRI	The Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Neuroscience Institutes Network (ENI-NET); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by grants from The Wellcome Trust, the Medical Research Council, and European Neuroscience Institutes Network (ENI-NET).	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; TSUBOKAWA H, 1995, J NEUROPHYSIOL, V74, P218, DOI 10.1152/jn.1995.74.1.218; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Ying HS, 1997, J NEUROSCI, V17, P9536	37	55	58	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14230	14235		10.1074/jbc.M901203200	http://dx.doi.org/10.1074/jbc.M901203200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321442	Green Published, hybrid			2022-12-25	WOS:000266286100029
J	Saita, S; Shirane, M; Natume, T; Iemura, S; Nakayama, KI				Saita, Shotaro; Shirane, Michiko; Natume, Tohru; Iemura, Shun-ichiro; Nakayama, Keiichi I.			Promotion of Neurite Extension by Protrudin Requires Its Interaction with Vesicle-associated Membrane Protein-associated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LIPID-BINDING PROTEINS; ENDOPLASMIC-RETICULUM; FFAT MOTIF; VAP; TRAFFICKING; MUTATION; FKBP38; VAMP; IMMUNOPHILINS	Protrudin is a protein that contains a Rab11-binding domain and a FYVE (lipid-binding) domain and that functions to promote neurite formation through interaction with the GDP-bound form of Rab11. Protrudin also contains a short sequence motif designated FFAT (two phenylalanines in an acidic tract), which in other proteins has been shown to mediate binding to vesicle-associated membrane protein-associated protein (VAP). We now show that protrudin associates and colocalizes with VAP-A, an isoform of VAP expressed in the endoplasmic reticulum. Both the interaction between protrudin and VAP-A as well as the induction of process formation by protrudin were markedly inhibited by mutation of the FFAT motif. Furthermore, depletion of VAP-A by RNA interference resulted in mislocalization of protrudin as well as in inhibition of neurite outgrowth induced by nerve growth factor in rat pheochromocytoma PC12 cells. These defects resulting from depletion of endogenous rat VAP-A in PC12 cells were corrected by forced expression of (RNA interference-resistant) human VAP-A but not by VAP-A mutants that have lost the ability to interact with protrudin. These results suggest that VAP-A is an important regulator both of the subcellular localization of protrudin and of its ability to stimulate neurite outgrowth.	[Saita, Shotaro; Shirane, Michiko; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Saita, Shotaro; Shirane, Michiko; Nakayama, Keiichi I.] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Natume, Tohru; Iemura, Shun-ichiro] Natl Inst Adv Ind Sci, Kohtoh Ku, Tokyo 1350064, Japan	Kyushu University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Saita, Shotaro/0000-0002-7406-8361; Shirane, Michiko/0000-0002-8297-9245	Grants-in-Aid for Scientific Research [20670003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Lapierre LA, 1999, J CELL SCI, V112, P3723; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Mitne-Neto M, 2007, PROTEIN EXPRES PURIF, V55, P139, DOI 10.1016/j.pep.2007.04.007; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Shirane M, 2008, GENES CELLS, V13, P635, DOI 10.1111/j.1365-2443.2008.01194.x; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Takenawa T, 2006, IUBMB LIFE, V58, P296, DOI 10.1080/15216540600732039; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	35	68	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13766	13777		10.1074/jbc.M807938200	http://dx.doi.org/10.1074/jbc.M807938200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289470	hybrid, Green Published			2022-12-25	WOS:000265877300054
J	Shigemoto, T; Kageyama, M; Hirai, R; Zheng, JP; Yoneyama, M; Fujita, T				Shigemoto, Taeko; Kageyama, Maiko; Hirai, Reiko; Zheng, JiPing; Yoneyama, Mitsutoshi; Fujita, Takashi			Identification of Loss of Function Mutations in Human Genes Encoding RIG-I and MDA5 IMPLICATIONS FOR RESISTANCE TO TYPE I DIABETES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL RESPONSES; INNATE IMMUNITY; RNA; RECOGNITION; HELICASE; MECHANISM; DOMAIN; ACID; LGP2	Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are essential for detecting viral RNA and triggering antiviral responses, including production of type I interferon. We analyzed the phenotype of non-synonymous mutants of human RIG-I and MDA5 reported in databases by functional complementation in cell cultures. Of seven missense mutations of RIG-I, S183I, which occurs within the second caspase recruitment domain repeat, inactivated this domain and conferred a dominant inhibitory function. Of 10 mutants of MDA5, two exhibited loss of function. A nonsense mutation, E627*, resulted in deletion of the C-terminal region and double-stranded RNA (dsRNA) binding activity. Another loss of function mutation, I923V, which occurs within the C-terminal domain, did not affect dsRNA binding activity, suggesting a novel and essential role for this residue in the signaling. Remarkably, these mutations are implicated in resistance to type I diabetes. However, the A946T mutation of MDA5, which has been implicated in type I diabetes by previous genetic analyses, affected neither dsRNA binding nor IFN gene activation. These results provide new insights into the structure-function relationship of RIG-I-like receptors as well as into human RIG-I-like receptor polymorphisms, antiviral innate immunity, and autoimmune diseases.	[Shigemoto, Taeko; Kageyama, Maiko; Hirai, Reiko; Zheng, JiPing; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan; [Shigemoto, Taeko; Kageyama, Maiko; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto 6068507, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Fujita, T (corresponding author), Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408; zheng, ji ping/0000-0002-7393-8054	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical Pharmaceutical Research; Nippon Boehringer Ingelheim	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical Pharmaceutical Research; Nippon Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Science and Technology Agency, The Mochida Memorial Foundation for Medical Pharmaceutical Research, and Nippon Boehringer Ingelheim.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; NEJENTSEV S, 2009, SCIENCE         0305, DOI DOI 10.1126/SCIENCE.1167728; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	17	116	118	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13348	13354		10.1074/jbc.M809449200	http://dx.doi.org/10.1074/jbc.M809449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324880	Green Published, hybrid			2022-12-25	WOS:000265877300010
J	Sudhaharan, T; Liu, P; Foo, YH; Bu, WY; Lim, KB; Wohland, T; Ahmed, S				Sudhaharan, Thankiah; Liu, Ping; Foo, Yong Hwee; Bu, Wenyu; Lim, Kim Buay; Wohland, Thorsten; Ahmed, Sohail			Determination of in Vivo Dissociation Constant, K-D, of Cdc42-Effector Complexes in Live Mammalian Cells Using Single Wavelength Fluorescence Cross-correlation Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; RHO-GTPASES; PROTEINS; CDC42; BIOLOGY; BINDING; ACTIN	The RhoGTPase Cdc42 coordinates cell morphogenesis, cell cycle, and cell polarity decisions downstream of membrane-bound receptors through distinct effector pathways. Cdc42-effector protein interactions represent important elements of cell signaling pathways that regulate cell biology in systems as diverse as yeast and humans. To derive mechanistic insights into cell signaling pathways, it is vital that we generate quantitative data from in vivo systems. We need to be able to measure parameters such as protein concentrations, rates of diffusion, and dissociation constants (K-D) of protein-protein interactions in vivo. Here we show how single wavelength fluorescence cross-correlation spectroscopy in combination with Forster resonance energy transfer analysis can be used to determine K-D of Cdc42-effector interactions in live mammalian cells. Constructs encoding green fluorescent protein or monomeric red fluorescent protein fusion proteins of Cdc42, an effector domain (CRIB), and two effectors, neural Wiskott-Aldrich syndrome protein (N-WASP) and insulin receptor substrate protein (IRSp53), were expressed as pairs in Chinese hamster ovary cells, and concentrations of free protein as well as complexed protein were determined. The measured K-D for Cdc42V12-N-WASP, Cdc42V12-CRIB, and Cdc42V12-IRSp53 was 27, 250, and 391 nM, respectively. The determination of K-D for Cdc42-effector interactions opens the way to describe cell signaling pathways quantitatively in vivo in mammalian cells.	[Sudhaharan, Thankiah; Foo, Yong Hwee; Bu, Wenyu; Lim, Kim Buay; Ahmed, Sohail] Inst Med Biol, Singapore 138665, Singapore; [Liu, Ping; Foo, Yong Hwee; Wohland, Thorsten] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138665, Singapore.	sohail.ahmed@imb.a-star.edu.sg	Wohland, Thorsten/H-8285-2012; WOHLAND, THORSTEN/R-6404-2019	Wohland, Thorsten/0000-0002-0148-4321; Foo, Yong Hwee/0000-0003-2337-469X	Singapore Bioimaging Consortium [SBIC 003/2005]	Singapore Bioimaging Consortium(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore Bioimaging Consortium Grant SBIC 003/2005.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDMAN R, 2005, LIVE CELL IMAGING LA; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Hillesheim LN, 2006, BIOPHYS J, V91, P4273, DOI 10.1529/biophysj.106.085845; Hwang LC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862614; Hwang LC, 2006, BIOPHYS J, V91, P715, DOI 10.1529/biophysj.105.074120; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Liu P, 2008, TRENDS ENDOCRIN MET, V19, P181, DOI 10.1016/j.tem.2008.02.004; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	28	45	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13602	13609		10.1074/jbc.M900894200	http://dx.doi.org/10.1074/jbc.M900894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19293156	hybrid, Green Published			2022-12-25	WOS:000265877300037
J	Frost, B; Jacks, RL; Diamond, MI				Frost, Bess; Jacks, Rachel L.; Diamond, Marc I.			Propagation of Tau Misfolding from the Outside to the Inside of a Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; NEURONAL CELLS; NEUROFIBRILLARY DEGENERATION; FRONTOTEMPORAL DEMENTIA; EXTRACELLULAR TAU; MAMMALIAN-CELLS; PROTEIN; TAUOPATHIES; ASSOCIATION	Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.	[Frost, Bess; Jacks, Rachel L.; Diamond, Marc I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Diamond, Marc I.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Frost, Bess; Jacks, Rachel L.; Diamond, Marc I.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Diamond, MI (corresponding author), GH-S572B 600 16th St, San Francisco, CA 94143 USA.	marc.diamond@ucsf.edu		Frost, Bess/0000-0002-1212-8138	NINDS NIH HHS [R01 NS50284-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Delacourte A, 2005, FOLIA NEUROPATHOL, V43, P244; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; ENDOH R, 1993, BRAIN RES, V601, P164, DOI 10.1016/0006-8993(93)91707-Y; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	32	816	850	2	135	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12845	12852		10.1074/jbc.M808759200	http://dx.doi.org/10.1074/jbc.M808759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282288	hybrid, Green Published			2022-12-25	WOS:000265688300030
J	Sun, TP; Shieh, SY				Sun, T-P; Shieh, S-Y			Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress	ONCOGENE			English	Article						CHK1; FEM1B; replication stress	DNA-DAMAGE CHECKPOINTS; SEX-DETERMINATION; STRUCTURAL BASIS; GENE FAMILY; ATR; CLASPIN; PROTEIN; PHOSPHORYLATION; BINDING; P53	Human checkpoint kinase 1 (CHK1) is an essential kinase required to preserve genome stability, and is activated by DNA replication blockage through the ataxia-telangiectasia-mutated-and-Rad3-related (ATR)/ATRIP-signaling pathway. In this report, we show that a novel CHK1-interacting protein, FEM1B ( human homologue of the Caenorhabditis elegans sex determination fem1 protein), identified by a yeast two-hybrid screen, is involved in the activation of CHK1 by replication stress. Depletion of FEM1B by small interfering RNA in cancer cells impairs the activation of CHK1 kinase activity and attenuates the induction of CHK1 Ser345 phosphorylation upon replication interference. It is to be noted that, CHK2 Thr68 phosphorylation is not altered by FEM1B downregulation. By fractionation, we further demonstrated that FEM1B is able to associate with chromatin, and such association facilitates chromatin loading of the Rad9 protein. Consistently, ATR activity is poorly maintained in FEM1B knockdown cells; and FEM1B-ablated cells are as sensitive to replication block as CHK1-depleted cells. Our study has uncovered an adaptor protein FEM1B, which acts as a bridge linking CHK1 and Rad9, thus facilitating checkpoint signaling induced by replication stress. Oncogene (2009) 28, 1971-1981; doi:10.1038/onc.2009.58; published online 30 March 2009	[Sun, T-P; Shieh, S-Y] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Sun, T-P] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430	Academia Sinica, Taiwan	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	We thank Shiaw-Wei Tyan for his assistance with yeast library screening. We are also grateful to Drs Hsiu-Ming Shih for the human testis cDNA library; Victor Yu for pXJ-HA-F1Aa; Carol Prives for GST-Cdc25C<INF>200-256</INF>; Howard Lieberman for Rad9 cDNA; Randal Tibbetts and Robert Abraham for FlagATR. This study was supported by funds from Academia Sinica, Taiwan to S-Y Shieh.	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Chan SL, 1999, J BIOL CHEM, V274, P32461, DOI 10.1074/jbc.274.45.32461; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; Jamil S, 2008, MOL BIOL CELL, V19, P3212, DOI 10.1091/mbc.E07-11-1171; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Krakow D, 2001, GENE, V279, P213, DOI 10.1016/S0378-1119(01)00756-9; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lu DY, 2005, MOL CELL BIOL, V25, P6570, DOI 10.1128/MCB.25.15.6570-6577.2005; Machida YJ, 2005, J BIOL CHEM, V280, P6253, DOI 10.1074/jbc.R400037200; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Shieh SY, 2000, GENE DEV, V14, P289; Ventura-Holman T, 2003, GENE, V314, P133, DOI 10.1016/S0378-1119(03)00712-1; Ventura-Holman T, 1998, GENOMICS, V54, P221, DOI 10.1006/geno.1998.5569; Ventura-Holman T, 2000, BIOCHEM BIOPH RES CO, V267, P317, DOI 10.1006/bbrc.1999.1942; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	38	6	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2009	28	18					1971	1981		10.1038/onc.2009.58	http://dx.doi.org/10.1038/onc.2009.58			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	442DT	19330022				2022-12-25	WOS:000265820900004
J	Kim, HM; Hwang, DH; Lee, JE; Kim, SU; Kim, BG				Kim, Hyuk Min; Hwang, Dong Hoon; Lee, Jong Eun; Kim, Seung U.; Kim, Byung G.			Ex Vivo VEGF Delivery by Neural Stem Cells Enhances Proliferation of Glial Progenitors, Angiogenesis, and Tissue Sparing after Spinal Cord Injury	PLOS ONE			English	Article								The present study was undertaken to examine multifaceted therapeutic effects of vascular endothelial growth factor (VEGF) in a rat spinal cord injury (SCI) model, focusing on its capability to stimulate proliferation of endogenous glial progenitor cells. Neural stem cells (NSCs) can be genetically modified to efficiently transfer therapeutic genes to diseased CNS. We adopted an ex vivo approach using immortalized human NSC line (F3 cells) to achieve stable and robust expression of VEGF in the injured spinal cord. Transplantation of NSCs retrovirally transduced to overexpress VEGF (F3. VEGF cells) at 7 days after contusive SCI markedly elevated the amount of VEGF in the injured spinal cord tissue compared to injection of PBS or F3 cells without VEGF. Concomitantly, phosphorylation of VEGF receptor flk-1 increased in F3. VEGF group. Stereological counting of BrdU+ cells revealed that transplantation of F3. VEGF significantly enhanced cellular proliferation at 2 weeks after SCI. The number of proliferating NG2+ glial progenitor cells (NG2+/BrdU+) was also increased by F3. VEGF. Furthermore, transplantation of F3. VEGF increased the number of early proliferating cells that differentiated into mature oligodendrocytes, but not astrocytes, at 6 weeks after SCI. F3. VEGF treatment also increased the density of blood vessels in the injured spinal cord and enhanced tissue sparing. These anatomical results were accompanied by improved BBB locomotor scores. The multifaceted effects of VEGF on endogenous gliogenesis, angiogenesis, and tissue sparing could be utilized to improve functional outcomes following SCI.	[Kim, Hyuk Min; Hwang, Dong Hoon; Kim, Byung G.] Ajou Univ, Sch Med, Inst Med Sci, Brain Dis Res Ctr, Suwon 441749, South Korea; [Kim, Byung G.] Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea; [Lee, Jong Eun] Yonsei Univ, Coll Med, Dept Anat, Seoul 120749, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V5Z 1M9, Canada; [Kim, Seung U.] Chung Ang Univ, Sch Med, Med Res Inst, Seoul, South Korea	Ajou University; Ajou University; Yonsei University; Yonsei University Health System; University of British Columbia; Chung Ang University; Chung Ang University Hospital	Kim, HM (corresponding author), Ajou Univ, Sch Med, Inst Med Sci, Brain Dis Res Ctr, Suwon 441749, South Korea.	kimbg@ajou.ac.kr	Kim, Byung Gon/L-6884-2019	Kim, Byung Gon/0000-0003-2233-9569; Lee, Jong Eun/0000-0001-6203-7413	Korean Government [KRF-2007-E00200, R01-2007-000-20617-0]	Korean Government(Korean Government)	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MEST, KRF-2007-E00200) and by the Korean Science and Engineering Foundation (KOSEF) grant funded by the Korea government(MEST) (R01-2007-000-20617-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Bhat RV, 1996, GLIA, V17, P169; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; BREAKEFIELD X, 1999, CNS REGENERATION BAS, P251; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Davis LE, 2006, LANCET NEUROL, V5, P7, DOI 10.1016/S1474-4422(05)70259-3; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gundersen G, 1998, ANIM BEHAV, V56, P1355, DOI 10.1006/anbe.1998.0911; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jandial R, 2008, MOL THER, V16, P450, DOI 10.1038/sj.mt.6300402; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Mani N, 2005, EXP NEUROL, V192, P394, DOI 10.1016/j.expneurol.2004.12.022; Martinez-Serrano A, 1998, P NATL ACAD SCI USA, V95, P1858, DOI 10.1073/pnas.95.4.1858; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; WAXMAN SG, 1992, J NEUROTRAUM, V9, pS105; Weiss S, 1996, J NEUROSCI, V16, P7599; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	44	93	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4987	10.1371/journal.pone.0004987	http://dx.doi.org/10.1371/journal.pone.0004987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319198	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200016
J	Remais, J; Chen, L; Seto, E				Remais, Justin; Chen, Lin; Seto, Edmund			Leveraging Rural Energy Investment for Parasitic Disease Control: Schistosome Ova Inactivation and Energy Co-Benefits of Anaerobic Digesters in Rural China	PLOS ONE			English	Article							BIOMASS FUELS; AIR-POLLUTION; TRANSMISSION; HEALTH; JAPONICUM; PATHOGENS; SICHUAN; AREAS; MODEL	Background: Cooking and heating remain the most energy intensive activities among the world's poor, and thus improved access to clean energies for these tasks has been highlighted as a key requirement of attaining the major objectives of the UN Millennium Development Goals. A move towards clean energy technologies such as biogas systems (which produce methane from human and animal waste) has the potential to provide immediate benefits for the control of neglected tropical diseases. Here, an assessment of the parasitic disease and energy benefits of biogas systems in Sichuan Province, China, is presented, highlighting how the public health sector can leverage the proliferation of rural energy projects for infectious disease control. Methodology/Findings: First, the effectiveness of biogas systems at inactivating and removing ova of the human parasite Schistosoma japonicum is experimentally evaluated. Second, the impact of biogas infrastructure on energy use and environmental quality as reported by surveyed village populations is assessed, as is the community acceptance of the technology. No viable eggs were recovered in the effluent collected weekly from biogas systems for two months following seeding with infected stool. Less than 1% of ova were recovered viable from a series of nylon bags seeded with ova, a 2-log removal attributable to biochemical inactivation. More than 90% of Ascaris lumbricoides ova (used as a proxy for S. japonicum ova) counted at the influent of two biogas systems were removed in the systems when adjusted for system residence time, an approximate 1-log removal attributable to sedimentation. Combined, these inactivation/removal processes underscore the promise of biogas infrastructure for reducing parasite contamination resulting from nightsoil use. When interviewed an average of 4 years after construction, villagers attributed large changes in fuel usage to the installation of biogas systems. Household coal usage decreased by 68%, wood by 74%, and crop waste by 6%. With reported energy savings valued at roughly 600 CNY per year, 2-3 years were required to recoup the capital costs of biogas systems. In villages without subsidies, no new biogas systems were implemented. Conclusions: Sustainable strategies that integrate rural energy needs and sanitation offer tremendous promise for long-term control of parasitic diseases, while simultaneously reducing energy costs and improving quality of life. Government policies can enhance the financial viability of such strategies by introducing fiscal incentives for joint sanitation/sustainable energy projects, along with their associated public outreach and education programs.	[Remais, Justin] Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA; [Chen, Lin] Sichuan Provinc Ctr Dis Control & Prevent, Inst Parasit Dis, Sichuan, Peoples R China; [Seto, Edmund] Univ Calif Berkeley, Sch Publ Hlth, Ctr Occupat & Environm Hlth, Berkeley, CA 94720 USA	Emory University; Rollins School Public Health; University of California System; University of California Berkeley	Remais, J (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Remais, Justin/V-3207-2019	Remais, Justin/0000-0002-0223-4615	National Institute for Allergy and Infectious Disease [R01 AI-050612]; NIH/NSF Ecology of Infectious Disease Program [0622743]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050612] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NSF Ecology of Infectious Disease Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institute for Allergy and Infectious Disease (grant R01 AI-050612) and the NIH/NSF Ecology of Infectious Disease Program (grant 0622743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOTT M, 1984, BIOGAS BIOFERTILIZER, pR11; *ARTI, 2006, COMM IMPR BIOM FUELS; Borges ESM, 2005, WATER SCI TECHNOL, V52, P227, DOI 10.2166/wst.2005.0698; CAI J, 2007, RENEWABLE S IN PRESS; CHEN B H, 1990, World Health Statistics Quarterly, V43, P127; *CHIN MIN HLTH, 2000, HDB SCHIST CONTR; DONG R, 2006, ASSESSMENT IMPROVEME; Fenwick A, 2006, SCIENCE, V313, P1077, DOI 10.1126/science.1127184; *FOOD AGR ORG UN, 1986, BIOG 2 BUILD BETT BI; *FOOD AGR ORG UN, 1984, BIOG WHAT IT IS IT I; GUNNERSON CG, 1986, ANAEROBIC DIGESTION, pR15; Haines A., 2007, LANCET; *HDIP, 2005, PAK EN YB; House D., 1981, BIOGAS HDB; HU R, 2005, IND BIOTECHNOLOGY, P222; Ilyas S. Z., 2006, AM EURASIAN J SCI RE, V1, P42; Islam AKMS, 2006, RENEW ENERG, V31, P677, DOI 10.1016/j.renene.2005.08.004; JINGFEI WXL, 2005, RENEW SUST ENERG REV, V9, P229; KISHORE VVN, 1987, FIXED DOME BIOGAS PL, pR7; LI J, 2006, ANAEROBIC DIGESTION; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Liang S, 2005, TROP MED INT HEALTH, V10, P263, DOI 10.1111/j.1365-3156.2005.01386.x; Liang S, 2007, P NATL ACAD SCI USA, V104, P7110, DOI 10.1073/pnas.0701878104; LICHTMAN R, 1987, WORLD DEV, V15, P347, DOI 10.1016/0305-750X(87)90018-0; MARCHAIM U, 1992, BIOGAS PROCESSES SUS, pR7; MCGARRY MG, 1978, COMPOST FERTILIZER B; NAKAGAWA CH, 1981, CHINESE BIOGAS DIGES; National Development and Reform Commission, 2007, MED LONG TERM DEV PL; Ni JQ, 1996, ENERG CONVERS MANAGE, V37, P1525, DOI 10.1016/0196-8904(95)00354-1; Plachy P, 1996, VET MED-CZECH, V41, P255; Qi XS, 2005, ECOL ENG, V24, P177, DOI 10.1016/j.ecoleng.2004.11.001; RAVINDRANATH NH, 1997, ENERGY POLICY, V25; SANTERRE MT, 1982, WORLD DEV, V10, P239, DOI 10.1016/0305-750X(82)90013-4; SASSE L, 1984, BIOGAS PLANTS DESIGN; Schonning C, 2007, J WATER HEALTH, V5, P117, DOI 10.2166/wh.2006.049; Shrestha IL, 2005, INT J OCCUP ENV HEAL, V11, P150, DOI 10.1179/oeh.2005.11.2.150; Shuval H.I., 1986, WASTEWATER IRRIGATIO; SINGH L, 1995, B ENVIRON CONTAM TOX, V54, P472, DOI 10.1007/BF00195123; SMIL V, 2004, CHINAS PAST CHINAS F, pR15; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; Smith SR, 2005, WASTE MANAGE, V25, P417, DOI 10.1016/j.wasman.2005.02.010; Spear RC, 2004, AM J TROP MED HYG, V70, P48, DOI 10.4269/ajtmh.2004.70.48; Spear RC, 2002, ENVIRON HEALTH PERSP, V110, P907, DOI 10.1289/ehp.02110907; SRINIVASAN S, 2007, RENEWABLE S IN PRESS; SUBRAMANIAN SK, 1977, BIOGAS SYSTEMS ASIA, pR10; Svensson K, 2004, J AGR SCI-CAMBRIDGE, V142, P461, DOI 10.1017/S0021859604004514; *UN EC SOC COMM AS, 1980, GUID BIOG DEV; *UN EC SOC COMM AS, 1984, UPD GUIDB BIOG DEV, pR11; *UNAPCAEM, 2007, REC DEV BIOG TECHN P; *UNESCAP, 2007, REC DEV BIOG TECHN P; Van Buren A., 1979, CHINESE BIOGAS MANUA; VANBUREN EA, 1981, BIOGAS FERTILIZER SY; Wang XH, 2007, RENEW SUST ENERG REV, V11, P1018, DOI 10.1016/j.rser.2005.08.001; WANG Y, 2002, CHINA BIOGAS, V20, P46; *WHO, 1983, CELL FAEC THICK EX T; YAO Y, 1992, BIOGAS TECHNOLOGY CH; ZENG B, 2000, CHINA BIOGAS, V18, P31; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang PD, 2007, RENEW SUST ENERG REV, V11, P1903, DOI 10.1016/j.rser.2005.11.009; 1977, CHIN MED J ENGL, V3, P361	60	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4856	10.1371/journal.pone.0004856	http://dx.doi.org/10.1371/journal.pone.0004856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OK	19293926	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496600004
J	Ferreira, VM; Gomes, TS; Reis, LA; Ferreira, AT; Razvickas, CV; Schor, N; Boim, MA				Ferreira, Vanessa M.; Gomes, Thiago S.; Reis, Luciana A.; Ferreira, Alice T.; Razvickas, Clara V.; Schor, Nestor; Boim, Mirian A.			Receptor-Induced Dilatation in the Systemic and Intrarenal Adaptation to Pregnancy in Rats	PLOS ONE			English	Article								Normal pregnancy is associated with systemic and intrarenal vasodilatation resulting in an increased glomerular filtration rate. This adaptive response occurs in spite of elevated circulating levels of angiotensin II (Ang II). In the present study, we evaluated the potential mechanisms responsible for this adaptation. The reactivity of the mesangial cells (MCs) cultured from 14-day-pregnant rats to Ang II was measured through changes in the intracellular calcium concentration ([Cai]). The expression levels of inducible nitric oxide synthase (iNOS), the Ang II-induced vasodilatation receptor AT2, and the relaxin (LGR7) receptor were evaluated in cultured MCs and in the aorta, renal artery and kidney cortex by real time-PCR. The intrarenal distribution of LGR7 was further analyzed by immunohistochemistry. The MCs displayed a relative insensitivity to Ang II, which was paralleled by an impressive increase in the expression level of iNOS, AT2 and LGR7. These results suggest that the MCs also adapt to the pregnancy, thereby contributing to the maintenance of the glomerular surface area even in the presence of high levels of Ang II. The mRNA expression levels of AT2 and LGR7 also increased in the aorta, renal artery and kidney of the pregnant animals, whereas the expression of the AT1 did not significantly change. This further suggests a role of these vasodilatation-induced receptors in the systemic and intrarenal adaptation during pregnancy. LGR7 was localized in the glomeruli and on the apical membrane of the tubular cells, with stronger labeling in the kidneys of pregnant rats. These results suggest a role of iNOS, AT2, and LGR7 in the systemic vasodilatation and intrarenal adaptation to pregnancy and also suggest a pivotal role for relaxin in the tubular function during gestation.	[Ferreira, Vanessa M.; Gomes, Thiago S.; Reis, Luciana A.; Razvickas, Clara V.; Schor, Nestor; Boim, Mirian A.] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Gomes, Thiago S.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Ferreira, Alice T.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	mirian@nefro.epm.br	Batista, Marcelo/K-4305-2013; Boim, Mirian A/L-6574-2013; Schor, Nestor/K-4364-2013		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); Fundacao Oswaldo Ramos (FOR); Fundo de Auxilio aos Docentes e Alunos (FADA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Ramos (FOR); Fundo de Auxilio aos Docentes e Alunos (FADA)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Fundacao Oswaldo Ramos (FOR), and Fundo de Auxilio aos Docentes e Alunos (FADA) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Baylis C, 1996, KIDNEY INT, V49, P1727, DOI 10.1038/ki.1996.256; BAYLIS C, 1987, AM J KIDNEY DIS, V9, P260, DOI 10.1016/S0272-6386(87)80119-1; BAYLIS C, 1980, J PHYSIOL-LONDON, V305, P405, DOI 10.1113/jphysiol.1980.sp013372; BAYLIS C, 1992, CLIN EXP HYPERTENS B, V11, P1117; Bobadilla RA, 2003, CAN J PHYSIOL PHARM, V81, P1, DOI 10.1139/Y02-168; Bogzil AH, 2005, AM J PHYSIOL-REG I, V288, pR322, DOI 10.1152/ajpregu.00509.2004; BOIM MA, 1994, BRAZ J MED BIOL RES, V27, P1431; Burrell JH, 1997, EUR J PHARMACOL, V330, P257, DOI 10.1016/S0014-2999(97)00167-2; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Conrad KP, 1999, AM J PHYSIOL-RENAL, V276, pF767, DOI 10.1152/ajprenal.1999.276.5.F767; Conrad KP, 2005, ANN NY ACAD SCI, V1041, P147, DOI 10.1196/annals.1282.022; Conrad KP, 2004, J SOC GYNECOL INVEST, V11, P438, DOI 10.1016/j.jsgi.2004.05.002; CONRAD KP, 1991, J CLIN INVEST, V87, P1700, DOI 10.1172/JCI115187; Cox BE, 1996, AM J PHYSIOL-HEART C, V271, pH212, DOI 10.1152/ajpheart.1996.271.1.H212; Danielson LA, 1999, J CLIN INVEST, V103, P525, DOI 10.1172/JCI5630; DANIELSON LA, 1995, J CLIN INVEST, V96, P482, DOI 10.1172/JCI118059; Danielson LA, 2000, AM J PHYSIOL-REG I, V279, pR1298, DOI 10.1152/ajpregu.2000.279.4.R1298; Debrah DO, 2006, ENDOCRINOLOGY, V147, P5126, DOI 10.1210/en.2006-0567; GREENSPON SA, 1950, ARCH PATHOL, V49, P291; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hadad SJ, 1997, KIDNEY INT, V51, P87, DOI 10.1038/ki.1997.11; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; MACKANJEE HR, 1991, AM J OBSTET GYNECOL, V165, P1641, DOI 10.1016/0002-9378(91)90008-F; Nistri Silvia, 2003, Reprod Biol Endocrinol, V1, P5, DOI 10.1186/1477-7827-1-5; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Novak J, 2002, AM J PHYSIOL-REG I, V283, pR349, DOI 10.1152/ajpregu.00635.2001; Novak J, 2006, FASEB J, V20, P2352, DOI 10.1096/fj.06-6263com; RAIJ L, 1995, KIDNEY INT, V48, P20, DOI 10.1038/ki.1995.262; Schauser KH, 1998, BIOL REPROD, V59, P684, DOI 10.1095/biolreprod59.3.684; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; SCHRIER RW, 1987, AM J KIDNEY DIS, V9, P284, DOI 10.1016/S0272-6386(87)80123-3; SHANMUGAM S, 1995, AM J PHYSIOL-RENAL, V268, pF922, DOI 10.1152/ajprenal.1995.268.5.F922; Shanmugam S, 1996, CELL BIOL INT, V20, P169, DOI 10.1006/cbir.1996.0021; SHERWOOD OD, 1994, RELAXIN, P861; SHULTZ PJ, 1994, KIDNEY INT, V46, P683, DOI 10.1038/ki.1994.321; Siragy HM, 1996, J CLIN INVEST, V97, P1978, DOI 10.1172/JCI118630; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Smith MC, 2006, J AM SOC NEPHROL, V17, P3192, DOI 10.1681/ASN.2005090950; WILSON M, 1980, AM J MED, V68, P97, DOI 10.1016/0002-9343(80)90178-3	41	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4845	10.1371/journal.pone.0004845	http://dx.doi.org/10.1371/journal.pone.0004845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287481	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400007
J	Mushlin, RA; Gallagher, S; Kershenbaum, A; Rebbeck, TR				Mushlin, Richard A.; Gallagher, Stephen; Kershenbaum, Aaron; Rebbeck, Timothy R.			Clique-Finding for Heterogeneity and Multidimensionality in Biomarker Epidemiology Research: The CHAMBER Algorithm	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN METABOLISM GENOTYPES; GENE; REGRESSION; STATISTICS; DISCOVERY	Background: Commonly-occurring disease etiology may involve complex combinations of genes and exposures resulting in etiologic heterogeneity. We present a computational algorithm that employs clique-finding for heterogeneity and multidimensionality in biomedical and epidemiological research (the "CHAMBER'' algorithm). Methodology/Principal Findings: This algorithm uses graph-building to (1) identify genetic variants that influence disease risk and (2) predict individuals at risk for disease based on inherited genotype. We use a set-covering algorithm to identify optimal cliques and a Boolean function that identifies etiologically heterogeneous groups of individuals. We evaluated this approach using simulated case-control genotype-disease associations involving two-and four-gene patterns. The CHAMBER algorithm correctly identified these simulated etiologies. We also used two population-based case-control studies of breast and endometrial cancer in African American and Caucasian women considering data on genotypes involved in steroid hormone metabolism. We identified novel patterns in both cancer sites that involved genes that sulfate or glucuronidate estrogens or catecholestrogens. These associations were consistent with the hypothesized biological functions of these genes. We also identified cliques representing the joint effect of multiple candidate genes in all groups, suggesting the existence of biologically plausible combinations of hormone metabolism genes in both breast and endometrial cancer in both races. Conclusions: The CHAMBER algorithm may have utility in exploring the multifactorial etiology and etiologic heterogeneity in complex disease.	[Gallagher, Stephen; Rebbeck, Timothy R.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Gallagher, Stephen; Rebbeck, Timothy R.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Mushlin, Richard A.] PsychoGenics Inc, Tarrytown, NY USA; [Kershenbaum, Aaron] IBM Corp, TJ Watson Res Ctr, Yorktown Hts, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; International Business Machines (IBM)	Rebbeck, TR (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	rebbeck@mail.med.upenn.edu	Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900	Commonwealth of Pennsylvania and Public Health Service [P01-CA77596]; NATIONAL CANCER INSTITUTE [P01CA077596] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania and Public Health Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the Commonwealth of Pennsylvania and Public Health Service grant P01-CA77596. The study sponsors had no say in study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit it for publication. The authors have no financial, personal, or professional interests that could be construed to have influenced the paper. The WISE Study group includes: Andrea Troxel, Mona Baumgarten, Jesse Berlin, Michelle Berlin, Greta Bunin, Rebecca Blanchard, Lewis Chodosh, Ekaterina Shatalova, Stephen Rubin, Angela M. DeMichele, Sandra Norman, Rita Schinnar, Brian Strom.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2017, CLASSIFICATION REGRE; Brinza D, 2006, BIOINFORMATICS, V22, P371, DOI 10.1093/bioinformatics/bti785; Chen JB, 2007, GENET EPIDEMIOL, V31, P238, DOI 10.1002/gepi.20205; Conti DV, 2003, HUM HERED, V56, P83, DOI 10.1159/000073736; CORTESSIS V, 2004, TOXICOKINETIC GENETI, P127; ERLENKOTTER D, 1978, OPER RES, V26, P992, DOI 10.1287/opre.26.6.992; Foulkes AS, 2005, STAT MED, V24, P775, DOI 10.1002/sim.1965; FRIEDMAN JH, 1974, IEEE T COMPUT, VC 23, P881, DOI 10.1109/T-C.1974.224051; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Hoh J, 2000, P NATL ACAD SCI USA, V97, P9615, DOI 10.1073/pnas.170179197; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; KIRA K, 1992, MACHINE LEARNING /, P249; KONONENKO I, P EUR C MACH LEARN N, P171; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lepre J, 2004, BIOINFORMATICS, V20, P1033, DOI 10.1093/bioinformatics/bth035; LIEHR JG, 1990, MUTAT RES, V238, P269, DOI 10.1016/0165-1110(90)90018-7; Michie D., 1994, MACHINE LEARNING NEU; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; MUSHLIN R, 2007, IBM SYSTEMS IN PRESS; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; PAVLOV Y, 1997, PROBABILITY METHODS, V1; Quinlan JR, 1993, C4 5 PROGRAMS MACHIN; Rebbeck TR, 2007, CANCER EPIDEM BIOMAR, V16, P1318, DOI 10.1158/1055-9965.EPI-07-0084; Rebbeck TR, 2007, CANCER EPIDEM BIOMAR, V16, P444, DOI 10.1158/1055-9965.EPI-06-0800; Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1007/BF00116037; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Shannon WD, 2001, GENET EPIDEMIOL, V20, P293, DOI 10.1002/gepi.1; Strom BL, 2006, AM J EPIDEMIOL, V164, P775, DOI 10.1093/aje/kwj316; Tahri-Daizadeh N, 2004, ANN HUM GENET, V68, P405, DOI 10.1046/j.1529-8817.2004.00107.x; Tahri-Daizadeh N, 2003, GENOME RES, V13, P1952, DOI 10.1101/gr.1254203; THOMAS H, 2001, INTRO ALGORITHMS, P643; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042; WITTEN IH, 2005, DATA MINING PRACTICA	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4862	10.1371/journal.pone.0004862	http://dx.doi.org/10.1371/journal.pone.0004862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287484	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496400012
J	Spring, S; Lunsdorf, H; Fuchs, BM; Tindall, BJ				Spring, Stefan; Luensdorf, Heinrich; Fuchs, Bernhard M.; Tindall, Brian J.			The Photosynthetic Apparatus and Its Regulation in the Aerobic Gammaproteobacterium Congregibacter litoralis gen. nov., sp nov.	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES 2.4.1; ANOXYGENIC PHOTOTROPHIC BACTERIA; ELECTRON-TRANSPORT; RHODOSPIRILLUM-RUBRUM; CHROMATIUM-VINOSUM; ROSEOBACTER CLADE; TERMINAL OXIDASE; LIGHT-INTENSITY; SURFACE WATERS; CYTOCHROME-C	Background: There is accumulating evidence that in some marine environments aerobic bacteriochlorophyll a-producing bacteria represent a significant part of the microbial population. The interaction of photosynthesis and carbon metabolism in these interesting bacteria is still largely unknown and requires further investigation in order to estimate their contribution to the marine carbon cycle. Methodology/Principal Findings: Here, we analyzed the structure, composition and regulation of the photosynthetic apparatus in the obligately aerobic marine gammaproteobacterium KT71(T). Photoheterotrophically grown cells were characterized by a poorly developed lamellar intracytoplasmic membrane system, a type 1 light-harvesting antenna complex and a photosynthetic reaction center associated with a tetraheme cytochrome c. The only photosynthetic pigments produced were bacteriochlorophyll a and spirilloxanthin. Under semiaerobic conditions KT71(T) cells expressing a photosynthetic apparatus showed a light-dependent increase of growth yield in the range of 1.3-2.5 fold. The expression level of the photosynthetic apparatus depended largely on the utilized substrate, the intermediary carbon metabolism and oxygen tension. In addition, pigment synthesis was strongly influenced by light, with blue light exerting the most significant effect, implicating that proteins containing a BLUF domain may be involved in regulation of the photosynthetic apparatus. Several phenotypic traits in KT71(T) could be identified that correlated with the assumed redox state of growing cells and thus could be used to monitor the cellular redox state under various incubation conditions. Conclusions/Significance: In a hypothetical model that explains the regulation of the photosynthetic apparatus in strain KT71(T) we propose that the expression of photosynthesis genes depends on the cellular redox state and is maximal under conditions that allow a balanced membrane redox state. So far, bacteria capable of an obligately aerobic, photosynthetic metabolism constitute a unique phenotype within the class Gammaproteobacteria, so that it is justified to propose a new genus and species, Congregibacter litoralis gen. nov, sp. nov., represented by the type strain KT71(T) (= DSM 17192(T) = NBRC 104960(T)).	[Spring, Stefan; Tindall, Brian J.] Deutsch Sammlung Mikroorganismen & Zellkulturen, D-3300 Braunschweig, Germany; [Luensdorf, Heinrich] Helmholtz Zent Infektionsforsch, Braunschweig, Germany; [Fuchs, Bernhard M.] Max Planck Inst Marine Mikrobiol, Bremen, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Max Planck Society	Spring, S (corresponding author), Deutsch Sammlung Mikroorganismen & Zellkulturen, D-3300 Braunschweig, Germany.	ssp@dsmz.de	Spring, Stefan/N-6933-2013	Spring, Stefan/0000-0001-6247-0938; Fuchs, Bernhard/0000-0001-9828-1290	Leibniz Association; Helmholtz Society; Max Planck Society	Leibniz Association; Helmholtz Society(Helmholtz Association); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Research of SS and BJT is supported by the Leibniz Association (WGL), HL is supported by the Helmholtz Society (HGF) and BMF by the Max Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalidis I, 1999, PHOTOSYNTH RES, V62, P31, DOI 10.1023/A:1006384113191; Allgaier M, 2003, APPL ENVIRON MICROB, V69, P5051, DOI 10.1128/AEM.69.9.5051-5059.2003; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; BAUER C, 1993, TRENDS GENET, V9, P56, DOI 10.1016/0168-9525(93)90188-N; Beatty JT, 2002, PHOTOSYNTH RES, V73, P109, DOI 10.1023/A:1020493518379; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Brostedt E, 1997, FEMS MICROBIOL LETT, V150, P263, DOI 10.1111/j.1574-6968.1997.tb10379.x; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Candela M, 2001, ARCH MICROBIOL, V175, P168, DOI 10.1007/s002030100251; Cho JC, 2007, ENVIRON MICROBIOL, V9, P1456, DOI 10.1111/j.1462-2920.2007.01264.x; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Cho SH, 2004, MICROBIOL-SGM, V150, P697, DOI 10.1099/mic.0.26777-0; CLAYTON RK, 1955, ARCH MIKROBIOL, V22, P180, DOI 10.1007/BF00409304; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; COREMANS JMCC, 1985, BIOCHIM BIOPHYS ACTA, V807, P134, DOI 10.1016/0005-2728(85)90116-1; Cousin S, 2008, INT MICROBIOL, V11, P91, DOI 10.2436/20.1501.01.48; Csotonyi JT, 2008, EXTREMOPHILES, V12, P529, DOI 10.1007/s00792-008-0156-8; DREWS G, 1985, MICROBIOL REV, V49, P59, DOI 10.1128/MMBR.49.1.59-70.1985; Dubbs JM, 2004, FEMS MICROBIOL REV, V28, P353, DOI 10.1016/j.femsre.2004.01.002; Eiler A, 2006, APPL ENVIRON MICROB, V72, P7431, DOI 10.1128/AEM.01559-06; Eilers H, 2001, APPL ENVIRON MICROB, V67, P5134, DOI 10.1128/AEM.67.11.5134-5142.2001; Elsen S, 2005, MOL MICROBIOL, V57, P17, DOI 10.1111/j.1365-2958.2005.04655.x; Fuchs BM, 2007, P NATL ACAD SCI USA, V104, P2891, DOI 10.1073/pnas.0608046104; FUJIWARA T, 1992, J BIOCHEM, V112, P290, DOI 10.1093/oxfordjournals.jbchem.a123893; Gerhardt P., 1994, METHODS GEN MOL BACT; Giraud E, 2004, J BIOL CHEM, V279, P15076, DOI 10.1074/jbc.M312113200; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Graeber I, 2008, INT J SYST EVOL MICR, V58, P585, DOI 10.1099/ijs.0.65438-0; Grammel H, 2003, APPL ENVIRON MICROB, V69, P6577, DOI 10.1128/AEM.69.11.6577-6586.2003; Grammel H, 2008, J BACTERIOL, V190, P4912, DOI 10.1128/JB.00423-08; Happ HN, 2005, MOL MICROBIOL, V58, P903, DOI 10.1111/j.1365-2958.2005.04882.x; HARASHIMA K, 1987, PLANT CELL PHYSIOL, V28, P365; Hill BC, 1996, BIOCHEMISTRY-US, V35, P6136, DOI 10.1021/bi952486f; HOCHKOEPPLER A, 1995, FEBS LETT, V375, P197, DOI 10.1016/0014-5793(95)01188-K; HOCHKOEPPLER A, 1995, BBA-BIOENERGETICS, V1229, P73, DOI 10.1016/0005-2728(94)00189-C; HOLT SC, 1965, J BACTERIOL, V89, P1421, DOI 10.1128/JB.89.5.1421-1429.1965; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jaubert M, 2004, J BIOL CHEM, V279, P44407, DOI 10.1074/jbc.M408039200; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; JURTSHUK P, 1976, APPL ENVIRON MICROB, V31, P668, DOI 10.1128/AEM.31.5.668-679.1976; Kaksonen AH, 2006, INT J SYST EVOL MICR, V56, P2603, DOI 10.1099/ijs.0.64439-0; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; KELLY DP, 1968, ARCH MIKROBIOL, V61, P59, DOI 10.1007/BF00704292; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Koblizek M, 2005, FEMS MICROBIOL ECOL, V51, P353, DOI 10.1016/j.femsec.2004.09.016; Kolber Z, 2007, OCEANOGRAPHY, V20, P79, DOI 10.5670/oceanog.2007.51; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; LOTSPEICH WD, 1952, BIOCHEM J, V51, P20, DOI 10.1042/bj0510020; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lunsdorf H, 2001, METHODS ENZYMOL, V336, P317; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; MEYER TE, 1994, METHOD ENZYMOL, V243, P435; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Oh JI, 2000, EMBO J, V19, P4237, DOI 10.1093/emboj/19.16.4237; Pernthaler A, 2005, APPL ENVIRON MICROB, V71, P4638, DOI 10.1128/AEM.71.8.4638-4644.2005; PETERS RA, 1953, NATURE, V171, P1111, DOI 10.1038/1711111a0; PETTIGREW GW, 1988, BIOCHEM J, V252, P427, DOI 10.1042/bj2520427; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rathgeber C, 2004, PHOTOSYNTH RES, V81, P113, DOI 10.1023/B:PRES.0000035036.49977.bc; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; SCHWERZMANN RU, 1989, PLANT CELL PHYSIOL, V30, P497, DOI 10.1093/oxfordjournals.pcp.a077768; Smith L, 1978, Methods Enzymol, V53, P202; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stouthamer A. H., 1979, INT REV BIOCHEM, V21, P1; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; TAUSCHEL HD, 1967, ARCH MIKROBIOL, V59, P381, DOI 10.1007/BF00412163; TINDALL BJ, 1990, FEMS MICROBIOL LETT, V66, P199; Urios L, 2008, INT J SYST EVOL MICR, V58, P1233, DOI 10.1099/ijs.0.65470-0; Van Driessche G, 2003, J MOL EVOL, V57, P181, DOI 10.1007/s00239-003-2465-y; VANDERREST M, 1974, J BIOL CHEM, V249, P6446; VANGEMERDEN H, 1980, ARCH MICROBIOL, V125, P115, DOI 10.1007/BF00403207; Yeliseev AA, 1996, J BACTERIOL, V178, P5877, DOI 10.1128/jb.178.20.5877-5883.1996; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; [No title captured]	90	65	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4866	10.1371/journal.pone.0004866	http://dx.doi.org/10.1371/journal.pone.0004866			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287491	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496400014
J	Pontoppidan, MB; Himaman, W; Hywel-Jones, NL; Boomsma, JJ; Hughes, DP				Pontoppidan, Maj-Britt; Himaman, Winanda; Hywel-Jones, Nigel L.; Boomsma, Jacobus J.; Hughes, David P.			Graveyards on the Move: The Spatio-Temporal Distribution of Dead Ophiocordyceps-Infected Ants	PLOS ONE			English	Article								Parasites are likely to play an important role in structuring host populations. Many adaptively manipulate host behaviour, so that the extended phenotypes of these parasites and their distributions in space and time are potentially important ecological variables. The fungus Ophiocordyceps unilateralis, which is pan-tropical in distribution, causes infected worker ants to leave their nest and die under leaves in the understory of tropical rainforests. Working in a forest dynamic plot in Southern Thailand we mapped the occurrence of these dead ants by examining every leaf in 1,360 m 2 of primary rainforest. We established that high density aggregations exist (up to 26 dead ants/m(2)), which we coined graveyards. We further established that graveyards are patchily distributed in a landscape with no or very few O. unilateralis-killed ants. At some, but not all, spatial scales of analysis the density of dead ants correlated with temperature, humidity and vegetation cover. Remarkably, having found 2243 dead ants inside graveyards we only found 2 live ants of the principal host, ant Camponotus leonardi, suggesting that foraging host ants actively avoid graveyards. We discovered that the principal host ant builds nests in high canopy and its trails only occasionally descend to the forest floor where infection occurs. We advance the hypothesis that rare descents may be a function of limited canopy access to tree crowns and that resource profitability of such trees is potentially traded off against the risk of losing workers due to infection when forest floor trails are the only access routes. Our work underscores the need for an integrative approach that recognises multiple facets of parasitism, such as their extended phenotypes.	[Pontoppidan, Maj-Britt] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark; [Himaman, Winanda] Natl Park Wildlife & Plant Conserv Dt, Forest Entomol & Microbiol Grp, Bangkok, Thailand; [Hywel-Jones, Nigel L.] Natl Ctr Genet Engn & Biotechnol, Mycol Lab, Pathum Thani, Thailand; [Boomsma, Jacobus J.; Hughes, David P.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, DK-1168 Copenhagen, Denmark; [Hughes, David P.] Harvard Univ, Dept Organism & Evolut Biol, Museum Comparative Zool Labs, Cambridge, MA 02138 USA; [Hughes, David P.] Univ Exeter, Sch Biosci, Exeter EX4 4QJ, Devon, England	University of Copenhagen; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Copenhagen; Harvard University; University of Exeter	Pontoppidan, MB (corresponding author), Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark.	mbp@bio.ku.dk; dhughes@oeb.harvard.edu	Boomsma, Jacobus J/M-2785-2014	Boomsma, Jacobus J/0000-0002-3598-1609	Oticon; Novozymes/WWF; Marie Curie Individual Intra-European Fellowships [MEIF-CT-2006-041613]	Oticon; Novozymes/WWF; Marie Curie Individual Intra-European Fellowships	M.B.P. was supported by a grant from Oticon and a Novozymes/WWF Biodiversity Grant to D.P.H who is also supported by a Marie Curie Individual Intra-European Fellowships in the Framework Program 6 (MEIF-CT-2006-041613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs S, 2001, J INVERTEBR PATHOL, V78, P59, DOI 10.1006/jipa.2001.5050; Arthurs S, 2001, BIOCONTROL SCI TECHN, V11, P411, DOI 10.1080/09583150120055826; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Dawkins R., 1982, pi; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Evans H.C., 1989, P205; Evans H. C., 2003, Clavicipitalean Fungi: evolutionary biology, chemistry, biocontrol and cultural impacts, P517; EVANS HC, 1982, T BRIT MYCOL SOC, V79, P431, DOI 10.1016/S0007-1536(82)80037-5; EVANS HC, 1982, ECOL ENTOMOL, V7, P47, DOI 10.1111/j.1365-2311.1982.tb00643.x; EVANS HC, 1984, T BRIT MYCOL SOC, V82, P127, DOI 10.1016/S0007-1536(84)80219-3; Fargues J, 1998, BIOCONTROL SCI TECHN, V8, P323, DOI 10.1080/09583159830135; HYWELJONES NL, 2001, RES REPORTS 2001 BIO, P34; Luz C, 1997, MYCOPATHOLOGIA, V138, P117, DOI 10.1023/A:1006803812504; MAEYAMA T, 1994, SOCIOBIOLOGY, V24, P115; Miura O, 2006, P ROY SOC B-BIOL SCI, V273, P1323, DOI 10.1098/rspb.2005.3451; Moore J., 2002, PARASITES BEHAV ANIM; MULLER CB, 1994, ANIM BEHAV, V48, P961, DOI 10.1006/anbe.1994.1321; Perry JN, 2002, ECOSCIENCE, V9, P133, DOI 10.1080/11956860.2002.11682699; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Perry JN, 1998, ECOLOGY, V79, P1008, DOI 10.1890/0012-9658(1998)079[1008:MOSPFC]2.0.CO;2; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Sanders NJ, 2007, BIOTROPICA, V39, P422, DOI 10.1111/j.1744-7429.2007.00263.x; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 1998, P ROY SOC B-BIOL SCI, V265, P1091, DOI 10.1098/rspb.1998.0403; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; Zar JH, 1999, BIOSTATISTICAL ANAL	32	64	68	1	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4835	10.1371/journal.pone.0004835	http://dx.doi.org/10.1371/journal.pone.0004835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279680	Green Published, gold			2022-12-25	WOS:000265496200012
J	Maruyama, Y; Ogura, T; Mio, K; Kato, K; Kaneko, T; Kiyonaka, S; Mori, Y; Sato, C				Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Kato, Kenta; Kaneko, Takeshi; Kiyonaka, Shigeki; Mori, Yasuo; Sato, Chikara			Tetrameric Orai1 Is a Teardrop-shaped Molecule with a Long, Tapered Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATIC PARTICLE PICKUP; OPERATED CA2+ ENTRY; CRAC CHANNEL; PLASMA-MEMBRANE; 3-DIMENSIONAL RECONSTRUCTION; ENDOPLASMIC-RETICULUM; STORE DEPLETION; CALCIUM-CHANNEL; CATION CHANNEL; NEURAL-NETWORK	The Ca2+ release-activated Ca2+ channel is a principal regulator of intracellular Ca2+ rise, which conducts various biological functions, including immune responses. This channel, involved in store-operated Ca2+ influx, is believed to be composed of at least two major components. Orai1 has a putative channel pore and locates in the plasma membrane, and STIM1 is a sensor for luminal Ca2+ store depletion in the endoplasmic reticulum membrane. Here we have purified the FLAG-fused Orai1 protein, determined its tetrameric stoichiometry, and reconstructed its three-dimensional structure at 21-angstrom resolution from 3681 automatically selected particle images, taken with an electron microscope. This first structural depiction of a member of the Orai family shows an elongated teardrop-shape 150 angstrom in height and 95 angstrom in width. Antibody decoration and volume estimation from the amino acid sequence indicate that the widest transmembrane domain is located between the round extracellular domain and the tapered cytoplasmic domain. The cytoplasmic length of 100 angstrom is sufficient for direct association with STIM1. Orifices close to the extracellular and intracellular membrane surfaces of Orai1 seem to connect outside the molecule to large internal cavities.	[Sato, Chikara] AIST, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Kato, Kenta; Kaneko, Takeshi; Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Kyoto University	Sato, C (corresponding author), AIST, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Mio, Kazuhiro/L-7488-2018; Kiyonaka, Shigeki/AAM-7303-2021; Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496; 	Japan New Energy and Industrial Technology Development Organization; Precursory Research for Embryonic Science and Technology of the Japan Science Agency; National Institute of Advanced Industrial Science and Technology (AIST); Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Precursory Research for Embryonic Science and Technology of the Japan Science Agency; National Institute of Advanced Industrial Science and Technology (AIST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Science Research on Priority Areas, Structure of Biological Macromolecular Assemblies, by a grant from the Japan New Energy and Industrial Technology Development Organization (to C. S.), by a grant from Precursory Research for Embryonic Science and Technology of the Japan Science Agency (to T. O.), and by grants from the National Institute of Advanced Industrial Science and Technology (AIST).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Franck J., 2006, 3 DIMENSIONAL ELECT, P91; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARAUZ G, 1986, OPTIK, V73, P146; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mio K, 2008, J BIOL CHEM, V283, P30300, DOI 10.1074/jbc.M803185200; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	56	65	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13676	13685		10.1074/jbc.M900812200	http://dx.doi.org/10.1074/jbc.M900812200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289460	Green Published, hybrid			2022-12-25	WOS:000265877300045
J	Sinnett-Smith, J; Jacamo, R; Kui, R; Wang, YZM; Young, SH; Rey, O; Waldron, RT; Rozengurt, E				Sinnett-Smith, James; Jacamo, Rodrigo; Kui, Robert; Wang, YunZu M.; Young, Steven H.; Rey, Osvaldo; Waldron, Richard T.; Rozengurt, Enrique			Protein Kinase D Mediates Mitogenic Signaling by G(q)-coupled Receptors through Protein Kinase C-independent Regulation of Activation Loop Ser(744) and Ser(748) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; POTENTIATES DNA-SYNTHESIS; GROWTH-FACTOR RECEPTOR; D PKD ACTIVATION; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; RAPIDLY STIMULATE; SWISS 3T3-CELLS; MAJOR SUBSTRATE; BOMBESIN FAMILY	Rapid protein kinase D(PKD) activation and phosphorylation via protein kinase C(PKC) have been extensively documented in many cell types cells stimulated by multiple stimuli. In contrast, little is known about the role and mechanism(s) of a recently identified sustained phase of PKD activation in response to G protein-coupled receptor agonists. To elucidate the role of biphasic PKD activation, we used Swiss 3T3 cells because PKD expression in these cells potently enhanced duration of ERK activation and DNA synthesis in response to G(q)-coupled receptor agonists. Cell treatment with the preferential PKC inhibitors GF109203X or Go6983 profoundly inhibited PKD activation induced by bombesin stimulation for < 15 min but did not prevent PKD catalytic activation induced by bombesin stimulation for longer times (> 60 min). The existence of sequential PKC-dependent and PKC-independent PKD activation was demonstrated in 3T3 cells stimulated with various concentrations of bombesin (0.3-10 nM) or with vasopressin, a different G(q)-coupled receptor agonist. To gain insight into the mechanisms involved, we determined the phosphorylation state of the activation loop residues Ser(744) and Ser(748). Transphosphorylation targeted Ser(744), whereas autophosphorylation was the predominant mechanism for Ser(748) in cells stimulated with G(q)-coupled receptor agonists. We next determined which phase of PKD activation is responsible for promoting enhanced ERK activation and DNA synthesis in response to G(q)-coupled receptor agonists. We show, for the first time, that the PKC-independent phase of PKD activation mediates prolonged ERK signaling and progression to DNA synthesis in response to bombesin or vasopressin through a pathway that requires epidermal growth factor receptor-tyrosine kinase activity. Thus, our results identify a novel mechanism of G(q)-coupled receptor-induced mitogenesis mediated by sustained PKD activation through a PKC-independent pathway.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis,CURE, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002; Rey, Osvaldo/0000-0003-1575-9864	National Institutes of Health [R0-1 DK 55003, R0-1 DK56930, P30 DK41301]; NATIONAL CANCER INSTITUTE [K22CA128883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056930, R21DK071783, P30DK041301, R01DK055003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 DK 55003, R0-1 DK56930, and P30 DK41301 (to E. R.).	Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Bridges AJ, 1996, J MED CHEM, V39, P267, DOI 10.1021/jm9503613; BROOKS SF, 1992, J BIOL CHEM, V267, P14212; BROOKS SF, 1991, EMBO J, V10, P2497, DOI 10.1002/j.1460-2075.1991.tb07789.x; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Geiges D, 1997, BIOCHEM PHARMACOL, V53, P865, DOI 10.1016/S0006-2952(96)00885-4; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Guha S, 2002, CANCER RES, V62, P1632; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 1998, J CELL PHYSIOL, V177, P507, DOI 10.1002/(SICI)1097-4652(199812)177:4<507::AID-JCP2>3.0.CO;2-K; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Santiskulvong C, 2001, AM J PHYSIOL-CELL PH, V281, pC886, DOI 10.1152/ajpcell.2001.281.3.C886; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Seufferlein T, 1996, MOL BIOL CELL, V7, P1865, DOI 10.1091/mbc.7.12.1865; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616; ZACHARY I, 1987, J BIOL CHEM, V262, P3947; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	59	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13434	13445		10.1074/jbc.M806554200	http://dx.doi.org/10.1074/jbc.M806554200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289471	hybrid, Green Published			2022-12-25	WOS:000265877300019
J	Watanabe, H; Smith, MJ; Heilig, E; Beglopoulos, V; Kelleher, RJ; Shen, J				Watanabe, Hirotaka; Smith, Miriam J.; Heilig, Elizabeth; Beglopoulos, Vassilios; Kelleher, Raymond J., III; Shen, Jie			Indirect Regulation of Presenilins in CREB-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; ALZHEIMERS-DISEASE; PROTEOLYTIC RELEASE; GAMMA-SECRETASE; STEM-CELLS; EXPRESSION; ERK; PHOSPHORYLATION; PATHWAY; KINASE	Presenilins are essential for synaptic function, memory formation, and neuronal survival. Previously, we reported that expression of cAMP response element-binding protein (CREB) target genes is reduced in the cerebral cortex of presenilin (PS) conditional double knock-out (cDKO) mice. To determine whether the reduced expression of the CREB target genes in these mutant mice is due to loss of presenilin directly or secondary to the impaired neuronal activity, we established a sensitive luciferase reporter system to assess direct transcriptional regulation in cultured cells. We first used immortalized PS-deficient mouse embryonic fibroblasts (MEFs), and found that both CREB-mediated transcription and Notch-mediated HES1 transcription are decreased. However, the ubiquitin-C promoter-mediated transcription is also reduced, and among these three reporters, transfection of exogenous PS1 can rescue only the Notch-mediated HES1 transcription. Further Northern analysis revealed transcriptional alterations of Creb, ubiquitin-C, and other housekeeping genes in PS-deficient MEFs, indicating transcriptional dysregulation in these cells. We then used the Cre/loxP system to develop a postnatal PS-deficient cortical neuronal culture. Surprisingly, in these PS-null neurons, CREB-mediated transcription is not significantly decreased, and levels of total and phosphorylated CREB proteins are unchanged as well. Notch-mediated HES1 transcription is markedly reduced, and this reduction can be rescued by exogenous PS1. Together, our findings suggest that CREB-mediated transcription is regulated indirectly by PS in the adult cerebral cortex, and that attenuation of CREB target gene expression in PS cDKO mice is likely due to reduced neuronal activity in these mutant brains.	[Watanabe, Hirotaka; Smith, Miriam J.; Beglopoulos, Vassilios; Shen, Jie] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Heilig, Elizabeth; Kelleher, Raymond J., III] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Shen, J (corresponding author), Harvard New Res Bldg,Rm 636E,77 Ave Louis Pasteur, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Smith, Miriam/J-4001-2015; Watanabe, Hirotaka/GZA-8002-2022; Shen, Jie/GXH-9449-2022	Smith, Miriam/0000-0002-3184-0817; 	National Institutes of Health [NS41783]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS41783 (to J. S.).	BAKER RT, 1989, AM J HUM GENET, V44, P534; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Barnes NY, 2008, J NEUROCHEM, V104, P1637, DOI 10.1111/j.1471-4159.2007.05102.x; Beglopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P33, DOI 10.1016/j.tips.2005.11.010; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Dehvari N, 2008, NEUROSCI LETT, V436, P77, DOI 10.1016/j.neulet.2008.02.063; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Handler M, 2000, DEVELOPMENT, V127, P2593; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; Kim MY, 2005, BIOCHEM BIOPH RES CO, V332, P609, DOI 10.1016/j.bbrc.2005.05.001; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mitsuda N, 2001, J BIOL CHEM, V276, P9688, DOI 10.1074/jbc.M006153200; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	45	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13705	13713		10.1074/jbc.M809168200	http://dx.doi.org/10.1074/jbc.M809168200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289467	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000265877300048
J	Yamamoto, T; Ryan, RO				Yamamoto, Taichi; Ryan, Robert O.			Domain Swapping Reveals That Low Density Lipoprotein (LDL) Type A Repeat Order Affects Ligand Binding to the LDL Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGION; PH	The low density lipoprotein receptor (LDLR) plays a key role in plasma cholesterol homeostasis by binding and internalizing lipoprotein ligands. Studies have revealed that one or more of the seven LDL type A repeats (LA1-LA7) in the receptor are responsible for apolipoprotein binding. In the present study, protein engineering was performed to swap or replace key LA repeats in a recombinant soluble LDLR (sLDLR). Although wild type sLDLR showed strong ligand binding activity, an sLDLR variant in which LA repeat 5 was replaced by a second copy of LA repeat 2 showed low binding activity. Likewise, a variant wherein LA repeats 2 and 5 were swapped displayed low binding activity. At the same time, substitution of LA repeat 2 with a second a copy of repeat 5 resulted in a receptor with ligand binding activity similar to wild type LDLR. When binding assays were conducted with human low density lipoprotein as ligand, LA repeat order was a less important determinant of binding activity. Taken together, the data indicate that the sequential order of LA repeats plays a key role in ligand binding properties of LDLR.	[Yamamoto, Taichi; Ryan, Robert O.] Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ryan, RO (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rryan@chori.org			National Institutes of Health [HL 64159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL064159, R01HL064159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 64159 (to R. O. R.).	Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kiss RS, 2003, J BIOL CHEM, V278, P21952, DOI 10.1074/jbc.M302676200; Kong WJ, 2006, J MOL MED, V84, P29, DOI 10.1007/s00109-005-0717-6; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yamamoto T, 2006, BBA-MOL CELL BIOL L, V1761, P1100, DOI 10.1016/j.bbalip.2006.07.006; Yamamoto T, 2006, J LIPID RES, V47, P1091, DOI 10.1194/jlr.D600001-JLR200; Zhao ZZ, 2008, J BIOL CHEM, V283, P26528, DOI 10.1074/jbc.M804624200	19	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13396	13400		10.1074/jbc.M900194200	http://dx.doi.org/10.1074/jbc.M900194200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19329437	hybrid, Green Published			2022-12-25	WOS:000265877300015
J	Kimbrel, EA; Kung, AL				Kimbrel, Erin A.; Kung, Andrew L.			The F-box Protein beta-TrCp1/Fbw1a Interacts with p300 to Enhance beta-Catenin Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE RECEPTOR; COLORECTAL-CANCER CELLS; CREB-BINDING PROTEIN; GENE-EXPRESSION; DEPENDENT DEGRADATION; MOLECULAR-MECHANISMS; COACTIVATOR P300; COLON-CARCINOMA; MESSENGER-RNA; ACTIVATION	Hyperactivated beta-catenin is a commonly found molecular abnormality in colon cancer, and its nuclear accumulation is thought to promote the expression of genes associated with cellular proliferation and transformation. The p300 transcriptional co-activator binds to beta-catenin and facilitates transcription by recruiting chromatin remodeling complexes and general transcriptional apparatus. We have found that beta-TrCp1/Fbw1a, a member of the Skp1/Cullin/Rbx1/F-box E3 ubiquitin ligase complex, binds directly to p300 and co-localizes with it to beta-catenin target gene promoters. Our data show that Fbw1a, which normally targets beta-catenin for degradation, works together with p300 to enhance the transcriptional activity of beta-catenin, whereas other F-box/WD40 proteins do not. Fbw1a also cooperates with p300 to co-activate transcription by SMAD3, another Fbw1a ubiquitylation target, but not p53 or HIF-1 alpha, which are substrates for other ubiquitin ligase complexes. These results suggest that, although Fbw1a is part of a negative feedback loop for controlling beta-catenin levels in normal cells, its overexpression and binding to p300 may contribute to hyperactivated beta-catenin transcriptional activity in colon cancer cells.	[Kung, Andrew L.] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kung, AL (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	andrew_kung@dfci.harvard.edu	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X	Dana-Farber Cancer Institute Pediatric Oncology Department	Dana-Farber Cancer Institute Pediatric Oncology Department	This work was supported by an Abraham fellowship through the Dana-Farber Cancer Institute Pediatric Oncology Department and an Aid for Cancer Research fellowship (to E. A. K.).	Allende-Vega N, 2007, ONCOGENE, V26, P4234, DOI 10.1038/sj.onc.1210209; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bordonaro M, 2004, NUCLEIC ACIDS RES, V32, P2660, DOI 10.1093/nar/gkh596; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Chen X, 2008, ACTA BIOCH BIOPH SIN, V40, P577, DOI 10.1111/j.1745-7270.2008.00440.x; Chen YH, 2007, NUCLEIC ACIDS RES, V35, P2084, DOI 10.1093/nar/gkm095; Chen YH, 2007, EXP PHYSIOL, V92, P99, DOI 10.1113/expphysiol.2006.036079; Chiaur DS, 2000, CYTOGENET CELL GENET, V88, P255, DOI 10.1159/000015532; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Goodman RH, 2000, GENE DEV, V14, P1553; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Ishihama K, 2007, J CLIN PATHOL, V60, P1205, DOI 10.1136/jcp.2005.029165; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, GENE DEV, V14, P272; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Li Q, 2002, MOL ENDOCRINOL, V16, P2819, DOI 10.1210/me.2002-0154; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Matsuda S, 2004, J BIOL CHEM, V279, P14055, DOI 10.1074/jbc.M310188200; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muraoka M, 1996, ONCOGENE, V12, P1565; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200	71	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13033	13044		10.1074/jbc.M901248200	http://dx.doi.org/10.1074/jbc.M901248200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19297328	hybrid, Green Published			2022-12-25	WOS:000265688300051
J	Sugiyama, T; Levy, BD; Michel, T				Sugiyama, Toru; Levy, Bruce D.; Michel, Thomas			Tetrahydrobiopterin Recycling, a Key Determinant of Endothelial Nitric-oxide Synthase-dependent Signaling Pathways in Cultured Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GROWTH-FACTOR; PHOSPHORYLATION; SUPEROXIDE; PROTEIN; BIOSYNTHESIS; DYSFUNCTION; ACTIVATION; EXPRESSION; AKT	Tetrahydrobiopterin (BH4) is a key redox-active cofactor in endothelial isoform of NO synthase (eNOS) catalysis and is an important determinant of NO-dependent signaling pathways. BH4 oxidation is observed in vascular cells in the setting of the oxidative stress associated with diabetes. However, the relative roles of de novo BH4 synthesis and BH4 redox recycling in the regulation of eNOS bioactivity remain incompletely defined. We used small interference RNA (siRNA)-mediated "knock-down" GTP cyclohydrolase-1 (GTPCH1), the rate-limiting enzyme in BH4 biosynthesis, and dihydrofolate reductase (DHFR), an enzyme-recycling oxidized BH4 (7,8-dihydrobiopterin (BH2)), and studied the effects on eNOS regulation and biopterin metabolism in cultured aortic endothelial cells. Knockdown of either DHFR or GTPCH1 attenuated vascular endothelial growth factor (VEGF)-induced eNOS activity and NO production; these effects were recovered by supplementation with BH4. In contrast, supplementation with BH2 abolished VEGF-induced NO production. DHFR but not GTPCH1 knockdown increased reactive oxygen species (ROS) production. The increase in ROS production seen with siRNA-mediated DHFR knockdown was abolished either by simultaneous siRNA-mediated knockdown of eNOS or by supplementing with BH4. In contrast, addition of BH2 increased ROS production; this effect of BH2 was blocked by BH4 supplementation. DHFR but not GTPCH1 knockdown inhibited VEGF-induced dephosphorylation of eNOS at the inhibitory site serine 116; these effects were recovered by supplementation with BH4. These studies demonstrate a striking contrast in the pattern of eNOS regulation seen by the selective modulation of BH4 salvage/reduction versus de novo BH4 synthetic pathways. Our findings suggest that the depletion of BH4 is not sufficient to perturb NO signaling, but rather that concentration of intracellular BH2, as well as the relative concentrations of BH4 and BH2, together play a determining role in the redox regulation of eNOS-modulated endothelial responses.	[Sugiyama, Toru; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Levy, Bruce D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Dept Med, 75 Francis St,Thorn Bldg,Rm 1210A, Boston, MA 02115 USA.	thomas_michel@harvard.edu			National Institutes of Health [HL46457, HL48743, GM36259, HL090927, AI068084, HL068669]; American Heart Association postdoctoral fellowship; uehara Memorial Foundation postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, R29HL046457, R01HL068669, P01HL048743, R01HL090927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068084, R56AI068084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); uehara Memorial Foundation postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to T. M.) and Grants HL090927, AI068084, and HL068669 (to B. D. L.). This work was also supported by an American Heart Association postdoctoral fellowship and a uehara Memorial Foundation postdoctoral fellowship (to T. S.).	Arnal JF, 1999, CELL MOL LIFE SCI, V55, P1078, DOI 10.1007/s000180050358; BOGDAN C, 1995, FEBS LETT, V363, P69, DOI 10.1016/0014-5793(95)00284-G; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Cosentino F, 1999, CARDIOVASC RES, V43, P274, DOI 10.1016/S0008-6363(99)00134-0; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Gorren ACF, 2000, BIOCHEMISTRY-US, V39, P11763, DOI 10.1021/bi0007775; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hasegawa H, 2005, MOL GENET METAB, V86, pS2, DOI 10.1016/j.ymgme.2005.09.002; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heller R, 2006, EUR J CLIN PHARMACOL, V62, P21, DOI 10.1007/s00228-005-0009-7; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Ishii M, 1997, LIFE SCI, V61, P739, DOI 10.1016/S0024-3205(97)00538-9; Katusic ZS, 2001, AM J PHYSIOL-HEART C, V281, pH981, DOI 10.1152/ajpheart.2001.281.3.H981; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2007, J BIOL CHEM, V282, P32719, DOI 10.1074/jbc.M706815200; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Meininger CJ, 2000, BIOCHEM J, V349, P353, DOI 10.1042/0264-6021:3490353; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moat SJ, 2006, EUR J PHARMACOL, V530, P250, DOI 10.1016/j.ejphar.2005.11.047; Moens AL, 2006, ARTERIOSCL THROM VAS, V26, P2439, DOI 10.1161/01.ATV.0000243924.00970.cb; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Rinaldi M, 2007, VET IMMUNOL IMMUNOP, V115, P107, DOI 10.1016/j.vetimm.2006.09.009; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shaul PW, 2003, J PHYSIOL-LONDON, V547, P21, DOI 10.1113/jphysiol.2002.031534; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tai NW, 2004, BIOCHEM J, V378, P999, DOI 10.1042/BJ20031396; THORNY B, 2000, BIOCHEM J, V347, P1; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Werner-Felmayer G, 2002, CURR DRUG METAB, V3, P159, DOI 10.2174/1389200024605073; Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069	47	76	78	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12691	12700		10.1074/jbc.M809295200	http://dx.doi.org/10.1074/jbc.M809295200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286667	Green Published, hybrid			2022-12-25	WOS:000265688300013
J	Landgrebe, M; Frick, U; Hauser, S; Hajak, G; Langguth, B				Landgrebe, Michael; Frick, Ulrich; Hauser, Simone; Hajak, Goeran; Langguth, Berthold			Association of Tinnitus and Electromagnetic Hypersensitivity: Hints for a Shared Pathophysiology?	PLOS ONE			English	Article							AUDITORY-CORTEX; FIELD EXPOSURE; ANTICIPATION; EXCITABILITY; SYMPTOMS	Background: Tinnitus is a frequent condition with high morbidity and impairment in quality of life. The pathophysiology is still incompletely understood. Electromagnetic fields are discussed to be involved in the multi-factorial pathogenesis of tinnitus, but data proofing this relationship are very limited. Potential health hazards of electromagnetic fields (EMF) have been under discussion for long. Especially, individuals claiming themselves to be electromagnetic hypersensitive suffer from a variety of unspecific symptoms, which they attribute to EMF-exposure. The aim of the study was to elucidate the relationship between EMF-exposure, electromagnetic hypersensitivity and tinnitus using a case-control design. Methodology: Tinnitus occurrence and tinnitus severity were assessed by questionnaires in 89 electromagnetic hypersensitive patients and 107 controls matched for age-, gender, living surroundings and workplace. Using a logistic regression approach, potential risk factors for the development of tinnitus were evaluated. Findings: Tinnitus was significantly more frequent in the electromagnetic hypersensitive group (50.72% vs. 17.5%) whereas tinnitus duration and severity did not differ between groups. Electromagnetic hypersensitivity and tinnitus were independent risk factors for sleep disturbances. However, measures of individual EMF-exposure like e. g. cell phone use did not show any association with tinnitus. Conclusions: Our data indicate that tinnitus is associated with subjective electromagnetic hypersensitivity. An individual vulnerability probably due to an over activated cortical distress network seems to be responsible for, both, electromagnetic hypersensitivity and tinnitus. Hence, therapeutic efforts should focus on treatment strategies (e. g. cognitive behavioral therapy) aiming at normalizing this dysfunctional distress network.	[Landgrebe, Michael; Frick, Ulrich; Hauser, Simone; Hajak, Goeran; Langguth, Berthold] Univ Regensburg, Dept Psychiat Psychosomat & Psychotherapy, Regensburg, Germany; [Frick, Ulrich] Carinthia Univ Appl Sci, Feldkirchen, Austria	University of Regensburg	Landgrebe, M (corresponding author), Univ Regensburg, Dept Psychiat Psychosomat & Psychotherapy, Regensburg, Germany.	michael.landgrebe@medbo.de	Langguth, Berthold/AAP-2638-2021		German Federal Ministry for the Environment; Nature Conservation; Nuclear Safety [StSch 4357]; Tinnitus Research Initiative	German Federal Ministry for the Environment; Nature Conservation; Nuclear Safety; Tinnitus Research Initiative	This study has been supported by a grant from the German Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (UFOPLAN project StSch 4357) and the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Davidson HC, 2007, INT J AUDIOL, V46, P113, DOI 10.1080/14992020600690472; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eulitz C, 1998, NEUROREPORT, V9, P3229, DOI 10.1097/00001756-199810050-00018; Frick U, 2005, BIOELECTROMAGNETICS, V26, P287, DOI 10.1002/bem.20085; Frick U, 2006, UMWELTMEDIZIN FORSCH, V11, P11; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Hardell L, 2003, NEUROEPIDEMIOLOGY, V22, P124, DOI 10.1159/000068745; Hillert L, 1999, J PSYCHOSOM RES, V47, P429, DOI 10.1016/S0022-3999(99)00048-3; Hillert L, 1998, PSYCHOTHER PSYCHOSOM, V67, P302, DOI 10.1159/000012295; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; Hoffman H., 2004, TINNITUS THEORY MANA, P16; Kleinjung T, 2007, PSYCHIAT PRAX, V34, pS140, DOI 10.1055/s-2006-940218; Krause CM, 2007, BIOELECTROMAGNETICS, V28, P296, DOI 10.1002/bem.20300; Landgrebe M, 2008, PSYCHOL MED, V38, P1781, DOI 10.1017/S0033291708003097; Landgrebe M, 2008, NEUROIMAGE, V41, P1336, DOI 10.1016/j.neuroimage.2008.04.171; Landgrebe M, 2007, J PSYCHOSOM RES, V62, P283, DOI 10.1016/j.jpsychores.2006.11.007; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Lyskov E, 2001, BIOELECTROMAGNETICS, V22, P457, DOI 10.1002/bem.73; Lyskov E, 2001, INT J PSYCHOPHYSIOL, V42, P233, DOI 10.1016/S0167-8760(01)00141-6; Maby E, 2004, MED BIOL ENG COMPUT, V42, P562, DOI 10.1007/BF02351000; Maier R, 2004, ACTA NEUROL SCAND, V110, P46, DOI 10.1111/j.1600-0404.2004.00260.x; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Mortazavi SMJ, 2007, BIOELECTROMAGNETICS, V28, P326, DOI 10.1002/bem.20305; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nelson C.B., 2001, SCORING WORLD HLTH O; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Papageorgioua CC, 2006, NEUROSCI LETT, V397, P99, DOI 10.1016/j.neulet.2005.12.001; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Roosli M, 2004, INT J HYG ENVIR HEAL, V207, P141, DOI 10.1078/1438-4639-00269; Rubin GJ, 2005, PSYCHOSOM MED, V67, P224, DOI 10.1097/01.psy.0000155664.13300.64; Rubin GJ, 2006, PSYCHOTHER PSYCHOSOM, V75, P12, DOI 10.1159/000089222; Sandstrom M, 2003, INT J PSYCHOPHYSIOL, V49, P227, DOI 10.1016/S0167-8760(03)00145-4; SCHLEE W, 2008, SEMINARS HE IN PRESS; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann EM, 2001, BIOL PSYCHIAT, V50, P377, DOI 10.1016/S0006-3223(01)01210-0; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	45	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5026	10.1371/journal.pone.0005026	http://dx.doi.org/10.1371/journal.pone.0005026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325894	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499600008
J	Fox, BA; Sheppard, PO; O'Hara, PJ				Fox, Brian A.; Sheppard, Paul O.; O'Hara, Patrick J.			The Role of Genomic Data in the Discovery, Annotation and Evolutionary Interpretation of the Interferon-Lambda Family	PLOS ONE			English	Article							IFN-LAMBDA; GENE; RECEPTOR; IDENTIFICATION; CONSERVATION; ZEBRAFISH; CYTOKINES; SYSTEM; NUMBER; IL-29	Background: Type-I interferons, type-II interferons, and the IL-10 family are helical cytokines with similar three-dimensional folds. However, their homologous relationship is difficult to detect on the basis of sequence alone. We have previously described the discovery of the human type-III interferons (IFN lambda-1, -2, -3 or IL-29, IL-28A, IL-28B), which required a combination of manual and computational techniques applied to predicted protein sequences. Principal Findings: Here we describe how the use of gene structure analysis and comparative genomics enabled a more extensive understanding of these genes early in the discovery process. More recently, additional mammalian genome sequences have shown that there are between one and potentially nine copies of interferon lambda genes in each genome, and that several species have single exon versions of the interferon lambda gene. Significance: The variable number of single exon type-I interferons in mammals, along with recently identified genes in zebrafish homologous to interferons allows a story of interferon evolution to be proposed. This model suggests that the gene duplications and single exon retrotransposons of mammalian type-III interferons are positively selected for within a genome. These characteristics are also shared with the fish interferons and could be responsible for the generation of the IL10 family and also the single exon type-I interferons.	[Fox, Brian A.; Sheppard, Paul O.; O'Hara, Patrick J.] Zymogenet Inc, Bioinformat Dept, Seattle, WA 98105 USA	Zymogenet Inc.	Fox, BA (corresponding author), Zymogenet Inc, Bioinformat Dept, Seattle, WA 98105 USA.	bfox@novonordisk.com		Fox, Brian/0000-0001-6620-3853	ZymoGenetics	ZymoGenetics	This study was funded by ZymoGenetics. As an employer, the funder(s) had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript	Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brosius J, 1995, VIRUS GENES, V11, P163, DOI 10.1007/BF01728656; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Conklin D, 2005, BIOINFORMATICS, V21, P1776, DOI 10.1093/bioinformatics/bti283; Conklin D, 2004, J COMPUT BIOL, V11, P1189, DOI 10.1089/cmb.2004.11.1189; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002; Krivan W, 2005, LECT NOTES COMPUT SC, V3318, P22; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Long S, 2004, DEV COMP IMMUNOL, V28, P97, DOI 10.1016/S0145-305X(03)00122-8; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Robertsen B, 2003, J INTERF CYTOK RES, V23, P601, DOI 10.1089/107999003322485107; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; SHEPPARD PO, 2002, Patent No. 0202627; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Vogel JH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-230; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Woelk CH, 2007, GENE, V397, P38, DOI 10.1016/j.gene.2007.03.018; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	37	59	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4933	10.1371/journal.pone.0004933	http://dx.doi.org/10.1371/journal.pone.0004933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300512	Green Submitted, gold, Green Published			2022-12-25	WOS:000265496800011
J	Bansal, K; Kapoor, N; Narayana, Y; Puzo, G; Gilleron, M; Balaji, KN				Bansal, Kushagra; Kapoor, Nisha; Narayana, Yeddula; Puzo, Germain; Gilleron, Martine; Balaji, Kithiganahalli Narayanaswamy			PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling	PLOS ONE			English	Article								Activation of inflammatory immune responses during granuloma formation by the host upon infection of mycobacteria is one of the crucial steps that is often associated with tissue remodeling and breakdown of the extracellular matrix. In these complex processes, cyclooxygenase-2 (COX-2) plays a major role in chronic inflammation and matrix metalloproteinase-9 (MMP-9) significantly in tissue remodeling. In this study, we investigated the molecular mechanisms underlying Phosphatidyl-myo-inositol dimannosides (PIM2), an integral component of the mycobacterial envelope, triggered COX-2 and MMP-9 expression in macrophages. PIM2 triggers the activation of Phosphoinositide-3 Kinase (PI3K) and Notch1 signaling leading to COX-2 and MMP-9 expression in a Toll-like receptor 2 (TLR2)-MyD88 dependent manner. Notch1 signaling perturbations data demonstrate the involvement of the cross-talk with members of PI3K and Mitogen activated protein kinase pathway. Enforced expression of the cleaved Notch1 in macrophages induces the expression of COX-2 and MMP-9. PIM2 triggered significant p65 nuclear factor-kappa B (NF-kappa B) nuclear translocation that was dependent on activation of PI3K or Notch1 signaling. Furthermore, COX-2 and MMP-9 expression requires Notch1 mediated recruitment of Suppressor of Hairless (CSL) and NF-kappa B to respective promoters. Inhibition of PIM2 induced COX-2 resulted in marked reduction in MMP-9 expression clearly implicating the role of COX-2 dependent signaling events in driving the MMP-9 expression. Taken together, these data implicate PI3K and Notch1 signaling as obligatory early proximal signaling events during PIM2 induced COX-2 and MMP-9 expression in macrophages.	[Bansal, Kushagra; Kapoor, Nisha; Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Puzo, Germain; Gilleron, Martine] Univ Paul Sabatier, Toulouse, France; [Puzo, Germain; Gilleron, Martine] CNRS, Inst Pharmacol Biol Struct, Dept Mol Mechanisms Mycobact Infect, Toulouse, France	Indian Institute of Science (IISC) - Bangalore; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bansal, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Yeddula, Narayana/H-4893-2011	GILLERON, Martine/0000-0002-2581-3302	Department of Biotechnology (DBT); Department of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR) [fellowship]; Indian Institute of Science, Bangalore, India [fellowship]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Science, Bangalore, India	This study was funded by the Department of Biotechnology (DBT), Department of Science and Technology (DST), Council for Scientific and Industrial Research (CSIR). Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) is acknowledged. KB and NK acknowledges fellowship from Indian Institute of Science, Bangalore, India. YN is supported by a fellowship from CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Basu S, 2007, CELL MICROBIOL, V9, P2804, DOI 10.1111/j.1462-5822.2007.00997.x; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Hoppe HC, 1997, INFECT IMMUN, V65, P3896, DOI 10.1128/IAI.65.9.3896-3905.1997; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Lee KY, 2004, J NEUROL SCI, V220, P73, DOI 10.1016/j.jns.2004.02.008; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Masuya M, 2002, INT J HEMATOL, V75, P269, DOI 10.1007/BF02982040; Matsuura E, 2000, J NEUROL SCI, V173, P45, DOI 10.1016/S0022-510X(99)00303-2; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Okamoto T, 2004, BIOL CHEM, V385, P997, DOI 10.1515/BC.2004.130; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pathak SK, 2004, J BIOL CHEM, V279, P55127, DOI 10.1074/jbc.M409885200; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rojas RE, 2006, J IMMUNOL, V177, P2959, DOI 10.4049/jimmunol.177.5.2959; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Shibata Y, 2006, J LEUKOCYTE BIOL, V80, P590, DOI 10.1189/jlb.1205737; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Vas V, 2004, J LEUKOCYTE BIOL, V75, P714, DOI 10.1189/jlb.1003462; Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589; WHO, 2007, WHOHTMTB2007376; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	52	48	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4911	10.1371/journal.pone.0004911	http://dx.doi.org/10.1371/journal.pone.0004911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290049	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000265496500011
J	Franciosa, G; Maugliani, A; Scalfaro, C; Aureli, P				Franciosa, Giovanna; Maugliani, Antonella; Scalfaro, Concetta; Aureli, Paolo			Evidence that Plasmid-Borne Botulinum Neurotoxin Type B Genes Are Widespread among Clostridium botulinum Serotype B Strains	PLOS ONE			English	Article								Background: Plasmids that encode certain subtypes of the botulinum neurotoxin type B have recently been detected in some Clostridium botulinum strains. The objective of the present study was to investigate the frequency with which plasmid carriage of the botulinum neurotoxin type B gene (bont/B) occurs in strains of C. botulinum type B, Ab, and A(B), and whether plasmid carriage is bont/B subtype-related. Methodology/Principal Findings: PCR-Restriction fragment length polymorphism was employed to identify subtypes of the bont/B gene. Pulsed-field gel electrophoresis and Southern blot hybridization with specific probes were performed to analyze the genomic location of the bont/B subtype genes. All five known bont/B subtype genes were detected among the strains; the most frequently detected subtype genes were bont/B1 and /B2. Surprisingly, the bont/B subtype gene was shown to be plasmid-borne in >50% of the total strains. The same bont/B subtype gene was associated with the chromosome in some strains, whereas it was associated with a plasmid in others. All five known bont/B subtype genes were in some cases found to reside on plasmids, though with varying frequency (e. g., most of the bont/B1 subtype genes were located on plasmids, whereas all but one of the bont/B2 subtypes were chromosomally-located). Three bivalent isolates carried both bont/A and /B genes on the same plasmid. The plasmids carrying the bont gene were five different sizes, ranging from similar to 55 kb to similar to 245 kb. Conclusions/Significance: The unexpected finding of the widespread distribution of plasmids harboring the bont/B gene among C. botulinum serotype B strains provides a chance to examine their contribution to the dissemination of the bont genes among heterogeneous clostridia, with potential implications on issues related to pathogenesis and food safety.	[Franciosa, Giovanna; Maugliani, Antonella; Scalfaro, Concetta; Aureli, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Unit Microorganisms & Food Technol, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Franciosa, G (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Unit Microorganisms & Food Technol, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.franciosa@iss.it	FRANCIOSA, GIOVANNA/C-7040-2015; MAUGLIANI, ANTONELLA/C-3920-2015; SCALFARO, CONCETTA/C-7041-2015	FRANCIOSA, GIOVANNA/0000-0003-1520-4826; MAUGLIANI, ANTONELLA/0000-0002-2745-1472; SCALFARO, CONCETTA/0000-0001-8626-7563	Italy-USA Agreement [28C4]	Italy-USA Agreement	This study was supported by the Italy-USA Agreement: Preparedness against attacks with biological agents (no. 28C4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; CAMPBELL K, 1993, BIOCHIM BIOPHYS ACTA, V1216, P487, DOI 10.1016/0167-4781(93)90020-E; Centers for Disease Control and Prevention, 1998, HDB EP CLIN LAB WORK; EKLUND MW, 1972, NATURE-NEW BIOL, V235, P16, DOI 10.1038/newbio235016a0; EKLUND MW, 1988, APPL ENVIRON MICROB, V54, P1405, DOI 10.1128/AEM.54.6.1405-1408.1988; FINN CW, 1984, SCIENCE, V224, P881, DOI 10.1126/science.6326263; Franciosa G, 2004, APPL ENVIRON MICROB, V70, P7192, DOI 10.1128/AEM.70.12.7192-7199.2004; FRANCIOSA G, 1994, J CLIN MICROBIOL, V32, P1911, DOI 10.1128/JCM.32.8.1911-1917.1994; Franciosa G, 2006, FEMS MICROBIOL LETT, V261, P88, DOI 10.1111/j.1574-6968.2006.00331.x; GIMENEZ DF, 1995, INT J FOOD MICROBIOL, V27, P1, DOI 10.1016/0168-1605(94)00144-U; HATHEWAY CL, 1981, J CLIN MICROBIOL, V14, P607, DOI 10.1128/JCM.14.6.607-611.1981; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; INOUE K, 1970, JPN J MICROBIOL, V14, P87, DOI 10.1111/j.1348-0421.1970.tb00495.x; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P951, DOI 10.1016/j.fct.2008.02.006; Kirma N, 2004, FEMS MICROBIOL LETT, V231, P159, DOI 10.1016/S0378-1097(03)00911-X; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; Raphael BH, 2008, APPL ENVIRON MICROB, V74, P4390, DOI 10.1128/AEM.00260-08; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; SIMSKE JS, 1989, NUCLEIC ACIDS RES, V17, P4359, DOI 10.1093/nar/17.11.4359; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; TERRE H, 1999, EUROSURVEILLANCE, V4, P2; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000; Yamakawa K, 1997, J CLIN MICROBIOL, V35, P2163, DOI 10.1128/JCM.35.8.2163-2164.1997; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	32	58	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4829	10.1371/journal.pone.0004829	http://dx.doi.org/10.1371/journal.pone.0004829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287483	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496400004
J	Alberts, JB				Alberts, Jonathan B.			Biophysically Realistic Filament Bending Dynamics in Agent-Based Biological Simulation	PLOS ONE			English	Article							SEGREGATION; SPINDLE; MOTORS	An appealing tool for study of the complex biological behaviors that can emerge from networks of simple molecular interactions is an agent-based, computational simulation that explicitly tracks small-scale local interactions - following thousands to millions of states through time. For many critical cell processes (e. g. cytokinetic furrow specification, nuclear centration, cytokinesis), the flexible nature of cytoskeletal filaments is likely to be critical. Any computer model that hopes to explain the complex emergent behaviors in these processes therefore needs to encode filament flexibility in a realistic manner. Here I present a numerically convenient and biophysically realistic method for modeling cytoskeletal filament flexibility in silico. Each cytoskeletal filament is represented by a series of rigid segments linked end-to-end in series with a variable attachment point for the translational elastic element. This connection scheme allows an empirically tuning, for a wide range of segment sizes, viscosities, and time-steps, that endows any filament species with the experimentally observed (or theoretically expected) static force deflection, relaxation time-constant, and thermal writhing motions. I additionally employ a unique pair of elastic elements-one representing the axial and the other the bending rigidity-that formulate the restoring force in terms of single time-step constraint resolution. This method is highly local -adjacent rigid segments of a filament only interact with one another through constraint forces-and is thus well-suited to simulations in which arbitrary additional forces (e. g. those representing interactions of a filament with other bodies or cross-links / entanglements between filaments) may be present. Implementation in code is straightforward; Java source code is available at www.celldynamics.org.	[Alberts, Jonathan B.] Univ Washington, Dept Biol, Ctr Cell Dynam, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Alberts, JB (corresponding author), Univ Washington, Dept Biol, Ctr Cell Dynam, Seattle, WA 98195 USA.	jalberts@u.washington.edu			National Institutes of Health [NIGMS 5P50 GM 666050-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded under National Institutes of Health grant NIGMS 5P50 GM 666050-02. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS B, 2007, MOL BIOL CELL, P965; Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Carlsson AE, 2001, BIOPHYS J, V81, P1907, DOI 10.1016/S0006-3495(01)75842-0; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Howard J., 2001, MECH MOTOR PROTEINS; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Nedelec F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/427; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Schaus TE, 2008, BIOPHYS J, V95, P1393, DOI 10.1529/biophysj.107.125005; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758	15	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4748	10.1371/journal.pone.0004748	http://dx.doi.org/10.1371/journal.pone.0004748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283085	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496300001
J	Kenefic, LJ; Pearson, T; Okinaka, RT; Schupp, JM; Wagner, DM; Ravel, J; Hoffmaster, AR; Trim, CP; Chung, WK; Beaudry, JA; Foster, JT; Mead, JI; Keim, P				Kenefic, Leo J.; Pearson, Talima; Okinaka, Richard T.; Schupp, James M.; Wagner, David M.; Ravel, Jacques; Hoffmaster, Alex R.; Trim, Carla P.; Chung, Wai-Kwan; Beaudry, Jodi A.; Foster, Jeffrey T.; Mead, James I.; Keim, Paul			Pre-Columbian Origins for North American Anthrax	PLOS ONE			English	Article								Disease introduction into the New World during colonial expansion is well documented and had a major impact on indigenous populations; however, few diseases have been associated with early human migrations into North America. During the late Pleistocene epoch, Asia and North America were joined by the Beringian Steppe ecosystem which allowed animals and humans to freely cross what would become a water barrier in the Holocene. Anthrax has clearly been shown to be dispersed by human commerce and trade in animal products contaminated with Bacillus anthracis spores. Humans appear to have brought B. anthracis to this area from Asia and then moved it further south as an ice-free corridor opened in central Canada similar to 13,000 ybp. In this study, we have defined the evolutionary history of Western North American (WNA) anthrax using 2,850 single nucleotide polymorphisms (SNPs) and 285 geographically diverse B. anthracis isolates. Phylogeography of the major WNA B. anthracis clone reveals ancestral populations in northern Canada with progressively derived populations to the south; the most recent ancestor of this clonal lineage is in Eurasia. Our phylogeographic patterns are consistent with B. anthracis arriving with humans via the Bering Land Bridge. This northern-origin hypothesis is highly consistent with our phylogeographic patterns and rates of SNP accumulation observed in current day B. anthracis isolates. Continent-wide dispersal of WNA B. anthracis likely required movement by later European colonizers, but the continent's first inhabitants may have seeded the initial North American populations.	[Kenefic, Leo J.; Pearson, Talima; Okinaka, Richard T.; Schupp, James M.; Wagner, David M.; Trim, Carla P.; Chung, Wai-Kwan; Beaudry, Jodi A.; Foster, Jeffrey T.; Mead, James I.; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD USA; [Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Bacterial Zoonoses Branch, Atlanta, GA USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA	Northern Arizona University; University System of Maryland; University of Maryland Baltimore; Centers for Disease Control & Prevention - USA; Translational Genomics Research Institute	Kenefic, LJ (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Pearson, Talima/O-7840-2019; Ravel, Jacques/D-2530-2009; Keim, Paul S/A-2269-2010; Wagner, David M/A-5125-2010	Pearson, Talima/0000-0003-3696-041X; Wagner, David/0000-0003-2684-6007; Ravel, Jacques/0000-0002-0851-2233; Foster, Jeffrey/0000-0001-8235-8564	NIH NIGMS [1R01GM060795]; DHS [NBCH2070001]; NIH NIAID [N01-AI15447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060795] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DHS(United States Department of Homeland Security (DHS)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NIGMS (1R01GM060795), DHS (NBCH2070001) and NIH NIAID (N01-AI15447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; BRACHMAN PS, 1970, ANN NY ACAD SCI, V174, P577, DOI 10.1111/j.1749-6632.1970.tb45583.x; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; Dragon DC, 2005, APPL ENVIRON MICROB, V71, P1610, DOI 10.1128/AEM.71.3.1610-1615.2005; Dragon DC, 2001, ARCTIC, V54, P32; Eskey CR., 1940, PUB HLTH B, V254, P1; GREEN DM, 1958, LANCET, V2, P153; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; HANSON ROBERT P., 1959, JOUR AMER VET MED ASSOC, V135, P463; Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x; KENEFIC L, 2008, EMERG INFEC IN PRESS; KLEMM DORIS M., 1959, JOUR AMER VET MED ASSOC, V135, P458; LINK V B, 1955, Public Health Monogr, V26, P1; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; *MMWR, 2006, MMWR-MORBID MORTAL W, V55, P280; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Pavesi A, 2004, J MOL EVOL, V58, P304, DOI 10.1007/s00239-003-2552-0; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Plotkin SA, 2002, AM J MED, V112, P4, DOI 10.1016/S0002-9343(01)01050-6; PLOTKIN SA, 2002, AM J MED, V112, P12; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Swofford D., 2003, PHYLOGENETIC ANAL US; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06	27	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4813	10.1371/journal.pone.0004813	http://dx.doi.org/10.1371/journal.pone.0004813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283072	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496300003
J	Rao, S; Kong, WP; Wei, CJ; Yang, ZY; Nason, M; Styles, D; DeTolla, LJ; Sorrell, EM; Song, HC; Wan, HQ; Ramirez-Nieto, GC; Perez, D; Nabel, GJ				Rao, Srinivas; Kong, Wing-Pui; Wei, Chih-Jen; Yang, Zhi-Yong; Nason, Martha; Styles, Darrel; DeTolla, Louis J.; Sorrell, Erin M.; Song, Haichen; Wan, Hongquan; Ramirez-Nieto, Gloria C.; Perez, Daniel; Nabel, Gary J.			Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice	PLOS ONE			English	Article								Background: Sustained outbreaks of highly pathogenic avian influenza (HPAI) H5N1 in avian species increase the risk of reassortment and adaptation to humans. The ability to contain its spread in chickens would reduce this threat and help maintain the capacity for egg-based vaccine production. While vaccines offer the potential to control avian disease, a major concern of current vaccines is their potency and inability to protect against evolving avian influenza viruses. Methodology/Principal Findings: The ability of DNA vaccines encoding hemagglutinin (HA) proteins from different HPAI H5N1 serotypes was evaluated for its ability to elicit neutralizing antibodies and to protect against homologous and heterologous HPAI H5N1 strain challenge in mice and chickens after DNA immunization by needle and syringe or with a pressure injection device. These vaccines elicited antibodies that neutralized multiple strains of HPAI H5N1 when given in combinations containing up to 10 HAs. The response was dose-dependent, and breadth was determined by the choice of the influenza virus HA in the vaccine. Monovalent and trivalent HA vaccines were tested first in mice and conferred protection against lethal H5N1 A/Vietnam/1203/2004 challenge 68 weeks after vaccination. In chickens, protection was observed against heterologous strains of HPAI H5N1 after vaccination with a trivalent H5 serotype DNA vaccine with doses as low as 5 mg DNA given twice either by intramuscular needle injection or with a needle-free device. Conclusions/Significance: DNA vaccines offer a generic approach to influenza virus immunization applicable to multiple animal species. In addition, the ability to substitute plasmids encoding different strains enables rapid adaptation of the vaccine to newly evolving field isolates.	[Rao, Srinivas; Kong, Wing-Pui; Wei, Chih-Jen; Yang, Zhi-Yong; Nason, Martha; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Styles, Darrel] United States Dept Agr, Anim & Plant Hlth Inspect Serv, Riverdale, MD USA; [Sorrell, Erin M.; Song, Haichen; Wan, Hongquan; Ramirez-Nieto, Gloria C.; Perez, Daniel] Univ Maryland, Coll Vet Med, College Pk, MD USA; [DeTolla, Louis J.] Univ Maryland Baltimore, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Rao, S (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA.	gnabel@nih.gov	Perez, Daniel R./D-5044-2016; Ramirez-Nieto, Gloria C/N-2600-2018; Wei, Chih/GVT-5734-2022	Perez, Daniel R./0000-0002-6569-5689; Ramirez-Nieto, Gloria C/0000-0002-8313-1609; Wan, Hongquan/0000-0002-6374-0343	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND G, EFFICACY AGROJET MIT; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Barry MA, 1997, VACCINE, V15, P788, DOI 10.1016/S0264-410X(96)00265-4; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Enserink M, 2004, SCIENCE, V306, P2016, DOI 10.1126/science.306.5704.2016; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Fomsgaard A, 1999, IMMUNOL LETT, V65, P127, DOI 10.1016/S0165-2478(98)00135-7; Gares SL, 2006, CLIN VACCINE IMMUNOL, V13, P958, DOI 10.1128/CVI.00080-06; Grim KC, 2004, J ZOO WILDLIFE MED, V35, P154, DOI 10.1638/03-060; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Higginson Ray, 2005, Br J Nurs, V14, P632; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Jiang Y, 2007, ANTIVIR RES, V75, P234, DOI 10.1016/j.antiviral.2007.03.009; Kapczynski DR, 2003, AVIAN DIS, V47, P1376, DOI 10.1637/7033; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; Kodihalli S, 2000, VACCINE, V18, P2592, DOI 10.1016/S0264-410X(99)00485-5; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kumar M, 2007, AVIAN DIS, V51, P481, DOI 10.1637/7605-041706R1.1; Kutzler MA, 2004, JAVMA-J AM VET MED A, V225, P414, DOI 10.2460/javma.2004.225.414; Lee CW, 2006, CLIN VACCINE IMMUNOL, V13, P395, DOI 10.1128/CVI.13.3.395-402.2006; Li SQ, 1999, J INFECT DIS, V179, P1132, DOI 10.1086/314713; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; McCluskie MJ, 1999, MOL MED, V5, P287, DOI 10.1007/BF03402065; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Oshop GL, 2002, VET IMMUNOL IMMUNOP, V89, P1, DOI 10.1016/S0165-2427(02)00189-7; Rao SS, 2006, VACCINE, V24, P367, DOI 10.1016/j.vaccine.2005.07.072; Raviprakash Kanakatte, 2006, V127, P83; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robinson H L, 1997, Semin Immunol, V9, P271, DOI 10.1006/smim.1997.0083; Roh HJ, 2006, J VET SCI, V7, P361, DOI 10.4142/jvs.2006.7.4.361; Ruiz LM, 2007, VET PARASITOL, V144, P138, DOI 10.1016/j.vetpar.2006.09.033; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Skinner MA, 2003, INFECT IMMUN, V71, P4901, DOI 10.1128/IAI.71.9.4901-4907.2003; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Sorrell EM, 2007, CYTOGENET GENOME RES, V117, P394, DOI 10.1159/000103203; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Subbarao K, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030040; Swayne DE, 2006, ANN NY ACAD SCI, V1081, P174, DOI 10.1196/annals.1373.021; Taubenberger JK, 2007, JAMA-J AM MED ASSOC, V297, P2025, DOI 10.1001/jama.297.18.2025; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Verminnen K, 2005, VACCINE, V23, P4509, DOI 10.1016/j.vaccine.2005.04.014; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463	55	42	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2432	10.1371/journal.pone.0002432	http://dx.doi.org/10.1371/journal.pone.0002432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	19293944	gold, Green Published			2022-12-25	WOS:000263280700017
J	Saggu, M; Zebger, I; Ludwig, M; Lenz, O; Friedrich, B; Hildebrandt, P; Lendzian, F				Saggu, Miguel; Zebger, Ingo; Ludwig, Marcus; Lenz, Oliver; Friedrich, Baerbel; Hildebrandt, Peter; Lendzian, Friedhelm			Spectroscopic Insights into the Oxygen-tolerant Membrane-associated [NiFe] Hydrogenase of Ralstonia eutropha H16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VULGARIS MIYAZAKI-F; IRON-SULFUR CLUSTER; DESULFOVIBRIO-GIGAS HYDROGENASE; DENSITY-FUNCTIONAL THEORY; NAD-REDUCING HYDROGENASE; ELECTRON-SPIN-RESONANCE; SINGLE-CRYSTAL EPR; LOW-LEVEL H-2; ACTIVE-SITE; CHROMATIUM-VINOSUM	This study provides the first spectroscopic characterization of the membrane-bound oxygen-tolerant [NiFe] hydrogenase (MBH) from Ralstonia eutropha H16 in its natural environment, the cytoplasmic membrane. The H-2-converting MBH is composed of a large subunit, harboring the [NiFe] active site, and a small subunit, capable in coordinating one [3Fe4S] and two [4Fe4S] clusters. The hydrogenase dimer is electronically connected to a membrane-integral cytochrome b. EPR and Fourier transform infrared spectroscopy revealed a strong similarity of the MBH active site with known [NiFe] centers from strictly anaerobic hydrogenases. Most redox states characteristic for anaerobic [NiFe] hydrogenases were identified except for one remarkable difference. The formation of the oxygen-inhibited Ni-u-A state was never observed. Furthermore, EPR data showed the presence of an additional paramagnetic center at high redox potential (+ 290 mV), which couples magnetically to the [3Fe4S] center and indicates a structural and/or redox modification at or near the proximal [4Fe4S] cluster. Additionally, significant differences regarding the magnetic coupling between the Ni-a-C state and [4Fe4S] clusters were observed in the reduced form of the MBH. The spectroscopic properties are discussed with regard to the unusual oxygen tolerance of this hydrogenase and in comparison with those of the solubilized, dimeric form of the MBH.	[Saggu, Miguel; Zebger, Ingo; Hildebrandt, Peter; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Ludwig, Marcus; Lenz, Oliver; Friedrich, Baerbel] Humboldt Univ, Dept Microbiol, Inst Biol, D-10115 Berlin, Germany	Technical University of Berlin; Humboldt University of Berlin	Zebger, I (corresponding author), Tech Univ Berlin, Inst Chem, PC14,Str 17 Juni 135, D-10623 Berlin, Germany.	ingo.zebger@tu-berlin.de; f.lendzian@tu-berlin.de	Hildebrandt, Peter/J-5658-2014; Lenz, Oliver/N-5130-2019; Saggu, Miguel/B-1224-2009; Lenz, Oliver/C-1582-2019	Hildebrandt, Peter/0000-0003-1030-5900; Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128	Deutsche Forschungsgemeinschaft [SFB 498 TP C1, TP C9]; Cluster of Excellence "Unifying Concepts in Catalysis,"; Federal Ministry of Education and Research ["Bio-H2"]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Unifying Concepts in Catalysis,"(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 498 TP C1, TP C9 and by Cluster of Excellence "Unifying Concepts in Catalysis," and by the Federal Ministry of Education and Research (BMBF, project "Bio-H2").	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Agrawal AG, 2006, J PHYS CHEM B, V110, P8142, DOI 10.1021/jp0573902; ALBRACHT SPJ, 1983, BIOCHIM BIOPHYS ACTA, V724, P309, DOI 10.1016/0005-2728(83)90089-0; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; ALBRACHT SPJ, 1984, BIOCHIM BIOPHYS ACTA, V766, P245, DOI 10.1016/0005-2728(84)90238-X; ALBRACHT SPJ, 1982, BIOCHIM BIOPHYS ACTA, V681, P330, DOI 10.1016/0005-2728(82)90041-X; Aragno M., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. 1., P344; BAGLEY KA, 1995, BIOCHEMISTRY-US, V34, P5527, DOI 10.1021/bi00016a026; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; CAMMACK R, 1986, BIOCHIMIE, V68, P85, DOI 10.1016/S0300-9084(86)81072-0; Cammack R., 2001, HYDROGEN FUEL LEARNI; COREMANS JMCC, 1992, BIOCHIM BIOPHYS ACTA, V1119, P157, DOI 10.1016/0167-4838(92)90386-R; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; Dole F, 1996, BIOCHEMISTRY-US, V35, P16399, DOI 10.1021/bi961662x; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; FERNANDEZ VM, 1985, BIOCHIM BIOPHYS ACTA, V832, P69, DOI 10.1016/0167-4838(85)90175-X; Fichtner C, 2003, PHYS CHEM CHEM PHYS, V5, P5507, DOI 10.1039/b310205j; Fichtner C, 2006, BIOCHEMISTRY-US, V45, P9706, DOI 10.1021/bi0602462; Foerster S, 2005, J BIOL INORG CHEM, V10, P51, DOI 10.1007/s00775-004-0613-5; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.mi.47.100193.002031; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; Kurkin S, 2004, BIOCHEMISTRY-US, V43, P6820, DOI 10.1021/bi049854c; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; PODZUWEIT HG, 1987, BIOCHIM BIOPHYS ACTA, V905, P435, DOI 10.1016/0005-2736(87)90473-1; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schroder O, 2007, J BIOL INORG CHEM, V12, P212, DOI 10.1007/s00775-006-0185-7; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; SURERUS KK, 1994, BIOCHEMISTRY-US, V33, P4980, DOI 10.1021/bi00182a029; Trofanchuk O, 2000, J BIOL INORG CHEM, V5, P36, DOI 10.1007/PL00010654; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; van Gastel M, 2006, J BIOL INORG CHEM, V11, P41, DOI 10.1007/s00775-005-0048-7; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1	67	83	84	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16264	16276		10.1074/jbc.M805690200	http://dx.doi.org/10.1074/jbc.M805690200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19304663	Green Published, hybrid			2022-12-25	WOS:000266730900024
J	Darwanto, A; Theruvathu, JA; Sowers, JL; Rogstad, DK; Pascal, T; Goddard, WA; Sowers, LC				Darwanto, Agus; Theruvathu, Jacob A.; Sowers, James L.; Rogstad, Daniel K.; Pascal, Tod; Goddard, William A., III; Sowers, Lawrence C.			Mechanisms of Base Selection by Human Single-stranded Selective Monofunctional Uracil-DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 5-FORMYLURACIL-DNA GLYCOSYLASE; DENSITY-FUNCTIONAL THEORY; SOLVATION FREE-ENERGIES; PRINCIPLES CALCULATION; BASIS-SETS; SMUG1; OLIGONUCLEOTIDES; IDENTIFICATION; 5-CARBOXY-2'-DEOXYURIDINE; SPECIFICITY	hSMUG1 (human single-stranded selective monofunctional uracil-DNA glyscosylase) is one of three glycosylases encoded within a small region of human chromosome 12. Those three glycosylases, UNG (uracil-DNA glycosylase), TDG (thymine-DNA glyscosylase), and hSMUG1, have in common the capacity to remove uracil from DNA. However, these glycosylases also repair other lesions and have distinct substrate preferences, indicating that they have potentially redundant but not overlapping physiological roles. The mechanisms by which these glycosylases locate and selectively remove target lesions are not well understood. In addition to uracil, hSMUG1 has been shown to remove some oxidized pyrimidines, suggesting a role in the repair of DNA oxidation damage. In this paper, we describe experiments in which a series of oligonucleotides containing purine and pyrimidine analogs have been used to probe mechanisms by which hSMUG1 distinguishes potential substrates. Our results indicate that the preference of hSMUG1 for mispaired uracil over uracil paired with adenine is best explained by the reduced stability of a duplex containing a mispair, consistent with previous reports with Escherichia coli mispaired uracil-DNA glycosylase. We have also extended the substrate range of hSMUG1 to include 5-carboxyuracil, the last in the series of damage products from thymine methyl group oxidation. The properties used by hSMUG1 to select damaged pyrimidines include the size and free energy of solvation of the 5-substituent but not electronic inductive properties. The observed distinct mechanisms of base selection demonstrated for members of the uracil glycosylase family help explain how considerable diversity in chemical lesion repair can be achieved.	[Darwanto, Agus; Theruvathu, Jacob A.; Sowers, James L.; Rogstad, Daniel K.; Sowers, Lawrence C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Pascal, Tod; Goddard, William A., III; Sowers, Lawrence C.] CALTECH, Dept Chem, Pasadena, CA 91125 USA	Loma Linda University; California Institute of Technology	Sowers, LC (corresponding author), 11021 Campus St,Rm 101, Loma Linda, CA 92350 USA.	lsowers@llu.edu			National Institutes of Health [CA112293]; NATIONAL CANCER INSTITUTE [R01CA112293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112293.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; ALCANTARA R, 1965, PHOTOCHEM PHOTOBIOL, V4, P473; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; BETHOD T, 1997, J PHOTOCHEM PHOTOBIO, V104, P97; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bryantsev VS, 2007, J PHYS CHEM A, V111, P4422, DOI 10.1021/jp071040t; Cerny J, 2005, PHYS CHEM CHEM PHYS, V7, P1624, DOI 10.1039/b502769c; CLOUGH DW, 1978, ANTIMICROB AGENTS CH, V14, P126, DOI 10.1128/AAC.14.1.126; Cui ZF, 2008, ANAL BIOCHEM, V379, P196, DOI 10.1016/j.ab.2008.04.031; Cybulski SM, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829044; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Di Noia JM, 2006, EMBO J, V25, P585, DOI 10.1038/sj.emboj.7600939; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Fujimoto J, 1997, CHEM RES TOXICOL, V10, P1254, DOI 10.1021/tx970102b; Gait M. J, 1984, OLIGONUCLEOTIDE SYNT; Guerniou V, 2003, NUCLEOS NUCLEOT NUCL, V22, P1073, DOI 10.1081/NCN-120022739; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HOBZA P, 1995, J COMPUT CHEM, V16, P1315, DOI 10.1002/jcc.540161102; Jang YH, 2001, J PHYS CHEM A, V105, P274, DOI 10.1021/jp994432b; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kelly CP, 2006, J PHYS CHEM A, V110, P2493, DOI 10.1021/jp055336f; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365; La Francois CJ, 2000, CHEM RES TOXICOL, V13, P462, DOI 10.1021/tx990209u; Liu PF, 2008, J BIOL CHEM, V283, P8829, DOI 10.1074/jbc.M707174200; Marten B, 1996, J PHYS CHEM-US, V100, P11775, DOI 10.1021/jp953087x; Masaoka A, 2003, BIOCHEMISTRY-US, V42, P5003, DOI 10.1021/bi0273213; Matsubara M, 2004, NUCLEIC ACIDS RES, V32, P5291, DOI 10.1093/nar/gkh859; Matsubara M, 2003, BIOCHEMISTRY-US, V42, P4993, DOI 10.1021/bi027322v; MATSUDAIRA P, 1990, METHOD ENZYMOL, V182, P602; Mendes CLD, 2006, J PHYS CHEM A, V110, P4034, DOI 10.1021/jp053520v; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; PEREZJORDA JM, 1995, CHEM PHYS LETT, V233, P134, DOI 10.1016/0009-2614(94)01402-H; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Rao JS, 2006, INT J QUANTUM CHEM, V106, P1217, DOI 10.1002/qua.20862; Rogstad DK, 2004, BIOCHEMISTRY-US, V43, P5688, DOI 10.1021/bi030247j; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; SibghatUllah, 1996, BIOCHEMISTRY-US, V35, P12926, DOI 10.1021/bi961022u; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; SOWERS LC, 1987, MUTAT RES, V177, P201, DOI 10.1016/0027-5107(87)90003-0; SOWERS LC, 1993, J ORG CHEM, V58, P1664, DOI 10.1021/jo00059a011; Sugiyama H, 1996, TETRAHEDRON LETT, V37, P9067, DOI 10.1016/S0040-4039(96)02130-2; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Zhao Y, 2005, J CHEM THEORY COMPUT, V1, P415, DOI 10.1021/ct049851d; Zhao Y, 2008, J PHYS CHEM C, V112, P4061, DOI 10.1021/jp710918f; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993; Zielenkiewicz W, 2003, THERMOCHIM ACTA, V405, P155, DOI 10.1016/S0040-6031(03)00128-X	57	34	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15835	15846		10.1074/jbc.M807846200	http://dx.doi.org/10.1074/jbc.M807846200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19324873	Green Published, hybrid			2022-12-25	WOS:000266501000052
J	Brognard, J; Niederst, M; Reyes, G; Warfel, N; Newton, AC				Brognard, John; Niederst, Matthew; Reyes, Gloria; Warfel, Noel; Newton, Alexandra C.			Common Polymorphism in the Phosphatase PHLPP2 Results in Reduced Regulation of Akt and Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; RICTOR-MTOR COMPLEX; BREAST-CANCER CELLS; CELLULAR-SURVIVAL; TUMOR-SUPPRESSOR; PROSTATE-CANCER; IN-VIVO; PHOSPHORYLATION; ACTIVATION; ESTROGEN	PHLPP2 (PH domain leucine-rich repeat protein phosphatase 2) terminates Akt and protein kinase C (PKC) activity by specifically dephosphorylating these kinases at a key regulatory site, the hydrophobic motif (Ser-473 in Akt1). Here we identify a polymorphism that results in an amino acid change from a Leu to Ser at codon 1016 in the phosphatase domain of PHLPP2, which reduces phosphatase activity toward Akt both in vitro and in cells, in turn resulting in reduced apoptosis. Depletion of endogenous PHLPP2 variants in breast cancer cells revealed the Ser-1016 variant is less functional toward both Akt and PKC. In pair-matched high grade breast cancer samples we observed retention of only the Ser allele from heterozygous patients (identical results were observed in a pair-matched normal and tumor cell line). Thus, we have identified a functional polymorphism that impairs the activity of PHLPP2 and correlates with elevated Akt phosphorylation and increased PKC levels.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Brognard, John; Niederst, Matthew; Warfel, Noel] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615; Warfel, Noel/0000-0001-6410-9011	National Institutes of Health [GM067946]; Department of Defense Breast Cancer Research Program Predoctoral [BC043239]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM067946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Predoctoral(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067946 (to A.C.N.). This work was also supported by Department of Defense Breast Cancer Research Program Predoctoral Grant BC043239 to J.B.), awarded and administered by the U.S. Army Medical Research Acquisition Activity, Fort Detrick, MD.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brognard J, 2001, CANCER RES, V61, P3986; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Callen DF, 2002, CANCER GENET CYTOGEN, V133, P76, DOI 10.1016/S0165-4608(01)00565-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Driouch K, 1997, GENE CHROMOSOME CANC, V19, P185, DOI 10.1002/(SICI)1098-2264(199707)19:3<185::AID-GCC8>3.0.CO;2-U; Faridi J, 2003, CLIN CANCER RES, V9, P2933; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sun M, 2001, CANCER RES, V61, P5985; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762	35	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15215	15223		10.1074/jbc.M901468200	http://dx.doi.org/10.1074/jbc.M901468200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324870	Green Published, hybrid			2022-12-25	WOS:000266288200056
J	Kandegedara, A; Thiyagarajan, S; Kondapalli, KC; Stemmler, TL; Rosen, BP				Kandegedara, Ashoka; Thiyagarajan, Saravanamuthu; Kondapalli, Kalyan C.; Stemmler, Timothy L.; Rosen, Barry P.			Role of Bound Zn(II) in the CadC Cd(II)/Pb(II)/Zn(II)-responsive Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; CADMIUM RESISTANCE; BINDING-SITES; CRYSTAL-STRUCTURE; PROTEIN; CD(II); PB(II); SMTB	The Staphylococcus aureus plasmid pI258 cadCA operon encodes a P-type ATPase, CadA, that confers resistance to Cd(II)/Pb(II)/Zn(II). Expression is regulated by CadC, a homodimeric repressor that dissociates from the cad operator/promoter upon binding of Cd(II), Pb(II), or Zn(II). CadC is a member of the ArsR/SmtB family of metalloregulatory proteins. The crystal structure of CadC shows two types of metal binding sites, termed Site 1 and Site 2, and the homodimer has two of each. Site 1 is the physiological inducer binding site. The two Site 2 metal binding sites are formed at the dimerization interface. Site 2 is not regulatory in CadC but is regulatory in the homologue SmtB. Here the role of each site was investigated by mutagenesis. Both sites bind either Cd(II) or Zn(II). However, Site 1 has higher affinity for Cd(II) over Zn(II), and Site 2 prefers Zn(II) over Cd(II). Site 2 is not required for either derepression or dimerization. The crystal structure of the wild type with bound Zn(II) and of a mutant lacking Site 2 was compared with the SmtB structure with and without bound Zn(II). We propose that an arginine residue allows for Zn(II) regulation in SmtB and, conversely, a glycine results in a lack of regulation by Zn(II) in CadC. We propose that a glycine residue was ancestral whether the repressor binds Zn(II) at a Site 2 like CadC or has no Site 2 like the paralogous ArsR and implies that acquisition of regulatory ability in SmtB was a more recent evolutionary event.	[Rosen, Barry P.] Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA; [Kandegedara, Ashoka; Thiyagarajan, Saravanamuthu; Kondapalli, Kalyan C.; Stemmler, Timothy L.; Rosen, Barry P.] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA	State University System of Florida; Florida International University; Wayne State University	Rosen, BP (corresponding author), Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, 11200 SW 8th St,HLS 2 693, Miami, FL 33199 USA.	brosen@fiu.edu	Kondapalli, Kalyan C/N-8097-2019; S, Thiyagarajan/AAU-3934-2021	Thiyagarajan, Saravanamuthu/0000-0001-6960-2729; Rosen, Barry P./0000-0002-5230-4271	National Institutes of Health [AI043428, DK068139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI043428 (to B. P. R.) and DK068139 (to T. L. S.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Busenlehner LS, 2001, BIOCHEMISTRY-US, V40, P4426, DOI 10.1021/bi010006g; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; CORBISIER P, 1993, FEMS MICROBIOL LETT, V110, P231, DOI 10.1111/j.1574-6968.1993.tb06325.x; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENDO G, 1995, J BACTERIOL, V177, P4437, DOI 10.1128/jb.177.15.4437-4441.1995; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; MARTELL AE, 1977, OTHER ORGANIC LIGAND, P168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Sun Y, 2001, J BIOL CHEM, V276, P14955, DOI 10.1074/jbc.M010595200; Teichert F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-425; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wong MD, 2002, J BIOL CHEM, V277, P40930, DOI 10.1074/jbc.M206536200; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005	24	17	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14958	14965		10.1074/jbc.M809179200	http://dx.doi.org/10.1074/jbc.M809179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19286656	hybrid, Green Published			2022-12-25	WOS:000266288200032
J	Martino, MEB; Olsen, JC; Fulcher, NB; Wolfgang, MC; O'Neal, WK; Ribeiro, CMP				Martino, Mary E. B.; Olsen, John C.; Fulcher, Nanette B.; Wolfgang, Matthew C.; O'Neal, Wanda K.; Ribeiro, Carla M. P.			Airway Epithelial Inflammation-induced Endoplasmic Reticulum Ca2+ Store Expansion Is Mediated by X-box Binding Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN; ER STRESS; MEMBRANE BIOGENESIS; MOUSE MODEL; XBP1; IRE1; COORDINATION	Inflamed cystic fibrosis (CF) human bronchial epithelia (HBE), or normal HBE exposed to supernatant from mucopurulent material (SMM) from CF airways, exhibit endoplasmic reticulum (ER)/Ca2+ store expansion and amplified Ca2+-mediated inflammation. HBE inflammation triggers an unfolded protein response (UPR) coupled to mRNA splicing of X-box binding protein-1 (XBP-1). Because spliced XBP-1 (XBP-1s) promotes ER expansion in other cellular models, we hypothesized that XBP-1s is responsible for the ER/Ca2+ store expansion in inflamed HBE. XBP-1s was increased in freshly isolated infected/inflamed CF in comparison with normal HBE. The link between airway epithelial inflammation, XBP-1s, and ER/Ca2+ store expansion was then addressed in murine airways challenged with phosphate-buffered saline or Pseudomonas aeruginosa. P. aeruginosa-challenged mice exhibited airway epithelial ER/Ca2+ store expansion, which correlated with airway inflammation. P. aeruginosa-induced airway inflammation triggered XBP-1s in ER stress-activated indicator (ERAI) mice. To evaluate the functional role of XBP-1s in airway inflammation linked to ER/Ca2+ store expansion, control, XBP-1s, or dominant negative XBP- 1 (DN-XBP-1) stably expressing 16HBE14o(-) cell lines were used. Studies with cells transfected with an unfolded protein response element (UPRE) luciferase reporter plasmid confirmed that the UPRE was activated or inhibited by expression of XBP-1s or DN-XBP-1, respectively. Expression of XBP-1s induced ER/Ca2+ store expansion and potentiated bradykinin-increased interleukin (IL)-8 secretion, whereas expression of DN-XBP-1 inhibited bradykinin-dependent IL-8 secretion. In addition, expression of DN-XBP-1 blunted SMM-induced ER/Ca2+ store expansion and SMM-induced IL-8 secretion. These findings suggest that, in inflamed HBE, XBP-1s is responsible for the ER/Ca2+ store expansion that confers amplification of Ca2+-dependent inflammatory responses.	[Martino, Mary E. B.; Olsen, John C.; Fulcher, Nanette B.; Wolfgang, Matthew C.; O'Neal, Wanda K.; Ribeiro, Carla M. P.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Olsen, John C.; O'Neal, Wanda K.; Ribeiro, Carla M. P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Wolfgang, Matthew C.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ribeiro, CMP (corresponding author), CB 7248,7013 Thurston Bowles Bldg, Chapel Hill, NC 27599 USA.	carla_ribeiro@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009		Cystic Fibrosis Foundation [RIBEIR07G0]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by Cystic Fibrosis Foundation Grant RIBEIR07G0 (to C. M. P. R.).	Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Johnson LG, 1998, J VIROL, V72, P8861, DOI 10.1128/JVI.72.11.8861-8872.1998; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nanua S, 2006, BIOCHEM BIOPH RES CO, V343, P135, DOI 10.1016/j.bbrc.2006.02.137; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pedrosa CM, 2001, CILIA AND MUCUS: FROM DEVELOPMENT TO RESPIRATORY DEFENSE, P303; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, J CELL SCI, V113, P3697; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	35	62	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14904	14913		10.1074/jbc.M809180200	http://dx.doi.org/10.1074/jbc.M809180200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321437	hybrid, Green Published			2022-12-25	WOS:000266288200026
J	Namkung, Y; Dipace, C; Javitch, JA; Sibley, DR				Namkung, Yoon; Dipace, Concetta; Javitch, Jonathan A.; Sibley, David R.			G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D-2 Dopamine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; HAMSTER OVARY CELLS; D2 RECEPTORS; ADENYLATE-CYCLASE; ARRESTIN BINDING; BETA-ARRESTINS; INTERNALIZATION; SENSITIZATION; ISOFORMS; RESPONSIVENESS	We investigated the role of G protein-coupled receptor kinase (GRK)-mediated phosphorylation in agonist-induced desensitization, arrestin association, endocytosis, and intracellular trafficking of the D-2 dopamine receptor (DAR). Agonist activation of D-2 DARs results in rapid and sustained receptor phosphorylation that is solely mediated by GRKs. A survey of GRKs revealed that only GRK2 or GRK3 promotes D-2 DAR phosphorylation. Mutational analyses resulted in the identification of eight serine/threonine residues within the third cytoplasmic loop of the receptor that are phosphorylated by GRK2/3. Simultaneous mutation of these eight residues results in a receptor construct, GRK(-), that is completely devoid of agonist-promoted GRK-mediated receptor phosphorylation. We found that both wild-type (WT) and GRK(-) receptors underwent a similar degree of agonist-induced desensitization as assessed using [S-35]GTP gamma S binding assays. Similarly, both receptor constructs internalized to the same extent in response to agonist treatment. Furthermore, using bioluminescence resonance energy transfer assays to directly assess receptor association with arrestin3, we found no differences between the WT and GRK(-) receptors. Thus, phosphorylation is not required for arrestin-receptor association or agonist-induced desensitization or internalization. In contrast, when we examined recycling of the D-2 DARs to the cell surface, subsequent to agonist-induced endocytosis, the GRK(-) construct exhibited less recycling in comparison with the WT receptor. This impairment appears to be due to a greater propensity of the GRK(-) receptors to down-regulate once internalized. In contrast, if the receptor is highly phosphorylated, then receptor recycling is promoted. These results reveal a novel role for GRK-mediated phosphorylation in regulating the post-endocytic trafficking of a G protein-coupled receptor.	[Namkung, Yoon; Sibley, David R.] NINDS, Mol Neuropharmacol Sect, NIH, Bethesda, MD 20892 USA; [Dipace, Concetta; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Dipace, Concetta; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Dipace, Concetta; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Columbia University; Columbia University; Columbia University	Sibley, DR (corresponding author), NINDS, Mol Neuropharmacol Sect, NIH, 5625 Fishers Ln,Rm 4S-04,MSC 9405, Bethesda, MD 20892 USA.	sibley@helix.nih.gov	Sibley, David/AAC-3591-2019	Javitch, Jonathan/0000-0001-7395-2967	NINDS; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	work was supported, in whole or in part, by a National Institutes of Health grant from NINDS (Intramural Research Program).	AGUI T, 1988, J BIOCHEM-TOKYO, V103, P436, DOI 10.1093/oxfordjournals.jbchem.a122288; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; BARTON AC, 1991, MOL PHARMACOL, V39, P650; BATES MD, 1991, MOL PHARMACOL, V39, P55; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gardner B, 1996, BRIT J PHARMACOL, V118, P1544, DOI 10.1111/j.1476-5381.1996.tb15572.x; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Itokawa M, 1996, MOL PHARMACOL, V49, P560; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; Kapur S, 2001, BIOL PSYCHIAT, V50, P873, DOI 10.1016/S0006-3223(01)01251-3; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim OJ, 2008, J RECEPT SIG TRANSD, V28, P453, DOI [10.1080/10799890802379410, 10.1080/10799890802379410 ]; Kim OJ, 2008, J NEUROCHEM, V106, P83, DOI 10.1111/j.1471-4159.2008.05348.x; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Lan HX, 2009, MOL PHARMACOL, V75, P19, DOI 10.1124/mol.108.050542; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Neve KA, 2006, MOL PHARMACOL, V69, P673, DOI 10.1124/mol.105.021535; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Seeman P, 2007, SYNAPSE, V61, P1013, DOI 10.1002/syn.20453; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SIBLEY DR, 1997, DOPAMINE RECEPTORS, P383; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Watts VJ, 1996, MOL PHARMACOL, V50, P966; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; ZHANG LJ, 1994, MOL PHARMACOL, V45, P878	55	73	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15038	15051		10.1074/jbc.M900388200	http://dx.doi.org/10.1074/jbc.M900388200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332542	Green Published, hybrid			2022-12-25	WOS:000266288200040
J	Ordonez, E; Van Belle, K; Roos, G; De Galan, S; Letek, M; Gil, JA; Wyns, L; Mateos, LM; Messens, J				Ordonez, Efren; Van Belle, Karolien; Roos, Goedele; De Galan, Sandra; Letek, Michal; Gil, Jose A.; Wyns, Lode; Mateos, Luis M.; Messens, Joris			Arsenate Reductase, Mycothiol, and Mycoredoxin Concert Thiol/Disulfide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM-GLUTAMICUM ATCC-13032; AUREUS PLASMID PI258; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; DISULFIDE OXIDOREDUCTASE; LEISHMANIA-MAJOR; HYDROGEN DONOR; ARSENITE; THIOL; GLUTATHIONE	We identified the first enzymes that use mycothiol and mycoredoxin in a thiol/disulfide redox cascade. The enzymes are two arsenate reductases from Corynebacterium glutamicum (Cg ArsC1 and Cg ArsC2), which play a key role in the defense against arsenate. In vivo knockouts showed that the genes for Cg_ArsC1 and Cg_ArsC2 and those of the enzymes of the mycothiol biosynthesis pathway confer arsenate resistance. With steady-state kinetics, arsenite analysis, and theoretical reactivity analysis, we unraveled the catalytic mechanism for the reduction of arsenate to arsenite in C. glutamicum. The active site thiolate in Cg_ArsCs facilitates adduct formation between arsenate and mycothiol. Mycoredoxin, a redox enzyme for which the function was never shown before, reduces the thiol-arseno bond and forms arsenite and a mycothiol-mycoredoxin mixed disulfide. A second molecule of mycothiol recycles mycoredoxin and forms mycothione that, in its turn, is reduced by the NADPH-dependent mycothione reductase. Cg_ArsCs show a low specificity constant of similar to 5 M-1 s(-1), typically for a thiol/disulfide cascade with nucleophiles on three different molecules. With the in vitro reconstitution of this novel electron transfer pathway, we have paved the way for the study of redox mechanisms in actinobacteria.	[Ordonez, Efren; Letek, Michal; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Dept Mol Biol, Area Microbiol, E-24071 Leon, Spain; [Van Belle, Karolien; Roos, Goedele; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Van Belle, Karolien; Roos, Goedele; Wyns, Lode; Messens, Joris] Vrije Univ Brussels, Dept Mol & Cellular Interact, Vlaams Inst Biotechnol, B-1050 Brussels, Belgium; [Van Belle, Karolien; Roos, Goedele; Wyns, Lode; Messens, Joris] Vrije Univ Brussels, Dept Struct Biol Brussels, B-1050 Brussels, Belgium; [De Galan, Sandra] Vrije Univ Brussels, Dept Analyt Chem, B-1050 Brussels, Belgium; [Roos, Goedele] Vrije Univ Brussels, Dept Gen Chem, B-1050 Brussels, Belgium	Universidad de Leon; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Mateos, LM (corresponding author), Univ Leon, Dept Mol Biol, Area Microbiol, E-24071 Leon, Spain.	luis.mateos@unileon.es; joris.messens@vib-vub.be	Letek, Michal/K-3903-2019; Gil, José A./L-1800-2019; Messens, Joris/AAH-3008-2020; Gil, Jose A./C-3902-2009; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Letek, Michal/AAH-4292-2019; Letek, Michal/C-6345-2008	Letek, Michal/0000-0002-9509-5174; Gil, José A./0000-0002-5069-2637; Messens, Joris/0000-0002-2128-8264; Gil, Jose A./0000-0002-5069-2637; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Letek, Michal/0000-0002-9509-5174	Vlaams Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Science and Technology Ministry from Spain [BIO2008-00519, BIO2005-02723]	Vlaams Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Science and Technology Ministry from Spain	This work was supported by the Vlaams Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), the Onderzoeksraad of the Vrije Universiteit Brussel, and Science and Technology Ministry from Spain Grants BIO2008-00519 and BIO2005-02723.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bennett MS, 2001, P NATL ACAD SCI USA, V98, P13577, DOI 10.1073/pnas.241397198; Bunik V, 1999, PROTEIN SCI, V8, P65; Bzymek KP, 2007, J BACTERIOL, V189, P6796, DOI 10.1128/JB.00644-07; delCardayre SB, 1998, J BIOL CHEM, V273, P5752, DOI 10.1074/jbc.273.10.5752; Demel S, 2004, PROTEIN SCI, V13, P2330, DOI 10.1110/ps.04787204; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Duan GL, 2007, NEW PHYTOL, V174, P311, DOI 10.1111/j.1469-8137.2007.02009.x; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Feng J, 2006, J BIOL CHEM, V281, P10778, DOI 10.1074/jbc.M513192200; Frisch M.J., 2016, GAUSSIAN 16 REVISION; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Healy SM, 1999, BIOL TRACE ELEM RES, V68, P249, DOI 10.1007/BF02783907; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; JI GY, 1994, BIOCHEMISTRY-US, V33, P7294, DOI 10.1021/bi00189a034; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Latinwo LM, 1998, BIOCHEM BIOPH RES CO, V242, P67, DOI 10.1006/bbrc.1997.7911; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Mateos LM, 2006, INT MICROBIOL, V9, P207; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; Messens J, 2002, P NATL ACAD SCI USA, V99, P8506, DOI 10.1073/pnas.132142799; Messens J, 2002, J BIOL INORG CHEM, V7, P146, DOI 10.1007/s007750100282; Messens J, 1999, BIOCHEMISTRY-US, V38, P16857, DOI 10.1021/bi9911841; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; MissetSmits M, 1997, FEBS LETT, V409, P221, DOI 10.1016/S0014-5793(97)00510-3; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Mukhopadhyay R, 2009, J MOL BIOL, V386, P1229, DOI 10.1016/j.jmb.2008.07.056; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Pearson RG., 1997, CHEM HARDNESS PLACE; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Roos G, 2006, CHEMBIOCHEM, V7, P981, DOI 10.1002/cbic.200500507; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; SPIES HSC, 1994, EUR J BIOCHEM, V224, P203, DOI 10.1111/j.1432-1033.1994.tb20013.x; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Vogt RN, 2003, BIOCHEM J, V374, P657, DOI 10.1042/BJ20030642; Wang R, 2007, J BIOL CHEM, V282, P16288, DOI 10.1074/jbc.M610347200; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	55	75	79	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15107	15116		10.1074/jbc.M900877200	http://dx.doi.org/10.1074/jbc.M900877200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19286650	Green Published, hybrid			2022-12-25	WOS:000266288200046
J	Cedzich, A; Huttenlocher, F; Kuhn, BM; Pfannstiel, J; Gabler, L; Stintzi, A; Schaller, A				Cedzich, Anna; Huttenlocher, Franziska; Kuhn, Benjamin M.; Pfannstiel, Jens; Gabler, Leszek; Stintzi, Annick; Schaller, Andreas			The Protease-associated Domain and C-terminal Extension Are Required for Zymogen Processing, Sorting within the Secretory Pathway, and Activity of Tomato Subtilase 3 (SlSBT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE PC5A; SUBTILISIN-LIKE PROTEASE; SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; CLEAVAGE SPECIFICITY; ARABIDOPSIS-THALIANA; CELLULAR TRAFFICKING; CUTTING EDGE; PLANT-CELLS; FURIN	A transgenic plant cell suspension culture was established as a versatile and efficient expression system for the subtilase SlSBT3 from tomato. The recombinant protease was purified to homogeneity from culture supernatants by fractionated ammonium sulfate precipitation, batch adsorption to cation exchange material, and anion exchange chromatography. Purified SlSBT3 was identified as a 79-kDa glycoprotein with both complex and paucimannosidic type glycan chains at Asn(177), Asn(203), Asn(376), Asn(697), and Asn(745). SlSBT3 was found to be a very stable enzyme, being fully active at 60 degrees C and showing highest activity at alkaline conditions with a maximum between pH 7.5 and 8.0. Substrate specificity of SlSBT3 was analyzed in detail, revealing a preference for Gln and Lys in the P-1 and P-2 positions of oligopeptide substrates, respectively. Similar to bacterial, yeast, and mammalian subtilases, SlSBT3 is synthesized as a preproenzyme, and processing of the prodomain in the endoplasmic reticulum is a prerequisite for passage through the secretory pathway. SlSBT3 S538A and S538C active site mutants accumulated intracellularly as unprocessed zymogens, indicating that prodomain cleavage occurs autocatalytically. The wild-type SlSBT3 protein failed to cleave the prodomain of the S538A mutant in trans, demonstrating that zymogen maturation is an intramolecular process. Distinguishing features of plant as compared with mammalian subtilases include the insertion of a large protease-associated domain between the His and Ser residues of the catalytic triad and the C-terminal extension to the catalytic domain. Both features were found to be required for SlSBT3 activity and, consequently, for prodomain processing and secretion.	[Cedzich, Anna; Huttenlocher, Franziska; Kuhn, Benjamin M.; Gabler, Leszek; Stintzi, Annick; Schaller, Andreas] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany; [Pfannstiel, Jens] Univ Hohenheim, Life Sci Ctr, D-70593 Stuttgart, Germany; [Pfannstiel, Jens] Univ Hohenheim, Inst Physiol, Dept Biosci, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim; University Hohenheim	Schaller, A (corresponding author), Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany.	schaller@uni-hohenheim.de	Schaller, Andreas/AAC-1940-2020	Schaller, Andreas/0000-0001-6872-9576; Stintzi, Annick/0000-0002-6479-8184	Deutsche Forschungsgemeinschaft [SCHA591/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA591/2 (to A.S.).	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Berger D, 2000, GENE DEV, V14, P1119; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; Boyd PM, 2002, BBA-PROTEIN STRUCT M, V1596, P269, DOI 10.1016/S0167-4838(02)00228-5; BRUINENBERG PG, 1994, BIOCHEM J, V302, P957, DOI 10.1042/bj3020957; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DE B, 1996, J CELL BIOL, V135, P1261; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FELIX G, 1995, PLANT J, V7, P381, DOI 10.1046/j.1365-313X.1995.7030381.x; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Huet Y, 2008, BIOL CHEM, V389, P91, DOI 10.1515/BC.2008.006; Janzik I, 2000, J BIOL CHEM, V275, P5193, DOI 10.1074/jbc.275.7.5193; KLEIN TM, 1988, BIO-TECHNOL, V6, P559, DOI 10.1038/nbt0588-559; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; LI YY, 1994, J BIOL CHEM, V269, P4169; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Lusson J, 1997, BIOCHEM J, V326, P737, DOI 10.1042/bj3260737; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; NEBES VL, 1991, J BIOL CHEM, V266, P22851; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Patel AK, 2007, J AGR FOOD CHEM, V55, P5809, DOI 10.1021/jf063700h; PIETRZAK M, 1986, NUCLEIC ACIDS RES, V14, P5857, DOI 10.1093/nar/14.14.5857; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rovere C, 1999, J BIOL CHEM, V274, P12461, DOI 10.1074/jbc.274.18.12461; RUDENSKAYA GN, 1995, PLANTA, V196, P174, DOI 10.1007/BF00193231; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schnorf Martin, 1991, Transgenic Research, V1, P23, DOI 10.1007/BF02512993; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Tanaka H, 2001, DEVELOPMENT, V128, P4681; Terp N, 2000, J PLANT PHYSIOL, V156, P468, DOI 10.1016/S0176-1617(00)80161-3; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; TRIMBLE RB, 1987, METHOD ENZYMOL, V138, P763; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; YAMAGATA H, 1994, J BIOL CHEM, V269, P32725; Yonezawa H, 2000, BIOSCI BIOTECH BIOCH, V64, P2104, DOI 10.1271/bbb.64.2104	68	51	53	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14068	14078		10.1074/jbc.M900370200	http://dx.doi.org/10.1074/jbc.M900370200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19332543	hybrid, Green Published			2022-12-25	WOS:000266286100013
J	Jeong, BC; Lee, YS; Park, YY; Bae, IH; Kim, DK; Koo, SH; Choi, HR; Kim, SH; Franceschi, RT; Koh, JT; Choi, HS				Jeong, Byung-Chul; Lee, Yong-Soo; Park, Yun-Yong; Bae, In-Ho; Kim, Don-Kyu; Koo, Seung-Hoi; Choi, Hong-Ran; Kim, Sun-Hun; Franceschi, Renny T.; Koh, Jeong-Tae; Choi, Hueng-Sik			The Orphan Nuclear Receptor Estrogen Receptor-related Receptor gamma Negatively Regulates BMP2-induced Osteoblast Differentiation and Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; ALPHA ERR-ALPHA; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; MORPHOGENETIC PROTEIN-2; OSTEOCALCIN GENE; CELL-LINE; RUNX2; INTERACTS; PROMOTER	Estrogen receptor-related receptor gamma(ERR gamma/ERR3/NR3B3) is a member of the orphan nuclear receptor with important functions in development and homeostasis. Recently it has been reported that ERR alpha is involved in osteoblast differentiation and bone formation. In the present study we examined the role of ERR gamma in osteoblast differentiation. Here, we showed that ERR gamma is expressed in osteoblast progenitors and primary osteoblasts, and its expression is increased temporarily by BMP2. Overexpression of ERR gamma reduced BMP2-induced alkaline phosphatase activity and osteocalcin production as well as calcified nodule formation, whereas inhibition of ERR gamma expression significantly enhanced BMP2-induced osteogenic differentiation and mineralization, suggesting that endogenous ERR gamma plays an important role in osteoblast differentiation. In addition, ERR gamma significantly repressed Runx2 transactivity on osteocalcin and bone sialoprotein promoters. We also observed that ERR gamma physically interacts with Runx2 in vitro and in vivo and competes with p300 to repress Runx2 transactivity. Notably, intramuscular injection of ERR gamma strongly inhibited BMP2-induced ectopic bone formation in a dose-dependent manner. Taken together, these results suggest that ERR gamma is a novel negative regulator of osteoblast differentiation and bone formation via its regulation of Runx2 transactivity.	[Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Dent Sci Res Inst, Kwangju 500757, South Korea; [Lee, Yong-Soo; Park, Yun-Yong; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Franceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); University of Michigan System; University of Michigan	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Dent Sci Res Inst, Kwangju 500757, South Korea.	jtkoh@chonnam.ac.kr; hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015; Lee, Yong-Soo/AAI-7059-2020	Koo, Seung-Hoi/0000-0001-8769-2879; 	National Research Laboratory [M1-05004705J-4710]; Korean Government Ministry of Education and Human Resource Development [KRF-2007-313-E00469]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013386] Funding Source: NIH RePORTER	National Research Laboratory(Korea Science and Engineering Foundation); Korean Government Ministry of Education and Human Resource Development(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Research Laboratory Grant M1-05004705J-4710 (to H.-S.C.) and the Korea Research Foundation Grant, funded in part by Korean Government Ministry of Education and Human Resource Development Grant KRF-2007-313-E00469 (to J.-T.K.).	Bonnelye E, 2002, J BONE MINER RES, V17, P1392, DOI 10.1359/jbmr.2002.17.8.1392; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Huppunen J, 2004, MOL CELL ENDOCRINOL, V219, P151, DOI 10.1016/j.mce.2004.01.002; Javed A, 2000, J CELL SCI, V113, P2221; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Koh JT, 2006, MOL THER, V14, P684, DOI 10.1016/j.ymthe.2006.05.021; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MK, 2006, J CELL BIOCHEM, V99, P986, DOI 10.1002/jcb.20990; Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shafritz AB, 1998, CLIN ORTHOP RELAT R, P46; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114	36	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14211	14218		10.1074/jbc.M808345200	http://dx.doi.org/10.1074/jbc.M808345200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324883	hybrid, Green Published			2022-12-25	WOS:000266286100027
J	Topping, RP; Wilkinson, JC; Scarpinato, KD				Topping, Ryan P.; Wilkinson, John C.; Scarpinato, Karin Drotschmann			Mismatch Repair Protein Deficiency Compromises Cisplatin-induced Apoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; MICROSATELLITE INSTABILITY; METHYLATING AGENTS; CASPASE ACTIVATION; G(2) CHECKPOINT; OVARIAN-CANCER; MUTS HOMOLOGS; TUMOR-CELLS; RESISTANCE; EXPRESSION	Mismatch repair (MMR) proteins participate in cytotoxicity induced by certain DNA damage-inducing agents, including cisplatin (cis-diamminedichloroplatinum(II), CDDP), a cancer chemotherapeutic drug utilized clinically to treat a variety of malignancies. MMR proteins have been demonstrated to bind to CDDP-DNA adducts and initiate MMR protein-dependent cell death in cells treated with CDDP; however, the molecular events underlying this death remain unclear. As MMR proteins have been suggested to be important in clinical responses to CDDP, a clear understanding of MMR protein-dependent, CDDP-induced cell death is critical. In this report, we demonstrate MMR protein-dependent relocalization of cytochrome c to the cytoplasm and cleavage of caspase-9, caspase-3, and poly(ADP-ribose) polymerase upon treatment of cells with CDDP. Chemical inhibition of caspases specifically attenuates CDDP/MMR protein-dependent cytotoxicity, suggesting that a caspase-dependent signaling mechanism is required for the execution of this cell death. p53 protein levels were up-regulated independently of MMR protein status, suggesting that p53 is not a mediator of MMR-dependent, CDDP-induced death. This work is the first indication of a required signaling mechanism in CDDP-induced, MMR protein-dependent cytotoxicity, which can be uncoupled from other CDDP response pathways, and defines a critical contribution of MMR proteins to the control of cell death.	[Topping, Ryan P.; Scarpinato, Karin Drotschmann] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Wilkinson, John C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Scarpinato, Karin Drotschmann] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Scarpinato, KD (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	kscarpin@wfubmc.edu			National Institutes of Health [CA101829]; Comprehensive Cancer Center at Wake Forest University School of Medicine; Dept. of Defense Prostate Cancer Research Program [W81XWH-08-1-0045]; NATIONAL CANCER INSTITUTE [R01CA101829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center at Wake Forest University School of Medicine; Dept. of Defense Prostate Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA101829 from NCI (to K. D. S.). This work was also supported by the Comprehensive Cancer Center at Wake Forest University School of Medicine and a "Golfers against Cancer" grant (to K. D. S.) and by Grant W81XWH-08-1-0045 from the Dept. of Defense Prostate Cancer Research Program (to J.C.W.).	Aebi S, 1997, CLIN CANCER RES, V3, P1763; Avdievich E, 2008, P NATL ACAD SCI USA, V105, P4247, DOI 10.1073/pnas.0800276105; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Clodfelter JE, 2005, NUCLEIC ACIDS RES, V33, P3323, DOI 10.1093/nar/gki646; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Drotschmann K, 2004, DNA REPAIR, V3, P729, DOI 10.1016/j.dnarep.2004.02.011; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fink D, 1996, CANCER RES, V56, P4881; Gong JG, 1999, NATURE, V399, P806; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Kishi K, 2003, CLIN CANCER RES, V9, P4368; KOI M, 1994, CANCER RES, V54, P4308; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Mayer F, 2002, CANCER RES, V62, P2758; Nehme A, 1997, CANCER RES, V57, P3253; Pani E, 2007, CELL CYCLE, V6, P1796, DOI 10.4161/cc.6.14.4472; Papouli E, 2004, CANCER RES, V64, P3391, DOI 10.1158/0008-5472.CAN-04-0513; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Samimi G, 2000, CLIN CANCER RES, V6, P1415; Sartorius UA, 2002, INT J CANCER, V97, P584, DOI 10.1002/ijc.10096; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Sedletska Y, 2007, J MOL BIOL, V369, P27, DOI 10.1016/j.jmb.2007.02.048; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tai YT, 1998, J CLIN ONCOL, V16, P2583, DOI 10.1200/JCO.1998.16.8.2583; Umar A, 1998, GENETICS, V148, P1637; Umar A, 1997, CANCER RES, V57, P3949; Vaisman A, 1998, CANCER RES, V58, P3579; Velasco A, 2008, INT J CANCER, V122, P1774, DOI 10.1002/ijc.23291; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215	42	52	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14029	14039		10.1074/jbc.M809303200	http://dx.doi.org/10.1074/jbc.M809303200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19286655	hybrid, Green Published			2022-12-25	WOS:000266286100009
J	Boumechache, M; Masin, M; Edwardson, JM; Gorecki, DC; Murrell-Lagnado, R				Boumechache, Miyyada; Masin, Marianela; Edwardson, J. Michael; Gorecki, Dariusz C.; Murrell-Lagnado, Ruth			Analysis of Assembly and Trafficking of Native P2X4 and P2X7 Receptor Complexes in Rodent Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(4) RECEPTORS; PORE PROPERTIES; SUBUNITS; CHANNEL; ACTIVATION; TRIMERS; STATE; FORM	P2X4 and P2X7 are the predominant P2X receptor subtypes expressed in immune cells. Having previously shown a structural and functional interaction between the two recombinant receptors, our aims here were to identify the preferred assembly pathway of the endogenous receptors in macrophage-like cells and to investigate the trafficking of these receptors between the plasma membrane and intracellular sites. We exploited the difference in size between the two subunits, and we used a combination of cross-linkers and blue native-PAGE analysis to investigate the subunit composition of complexes present in primary cultures of rat microglia and macrophages from wild type and P2X7(-/-) mice. Our results indicate that the preferred assembly pathway for both receptors is the formation of homotrimers. Homotrimers of P2X7 were able to co-immunoprecipitate with P2X4, suggesting that an interaction occurs between rather than within receptor complexes. In both macrophages and microglia, P2X7 receptors were predominantly at the cell surface, whereas P2X4 receptors were predominantly intracellular. There were clear cell type-dependent differences in the extent to which P2X4 receptors trafficked to and from the surface; trafficking was much more dynamic in microglia than in the macrophages, and further activation of cultured microglia with relatively short (3-h) incubations with lipopolysaccharide caused an similar to 4-fold increase in the fraction of receptors at the surface with only a 1.2-fold increase in total expression. The redistribution of intracellular receptors is thus an efficient means of enhancing the functional expression of P2X4 at the plasma membrane of microglia.	[Boumechache, Miyyada; Masin, Marianela; Edwardson, J. Michael; Murrell-Lagnado, Ruth] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England	University of Cambridge; University of Portsmouth	Murrell-Lagnado, R (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Ct Rd, Cambridge CB2 1PD, England.	rdm1003@cam.ac.uk		Gorecki, Dariusz/0000-0003-3584-1654; Murrell-Lagnado, Ruth/0000-0003-2743-7977	Biotechnology and Biological Sciences Research Council [BB/F001320/1]; Interreg IV; BBSRC [BB/F001320/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Interreg IV; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F001320/1 (to R. M.- L.) and the Interreg IV (AdMiN) (to D. C. G.).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Ding SH, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-17; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kuehnel MP, 2009, J CELL SCI, V122, P499, DOI 10.1242/jcs.034199; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Ma WY, 2006, J PHYSIOL-LONDON, V571, P503, DOI 10.1113/jphysiol.2005.103408; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Raouf R, 2007, NEUROPHARMACOLOGY, V53, P496, DOI 10.1016/j.neuropharm.2007.06.010; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786	26	98	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13446	13454		10.1074/jbc.M901255200	http://dx.doi.org/10.1074/jbc.M901255200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304656	hybrid, Green Published			2022-12-25	WOS:000265877300020
J	Crose, LES; Hilder, TL; Sciaky, N; Johnson, GL				Crose, Lisa E. S.; Hilder, Thomas L.; Sciaky, Noah; Johnson, Gary L.			Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE; DOMAIN; GTPASES	Mutation of CCM2 predisposes individuals to cerebral cavernous malformations, vascular abnormalities that cause seizures and hemorrhagic stroke. CCM2 has been proposed to regulate the activity of RhoA for maintenance of vascular integrity. Herein, we define a novel mechanism where the CCM2 phosphotyrosine binding (PTB) domain binds the ubiquitin ligase (E3) Smurf1, controlling RhoA degradation. Brain endothelial cells with knockdown of CCM2 have increased RhoA protein and display impaired directed cell migration. CCM2 binding of Smurf1 increases Smurf1-mediated degradation of RhoA. CCM2 does not significantly alter the catalytic activity of Smurf1, nor is CCM2 a Smurf1 substrate. Rather the CCM2-Smurf1 interaction functions to localize Smurf1 for RhoA degradation. These findings provide a molecular mechanism for the pathogenesis of cerebral cavernous malformations (CCM) resulting from loss of CCM2-mediated localization of Smurf1, which controls RhoA degradation required for maintenance of normal endothelial cell physiology.	[Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 4016 Genet Med Bldg,Campus Box 7365, Chapel Hill, NC 27599 USA.	glj@med.unc.edu			NIGMS NIH HHS [R01 GM068820] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068820] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	14	64	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13301	13305		10.1074/jbc.C900009200	http://dx.doi.org/10.1074/jbc.C900009200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318350	hybrid, Green Published			2022-12-25	WOS:000265877300005
J	Kent, T; Kashkina, E; Anikin, M; Temiakov, D				Kent, Tatyana; Kashkina, Ekaterina; Anikin, Michael; Temiakov, Dmitry			Maintenance of RNA-DNA Hybrid Length in Bacterial RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; THERMUS-THERMOPHILUS; STRUCTURAL BASIS; LID ELEMENT; MECHANISM; COMPLEX; CONFORMATIONS; PROCESSIVITY; MISALIGNMENT; TERMINATION	During transcription elongation the nascent RNA remains base-paired to the template strand of the DNA before it is displaced and the two strands of the DNA reanneal, resulting in the formation of a transcription "bubble" of similar to 10 bp. To examine how the length of the RNA-DNA hybrid is maintained, we assembled transcription elongation complexes on synthetic nucleic acid scaffolds that mimic the situation in which transcript displacement is compromised and the polymerase synthesizes an extended hybrid. We found that in such complexes bacterial RNA polymerase exhibit an intrinsic endonucleolytic cleavage activity that restores the hybrid to its normal length. Mutations in the region of the RNA polymerase near the site of RNA-DNA separation result in altered RNA displacement and translocation functions and as a consequence in different patterns of proofreading activities. Our data corroborate structural findings concerning the elements involved in the maintenance of the length of the RNA-DNA hybrid and suggest interplay between polymerase translocation, DNA strand separation, and intrinsic endonucleolytic activity.	[Kent, Tatyana; Kashkina, Ekaterina; Anikin, Michael; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Temiakov, D (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA.	d.temiakov@umdnj.edu		KENT, Tatiana/0000-0001-8237-0184	National Institutes of Health [GM38147, GM74252]; University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074252, R01GM038147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38147 (to W. T. McAllister) and GM74252 (to D. G. Vassylyev).; This work was also supported by the University of Medicine and Dentistry of New Jersey Foundation (to D. T.).	Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Jiang ML, 2004, MOL CELL, V15, P777, DOI 10.1016/j.molcel.2004.07.019; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kashlev M, 2002, J BIOL CHEM, V277, P14501, DOI 10.1074/jbc.M200215200; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Korzheva N, 2001, CURR OPIN MICROBIOL, V4, P119, DOI 10.1016/S1369-5274(00)00176-4; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	25	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13497	13504		10.1074/jbc.M901898200	http://dx.doi.org/10.1074/jbc.M901898200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19321439	hybrid, Green Published			2022-12-25	WOS:000265877300026
J	Lee, EC; Desai, U; Gololobov, G; Hong, S; Feng, X; Yu, XC; Gay, J; Wilganowski, N; Gao, CH; Du, LL; Chen, J; Hu, Y; Zhao, SR; Kirkpatrick, L; Schneider, M; Zambrowicz, BP; Landes, G; Powell, DR; Sonnenburg, WK				Lee, E-Chiang; Desai, Urvi; Gololobov, Gennady; Hong, Seokjoo; Feng, Xiao; Yu, Xuan-Chuan; Gay, Jason; Wilganowski, Nat; Gao, Cuihua; Du, Ling-Ling; Chen, Joan; Hu, Yi; Zhao, Sharon; Kirkpatrick, Laura; Schneider, Matthias; Zambrowicz, Brian P.; Landes, Greg; Powell, David R.; Sonnenburg, William K.			Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONFASTING TRIGLYCERIDES; LIPID-METABOLISM; RISK; PROTEIN-3; TISSUE; LOCI	Angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) are secreted proteins that regulate triglyceride (TG) metabolism in part by inhibiting lipoprotein lipase (LPL). Recently, we showed that treatment of wild-type mice with monoclonal antibody (mAb) 14D12, specific for ANGPTL4, recapitulated the Angptl4 knock-out (-/-) mouse phenotype of reduced serum TG levels. In the present study, we mapped the region of mouse ANGPTL4 recognized by mAb 14D12 to amino acids Gln(29)-His(53), which we designate as specific epitope 1 (SE1). The 14D12 mAb prevented binding of ANGPTL4 with LPL, consistent with its ability to neutralize the LPL-inhibitory activity of ANGPTL4. Alignment of all angiopoietin family members revealed that a sequence similar to ANGPTL4 SE1 was present only in ANGPTL3, corresponding to amino acids Glu(32)-His(55). We produced a mouse mAb against this SE1-like region in ANGPTL3. This mAb, designated 5.50.3, inhibited the binding of ANGPTL3 to LPL and neutralized ANGPTL3-mediated inhibition of LPL activity in vitro. Treatment of wild-type as well as hyperlipidemic mice with mAb 5.50.3 resulted in reduced serum TG levels, recapitulating the lipid phenotype found in Angptl3(-/-) mice. These results show that the SE1 region of ANGPTL3 and ANGPTL4 functions as a domain important for binding LPL and inhibiting its activity in vitro and in vivo. Moreover, these results demonstrate that therapeutic antibodies that neutralize ANGPTL4 and ANGPTL3 may be useful for treatment of some forms of hyperlipidemia.	[Lee, E-Chiang; Gololobov, Gennady; Hong, Seokjoo; Feng, Xiao; Gao, Cuihua; Du, Ling-Ling; Chen, Joan; Kirkpatrick, Laura; Zambrowicz, Brian P.; Landes, Greg; Powell, David R.; Sonnenburg, William K.] Lexicon Pharmaceut Inc, Dept Biotherapeut, The Woodlands, TX 77381 USA; [Desai, Urvi; Gay, Jason; Wilganowski, Nat; Schneider, Matthias; Zambrowicz, Brian P.; Powell, David R.] Lexicon Pharmaceut Inc, Dept Pharmaceut Biol, The Woodlands, TX 77381 USA; [Yu, Xuan-Chuan; Zambrowicz, Brian P.] Lexicon Pharmaceut Inc, Dept Pharmaceut Discovery, The Woodlands, TX 77381 USA; [Hu, Yi; Zhao, Sharon; Zambrowicz, Brian P.] Lexicon Pharmaceut Inc, Dept Mol Biol, The Woodlands, TX 77381 USA	Lexicon Pharmaceuticals; Lexicon Pharmaceuticals; Lexicon Pharmaceuticals; Lexicon Pharmaceuticals	Lee, EC (corresponding author), Lexicon Pharmaceut Inc, Dept Biotherapeut, The Woodlands, TX 77381 USA.	elee@lexpharma.com; wsonnenburg@lexpharma.com						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Hatsuda S, 2007, J VASC RES, V44, P61, DOI 10.1159/000098153; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; *NAT RES COUNC I L, 1996, GUID CAR US LAB AN; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Panteghini M, 2001, ANN CLIN BIOCHEM, V38, P365, DOI 10.1258/0004563011900876; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; ZILVERSMIT DB, 1995, CLIN CHEM, V41, P153	26	123	141	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13735	13745		10.1074/jbc.M807899200	http://dx.doi.org/10.1074/jbc.M807899200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318355	Green Published, hybrid			2022-12-25	WOS:000265877300051
J	Forster, ML; Mahn, JJ; Tsai, B				Forster, Michele L.; Mahn, James J.; Tsai, Billy			Generating an Unfoldase from Thioredoxin-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; HUMAN PROLYL 4-HYDROXYLASE; TRIGLYCERIDE TRANSFER PROTEIN; CHOLERA-TOXIN; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; FUNCTIONAL-PROPERTIES; REDUCED RIBONUCLEASE; CATALYTIC-ACTIVITY; STRUCTURAL DOMAIN	Protein-disulfide isomerase (PDI), an endoplasmic reticulum (ER)-resident protein, is primarily known as a catalyst of oxidative protein folding but also has a protein unfolding activity. We showed previously that PDI unfolds the cholera toxin A1 (CTA1) polypeptide to facilitate the ER-to-cytosol retrotranslocation of the toxin during intoxication. We now provide insight into the mechanism of this unfoldase activity. PDI includes two redox-active (a and a') and two redox-inactive (b and b')thioredoxin-like domains, a linker (x), and a C-terminal domain (c) arranged as abb' xa' c. Using recombinant PDI fragments, we show that binding of CTA1 by the continuous PDIbb' xa' fragment is necessary and sufficient to trigger unfolding. The specific linear arrangement of bb' xa' and the type a domain (a' versus a) C-terminal to bb' x are additional determinants of activity. These data suggest a general mechanism for the unfoldase activity of PDI: the concurrent and specific binding of bb' xa' to particular regions along the CTA1 molecule triggers its unfolding. Furthermore, we show the bb' domains of PDI are indispensable to the unfolding reaction, whereas the function of its a' domain can be substituted partially by the a' domain from ERp57 (abb' xa' c) or ERp72 (ca degrees abb' xa'), PDI-like proteins that do not unfold CTA1 normally. However, the bb' domains of PDI were insufficient to convert full-length ERp57 into an unfoldase because the a domain of ERp57 inhibited toxin binding. Thus, we propose that generating an unfoldase from thioredoxin-like domains requires the bb'(x) domains of PDI followed by an a' domain but not preceded by an inhibitory a domain.	[Forster, Michele L.; Mahn, James J.; Tsai, Billy] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tsai, B (corresponding author), 109 Zina Pitcher Pl,3043 BSRB, Ann Arbor, MI 48109 USA.	btsai@umich.edu						Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Darby NJ, 1999, FEBS LETT, V448, P167, DOI 10.1016/S0014-5793(99)00374-9; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; GIVOL D, 1964, J BIOL CHEM, V239, P3114; GOLDBERGER RF, 1964, J BIOL CHEM, V239, P1406; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Kramer B, 2001, BIOCHEM J, V357, P83, DOI 10.1042/0264-6021:3570083; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lencer WI, 2001, AM J PHYSIOL-GASTR L, V280, pG781, DOI 10.1152/ajpgi.2001.280.5.G781; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	54	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13045	13056		10.1074/jbc.M808352200	http://dx.doi.org/10.1074/jbc.M808352200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19289469	Green Published, hybrid			2022-12-25	WOS:000265688300052
J	Shanmukhappa, K; Matte, U; Degen, JL; Bezerra, JA				Shanmukhappa, Kumar; Matte, Ursula; Degen, Jay L.; Bezerra, Jorge A.			Plasmin-mediated Proteolysis Is Required for Hepatocyte Growth Factor Activation during Liver Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; SERINE-PROTEASE; IN-VITRO; UROKINASE; REGENERATION; RECEPTOR; INJURY; MICE; HGF; HEPSIN	The physiological relevance of the activation of hepatocyte growth factor (Hgf) by the plasminogen (Plg) system of proteases and its contribution to tissue repair are largely undefined. Here, we investigated whether the defective liver repair in mice lacking Plg is due to impaired activation of Hgf. Loss of Plg in vivo suppressed Hgf activation and signaling through its Met tyrosine kinase receptor. Without Plg, hepatocytes were unresponsive to Hgf-induced proliferation and migration, with a more pronounced impairment in hepatocyte movement within the hepatic environment. Most notably, circumventing the defect in proteolytic activation of Hgf by the downstream expression of an activated Met receptor corrected the functional deficits and improved liver repair in Plg-deficient mice. These findings support a fibrinolysis-unrelated role for Plg in modulating cell proliferation and migration by activation of Hgf.	[Shanmukhappa, Kumar; Bezerra, Jorge A.] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Degen, Jay L.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Matte, Ursula] Hosp Clin, BR-90035903 Porto Alegre, RS, Brazil	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Bezerra, JA (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jorge.bezerra@cchmc.org	Matte, Ursula/J-4589-2012; Da Silveira Matte umatte, Ursula/U-3912-2019	Da Silveira Matte umatte, Ursula/0000-0003-4977-6662	National Institutes of Health [DK55710, AR049822]; Integrative Morphology Core of the Digestive Health Center [HL085357, DK032512]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Morphology Core of the Digestive Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55710 (to J.A.B.), AR049822 and HL085357 (to J.L.D.), and DK032512 (Integrative Morphology Core of the Digestive Health Center).	AMICONE L, 1995, GENE, V162, P323, DOI 10.1016/0378-1119(95)00277-D; Bezerra JA, 1999, P NATL ACAD SCI USA, V96, P15143, DOI 10.1073/pnas.96.26.15143; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Burr AW, 1998, J PATHOL, V185, P298; Currier AR, 2003, AM J PHYSIOL-GASTR L, V284, pG508, DOI 10.1152/ajpgi.00336.2002; GAK E, 1992, FEBS LETT, V311, P17, DOI 10.1016/0014-5793(92)81356-Q; Hattori N, 2004, AM J PATHOL, V164, P1091, DOI 10.1016/S0002-9440(10)63196-3; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; Kaido T, 1996, BIOCHEM BIOPH RES CO, V218, P1, DOI 10.1006/bbrc.1996.0001; Li ZD, 2007, AM J PHYSIOL-GASTR L, V292, pG639, DOI 10.1152/ajpgi.00292.2006; MARS WM, 1993, AM J PATHOL, V143, P949; MATSUDA Y, 1995, J BIOCHEM-TOKYO, V118, P643, DOI 10.1093/oxfordjournals.jbchem.a124958; Matsumoto K, 1997, CIBA F SYMP, V212, P198; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyazawa K, 1996, J BIOL CHEM, V271, P3615; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; PEPPER MS, 1992, J BIOL CHEM, V267, P20493; Ried S, 1999, J BIOL CHEM, V274, P16377, DOI 10.1074/jbc.274.23.16377; Shanmukhappa K, 2005, P NATL ACAD SCI USA, V102, P10182, DOI 10.1073/pnas.0501691102; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Stolz DB, 1997, J CELL PHYSIOL, V170, P57; Webb CP, 2000, CANCER RES, V60, P342; Yu IS, 2000, THROMB HAEMOSTASIS, V84, P865, DOI 10.1055/s-0037-1614129	31	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12917	12923		10.1074/jbc.M807313200	http://dx.doi.org/10.1074/jbc.M807313200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286661	hybrid, Green Published			2022-12-25	WOS:000265688300037
J	Dutta, D; Ensminger, AW; Zucker, JP; Chess, A				Dutta, Devkanya; Ensminger, Alexander W.; Zucker, Jacob P.; Chess, Andrew			Asynchronous Replication and Autosome-Pair Non-Equivalence in Human Embryonic Stem Cells	PLOS ONE			English	Article								A number of mammalian genes exhibit the unusual properties of random monoallelic expression and random asynchronous replication. Such exceptional genes include genes subject to X inactivation and autosomal genes including odorant receptors, immunoglobulins, interleukins, pheromone receptors, and p120 catenin. In differentiated cells, random asynchronous replication of interspersed autosomal genes is coordinated at the whole chromosome level, indicative of chromosome-pair non-equivalence. Here we have investigated the replication pattern of the random asynchronously replicating genes in undifferentiated human embryonic stem cells, using fluorescence in situ hybridization based assay. We show that allele-specific replication of X-linked genes and random monoallelic autosomal genes occur in human embryonic stem cells. The direction of replication is coordinated at the whole chromosome level and can cross the centromere, indicating the existence of autosome-pair non-equivalence in human embryonic stem cells. These results suggest that epigenetic mechanism(s) that randomly distinguish between two parental alleles are emerging in the cells of the inner cell mass, the source of human embryonic stem cells.	[Dutta, Devkanya; Ensminger, Alexander W.; Zucker, Jacob P.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Dutta, D (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA.	chess@chgr.mgh.harvard.edu		Ensminger, Alexander/0000-0003-0824-3704	National Institute of Health	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by funding obtained from National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bergstrom R, 2007, CELL CYCLE, V6, P450, DOI 10.4161/cc.6.4.3854; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Ensminger AW, 2004, HUM MOL GENET, V13, P651, DOI 10.1093/hmg/ddh062; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; HARNDEN DG, 1961, LANCET, V2, P488; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Koestenbauer S, 2006, AM J REPROD IMMUNOL, V55, P169, DOI 10.1111/j.1600-0897.2005.00354.x; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	35	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4970	10.1371/journal.pone.0004970	http://dx.doi.org/10.1371/journal.pone.0004970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325893	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499600003
J	Harrist, AV; Ryzhova, EV; Harvey, T; Gonzalez-Scarano, F				Harrist, Alexia V.; Ryzhova, Elena V.; Harvey, Thomas; Gonzalez-Scarano, Francisco			Anx2 Interacts with HIV-1 Gag at Phosphatidylinositol (4,5) Bisphosphate-Containing Lipid Rafts and Increases Viral Production in 293T Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; DETERGENT-RESISTANT MEMBRANES; FUSION INHIBITOR T-20; PLASMA-MEMBRANE; ANNEXIN-II; FLUORESCENCE COMPLEMENTATION; INTRACELLULAR TRAFFICKING; REGULATED EXOCYTOSIS; INFECTIOUS HIV-1	The neuronal damage characteristic of HIV-1-mediated CNS diseases is inflicted by HIV-1 infected brain macrophages. Several steps of viral replication, including assembly and budding, differ between macrophages and T cells; it is likely that cell-specific host factors mediate these differences. We previously defined Annexin 2 (Anx2) as an HIV Gag binding partner in human monocyte-derived macrophages (MDMs) that promotes proper viral assembly. Anx2, a calcium-dependent membrane-binding protein that can aggregate phospholipid-containing lipid rafts, is expressed to high levels in macrophages, but not in T lymphocytes or the 293T cell line. Here, we use bimolecular fluorescence complementation in the 293T cell model to demonstrate that Anx2 and HIV-1 Gag interact at the phosphatidylinositol (4,5) bisphosphate-containing lipid raft membrane domains at which Gag mediates viral assembly. Furthermore, we demonstrate that Anx2 expression in 293T cells increases Gag processing and HIV-1 production. These data provide new evidence that Anx2, by interacting with Gag at the membranes that support viral assembly, functions in the late stages of HIV-1 replication.	[Harrist, Alexia V.; Ryzhova, Elena V.; Harvey, Thomas; Gonzalez-Scarano, Francisco] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Harrist, Alexia V.; Ryzhova, Elena V.; Harvey, Thomas; Gonzalez-Scarano, Francisco] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Harrist, AV (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	scarano@upenn.edu			National Institute of Neurological Disorders and Stroke, National Institutes of Health [F30 NS055523]; Penn Center for AIDS Research (CFAR) [P30 AI 045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS027405, P01NS027405, F30NS055523] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Penn Center for AIDS Research (CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by PHS Grant NS-27405; A.V.H. is supported by Ruth L. Kirschstein National Research Service Award F30 NS055523 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health. This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR) (P30 AI 045008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Albright AV, 2004, VIROLOGY, V325, P328, DOI 10.1016/j.virol.2004.04.028; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Boyko V, 2006, MOL CELL, V23, P281, DOI 10.1016/j.molcel.2006.05.028; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brownstein C, 2004, BLOOD, V103, P317, DOI 10.1182/blood-2003-04-1304; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derry MEC, 2007, J GEN VIROL, V88, P19, DOI 10.1099/vir.0.82294-0; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; EIDELS L, 1983, MICROBIOL REV, V47, P596, DOI 10.1128/MMBR.47.4.596-620.1983; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Finzi A, 2006, J VIROL, V80, P9789, DOI 10.1128/JVI.01055-06; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Ilangumaran S, 1996, ANAL BIOCHEM, V235, P49, DOI 10.1006/abio.1996.0090; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Liu L, 1999, CELL SIGNAL, V11, P317, DOI 10.1016/S0898-6568(98)00047-3; Loomis RJ, 2006, TRAFFIC, V7, P1643, DOI 10.1111/j.1600-0854.2006.00503.x; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; NAKATA T, 1990, J CELL BIOL, V110, P13, DOI 10.1083/jcb.110.1.13; Nermut MV, 2003, VIROLOGY, V305, P219, DOI 10.1006/viro.2002.1692; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Ono A, 2005, J VIROL, V79, P14131, DOI 10.1128/JVI.79.22.14131-14140.2005; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; ORENSTEIN JM, 1988, J VIROL, V62, P2578, DOI 10.1128/JVI.62.8.2578-2586.1988; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Sato K, 2008, J VIROL, V82, P1021, DOI 10.1128/JVI.01044-07; SENDA T, 1994, CELL TISSUE RES, V277, P51; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020; Wahl SM, 2006, J LEUKOCYTE BIOL, V80, P973, DOI 10.1189/jlb.0306130; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	107	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5020	10.1371/journal.pone.0005020	http://dx.doi.org/10.1371/journal.pone.0005020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325895	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499600006
J	Lam, JBB; Chow, KHM; Xu, AM; Lam, KSL; Liu, J; Wong, NS; Moon, RT; Shepherd, PR; Cooper, GJS; Wang, Y				Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Lam, Karen S. L.; Liu, Jing; Wong, Nai-Sum; Moon, Randall T.; Shepherd, Peter R.; Cooper, Garth J. S.; Wang, Yu			Adiponectin Haploinsufficiency Promotes Mammary Tumor Development in MMTV-PyVT Mice by Modulation of Phosphatase and Tensin Homolog Activities	PLOS ONE			English	Article								Background: Adiponectin is an adipokine possessing beneficial effects on obesity-related medical complications. A negative association of adiponectin levels with breast cancer development has been demonstrated. However, the precise role of adiponectin deficiency in mammary carcinogenesis remains elusive. Methodology/Principal Findings: In the present study, MMTV-polyomavirus middle T antigen (MMTV-PyVT) transgenic mice with reduced adiponectin expressions were established and the stromal effects of adiponectin haploinsufficiency on mammary tumor development evaluated. In mice from both FVB/N and C57BL/6J backgrounds, insufficient adiponectin production promoted mammary tumor onset and development. A distinctive basal-like subtype of tumors, with a more aggressive phenotype, was derived from adiponectin haplodeficient MMTV-PyVT mice. Comparing with those from control MMTV-PyVT mice, the isolated mammary tumor cells showed enhanced tumor progression in re-implanted nude mice, accelerated proliferation in primary cultures, and hyperactivated phosphatidylinositol-3-kinase (PI3K)/Akt/beta-catenin signaling, which at least partly attributed to the decreased phosphatase and tensin homolog (PTEN) activities. Further analysis revealed that PTEN was inactivated by a redox-regulated mechanism. Increased association of PTEN-thioredoxin complexes was detected in tumors derived from mice with reduced adiponectin levels. The activities of thioredoxin (Trx1) and thioredoxin reductase (TrxR1) were significantly elevated, whereas treatment with either curcumin, an irreversible inhibitor of TrxR1, or adiponectin largely attenuated their activities and resulted in the re-activation of PTEN in these tumor cells. Moreover, adiponectin could inhibit TrxR1 promoter-mediated transcription and restore the mRNA expressions of TrxR1. Conclusion: Adiponectin haploinsufficiency facilitated mammary tumorigenesis by down-regulation of PTEN activity and activation of PI3K/Akt signalling pathway through a mechanism involving Trx1/TrxR1 redox regulations.	[Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Liu, Jing; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Lam, Karen S. L.; Liu, Jing] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Janice B. B.; Chow, Kim H. M.; Xu, Aimin; Lam, Karen S. L.; Liu, Jing; Wang, Yu] Univ Hong Kong, Res Ctr Heart, Brain, Hormone, & Healthy Aging, Hong Kong, Peoples R China; [Wong, Nai-Sum] Univ Hong Kong, Dept Biochem, Hong Kong, Peoples R China; [Wang, Yu] Univ Hong Kong, Inst Mol Technol Drug Discovery & Synthesis, Open Lab Chem Biol, Hong Kong, Peoples R China; [Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Lam, Janice B. B.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Shepherd, Peter R.; Cooper, Garth J. S.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Auckland; University of Auckland	Lam, JBB (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	yuwanghk@hku.hk	Moon, Randall/M-5605-2019; Cooper, Garth JS/I-3201-2015; Moon, Randall T/B-1743-2014; Xu, Aimin/D-3291-2013	Moon, Randall/0000-0002-9352-1408; Cooper, Garth JS/0000-0001-5241-3163; Moon, Randall T/0000-0002-9352-1408; Xu, Aimin/0000-0002-0668-033X; Chow, Hei-Man/0000-0003-1203-2096; wang, yu/0000-0001-8697-2940	University of Hong Kong [Seeding Funds for Basic Research]; Hong Kong Research Grant Council [HKU 777908M, HKU 779707M]; University Grants Committee, HKSAR [AoE/P-10-01]; US National Institutes of Health [HL-51586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	University of Hong Kong(University of Hong Kong); Hong Kong Research Grant Council(Hong Kong Research Grants Council); University Grants Committee, HKSAR; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the grants from Seeding Funds for Basic Research of the University of Hong Kong (Y. Wang), Hong Kong Research Grant Council grants HKU 777908M (Y. Wang) and HKU 779707M (A. Xu), and the Area of Excellent Scheme (AoE/P-10-01) established under the University Grants Committee, HKSAR. Adiponectin knockout mice were kindly provided by Dr. Lawrence Chan at Baylor College of Medicine, who generated these mice with the support of the US National Institutes of Health grant HL-51586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi JD, 2007, HORM METAB RES, V39, P9, DOI 10.1055/s-2007-956518; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Baillargeon J, 2006, INT J ONCOL, V28, P737; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Berstein L M, 2005, Adv Gerontol, V16, P51; Bloomfield KL, 2003, GENE, V319, P107, DOI 10.1016/S0378-1119(03)00799-6; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chen DC, 2006, CANCER LETT, V237, P109, DOI 10.1016/j.canlet.2005.05.047; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; JARDE T, 2008, P NUTR SOC, V67, pE184; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; LIU J, 2008, CARCINOGENESIS, V28, P163; Livasy CA, 2007, HUM PATHOL, V38, P197, DOI 10.1016/j.humpath.2006.08.017; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; McTiernan A, 2005, ONCOLOGY-NY, V19, P871; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; NAKAYAMA S, 2007, BREAST CANC RES TREA; Pfeiler GH, 2008, ONCOL REP, V19, P787; Pischon T, 2008, P NUTR SOC, V67, P128, DOI 10.1017/S0029665108006976; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tamura T, 2002, METHOD ENZYMOL, V347, P297; Tian YF, 2007, ENDOCR-RELAT CANCER, V14, P669, DOI 10.1677/ERC-06-0089; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Tureckova J, 2006, INT J MOL MED, V17, P69; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Varticovski L, 2007, CLIN CANCER RES, V13, P2168, DOI 10.1158/1078-0432.CCR-06-0918; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang Y, 2007, CELL RES, V17, P280, DOI 10.1038/cr.2007.14; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Zhao H, 2005, CANCER RES, V65, P6864, DOI 10.1158/0008-5472.CAN-05-0181; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444	57	65	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4968	10.1371/journal.pone.0004968	http://dx.doi.org/10.1371/journal.pone.0004968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319191	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200010
J	Saleh, N; Moutereau, S; Durr, A; Krystkowiak, P; Azulay, JP; Tranchant, C; Broussolle, E; Morin, F; Bachoud-Levi, AC; Maison, P				Saleh, Nadine; Moutereau, Stephane; Durr, Alexandra; Krystkowiak, Pierre; Azulay, Jean-Philippe; Tranchant, Christine; Broussolle, Emmanuel; Morin, Francoise; Bachoud-Levi, Anne-Catherine; Maison, Patrick			Neuroendocrine Disturbances in Huntington's Disease	PLOS ONE			English	Article								Background: Huntington's disease (HD) is a severe inherited neurodegenerative disorder characterized, in addition to neurological impairment, by weight loss suggesting endocrine disturbances. The aims of this study were to look for neuroendocrine disturbances in patients with Huntington's disease (HD) and to determine the relationship with weight loss seen in HD Methods and Finding: We compared plasma levels of hormones from the five pituitary axes in 219 patients with genetically documented HD and in 71 sex-and age-matched controls. Relationships between hormone levels and disease severity, including weight-loss severity, were evaluated. Growth hormone (GH) and standard deviation score of insulin-like growth factor 1 (SDS IGF-1) were significantly higher in patients than in controls (0.25 (0.01-5.89) vs. 0.15 (0.005-4.89) ng/ml, p = 0.013 and 0.16 +/- 1.02 vs. 0.06 +/- 0.91, p = 0.039; respectively). Cortisol was higher (p = 0.002) in patients (399.14 +/- 160.5 nmol/L vs. 279.8 +/- 130.1 nmol/L), whereas no differences were found for other hormone axes. In patients, elevations in GH and IGF-1 and decreases in thyroid-stimulating hormone, free triiodothyronine and testosterone (in men) were associated with severity of impairments (Independence scale, Functional score, Total Functional Capacity, Total Motor score, Behavioral score). Only GH was independently associated with body mass index (beta = 20.26, p = 0.001). Conclusion: Our data suggest that the thyrotropic and in men gonadotropic axes are altered in HD according to the severity of the disease. The somatotropic axis is overactive even in patients with early disease, and could be related to the weight loss seen in HD patients.	[Saleh, Nadine; Durr, Alexandra; Bachoud-Levi, Anne-Catherine] Grp Henri Mondor Albert Chenevier Pitie Salpetrie, AP HP, Ctr Reference Malad Huntington, Paris, France; [Saleh, Nadine; Maison, Patrick] Grp Henri Mondor Albert Chenevier Pitie Salpetrie, AP HP, Serv Pharmacol Clin, Paris, France; [Saleh, Nadine; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Univ Paris 12, Fac Med, F-94010 Creteil, France; [Saleh, Nadine; Bachoud-Levi, Anne-Catherine; Maison, Patrick] INSERM, Unite U955, Equipe 1, Creteil, France; [Moutereau, Stephane] Grp Henri Mondor Albert Chenevier, AP HP, Serv Biochim, Paris, France; [Durr, Alexandra] Pitie Salpetriere, Dept Genet Cytogenet & Embryol, INSERM, U289, Paris, France; [Krystkowiak, Pierre] CHU Amiens, Neurol Dept, Amiens, France; [Azulay, Jean-Philippe] La Timone Hosp, CNRS, APM, Marseille, France; [Tranchant, Christine] Hop Univ, Neurol Dept, Strasbourg, France; [Broussolle, Emmanuel] Pierre Wertheimer Neurol Hosp, Neurol Dept, Lyon, France; [Morin, Francoise] EFS Ile France, Bobigny, France; [Bachoud-Levi, Anne-Catherine] Ecole Normale Superieure, Dept Etudes Cognitives, Paris, France; [Maison, Patrick] Grp Henri Mondor Albert Chenevier, AP HP, Unite Rech Clin, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; CHU Lyon; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Saleh, N (corresponding author), Grp Henri Mondor Albert Chenevier Pitie Salpetrie, AP HP, Ctr Reference Malad Huntington, Paris, France.	bachoud@gmail.com	Broussolle, Emmanuel/H-1592-2017; Bachoud-Lévi, Anne-Catherine/GYU-8680-2022	Broussolle, Emmanuel/0000-0002-0410-9519; Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; tranchant, christine/0000-0002-2895-1292	Institut National de la Sante et de la Recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS)- Institut des Maladies Rares.	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS)- Institut des Maladies Rares.	This work was supported by cooperative contracts between the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association Francaise contre les Myopathies (AFM), as well as by the Association Huntington France (AHF) and the Groupement d'Interet Scientifique (GIS)- Institut des Maladies Rares. The funder had no role in the study design, data collection and analysis,the decision to publish or preparation of the manuscript.	Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; BRANDT J, 1991, P241; BRUYN GW, 1973, LANCET, V1, P1382; Busiguina S, 2000, NEUROBIOL DIS, V7, P657, DOI 10.1006/nbdi.2000.0311; CAINE E, 1978, LIFE SCI, V22, P911, DOI 10.1016/0024-3205(78)90616-1; CARACENI T, 1977, J CLIN ENDOCR METAB, V44, P870, DOI 10.1210/jcem-44-5-870; CHALMERS RJ, 1978, J NEUROL NEUROSUR PS, V41, P135, DOI 10.1136/jnnp.41.2.135; de Aguilar JLG, 2003, NEUROENDOCRINOLOGY, V78, P244, DOI 10.1159/000074445; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Dore S, 2000, Pharm Acta Helv, V74, P273, DOI 10.1016/S0031-6865(99)00037-0; FEDOROFF JP, 1994, J NEUROPSYCH CLIN N, V6, P147; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; HAYDEN MR, 1977, LANCET, V2, P423; HEUSER IJE, 1991, BIOL PSYCHIAT, V30, P943, DOI 10.1016/0006-3223(91)90007-9; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; KREMER HPH, 1991, NEUROSCI LETT, V132, P101, DOI 10.1016/0304-3940(91)90443-W; KREMER HPH, 1990, J NEUROPATH EXP NEUR, V49, P371, DOI 10.1097/00005072-199007000-00002; LAVIN PJM, 1981, J NEUROL NEUROSUR PS, V44, P414, DOI 10.1136/jnnp.44.5.414; LEBLHUBER F, 1995, J NEUROL SCI, V132, P76, DOI 10.1016/0022-510X(95)00114-H; LEOPOLD NA, 1975, J CLIN ENDOCR METAB, V41, P160, DOI 10.1210/jcem-41-1-160; LEVY CL, 1979, LIFE SCI, V24, P743, DOI 10.1016/0024-3205(79)90357-6; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; MULLER EE, 1977, LANCET, V2, P764; Nagel BHP, 1997, EUR J PEDIATR, V156, P758, DOI 10.1007/s004310050707; Oge A, 2005, ENDOCR J, V52, P213, DOI 10.1507/endocrj.52.213; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; PHILLIPSON OT, 1976, CLIN SCI MOL MED, V50, P551, DOI 10.1042/cs0500551; PODOLSKY S, 1974, J CLIN ENDOCR METAB, V39, P36, DOI 10.1210/jcem-39-1-36; POLLERI A, 1980, LIFE SCI, V26, P1609, DOI 10.1016/0024-3205(80)90364-1; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Van den Berghe G, 2003, ENDOCRIN METAB CLIN, V32, P385, DOI 10.1016/S0889-8529(03)00005-7; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Yilmaz N, 2007, MED PRIN PRACT, V16, P137, DOI 10.1159/000098367	43	88	91	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4962	10.1371/journal.pone.0004962	http://dx.doi.org/10.1371/journal.pone.0004962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319184	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499200009
J	Stegemann, S; Dahlberg, S; Kroger, A; Gereke, M; Bruder, D; Henriques-Normark, B; Gunzer, M				Stegemann, Sabine; Dahlberg, Sofia; Kroeger, Andrea; Gereke, Marcus; Bruder, Dunja; Henriques-Normark, Birgitta; Gunzer, Matthias			Increased Susceptibility for Superinfection with Streptococcus pneumoniae during Influenza Virus Infection Is Not Caused by TLR7-Mediated Lymphopenia	PLOS ONE			English	Article								Influenza A virus (IAV) causes respiratory tract infections leading to recurring epidemics with high rates of morbidity and mortality. In the past century IAV induced several world-wide pandemics, the most aggressive occurring in 1918 with a death toll of 20-50 million cases. However, infection with IAV alone is rarely fatal. Instead, death associated with IAV is usually mediated by superinfection with bacteria, mainly Streptococcus pneumoniae. The reasons for this increased susceptibility to bacterial superinfection have not been fully elucidated. We previously demonstrated that triggering of TLR7 causes immune incompetence in mice by induction of lymphopenia. IAV is recognized by TLR7 and infections can lead to lymphopenia. Since lymphocytes are critical to protect from S. pneumoniae it has long been speculated that IAV-induced lymphopenia might mediate increased susceptibility to superinfection. Here we show that sub-lethal pre-infections of mice with IAV-PR8/A/34 strongly increased their mortality in non-lethal SP infections, surprisingly despite the absence of detectable lymphopenia. In contrast to SP-infection alone co-infected animals were unable to control the exponential growth of SP. However, lymphopenia forced by TLR7-triggering or antibody-mediated neutropenia did not increase SP-susceptibility or compromise the ability to control SP growth. Thus, the immune-incompetence caused by transient lympho or leukopenia is not sufficient to inhibit potent antibacterial responses of the host and mechanisms distinct from leukodepletion must account for increased bacterial superinfection during viral defence.	[Stegemann, Sabine; Gunzer, Matthias] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Stegemann, Sabine; Gereke, Marcus; Bruder, Dunja] Helmholtz Ctr Infect Res, Res Grp Immuneregulat, Braunschweig, Germany; [Dahlberg, Sofia; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Dahlberg, Sofia; Henriques-Normark, Birgitta] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Kroeger, Andrea] Helmholtz Ctr Infect Res, Dept Gene Regulat & Different, Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Helmholtz Association; Helmholtz-Center for Infection Research	Stegemann, S (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	Matthias.gunzer@med.ovgu.de	Stegemann-Koniszewski, Sabine/AAS-1926-2020; Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055	German Research Foundation (DFG) [SFB 587]; Deutsche Forschungsgemeinschaft; Torsten och Ragnar Soederbergs Foundation; Swedish Research Council	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Torsten och Ragnar Soederbergs Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the International Research Training Group 1273 funded by the German Research Foundation (DFG) and by grants from the Deutsche Forschungsgemeinschaft to M. Gunzer. and B.H-N, the Torsten och Ragnar Soederbergs Foundation and the Swedish Research Council to B.H-N and the DFG (SFB 587) to D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan I, 2000, J INFECTION, V40, P256, DOI 10.1053/jinf.2000.0653; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Denny P, 2003, MAMM GENOME, V14, P448, DOI 10.1007/S00335-002-2261-9; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Garcia-Sastre A, 2006, J INFECT DIS, V194, pS127, DOI 10.1086/507546; Gauthier JF, 2007, INFECT IMMUN, V75, P5361, DOI 10.1128/IAI.02008-06; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; HEIL F, 2004, SCIENCE; HESTDAL K, 1991, J IMMUNOL, V147, P22; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KAMPHUIS E, 2006, BLOOD; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Marks M, 2007, INFECT IMMUN, V75, P1586, DOI 10.1128/IAI.01579-06; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; NAVARINI AA, 2006, P NATL ACAD SCI US; Paterson GK, 2006, MICROBIOL-SGM, V152, P285, DOI 10.1099/mic.0.28551-0; Preston JA, 2004, EUR RESPIR J, V23, P224, DOI 10.1183/09031936.03.00081403; REED LJ, 1938, AM J HYG, V27; Reis e Sousa A, 2006, SCIENCE; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Speshock JL, 2007, INFECT IMMUN, V75, P3102, DOI 10.1128/IAI.01943-06; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392	45	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4840	10.1371/journal.pone.0004840	http://dx.doi.org/10.1371/journal.pone.0004840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290047	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496500001
J	Gemenetzidis, E; Bose, A; Riaz, AM; Chaplin, T; Young, BD; Ali, M; Sugden, D; Thurlow, JK; Cheong, SC; Teo, SH; Wan, H; Waseem, A; Parkinson, EK; Fortune, F; Teh, MT				Gemenetzidis, Emilios; Bose, Amrita; Riaz, Adeel M.; Chaplin, Tracy; Young, Bryan D.; Ali, Muhammad; Sugden, David; Thurlow, Johanna K.; Cheong, Sok-Ching; Teo, Soo-Hwang; Wan, Hong; Waseem, Ahmad; Parkinson, Eric K.; Fortune, Farida; Teh, Muy-Teck			FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation	PLOS ONE			English	Article							GENETIC PROGRESSION MODEL; ORAL SUBMUCOUS FIBROSIS; TRANSCRIPTION FACTOR; PLK1-DEPENDENT PHOSPHORYLATION; CLINICAL-IMPLICATIONS; FIELD CANCERIZATION; MESENCHYMAL CELLS; EPITHELIAL-CELLS; FAMILY-MEMBER; NECK-CANCER	Background: Cancer associated with smoking and drinking remains a serious health problem worldwide. The survival of patients is very poor due to the lack of effective early biomarkers. FOXM1 overexpression is linked to the majority of human cancers but its mechanism remains unclear in head and neck squamous cell carcinoma (HNSCC). Methodology/Principal Findings: FOXM1 mRNA and protein expressions were investigated in four independent cohorts (total 75 patients) consisting of normal, premalignant and HNSCC tissues and cells using quantitative PCR (qPCR), expression microarray, immunohistochemistry and immunocytochemistry. Effect of putative oral carcinogens on FOXM1 transcriptional activity was dose-dependently assayed and confirmed using a FOXM1-specific luciferase reporter system, qPCR, immunoblotting and short-hairpin RNA interference. Genome-wide single nucleotide polymorphism (SNP) array was used to 'trace' the genomic instability signature pattern in 8 clonal lines of FOXM1-induced malignant human oral keratinocytes. Furthermore, acute FOXM1 upregulation in primary oral keratinocytes directly induced genomic instability. We have shown for the first time that overexpression of FOXM1 precedes HNSCC malignancy. Screening putative carcinogens in human oral keratinocytes surprisingly showed that nicotine, which is not perceived to be a human carcinogen, directly induced FOXM1 mRNA, protein stabilisation and transcriptional activity at concentrations relevant to tobacco chewers. Importantly, nicotine also augmented FOXM1-induced transformation of human oral keratinocytes. A centrosomal protein CEP55 and a DNA helicase/putative stem cell marker HELLS, both located within a consensus loci (10q23), were found to be novel targets of FOXM1 and their expression correlated tightly with HNSCC progression. Conclusions/Significance: This study cautions the potential co-carcinogenic effect of nicotine in tobacco replacement therapies. We hypothesise that aberrant upregulation of FOXM1 may be inducing genomic instability through a program of malignant transformation involving the activation of CEP55 and HELLS which may facilitate aberrant mitosis and epigenetic modifications. Our finding that FOXM1 is upregulated early during oral cancer progression renders FOXM1 an attractive diagnostic biomarker for early cancer detection and its candidate mechanistic targets, CEP55 and HELLS, as indicators of malignant conversion and progression.	[Gemenetzidis, Emilios; Bose, Amrita; Riaz, Adeel M.; Ali, Muhammad; Wan, Hong; Waseem, Ahmad; Parkinson, Eric K.; Fortune, Farida; Teh, Muy-Teck] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Chaplin, Tracy; Young, Bryan D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Canc Res UK Med Oncol Lab, London, England; [Sugden, David] Kings Coll London, Sch Biomed & Hlth Sci, Div Reproduct & Endocrinol, London WC2R 2LS, England; [Thurlow, Johanna K.] Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Cheong, Sok-Ching; Teo, Soo-Hwang] Canc Res Initiatives Fdn CARIF, Subang Jaya Med Ctr, Outpatient Ctr 2 fl, Selangor, Malaysia	University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London; University of London; King's College London; Beatson Institute	Teh, MT (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	m.t.teh@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016; Teo, Soo-hwang/H-2353-2014	Teh, Muy-Teck/0000-0002-7725-8355; 	MRC [PhD studentship]; Institute of Dentistry; Barts and the London School of Medicine and Dentistry; Queen Mary University of London	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Dentistry; Barts and the London School of Medicine and Dentistry; Queen Mary University of London	This work was co-funded by MRC PhD studentship (E.G.) and the Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London. The sponsors had no role in the study design, data collection and analysis, interpretation of the results, the preparation of the manuscript, or the decision to submit the manuscript for publication.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Banerjee AG, 2007, MOL CELL BIOCHEM, V305, P113, DOI 10.1007/s11010-007-9534-2; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bock FG, 1980, BANBURY REPORT SAFE, P129; Braakhuis BJM, 2004, J ORAL PATHOL MED, V33, P317; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Califano J, 1996, CANCER RES, V56, P2488; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Deng H, 1997, NAT BIOTECHNOL, V15, P1388, DOI 10.1038/nbt1297-1388; EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408; Einbond LS, 2007, ANTICANCER RES, V27, P697; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gasparotto D, 1999, INT J CANCER, V84, P432, DOI 10.1002/(SICI)1097-0215(19990820)84:4<432::AID-IJC18>3.0.CO;2-#; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Hamid S, 2007, INT J MOL MED, V19, P453; Homsy W, 1997, J CLIN PHARMACOL, V37, P728, DOI 10.1002/j.1552-4604.1997.tb04360.x; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hunter KD, 2006, CANCER RES, V66, P7405, DOI 10.1158/0008-5472.CAN-06-0186; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Katoh M, 2004, INT J ONCOL, V25, P1495; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; KULKARNI PS, 1995, CARCINOGENESIS, V16, P2515, DOI 10.1093/carcin/16.10.2515; Lalli A, 2008, J ORAL PATHOL MED, V37, P211, DOI 10.1111/j.1600-0714.2007.00609.x; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2000, CANCER RES, V60, P3612; Lee HJ, 2005, J ORAL PATHOL MED, V34, P436, DOI 10.1111/j.1600-0714.2005.00342.x; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Muller A, 2007, BIOINFORMATICS, V23, P496, DOI 10.1093/bioinformatics/btl608; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ransom DT, 1996, HEAD NECK-J SCI SPEC, V18, P248; REISS M, 1985, J NATL CANCER I, V74, P1015; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; RHEINWALD JG, 1981, CANCER RES, V41, P1657; ROSOWSKY A, 1987, CANCER RES, V47, P5913; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Singh B, 2001, CANCER RES, V61, P4506; Staab CA, 2004, ATLA-ALTERN LAB ANIM, V32, P401, DOI 10.1177/026119290403200412; Takebayashi S, 2004, GENE CHROMOSOME CANC, V41, P145, DOI 10.1002/gcc.20066; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Teh MT, 2008, J ORAL PATHOL MED, V37, P430, DOI 10.1111/j.1600-0714.2008.00643.x; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker DM, 2003, PATHOLOGY, V35, P376, DOI 10.1080/00310290310001602558; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yano M, 2004, INT J CANCER, V112, P8, DOI 10.1002/ijc.20407; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	68	143	150	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4849	10.1371/journal.pone.0004849	http://dx.doi.org/10.1371/journal.pone.0004849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287496	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400010
J	Guilherme, A; Tesz, GJ; Guntur, KVP; Czech, MP				Guilherme, Adilson; Tesz, Gregory J.; Guntur, Kalyani V. P.; Czech, Michael P.			Tumor Necrosis Factor-alpha Induces Caspase-mediated Cleavage of Peroxisome Proliferator-activated Receptor gamma in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; FATTY-ACIDS; TNF-ALPHA; RXR-ALPHA; EXPRESSION; TRANSCRIPTION; ADIPOGENESIS	The nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-dependent transcription factor that acts as a primary regulator of adipogenesis and controls adipocyte metabolism and insulin action. Increased expression of tumor necrosis factor (TNF alpha) in adipose tissue of obese subjects potently suppresses the expression of PPAR gamma and attenuates adipocyte functions. Here we show that PPAR gamma is a substrate of caspase-3 and caspase-6 during TNF alpha receptor signaling in adipocytes, and the consequent PPAR gamma cleavage disrupts its nuclear localization. TNF alpha treatment of 3T3-L1 adipocytes decreases full-length PPAR gamma while increasing the level of a 45-kDa immunoreactive PPAR gamma fragment. Specific inhibitors of caspase-3 and caspase-6 attenuate the cleavage of PPAR gamma protein in response to TNF alpha in cultured adipocytes. Incubation of nuclear fractions with recombinant caspase-3 and caspase-6 also generates a 45-kDa PPAR gamma cleavage product. Dispersion of nuclear PPAR gamma to the cytoplasm in response to TNF alpha treatment occurs in parallel with detection of activated caspase-3. We suggest that activation of the caspase cascade by TNF alpha down-regulates PPAR gamma protein and PPAR gamma-mediated metabolic processes in adipose cells.	[Guilherme, Adilson; Tesz, Gregory J.; Guntur, Kalyani V. P.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			National Institutes of Health [DK30898, DK030638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R37DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30898 and DK030638 (to M. P. C.).	Akiyama TE, 2002, MOL ENDOCRINOL, V16, P707, DOI 10.1210/me.16.4.707; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Berger J, 2000, MOL CELL ENDOCRINOL, V162, P57, DOI 10.1016/S0303-7207(00)00211-2; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; FREIDENBERG GR, 1988, J CLIN INVEST, V82, P1398, DOI 10.1172/JCI113744; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He F, 2008, OBESITY, V16, P1735, DOI 10.1038/oby.2008.269; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Nisoli E, 2006, CELL DEATH DIFFER, V13, P2154, DOI 10.1038/sj.cdd.4401956; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Oakes ND, 1997, DIABETES, V46, P2022, DOI 10.2337/diabetes.46.12.2022; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Sabatino L, 2005, J BIOL CHEM, V280, P26517, DOI 10.1074/jbc.M502716200; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457	54	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17082	17091		10.1074/jbc.M809042200	http://dx.doi.org/10.1074/jbc.M809042200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19321447	Green Published, hybrid			2022-12-25	WOS:000266962400046
J	Clark, K; Plater, L; Peggie, M; Cohen, P				Clark, Kristopher; Plater, Lorna; Peggie, Mark; Cohen, Philip			Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and I kappa B Kinase epsilon A DISTINCT UPSTREAM KINASE MEDIATES SER-172 PHOSPHORYLATION AND ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-RELATED KINASE; SIGNALING PATHWAY; VIRAL-INFECTION; ANTIVIRAL IMMUNITY; ACTIVATION; PHOSPHORYLATION; INNATE; TRANSCRIPTION; BINDING; TANK	TANK-binding kinase 1 (TBK1) and I kappa B kinase epsilon (IKK epsilon) regulate the production of Type 1 interferons during bacterial and viral infection, but the lack of useful pharmacological inhibitors has hampered progress in identifying additional physiological roles of these protein kinases and how they are regulated. Here we demonstrate that BX795, a potent and relatively specific inhibitor of TBK1 and IKK epsilon, blocked the phosphorylation, nuclear translocation, and transcriptional activity of interferon regulatory factor 3 and, hence, the production of interferon-beta in macrophages stimulated with poly(I: C) or lipopolysaccharide (LPS). In contrast, BX795 had no effect on the canonical NF kappa B signaling pathway. Although BX795 blocked the autophosphorylation of overexpressed TBK1 and IKK epsilon at Ser-172 and, hence, the autoactivation of these protein kinases, it did not inhibit the phosphorylation of endogenous TBK1 and IKK epsilon at Ser-172 in response to LPS, poly(I: C), interleukin-1 alpha (IL-1 alpha), or tumor necrosis factor alpha and actually enhanced the LPS, poly(I: C), and IL-1 alpha-stimulated phosphorylation of this residue. These results demonstrate that the phosphorylation of Ser-172 and the activation of TBK1 and IKK epsilon are catalyzed by a distinct protein kinase(s) in vivo and that TBK1 and IKK epsilon control a feedback loop that limits their activation by LPS, poly(I: C) and IL-1 alpha (but not tumor necrosis factor alpha) to prevent the hyperactivation of these enzymes.	[Clark, Kristopher; Plater, Lorna; Peggie, Mark; Cohen, Philip] Univ Dundee, Sir James Black Ctr, MRC, Prot Phosphorylat Unit,Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, Sir James Black Ctr, MRC, Prot Phosphorylat Unit,Coll Life Sci, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk			United Kingdom Medical Research Council; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck-Serono; Pfizer; MRC [MC_EX_G0800765] Funding Source: UKRI; Medical Research Council [MC_EX_G0800765] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck-Serono(Merck & Company); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the United Kingdom Medical Research Council, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck- Serono, and Pfizer.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	40	269	283	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14136	14146		10.1074/jbc.M109.000414	http://dx.doi.org/10.1074/jbc.M109.000414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307177	hybrid, Green Published			2022-12-25	WOS:000266286100020
J	Chakrabarti, P; Kandror, KV				Chakrabarti, Partha; Kandror, Konstantin V.			FoxO1 Controls Insulin-dependent Adipose Triglyceride Lipase (ATGL) Expression and Lipolysis in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; METABOLISM; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; LONGEVITY; RECEPTOR; PROTEIN; FAMILY; CELLS	FoxO1 represents a central regulator of metabolism in several cell types. Although FoxO1 is abundant in adipocytes, its biological functions in these cells remain largely unknown. We show here that the promotor region of the rate-limiting lipolytic enzyme, adipose triglyceride lipase (ATGL), has two FoxO1-binding sites, and co-transfection with wild type and unphosphorylated FoxO1 mutant activates the expression of luciferase driven by the ATGL promotor. In 3T3-L1 adipocytes, insulin controls nucleo-cytoplasmic shuttling of FoxO1 and regulates its interaction with endogenous ATGL promotors. Knockdown of FoxO1 in 3T3-L1 adipocytes decreases the expression of ATGL and attenuates basal and isoproterenol-stimulated lipolysis. Infection of mouse embryonic fibroblasts with FoxO1-encoding lentivirus increases ATGL expression and renders it sensitive to regulation by insulin. Thus, FoxO1 may play an important role in the regulation of lipolysis in adipocytes by controlling the expression of ATGL.	[Chakrabarti, Partha; Kandror, Konstantin V.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K124D,715 Albany St, Boston, MA 02118 USA.	kandror@biochem.bumc.bu.edu		Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health Research [DK52057, DK56736]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK052057, R01DK056736] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Research Grants DK52057 and DK56736 (to K. V. K.). This work was also supported by a research award from the American Diabetes Association (to K. V. K.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Czech MP, 2003, P NATL ACAD SCI USA, V100, P11198, DOI 10.1073/pnas.2135308100; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; FRAZE E, 1985, J CLIN ENDOCR METAB, V61, P807, DOI 10.1210/jcem-61-5-807; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Oknianska A, 2007, BIOCHEM BIOPH RES CO, V353, P1080, DOI 10.1016/j.bbrc.2006.12.141; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Vihervaara T, 2008, J MOL BIOL, V376, P1215, DOI 10.1016/j.jmb.2007.12.042; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	153	159	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13296	13300		10.1074/jbc.C800241200	http://dx.doi.org/10.1074/jbc.C800241200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297333	Green Published, hybrid			2022-12-25	WOS:000265877300004
J	Diering, GH; Church, J; Numata, M				Diering, Graham H.; Church, John; Numata, Masayuki			Secretory Carrier Membrane Protein 2 Regulates Cell-surface Targeting of Brain-enriched Na+/H+ Exchanger NHE5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINOCEREBELLAR ATAXIA TYPE-4; INTRACELLULAR PH; MOLECULAR-CLONING; PLASMA-MEMBRANE; FUNCTIONAL EXPRESSION; MONOCLONAL-ANTIBODIES; CEREBELLAR-ATAXIA; NERVE-TERMINALS; SCAMP1 FUNCTION; SPERM MOTILITY	NHE5 is a brain-enriched Na+/H+ exchanger that dynamically shuttles between the plasma membrane and recycling endosomes, serving as a mechanism that acutely controls the local pH environment. In the current study we show that secretory carrier membrane proteins (SCAMPs), a group of tetraspanning integral membrane proteins that reside in multiple secretory and endocytic organelles, bind to NHE5 and co-localize predominantly in the recycling endosomes. In vitro protein-protein interaction assays revealed that NHE5 directly binds to the N- and C-terminal cytosolic extensions of SCAMP2. Heterologous expression of SCAMP2 but not SCAMP5 increased cell-surface abundance as well as transporter activity of NHE5 across the plasma membrane. Expression of a deletion mutant lacking the SCAMP2-specific N-terminal cytosolic domain, and a mini-gene encoding the N-terminal extension, reduced the transporter activity. Although both Arf6 and Rab11 positively regulate NHE5 cell-surface targeting and NHE5 activity across the plasma membrane, SCAMP2-mediated surface targeting of NHE5 was reversed by dominant-negative Arf6 but not by dominant-negative Rab11. Together, these results suggest that SCAMP2 regulates NHE5 transit through recycling endosomes and promotes its surface targeting in an Arf6-dependent manner.	[Diering, Graham H.; Numata, Masayuki] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Church, John] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Numata, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	mnumata@interchange.ubc.ca			Canadian Institutes of Health Research Operating Grants [MOP144919, MOP77616]; Michael Smith Foundation for Health Research ( MSFHR)	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research ( MSFHR)(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP144919 ( to M. N.) and MOP77616 ( to J. C.), and by Michael Smith Foundation for Health Research ( MSFHR) establishment grants ( to M. N.).	ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Attaphitaya S, 2001, AM J PHYSIOL-CELL PH, V281, pC1146, DOI 10.1152/ajpcell.2001.281.4.C1146; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Battaglino RA, 2008, BONE, V42, P180, DOI 10.1016/j.bone.2007.09.046; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen YH, 1998, J NEUROSCI, V18, P2982; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Flanigan K, 1996, AM J HUM GENET, V59, P392; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Hellenbroich Y, 2005, J NEUROL, V252, P1472, DOI 10.1007/s00415-005-0892-y; Hellenbroich Y, 2003, J NEUROL, V250, P668, DOI 10.1007/s00415-003-1052-x; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hubbard C, 2000, MOL BIOL CELL, V11, P2933, DOI 10.1091/mbc.11.9.2933; Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x; Jang IS, 2006, J NEUROCHEM, V99, P1224, DOI 10.1111/j.1471-4159.2006.04168.x; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lin PJC, 2007, CELL SIGNAL, V19, P978, DOI 10.1016/j.cellsig.2006.11.006; Lin PJC, 2005, J CELL SCI, V118, P1885, DOI 10.1242/jcs.02315; Liu LX, 2005, MOL BIOL CELL, V16, P4463, DOI 10.1091/mbc.E05-03-0231; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Nagaoka U, 2000, NEUROLOGY, V54, P1971, DOI 10.1212/WNL.54.10.1971; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; OTSU K, 1992, J BIOL CHEM, V267, P8089; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Porcelli AM, 2002, BBA-MOL CELL RES, V1542, P125, DOI 10.1016/S0167-4889(01)00173-2; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rocha MA, 2008, J NEUROCHEM, V106, P231, DOI 10.1111/j.1471-4159.2008.05355.x; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smith GAM, 1998, J PHYSIOL-LONDON, V512, P487, DOI 10.1111/j.1469-7793.1998.487be.x; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Trudeau LE, 1999, J NEUROPHYSIOL, V81, P2627, DOI 10.1152/jn.1999.81.6.2627; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002	77	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13892	13903		10.1074/jbc.M807055200	http://dx.doi.org/10.1074/jbc.M807055200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19276089	Green Published, hybrid			2022-12-25	WOS:000265877300065
J	Rodriguez-Escudero, I; Andres-Pons, A; Pulido, R; Molina, M; Cid, VJ				Rodriguez-Escudero, Isabel; Andres-Pons, Amparo; Pulido, Rafael; Molina, Maria; Cid, Victor J.			Phosphatidylinositol 3-Kinase-dependent Activation of Mammalian Protein Kinase B/Akt in Saccharomyces cerevisiae, an in Vivo Model for the Functional Study of Akt Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; P110-ALPHA SUBUNIT; CRYSTAL-STRUCTURE; ONCOGENIC PI3K; YEAST; SCH9; INTEGRITY; PHOSPHORYLATION; PATHWAY; COMPLEX	In animal cells, Akt (also called protein kinase B) is activated by stimuli that elevate the level of phosphatidylinositol 3,4,5-trisphosphate and is a major effector for eliciting responses that support cell growth and survival. We have shown previously that co-expression of Akt1 in budding yeast (Saccharomyces cerevisiae) along with hyperactive p110 alpha, the catalytic subunit of mammalian phosphatidylinositol 3-kinase, results in Akt1 relocalization to cellular membranes and activation. In the present study, we show that activation of all three mammalian Akt isoforms by wild-type p110 alpha causes deleterious effects on yeast cell growth. Toxicity of Akt in S. cerevisiae required its catalytic activity, its pleckstrin homology domain, and phosphorylation of its activation loop, but not phosphorylation of its hydrophobic motif. We demonstrate that expression in yeast of the only purported oncogenic allele, Akt1(E17K), leads to enhanced phenotypes. Ala-scanning mutagenesis of the VL1 region within the phosphatidylinositol 3,4,5-trisphosphate-interacting pocket of the Akt1 pleckstrin homology domain revealed that most residues in this region are essential for Akt1 activity. We found that active Akt leads to enhanced signaling through the yeast cell wall integrity pathway. This effect requires the upstream Rho1 activator Rom 2 and involves both phosphorylation of the MAPK Slt2 and expression of its transcriptional targets, thus providing a quantitative reporter system for heterologous Akt activity in vivo. Collectively, our results disclose a heterologous yeast system that allows the functional assessment in vivo of both loss-of-function and tumorigenic Akt alleles.	[Rodriguez-Escudero, Isabel; Molina, Maria; Cid, Victor J.] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Andres-Pons, Amparo; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46012, Spain	Complutense University of Madrid; Prince Felipe Research Center	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Pza Ramon & Cajan S-N, E-28040 Madrid, Spain.	vicjcid@farm.ucm.es	Molina, Maria/ABE-7186-2021; JIMENEZ CID, VICTOR/ABC-4858-2021; CID, VICTOR JIMENEZ/I-1240-2015; Rodríguez, Isabel/I-5955-2017	Molina, Maria/0000-0003-0074-3309; JIMENEZ CID, VICTOR/0000-0002-3933-2016; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Rodríguez, Isabel/0000-0002-1792-1143; Andres-Pons, Amparo/0000-0001-5801-4024; Pulido, Rafael/0000-0001-9100-248X	Ministerio Educacion y Ciencia [BIO2007-67299]; Comunidad Autonoma de Madrid [S-SAL-0246-2006, 920628]; Ministerio de Educacion y Ciencia [SAF2006-083139]; Instituto de Salud Carlos III, Spain [ISCIII-RETIC RD06/0020]; Fundacion Mutua Madrilena; Ayuntamiento de Valencia, Spain	Ministerio Educacion y Ciencia(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Ayuntamiento de Valencia, Spain	This work was supported in part by Grant BIO2007-67299 from Ministerio Educacion y Ciencia, Grant S-SAL-0246-2006 and the Programme for Universidad Complutense de Madrid Research Groups (920628) from Comunidad Autonoma de Madrid (to M. M.) and by Grant SAF2006-083139 from Ministerio de Educacion y Ciencia, Grant ISCIII-RETIC RD06/0020 from Instituto de Salud Carlos III, Spain, and Fundacion Mutua Madrilena (to R. P.). 1 Recipient of a predoctoral fellowship from Ayuntamiento de Valencia, Spain.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andres-Pons A, 2007, CANCER RES, V67, P9731, DOI 10.1158/0008-5472.CAN-07-1278; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Brodbeck D, 2001, J BIOL CHEM, V276, P29550, DOI 10.1074/jbc.M104633200; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Liu ZN, 2006, CELL CYCLE, V5, P675, DOI 10.4161/cc.5.7.2605; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pascual-Ahuir A, 2007, CELL CYCLE, V6, P2445, DOI 10.4161/cc.6.20.4792; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	53	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13373	13383		10.1074/jbc.M807867200	http://dx.doi.org/10.1074/jbc.M807867200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307184	Green Published, hybrid			2022-12-25	WOS:000265877300013
J	Yu, HT; Yu, MA; Li, CY; Zhan, YQ; Xu, WX; Li, YH; Li, W; Wang, ZD; Ge, CH; Yang, XM				Yu, Hai-Tao; Yu, Miao; Li, Chang-Yan; Zhan, Yi-Qun; Xu, Wang-Xiang; Li, Yong-Hui; Li, Wei; Wang, Zhi-Dong; Ge, Chang-Hui; Yang, Xiao-Ming			Specific Expression and Regulation of Hepassocin in the Liver and Down-regulation of the Correlation of HNF1 alpha with Decreased Levels of Hepassocin in Human Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDRODYNAMICS-BASED TRANSFECTION; ENRICHED TRANSCRIPTION FACTORS; NUCLEAR FACTOR; FACTOR-I; ALBUMIN GENE; MOUSE; DNA; REGENERATION; HEPATOCYTES; FIBRINOGEN	Hepassocin (HPS), is a liver-specific gene with mitogenic activity on isolated hepatocytes. It is up-regulated following partial hepatectomy and down-regulated frequently in heptocellular carcinoma (HCC). However, very little is known about the HPS transcription regulation mechanism. In this study, we identified HNF1 alpha (hepatocyte nuclear factor-1 alpha) as an important liver-specific cis-acting element for HPS using in vivo luciferase assays. Deletion of the HNF1 binding site not only led to a complete loss of HPS promoter activity in vivo but also abolished the induction of the HPS promoter by HNF1 alpha. An electrophoretic mobility shift assay demonstrated that HNF1 alpha interacted with the HPS gene promoter in vitro. Chromatin immunoprecipitation showed that HNF1 alpha interacted with HMGB1 and CREB-binding protein, and all of them were recruited to the HPS promoter in vivo. Moreover, HNF1 alpha expression was lower in HCC cell lines and tissues and correlated significantly with the down-regulation of HPS expression. Re-expression of HNF1 alpha in human hepatoma HepG2 cells reinduced HPS expression. In contrast, knockdown of endogenous HNF1 alpha expression by small interfering RNA resulted in a significant reduction of HPS expression. Furthermore, we found that partial hepatectomy and IL-6 significantly induced promoter activity of HPS, depending on STAT3 and HNF1 binding sites in the HPS promoter. These results demonstrate that the HNF1 binding site and HNF1 alpha are critical to liver-specific expression of HPS, and down-regulation or loss of HNF1 alpha causes, at least in part, the transcriptional down-regulation of HPS in HCC.	[Yu, Hai-Tao; Yu, Miao; Li, Chang-Yan; Zhan, Yi-Qun; Xu, Wang-Xiang; Li, Yong-Hui; Li, Wei; Wang, Zhi-Dong; Ge, Chang-Hui; Yang, Xiao-Ming] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Yu, Hai-Tao; Yu, Miao; Li, Chang-Yan; Zhan, Yi-Qun; Xu, Wang-Xiang; Li, Yong-Hui; Li, Wei; Wang, Zhi-Dong; Ge, Chang-Hui; Yang, Xiao-Ming] State Key Lab Prote, Beijing 100850, Peoples R China; [Yang, Xiao-Ming] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Academy of Military Medical Sciences - China; Tianjin University	Yang, XM (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.	xmyang2@nic.bmi.ac.cn	li, tao/B-2402-2008		Special Funds for Major State Basic Research of China [Special Funds for Major State Basic Research of China (2006CB910802]; National Program on Key Basic Research Projects [2004CB518903]	Special Funds for Major State Basic Research of China; National Program on Key Basic Research Projects(National Basic Research Program of China)	This work was partially supported by the Special Funds for Major State Basic Research of China (2006CB910802) and the National Program on Key Basic Research Projects (2004CB518903).	Andre FM, 2006, GENE THER, V13, P1619, DOI 10.1038/sj.gt.3302827; Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/jgm.574; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Bosserhoff AK, 2003, J BIOL CHEM, V278, P15225, DOI 10.1074/jbc.M212639200; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CHANG HK, 1989, MOL CELL BIOL, V9, P5189, DOI 10.1128/MCB.9.11.5189; CLAIRMONT A, 1994, CANCER RES, V54, P1319; COSTA RH, 1988, MOL CELL BIOL, V8, P81, DOI 10.1128/MCB.8.1.81; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Dohda T, 2004, J BIOCHEM, V136, P313, DOI 10.1093/jb/mvh123; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hara H, 2000, BBA-GENE STRUCT EXPR, V1492, P31, DOI 10.1016/S0167-4781(00)00056-7; Hayashi Y, 1999, J CLIN PATHOL-MOL PA, V52, P19; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Institute of Laboratory Animal Research Commission on Life Sciences National Research Council, 1996, GUID CAR US LAB AN, P21; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; TSUTSUMI K, 1989, MOL CELL BIOL, V9, P4923, DOI 10.1128/MCB.9.11.4923; van Wering HM, 2002, J BIOL CHEM, V277, P27659, DOI 10.1074/jbc.M203645200; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Yan J, 2002, CELL RES, V12, P353, DOI 10.1038/sj.cr.7290137; Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785; Yu M, 2008, NUCLEIC ACIDS RES, V36, P1209, DOI 10.1093/nar/gkm1131; Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6	34	42	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13335	13347		10.1074/jbc.M806393200	http://dx.doi.org/10.1074/jbc.M806393200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304666	hybrid, Green Published			2022-12-25	WOS:000265877300009
J	Lee, J; Wang, XF; Di Jeso, B; Arvan, P				Lee, Jaemin; Wang, Xiaofan; Di Jeso, Bruno; Arvan, Peter			The Cholinesterase-like Domain, Essential in Thyroglobulin Trafficking for Thyroid Hormone Synthesis, Is Required for Protein Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN ACETYLCHOLINESTERASE; INTERSUBUNIT DISULFIDE BONDS; MISSENSE MUTATION G2320R; ENDOPLASMIC-RETICULUM; CONGENITAL GOITER; GOITROUS HYPOTHYROIDISM; TORPEDO-CALIFORNICA; GENE; SECRETION; OLIGOMERIZATION	The carboxyl-terminal cholinesterase-like (ChEL) domain of thyroglobulin (Tg) has been identified as critically important in Tg export from the endoplasmic reticulum. In a number of human kindreds suffering from congenital hypothyroidism, and in the cog congenital goiter mouse and rdw rat dwarf models, thyroid hormone synthesis is inhibited because of mutations in the ChEL domain that block protein export from the endoplasmic reticulum. We hypothesize that Tg forms homodimers through noncovalent interactions involving two predicted alpha-helices in each ChEL domain that are homologous to the dimerization helices of acetylcholinesterase. This has been explored through selective epitope tagging of dimerization partners and by inserting an extra, unpaired Cys residue to create an opportunity for intermolecular disulfide pairing. We show that the ChEL domain is necessary and sufficient for Tg dimerization; specifically, the isolated ChEL domain can dimerize with full-length Tg or with itself. Insertion of an N-linked glycan into the putative upstream dimerization helix inhibits homodimerization of the isolated ChEL domain. However, interestingly, co-expression of upstream Tg domains, either in cis or in trans, overrides the dimerization defect of such a mutant. Thus, although the ChEL domain provides a nidus for Tg dimerization, interactions of upstream Tg regions with the ChEL domain actively stabilizes the Tg dimer complex for intracellular transport.	[Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA; [Lee, Jaemin; Arvan, Peter] Univ Michigan, Med Ctr, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA; [Di Jeso, Bruno] Univ Lecce, Ctr Ecotekne, Lab Patol Gen, Dipartimento Sci & Tecnol Biol Ambientali,Fac Sci, I-73100 Lecce, Italy	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Salento	Arvan, P (corresponding author), Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141; di jeso, bruno/0000-0001-8713-5984	National Institutes of Health [DK40344]; Ministero dell'Universita e della Ricerca [PRIN 2006069102_004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, R29DK040344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK40344 ( to P. A.). This work was also supported in part by the Ministero dell'Universita e della Ricerca PRIN 2006069102_004 (to B. D. J.).	Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; BERG G, 1980, MOL CELL ENDOCRINOL, V20, P87, DOI 10.1016/0303-7207(80)90096-9; BERG G, 1975, BIOCHIM BIOPHYS ACTA, V386, P422, DOI 10.1016/0005-2795(75)90285-8; BERG JM, 1980, J MED GENET, V17, P144, DOI 10.1136/jmg.17.2.144; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Caputo M, 2007, CLIN ENDOCRINOL, V67, P351, DOI 10.1111/j.1365-2265.2007.02889.x; Caron P, 2003, J CLIN ENDOCR METAB, V88, P3546, DOI 10.1210/jc.2002-021744; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; DIJESO B, 2004, THYROID, P77; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; GOUGH NR, 1995, J NEUROCHEM, V65, P2734; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; KEREM A, 1993, J BIOL CHEM, V268, P180; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kitanaka S, 2006, J HUM GENET, V51, P379, DOI 10.1007/s10038-006-0360-2; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Matakidou A, 2004, CARCINOGENESIS, V25, P369, DOI 10.1093/carcin/bgh027; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; MORI N, 1987, P NATL ACAD SCI USA, V84, P2813, DOI 10.1073/pnas.84.9.2813; Pardo V, 2008, THYROID, V18, P783, DOI 10.1089/thy.2007.0321; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Reddy PS, 1998, BIOESSAYS, V20, P546, DOI 10.1002/(SICI)1521-1878(199807)20:7<546::AID-BIES5>3.0.CO;2-I; Rivolta CM, 2006, CLIN CHIM ACTA, V374, P8, DOI 10.1016/j.cca.2006.05.043; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SEED RANDOLPH W., 1965, SCIENCE, V149, P1380, DOI 10.1126/science.149.3690.1380; SEED RW, 1965, J BIOL CHEM, V240, P764; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; SWILLENS S, 1986, BIOCHEM BIOPH RES CO, V137, P142, DOI 10.1016/0006-291X(86)91187-3; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; VELAN B, 1991, J BIOL CHEM, V266, P23977; Veneziani BM, 1999, BIOCHIMIE, V81, P517, DOI 10.1016/S0300-9084(99)80104-7; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	43	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12752	12761		10.1074/jbc.M806898200	http://dx.doi.org/10.1074/jbc.M806898200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276074	Green Published, hybrid			2022-12-25	WOS:000265688300020
J	Mohamed, TMA; Oceandy, D; Prehar, S; Alatwi, N; Hegab, Z; Baudoin, FM; Pickard, A; Zaki, AO; Nadif, R; Cartwright, EJ; Neyses, L				Mohamed, Tamer M. A.; Oceandy, Delvac; Prehar, Sukhpal; Alatwi, Nasser; Hegab, Zeinab; Baudoin, Florence M.; Pickard, Adam; Zaki, Aly O.; Nadif, Raja; Cartwright, Elizabeth J.; Neyses, Ludwig			Specific Role of Neuronal Nitric-oxide Synthase when Tethered to the Plasma Membrane Calcium Pump in Regulating the beta-Adrenergic Signal in the Myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES CARDIAC REPOLARIZATION; TROPONIN-I; CARDIOVASCULAR-SYSTEM; HEART-FAILURE; PHOSPHODIESTERASES; PHOSPHORYLATION; CGMP; OVEREXPRESSION; CONTRACTILITY; ACTIVATION	The cardiac neuronal nitric-oxide synthase (nNOS) has been described as a modulator of cardiac contractility. We have demonstrated previously that isoform 4b of the sarcolemmal calcium pump (PMCA4b) binds to nNOS in the heart and that this complex regulates beta-adrenergic signal transmission in vivo. Here, we investigated whether the nNOS-PMCA4b complex serves as a specific signaling modulator in the heart. PMCA4b transgenic mice (PMCA4b-TG) showed a significant reduction in nNOS and total NOS activities as well as in cGMP levels in the heart compared with their wild type (WT) littermates. In contrast, PMCA4b-TG hearts showed an elevation in cAMP levels compared with the WT. Adult cardiomyocytes isolated from PMCA4b-TG mice demonstrated a 3-fold increase in Ser(16) phospholamban (PLB) phosphorylation as well as Ser(22) and Ser(23) cardiac troponin I (cTnI) phosphorylation at base line compared with the WT. In addition, the relative induction of PLB phosphorylation and cTnI phosphorylation following isoproterenol treatment was severely reduced in PMCA4b-TG myocytes, explaining the blunted physiological response to the beta-adrenergic stimulation. In keeping with the data from the transgenic animals, neonatal rat cardiomyocytes overexpressing PMCA4b showed a significant reduction in nitric oxide and cGMP levels. This was accompanied by an increase in cAMP levels, which led to an increase in both PLB and cTnI phosphorylation at base line. Elevated cAMP levels were likely due to the modulation of cardiac phosphodiesterase, which determined the balance between cGMP and cAMP following PMCA4b overexpression. In conclusion, these results showed that the nNOS-PMCA4b complex regulates contractility via cAMP and phosphorylation of both PLB and cTnI.	[Neyses, Ludwig] Univ Manchester, Dept Cardiol, Manchester M13 9PT, Lancs, England; Cent Manchester NHS Fdn Trust, Biomed Res Ctr, Manchester M13 9PT, Lancs, England	University of Manchester	Neyses, L (corresponding author), Univ Manchester, Dept Cardiol, 1-302 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Ludwig.Neyses@cmft.nhs.uk	Oceandy, Delvac/G-9911-2015; Neyses, Ludwig/AGY-7446-2022	Oceandy, Delvac/0000-0002-6242-6491; Hegab, Zeinab/0000-0001-7381-4425; Prehar, Sukhpal/0000-0002-4334-7931; Cartwright, Elizabeth/0000-0002-6836-7795; Baudoin, Florence/0000-0002-2300-1490; pickard, adam/0000-0001-9757-143X	Medical Research Council Programme [G0500025]; British Heart Foundation Project [PG-05-082]; Manchester Biomedical Research Centre; National Institute for Health Research; MRC [G0500025] Funding Source: UKRI; Medical Research Council [G0500025] Funding Source: researchfish	Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Project(British Heart Foundation); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Programme Grant G0500025 (to L. N.) and British Heart Foundation Project Grant PG-05-082 (to D. O., E. J. C., and L. N.). This work was also supported by Manchester Biomedical Research Centre, which is funded by the National Institute for Health Research.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; CARAFOLI E, 1991, ANNU REV PHYSIOL, V53, P531, DOI 10.1146/annurev.physiol.53.1.531; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Hammes A, 1998, CIRC RES, V83, P877; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; MERY PF, 1993, J BIOL CHEM, V268, P26286; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Osadchii OE, 2007, CARDIOVASC DRUG THER, V21, P171, DOI 10.1007/s10557-007-6014-6; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tavernier B, 2001, FASEB J, V15, P294, DOI 10.1096/fj.00-0433fje; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Vandsburger MH, 2007, EUR HEART J, V28, P2792, DOI 10.1093/eurheartj/ehm241; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Xu KY, 2003, J BIOL CHEM, V278, P41798, DOI 10.1074/jbc.M306865200; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798	34	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12091	12098		10.1074/jbc.M809112200	http://dx.doi.org/10.1074/jbc.M809112200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19278978	Green Published, hybrid			2022-12-25	WOS:000265494600041
J	Jubelin, G; Chavez, CV; Taieb, F; Banfield, MJ; Samba-Louaka, A; Nobe, R; Nougayrede, JP; Zumbihl, R; Givaudan, A; Escoubas, JM; Oswald, E				Jubelin, Gregory; Chavez, Carolina Varela; Taieb, Frederic; Banfield, Mark J.; Samba-Louaka, Ascel; Nobe, Rika; Nougayrede, Jean-Philippe; Zumbihl, Robert; Givaudan, Alain; Escoubas, Jean-Michel; Oswald, Eric			Cycle Inhibiting Factors (CIFs) Are a Growing Family of Functional Cyclomodulins Present in Invertebrate and Mammal Bacterial Pathogens	PLOS ONE			English	Article							HOST-CELL-CYCLE; III SECRETION SYSTEM; PHOTORHABDUS-ASYMBIOTICA; YERSINIA EFFECTOR; PROTEIN; SYMBIOSIS; YOPJ; LUMINESCENS; RECOGNITION; ACTIVATION	The cycle inhibiting factor (Cif) produced by enteropathogenic and enterohemorrhagic Escherichia coli was the first cyclomodulin to be identified that is injected into host cells via the type III secretion machinery. Cif provokes cytopathic effects characterized by G(1) and G(2) cell cycle arrests, accumulation of the cyclin-dependent kinase inhibitors (CKIs) p21(waf1/cip1) and p27(kip1) and formation of actin stress fibres. The X-ray crystal structure of Cif revealed it to be a divergent member of a superfamily of enzymes including cysteine proteases and acetyltransferases that share a conserved catalytic triad. Here we report the discovery and characterization of four Cif homologs encoded by different pathogenic or symbiotic bacteria isolated from vertebrates or invertebrates. Cif homologs from the enterobacteria Yersinia pseudotuberculosis, Photorhabdus luminescens, Photorhabdus asymbiotica and the beta-proteobacterium Burkholderia pseudomallei all induce cytopathic effects identical to those observed with Cif from pathogenic E. coli. Although these Cif homologs are remarkably divergent in primary sequence, the catalytic triad is strictly conserved and was shown to be crucial for cell cycle arrest, cytoskeleton reorganization and CKIs accumulation. These results reveal that Cif proteins form a growing family of cyclomodulins in bacteria that interact with very distinct hosts including insects, nematodes and humans.	[Jubelin, Gregory; Taieb, Frederic; Samba-Louaka, Ascel; Nobe, Rika; Nougayrede, Jean-Philippe; Oswald, Eric] INRA, UMR1225, F-31931 Toulouse, France; [Jubelin, Gregory; Taieb, Frederic; Samba-Louaka, Ascel; Nobe, Rika; Nougayrede, Jean-Philippe; Oswald, Eric] Univ Toulouse, ENVT, UMR 1225, F-31042 Toulouse, France; [Chavez, Carolina Varela; Zumbihl, Robert; Givaudan, Alain; Escoubas, Jean-Michel] INRA, Lab EMIP, UMR 1133, Montpellier, France; [Chavez, Carolina Varela; Zumbihl, Robert; Givaudan, Alain; Escoubas, Jean-Michel] Univ Montpellier 2, Lab EMIP, UMR 1133, F-34095 Montpellier, France; [Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE; Universite de Montpellier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Jubelin, G (corresponding author), INRA, UMR1225, F-31931 Toulouse, France.	e.oswald@envt.fr	Banfield, Mark/C-7453-2013; ESCOUBAS, Jean-Michel/G-4027-2010; Nougayrede, Jean-Philippe/I-6362-2019; Samba-Louaka, Ascel/H-7073-2016	Banfield, Mark/0000-0001-8921-3835; ESCOUBAS, Jean-Michel/0000-0002-6138-1148; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; JUBELIN, Gregory/0000-0002-9902-0663; taieb, frederic/0000-0001-9612-2069; Samba-Louaka, Ascel/0000-0003-4417-6254	Agence Nationale de la Recherche [ANR-05-MIIM-009]; Biotechnology and Biological Sciences (UK) [BB/F0087321]; Royal Society (UK) [University Research Fellowship]; INRA and Languedoc-Rousillon region; BBSRC [BB/F008732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008732/1] Funding Source: researchfish	Agence Nationale de la Recherche(French National Research Agency (ANR)); Biotechnology and Biological Sciences (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society (UK)(Royal Society of London); INRA and Languedoc-Rousillon region; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant ANR-05-MIIM-009 from the Agence Nationale de la Recherche and Grant BB/F0087321 from the Biotechnology and Biological Sciences (UK, to MJB). MJB is supported by the Royal Society (UK) through the award of a University Research Fellowship. CVC is supported by a grant from INRA and Languedoc-Rousillon region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2004, INT J SYST EVOL MICR, V54, P1301, DOI 10.1099/ijs.0.03005-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Carnoy C, 2002, J BACTERIOL, V184, P4489, DOI 10.1128/JB.184.16.4489-4499.2002; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Hurst MRH, 2007, FEMS MICROBIOL LETT, V270, P42, DOI 10.1111/j.1574-6968.2007.00645.x; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; KAMBARA K, 2008, MOL MICROBIOL, DOI DOI 10.1111/J.1365-2958.2008.06507; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Marches O, 2000, INFECT IMMUN, V68, P2171, DOI 10.1128/IAI.68.4.2171-2182.2000; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Naktin J, 1999, CLIN LAB MED, V19, P523; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Nougayrede JP, 2001, INFECT IMMUN, V69, P6785, DOI 10.1128/IAI.69.11.6785-6795.2001; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schesser K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/mpat.1999.0324; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	47	47	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4855	10.1371/journal.pone.0004855	http://dx.doi.org/10.1371/journal.pone.0004855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308257	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499000002
J	Cebrian, J; Shurin, JB; Borer, ET; Cardinale, BJ; Ngai, JT; Smith, MD; Fagan, WF				Cebrian, Just; Shurin, Jonathan B.; Borer, Elizabeth T.; Cardinale, Bradley J.; Ngai, Jacqueline T.; Smith, Melinda D.; Fagan, William F.			Producer Nutritional Quality Controls Ecosystem Trophic Structure	PLOS ONE			English	Article								Trophic structure, or the distribution of biomass among producers and consumers, determines key ecosystem values, such as the abundance of infectious, harvestable or conservation target species, and the storage and cycling of carbon and nutrients. There has been much debate on what controls ecosystem trophic structure, yet the answer is still elusive. Here we show that the nutritional quality of primary producers controls the trophic structure of ecosystems. By increasing the efficiency of trophic transfer, higher producer nutritional quality results in steeper ecosystem trophic structure, and those changes are more pronounced in terrestrial than in aquatic ecosystems probably due to the more stringent nutritional limitation of terrestrial herbivores. These results explain why ecosystems composed of highly nutritional primary producers feature high consumer productivity, fast energy recycling, and reduced carbon accumulation. Anthropogenic changes in producer nutritional quality, via changes in trophic structure, may alter the values and functions of ecosystems, and those alterations may be more important in terrestrial ecosystems.	[Cebrian, Just] Univ S Alabama, Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Cebrian, Just] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL USA; [Shurin, Jonathan B.; Ngai, Jacqueline T.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Borer, Elizabeth T.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Cardinale, Bradley J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA USA; [Smith, Melinda D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Dauphin Island Sea Lab; University of South Alabama; University of South Alabama; University of British Columbia; Oregon State University; University of California System; University of California Santa Barbara; Yale University; University System of Maryland; University of Maryland College Park	Cebrian, J (corresponding author), Univ S Alabama, Dauphin Isl Sea Lab, Dauphin Isl, AL USA.	jcebrian@disl.org	Cardinale, Bradley J/I-7076-2013; Smith, Melinda D/J-8987-2014	Borer, Elizabeth/0000-0003-2259-5853	National Science Foundation; University of California; University of California at Santa Barbara	National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); University of California at Santa Barbara	This work was supported by funding provided by the National Science Foundation, the University of California, and the University of California at Santa Barbara to the NCEAS working group "Trophic Comparison Across Ecosystems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; CEBRIAN J, 1995, SCIENCE, V268, P1606, DOI 10.1126/science.268.5217.1606; Cebrian J, 2004, ECOL LETT, V7, P232, DOI 10.1111/j.1461-0248.2004.00574.x; CEBRIAN J, 1994, FUNCT ECOL, V8, P518, DOI 10.2307/2390077; DELGIORGIO PA, 1995, AM NAT, V146, P135, DOI 10.1086/285790; Duffy JE, 2006, MAR ECOL PROG SER, V311, P179, DOI 10.3354/meps311179; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; ELSER JJ, 1994, NATURE, V370, P211, DOI 10.1038/370211a0; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.2307/177061; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Marba N, 2007, P NATL ACAD SCI USA, V104, P15777, DOI 10.1073/pnas.0703476104; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; ODUM HT, 1957, ECOL MONOGR, V27, P55, DOI 10.2307/1948571; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Zar, 2011, BIOSTAT ANAL	29	106	108	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4929	10.1371/journal.pone.0004929	http://dx.doi.org/10.1371/journal.pone.0004929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300514	Green Published, gold			2022-12-25	WOS:000265496800010
J	Delgado-Eckert, E				Delgado-Eckert, Edgar			Reverse Engineering Time Discrete Finite Dynamical Systems: A Feasible Undertaking?	PLOS ONE			English	Article							NETWORKS	With the advent of high-throughput profiling methods, interest in reverse engineering the structure and dynamics of biochemical networks is high. Recently an algorithm for reverse engineering of biochemical networks was developed by Laubenbacher and Stigler. It is a top-down approach using time discrete dynamical systems. One of its key steps includes the choice of a term order, a technicality imposed by the use of Grobner-bases calculations. The aim of this paper is to identify minimal requirements on data sets to be used with this algorithm and to characterize optimal data sets. We found minimal requirements on a data set based on how many terms the functions to be reverse engineered display. Furthermore, we identified optimal data sets, which we characterized using a geometric property called "general position''. Moreover, we developed a constructive method to generate optimal data sets, provided a codimensional condition is fulfilled. In addition, we present a generalization of their algorithm that does not depend on the choice of a term order. For this method we derived a formula for the probability of finding the correct model, provided the data set used is optimal. We analyzed the asymptotic behavior of the probability formula for a growing number of variables n (i.e. interacting chemicals). Unfortunately, this formula converges to zero as fast as r(q(n)), where q is an element of N and 0<r<1. Therefore, even if an optimal data set is used and the restrictions in using term orders are overcome, the reverse engineering problem remains unfeasible, unless prodigious amounts of data are available. Such large data sets are experimentally impossible to generate with today's technologies.	[Delgado-Eckert, Edgar] Tech Univ Munich, Ctr Math Sci, D-8046 Garching, Germany; [Delgado-Eckert, Edgar] Tufts Univ, Dept Pathol, Boston, MA USA	Technical University of Munich; Tufts University	Delgado-Eckert, E (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	edgar.delgado-eckert@mytum.de	Delgado-Eckert, Edgar/AEV-0018-2022	Delgado-Eckert, Edgar/0000-0001-6415-4971	Public Health Research [RO1 AI062989]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062989] Funding Source: NIH RePORTER	Public Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Research Grant RO1 AI062989 to Dr. David Thorley-Lawson at Tufts University, Boston, MA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2006, J THEOR BIOL, V238, P317, DOI 10.1016/j.jtbi.2005.05.010; BERNARD M, 2005, P 2005 INT S SYMB AL; CABOARA M, 1997, P ISSAC 97 MAUI HAW, P404; Cox D., 1997, UNDERGRADUATE TEXTS, DOI 10.1007/978-3-662-41154-4; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dimitrova ES, 2007, ISSAC 2007: PROCEEDINGS OF THE 2007 INTERNATIONAL SYMPOSIUM ON SYMBOLIC AND ALGEBRAIC COMPUTATION, P122; DIMITROVA ES, 2005, DISCRETIZATION TIME; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gentle J. E., 2007, MATRIX ALGEBRA; Golan J.S., 2004, LINEAR ALGEBRA BEGIN; Jarrah AS, 2007, ADV APPL MATH, V39, P477, DOI 10.1016/j.aam.2006.08.004; Just W, 2006, J COMPUT BIOL, V13, P1435, DOI 10.1089/cmb.2006.13.1435; Kauffman S.A., 1993, ORIGINS ORDER; Kehrein A, 2005, ALGORITHM COMP MATH, V14, P169; Kehrein A, 2005, J PURE APPL ALGEBRA, V196, P251, DOI 10.1016/j.jpaa.2004.08.028; Krupa B, 2002, J THEOR BIOL, V219, P257, DOI 10.1006/jtbi.2002.3119; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Ljung L., 1999, SYSTEM IDENTIFICATIO; LORENZO R, 1998, GROBNER BASES APPL, P179; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; MEYBERG K, 1975, MATH GRUNDLAGEN MATH; Moller H.M., 1982, CONSTRUCTION MULTIVA, P24; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4939	10.1371/journal.pone.0004939	http://dx.doi.org/10.1371/journal.pone.0004939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295916	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000265496700011
J	Reinke, S; Karhausen, T; Doehner, W; Taylor, W; Hottenrott, K; Duda, GN; Reinke, P; Volk, HD; Anker, SD				Reinke, Simon; Karhausen, Tim; Doehner, Wolfram; Taylor, William; Hottenrott, Kuno; Duda, Georg N.; Reinke, Petra; Volk, Hans-Dieter; Anker, Stefan D.			The Influence of Recovery and Training Phases on Body Composition, Peripheral Vascular Function and Immune System of Professional Soccer Players	PLOS ONE			English	Article								Professional soccer players have a lengthy playing season, throughout which high levels of physical stress are maintained. The following recuperation period, before starting the next pre-season training phase, is generally considered short but sufficient to allow a decrease in these stress levels and therefore a reduction in the propensity for injury or musculoskeletal tissue damage. We hypothesised that these physical extremes influence the body composition, blood flow, and endothelial/immune function, but that the recuperation may be insufficient to allow a reduction of tissue stress damage. Ten professional football players were examined at the end of the playing season, at the end of the season intermission, and after the next pre-season endurance training. Peripheral blood flow and body composition were assessed using venous occlusion plethysmography and DEXA scanning respectively. In addition, selected inflammatory and immune parameters were analysed from blood samples. Following the recuperation period a significant decrease of lean body mass from 74.4 +/- 4.2 kg to 72.2 +/- 3.9 kg was observed, but an increase of fat mass from 10.3 +/- 5.6 kg to 11.1 +/- 5.4 kg, almost completely reversed the changes seen in the pre-season training phase. Remarkably, both resting and post-ischemic blood flow (7.3 +/- 3.4 and 26.0 +/- 6.3 ml/100 ml/min) respectively, were strongly reduced during the playing and training stress phases, but both parameters increased to normal levels (9.0 +/- 2.7 and 33.9 +/- 7.6 ml/100 ml/min) during the season intermission. Recovery was also characterized by rising levels of serum creatinine, granulocytes count, total IL-8, serum nitrate, ferritin, and bilirubin. These data suggest a compensated hypo-perfusion of muscle during the playing season, followed by an intramuscular ischemia/reperfusion syndrome during the recovery phase that is associated with muscle protein turnover and inflammatory endothelial reaction, as demonstrated by iNOS and HO-1 activation, as well as IL-8 release. The data provided from this study suggest that the immune system is not able to function fully during periods of high physical stress. The implications of this study are that recuperation should be carefully monitored in athletes who undergo intensive training over extended periods, but that these parameters may also prove useful for determining an individual's risk of tissue stress and possibly their susceptibility to progressive tissue damage or injury.	[Reinke, Simon; Karhausen, Tim; Doehner, Wolfram; Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, CVK, D-13353 Berlin, Germany; [Reinke, Simon; Taylor, William; Duda, Georg N.; Reinke, Petra; Volk, Hans-Dieter] Charite, BCRT, D-13353 Berlin, Germany; [Reinke, Simon; Taylor, William; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Reinke, Simon; Taylor, William; Hottenrott, Kuno; Duda, Georg N.] Charite, Ctr Musculoskelet Surg, D-13353 Berlin, Germany; Univ Halle Wittenberg, Dept Sportwissenschaft, D-4010 Halle, Germany; [Reinke, Petra] Charite, Dept Nephrol & Internal Intensive Care, CVK, D-13353 Berlin, Germany; [Volk, Hans-Dieter] Charite, Inst Med Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reinke, S (corresponding author), Charite, Dept Cardiol, Div Appl Cachexia Res, CVK, D-13353 Berlin, Germany.	simon.reinke@charite.de	volk, hans-dieter/AAV-8053-2021; Taylor, William R./F-8692-2010; Duda, Georg N/H-2085-2016	volk, hans-dieter/0000-0002-7743-6668; Taylor, William R./0000-0003-4060-4098; Duda, Georg N/0000-0001-7605-3908; Reinke, Petra/0000-0003-0771-4375; Doehner, Wolfram/0000-0001-7598-708X; Reinke, Simon/0000-0002-3451-9383	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung) [0313911]	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung - 0313911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADTKE G, 1999, LEHRBUCH SPORTMEDIZI; BERNDT G, 2004, ANTIOXIDATIVE WIRKUN; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boutcher YN, 2005, EUR J APPL PHYSIOL, V95, P83, DOI 10.1007/s00421-005-1377-5; CHEN HI, 2007, CHIN J PHYSL, V50, P149; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Doehner W, 2001, AM HEART J, V141, P792, DOI 10.1067/mhj.2001.114367; Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843; Duda GN, 2008, EXERC SPORT SCI REV, V36, P64, DOI 10.1097/JES.0b013e318168eb88; FROBOSE I, 1990, Z ORTHOP GRENZGEB, V128, P218, DOI 10.1055/s-2008-1039503; Hale T, 2008, J SPORT SCI, V26, P365, DOI 10.1080/02640410701701016; HARRE D, 1982, TRAININGSLEHRE; Hollmann W, 2001, SPORTS MED, V31, P315, DOI 10.2165/00007256-200131050-00002; HOLLMANN W, 1990, SPORTMEDIZIN ARBEITS; Ispirlidis I, 2008, CLIN J SPORT MED, V18, P423, DOI 10.1097/JSM.0b013e3181818e0b; Jugdutt Bodh I, 2002, Heart Fail Rev, V7, P391, DOI 10.1023/A:1020718619155; Kreckel V, 2004, SPORTVERLETZ SPORTSC, V18, P142, DOI 10.1055/s-2004-813149; Kroidl RF, 2007, KURSBUCH SPIROERGOME; Liesen H, 1997, SPORT IMMUNSYSTEM; Lind E, 2005, PREV MED, V40, P407, DOI 10.1016/j.ypmed.2004.07.006; LOTZERICH H, 1995, HOCHLEISTUNGSSPORT I; Malm C, 1999, J APPL PHYSIOL, V86, P461, DOI 10.1152/jappl.1999.86.2.461; NEUMANN G, 1997, SPORT MED; Niess AM, 1999, FREE RADICAL BIO MED, V26, P184, DOI 10.1016/S0891-5849(98)00192-0; Poveda JJ, 1997, EUR J CLIN INVEST, V27, P967, DOI 10.1046/j.1365-2362.1997.2220763.x; Qi WN, 2004, J APPL PHYSIOL, V97, P1323, DOI 10.1152/japplphysiol.00380.2004; SCHELLONG SM, 1998, PATHOPHYSIOLOGY KLIN, V27, P207; Scott A, 2004, BRIT J SPORT MED, V38, P372, DOI 10.1136/bjsm.2004.011312; Steinacker JM, 1998, MED SCI SPORT EXER, V30, P1158, DOI 10.1097/00005768-199807000-00022; Thomas L., 2005, LABOR DIAGNOSE; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wassermann K, 2005, PRINCIPLES EXERCISE, V4th; Wienecke E, 1998, PATIENT BUNDESLIGA	34	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4910	10.1371/journal.pone.0004910	http://dx.doi.org/10.1371/journal.pone.0004910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293937	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496600010
J	Kalantari, P; Narayan, V; Henderson, AJ; Prabhu, KS				Kalantari, Parisa; Narayan, Vivek; Henderson, Andrew J.; Prabhu, K. Sandeep			15-Deoxy-Delta(12,14)-prostaglandin J(2) inhibits HIV-1 transactivating protein, Tat, through covalent modification	FASEB JOURNAL			English	Article						alkylation; cysteine thiols; arachidonic acid metabolite; cyclopentenone prostaglandins	HUMAN-IMMUNODEFICIENCY-VIRUS; CHROMATIN-REMODELING COMPLEX; LONG TERMINAL REPEAT; METAL-LINKED DIMER; CYCLOPENTENONE PROSTAGLANDINS; KAPPA-B; TRANSCRIPTIONAL INITIATION; DNA-BINDING; PPAR-GAMMA; REPLICATION	Controlling the HIV/AIDS epidemic remains a major challenge, with approximately 5 million new HIV infections annually. Cyclopentenone prostaglandins (CyPG), such as 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)), are arachidonic acid-derived endogenous electrophiles that possess anti-HIV activity by an unknown mechanism. Given that the reactive alpha,beta-unsaturated ketone in the cyclopentenone ring of 15d-PGJ(2) covalently modifies key Cys thiols in select proteins, we hypothesized that 15d-PGJ(2) inhibits HIV transcription and replication by targeting Cys thiols in HIV-1 Tat. Tat is a potent transactivator of viral gene expression required for HIV transcriptional elongation and replication. Our studies indicate that 15d-PGJ(2) treatment of cells inhibits Tat-dependent transcription and replication of HIV-1, while 9,10-dihydro-15d-PGJ(2), PGE(2), PGF(2 alpha), or PGD(2) that lack the reactive alpha,beta-unsaturated ketone were ineffective. The inhibition of Tat activity by 15d-PGJ(2) was dose-dependent, with an IC50 of 1.2 mu M and independent of NF-kappa B pathway. Furthermore, using a biotinylated derivative of 15d-PGJ(2), we demonstrate that 15d-PGJ(2) modifies free Cys-thiols in Tat to form covalent Michael adducts and that the interaction was further increased on reduction of Tat. 15d-PGJ(2)-modified Tat was unable to transactivate the HIV long terminal repeat in U937 human macrophages. These data demonstrate that Tat acts as a molecular target of CyPG leading to the inhibition of transcription and also suggest a novel therapeutic approach to complement current antiretroviral strategies for HIV/AIDS.-Kalantari, P., Narayan, V., Henderson, A. J., Prabhu, K. S. 15-Deoxy-Delta(12,14)-prostaglandin J(2) inhibits HIV-1 transactivating protein, Tat, through covalent modification. FASEB J. 23, 2366-2373 (2009)	[Kalantari, Parisa; Narayan, Vivek; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Kalantari, Parisa; Narayan, Vivek; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med, Ctr HIV AIDS Care & Res, Boston, MA 02118 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University	Prabhu, KS (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, 115 Henning Bldg, University Pk, PA 16802 USA.	ksp4@psu.edu		PRABHU, NARAYAN/0000-0002-8359-2587; Narayan, Vivek/0000-0002-3232-7898; Henderson, Andrew/0000-0002-9299-5302	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported, in part, by Public Health Service grants from the NIH to A. J. H. and K. S. P. and an intramural seed grant from the College of Agricultural Sciences, Pennsylvania State University, to K. S. P. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: monoclonal antibody to HIV-1 Tat (NT3 2D1.1; catalog no. 4138) from Dr. Jonathan Karn; pHis-Tat from Drs. Abhay Patki and M. M. Lederman, courtesy of the UK National Institute for Biological Standards and Control (NIBSC) Centralized Facility for AIDS Reagents. We are grateful to Dr. Kalipada Pahan (Rush University, Chicago, IL, USA) for providing the iNOS promoter-Luc construct. We also thank Professor C. Channa Reddy for his invaluable suggestions.	Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; AMICI C, 1991, J GEN VIROL, V72, P1877, DOI 10.1099/0022-1317-72-8-1877; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1988, P NATL ACAD SCI USA, V85, P6297, DOI 10.1073/pnas.85.17.6297; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Hayes MM, 2002, J BIOL CHEM, V277, P16913, DOI 10.1074/jbc.M200875200; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; HUGHESFULFORD M, 1992, ANTIMICROB AGENTS CH, V36, P2253, DOI 10.1128/AAC.36.10.2253; Ishihara Shunji, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P379, DOI 10.2174/1568011043352902; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kirsch T, 1996, PROTEIN EXPRES PURIF, V8, P75, DOI 10.1006/prep.1996.0076; KOKEN SEC, 1994, J BIOL CHEM, V269, P8366; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; KRETZSCHMAR M, 1992, GENE DEV, V6, P761, DOI 10.1101/gad.6.5.761; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lima RG, 2006, AIDS RES HUM RETROV, V22, P763, DOI 10.1089/aid.2006.22.763; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MASTROMARINO P, 1993, ANTIVIR RES, V20, P209, DOI 10.1016/0166-3542(93)90021-A; NABEL GJ, 1988, SCIENCE, V239, P1299, DOI 10.1126/science.2830675; Pande V, 2005, BIOORG MED CHEM LETT, V15, P4057, DOI 10.1016/j.bmcl.2005.06.025; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Patki AH, 1996, CELL IMMUNOL, V169, P40, DOI 10.1006/cimm.1996.0088; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; PICA F, 1993, ANTIVIR RES, V20, P193, DOI 10.1016/0166-3542(93)90020-J; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rozera C, 1996, J CLIN INVEST, V97, P1795, DOI 10.1172/JCI118609; SANTORO MG, 1982, J GEN VIROL, V63, P435, DOI 10.1099/0022-1317-63-2-435; SANTORO MG, 1983, PROSTAGLANDINS, V25, P353, DOI 10.1016/0090-6980(83)90038-2; SANTORO MG, 1980, SCIENCE, V209, P1032, DOI 10.1126/science.6157190; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Strandell A, 2000, HUM REPROD, V15, P14; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900	46	29	31	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2366	2373		10.1096/fj.08-124982	http://dx.doi.org/10.1096/fj.08-124982			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19299483	Green Published			2022-12-25	WOS:000268836700005
J	Pless, SA; Lynch, JW				Pless, Stephan A.; Lynch, Joseph W.			Ligand-specific Conformational Changes in the alpha 1 Glycine Receptor Ligand-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; CYS-LOOP RECEPTORS; GABA(A) RECEPTOR; CRYSTAL-STRUCTURE; AGONIST-BINDING; EXTRACELLULAR DOMAIN; STRYCHNINE BINDING; CHARGED RESIDUES; F-LOOP	Understanding the activation mechanism of Cys loop ion channel receptors is key to understanding their physiological and pharmacological properties under normal and pathological conditions. The ligand-binding domains of these receptors comprise inner and outer beta-sheets and structural studies indicate that channel opening is accompanied by conformational rearrangements in both beta-sheets. In an attempt to resolve ligand-dependent movements in the ligand-binding domain, we employed voltage-clamp fluorometry on alpha 1 glycine receptors to compare changes mediated by the agonist, glycine, and by the antagonist, strychnine. Voltage-clamp fluorometry involves labeling introduced cysteines with environmentally sensitive fluorophores and inferring structural rearrangements from ligand-induced fluorescence changes. In the inner beta-sheet, we labeled residues in loop 2 and in binding domain loops D and E. At each position, strychnine and glycine induced distinct maximal fluorescence responses. The pre-M1 domain responded similarly; at each of four labeled positions glycine produced a strong fluorescence signal, whereas strychnine did not. This suggests that glycine induces conformational changes in the inner beta-sheet and pre-M1 domain that may be important for activation, desensitization, or both. In contrast, most labeled residues in loops C and F yielded fluorescence changes identical in magnitude for glycine and strychnine. A notable exception was H201C in loop C. This labeled residue responded differently to glycine and strychnine, thus underlining the importance of loop C in ligand discrimination. These results provide an important step toward mapping the domains crucial for ligand discrimination in the ligand-binding domain of glycine receptors and possibly other Cys loop receptors.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	Australian Research Council; National Health and Medical Research Council of Australia; University of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by an International Postgraduate Research Scholarship from the University of Queensland.; Supported by a National Health and Medical Research Council of Australia Senior Research Fellowship.	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; BARNARD EA, 1992, TRENDS BIOCHEM SCI, V17, P368, DOI 10.1016/0968-0004(92)90002-Q; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2004, BIOCHEM SOC T, V32, P540, DOI 10.1042/BST0320540; Kash TL, 2004, NEUROSCI LETT, V371, P230, DOI 10.1016/j.neulet.2004.09.002; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Khatri A, 2009, BIOPHYS J, V96, P45, DOI 10.1016/j.bpj.2008.09.011; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Le Novere N, 2001, PHILOS T R SOC B, V356, P1121; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; Padgett CL, 2008, J BIOL CHEM, V283, P2702, DOI 10.1074/jbc.M705699200; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Virkki LV, 2006, J BIOL CHEM, V281, P28837, DOI 10.1074/jbc.M603861200; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YOUNG AB, 1974, P NATL ACAD SCI USA, V71, P4002, DOI 10.1073/pnas.71.10.4002; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Zhang JL, 2009, J PHYSIOL-LONDON, V587, P139, DOI 10.1113/jphysiol.2008.160093	55	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15847	15856		10.1074/jbc.M809343200	http://dx.doi.org/10.1074/jbc.M809343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19286654	Green Published, hybrid			2022-12-25	WOS:000266501000053
J	Yuan, W; Xie, JW; Long, CZ; Erdjument-Bromage, H; Ding, XJ; Zheng, Y; Tempst, P; Chen, S; Zhu, B; Reinberg, D				Yuan, Wen; Xie, Jingwei; Long, Chengzu; Erdjument-Bromage, Hediye; Ding, Xiaojun; Zheng, Yong; Tempst, Paul; Chen, She; Zhu, Bing; Reinberg, Danny			Heterogeneous Nuclear Ribonucleoprotein L Is a Subunit of Human KMT3a/Set2 Complex Required for H3 Lys-36 Trimethylation Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE H3; HNRNP-L; GENE-EXPRESSION; TRANSCRIPTIONAL ELONGATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; H3K36 METHYLATION; MESSENGER-RNAS; SET2	The presence of histone H3 lysine 36 methylation (H3K36me) correlates with actively transcribed genes. In yeast, histone H3K36me mediated by KMT3 (also known as Set2) recruits a histone deacetylase complex, Rpd3s, to ensure the fidelity of transcription initiation. We report the purification of human KMT3a (also known as HYPB or hSet2) complex and the identification of a novel, higher eukaryotic specific subunit, heterogeneous nuclear ribonucleoprotein L (HnRNP-L). Interestingly, although KMT3a has intrinsic activity in vitro, HnRNP-L is essential in vivo. Moreover, KMT3a generates mono-, di-, and trimethylated products in vitro, but RNA interference against KMT3a or HnRNP-L down-regulates exclusively the H3K36me3 mark in vivo.	[Yuan, Wen; Xie, Jingwei; Long, Chengzu; Ding, Xiaojun; Zheng, Yong; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yuan, Wen] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xie, Jingwei] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Xie, Jingwei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Zheng, Yong; Zhu, Bing; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA	National Institute of Biological Sciences, Beijing; China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; New York University	Zhu, B (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhong Guan Cun Life Sci Pk, Beijing 102206, Peoples R China.	zhubing@nibs.ac.cn; reinbd01@med.nyu.edu	xie, jing/GRY-1689-2022	Erdjument-Bromage, Hediye/0000-0003-0224-3594; Reinberg, Danny/0000-0003-4288-2016; Tempst, Paul/0000-0002-6680-3987; yuan, wen/0000-0003-0029-2544	National Institutes of Health [GM37120]; NCI [P30 CA08748]; Howard Hughes Medical Institute; Chinese Ministry of Science and Technology [2007AA02Z1A6]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037120, R37GM037120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM37120. This work was also supported by the NCI Cancer Center Support Grant P30 CA08748 (to P. T.), by the Howard Hughes Medical Institute (to D. R.), and by the Chinese Ministry of Science and Technology 863 Project 2007AA02Z1A6 (to B. Z.).	Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Konarska MM, 2005, GENE DEV, V19, P2255, DOI 10.1101/gad.1363105; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	47	72	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15701	15707		10.1074/jbc.M808431200	http://dx.doi.org/10.1074/jbc.M808431200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19332550	Green Published, hybrid			2022-12-25	WOS:000266501000039
J	Manolopoulou, M; Guo, Q; Malito, E; Schilling, AB; Tang, WJ				Manolopoulou, Marika; Guo, Qing; Malito, Enrico; Schilling, Alexander B.; Tang, Wei-Jen			Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-CAPTURE DISSOCIATION; AMYLOID-BETA PEPTIDE; MACROMOLECULAR STRUCTURES; SUBSTRATE RECOGNITION; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; DISULFIDE BONDS; ALPHA-HELIX; IN-VIVO; RECEPTOR	Insulin is a hormone vital for glucose homeostasis, and insulin-degrading enzyme( (IDE) plays a key role in its clearance. IDE exhibits a remarkable specificity to degrade insulin without breaking the disulfide bonds that hold the insulin A and B chains together. Using Fourier transform ion cyclotron resonance (FTICR) mass spectrometry to obtain high mass accuracy, and electron capture dissociation (ECD) to selectively break the disulfide bonds in gas phase fragmentation, we determined the cleavage sites and composition of human insulin fragments generated by human IDE. Our time-dependent analysis of IDE-digested insulin fragments reveals that IDE is highly processive in its initial cleavage at the middle of both the insulin A and B chains. This ensures that IDE effectively splits insulin into inactive N- and C-terminal halves without breaking the disulfide bonds. To understand the molecular basis of the recognition and unfolding of insulin by IDE, we determined a 2.6- angstrom resolution insulin-bound IDE structure. Our structure reveals that IDE forms an enclosed catalytic chamber that completely engulfs and intimately interacts with a partially unfolded insulin molecule. This structure also highlights how the unique size, shape, charge distribution, and exosite of the IDE catalytic chamber contribute to its high affinity (similar to 100 nM) for insulin. In addition, this structure shows how IDE utilizes the interaction of its exosite with the N terminus of the insulin A chain as well as other properties of the catalytic chamber to guide the unfolding of insulin and allowing for the processive cleavages.	[Manolopoulou, Marika; Guo, Qing; Malito, Enrico; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Schilling, Alexander B.] Univ Illinois, Prote & Informat Serv Facil, Chicago, IL 60612 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM81539]; American Health Assistance Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM81539 (to W.- J. T.). This work was also supported by the American Health Assistance Foundation (to E. M.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; DAVIES JG, 1988, BIOCHEM J, V249, P209, DOI 10.1042/bj2490209; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DUCKWORTH WC, 1988, J BIOL CHEM, V263, P1826; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FRANK BH, 1983, J CHROMATOGR, V266, P239, DOI 10.1016/S0021-9673(01)90897-0; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Grasso G, 2007, J MASS SPECTROM, V42, P1590, DOI 10.1002/jms.1348; HAMLIN JL, 1974, J BIOL CHEM, V249, P21; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page JS, 2004, CURR OPIN BIOTECH, V15, P3, DOI 10.1016/j.copbio.2004.01.002; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; Uggerud E, 2004, INT J MASS SPECTROM, V234, P45, DOI 10.1016/j.ijms.2004.01.020; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wefing S, 2006, ANAL CHEM, V78, P1235, DOI 10.1021/ac051634x; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Zubarev RA, 1999, J AM CHEM SOC, V121, P2857, DOI 10.1021/ja981948k; Zubarev RA, 2004, CURR OPIN BIOTECH, V15, P12, DOI 10.1016/j.copbio.2003.12.002; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	50	60	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14177	14188		10.1074/jbc.M900068200	http://dx.doi.org/10.1074/jbc.M900068200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321446	Green Published, hybrid			2022-12-25	WOS:000266286100024
J	Warren, CM; Kobayashi, T; Solaro, RJ				Warren, Chad M.; Kobayashi, Tomoyoshi; Solaro, R. John			Sites of Intra- and Intermolecular Cross-linking of the N-terminal Extension of Troponin I in Human Cardiac Whole Troponin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED RABBIT HEART; MASS-SPECTROMETRY; PHOSPHORYLATION; EXPRESSION; RELAXATION; ADRENALINE; ACTIVATION; DEPENDENCE; PROTEINS; BINDING	Our previous studies (Howarth, J.W., Meller, J., Solaro, R.J., Trewhella, J., and Rosevear, P. R. (2007) J. Mol. Biol. 373, 706-722) of the unique N-terminal region of human cardiac troponin I (hcTnI), predicted a possible intramolecular interaction near the basic inhibitory peptide. To explore this possibility, we generated single cysteine mutants (hcTnI-S5C and hcTnI-I19C), which were labeled with the hetero-bifunctional crosslinker benzophenone-4-maleimide. The labeled hcTnI was reconstituted to whole troponin and exposed to UV light to form cross-linked proteins. Reversed-phase high-performance liquid chromatography and SDS-PAGE indicated intra- and intermolecular cross-linking with hcTnC and hcTnT. Moreover, using tandem mass spectrometry and Edman sequencing, specific intramolecular sites of interaction were determined at position Met-154 (I19C mutant) and Met-155 (S5C mutant) of hcTnI and intermolecular interactions at positions Met-47 and Met-80 of hcTnC in all conditions. Even though specific intermolecular cross-linked sites did not differ, the relative abundance of cross-linking was altered. We also measured the Ca2+-dependent ATPase rate of reconstituted thin filament-myosin-S1 preparation regulated by either cross-linked or non-labeled troponin. Ca2+ regulation of the ATPase rate was lost when the Cys-5 hcTnI mutant was cross-linked in the absence of Ca2+, but only partially inhibited with Cys-19 cross-linking in either the presence or absence of Ca2+. This result indicates different functional effects of cross-linking to Met-154 and Met-155, which are located on different sides of the hcTnI switch peptide. Our data provide novel evidence identifying interactions of the hcTnI-N terminus with specific intra- and intermolecular sites.	Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Warren, CM (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys MC 901, 835 S Wolcott Ave, Chicago, IL 60612 USA.	cmwarren@uic.edu			National Institutes of Health [PO1 HL 62426, RO1 HL 82923]; The Searle Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Searle Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 62426 (Project 1) (to R.J.S.) and RO1 HL 82923 (to T. K.). Use of LTQ-FT and Voyager De Pro was provided by the CBC-UIC research Resources Center Proteomics and Informatics Services Facility, which was established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium. The ABI 4700 was used at the Proteomics Core Facility at the University of Chicago.	Arteaga GM, 2000, J PHYSIOL-LONDON, V526, P541, DOI 10.1111/j.1469-7793.2000.t01-1-00541.x; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Leszyk J, 1998, J MUSCLE RES CELL M, V19, P479, DOI 10.1023/A:1005352324741; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; MOIR AJG, 1980, BIOCHEM J, V185, P505, DOI 10.1042/bj1850505; Parker L, 2008, J MASS SPECTROM, V43, P518, DOI 10.1002/jms.1342; Rarick HM, 1996, J BIOL CHEM, V271, P27039, DOI 10.1074/jbc.271.43.27039; RAY KP, 1976, FEBS LETT, V70, P11, DOI 10.1016/0014-5793(76)80716-8; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; WANG ZY, 1990, J BIOL CHEM, V265, P4953; Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi036128l; Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Westfall MV, 2007, J MOL CELL CARDIOL, V43, P107, DOI 10.1016/j.yjmcc.2007.05.017; Wolska BM, 2001, J PHYSIOL-LONDON, V536, P863, DOI 10.1111/j.1469-7793.2001.00863.x; Yu ET, 2008, J PROTEOME RES, V7, P4848, DOI 10.1021/pr800443f; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008	30	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14258	14266		10.1074/jbc.M807621200	http://dx.doi.org/10.1074/jbc.M807621200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321456	Green Published, hybrid			2022-12-25	WOS:000266286100032
J	Laursen, M; Bublitz, M; Moncoq, K; Olesen, C; Moller, JV; Young, HS; Nissen, P; Morth, JP				Laursen, Mette; Bublitz, Maike; Moncoq, Karine; Olesen, Claus; Moller, Jesper Vuust; Young, Howard S.; Nissen, Poul; Morth, J. Preben			Cyclopiazonic Acid Is Complexed to a Divalent Metal Ion When Bound to the Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SEGMENT M1; CRYSTAL-STRUCTURE; CALCIUM-PUMP; ATP-BINDING; K+-ATPASE; INHIBITION; TRANSPORT; DOMAIN; THAPSIGARGIN; CA-2+-ATPASE	We have determined the structure of the sarco(endo) plasmic reticulum Ca2+-ATPase (SERCA) in an E2.P-i-like form stabilized as a complex with MgF42-, an ATP analog, adenosine 5'-(beta,gamma-methylene) triphosphate (AMPPCP), and cyclopiazonic acid (CPA). The structure determined at 2.5 angstrom resolution leads to a significantly revised model of CPA binding when compared with earlier reports. It shows that a divalent metal ion is required for CPA binding through coordination of the tetramic acid moiety at a characteristic kink of the M1 helix found in all P-type ATPase structures, which is expected to be part of the cytoplasmic cation access pathway. Our model is consistent with the biochemical data on CPA function and provides new measures in structure-based drug design targeting Ca2+-ATPases, e. g. from pathogens. We also present an extended structural basis of ATP modulation pinpointing key residues at or near the ATP binding site. A structural comparison to the Na+, K+-ATPase reveals that the Phe(93) side chain occupies the equivalent binding pocket of the CPA site in SERCA, suggesting an important role of this residue in stabilization of the potassium-occluded E2 state of Na+, K+-ATPase.	[Laursen, Mette; Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul; Morth, J. Preben] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Laursen, Mette; Bublitz, Maike; Nissen, Poul; Morth, J. Preben] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Olesen, Claus; Moller, Jesper Vuust] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Moncoq, Karine; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Moncoq, Karine; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2H7, Canada	Danmarks Grundforskningsfond; Aarhus University; Aarhus University; University of Alberta; National Research Council Canada; University of Alberta	Morth, JP (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jpm@mb.au.dk	Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Bublitz, Maike/0000-0003-3161-418X; Olesen, Claus/0000-0002-0462-1686; Laursen, Mette/0000-0002-6265-2069; Nissen, Poul/0000-0003-0948-6628; Young, Howard/0000-0002-5990-8422	Danish National Research Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Aarhus University Research Foundation; Fabrikant Vilhelm Pedersen og hustrus legat	Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University Research Foundation; Fabrikant Vilhelm Pedersen og hustrus legat	This work was supported by a center of excellence grant from the Danish National Research Foundation and by a Hallas-Moller research stipend from the Novo Nordisk Foundation (to P. N.) and by grants from the Danish Medical Research Council, Aarhus University Research Foundation and Novo Nordisk Foundation and the "Fabrikant Vilhelm Pedersen og hustrus legat" (to J. V. M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman MC, 2003, BIOCHEMISTRY-US, V42, P3556, DOI 10.1021/bi026071n; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALLAGHER RT, 1978, MYCOPATHOLOGIA, V66, P31, DOI 10.1007/BF00683969; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; HOLZAPFE.CW, 1968, TETRAHEDRON, V24, P2101, DOI 10.1016/0040-4020(68)88113-X; Hua SM, 2005, J BIOL CHEM, V280, P17579, DOI 10.1074/jbc.M500472200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Johnson NA, 2009, ARCH BIOCHEM BIOPHYS, V481, P157, DOI 10.1016/j.abb.2008.11.010; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; LEBRUN MH, 1985, J INORG BIOCHEM, V24, P167, DOI 10.1016/0162-0134(85)85001-7; Ma HL, 1999, BIOCHEMISTRY-US, V38, P15522, DOI 10.1021/bi991523q; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; Martinez-Azorin F, 2004, FEBS LETT, V576, P73, DOI 10.1016/j.febslet.2004.08.064; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Schobert R, 2008, BIOORGAN MED CHEM, V16, P4203, DOI 10.1016/j.bmc.2008.02.069; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sobolev VS, 2005, J AOAC INT, V88, P1367; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Soler F, 1998, BIOCHEMISTRY-US, V37, P4266, DOI 10.1021/bi971455c; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; STEYN PS, 1976, PHYTOCHEMISTRY, V15, P1977, DOI 10.1016/S0031-9422(00)88860-3; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018	45	78	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13513	13518		10.1074/jbc.C900031200	http://dx.doi.org/10.1074/jbc.C900031200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289472	Green Published, hybrid			2022-12-25	WOS:000265877300028
J	Lee, IH; Campbell, CR; Song, SH; Day, ML; Kumar, S; Cook, DI; Dinudom, A				Lee, Il-Ha; Campbell, Craig R.; Song, Sung-Hee; Day, Margot L.; Kumar, Sharad; Cook, David I.; Dinudom, Anuwat			The Activity of the Epithelial Sodium Channels Is Regulated by Caveolin-1 via a Nedd4-2-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIDDLES-SYNDROME MUTATIONS; SUBUNIT MESSENGER-RNAS; LIPID RAFTS; MEMBRANE CHOLESTEROL; MEDIATED ENDOCYTOSIS; SURFACE EXPRESSION; APICAL MEMBRANE; NA+ TRANSPORT; CLATHRIN; PROTEIN	It has recently been shown that the epithelial Na+ channel (ENaC) is compartmentalized in caveolin-rich lipid rafts and that pharmacological depletion of membrane cholesterol, which disrupts lipid raft formation, decreases the activity of ENaC. Here we show, for the first time, that a signature protein of caveolae, caveolin-1 (Cav-1), down-regulates the activity and membrane surface expression of ENaC. Physical interaction between ENaC and Cav-1 was also confirmed in a coimmuno-precipitation assay. We found that the effect of Cav-1 on ENaC requires the activity of Nedd4-2, a ubiquitin protein ligase of the Nedd4 family, which is known to induce ubiquitination and internalization of ENaC. The effect of Cav-1 on ENaC requires the proline-rich motifs at the C termini of the beta- and gamma-subunits of ENaC, the binding motifs that mediate interaction with Nedd4-2. Taken together, our data suggest that Cav-1 inhibits the activity of ENaC by decreasing expression of ENaC at the cell membrane via a mechanism that involves the promotion of Nedd4-2-dependent internalization of the channel.	[Lee, Il-Ha; Campbell, Craig R.; Song, Sung-Hee; Day, Margot L.; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Discipline Physiol, Bosch Inst, Fac Med, Sydney, NSW 2006, Australia; [Kumar, Sharad] Hanson Inst, Ctr Canc Biol, Adelaide, SA 5000, Australia	University of Sydney; Centre for Cancer Biology; Hanson Institute	Dinudom, A (corresponding author), Univ Sydney, Discipline Physiol, Bosch Inst, Fac Med, Sydney, NSW 2006, Australia.	anuwat@physiol.usyd.edu.au	Kumar, Sharad/AAX-7787-2020; Campbell, Craig R/B-5983-2012	Kumar, Sharad/0000-0001-7126-9814; Campbell, Craig R/0000-0002-0843-7579; Day, Margot/0000-0002-8689-7458	National Health and Medical Research Council of Australia [508086]; Australian Research Council [DP0774320]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia Grant 508086 and Australian Research Council Grant DP0774320.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; Callera GE, 2007, CURR OPIN NEPHROL HY, V16, P90, DOI 10.1097/MNH.0b013e328040bfbd; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Farman N, 1997, AM J PHYSIOL-CELL PH, V272, pC131, DOI 10.1152/ajpcell.1997.272.1.C131; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gonzalez MI, 2007, J BIOL CHEM, V282, P29855, DOI 10.1074/jbc.M704738200; Guzzi F, 2001, BIOCHEM J, V355, P323, DOI 10.1042/0264-6021:3550323; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, KIDNEY INT, V60, P466, DOI 10.1046/j.1523-1755.2001.060002466.x; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu Jiang, 2007, Pathophysiology, V14, P171, DOI 10.1016/j.pathophys.2007.09.008; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matsushita K, 1996, AM J PHYSIOL-LUNG C, V271, pL332, DOI 10.1152/ajplung.1996.271.2.L332; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V294, pF1157, DOI 10.1152/ajprenal.00339.2007; Ramminger SJ, 2000, J PHYSIOL-LONDON, V524, P539, DOI 10.1111/j.1469-7793.2000.t01-1-00539.x; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Yuan T, 2007, CELL RES, V17, P772, DOI 10.1038/cr.2007.73; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; ZURZOLO C, 1994, EMBO J, V13, P42, DOI 10.1002/j.1460-2075.1994.tb06233.x	75	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12663	12669		10.1074/jbc.M809737200	http://dx.doi.org/10.1074/jbc.M809737200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19304660	hybrid, Green Published			2022-12-25	WOS:000265688300010
J	Sato, T; Nakashima, A; Guo, L; Tamanoi, F				Sato, Tatsuhiro; Nakashima, Akio; Guo, Lea; Tamanoi, Fuyuhiko			Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; SMALL GTPASE-RHEB; MAMMALIAN TARGET; KINASE-ACTIVITY; RAPAMYCIN COMPLEX-1; RAS PROTEINS; CELL-GROWTH; ADENYLATE-CYCLASE; BINDING PARTNER; FISSION YEAST	Rheb G-protein plays critical roles in the TSC/Rheb/mTOR signaling pathway by activating mTORC1. The activation of mTORC1 by Rheb can be faithfully reproduced in vitro by using mTORC1 immunoprecipitated by the use of anti-raptor antibody from mammalian cells starved for nutrients. The low in vitro kinase activity against 4E-BP1 of this mTORC1 preparation is dramatically increased by the addition of recombinant Rheb. On the other hand, the addition of Rheb does not activate mTORC2 immunoprecipitated from mammalian cells by the use of anti-rictor antibody. The activation of mTORC1 is specific to Rheb, because other G-proteins such as KRas, RalA/B, and Cdc42 did not activate mTORC1. Both Rheb1 and Rheb2 activate mTORC1. In addition, the activation is dependent on the presence of bound GTP. We also find that the effector domain of Rheb is required for the mTORC1 activation. FKBP38, a recently proposed mediator of Rheb action, appears not to be involved in the Rheb-dependent activation of mTORC1 in vitro, because the preparation of mTORC1 that is devoid of FKBP38 is still activated by Rheb. The addition of Rheb results in a significant increase of binding of the substrate protein 4E-BP1 to mTORC1. PRAS40, a TOR signaling (TOS) motif-containing protein that competes with the binding of 4EBP1 to mTORC1, inhibits Rheb-induced activation of mTORC1. A preparation of mTORC1 that is devoid of raptor is not activated by Rheb. Rheb does not induce autophosphorylation of mTOR. These results suggest that Rheb induces alteration in the binding of 4E-BP1 with mTORC1 to regulate mTORC1 activation.	[Sato, Tatsuhiro; Nakashima, Akio; Guo, Lea; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Inst Mol Biol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Inst Mol Biol, Jonsson Comprehens Canc Ctr, 1602 Mol Sci Bldg, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			National Institutes of Health [CA41996]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA41996.	Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; BROEK D, 1985, CELL, V41, P763, DOI 10.1016/S0092-8674(85)80057-X; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Eguchi S, 2006, GENES CELLS, V11, P757, DOI 10.1111/j.1365-2443.2006.00977.x; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GOMEZ M, 1999, TUBEROUS SELEROSIS C; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2007, J BIOL CHEM, V282, P18542, DOI 10.1074/jbc.M610736200; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Mizuki N, 1996, GENOMICS, V34, P114, DOI 10.1006/geno.1996.0248; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Narayanan V, 2003, PEDIATR NEUROL, V29, P404, DOI 10.1016/j.pediatrneurol.2003.09.002; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2008, METHOD ENZYMOL, V438, P307, DOI 10.1016/S0076-6879(07)38021-X; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang WL, 2001, MOL MICROBIOL, V41, P1339, DOI 10.1046/j.1365-2958.2001.02599.x; Yonezawa K, 2004, BIOCHEM BIOPH RES CO, V313, P437, DOI 10.1016/j.bbrc.2003.07.018; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	60	141	145	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12783	12791		10.1074/jbc.M809207200	http://dx.doi.org/10.1074/jbc.M809207200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19299511	hybrid, Green Published			2022-12-25	WOS:000265688300023
J	Wang, Y; Li, D; Nurieva, R; Yang, J; Sen, M; Carreno, R; Lu, S; McIntyre, BW; Molldrem, JJ; Legge, GB; Ma, Q				Wang, Yang; Li, Dan; Nurieva, Roza; Yang, Justin; Sen, Mehmet; Carreno, Roberto; Lu, Sijie; McIntyre, Bradley W.; Molldrem, Jeffrey J.; Legge, Glen B.; Ma, Qing			LFA-1 Affinity Regulation Is Necessary for the Activation and Proliferation of Naive T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERSUS-HOST-DISEASE; ADHESION MOLECULES; STRUCTURAL BASIS; CONFORMATIONAL REGULATION; CLINICAL-TRIALS; I-DOMAIN; ANTIGEN-1; BINDING; GENERATION; ANTIBODIES	The activation of LFA-1 (lymphocyte function-associated antigen) is a critical event for T cell co-stimulation. The mechanism of LFA-1 activation involves both affinity and avidity regulation, but the role of each in T cell activation remains unclear. We have identified antibodies that recognize and block different affinity states of the mouse LFA-1 I-domain. Monoclonal antibody 2D7 preferentially binds to the low affinity conformation, and this specific binding is abolished when LFA-1 is locked in the high affinity conformation. In contrast, M17/4 can bind both the locked high and low affinity forms of LFA-1. Although both 2D7 and M17/4 are blocking antibodies, 2D7 is significantly less potent than M17/4 in blocking LFA-1-mediated adhesion; thus, blocking high affinity LFA-1 is critical for preventing LFA-1-mediated adhesion. Using these reagents, we investigated whether LFA-1 affinity regulation affects T cell activation. We found that blocking high affinity LFA-1 prevents interleukin-2 production and T cell proliferation, demonstrated by TCR cross-linking and antigen-specific stimulation. Furthermore, there is a differential requirement of high affinity LFA-1 in the activation of CD4(+) and CD8(+) T cells. Although CD4(+) T cell activation depends on both high and low affinity LFA-1, only high affinity LFA-1 provides co-stimulation for CD8(+) T cell activation. Together, our data demonstrated that the I-domain of LFA-1 changes to the high affinity state in primary T cells, and high affinity LFA-1 is critical for facilitating T cell activation. This implicates LFA-1 activation as a novel regulatory mechanism for the modulation of T cell activation and proliferation.	[Wang, Yang; Li, Dan; Yang, Justin; Lu, Sijie; Molldrem, Jeffrey J.; Ma, Qing] Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Nurieva, Roza; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sen, Mehmet; Carreno, Roberto; Legge, Glen B.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Ma, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Unit 900,1515 Holcombe Blvd, Houston, TX 77030 USA.	qma@mdanderson.org			American Cancer Society [RSG-08-183-01-LIB]	American Cancer Society(American Cancer Society)	This work was supported by American Cancer Society Grant RSG-08-183-01-LIB (to Q.M.).	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; BLAZAR BR, 1995, BLOOD, V85, P2607, DOI 10.1182/blood.V85.9.2607.bloodjournal8592607; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carreno R, 2008, J BIOL CHEM, V283, P10642, DOI 10.1074/jbc.M704699200; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2003, ANN NY ACAD SCI, V987, P51, DOI 10.1111/j.1749-6632.2003.tb06032.x; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; Gordon KB, 2003, JAMA-J AM MED ASSOC, V290, P3073, DOI 10.1001/jama.290.23.3073; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HARNING R, 1991, TRANSPLANTATION, V52, P842, DOI 10.1097/00007890-199111000-00017; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Hynes RO, 2003, SCIENCE, V300, P755, DOI 10.1126/science.1084854; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jenkinson SR, 2005, J IMMUNOL, V174, P3401, DOI 10.4049/jimmunol.174.6.3401; JOHNSTON SC, 1990, J IMMUNOL, V145, P1181; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kootstra CJ, 1997, CLIN EXP IMMUNOL, V108, P324, DOI 10.1046/j.1365-2249.1997.3641266.x; Krogsgaard M, 2003, SEMIN IMMUNOL, V15, P307, DOI 10.1016/j.smim.2003.09.002; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Legge GB, 2002, PROTEINS, V48, P151, DOI 10.1002/prot.10134; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Scheinfeld N, 2006, EXPERT OPIN DRUG SAF, V5, P197, DOI 10.1517/14740338.5.2.197; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; VANKOOYK Y, 1994, TRANSPLANT P, V26, P401; Vorup-Jensen T, 2007, BBA-PROTEINS PROTEOM, V1774, P1148, DOI 10.1016/j.bbapap.2007.06.014; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wooten DK, 1999, J LEUKOCYTE BIOL, V65, P127, DOI 10.1002/jlb.65.1.127; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	61	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12645	12653		10.1074/jbc.M807207200	http://dx.doi.org/10.1074/jbc.M807207200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19297325	Green Published, hybrid			2022-12-25	WOS:000265688300008
J	Brodhun, F; Gobel, C; Hornung, E; Feussner, I				Brodhun, Florian; Goebel, Cornelia; Hornung, Ellen; Feussner, Ivo			Identification of PpoA from Aspergillus nidulans as a Fusion Protein of a Fatty Acid Heme Dioxygenase/Peroxidase and a Cytochrome P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS GAEUMANNOMYCES-GRAMINIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; HUMAN PROSTACYCLIN SYNTHASE; MONOXIDE-BINDING PIGMENT; ALLENE OXIDE SYNTHASE; LOWER OXYGEN-CONTENT; HYDROPEROXIDE ISOMERASE; CRYSTAL-STRUCTURE; LINOLEIC-ACID; REACTION-KINETICS	The homothallic ascomycete Aspergillus nidulans serves as model organism for filamentous fungi because of its ability to propagate with both asexual and sexual life cycles, and fatty acid-derived substances regulate the balance between both cycles. These so-called psi (precocious sexual inducer) factors are produced by psi factor-producing oxygenases (Ppo enzymes). Bioinformatic analysis predicted the presence of two different heme domains in Ppo proteins: in the N-terminal region, a fatty acid heme dioxygenase/peroxidase domain is predicted, whereas in the C-terminal region, a P450 heme thiolate domain is predicted. To analyze the reaction catalyzed by Ppo enzymes, PpoA was expressed in Escherichia coli as an active enzyme. The protein was purified by 62-fold and identified as a homotetrameric ferric heme protein that metabolizes mono-as well as polyunsaturated C-16 and C-18 fatty acids at pH similar to 7.25. The presence of thiolate-ligated heme was confirmed on the basis of sequence alignments and the appearance of a characteristic 450 nm CO-binding spectrum. Studies on its reaction mechanism revealed that PpoA uses different heme domains to catalyze two separate reactions. Within the heme peroxidase domain, linoleic acid is oxidized to (8R)-hydroperoxyoctadecadienoic acid by abstracting a H-atom from C-8 of the fatty acid, yielding a carbon-centered radical that reacts with molecular dioxygen. In the second reaction step, 8-hydroperoxyoctadecadienoic acid is isomerized within the P450 heme thiolate domain to 5,8-dihydroxyoctadecadienoic acid. We identify PpoA as a bifunctional P450 fusion protein that uses a previously unknown reaction mechanism for forming psi factors.	[Brodhun, Florian; Goebel, Cornelia; Hornung, Ellen; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany	University of Gottingen	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	German Research Foundation (IRTG 1422). [IRTG 1422]	German Research Foundation (IRTG 1422).(German Research Foundation (DFG))	This work was supported by the German Research Foundation (IRTG 1422).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BOWERS WS, 1986, SCIENCE, V232, P105, DOI 10.1126/science.232.4746.105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODOWSKY ID, 1992, BIOCHIM BIOPHYS ACTA, V1124, P59, DOI 10.1016/0005-2760(92)90126-G; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; BRODOWSKY ID, 1993, BIOCHIM BIOPHYS ACTA, V1168, P68, DOI 10.1016/0005-2760(93)90267-D; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Koshiishi I, 2006, BIOCHEM J, V395, P303, DOI 10.1042/BJ20051595; Koshiishi I, 2005, J LIPID RES, V46, P2506, DOI 10.1194/jlr.D500006-JLR200; KULMACZ RJ, 1987, PROSTAGLANDINS, V34, P225, DOI 10.1016/0090-6980(87)90246-2; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Kupfer R, 2001, BIOCHEMISTRY-US, V40, P11490, DOI 10.1021/bi010914d; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; LAU SMC, 1993, BIOCHEMISTRY-US, V32, P1945, DOI 10.1021/bi00059a010; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; MAZUR P, 1990, TETRAHEDRON LETT, V31, P3837, DOI 10.1016/S0040-4039(00)97482-3; MAZUR P, 1991, J CHEM SOC CHEM COMM, P1486, DOI 10.1039/c39910001486; OHKI S, 1979, J BIOL CHEM, V254, P829; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Sasaki M, 2005, APPL ENVIRON MICROB, V71, P8024, DOI 10.1128/AEM.71.12.8024-8030.2005; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Takajo T, 2007, J LIPID RES, V48, P1371, DOI 10.1194/jlr.M700055-JLR200; Takajo T, 2007, J LIPID RES, V48, P855, DOI 10.1194/jlr.M600446-JLR200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Yeh HC, 2005, BBA-MOL CELL BIOL L, V1738, P121, DOI 10.1016/j.bbalip.2005.11.007	55	73	78	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11792	11805		10.1074/jbc.M809152200	http://dx.doi.org/10.1074/jbc.M809152200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19286665	hybrid, Green Published			2022-12-25	WOS:000265494600011
J	Grzybek, M; Kubiak, J; Lach, A; Przybylo, M; Sikorski, AF				Grzybek, Michal; Kubiak, Jakub; Lach, Agnieszka; Przybylo, Magdalena; Sikorski, Aleksander F.			A Raft-Associated Species of Phosphatidylethanolamine Interacts with Cholesterol Comparably to Sphingomyelin. A Langmuir-Blodgett Monolayer Study	PLOS ONE			English	Article							LIPID RAFTS; DOMAIN FORMATION; QUANTITATIVE-ANALYSIS; MEMBRANE DOMAINS; MODEL MEMBRANES; RESONANCE; PROTEINS; VESICLES; DYNAMICS; LEAFLET	Background: Specific interactions between sphingomyelin (SM) and cholesterol (Ch) are commonly believed to play a key role in the formation of rafts in the biological membranes. A weakness of this model is the implication that these microdomains are confined to the outer bilayer leaflet. The cytoplasmic leaflet, which contains the bulk of phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylinositol (PI), is thought also to harbour half of the membrane cholesterol. Moreover, SLPE (1-stearoyl-2-linoleoyl-sn-glycero-3-phosphatidyl-ethanolamine) has recently been shown to be enriched in isolated detergent-resistant membranes (DRM), and this enrichment was independent of the method of isolation of DRM. Methodology/Principal Findings: Here we present quantitative evidence coming from Langmuir-Blodgett monolayer experiments that SLPE forms complex with Ch similar to that between SM and Ch. The energies of these interactions as calculated form the monolayer studies are highly negative. FRAP analysis showed that NBD-Ch recovery was similar in liposomes composed of DOPC/Ch SM or SLPE but not DPPE, providing further evidence that SLPE may form an l(o) phase in the presence of high Ch concentration. Experiments on the solubility of DOPC liposomes containing DPPE/Ch (1:1), SM/Ch (1:1) or SLPE/Ch (1:1) showed the presence of Triton X-100 insoluble floating fraction (TIFF) in the case of SM/Ch or SLPE/Ch but not in DPPE/Ch containing liposomes. Quantitative determination of particular lipid species in the TIFF fraction confirms the conclusion that SLPE (or similar PE species) could be an important constituent of the inner leaflet raft. Conclusion: Such interactions suggest a possible existence of inner-leaflet nanoscale assemblies composed of cholesterol complexes with SLPE or similar unsaturated PE species.	[Grzybek, Michal; Kubiak, Jakub; Lach, Agnieszka; Sikorski, Aleksander F.] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-50138 Wroclaw, Poland; [Przybylo, Magdalena; Sikorski, Aleksander F.] Academ Ctr Biotechnol Lipid Aggregates, Wroclaw, Poland	University of Wroclaw	Grzybek, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander F/C-3361-2009; Sikorski, Aleksander/HGD-5159-2022; Grzybek, Michal/D-3802-2017; Przybylo, Magda/Y-8014-2018	Grzybek, Michal/0000-0003-2083-0506; Sikorski, Aleksander F./0000-0003-3779-8266; Kubiak, Jakub/0000-0002-6734-9763; Przybylo, Magda/0000-0002-0216-6456; Biernatowska, Agnieszka/0000-0002-7028-8412	University of Wroclaw Research Fund	University of Wroclaw Research Fund	University of Wroclaw Research Fund. The funder had no role in study design, data collection and analysis, decision to publish or prepaartion of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chachaty C, 2005, BIOPHYS J, V88, P4032, DOI 10.1529/biophysj.104.054155; Collado MI, 2005, BIOCHEMISTRY-US, V44, P4911, DOI 10.1021/bi0474970; Coste V, 2006, BBA-BIOMEMBRANES, V1758, P460, DOI 10.1016/j.bbamem.2006.03.003; Coste V, 2006, COLLOID SURFACE A, V282, P402, DOI 10.1016/j.colsurfa.2005.12.044; COURCHAINE AJ, 1959, CLIN CHEM, V5, P609; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dynarowicz-Latka P, 2004, COLLOID SURFACE B, V37, P21, DOI 10.1016/j.colsurfb.2004.06.007; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Frazier ML, 2007, BIOPHYS J, V92, P2422, DOI 10.1529/biophysj.106.100107; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; GOODRICH F, 1985, P 2 INT C SURF ACT 8; Grzybek M, 2005, GEN PHYSIOL BIOPHYS, V24, P449; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Holopainen JM, 2004, BIOPHYS J, V86, P1510, DOI 10.1016/S0006-3495(04)74219-8; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; Li XM, 2003, BIOPHYS J, V85, P3788, DOI 10.1016/S0006-3495(03)74794-8; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; MARSH D, 1976, BIOCHEMISTRY-US, V15, P3570, DOI 10.1021/bi00661a027; McConnell H, 2006, P NATL ACAD SCI USA, V103, P1184, DOI 10.1073/pnas.0510514103; McQuaw CM, 2005, LANGMUIR, V21, P807, DOI 10.1021/la0479455; Pare C, 1998, BIOPHYS J, V74, P899, DOI 10.1016/S0006-3495(98)74013-5; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pucadyil TJ, 2007, J PHYS CHEM B, V111, P1975, DOI 10.1021/jp066092h; Quinn PJ, 2005, BBA-BIOMEMBRANES, V1713, P5, DOI 10.1016/j.bbamem.2005.04.013; Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Rog T, 2006, BIOPHYS J, V91, P3756, DOI 10.1529/biophysj.106.080887; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shaikh SR, 2006, J AM CHEM SOC, V128, P5375, DOI 10.1021/ja057949b; Shaikh SR, 2002, BIOCHEMISTRY-US, V41, P10593, DOI 10.1021/bi025712b; Shaw JE, 2006, BIOPHYS J, V90, P2170, DOI 10.1529/biophysj.105.073510; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; Sostarecz AG, 2004, J AM CHEM SOC, V126, P13882, DOI 10.1021/ja0472127; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Wang TY, 2001, BIOPHYS J, V81, P2762, DOI 10.1016/S0006-3495(01)75919-X	49	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5053	10.1371/journal.pone.0005053	http://dx.doi.org/10.1371/journal.pone.0005053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330037	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499700004
J	Heffelfinger, JD; Voetsch, AC; Nakamura, GV; Sullivan, PS; McNaghten, AD; Huang, L				Heffelfinger, James D.; Voetsch, Andrew C.; Nakamura, Glenn V.; Sullivan, Patrick S.; McNaghten, A. D.; Huang, Laurence			Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; CARINII PNEUMONIA; UNITED-STATES; DRUG-USE; ADHERENCE; PATIENT; EPIDEMIOLOGY; BIAS; AIDS	Background: Despite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis. Methodology/Principal Findings: We used 2000-2004 data from the Supplement to HIV/AIDS Surveillance (SHAS) project, a cross-sectional interview project of HIV-infected persons >= 18 years conducted in 18 states. We limited the analysis to persons who denied having prior PCP, reported having a current prescription to prevent PCP, and answered the question "In the past 30 days, how often were you able to take the PCP medication(s) exactly the way your doctor told you to take them?'' We used multivariable logistic regression to describe factors associated with nonadherence. Of 1,666 subjects prescribed PCP prophylaxis, 305 (18.3%) were nonadherent. Persons were more likely to be nonadherent if they reported using marijuana (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI] = 1.1-2.4), non-injection drugs other than marijuana (aOR = 1.5, 95% CI = 1.0-2.1), or injection drugs (aOR = 2.3, 95% CI = 1.3-4.1) in the past year; their mental health was "not good'' for >= 1 day during the past month (aOR = 1.6, 95% CI = 1.2-2.2); their most recent CD4 count was,200 cells/mu L (aOR = 1.6, 95% CI = 1.1-2.2); or taking ART usually (aOR = 9.6, 95% CI = 6.7-13.7) or sometimes/rarely/never (aOR = 18.4, 95% CI = 11.1-30.4), compared with always, as prescribed. Conclusion/Significance: Providers should inquire about and promote strategies to improve adherence to PCP prophylaxis, particularly among persons who use illicit drugs, have mental health issues, and who are not compliant with ART to reduce the occurrence of PCP.	[Heffelfinger, James D.; Voetsch, Andrew C.; Nakamura, Glenn V.; McNaghten, A. D.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Huang, Laurence] Univ Calif San Francisco, HIV AIDS Div, San Francisco, CA 94143 USA; [Huang, Laurence] Univ Calif San Francisco, Div Pulmonary & Critical Care Med, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Heffelfinger, JD (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	izh7@cdc.gov	Voetsch, Andrew/CAF-1978-2022; Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021	Huang, Laurence/0000-0003-3888-2195; Voetsch, Andrew/0000-0002-0783-1312; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institutes of Health (NIH) [K24 087713]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LH was partly funded by the National Institutes of Health (NIH) K24 087713. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Buehler JW, 1996, PUBLIC HEALTH REP, V111, P133; Carrieri MP, 2006, JAIDS-J ACQ IMM DEF, V41, P477, DOI 10.1097/01.qai.0000186364.27587.0e; *CDC, 1990, HIV AIDS SURV REP 19; *CDC, 1993, HIV AIDS SURV REP 19; Eldred LJ, 1998, J ACQ IMMUN DEF SYND, V18, P117, DOI 10.1097/00042560-199806010-00003; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466; HAYNES RB, 1980, HYPERTENSION, V2, P757, DOI 10.1161/01.HYP.2.6.757; Holmes WC, 2002, J GEN INTERN MED, V17, P677, DOI 10.1046/j.1525-1497.2002.00746.x; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kaplan JE, 1999, J ACQ IMMUN DEF SYND, V21, P228, DOI 10.1097/00126334-199907010-00008; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Lafeuillade A, 2001, INT J STD AIDS, V12, P18, DOI 10.1258/0956462011924290; Lundberg BE, 2000, AIDS, V14, P2559, DOI 10.1097/00002030-200011100-00019; Maisto SA, 2003, AM J ADDICTION, V12, pS12, DOI 10.1111/j.1521-0391.2003.tb00493.x; Martini M, 2004, EUR J EPIDEMIOL, V19, P585, DOI 10.1023/B:EJEP.0000032353.03967.ef; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Murri R, 2004, J GEN INTERN MED, V19, P1104, DOI 10.1111/j.1525-1497.2004.30248.x; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; SAMET JH, 1992, AM J MED, V92, P495, DOI 10.1016/0002-9343(92)90746-X; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; Sullivan PS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000552; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Teshale EH, 2007, CLIN INFECT DIS, V44, P879, DOI 10.1086/511862; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e5002	10.1371/journal.pone.0005002	http://dx.doi.org/10.1371/journal.pone.0005002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319199	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200019
J	Warraich, HJ; Javed, F; Faraz-Ul-Haq, M; Khawaja, FB; Saleem, S				Warraich, Haider Javed; Javed, Faisal; Faraz-ul-Haq, Mohammed; Khawaja, Fariha Batool; Saleem, Sarah			Prevalence of Obesity in School-Going Children of Karachi	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PAKISTANI POPULATION; HEALTH-STATUS; OVERWEIGHT; UNDERNUTRITION; INTERVENTIONS; ASSOCIATION; TRANSITION; WEIGHT; INDIA	Background: Obesity is an emerging problem in Pakistan. The authors sought to determine prevalence of obesity and malnutrition in school-going children, from grades 6(th) to 8(th) of different schools of Karachi and assess associations that affect the weight of the children. Methodology/Principal Findings: A cross sectional study design with children studying in grades 6(th) to 8(th) grade, in different schools of Karachi. We visited 10 schools of which 4 consented; two subsidized government schools and two private schools. A questionnaire was developed in consultation with a qualified nutritionist. Height and weight were measured on calibrated scales. A modified BMI criterion for Asian populations was used. Data was collected from 284 students. Of our sample, 52% were found to be underweight whereas 34% of all the children were normal. Of the population, 6% was obese and 8% overweight. Of all obese children, 70% belonged to the higher socio-economic status (SES) group, while of the underweight children, 63.3% were in the lower SES. Amongst obese children in our study, 65% ate meat every day, compared to 33% of normal kids. Conclusion: Obesity and undernutrition co-exist in Pakistani school-children. Our study shows that socio-economic factors are important since obesity and overweight increase with SES. Higher SES groups should be targeted for overweight while underweight is a problem of lower SES. Meat intake and lack of physical activity are some of the other factors that have been highlighted in our study.	[Warraich, Haider Javed; Javed, Faisal; Faraz-ul-Haq, Mohammed; Khawaja, Fariha Batool] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Warraich, HJ (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	haider_warrraich@hotmail.com						Aeberli I, 2007, SWISS MED WKLY, V137, P424; Ahmad K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-51; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Bharmal F Y, 2000, J Pak Med Assoc, V50, P159; Bogdanska A, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P213; Boon CS, 2005, CRIT REV FOOD SCI, V45, P511, DOI 10.1080/10408690590957160; Carvalhal MM, 2007, EUR J PUBLIC HEALTH, V17, P42, DOI 10.1093/eurpub/ckl093; Chhatwal J, 2004, ASIA PAC J CLIN NUTR, V13, P231; Dennis Barbara, 2006, J Pak Med Assoc, V56, P267; Dowda M, 2001, ARCH PEDIAT ADOL MED, V155, P711, DOI 10.1001/archpedi.155.6.711; DURKIN MS, 1994, SOC SCI MED, V38, P1289, DOI 10.1016/0277-9536(94)90192-9; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; JAFAR T, 2007, ARCH DIS CHILD; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Khor Geok Lin, 2003, Nepal Med Coll J, V5, P113; Menghetti E, 2004, Minerva Pediatr, V56, P311; Misra A, 2006, DIABETES RES CLIN PR, V71, P101, DOI 10.1016/j.diabres.2005.06.006; Nagel G, 2008, CLIN CHEM, V54, P317, DOI 10.1373/clinchem.2007.094821; Nanan D, 2001, AM J PUBLIC HEALTH, V91, P1545, DOI 10.2105/AJPH.91.10.1545; Pappas G, 2001, AM J PUBLIC HEALTH, V91, P93, DOI 10.2105/AJPH.91.1.93; Planinsec J, 2004, COLLEGIUM ANTROPOL, V28, P747; Ramachandran A, 2002, DIABETES RES CLIN PR, V57, P185, DOI 10.1016/S0168-8227(02)00056-6; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Shah SM, 2003, PEDIATR INT, V45, P49, DOI 10.1046/j.1442-200X.2003.01652.x; Sidhu S, 2005, COLLEGIUM ANTROPOL, V29, P53; Singh RB, 2007, ACTA CARDIOL, V62, P119, DOI 10.2143/AC.62.2.2020231; Verma M, 1994, Indian Pediatr, V31, P1065; Walker L, 2001, Pediatr Rev, V22, P250; *WHO GSOD PHYS ACT, 2008, OB OV	29	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4816	10.1371/journal.pone.0004816	http://dx.doi.org/10.1371/journal.pone.0004816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PI	19308262	Green Published, gold			2022-12-25	WOS:000265499000001
J	Allen, JM; Light, JE; Perotti, MA; Braig, HR; Reed, DL				Allen, Julie M.; Light, Jessica E.; Perotti, M. Alejandra; Braig, Henk R.; Reed, David L.			Mutational Meltdown in Primary Endosymbionts: Selection Limits Muller's Ratchet	PLOS ONE			English	Article							BACTERIAL ENDOSYMBIONTS; EVOLUTIONARY RELATIONSHIPS; ACCELERATED EVOLUTION; SYMBIOSIS; GENOME; LICE; PHYLOGENETICS; COSPECIATION; TOPOLOGIES; INSIGHTS	Background: Primary bacterial endosymbionts of insects (p-endosymbionts) are thought to be undergoing the process of Muller's ratchet where they accrue slightly deleterious mutations due to genetic drift in small populations with negligible recombination rates. If this process were to go unchecked over time, theory predicts mutational meltdown and eventual extinction. Although genome degradation is common among p-endosymbionts, we do not observe widespread p-endosymbiont extinction, suggesting that Muller's ratchet may be slowed or even stopped over time. For example, selection may act to slow the effects of Muller's ratchet by removing slightly deleterious mutations before they go to fixation thereby causing a decrease in nucleotide substitutions rates in older p-endosymbiont lineages. Methodology/Principal Findings: To determine whether selection is slowing the effects of Muller's ratchet, we determined the age of the Candidatus Riesia/sucking louse assemblage and analyzed the nucleotide substitution rates of several p-endosymbiont lineages that differ in the length of time that they have been associated with their insect hosts. We find that Riesia is the youngest p-endosymbiont known to date, and has been associated with its louse hosts for only 13-25 My. Further, it is the fastest evolving p-endosymbiont with substitution rates of 19-34% per 50 My. When comparing Riesia to other insect p-endosymbionts, we find that nucleotide substitution rates decrease dramatically as the age of endosymbiosis increases. Conclusions/Significance: A decrease in nucleotide substitution rates over time suggests that selection may be limiting the effects of Muller's ratchet by removing individuals with the highest mutational loads and decreasing the rate at which new mutations become fixed. This countering effect of selection could slow the overall rate of endosymbiont extinction.	[Allen, Julie M.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Light, Jessica E.; Reed, David L.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL USA; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Plant Sci Lab, Reading RG6 2AH, Berks, England; [Braig, Henk R.] Univ Wales Coll Cardiff, Sch Biol Sci, Cardiff CF1 3NS, S Glam, Wales	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Reading; Cardiff University	Allen, JM (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	juliema@ufl.edu	Braig, Henk/I-5477-2013	Braig, Henk/0000-0001-9592-1141	University of Florida [Research Opportunity SEED Fund]; National Science Foundation [DEB 0445712, DEB 0555024, DEB 0717165]; American Philosophical Society; Leverhulme Trust; NERC	University of Florida(University of Florida); National Science Foundation(National Science Foundation (NSF)); American Philosophical Society; Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants to DLR from the University of Florida Research Opportunity SEED Fund and the National Science Foundation (DEB 0445712, DEB 0555024, and DEB 0717165), and from grants to JMA from the American Philosophical Society. MAP and HRB were supported by the Leverhulme Trust and NERC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aksoy S., 1995, Insect Molecular Biology, V4, P15, DOI 10.1111/j.1365-2583.1995.tb00003.x; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; BANDI C, 1995, P ROY SOC B-BIOL SCI, V259, P293, DOI 10.1098/rspb.1995.0043; Bergstrom CT, 1998, GENETICS, V149, P2135; BRAIG HR, 2009, INSECT SYMBIOSIS, V3, P221; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BUTCHER D, 1995, GENETICS, V141, P431; Canback B, 2004, MOL BIOL EVOL, V21, P1110, DOI 10.1093/molbev/msh122; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Corsaro D, 1999, CRIT REV MICROBIOL, V25, P39, DOI 10.1080/10408419991299167; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Dedeine F, 2003, CONT T ENT, P267; Degnan PH, 2004, SYST BIOL, V53, P95, DOI 10.1080/10635150490264842; Delmotte F, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-56; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; FELSENSTEIN J, 1974, GENETICS, V78, P737; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Hurst LD, 1996, NATURE, V381, P650, DOI 10.1038/381650a0; Hypsa V, 2007, MICROB ECOL, V54, P242, DOI 10.1007/s00248-006-9194-x; Ihlen PG, 2002, BIOL J LINN SOC, V77, P535, DOI 10.1046/j.1095-8312.2002.00127.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; KONDRASHOV AS, 1994, GENETICS, V136, P1469; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI [10.2307/2409502, 10.1111/j.1558-5646.1990.tb05244.x]; Maddison WP., 2000, MACCLADE ANAL PHYLOG; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; O'Fallon B, 2008, EVOLUTION, V62, P361, DOI 10.1111/j.1558-5646.2007.00289.x; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Perotti MA, 2007, FASEB J, V21, P1058, DOI 10.1096/fj.06-6808com; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; PEROTTI MA, 2009, INSECT SYMBIOSIS, V3, P205; Poinar GO., 1992, LIFE AMBER; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reed DL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-7; Reed DL, 2002, MICROB ECOL, V44, P78, DOI 10.1007/s00248-002-0009-4; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; WALLACE B, 1987, J HERED, V78, P134, DOI 10.1093/oxfordjournals.jhered.a110345; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	69	32	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4969	10.1371/journal.pone.0004969	http://dx.doi.org/10.1371/journal.pone.0004969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305500	Green Published, Green Submitted, gold			2022-12-25	WOS:000265498800016
J	Chen, LG; Sanderson, RD				Chen, Ligong; Sanderson, Ralph D.			Heparanase Regulates Levels of Syndecan-1 in the Nucleus	PLOS ONE			English	Article								Syndecan-1 is a transmembrane heparan sulfate-bearing proteoglycan known to regulate multiple biological functions at the cell surface and within the extracellular matrix. Its functional activity can be modulated by heparanase, an enzyme that cleaves heparan sulfate chains and whose expression has been associated with an aggressive phenotype in many cancers. In addition to remodeling syndecan-1 by cleaving its heparan sulfate chains, heparanase influences syndecan-1 location by upregulating expression of enzymes that accelerate its shedding from the cell surface. In the present study we discovered that heparanase also alters the level of nuclear syndecan-1. Upon upregulation of heparanase expression or following addition of recombinant heparanase to myeloma cells, the nuclear localization of syndecan-1 drops dramatically as revealed by confocal microscopy, western blotting and quantification by ELISA. This effect requires enzymatically active heparanase because cells expressing high levels of mutated, enzymatically inactive heparanase, failed to diminish syndecan-1 levels in the nucleus. Although heparan sulfate function within the nucleus is not well understood, there is emerging evidence that it may act to repress transcriptional activity. The resulting changes in gene expression facilitated by the loss of nuclear syndecan-1 could explain how heparanase enhances expression of MMP-9, VEGF, tissue factor and perhaps other effectors that condition the tumor microenvironment to promote an aggressive cancer phenotype.	[Chen, Ligong; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Univ Alabama, Ctr Metabol Bone Dis, Birmingham, AL USA; [Sanderson, Ralph D.] Univ Alabama, Comprehensive Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	sanderson@uab.edu			NIH [CA135075, CA103054, CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA103054, R01CA135075] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by NIH grants CA135075, CA103054 (to RDS) and by CA013148 (cancer center core support grant to the UAB Comprehensive Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borset M, 2000, BLOOD, V96, P2528; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Costes V, 1999, HUM PATHOL, V30, P1405, DOI 10.1016/S0046-8177(99)90160-0; Dobra K, 2003, ANTICANCER RES, V23, P2435; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; Joshi R, 2008, J CLIN PATHOL, V61, P213, DOI 10.1136/jcp.2007.049130; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liang Y, 1997, J CELL BIOL, V139, P851, DOI 10.1083/jcb.139.4.851; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; MALI M, 1990, J BIOL CHEM, V265, P6884; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; NADIR Y, 2006, J THROMB HAEMOST; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Richardson TP, 2001, J CELL SCI, V114, P1613; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; Schubert SY, 2004, LAB INVEST, V84, P535, DOI 10.1038/labinvest.3700084; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	35	86	87	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4947	10.1371/journal.pone.0004947	http://dx.doi.org/10.1371/journal.pone.0004947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305494	Green Submitted, gold, Green Published			2022-12-25	WOS:000265498800005
J	Batiz, LF; De Blas, GA; Michaut, MA; Ramirez, AR; Rodriguez, F; Ratto, MH; Oliver, C; Tomes, CN; Rodriguez, EM; Mayorga, LS				Federico Batiz, Luis; De Blas, Gerardo A.; Michaut, Marcela A.; Ramirez, Alfredo R.; Rodriguez, Facundo; Ratto, Marcelo H.; Oliver, Cristian; Tomes, Claudia N.; Rodriguez, Esteban M.; Mayorga, Luis S.			Sperm from Hyh Mice Carrying a Point Mutation in alpha SNAP Have a Defect in Acrosome Reaction	PLOS ONE			English	Article								Hydrocephalus with hop gait (hyh) is a recessive inheritable disease that arose spontaneously in a mouse strain. A missense mutation in the Napa gene that results in the substitution of a methionine for isoleucine at position 105 (M105I) of alpha SNAP has been detected in these animals. alpha SNAP is a ubiquitous protein that plays a key role in membrane fusion and exocytosis. In this study, we found that male hyh mice with a mild phenotype produced morphologically normal and motile sperm, but had a strongly reduced fertility. When stimulated with progesterone or A23187 (a calcium ionophore), sperm from these animals had a defective acrosome reaction. It has been reported that the M105I mutation affects the expression but not the function of the protein. Consistent with an hypomorphic phenotype, the testes and epididymides of hyh mice had low amounts of the mutated protein. In contrast, sperm had aSNAP levels indistinguishable from those found in wild type cells, suggesting that the mutated protein is not fully functional for acrosomal exocytosis. Corroborating this possibility, addition of recombinant wild type aSNAP rescued exocytosis in streptolysin O-permeabilized sperm, while the mutant protein was ineffective. Moreover, addition of recombinant aSNAP. M105I inhibited acrosomal exocytosis in permeabilized human and wild type mouse sperm. We conclude that the M105I mutation affects the expression and also the function of aSNAP, and that a fully functional aSNAP is necessary for acrosomal exocytosis, a key event in fertilization.	[Federico Batiz, Luis; Oliver, Cristian; Rodriguez, Esteban M.] Univ Austral Chile, Facultad de Medicina, Inst Anat Histol Patol, Valdivia, Chile; [De Blas, Gerardo A.; Michaut, Marcela A.; Rodriguez, Facundo; Tomes, Claudia N.; Mayorga, Luis S.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol Embriol IHEM CONICET, Lab Biol Celular Mol, Mendoza, Argentina; [Ramirez, Alfredo R.; Ratto, Marcelo H.] Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Unidad Reprod, Valdivia, Chile	Universidad Austral de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Universidad Austral de Chile	Mayorga, LS (corresponding author), Univ Austral Chile, Facultad de Medicina, Inst Anat Histol Patol, Valdivia, Chile.	lmayorga@fcm.uncu.edu.ar	Ratto, Marcelo/AAV-8250-2020; Ramirez, Alfredo/AAF-8536-2020; Michaut, Marcela Alejandra/D-3725-2015	Michaut, Marcela Alejandra/0000-0002-0528-6605; Mayorga, Luis S/0000-0002-5995-0671; Batiz, Luis Federico/0000-0002-3043-8797; Ratto, Marcelo Hector/0000-0002-6072-7469; Ramirez, Alfredo/0000-0003-4782-4261	Fondecyt [1070241]; ANPCyT; CONICET (Argentina) [fellowship]; Fundacion Florencio Fiorini (Argentina); Institut Pasteur-Montevideo (Uruguay); International Brain Research Organization (IBRO, France); CONICYT (Chile) [fellowship]; Escuela de Graduados, Facultad de Ciencias, UACh; Programa de Integracion, Universidad Nacional de Cuyo, Argentina;  [DID-UACh D-2005-12]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANPCyT(ANPCyT); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini (Argentina); Institut Pasteur-Montevideo (Uruguay); International Brain Research Organization (IBRO, France); CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Escuela de Graduados, Facultad de Ciencias, UACh; Programa de Integracion, Universidad Nacional de Cuyo, Argentina; 	This work was supported by grants Fondecyt 1070241 to EMR, ANPCyT and CONICET (Argentina) to LSM, DID-UACh D-2005-12 to LFB, and Fundacion Florencio Fiorini (Argentina), Institut Pasteur-Montevideo (Uruguay), and International Brain Research Organization (IBRO, France) to GADB. The work of GADB and FR was supported by CONICET fellowships (Argentina). LFB was supported by a CONICYT fellowship (Chile) and by Escuela de Graduados, Facultad de Ciencias, UACh. MAM received support from Programa de Integracion, Universidad Nacional de Cuyo, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Batiz LF, 2006, NEUROBIOL DIS, V23, P152, DOI 10.1016/j.nbd.2006.02.009; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Diaz A, 1996, ANDROLOGIA, V28, P21; Gissen P, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050294; Green M. C., 1991, HDB GENETICALLY STAN; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kitamura K, 2003, J BIOL CHEM, V278, P44417, DOI 10.1074/jbc.M304306200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; QUINN P, 1985, FERTIL STERIL, V44, P493; Ramalho-Santos J, 2001, EXP CELL RES, V267, P45, DOI 10.1006/excr.2000.5119; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; TOMES C, 2006, MOL MECH EXOCYTOSIS, P117; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Whitten WK, 1971, ADV BIOSCI, V6, P129, DOI DOI 10.1016/B978-0-08-017571-3.50013-9; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; Yanagimachi R., 1994, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zhao LM, 2008, REPRODUCTION, V136, P323, DOI 10.1530/REP-07-0569; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	33	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4963	10.1371/journal.pone.0004963	http://dx.doi.org/10.1371/journal.pone.0004963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305511	Green Submitted, Green Published, gold			2022-12-25	WOS:000265498800011
J	Hamza, MS; Pott, S; Vega, VB; Thomsen, JS; Kandhadayar, GS; Ng, PWP; Chiu, KP; Pettersson, S; Wei, CL; Ruan, YJ; Liu, ET				Hamza, Mohamed Sabry; Pott, Sebastian; Vega, Vinsensius B.; Thomsen, Jane S.; Kandhadayar, Gopalan Srinivasan; Ng, Patrick Wei Pern; Chiu, Kuo Ping; Pettersson, Sven; Wei, Chia Lin; Ruan, Yijun; Liu, Edison T.			De-Novo Identification of PPAR gamma/RXR Binding Sites and Direct Targets during Adipogenesis	PLOS ONE			English	Article								Background: The pathophysiology of obesity and type 2 diabetes mellitus is associated with abnormalities in endocrine signaling in adipose tissue and one of the key signaling affectors operative in these disorders is the nuclear hormone transcription factor peroxisome proliferator-activated receptor-gamma (PPAR gamma). PPAR gamma has pleiotropic functions affecting a wide range of fundamental biological processes including the regulation of genes that modulate insulin sensitivity, adipocyte differentiation, inflammation and atherosclerosis. To date, only a limited number of direct targets for PPAR gamma have been identified through research using the well established pre-adipogenic cell line, 3T3-L1. In order to obtain a genome-wide view of PPAR gamma binding sites, we applied the pair end-tagging technology (ChIP-PET) to map PPAR gamma binding sites in 3T3-L1 preadipocyte cells. Methodology/Principal Findings: Coupling gene expression profile analysis with ChIP-PET, we identified in a genome-wide manner over 7700 DNA binding sites of the transcription factor PPAR gamma and its heterodimeric partner RXR during the course of adipocyte differentiation. Our validation studies prove that the identified sites are bona fide binding sites for both PPAR gamma and RXR and that they are functionally capable of driving PPAR gamma specific transcription. Our results strongly indicate that PPAR gamma is the predominant heterodimerization partner for RXR during late stages of adipocyte differentiation. Additionally, we find that PPAR gamma/RXR association is enriched within the proximity of the 59 region of the transcription start site and this association is significantly associated with transcriptional up-regulation of genes involved in fatty acid and lipid metabolism confirming the role of PPAR gamma as the master transcriptional regulator of adipogenesis. Evolutionary conservation analysis of these binding sites is greater when adjacent to up-regulated genes than down-regulated genes, suggesting the primordial function of PPAR gamma/RXR is in the induction of genes. Our functional validations resulted in identifying novel PPAR gamma direct targets that have not been previously reported to promote adipogenic differentiation. Conclusions/Significance: We have identified in a genome-wide manner the binding sites of PPAR gamma and RXR during the course of adipogenic differentiation in 3T3L1 cells, and provide an important resource for the study of PPAR gamma function in the context of adipocyte differentiation.	[Hamza, Mohamed Sabry; Pott, Sebastian; Vega, Vinsensius B.; Thomsen, Jane S.; Kandhadayar, Gopalan Srinivasan; Ng, Patrick Wei Pern; Chiu, Kuo Ping; Pettersson, Sven; Wei, Chia Lin; Ruan, Yijun; Liu, Edison T.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Pott, Sebastian; Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-10401 Stockholm, Sweden	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet	Vega, VB (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	liue@gis.a-star.edu.sg	Liu, Edison/C-4141-2008; Hamza, Sabry/B-8184-2011; Chiu, Kuo-Ping/AAG-8855-2020; Pettersson, Sven/F-9511-2015	Chiu, Kuo-Ping/0000-0001-9144-0674; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502	Singapore Agency for Science, Technology and Research (A*STAR); Karolinska Institutet	Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Karolinska Institutet(Karolinska Institutet)	This study was supported by the Singapore Agency for Science, Technology and Research (A*STAR). SP was funded by grants from Karolinska Institutet through Sven Pettersson and by an A*STAR-KI exchange scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2002, CURR OPIN CLIN NUTR, V5, P385, DOI 10.1097/00075197-200207000-00006; Balakumar P, 2007, PHARMACOLOGY, V80, P1, DOI 10.1159/000102594; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Chaldakov GN, 2003, CURR PHARM DESIGN, V9, P1023, DOI 10.2174/1381612033455152; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Dominiczak MH, 2003, CLIN CHEM LAB MED, V41, P1266, DOI 10.1515/CCLM.2003.194; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; FITZPATRICK DR, 1995, GENOMICS, V27, P457, DOI 10.1006/geno.1995.1077; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; KELLER P, 2008, J BIOL CHEM; Ko JA, 2006, J CELL SCI, V119, P5106, DOI 10.1242/jcs.03290; Krishnan A, 2007, CURR MOL MED, V7, P532, DOI 10.2174/156652407781695765; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Okuno M, 2001, BIOCHEM J, V353, P193, DOI 10.1042/0264-6021:3530193; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Popivanova BK, 2007, CANCER SCI, V98, P321, DOI 10.1111/j.1349-7006.2007.00390.x; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Takano H, 2004, CURR PHARM DESIGN, V10, P2779, DOI 10.2174/1381612043383719; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VEGA VB, 2008, INT C COMP SCI 2008; Walczak R, 2002, J LIPID RES, V43, P177; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200; 1997, J BIOL CHEM, V272, P20108	51	90	94	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4907	10.1371/journal.pone.0004907	http://dx.doi.org/10.1371/journal.pone.0004907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300518	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496800008
J	Sugiura, H; Dickinson, MH				Sugiura, Hiroki; Dickinson, Michael H.			The Generation of Forces and Moments during Visual-Evoked Steering Maneuvers in Flying Drosophila	PLOS ONE			English	Article							LEADING-EDGE VORTEX; INSECT FLIGHT; MELANOGASTER; DYNAMICS; MOTION; WINGS; AERODYNAMICS; ROTATION; BEHAVIOR; THRUST	Sideslip force, longitudinal force, rolling moment, and pitching moment generated by tethered fruit flies, Drosophila melanogaster, were measured during optomotor reactions within an electronic flight simulator. Forces and torques were acquired by optically measuring the angular deflections of the beam to which the flies were tethered using a laser and a photodiode. Our results indicate that fruit flies actively generate both sideslip and roll in response to a lateral focus of expansion (FOE). The polarity of this behavior was such that the animal's aerodynamic response would carry it away from the expanding pattern, suggesting that it constitutes an avoidance reflex or centering response. Sideslip forces and rolling moments were sinusoidal functions of FOE position, whereas longitudinal force was proportional to the absolute value of the sine of FOE position. Pitching moments remained nearly constant irrespective of stimulus position or strength, with a direction indicating a tonic nose-down pitch under tethered conditions. These experiments expand our understanding of the degrees of freedom that a fruit fly can actually control in flight.	[Sugiura, Hiroki] Japan Aerosp Explorat Agcy, Tokyo, Japan; [Dickinson, Michael H.] CALTECH, Pasadena, CA 91125 USA	Japan Aerospace Exploration Agency (JAXA); California Institute of Technology	Sugiura, H (corresponding author), Japan Aerosp Explorat Agcy, Tokyo, Japan.	sugiura.hiroki@jaxa.jp	Sikandar, Usama/F-6586-2016					Balint CN, 2004, J EXP BIOL, V207, P3813, DOI 10.1242/jeb.01229; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; BLONDEAU J, 1981, J EXP BIOL, V92, P155; BLONDEAU J, 1982, J COMP PHYSIOL, V145, P321, DOI 10.1007/BF00619336; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; DAVID CT, 1985, NATURE, V313, P48, DOI 10.1038/313048a0; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 1996, J EXP BIOL, V199, P2085; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DICKSON WB, 2006, 200634 AIAA; Duistermars BJ, 2007, J EXP BIOL, V210, P3218, DOI 10.1242/jeb.007807; FONTAINE E, 2009, J EXP BIOL IN PRESS; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Franceschini N, 2007, CURR BIOL, V17, P329, DOI 10.1016/j.cub.2006.12.032; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1987, J EXP BIOL, V128, P35; GOTZ KG, 1984, BIOL CYBERN, V51, P135, DOI 10.1007/BF00357927; HEISENBERG M, 1988, J COMP PHYSIOL A, V163, P373, DOI 10.1007/BF00604013; Hollick FSJ, 1941, PHILOS T ROY SOC B, V230, P357; HUMBERT J, 2005, 20056280 AIAA; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 2007, J EXP BIOL, V210, P1362, DOI 10.1242/jeb.02746; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; Ramamurti R, 2002, J EXP BIOL, V205, P1507; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; RISTROPH L, 2008, J EXP BIOL IN PRESS; Schenato L, 2001, IEEE INT CONF ROBOT, P1641, DOI 10.1109/ROBOT.2001.932846; Shimoyama I., 1993, IEEE Control Systems Magazine, V13, P37, DOI 10.1109/37.184791; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; STEVENS BL, 2003, AIRCRAFT CONTROL SIM, P73; Sun Y, 2005, J MICROELECTROMECH S, V14, P4, DOI 10.1109/JMEMS.2004.839028; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Tanikawa T, 2001, IEEE INT CONF ROBOT, P610, DOI 10.1109/ROBOT.2001.932617; Taylor GK, 2005, J ROY SOC INTERFACE, V2, P197, DOI 10.1098/rsif.2005.0036; Taylor GK, 2001, BIOL REV, V76, P449, DOI 10.1017/S1464793101005759; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; ZANKER JM, 1990, PHILOS T ROY SOC B, V327, P19, DOI 10.1098/rstb.1990.0041	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4883	10.1371/journal.pone.0004883	http://dx.doi.org/10.1371/journal.pone.0004883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300507	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000265496800004
J	Iwami, S; Suzuki, T; Takeuchi, Y				Iwami, Shingo; Suzuki, Takafumi; Takeuchi, Yasuhiro			Paradox of Vaccination: Is Vaccination Really Effective against Avian Flu Epidemics?	PLOS ONE			English	Article							H5N1 INFLUENZA VARIANT; DRUG-RESISTANCE; H7N7 EPIDEMIC; VIRUS; EMERGENCE; NETHERLANDS; INFECTION; POULTRY; SPREAD; STRAIN	Background: Although vaccination can be a useful tool for control of avian influenza epidemics, it might engender emergence of a vaccine-resistant strain. Field and experimental studies show that some avian influenza strains acquire resistance ability against vaccination. We investigated, in the context of the emergence of a vaccine-resistant strain, whether a vaccination program can prevent the spread of infectious disease. We also investigated how losses from immunization by vaccination imposed by the resistant strain affect the spread of the disease. Methods and Findings: We designed and analyzed a deterministic compartment model illustrating transmission of vaccine-sensitive and vaccine-resistant strains during a vaccination program. We investigated how the loss of protection effectiveness impacts the program. Results show that a vaccination to prevent the spread of disease can instead spread the disease when the resistant strain is less virulent than the sensitive strain. If the loss is high, the program does not prevent the spread of the resistant strain despite a large prevalence rate of the program. The epidemic's final size can be larger than that before the vaccination program. We propose how to use poor vaccines, which have a large loss, to maximize program effects and describe various program risks, which can be estimated using available epidemiological data. Conclusions: We presented clear and simple concepts to elucidate vaccination program guidelines to avoid negative program effects. Using our theory, monitoring the virulence of the resistant strain and investigating the loss caused by the resistant strain better development of vaccination strategies is possible.	[Iwami, Shingo; Takeuchi, Yasuhiro] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan; [Suzuki, Takafumi] Shizuoka Univ, Grad Sch Engn, Shizuoka, Japan	Shizuoka University; Shizuoka University	Iwami, S (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.	takeuchi@sys.eng.shizuoka.ac.jp			Japan Society for the Promotion of Science for Young Scientists [Research Fellowships]	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; ANDERSON R M, 1991; Capua A, 2004, VACCINE, V22, P4137, DOI 10.1016/j.vaccine.2004.04.017; Capua I, 2007, REV SCI TECH OIE, V26, P217, DOI 10.20506/rst.26.1.1741; Capua I, 2004, EUR J CLIN MICROBIOL, V23, P1, DOI 10.1007/s10096-003-1059-3; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Elbers ARW, 2005, AVIAN PATHOL, V34, P181, DOI 10.1080/03079450500096497; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Guan Y, 2007, POULTRY SCI, V86, P437, DOI 10.1093/ps/86.3.437; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; IWAMI S, GEOGRAPHICA IN PRESS; Iwami S, 2008, J THEOR BIOL, V252, P732, DOI 10.1016/j.jtbi.2008.02.020; Iwami S, 2007, MATH BIOSCI, V207, P1, DOI 10.1016/j.mbs.2006.08.001; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Leung FC, 2007, POULTRY SCI, V86, P435, DOI 10.1093/ps/86.3.435; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Marangon S, 2008, ZOONOSES PUBLIC HLTH, V55, P65, DOI 10.1111/j.1863-2378.2007.01086.x; McCaw JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002362; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Pasquato A, 2008, J MOL NEUROSCI, V35, P339, DOI 10.1007/s12031-008-9052-z; Peyre M, 2009, EPIDEMIOL INFECT, V137, P1, DOI 10.1017/S0950268808001039; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Savill NJ, 2006, NATURE, V442, P757, DOI 10.1038/442757a; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Swayne DE, 1999, AVIAN PATHOL, V28, P245, DOI 10.1080/03079459994731; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004; WEBSTER RG, 1985, J VIROL, V55, P173, DOI 10.1128/JVI.55.1.173-176.1985	37	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4915	10.1371/journal.pone.0004915	http://dx.doi.org/10.1371/journal.pone.0004915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19295921	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496600011
J	Santhanam, AN; Bindewald, E; Rajasekhar, VK; Larsson, O; Sonenberg, N; Colburn, NH; Shapiro, BA				Santhanam, Arti N.; Bindewald, Eckart; Rajasekhar, Vinagolu K.; Larsson, Ola; Sonenberg, Nahum; Colburn, Nancy H.; Shapiro, Bruce A.			Role of 3 ' UTRs in the Translation of mRNAs Regulated by Oncogenic eIF4E-A Computational Inference	PLOS ONE			English	Article							SECONDARY STRUCTURE; INITIATION; EXPRESSION; MICRORNAS; CELLS; RECRUITMENT; ACTIVATION; PREDICTION; MIRBASE; PROTEIN	Eukaryotic cap-dependent mRNA translation is mediated by the initiation factor eIF4E, which binds mRNAs and stimulates efficient translation initiation. eIF4E is often overexpressed in human cancers. To elucidate the molecular signature of eIF4E target mRNAs, we analyzed sequence and structural properties of two independently derived polyribosome recruited mRNA datasets. These datasets originate from studies of mRNAs that are actively being translated in response to cells overexpressing eIF4E or cells with an activated oncogenic AKT: eIF4E signaling pathway, respectively. Comparison of eIF4E target mRNAs to mRNAs insensitive to eIF4E-regulation has revealed surprising features in mRNA secondary structure, length and microRNA-binding properties. Fold-changes (the relative change in recruitment of an mRNA to actively translating polyribosomal complexes in response to eIF4E overexpression or AKT upregulation) are positively correlated with mRNA G+C content and negatively correlated with total and 3'UTR length of the mRNAs. A machine learning approach for predicting the fold change was created. Interesting tendencies of secondary structure stability are found near the start codon and at the beginning of the 3'UTR region. Highly upregulated mRNAs show negative selection (site avoidance) for binding sites of several microRNAs. These results are consistent with the emerging model of regulation of mRNA translation through a dynamic balance between translation initiation at the 5'UTR and microRNA binding at the 3'UTR.	[Santhanam, Arti N.] NCI, Gene Regulat Sect, Lab Canc Prevent, Frederick, MD 21701 USA; [Bindewald, Eckart; Colburn, Nancy H.] NCI, SAIC Frederick Inc, Basic Res Program, Frederick, MD USA; [Rajasekhar, Vinagolu K.] Memorial Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY USA; [Larsson, Ola; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Larsson, Ola; Sonenberg, Nahum] McGill Univ, McGill Canc Ctr, Montreal, PQ H3A 2T5, Canada; [Shapiro, Bruce A.] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Memorial Sloan Kettering Cancer Center; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Santhanam, AN (corresponding author), NCI, Gene Regulat Sect, Lab Canc Prevent, Frederick, MD 21701 USA.	bshapiro@ncifcrf.gov	Larsson, Ola/F-8151-2013	Larsson, Ola/0000-0003-1412-1308; Vinagolu, Rajasekhar/0000-0002-7364-2675	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010026, ZIABC008382] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bindewald E, 2006, RNA, V12, P342, DOI 10.1261/rna.2164906; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; FILIPOWICZ W, 2008, NAT REV GENET; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HARVEY M, 1995, INTUITIVE BIOSTATIST; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Hon LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r166; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; KUMAR MS, 2008, P NATL ACAD SCI US; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Polunovsky Vitaly A, 2006, RNA Biol, V3, P10; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shantz LM, 1996, CANCER RES, V56, P3265; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; WU Z, 2003, MODEL BASED BACKGROU; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Zimmer SG, 2000, ANTICANCER RES, V20, P1343	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4868	10.1371/journal.pone.0004868	http://dx.doi.org/10.1371/journal.pone.0004868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290046	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496500005
J	Hoerndli, FJ; Walser, M; Hoier, EF; de Quervain, D; Papassotiropoulos, A; Hajnal, A				Hoerndli, Frederic J.; Walser, Michael; Hoier, Erika Froehli; de Quervain, Dominique; Papassotiropoulos, Andreas; Hajnal, Alex			A Conserved Function of C. elegans CASY-1 Calsyntenin in Associative Learning	PLOS ONE			English	Article								Background: Whole-genome association studies in humans have enabled the unbiased discovery of new genes associated with human memory performance. However, such studies do not allow for a functional or causal testing of newly identified candidate genes. Since polymorphisms in Calsyntenin 2 (CLSTN2) showed a significant association with episodic memory performance in humans, we tested the C. elegans CLSTN2 ortholog CASY-1 for possible functions in the associative behavior of C. elegans. Methodology/Principal Findings: Using three different associative learning paradigms and functional rescue experiments, we show that CASY-1 plays an important role during associative learning in C. elegans. Furthermore, neuronal expression of human CLSTN2 in C. elegans rescues the learning defects of casy-1 mutants. Finally, genetic interaction studies and neuron-specific expression experiments suggest that CASY-1 may regulate AMPA-like GLR-1 glutamate receptor signaling. Conclusion/Significance: Our experiments demonstrate a remarkable conservation of the molecular function of Calsyntenins between nematodes and humans and point at a role of C. elegans casy-1 in regulating a glutamate receptor signaling pathway.			Hajnal, A (corresponding author), Univ Zurich, Inst Zool, Zurich, Switzerland.	ahajnal@zool.uzh.ch		Hajnal, Alex/0000-0002-4098-3721; Walser, Michael/0000-0003-3506-4621; Hoerndli, Frederic/0000-0001-6838-0386; Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464				Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; BRENNER S, 1974, GENETICS, V77, P71; Cassata G, 2000, GENESIS, V27, P141, DOI 10.1002/1526-968X(200008)27:4<141::AID-GENE20>3.0.CO;2-K; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Colbert HA, 1997, J NEUROSCI, V17, P8259; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; JACOBSEN LK, 2008, BIOL PSYCHIAT; KANDEL ER, 1983, COLD SPRING HARB SYM, V48, P821, DOI 10.1101/SQB.1983.048.01.085; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; Morrison GE, 2001, BEHAV NEUROSCI, V115, P640, DOI 10.1037//0735-7044.115.3.640; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rose JK, 2003, J NEUROSCI, V23, P9595; Saeki S, 2001, J EXP BIOL, V204, P1757; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SPEAR NE, 1985, ANN NY ACAD SCI, V443, P42, DOI 10.1111/j.1749-6632.1985.tb27062.x; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	29	28	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4880	10.1371/journal.pone.0004880	http://dx.doi.org/10.1371/journal.pone.0004880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287492	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496400020
J	Nagaoka, K; Aoki, F; Hayashi, M; Muroi, Y; Sakurai, T; Itoh, K; Ikawa, M; Okabe, M; Imakawa, K; Sakai, S				Nagaoka, Kentaro; Aoki, Fugaku; Hayashi, Mizuna; Muroi, Yoshikage; Sakurai, Toshihiro; Itoh, Kikuji; Ikawa, Masahito; Okabe, Masaru; Imakawa, Kazuhiko; Sakai, Senkiti			L-Amino acid oxidase plays a crucial role in host defense in the mammary glands	FASEB JOURNAL			English	Article						antibacterial; milk; H2O2; mastitis	CELL-DEATH; MASTITIS; MILK; EXPRESSION; INFECTION; VENOM; EVOLUTION; ACHACIN; CLONING	The innate immune system plays an important role in protecting organs that are continuous with the outer surface of the body from bacterial infection. The antibacterial factors involved in this system have been sought in exocrine glands, particularly in the mammary glands. Because milk produced in the mammary glands is enriched in various nutrients, supporting the proliferation of bacteria, mammary glands appear to be at the greatest risk of bacterial infection and proliferation. Here, we show that mouse milk contains L-amino acid oxidase (LAO), a lactating mammary gland-specific protein that displays antibacterial activity in vitro through the production of hydrogen peroxide from free amino acids. We produced LAO-disrupted mouse lines to define the physiological properties and importance of the protein in vivo. The LAO-knockout mice were healthy and had normal mammary gland development; however, the antibacterial activity normally observed in milk from wild-type mice was absent from the milk of knockout mice. The content of free amino acids targeted by LAO was very low in wild-type milk, whereas these amino acids were abundant in LAO-knockout milk. Knockout mice exhibited weak resistance to an intramammary bacterial challenge compared to their wild-type counterparts. Further, preadministration of wild-type milk whey reduced the severity of bacterial infection in LAO-knockout mice. These results demonstrate that milk LAO protects the mammary gland against bacterial infection, and this antibacterial effect may be due to the generation of hydrogen peroxide by using free amino acids abundantly present in milk. Nagaoka, K., Aoki, F., Hayashi, M., Muroi, Y., Sakurai, T., Itoh, K., Ikawa, M., Okabe, M., Imakawa, K., Sakai, S. L-Amino acid oxidase plays a crucial role in host defense in the mammary glands. FASEB J. 23, 2514-2520 (2009)	[Nagaoka, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Anim Breeding, Bunkyo Ku, Tokyo 1138657, Japan; [Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Publ Hlth, Tokyo 1138657, Japan; [Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Osaka, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Osaka University	Nagaoka, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Anim Breeding, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akenaga@mail.ecc.u-tokyo.ac.jp	Nagaoka, Kentaro/C-2019-2013; AOKI, FUGAKU/AAO-7617-2021; Imakawa, Kazuhiko/AAD-3211-2022; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	Nagaoka, Kentaro/0000-0003-1038-1380; ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Dr. Li Jun You for technical support in determining the milk amino acid content, Dr. Joel Richter for his critical reading of the manuscript, Kimiko Tachikawa for animal care, and Akiko Kawai and Masato Tanaka for technical assistance with gene disruption. This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science.	Ande SR, 2006, APOPTOSIS, V11, P1439, DOI 10.1007/s10495-006-7959-9; Barbosa-Cesnik C, 2003, JAMA-J AM MED ASSOC, V289, P1609, DOI 10.1001/jama.289.13.1609; Bernt K, 2001, ADV EXP MED BIOL, V501, P11; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; COUDERT M, 1975, ARCH MICROBIOL, V102, P151, DOI 10.1007/BF00428360; DETILLEUX JC, 1995, VET IMMUNOL IMMUNOP, V44, P251, DOI 10.1016/0165-2427(94)05302-9; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; DUERRE JA, 1975, J BACTERIOL, V121, P656, DOI 10.1128/JB.121.2.656-663.1975; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; EVANS M, 1995, BREASTFEED REV, V3, P65; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; Kanzawa N, 2004, ARCH BIOCHEM BIOPHYS, V422, P103, DOI 10.1016/j.abb.2003.12.007; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; MAGA EA, 1994, TRANSGENIC RES, V3, P36, DOI 10.1007/BF01976025; MARSHALL BR, 1975, JAMA-J AM MED ASSOC, V233, P1377, DOI 10.1001/jama.233.13.1377; NIEDERMANN DM, 1990, J BIOL CHEM, V265, P17246; Osterman K L, 2000, J Hum Lact, V16, P297, DOI 10.1177/089033440001600405; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; RASSIN DK, 1978, EARLY HUM DEV, V2, P1, DOI 10.1016/0378-3782(78)90048-8; Samel M, 2006, BBA-PROTEINS PROTEOM, V1764, P707, DOI 10.1016/j.bbapap.2006.01.021; Semba RD, 2000, ANN NY ACAD SCI, V918, P156; SKARNES RC, 1970, NATURE, V225, P1072, DOI 10.1038/2251072a0; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Sun YP, 2002, J BIOL CHEM, V277, P19080, DOI 10.1074/jbc.M200936200; Tonismagi K, 2006, TOXICON, V48, P227, DOI 10.1016/j.toxicon.2006.05.004; VALLON O, 1993, EUR J BIOCHEM, V215, P351, DOI 10.1111/j.1432-1033.1993.tb18041.x; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; Vorbach C, 2006, BIOESSAYS, V28, P606, DOI 10.1002/bies.20423; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795; Yarus S, 1996, P NATL ACAD SCI USA, V93, P14118, DOI 10.1073/pnas.93.24.14118; Zhang YJ, 2003, BIOCHEM BIOPH RES CO, V309, P598, DOI 10.1016/j.bbrc.2003.08.044	34	32	34	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2514	2520		10.1096/fj.08-126466	http://dx.doi.org/10.1096/fj.08-126466			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19276171				2022-12-25	WOS:000268836700019
J	E, SY; Lai, YJ; Tsukahara, R; Chen, CS; Fujiwara, Y; Yue, JM; Yu, JH; Guo, H; Kihara, A; Tigyi, G; Lin, FT				E, Shuyu; Lai, Yun-Ju; Tsukahara, Ryoko; Chen, Chen-Shan; Fujiwara, Yuko; Yue, Junming; Yu, Jei-Hwa; Guo, Huazhang; Kihara, Akio; Tigyi, Gabor; Lin, Fang-Tsyr			Lysophosphatidic Acid 2 Receptor-mediated Supramolecular Complex Formation Regulates Its Antiapoptotic Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-MIGRATION; COLON-CANCER CELLS; PROTEIN INTERACTIONS; LPA(2) RECEPTOR; DOWN-REGULATION; PDZ DOMAIN; PHOSPHORYLATION; ACTIVATION; SPECIFICITY; ASSOCIATION	The G protein-coupled lysophosphatidic acid 2 (LPA(2)) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA(2). LPA(2) differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA(2) responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA(2)-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA(2). Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA(2)-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA(2)-mediated full activation of antiapoptotic signaling.	[E, Shuyu; Tsukahara, Ryoko; Fujiwara, Yuko; Yue, Junming; Guo, Huazhang; Tigyi, Gabor] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Lai, Yun-Ju; Chen, Chen-Shan; Lin, Fang-Tsyr] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Yu, Jei-Hwa] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Hokkaido University	Tigyi, G (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.	gtigyi@physio1.utmem.edu; flin@uab.edu	KIHARA, AKIO/A-3802-2012; e, s/GWU-7511-2022	KIHARA, AKIO/0000-0001-5889-0788; 	National Institutes of Health [CA92160, AI 080405, CA100848]; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA100848, R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92160 (to G. T.), AI 080405 (to G. T.), and CA100848 (to F. L.). This work was also supported by a grant from the Marsha Rivkin Center for Ovarian Cancer Research (to F. L.). G. T. is a founder of RxBio Inc. and a member of the scientific advisory board.	Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Chun J, 2002, BIOCHEM BIOPH RES CO, V298, P207, DOI 10.1016/S0006-291X(02)02428-2; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Lai YJ, 2005, MOL CELL BIOL, V25, P5859, DOI 10.1128/MCB.25.14.5859-5868.2005; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lin FT, 2008, BBA-MOL CELL BIOL L, V1781, P558, DOI 10.1016/j.bbalip.2008.04.013; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Parrill AL, 2008, BBA-MOL CELL BIOL L, V1781, P540, DOI 10.1016/j.bbalip.2008.04.011; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang HQ, 2005, ONCOGENE, V24, P3574, DOI 10.1038/sj.onc.1208463; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yun CC, 2005, AM J PHYSIOL-CELL PH, V289, pC2, DOI 10.1152/ajpcell.00610.2004; Zhang HC, 2007, CELL SIGNAL, V19, P261, DOI 10.1016/j.cellsig.2006.06.008	29	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14558	14571		10.1074/jbc.M900185200	http://dx.doi.org/10.1074/jbc.M900185200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19293149	Green Published, hybrid			2022-12-25	WOS:000266286100062
J	Fu, W; Ma, QP; Chen, L; Li, PF; Zhang, M; Ramamoorthy, S; Nawaz, Z; Shimojima, T; Wang, HB; Yang, YH; Shen, Z; Zhang, YT; Zhang, XH; Nicosia, SV; Zhang, YP; Pledger, JW; Chen, JD; Bai, WL				Fu, Wei; Ma, Qiuping; Chen, Lei; Li, Pengfei; Zhang, Mu; Ramamoorthy, Sivapriya; Nawaz, Zafar; Shimojima, Tsukasa; Wang, Hengbin; Yang, Yonghua; Shen, Zheng; Zhang, Yingtao; Zhang, Xiaohong; Nicosia, Santo V.; Zhang, Yanping; Pledger, Jack W.; Chen, Jiandong; Bai, Wenlong			MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; OXIDATIVE-STRESS; PROSTATE-CANCER; PROTEASOMAL DEGRADATION; DOWN-REGULATION; DNA-DAMAGE; CELL-DEATH; LIFE-SPAN	Members of the FOXO (forkhead O) class of transcription factors are tumor suppressors that also control aging and organismal life span. MammalianFOXOdegradation is proteasomemediated, although the ubiquitin E3 ligase for FOXO factors remains to be defined. We show that MDM2 binds to FOXO1 and FOXO3A and promotes their ubiquitination and degradation, a process apparently dependent on FOXO phosphorylation at AKT sites and the E3 ligase activity of MDM2. Binding of MDM2 to FOXO occurs through the region of MDM2 that directs its cellular trafficking and the forkhead box of FOXO1. MDM2 promotes the ubiquitination of FOXO1 in a cell-free system, and its knockdown by small interfering RNA causes accumulation of endogenous FOXO3A protein in cells and enhances the expression of FOXO target genes. In cells stably expressing a temperature-sensitive p53 mutant, activation of p53 by shifting to permissive temperatures leads to MDM2 induction and degradation of endogenous FOXO3A. These data suggest that MDM2 acts as an ubiquitin E3 ligase, downstream of p53, to regulate the degradation of mammalian FOXO factors.	[Fu, Wei; Ma, Qiuping; Chen, Lei; Li, Pengfei; Zhang, Mu; Yang, Yonghua; Shen, Zheng; Zhang, Yingtao; Zhang, Xiaohong; Nicosia, Santo V.; Bai, Wenlong] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; [Fu, Wei; Ma, Qiuping; Chen, Lei; Li, Pengfei; Zhang, Mu; Yang, Yonghua; Shen, Zheng; Zhang, Yingtao; Zhang, Xiaohong; Nicosia, Santo V.; Bai, Wenlong] Univ S Florida, Coll Med, Dept Cell Biol, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Nicosia, Santo V.; Pledger, Jack W.; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Program Expt Therapeut, Tampa, FL 33612 USA; [Ramamoorthy, Sivapriya; Nawaz, Zafar; Pledger, Jack W.; Chen, Jiandong] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Shimojima, Tsukasa; Wang, Hengbin] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35233 USA; [Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27514 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Miami; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC 11, Tampa, FL 33612 USA.	wbai@health.usf.edu	高, 雨莉/HGU-8187-2022; Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Fu, Wei/0000-0003-0506-5594; Wang, Hengbin/0000-0003-2414-0609	National Institutes of Health [CA93666, CA111334]; Department of Defense Prostate Cancer [DAMD17-021-0140]; American Heart Association Predoctoral Fellowship [0315115B]; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA093666, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer(United States Department of Defense); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA93666 (to W. B.) and CA111334 (to W. B.). This work was also supported by Department of Defense Prostate Cancer Grant DAMD17-021-0140 (to W. B.) and American Heart Association Predoctoral Fellowship 0315115B (to W. F.).	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Freedman DA, 1999, CANCER RES, V59, P1; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Jin SK, 2001, J CELL SCI, V114, P4139; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Katoh M, 2004, INT J ONCOL, V25, P1495; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; LUNA RMD, 1995, NATURE, V378, P203; Macri E, 1998, CANCER METAST REV, V17, P337, DOI 10.1023/A:1006133620914; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McMasters KM, 1996, ONCOGENE, V13, P1731; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Pochampally R, 1999, J BIOL CHEM, V274, P15271, DOI 10.1074/jbc.274.21.15271; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	60	140	144	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					13987	14000		10.1074/jbc.M901758200	http://dx.doi.org/10.1074/jbc.M901758200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321440	Green Published, hybrid			2022-12-25	WOS:000266286100005
J	Thangasamy, A; Rogge, J; Ammanamanchi, S				Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar			Recepteur d'Origine Nantais Tyrosine Kinase Is a Direct Target of Hypoxia-inducible Factor-1 alpha-mediated Invasion of Breast Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; MEDIATED INVASION; CANCER; RON; EXPRESSION; OVEREXPRESSION; METASTASIS; PROGNOSIS; PATHWAY; MODEL	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) overexpression was shown to be associated with invasion and metastasis of tumors and tumor cell lines. The identification of molecular targets that contribute to HIF-1 alpha-mediated invasion is under intensive investigation. We have analyzed the role of recepteur d'origine nantais (RON), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) that plays a role in breast cancer cell invasion as one of the molecular targets of HIF-1 alpha. Analysis of a panel of breast cancer cell lines indicated a correlation between HIF-1 alpha and RON expression. Treatment of HIF-1 alpha-and RON-positive breast cancer cells with HIF-1 alpha inhibitor, echinomycin, led to the inhibition of HIF-1 alpha activity and RON expression. We have identified HIF-1 alpha binding site on the RON promoter. Chromatin immunoprecipitation analysis and site-directed mutagenesis of the RON promoter confirmed the binding of HIF-1 alpha to RON promoter. HIF-1 alpha inhibitor-, echinomycin-, or short hairpin RNA-mediated selective knockdown of HIF-1 alpha or HIF-1 alpha target RON tyrosine kinase abrogated RON gene expression, and the RON ligand macrophage-stimulating protein mediated invasion of breast cancer cells. Consequently, the data presented herein demonstrated RON as a novel molecular target of HIF-1 alpha and suggest a potential therapeutic role for HIF-1 alpha or RON tyrosine kinase inhibitors in the blockade of RON tyrosine kinase-mediated invasion of carcinoma cells.	[Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Ammanamanchi, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ammanamanchi@uthscsa.edu			National Institutes of Health [P30 CA54174]; NCl; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCl; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 CA54174 from the NCl.	Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; DELGATTO F, 1995, BBA-GENE STRUCT EXPR, V1263, P93, DOI 10.1016/0167-4781(95)00082-R; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Narasimhan M, 2008, CANCER RES, V68, P5185, DOI 10.1158/0008-5472.CAN-07-6883; Thangasamy A, 2008, J BIOL CHEM, V283, P5335, DOI 10.1074/jbc.M706957200; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Wang MH, 2007, J PATHOL, V213, P402, DOI 10.1002/path.2245; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Zhong H, 2000, CANCER RES, V60, P1541; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	22	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14001	14010		10.1074/jbc.M809320200	http://dx.doi.org/10.1074/jbc.M809320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307182	Green Published, hybrid			2022-12-25	WOS:000266286100006
J	Xu, B; Huang, K; Chu, YC; Hu, SQ; Nakagawa, S; Wang, SH; Wang, RY; Whittaker, J; Katsoyannis, PG; Weiss, MA				Xu, Bin; Huang, Kun; Chu, Ying-Chi; Hu, Shi-Quan; Nakagawa, Satoe; Wang, Shuhua; Wang, Run-Ying; Whittaker, Jonathan; Katsoyannis, Panayotis G.; Weiss, Michael A.			Decoding the Cryptic Active Conformation of a Protein by Synthetic Photoscanning INSULIN INSERTS A DETACHABLE ARM BETWEEN RECEPTOR DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-ASSOCIATED MUTATIONS; ALANINE-SCANNING MUTAGENESIS; PHOTO-CROSS-LINKING; CHAIN ALPHA-HELIX; B-CHAIN; CRYSTAL-STRUCTURE; BINDING-SITE; BIOLOGICAL-ACTIVITY; CHIRAL MUTAGENESIS; NEGATIVE COOPERATIVITY	Proteins evolve in a fitness landscape encompassing a complex network of biological constraints. Because of the interrelation of folding, function, and regulation, the ground-state structure of a protein may be inactive. A model is provided by insulin, a vertebrate hormone central to the control of metabolism. Whereas native assembly mediates storage within pancreatic beta-cells, the active conformation of insulin and its mode of receptor binding remain elusive. Here, functional surfaces of insulin were probed by photocross-linking of an extensive set of azido derivatives constructed by chemical synthesis. Contacts are circumferential, suggesting that insulin is encaged within its receptor. Mapping of photoproducts to the hormone-binding domains of the insulin receptor demonstrated alternating contacts by the B-chain beta-strand (residues B24-B28). Whereas even-numbered probes (at positions B24 and B26) contact the N-terminal L1 domain of the alpha-subunit, odd-numbered probes (at positions B25 and B27) contact its C-terminal insert domain. This alternation corresponds to the canonical structure of a beta-strand (wherein successive residues project in opposite directions) and so suggests that the B-chain inserts between receptor domains. Detachment of a receptor-binding arm enables photo engagement of surfaces otherwise hidden in the free hormone. The arm and associated surfaces contain sites also required for nascent folding and self-assembly of storage hexamers. The marked compression of structural information within a short polypeptide sequence rationalizes the diversity of diabetes-associated mutations in the insulin gene. Our studies demonstrate that photo-scanning mutagenesis can decode the active conformation of a protein and so illuminate cryptic constraints underlying its evolution.	[Xu, Bin; Huang, Kun; Hu, Shi-Quan; Wang, Shuhua; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Chu, Ying-Chi; Wang, Run-Ying; Katsoyannis, Panayotis G.] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; [Nakagawa, Satoe] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Case Western Reserve University; Icahn School of Medicine at Mount Sinai; University of Chicago	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012	Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK065980, DK56673, DK040949, DK069764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK056673, R56DK065980, R01DK040949, R01DK065980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK065980 (to J.W.), DK56673 (to P.G.K.), and DK040949 and DK069764 (to M.A.W.).	ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BLUNDELL TL, 1972, DIABETES, V21, P492, DOI 10.2337/diab.21.2.S492; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; EBERLE AN, 1985, METHOD ENZYMOL, V109, P129; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; FABRY M, 1992, J BIOL CHEM, V267, P8950; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P1405, DOI 10.1021/bi00302a011; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kurapkat G, 1999, PROTEIN SCI, V8, P499; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LENZ V, 1991, BIOL CHEM H-S, V372, P495, DOI 10.1515/bchm3.1991.372.2.495; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; *PEK INS STRUCT GR, 1971, PEKING REV, V40, P11; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SCHWARTZ G, 1978, BIOCHEMISTRY-US, V17, P4550, DOI 10.1021/bi00614a029; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SCHWARTZ GP, 1989, P NATL ACAD SCI USA, V86, P458, DOI 10.1073/pnas.86.2.458; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; WAN Z, 1988, SCI CHINA SER B, V31, P1426; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Ward C, 2008, ACTA PHYSIOL, V192, P3, DOI 10.1111/j.1748-1716.2007.01781.x; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; YIP CC, 1988, BIOCHEM BIOPH RES CO, V157, P321, DOI 10.1016/S0006-291X(88)80050-0; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w	84	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14597	14608		10.1074/jbc.M900087200	http://dx.doi.org/10.1074/jbc.M900087200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321435	Green Published, hybrid			2022-12-25	WOS:000266286100065
J	Snyder, M; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			The Minichromosome Maintenance Proteins 2-7 (MCM2-7) Are Necessary for RNA Polymerase II (Pol II)-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; HELICASE ACTIVITY; HUMAN-CELLS; IFN-GAMMA; COMPLEXES; ORIGINS; ACTIVATION; CHROMATIN; MCM5	The MCM2-7 (minichromosome maintenance) proteins are a family of evolutionarily highly conserved proteins. They are essential for DNA replication in yeast and are considered to function as DNA helicases. However, it has long been shown that there is an overabundance of the MCM2-7 proteins when compared with the number of DNA replication origins in chromatin. It has been suggested that the MCM2-7 proteins may function in other biological processes that require the unwinding of the DNA helix. In this report, we show that RNA polymerase II (Pol II)-mediated transcription is dependent on MCM5 and MCM2 proteins. Furthermore, the MCM2-7 proteins are co-localized with RNA Pol II on chromatins of constitutively transcribing genes, and MCM5 is required for transcription elongation of RNA Pol II. Finally, we demonstrate that the integrity of the MCM2-7 hexamer complex and the DNA helicase domain in MCM5 are essential for the process of transcription.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [GM61652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61652 (to J. J. Z.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Eisen A, 1998, BIOESSAYS, V20, P634, DOI 10.1002/(SICI)1521-1878(199808)20:8<634::AID-BIES6>3.0.CO;2-I; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Holthoff HP, 1998, J BIOL CHEM, V273, P7320, DOI 10.1074/jbc.273.13.7320; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lei M, 1996, MOL CELL BIOL, V16, P5081; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; Newlon CS, 1997, CELL, V91, P717, DOI 10.1016/S0092-8674(00)80459-6; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Tsuyama T, 2005, NUCLEIC ACIDS RES, V33, P765, DOI 10.1093/nar/gki226; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963	35	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13466	13472		10.1074/jbc.M809471200	http://dx.doi.org/10.1074/jbc.M809471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318354	hybrid, Green Published			2022-12-25	WOS:000265877300022
J	Li, H; Choi, YJ; Hanes, MA; Marple, T; Vogel, H; Hasty, P				Li, H.; Choi, Y. J.; Hanes, M. A.; Marple, T.; Vogel, H.; Hasty, P.			Deleting Ku70 is milder than deleting Ku80 in p53-mutant mice and cells	ONCOGENE			English	Article						DNA double-strand break; non-homologous end joining; pro-B-cell lymphoma; medulloblastoma; T-cell lymphoma	V(D)J RECOMBINATION; RAG-1-INDUCED DSBS; SPONTANEOUS TUMORS; DNA-DAMAGE; PROTEIN; P53; DEFICIENT; TRANSLOCATION; MECHANISM; BINDING	Ku70 forms a heterodimer with Ku80, called Ku that is well known for repairing DNA double-strand breaks through non-homologous end joining. As a result, deletion of either causes a very similar phenotype in mice that includes hypersensitivity to clastogens and early aging. In addition, deletion of Ku80 along with the cell cycle checkpoint protein, p53, dramatically increases the incidence of pro-B-cell lymphoma. Even though Ku70-p53-mutant mice have not been analysed, a logical assumption is they would exhibit the same cancer phenotype. Here, we test this assumption by comparing p53-mutant littermates deleted for either Ku70 or Ku80 or both. We find this assumption to be incorrect as p53-mutants live significantly longer when deleted for Ku70 rather than Ku80 or Ku70 + Ku80. We also find the former cohort displays much lower levels of pro-B-cell lymphoma than the latter two cohorts. As pro-B-cell lymphoma is caused by a translocation between chromosomes 12 and 15, we tested fibroblasts for DNA repair capacity, and found that p53-mutant fibroblasts are more sensitive to streptonigrin and paraquat when deleted for Ku80 as compared with Ku70. Thus, Ku80 may function outside the Ku heterodimer to influence DNA damage repair presenting the possibility that Ku80 influenced the open coding ends in a manner that suppressed a cancer-causing translocation.	[Li, H.; Choi, Y. J.; Marple, T.; Hasty, P.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA; [Li, H.; Choi, Y. J.; Marple, T.; Hasty, P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Hanes, M. A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Lab Anim Resources, San Antonio, TX 78245 USA; [Vogel, H.] Stanford Univ, Med Ctr, Dept Pathol, Palo Alto, CA 94304 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Stanford University	Hasty, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, 15355 Lambda Dr, San Antonio, TX 78245 USA.	hastye@uthscsa.edu		Hasty, Paul/0000-0003-3046-0131; Vogel, Otto Hannes/0000-0002-0960-3508	NIH [R01 CA76317-05A1, 3P30 CA054174-16S2, P01 AG17242, UO1 ES11044]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA076317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the following grants from the NIH: R01 CA76317-05A1, 3P30 CA054174-16S2, P01 AG17242 and UO1 ES11044 to PH.	Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; Brown KD, 2000, J BIOL CHEM, V275, P6651, DOI 10.1074/jbc.275.9.6651; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Holcomb VB, 2006, ONCOGENE, V25, P7159, DOI 10.1038/sj.onc.1209704; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; Holcomb VB, 2007, MECH AGEING DEV, V128, P601, DOI 10.1016/j.mad.2007.08.006; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Koike M, 2000, BIOCHEM BIOPH RES CO, V276, P1105, DOI 10.1006/bbrc.2000.3567; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lim JW, 2008, INT J BIOCHEM CELL B, V40, P2065, DOI 10.1016/j.biocel.2008.02.015; Marple T, 2004, MUTAT RES-FUND MOL M, V554, P253, DOI 10.1016/j.mrfmmm.2004.05.004; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Romero F, 1996, MOL CELL BIOL, V16, P37; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Song KY, 2001, J BIOL CHEM, V276, P8321, DOI 10.1074/jbc.M008779200; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	33	14	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2009	28	16					1875	1878		10.1038/onc.2009.57	http://dx.doi.org/10.1038/onc.2009.57			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PW	19330025				2022-12-25	WOS:000265640500006
J	Millar, EKA; Dean, JL; McNeil, CM; O'Toole, SA; Henshall, SM; Tran, T; Lin, J; Quong, A; Comstock, CES; Witkiewicz, A; Musgrove, EA; Rui, H; LeMarchand, L; Setiawan, VW; Haiman, CA; Knudsen, KE; Sutherland, RL; Knudsen, ES				Millar, E. K. A.; Dean, J. L.; McNeil, C. M.; O'Toole, S. A.; Henshall, S. M.; Tran, T.; Lin, J.; Quong, A.; Comstock, C. E. S.; Witkiewicz, A.; Musgrove, E. A.; Rui, H.; LeMarchand, L.; Setiawan, V. W.; Haiman, C. A.; Knudsen, K. E.; Sutherland, R. L.; Knudsen, E. S.			Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome	ONCOGENE			English	Article						cyclin D1b; breast cancer; polymorphism; estrogen receptor; prognosis	SQUAMOUS-CELL CARCINOMA; ADJUVANT TAMOXIFEN; POLYMORPHISM; RISK; AMPLIFICATION; PROGNOSIS; ISOFORM; GENE; VARIANT; ALLELE	Aberrant expression of cyclin D1 protein is a common feature of breast cancer. However, the CCND1 gene encodes two gene products, cyclin D1a and cyclin D1b, which have discrete mechanisms of regulation and impact on cell behavior. A polymorphism at nucleotide 870 in the CCND1 gene, rs603965, influences the relative production of the encoded proteins and can impart increased risk for tumor development. Here, the impact of both the G/A870 polymorphism and cyclin D1b protein production on breast cancer risk, disease phenotype and patient outcome was analysed. In a large multiethnic case-control study, the G/A870 polymorphism conferred no significant risk for breast cancer overall or by stage or estrogen receptor (ER) status. However, the cyclin D1b protein was found to be upregulated in breast cancer, independent of cyclin D1a levels, and exhibited heterogeneous levels in breast cancer specimens. High cyclin D1a expression inversely correlated with the Ki67 proliferation marker and was not associated with clinical outcome. In contrast, elevated cyclin D1b expression was independently associated with adverse outcomes, including recurrence, distant metastasis and decreased survival. Interestingly, cyclin D1b was particularly associated with poor outcome in the context of ER-negative breast cancer. Thus, specific cyclin D1 isoforms are associated with discrete forms of breast cancer and high cyclin D1b protein levels hold prognostic potential.	[Dean, J. L.; Tran, T.; Lin, J.; Quong, A.; Comstock, C. E. S.; Witkiewicz, A.; Rui, H.; Knudsen, K. E.; Knudsen, E. S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Millar, E. K. A.; McNeil, C. M.; O'Toole, S. A.; Henshall, S. M.; Musgrove, E. A.; Sutherland, R. L.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Millar, E. K. A.] St George Hosp, Dept Anat Pathol S Eastern Area Lab Serv, Sydney, NSW, Australia; [Dean, J. L.; Tran, T.; Lin, J.; Comstock, C. E. S.; Witkiewicz, A.; Rui, H.; Knudsen, K. E.; Knudsen, E. S.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Witkiewicz, A.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [LeMarchand, L.] Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; [Setiawan, V. W.; Haiman, C. A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Knudsen, K. E.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA	Jefferson University; Garvan Institute of Medical Research; St George Hospital; Jefferson University; Jefferson University; Cancer Research Center of Hawaii; University of Southern California; Jefferson University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, BLSB Room 1002,233 S 10th St, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org	Millar, Ewan/ABE-9127-2020; Comstock, Clay/B-6122-2008; Sutherland, Robert L/A-8378-2008; McNeil, Catriona/F-6817-2010	Millar, Ewan/0000-0002-9778-3253; Comstock, Clay/0000-0001-5867-1489; Knudsen, Karen/0000-0002-1301-890X; Setiawan, Veronica/0000-0001-9239-5692	National Health and Medical Research Council of Australia [276408]; Cancer Institute NSW; Petre Foundation; RT Hall Trust; National Institutes of Health [CA104213, CA099996]; NATIONAL CANCER INSTITUTE [R01CA099996, R01CA104213] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Petre Foundation; RT Hall Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank all of the laboratory and administrative staff that contributed to the editing and preparation of the manuscript. This work was supported by the following grants: the National Health and Medical Research Council of Australia (Grant no. 276408), the Cancer Institute NSW, the Petre Foundation and the RT Hall Trust, the National Institutes of Health Grant CA104213 (ESK), the National Institutes of Health Grant CA099996 (KEK). We thank Drs Paul Crea and Davendra Segara of St Vincent's Clinic for access to patient material and data.	Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Bala S, 2001, CANCER RES, V61, P6042; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Carrere N, 2005, HAEMATOLOGICA, V90, P854; Ceschi M, 2005, CARCINOGENESIS, V26, P1457, DOI 10.1093/carcin/bgi093; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; COMSTOCK CES, 2009, CLIN CANC RES UNPUB; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; Gupta VK, 2008, CLIN CANCER RES, V14, P7804, DOI 10.1158/1078-0432.CCR-08-0744; Holley SL, 2005, INT J CANCER, V114, P364, DOI 10.1002/ijc.20750; Holley SL, 2001, AM J PATHOL, V159, P1917, DOI 10.1016/S0002-9440(10)63038-6; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Knudsen KE, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-15; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Krieger S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-238; Krippl P, 2003, BREAST CANCER RES TR, V82, P165, DOI 10.1023/B:BREA.0000004372.20461.33; Lu FM, 2003, CANCER RES, V63, P7056; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Matthias C, 1998, CLIN CANCER RES, V4, P2411; Naidu R, 2008, NEOPLASMA, V55, P87; Pabalan N, 2008, CANCER EPIDEM BIOMAR, V17, P2773, DOI 10.1158/1055-9965.EPI-08-0169; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Rudas M, 2008, CLIN CANCER RES, V14, P1767, DOI 10.1158/1078-0432.CCR-07-4122; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; Shu XO, 2005, CANCER EPIDEM BIOMAR, V14, P91; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Spruck C, 2006, CANCER RES, V66, P7355, DOI 10.1158/0008-5472.CAN-05-3240; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wang Y, 2008, CANCER RES, V68, P5628, DOI 10.1158/0008-5472.CAN-07-3170; Yu CP, 2008, BREAST CANCER RES TR, V107, P95, DOI 10.1007/s10549-007-9522-y; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	44	67	68	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1812	1820		10.1038/onc.2009.13	http://dx.doi.org/10.1038/onc.2009.13			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19287456	Green Accepted			2022-12-25	WOS:000265640400008
J	Stork, W; Diezel, C; Halitschke, R; Galis, I; Baldwin, IT				Stork, William; Diezel, Celia; Halitschke, Rayko; Galis, Ivan; Baldwin, Ian T.			An Ecological Analysis of the Herbivory-Elicited JA Burst and Its Metabolism: Plant Memory Processes and Predictions of the Moving Target Model	PLOS ONE			English	Article								Background: Rapid herbivore-induced jasmonic acid (JA) accumulation is known to mediate many induced defense responses in vascular plants, but little is known about how JA bursts are metabolized and modified in response to repeated elicitations, are propagated throughout elicited leaves, or how they directly influence herbivores. Methodology/Principal Findings: We found the JA burst in a native population of Nicotiana attenuata to be highly robust despite environmental variation and we examined the JA bursts produced by repeated elicitations with Manduca sexta oral secretions (OS) at whole- and within-leaf spatial scales. Surprisingly, a 2(nd) OS-elicitation suppressed an expected JA burst at both spatial scales, but subsequent elicitations caused more rapid JA accumulation in elicited tissue. The baseline of induced JA/JA-Ile increased with number of elicitations in discrete intervals. Large veins constrained the spatial spread of JA bursts, leading to heterogeneity within elicited leaves. 1(st)-instar M. sexta larvae were repelled by elicitations and changed feeding sites. JA conjugated with isoleucine (JA-Ile) translates elicitations into defense production (e. g., TPIs), but conjugation efficiency varied among sectors and depended on NaWRKY3/6 transcription factors. Elicited TPI activity correlated strongly with the heterogeneity of JA/JA-Ile accumulations after a single elicitation, but not repeated elicitations. Conclusions/Significance: Ecologically informed scaling of leaf elicitation reveals the contribution of repeated herbivory events to the formation of plant memory of herbivory and the causes and importance of heterogeneity in induced defense responses. Leaf vasculature, in addition to transmitting long-distance damage cues, creates heterogeneity in JA bursts within attacked leaves that may be difficult for an attacking herbivore to predict. Such unpredictability is a central tenet of the Moving Target Model of defense, which posits that variability in itself is defensive.	[Stork, William; Diezel, Celia; Halitschke, Rayko; Galis, Ivan; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Stork, W (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Beutenberg Campus, Jena, Germany.	baldwin@ice.mpg.de	Galis, Ivan/F-5734-2011; Halitschke, Rayko/AAY-2365-2020; Baldwin, Ian T/K-1809-2013	Halitschke, Rayko/0000-0002-1109-8782; Baldwin, Ian/0000-0001-5371-2974; Galis, Ivan/0000-0001-9840-8845	Max Planck Society; Deutscher Akademischer Austauschdienst	Max Planck Society(Max Planck Society); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	Funding provided by the Max Planck Society and the Deutscher Akademischer Austauschdienst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1994, AM NAT, V144, P813, DOI 10.1086/285708; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; BALDWIN IT, 1994, J CHEM ECOL, V20, P2373, DOI 10.1007/BF02033208; Beckers GJ, 2007, CURR OPIN PLANT BIOL, V10, P425, DOI 10.1016/j.pbi.2007.06.002; Bernays EA, 2000, J INSECT PHYSIOL, V46, P825, DOI 10.1016/S0022-1910(99)00172-9; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Conconi A, 1996, NATURE, V383, P826, DOI 10.1038/383826a0; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; GALIS I, 2008, PLANT CELL IN PRESS; GFELLER A, 2006, SCI STKE, pCM1; Giri AP, 2006, PLANT PHYSIOL, V142, P1621, DOI 10.1104/pp.106.088781; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; JONGSMA MA, 1993, ANAL BIOCHEM, V212, P79, DOI 10.1006/abio.1993.1294; JONGSMA MA, 1994, PLANTA, V195, P29, DOI 10.1007/BF00206288; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; OHNMEISS TE, 1994, ECOLOGY, V75, P995, DOI 10.2307/1939423; Orians CM, 2000, J CHEM ECOL, V26, P471, DOI 10.1023/A:1005469724427; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Preston CA, 1999, ECOLOGY, V80, P481, DOI 10.1890/0012-9658(1999)080[0481:PANSRG]2.0.CO;2; Rakwal R, 2000, ELECTROPHORESIS, V21, P2492, DOI 10.1002/1522-2683(20000701)21:12<2492::AID-ELPS2492>3.0.CO;2-2; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schittko U, 2000, PLANTA, V210, P343, DOI 10.1007/PL00008143; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; SEMBDNER G, 1993, ANNU REV PLANT PHYS, V44, P569, DOI 10.1146/annurev.pp.44.060193.003033; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; SKIBBE M, 2008, PLANT CELL IN PRESS; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; van Bentem SD, 2007, TRENDS PLANT SCI, V12, P404, DOI 10.1016/j.tplants.2007.08.007; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Van Dam NM, 2001, ECOL ENTOMOL, V26, P578, DOI 10.1046/j.1365-2311.2001.00366.x; von Dahl CC, 2004, PHYSIOL PLANTARUM, V120, P474, DOI 10.1111/j.0031-9317.2004.00269.x; Wang L, 2007, PLANTA, V226, P159, DOI 10.1007/s00425-007-0477-3; Winz RA, 2001, PLANT PHYSIOL, V125, P2189, DOI 10.1104/pp.125.4.2189; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2006, PLANTA, V224, P750, DOI 10.1007/s00425-006-0256-6; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x	65	47	49	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4697	10.1371/journal.pone.0004697	http://dx.doi.org/10.1371/journal.pone.0004697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277115	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496100004
J	Abe, Y; Yoon, SO; Kubota, K; Mendoza, MC; Gygi, SP; Blenis, J				Abe, Yuki; Yoon, Sang-Oh; Kubota, Kazuishi; Mendoza, Michelle C.; Gygi, Steven P.; Blenis, John			p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR COMPLEX; IN-VIVO; MOLECULAR CHAPERONES; CYTOPLASMIC CHAPERONIN; PROTEIN-SYNTHESIS; NASCENT CHAIN; AKT SUBSTRATE; IDENTIFICATION; RSK; ACTIN	Chaperonin containing TCP-1 (CCT) is a large multisubunit complex that mediates protein folding in eukaryotic cells. CCT participates in the folding of newly synthesized polypeptides, including actin, tubulin, and several cell cycle regulators; therefore, CCT plays an important role in cytoskeletal organization and cell division. Here we identify the chaperonin CCT as a novel physiological substrate for p90 ribosomal S6 kinase (RSK) and p70 ribosomal S6 kinase (S6K). RSK phosphorylates the beta subunit of CCT in response to tumor promoters or growth factors that activate the Ras-mitogen-activated protein kinase (MAPK) pathway. CCT beta Ser-260 was identified as the RSK site by mass spectrometry and confirmed by site-directed mutagenesis. RSK-dependent Ser-260 phosphorylation was sensitive to the MEK inhibitor UO126 and the RSK inhibitor BID-1870. Insulin weakly activates RSK but strongly activates the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway and utilizes S6K to regulate CCT beta phosphorylation. Thus, the Ras-MAPK and PI3K-mTOR pathways converge on CCT beta Ser-260 phosphorylation in response to multiple agonists in various mammalian cells. We also show that RNA interference-mediated knockdown of endogenous CCT beta causes impaired cell proliferation that can be rescued with ectopically expressed murine CCT beta wild-type or phosphomimetic mutant S260D, but not the phosphorylation-deficient mutant S260A. Although the molecular mechanism of CCT beta regulation remains unclear, our findings demonstrate a link between oncogene and growth factor signaling and chaperonin CCT-mediated cellular activities.	[Abe, Yuki; Yoon, Sang-Oh; Kubota, Kazuishi; Mendoza, Michelle C.; Gygi, Steven P.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blenis, J (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	john_blenis@hms.harvard.edu			National Institutes of Health [R37CA046595, RO1GM051405, HG3456]; NATIONAL CANCER INSTITUTE [R37CA046595] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37CA046595 (to J.B.), RO1GM051405 (to J.B.), and HG3456 (to S. P. G.).	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Archibald JM, 2001, J STRUCT BIOL, V135, P157, DOI 10.1006/jsbi.2001.4353; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN XY, 1994, P NATL ACAD SCI USA, V91, P9111, DOI 10.1073/pnas.91.19.9111; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; GROVE JR, 1993, BIOCHEMISTRY-US, V32, P7727, DOI 10.1021/bi00081a018; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; HOFFMAN M, 2003, Patent No. 03020722; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Konishi H, 2007, J BIOL CHEM, V282, P23491, DOI 10.1074/jbc.M611703200; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Ma X, 2008, BBA-PROTEINS PROTEOM, V1784, P882, DOI 10.1016/j.bbapap.2008.02.008; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin KA, 2001, J BIOL CHEM, V276, P7884, DOI 10.1074/jbc.M006969200; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Miller EJ, 2006, PROTEIN SCI, V15, P1522, DOI 10.1110/ps.052001606; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Szpikowska BK, 1998, PROTEIN SCI, V7, P1524, DOI 10.1002/pro.5560070705; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhao YG, 2001, J BIOL CHEM, V276, P32822, DOI 10.1074/jbc.M105562200	62	67	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14939	14948		10.1074/jbc.M900097200	http://dx.doi.org/10.1074/jbc.M900097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332537	Green Published, hybrid			2022-12-25	WOS:000266288200030
J	Marty, NJ; Rajalingam, D; Kight, AD; Lewis, NE; Fologea, D; Kumar, TKS; Henry, RL; Goforth, RL				Marty, Naomi J.; Rajalingam, Dakshinamurthy; Kight, Alicia D.; Lewis, Nathaniel E.; Fologea, Daniel; Kumar, Thallapuranam Krishnaswamy Suresh; Henry, Ralph L.; Goforth, Robyn L.			The Membrane-binding Motif of the Chloroplast Signal Recognition Particle Receptor (cpFtsY) Regulates GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRP-RECEPTOR; CIRCULAR-DICHROISM; THYLAKOID MEMBRANE; PROTEIN-TRANSPORT; FTSY; DOMAIN; RNA; PHENYLALANINE; POLYPEPTIDE; TRANSLOCASE	The chloroplast signal recognition particle (cpSRP) and its receptor (cpFtsY) function in thylakoid biogenesis to target integral membrane proteins to thylakoids. Unlike cytosolic SRP receptors in eukaryotes, cpFtsY partitions between thylakoid membranes and the soluble stroma. Based on sequence alignments, a membrane-binding motif identified in Escherichia coli FtsY appears to be conserved in cpFtsY, yet whether the proposed motif is responsible for the membrane-binding function of cpFtsY has yet to be shown experimentally. Our studies show that a small N-terminal region in cpFtsY stabilizes a membrane interaction critical to cpFtsY function in cpSRP-dependent protein targeting. This membrane-binding motif is both necessary and sufficient to direct cpFtsY and fused passenger proteins to thylakoids. Our results demonstrate that the cpFtsY membrane-binding motif may be functionally replaced by the corresponding region from E. coli, confirming that the membrane-binding motif is conserved among organellar and prokaryotic homologs. Furthermore, the capacity of cpFtsY for lipid binding correlates with liposome-induced GTP hydrolysis stimulation. Mutations that debilitate the membrane-binding motif in cpFtsY result in higher rates of GTP hydrolysis, suggesting that negative regulation is provided by the intact membrane-binding region in the absence of a bilayer. Furthermore, NMR and CD structural studies of the N-terminal region and the analogous region in the E. coli SRP receptor revealed a conformational change in secondary structure that takes place upon lipid binding. These studies suggest that the cpFtsY membrane-binding motif plays a critical role in the intramolecular communication that regulates cpSRP receptor functions at the membrane.	[Marty, Naomi J.; Kight, Alicia D.; Lewis, Nathaniel E.; Fologea, Daniel; Henry, Ralph L.; Goforth, Robyn L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Rajalingam, Dakshinamurthy; Kumar, Thallapuranam Krishnaswamy Suresh] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Goforth, RL (corresponding author), Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA.	Robyn.Goforth@uark.edu	Kumar, Suresh Thallapuranam/R-5606-2016; Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020	Kumar, Suresh Thallapuranam/0000-0001-7262-1373; Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604	National Institutes of Health [P20RR15569]; Department of Energy [DE-FG02-01ER15161]; Arkansas Bioscience Institute; National Science Foundation [0139570]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Arkansas Bioscience Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR15569 (to R. L. G. and T. K. S. K.) from the Centers of Biomedical Research Excellence Program of the National Center for Research Resources. This work was also supported by Department of Energy Grant DE-FG02-01ER15161 (to R. L. H., T. K. S. K., and R. L. G.), the Arkansas Bioscience Institute, and the National Science Foundation GK-12 Outreach funded by National Science Foundation Grant 0139570.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; BUSH CA, 1978, BIOCHEMISTRY-US, V17, P4951, DOI 10.1021/bi00616a015; CARNEY J, 2006, CURR PROTOCOLS PROTE; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1989, J BIOL CHEM, V264, P14225; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DOUCE R, 1996, ADV PHOTOSYNTH, V4, P69; Egea PF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003619; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; GODDARD TD, 1997, SPARKY3; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Henry R, 2007, ENZYMES, V25, P493, DOI 10.1016/S1874-6047(07)25019-X; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Samuelsson T, 1999, NUCLEIC ACIDS RES, V27, P169, DOI 10.1093/nar/27.1.169; Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; Wang YJ, 1997, J BIOMOL NMR, V10, P373, DOI 10.1023/A:1018315729609; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	44	20	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14891	14903		10.1074/jbc.M900775200	http://dx.doi.org/10.1074/jbc.M900775200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19293157	hybrid, Green Published			2022-12-25	WOS:000266288200025
J	Lee, SB; Ou, DSC; Lee, CF; Juan, LJ				Lee, Sung-Bau; Ou, Derick S-C.; Lee, Chung-Fan; Juan, Li-Jung			Gene-specific Transcriptional Activation Mediated by the p150 Subunit of the Chromatin Assembly Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; S-PHASE; HUMAN CYTOMEGALOVIRUS; CELL-DIVISION; MOUSE CELLS; FACTOR-I; PROTEIN; CAF-1; YEAST; INHERITANCE	Chromatin assembly factor 1 contains three subunits, p150, p60, and p48. It is essential for coupling nucleosome assembly to newly synthesized DNA. Whether chromatin assembly factor 1 subunits have functions beyond escorting histones, which depends on the complex formation of p150 and p60, has been an issue of great interest. This study reveals a novel role of p150, but not p60, in gene-specific transcriptional activation. We found that p150 transcriptionally activated an essential viral promoter, the major immediate early promoter (MIEP) of the human cytomegalovirus, independently of p60. Knocking down p150 decreased the MIEP function in both transfected and virally infected cells. The chromatin immunoprecipitation analysis and the in vitro protein-DNA binding assay demonstrated that p150 used its KER domain to associate with the MIEP from -593 to -574 bp. The N-terminal 244 residues were also found essential for p150-mediated MIEP activation, likely through recruiting the acetyltransferase p300 to acetylate local histones. Domain swapping experiments further showed that the KER and the N terminus of p150 acted as an independent DNA binding and transcriptional activation domain, respectively. Because p60 did not seem involved in the reaction, together these results indicate for the first time that p150 directly activates transcription, independently of its histone deposition function.	[Lee, Sung-Bau; Ou, Derick S-C.; Lee, Chung-Fan; Juan, Li-Jung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Sung-Bau] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Lee, Sung-Bau; Lee, Chung-Fan] Natl Hlth Res Inst, Inst Canc Res, Zhunan Town 350, Miaoli County, Taiwan; [Ou, Derick S-C.] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu 300, Taiwan; [Lee, Chung-Fan] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Health Research Institutes - Taiwan; National Tsing Hua University; National Taiwan University	Juan, LJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ljjuan@gate.sinica.edu.tw	Juan, Li-Jung/H-6631-2015; Lee, Sung-Bau/AAJ-5176-2021	Lee, Sung-Bau/0000-0002-8628-8687; Ou, Shi-Chen/0000-0002-9129-9030	Genomics Research Center; National Health Research Institutes	Genomics Research Center; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by grants from the Genomics Research Center and the National Health Research Institutes ( to L.-J.J.).	Banks GC, 1999, J BIOL CHEM, V274, P16536, DOI 10.1074/jbc.274.23.16536; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Marheineke K, 1998, J BIOL CHEM, V273, P15279, DOI 10.1074/jbc.273.24.15279; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Monson EK, 1997, P NATL ACAD SCI USA, V94, P13081, DOI 10.1073/pnas.94.24.13081; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Ramirez-Parra E, 2007, TRENDS PLANT SCI, V12, P570, DOI 10.1016/j.tplants.2007.10.002; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SPAETE RR, 1987, P NATL ACAD SCI USA, V84, P7213, DOI 10.1073/pnas.84.20.7213; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005	32	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14040	14049		10.1074/jbc.M901833200	http://dx.doi.org/10.1074/jbc.M901833200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324875	Green Published, hybrid			2022-12-25	WOS:000266286100010
J	Thompson, BR; Mazurkiewicz-Munoz, AM; Suttles, J; Carter-Su, C; Bernlohr, DA				Thompson, Brian R.; Mazurkiewicz-Munoz, Anna M.; Suttles, Jill; Carter-Su, Christin; Bernlohr, David A.			Interaction of Adipocyte Fatty Acid-binding Protein (AFABP) and JAK2 AFABP/aP2 AS A REGULATOR OF JAK2 SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID-BINDING; APOLIPOPROTEIN-E; AP2; INTERLEUKIN-6; CYTOKINE; SOCS3; ATHEROSCLEROSIS; MACROPHAGES; ACTIVATION	Adipocyte fatty acid-binding protein (AFABP/aP2) facilitates the intracellular solubilization and trafficking of lipids within the aqueous environment of the cell. Studies in the AFABP/aP2 knock-out mouse suggest that the protein may have roles in cellular processes broader than lipid transport. We present herein the finding that AFABP/aP2 interacts with JAK2 in a fatty acid-dependent manner. This interaction was established using yeast two-hybrid analysis, co-immunoprecipitation from adipose tissue, and 3T3-L1 adipocytes as well as in 293 cells overexpressing JAK2 and AFABP/aP2. Mutational analysis of AFABP/aP2 (R126L/Y128F) revealed that fatty acid binding activity is necessary for the interaction and that Asp18 of the helix-turn-helix motif forms a component of the interaction domain. Mutational analysis of JAK2 (Y1007F/Y1008F) revealed that AFABP/aP2 associates with the basal unphosphorylated form of the protein. Interleukin-6, but not interleukin-10, stimulated phosphorylation of STAT3, and induction of SOCS3 mRNA expression were potentiated in a time-and dose-dependent manner in macrophage cell lines derived from AFABP/aP2-EFABP/mal1 double knock-out mice relative to cells from wild type animals. These results suggest that ligand-bound AFABP/aP2 binds to and attenuates JAK2 signaling and establishes a new role for AFABP/aP2 as a fatty acid sensor affecting cellular metabolism via protein-protein interactions.	[Thompson, Brian R.; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Mazurkiewicz-Munoz, Anna M.; Carter-Su, Christin] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Suttles, Jill] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Louisville	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	Bernl001@umn.edu			National Institutes of Health [DK053189, R01 AI048850, DK34171]; Minnesota Obesity Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034171, R01DK053189, R01DK034171, R56DK053189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Obesity Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK053189 (to D. A. B.), R01 AI048850 (to J. S.), and NIH DK34171 (to C. C.- S.). This work was also supported by the Minnesota Obesity Center.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Clemons-Miller AR, 2000, IMMUNOBIOLOGY, V202, P477, DOI 10.1016/S0171-2985(00)80105-9; Coe NR, 1999, J LIPID RES, V40, P967; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Hertzel AV, 2002, J LIPID RES, V43, P2105, DOI 10.1194/jlr.M200227-JLR200; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; SHA RS, 1993, J BIOL CHEM, V268, P7885; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; XU ZH, 1993, J BIOL CHEM, V268, P7874; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	42	36	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13473	13480		10.1074/jbc.M900075200	http://dx.doi.org/10.1074/jbc.M900075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318353	hybrid, Green Published			2022-12-25	WOS:000265877300023
J	Bertini, I; Fragai, M; Luchinat, C; Melikian, M; Mylonas, E; Sarti, N; Svergun, DI				Bertini, Ivano; Fragai, Marco; Luchinat, Claudio; Melikian, Maxime; Mylonas, Efstratios; Sarti, Niko; Svergun, Dmitri I.			Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; NEUTROPHIL COLLAGENASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; SUBSTRATE-SPECIFICITY; SURFACE ACCESSIBILITY; ACTIVATION MECHANISM; TISSUE INHIBITORS; PEPTIDE MODELS; NMR RELAXATION	The presence of extensive reciprocal conformational freedom between the catalytic and the hemopexin-like domains of fulllength matrix metalloproteinase-1 (MMP-1) is demonstrated by NMR and small angle x-ray scattering experiments. This finding is discussed in relation to the essentiality of the hemopexin-like domain for the collagenolytic activity of MMP-1. The conformational freedom experienced by the present system, having the shortest linker between the two domains, when compared with similar findings on MMP-12 and MMP-9 having longer and the longest linker within the family, respectively, suggests this type of conformational freedom to be a general property of all MMPs.	[Bertini, Ivano; Fragai, Marco; Luchinat, Claudio; Melikian, Maxime; Sarti, Niko] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Bertini, Ivano; Sarti, Niko] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Fragai, Marco; Luchinat, Claudio] Univ Florence, Dept Agr Biotechnol, I-50144 Florence, Italy; [Mylonas, Efstratios; Svergun, Dmitri I.] Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	University of Florence; University of Florence; University of Florence; European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Bertini, I (corresponding author), Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Mylonas, Efstratios/AAC-4948-2022; Fragai, Marco/K-4732-2015	Fragai, Marco/0000-0002-8440-1690; Melikian, Maxime/0000-0003-4846-1749; Svergun, Dmitri/0000-0003-0830-5696; Luchinat, Claudio/0000-0003-2271-8921; Mylonas, Efstratios/0000-0003-4476-3010	European Commission [MEST-CT-2004-504391]; SFMET [201640]; SPINE2-COMPLEXES [031220]; Nano4Drugs [LSHB-CT-2005019102]; Ministero dell'Istruzione, dell'Universita` e della Ricerca [2005039878, RBLA032ZM7, RBIP06LSS2]; Ente Cassa di Risparmio di Firenze	European Commission(European CommissionEuropean Commission Joint Research Centre); SFMET; SPINE2-COMPLEXES; Nano4Drugs; Ministero dell'Istruzione, dell'Universita` e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the European Commission (Projects MEST-CT-2004-504391, SFMET Number 201640, SPINE2-COMPLEXES Number 031220, and Nano4Drugs Number LSHB-CT-2005019102), the Ministero dell'Istruzione, dell'Universita` e della Ricerca (PRIN 2005, Protocollo Number 2005039878, Protocollo RBLA032ZM7, Protocollo RBIP06LSS2), and the Ente Cassa di Risparmio di Firenze.	Aime S, 2002, J BIOL INORG CHEM, V7, P617, DOI 10.1007/s00775-002-0340-8; Andreini C, 2004, J PROTEOME RES, V3, P21, DOI 10.1021/pr0340476; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernini A, 2008, BIOPHYS CHEM, V137, P71, DOI 10.1016/j.bpc.2008.07.003; Bertini I, 2004, ANGEW CHEM INT EDIT, V43, P2254, DOI 10.1002/anie.200353453; Bertini I, 2003, ANGEW CHEM INT EDIT, V42, P2673, DOI 10.1002/anie.200350957; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; ESPOSITO G, 1992, J MOL BIOL, V224, P659, DOI 10.1016/0022-2836(92)90551-T; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Gioia M, 2002, J BIOL CHEM, V277, P23123, DOI 10.1074/jbc.M110873200; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Impagliazzo A, 2004, J AM CHEM SOC, V126, P5658, DOI 10.1021/ja049619h; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Nesi A, 2007, CHEMBIOCHEM, V8, P1367, DOI 10.1002/cbic.200700055; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PENG JW, 1994, METHOD ENZYMOL, V239, P563; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Scarselli M, 1998, EUR J BIOCHEM, V254, P313, DOI 10.1046/j.1432-1327.1998.2540313.x; Scarselli M, 1999, J BIOMOL NMR, V15, P125, DOI 10.1023/A:1008319507565; Spiga O, 2002, FEBS LETT, V511, P33, DOI 10.1016/S0014-5793(01)03274-4; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang TZ, 2005, J AM CHEM SOC, V127, P828, DOI 10.1021/ja045743p; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411	66	64	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12821	12828		10.1074/jbc.M809627200	http://dx.doi.org/10.1074/jbc.M809627200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282283	Green Published, hybrid			2022-12-25	WOS:000265688300027
J	Galli, C; Fu, Q; Wang, WF; Olsen, BR; Manolagas, SC; Jilka, RL; O'Brien, CA				Galli, Carlo; Fu, Qiang; Wang, WenFang; Olsen, Bjorn R.; Manolagas, Stavros C.; Jilka, Robert L.; O'Brien, Charles A.			Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; OSTEOCLAST-DIFFERENTIATION-FACTOR; DISTANT TRANSCRIPTIONAL ENHANCER; INCREASED BONE-FORMATION; GROWTH-FACTOR-BETA; RECEPTOR ACTIVATOR; MESSENGER-RNA; OSTEOPROTEGERIN EXPRESSION; MEDIATED DEGRADATION; TARGETED DELETION	Differentiation of bone-resorbing osteoclasts from hematopoietic precursors depends upon expression of the cytokine receptor activator of NF kappa B ligand (RANKL) by fibroblastic stromal cells, which some evidence suggests are of the osteoblast lineage. We have shown previously that hormonal-responsiveness of the murine RANKL gene is mediated in part by a distal enhancer that binds Runx2, a transcription factor required for commitment to the osteoblast lineage, supporting the idea that osteoclast-supporting stromal cells may be osteoblasts or their progenitors. However, in this study we demonstrate that parathyroid hormone (PTH) stimulation of RANKL in mice is not affected by a significant reduction in the number of osteoblasts. Consistent with this, neither Runx2, nor Cbfb, a binding partner essential for Runx activity, are required for basal or PTH-stimulated RANKL expression in fibroblastic stromal cell models. Nonetheless, RANKL responsiveness to PTH was elevated in cultured calvaria cells expressing high levels of osterix, another transcription factor required for osteoblast differentiation, and this was associated with elevated PTH receptor expression. The responsiveness of RANKL to 1,25-dihydroxyvitamin D-3 was not elevated in the osterix-expressing cells. Together, these results suggest that commitment to the osteoblast lineage is not a requirement for RANKL gene transcription in fibroblastic stromal cells but may enhance responsiveness of this gene to specific hormones via control of their receptors.	[Galli, Carlo; Fu, Qiang; Manolagas, Stavros C.; Jilka, Robert L.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Galli, Carlo; Fu, Qiang; Manolagas, Stavros C.; Jilka, Robert L.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Wang, WenFang; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, 4301 W Markham St,MS 587, Little Rock, AR 72205 USA.	caobrien@uams.edu	Galli, Carlo/D-4728-2014; O'Brien, Charles A./AAL-5078-2020	Galli, Carlo/0000-0001-7476-7181; 	National Institutes of Health [R01 AR049794, P01 AG13918]; University of Parma; UAMS Tobacco Settlement Funds; Veterans Affairs Merit Reviews; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Parma; UAMS Tobacco Settlement Funds; Veterans Affairs Merit Reviews(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR049794 (to C.A.O.) and P01 AG13918 (to S. C. M.). This work was also supported by an institutional award from the University of Parma (to C. G.), UAMS Tobacco Settlement Funds, and by Veterans Affairs Merit Reviews (to S. C. M. and R.L.J.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Gao YH, 1998, BIOCHEM BIOPH RES CO, V252, P697, DOI 10.1006/bbrc.1998.9643; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Ikeda T, 2001, J BONE MINER RES, V16, P1416, DOI 10.1359/jbmr.2001.16.8.1416; Ishida A, 2002, J BIOL CHEM, V277, P26217, DOI 10.1074/jbc.M111093200; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lien CY, 2007, STEM CELLS, V25, P1462, DOI 10.1634/stemcells.2006-0391; Lin SC, 1997, J CLIN INVEST, V100, P1980, DOI 10.1172/JCI119729; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MAJESKA RJ, 1982, CALCIFIED TISSUE INT, V34, P59, DOI 10.1007/BF02411210; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANOLAGAS SC, 1996, PRINCIPLES BONE BIOL; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Mori K, 2006, J CELL BIOCHEM, V98, P1629, DOI 10.1002/jcb.20891; Nagy A., 2003, MANIPULATING MOUSE E; Notoya M, 2004, BIOCHEM BIOPH RES CO, V324, P655, DOI 10.1016/j.bbrc.2004.09.101; O'Brien CA, 2002, BONE, V30, P453, DOI 10.1016/S8756-3282(01)00692-5; OBrien CA, 1997, J BIOL CHEM, V272, P15003, DOI 10.1074/jbc.272.23.15003; Ominsky MS, 2008, J BONE MINER RES, V23, P672, DOI 10.1359/JBMR.080109; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Quinn JMW, 2000, J BONE MINER RES, V15, P1459, DOI 10.1359/jbmr.2000.15.8.1459; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Silvestrini G, 2005, J MOL HISTOL, V36, P59, DOI 10.1007/s10735-004-3839-1; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tang YY, 2000, FEBS LETT, V470, P167, DOI 10.1016/S0014-5793(00)01312-0; Tat SK, 2008, BONE, V43, P284, DOI 10.1016/j.bone.2008.04.006; Tozum TF, 2004, CALCIFIED TISSUE INT, V75, P60, DOI 10.1007/s00223-004-0119-8; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	61	37	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12654	12662		10.1074/jbc.M806628200	http://dx.doi.org/10.1074/jbc.M806628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279010	Green Published, hybrid			2022-12-25	WOS:000265688300009
J	He, XQ; Ma, Q				He, Xiaoqing; Ma, Qiang			Induction of Metallothionein I by Arsenic via Metal-activated Transcription Factor 1 CRITICAL ROLE OF C-TERMINAL CYSTEINE RESIDUES IN ARSENIC SENSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE TRANSCRIPTION; FACTOR MTF-1; ZINC FINGERS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; NAD(P)H-QUINONE OXIDOREDUCTASE; HEAVY-METALS; MOUSE; PROTECTION	Metal-activated transcription factor 1 (MTF1) mediates the induction of metallothioneins I and II by zinc and stress signals. The mechanism of MTF1 activation has not been well understood. We analyzed the interaction between arsenic (As3+) and MTF1 for Mt1 induction. As3+ potently induces Mt1 mRNA expression in mouse hepa1c1c7 cells. Induction is dependent upon functional MTF1 as induction is lost in Mtf1 knockout cells but is restored upon reconstitution with Mtf1; moreover, As3+ induces the binding of MTF1 to the metal response elements of endogenous Mt1. Induction is not affected by modulating zinc concentrations but is markedly enhanced by cycloheximide. Phenylarsine oxide (PAO), which covalently binds to vicinal protein cysteine thiol groups, induces Mt1 with a magnitude of higher potency than that of As3+. PAO affinity beads effectively pulls down the carboxyl half of MTF1 (MTF1(321-675)) by binding to a cluster of five cysteine residues near the terminus. Preincubation with As3+, Cd2+, Co2+, Ni2+, Ag+, Hg2+, and Bi3+ blocks pulldown ofMTF1(321-675) by PAO beads in vitro and in vivo, indicating that binding of the metal inducers to the same C-terminal cysteine cluster as PAO occurs. Deletion of the C-terminal cysteine cluster or mutation of the cysteine residues abolishes or markedly reduces the transcription activation activity of MTF1 and the ability of MTF1 to restore Mt1 induction in Mtf1 knockout cells. The findings demonstrate a critical role of the C-terminal cysteine cluster of MTF1 in arsenic sensing and gene transcription via arsenic-cysteine thiol interaction.	[He, Xiaoqing; Ma, Qiang] NIOSH, Receptor Biol Lab, Toxicol & Mol Biol Branch, Hlth Effects Lab,Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Ma, Qiang] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University	Ma, Q (corresponding author), NIOSH, Receptor Biol Lab, Toxicol & Mol Biol Branch, Hlth Effects Lab,Ctr Dis Control & Prevent, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	qam1@cdc.gov	Ebenso, Eno E./D-2585-2011; ma, qiang/HCI-1013-2022; EBENSO, ENO/AAB-6762-2022	Ebenso, Eno E./0000-0002-0411-9258; EBENSO, ENO/0000-0002-0411-9258				Adams TK, 2002, ENVIRON HEALTH PERSP, V110, P813, DOI 10.1289/ehp.02110s5813; Aitken Alastair, 1996, P487, DOI 10.1007/978-1-60327-259-9_82; Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Bi YY, 2006, J BIOCHEM MOL TOXIC, V20, P57, DOI 10.1002/jbt.20116; Bianco NR, 2005, BIOCHEM J, V385, P279, DOI 10.1042/BJ20040959; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chappell WR, 1997, ENVIRON HEALTH PERSP, V105, P1060, DOI 10.1289/ehp.971051060; Chen XH, 2004, J BIOL CHEM, V279, P4515, DOI 10.1074/jbc.M308924200; Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Giedroc DP, 2001, J BIOL CHEM, V276, P42322, DOI 10.1074/jbc.M106517200; Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552; GOMEZCAMINERO A, 2001, ENVIRON HEALTH CRIT, V224, P1; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; He XQ, 2007, TOXICOL SCI, V98, P298, DOI 10.1093/toxsci/kfm081; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Jiang HM, 2003, J BIOL CHEM, V278, P30394, DOI 10.1074/jbc.M303598200; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; LEONARD A, 1980, MUTAT RES, V75, P49, DOI 10.1016/0165-1110(80)90027-5; Li Y, 2006, MOL CELL BIOL, V26, P5580, DOI 10.1128/MCB.00471-06; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Liu J, 2008, CASARETT DOULLS TOXI, P931; Ma Q, 2004, BIOCHEM J, V377, P205, DOI 10.1042/BJ20031123; Ma Q, 2008, CHEM RES TOXICOL, V21, P1651, DOI 10.1021/tx800156s; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Mastin JP, 2005, CARDIOVASC TOXICOL, V5, P91, DOI 10.1385/CT:5:2:091; Maur AAD, 1999, BIOL CHEM, V380, P175, DOI 10.1515/BC.1999.026; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Nishikimi A, 2001, BIOCHEM J, V356, P621, DOI 10.1042/0264-6021:3560621; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; SARKAR B, 1983, BIOL ASPECTS METALS, P1; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Saydam N, 2003, J BIOL CHEM, V278, P31879, DOI 10.1074/jbc.M302138200; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Tamura Y, 2005, ONCOGENE, V24, P399, DOI 10.1038/sj.onc.1208197; TAYLOR PR, 1989, BRIT J IND MED, V46, P881; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003	53	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12609	12621		10.1074/jbc.M901204200	http://dx.doi.org/10.1074/jbc.M901204200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276070	Green Published, hybrid			2022-12-25	WOS:000265688300005
J	Pakotiprapha, D; Liu, Y; Verdine, GL; Jeruzalmi, D				Pakotiprapha, Danaya; Liu, Yi; Verdine, Gregory L.; Jeruzalmi, David			A Structural Model for the Damage-sensing Complex in Bacterial Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; (A)BC EXCINUCLEASE; LIGHT-SCATTERING; COUPLING FACTOR; ACTIVE-SITE; NMR SYSTEM; 5 INCISION; UVRB; DNA; BINDING	Nucleotide excision repair is distinguished from other DNA repair pathways by its ability to process a wide range of structurally unrelated DNA lesions. In bacteria, damage recognition is achieved by the UvrA.UvrB ensemble. Here, we report the structure of the complex between the interaction domains of UvrA and UvrB. These domains are necessary and sufficient for full-length UvrA and UvrB to associate and thereby form the DNA damage-sensing complex of bacterial nucleotide excision repair. The crystal structure and accompanying biochemical analyses suggest a model for the complete damage-sensing complex.	[Pakotiprapha, Danaya; Liu, Yi; Verdine, Gregory L.; Jeruzalmi, David] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Pakotiprapha, Danaya; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu; dj@mcb.harvard.edu	Pakotiprapha, Danaya/B-1032-2013	Pakotiprapha, Danaya/0000-0002-5017-8283	National Institutes of Health [CA100742]; National Center for Research Resources [RR-15301]; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100742 (to G. L. V.). This work was also supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health.	Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BERTRANDBURGGRAF E, 1991, J MOL BIOL, V219, P27, DOI 10.1016/0022-2836(91)90854-Y; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Delagoutte E, 2002, J MOL BIOL, V320, P73, DOI 10.1016/S0022-2836(02)00401-1; DellaVecchia MJ, 2004, J BIOL CHEM, V279, P45245, DOI 10.1074/jbc.M408659200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folta-Stogniew Ewa, 2006, V328, P97; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HSU DS, 1995, J BIOL CHEM, V270, P8319, DOI 10.1074/jbc.270.14.8319; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN JJ, 1992, J BIOL CHEM, V267, P17693; LIN JJ, 1992, J BIOL CHEM, V267, P17688; Malta E, 2007, BIOCHEMISTRY-US, V46, P9080, DOI 10.1021/bi7002235; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Moolenaar GF, 2000, J BIOL CHEM, V275, P8044, DOI 10.1074/jbc.275.11.8044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORREN DK, 1992, J BIOL CHEM, V267, P780; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakotiprapha D, 2008, MOL CELL, V29, P122, DOI 10.1016/j.molcel.2007.10.026; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truglio JJ, 2006, NAT STRUCT MOL BIOL, V13, P360, DOI 10.1038/nsmb1072; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Truglio JJ, 2004, EMBO J, V23, P2498, DOI 10.1038/sj.emboj.7600263; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485	34	40	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12837	12844		10.1074/jbc.M900571200	http://dx.doi.org/10.1074/jbc.M900571200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19287003	Green Published, hybrid			2022-12-25	WOS:000265688300029
J	Sun, W; Shahinas, D; Bonvin, J; Hou, WJ; Kimber, MS; Turnbull, J; Christendat, D				Sun, Warren; Shahinas, Dea; Bonvin, Julie; Hou, Wenjuan; Kimber, Matthew S.; Turnbull, Joanne; Christendat, Dinesh			The Crystal Structure of Aquifex aeolicus Prephenate Dehydrogenase Reveals the Mode of Tyrosine Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYRA PROTEIN FAMILY; ESCHERICHIA-COLI; AROGENATE DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; BIOSYNTHESIS; REFINEMENT; PATHWAY; SYNECHOCYSTIS; PURIFICATION	TyrA proteins belong to a family of dehydrogenases that are dedicated to L-tyrosine biosynthesis. The three TyrA subclasses are distinguished by their substrate specificities, namely the prephenate dehydrogenases, the arogenate dehydrogenases, and the cyclohexadienyl dehydrogenases, which utilize prephenate, L-arogenate, or both substrates, respectively. The molecular mechanism responsible for TyrA substrate selectivity and regulation is unknown. To further our understanding of TyrA-catalyzed reactions, we have determined the crystal structures of Aquifex aeolicus prephenate dehydrogenase bound with NAD(+) plus either 4-hydroxyphenylpyuvate, 4-hydroxyphenylpropionate, or L-tyrosine and have used these structures as guides to target active site residues for site-directed mutagenesis. From a combination of mutational and structural analyses, we have demonstrated that His-147 and Arg-250 are key catalytic and binding groups, respectively, and Ser-126 participates in both catalysis and substrate binding through the ligand 4-hydroxyl group. The crystal structure revealed that tyrosine, a known inhibitor, binds directly to the active site of the enzyme and not to an allosteric site. The most interesting finding though, is that mutating His-217 relieved the inhibitory effect of tyrosine on A. aeolicus prephenate dehydrogenase. The identification of a tyrosine-insensitive mutant provides a novel avenue for designing an unregulated enzyme for application in metabolic engineering.	[Sun, Warren; Shahinas, Dea; Christendat, Dinesh] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Bonvin, Julie; Hou, Wenjuan; Turnbull, Joanne] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada; [Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Toronto; Concordia University - Canada; University of Guelph	Christendat, D (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	dinesh.christendat@utoronto.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada; United States Dept. of Energy; Office of Energy Research [W-31-109-ENG-38]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); United States Dept. of Energy; Office of Energy Research	This work was supported in part by research grants from the Natural Sciences and Engineering Research Council of Canada (to D.C. and J.T.). Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Energy Research, under Contract W-31-109-ENG-38.	BONNER C, 1987, METHOD ENZYMOL, V142, P488; BONNER C, 1987, METHOD ENZYMOL, V142, P479; Bonner CA, 2004, BIOCHEM J, V382, P279, DOI 10.1042/BJ20031809; Bonner CA, 2008, MICROBIOL MOL BIOL R, V72, P13, DOI 10.1128/MMBR.00026-07; Bonvin J, 2006, PROTEIN SCI, V15, P1417, DOI 10.1110/ps.051942206; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAMPNEY WS, 1970, J BIOL CHEM, V245, P3763; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Christendat D, 1998, BIOCHEMISTRY-US, V37, P15703, DOI 10.1021/bi981412b; Christendat D, 1999, BIOCHEMISTRY-US, V38, P4782, DOI 10.1021/bi982673o; Cleland W W, 1979, Methods Enzymol, V63, P103; COBBETT CS, 1987, J BACTERIOL, V169, P2500, DOI 10.1128/jb.169.6.2500-2506.1987; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEWICK PM, 1984, NAT PROD REP, V1, P451, DOI 10.1039/np9840100451; Duzinski P K, 1976, Prep Biochem, V6, P113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; FAZEL AM, 1979, J BACTERIOL, V138, P805, DOI 10.1128/JB.138.3.805-815.1979; FAZEL AM, 1980, P NATL ACAD SCI-BIOL, V77, P1270, DOI 10.1073/pnas.77.3.1270; JENSEN RA, 1975, J MOL EVOL, V4, P249, DOI 10.1007/BF01732984; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Legrand P, 2006, STRUCTURE, V14, P767, DOI 10.1016/j.str.2006.01.006; LINDBLAD B, 1977, J BIOL CHEM, V252, P5073; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Meganathan R, 2001, VITAM HORM, V61, P173; Memelink J, 2004, NAT BIOTECHNOL, V22, P1526, DOI 10.1038/nbt1204-1526; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rinaldi AC, 1998, EUR J BIOCHEM, V251, P91, DOI 10.1046/j.1432-1327.1998.2510091.x; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; SAMPATHKUMAR P, 1982, BIOCHIM BIOPHYS ACTA, V702, P212, DOI 10.1016/0167-4838(82)90505-2; Song J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-13; Sun W, 2006, J BIOL CHEM, V281, P12919, DOI 10.1074/jbc.M511986200; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; TURNBULL J, 1991, BIOCHEMISTRY-US, V30, P7783, DOI 10.1021/bi00245a017; TURNBULL J, 1991, BIOCHEMISTRY-US, V30, P7777, DOI 10.1021/bi00245a016; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; XIA T, 1993, J MOL EVOL, V36, P107, DOI 10.1007/BF00166246; Xie G, 2000, COMP BIOCHEM PHYS C, V125, P65, DOI 10.1016/S0742-8413(99)00090-0	42	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13223	13232		10.1074/jbc.M806272200	http://dx.doi.org/10.1074/jbc.M806272200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279014	hybrid, Green Published			2022-12-25	WOS:000265688300069
J	Carbone, L; Mootnick, AR; Nadler, T; Moisson, P; Ryder, O; Roos, C; de Jong, PJ				Carbone, Lucia; Mootnick, Alan R.; Nadler, Tilo; Moisson, Pierre; Ryder, Oliver; Roos, Christian; de Jong, Pieter J.			A Chromosomal Inversion Unique to the Northern White-Cheeked Gibbon	PLOS ONE			English	Article							EVOLUTION; NOMASCUS; PHYLOGENY; TAXONOMY; CONCOLOR; GENOME; GENE	The gibbon family belongs to the superfamily Hominoidea and includes 15 species divided into four genera. Each genus possesses a distinct karyotype with chromosome numbers varying from 38 to 52. This diversity is the result of numerous chromosomal changes that have accumulated during the evolution of the gibbon lineage, a quite unique feature in comparison with other hominoids and most of the other primates. Some gibbon species and subspecies rank among the most endangered primates in the world. Breeding programs can be extremely challenging and hybridization plays an important role within the factors responsible for the decline of captive gibbons. With less than 500 individuals left in the wild, the northern white-cheeked gibbon (Nomascus leucogenys leucogenys, NLE) is the most endangered primate in a successful captive breeding program. We present here the analysis of an inversion that we show being specific for the northern white-cheeked gibbon and can be used as one of the criteria to distinguish this subspecies from other gibbon taxa. The availability of the sequence spanning for one of the breakpoints of the inversion allows detecting it by a simple PCR test also on low quality DNA. Our results demonstrate the important role of genomics in providing tools for conservation efforts.	[Carbone, Lucia; de Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; [Mootnick, Alan R.] Gibbon Conservat Ctr GCC, Santa Clara, CA USA; [Nadler, Tilo] Endangered Primate Rescue Ctr, Cuc Phuong Natl Pk, Nho Quan, Ninh Binh, Vietnam; [Moisson, Pierre] Parc Zool Botan, Mulhouse, France; [Ryder, Oliver] Zool Soc San Diego, San Diego, CA USA; [Roos, Christian] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Zoological Society of San Diego; Deutsches Primatenzentrum (DPZ)	Carbone, L (corresponding author), Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA.	lcarbone@chori.org						Carbone L, 2006, PLOS GENET, V2, P2162, DOI 10.1371/journal.pgen.0020223; COUTURIER J, 1991, FOLIA PRIMATOL, V56, P95, DOI 10.1159/000156533; DUTRILLAUX B, 1975, CYTOGENET CELL GENET, V15, P81, DOI 10.1159/000130504; ELLIOT DG, 1913, REVIEW PRIMATES, V3, P262; Geissmann T, 2002, EVOL ANTHROPOL, V11, P28, DOI 10.1002/evan.10047; Groves CP, 2001, PRIMATE TAXONOMY; Hall LM, 1998, MOL PHYLOGENET EVOL, V10, P281, DOI 10.1006/mpev.1998.0539; Hirai H, 2007, HUM GENET, V122, P477, DOI 10.1007/s00439-007-0425-0; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Konrad R, 2006, INT J PRIMATOL, V27, P713, DOI 10.1007/s10764-006-9042-3; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MARGULIS S, 2008, N AM REGIONAL STUDBO; Misceo D, 2008, GENOME RES, V18, P1530, DOI 10.1101/gr.078295.108; MOISSON P, 2007, EUROPEAN STUDBOOK CR; Monda K, 2007, AM J PRIMATOL, V69, P1285, DOI 10.1002/ajp.20439; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Mootnick Alan R., 2006, Primate Conservation, V21, P103, DOI 10.1896/0898-6207.21.1.103; MOOTNICK AR, 2007, PRIMATE CONSERVATION, V22, P16; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; Nakayama K, 2006, GENOME RES, V16, P485, DOI 10.1101/gr.4763906; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; PROUTY LA, 1983, CYTOGENET CELL GENET, V35, P141, DOI 10.1159/000131856; Roberto R, 2007, GENOME RES, V17, P249, DOI 10.1101/gr.6052507; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; STANYON R, 1983, J HUM EVOL, V12, P305, DOI 10.1016/S0047-2484(83)80152-3; VANTUINEN P, 1989, CYTOGENET CELL GENET, V51, P1094	29	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4999	10.1371/journal.pone.0004999	http://dx.doi.org/10.1371/journal.pone.0004999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319194	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499200018
J	Clarke, RA; Zhao, ZM; Guo, AY; Roper, K; Teng, L; Fang, ZM; Samaratunga, H; Lavin, MF; Gardiner, RA				Clarke, Raymond A.; Zhao, Zhongming; Guo, An-Yuan; Roper, Kathrein; Teng, Linda; Fang, Zhi-Ming; Samaratunga, Hema; Lavin, Martin F.; Gardiner, Robert A.			New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression	PLOS ONE			English	Article							NONCODING RNAS; EXPRESSION; PREDISPOSITION; MUTATIONS; PROTEINS; FAMILIES; LINKAGE; BNIP2; SRY	Background: The prostate cancer antigen 3 (PCA3/DD3) gene is a highly specific biomarker upregulated in prostate cancer (PCa). In order to understand the importance of PCA3 in PCa we investigated the organization and evolution of the PCA3 gene locus. Methods/Principal Findings: We have employed cDNA synthesis, RTPCR and DNA sequencing to identify 4 new transcription start sites, 4 polyadenylation sites and 2 new differentially spliced exons in an extended form of PCA3. Primers designed from these novel PCA3 exons greatly improve RT-PCR based discrimination between PCa, PCa metastases and BPH specimens. Comparative genomic analyses demonstrated that PCA3 has only recently evolved in an anti-sense orientation within a second gene, BMCC1/PRUNE2. BMCC1 has been shown previously to interact with RhoA and RhoC, determinants of cellular transformation and metastasis, respectively. Using RT-PCR we demonstrated that the longer BMCC1-1 isoform - like PCA3 - is upregulated in PCa tissues and metastases and in PCa cell lines. Furthermore PCA3 and BMCC1-1 levels are responsive to dihydrotestosterone treatment. Conclusions/Significance: Upregulation of two new PCA3 isoforms in PCa tissues improves discrimination between PCa and BPH. The functional relevance of this specificity is now of particular interest given PCA3's overlapping association with a second gene BMCC1, a regulator of Rho signalling. Upregulation of PCA3 and BMCC1 in PCa has potential for improved diagnosis.	[Clarke, Raymond A.; Fang, Zhi-Ming] Univ New S Wales, St George Hosp Clin Sch Med, Canc Care Ctr, Prostate Canc Inst, Kogarah, NSW, Australia; [Clarke, Raymond A.; Teng, Linda; Lavin, Martin F.] Queensland Inst Med Res, Div Canc & Cell Biol, Brisbane, Qld, Australia; [Zhao, Zhongming; Guo, An-Yuan] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Zhao, Zhongming; Guo, An-Yuan] Virginia Commonwealth Univ, Ctr Study Biol Complexity, Richmond, VA USA; [Roper, Kathrein] Stanford Univ, Hopkins Marine Stn, Stanford, CA 94305 USA; [Samaratunga, Hema] Sullivan & Nicolaides Pathol, Brisbane, Qld, Australia; [Lavin, Martin F.; Gardiner, Robert A.] Univ Queensland, Ctr Clin Res, St Lucia, Qld 4067, Australia	St George Hospital; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; Virginia Commonwealth University; Virginia Commonwealth University; Stanford University; University of Queensland	Clarke, RA (corresponding author), Univ New S Wales, St George Hosp Clin Sch Med, Canc Care Ctr, Prostate Canc Inst, Kogarah, NSW, Australia.	martin.lavin@qimr.edu.au; f.gardiner@uq.edu.au	Lavin, Martin F/F-5961-2014; Samaratunga, Hemamali M L/D-1559-2013; Gardiner, Robert/G-2096-2010; Guo, An-Yuan/K-3656-2012	Lavin, Martin F/0000-0002-5940-4769; Samaratunga, Hemamali M L/0000-0001-5796-1791; Clarke, Raymond/0000-0002-7196-9623	Australian National Health and Medical Research Council; Cancer Council of Queensland; NIH [LM009598]; National Library of Medicine; Thomas F. and Kate Miller Jeffress Memorial Trust Fund; American Cancer Society [IRG-73-001-31]; NATIONAL LIBRARY OF MEDICINE [R03LM009598] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Thomas F. and Kate Miller Jeffress Memorial Trust Fund; American Cancer Society(American Cancer Society); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding is provided by Australian National Health and Medical Research Council and the Cancer Council of Queensland. Zhongming Zhao is supported by a NIH grant (LM009598) from the National Library of Medicine, the Thomas F. and Kate Miller Jeffress Memorial Trust Fund, and Institutional Research Grant IRG-73-001-31 from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarotto E, 2008, INT J CANCER, V122, P969, DOI 10.1002/ijc.23343; Bratt O, 2007, BJU INT, V99, P743, DOI 10.1111/j.1464-410X.2006.06666.x; Brossner C, 2000, BJU INT, V85, P705, DOI 10.1046/j.1464-410x.2000.00558.x; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Chu JX, 2002, BBA-MOL BASIS DIS, V1587, P183, DOI 10.1016/S0925-4439(02)00081-9; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Datta MW, 2007, ADV ANAT PATHOL, V14, P408, DOI 10.1097/PAP.0b013e318155709a; Engers R, 2007, WORLD J UROL, V25, P595, DOI 10.1007/s00345-007-0209-0; Frith MC, 2007, GENE, V403, P188, DOI 10.1016/j.gene.2007.08.012; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Langeberg WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4101, DOI 10.2741/2374; LAZAR MA, 1990, J BIOL CHEM, V265, P12859; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Machida T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/sj.onc.1209225; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanna CR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-169; Schalken JA, 2003, UROLOGY, V62, P34, DOI 10.1016/S0090-4295(03)00759-3; SCHRODER FH, 2003, PROSTATE CANC; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Thompson HH, 2005, IEEE SECUR PRIV, V3, P66, DOI 10.1109/MSP.2005.3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson M, 2008, PROSTATE, V68, P1248, DOI 10.1002/pros.20792; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan X, 2001, J BIOL CHEM, V276, P46647, DOI 10.1074/jbc.M108404200; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	42	65	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4995	10.1371/journal.pone.0004995	http://dx.doi.org/10.1371/journal.pone.0004995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319183	Green Published, gold			2022-12-25	WOS:000265499200017
J	Garzia, L; Andolfo, I; Cusanelli, E; Marino, N; Petrosino, G; De Martino, D; Esposito, V; Galeone, A; Navas, L; Esposito, S; Gargiulo, S; Fattet, S; Donofrio, V; Cinalli, G; Brunetti, A; Del Vecchio, L; Northcott, PA; Delattre, O; Taylor, MD; Iolascon, A; Zollo, M				Garzia, Livia; Andolfo, Immacolata; Cusanelli, Emilio; Marino, Natascia; Petrosino, Giuseppe; De Martino, Daniela; Esposito, Veronica; Galeone, Aldo; Navas, Luigi; Esposito, Silvia; Gargiulo, Sara; Fattet, Sarah; Donofrio, Vittoria; Cinalli, Giuseppe; Brunetti, Arturo; Del Vecchio, Luigi; Northcott, Paul A.; Delattre, Olivier; Taylor, Michael D.; Iolascon, Achille; Zollo, Massimo			MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma	PLOS ONE			English	Article								Background: Through negative regulation of gene expression, microRNAs (miRNAs) can function in cancers as oncosuppressors, and they can show altered expression in various tumor types. Here we have investigated medulloblastoma tumors (MBs), which arise from an early impairment of developmental processes in the cerebellum, where Notch signaling is involved in many cell-fate-determining stages. MBs occur bimodally, with the peak incidence seen between 3-4 years and 8-9 years of age, although it can also occur in adults. Notch regulates a subset of the MB cells that have stem-cell-like properties and can promote tumor growth. On the basis of this evidence, we hypothesized that miRNAs targeting the Notch pathway can regulated these phenomena, and can be used in anti-cancer therapies. Methodology/Principal Findings: In a screening of MB cell lines, the miRNA miR-199b-5p was seen to be a regulator of the Notch pathway through its targeting of the transcription factor HES1. Down-regulation of HES1 expression by miR-199b-5p negatively regulates the proliferation rate and anchorage-independent growth of MB cells. MiR-199b-5p over-expression blocks expression of several cancer stem-cell genes, impairs the engrafting potential of MB cells in the cerebellum of athymic/nude mice, and of particular interest, decreases the MB stem-cell-like (CD133+) subpopulation of cells. In our analysis of 61 patients with MB, the expression of miR-199b-5p in the non-metastatic cases was significantly higher than in the metastatic cases (P = 0.001). Correlation with survival for these patients with high levels of miR-199b expression showed a positive trend to better overall survival than for the low-expressing patients. These data showing the down-regulation of miR-199b-5p in metastatic MBs suggest a potential silencing mechanism through epigenetic or genetic alterations. Upon induction of de-methylation using 5-aza-deoxycytidine, lower miR-199b-5p expression was seen in a panel of MB cell lines, supported an epigenetic mechanism of regulation. Furthermore, two cell lines (Med8a and UW228) showed significant upregulation of miR-199b-5p upon treatment. Infection with MB cells in an induced xenograft model in the mouse cerebellum and the use of an adenovirus carrying miR-199b-5p indicate a clinical benefit through this negative influence of miR-199b-5p on tumor growth and on the subset of MB stem-cell-like cells, providing further proof of concept. Conclusions/Significance: Despite advances in our understanding of the pathogenesis of MB, one-third of these patients remain incurable and current treatments can significantly damage long-term survivors. Here we show that miR-199b-5p expression correlates with metastasis spread, identifying a new molecular marker for a poor-risk class in patients with MB. We further show that in a xenograft model, MB tumor burden can be reduced, indicating the use of miR-199b-5p as an adjuvant therapy after surgery, in combination with radiation and chemotherapy, for the improvement of anti-cancer MB therapies and patient quality of life. To date, this is the first report that expression of a miRNA can deplete the tumor stem cells, indicating an interesting therapeutic approach for the targeting of these cells in brain tumors.	[Garzia, Livia; Andolfo, Immacolata; Cusanelli, Emilio; Marino, Natascia; Petrosino, Giuseppe; De Martino, Daniela; Esposito, Silvia; Brunetti, Arturo; Del Vecchio, Luigi; Iolascon, Achille; Zollo, Massimo] Ctr Ingn Genet & Biotecnol Avanzate, CEINGE, Naples, Italy; [Esposito, Veronica; Galeone, Aldo] Univ Naples Federico 2, Dip Chim Sostanze Nat, Naples, Italy; [Navas, Luigi] Univ Naples Federico 2, Dip Sci Clin Vet, Sez Clin Chirurg, Naples, Italy; [Gargiulo, Sara] Univ Naples Federico 2, Diagnost Imaging Dept, Naples, Italy; [Gargiulo, Sara] IBB CNR, Naples, Italy; [Fattet, Sarah; Delattre, Olivier] Inst Curie, Unite Genet Biol Canc, Paris, France; [Donofrio, Vittoria] Anat Patol Ospedale Pausilipon AORN Santobono Paus, Naples, Italy; [Cinalli, Giuseppe] Santobono Pausilipon Childrens Hosp, Naples, Italy; [Brunetti, Arturo] Univ Naples Federico 2, Inst Biostructures & Bioimages, Dept Biomorphol & Funct Sci, Natl Res Council, Naples, Italy; [Del Vecchio, Luigi; Iolascon, Achille; Zollo, Massimo] Univ Naples Federico 2, Dip Biochim Biotecnol Med, DBBM, Naples, Italy; [Northcott, Paul A.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada; [Zollo, Massimo] Univ Naples Federico 2, Fac Sci Biotecnol, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Naples Federico II	Garzia, L (corresponding author), Ctr Ingn Genet & Biotecnol Avanzate, CEINGE, Naples, Italy.	zollo@ceinge.unina.it	Zollo, Massimo/K-5857-2016; Andolfo, Immacolata/Q-4012-2019; Andolfo, Immacolata/K-7381-2016; Iolascon, Achille/A-4461-2014; cinalli, giuseppe/AAC-3889-2022; Galeone, Aldo/H-7248-2019; Navas, Luigi/ABI-6516-2020; Marino, Natascia/AAM-5941-2021; NAVAS, Luigi/AAT-2506-2021; Northcott, Paul A/N-4022-2018; Brunetti, Arturo/AAE-5261-2019; Cusanelli, Emilio/G-6092-2015	Zollo, Massimo/0000-0002-0970-7243; Andolfo, Immacolata/0000-0003-0493-812X; Andolfo, Immacolata/0000-0003-0493-812X; cinalli, giuseppe/0000-0002-7797-8483; Galeone, Aldo/0000-0001-8805-6348; Marino, Natascia/0000-0001-6771-8963; NAVAS, Luigi/0000-0002-1851-5016; Northcott, Paul A/0000-0002-1220-5252; Brunetti, Arturo/0000-0001-7057-3494; Cusanelli, Emilio/0000-0002-7683-8542; Petrosino, Giuseppe/0000-0002-2835-4308; Esposito, Veronica/0000-0002-1724-7128; Gargiulo, Sara/0000-0003-1894-1047; delattre, olivier/0000-0002-8730-2276; iolascon, achille/0000-0002-9558-0356; Taylor, Michael/0000-0001-7009-3466	FP6-E.E.T pipeline [LSH-CT-2006-037260]; FP7-Tumic [HEALTH-F2-2008-201662]; Associazione contro la lotta al Neuroblastoma Italiana Progetto Pensiero; AIRC [2007]; Progetto AIRC Tumori Pediatrici; Associazione Open Neuroblastoma; Scuola Europea di Medicina Molecolare (SEMM-CEINGE) [Fellowship]; AIRC-FIRC [Fellowship]	FP6-E.E.T pipeline; FP7-Tumic; Associazione contro la lotta al Neuroblastoma Italiana Progetto Pensiero; AIRC(Fondazione AIRC per la ricerca sul cancro); Progetto AIRC Tumori Pediatrici(Fondazione AIRC per la ricerca sul cancro); Associazione Open Neuroblastoma; Scuola Europea di Medicina Molecolare (SEMM-CEINGE); AIRC-FIRC(Fondazione AIRC per la ricerca sul cancro)	This study was supported by FP6-E.E.T pipeline LSH-CT-2006-037260 (MZ), FP7-Tumic HEALTH-F2-2008-201662 (MZ), Associazione contro la lotta al Neuroblastoma Italiana Progetto Pensiero (AI,MZ), AIRC grant 2007 (MZ), Progetto AIRC Tumori Pediatrici 2008 (MZ). Associazione Open Neuroblastoma (AI), a Scuola Europea di Medicina Molecolare (SEMM-CEINGE) Fellowship (EC), and AIRC-FIRC Fellowships (LG, NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Buhren J, 2000, J NEUROPATH EXP NEUR, V59, P229; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; EBERHART C, 2007, NEUROSURG CLIN N AM, V18, pR8; Eberhart CG, 2007, NEUROSURG CLIN N AM, V18, P59, DOI 10.1016/j.nec.2006.10.005; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grill J, 2005, LANCET ONCOL, V6, P573, DOI 10.1016/S1470-2045(05)70252-7; Grill J, 2006, LANCET ONCOL, V7, P787, DOI 10.1016/S1470-2045(06)70872-5; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; KATSETOS CD, 1995, CLIN NEUROPATHOL, V14, P72; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kombogiorgas D, 2007, CHILD NERV SYST, V23, P399, DOI 10.1007/s00381-006-0258-5; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li XN, 2004, CLIN CANCER RES, V10, P1150, DOI 10.1158/1078-0432.CCR-0747-3; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; MacDonald TJ, 2008, J CHILD NEUROL, V23, P1195, DOI 10.1177/0883073808321769; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PATRICE SJ, 1995, PEDIATR NEUROSURG, V22, P197, DOI 10.1159/000120901; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Sandberg AA, 2002, AM J MED GENET, V115, P173, DOI 10.1002/ajmg.10693; Schabet M, 1997, MED PEDIATR ONCOL, V29, P92, DOI 10.1002/(SICI)1096-911X(199708)29:2<92::AID-MPO5>3.0.CO;2-M; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang SY, 2005, J NEUROSURG, V102, P417, DOI 10.3171/ped.2005.102.4.0417; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	56	209	224	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4998	10.1371/journal.pone.0004998	http://dx.doi.org/10.1371/journal.pone.0004998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308264	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499000012
J	Piuri, M; Jacobs, WR; Hatfull, GF				Piuri, Mariana; Jacobs, William R., Jr.; Hatfull, Graham F.			Fluoromycobacteriophages for Rapid, Specific, and Sensitive Antibiotic Susceptibility Testing of Mycobacterium tuberculosis	PLOS ONE			English	Article							LUCIFERASE REPORTER PHAGES; DRUG-RESISTANT TUBERCULOSIS; RIFAMPICIN RESISTANCE; MULTIDRUG-RESISTANT; FLOW-CYTOMETRY; ASSAY; IDENTIFICATION; FLUORESCENCE; DIAGNOSIS; SAFE	Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis is of paramount importance as multiple- and extensively-drug resistant strains of M. tuberculosis emerge and spread. We describe here a virus-based assay in which fluoromycobacteriophages are used to deliver a GFP or ZsYellow fluorescent marker gene to M. tuberculosis, which can then be monitored by fluorescent detection approaches including fluorescent microscopy and flow cytometry. Pre-clinical evaluations show that addition of either Rifampicin or Streptomycin at the time of phage addition obliterates fluorescence in susceptible cells but not in isogenic resistant bacteria enabling drug sensitivity determination in less than 24 hours. Detection requires no substrate addition, fewer than 100 cells can be identified, and resistant bacteria can be detected within mixed populations. Fluorescence withstands fixation by paraformaldehyde providing enhanced biosafety for testing MDR-TB and XDR-TB infections.	[Piuri, Mariana; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Piuri, M (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		Piuri, Mariana/0000-0001-9058-8247; Jacobs, William/0000-0003-3321-3080	National Institutes of Health [AI-51519, AI21670]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by NIH grant AI21670 to WRJ. This work was funded in part by HHMI's international research programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2004, INT J TUBERC LUNG D, V8, P1114; Albert H, 2001, INT J TUBERC LUNG D, V5, P906; Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Banaiee N, 2003, J MED MICROBIOL, V52, P557, DOI 10.1099/jmm.0.05149-0; Banaiee N, 2001, J CLIN MICROBIOL, V39, P3883, DOI 10.1128/JCM.39.11.3883-3888.2001; Banaiee N, 2008, TUBERCULOSIS, V88, P64, DOI 10.1016/j.tube.2007.08.006; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Carriere C, 1997, J CLIN MICROBIOL, V35, P3232; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Eltringham IJ, 1999, J CLIN MICROBIOL, V37, P3528, DOI 10.1128/JCM.37.11.3528-3532.1999; Ford M. E., 1998, Tubercle and Lung Disease, V79, P63, DOI 10.1054/tuld.1998.0007; Fuhrmann S, 2008, CYTOM PART A, V73A, P1100, DOI 10.1002/cyto.a.20614; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hanscheid T, 2008, T ROY SOC TROP MED H, V102, P520, DOI 10.1016/j.trstmh.2008.02.020; Hazbon MH, 2003, J CLIN MICROBIOL, V41, P4865, DOI 10.1128/JCM.41.10.4865-4869.2003; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Hoek KGP, 2008, J CLIN MICROBIOL, V46, P1369, DOI 10.1128/JCM.02343-07; Jacobs W R Jr, 1989, Acta Leprol, V7 Suppl 1, P203; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; Kalantri S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-59; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kirk SM, 1998, J CLIN MICROBIOL, V36, P1568, DOI 10.1128/JCM.36.6.1568-1573.1998; Kumar V, 2008, TUBERCULOSIS, V88, P616, DOI 10.1016/j.tube.2008.02.007; Lawn SD, 2006, BRIT MED J, V333, P559, DOI 10.1136/bmj.38971.587222.AB; Luby-Phelps K, 2003, J HISTOCHEM CYTOCHEM, V51, P271, DOI 10.1177/002215540305100301; Moore AV, 1999, J CLIN MICROBIOL, V37, P479, DOI 10.1128/JCM.37.3.479-483.1999; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; OJHA AK, 2008, MOL MICROBIOL; Pai M, 2005, J INFECTION, V51, P175, DOI 10.1016/j.jinf.2005.05.017; Pearson RE, 1996, GENE, V183, P129, DOI 10.1016/S0378-1119(96)00530-6; Pina-Vaz C, 2005, J MED MICROBIOL, V54, P77, DOI 10.1099/jmm.0.45627-0; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Riska PF, 1997, J CLIN MICROBIOL, V35, P3225, DOI 10.1128/JCM.35.12.3225-3231.1997; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; Schwebach JR, 2001, J CLIN MICROBIOL, V39, P769, DOI 10.1128/JCM.39.2.769-771.2001; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; Watterson SA, 2000, J CLIN PATHOL, V53, P727, DOI 10.1136/jcp.53.10.727; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; Wilson SM, 1997, NAT MED, V3, P465, DOI 10.1038/nm0497-465; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10	48	75	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4870	10.1371/journal.pone.0004870	http://dx.doi.org/10.1371/journal.pone.0004870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300517	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265496800003
J	St-Onge, M; Dumas, A; Michaud, A; Laflamme, C; Dussault, AA; Pouliot, M				St-Onge, Mireille; Dumas, Aline; Michaud, Annick; Laflamme, Cynthia; Dussault, Andree-Anne; Pouliot, Marc			Impact of Anti-Inflammatory Agents on the Gene Expression Profile of Stimulated Human Neutrophils: Unraveling Endogenous Resolution Pathways	PLOS ONE			English	Article							ACTIVATED HUMAN NEUTROPHILS; ARACHIDONIC-ACID RELEASE; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; LEUKOTRIENE BIOSYNTHESIS; ADENOSINE RECEPTOR; CYCLIC-AMP; ENDOTHELIAL-CELLS; DOWN-REGULATION; ENZYME-RELEASE	Adenosine, prostaglandin E-2, or increased intracellular cyclic AMP concentration each elicit potent anti-inflammatory events in human neutrophils by inhibiting functions such as phagocytosis, superoxide production, adhesion and cytokine release. However, the endogenous molecular pathways mediating these actions are poorly understood. In the present study, we examined their impact on the gene expression profile of stimulated neutrophils. Purified blood neutrophils from healthy donors were stimulated with a cocktail of inflammatory agonists in the presence of at least one of the following anti-inflammatory agents: adenosine A(2A) receptor agonist CGS 21680, prostaglandin E-2, cyclic-AMP-elevating compounds forskolin and RO 20-1724. Total RNA was analyzed using gene chips and real-time PCR. Genes encoding transcription factors, enzymes and regulatory proteins, as well as secreted cytokines/chemokines showed differential expression. We identified 15 genes for which the anti-inflammatory agents altered mRNA levels. The agents affected the expression profile in remarkably similar fashion, suggesting a central mechanism limiting cell activation. We have identified a set of genes that may be part of important resolution pathways that interfere with cell activation. Identification of these pathways will improve understanding of the capacity of tissues to terminate inflammatory responses and contribute to the development of therapeutic strategies based on endogenous resolution.	[St-Onge, Mireille; Dumas, Aline; Michaud, Annick; Laflamme, Cynthia; Dussault, Andree-Anne; Pouliot, Marc] Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, CHUQ, Quebec City, PQ G1K 7P4, Canada; [St-Onge, Mireille; Dumas, Aline; Michaud, Annick; Laflamme, Cynthia; Dussault, Andree-Anne; Pouliot, Marc] Univ Laval, Fac Med, Dept Anat Physiol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	St-Onge, M (corresponding author), Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, CHUQ, Quebec City, PQ G1K 7P4, Canada.	Marc.Pouliot@crchul.ulaval.ca	Pouliot, Marc/G-4103-2016; Poubelle, Patrice E/G-6537-2013	Pouliot, Marc/0000-0002-2466-5424; Dumas, Aline/0000-0001-5718-7206	Canadian Institutes of Health Research [MOP-64315, NSM-72200]; Fonds de la Recherche en Sante du Quebec (FRSQ) [Senior Investigator Scholarship, studentship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work is supported by grants from the Canadian Institutes of Health Research (CIHR, to MP; grants no. MOP-64315 & NSM-72200). MP is the recipient of a Senior Investigator Scholarship from the Fonds de la Recherche en Sante du Quebec (FRSQ) and MSO is the recipient of a studentship award from the FRSQ. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Boraschi D, 2006, VITAM HORM, V74, P229, DOI 10.1016/S0083-6729(06)74009-2; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Cadieux JS, 2005, J CELL SCI, V118, P1437, DOI 10.1242/jcs.01737; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Conte FD, 2008, J LEUKOCYTE BIOL, V84, P652, DOI 10.1189/jlb.1207827; Cristalli G, 2008, CURR PHARM DESIGN, V14, P1525, DOI 10.2174/138161208784480081; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; de Boer Willem I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P205; Denecke B, 1999, J BIOL CHEM, V274, P26860, DOI 10.1074/jbc.274.38.26860; DIANZANI C, 1994, EUR J PHARMACOL, V263, P223, DOI 10.1016/0014-2999(94)90547-9; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; EDWARDS SW, 1994, BIOCH PHYSL NEUTROPH, P1; FANTONE JC, 1981, PROSTAG LEUKOTR ESS, V7, P195, DOI 10.1016/0161-4630(81)90062-8; FANTONE JC, 1983, J IMMUNOL, V130, P1495; FARRE AL, 1993, CIRCULATION, V88, P1166, DOI 10.1161/01.CIR.88.3.1166; FELSCH A, 1995, J IMMUNOL, V155, P333; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; Flamand N, 2000, AM J RESP CRIT CARE, V161, pS88, DOI 10.1164/ajrccm.161.supplement_1.ltta-18; Gaga M, 2008, ALLERGY, V63, P703, DOI 10.1111/j.1398-9995.2007.01578.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gawlik Radoslaw, 2007, Otolaryngol Pol, V61, P567, DOI 10.1016/S0030-6657(07)70486-9; GIRARD D, 2007, PHENOTYPIC FUNCTIONA; Golovko O, 2005, J STEROID BIOCHEM, V94, P197, DOI 10.1016/j.jsbmb.2005.01.019; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HASKO BNC, 2007, ADENOSINE RECEPTORS; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hisaoka M, 2004, CANCER GENET CYTOGEN, V152, P101, DOI 10.1016/j.cancergencyto.2003.11.011; Kassuya CAL, 2008, PEPTIDES, V29, P1329, DOI 10.1016/j.peptides.2008.03.008; Kinsel JF, 2003, ANN RHEUM DIS, V62, P22; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Krump E, 1999, ADV EXP MED BIOL, V447, P107; Krump E, 1996, BRIT J PHARMACOL, V117, P1639, DOI 10.1111/j.1476-5381.1996.tb15334.x; Krump E, 1997, J EXP MED, V186, P1401, DOI 10.1084/jem.186.8.1401; Kugelmeier P, 2008, J PANCREAS, V9, P133; Kunter U, 2005, KIDNEY INT, V68, P1520, DOI 10.1111/j.1523-1755.2005.00564.x; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; LEHMEYER JE, 1978, CLIN IMMUNOL IMMUNOP, V9, P482, DOI 10.1016/0090-1229(78)90144-7; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; LYNCH JP, 1985, AM J MED, V78, P691, DOI 10.1016/0002-9343(85)90416-4; MARONE G, 1980, J IMMUNOL, V125, P2277; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; MCCOLL SR, 1990, J IMMUNOL, V145, P3047; MCDONALD PP, 1993, J LIPID MEDIATOR, V6, P59; Miao TZ, 2008, MOL CELL NEUROSCI, V37, P367, DOI 10.1016/j.mcn.2007.10.010; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; OFLAHERTY JT, 1979, PROSTAGLANDINS, V17, P201, DOI 10.1016/0090-6980(79)90039-X; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Pharoah DS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1913; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; Pouliot M, 2006, ADENOSINE RECEPTORS, P89; RIVKIN I, 1975, J IMMUNOL, V115, P1126; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; Thibault N, 2000, BLOOD, V95, P519, DOI 10.1182/blood.V95.2.519; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; Visser SS, 2000, BIOCHEM PHARMACOL, V60, P993, DOI 10.1016/S0006-2952(00)00414-7; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Williams CS, 1996, AM J PHYSIOL-GASTR L, V270, pG393; Wu XW, 2003, SHOCK, V19, P314, DOI 10.1097/00024382-200304000-00004; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang SY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-150; Zhao ZQ, 1996, AM J PHYSIOL-HEART C, V271, pH1456, DOI 10.1152/ajpheart.1996.271.4.H1456; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	78	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4902	10.1371/journal.pone.0004902	http://dx.doi.org/10.1371/journal.pone.0004902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295914	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496700005
J	Rigola, D; van Oeveren, J; Janssen, A; Bonne, A; Schneiders, H; van der Poel, HJA; van Orsouw, NJ; Hogers, RCJ; de Both, MTJ; van Eijk, MJT				Rigola, Diana; van Oeveren, Jan; Janssen, Antoine; Bonne, Anita; Schneiders, Harrie; van der Poel, Hein J. A.; van Orsouw, Nathalie J.; Hogers, Rene C. J.; de Both, Michiel T. J.; van Eijk, Michiel J. T.			High-Throughput Detection of Induced Mutations and Natural Variation Using KeyPoint (TM) Technology	PLOS ONE			English	Article								Reverse genetics approaches rely on the detection of sequence alterations in target genes to identify allelic variants among mutant or natural populations. Current (pre-) screening methods such as TILLING and EcoTILLING are based on the detection of single base mismatches in heteroduplexes using endonucleases such as CEL 1. However, there are drawbacks in the use of endonucleases due to their relatively poor cleavage efficiency and exonuclease activity. Moreover, prescreening methods do not reveal information about the nature of sequence changes and their possible impact on gene function. We present KeyPoint (TM) technology, a high-throughput mutation/polymorphism discovery technique based on massive parallel sequencing of target genes amplified from mutant or natural populations. KeyPoint combines multidimensional pooling of large numbers of individual DNA samples and the use of sample identification tags ("sample barcoding'') with next-generation sequencing technology. We show the power of KeyPoint by identifying two mutants in the tomato elF4E gene based on screening more than 3000 M2 families in a single GS FLX sequencing run, and discovery of six haplotypes of tomato elF4E gene by re-sequencing three amplicons in a subset of 92 tomato lines from the EU-SOL core collection. We propose KeyPoint technology as a broadly applicable amplicon sequencing approach to screen mutant populations or germplasm collections for identification of (novel) allelic variation in a high-throughput fashion.	[Rigola, Diana; van Oeveren, Jan; Janssen, Antoine; Bonne, Anita; Schneiders, Harrie; van der Poel, Hein J. A.; van Orsouw, Nathalie J.; Hogers, Rene C. J.; de Both, Michiel T. J.; van Eijk, Michiel J. T.] Keygene NV, Wageningen, Netherlands	Keygene N.V.	Rigola, D (corresponding author), Keygene NV, Wageningen, Netherlands.	diana.rigola@keygene.com	赵, 鹏/B-8401-2009		Keygene N.V.	Keygene N.V.(Keygene N.V.)	Keygene N.V. funded the research and had role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Den Dunnen JT, 1999, HUM MUTAT, V14, P95, DOI 10.1002/(SICI)1098-1004(1999)14:2<95::AID-HUMU1>3.0.CO;2-G; Gilchrist EJ, 2005, CURR OPIN PLANT BIOL, V8, P211, DOI 10.1016/j.pbi.2005.01.004; Gilchrist EJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-262; Greene EA, 2003, GENETICS, V164, P731; Hestekin CN, 2006, ELECTROPHORESIS, V27, P3805, DOI 10.1002/elps.200600421; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jenkins GJS, 2004, MUTAGENESIS, V19, P3, DOI 10.1093/mutage/geg037; Li J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm403; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; STUART CN, 1993, BIOTECHNIQUES, V14, P748; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Taylor GR, 1999, ELECTROPHORESIS, V20, P1125, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1125::AID-ELPS1125>3.0.CO;2-O; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	27	75	87	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4761	10.1371/journal.pone.0004761	http://dx.doi.org/10.1371/journal.pone.0004761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283079	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496300002
J	Igual, JM; Tavecchia, G; Jenouvrier, S; Forero, MG; Oro, D				Manuel Igual, Jose; Tavecchia, Giacomo; Jenouvrier, Stephanie; Forero, Manuela G.; Oro, Daniel			Buying Years to Extinction: Is Compensatory Mitigation for Marine Bycatch a Sufficient Conservation Measure for Long-Lived Seabirds?	PLOS ONE			English	Article								Along the lines of the 'polluter pays principle', it has recently been proposed that the local long-line fishing industry should fund eradication of terrestrial predators at seabird breeding colonies, as a compensatory measure for the bycatch caused by the fishing activity. The measure is economically sound, but a quantitative and reliable test of its biological efficacy has never been conducted. Here, we investigated the demographic consequences of predator eradication for Cory's shearwater Calonectris diomedea, breeding in the Mediterranean, using a population model that integrates demographic rates estimated from individual life-history information with experimental measures of predation and habitat structure. We found that similar values of population growth rate can be obtained by different combinations of habitat characteristics, predator abundance and adult mortality, which explains the persistence of shearwater colonies in islands with introduced predators. Even so, given the empirically obtained values of survival, all combinations of predator abundance and habitat characteristics projected a decline in shearwater numbers. Perturbation analyses indicated that the value and the sensitivity of shearwater population growth rates were affected by all covariates considered and their interactions. A decrease in rat abundance delivered only a small increase in the population growth rate, whereas a change in adult survival (a parameter independent of rat abundance) had the strongest impact on population dynamics. When adult survival is low, rat eradication would allow us to "buy'' years before extinction but does not reverse the process. Rat eradication can therefore be seen as an emergency measure if threats on adult survival are eliminated in the medium-term period. For species with low fecundity and long life expectancy, our results suggest that rat control campaigns are not a sufficient, self-standing measure to compensate the biological toll of long-line fisheries.	[Manuel Igual, Jose; Tavecchia, Giacomo; Oro, Daniel] Imedea CSIC UIB, Esporles, Spain; [Forero, Manuela G.] CSIC Estac Biol Donana, Dept Biol Conservat, Seville, Spain; [Jenouvrier, Stephanie] Woods Hole Oceanograph Inst, Woods Hole, MA USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Woods Hole Oceanographic Institution	Igual, JM (corresponding author), Imedea CSIC UIB, Esporles, Spain.	g.tavecchia@uib.es	Oro, Daniel/H-4208-2012; Tavecchia, Giacomo/N-3961-2014; Igual, Jose/N-3975-2014	Oro, Daniel/0000-0003-4782-3007; Tavecchia, Giacomo/0000-0001-5435-2691; Igual, Jose/0000-0002-8369-3150; jenouvrier, stephanie/0000-0003-3324-2383	Consejo Superior de Investigaciones Cientificas (CSIC, Spain) [Ramon y Cajal fellowship]; Spanish Minister of Science and Tecnology (MCyT) [REN2002-00450/GLO, BOS2003-01960]; Organismo Autonomo de Parques Nacionales (OAPN)	Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Spanish Minister of Science and Tecnology (MCyT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Organismo Autonomo de Parques Nacionales (OAPN)	M.G.F. and G.T. were supported by a Ramon y Cajal fellowship from the Consejo Superior de Investigaciones Cientificas (CSIC, Spain). Financial support was provided by the projects REN2002-00450/GLO and BOS2003-01960 of the Spanish Minister of Science and Tecnology (MCyT), and the Organismo Autonomo de Parques Nacionales (OAPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GB, 2005, BIOL CONSERV, V126, P306, DOI 10.1016/j.biocon.2005.06.001; BAXTER PWJ, 2008, CONSERVATIO IN PRESS, DOI DOI 10.1111/J.1523-1739.2007.00850.X; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; BELLVER JA, 2003, YACIMIENTO NEOLITICO; BROSTROM G, 2003, GEN LINEAR MODELS RA; CALDERON S, 1894, ANALES SOC ESPANOLA, V23, P903; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Choquet R, 2005, U CARE2 2 USERS MANU; Cooper J, 2003, SCI MAR, V67, P57, DOI 10.3989/scimar.2003.67s257; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Cuthbert R, 2001, BIOL CONSERV, V100, P163, DOI 10.1016/S0006-3207(00)00234-2; De Leon A, 2006, BIRD STUDY, V53, P64, DOI 10.1080/00063650609461417; Doak D, 2007, FRONT ECOL ENVIRON, V5, P350, DOI 10.1890/1540-9295(2007)5[350:CMFMBW]2.0.CO;2; FAO, 2005, 753 FAO; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; HOOKER S, 1995, NEW ZEAL J ZOOL, V22, P291, DOI 10.1080/03014223.1995.9518044; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Hunter CM, 2005, J ANIM ECOL, V74, P589, DOI 10.1111/j.1365-2656.2005.00929.x; Igual JM, 2007, BIOL CONSERV, V137, P189, DOI 10.1016/j.biocon.2007.02.003; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; Jenouvrier S, 2009, GLOBAL CHANGE BIOL, V15, P268, DOI 10.1111/j.1365-2486.2008.01715.x; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jones IL, 2002, OECOLOGIA, V133, P38, DOI 10.1007/s00442-002-0991-8; LANDE R, 1988, OECOLOGIA, V75, P601, DOI 10.1007/BF00776426; Lande R., 2003, OXFORD SERIES ECOLOG; Le Corre M, 2008, NATURE, V451, P134, DOI 10.1038/451134a; Lebreton JD, 2005, AUST NZ J STAT, V47, P49, DOI 10.1111/j.1467-842X.2005.00371.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; *MATHWORKS INC, 2000, MATLAB; MOORS PJ, 1984, INT COUNCIL BIRD PRE, V2, P667; Mougin J.-L., 1987, Oiseau et la Revue Francaise d'Ornithologie, V57, P201; Mougin J.-L., 2002, Avocetta, V26, P7; *OECD, 1995, OECDGD95124; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Pascal Michel, 2008, Endangered Species Research, V4, P267, DOI 10.3354/esr00080; Priddel D, 2007, FRONT ECOL ENVIRON, V5, P407, DOI 10.1890/i1540-9295-5-8-407.1; Quillfeldt P, 2008, POLAR BIOL, V31, P333, DOI 10.1007/s00300-007-0363-2; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; WARHAM J, 1990, PETRELS THEIR ECOLOG; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2; Williams B. K., 2002, ANAL MANAGEMENT ANIM	49	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4826	10.1371/journal.pone.0004826	http://dx.doi.org/10.1371/journal.pone.0004826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279685	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496200007
J	Schmidt-Glenewinkel, H; Reinz, E; Eils, R; Brady, NR				Schmidt-Glenewinkel, Hannah; Reinz, Eileen; Eils, Roland; Brady, Nathan R.			Systems Biological Analysis of Epidermal Growth Factor Receptor Internalization Dynamics for Altered Receptor Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-RECEPTOR; SIGNAL-TRANSDUCTION; MEDIATED ENDOCYTOSIS; ERBB RECEPTORS; BREAST-CANCER; LIVING CELLS; TYROSINE KINASES; FLOW-CYTOMETRY; ACTIVATION; PROTEIN	Epidermal growth factor (EGF) receptor ( EGFR) overexpression is a hallmark of many cancers. EGFR endocytosis is a critical step in signal attenuation, raising the question of how receptor expression levels affect the internalization process. Here we combined quantitative experimental and mathematical modeling approaches to investigate the role of the EGFR expression level on the rate of receptor internalization. Using tetramethyl-rhodamine-labeled EGF, we established assays for quantifying EGF-triggered EGFR internalization by both high resolution confocal microscopy and flow cytometry. We determined that the flow cytometry approach was more sensitive for examining large populations of cells. Mathematical modeling was used to investigate the relationship between EGF internalization kinetics, EGFR expression, and internalization machinery. We predicted that the standard parameter used to assess internalization kinetics, the temporal evolution r(t) of the ratio of internalized versus surface-located ligand.receptor complexes, does not describe a straight line, as proposed previously. Instead, a convex or concave curve occurs depending on whether initial receptor numbers or internalization adaptors are limiting the uptake reaction, respectively. To test model predictions, we measured EGF-EGFR binding and internalization in cells expressing different levels of green fluorescent protein-EGFR. As expected, surface binding of rhodamine-labeled EGF increased with green fluorescent protein-EGFR expression level. Unexpectedly, internalization of ligand.receptor complexes increased linearly with increasing receptor expression level, suggesting that receptors and not internalization adaptors were limiting the uptake in our experimental model. Finally, determining the ratio of internalized versus surface-located ligand.receptor complexes for this cell line confirmed that	[Eils, Roland] Univ Heidelberg, German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Reinz, Eileen] Univ Heidelberg, German Canc Res Ctr, Infect & Canc Res Program, D-69120 Heidelberg, Germany; [Eils, Roland] Univ Heidelberg, Inst Pharm & Mol Biotechnol & Bioquant, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), Univ Heidelberg, German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany.	r.eils@dkfz.de	Eils, Roland/B-6121-2009; Brady, Nathan/H-2452-2013	Eils, Roland/0000-0002-0034-4036; Brady, Nathan/0000-0002-1901-5996	Initiative and Networking Fund of the Helmholtz Association	Initiative and Networking Fund of the Helmholtz Association	This work was supported in part by SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Baulida J, 1996, J BIOL CHEM, V271, P5251; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Bruin K, 2007, MOL THER, V15, P1297, DOI 10.1038/sj.mt.6300176; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Jarvella S, 2006, NEUROPATH APPL NEURO, V32, P441, DOI 10.1111/j.1365-2990.2006.00758.x; Kapoor V, 2007, NAT METHODS, V4, P678, DOI 10.1038/nmeth0907-678; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kazazic M, 2006, TRAFFIC, V7, P1518, DOI 10.1111/j.1600-0854.2006.00487.x; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; LUND KA, 1990, J BIOL CHEM, V265, P15713; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; OPRESKO LK, 1987, J BIOL CHEM, V262, P4109; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Revillion F, 1998, EUR J CANCER, V34, P791, DOI 10.1016/S0959-8049(97)10157-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt-Glenewinkel H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-32; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Telford W, 2005, CYTOM PART A, V68A, P36, DOI 10.1002/cyto.a.20182; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; Tse GMK, 2009, BREAST CANCER RES TR, V114, P441, DOI 10.1007/s10549-008-0030-5; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	52	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17243	17252		10.1074/jbc.M809586200	http://dx.doi.org/10.1074/jbc.M809586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19297331	Green Published, hybrid			2022-12-25	WOS:000266962400061
J	Ren, J; Hascall, VC; Wang, AM				Ren, Juan; Hascall, Vincent C.; Wang, Aimin			Cyclin D3 Mediates Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes in Mesangial Cells Stimulated to Divide in Hyperglycemic Medium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE-CELLS; ADIPOCYTE DIFFERENTIATION; ENDOPLASMIC-RETICULUM; DIABETIC-NEPHROPATHY; DEPENDENT KINASES; C/EBP-ALPHA; GLUCOSE; GROWTH; PROLIFERATION	Serum-starved, growth-arrested, near confluent rat mesangial cell cultures were stimulated to divide in medium with low (5.6 mM) or high (25.6 mM) glucose. In high glucose cultures Western blots showed large increases in cyclin D3 and CCAAT/enhancer-binding protein alpha (C/EBP alpha) at 48-72 h, concurrent with the production of a monocyte-adhesive hyaluronan matrix, whereas low glucose and mannitol osmotic control cultures did not. Cyclin D3 small interfering RNA inhibited both the synthesis of this matrix and the up-regulation of C/EBP alpha in cultures exposed to high glucose, indicating that cyclin D3 is a key mediator in regulating responses of dividing mesangial cells to hyperglycemia. A complex with cyclin D3, cyclin-dependent kinase 4, and C/EBP alpha was observed at 48-72 h in the hyperglycemic cultures, and cyclin D3 and C/EBP alpha were spatially co-localized in coalesced perinuclear honeycomb-like structures with embedded hyaluronan. Furthermore, microtubule-associated protein 1 light chain 3, a marker for autophagy, colocalizes with these structures. These results suggest that cyclin D3 is a central coordinator that controls the organization of a complex set of proteins that regulate autophagy, formation of the monocyte-adhesive hyaluronan matrix, and C/EBP alpha-mediated lipogenesis. Abnormal deposits of hyaluronan, cyclin D3, and C/EBP alpha were present in glomeruli of kidney sections from hyperglycemic rats 4 weeks after streptozotocin treatment, indicating that similar processes likely occur in vivo. Mesangial cell cultures treated with poly(I:C) or tunicamycin in normal glucose media synthesized monocyte-adhesive hyaluronan matrices but with concurrent down-regulation of cyclin D3. This indicates that the cyclin D3 mechanism is induced by hyperglycemia and is distinct from those involved in these cell stress responses.	[Wang, Aimin] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wang, AM (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			National Institutes of Health [R01 DK62934, 1P30 AR-050953]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK62934 (to A. W.) and 1P30 AR-050953.	Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CALVO JC, 1993, ARCH BIOCHEM BIOPHYS, V302, P468, DOI 10.1006/abbi.1993.1241; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; Doglioni C, 1998, J PATHOL, V185, P159, DOI 10.1002/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Fujimoto M, 2005, BBA-MOL CELL RES, V1745, P38, DOI 10.1016/j.bbamcr.2004.12.007; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HAYASHI JN, 1991, VIRCHOWS ARCH B, V60, P245, DOI 10.1007/BF02899553; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Rickheim DG, 2002, HEPATOLOGY, V36, P30, DOI 10.1053/jhep.2002.33996; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sakaki K, 2008, AUTOPHAGY, V4, P841, DOI 10.4161/auto.6607; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; Takeda M, 2001, METABOLISM, V50, P789, DOI 10.1053/meta.2001.24207; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; TOOLE BP, 2000, PROTEOGLYCANS STRUCT, P61; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Young B., 1992, Journal of the American Society of Nephrology, V3, P770; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139; Zheng XL, 2007, DIABETOLOGIA, V50, P881, DOI 10.1007/s00125-006-0543-6	50	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16621	16632		10.1074/jbc.M806430200	http://dx.doi.org/10.1074/jbc.M806430200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19276076	Green Published, hybrid			2022-12-25	WOS:000266730900058
J	Hoegy, F; Lee, XY; Noel, S; Rognan, D; Mislin, GLA; Reimmann, C; Schalk, IJ				Hoegy, Francoise; Lee, Xiaoyun; Noel, Sabrina; Rognan, Didier; Mislin, Gaetan L. A.; Reimmann, Cornelia; Schalk, Isabelle J.			Stereospecificity of the Siderophore Pyochelin Outer Membrane Transporters in Fluorescent Pseudomonads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FERRIC ENTEROBACTIN; FERRIPYOCHELIN RECEPTOR; COORDINATION CHEMISTRY; AERUGINOSA REQUIRES; OPTICAL ANTIPODE; IRON UPTAKE; BINDING; ACID; TONB	Pyochelin (Pch) and enantio-pyochelin (EPch) are enantiomer siderophores that are produced by Pseudomonas aeruginosa and Pseudomonas fluorescens, respectively, under iron limitation. Pch promotes growth of P. aeruginosa when iron is scarce, and EPch carries out the same biological function in P. fluorescens. However, the two siderophores are unable to promote growth in the heterologous species, indicating that siderophore-mediated iron uptake is highly stereospecific. In the present work, using binding and iron uptake assays, we found that FptA, the Fe-Pch outer membrane transporter of P. aeruginosa, recognized (K-d = 2.5 +/- 1.1 nM) and transported Fe-Pch but did not interact with Fe-EPch. Likewise, FetA, the Fe-EPch receptor of P. fluorescens, was specific for Fe-EPch (K-d = 3.7 +/- 2.1 nM) but did not bind and transport Fe-Pch. Growth promotion experiments performed under iron-limiting conditions confirmed that FptA and FetA are highly specific for Pch and EPch, respectively. When fptA and fetA along with adjacent transport genes involved in siderophore uptake were swapped between the two bacterial species, P. aeruginosa became able to utilize Fe-EPch as an iron source, and P. fluorescens was able to grow with Fe-Pch. Docking experiments using the FptA structure and binding assays showed that the stereospecificity of Pch recognition by FptA was mostly due to the configuration of the siderophore chiral centers C4 '' and C2 '' and was only weakly dependent on the configuration of the C4' carbon atom. Together, these findings increase our understanding of the stereospecific interaction between Pch and its outer membrane receptor FptA.	[Hoegy, Francoise; Noel, Sabrina; Mislin, Gaetan L. A.; Schalk, Isabelle J.] Univ Strasbourg, ESBS, CNRS, F-67413 Strasbourg, France; [Lee, Xiaoyun; Reimmann, Cornelia] Univ Lausanne, Dept Microbiol Fondamentale, Quartier UNIL Sorge, CH-1015 Lausanne, Switzerland; [Rognan, Didier] Univ Strasbourg, Dept Pharmacochim Commun Cellulaire, CNRS, Fac Pharm 74, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schalk, IJ (corresponding author), Univ Strasbourg, ESBS, CNRS, FRE3211,Blvd Sebastien Brant,BP 10412, F-67413 Strasbourg, France.	schalk@esbs.u-strasbg.fr	Rognan, Didier/B-9939-2014		CNRS; Vaincre la Mucoviscidose; Agence Nationale de Recherche [ANR-05-JCJC-0181-01]; Swiss National Science Foundation [31-113955/1]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Vaincre la Mucoviscidose; Agence Nationale de Recherche(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the CNRS, the association Vaincre la Mucoviscidose (French Association against Cystic Fibrosis), Agence Nationale de Recherche Grant ANR-05-JCJC-0181-01, and Swiss National Science Foundation for Scientific Research Project 31-113955/1).	ANKENBAUER RG, 1994, J BACTERIOL, V176, P307, DOI 10.1128/JB.176.2.307-319.1994; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5344, DOI 10.1128/jb.170.11.5344-5351.1988; Barnard TJ, 2001, MOL MICROBIOL, V41, P527, DOI 10.1046/j.1365-2958.2001.02473.x; BERGERON RJ, 1985, J BIOL CHEM, V260, P7936; Bergeron RJ, 2001, J MED CHEM, V44, P2469, DOI 10.1021/jm010019s; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Braun V, 2003, FRONT BIOSCI-LANDMRK, V8, pS1409, DOI 10.2741/1232; Castignetti D, 1997, CURR MICROBIOL, V34, P250, DOI 10.1007/s002849900178; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; COX CD, 1980, J BACTERIOL, V142, P581, DOI 10.1128/JB.142.2.581-587.1980; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Darling P, 1998, INFECT IMMUN, V66, P874, DOI 10.1128/IAI.66.2.874-877.1998; DEMANGE P, 1990, BIOL MET, V3, P155; DRECHSEL H, 1992, BIOMETALS, V5, P141, DOI 10.1007/BF01061320; ECKER DJ, 1986, J BACTERIOL, V167, P666, DOI 10.1128/jb.167.2.666-673.1986; FARINHA MA, 1990, FEMS MICROBIOL LETT, V70, P221, DOI 10.1016/S0378-1097(05)80043-6; Greenwald J, 2007, J BIOL CHEM, V282, P2987, DOI 10.1074/jbc.M609238200; HEINRICHS DE, 1993, J BACTERIOL, V175, P5882, DOI 10.1128/JB.175.18.5882-5889.1993; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; KEEL C, 1989, PHYTOPATHOLOGY, V79, P584, DOI 10.1094/Phyto-79-584; Klumpp C, 2005, BIOORG MED CHEM LETT, V15, P1721, DOI 10.1016/j.bmcl.2005.01.034; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LIU PV, 1978, INFECT IMMUN, V22, P878, DOI 10.1128/IAI.22.3.878-890.1978; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Michel L, 2005, MOL MICROBIOL, V58, P495, DOI 10.1111/j.1365-2958.2005.04837.x; Michel L, 2007, MICROBIOL-SGM, V153, P1508, DOI 10.1099/mic.0.2006/002915-0; Mislin GLA, 2006, J MOL BIOL, V357, P1437, DOI 10.1016/j.jmb.2006.01.080; Mossialos D, 2007, FUTURE MICROBIOL, V2, P387, DOI 10.2217/17460913.2.4.387; MULLER G, 1985, J BIOL CHEM, V260, P3921; Munzinger M, 1999, BIOMETALS, V12, P189, DOI 10.1023/A:1009259118034; NEILANDS JB, 1981, J BIOL CHEM, V256, P3831; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Phoebe CH, 2001, J ANTIBIOT, V54, P56; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Reimmann C, 1998, MICROBIOL-UK, V144, P3135, DOI 10.1099/00221287-144-11-3135; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; RINEHART KL, 1995, J ORG CHEM, V60, P2786, DOI 10.1021/jo00114a029; Sambrook J, 2001, MOL CLONING LAB MANU; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Schlegel K, 2004, BIOMETALS, V17, P409, DOI 10.1023/B:BIOM.0000029437.42633.73; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; SOKOL PA, 1986, J CLIN MICROBIOL, V23, P560, DOI 10.1128/JCM.23.3.560-562.1986; STANISICH VA, 1972, GENET RES, V19, P91, DOI 10.1017/S0016672300014294; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Tseng CF, 2006, J BIOL INORG CHEM, V11, P419, DOI 10.1007/s00775-006-0088-7; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; WINKELMANN G, 1979, FEBS LETT, V97, P43, DOI 10.1016/0014-5793(79)80048-4; WINKELMANN G, 1981, FEMS MICROBIOL LETT, V11, P237, DOI 10.1016/0378-1097(81)90068-9; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Zamri A, 2000, TETRAHEDRON, V56, P249, DOI 10.1016/S0040-4020(99)00946-1	57	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14949	14957		10.1074/jbc.M900606200	http://dx.doi.org/10.1074/jbc.M900606200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297329	Green Published, hybrid			2022-12-25	WOS:000266288200031
J	Stuart, SA; Wang, JYJ				Stuart, Scott A.; Wang, Jean Y. J.			Ionizing Radiation Induces ATM-independent Degradation of p21(Cip1) in Transformed Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; DNA-DAMAGE; UBIQUITIN LIGASE; NUCLEAR ANTIGEN; ATAXIA-TELANGIECTASIA; PROTEIN-KINASES; UV-IRRADIATION; IN-VIVO; S-PHASE; PCNA	The cyclin-dependent kinase inhibitor p21(Cip1) plays an important role in the cellular response to DNA damage. In normal cells, genotoxic stress activates the ATM-p53 pathway that up-regulates the expression of p21(Cip1) leading to cell cycle arrest. However, we have found that in several neoplastic cell lines, ionizing radiation (IR) induces ubiquitin-dependent degradation of p21(Cip1). This process is independent of the ATM pathway as it occurs in immortalized A-T fibroblasts. Knockdown of Skp2, an F-box protein capable of regulating the normal turnover of p21(Cip1), does not prevent the IR-induced degradation. Instead, this process requires the Cul4-DDB1(Cdt2) E3 ligase as knockdown of either DDB1 or Cdt2 rescues p21(Cip1) degradation after IR. Mutating the proliferating cell nuclear antigen-binding site of p21(Cip1) also prevents its IR-induced degradation suggesting that the p21(Cip1)-proliferating cell nuclear antigen interaction is critical for this event. Although ectopic expression of a nondegradable p21(Cip1) did not by itself affect the clonogenic survival of HEK293 cells after IR, the degradation of p21(Cip1) and other targets of the Cul4-DDB1(Cdt2) E3 ligase may collectively contribute to the survival of neoplastic cells after ionizing radiation.	[Stuart, Scott A.; Wang, Jean Y. J.] Univ Calif San Diego, Biomed Sci Grad Program, Sch Med, La Jolla, CA 92093 USA; [Wang, Jean Y. J.] Univ Calif San Diego, Div Hematol Oncol, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Wang, Jean Y. J.] Univ Calif San Diego, Moores Canc Ctr, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, JYJ (corresponding author), 3855 Hlth Sci Dr,MC 0820, La Jolla, CA 92122 USA.	jywang@ucsd.edu			National Institutes of Health [CA43054, CA067754]; NATIONAL CANCER INSTITUTE [R37CA043054, T32CA067754, R01CA043054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA43054 (to J.Y.J.W.). Supported in part by National Institutes of Health Training Grant CA067754.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; EL DW, 1993, CELL, V75, P817; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; HARPER JW, 1993, CELL, V75, P805; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; KROSS J, 1982, BIOCHEMISTRY-US, V21, P4310, DOI 10.1021/bi00261a021; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Miura M, 1996, RADIAT RES, V145, P75, DOI 10.2307/3579198; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Prives C, 2008, CELL CYCLE, V7, P3840, DOI 10.4161/cc.7.24.7243; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	46	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15061	15070		10.1074/jbc.M808810200	http://dx.doi.org/10.1074/jbc.M808810200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332548	hybrid, Green Published			2022-12-25	WOS:000266288200042
J	Beuria, TK; Mullapudi, S; Mileykovskaya, E; Sadasivam, M; Dowhan, W; Margolin, W				Beuria, Tushar K.; Mullapudi, Srinivas; Mileykovskaya, Eugenia; Sadasivam, Mahalakshmi; Dowhan, William; Margolin, William			Adenine Nucleotide-dependent Regulation of Assembly of Bacterial Tubulin-like FtsZ by a Hypermorph of Bacterial Actin-like FtsA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSZ; MEMBRANE TARGETING SEQUENCE; Z-RING; BACILLUS-SUBTILIS; FILAMENT TURNOVER; SEPTAL RING; IN-VITRO; DYNAMICS; ZIPA	Cytokinesis in bacteria depends upon the contractile Z ring, which is composed of dynamic polymers of the tubulin homolog FtsZ as well as other membrane-associated proteins such as FtsA, a homolog of actin that is required for membrane attachment of the Z ring and its subsequent constriction. Here we show that a previously characterized hypermorphic mutant FtsA (FtsA*) partially disassembled FtsZ polymers in vitro. This effect was strictly dependent on ATP or ADP binding to FtsA* and occurred at sub-stoichiometric levels relative to FtsZ, similar to cellular levels. Nucleotide-bound FtsA* did not affect FtsZ GTPase activity or the critical concentration for FtsZ assembly but was able to disassemble preformed FtsZ polymers, suggesting that FtsA* acts on FtsZ polymers. Microscopic examination of the inhibited FtsZ polymers revealed a transition from long, straight polymers and polymer bundles to mainly short, curved protofilaments. These results indicate that a bacterial actin, when activated by adenine nucleotides, can modify the length distribution of bacterial tubulin polymers, analogous to the effects of actin-depolymerizing factor/cofilin on F-actin.	[Beuria, Tushar K.; Sadasivam, Mahalakshmi; Margolin, William] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Mullapudi, Srinivas; Mileykovskaya, Eugenia; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Margolin, W (corresponding author), Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, 6431 Fannin St, Houston, TX 77030 USA.	William.Margolin@uth.tmc.edu		Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [R01-GM61074, R37-GM20478]; John S. Dunn research foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM061074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn research foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM61074 (to W.M.) and R37-GM20478 (to W.D.). This work was also supported by a grant from the John S. Dunn research foundation (to W.D.).	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chung KM, 2007, J BIOL CHEM, V282, P14891, DOI 10.1074/jbc.M605177200; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEWAR SJ, 1992, J BACTERIOL, V174, P6314, DOI 10.1128/JB.174.19.6314-6316.1992; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shiomi D, 2008, MOL MICROBIOL, V67, P558, DOI 10.1111/j.1365-2958.2007.06085.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Yan K, 2000, BIOCHEM BIOPH RES CO, V270, P387, DOI 10.1006/bbrc.2000.2439; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	61	48	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14079	14086		10.1074/jbc.M808872200	http://dx.doi.org/10.1074/jbc.M808872200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297332	hybrid, Green Published			2022-12-25	WOS:000266286100014
J	Bynagari, YS; Nagy, B; Tuluc, F; Bhavaraju, K; Kim, S; Vijayan, KV; Kunapuli, SP				Bynagari, Yamini S.; Nagy, Bela, Jr.; Tuluc, Florin; Bhavaraju, Kamala; Kim, Soochong; Vijayan, K. Vinod; Kunapuli, Satya P.			Mechanism of Activation and Functional Role of Protein Kinase C eta in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP RECEPTORS; INTEGRIN ALPHA(IIB)BETA(3); P2Y(12) RECEPTOR; TYROSINE KINASE; MOLECULAR-BASIS; DOWN-REGULATION; PATHWAYS; GENERATION; ISOFORM; EPSILON	The novel class of protein kinase C (nPKC) isoform eta is expressed in platelets, but not much is known about its activation and function. In this study, we investigated the mechanism of activation and functional implications of nPKC eta using pharmacological and gene knock-out approaches. nPKC eta was phosphorylated (at Thr-512) in a time-and concentration-dependent manner by 2MeSADP. Pretreatment of platelets with MRS-2179, a P2Y(1) receptor antagonist, or YM-254890, a G(q) blocker, abolished 2MeSADP-induced phosphorylation of nPKC eta. Similarly, ADP failed to activate nPKC eta in platelets isolated from P2Y(1) and G(q) knock-out mice. However, pretreatment of platelets with P2Y(12) receptor antagonist, AR-C69331MX did not interfere with ADP-induced nPKC eta phosphorylation. In addition, when platelets were activated with 2MeSADP under stirring conditions, although nPKC eta was phosphorylated within 30 s by ADP receptors, it was also dephosphorylated by activated integrin alpha(II)b beta(3) mediated outside-in signaling. Moreover, in the presence of SC-57101, alpha(II)b beta(3) receptor antagonist, nPKC eta dephosphorylation was inhibited. Furthermore, in murine platelets lacking PP1C gamma, a catalytic subunit of serine/threonine phosphatase, alpha(II)b beta(3) failed to dephosphorylate n PKC eta. Thus, we conclude that ADP activates nPKC eta via P2Y(1) receptor and is subsequently dephosphorylated by PP1 gamma phosphatase activated by alpha(II)b beta(3) integrin. In addition, pretreatment of platelets with eta-RACK antagonistic peptides, a specific inhibitor of nPKC eta, inhibited ADP-induced thromboxane generation. However, these peptides had no affect on ADP-induced aggregation when thromboxane generation was blocked. In summary, nPKC eta positively regulates agonist-induced thromboxane generation with no effects on platelet aggregation.	[Bynagari, Yamini S.; Nagy, Bela, Jr.; Tuluc, Florin; Bhavaraju, Kamala; Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine	Kunapuli, SP (corresponding author), Temple Univ, Sch Med, Dept Physiol, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Tuluc, Petronel/C-2527-2011		National Institutes of Health [HL81322, HL93231, HL80444, HL60683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, R01HL080444, R01HL060683, R01HL081322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81322, HL93231, HL80444, and HL60683.	Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Brass LF, 1999, J CLIN INVEST, V104, P1663, DOI 10.1172/JCI8944; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; CHARI R, 2009, ARTERIOSCLE IN PRESS; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dangelmaier C, 2000, EUR J BIOCHEM, V267, P2283, DOI 10.1046/j.1432-1327.2000.01235.x; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; GUSHIKEN FC, 2007, BLOOD, V110, pA135; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Joseph EK, 2007, PAIN, V132, P67, DOI 10.1016/j.pain.2007.01.027; Kawasaki T, 2003, THROMB HAEMOSTASIS, V90, P406, DOI 10.1160/TH03-02-0115; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kunapuli Satva P, 2002, ScientificWorldJournal, V2, P424; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Lum H, 2001, AM J PHYSIOL-LUNG C, V281, pL546, DOI 10.1152/ajplung.2001.281.3.L546; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; MOCHLYROSEN D, 1991, J BIOL CHEM, V266, P14866; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Offermanns S, 2000, BIOL CHEM, V381, P389, DOI 10.1515/BC.2000.051; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Vijayan KV, 2005, J BIOL CHEM, V280, P21756, DOI 10.1074/jbc.M500872200; Yang X, 1997, THROMB RES, V88, P317, DOI 10.1016/S0049-3848(97)00261-2	55	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13413	13421		10.1074/jbc.M808970200	http://dx.doi.org/10.1074/jbc.M808970200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19286657	Green Published, hybrid			2022-12-25	WOS:000265877300017
J	Lu, RJ; Li, Y; Zhang, YW; Chen, YJ; Shields, AD; Winder, DG; Angelotti, T; Jiao, K; Limbird, LE; Zhou, Y; Wang, Q				Lu, Roujian; Li, Yong; Zhang, Youwen; Chen, Yunjia; Shields, Angela D.; Winder, Danny G.; Angelotti, Timothy; Jiao, Kai; Limbird, Lee E.; Zhou, Yi; Wang, Qin			Epitope-tagged Receptor Knock-in Mice Reveal That Differential Desensitization of alpha(2)-Adrenergic Responses Is because of Ligand-selective Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID RECEPTOR; PROTEIN-COUPLED RECEPTORS; AGONIST-SPECIFIC REGULATION; BETA-ADRENERGIC-RECEPTORS; HUMAN ASTROCYTOMA-CELLS; ALPHA(2A)-ADRENERGIC RECEPTOR; SYMPATHETIC NEURONS; 7-TRANSMEMBRANE RECEPTORS; ADENYLATE-CYCLASE; BETA-2-ADRENERGIC RECEPTOR	Although ligand-selective regulation of G protein-coupled receptor-mediated signaling and trafficking are well documented, little is known about whether ligand-selective effects occur on endogenous receptors or whether such effects modify the signaling response in physiologically relevant cells. Using a gene targeting approach, we generated a knock-in mouse line, in which N-terminal hemagglutinin epitope-tagged alpha(2)A-adrenergic receptor (AR) expression was driven by the endogenous mouse alpha(2A)AR gene locus. Exploiting this mouse line, we evaluated alpha(2A)AR trafficking and alpha(2A)AR-mediated inhibition of Ca2+ currents in native sympathetic neurons in response to clonidine and guanfacine, two drugs used for treatment of hypertension, attention deficit and hyperactivity disorder, and enhancement of analgesia through actions on the alpha(2A)AR subtype. We discovered a more rapid desensitization of Ca2+ current suppression by clonidine than guanfacine, which paralleled a more marked receptor phosphorylation and endocytosis of alpha(2A)AR evoked by clonidine than by guanfacine. Clonidine-induced alpha(2A)AR desensitization, but not receptor phosphorylation, was attenuated by blockade of endocytosis with concanavalin A, indicating a critical role for internalization of alpha(2A)AR in desensitization to this ligand. Our data on endogenous receptor-mediated signaling and trafficking in native cells reveal not only differential regulation of G protein- coupled receptor endocytosis by different ligands, but also a differential contribution of receptor endocytosis to signaling desensitization. Taken together, our data suggest that these HA-alpha(2A)AR knock-in mice will serve as an important model in developing ligands to favor endocytosis or nonendocytosis of receptors, depending on the target cell and pathophysiology being addressed.	[Lu, Roujian; Zhang, Youwen; Chen, Yunjia; Wang, Qin] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Li, Yong; Wang, Qin] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Li, Yong] Shanghai Jiao Tong Univ, Dept Neurobiol, Sch Med, Shanghai 200025, Peoples R China; [Shields, Angela D.; Winder, Danny G.] Vanderbilt Univ, Dept Mol Physiol, Nashville, TN 37232 USA; [Angelotti, Timothy] Stanford Univ, Dept Anesthesia, CCM, Stanford, CA 94305 USA; [Limbird, Lee E.] Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA; [Zhou, Yi] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Shanghai Jiao Tong University; Vanderbilt University; Stanford University; Meharry Medical College; State University System of Florida; Florida State University	Wang, Q (corresponding author), 958 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	qinwang@uab.edu	Li, Yong/ABB-5588-2021; Winder, Danny G./H-4857-2013; Angelotti, Timothy/AAD-3714-2022	Angelotti, Timothy/0000-0002-0100-2011; Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020	National Institutes of Health [DK43852, HL25182, MH079075, MH081917, NS050355]; American Heart Association [0630103N, 0635497N]; NINDS [KO8 Grant NS050654]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917, R21MH079075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050355, K08NS050654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43852 and HL25182 (to L. E. L.), MH079075 (to Q. W.), MH081917 (to Q.W.), and NS050355 (to Y.Z.). This work was also supported by American Heart Association Awards 0630103N (to Q. W.) and 0635497N (to Y.Z.).; Supported by National Institutes of Health KO8 Grant NS050654 from NINDS.	Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; Alvarez VA, 2002, J NEUROSCI, V22, P5769; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Banaschewski T, 2004, EUR CHILD ADOLES PSY, V13, P102, DOI 10.1007/s00787-004-1010-x; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Bisello A, 2004, MOL ENDOCRINOL, V18, P1486, DOI 10.1210/me.2003-0487; Bisello A, 2002, J BIOL CHEM, V277, P38524, DOI 10.1074/jbc.M202544200; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Boudin H, 2000, J NEUROSCI, V20, P5932, DOI 10.1523/JNEUROSCI.20-16-05932.2000; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Bushell T, 2002, MOL PHARMACOL, V61, P55, DOI 10.1124/mol.61.1.55; CARCHMAN SH, 1987, J CLIN PHARMACOL, V27, P762, DOI 10.1002/j.1552-4604.1987.tb02993.x; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; CHENG K, 2001, ADV ABNORMAL PSYCHOL, P507; Cormack JR, 2005, J CLIN NEUROSCI, V12, P375, DOI 10.1016/j.jocn.2004.06.008; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Hanley NRS, 2002, J PHARMACOL EXP THER, V300, P468, DOI 10.1124/jpet.300.2.468; Hein L, 1999, ANN NY ACAD SCI, V881, P265, DOI 10.1111/j.1749-6632.1999.tb09368.x; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Jasper JR, 1998, BIOCHEM PHARMACOL, V55, P1035, DOI 10.1016/S0006-2952(97)00631-X; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Kable JW, 2000, J PHARMACOL EXP THER, V293, P1; KEEFER JR, 1993, J BIOL CHEM, V268, P11340; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KENAKIN T, 2007, TRENDS PHARMACOL SCI, V16, P232; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; MacDonald E, 1997, TRENDS PHARMACOL SCI, V18, P211; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; MANINTVELD AJ, 1997, ANTIHYPERTENSIVE DRU, P427; Marie N, 2003, J BIOL CHEM, V278, P22795, DOI 10.1074/jbc.M300084200; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Oates J. A., 2001, GOODMAN GILMANS PHAR, V10, P871; Olli-Lahdesmaki T, 2003, EUR J CELL BIOL, V82, P231, DOI 10.1078/0171-9335-00311; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Ryman-Rasmussen JP, 2005, MOL PHARMACOL, V68, P1039, DOI 10.1124/mol.105.012153; Scahill L, 1999, J Child Adolesc Psychiatr Nurs, V12, P168, DOI 10.1111/j.1744-6171.1999.tb00065.x; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sica Domenic A, 2007, J Clin Hypertens (Greenwich), V9, P399, DOI 10.1111/j.1524-6175.2007.07161.x; SU YF, 1979, J BIOL CHEM, V254, P38; SURPRENANT A, 1992, SCIENCE, V257, P977, DOI 10.1126/science.1354394; Tan CM, 2002, P NATL ACAD SCI USA, V99, P12471, DOI 10.1073/pnas.122368499; Trafton JA, 2000, J NEUROSCI, V20, P8578; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Velazquez B, 2000, MOL CELL BIOCHEM, V206, P75, DOI 10.1023/A:1007091127392; VIDOVIC M, 1994, MOL BRAIN RES, V22, P49, DOI 10.1016/0169-328X(94)90031-0; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang RX, 1997, MOL PHARMACOL, V52, P1071, DOI 10.1124/mol.52.6.1071; Wang YL, 2003, J PHARMACOL EXP THER, V307, P1127, DOI 10.1124/jpet.103.055814; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; YAMAUCHI A, 1973, J ANAT, V114, P271; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang J, 1999, J RECEPT SIGNAL TR R, V19, P301, DOI 10.3109/10799899909036653	80	27	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13233	13243		10.1074/jbc.M807535200	http://dx.doi.org/10.1074/jbc.M807535200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276088	Green Published, hybrid			2022-12-25	WOS:000265688300070
J	Morales, AA; Gutman, D; Cejas, PJ; Lee, KP; Boise, LH				Morales, Alejo A.; Gutman, Delia; Cejas, Pedro J.; Lee, Kelvin P.; Boise, Lawrence H.			Reactive Oxygen Species Are Not Required for an Arsenic Trioxide-induced Antioxidant Response or Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA CELLS; TRANSCRIPTION FACTOR NRF2; HEME OXYGENASE-1; MOLECULAR-MECHANISMS; UP-REGULATION; GENE-EXPRESSION; CANCER-CELLS; INTRACELLULAR GLUTATHIONE; IMMUNOMODULATORY AGENT; SIGNAL-TRANSDUCTION	Arsenicals are both environmental carcinogens as well as therapeutic agents for the treatment of trypanosomiasis and more recently cancer. Arsenic trioxide (ATO) has been successfully used for the treatment of acute promyelocytic leukemia (APL) and has activity in multiple myeloma (MM). While signaling events associated with carcinogenesis have been well studied, it still remains to be determined which of these events are involved in anti-cancer signaling. To better define this response, gene expression profiling following ATO treatment of four MM cell lines was performed. The pattern was consistent with a strong antioxidative response, particularly of genes activated by Nrf2. While Nrf2 is expressed constitutively at the mRNA level, the protein is not detected in untreated cells. Consistent with inactivation of Keap1, Nrf2 protein is stabilized and present in the nucleus within 6 h of ATO treatment. Despite the activation of this antioxidative response, ROS may not be important in ATO-induced death. Inhibition of ATO-induced ROS with butylated hydroxyanisole (BHA) does not affect Nrf2 activation or cell death. Moreover, silencing Nrf2 had no effect on ATO-induced apoptosis. Together these data suggest that ROS is not important in the induction of the antioxidative response or cellular death by ATO.	[Morales, Alejo A.; Gutman, Delia; Cejas, Pedro J.; Boise, Lawrence H.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Morales, Alejo A.; Gutman, Delia; Cejas, Pedro J.; Boise, Lawrence H.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	University of Miami; University of Miami; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Boise, LH (corresponding author), 1600 NW 10th Ave,RMSB,Rm 3153, Miami, FL 33136 USA.	lboise@med.miami.edu	Boise, Lawrence/AAD-2314-2019	Boise, Lawrence/0000-0001-9436-8815	National Institutes of Health [R01 CA129968, CA97243, CA127910]; Multiple Myeloma Foundation; NATIONAL CANCER INSTITUTE [R01CA129968, R01CA127910, R01CA097243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA129968, CA97243, and CA127910. This work was also supported by a Senior Research Award from the Multiple Myeloma Foundation.	Abraham NG, 2007, CURR GENE THER, V7, P89, DOI 10.2174/156652307780363134; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; ALBORES A, 1992, CHEM-BIOL INTERACT, V85, P127, DOI 10.1016/0009-2797(92)90057-R; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berenson JR, 2006, CLIN LYMPHOMA MYELOM, V7, P192, DOI 10.3816/CLM.2006.n.058; Bonati A, 2006, CURR PHARM BIOTECHNO, V7, P397, DOI 10.2174/138920106779116829; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Fujita H, 2008, BRAIN RES, V1206, P1, DOI 10.1016/j.brainres.2008.01.081; Gallagher RE, 2001, LEUKEMIA RES, V25, P237, DOI 10.1016/S0145-2126(00)00144-2; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; GOUILL S, 2005, ONCOGENE, V24, P8076; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Harada H, 2008, FREE RADICAL RES, V42, P297, DOI 10.1080/10715760801975735; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hussein MA, 2001, MED ONCOL, V18, P239, DOI 10.1385/MO:18:4:239; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kajiguchi T, 2006, CANCER SCI, V97, P540, DOI 10.1111/j.1349-7006.2006.00199.x; Kalmadi SR, 2006, ACTA HAEMATOL-BASEL, V116, P1, DOI 10.1159/000092341; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Krause C, 2008, ANTICANCER RES, V28, P2585; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Ma Q, 2004, BIOCHEM J, V377, P205, DOI 10.1042/BJ20031123; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, CANCER RES, V62, P3893; Min JY, 2006, J NEURAL TRANSM, V113, P1821, DOI 10.1007/s00702-006-0500-z; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Munshi NC, 2002, LEUKEMIA, V16, P1835, DOI 10.1038/sj.leu.2402599; Ngu TT, 2006, J AM CHEM SOC, V128, P12473, DOI 10.1021/ja062914c; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nowis D, 2006, ONCOGENE, V25, P3365, DOI 10.1038/sj.onc.1209378; Park WH, 2000, CANCER RES, V60, P3065; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rousselot P, 2004, LEUKEMIA, V18, P1518, DOI 10.1038/sj.leu.2403424; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Sasaki T, 2005, VIRCHOWS ARCH, V446, P525, DOI 10.1007/s00428-005-1247-x; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Shen ZY, 2003, INT J MOL MED, V11, P479; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Toyama M, 2002, J BIOCHEM, V132, P217, DOI 10.1093/oxfordjournals.jbchem.a003213; Volm M, 2002, BRIT J CANCER, V87, P251, DOI 10.1038/sj.bjc.6600463; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Woo SH, 2004, INT J CANCER, V112, P596, DOI 10.1002/ijc.20433; Yamamoto N, 2007, J BIOL CHEM, V282, P4364, DOI 10.1074/jbc.M603712200; Yan W, 2007, BIOCHEM BIOPH RES CO, V355, P1038, DOI 10.1016/j.bbrc.2007.02.064; Zhou P, 2005, BRIT J HAEMATOL, V128, P636, DOI 10.1111/j.1365-2141.2005.05369.x	68	35	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12886	12895		10.1074/jbc.M806546200	http://dx.doi.org/10.1074/jbc.M806546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279006	Green Published, hybrid			2022-12-25	WOS:000265688300034
J	Wu, TJ; Chiang, YH; Lin, YC; Tsai, CR; Yu, TY; Sung, MT; Lee, YHW; Lin, JJ				Wu, Tzung-Ju; Chiang, Yi-Hsuan; Lin, Yi-Chien; Tsai, Chang-Ru; Yu, Tai-Yuan; Sung, Ming-Ta; Lee, Yan-Hwa Wu; Lin, Jing-Jer			Sequential Loading of Saccharomyces cerevisiae Ku and Cdc13p to Telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; STRAND BREAK REPAIR; SINGLE-STRAND; YEAST KU; IN-VIVO; RIF PROTEINS; SIR PROTEINS; MAINTENANCE; MECHANISM; LENGTH	Ku is a heterodimeric protein involved in nonhomologous end-joining of the DNA double-stranded break repair pathway. It binds to the double-stranded DNA ends and then activates a series of repair enzymes that join the broken DNA. In addition to its function in DNA repair, the yeast Saccharomyces cerevisiae Ku (Yku) is also a component of telomere protein-DNA complexes that affect telomere function. The yeast telomeres are composed of duplex C1-3(A/T)G(1-3) telomeric DNA repeats plus single-stranded TG(1-3) telomeric DNA tails. Here we show that Yku is capable of binding to a tailed-duplex DNA formed by telomeric DNA that mimics the structure of telomeres. Addition of Cdc13p, a single-stranded telomeric DNA-binding protein, to the Yku-DNA complex enables the formation of a ternary complex with Cdc13p binding to the single-stranded tail of the DNA substrate. Because pre-loading of Cdc13p to the single-stranded telomeric tail inhibits the binding of Yku, the results suggested that loading of Yku and Cdc13p to telomeres is sequential. Through generating a double-stranded break near telomeric DNA sequences, we found that Ku protein appears to bind to the de novo synthesized telomeres earlier than that of Cdc13p in vivo. Thus, our results indicated that Yku interacts directly with telomeres and that sequential loading of Yku followed by Cdc13p to telomeres is required for both proteins to form a ternary complex on telomeres. Our results also offer a mechanism that the binding of Cdc13p to telomeres might prevent Yku from initiating DNA double-stranded break repair pathway on telomeres.	[Lin, Yi-Chien; Lee, Yan-Hwa Wu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wu, Tzung-Ju; Chiang, Yi-Hsuan; Lin, Yi-Chien; Tsai, Chang-Ru; Yu, Tai-Yuan; Sung, Ming-Ta; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YHW (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	yhwulee@ym.edu.tw; jjlin@ym.edu.tw	Lin, Jing-Jer/G-8068-2015	Lee Wu, Yan-Hwa/0000-0001-7299-7354; LIN, JING-JER/0000-0001-8250-7398	National Science Council, Taiwan [97-2311-B-010-005-MY3, 97-3112-B-010-013]; National Health Research Institute [NHRI-EX97-9625SI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by National Science Council, Taiwan, Grants 97-2311-B-010-005-MY3 and 97-3112-B-010-013 and National Health Research Institute Grant NHRI-EX97-9625SI.	Anderson EM, 2002, NUCLEIC ACIDS RES, V30, P4305, DOI 10.1093/nar/gkf554; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; BLACKBURN EH, 1990, J BIOL CHEM, V265, P5919; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Cosgrove AJ, 2002, GENE DEV, V16, P2485, DOI 10.1101/gad.231602; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; FALZON M, 1993, J BIOL CHEM, V268, P10546; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lin YC, 2001, J BIOL CHEM, V276, P24588, DOI 10.1074/jbc.M101642200; Lin YC, 2007, BIOCHEM J, V403, P289, DOI 10.1042/BJ20061698; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MIMORI T, 1986, J BIOL CHEM, V261, P375; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Miyoshi T, 2003, J BIOL CHEM, V278, P1924, DOI 10.1074/jbc.M208813200; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; ONO M, 1994, NUCLEIC ACIDS RES, V22, P3918, DOI 10.1093/nar/22.19.3918; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Pang TL, 2003, J BIOL CHEM, V278, P9318, DOI 10.1074/jbc.M208347200; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Stellwagen AE, 2003, GENE DEV, V17, P1; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	41	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12801	12808		10.1074/jbc.M809131200	http://dx.doi.org/10.1074/jbc.M809131200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276071	Green Published, hybrid			2022-12-25	WOS:000265688300025
J	Lee, DH; Shi, JJ; Jeoung, NH; Kim, MS; Zabolotny, JM; Lee, SW; White, MF; Wei, L; Kim, YB				Lee, Dae Ho; Shi, Jianjian; Jeoung, Nam Ho; Kim, Min Seon; Zabolotny, Janice M.; Lee, Sam W.; White, Morris F.; Wei, Lei; Kim, Young-Bum			Targeted Disruption of ROCK1 Causes Insulin Resistance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RHO; SERINE/THREONINE KINASE; PATHWAY; GTPASE; GLUT4; PHOSPHORYLATION; TRANSLOCATION; CYTOSKELETON; ADIPOCYTES; ACTIVATION	Insulin signaling is essential for normal glucose homeostasis. Rho-kinase (ROCK) isoforms have been shown to participate in insulin signaling and glucose metabolism in cultured cell lines. To investigate the physiological role of ROCK1 in the regulation of whole body glucose homeostasis and insulin sensitivity in vivo, we studied mice with global disruption of ROCK1. Here we show that, at 16 - 18 weeks of age, ROCK1-deficient mice exhibited insulin resistance, as revealed by the failure of blood glucose levels to decrease after insulin injection. However, glucose tolerance was normal in the absence of ROCK1. These effects were independent of changes in adiposity. Interestingly, ROCK1 gene ablation caused a significant increase in glucose-induced insulin secretion, leading to hyperinsulinemia. To determine the mechanism(s) by which deletion of ROCK1 causes insulin resistance, we measured the ability of insulin to activate phosphatidylinositol 3-kinase and multiple distal pathways in skeletal muscle. Insulin-stimulated phosphatidylinositol 3-kinase activity associated with IRS-1 or phospho-tyrosine was also reduced similar to 40% without any alteration in tyrosine phosphorylation of insulin receptor in skeletal muscle. Concurrently, serine phosphorylation of IRS-1 at serine 632/635, which is phosphorylated by ROCK in vitro, was also impaired in these mice. Insulin-induced phosphorylation of Akt, AS160, S6K, and S6 was also decreased in skeletal muscle. These data suggest that ROCK1 deficiency causes systemic insulin resistance by impairing insulin signaling in skeletal muscle. Thus, our results identify ROCK1 as a novel regulator of glucose homeostasis and insulin sensitivity in vivo, which could lead to new treatment approaches for obesity and type 2 diabetes.	[Shi, Jianjian; Wei, Lei] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, Indianapolis, IN 46202 USA; [Lee, Dae Ho; Zabolotny, Janice M.; Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Lee, Dae Ho; Zabolotny, Janice M.; Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Jeoung, Nam Ho] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Jeoung, Nam Ho] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Kim, Min Seon] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Internal Med, Seoul 138736, South Korea; [Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [White, Morris F.] Childrens Hosp, Div Endocrinol, Howard Hughes Med Inst, Boston, MA 02115 USA; [White, Morris F.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of Ulsan; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Wei, L (corresponding author), Indiana Univ, Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, 1044 W Walnut St,R4-370, Indianapolis, IN 46202 USA.	lewei@iupui.edu; ykim2@bidmc.harvard.edu		Jeoung, Nam Ho/0000-0002-7584-3761	National Institutes of Health [DK43051, DK38712, CA127247, HL072897, HL085098]; American Diabetes Association [7-05-PPG-02, 1-09-RA-87]; Showalter Trust [89829]; Korean Ministry of Health and Welfare Grant [A06-2363]; Korea Science and Engineering Foundation [R-01-2006-000-108060-0]; NATIONAL CANCER INSTITUTE [R01CA127247] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072897, P01HL085098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R37DK043051, R55DK038712, R01DK043051, R29DK038712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Showalter Trust; Korean Ministry of Health and Welfare Grant; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43051 (to Y.B.K.), DK38712 (to M. F. W.), CA127247 (to S. W. L.), and HL072897 and HL085098 (to L. W.). This work was also supported by American Diabetes Association Grants 7-05-PPG-02 and 1-09-RA-87 (to Y.B.K.), Showalter Trust Grant 89829 (to J.S.), Korean Ministry of Health and Welfare Grant A06-2363 (to M. S. K.), and Korea Science and Engineering Foundation Grant R-01-2006-000-108060-0 (to M. S. K.).	Chappell J, 2000, J BIOL CHEM, V275, P31792, DOI 10.1074/jbc.M004798200; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; DeFronzo RA, 1997, DIABETES REV, V5, P177; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; HAMMAR E, 2009, ENDOCRINOLO IN PRESS; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hu E, 2005, EXPERT OPIN THER TAR, V9, P715, DOI 10.1517/14728222.9.4.715; Hu Erding, 2003, Curr Opin Investig Drugs, V4, P1065; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nakamura Y, 2006, BIOCHEM BIOPH RES CO, V350, P68, DOI 10.1016/j.bbrc.2006.08.192; *NIH, 1996, NIH PUBL, V85; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shirai H, 2007, CURR OPIN NEPHROL HY, V16, P111, DOI 10.1097/MNH.0b013e3280148e4f; Tsakiridis T, 1999, MICROSC RES TECHNIQ, V47, P79, DOI 10.1002/(SICI)1097-0029(19991015)47:2<79::AID-JEMT1>3.0.CO;2-S; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8	34	98	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11776	11780		10.1074/jbc.C900014200	http://dx.doi.org/10.1074/jbc.C900014200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276091	Green Published, hybrid			2022-12-25	WOS:000265494600009
J	Chung, BM; Dimri, M; George, M; Reddi, AL; Chen, G; Band, V; Band, H				Chung, B. M.; Dimri, M.; George, M.; Reddi, A. L.; Chen, G.; Band, V.; Band, H.			The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants	ONCOGENE			English	Article						mutant EGFR; Src; transformation	GROWTH-FACTOR-RECEPTOR; C-SRC; KINASE INHIBITOR; SIGNAL TRANSDUCERS; TYROSINE KINASES; DOWN-REGULATION; MUTATIONS; ACTIVATION; GEFITINIB; SURVIVAL	Non-small cell lung cancer (NSCLC)-associated epidermal growth factor receptor (EGFR) mutants are constitutively active and induce ligand-independent transformation in non-malignant cell lines. We investigated the possibility that the ability of mutant EGFRs to transform cells reflects a constitutive cooperativity with Src using a system in which the overexpression of mutant, but not wild-type, EGFR induced anchorage-independent cell growth. Src was constitutively activated and showed enhanced interaction with mutant EGFRs, suggesting that constitutive EGFR-Src cooperativity may contribute to mutant EGFR-mediated oncogenesis. Indeed, the mutant EGFR-mediated cell transformation was inhibited by Src- as well as EGFR-directed inhibitors. Importantly, a tyrosine to phenylalanine mutation of the major Src phosphorylation site on EGFR, Y845, reduced the constitutive phosphorylation of NSCLC-EGFR mutants, as well as that of STAT3, Akt, Erk and Src, and reduced the mutant EGFR-Src association as well as proliferation, migration and anchorage-independent growth. Reduced anchorage-independent growth and migration were also observed when dominant-negative-Src was expressed in mutant EGFR-expressing cells. Overall, our findings show that mutant EGFR-Src interaction and cooperativity play critical roles in constitutive engagement of the downstream signaling pathways that allow NSCLC-associated EGFR mutants to mediate oncogenesis, and support the rationale to target Src- dependent signaling pathways in mutant EGFR-mediated malignancies.	[Chung, B. M.; George, M.; Band, H.] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Nebraska Med Ctr, Omaha, NE 68198 USA; [Band, H.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Nebraska Med Ctr, Omaha, NE 68198 USA; [Band, V.; Band, H.] Univ Nebraska Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Nebraska Med Ctr, Omaha, NE 68198 USA; [Band, V.; Band, H.] Univ Nebraska Med Ctr, UNMC Eppley Canc Ctr, Nebraska Med Ctr, Omaha, NE 68198 USA; [Chung, B. M.; Dimri, M.; George, M.; Reddi, A. L.; Chen, G.; Band, V.; Band, H.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Feinberg Sch Med, Evanston NW Healthcare Res Inst,Dept Med, Evanston, IL USA; [Chung, B. M.; Dimri, M.; George, M.; Reddi, A. L.; Chen, G.; Band, V.; Band, H.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Nebraska Med Ctr, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu	Chung, Byung Min/H-6219-2019	Chung, Byung Min/0000-0003-1262-5107	NIH [CA87986, CA105489, CA99900, CA116552, CA99163, CA94143, CA96844, CA81076]; Department of Defense Breast Cancer Research [W81XVVH-08-1-0617, DAMD17-02-1-0508]; NCI Cancer Center of Nanotechnology Excellence [1U54 CA119341-01]; NCI Breast Cancer SPORE and AVON Breast Cancer Fund; H Foundation, Chicago, IL, USA; Jean Ruggles-Romoser Chair of Cancer Research; Duckworth Family Chair of Breast Cancer Research; Malkin Scholarship; NCI Cancer Center Core Grant; NATIONAL CANCER INSTITUTE [R01CA099900, R01CA076118, R01CA099163, R01CA081076, R01CA087986, R01CA094143, R01CA105489, R01CA096844, U54CA119341, R01CA116552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); NCI Cancer Center of Nanotechnology Excellence; NCI Breast Cancer SPORE and AVON Breast Cancer Fund; H Foundation, Chicago, IL, USA; Jean Ruggles-Romoser Chair of Cancer Research; Duckworth Family Chair of Breast Cancer Research; Malkin Scholarship; NCI Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Band laboratories for helpful suggestions and discussion. This work was supported by: the NIH grants CA87986, CA105489, CA99900, CA116552 and CA99163 to HB, and CA94143, CA96844 and CA81076 to VB; Department of Defense Breast Cancer Research Grants W81XVVH-08-1-0617 (HB) and DAMD17-02-1-0508 (VB); the NCI Cancer Center of Nanotechnology Excellence Grant NCI 1U54 CA119341-01 (HB and VB); the NCI Breast Cancer SPORE and AVON Breast Cancer Fund at Robert H Lurie Cancer Center, Northwestern University; the H Foundation, Chicago, IL, USA; the Jean Ruggles-Romoser Chair of Cancer Research (HB) and the Duckworth Family Chair of Breast Cancer Research (VB); and the Malkin Scholarship (BMC). UNMC-Eppley Cancer Center is supported by an NCI Cancer Center Core Grant.	Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; ANN PAB, 2004, ONCOGENE, V23, P7957; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Fu YN, 2008, ONCOGENE, V27, P957, DOI 10.1038/sj.onc.1210684; Golas JM, 2003, CANCER RES, V63, P375; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kazansky AV, 2001, CELL GROWTH DIFFER, V12, P1; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Maeda M, 2006, J BIOL CHEM, V281, P59, DOI 10.1074/jbc.M503304200; Masaki T, 2003, EUR J CANCER, V39, P1447, DOI 10.1016/S0959-8049(03)00276-4; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; MUTHUSWAMY SK, 1995, ONCOGENE, V11, P271; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042; Yanga S, 2008, EXP CELL RES, V314, P413, DOI 10.1016/j.yexcr.2007.09.002; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	40	43	46	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2009	28	16					1821	1832		10.1038/onc.2009.31	http://dx.doi.org/10.1038/onc.2009.31			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PW	19305428	Green Accepted			2022-12-25	WOS:000265640500001
J	Liu, S; Ji, K; Chen, JM; Tai, D; Jiang, WM; Hou, GY; Chen, J; Li, JP; Huang, BX				Liu, Shuo; Ji, Kang; Chen, Jiming; Tai, Di; Jiang, Wenming; Hou, Guangyu; Chen, Jie; Li, Jinping; Huang, Baoxu			Panorama Phylogenetic Diversity and Distribution of Type A Influenza Virus	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; HEMAGGLUTININ GENE; SOUTHERN CHINA; H1N2 VIRUS; SWINE; PIGS; EVOLUTION; EMERGENCE; TRANSMISSION; H2	Background: Type A influenza virus is one of important pathogens of various animals, including humans, pigs, horses, marine mammals and birds. Currently, the viral type has been classified into 16 hemagglutinin and 9 neuraminidase subtypes, but the phylogenetic diversity and distribution within the viral type largely remain unclear from the whole view. Methodology/Principal Findings: The panorama phylogenetic trees of influenza A viruses were calculated with representative sequences selected from approximately 23000 candidates available in GenBank using web servers in NCBI and the software MEGA 4.0. Lineages and sublineages were classified according to genetic distances, topology of the phylogenetic trees and distributions of the viruses in hosts, regions and time. Conclusions/Significance: Here, two panorama phylogenetic trees of type A influenza virus covering all the 16 hemagglutinin subtypes and 9 neuraminidase subtypes, respectively, were generated. The trees provided us whole views and some novel information to recognize influenza A viruses including that some subtypes of avian influenza viruses are more complicated than Eurasian and North American lineages as we thought in the past. They also provide us a framework to generalize the history and explore the future of the viral circulation and evolution in different kinds of hosts. In addition, a simple and comprehensive nomenclature system for the dozens of lineages and sublineages identified within the viral type was proposed, which if universally accepted, will facilitate communications on the viral evolution, ecology and epidemiology.	[Liu, Shuo; Ji, Kang; Chen, Jiming; Tai, Di; Jiang, Wenming; Hou, Guangyu; Chen, Jie; Li, Jinping; Huang, Baoxu] China Anim Hlth & Epidemiol Ctr, Lab Anim Epidemiol Surveillance, Qingdao, Peoples R China; [Ji, Kang; Tai, Di] Univ NE China, Coll Vet Sci, Harbin, Peoples R China	China Animal Health & Epidemiology Center	Liu, S (corresponding author), China Anim Hlth & Epidemiol Ctr, Lab Anim Epidemiol Surveillance, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Jiming/AAA-3575-2020; Chen, Ji-Ming/AHD-7398-2022	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China	Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China	This work was partially supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks J, 1998, ARCH VIROL, V143, P781, DOI 10.1007/s007050050329; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brown IH, 1997, ARCH VIROL, V142, P1045, DOI 10.1007/s007050050140; CALLAN RJ, 1995, J GEN VIROL, V76, P199, DOI 10.1099/0022-1317-76-1-199; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen JM, 2007, ARCH VIROL, V152, P415, DOI 10.1007/s00705-006-0852-6; CHENG J, 2007, J UBIQUITOUS COMPUTI, V1, P35, DOI DOI 10.1166/JUCI.2007.004; Choi YK, 2004, EMERG INFECT DIS, V10, P2156, DOI 10.3201/eid1012.040581; Chutinimitkul S, 2008, ARCH VIROL, V153, P1049, DOI 10.1007/s00705-008-0097-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; GUO YJ, 1992, VIROLOGY, V188, P245, DOI 10.1016/0042-6822(92)90754-D; Karasin AI, 2004, J CLIN MICROBIOL, V42, P4349, DOI 10.1128/JCM.42.9.4349-4354.2004; KIDA H, 1988, VIROLOGY, V162, P160, DOI 10.1016/0042-6822(88)90405-9; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Muller I, 2005, BIOL RES, V38, P55, DOI 10.4067/S0716-97602005000100008; NAEVE CW, 1983, VIROLOGY, V129, P298, DOI 10.1016/0042-6822(83)90169-1; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Payungporn S, 2008, EMERG INFECT DIS, V14, P902, DOI 10.3201/eid1406.071270; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shin JY, 2006, J CLIN MICROBIOL, V44, P3923, DOI 10.1128/JCM.00904-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; WAHLGREN J, 2008, VECTOR BORNE ZOONOTI; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO OIE FAO H5N1, 2008, UN NOM SYST HIGHL PA; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0	43	84	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5022	10.1371/journal.pone.0005022	http://dx.doi.org/10.1371/journal.pone.0005022			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325912	Green Published, gold			2022-12-25	WOS:000265499600007
J	Lagirand-Cantaloube, J; Cornille, K; Csibi, A; Batonnet-Pichon, S; Leibovitch, MP; Leibovitch, SA				Lagirand-Cantaloube, Julie; Cornille, Karen; Csibi, Alfredo; Batonnet-Pichon, Sabrina; Leibovitch, Marie Pierre; Leibovitch, Serge A.			Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo	PLOS ONE			English	Article								Ubiquitin ligase Atrogin1/Muscle Atrophy F-box ( MAFbx) up-regulation is required for skeletal muscle atrophy but substrates and function during the atrophic process are poorly known. The transcription factor MyoD controls myogenic stem cell function and differentiation, and seems necessary to maintain the differentiated phenotype of adult fast skeletal muscle fibres. We previously showed that MAFbx mediates MyoD proteolysis in vitro. Here we present evidence that MAFbx targets MyoD for degradation in several models of skeletal muscle atrophy. In cultured myotubes undergoing atrophy, MAFbx expression increases, leading to a cytoplasmic-nuclear shuttling of MAFbx and a selective suppression of MyoD. Conversely, transfection of myotubes with sh-RNA-mediated MAFbx gene silencing (shRNAi) inhibited MyoD proteolysis linked to atrophy. Furthermore, overexpression of a mutant MyoDK133R lacking MAFbx-mediated ubiquitination prevents atrophy of mouse primary myotubes and skeletal muscle fibres in vivo. Regarding the complex role of MyoD in adult skeletal muscle plasticity and homeostasis, its rapid suppression by MAFbx seems to be a major event leading to skeletal muscle wasting. Our results point out MyoD as the second MAFbx skeletal muscle target by which powerful therapies could be developed.	[Lagirand-Cantaloube, Julie; Cornille, Karen; Csibi, Alfredo; Leibovitch, Marie Pierre; Leibovitch, Serge A.] INRA, Lab Genom Fonctionnelle Myogenese, UM II, UMR866, Montpellier, France; [Batonnet-Pichon, Sabrina] EA 300, Paris, France	INRAE; Universite de Montpellier	Lagirand-Cantaloube, J (corresponding author), CNRS, IFR122, UMR5237, Montpellier, France.	leibovs@supagro.inra.fr			Association Francaise contre les Myopathies (AFM) [graduate fellowship]; INRA [graduate fellowship]; Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de la Recherche et de la Technologie (MRT) [graduate fellowship]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); INRA; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de la Recherche et de la Technologie (MRT)	This work was supported by grants from the Association Francaise contre les Myopathies (AFM), the department PHASE from INRA and the Institut National de la Sante et de la Recherche Medicale (INSERM). J. Lagirand-Cantaloube held a graduate fellowship from the Ministere de la Recherche et de la Technologie (MRT) and an AFM fellowship. Mr. A. Csibi holds a graduate AFM and INRA fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Allen DL, 2001, J BIOL CHEM, V276, P43524, DOI 10.1074/jbc.M108017200; Batonnet S, 2004, J BIOL CHEM, V279, P5413, DOI 10.1074/jbc.M310315200; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; LIU CC, 2001, CURR RHEUMATOL REP, V4, P325; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sirri V, 2003, ONCOGENE, V22, P5658, DOI 10.1038/sj.onc.1206690; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tintignac LAJ, 2004, MOL CELL BIOL, V24, P1809, DOI 10.1128/MCB.24.4.1809-1821.2004; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	35	148	158	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4973	10.1371/journal.pone.0004973	http://dx.doi.org/10.1371/journal.pone.0004973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319192	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499200011
J	Chen, JJ; Tsai, CH; Cai, X; Horhota, AT; McLaughlin, LW; Szostak, JW				Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Horhota, Allen T.; McLaughlin, Larry W.; Szostak, Jack W.			Enzymatic Primer-Extension with Glycerol-Nucleoside Triphosphates on DNA Templates	PLOS ONE			English	Article								Background: Glycerol nucleic acid (GNA) has an acyclic phosphoglycerol backbone repeat-unit, but forms stable duplexes based on Watson-Crick base-pairing. Because of its structural simplicity, GNA is of particular interest with respect to the possibility of evolving functional polymers by in vitro selection. Template-dependent GNA synthesis is essential to any GNA-based selection system. Principal Findings: In this study, we investigated the ability of various DNA polymerases to use glycerol-nucleoside triphosphates (gNTPs) as substrates for GNA synthesis on DNA templates. Therminator DNA polymerase catalyzes quantitative primer-extension by the incorporation of two glyceronucleotides, with much less efficient extension up to five glyceronucleotides. Steady-state kinetic experiments suggested that GNA synthesis by Therminator was affected by both decreased catalytic rates and weakened substrate binding, especially for pyrimidines. In an attempt to improve pyrimidine incorporation by providing additional stacking interactions, we synthesized two new gNTP analogs with 5-propynyl substituted pyrimidine nucleobases. This led to more efficient incorporation of gC, but not gT. Conclusions: We suggest that directed evolution of Therminator might lead to mutants with improved substrate binding and catalytic efficiency.	[Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Chen, Jesse J.; Tsai, Ching-Hsuan; Cai, Xin; Szostak, Jack W.] Massachusetts Gen Hosp, Ctr Comput & Integrative Biol, Boston, MA 02114 USA; [Horhota, Allen T.; McLaughlin, Larry W.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02167 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston College	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			Harvard Origins of Life Initiative [fellowship]; NSF [CHE 0434507, MCB 0451488]; Howard Hughes Medical Institute	Harvard Origins of Life Initiative; NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	JJC was supported by a fellowship from the Harvard Origins of Life Initiative. This work was supported by NSF grants CHE 0434507 to JWS and MCB 0451488 to LWM. JWS is an Investigator of the Howard Hughes Medical Institute and CHT is a Research Associate of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner SA, 2004, ACCOUNTS CHEM RES, V37, P784, DOI 10.1021/ar040004z; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Chaput JC, 2003, J AM CHEM SOC, V125, P9274, DOI 10.1021/ja035917n; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; FROEHLER BC, 1992, TETRAHEDRON LETT, V33, P5307, DOI 10.1016/S0040-4039(00)79079-4; FROEHLER BC, 1983, NUCLEIC ACIDS RES, V11, P8031, DOI 10.1093/nar/11.22.8031; He JL, 2002, NUCLEIC ACIDS RES, V30, P5485, DOI 10.1093/nar/gkf689; Heuberger BD, 2008, J AM CHEM SOC, V130, P412, DOI 10.1021/ja0770680; HOBBS FW, 1989, J ORG CHEM, V54, P3420, DOI 10.1021/jo00275a030; Horhota A, 2005, J AM CHEM SOC, V127, P7427, DOI 10.1021/ja0428255; Horhota AT, 2006, ORG LETT, V8, P5345, DOI 10.1021/ol062232u; Kempeneers V, 2005, NUCLEIC ACIDS RES, V33, P3828, DOI 10.1093/nar/gki695; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Kuwahara M, 2006, NUCLEIC ACIDS RES, V34, P5383, DOI 10.1093/nar/gkl637; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; ROBINS MJ, 1983, J ORG CHEM, V48, P1854, DOI 10.1021/jo00159a012; Sakthivel K, 1998, ANGEW CHEM INT EDIT, V37, P2872, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2872::AID-ANIE2872>3.0.CO;2-5; Sawai H, 2001, CHEM COMMUN, P2604, DOI 10.1039/b107838k; Schlegel MK, 2008, J AM CHEM SOC, V130, P8158, DOI 10.1021/ja802788g; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Seela F, 2007, ORG BIOMOL CHEM, V5, P1858, DOI 10.1039/b704583b; Tsai CH, 2007, P NATL ACAD SCI USA, V104, P14598, DOI 10.1073/pnas.0704211104; Wang JX, 2005, NUCLEOS NUCLEOT NUCL, V24, P947, DOI 10.1081/NCN-200059307; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Yang YW, 2007, J MOL EVOL, V65, P289, DOI 10.1007/s00239-007-9017-9; Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z; Zhang LL, 2005, J AM CHEM SOC, V127, P74, DOI 10.1021/ja043904j; Zhang Y, 2005, IEEE T WIREL COMMUN, V4, P653, DOI 10.1109/TWC.2004.842947	28	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4949	10.1371/journal.pone.0004949	http://dx.doi.org/10.1371/journal.pone.0004949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305495	gold, Green Published, Green Submitted			2022-12-25	WOS:000265498800006
J	Li, S; Rao, LL; Ren, XP; Bai, XW; Zheng, R; Li, JZ; Wang, ZJ; Liu, H				Li, Shu; Rao, Li-Lin; Ren, Xiao-Peng; Bai, Xin-Wen; Zheng, Rui; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan			Psychological Typhoon Eye in the 2008 Wenchuan Earthquake	PLOS ONE			English	Article							PERCEPTION; RISK	Background: On May 12, 2008, an earthquake measuring 8.0 on the Richter scale jolted Wenchuan, China, leading to 69,227 deaths and 374,643 injured, with 17,923 listed as missing as of Sept. 25, 2008, and shook the whole nation. We assessed the devastating effects on people's post-earthquake concern about safety and health. Methodology/Principal Findings: From June 4 to July 15, 2008, we surveyed a convenience sample of 2,262 adults on their post-earthquake concern about safety and health. Residents in non-devastated areas (Fujian and Hunan Provinces, and Beijing) and devastated areas (Sichuan and Gansu Provinces) responded to a questionnaire of 5 questions regarding safety measures, epidemic disease, medical workers, psychological workers, and medication. The ANOVAs showed a significant effect of residential devastation level on the estimated number of safety measures needed, the estimated probability of the outbreak of an epidemic, and the estimated number of medical and psychological workers needed (Ps<0.001). The post-earthquake concern decreased significantly as the level of residential devastation increased. Because of the similarity with the meteorological phenomenon of the eye of a typhoon, we dubbed these findings a "Psychological Typhoon Eye'': the closer to the center of the devastated areas, the less the concern about safety and health a resident felt. Conclusions/Significance: Contrary to common perception and ripple effect that the impact of an unfortunate event decays gradually as ripples spread outward from a center, a "Psychological Typhoon Eye'' effect was observed where the post-earthquake concern was at its lowest level in the extremely devastated areas. The resultant findings may have implications for Chinese governmental strategies for putting "psychological comfort'' into effect.	[Li, Shu; Rao, Li-Lin; Ren, Xiao-Peng; Bai, Xin-Wen; Zheng, Rui; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Ren, XP (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	renxp@psych.ac.cn; baixw@psych.ac.cn; zhengrui@psych.ac.cn	Xinwen, Bai/A-3827-2014	Xinwen, Bai/0000-0002-4750-4164	Hundred Talents Program of Chinese Academy of Sciences [KSCX2-YW-R-130]; Knowledge Innovation Project of the Chinese Academy of Sciences [KKCX1-YW-05]; National Natural Science Foundation of China [70671099]	Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the "Hundred Talents Program" of Chinese Academy of Sciences, the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-130; KKCX1-YW-05) and the National Natural Science Foundation of China (No. 70671099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DEATH TOLL CHIN MAY; [Anonymous], 2007, 17 NAT C COMM PART C; Chen WK, 2001, ANN EMERG MED, V38, P556, DOI 10.1067/mem.2001.119054; *CHIN MED ASS, 2008, MESS PRES CHIN MED A; Festinger L., 1957, THEORY COGNITIVE DIS, V2; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G., 1991, EUROPEAN REV SOCIAL, V2, P83, DOI [https://doi.org/10.1080/14792779143000033, DOI 10.1080/14792779143000033, 10.1080/14792779143000033]; Guedeney C., 1973, ANGOISSE ATOMIQUE CE; HENDERSON AS, 1972, LANCET, V1, P1111; KUAI YH, 2008, SO PEOPLE WEEKL 0601, P56; [梁哲 LIANG Zhe], 2008, [自然灾害学报, Journal of Natural Disasters], V17, P25; MADERTHANER R, 1978, J APPL PSYCHOL, V63, P380, DOI 10.1037/0021-9010.63.3.380; MAGNIER M, 2008, LOS ANGELES TIM 0517, pA1; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; *TREE HUGG, 2008, AFT CHIN EARTHQ GRAS; Wilson H.V., 1904, MEMOIRS MUSEUM COMP, V30, P139; *XINH NEWS AG, 2008, HU URG WWELF I CONTR; *XINH NEWS AG, 2008, CHIN SAYS BLOOD EN M; Zhang K, 2007, JPN PSYCHOL RES, V49, P172, DOI 10.1111/j.1468-5884.2007.00344.x	20	43	51	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4964	10.1371/journal.pone.0004964	http://dx.doi.org/10.1371/journal.pone.0004964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PG	19305501	gold, Green Submitted, Green Published			2022-12-25	WOS:000265498800012
J	Wetzels, CTAH; Hoefnagel, JGM; Bakkers, JMJE; Dijkman, HBPM; Blokx, WAM; Melchers, WJG				Wetzels, Charlotte T. A. H.; Hoefnagel, Jolanda G. M.; Bakkers, Judith M. J. E.; Dijkman, Henry B. P. M.; Blokx, Willeke A. M.; Melchers, Willem J. G.			Ultrastructural Proof of Polyomavirus in Merkel Cell Carcinoma Tumour Cells and Its Absence in Small Cell Carcinoma of the Lung	PLOS ONE			English	Article								Background: A new virus called the Merkel Cell Polyomavirus (MCPyV) has recently been found in Merkel Cell Carcinoma (MCC). MCC is a rare aggressive small cell neuroendocrine carcinoma primarily derived from the skin, morphologically indistinguishable from small cell lung carcinoma (SCLC). So far the actual presence of the virus in MCC tumour cells on a morphological level has not been demonstrated, and the presence of MCPyV in other small cell neuroendocrine carcinomas has not been studied yet. Methodology/Principal Findings: We investigated MCC tissue samples from five patients and SCLCs from ten patients for the presence of MCPyV-DNA by PCR and sequencing. Electron microscopy was used to search ultrastructurally for morphological presence of the virus in MCPyV-DNA positive samples. MCPyV was detected in two out of five primary MCCs. In one MCC patient MCPyV-DNA was detected in the primary tumour as well as in the metastasis, strongly suggesting integration of MCPyV in the cellular DNA of the tumour in this patient. In the primary MCC of another patient viral particles in tumour cell nuclei and cytoplasm were identified by electron microscopy, indicating active viral replication in the tumour cells. In none of the SCLCs MCPyV-DNA was detected. Conclusions/Significance: Our results strongly suggest that MCPyV is an oncogenic polyomavirus in humans, and is potentially causally related to the development of MCC but not to the morphological similar SCLC.	[Wetzels, Charlotte T. A. H.; Dijkman, Henry B. P. M.; Blokx, Willeke A. M.] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Hoefnagel, Jolanda G. M.; Bakkers, Judith M. J. E.; Melchers, Willem J. G.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Wetzels, CTAH (corresponding author), Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	C.Wetzels@pathol.umcn.nl	Blokx, W.A.M./L-4205-2015; Melchers, Willem/C-8819-2015	Blokx, Willeke/0000-0002-4647-8830; Melchers, Willem/0000-0002-5446-2230				BECKER JC, 2008, J INVEST DE IN PRESS; Bialasiewicza S, 2007, J CLIN VIROL, V40, P9, DOI 10.1016/j.jcv.2007.07.015; CLAAS ECJ, 1989, AM J PATHOL, V135, P703; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; GARNESKI KM, 2008, J INVEST DERMATOL; GRECO FA, 1979, NEW ENGL J MED, V301, P355, DOI 10.1056/NEJM197908163010704; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; HAYAT MA, 1989, PRINCIPLES TECHNIQUE, P38; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Hoevenaars BM, 2008, INT J CANCER, V123, P2767, DOI 10.1002/ijc.23857; HOGAN TF, 1980, ANN INTERN MED, V92, P373, DOI 10.7326/0003-4819-92-3-373; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Krasagakis K, 2003, INT J DERMATOL, V42, P669, DOI 10.1046/j.1365-4362.2003.01912.x; Lewis KG, 2006, ARCH DERMATOL, V142, P693, DOI 10.1001/archderm.142.6.693; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Penn I, 1999, TRANSPLANTATION, V68, P1717, DOI 10.1097/00007890-199912150-00015; Poulin DL, 2006, J CLIN ONCOL, V24, P4356, DOI 10.1200/JCO.2005.03.7101; Poulsen M, 2004, LANCET ONCOL, V5, P593, DOI 10.1016/S1470-2045(04)01593-1; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; van der Heijden HFM, 2005, SOUTH MED J, V98, P345, DOI 10.1097/01.SMJ.0000145724.40477.50; van Hamont D, 2008, CARCINOGENESIS, V29, P840, DOI 10.1093/carcin/bgm287; Van Harmont D, 2008, REV MED VIROL, V18, P117, DOI 10.1002/rmv.561; zur Hausen H, 2008, INT J CANCER, V123, P247, DOI 10.1002/ijc.23620	25	52	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4958	10.1371/journal.pone.0004958	http://dx.doi.org/10.1371/journal.pone.0004958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305499	Green Published, Green Submitted, gold			2022-12-25	WOS:000265498800009
J	Scotcher, MC; McGarvey, JA; Johnson, EA; Stanker, LH				Scotcher, Miles C.; McGarvey, Jeffery A.; Johnson, Eric A.; Stanker, Larry H.			Epitope Characterization and Variable Region Sequence of F1-40, a High-Affinity Monoclonal Antibody to Botulinum Neurotoxin Type A (Hall Strain)	PLOS ONE			English	Article								Background: Botulism, an often fatal neuroparalytic disease, is caused by botulinum neurotoxins (BoNT) which consist of a family of seven serotypes (A-H) produced by the anaerobic bacterium Clostridium botulinum. BoNT, considered the most potent biological toxin known, is a 150 kDa protein consisting of a 100 kDa heavy-chain (Hc) and a 50 kDa light-chain (Lc). F1-40 is a mouse-derived, IgG1 monoclonal antibody that binds the light chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection. We report the fine epitope mapping of F1-40 and the deduced amino acid sequence of the variable regions of the heavy and light chains of the antibody. Methods and Findings: To characterize the binding epitope of F1-40, three complementary experimental approaches were selected. Firstly, recombinant peptide fragments of BoNT/A light-chain were used in Western blots to identify the epitope domains. Secondly, a peptide phage-display library was used to identify the specific amino acid sequences. Thirdly, the three-dimensional structure of BoNT/A was examined in silico, and the amino acid sequences determined from the phage-display studies were mapped onto the three-dimensional structure in order to visualize the epitope. F1-40 was found to bind a peptide fragment of BoNT/A, designated L1-3, which spans from T125 to L200. The motif QPDRS was identified by phage-display, and was mapped to a region within L1-3. When the three amino acids Q138, P139 and D140 were all mutated to glycine, binding of F1-40 to the recombinant BoNT/A light chain peptide was abolished. Q-138, P-139 and D-140 form a loop on the external surface of BoNT/A, exposed to solvent and accessible to F1-40 binding. Conclusions: The epitope of F1-40 was localized to a single exposed loop (beta 4, beta 5) on the Lc of BoNT. Furthermore amino acids Q138, P139 and D140 forming the tip of the loop appear critical for binding.	[Scotcher, Miles C.; McGarvey, Jeffery A.; Stanker, Larry H.] ARS, USDA, Western Reg Res Ctr, Albany, CA USA; [Johnson, Eric A.] Univ Wisconsin, Food Res Inst, Dept Bacteriol, Madison, WI 53706 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Scotcher, MC (corresponding author), ARS, USDA, Western Reg Res Ctr, Albany, CA USA.	lstanker@pw.usda.gov			United States Department of Agriculture, Agricultural Research Service, CRIS [5325-42000-043-00D]	United States Department of Agriculture, Agricultural Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS project 5325-42000-043-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arndt JW, 2005, BIOCHEMISTRY-US, V44, P9574, DOI 10.1021/bi0505924; ARNON SS, 2001, JAMA-J AM MED ASSOC, V85, P1059; Brin MF, 1997, MUSCLE NERVE, pS146; CHENG L, 2008, 45 INT BOT RES COORD, pA8; Dolimbek BZ, 2008, MOL IMMUNOL, V45, P910, DOI 10.1016/j.molimm.2007.08.007; GIBB G, 2007, CASTLEBERRYS FOODS M; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Ginsberg M. M., 2007, Morbidity and Mortality Weekly Report, V56, P767; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hengen PN, 1996, TRENDS BIOCHEM SCI, V21, P400, DOI 10.1016/S0968-0004(96)30035-2; Hill HR, 1996, MOL MICROBIOL, V20, P685, DOI 10.1111/j.1365-2958.1996.tb02508.x; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LAMANNA C, 1959, SCIENCE, V130, P763, DOI 10.1126/science.130.3378.763; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li Y, 2008, VACCINE, V26, P1263, DOI 10.1016/j.vaccine.2007.11.055; Li Y, 2007, J IMMUNOL METHODS, V325, P1, DOI 10.1016/j.jim.2007.05.005; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Manoutcharian K., 2001, Current Pharmaceutical Biotechnology, V2, P217; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; MORRISON S, 2002, CURRENT PROTOCOLS IM; Mullaney BP, 2001, INFECT IMMUN, V69, P6511, DOI 10.1128/IAI.69.10.6511-6514.2001; Niwa K, 2007, FEMS IMMUNOL MED MIC, V49, P346, DOI 10.1111/j.1574-695X.2006.00205.x; RECINOS A, 1995, GENE, V158, P311, DOI 10.1016/0378-1119(95)00097-P; RECINOS A, 1994, GENE, V149, P385, DOI 10.1016/0378-1119(94)90185-6; REYNOLDS G, 2007, CASTLEBERRYS RECALL; Sharma SK, 2005, J FOOD PROTECT, V68, P1256, DOI 10.4315/0362-028X-68.6.1256; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756; Wu HC, 2001, APPL ENVIRON MICROB, V67, P3201, DOI 10.1128/AEM.67.7.3201-3207.2001; Zilinskas RA, 1997, JAMA-J AM MED ASSOC, V278, P418, DOI 10.1001/jama.278.5.418	42	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4924	10.1371/journal.pone.0004924	http://dx.doi.org/10.1371/journal.pone.0004924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290051	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496500018
J	Wang, JB; Fang, SG; Xiao, H; Chen, B; Tam, JP; Liu, DX				Wang, Jibin; Fang, Shouguo; Xiao, Han; Chen, Bo; Tam, James P.; Liu, Ding Xiang			Interaction of the Coronavirus Infectious Bronchitis Virus Membrane Protein with beta-Actin and Its Implication in Virion Assembly and Budding	PLOS ONE			English	Article								Coronavirus M protein is an essential component of virion and plays pivotal roles in virion assembly, budding and maturation. The M protein is integrated into the viral envelope with three transmembrane domains flanked by a short amino-terminal ectodomain and a large carboxy-terminal endodomain. In this study, we showed co-purification of the M protein from coronavirus infectious bronchitis virus (IBV) with actin. To understand the cellular factors that may be involved in virion assembly, budding and maturation processes, IBV M was used as the bait in a yeast two-hybrid screen, resulting in the identification of beta-actin as a potentially interacting partner. This interaction was subsequently confirmed by coimmunoprecipitation and immunofluorescence microscopy in mammalian cells, and mutation of amino acids A159 and K160 on the M protein abolished the interaction. Introduction of the A159-K160 mutation into an infectious IBV clone system blocks the infectivity of the clone, although viral RNA replication and subgenomic mRNA transcription were actively detected. Disruption of actin filaments with cell-permeable agent cytochalasin D at early stages of the infection cycle led to the detection of viral protein synthesis in infected cells but not release of virus particles to the cultured media. However, the same treatment at late stages of the infection cycle did not affect the release of virus particles to the media, suggesting that disruption of the actin filaments might block virion assembly and budding, but not release of the virus particles. This study reveals an essential function of actin in the replication cycle of coronavirus.			Liu, DX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	dxliu@imcb.a-star.edu.sg	Liu, Ding Xiang/A-2226-2011; Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X				ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; EHRNST A, 1975, CELL, V5, P351, DOI 10.1016/0092-8674(75)90053-7; EHRNST A, 1976, EXP CELL BIOL, V44, P198; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; FLEISSNER E, 1973, J VIROL, V11, P250, DOI 10.1128/JVI.11.2.250-262.1973; Gardet A, 2006, J VIROL, V80, P3947, DOI 10.1128/JVI.80.8.3947-3956.2006; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; Gissen P, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050294; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; GRAZI E, 1989, BIOCHEM INT, V19, P1345; Griffiths G, 1992, Semin Cell Biol, V3, P367, DOI 10.1016/1043-4682(92)90022-N; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; KRIJNSELOCKER J, 1992, J BIOL CHEM, V267, P14094; Lai MMC, 1998, VIROLOGY, V244, P1, DOI 10.1006/viro.1998.9098; LAMB RA, 1976, VIROLOGY, V69, P116, DOI 10.1016/0042-6822(76)90199-9; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; LIU DX, 1991, VIROLOGY, V185, P911, DOI 10.1016/0042-6822(91)90572-S; Liu DX, 1997, J VIROL, V71, P1814, DOI 10.1128/JVI.71.3.1814-1820.1997; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003; Nguyen VP, 1997, J VIROL, V71, P9278, DOI 10.1128/JVI.71.12.9278-9284.1997; Ogino T, 2003, BIOCHEM BIOPH RES CO, V311, P283, DOI 10.1016/j.bbrc.2003.09.205; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; OREILLY G, 1993, FEBS LETT, V321, P69, DOI 10.1016/0014-5793(93)80623-3; ORVELL C, 1978, J GEN VIROL, V41, P527, DOI 10.1099/0022-1317-41-3-527; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Rottier PJM, 1995, CORONAVIRIDAE, P115; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; STERN DF, 1982, J VIROL, V42, P208, DOI 10.1128/JVI.42.1.208-219.1982; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Surjit M, 2004, BIOCHEM J, V383, P13, DOI 10.1042/BJ20040984; TYRRELL DLJ, 1978, J GEN VIROL, V39, P219, DOI 10.1099/0022-1317-39-2-219; VANDEKERCKHOVE J, 1992, Current Opinion in Cell Biology, V4, P36, DOI 10.1016/0955-0674(92)90056-I; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Zhou B, 2008, J VIROL, V82, P6962, DOI 10.1128/JVI.00133-08	42	38	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4908	10.1371/journal.pone.0004908	http://dx.doi.org/10.1371/journal.pone.0004908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287488	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400024
J	Goult, BT; Bate, N; Anthis, NJ; Wegener, KL; Gingras, AR; Patel, B; Barsukov, IL; Campbell, ID; Roberts, GCK; Critchley, DR				Goult, Benjamin T.; Bate, Neil; Anthis, Nicholas J.; Wegener, Kate L.; Gingras, Alexandre R.; Patel, Bipin; Barsukov, Igor L.; Campbell, Iain D.; Roberts, Gordon C. K.; Critchley, David R.			The Structure of an Interdomain Complex That Regulates Talin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; VINCULIN-BINDING-SITE; INTEGRIN ACTIVATION; PHOSPHORYLATION SITES; MOUSE DEVELOPMENT; FOCAL ADHESIONS; CHEMICAL-SHIFT; IN-VIVO; DOMAIN; ROD	Talin is a large flexible rod-shaped protein that activates the integrin family of cell adhesion molecules and couples them to cytoskeletal actin. It exists in both globular and extended conformations, and an intramolecular interaction between the N-terminal F3 FERM subdomain and the C-terminal part of the talin rod contributes to an autoinhibited form of the molecule. Here, we report the solution structure of the primary F3 binding domain within the C-terminal region of the talin rod and use intermolecular nuclear Overhauser effects to determine the structure of the complex. The rod domain (residues 1655-1822) is an amphipathic five-helix bundle; Tyr- 377 of F3 docks into a hydrophobic pocket at one end of the bundle, whereas a basic loop in F3 (residues 316-326) interacts with a cluster of acidic residues in the middle of helix 4. Mutation of Glu-1770 abolishes binding. The rod domain competes with beta 3-integrin tails for binding to F3, and the structure of the complex suggests that the rod is also likely to sterically inhibit binding of the FERM domain to the membrane.	[Goult, Benjamin T.; Bate, Neil; Gingras, Alexandre R.; Patel, Bipin; Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Anthis, Nicholas J.; Wegener, Kate L.; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Leicester; University of Oxford; University of Liverpool	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk	Gingras, Alexandre R/E-1867-2011; Goult, Benjamin T/B-3127-2009; Wegener, Kate/E-5077-2010	Gingras, Alexandre R/0000-0002-5373-0176; Goult, Benjamin T/0000-0002-3438-2807; Wegener, Kate/0000-0002-1562-6060; Anthis, Nicholas/0000-0002-1881-450X	National Institutes of Health [U54 GM64346]; Wellcome Trust; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 GM64346 through the Cell Migration Consortium. This work was also supported by grants from the Wellcome Trust and Cancer Research UK.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Baxter NJ, 1998, J MOL BIOL, V284, P1625, DOI 10.1006/jmbi.1998.2265; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chen NT, 2005, BIOCHEM BIOPH RES CO, V337, P670, DOI 10.1016/j.bbrc.2005.09.100; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MOLONY L, 1987, J BIOL CHEM, V262, P7790; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, J CELL SCI, V119, P1632, DOI 10.1242/jcs.02859; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; ZHANG X, 2008, NAT CELL BIOL	48	94	98	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15097	15106		10.1074/jbc.M900078200	http://dx.doi.org/10.1074/jbc.M900078200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297334	Green Published, hybrid			2022-12-25	WOS:000266288200045
J	Nott, SL; Huang, YF; Li, XD; Fluharty, BR; Qiu, X; Welshons, WV; Yeh, S; Muyan, M				Nott, Stephanie L.; Huang, Yanfang; Li, Xiaodong; Fluharty, Brian R.; Qiu, Xing; Welshons, Wade V.; Yeh, ShuYuan; Muyan, Mesut			Genomic Responses from the Estrogen-responsive Element-dependent Signaling Pathway Mediated by Estrogen Receptor alpha Are Required to Elicit Cellular Alterations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DNA-BINDING DOMAIN; HYALURONAN SYNTHASE-2 GENE; PLASMINOGEN-ACTIVATOR; ER-ALPHA; MESSENGER-RNA; TARGET GENES; TRANSCRIPTIONAL RESPONSES; ESTRADIOL REGULATION; RETINOIC ACID	Estrogen (E2) signaling is conveyed by the transcription factors estrogen receptor (ER) alpha and beta. ERs modulate the expression of genes involved in cellular proliferation, motility, and death. The regulation of transcription by E2-ER alpha through binding to estrogen-responsive elements (EREs) in DNA constitutes the ERE-dependent signaling pathway. E2-ER alpha also modulates gene expression by interacting with transregulators bound to cognate DNA-regulatory elements, and this regulation is referred to as the ERE-independent signaling pathway. The relative importance of the ERE-independent pathway in E2-ER alpha signaling is unclear. To address this issue, we engineered an ERE-binding defective ER alpha mutant (ER alpha(EBD)) by changing residues in an alpha-helix of the protein involved in DNA binding to render the receptor functional only through the ERE-independent signaling pathway. Using recombinant adenovirus-infected ER-negative MDA-MB-231 cells derived from a breast adenocarcinoma, we found that E2-ER alpha(EBD) modulated the expression of a subset of ER alpha-responsive genes identified by microarrays and verified by quantitative PCR. However, E2-ER alpha(EBD) did not affect cell cycle progression, cellular growth, death, or motility in contrast to E2-ER alpha. ER alpha(EBD) in the presence of E2 was also ineffective in inducing phenotypic alterations in ER-negative U-2OS cells derived from an osteosarcoma. E2-ER alpha, on the other hand, effectively repressed growth in this cell line. Our findings suggest that genomic responses from the ERE-dependent signaling pathway are required for E2-ER alpha to induce alterations in cellular responses.	[Nott, Stephanie L.; Huang, Yanfang; Li, Xiaodong; Fluharty, Brian R.; Muyan, Mesut] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Qiu, Xing] Univ Rochester, Sch Med, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Yeh, ShuYuan] Univ Rochester, Sch Med, Dept Urol, Rochester, NY 14642 USA; [Muyan, Mesut] Univ Rochester, Sch Med, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Welshons, Wade V.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Missouri System; University of Missouri Columbia	Muyan, M (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	mesut_muyan@urmc.rochester.edu	Muyan, Mesut/AAZ-4888-2020	Muyan, Mesut/0000-0003-3058-6228	NCI [CA113682]; Susan G. Komen Foundation; University of Rochester Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [R01CA113682] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); University of Rochester Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113682 from the NCI (to M.M.). This work was also supported by grants from the Susan G. Komen Foundation (to M.M.) and the University of Rochester Clinical and Translational Science Institute (to M.M.).	AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bjornstrom L, 2002, J BIOL CHEM, V277, P48479, DOI 10.1074/jbc.C200570200; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUTLER WB, 1979, BIOCHEM BIOPH RES CO, V90, P1328, DOI 10.1016/0006-291X(79)91181-1; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Christian CA, 2008, ENDOCRINOLOGY, V149, P5328, DOI 10.1210/en.2008-0520; Costa M, 1998, EUR J BIOCHEM, V258, P123, DOI 10.1046/j.1432-1327.1998.2580123.x; COUSIN E, 1991, NUCLEIC ACIDS RES, V19, P3881, DOI 10.1093/nar/19.14.3881; Dai MH, 2007, BIOINFORMATICS, V23, P2185, DOI 10.1093/bioinformatics/btm297; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis AJ, 2000, GEN COMP ENDOCR, V119, P308, DOI 10.1006/gcen.2000.7522; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dzau VJ, 2002, CIRC RES, V90, P1234, DOI 10.1161/01.RES.0000025209.24283.73; ElAshry D, 1996, J STEROID BIOCHEM, V59, P261, DOI 10.1016/S0960-0760(96)00118-5; Ferreira MC, 2008, J MOL HISTOL, V39, P535, DOI 10.1007/s10735-008-9194-x; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; GARCIA M, 1992, P NATL ACAD SCI USA, V89, P11538, DOI 10.1073/pnas.89.23.11538; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Glidewell-Kenney C, 2008, ENDOCRINOLOGY, V149, P4168, DOI 10.1210/en.2007-1807; Gorczyca W, 1998, METH MOL B, V91, P217; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harbig J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni027; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; Huang J, 2004, MOL CELL ENDOCRINOL, V218, P65, DOI 10.1016/j.mce.2003.12.005; Huang S, 2005, GLOBAL NETW, V5, P379, DOI 10.1111/j.1471-0374.2005.00125.x; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Klebanov L, 2006, COMPUT STAT DATA AN, V50, P3619, DOI 10.1016/j.csda.2005.08.005; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laufs S, 2006, CELL CYCLE, V5, P1760; Lazennec G, 1999, MOL CELL ENDOCRINOL, V149, P93, DOI 10.1016/S0303-7207(98)00254-8; Levenson AS, 1998, BRIT J CANCER, V78, P88, DOI 10.1038/bjc.1998.447; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Li XD, 2008, J MOL ENDOCRINOL, V40, P211, DOI 10.1677/JME-07-0156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUISI BF, 1994, VITAM HORM, V49, P1; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Margueron R, 2003, J ENDOCRINOL, V179, P41, DOI 10.1677/joe.0.1790041; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Murakami Y, 2005, J REPROD DEVELOP, V51, P639, DOI 10.1262/jrd.17029; Muyan M, 2001, MOL CELL ENDOCRINOL, V182, P249, DOI 10.1016/S0303-7207(01)00493-2; Nguyen D, 2007, NUCLEIC ACIDS RES, V35, P3465, DOI 10.1093/nar/gkm241; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Oesterreich S, 2001, CANCER RES, V61, P5771; Renier M A, 1998, Eur J Contracept Reprod Health Care, V3, P129; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SCHWABE JWR, 1995, STRUCTURE, V3, P201, DOI 10.1016/S0969-2126(01)00150-2; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; TAKAHASHI T, 1994, CELL GROWTH DIFFER, V5, P919; Wang LH, 2004, NAT MED, V10, P40, DOI 10.1038/nm969; Wang LH, 2003, CANCER RES, V63, P2046; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WESTFALL PH, 1993, RESAMPLING BASED MUL, P36; Yi P, 2002, MOL ENDOCRINOL, V16, P674, DOI 10.1210/me.16.4.674; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323	78	19	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15277	15288		10.1074/jbc.M900365200	http://dx.doi.org/10.1074/jbc.M900365200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321454	Green Published, hybrid			2022-12-25	WOS:000266288200062
J	Geng, Y; Hoke, A; Delpire, E				Geng, Yang; Hoke, Ahmet; Delpire, Eric			The Ste20 Kinases Ste20-related Proline-Alanine-rich Kinase and Oxidative-stress Response 1 Regulate NKCC1 Function in Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CHLORIDE REGULATION; NA-K-2CL COTRANSPORTER; NA+-K+-2CL(-) COTRANSPORTER; SPAK; OSR1; PHOSPHORYLATION; HYPERALGESIA; ACTIVATION; CLONING; GROWTH	NKCC1 is highly expressed in dorsal root ganglion neurons, where it is involved in gating sensory information. In a recent study, it was shown that peripheral nerve injury results in increased NKCC1 activity, not due to an increase in cotransporter expression, but to increased phosphorylation of the cotransporter (Pieraut, S., Matha, V., Sar, C., Hubert, T., Mechaly, I., Hilaire, C., Mersel, M., Delpire, E., Valmier, J., and Scamps, F. (2007) J. Neurosci. 27, 6751-6759). Our laboratory has also identified two Ste20-like kinases that bind and phosphorylate NKCC1: Ste20-related proline-alanine-rich kinase (SPAK) and oxidative-stress response 1 (OSR1). In this study, we show that both kinases are expressed at similar expression levels in spinal cord and dorsal root ganglion neurons, and that both kinases participate equally in the regulation of NKCC1. Using a novel fluorescence method to assay NKCC1 activity in single cells, we show a 50% reduction in NKCC1 activity in DRG neurons isolated from SPAK knockout mice, indicating that another kinase, e. g. OSR1, is present to phosphorylate and activate the cotransporter. Using a nociceptive dorsal root ganglion sensory neuronal cell line, which expresses the same cation-chloride cotransporters and kinases as native DRG neurons, and gene silencing via short hairpin RNA, we demonstrate a direct relationship between kinase expression and cotransporter activity. We show that inactivation of either kinase significantly affects NKCC1 activity, whereas inactivation of both kinases results in an additive effect. In summary, our study demonstrates redundancy of kinases in the regulation of NKCC1 in dorsal root ganglion neurons.	[Geng, Yang; Delpire, Eric] Vanderbilt Univ, Med Ctr, Grad Program Neurosci, Nashville, TN 37232 USA; [Geng, Yang; Delpire, Eric] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; [Hoke, Ahmet] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA	Vanderbilt University; Vanderbilt University; Johns Hopkins University	Delpire, E (corresponding author), Dept Anesthesiol, T-4202 MCN 1161 21st Ave, S Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu		Hoke, Ahmet/0000-0003-1215-3373	National Institutes of Health [GM074771, NS53658]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM074771 and NS53658 (to E. D.).	Akai S, 2007, J BIOL CHEM, V282, P23996, DOI 10.1074/jbc.M702819200; ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Chen WR, 2007, J PERIPHER NERV SYST, V12, P121, DOI 10.1111/j.1529-8027.2007.00131.x; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Granados-Soto V, 2005, PAIN, V114, P231, DOI 10.1016/j.pain.2004.12.023; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Laird JMA, 2004, NEUROSCI LETT, V361, P200, DOI 10.1016/j.neulet.2003.12.015; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Sung KW, 2000, J NEUROSCI, V20, P7531; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Yan Y, 2007, BBA-GENE STRUCT EXPR, V1769, P106, DOI 10.1016/j.bbaexp.2007.01.003; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	29	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14020	14028		10.1074/jbc.M900142200	http://dx.doi.org/10.1074/jbc.M900142200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307180	hybrid, Green Published			2022-12-25	WOS:000266286100008
J	Bhattacharya, R; Cabral, F				Bhattacharya, Rajat; Cabral, Fernando			Molecular Basis for Class V beta-Tubulin Effects on Microtubule Assembly and Paclitaxel Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; CONFER RESISTANCE; C-TERMINUS; CAENORHABDITIS-ELEGANS; ANTIMITOTIC DRUGS; ALPHA-TUBULIN; ISOTYPES; EXPRESSION; MUTATIONS; MECHANISMS	Vertebrates produce at least seven distinct beta-tubulin isotypes that coassemble into all cellular microtubules. The functional differences among these tubulin isoforms are largely unknown, but recent studies indicate that tubulin composition can affect microtubule properties and cellular microtubule-dependent behavior. One of the isotypes whose incorporation causes the largest change in microtubule assembly is beta 5-tubulin. Overexpression of this isotype can almost completely destroy the microtubule network, yet it appears to be required in smaller amounts for normal mitotic progression. Moderate levels of overexpression can also confer paclitaxel resistance. Experiments using chimeric constructs and site-directed mutagenesis now indicate that the hypervariable C-terminal region of beta 5 plays no role in these phenotypes. Instead, we demonstrate that two residues found in beta 5 (Ser-239 and Ser-365) are each sufficient to inhibit microtubule assembly and confer paclitaxel resistance when introduced into beta 1-tubulin; yet the single mutation of residue Ser-239 in beta 5 eliminates its ability to confer these phenotypes. Despite the high degree of conservation among beta-tubulin isotypes, mutations affecting residue 365 demonstrate that amino acid substitutions can be context sensitive; i.e. an amino acid change in one isotype will not necessarily produce the same phenotype when introduced into a different isotype. Modeling studies indicate that residue Cys-239 of beta 1-tubulin is close to a highly conserved Cys-354 residue suggesting the possibility that disulfide formation could play a significant role in the stability of microtubules formed with beta 1-but not with beta 5-tubulin.	[Bhattacharya, Rajat; Cabral, Fernando] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cabral, F (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu		Bhattacharya, Rajat/0000-0001-5693-6754	National Institutes of Health [CA85935]; National Science Foundation [0516080]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85935 (to F. C.). This work was also supported by National Science Foundation Grant 0516080 (to F. C.).	ABRAHAM I, 1983, J CELL BIOL, V97, P1055, DOI 10.1083/jcb.97.4.1055; AHMAD S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P252, DOI 10.1016/0167-4781(91)90112-Y; BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; Bhattacharya R, 2004, MOL BIOL CELL, V15, P3123, DOI 10.1091/mbc.E04-01-0060; Bhattacharya R, 2008, CELL MOTIL CYTOSKEL, V65, P708, DOI 10.1002/cm.20292; Blade K, 1999, J CELL SCI, V112, P2213; BOND JF, 1986, CELL, V44, P461, DOI 10.1016/0092-8674(86)90467-8; Britto PJ, 2005, BIOCHEM J, V389, P549, DOI 10.1042/BJ20042118; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; CABRAL F, 1991, PHARMACOL THERAPEUT, V52, P159, DOI 10.1016/0163-7258(91)90006-8; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; Cabral Fernando, 2008, P337, DOI 10.1007/978-1-59745-336-3_14; CABRAL FR, 1986, ANN NY ACAD SCI, V466, P745, DOI 10.1111/j.1749-6632.1986.tb38456.x; Chaudhuri AR, 2001, BIOCHEMISTRY-US, V40, P8834, DOI 10.1021/bi0101603; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; Ganguly A, 2008, CELL CYCLE, V7, P3187, DOI 10.4161/cc.7.20.6814; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; Hari M, 2003, MOL CANCER THER, V2, P597; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; MARYA PK, 1994, J CELL SCI, V107, P339; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Niederstrasser H, 2002, J MOL BIOL, V316, P817, DOI 10.1006/jmbi.2001.5360; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Popodi EM, 2008, CELL MOTIL CYTOSKEL, V65, P216, DOI 10.1002/cm.20256; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SAWADA T, 1989, J BIOL CHEM, V264, P3013; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; STEMME S, 1985, BRAIN RES, V359, P140, DOI 10.1016/0006-8993(85)91421-0; SULLIVAN KF, 1986, MOL CELL BIOL, V6, P4409, DOI 10.1128/MCB.6.12.4409; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vent J, 2005, J CELL SCI, V118, P4333, DOI 10.1242/jcs.02550; Wang YQ, 2006, BIOCHEMISTRY-US, V45, P185, DOI 10.1021/bi051207d; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Yang HL, 2007, J BIOL CHEM, V282, P27058, DOI 10.1074/jbc.M704101200; Yin SH, 2007, MOL CANCER THER, V6, P2798, DOI 10.1158/1535-7163.MCT-06-0791	55	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13023	13032		10.1074/jbc.M900167200	http://dx.doi.org/10.1074/jbc.M900167200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282281	Green Published, hybrid			2022-12-25	WOS:000265688300050
J	Varrin-Doyer, M; Vincent, P; Cavagna, S; Auvergnon, N; Noraz, N; Rogemond, V; Honnorat, J; Moradi-Ameli, M; Giraudon, P				Varrin-Doyer, Michel; Vincent, Peggy; Cavagna, Sylvie; Auvergnon, Nathalie; Noraz, Nelly; Rogemond, Veronique; Honnorat, Jerome; Moradi-Ameli, Mahnaz; Giraudon, Pascale			Phosphorylation of Collapsin Response Mediator Protein 2 on Tyr-479 Regulates CXCL12-induced T Lymphocyte Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; NEURITE OUTGROWTH; GROWTH CONE; CRMP-2; BRAIN; EXPRESSION; CXCL12; CELLS; DISORDERS	In the central nervous system, collapsin response mediator protein 2 (CRMP2) is a transducer protein that supports the semaphorin-induced guidance of axons toward their cognate target. However, we previously showed that CRMP2 is also expressed in immune cells and plays a crucial role in T lymphocyte migration. Here we further investigated the molecular mechanisms underlying CRMP2 function in chemokine-directed T-cell motility. Examining Jurkat T-cells treated with the chemokine CXCL12, we found that 1) CXCL12 induces a dynamic re-localization of CRMP2 to uropod, the flexible structure of migrating lymphocyte, and increases its binding to the cytoskeletal protein vimentin; 2) CXCL12 decreases phosphorylation of the glycogen synthase kinase-3 beta-targeted residues CRMP2-Thr-509/514; and 3) tyrosine Tyr-479 is a new phosphorylation CRMP2 residue and a target for the Src-family kinase Yes. Moreover, phospho-Tyr-479 increased under CXCL12 signaling while phospho-Thr-509/514 decreased. The functional importance of this tyrosine phosphorylation was demonstrated by Y479F mutation that strongly reduced CXCL12-mediated T-cell polarization and motility as tested in a transmigration model and on neural tissue. We propose that differential phosphorylation by glycogen synthase kinase-3 beta and Yes modulates the contribution of CRMP2 to cytoskeletal reorganization during chemokine-directed T-cell migration. In addition to providing a novel mechanism for T lymphocyte motility, our findings reveal CRMP2 as a transducer of chemokine signaling.	[Giraudon, Pascale] Univ Lyon 1, INSERM, Dept Neurooncol & Neuroinflammat, Fac Med R Laennec,U842, F-69372 Lyon, France; Univ Lyon 1, UMR S842, F-69372 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Giraudon, P (corresponding author), Univ Lyon 1, INSERM, Dept Neurooncol & Neuroinflammat, Fac Med R Laennec,U842, Rue Guillaume Paradin, F-69372 Lyon, France.	pascale.giraudon@inserm.fr	noraz, nelly/H-9477-2017; Rogemond, Veronique/J-4824-2017; Honnorat, jerome/G-6394-2017	noraz, nelly/0000-0003-4076-9773; Rogemond, Veronique/0000-0003-2098-920X; Honnorat, jerome/0000-0002-4721-5952	French Agency of Research on Multiple Sclerosis; INSERM; Agence Nationale de la Recherche	French Agency of Research on Multiple Sclerosis; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants and fellowships from the French Agency of Research on Multiple Sclerosis, INSERM, and Agence Nationale de la Recherche.	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Buttner B, 2005, BIOCHEMISTRY-US, V44, P6938, DOI 10.1021/bi050066c; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lataillade JJ, 2004, EUR CYTOKINE NETW, V15, P177; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vicente-Manzanares M, 2005, BLOOD, V105, P3026, DOI 10.1182/blood-2004-07-2925; Vicente-Manzanares Miguel, 2004, Methods Mol Biol, V239, P53; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Vuaillat C, 2008, J NEUROIMMUNOL, V193, P38, DOI 10.1016/j.jneuroim.2007.09.033; Werdich Xiang Q., 2005, Angiogenesis, V8, P315; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013	41	38	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13265	13276		10.1074/jbc.M807664200	http://dx.doi.org/10.1074/jbc.M807664200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276087	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000265688300073
J	Sato, Y; Isaji, T; Tajiri, M; Yoshida-Yamamoto, S; Yoshinaka, T; Somehara, T; Fukuda, T; Wada, Y; Gu, JG				Sato, Yuya; Isaji, Tomoya; Tajiri, Michiko; Yoshida-Yamamoto, Shumi; Yoshinaka, Tsuyoshi; Somehara, Toshiaki; Fukuda, Tomohiko; Wada, Yoshinao; Gu, Jianguo			An N-Glycosylation Site on the beta-Propeller Domain of the Integrin alpha 5 Subunit Plays Key Roles in Both Its Function and Site-specific Modification by beta 1,4-N-Acetylglucosaminyltransferase III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; ACETYLGLUCOSAMINYLTRANSFERASE-III; LIGAND-BINDING; STRUCTURAL DETERMINANTS; ALTERED GLYCOSYLATION; EXTRACELLULAR SEGMENT; PROTEIN GLYCOSYLATION; FIBRONECTIN RECEPTOR; MESODERMAL DEFECTS; CRYSTAL-STRUCTURE	Recently we reported that N-glycans on the beta-propeller domain of the integrin alpha 5 subunit (S-3,4,5) are essential for alpha 5 beta 1 heterodimerization, expression, and cell adhesion. Herein to further investigate which N-glycosylation site is the most important for the biological function and regulation, we characterized the S-3,4,5 mutants in detail. We found that site-4 is a key site that can be specifically modified by N-acetylglucosaminyltransferase III (GnT-III). The introduction of bisecting GlcNAc into the S-3,4,5 mutant catalyzed by GnT-III decreased cell adhesion and migration on fibronectin, whereas overexpression of N-acetylglucosaminyltransferase V (GnT-V) promoted cell migration. The phenomenon is similar to previous observations that the functions of the wild-type alpha 5 subunit were positively and negatively regulated by GnT-V and GnT-III, respectively, suggesting that the alpha 5 subunit could be duplicated by the S-3,4,5 mutant. Interestingly GnT-III specifically modified the S-4,5 mutant but not the S-3,5 mutant. This result was confirmed by erythroagglutinating phytohemagglutinin lectin blot analysis. The reduction in cell adhesion was consistently observed in the S-4,5 mutant but not in the S-3,5 mutant cells. Furthermore mutation of site-4 alone resulted in a substantial decrease in erythroagglutinating phytohemagglutinin lectin staining and suppression of cell spread induced by GnT-III compared with that of either the site-3 single mutant or wild-type alpha 5. These results, taken together, strongly suggest that N-glycosylation of site-4 on the alpha 5 subunit is the most important site for its biological functions. To our knowledge, this is the first demonstration that site-specific modification of N-glycans by a glycosyltransferase results in functional regulation.	[Sato, Yuya; Isaji, Tomoya; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Tajiri, Michiko; Yoshida-Yamamoto, Shumi; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; [Tajiri, Michiko; Yoshida-Yamamoto, Shumi; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Yoshinaka, Tsuyoshi; Somehara, Toshiaki] Wako Pure Chem Ind Ltd, Lab Chem Div, Chuo Ku, Osaka 5408605, Japan	Tohoku Medical & Pharmaceutical University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation, Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was supported in part by Core Research for Evolutional Science and Technology; the Japan Science and Technology Agency; the "Academic Frontier" Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the core to core program (Japan Society for the Promotion of Science); and Takeda Science Foundation, Japan.	AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; DWEK RA, 1995, BIOCHEM SOC T, V23, P1; Endo T, 2006, METHOD ENZYMOL, V417, P137, DOI 10.1016/S0076-6879(06)17011-1; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Goh KL, 1997, DEVELOPMENT, V124, P4309; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guo HB, 2002, CANCER RES, V62, P6837; Hoffmeister KM, 2003, SCIENCE, V301, P1531, DOI 10.1126/science.1085322; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Josefsson EC, 2005, J BIOL CHEM, V280, P18025, DOI 10.1074/jbc.M501178200; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; KAWANO T, 1993, INT J CANCER, V53, P91, DOI 10.1002/ijc.2910530118; Koyota S, 2001, J BIOL CHEM, V276, P32867, DOI 10.1074/jbc.M102371200; Liu YM, 2008, PROTEINS, V73, P989, DOI 10.1002/prot.22126; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pretzlaff RK, 2000, CELL ADHES COMMUN, V7, P491, DOI 10.3109/15419060009040306; Sasai K, 2003, J BIOL CHEM, V278, P25295, DOI 10.1074/jbc.M301913200; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; WATT FM, 1994, CURR BIOL, V4, P270, DOI 10.1016/S0960-9822(00)00063-4; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602; YAMASHITA K, 1983, J BIOL CHEM, V258, P4753; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	44	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11873	11881		10.1074/jbc.M807660200	http://dx.doi.org/10.1074/jbc.M807660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276077	Green Published, hybrid			2022-12-25	WOS:000265494600019
J	Granville, CA; Memmott, RM; Balogh, A; Mariotti, J; Kawabata, S; Han, W; LoPiccolo, J; Foley, J; Liewehr, DJ; Steinberg, SM; Fowler, DH; Hollander, MC; Dennis, PA				Granville, Courtney A.; Memmott, Regan M.; Balogh, Andria; Mariotti, Jacopo; Kawabata, Shigeru; Han, Wei; LoPiccolo, Jaclyn; Foley, Jason; Liewehr, David J.; Steinberg, Seth M.; Fowler, Daniel H.; Hollander, M. Christine; Dennis, Phillip A.			A Central Role for Foxp3+Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis	PLOS ONE			English	Article								Background: K-Ras mutations are characteristic of human lung adenocarcinomas and occur almost exclusively in smokers. In preclinical models, K-Ras mutations are necessary for tobacco carcinogen-driven lung tumorigenesis and are sufficient to cause lung adenocarcinomas in transgenic mice. Because these mutations confer resistance to commonly used cytotoxic chemotherapies and targeted agents, effective therapies that target K-Ras are needed. Inhibitors of mTOR such as rapamycin can prevent K-Ras-driven lung tumorigenesis and alter the proportion of cytotoxic and Foxp3+ regulatory T cells, suggesting that lung-associated T cells might be important for tumorigenesis. Methods: Lung tumorigenesis was studied in three murine models that depend on mutant K-Ras; a tobacco carcinogen-driven model, a syngeneic inoculation model, and a transgenic model. Splenic and lung-associated T cells were studied using flow cytometry and immunohistochemistry. Foxp3+ cells were depleted using rapamycin, an antibody, or genetic ablation. Results: Exposure of A/J mice to a tobacco carcinogen tripled lung-associated Foxp3+ cells prior to tumor development. At clinically relevant concentrations, rapamycin prevented this induction and reduced lung tumors by 90%. In A/J mice inoculated with lung adenocarcinoma cells resistant to rapamycin, antibody-mediated depletion of Foxp3+ cells reduced lung tumorigenesis by 80%. Likewise, mutant K-Ras transgenic mice lacking Foxp3+ cells developed 75% fewer lung tumors than littermates with Foxp3+ cells. Conclusions: Foxp3+ regulatory T cells are required for K-Ras-mediated lung tumorigenesis in mice. These studies support clinical testing of rapamycin or other agents that target Treg in K-Ras driven human lung cancer.	[Granville, Courtney A.; Memmott, Regan M.; Balogh, Andria; Kawabata, Shigeru; Han, Wei; LoPiccolo, Jaclyn; Hollander, M. Christine; Dennis, Phillip A.] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Mariotti, Jacopo; Foley, Jason; Fowler, Daniel H.] NCI, Ctr Canc Res, Expt Transplant & Immunol Branch, Bethesda, MD USA; [Liewehr, David J.; Steinberg, Seth M.] NCI, Ctr Canc Res, Biostat & Data Management Sect, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Granville, CA (corresponding author), NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	pdennis@nih.gov	Kawabata, Shigeru/C-1506-2014; Liewehr, David J/GWV-3570-2022; mariotti, jacopo/AAQ-8057-2021	Kawabata, Shigeru/0000-0003-3948-4500; mariotti, jacopo/0000-0001-6528-9296; Memmott, Regan/0000-0001-5881-9252	Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [Z01SC010288, Z01SC010292, ZIASC010288, ZIASC010292, ZIABC011220] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELINSKY SA, 1992, CANCER RES, V52, P3164; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Granville CA, 2007, CLIN CANCER RES, V13, P2281, DOI 10.1158/1078-0432.CCR-06-2570; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V88; Ishibashi Y, 2006, ONCOL REP, V15, P1315; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; MILLS NE, 1995, CANCER RES, V55, P1444; Mita MM, 2008, J CLIN ONCOL, V26, P361, DOI 10.1200/JCO.2007.12.0345; Murin S, 2004, CHEST, V125, P1467, DOI 10.1378/chest.125.4.1467; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Razani-Boroujerdi S, 2007, AM J RESP CELL MOL, V36, P13, DOI 10.1165/rcmb.2005-0330OC; Rioux N, 1998, CANCER RES, V58, P5354; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schwarz S, 2008, J ORAL PATHOL MED, V37, P485, DOI 10.1111/j.1600-0714.2008.00641.x; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Vuillemenot BR, 2004, CARCINOGENESIS, V25, P623, DOI 10.1093/carcin/bgh038; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Westra WH, 1996, CANCER RES, V56, P2224; WESTRA WH, 1993, CANCER-AM CANCER SOC, V72, P432, DOI 10.1002/1097-0142(19930715)72:2<432::AID-CNCR2820720219>3.0.CO;2-#; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	34	54	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5061	10.1371/journal.pone.0005061	http://dx.doi.org/10.1371/journal.pone.0005061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330036	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499700006
J	Zelano, C; Montag, J; Khan, R; Sobel, N				Zelano, Christina; Montag, Jessica; Khan, Rehan; Sobel, Noam			A Specialized Odor Memory Buffer in Primary Olfactory Cortex	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; RECOGNITION MEMORY; SOMATOSENSORY CORTEX; ENTORHINAL CORTEX; PREFRONTAL CORTEX; PIRIFORM CORTEX; TERM-MEMORY; INFORMATION; BRAIN; FMRI	Background: The neural substrates of olfactory working memory are unknown. We addressed the questions of whether olfactory working memory involves a verbal representation of the odor, or a sensory image of the odor, or both, and the location of the neural substrates of these processes. Methodology/Principal Findings: We used functional magnetic resonance imaging to measure activity in the brains of subjects who were remembering either nameable or unnameable odorants. We found a double dissociation whereby remembering nameable odorants was reflected in sustained activity in prefrontal language areas, and remembering unnameable odorants was reflected in sustained activity in primary olfactory cortex. Conclusions/Significance: These findings suggest a novel dedicated mechanism in primary olfactory cortex, where odor information is maintained in temporary storage to subserve ongoing tasks.	[Zelano, Christina; Khan, Rehan; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Montag, Jessica] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Weizmann Institute of Science; University of Wisconsin System; University of Wisconsin Madison	Zelano, C (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	czelano@gmail.com	Khan, Rehan/AAR-4803-2020	Khan, Rehan/0000-0001-8724-5788; Sobel, Noam/0000-0002-3232-9391	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	This work was funded by a grant from the Israeli Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2007, PSYCHOLOGIA, V50, P76, DOI 10.2117/psysoc.2007.76; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 2007, WORKING MEMORY THOUG; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cerf-Ducastel B, 2006, NEUROIMAGE, V31, P386, DOI 10.1016/j.neuroimage.2005.11.009; Dade LA, 2001, NEUROIMAGE, V14, P650, DOI 10.1006/nimg.2001.0868; DEWIJK RA, 1995, ODOR IDENTIFICATION; Djordjevic J, 2005, NEUROIMAGE, V24, P791, DOI 10.1016/j.neuroimage.2004.09.035; ENGEN T, 1973, J EXP PSYCHOL, V100, P221, DOI 10.1037/h0035492; Feredoes E, 2007, J NEUROSCI, V27, P11003, DOI 10.1523/JNEUROSCI.1573-07.2007; Fiez JA, 1996, J NEUROSCI, V16, P808; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Harris JA, 2002, J NEUROSCI, V22, P8720; Jehl C, 1997, PERCEPT PSYCHOPHYS, V59, P100, DOI 10.3758/BF03206852; Johnson BN, 2007, J NEUROSCI METH, V160, P231, DOI 10.1016/j.jneumeth.2006.09.008; Jonides J, 1998, J NEUROSCI, V18, P5026; Larsson M, 1997, MEMORY, V5, P361; MAI J, 1997, ATLAS HUMAN BRAIN AC; Miles C, 2005, MEM COGNITION, V33, P1303, DOI 10.3758/BF03193230; Miller GA, 1960, PLANS STRUCTURE BEHA; MURPHY C, 1991, AM J PSYCHOL, V104, P161, DOI 10.2307/1423153; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Parr WV, 2002, CHEM SENSES, V27, P747, DOI 10.1093/chemse/27.8.747; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PORTER J, 2005, NEURON; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Rama P, 2001, COGN AFFECT BEHAV NE, V1, P161, DOI 10.3758/CABN.1.2.161; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Savic I, 2000, CHEM SENSES, V25, P517, DOI 10.1093/chemse/25.5.517; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; White TL, 1998, ANN NY ACAD SCI, V855, P635, DOI 10.1111/j.1749-6632.1998.tb10636.x; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Yeshurun Y, 2008, BEHAV NEUROSCI, V122, P1031, DOI 10.1037/a0012806; Yonelinas AP, 2007, HIPPOCAMPUS, V17, P1134, DOI 10.1002/hipo.20341; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533	46	52	53	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4965	10.1371/journal.pone.0004965	http://dx.doi.org/10.1371/journal.pone.0004965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PG	19305509	gold, Green Submitted, Green Published			2022-12-25	WOS:000265498800013
J	Pendergast, JS; Nakamura, W; Friday, RC; Hatanaka, F; Takumi, T; Yamazaki, S				Pendergast, Julie S.; Nakamura, Wataru; Friday, Rio C.; Hatanaka, Fumiyuki; Takumi, Toru; Yamazaki, Shin			Robust Food Anticipatory Activity in BMAL1-Deficient Mice	PLOS ONE			English	Article							ENTRAINED CIRCADIAN-RHYTHMS; FEEDING SCHEDULES; CLOCK; RATS; BEHAVIOR; COMPONENTS; NPAS2; MPER2; MOP3	Food availability is a potent environmental cue that directs circadian locomotor activity in rodents. Even though nocturnal rodents prefer to forage at night, daytime food anticipatory activity (FAA) is observed prior to short meals presented at a scheduled time of day. Under this restricted feeding regimen, rodents exhibit two distinct bouts of activity, a nocturnal activity rhythm that is entrained to the light-dark cycle and controlled by the master clock in the suprachiasmatic nuclei (SCN) and a daytime bout of activity that is phase-locked to mealtime. FAA also occurs during food deprivation, suggesting that a food-entrainable oscillator (FEO) keeps time in the absence of scheduled feeding. Previous studies have demonstrated that the FEO is anatomically distinct from the SCN and that FAA is observed in mice lacking some circadian genes essential for timekeeping in the SCN. In the current study, we optimized the conditions for examining FAA during restricted feeding and food deprivation in mice lacking functional BMAL1, which is critical for circadian rhythm generation in the SCN. We found that BMAL1-deficient mice displayed FAA during restricted feeding in 12hr light: 12hr dark (12L: 12D) and 18L:6D lighting cycles, but distinct activity during food deprivation was observed only in 18L: 6D. While BMAL1-deficient mice also exhibited robust FAA during restricted feeding in constant darkness, mice were hyperactive during food deprivation so it was not clear that FAA consistently occurred at the time of previously scheduled food availability. Taken together, our findings suggest that optimization of experimental conditions such as photoperiod may be necessary to visualize FAA in genetically modified mice. Furthermore, the expression of FAA may be possible without a circadian oscillator that depends on BMAL1.	[Pendergast, Julie S.; Friday, Rio C.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Nakamura, Wataru; Hatanaka, Fumiyuki; Takumi, Toru] Osaka Biosci Inst, Suita, Osaka, Japan	Vanderbilt University	Pendergast, JS (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	shin.yamazaki@vanderbilt.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Yamazaki, Shin/0000-0002-6691-1531	National Institutes of Health [NS051278]; Japan Ministry of Education; Japan Society for the Promotion of Science [Fellowship]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a National Institutes of Health grant (NS051278 to S.Y.), Research Grants from the Japan Ministry of Education (to T.T.), and a Japan Society for the Promotion of Science Fellowship (to W.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; BOLLES RC, 1962, J COMP PHYSIOL PSYCH, V55, P760, DOI 10.1037/h0046716; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; Iijima M, 2005, NEUROSCI RES, V52, P166, DOI 10.1016/j.neures.2005.03.003; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mistlberger RE, 2008, SCIENCE, V322, DOI 10.1126/science.1161284; Mistlberger RE, 2001, BRAIN RES, V919, P283, DOI 10.1016/S0006-8993(01)03042-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MOOREEDE MC, 1982, CLOCKS TIME US PHYSL, pR12; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Richter CP, 1927, Q REV BIOL, V2, P307, DOI 10.1086/394279; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STEPHAN FK, 1992, PHYSIOL BEHAV, V52, P985, DOI 10.1016/0031-9384(92)90381-B; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	41	84	87	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4860	10.1371/journal.pone.0004860	http://dx.doi.org/10.1371/journal.pone.0004860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300505	Green Submitted, gold, Green Published			2022-12-25	WOS:000265496800001
J	Mahdi, RN; Rouchka, EC				Mahdi, Rami N.; Rouchka, Eric C.			RBF-TSS: Identification of Transcription Start Site in Human Using Radial Basis Functions Network and Oligonucleotide Positional Frequencies	PLOS ONE			English	Article								Accurate identification of promoter regions and transcription start sites (TSS) in genomic DNA allows for a more complete understanding of the structure of genes and gene regulation within a given genome. Many recently published methods have achieved high identification accuracy of TSS. However, models providing more accurate modeling of promoters and TSS are needed. A novel identification method for identifying transcription start sites that improves the accuracy of TSS recognition for recently published methods is proposed. This method incorporates a metric feature based on oligonucleotide positional frequencies, taking into account the nature of promoters. A radial basis function neural network for identifying transcription start sites (RBF-TSS) is proposed and employed as a classification algorithm. Using non-overlapping chunks (windows) of size 50 and 500 on the human genome, the proposed method achieves an area under the Receiver Operator Characteristic curve (auROC) of 94.75% and 95.08% respectively, providing increased performance over existing TSS prediction methods.			Rouchka, EC (corresponding author), Univ Louisville, Dept Comp Sci & Comp Engn, Louisville, KY 40292 USA.	eric.rouchka@louisville.edu			NCRR NIH HHS [P20 RR016481, P20 RR16481] Funding Source: Medline; NIEHS NIH HHS [P30 ES014443] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bajic VB, 2003, GENOME RES, V13, P1923, DOI 10.1101/gr.869803; BAJIC VB, 2004, IN SILICO BIOL, V4, P109; Broomhead D. S., 1988, Complex Systems, V2, P321; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Goni JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r263; Igel C, 2003, NEUROCOMPUTING, V50, P105, DOI 10.1016/S0925-2312(01)00700-7; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kel-Margoulis OV, 2002, NUCLEIC ACIDS RES, V30, P332, DOI 10.1093/nar/30.1.332; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KONDRAKHIN YV, 1995, COMPUT APPL BIOSCI, V11, P477; Krogh A., 1995, ADV NEURAL INFORM PR, V4, P950; MAHDI RN, 2008, P 7 INT C MACH LEARN, P203; Narang V, 2005, ARTIF INTELL MED, V35, P107, DOI 10.1016/j.artmed.2005.02.005; Ohler U, 2000, GENOME RES, V10, P539, DOI 10.1101/gr.10.4.539; ORR MJL, 2008, INTRO RADIAL BASIS F; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Schwenker F, 2001, NEURAL NETWORKS, V14, P439, DOI 10.1016/S0893-6080(01)00027-2; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Werner T, 1999, MAMM GENOME, V10, P168, DOI 10.1007/s003359900963; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4878	10.1371/journal.pone.0004878	http://dx.doi.org/10.1371/journal.pone.0004878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287502	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496400018
J	Noels, H; Somers, R; Liu, HX; Ye, HT; Du, MQ; De Wolf-Peeters, C; Marynen, P; Baens, M				Noels, Heidi; Somers, Riet; Liu, Hongxiang; Ye, Hongtao; Du, Ming-Qing; De Wolf-Peeters, Christiane; Marynen, Peter; Baens, Mathijs			Auto-Ubiquitination-Induced Degradation of MALT1-API2 Prevents BCL10 Destabilization in t(11;18)(q21;q21)-Positive MALT Lymphoma	PLOS ONE			English	Article								Background: The translocation t(11;18)(q21;q21) is the most frequent chromosomal aberration associated with MALT lymphoma and results in constitutive NF-kappa B activity via the expression of an API2-MALT1 fusion protein. The properties of the reciprocal MALT1-API2 were never investigated as it was reported to be rarely transcribed. Principal Findings: Our data indicate the presence of MALT1-API2 transcripts in the majority of t(11;18)(q21;q21)-positive MALT lymphomas. Based on the breakpoints in the MALT1 and API2 gene, the MALT1-API2 protein contains the death domain and one or both immunoglobulin-like domains of MALT1 (similar to 90% of cases) - mediating the possible interaction with BCL10 - fused to the RING domain of API2. Here we show that this RING domain enables MALT1-API2 to function as an E3 ubiquitin ligase for BCL10, inducing its ubiquitination and proteasomal degradation in vitro. Expression of MALT1-API2 transcripts in t( 11; 18)( q21; q21)- positive MALT lymphomas was however not associated with a reduction of BCL10 protein levels. Conclusion: As we observed MALT1-API2 to be an efficient target of its own E3 ubiquitin ligase activity, our data suggest that this inherent instability of MALT1-API2 prevents its accumulation and renders a potential effect on MALT lymphoma development via destabilization of BCL10 unlikely.	[Noels, Heidi; Somers, Riet; Marynen, Peter; Baens, Mathijs] VIB, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; [Noels, Heidi; Somers, Riet; Marynen, Peter; Baens, Mathijs] Univ Leuven, Ctr Human Genet Mol Genet, Human Genome Lab, Louvain, Belgium; [Liu, Hongxiang; Ye, Hongtao; Du, Ming-Qing; De Wolf-Peeters, Christiane] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1TN, England; [De Wolf-Peeters, Christiane] Univ Leuven, Dept Morphol & Mol Pathol, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Cambridge; KU Leuven	Noels, H (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany.	Thijs.Baens@med.kuleuven.be	Noels, Heidi/AAQ-2622-2020	Du, Ming-Qing/0000-0002-1017-5045	Interuniversity Attraction Poles [IAP5/25]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G050704]; Catholic University Leuven; Leukemia Research Fund, United Kingdom	Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Catholic University Leuven(KU Leuven); Leukemia Research Fund, United Kingdom	Supported by the Interuniversity Attraction Poles (IAP5/25), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G050704) and Catholic University Leuven (Concerted Action Grant to P.M.); and by the Leukemia Research Fund, United Kingdom (to M.Q.D.). H.N. is aspirant with the FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Baens M, 2000, GENE CHROMOSOME CANC, V29, P281, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1036>3.0.CO;2-I; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Ho L, 2005, BLOOD, V105, P2891, DOI 10.1182/blood-2004-06-2297; Hosokawa Y, 2005, BIOCHEM BIOPH RES CO, V334, P51, DOI 10.1016/j.bbrc.2005.06.058; Hosokawa Y, 2004, CANCER RES, V64, P3452, DOI 10.1158/0008-5472.CAN-03-3677; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Kalla J, 2000, LEUKEMIA, V14, P1967, DOI 10.1038/sj.leu.2401918; Lee JS, 2004, PROTEOMICS, V4, P3376, DOI 10.1002/pmic.200401000; Liu HX, 2001, BLOOD, V98, P1182, DOI 10.1182/blood.V98.4.1182; Liu HX, 2004, BRIT J HAEMATOL, V125, P318, DOI 10.1111/j.1365-2141.2004.04909.x; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Maes B, 2002, BLOOD, V99, P1398, DOI 10.1182/blood.V99.4.1398; Motegi M, 2000, AM J PATHOL, V156, P807, DOI 10.1016/S0002-9440(10)64948-6; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Remstein ED, 2006, AM J SURG PATHOL, V30, P1546, DOI 10.1097/01.pas.0000213275.60962.2a; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yui D, 2001, ONCOGENE, V20, P4317, DOI 10.1038/sj.onc.1204576; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4822	10.1371/journal.pone.0004822	http://dx.doi.org/10.1371/journal.pone.0004822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279678	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496200006
J	Oyer, JA; Chu, A; Brar, S; Turker, MS				Oyer, Jon A.; Chu, Adrian; Brar, Sukhmani; Turker, Mitchell S.			Aberrant Epigenetic Silencing Is Triggered by a Transient Reduction in Gene Expression	PLOS ONE			English	Article								Background: Aberrant epigenetic silencing plays a major role in cancer formation by inactivating tumor suppressor genes. While the endpoints of aberrant silencing are known, i.e., promoter region DNA methylation and altered histone modifications, the triggers of silencing are not known. We used the tet-off system to test the hypothesis that a transient reduction in gene expression will sensitize a promoter to undergo epigenetic silencing. Methodology/Principal Findings: The tet responsive promoter (PTRE) was used to drive expression of the selectable human HPRT cDNA in independent transfectants of an Hprt deficient mouse cell line. In this system, high basal HPRT expression is greatly reduced when doxycycline (Dox) is added to the culture medium. Exposure of the PTRE-HPRT transfectants to Dox induced HPRT deficient clones in a time dependent manner. A molecular analysis demonstrated promoter region DNA methylation, loss of histone modifications associated with expression (i.e., H3 lysine 9 and 14 acetylation and lysine 4 methylation), and acquisition of the repressive histone modification H3 lysine 9 methylation. These changes, which are consistent with aberrant epigenetic silencing, were not present in the Dox-treated cultures, with the exception of reduced H3 lysine 14 acetylation. Silenced alleles readily reactivated spontaneously or after treatment of cells with inhibitors of histone deacetylation and/or DNA methylation, but re-silencing of reactivated alleles did not require a new round of Dox exposure. Inhibition of histone deacetylation inhibited both the induction of silencing and re-silencing, whereas inhibition of DNA methylation had no such effect. Conclusions/Significance: This study demonstrates that a transient reduction in gene expression triggers a pathway for aberrant silencing in mammalian cells and identifies histone deacetylation as a critical early step in this process. DNA methylation, in contrast, is a secondary step in the silencing pathway under study. A model to explain these observations is offered.	[Oyer, Jon A.; Turker, Mitchell S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Chu, Adrian; Brar, Sukhmani; Turker, Mitchell S.] Oregon Hlth & Sci Univ, CROET, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Oyer, JA (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	turkerm@ohsu.edu		Oyer, Jon/0000-0002-5479-3400	NIH [ES015191]; DOD Concept Award [W81XWH-06-1-0579]; Medical Research Foundation; Oregon Award; CROET summer student fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015191] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Concept Award; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oregon Award; CROET summer student fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant ES015191 (MST), a DOD Concept Award W81XWH-06-1-0579 (MST), a Medical Research Foundation or Oregon Award (MST) and a CROET summer student fellowship (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Banelli B, 2000, ONCOGENE, V19, P4553, DOI 10.1038/sj.onc.1203807; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; EGGER G, 2007, CANC RES; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fahrner JA, 2002, CANCER RES, V62, P7213; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Hoffman AR, 2006, CELL MOL NEUROBIOL, V26, P425, DOI 10.1007/s10571-006-9057-5; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; LEE S, 2008, ONCOGENE; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Markus J, 2007, CANCER RES, V67, P992, DOI 10.1158/0008-5472.CAN-06-2964; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Mund C, 2006, EPIGENETICS-US, V1, P7; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sawan C, 2008, MUTAT RES-FUND MOL M, V642, P1, DOI 10.1016/j.mrfmmm.2008.03.002; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Shin-Darlak CY, 2005, DNA REPAIR, V4, P51, DOI 10.1016/j.dnarep.2004.08.006; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; TURKER MS, 1991, SOMAT CELL MOLEC GEN, V17, P151, DOI 10.1007/BF01232972; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yates PA, 1999, J BIOL CHEM, V274, P36357, DOI 10.1074/jbc.274.51.36357; Yates PA, 2003, MOL CELL BIOL, V23, P4461, DOI 10.1128/MCB.23.13.4461-4470.2003	43	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4832	10.1371/journal.pone.0004832	http://dx.doi.org/10.1371/journal.pone.0004832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279688	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496200009
J	Schmitt, A; Schuchhardt, J; Brockmann, GA				Schmitt, Armin; Schuchhardt, Johannes; Brockmann, Gudrun A.			The Action of Key Factors in Protein Evolution at High Temporal Resolution	PLOS ONE			English	Article								Background: Protein evolution is particularly shaped by the conservation of the amino acids' physico-chemical properties and the structure of the genetic code. While conservation is the result of negative selection against proteins with reduced functionality, the codon sequences determine the stochastic aspect of amino acid exchanges. Thus far, it is known that the genetic code is the dominant factor if little time has elapsed since the divergence of one gene into two, but physicochemical forces gain importance at greater evolutionary distances. Further details, however, on how the influence of these factors varies with time are unknown to date. Methodology/Principal Findings: Here, we derive each 10,000 divergence specific substitution matrices for orthologues and paralogues from the Pfam collection of multiple protein alignments and quantify the action of three physico-chemical forces and of the structure of the genetic code at high resolution using correlation analysis. For closely related proteins, the codon sequence similarity is the most influential factor controlling protein evolution, but its influence decreases rapidly as divergence grows. From a protein sequence divergence of about 20 percent on the maintenance of the hydrophobic character of an amino acid is the most influential factor. All factors lose importance from about 40 percent divergence on. This suggests that the original protein structure often does no longer represent a constraint to the protein sequence. The proteins then become free to adopt new functions. We furthermore show that the constraints exerted by both physicochemical forces and by the genetic code are quite comparable for orthologues and paralogues, however somewhat weaker for paralogues than for orthologues in weakly or moderately diverged proteins. Conclusion/Significance: Our analysis substantiates earlier findings that protein evolution is mainly governed by the structure of the genetic code in the early phase after divergence and by the conservation of physico-chemical properties at the later phase. We determine the level of sequence divergence from which on the conservation of the hydrophobic character is gaining importance over the genetic code to be 20 percent. The evolution of orthologues and paralogues is shaped by evolutionary forces in quite comparable ways.	[Schmitt, Armin; Brockmann, Gudrun A.] Humboldt Univ, Inst Anim Sci, Berlin, Germany; [Schuchhardt, Johannes] MicroDiscovery GmbH, Berlin, Germany; [Brockmann, Gudrun A.] Humboldt Univ, Interdisciplin Ctr Variabil & Adapt, D-1086 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Schmitt, A (corresponding author), Humboldt Univ, Inst Anim Sci, Berlin, Germany.	armin.schmitt@agrar.hu-berlin.de		Schmitt, Armin/0000-0002-4910-9467	German Ministry of Education and Research [20301716, 20301717]; European Union [FP6 LSHG-CT-2006-037457]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by grants from the German Ministry of Education and Research (GenoTrack 20301716, NGFNplus 20301717) and the European Union (FP6 LSHG-CT-2006-037457, SysProt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; Ardell DH, 2002, PHILOS T R SOC B, V357, P1625, DOI 10.1098/rstb.2002.1071; Ardell DH, 2001, J MOL EVOL, V53, P269, DOI 10.1007/s002390010217; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HAIG D, 1991, J MOL EVOL, V33, P412, DOI 10.1007/BF02103132; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; JUKES TH, 1979, NATURE, V281, P605, DOI 10.1038/281605a0; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Patthy Laszlo, 1999, PROTEIN EVOLUTION; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmitt AO, 2007, J THEOR BIOL, V249, P376, DOI 10.1016/j.jtbi.2007.08.001; SWANSON R, 1984, B MATH BIOL, V46, P187, DOI 10.1007/BF02460068; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; ZUCKERKANDL E, 1975, J MOL EVOL, V7, P1, DOI 10.1007/BF01732178; ZUCKERKANDL E, 1965, EVOLVING GENES PROTE, V263, P97	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4821	10.1371/journal.pone.0004821	http://dx.doi.org/10.1371/journal.pone.0004821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279682	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496200005
J	Maeda, A; Maeda, T; Golczak, M; Chou, S; Desai, A; Hoppel, CL; Matsuyama, S; Palczewski, K				Maeda, Akiko; Maeda, Tadao; Golczak, Marcin; Chou, Steven; Desai, Amar; Hoppel, Charles L.; Matsuyama, Shigemi; Palczewski, Krzysztof			Involvement of All-trans-retinal in Acute Light-induced Retinopathy of Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR OUTER SEGMENTS; LIPOFUSCIN FLUOROPHORE; INDUCED DEGENERATION; OXIDATIVE STRESS; EPITHELIAL-CELLS; INDUCED DAMAGE; VISUAL CYCLE; GENE ABCR; A2E; DEHYDROGENASE	Exposure to bright light can cause visual dysfunction and retinal photoreceptor damage in humans and experimental animals, but the mechanism(s) remain unclear. We investigated whether the retinoid cycle (i.e. the series of biochemical reactions required for vision through continuous generation of 11-cis-retinal and clearance of all-trans-retinal, respectively) might be involved. Previously, we reported that mice lacking two enzymes responsible for clearing all-trans-retinal, namely photoreceptor-specific ABCA4 (ATP-binding cassette transporter 4) and RDH8 (retinol dehydrogenase 8), manifested retinal abnormalities exacerbated by light and associated with accumulation of diretinoid-pyridinium-ethanolamine (A2E), a condensation product of all-trans-retinal and a surrogate marker for toxic retinoids. Now we show that these mice develop an acute, light-induced retinopathy. However, cross-breeding these animals with lecithin: retinol acyltransferase knock-out mice lacking retinoids within the eye produced progeny that did not exhibit such light-induced retinopathy until gavaged with the artificial chromophore, 9-cis-retinal. No significant ocular accumulation of A2E occurred under these conditions. These results indicate that this acute light-induced retinopathy requires the presence of free all-trans-retinal and not, as generally believed, A2E or other retinoid condensation products. Evidence is presented that the mechanism of toxicity may include plasma membrane permeability and mitochondrial poisoning that lead to caspase activation and mitochondria-associated cell death. These findings further understanding of the mechanisms involved in light-induced retinal degeneration.	[Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; [Hoppel, Charles L.; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Chou, Steven; Matsuyama, Shigemi] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			Case Western Reserve University); NATIONAL EYE INSTITUTE [R01EY009339, R01EY008123, K08EY019031, P30EY011373] Funding Source: NIH RePORTER	Case Western Reserve University); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. J. Lem for Gnat1<SUP>-/-</SUP> mice; Drs. L. T. Webster and J. von Lintig (Case Western Reserve University) for comments on the manuscript; and Drs. K. Lodowski, S. Shiose, S. Howell, S. Roos, M. Matosky, M. Singer, and H. Matsuyama (Case Western Reserve University) for technical support and advice about some of the procedures employed.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Baehr W, 2003, VISION RES, V43, P2957, DOI 10.1016/j.visres.2003.10.001; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Holownia A, 1999, BRAIN RES, V833, P202, DOI 10.1016/S0006-8993(99)01529-2; HOPPEL CL, 1972, J BIOL CHEM, V247, P832; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2007, BIOCHEMISTRY-US, V46, P10122, DOI 10.1021/bi7009635; Kim SR, 2008, EXP EYE RES, V86, P975, DOI 10.1016/j.exer.2008.03.016; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Siems W, 2002, FASEB J, V16, P1289, DOI 10.1096/fj.01-0765fje; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Tawa P, 2001, CELL DEATH DIFFER, V8, P30, DOI 10.1038/sj.cdd.4400769; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Verdegem PJE, 1997, TETRAHEDRON LETT, V38, P5355, DOI 10.1016/S0040-4039(97)01171-4; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	56	177	189	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15173	15183		10.1074/jbc.M900322200	http://dx.doi.org/10.1074/jbc.M900322200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19304658	Green Published, hybrid			2022-12-25	WOS:000266288200052
J	Makarava, N; Ostapchenko, VG; Savtchenko, R; Baskakov, IV				Makarava, Natallia; Ostapchenko, Valeriy G.; Savtchenko, Regina; Baskakov, Ilia V.			Conformational Switching within Individual Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CONVERSION; PRION PROTEIN; PHYSICAL-PROPERTIES; STRAIN; PRPSC	A key structural component of amyloid fibrils is a highly ordered, crystalline-like cross-beta-sheet core. Conformationally different amyloid structures can be formed within the same amino acid sequence. It is generally assumed that individual fibrils consist of conformationally uniform cross-beta-structures. Using mammalian recombinant prion protein (PrP), we showed that, contrary to common perception, amyloid is capable of accommodating a significant conformational switching within individual fibrils. The conformational switch occurred when the amino acid sequence of a PrP variant used as a precursor substrate in a fibrillation reaction was not compatible with the strain-specific conformation of the fibrillar template. Despite the mismatch in amino acid sequences between the substrate and template, individual fibrils recruited the heterologous PrP variant; however, the fibril elongation proceeded through a conformational adaptation, resulting in a change in amyloid strain within individual fibrils. This study illustrates the high adaptation potential of amyloid structures and suggests that conformational switching within individual fibrils may account for adaptation of amyloid strains to a heterologous substrate. This work proposes a new mechanistic explanation for the phenomenon of strain conversion and illustrates the direction in evolution of amyloid structures. This study also provides a direct illustration that catalytic activity of self-replicating amyloid structures is not ultimately coupled with their templating effect.	[Makarava, Natallia; Ostapchenko, Valeriy G.; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA; [Baskakov, Ilia V.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umbi.umd.edu		Ostapchenko, Valeriy/0000-0002-3629-7702	National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS045585 (to I. V. B.).	Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Ostapchenko VG, 2008, J MOL BIOL, V383, P1210, DOI 10.1016/j.jmb.2008.08.073; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576	24	51	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14386	14395		10.1074/jbc.M900533200	http://dx.doi.org/10.1074/jbc.M900533200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329794	hybrid, Green Published			2022-12-25	WOS:000266286100045
J	Li, XJ; Ranjith-Kumar, CT; Brooks, MT; Dharmaiah, S; Herr, AB; Kao, C; Li, PW				Li, Xiaojun; Ranjith-Kumar, C. T.; Brooks, Monica T.; Dharmaiah, S.; Herr, Andrew B.; Kao, Cheng; Li, Pingwei			The RIG-I-like Receptor LGP2 Recognizes the Termini of Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL INNATE IMMUNITY; TOLL-LIKE-RECEPTORS; INDUCIBLE GENE-I; STRUCTURAL BASIS; HELICASE LGP2; RESPONSES; ACID; MECHANISM; VIRUSES; DOMAIN	The RIG-I-like receptors (RLRs), RIG-I and MDA5, recognize single-stranded RNA with 5' triphosphates and double-stranded RNA (dsRNA) to initiate innate antiviral immune responses. LGP2, a homolog of RIG-I and MDA5 that lacks signaling capability, regulates the signaling of the RLRs. To establish the structural basis of dsRNA recognition by the RLRs, we have determined the 2.0-A resolution crystal structure of human LGP2 C-terminal domain bound to an 8-bp dsRNA. Two LGP2 C-terminal domain molecules bind to the termini of dsRNA with minimal contacts between the protein molecules. Gel filtration chromatography and analytical ultracentrifugation demonstrated that LGP2 binds blunt-ended dsRNA of different lengths, forming complexes with 2: 1 stoichiometry. dsRNA with protruding termini bind LGP2 and RIG-I weakly and do not stimulate the activation of RIG-I efficiently in cells. Surprisingly, full-length LGP2 containing mutations that abolish dsRNA binding retained the ability to inhibit RIG-I signaling.	[Li, Xiaojun; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ranjith-Kumar, C. T.; Dharmaiah, S.; Kao, Cheng] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Ranjith-Kumar, C. T.; Dharmaiah, S.; Kao, Cheng] Indiana Univ, Multidisciplinary Biochem Program, Bloomington, IN 47405 USA; [Brooks, Monica T.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University System of Ohio; University of Cincinnati	Li, PW (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pingwei@tamu.edu	Dharmaiah, Srisathiyanarayanan/B-2887-2009; Li, Xiaojun/J-4460-2012; Herr, Andrew/R-3049-2019; Kumar CT, Ranjith/J-5701-2016	Li, Xiaojun/0000-0001-8528-8258; Herr, Andrew/0000-0002-3598-3399; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962	National Institutes of Health [1RO1AI073335]; Robert Welch Foundation [A-1687]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1AI073335 ( to C. K.). This work was also supported by Robert Welch Foundation Grant A-1687 ( to P. L.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	34	108	118	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13881	13891		10.1074/jbc.M900818200	http://dx.doi.org/10.1074/jbc.M900818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19278996	Green Published, hybrid			2022-12-25	WOS:000265877300064
J	Stubs, G; Fingerle, V; Wilske, B; Gobel, UB; Zahringer, U; Schumann, RR; Schroder, NWJ				Stuebs, Gunthard; Fingerle, Volker; Wilske, Bettina; Goebel, Ulf B.; Zaehringer, Ulrich; Schumann, Ralf R.; Schroeder, Nicolas W. J.			Acylated Cholesteryl Galactosides Are Specific Antigens of Borrelia Causing Lyme Disease and Frequently Induce Antibodies in Late Stages of Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURGDORFERI; HELICOBACTER; GLYCOLIPIDS; LIPOPROTEIN; SPIROCHETE; GLUCOSIDE; TREPONEMA; VACCINE; EUROPE; CELLS	Borrelia burgdorferi sensu lato is the causative agent of Lyme disease (LD), an infectious disease occurring in North America, Europe, and Asia in different clinical stages. B. burgdorferi sensu lato encompasses at least 12 species, with B. burgdorferi sensu stricto, B. garinii, and B. afzelii being of highest clinical importance. Immunologic testing for LD as well as recent vaccination strategies exclusively refer to proteinaceous antigens. However, B. burgdorferi sensu stricto exhibits glycolipid antigens, including 6-O-acylated cholesteryl beta-D-galactopyranoside (ACGal), and first the data indicated that this compound may act as an immunogen. Here we investigated whether B. garinii and B. afzelii also possess this antigen, and whether antibodies directed against these compounds are abundant among patients suffering from different stages of LD. Gas-liquid chromatography/mass spectroscopy and NMR spectroscopy showed that both B. garinii and B. afzelii exhibit ACGal in high quantities. In contrast, B. hermsii causing relapsing fever features 6-O-acylated cholesteryl beta-D-glucopyranoside (ACGlc). Sera derived from patients diagnosed for LD contained antibodies against ACGal, with 80% of patients suffering from late stage disease exhibiting this feature. Antibodies reacted with ACGal from all three B. burgdorferi species tested, but not with ACGlc from B. hermsii. These data show that ACGal is present in all clinically important B. burgdorferi species, and that specific antibodies against this compound are frequently found during LD. ACGal may thus be an interesting tool for improving diagnostics as well as for novel vaccination strategies.	[Schroeder, Nicolas W. J.] Charite Med Ctr, Inst Neuropathol, D-10117 Berlin, Germany; [Stuebs, Gunthard; Goebel, Ulf B.; Schumann, Ralf R.] Charite Med Ctr, Inst Microbiol & Hyg, D-10117 Berlin, Germany; [Fingerle, Volker] Bavarian Hlth & Food Safety Author, D-85764 Oberschleissheim, Germany; [Wilske, Bettina] Univ Munich, Max von Pettenkofer Inst Med Microbiol & Hyg, D-80336 Munich, Germany; [Zaehringer, Ulrich] Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bavarian Health & Food Safety Authority; University of Munich; Forschungszentrum Borstel	Schroder, NWJ (corresponding author), Charite Med Ctr, Inst Neuropathol, D-10117 Berlin, Germany.	nicolas.schroeder@charite.de		Fingerle, Volker/0000-0002-3835-5646				Bacon R. M., 2007, Morbidity and Mortality Weekly Report, V56, P573; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Dennis David T., 2002, P251, DOI 10.1079/9780851996325.0251; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Goettner G, 2005, J CLIN MICROBIOL, V43, P3602, DOI 10.1128/JCM.43.8.3602-3609.2005; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Haque M, 1996, J BACTERIOL, V178, P2065, DOI 10.1128/jb.178.7.2065-2070.1996; Hauser U, 1998, J CLIN MICROBIOL, V36, P427, DOI 10.1128/JCM.36.2.427-436.1998; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; HONARVAR N, 1994, IMMUNOLOGY, V82, P389; Hossain H, 2001, BIOCHIMIE, V83, P683, DOI 10.1016/S0300-9084(01)01296-2; Hubalek Z, 1997, EUR J EPIDEMIOL, V13, P951, DOI 10.1023/A:1007426304900; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; LIVERMORE BP, 1978, INFECT IMMUN, V20, P215, DOI 10.1128/IAI.20.1.215-220.1978; LIVERMORE BP, 1974, J BACTERIOL, V120, P1268, DOI 10.1128/JB.120.3.1268-1273.1974; Nigrovic LE, 2007, EPIDEMIOL INFECT, V135, P1, DOI 10.1017/S0950268806007096; Ostberg Y, 2007, FEMS MICROBIOL LETT, V272, P22, DOI 10.1111/j.1574-6968.2007.00728.x; RADOLF JD, 1995, INFECT IMMUN, V63, P2154, DOI 10.1128/IAI.63.6.2154-2163.1995; Reed KD, 2002, J CLIN MICROBIOL, V40, P319, DOI 10.1128/JCM.40.2.319-324.2002; Rottem S, 2002, BIOCHEM BIOPH RES CO, V292, P1289, DOI 10.1006/bbrc.2001.2023; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SMITH PF, 1971, J BACTERIOL, V108, P986, DOI 10.1128/JB.108.3.986-991.1971; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; STEIM JM, 1967, BIOCHIM BIOPHYS ACTA, V144, P118, DOI 10.1016/0005-2760(67)90083-5; TAKI T, 1994, ANAL BIOCHEM, V221, P312, DOI 10.1006/abio.1994.1418; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Wilske B, 1996, INFECTION, V24, P208, DOI 10.1007/BF01713341; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480	38	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13326	13334		10.1074/jbc.M809575200	http://dx.doi.org/10.1074/jbc.M809575200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307181	Green Published, hybrid			2022-12-25	WOS:000265877300008
J	Zhu, Y; Bogomolovas, J; Labeit, S; Granzier, H				Zhu, Yi; Bogomolovas, Julius; Labeit, Siegfried; Granzier, Henk			Single Molecule Force Spectroscopy of the Cardiac Titin N2B Element EFFECTS OF THE MOLECULAR CHAPERONE alpha B-CRYSTALLIN WITH DISEASE-CAUSING MUTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIANT PROTEIN TITIN; SPRING ELEMENTS; HEART-MUSCLE; ELASTICITY; MECHANICS; ASSOCIATION; STIFFNESS; MYOCYTES; SEQUENCE; DOMAIN	The small heat shock protein alpha B-crystallin interacts with N2B-Us, a large unique sequence found in the N2B element of cardiac titin. Using single molecule force spectroscopy, we studied the effect of alpha B-crystallin on the N2B-Us and its flanking Ig-like domains. Ig domains from the proximal tandem Ig segment of titin were also studied. The effect of wild type alpha B-crystallin on the single molecule force-extension curve was determined as well as that of mutant alpha B-crystallins harboring the dilated cardiomyopathy missense mutation, R157H, or the desmin-related myopathy mutation, R120G. Results revealed that wild type alpha B-crystallin decreased the persistence length of the N2B-Us (from similar to 0.7 to similar to 0.2 nm) but did not alter its contour length. alpha B-crystallin also increased the unfolding force of the Ig domains that flank the N2B-Us (by 51 +/- 3 piconewtons); the rate constant of unfolding at zero force was estimated to be similar to 17-fold lower in the presence of alpha B-crystallin (1.4 x 10(-4) s(-1) versus 2.4 x 10(-3) s(-1)). We also found that alpha B-crystallin increased the unfolding force of Ig domains from the proximal tandem Ig segment by 28 +/- 6 piconewtons. The effects of alpha B-crystallin were attenuated by the R157H mutation (but were still significant) and were absent when using the R120G mutant. We conclude that alpha B-crystallin protects titin from damage by lowering the persistence length of the N2B-Us and reducing the Ig domain unfolding probability. Our finding that this effect is either attenuated (R157H) or lost (R120G) in disease causing alpha B-crystallin mutations suggests that the interaction between alpha B-crystallin and titin is important for normal heart function.	[Zhu, Yi; Granzier, Henk] Univ Arizona, Dept Mol & Cellular Biol, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Bogomolovas, Julius; Labeit, Siegfried] Univ Heidelberg, Med Fac Mannheim, D-68167 Mannheim, Germany	University of Arizona; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Sarver Mol Cardiovasc Res Program, MRB 325,POB 245217, Tucson, AZ 85724 USA.	granzier@email.arizona.edu	Bogomolovas, Julius/AAS-3642-2020; Bogomolovas, Julius/HGD-2595-2022	Bogomolovas, Julius/0000-0001-8344-1909; 	National Institutes of Health [HL62881]; Deutsche Forschungsgemeinschaft [La668/12-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62881 ( to H. G.). This work was also supported by Deutsche Forschungsgemeinschaft Grant La668/12-1 ( to S. L.).	Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Granzier H, 1997, BIOPHYS J, V73, P2043, DOI 10.1016/S0006-3495(97)78234-1; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kumarapeli ARK, 2004, J MOL CELL CARDIOL, V37, P1097, DOI 10.1016/j.yjmcc.2004.07.004; Labeit D, 2003, P NATL ACAD SCI USA, V100, P13716, DOI 10.1073/pnas.2235652100; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Leake MC, 2006, J STRUCT BIOL, V155, P263, DOI 10.1016/j.jsb.2006.02.017; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1998, BIOPHYS J, V75, P2613, DOI 10.1016/S0006-3495(98)77706-9; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Trombitas K, 1999, BIOPHYS J, V77, P3189, DOI 10.1016/S0006-3495(99)77149-3; TROMBITAS K, 1995, CIRC RES, V77, P856, DOI 10.1161/01.RES.77.4.856; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2002, J CARD FAIL, V8, pS287, DOI 10.1054/jcaf.2002.129279; Watanabe K, 2002, J STRUCT BIOL, V137, P248, DOI 10.1006/jsbi.2002.4458; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99	37	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13914	13923		10.1074/jbc.M809743200	http://dx.doi.org/10.1074/jbc.M809743200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19282282	Green Published, hybrid			2022-12-25	WOS:000265877300067
J	Norambuena, A; Metz, C; Vicuna, L; Silva, A; Pardo, E; Oyanadel, C; Massardo, L; Gonzalez, A; Soza, A				Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Massardo, Loreto; Gonzalez, Alfonso; Soza, Andrea			Galectin-8 Induces Apoptosis in Jurkat T Cells by Phosphatidic Acid-mediated ERK1/2 Activation Supported by Protein Kinase A Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PHOSPHOLIPASE-D ACTIVITY; GROWTH-FACTOR RECEPTOR; DEPENDENT KINASE; MAP KINASE; CYTOKINE SECRETION; MAPK/ERK PATHWAY; PLASMA-MEMBRANE; IMMUNE-RESPONSE	Galectins have been implicated in T cell homeostasis playing complementary pro-apoptotic roles. Here we show that galectin-8 (Gal-8) is a potent pro-apoptotic agent in Jurkat T cells inducing a complex phospholipase D/phosphatidic acid signaling pathway that has not been reported for any galectin before. Gal-8 increases phosphatidic signaling, which enhances the activity of both ERK1/2 and type 4 phosphodiesterases (PDE4), with a subsequent decrease in basal protein kinase A activity. Strikingly, rolipram inhibition of PDE4 decreases ERK1/2 activity. Thus Gal-8-induced PDE4 activation releases a negative influence of cAMP/protein kinase A on ERK1/2. The resulting strong ERK1/2 activation leads to expression of the death factor Fas ligand and caspase-mediated apoptosis. Several conditions that decrease ERK1/2 activity also decrease apoptosis, such as anti-Fas ligand blocking antibodies. In addition, experiments with freshly isolated human peripheral blood mononuclear cells, previously stimulated with anti-CD3 and anti-CD28, show that Gal-8 is pro-apoptotic on activated T cells, most likely on a subpopulation of them. Anti-Gal-8 autoantibodies from patients with systemic lupus erythematosus block the apoptotic effect of Gal-8. These results implicate Gal-8 as a novel T cell suppressive factor, which can be counterbalanced by function-blocking autoantibodies in autoimmunity.	[Metz, Claudia; Massardo, Loreto; Gonzalez, Alfonso; Soza, Andrea] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Fac Med, Santiago 6510260, Chile; [Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Gonzalez, Alfonso; Soza, Andrea] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Fac Ciencias Biol, Santiago 6510260, Chile; [Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Gonzalez, Alfonso; Soza, Andrea] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac, Fac Ciencias Biol, Santiago 6510260, Chile; [Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Gonzalez, Alfonso; Soza, Andrea] Millenium Inst Fundamental & Appl Biol, Inst Milenio Biol Fundamental & Aplicada, Santiago 7780344, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Soza, A (corresponding author), Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Fac Med, Marcoleta 367, Santiago 6510260, Chile.	amsoza@med.puc.cl	Vicuña, Lucas/AAD-5889-2019; Vicuña, Lucas/AAR-2636-2020; Vicuña, Lucas/O-3075-2015	Vicuña, Lucas/0000-0002-0901-0032; Oyanadel, Claudia/0000-0002-5018-9767; Pardo, Evelyn/0000-0002-2516-5632; Metz, Claudia/0000-0002-5093-3066; Soza, Andrea/0000-0003-3783-5231; Christine, Metz/0000-0002-1013-1691	Fondo Nacional de Desarrollo CientIfico y Tecnologico [1050715]; Fondo Nacional de Areas Prioritarias [13980001]; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia [PFB12/2007]; Ministerio de Planificacion y Cooperacion de Chile	Fondo Nacional de Desarrollo CientIfico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Nacional de Areas Prioritarias; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Ministerio de Planificacion y Cooperacion de Chile	This work was supported by Fondo Nacional de Desarrollo CientIfico y Tecnologico Grant 1050715, Fondo Nacional de Areas Prioritarias Grant 13980001, Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia Grant PFB12/2007, and the Millenium Institute for Fundamental and Applied Biology, which is financed in part by the Ministerio de Planificacion y Cooperacion de Chile.	Adams CL, 2004, J IMMUNOL, V173, P1579, DOI 10.4049/jimmunol.173.3.1579; Arbel-Goren R, 2005, J BIOL CHEM, V280, P19105, DOI 10.1074/jbc.M502060200; Arp J, 2003, MOL CELL BIOL, V23, P8042, DOI 10.1128/MCB.23.22.8042-8057.2003; Bacon KB, 1998, J IMMUNOL, V160, P1894; Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Bidon N, 2001, INT J MOL MED, V8, P245; Bidon-Wagner N, 2002, GLYCOCONJUGATE J, V19, P557, DOI 10.1023/B:GLYC.0000014086.38343.98; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; Dumont FJ, 1998, J IMMUNOL, V160, P2579; ElBawab S, 1997, EUR J BIOCHEM, V247, P1151, DOI 10.1111/j.1432-1033.1997.01151.x; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Fournel S, 1996, J IMMUNOL, V157, P4309; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Hadari YR, 2000, J CELL SCI, V113, P2385; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; Hedges JF, 2005, J IMMUNOL, V174, P6045, DOI 10.4049/jimmunol.174.10.6045; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Janssen O, 2000, CELL TISSUE RES, V301, P85, DOI 10.1007/s004419900155; Jimenez JL, 2001, J PHARMACOL EXP THER, V299, P753; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAMMER GM, 1994, J CLIN INVEST, V94, P422, DOI 10.1172/JCI117340; Kanda N, 2001, BIOCHEM PHARMACOL, V62, P495, DOI 10.1016/S0006-2952(01)00688-8; Kawai K, 2004, J ALLERGY CLIN IMMUN, V113, P1211, DOI 10.1016/j.jaci.2004.02.044; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kim K, 2003, BBA-MOL CELL RES, V1641, P13, DOI 10.1016/S0167-4889(03)00045-4; Krammer P H, 1999, Adv Immunol, V71, P163; Lahm H, 2003, GLYCOCONJUGATE J, V20, P227, DOI 10.1023/B:GLYC.0000025817.24297.17; Lahmers KK, 2006, J LEUKOCYTE BIOL, V80, P939, DOI 10.1189/jlb.0506353; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Li YQ, 1999, IMMUNOLOGY, V96, P524; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; MARCOZ P, 1993, BIOCHIM BIOPHYS ACTA, V1176, P129, DOI 10.1016/0167-4889(93)90187-T; MOLLINEDO F, 1994, J IMMUNOL, V153, P2457; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; NIELSEN HV, 1994, J IMMUNOL, V153, P2021; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Pardo E, 2006, REV MED CHILE, V134, P159; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Peter D, 2007, J IMMUNOL, V178, P4820, DOI 10.4049/jimmunol.178.8.4820; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 1999, CELL DEATH DIFFER, V6, P711, DOI 10.1038/sj.cdd.4400535; Ramstad C, 2000, CELL SIGNAL, V12, P557, DOI 10.1016/S0898-6568(00)00097-8; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Salazar G, 2002, MOL BIOL CELL, V13, P1677, DOI 10.1091/mbc.01-08-0403; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Tamir A, 1996, J IMMUNOL, V157, P1514; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; TOMIC S, 1995, J BIOL CHEM, V270, P21277, DOI 10.1074/jbc.270.36.21277; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Vespa GNR, 1999, J IMMUNOL, V162, P799; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005; Zhu L, 1999, IMMUNOLOGY, V97, P26; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	86	52	54	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12670	12679		10.1074/jbc.M808949200	http://dx.doi.org/10.1074/jbc.M808949200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276072	Green Published, hybrid			2022-12-25	WOS:000265688300011
J	Tsuchiya, M; Piras, V; Choi, SD; Akira, S; Tomita, M; Giuliani, A; Selvarajoo, K				Tsuchiya, Masa; Piras, Vincent; Choi, Sangdun; Akira, Shizuo; Tomita, Masaru; Giuliani, Alessandro; Selvarajoo, Kumar			Emergent Genome-Wide Control in Wildtype and Genetically Mutated Lipopolysaccarides-Stimulated Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; GENE-EXPRESSION; SELF-ORGANIZATION; LINKING INNATE; NETWORK; BIOLOGY; CELL; NORMALIZATION; LEVEL; MYD88	Large-scale gene expression studies have mainly focused on highly expressed and 'discriminatory' genes to decipher key regulatory processes. Biological responses are consequence of the concerted action of gene regulatory network, thus, limiting our attention to genes having the most significant variations is insufficient for a thorough understanding of emergent whole genome response. Here we comprehensively analyzed the temporal oligonucleotide microarray data of lipopolysaccharide (LPS) stimulated macrophages in 4 genotypes; wildtype, Myeloid Differentiation factor 88 (MyD88) knockout (KO), TIR-domain-containing adapter-inducing interferon-beta (TRIF) KO and MyD88/TRIF double KO (DKO). Pearson correlations computed on the whole genome expression between different genotypes are extremely high (> 0.98), indicating a strong co-regulation of the entire expression network. Further correlation analyses reveal genome-wide response is biphasic, i) acute-stochastic mode consisting of small number of sharply induced immune-related genes and ii) collective mode consisting of majority of weakly induced genes of diverse cellular processes which collectively adjust their expression level. Notably, temporal correlations of a small number of randomly selected genes from collective mode show scalability. Furthermore, in collective mode, the transition from large scatter in expression distributions for single ORFs to smooth linear lines emerges as an organizing principle when grouping of 50 ORFs and above. With this emergent behavior, the role of MyD88, TRIF and novel MyD88, TRIF-independent processes for gene induction can be linearly superposed to decipher quantitative whole genome differential control of transcriptional and mRNA decay machineries. Our work demonstrates genome-wide co-regulated responses subsequent to specific innate immune stimulus which have been largely neglected.	[Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Sch Media & Govern, Syst Biol Program, Tokyo 108, Japan; [Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Akira, Shizuo] Osaka Univ, Res Inst Microb Dis, Dept Host Defense, Suita, Osaka 565, Japan; [Giuliani, Alessandro] Ist Superiore Sanita, Dept Environm & Hlth, Rome, Italy	Keio University; Keio University; Ajou University; Osaka University; Istituto Superiore di Sanita (ISS)	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; kumar@ttck.keio.ac.jp	Piras, Vincent/K-3203-2012; Giuliani, Alessandro/K-7589-2016; Akira, Shizuo/C-3134-2009; Giuliani, Alessandro/AAF-1740-2020	Piras, Vincent/0000-0002-3427-0995; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Selvarajoo, Kumar/0000-0002-0314-9666	Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Yamagata Prefecture and Tsuruoka City, Japan; Korean Government (MOEHRD) [KRF-2006-311-C00482]	Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamagata Prefecture and Tsuruoka City, Japan; Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by Japan Science and Technology Agency/Core Research for Evolutional Science and Technology (JST CREST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Research fund by Yamagata Prefecture and Tsuruoka City, Japan. This work was also partly supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2006-311-C00482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Farkas I, 2003, PHYSICA A, V318, P601, DOI 10.1016/S0378-4371(02)01731-4; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Klevecz RR, 2008, FEBS J, V275, P2372, DOI 10.1111/j.1742-4658.2008.06399.x; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kurakin A, 2005, DEV GENES EVOL, V215, P46, DOI 10.1007/s00427-004-0448-7; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Pries R, 2008, CRIT REV IMMUNOL, V28, P201, DOI 10.1615/CritRevImmunol.v28.i3.20; SELVARAJOO K, 2008, E CELL SYST IN PRESS; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	40	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4905	10.1371/journal.pone.0004905	http://dx.doi.org/10.1371/journal.pone.0004905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300509	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496800006
J	Wu, G; Huang, H; Abreu, JG; He, X				Wu, Geng; Huang, He; Abreu, Jose Garcia; He, Xi			Inhibition of GSK3 Phosphorylation of beta-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6	PLOS ONE			English	Article							F-BOX PROTEIN; RECEPTOR-RELATED PROTEIN-5; SYNTHASE KINASE 3-BETA; SIGNALING PATHWAY; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; AXIS FORMATION; XENOPUS; COMPLEX; DEGRADATION	The Wnt/beta-catenin signaling pathway plays essential roles in cell proliferation and differentiation, and deregulated beta-catenin protein levels lead to many types of human cancers. On activation by Wnt, the Wnt co-receptor LDL receptor related protein 6 (LRP6) is phosphorylated at multiple conserved intracellular PPPSPXS motifs by glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1), resulting in recruitment of the scaffolding protein Axin to LRP6. As a result, beta-catenin phosphorylation by GSK3 is inhibited and beta-catenin protein is stabilized. However, how LRP6 phosphorylation and the ensuing LRP6-Axin interaction lead to the inhibition of beta-catenin phosphorylation by GSK3 is not fully understood. In this study, we reconstituted Axin-dependent beta-catenin phosphorylation by GSK3 and CK1 in vitro using recombinant proteins, and found that the phosphorylated PPPSPXS peptides directly inhibit beta-catenin phosphorylation by GSK3 in a sequence and phosphorylation-dependent manner. This inhibitory effect of phosphorylated PPPSPXS motifs is direct and specific for GSK3 phosphorylation of beta-catenin at Ser33/Ser37/Thr41 but not for CK1 phosphorylation of beta-catenin at Ser45, and is independent of Axin function. We also show that a phosphorylated PPPSPXS peptide is able to activate Wnt/beta-catenin signaling and to induce axis duplication in Xenopus embryos, presumably by inhibition of GSK3 in vivo. Based on these observations, we propose a working model that Axin recruitment to the phosphorylated LRP6 places GSK3 in the vicinity of multiple phosphorylated PPPSPXS motifs, which directly inhibit GSK3 phosphorylation of beta-catenin. This model provides a possible mechanism to account, in part, for inhibition of beta-catenin phosphorylation by Wnt-activated LRP6.	[Wu, Geng; Huang, He; Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Abreu, Jose Garcia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil	Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade Federal do Rio de Janeiro	Wu, G (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	geng.wu@sjtu.edu.cn; xi.he@childrens.harvard.edu	Neurociencia, Inct/I-1011-2013; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021	Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755	Leukemia and Lymphoma Society [Special Fellowship]; NIH [RO1-GM74241]; CIHR (Canadian Institute of Health Research) [postdoctoral fellowship]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Brazilian Scholarship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR (Canadian Institute of Health Research)(Canadian Institutes of Health Research (CIHR)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Leukemia and Lymphoma Society Special Fellowship to G. W, and by NIH RO1-GM74241 to X. H, who is a Leukemia and Lymphoma Society Scholar. HH is supported by a postdoctoral fellowship from CIHR (Canadian Institute of Health Research). JGA is a visiting professor and in part supported by a Brazilian Scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Wu G, 2006, BIOCHEMISTRY-US, V45, P5319, DOI 10.1021/bi0601149; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu G, 2004, MOL CELL, V13, P451, DOI 10.1016/S1097-2765(04)00090-5; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	55	148	157	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4926	10.1371/journal.pone.0004926	http://dx.doi.org/10.1371/journal.pone.0004926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293931	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496600013
J	Kim, HS; Lim, IK				Kim, Hong Seok; Lim, In Kyoung			Phosphorylated Extracellular Signal-regulated Protein Kinases 1 and 2 Phosphorylate Sp1 on Serine 59 and Regulate Cellular Senescence via Transcription of p21(Sdi1/Cip1/Waf1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-DIPLOID FIBROBLASTS; NADPH-OXIDASE ACTIVATION; INDUCED GROWTH ARREST; HUMAN T-CELLS; TYROSINE PHOSPHORYLATION; NUCLEAR ACCUMULATION; CYCLE PROGRESSION; PHOSPHOLIPASE-D; DOWN-REGULATION; RECEPTOR-ALPHA	Expression of p21(Sdi1) downstream of p53 is essential for induction of cellular senescence, although cancer cell senescence can also occur in the p53 null condition. We report herein that senescence-associated phosphorylated extracellular signal-regulated protein kinases 1 and 2 (SA-pErk1/2) enhanced p21(Sdi1) transcription by phosphorylating Sp1 on Ser(59) downstream of protein kinase C (PKC) alpha. Reactive oxygen species (ROS), which was increased in cellular senescence, significantly activated both PKC alpha and PKC beta I. However, PKC alpha, but not PKC beta I, regulated ROS generation and cell proliferation in senescent cells along with activation of cdk2, proven by siRNAs. PKC alpha-siRNA also reduced SA-pErk1/2 expression in old human diploid fibroblast cells, accompanied with changes of senescence phenotypes to young cell-like. Regulation of SA-pErk1/2 was also confirmed by using catalytically active PKC alpha and its DN-mutant construct. These findings strongly suggest a new pathway to regulate senescence phenotypes by ROS via Sp1 phosphorylation between PKC alpha and SA-pErk1/2: employing GST-Sp1 mutants and MEK inhibitor analyses, we found that SA-pErk1/2 regulated Sp1 phosphorylation on the Ser(59) residue in vivo, but not threonine, in cellular senescence, which regulated transcription of p21(Sdi1) expression. In summary, PKC alpha, which was activated in senescent cells by ROS strongly activated Erk1/2, and the SA-pErk1/2 in turn phosphorylated Sp1 on Ser(59). Sp1-enhanced transcription of p21(Sdi1) resulted in regulation of cellular senescence in primary human diploid fibroblast cells.	[Kim, Hong Seok; Lim, In Kyoung] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea	Ajou University	Lim, IK (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea.	iklim@ajou.ac.kr		Lim, In Kyoung/0000-0002-2399-607X	Korea Science and Engineering Foundation [R11-2002-097-08002-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Research Grant R11-2002-097-08002-0( 2008) provided by the Korea Science and Engineering Foundation.	Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; BILEZIKJIAN LM, 1987, MOL ENDOCRINOL, V1, P555, DOI 10.1210/mend-1-8-555; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; BRAWN MK, 1995, FREE RADICAL RES, V22, P23, DOI 10.3109/10715769509147525; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chaves MM, 2002, GERONTOLOGY, V48, P354, DOI 10.1159/000065503; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; CLEMENS MJ, 1992, J CELL SCI, V103, P881; COPPOCK DL, 1992, CELL GROWTH DIFFER, V3, P485; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DOI S, 1994, MOL CARCINOGEN, V11, P197, DOI 10.1002/mc.2940110405; FOJAS DB, 2001, EMBO J, V20, P5737; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; Hamada K, 1996, BBA-MOL CELL RES, V1310, P149, DOI 10.1016/0167-4889(95)00148-4; Hatoum A, 2001, CARCINOGENESIS, V22, P1955, DOI 10.1093/carcin/22.12.1955; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Kenessey A, 2006, AM J PHYSIOL-HEART C, V290, pH381, DOI 10.1152/ajpheart.00576.2005; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; Kim YK, 2003, ONCOGENE, V22, P6023, DOI 10.1038/sj.onc.1206875; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kwak IH, 2004, CANCER RES, V64, P572, DOI 10.1158/0008-5472.CAN-03-1856; Lim IK, 2000, MECH AGEING DEV, V119, P113, DOI 10.1016/S0047-6374(00)00167-6; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Maloney JA, 1998, AM J PHYSIOL-CELL PH, V274, pC974, DOI 10.1152/ajpcell.1998.274.4.C974; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; PALUMBO EJ, 1992, BIOCHEM BIOPH RES CO, V187, P1439, DOI 10.1016/0006-291X(92)90463-U; Salabat MR, 2006, PANCREAS, V33, P148, DOI 10.1097/01.mpa.0000226896.93945.41; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SASAGURI T, 1993, EXP CELL RES, V208, P311, DOI 10.1006/excr.1993.1251; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Schavinsky-Khrapunsky Y, 2003, BIOCHEM BIOPH RES CO, V304, P696, DOI 10.1016/S0006-291X(03)00650-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHARMA P, 1991, BIOCHEM BIOPH RES CO, V177, P1033, DOI 10.1016/0006-291X(91)90642-K; Sugibayashi R, 2001, ONCOGENE, V20, P1220, DOI 10.1038/sj.onc.1204206; Tan NY, 2008, CIRC RES, V102, pE38, DOI 10.1161/CIRCRESAHA.107.167395; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; VENABLE ME, 1994, J BIOL CHEM, V269, P26040; Vijayan K, 2004, AM J PHYSIOL-HEART C, V287, pH2777, DOI 10.1152/ajpheart.00171.2004; Wang JF, 2004, J BIOL CHEM, V279, P27088, DOI 10.1074/jbc.M314015200; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zheng XL, 2001, J BIOL CHEM, V276, P13822, DOI 10.1074/jbc.M011031200; ZHOU W, 1993, J BIOL CHEM, V268, P23041; Zupanska A, 2007, CELL SIGNAL, V19, P1268, DOI 10.1016/j.cellsig.2007.01.011	66	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15475	15486		10.1074/jbc.M808734200	http://dx.doi.org/10.1074/jbc.M808734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19318349	Green Published, hybrid			2022-12-25	WOS:000266501000016
J	Komiyama, T; Coppola, JM; Larsen, MJ; van Dort, ME; Ross, BD; Day, R; Rehemtulla, A; Fuller, RS				Komiyama, Tomoko; Coppola, Julia M.; Larsen, Martha J.; van Dort, Marcian E.; Ross, Brian D.; Day, Robert; Rehemtulla, Alnawaz; Fuller, Robert S.			Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASES; PROTEOLYTIC ACTIVATION; CRYSTAL-STRUCTURE; MATRIX-METALLOPROTEINASE; FURIN INHIBITORS; ANTHRAX TOXIN; D-ARGININE; CLEAVAGE; PROTEIN; GLYCOPROTEIN	Furin is a ubiquitously expressed proprotein convertase (PC) that plays a vital role in numerous disease processes including cancer metastasis, bacterial toxin activation (e. g. anthrax and Pseudomonas), and viral propagation (e. g. avian influenza and human immunodeficiency virus). To identify small molecule inhibitors of furin and related processing enzymes, we performed high-throughput screens of chemical diversity libraries utilizing both enzyme-based and cell-based assays. The screens identified partially overlapping sets of compounds that were further characterized for affinity, mechanism, and efficacy in additional cellular processing assays. Dicoumarols were identified as a class of compounds that inhibited furin non-competitively and reversibly with K-i values in the micromolar range. These compounds inhibited furin/furin-like activity both at the cell surface (protecting against anthrax toxin) and in the secretory pathway (blocking processing of the metastasis factor membrane-type 1 matrix metalloproteinase/MT1-MMP) at concentrations close to K-i values. Compounds tested exhibited distinct patterns of inhibition of other furin-family PCs (rat PACE4, human PC5/6 and human PC7), showing that dicoumarol derivatives might be developed as either generic or selective inhibitors of the PCs. The extensive clinical use, high bioavailability and relatively low toxicity of dicoumarols suggests that the dicoumarol structure will be a good starting point for development of drug-like inhibitors of furin and other PCs that can act both intracellularly and at the cell surface.	[Komiyama, Tomoko; Coppola, Julia M.; Fuller, Robert S.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Coppola, Julia M.; Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [van Dort, Marcian E.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Larsen, Martha J.] Univ Michigan, Inst Life Sci, Ctr Chem Genom, Ann Arbor, MI 48109 USA; [Day, Robert] Univ Sherbrooke, Fac Med, Sherbrooke, PQ J1H 5N4, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Sherbrooke	Rehemtulla, A (corresponding author), Univ Michigan, Med Ctr, BSRB Room A528,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	alnawaz@umich.edu; bfuller@umich.edu			National Institutes of Health NCI [P01CA85878, R24CA83099, P50CA093990, GM39697, GM50915]; Canadian Institutes of Health Research grants; NATIONAL CANCER INSTITUTE [P01CA085878, P50CA093990, R24CA083099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039697, R01GM050915, R55GM039697] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants P01CA85878, R24CA83099, and P50CA093990 ( to A. R. and B. D. R.) and GM39697 and GM50915 ( to R. S. F.). This work was also supported by Canadian Institutes of Health Research grants ( to R. D.).	Abdelmohsen K, 2005, ARCH BIOCHEM BIOPHYS, V434, P241, DOI 10.1016/j.abb.2004.11.002; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Arner EC, 2002, CURR OPIN PHARMACOL, V2, P322, DOI 10.1016/S1471-4892(02)00148-0; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Borges F, 2005, CURR MED CHEM, V12, P887, DOI 10.2174/0929867053507315; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Coppola JM, 2007, ANAL BIOCHEM, V364, P19, DOI 10.1016/j.ab.2007.01.013; Dixon M., 1979, ENZYMES, Vthird; Fear G, 2007, PHARMACOL THERAPEUT, V113, P354, DOI 10.1016/j.pharmthera.2006.09.001; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GARRED O, 1995, J BIOL CHEM, V270, P10817; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; GUMINSKA M, 1961, J MED PHARMACEUT CH, V3, P583, DOI 10.1021/jm50016a016; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hamstra DA, 1999, HUM GENE THER, V10, P235, DOI 10.1089/10430349950019020; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Komiyama T, 2005, ANTIMICROB AGENTS CH, V49, P3875, DOI 10.1128/AAC.49.9.3875-3882.2005; Komiyama T, 2003, P NATL ACAD SCI USA, V100, P8205, DOI 10.1073/pnas.1032865100; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; LOCKNER D, 1979, BRIT J CLIN PHARMACO, V8, P59, DOI 10.1111/j.1365-2125.1979.tb05910.x; Matsuzawa T, 2004, J BIOL CHEM, V279, P2866, DOI 10.1074/jbc.M310340200; McAlister V, 2006, CLIN INVEST MED, V29, P373; Mironov AA, 2004, EUR J CELL BIOL, V83, P263, DOI 10.1078/0171-9335-00377; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Sarac MS, 2004, INFECT IMMUN, V72, P602, DOI 10.1128/IAI.72.1.602-605.2004; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Segel I.H, 1993, ENZYME KINETICS; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stawowy P, 2005, J MOL MED, V83, P865, DOI 10.1007/s00109-005-0723-8; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; WATANABE M, 1995, J VIROL, V69, P3206, DOI 10.1128/JVI.69.5.3206-3210.1995; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	51	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15729	15738		10.1074/jbc.M901540200	http://dx.doi.org/10.1074/jbc.M901540200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19332539	Green Published, hybrid			2022-12-25	WOS:000266501000042
J	Feng, HT; Cheng, TS; Steer, JH; Joyce, DA; Pavlos, NJ; Leong, CL; Kular, J; Liu, JZ; Feng, X; Zheng, MH; Xu, JK				Feng, HaoTian; Cheng, Taksum; Steer, James H.; Joyce, David A.; Pavlos, Nathan J.; Leong, ChengLoon; Kular, Jasreen; Liu, Jianzhong; Feng, Xu; Zheng, Ming H.; Xu, Jiake			Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; GENE-EXPRESSION; BONE-RESORPTION; NUCLEAR-FACTOR; DC-STAMP; DIFFERENTIATION; MEF2; OSTEOPETROSIS; SUBUNIT	The V-ATPase d2 protein constitutes an important subunit of the V-ATPase proton pump, which regulates bone homeostasis; however, currently little is known about its transcriptional regulation. Here, in an attempt to understand regulation of the V-ATPase d2 promoter, we identified the presence of NFATc1, microphthalmia-associated transcription factor (MITF)- and myocyte enhancer factor 2 (MEF2)-binding sites within the V-ATPase d2 promoter using complementary bioinformatic analyses, chromatin immunoprecipitation, and electromobility shift assay. Intriguingly, activation of the V-ATPase d2 promoter by NFATc1 was enhanced by either MEF2 or MITF overexpression. By comparison, coexpression of MITF and MEF2 did not further enhance V-ATPase d2 promoter activity above that of expression of MITF alone. Consistent with a role in transcriptional regulation, both NFATc1 and MITF proteins translocated from the cytosol to the nucleus during RANKL-induced osteoclastogenesis, whereas MEF2 persisted in the nucleus of both osteoclasts and their mononuclear precursors. Targeted mutation of the putative NFATc1-,MITF-, or MEF2-binding sites in the V-ATPase d2 promoter impaired its transcriptional activation. Additionally retroviral overexpression of MITF or MEF2 in RAW264.7 cells potentiated RANKL-induced osteoclastogenesis and V-ATPase d2 gene expression. Based on these data, we propose that MEF2 and MITF function cooperatively with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.	[Feng, HaoTian; Cheng, Taksum; Pavlos, Nathan J.; Leong, ChengLoon; Kular, Jasreen; Zheng, Ming H.; Xu, Jiake] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Mol Orthopaed Lab, Nedlands, WA 6009, Australia; [Steer, James H.; Joyce, David A.] Univ Western Australia, Pharmacol Unit, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Liu, Jianzhong; Feng, Xu] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Western Australia; University of Western Australia; University of Alabama System; University of Alabama Birmingham	Xu, JK (corresponding author), Univ Western Australia, QEII Med Ctr, Sch Surg, Mol Orthopaed Lab, 2nd Floor,M Block, Nedlands, WA 6009, Australia.	jiake.xu@uwa.edu.au	Joyce, David/H-5156-2014	Pavlos, Nathan/0000-0001-7003-188X; Xu, Jiake/0000-0003-2021-8309; /0000-0002-2151-3433; Zheng, Minghao/0000-0003-1185-4768	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Beranger GE, 2007, J BONE MINER RES, V22, P975, DOI 10.1359/JBMR.070406; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crotti TN, 2006, GENE, V372, P92, DOI 10.1016/j.gene.2005.12.012; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Forgac M, 1999, J BIOENERG BIOMEMBR, V31, P57, DOI 10.1023/A:1005496530380; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Yip KHM, 2004, J BONE MINER RES, V19, P1905, DOI 10.1359/JBMR.040919; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960	33	80	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14667	14676		10.1074/jbc.M901670200	http://dx.doi.org/10.1074/jbc.M901670200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321441	Green Published, hybrid			2022-12-25	WOS:000266286100072
J	Imamura, Y; Fujigaki, Y; Oomori, Y; Usui, S; Wang, PL				Imamura, Yasuhiro; Fujigaki, Yoshihisa; Oomori, Yuriko; Usui, Syuhei; Wang, Pao-Li			Cooperation of Salivary Protein Histatin 3 with Heat Shock Cognate Protein 70 Relative to the G(1)/S Transition in Human Gingival Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT-KINASE INHIBITOR; HISTIDINE-RICH PROTEINS; HUMAN-PAROTID SECRETION; CANDIDA-ALBICANS; NUCLEAR EXPORT; IMMUNOSUPPRESSANT DEOXYSPERGUALIN; ANTICANDIDAL ACTIVITY; MOLECULAR CHAPERONES; GROWTH-FACTOR; CELL-CYCLE	Histatins, a family of salivary proteins, have antimicrobial activity. Candida albicans, which is killed by histatins, induces oral candidiasis in individuals with compromised immune systems. Although the functional significance of histatins has been documented, their biological and physiological functions against host cells have not been clarified. In this study, we found that histatin 3, a member of the histatin family, binds to heat shock cognate protein 70 (HSC70). These proteins were co-localized in the cytoplasm and nucleus in human gingival fibroblasts following non-heat and heat shock. Histatin 3 induced stimulation of DNA synthesis and cell survival in human gingival fibroblasts in a dose-dependent manner. This DNA synthesis was found to be dependent on HSC70 by knockdown experiments. The effect of heat shock on DNA synthesis induced by histatin 3 was similar to 2-fold higher than that of non-heat shock. When the histatin 3 uptake into cells was inhibited by monodansylcadaverine or when histatin 3 binding to HSC70 was precluded by 15-deoxyspergualin, DNA synthesis by histatin 3 was similar to 2-fold less than that without monodansylcadaverine or 15-deoxyspergualin. Although HSC70 directly bound to p27(Kip1) (a cyclin-dependent kinase inhibitor), histatin 3 increased the binding between those proteins but not with a peptide capable of binding to HSC70. Moreover histatin 3 prevented ATP-dependent dissociation of HSC70-p27(Kip1). ATP was unable to form a histatin 3-HSC70(D10N)-p27(Kip1) complex (HSC70(D10N) is a mutant attenuating ATPase activity). These findings suggest that histatin 3 may be involved in cell proliferation through the regulation of HSC70 and p27(Kip1) in oral cells.	[Imamura, Yasuhiro; Wang, Pao-Li] Matsumoto Dent Univ, Dept Pharmacol, Nagano 3990781, Japan; [Fujigaki, Yoshihisa] Matsumoto Dent Univ, Dept Community Dent, Nagano 3990781, Japan; [Oomori, Yuriko] Matsumoto Dent Univ, Dept Special Patient & Oral Care, Nagano 3990781, Japan; [Usui, Syuhei] Matsumoto Dent Univ, Dept Periodontol, Nagano 3990781, Japan	Matsumoto Dental University; Matsumoto Dental University; Matsumoto Dental University; Matsumoto Dental University	Wang, PL (corresponding author), Matsumoto Dent Univ, Dept Pharmacol, 1780 Gohbara, Nagano 3990781, Japan.	ohhourei@po.mdu.ac.jp			grant-in-aid for scientific research (C)	grant-in-aid for scientific research (C)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (C).	BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Fitzgerald DH, 2003, FEMS MICROBIOL LETT, V220, P247, DOI 10.1016/S0378-1097(03)00121-6; Gusman H, 2001, FEBS LETT, V489, P97, DOI 10.1016/S0014-5793(01)02077-4; HUANG SP, 1993, J BIOL CHEM, V268, P2063; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Komi A, 1998, EXP CELL RES, V243, P408, DOI 10.1006/excr.1998.4176; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; LAL K, 1992, J ACQ IMMUN DEF SYND, V5, P904; Lamian V, 1996, EXP CELL RES, V228, P84, DOI 10.1006/excr.1996.0302; Lin YZ, 1996, J BIOL CHEM, V271, P5305, DOI 10.1074/jbc.271.10.5305; Lindhe J, 2003, CLIN PERIODONTOLOGY, P19; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Malicet C, 2006, BIOCHEM BIOPH RES CO, V339, P284, DOI 10.1016/j.bbrc.2005.11.018; MANDELL RB, 1990, J CELL BIOL, V111, P1775, DOI 10.1083/jcb.111.5.1775; MIRALSKI KL, 1989, J CELL BIOL, V108, P413; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; MURAKAMI Y, 1994, BIOCHEM BIOPH RES CO, V198, P274, DOI 10.1006/bbrc.1994.1038; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Nakamura S, 1999, BIOCHEM BIOPH RES CO, V257, P340, DOI 10.1006/bbrc.1999.0442; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; NISHIKATA M, 1991, BIOCHEM BIOPH RES CO, V174, P625, DOI 10.1016/0006-291X(91)91463-M; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Panjwani N, 1999, J IMMUNOL, V163, P1936; PERINPANAYAGAM HER, 1995, J DENT RES, V74, P345, DOI 10.1177/00220345950740011001; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RAJI PA, 1990, J BIOL CHEM, V265, P3898; RAPAPORT E, 1979, P NATL ACAD SCI USA, V76, P1643, DOI 10.1073/pnas.76.4.1643; SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Takeda S, 1996, BIOCHEMISTRY-US, V35, P4636, DOI 10.1021/bi952903o; Tenovuo J, 1998, ACTA ODONTOL SCAND, V56, P250, DOI 10.1080/000163598428400; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TROXLER RF, 1990, J DENT RES, V69, P2, DOI 10.1177/00220345900690010101; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WANG PL, 2005, DENT JPN, V41, P39; WELCH WJ, 1988, J CELL BIOL, V106, P1117, DOI 10.1083/jcb.106.4.1117; XEUWEI S, 2003, J BIOL CHEM, V278, P28553; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301; Zeise E, 1998, CELL STRESS CHAPERON, V3, P94, DOI 10.1379/1466-1268(1998)003<0094:NTOSPH>2.3.CO;2	57	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14316	14325		10.1074/jbc.M807278200	http://dx.doi.org/10.1074/jbc.M807278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321452	Green Published, hybrid			2022-12-25	WOS:000266286100038
J	Sivashanmugam, A; Wang, JJ				Sivashanmugam, Arun; Wang, Jianjun			A Unified Scheme for Initiation and Conformational Adaptation of Human Apolipoprotein E N-terminal Domain upon Lipoprotein Binding and for Receptor Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL-RECEPTOR; LIPID-BINDING; EXCHANGEABLE APOLIPOPROTEIN; APOLIPOPHORIN-III; CHEMICAL-SHIFT; PROTEIN; ASSIGNMENT; APOE; CHOLESTEROL; TRANSPORT	We report here a high-resolution NMR structure of the complete receptor-binding domain of human apolipoprotein E3 (apoE3-NT). Similar to the crystal structure of apoE-NT, the NMR structure displayed an elongated four-helix bundle. However, additional unique structural features were also observed. The segments in the N and C termini, which were missing in the crystal structure, formed alpha-helices having extensive tertiary contacts with the bundle, which oriented these short helices at specific positions for receptor binding activity. Several buried hydrophilic residues observed in the bundle were located strategically between helices 1 and 2 and between helices 3 and 4, significantly destabilizing these helix-helix interfaces. In addition, these buried hydrophilic residues formed buried H-bonds, which may play a key role in specific lipid-free helix bundle recovery. A short helix, nHelix C, was fully solvent-exposed and nearly perpendicular to the bundle. This short helix likely plays a critical role in initiating protein-lipid interaction, causing a preferred conformational adaptation of the bundle at the weaker helix-helix interfaces. This produces an open conformation with two lobes of helices, helices 1 and 4 and helices 2 and 3, which may be the competent conformation for receptor binding activity. Thus, the NMR structure suggests a unified scheme for the initiation and helix bundle opening of apoE-NT upon lipoprotein-binding and for receptor binding activity.	[Sivashanmugam, Arun; Wang, Jianjun] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Wang, JJ (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	jjwang@med.wayne.edu			National Institutes of Health [RO1 HL074365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL074365 (to J.W.).	BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fisher CA, 1999, J LIPID RES, V40, P93; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Fisher CA, 1997, BIOCHEM CELL BIOL, V75, P45, DOI 10.1139/bcb-75-1-45; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gupta V, 2006, J BIOL CHEM, V281, P39294, DOI 10.1074/jbc.M608085200; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; LALAZAR A, 1989, J BIOL CHEM, V264, P8447; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Morrow JA, 2000, J BIOL CHEM, V275, P2576, DOI 10.1074/jbc.275.4.2576; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Redmond KA, 2006, FEBS J, V273, P558, DOI 10.1111/J.1742-4658.2005.05089.X; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Segelke BW, 2000, PROTEIN SCI, V9, P886, DOI 10.1110/ps.9.5.886; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WARDELL MR, 1991, J LIPID RES, V32, P521; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu C, 2005, J BIOMOL NMR, V32, P177, DOI 10.1007/s10858-005-6729-2; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v; Zhang YH, 2008, BIOMOL NMR ASSIGN, V2, P207, DOI 10.1007/s12104-008-9122-8; Zheng Y, 2004, J BIOMOL NMR, V30, P423, DOI 10.1007/s10858-004-4345-1	39	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14657	14666		10.1074/jbc.M901012200	http://dx.doi.org/10.1074/jbc.M901012200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307174	hybrid, Green Published			2022-12-25	WOS:000266286100071
J	Kaminska, M; Havrylenko, S; Decottignies, P; Le Marechal, P; Negrutskii, B; Mirande, M				Kaminska, Monika; Havrylenko, Svitlana; Decottignies, Paulette; Le Marechal, Pierre; Negrutskii, Boris; Mirande, Marc			Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ELONGATION FACTOR-I; MACROMOLECULAR COMPLEXES; POLYPEPTIDE COMPONENTS; MAMMALIAN-CELLS; TRANSLATION; LOCALIZATION; RABBIT; SHEEP; ASSOCIATION	The localization in space and in time of proteins within the cytoplasm of eukaryotic cells is a central question of the cellular compartmentalization of metabolic pathways. The assembly of proteins within stable or transient complexes plays an essential role in this process. Here, we examined the subcellular localization of the multi-aminoacyl-tRNA synthetase complex in human cells. The sequestration of its components within the cytoplasm rests on the presence of the eukaryotic-specific polypeptide extensions that characterize the human enzymes, as compared with their prokaryotic counterparts. The cellular mobility of several synthetases, assessed by measuring fluorescence recovery after photobleaching, suggested that they are not freely diffusible within the cytoplasm. Several of these enzymes, isolated by tandem affinity purification, were copurified with ribosomal proteins and actin. The capacity of aminoacyl-tRNA synthetases to interact with polyribosomes and with the actin cytoskeleton impacts their subcellular localization and mobility. Our observations have conceptual implications for understanding how translation machinery is organized in vivo.	[Kaminska, Monika; Havrylenko, Svitlana; Mirande, Marc] CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; [Havrylenko, Svitlana; Negrutskii, Boris] Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine; [Decottignies, Paulette; Le Marechal, Pierre] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Mirande, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	Marc.Mirande@lebs.cnrs-gif.fr	Negrutskii, Boris/G-6439-2016	Negrutskii, Boris/0000-0001-5974-1629	CNRS; Association pour la Recherche sur le Cancer; La Ligue; Fondation pour la Recherche Medicale; Bourse du Gouvernement Francais	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); La Ligue; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Bourse du Gouvernement Francais	This work was supported by grants from CNRS, the Association pour la Recherche sur le Cancer, and La Ligue.; Recipient of postdoctoral fellowships from the Fondation pour la Recherche Medicale and Association pour la Recherche sur le Cancer. Present address: Institut Pasteur, Unite de Biochimie Structurale et Cellulaire, 25 Rue du Docteur Roux, 75015 Paris, France.; Recipient of a Bourse du Gouvernement Francais.	BARBARESE E, 1995, J CELL SCI, V108, P2781; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Beaulande M, 2001, FEBS LETT, V494, P170, DOI 10.1016/S0014-5793(01)02340-7; BEC G, 1989, J BIOL CHEM, V264, P21131; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; DANG CV, 1983, J CELL BIOL, V96, P1138, DOI 10.1083/jcb.96.4.1138; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KAO J, 1994, J BIOL CHEM, V269, P9774; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; LUBYPHELPS K, 1994, CURR OPIN CELL BIOL, V6, P3, DOI 10.1016/0955-0674(94)90109-0; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; PAILLIEZ JP, 1984, J BIOL CHEM, V259, P5491; POPENKO VI, 1994, EUR J CELL BIOL, V65, P60; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sanders J, 1996, J CELL SCI, V109, P1113; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stapulionis R, 1997, J BIOL CHEM, V272, P24980, DOI 10.1074/jbc.272.40.24980; Tiedge H, 1996, J NEUROSCI, V16, P7171; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; USSERY MA, 1977, EUR J BIOCHEM, V72, P491, DOI 10.1111/j.1432-1033.1977.tb11272.x	40	52	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13746	13754		10.1074/jbc.M900480200	http://dx.doi.org/10.1074/jbc.M900480200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289464	Green Published, hybrid			2022-12-25	WOS:000265877300052
J	Nalbandian, A; Yan, BS; Pichugin, A; Bronson, RT; Kramnik, I				Nalbandian, A.; Yan, B-S; Pichugin, A.; Bronson, R. T.; Kramnik, I.			Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control	ONCOGENE			English	Article						Mycobacterium tuberculosis; sst1; chronic inflammation; squamous cell carcinoma; macrophages; epiregulin	MITOSIS-SPECIFIC PHOSPHORYLATION; GROWTH-FACTOR FAMILY; PULMONARY TUBERCULOSIS; CHRONIC INFLAMMATION; HISTONE H3; CANCER; EPIREGULIN; CARCINOMA; PATHOGENESIS; TUMORS	Coexistence of pulmonary tuberculosis (TB) and lung cancer in clinic poses significant challenges for the diagnostic and treatment of both diseases. Although association of chronic inflammation and cancer is well-documented, causal relationship between TB infection and lung cancer are not understood. We present experimental evidence that chronic TB infection induces cell dysplasia and squamous cell carcinoma (SCC) in a lung-specific manner. First, squamous cell aggregates consistently appeared within the lung tissue associated with chronic TB lesions, and in some cases resembled SCCs. A transplantable tumor was established after the transfer of cells isolated from TB lung lesions into syngeneic recipients. Second, the (Mycobacterium tuberculosis) MTB-infected macrophages play a pivotal role in TB-induced carcinogenesis by inducing DNA damage in their vicinity and by the production of a potent epidermal growth factor epiregulin, which may serve as a paracrine survival and growth factor responsible for squamous metaplasia and tumorigenesis. Third, lung carcinogenesis during the course of chronic TB infection was more pronounced in animals with severe lung tissue damage mediated by TB-susceptibility locus sst1. Together, our experimental findings showed a causal link between pulmonary TB and lung tumorigenesis and established a genetic model for further analysis of carcinogenic mechanisms activated by TB infection.	[Nalbandian, A.; Yan, B-S; Pichugin, A.; Kramnik, I.] Harvard Univ, Sch Med, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Yan, B-S] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Bronson, R. T.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; National Yang Ming Chiao Tung University; Harvard University; Harvard Medical School	Kramnik, I (corresponding author), Harvard Univ, Sch Med, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ikramnik@hsph.harvard.edu		Yan, Bo-Shiun/0000-0002-9613-4788; Pichugin, Alexander/0000-0002-2577-7284; Kramnik, Igor/0000-0001-6511-9246	NHLBI NIH HHS [R01 HL059836] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059836] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ardies C Murray, 2003, Integr Cancer Ther, V2, P238, DOI 10.1177/1534735403256332; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Baba I, 2000, CANCER RES, V60, P6886; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; CAGLE PT, 1985, CANCER, V56, P2031, DOI 10.1002/1097-0142(19851015)56:8<2031::AID-CNCR2820560824>3.0.CO;2-K; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dacosta N A, 1991, J Postgrad Med, V37, P185; Dalgleish AG, 2002, ADV CANCER RES, V84, P231, DOI 10.1016/S0065-230X(02)84008-8; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; GOPALAKRISHNAN P, 1975, AM SURGEON, V41, P405; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Inagaki N, 1997, J BIOL CHEM, V272, P25195, DOI 10.1074/jbc.272.40.25195; Jin DY, 2007, FRONT BIOSCI-LANDMRK, V12, P222, DOI 10.2741/2060; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Klein G, 2005, IMMUNOL LETT, V100, P29, DOI 10.1016/j.imlet.2005.06.024; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Kurasawa T, 1998, Nihon Rinsho, V56, P3167; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lawrence T, 2007, TRENDS PHARMACOL SCI, V28, P162, DOI 10.1016/j.tips.2007.02.003; Lee D, 2004, MOL CELL BIOL, V24, P8907, DOI 10.1128/MCB.24.20.8907-8916.2004; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Moutsopoulos NM, 2008, CURR OPIN IMMUNOL, V20, P234, DOI 10.1016/j.coi.2008.04.003; Naito Y, 2002, FREE RADICAL BIO MED, V33, P323, DOI 10.1016/S0891-5849(02)00868-7; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nussenzweig A, 2006, NATURE, V439, P406, DOI 10.1038/439406a; Oka K, 2005, ACTA BIOCHIM POL, V52, P311; Pastore S, 2006, EUR J DERMATOL, V16, P125; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sakuraba Motoki, 2006, Ann Thorac Cardiovasc Surg, V12, P53; SAKURAI R, 1989, JPN J MED, V28, P471; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Shirasawa S, 2004, P NATL ACAD SCI USA, V101, P13921, DOI 10.1073/pnas.0404217101; Takahashi M, 2003, CIRCULATION, V108, P2524, DOI 10.1161/01.CIR.0000096482.02567.8C; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; TING YM, 1976, RADIOLOGY, V119, P307, DOI 10.1148/119.2.307; Toyoda H, 1997, BIOCHEM J, V326, P69, DOI 10.1042/bj3260069; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang Y, 2004, CANCER RES, V64, P1647, DOI 10.1158/0008-5472.CAN-03-3273	48	84	96	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2009	28	17					1928	1938		10.1038/onc.2009.32	http://dx.doi.org/10.1038/onc.2009.32			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PX	19330024				2022-12-25	WOS:000265640600005
J	Sutherland, GT; Matigian, NA; Chalk, AM; Anderson, MJ; Silburn, PA; Mackay-Sim, A; Wells, CA; Mellick, GD				Sutherland, Greg T.; Matigian, Nicholas A.; Chalk, Alistair M.; Anderson, Matthew J.; Silburn, Peter A.; Mackay-Sim, Alan; Wells, Christine A.; Mellick, George D.			A Cross-Study Transcriptional Analysis of Parkinson's Disease	PLOS ONE			English	Article								The study of Parkinson's disease (PD), like other complex neurodegenerative disorders, is limited by access to brain tissue from patients with a confirmed diagnosis. Alternatively the study of peripheral tissues may offer some insight into the molecular basis of disease susceptibility and progression, but this approach still relies on brain tissue to benchmark relevant molecular changes against. Several studies have reported whole-genome expression profiling in post-mortem brain but reported concordance between these analyses is lacking. Here we apply a standardised pathway analysis to seven independent case-control studies, and demonstrate increased concordance between data sets. Moreover data convergence increased when the analysis was limited to the five substantia nigra (SN) data sets; this highlighted the down regulation of dopamine receptor signaling and insulin-like growth factor 1 (IGF1) signaling pathways. We also show that case-control comparisons of affected post mortem brain tissue are more likely to reflect terminal cytoarchitectural differences rather than primary pathogenic mechanisms. The implementation of a correction factor for dopaminergic neuronal loss predictably resulted in the loss of significance of the dopamine signaling pathway while axon guidance pathways increased in significance. Interestingly the IGF1 signaling pathway was also over-represented when data from non-SN areas, unaffected or only terminally affected in PD, were considered. Our findings suggest that there is greater concordance in PD whole-genome expression profiling when standardised pathway membership rather than ranked gene list is used for comparison.	[Sutherland, Greg T.; Matigian, Nicholas A.; Chalk, Alistair M.; Anderson, Matthew J.; Silburn, Peter A.; Mackay-Sim, Alan; Wells, Christine A.; Mellick, George D.] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Silburn, Peter A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Mellick, George D.] Princess Alexandra Hosp, Dept Neurol, Brisbane, Qld, Australia; [Mellick, George D.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia	Griffith University; University of Queensland; Royal Brisbane & Women's Hospital	Mellick, GD (corresponding author), Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.	g.mellick@griffith.edu.au	Mellick, George D./A-7650-2010; Wells, Christine A/A-5071-2010; Matigian, Nicholas A/A-4935-2009; Chalk, Alistair/O-3522-2019; Sutherland, Greg T/C-8674-2015; Matigian, Nicholas/AAF-9390-2020; Mackay-Sim, Alan/C-3431-2008; Sutherland, Greg/Q-5582-2019; Silburn, Peter A/A-3614-2011	Mellick, George D./0000-0002-7211-4651; Wells, Christine A/0000-0003-3133-3628; Matigian, Nicholas A/0000-0001-7735-9415; Chalk, Alistair/0000-0002-9630-6236; Sutherland, Greg T/0000-0003-2493-9736; Matigian, Nicholas/0000-0001-7735-9415; Mackay-Sim, Alan/0000-0003-4446-5371; Sutherland, Greg/0000-0003-2493-9736; 	Australian Federal Government Department of Health and Ageing; Queensland State Government Smartstate Programme; National Health and Medical	Australian Federal Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Queensland State Government Smartstate Programme; National Health and Medical	The authors kindly acknowledge funding provided by the Australian Federal Government Department of Health and Ageing (AMS), the Queensland State Government Smartstate Programme (CAW, AMS), National Health and Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Barcia C, 2005, J NEURAL TRANSM, V112, P1237, DOI 10.1007/s00702-004-0256-2; Beckert S, 2006, BIOCHEM BIOPH RES CO, V341, P67, DOI 10.1016/j.bbrc.2005.12.148; BOSSERS K, 2008, BRAIN PATHOL; Braak H, 2006, J NEURAL TRANSM-SUPP, P89; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Comella CL, 2007, MOVEMENT DISORD, V22, pS367, DOI 10.1002/mds.21682; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GIBB WRG, 1991, EUR NEUROL, V31, P48, DOI 10.1159/000116721; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hawkes C, 2006, ADV OTO-RHINO-LARYNG, V63, P133, DOI 10.1159/000093759; Hubbard PS, 2007, J ANAT, V211, P117, DOI 10.1111/j.1469-7580.2007.00748.x; Hughes AJ, 1997, EUR NEUROL, V38, P13, DOI 10.1159/000113471; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hwang KB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-159; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalaitzakis ME, 2008, ACTA NEUROPATHOL, V116, P125, DOI 10.1007/s00401-008-0381-3; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Marcotte ER, 2003, PHARMACOL THERAPEUT, V100, P63, DOI 10.1016/S0163-7258(03)00086-X; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Miele C, 2000, J BIOL CHEM, V275, P21695, DOI 10.1074/jbc.M000805200; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miller RM, 2005, NEUROSCIENTIST, V11, P539, DOI 10.1177/1073858405278330; Mirza B, 2000, NEUROSCIENCE, V95, P425; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; MURRELL W, 2008, STEM CELLS; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Preece P, 2003, MOL BRAIN RES, V116, P7, DOI 10.1016/S0169-328X(03)00208-0; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Rezak M, 2007, DM-DIS MON, V53, P259, DOI 10.1016/j.disamonth.2007.02.003; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Sutherland G, 2008, AM J MED GENET B, V147B, P495, DOI 10.1002/ajmg.b.30633; Vogt IR, 2006, EXP NEUROL, V199, P465, DOI 10.1016/j.expneurol.2006.01.008; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Ziemssen T, 2007, PARKINSONISM RELAT D, V13, P323, DOI 10.1016/j.parkreldis.2006.12.014	51	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4955	10.1371/journal.pone.0004955	http://dx.doi.org/10.1371/journal.pone.0004955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305504	Green Submitted, Green Published, gold			2022-12-25	WOS:000265498800008
J	Guo, TQ; Jou, W; Chanturiya, T; Portas, J; Gavrilova, O; McPherron, AC				Guo, Tingqing; Jou, William; Chanturiya, Tatyana; Portas, Jennifer; Gavrilova, Oksana; McPherron, Alexandra C.			Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity	PLOS ONE			English	Article								Myostatin (Mstn) is a secreted growth factor expressed in skeletal muscle and adipose tissue that negatively regulates skeletal muscle mass. Mstn(-/-) mice have a dramatic increase in muscle mass, reduction in fat mass, and resistance to diet-induced and genetic obesity. To determine how Mstn deletion causes reduced adiposity and resistance to obesity, we analyzed substrate utilization and insulin sensitivity in Mstn(-/-) mice fed a standard chow. Despite reduced lipid oxidation in skeletal muscle, Mstn(-/-) mice had no change in the rate of whole body lipid oxidation. In contrast, Mstn(-/-) mice had increased glucose utilization and insulin sensitivity as measured by indirect calorimetry, glucose and insulin tolerance tests, and hyperinsulinemic-euglycemic clamp. To determine whether these metabolic effects were due primarily to the loss of myostatin signaling in muscle or adipose tissue, we compared two transgenic mouse lines carrying a dominant negative activin IIB receptor expressed specifically in adipocytes or skeletal muscle. We found that inhibition of myostatin signaling in adipose tissue had no effect on body composition, weight gain, or glucose and insulin tolerance in mice fed a standard diet or a high-fat diet. In contrast, inhibition of myostatin signaling in skeletal muscle, like Mstn deletion, resulted in increased lean mass, decreased fat mass, improved glucose metabolism on standard and high-fat diets, and resistance to diet-induced obesity. Our results demonstrate that Mstn(-/-) mice have an increase in insulin sensitivity and glucose uptake, and that the reduction in adipose tissue mass in Mstn(-/-) mice is an indirect result of metabolic changes in skeletal muscle. These data suggest that increasing muscle mass by administration of myostatin antagonists may be a promising therapeutic target for treating patients with obesity or diabetes.	[Guo, Tingqing; Portas, Jennifer; McPherron, Alexandra C.] NIDDK, Genet Dev & Dis Branch, Natl Inst Hlth, Bethesda, MD USA; [Jou, William; Chanturiya, Tatyana; Gavrilova, Oksana] NIDDK, Mouse Metabol Core Lab, Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Guo, TQ (corresponding author), NIDDK, Genet Dev & Dis Branch, Natl Inst Hlth, Bethesda, MD USA.	mcpherrona@niddk.nih.gov		McPherron, Alexandra/0000-0002-5875-9154	Intramural Research Program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056022, Z01DK056020, Z01DK056022, Z01DK070002, ZIADK056020, ZICDK070002] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by the Intramural Research Program of the NIH, NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kim HS, 2001, BIOCHEM BIOPH RES CO, V281, P902, DOI 10.1006/bbrc.2001.4435; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mitchell MD, 2006, J CLIN ENDOCR METAB, V91, P1434, DOI 10.1210/jc.2005-2361; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Stolz LE, 2008, DIABETES OBES METAB, V10, P135, DOI 10.1111/j.1463-1326.2006.00672.x; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	49	271	293	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4937	10.1371/journal.pone.0004937	http://dx.doi.org/10.1371/journal.pone.0004937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295913	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496700010
J	Huang, K; Sanders, S; Singaraja, R; Orban, P; Cijsouw, T; Arstikaitis, P; Yanai, A; Hayden, MR; El-Husseini, A				Huang, Kun; Sanders, Shaun; Singaraja, Roshni; Orban, Paul; Cijsouw, Tony; Arstikaitis, Pamela; Yanai, Anat; Hayden, Michael R.; El-Husseini, Alaa			Neuronal palmitoyl acyl transferases exhibit distinct substrate specificity	FASEB JOURNAL			English	Article						acyl-biotin exchange; DHHC proteins; HIP14; HIP14L; huntingtin; SNAP25	HUNTINGTIN-INTERACTING PROTEIN-14; GABA(A) RECEPTORS; TRAFFICKING; DOMAIN; YEAST; IDENTIFICATION; EXPRESSION; SUBUNIT; PSD-95; HIP14	Palmitoylation, a post-translational modification of cysteine residues with the lipid palmitate, has recently emerged as an important mechanism for regulating protein trafficking and function. With the identification of 23 DHHC mammalian palmitoyl acyl transferases (PATs), a key question was the nature of substrate-enzyme specificity for these PATs. Using the acyl-biotin exchange palmitoylation assay, we compared the substrate specificity of four neuronal PATs, namely DHHC-3, DHHC-8, HIP14L (DHHC-13), and HIP14 (DHHC-17). Exogenous expression of enzymes and substrates in COS cells reveals that HIP14L and HIP14 modulate huntingtin palmitoylation, DHHC-8 modulates paralemmin-1 palmitoylation, and DHHC-3 shows the least substrate specificity. These in vitro data were validated by lentiviral siRNA- mediated knockdown of endogenous HIP14 and DHHC-3 in cultured rat cortical neurons. PATs require the presence of palmitoylated cysteines in order to interact with their substrates. To understand the elements that influence enzyme/substrate specificity further, we fused the HIP14 ankryin repeat domain to the N terminus of DHHC-3, which is not a PAT for huntingtin. This modification enabled DHHC-3 to behave similarly to HIP14 by modulating palmitoylation and trafficking of huntingtin. Taken together, this study indicates that individual PATs have specific substrate preference, determined by regulatory domains outside the DHHC domain of the enzymes.-Huang, K., Sanders, S., Singaraja, R., Orban, P., Cijsouw, T., Arstikaitis, P., Yanai, A., Hayden, M. R., El-Husseini, A. Neuronal palmitoyl acyl transferases exhibit distinct substrate specificity. FASEB J. 23, 2605-2615 ( 2009)	[Huang, Kun; Sanders, Shaun; Singaraja, Roshni; Orban, Paul; Yanai, Anat; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Arstikaitis, Pamela; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 4H4, Canada; [Cijsouw, Tony] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Hayden, Michael R.] British Columbia Childrens Hosp, Children & Family Res Inst, Vancouver, BC V6H 3V4, Canada	University of British Columbia; University of British Columbia; Vrije Universiteit Amsterdam; BC Childrens Hospital; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; Cijsouw, Anthony/B-8309-2008	Hayden, Michael R/0000-0001-5159-1419; Cijsouw, Anthony/0000-0002-3670-7863; Yanai, Anat/0000-0002-0792-6901; Singaraja, Roshni/0000-0002-3418-3867	Canadian Institutes for Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); High Q Foundation; MSFHR senior scholar; Heart and Stroke Foundation; Huntington Society of Canada; U. S. National Institutes of Health	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); High Q Foundation; MSFHR senior scholar(Michael Smith Foundation for Health Research); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Huntington Society of Canada; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This manuscript is dedicated to the memory of our dear colleague and mentor Dr. Alaa El-Hussseini, who tragically died during the completion of the work for this manuscript. We thank Esther Yu for her excellent technical assistance. This work was supported by grants to A. E. H. from the Canadian Institutes for Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), and the High Q Foundation. A. E. H. was an MSFHR senior scholar. M. R. H. is Canada Research Chair in Human Genetics and Molecular Medicine and is supported by CIHR, MSFHR, the High Q Foundation, the Heart and Stroke Foundation, the Huntington Society of Canada, and the U. S. National Institutes of Health.	Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Faul T, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-35; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kang RJ, 2004, J BIOL CHEM, V279, P50524, DOI 10.1074/jbc.M404981200; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Santamaria J, 2009, J NEUROSCI RES, V87, P532, DOI 10.1002/jnr.21866; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	36	119	125	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2605	2615		10.1096/fj.08-127399	http://dx.doi.org/10.1096/fj.08-127399			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19299482	Green Published			2022-12-25	WOS:000268836700029
J	MacDougall, DA; Wachten, S; Ciruela, A; Sinz, A; Cooper, DMF				MacDougall, David A.; Wachten, Sebastian; Ciruela, Antonio; Sinz, Andrea; Cooper, Dermot M. F.			Separate Elements within a Single IQ-like Motif in Adenylyl Cyclase Type 8 Impart Ca2+/Calmodulin Binding and Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; TARGET RECOGNITION; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; CALCIUM-ENTRY; INTACT-CELLS; CYCLIC-AMP; CALMODULIN; MECHANISMS; CHANNELS	The ubiquitous Ca2+-sensing protein calmodulin (CaM) fulfills its numerous signaling functions through a wide range of modular binding and activation mechanisms. By activating adenylyl cyclases (ACs) 1 and 8, Ca2+ acting via calmodulin impacts on the signaling of the other major cellular second messenger cAMP. In possessing two CaM-binding domains, a 1-5-8-14 motif at the N terminus and an IQ-like motif (IQlm) at the C terminus, AC8 offers particularly sophisticated regulatory possibilities. The IQlm has remained unexplored beyond the suggestion that it bound CaM, and the larger C2b region of which it is part was involved in the relief of autoinhibition of AC8. Here we attempt to distinguish the function of individual residues of the IQlm. From a complementary approach of in vitro and cell population AC activity assays, as well as CaM binding, we propose that the IQlm alone, and not the majority of the C2b, imparts CaM binding and autoinhibitory functions. Moreover, this duality of function is spatially separated and depends on amino acid side-chain character. Accordingly, residues critical for CaM binding are positively charged and clustered toward the C terminus, and those essential for the maintenance of autoinhibition are hydrophobic and more N-terminal. Secondary structure prediction of the IQlm supports this separation, with an ideally placed break in the alpha-helical nature of the sequence. We additionally find that the N and C termini of AC8 interact, which is an association specifically abrogated by fully Ca2+-bound, but not Ca2+-free, CaM. These data support a sophisticated activation mechanism of AC8 by CaM, in which the duality of the IQlm function is critical.	[MacDougall, David A.; Wachten, Sebastian; Ciruela, Antonio; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Saale, Germany	University of Cambridge; Martin Luther University Halle Wittenberg	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk		MacDougall, David/0000-0003-1811-288X	Wellcome Trust [RG31760]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant RG31760.	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COOPER DMF, 1994, METHOD ENZYMOL, V238, P71; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ihling C, 2006, J AM SOC MASS SPECTR, V17, P1100, DOI 10.1016/j.jasms.2006.04.020; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Masada N, 2009, J BIOL CHEM, V284, P4451, DOI 10.1074/jbc.M807359200; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135	48	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15573	15588		10.1074/jbc.M809585200	http://dx.doi.org/10.1074/jbc.M809585200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19305019	Green Published			2022-12-25	WOS:000266501000026
J	Berti, DA; Morano, C; Russo, LC; Castro, LM; Cunha, FM; Zhang, X; Sironi, J; Klitzke, CF; Ferro, ES; Fricker, LD				Berti, Denise A.; Morano, Cain; Russo, Lilian C.; Castro, Leandro M.; Cunha, Fernanda M.; Zhang, Xin; Sironi, Juan; Klitzke, Clecio F.; Ferro, Emer S.; Fricker, Lloyd D.			Analysis of Intracellular Substrates and Products of Thimet Oligopeptidase in Human Embryonic Kidney 293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANGIOTENSIN-CONVERTING ENZYME; ENDOPEPTIDASE EC 3.4.24.15; ANTIGEN PRESENTATION; RAT-BRAIN; SOLUBLE METALLOENDOPEPTIDASE; QUANTITATIVE PEPTIDOMICS; DEGRADATION-PRODUCTS; PROTEIN-DEGRADATION; NATURAL REGULATORS	Thimet oligopeptidase (EC 3.4.24.15; EP24.15) is an intracellular enzyme that has been proposed to metabolize peptides within cells, thereby affecting antigen presentation and G protein-coupled receptor signal transduction. However, only a small number of intracellular substrates of EP24.15 have been reported previously. Here we have identified over 100 peptides in human embryonic kidney 293 (HEK293) cells that are derived from intracellular proteins; many but not all of these peptides are substrates or products of EP24.15. First, cellular peptides were extracted from HEK293 cells and incubated in vitro with purified EP24.15. Then the peptides were labeled with isotopic tags and analyzed by mass spectrometry to obtain quantitative data on the extent of cleavage. A related series of experiments tested the effect of overexpression of EP24.15 on the cellular levels of peptides in HEK293 cells. Finally, synthetic peptides that corresponded to 10 of the cellular peptides were incubated with purified EP24.15 in vitro, and the cleavage was monitored by high pressure liquid chromatography and mass spectrometry. Many of the EP24.15 substrates identified by these approaches are 9-11 amino acids in length, supporting the proposal that EP24.15 can function in the degradation of peptides that could be used for antigen presentation. However, EP24.15 also converts some peptides into products that are 8-10 amino acids, thus contributing to the formation of peptides for antigen presentation. In addition, the intracellular peptides described here are potential candidates to regulate protein interactions within cells.	[Berti, Denise A.; Castro, Leandro M.; Cunha, Fernanda M.; Ferro, Emer S.] Univ Sao Paulo, Dept Dev & Cell Biol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; [Russo, Lilian C.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; [Klitzke, Clecio F.] Butantan Inst, CAT CEPID, Ctr Appl Toxicol, BR-05503900 Sao Paulo, Brazil; [Morano, Cain; Zhang, Xin; Sironi, Juan; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan; Yeshiva University; Albert Einstein College of Medicine	Ferro, ES (corresponding author), Univ Sao Paulo, Dept Dev & Cell Biol, Inst Biomed Sci, Av Lineu Prestes 1524,Sala 435, BR-05508900 Sao Paulo, Brazil.	eferro@usp.br; fricker@aecom.yu.edu	da Cunha, Fernanda M/G-3575-2012; Castro, Leandro M/E-5654-2014; Castro, Leandro/ABI-5520-2020; Russo, Lilian Cristina/O-7838-2014; Klitzke, Clecio Fernando/A-8920-2010; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; Ferro, Emer S/D-3908-2012; Castro, Leandro/O-6762-2019	da Cunha, Fernanda M/0000-0002-1583-5380; Castro, Leandro/0000-0002-7156-2006; Russo, Lilian Cristina/0000-0002-9846-1352; Klitzke, Clecio Fernando/0000-0001-5973-6088; Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006	National Institutes of Health [DK-51271, DA-04494]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/04933-2, 04/14846-0]; Financiadora de Estudos e Projetos [A-03/134]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Pesquisa; Instituto UNIEMP; Pro-reitoria de Posgraduacao, Universidade de Sao Paulo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa; Instituto UNIEMP; Pro-reitoria de Posgraduacao, Universidade de Sao Paulo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DK-51271 and DA-04494 (to L. D. F.). This work was also supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 04/04933-2 and 04/14846-0 (to E. S. F.), Financiadora de Estudos e Projetos A-03/134 (to E. S. F.), and fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to D. A. B.), Conselho Nacional de Pesquisa (to F. M. C. and E. S. F.), Instituto UNIEMP (to C. F. K.), and Pro-reitoria de Posgraduacao, Universidade de Sao Paulo (to L. D. F.).	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt I, 2005, PEPTIDES, V26, P2536, DOI 10.1016/j.peptides.2005.05.016; Brent R, 2006, NATURE, V440, P416, DOI 10.1038/440416a; Bruce LA, 2008, FEBS J, V275, P5607, DOI 10.1111/j.1742-4658.2008.06685.x; Carreno FR, 2005, J NEUROCHEM, V93, P10, DOI 10.1111/j.1471-4159.2004.02967.x; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2006, J MOL NEUROSCI, V28, P265, DOI 10.1385/JMN:28:3:265; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Che FY, 2005, J MASS SPECTROM, V40, P238, DOI 10.1002/jms.743; CHU TG, 1984, BIOCHEMISTRY-US, V23, P3598, DOI 10.1021/bi00311a005; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Cohen BA, 1998, P NATL ACAD SCI USA, V95, P14272, DOI 10.1073/pnas.95.24.14272; Colas P, 2000, P NATL ACAD SCI USA, V97, P13720, DOI 10.1073/pnas.97.25.13720; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DANDO PM, 1993, BIOCHEM J, V294, P451, DOI 10.1042/bj2940451; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; GRASSO G, 2009, J MASS SPEC IN PRESS; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Heimann AS, 2005, PHYSIOL GENOMICS, V20, P173, DOI 10.1152/physiolgenomics.00145.2004; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Kessler BM, 2002, MOL IMMUNOL, V39, P171, DOI 10.1016/S0161-5890(02)00100-1; Kim SI, 2003, J NEUROSCI RES, V74, P456, DOI 10.1002/jnr.10779; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; KNIGHT CG, 1995, BIOCHEM J, V308, P145, DOI 10.1042/bj3080145; Lecker SH, 2002, J PHYSIOL-LONDON, V545, P729, DOI 10.1113/jphysiol.2002.030429; Lim J, 2006, J NEUROCHEM, V96, P1169, DOI 10.1111/j.1471-4159.2005.03614.x; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Machado MFM, 2006, BIOCHEM BIOPH RES CO, V339, P520, DOI 10.1016/j.bbrc.2005.11.041; Montiel JL, 1997, J NEUROCHEM, V68, P354; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; Oliveira V, 2001, ANAL BIOCHEM, V292, P257, DOI 10.1006/abio.2001.5083; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; ORLOWSKI M, 1989, BIOCHEM J, V261, P951, DOI 10.1042/bj2610951; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251; Rammensee HG, 2002, NATURE, V419, P443, DOI 10.1038/419443a; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Shrimpton CN, 2000, BIOCHEM J, V345, P351, DOI 10.1042/0264-6021:3450351; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Yang XD, 1998, PHARMACEUT RES, V15, P1480, DOI 10.1023/A:1011926310666; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w	72	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14105	14116		10.1074/jbc.M807916200	http://dx.doi.org/10.1074/jbc.M807916200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19282285	Green Published, hybrid			2022-12-25	WOS:000266286100017
J	Mahmood, NABN; Biemans-Oldehinkel, E; Poolman, B				Mahmood, Nik A. B. N.; Biemans-Oldehinkel, Esther; Poolman, Bert			Engineering of Ion Sensing by the Cystathionine beta-Synthase Module of the ABC Transporter OpuA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBS DOMAIN PROTEIN; CRYSTAL-STRUCTURE; TEMPERATURE-DEPENDENCE; PHOSPHATIDIC-ACID; ESCHERICHIA-COLI; MG2+ TRANSPORTER; GLYCINE BETAINE; MEMBRANE; MECHANISM; CHANNEL	We have previously shown that the C-terminal cystathionine beta-synthase (CBS) domains of the nucleotide-binding domains of the ABC transporter OpuA, in conjunction with an anionic membrane surface function, act as sensor of internal ionic strength (I-in). Here, we show that a surface-exposed cationic region in the CBS module domain is critical for ion sensing. The consecutive substitution of up to five cationic residues led to a gradual decrease of the ionic strength dependence of transport. In fact, a 5-fold mutant was essentially independent of salt in the range from 0 to 250 mM KCl (or NaCl), supplemented to medium of 30 mM potassium phosphate. Importantly, the threshold temperature for transport was lowered by 5-7 degrees C and the temperature coefficient Q(10) was lowered from 8 to similar to 1.5 in the 5-fold mutant, indicating that large conformational changes are accompanying the CBS-mediated regulation of transport. Furthermore, by replacing the anionic C-terminal tail residues that extend the CBS module with histidines, the transport of OpuA became pH-dependent, presumably by additional charge interactions of the histidine residues with the membrane. The pH dependence was not observed at high ionic strength. Altogether the analyses of the CBS mutants support the notion that the osmotic regulation of OpuA involves a simple biophysical switching mechanism, in which nonspecific electrostatic interactions of a protein module with the membrane are sufficient to lock the transporter in the inactive state.	[Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Poolman, B (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Poolman, Bert/D-1882-2012		NWO-CW [700-50-302, 700-56-302]; Netherlands Proteomics Centre; European Union [504601]	NWO-CW(Netherlands Organization for Scientific Research (NWO)); Netherlands Proteomics Centre; European Union(European Commission)	This work was supported by "Top-subsidie" NWO-CW Grants 700-50-302 and 700-56-302 and funds from the Netherlands Proteomics Centre and European Union E-MeP (504601) programs.	Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MEIJER S, 2006, STRUCTURE, V14, P199; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; POOLMAN B, 2009, MICROBIOL M IN PRESS; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Ptak CP, 2005, BIOCHEMISTRY-US, V44, P62, DOI 10.1021/bi048390f; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Ragunathan P, 2008, BIOCHEM BIOPH RES CO, V375, P124, DOI 10.1016/j.bbrc.2008.07.140; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	32	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14368	14376		10.1074/jbc.M901238200	http://dx.doi.org/10.1074/jbc.M901238200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329426	Green Published, hybrid			2022-12-25	WOS:000266286100043
J	Olmos, Y; Valle, I; Borniquel, S; Tierrez, A; Soria, E; Lamas, S; Monsalve, M				Olmos, Yolanda; Valle, Inmaculada; Borniquel, Sara; Tierrez, Alberto; Soria, Estrella; Lamas, Santiago; Monsalve, Maria			Mutual Dependence of Foxo3a and PGC-1 alpha in the Induction of Oxidative Stress Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ENDOTHELIAL-CELLS; FORKHEAD PROTEINS; ACTIVATION; EXPRESSION; DYSFUNCTION; REGULATOR; NEURODEGENERATION; ANGIOGENESIS; INVOLVEMENT	Oxidative stress is a hallmark of metabolism-related diseases and a risk factor for atherosclerosis. FoxO factors have been shown to play a key role in vascular endothelial development and homeostasis. Foxo3a can protect quiescent cells from oxidative stress through the regulation of detoxification genes such as sod2 and catalase. Here we show that Foxo3a is a direct transcriptional regulator of a group of oxidative stress protection genes in vascular endothelial cells. Importantly, Foxo3a activity requires the transcriptional co-activator PGC-1 alpha, because it is severely curtailed in PGC-1 alpha-deficient endothelial cells. Foxo3a and PGC-1 alpha appear to interact directly, as shown by co-immunoprecipitation and in vitro interaction assays, and are recruited to the same promoter regions. The notion that Foxo3a and PGC-1 alpha interact directly to regulate oxidative stress protection genes in the vascular endothelium is supported by the observation that PGC-1 alpha transcriptional activity at the sod2 ( manganese superoxide dismutase) promoter requires a functional FoxO site. We also demonstrate that Foxo3a is a direct transcriptional regulator of PGC-1 alpha, suggesting that an auto-regulatory cycle regulates Foxo3a/PGC-1 alpha control of the oxidative stress response.	[Olmos, Yolanda; Valle, Inmaculada; Borniquel, Sara; Tierrez, Alberto; Monsalve, Maria] Fdn Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain; [Soria, Estrella; Lamas, Santiago] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Soria, Estrella; Lamas, Santiago] CSIC Friat Fisiopatol Vasc & Renal, Lab Mixto, Madrid 28040, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC)	Monsalve, M (corresponding author), Ctr Nacl Invest Cardiovasc, Melchor Fernandez Almagro 3,Rm S3M, Madrid 28029, Spain.	mmonsalve@cnic.es	Monsalve, Maria/K-4416-2014; Olmos, Yolanda/AAX-6661-2021; Lamas, Santiago/G-7308-2015	Monsalve, Maria/0000-0003-2796-1453; Olmos, Yolanda/0000-0002-5952-1607; Lamas, Santiago/0000-0001-5166-4155	Ministerio de Educacion y Ciencia [2007-00020, SAF2006-02410]; Spanish Society of Nephrology; Spanish Ministry of Health and Consumer Affairs; Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation	Ministerio de Educacion y Ciencia(Spanish Government); Spanish Society of Nephrology; Spanish Ministry of Health and Consumer Affairs(Spanish Government); Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation	This work was supported in part by Grant SAF2006-01619 from the Plan Nacional de I+D+I of the Ministerio de Educacion y Ciencia (to M. M.), Grant CSD 2007-00020 from the Ministerio de Educacion y Ciencia (to M. M. and S. L.), and Grant SAF2006-02410 from the Ministerio de Educacion y Ciencia and a grant-in-aid from the Spanish Society of Nephrology (to S. L.). The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Health and Consumer Affairs and the Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Balakumar P, 2008, TOXICOLOGY, V245, P49, DOI 10.1016/j.tox.2007.12.011; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Monsalve M, 2007, FRONT BIOSCI-LANDMRK, V12, P1131, DOI 10.2741/2132; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munoz C, 1996, J IMMUNOL, V157, P3587; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rangwala SM, 2007, BIOCHEM BIOPH RES CO, V357, P231, DOI 10.1016/j.bbrc.2007.03.126; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sano M, 2005, CELL METAB, V1, P216, DOI 10.1016/j.cmet.2005.03.009; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wersto RP, 1996, P NATL ACAD SCI USA, V93, P1167, DOI 10.1073/pnas.93.3.1167; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	39	163	169	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14476	14484		10.1074/jbc.M807397200	http://dx.doi.org/10.1074/jbc.M807397200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324885	Green Published, hybrid			2022-12-25	WOS:000266286100054
J	Mou, ZM; Tapper, AR; Gardner, PD				Mou, Zhongming; Tapper, Andrew R.; Gardner, Paul D.			The Armadillo Repeat-containing Protein, ARMCX3, Physically and Functionally Interacts with the Developmental Regulatory Factor Sox10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; ACETYLCHOLINE-RECEPTOR GENES; TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; SEGMENT POLARITY GENE; MOBILITY-GROUP DOMAIN; 4 SUBUNIT GENE; HIRSCHSPRUNG-DISEASE; BETA-CATENIN; MOUSE MODEL	Sox10 is a member of the group E Sox transcription factor family and plays key roles in neural crest development and subsequent cellular differentiation. Sox10 binds to regulatory sequences in target genes via its conserved high mobility group domain. In most cases, Sox10 exerts its transcriptional effects in concert with other DNA-binding factors, adaptor proteins, and nuclear import proteins. These interactions can lead to synergistic gene activation and can be cell type-specific. In earlier work, we demonstrated that Sox10 transactivates the nicotinic acetylcholine receptor alpha 3 and beta 4 subunit genes and does so only in neuronal-like cell lines, raising the possibility that Sox10 mediates its effects via interactions with co-regulatory factors. Here we describe the identification of the armadillo repeat-containing protein, ARMCX3, as a Sox10-interacting protein. Biochemical analyses indicate that ARMCX3 is an integral membrane protein of the mitochondrial outer membrane. Others have shown that Sox10 is a nucleocytoplasmic shuttling protein. We extend this observation and demonstrate that, in the cytoplasm, Sox10 is peripherally associated with the mitochondrial outer membrane. Both Sox10 and ARMCX3 are expressed in mouse brain and spinal cord as well as several cell lines. Over-expression of ARMCX3 increased the amount of mitochondrially associated Sox10. In addition, although ARMCX3 does not possess intrinsic transcriptional activity, it does enhance transactivation of the nicotinic acetylcholine receptor alpha 3 and beta 4 subunit gene promoters by Sox10. These results suggest that Sox10 is a membrane-associated factor whose transcriptional function is increased by direct interactions with ARMCX3 and raise the possibility of a signal transduction cascade between the nucleus and mitochondria through Sox10/ARMCX3 interactions.	[Mou, Zhongming; Tapper, Andrew R.; Gardner, Paul D.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01064 USA	University of Massachusetts System; University of Massachusetts Worcester	Gardner, PD (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, 303 Belmont St, Worcester, MA 01064 USA.	paul.gardner@umassmed.edu			National Institutes of Health [R01NS030243]; Philip Morris USA Inc; Philip Morris International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc; Philip Morris International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS030243 (to P. D. G.) from NINDS. This work was also supported by a grant from Philip Morris USA Inc. and Philip Morris International to (P. D. G.).	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Du Q, 1997, J BIOL CHEM, V272, P14990, DOI 10.1074/jbc.272.23.14990; Elworthy S, 2005, MECH DEVELOP, V122, P659, DOI 10.1016/j.mod.2004.12.008; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Medel YFF, 2007, J BIOL CHEM, V282, P19062, DOI 10.1074/jbc.M702354200; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Girard M, 2006, FEBS LETT, V580, P1635, DOI 10.1016/j.febslet.2006.02.011; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; HU MJ, 1994, J NEUROCHEM, V62, P392; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kurochkin IV, 2001, BIOCHEM BIOPH RES CO, V280, P340, DOI 10.1006/bbrc.2000.4125; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Liu Q, 1999, J NEUROSCI, V19, P9747; Maka M, 2005, DEV BIOL, V277, P155, DOI 10.1016/j.ydbio.2004.09.014; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Melnikova IN, 2000, NEUROPHARMACOLOGY, V39, P2615, DOI 10.1016/S0028-3908(00)00125-8; Melnikova IN, 2000, EUR J PHARMACOL, V393, P75, DOI 10.1016/S0014-2999(99)00884-5; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Smith CA, 2005, DEV DYNAM, V233, P188, DOI 10.1002/dvdy.20309; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Srinivas KS, 2004, J BIOCHEM BIOPH METH, V60, P23, DOI 10.1016/j.jbbm.2004.04.011; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	68	24	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13629	13640		10.1074/jbc.M901177200	http://dx.doi.org/10.1074/jbc.M901177200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304657	hybrid, Green Published			2022-12-25	WOS:000265877300040
J	Thieman, JR; Mishra, SK; Ling, K; Doray, B; Anderson, RA; Traub, LM				Thieman, James R.; Mishra, Sanjay K.; Ling, Kun; Doray, Balraj; Anderson, Richard A.; Traub, Linton M.			Clathrin Regulates the Association of PIPKI gamma 661 with the AP-2 Adaptor beta 2 Appendage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; COATED PITS; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PHOSPHOLIPASE-D; PIPKI-GAMMA; RECEPTOR INTERNALIZATION; FUNCTIONAL DISSECTION; STRUCTURAL BASIS; TERMINAL DOMAIN	The AP-2 clathrin adaptor differs fundamentally from the related AP-1, AP-3, and AP-4 sorting complexes because membrane deposition does not depend directly on an Arf family GTPase. Instead phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) appears to act as the principal compartmental cue for AP-2 placement at the plasma membrane as well as for the docking of numerous other important clathrin coat components at the nascent bud site. This PtdIns(4,5)P-2 dependence makes type I phosphatidylinositol 4-phosphate 5-kinases (PIPKIs) lynchpin enzymes in the assembly of clathrin-coated structures at the cell surface. PIPKI gamma is the chief 5-kinase at nerve terminals, and here we show that the 26-amino acid, alternatively spliced C terminus of PIPKI gamma 661 is an intrinsically unstructured polypeptide that binds directly to the sandwich subdomain of the AP-2 beta 2 subunit appendage. An aromatic side chain-based, extended interaction motif that also includes the two bulky C-terminal residues of the short PIPKI gamma 635 variant is necessary for beta 2 appendage engagement. The clathrin heavy chain accesses the same contact surface on the AP-2 beta 2 appendage, but because of additional clathrin binding sites located within the unstructured hinge segment of the beta 2 subunit, clathrin binds the beta 2 chain with a higher apparent affinity than PIPKI gamma 661. A clathrin-regulated interaction with AP-2 could allow PIPKI gamma 661 to be strategically positioned for regional PtdIns(4,5)P-2 generation during clathrin-coated vesicle assembly at the synapse.	[Thieman, James R.; Mishra, Sanjay K.; Traub, Linton M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Ling, Kun] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Doray, Balraj] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Anderson, Richard A.] Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Traub, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3500 Terrace St,S311BST, Pittsburgh, PA 15261 USA.	traub@pitt.edu		Traub, Linton/0000-0002-1303-0298; Doray, Balraj/0000-0003-3347-5013; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health [R01 DK53249, T32 DK061296, R01 CA104708]; American Heart Association Established Investigator Award [0540007N]; NATIONAL CANCER INSTITUTE [R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053249, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK53249 ( to L. M. T.), T32 DK061296 ( to J. R. T.), and R01 CA104708 ( to R. A. A.). This work was also supported in part by American Heart Association Established Investigator Award 0540007N.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Brough D, 2005, J CELL SCI, V118, P3019, DOI 10.1242/jcs.02426; Carvou N, 2007, CELL SIGNAL, V19, P42, DOI 10.1016/j.cellsig.2006.05.023; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Cupers P, 1998, J BIOL CHEM, V273, P1847, DOI 10.1074/jbc.273.4.1847; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Eden ER, 2007, HUM MOL GENET, V16, P2751, DOI 10.1093/hmg/ddm232; FISCHER V, 1991, NATURE, V349, P79; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; Giudici ML, 2006, FEBS LETT, V580, P6933, DOI 10.1016/j.febslet.2006.11.052; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; JADOT M, 1992, J BIOL CHEM, V267, P11069; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Knuehl C, 2006, TRAFFIC, V7, P1688, DOI 10.1111/j.1600-0854.2006.00499.x; Kong XM, 2006, J MOL BIOL, V359, P47, DOI 10.1016/j.jmb.2006.02.048; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Ramjaun AR, 1996, J BIOL CHEM, V271, P24856, DOI 10.1074/jbc.271.40.24856; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yaradanakul A, 2007, J MEMBRANE BIOL, V220, P53, DOI 10.1007/s00232-007-9074-4; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	100	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13924	13939		10.1074/jbc.M901017200	http://dx.doi.org/10.1074/jbc.M901017200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19287005	Green Published, hybrid			2022-12-25	WOS:000265877300068
J	Yamane, D; Zahoor, MA; Mohamed, YM; Azab, W; Kato, K; Tohya, Y; Akashi, H				Yamane, Daisuke; Zahoor, Muhammad A.; Mohamed, Yassir M.; Azab, Walid; Kato, Kentaro; Tohya, Yukinobu; Akashi, Hiroomi			Inhibition of Sphingosine Kinase by Bovine Viral Diarrhea Virus NS3 Is Crucial for Efficient Viral Replication and Cytopathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; INNATE IMMUNITY; APOPTOSIS; PROTEIN; ACTIVATION; CELLS; SPHINGOSINE-1-PHOSPHATE; CLEAVAGE; AUTOPROTEASE; EXPRESSION	Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid implicated in diverse cellular functions including survival, proliferation, tumorigenesis, inflammation, and immunity. Sphingosine kinase (SphK) contributes to these functions by converting sphingosine to S1P. We report here that the nonstructural protein NS3 from bovine viral diarrhea virus (BVDV), a close relative of hepatitis C virus (HCV), binds to and inhibits the catalytic activity of SphK1 independently of its serine protease activity, whereas HCV NS3 does not affect SphK1 activity. Uncleaved NS2-3 from BVDV was also found to interact with and inhibit SphK1. We suspect that inhibition of SphK1 activity by BVDV NS3 and NS2-3 may benefit viral replication, because SphK1 inhibition by small interfering RNA, chemical inhibitor, or overexpression of catalytically inactive SphK1 results in enhanced viral replication, although the mechanisms by which SphK1 inhibition leads to enhanced viral replication remain unknown. A role of SphK1 inhibition in viral cytopathogenesis is also suggested as overexpression of SphK1 significantly attenuates the induction of apoptosis in cells infected with cytopathogenic BVDV. These findings suggest that SphK is targeted by this virus to regulate its catalytic activity.	[Yamane, Daisuke; Zahoor, Muhammad A.; Mohamed, Yassir M.; Azab, Walid; Kato, Kentaro; Tohya, Yukinobu; Akashi, Hiroomi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Akashi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akashih@mail.ecc.u-tokyo.ac.jp	Zahoor, Muhammad/ADH-5812-2022	Zahoor, Muhammad/0000-0003-2302-3689; Azab, Walid/0000-0003-2880-7255	Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan,; Japan Society for the Promotion of Science	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan,(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid from the Ministry of Agriculture, Forestry and Fisheries of Japan, the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Buckwold VE, 2003, ANTIVIR RES, V60, P1, DOI 10.1016/S0166-3542(03)00174-8; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; French KJ, 2003, CANCER RES, V63, P5962; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Lackner T, 2005, J VIROL, V79, P9746, DOI 10.1128/JVI.79.15.9746-9755.2005; Lackner T, 2004, J VIROL, V78, P10765, DOI 10.1128/JVI.78.19.10765-10775.2004; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Machesky NJ, 2008, J BIOL CHEM, V283, P26148, DOI 10.1074/jbc.M710181200; Makino A, 2006, J VIROL, V80, P4482, DOI 10.1128/JVI.80.9.4482-4490.2006; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Nagai M, 2003, J GEN VIROL, V84, P447, DOI 10.1099/vir.0.18773-0; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Schweizer M, 1999, J GEN VIROL, V80, P1147, DOI 10.1099/0022-1317-80-5-1147; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; St-Louis MC, 2005, VET RES, V36, P213, DOI 10.1051/vetres:2004059; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Vassilev VB, 2000, VIRUS RES, V69, P95, DOI 10.1016/S0168-1702(00)00176-3; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997; Yamane D, 2005, MICROBES INFECT, V7, P1482, DOI 10.1016/j.micinf.2005.05.006; Yamane D, 2008, VET MICROBIOL, V129, P69, DOI 10.1016/j.vetmic.2007.11.004; Yamane D, 2006, J GEN VIROL, V87, P2961, DOI 10.1099/vir.0.81820-0; Zhang G, 2003, VIRUS RES, V97, P89, DOI 10.1016/S0168-1702(03)00223-5	37	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13648	13659		10.1074/jbc.M807498200	http://dx.doi.org/10.1074/jbc.M807498200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19293152	Green Published, hybrid			2022-12-25	WOS:000265877300042
J	Kitatani, K; Sheldon, K; Anelli, V; Jenkins, RW; Sun, Y; Grabowski, GA; Obeid, LM; Hannun, YA				Kitatani, Kazuyuki; Sheldon, Kely; Anelli, Viviana; Jenkins, Russell W.; Sun, Ying; Grabowski, Gregory A.; Obeid, Lina M.; Hannun, Yusuf A.			Acid beta-Glucosidase 1 Counteracts p38 delta-dependent Induction of Interleukin-6 POSSIBLE ROLE FOR CERAMIDE AS AN ANTI-INFLAMMATORY LIPID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; P38 MAP-KINASES; GAUCHER-DISEASE; FACTOR-ALPHA; EPITHELIAL-CELLS; TRANSDUCTION PATHWAYS; TRANSCRIPTION FACTORS; SELECTIVE-INHIBITION; CELLULAR-RESPONSES	Activation of protein kinase C (PKC) by the phorbol ester (phorbol 12-myristate 13-acetate) induces ceramide formation through the salvage pathway involving, in part, acid beta-glucosidase 1 (GBA1), which cleaves glucosylceramide to ceramide. Here, we examine the role of the GBA1-ceramide pathway, in regulating a pro-inflammatory pathway initiated by PKC and leading to activation of p38 and induction of interleukin 6 (IL-6). Inhibition of ceramide formation by fumonisin B1 or down-regulation of PKC delta potentiated PMA-induced activation of p38 in human breast cancer MCF-7 cells. Similarly, knockdown of GBA1 by small interfering RNAs or pharmacological inhibition of GBA1 promoted further activation of p38 after PMA treatment, implicating the GBA1-ceramide pathway in the termination of p38 activation. Knockdown of GBA1 also evoked the hyperproduction of IL-6 in response to 4 beta phorbol 12-myristate 13-acetate. On the other hand, increasing cellular ceramide with cell-permeable ceramide treatment resulted in attenuation of the IL-6 response. Importantly, silencing the delta isoform of the p38 family significantly attenuated the hyperproduction of IL-6. Reciprocally, p38 delta overexpression induced IL-6 biosynthesis. Thus, the GBA1-ceramide pathway is suggested to play an important role in terminating p38 delta activation responsible for IL-6 biosynthesis. Furthermore, the p38 delta isoform was identified as a novel and predominant target of ceramide signaling as well as a regulator of IL-6 biosynthesis.	[Kitatani, Kazuyuki; Sheldon, Kely; Anelli, Viviana; Jenkins, Russell W.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Obeid, Lina M.] Med Ctr, Dept Vet Affairs, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hannun, YA (corresponding author), 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; ANELLI, Viviana Vittoria/0000-0003-1964-3252; obeid, lina/0000-0002-0734-0847	NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NCI NIH HHS [CA87584, R01 CA087584] Funding Source: Medline; NIA NIH HHS [AG01683] Funding Source: Medline; NIDDK NIH HHS [DK36729] Funding Source: Medline; OCPHP CDC HHS [C06 PR018823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OCPHP CDC HHS		Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Asgeirsson KS, 1998, CYTOKINE, V10, P720, DOI 10.1006/cyto.1998.0349; Barak V, 1999, EUR CYTOKINE NETW, V10, P205; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bin Hong Y, 2006, J KOREAN MED SCI, V21, P733, DOI 10.3346/jkms.2006.21.4.733; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRUNE K, 1978, CANCER LETT, V4, P333, DOI 10.1016/S0304-3835(78)95612-4; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Charrow J, 2007, CLIN GENET, V71, P205, DOI 10.1111/j.1399-0004.2007.00769.x; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chiba N, 2007, J CELL PHYSIOL, V213, P126, DOI 10.1002/jcp.21101; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Costello R, 2006, LEUKEMIA LYMPHOMA, V47, P1365, DOI 10.1080/10428190600565453; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; De Cesaris P, 1998, J BIOL CHEM, V273, P7566, DOI 10.1074/jbc.273.13.7566; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fearns C, 2000, J LEUKOCYTE BIOL, V67, P705, DOI 10.1002/jlb.67.5.705; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hsu YW, 2001, J IMMUNOL, V166, P5388, DOI 10.4049/jimmunol.166.9.5388; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; KIM MY, 1991, J BIOL CHEM, V266, P484; Kitatani K, 2004, CELL SIGNAL, V16, P967, DOI 10.1016/j.cellsig.2004.02.003; Kitatani K, 2001, ARCH BIOCHEM BIOPHYS, V395, P208, DOI 10.1006/abbi.2001.2573; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; NAKADATE T, 1989, JPN J PHARMACOL, V49, P1, DOI 10.1254/jjp.49.1; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Pritts T, 2002, AM J SURG, V183, P372, DOI 10.1016/S0002-9610(02)00812-7; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Rosenbloom BE, 2005, BLOOD, V105, P4569, DOI 10.1182/blood-2004-12-4672; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Segui B, 2001, J CLIN INVEST, V108, P143, DOI 10.1172/JCI200111498; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Suarez-Cuervo C, 2004, CLIN EXP METASTAS, V21, P525, DOI 10.1007/s10585-004-3503-x; Sun Y, 2008, J LEUKOCYTE BIOL, V83, P1512, DOI 10.1189/jlb.0108076; Takeda S, 2006, J BIOCHEM, V139, P255, DOI 10.1093/jb/mvj026; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; UPDYKE LW, 1989, CARCINOGENESIS, V10, P1107, DOI 10.1093/carcin/10.6.1107; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Willaime S, 2001, EUR J NEUROSCI, V13, P2037, DOI 10.1046/j.0953-816x.2001.01581.x; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yoganathan S, 2003, LIPIDS, V38, P603, DOI 10.1007/s11745-003-1104-y; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008	75	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12979	12988		10.1074/jbc.M809500200	http://dx.doi.org/10.1074/jbc.M809500200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279008	Green Published, hybrid			2022-12-25	WOS:000265688300045
J	Westman, EL; McNally, DJ; Charchoglyan, A; Brewer, D; Field, RA; Lam, JS				Westman, Erin L.; McNally, David J.; Charchoglyan, Armen; Brewer, Dyanne; Field, Robert A.; Lam, Joseph S.			Characterization of WbpB, WbpE, and WbpD and Reconstitution of a Pathway for the Biosynthesis of UDP-2,3-diacetamido-2,3-dideoxy-D-mannuronic Acid in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ANTIGEN BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; PROTEIN; PAO1; LIPOPOLYSACCHARIDES; BACTERIA; ENZYMES	The lipopolysaccharide of Pseudomonas aeruginosa PAO1 contains an unusual sugar, 2,3-diacetamido-2,3-dideoxy-D-mannuronic acid (D-ManNAc3NAcA). wbpB, wbpE, and wbpD are thought to encode oxidase, transaminase, and N-acetyl-transferase enzymes. To characterize their functions, recombinant proteins were overexpressed and purified from heterologous hosts. Activities of His(6)-WbpB and His(6)-WbpE were detected only when both proteins were combined in the same reaction. Using a direct MALDI-TOF mass spectrometry approach, we identified ions that corresponded to the predicted products of WbpB (UDP-3-keto-D-GlcNAcA) and WbpE (UDP-D-GlcNAc3NA) in the coupled enzyme-substrate reaction. Additionally, in reactions involving WbpB, WbpE, and WbpD, an ion consistent with the expected product of WbpD (UDP-D-GlcNAc3NAcA) was identified. Preparative quantities of UDP-D-GlcNAc3NA and UDP-D-GlcNAc3NAcA were enzymatically synthesized. These compounds were purified by high-performance liquid chromatography, and their structures were elucidated by NMR spectroscopy. This is the first report of the functional characterization of these proteins, and the enzymatic synthesis of UDP-D-GlcNAc3NA and UDP-D-GlcNAc3NAcA.	[Westman, Erin L.; Charchoglyan, Armen; Brewer, Dyanne; Lam, Joseph S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [McNally, David J.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Field, Robert A.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	University of Guelph; University of Toronto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lam, JS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca		Field, Rob/0000-0001-8574-0275; Westman, Erin/0000-0003-3756-470X	Canadian Institutes of Health Research (CIHR) [MOP14687]; Biotechnology and Biological Sciences and Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Canadian Institutes of Health Research (CIHR) (Grant MOP14687 to J.S.L.). Studies in the Field laboratory are supported by the Biotechnology and Biological Sciences and Research Council.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrows LL, 2000, FEMS MICROBIOL LETT, V189, P135, DOI 10.1111/j.1574-6968.2000.tb09219.x; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; King JD, 2007, J MOL BIOL, V374, P749, DOI 10.1016/j.jmb.2007.09.055; KNIREL YA, 1994, BIOCHEMISTRY-MOSCOW+, V59, P1325; KNIREL YA, 1988, ACTA MICROBIOL HUNG, V35, P3; LIU PHV, 1990, J CLIN MICROBIOL, V28, P922, DOI 10.1128/JCM.28.5.922-925.1990; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Newton GJ, 2001, MOL MICROBIOL, V39, P1237, DOI 10.1046/j.1365-2958.2001.02311.x; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Pfostl A, 2008, BIOCHEM J, V410, P187, DOI 10.1042/BJ20071044; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; Rejzek M, 2009, ORG BIOMOL CHEM, V7, P1203, DOI 10.1039/b819607a; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; VUORIO R, 1991, FEBS LETT, V292, P90, DOI 10.1016/0014-5793(91)80841-P; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Wenzel CQ, 2005, MOL MICROBIOL, V57, P1288, DOI 10.1111/j.1365-2958.2004.04767.x; Westman EL, 2008, J BACTERIOL, V190, P6060, DOI 10.1128/JB.00579-08; Westman EL, 2007, BIOCHEM J, V405, P123, DOI 10.1042/BJ20070017	27	19	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11854	11862		10.1074/jbc.M808583200	http://dx.doi.org/10.1074/jbc.M808583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19282284	hybrid, Green Published			2022-12-25	WOS:000265494600017
J	Kwek, SS; Roy, R; Zhou, H; Climent, J; Martinez-Climent, JA; Fridlyand, J; Albertson, DG				Kwek, S. S.; Roy, R.; Zhou, H.; Climent, J.; Martinez-Climent, J. A.; Fridlyand, J.; Albertson, D. G.			Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis	ONCOGENE			English	Article						gene amplification; array CGH; breast cancer; 8p12; 11q13; CCND1	CANCER CELL-LINES; 8P11-12 AMPLICON; THERAPEUTIC TARGET; DNA AMPLIFICATION; INSTABILITY; FGFR1; COAMPLIFICATION; REARRANGEMENTS; ABERRATIONS	Co-amplification at chromosomes 8p11-8p12 and 11q12-11q14 occurs often in breast tumors, suggesting possible cooperation between genes in these regions in oncogenesis. We used high-resolution array comparative genomic hybridization (array CGH) to map the minimal amplified regions. The 8p and 11q amplicons are complex and consist of at least four amplicon cores at each site. Candidate oncogenes mapping to these regions were identified by combining copy number and RNA and protein expression analyses. These studies also suggested that CCND1 at 11q13 induced expression of ZNF703 mapping at 8p12, which was subsequently shown to be mediated by the Rb/E2F pathway. Nine candidate oncogenes from 8p12 and four from 11q13 were further evaluated for oncogenic function. None of the genes individually promoted colony formation in soft agar or collaborated with each other functionally. On the other hand, FGFR1 and DDHD2 at 8p12 cooperated functionally with MYC, whereas CCND1 and ZNF703 cooperated with a dominant negative form of TP53. These observations highlight the complexity and functional consequences of the genomic rearrangements that occur in these breast cancer amplicons, including transcriptional cross-talk between genes in the 8p and 11q amplicons, as well as their cooperation with major pathways of tumorigenesis.	[Albertson, D. G.] Univ Calif San Francisco, Canc Res Inst, San Francisco Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Roy, R.; Fridlyand, J.; Albertson, D. G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Climent, J.] Hosp Clin, Dept Hematol & Med Oncol, Valencia, Spain; [Martinez-Climent, J. A.] Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Fridlyand, J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Albertson, D. G.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Navarra; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Albertson, DG (corresponding author), Univ Calif San Francisco, Canc Res Inst, San Francisco Comprehens Canc Ctr, 2340 Sutter St,Box 0808, San Francisco, CA 94143 USA.	albertson@cc.ucsf.edu	Martinez-Climent, Jose A/I-9199-2012; Climent, Joan/O-5877-2017	Martinez-Climent, Jose A/0000-0002-7938-3950; Climent, Joan/0000-0002-8927-6614	NIH [CA90421, CA101359]; DOD BCRP [BC021074, DAMD17-03-1-0483]; NATIONAL CANCER INSTITUTE [R01CA101359, R01CA090421] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the UCSF Helen Diller Family Comprehensive Cancer Center Genome Analysis, Informatics, and Microarray Shared Resources for performing the TaqMan assays and printing the custom 8p11q array. This work was supported by NIH Grants CA90421 and CA101359. Serena S Kwek was the recipient of a DOD BCRP fellowship, Grant nos. BC021074, DAMD17-03-1-0483.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Agrawal A, 2006, EXP MOL PATHOL, V81, P115, DOI 10.1016/j.yexmp.2006.07.001; Bautista S, 1998, GENE CHROMOSOME CANC, V22, P268, DOI 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.0.CO;2-T; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Cuny M, 2000, CANCER RES, V60, P1077; ETHIER SP, 1993, CANCER RES, V53, P627; Ethier SP, 1996, J MAMMARY GLAND BIOL, V1, P111, DOI 10.1007/BF02096306; Forozan F, 1997, TRENDS GENET, V13, P405, DOI 10.1016/S0168-9525(97)01244-4; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Ho GH, 2001, BREAST CANCER RES TR, V65, P225, DOI 10.1023/A:1010686518990; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Kan CE, 2007, CANCER RES, V67, P9862, DOI 10.1158/0008-5472.CAN-07-0259; KARLSEDER J, 1994, GENE CHROMOSOME CANC, V9, P42, DOI 10.1002/gcc.2870090108; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Melchor L, 2007, INT J CANCER, V120, P714, DOI 10.1002/ijc.22354; Mineta H, 1997, ORAL ONCOL, V33B, P42, DOI 10.1016/S0964-1955(96)00039-5; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Patel DM, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802030; Paterson AL, 2007, GENE CHROMOSOME CANC, V46, P427, DOI 10.1002/gcc.20424; Pole JCM, 2006, ONCOGENE, V25, P5693, DOI 10.1038/sj.onc.1209570; Prentice LM, 2005, ONCOGENE, V24, P7281, DOI 10.1038/sj.onc.1208892; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Rodriguez C, 2004, CLIN CANCER RES, V10, P5785, DOI 10.1158/1078-0432.CCR-03-0410; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tashiro E, 2003, CANCER RES, V63, P424; Wang B, 1997, ANTICANCER RES, V17, P4387; Willmarth NE, 2004, BREAST CANCER RES, V6, pR531, DOI 10.1186/bcr900; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2007, INT J CANCER, V121, P1265, DOI 10.1002/ijc.22831; Yang ZQ, 2004, CANCER GENET CYTOGEN, V155, P57, DOI 10.1016/j.cancergencyto.2004.03.013	46	80	82	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2009	28	17					1892	1903		10.1038/onc.2009.34	http://dx.doi.org/10.1038/onc.2009.34			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PX	19330026	Green Accepted			2022-12-25	WOS:000265640600002
J	Pan, D; Zhang, LQ				Pan, Deng; Zhang, Liqing			Burst of Young Retrogenes and Independent Retrogene Formation in Mammals	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GENE DUPLICATION; DROSOPHILA-MELANOGASTER; PROCESSED PSEUDOGENES; DNA LOSS; EVOLUTION; GENOME; RATES; RETROTRANSPOSONS; IDENTIFICATION	Retroposition and retrogenes gain increasing attention as recent studies show that they play an important role in human new gene formation. Here we examined the patterns of retrogene distribution in 8 mammalian genomes using 4 non-mammalian genomes as a contrast. There has been a burst of young retrogenes not only in primate lineages as suggested in a recent study, but also in other mammalian lineages. In mammals, most of the retrofamilies (the gene families that have retrogenes) are shared between species. In these shared retrofamilies, 14%-18% of functional retrogenes may have originated independently in multiple mammalian species. Notably, in the independently originated retrogenes, there is an enrichment of ribosome related gene function. In sharp contrast, none of these patterns hold in non-mammals. Our results suggest that the recruitment of the specific L1 retrotransposons in mammals might have been an important evolutionary event for the split of mammals and non-mammals and retroposition continues to be an important active process in shaping the dynamics of mammalian genomes, as compared to being rather inert in non-mammals.	[Pan, Deng; Zhang, Liqing] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Zhang, Liqing] Virginia Tech, Program Genet Bioinformat & Computat Biol, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Pan, D (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	lqzhang@vt.edu	Pan, Deng/F-1794-2011		NSF [IIS-0710945]; AdvanceVT	NSF(National Science Foundation (NSF)); AdvanceVT	NSF Grant IIS-0710945 and AdvanceVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no financial interest.	Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Boissinot SP, 2004, J MOL EVOL, V58, P122, DOI 10.1007/s00239-003-2539-x; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BURCH JBE, 1993, P NATL ACAD SCI USA, V90, P8199, DOI 10.1073/pnas.90.17.8199; Casavant NC, 2000, GENETICS, V154, P1809; Crainey JL, 2005, MOL BIOL EVOL, V22, P2190, DOI 10.1093/molbev/msi217; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ezawa K, 2006, MOL BIOL EVOL, V23, P927, DOI 10.1093/molbev/msj093; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Haas NB, 2001, GENE, V265, P175, DOI 10.1016/S0378-1119(01)00344-4; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Li W. H, 1997, MOL EVOLUTION; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Muller J, 2004, MOL ECOL NOTES, V4, P786, DOI 10.1111/j.1471-8286.2004.00813.x; Nikolaev SI, 2007, P NATL ACAD SCI USA, V104, P20443, DOI 10.1073/pnas.0705658104; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; R Development Core Team, 2006, R LANG ENV STAT COMP; Robinson R, 2005, PLOS BIOL, V3, P1860, DOI 10.1371/journal.pbio.0030396; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Wakefield MJ, 2003, EMBO REP, V4, P143, DOI 10.1038/sj.embor.embor739; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	51	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5040	10.1371/journal.pone.0005040	http://dx.doi.org/10.1371/journal.pone.0005040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325906	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499600009
J	Pickard, GE; Baver, SB; Ogilvie, MD; Sollars, PJ				Pickard, Gary E.; Baver, Scott B.; Ogilvie, Malcolm D.; Sollars, Patricia J.			Light-Induced Fos Expression in Intrinsically Photosensitive Retinal Ganglion Cells in Melanopsin Knockout (Opn4(-/-)) Mice	PLOS ONE			English	Article								Retinal ganglion cells that express the photopigment melanopsin are intrinsically photosensitive (ipRGCs) and exhibit robust synaptically driven ON-responses to light, yet they will continue to depolarize in response to light when all synaptic input from rod and cone photoreceptors is removed. The light-evoked increase in firing of classical ganglion cells is determined by synaptic input from ON-bipolar cells in the proximal sublamina of the inner plexiform layer. OFF-bipolar cells synapse with ganglion cell dendrites in the distal sublamina of the inner plexiform layer. Of the several types of ipRGC that have been described, M1 ipRGCs send dendrites exclusively into the OFF region of the inner plexiform layer where they stratify near the border of the inner nuclear layer. We tested whether M1 ipRGCs with dendrites restricted to the OFF sublamina of the inner plexiform layer receive synaptic ON-bipolar input by examining light-induced gene expression in vivo using melanopsin knockout mice. Mice in which both copies of the melanopsin gene (opn4) have been replaced with the tau-lacZ gene (homozygous tau-lacZ(+/+) knockin mice) are melanopsin knockouts (opn4(-/-)) but M1 ipRGCs are specifically identified by their expression of beta-galactosidase. Approximately 60% of M1 ipRGCs in Opn4(-/-) mice exposed to 3 hrs of light expressed c-Fos; no beta-galactosidase-positive RGCs expressed c-Fos in the dark. Intraocular application of L-AP4, a compound which blocks transmission of visual signals between photoreceptors and ON-bipolar cells significantly reduced light-evoked c-Fos expression in M1 ipRGCs compared to saline injected eyes (66% saline vs 27% L-AP4). The results are the first description of a light-evoked response in an ipRGC lacking melanopsin and provide in vivo confirmation of previous in vitro observations illustrating an unusual circuit in the retina in which ganglion cells sending dendrites to the OFF sublamina of the inner plexiform layer receive excitatory synaptic input from ON-bipolar cells.	[Pickard, Gary E.; Baver, Scott B.; Ogilvie, Malcolm D.; Sollars, Patricia J.] Colorado State Univ, Dept Biomed Sci, Div Neurosci, Ft Collins, CO 80523 USA	Colorado State University	Pickard, GE (corresponding author), Colorado State Univ, Dept Biomed Sci, Div Neurosci, Ft Collins, CO 80523 USA.	gpickard2@unl.edu			NIH [R01 EY017809, R01 NS035615]; NATIONAL EYE INSTITUTE [R01EY017809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grants R01 EY017809 and R01 NS035615 to GEP and PJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CHAMBILLE I, 1993, BRAIN RES, V612, P138, DOI 10.1016/0006-8993(93)91654-B; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DOLAN RP, 1994, VISUAL NEUROSCI, V11, P23, DOI 10.1017/S095252380001107X; Dowling J. E., 1987, RETINA APPROACHABLE; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; Hanzlicek BW, 2004, VISUAL NEUROSCI, V21, P873, DOI 10.1017/S0952523804216078; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Haverkamp S, 2004, J COMP NEUROL, V468, P251, DOI 10.1002/cne.10962; Huerta JJ, 1997, NEUROSCI LETT, V232, P143, DOI 10.1016/S0304-3940(97)00595-8; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KOISTINAHO J, 1995, MOL BRAIN RES, V29, P53, DOI 10.1016/0169-328X(94)00218-4; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NUMURA A, 1994, CELL, V77, P361; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; RODIECK RW, 1973, VERTEBRATE RETINA PR; ROHRER B, 1995, BRAIN RES, V686, P169, DOI 10.1016/0006-8993(95)00370-6; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Snellman J, 2008, PROG RETIN EYE RES, V27, P450, DOI 10.1016/j.preteyeres.2008.03.003; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; VINEY TJ, 2007, CURR BIOL, V13, P1290; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; WONG KY, 2008, SOC NEUROSCI; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	43	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4984	10.1371/journal.pone.0004984	http://dx.doi.org/10.1371/journal.pone.0004984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319185	Green Published, gold			2022-12-25	WOS:000265499200015
J	Conroy, A; Serghides, L; Finney, C; Owino, SO; Kumar, S; Gowda, DC; Liles, WC; Moore, JM; Kain, KC				Conroy, Andrea; Serghides, Lena; Finney, Constance; Owino, Simon O.; Kumar, Sanjeev; Gowda, D. Channe; Liles, W. Conrad; Moore, Julie M.; Kain, Kevin C.			C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; COMPLEMENT ACTIVATION; PROINFLAMMATORY RESPONSES; HUMAN SYNCYTIOTROPHOBLAST; IMMUNE-RESPONSES; PREGNANCY; INNATE; GLYCOSYLPHOSPHATIDYLINOSITOL; EXPRESSION	Background: Placental malaria (PM) is a leading cause of maternal and infant mortality. Although the accumulation of parasitized erythrocytes (PEs) and monocytes within the placenta is thought to contribute to the pathophysiology of PM, the molecular mechanisms underlying PM remain unclear. Based on the hypothesis that excessive complement activation may contribute to PM, in particular generation of the potent inflammatory peptide C5a, we investigated the role of C5a in the pathogenesis of PM in vitro and in vivo. Methodology and Principal Findings: Using primary human monocytes, the interaction between C5a and malaria in vitro was assessed. CSA- and CD36-binding PEs induced activation of C5 in the presence of human serum. Plasmodium falciparum GPI (pfGPI) enhanced C5a receptor expression (CD88) on monocytes, and the co-incubation of monocytes with C5a and pfGPI resulted in the synergistic induction of cytokines (IL-6, TNF, IL-1 beta, and IL-10), chemokines (IL-8, MCP-1, MIP1 alpha, MIP1 beta) and the antiangiogenic factor sFlt-1 in a time and dose-dependent manner. This dysregulated response was abrogated by C5a receptor blockade. To assess the potential role of C5a in PM, C5a plasma levels were measured in malaria-exposed primigravid women in western Kenya. Compared to pregnant women without malaria, C5a levels were significantly elevated in women with PM. Conclusions and Significance: These results suggest that C5a may contribute to the pathogenesis of PM by inducing dysregulated inflammatory and angiogenic responses that impair placental function.	[Conroy, Andrea; Serghides, Lena; Finney, Constance; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Conroy, Andrea; Kain, Kevin C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Owino, Simon O.; Moore, Julie M.] Univ Georgia, Ctr Trop & Emerging Glob Dis, Athens, GA 30602 USA; [Owino, Simon O.; Moore, Julie M.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Owino, Simon O.] Kenya Govt Med Res Ctr, Ctr Glob Hlth Res, Kisumu, Kenya; [Kumar, Sanjeev; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Liles, W. Conrad; Kain, Kevin C.] Univ Hlth Network, Toronto Gen Hosp, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Kenya Medical Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Conroy, A (corresponding author), Univ Toronto, Toronto Gen Hosp, McLaughlin Rotman Ctr Global Hlth, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.on.ca	Conroy, Andrea/AAA-8356-2020; Serghides, Lena/C-7968-2018; Conroy, Andrea/ABC-5715-2020	Conroy, Andrea/0000-0002-5328-6511; Serghides, Lena/0000-0002-2817-6134; Conroy, Andrea/0000-0002-5328-6511; Finney, Constance AM/0000-0002-8459-8462; Kumar, Sanjeev/0000-0002-4454-9914; Gowda, Channe/0000-0002-6860-5108; Kain, Kevin/0000-0001-6068-1272	CIHR [Canada Research Chairs]; Ontario Genomics Institute; NIH [RO1050240];  [MT-13721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050240] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CIHR Team Grant in Malaria (KCK), operating grant MT-13721 (KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK; WCL). Recruitment of women in Kenya was supported by NIH RO1050240 (JMM) and could not have been possible without the invaluable participation of parturient women and dedicated Kenyan staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Albrecht EA, 2004, CURR ALLERGY ASTHM R, V4, P359, DOI 10.1007/s11882-004-0084-3; Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Caucheteux SM, 2003, IMMUNITY, V18, P169, DOI 10.1016/S1074-7613(03)00028-1; Chaisavaneeyakorn S, 2005, INFECT IMMUN, V73, P3287, DOI 10.1128/IAI.73.6.3287-3293.2005; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Charnock-Jones DS, 2000, BEST PRACT RES CL OB, V14, P953, DOI 10.1053/beog.2000.0137; CHENOWETH DE, 1978, P NATL ACAD SCI USA, V75, P3943, DOI 10.1073/pnas.75.8.3943; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Diagne N, 1997, T ROY SOC TROP MED H, V91, P166, DOI 10.1016/S0035-9203(97)90209-1; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GILLES HM, 1969, ANN TROP MED PARASIT, V63, P245, DOI 10.1080/00034983.1969.11686625; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; HUNT JS, 1989, J REPROD IMMUNOL, V16, P1, DOI 10.1016/0165-0378(89)90002-8; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Leopardi O, 1996, PATHOL RES PRACT, V192, P892, DOI 10.1016/S0344-0338(96)80068-9; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lucchi NW, 2007, J REPROD IMMUNOL, V73, P20, DOI 10.1016/j.jri.2006.05.005; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Lucchi NW, 2006, PLACENTA, V27, P384, DOI 10.1016/j.placenta.2005.04.009; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Muehlenbachs A, 2008, P NATL ACAD SCI USA, V105, P14488, DOI 10.1073/pnas.0803657105; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Roestenberg M, 2007, T ROY SOC TROP MED H, V101, P643, DOI 10.1016/j.trstmh.2007.02.023; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Serghides L, 2006, J INFECT DIS, V194, P133, DOI 10.1086/504721; SMEDEGARD G, 1989, AM J PATHOL, V135, P489; SOLOMKIN JS, 1981, SURGERY, V90, P319; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	67	56	58	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4953	10.1371/journal.pone.0004953	http://dx.doi.org/10.1371/journal.pone.0004953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308263	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499000006
J	Jandu, N; Ho, NKL; Donato, KA; Karmali, MA; Mascarenhas, M; Duffy, SP; Tailor, C; Sherman, PM				Jandu, Narveen; Ho, Nathan K. L.; Donato, Kevin A.; Karmali, Mohamed A.; Mascarenhas, Mariola; Duffy, Simon P.; Tailor, Chetankumar; Sherman, Philip M.			Enterohemorrhagic Escherichia coli O157:H7 Gene Expression Profiling in Response to Growth in the Presence of Host Epithelia	PLOS ONE			English	Article								Background: The pathogenesis of enterohemorrhagic Escherichia coli (EHEC) O157:H7 infection is attributed to virulence factors encoded on multiple pathogenicity islands. Previous studies have shown that EHEC O157:H7 modulates host cell signal transduction cascades, independent of toxins and rearrangement of the cytoskeleton. However, the virulence factors and mechanisms responsible for EHEC-mediated subversion of signal transduction remain to be determined. Therefore, the purpose of this study was to first identify differentially regulated genes in response to EHEC O157:H7 grown in the presence of epithelial cells, compared to growth in the absence of epithelial cells (that is, growth in minimal essential tissue culture medium alone, minimal essential tissue culture medium in the presence of 5% CO(2), and Penassay broth alone) and, second, to identify EHEC virulence factors responsible for pathogen modulation of host cell signal transduction. Methodology/Principal Findings: Overnight cultures of EHEC O157:H7 were incubated for 6 hr at 37 degrees C in the presence or absence of confluent epithelial (HEp-2) cells. Total RNA was then extracted and used for microarray analyses (Affymetrix E. coli Genome 2.0 gene chips). Relative to bacteria grown in each of the other conditions, EHEC O157:H7 cultured in the presence of cultured epithelial cells displayed a distinct gene-expression profile. A 2.0-fold increase in the expression of 71 genes and a 2.0-fold decrease in expression of 60 other genes were identified in EHEC O157:H7 grown in the presence of epithelial cells, compared to bacteria grown in media alone. Conclusion/Significance: Microarray analyses and gene deletion identified a protease on O-island 50, gene Z1787, as a potential virulence factor responsible for mediating EHEC inhibition of the interferon (IFN)-gamma-Jak1,2-STAT-1 signal transduction cascade. Up-regulated genes provide novel targets for use in developing strategies to interrupt the infectious process.	[Jandu, Narveen] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Jandu, Narveen; Ho, Nathan K. L.; Donato, Kevin A.; Duffy, Simon P.; Tailor, Chetankumar; Sherman, Philip M.] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Karmali, Mohamed A.; Mascarenhas, Mariola] Publ Hlth Agcy Canada, Lab Foodborne Zoonosis, Guelph, ON, Canada	Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Public Health Agency of Canada	Jandu, N (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	philip.sherman@sickkids.ca		Karmali, Mohamed/0000-0001-7308-6085; Duffy, Simon/0000-0002-1301-6031; Sherman, Philip/0000-0002-4733-6690	Canadian Institutes of Health Research (CIHR) [STP-53877]; CIHR/Canadian Digestive Health Foundation Doctoral Research Award; University of Toronto [Open Fellowship Award]; Canada Research Chair in Gastrointestinal Disease	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Canadian Digestive Health Foundation Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Canada Research Chair in Gastrointestinal Disease	This research was supported by an operating grant from the Canadian Institutes of Health Research (CIHR). NJ is the recipient of a CIHR/Canadian Digestive Health Foundation Doctoral Research Award, a CIHR Cell Signals Strategic Training Program STP-53877 Trainee Award and an Open Fellowship Award from the University of Toronto. PMS is the recipient of a Canada Research Chair in Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Ceponis PJM, 2003, INFECT IMMUN, V71, P1396, DOI 10.1128/IAI.71.3.1396-1404.2003; Dahan S, 2004, INFECT IMMUN, V72, P5452, DOI 10.1128/IAI.72.9.5452-5459.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dowd SE, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-30; Fitzmaurice J, 2004, MOL CELL PROBE, V18, P123, DOI 10.1016/j.mcp.2003.10.004; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Grys TE, 2006, J BACTERIOL, V188, P4646, DOI 10.1128/JB.01806-05; Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53; Haghjoo E, 2007, MOL MICROBIOL, V64, P1549, DOI 10.1111/j.1365-2958.2007.05754.x; Hain T, 2006, J BIOTECHNOL, V126, P37, DOI 10.1016/j.jbiotec.2006.03.047; Hancock V, 2007, INFECT IMMUN, V75, P966, DOI 10.1128/IAI.01748-06; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HONG YQ, 1992, CLIN IMMUNOL IMMUNOP, V62, P133, DOI 10.1016/0090-1229(92)90065-V; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; Jandu N, 2006, INFECT IMMUN, V74, P1809, DOI 10.1128/IAI.74.3.1809-1818.2006; Jandu N, 2007, MICROB PATHOGENESIS, V42, P62, DOI 10.1016/j.micpath.2006.10.005; Kaper JB, 2008, P NATL ACAD SCI USA, V105, P4535, DOI 10.1073/pnas.0801435105; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Kida Y, 2008, CELL MICROBIOL, V10, P1491, DOI 10.1111/j.1462-5822.2008.01142.x; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Noller AC, 2003, J CLIN MICROBIOL, V41, P675, DOI 10.1128/JCM.41.2.675-679.2003; Ogura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r138; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rashid RA, 2006, INFECT IMMUN, V74, P4142, DOI 10.1128/IAI.00299-06; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schramm G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-149; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Willenbrock H, 2006, J BACTERIOL, V188, P7713, DOI 10.1128/JB.01043-06; Wladyka B, 2008, CELL MOL BIOL LETT, V13, P212, DOI 10.2478/s11658-007-0048-4; Wu CF, 2003, BIOSENS BIOELECTRON, V19, P1, DOI 10.1016/S0956-5663(03)00118-0; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121	50	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4889	10.1371/journal.pone.0004889	http://dx.doi.org/10.1371/journal.pone.0004889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293938	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496600009
J	de Mendibil, IO; Vizmanos, JL; Novo, FJ				Ortiz de Mendibil, Inigo; Vizmanos, Jose L.; Novo, Francisco J.			Signatures of Selection in Fusion Transcripts Resulting From Chromosomal Translocations in Human Cancer	PLOS ONE			English	Article							STRAND BREAK REPAIR; CHRONIC MYELOID-LEUKEMIA; GENE FUSIONS; IDENTIFICATION; ABERRATIONS; REARRANGEMENTS; ORGANIZATION; GENERATION; STABILITY; PARTNER	Background: The recurrence and non-random distribution of translocation breakpoints in human tumors are usually attributed to local sequence features present in the vicinity of the breakpoints. However, it has also been suggested that functional constraints might contribute to delimit the position of translocation breakpoints within the genes involved, but a quantitative analysis of such contribution has been lacking. Methodology: We have analyzed two well-known signatures of functional selection, such as reading-frame compatibility and non-random combinations of protein domains, on an extensive dataset of fusion proteins resulting from chromosomal translocations in cancer. Conclusions: Our data provide strong experimental support for the concept that the position of translocation breakpoints in the genome of cancer cells is determined, to a large extent, by the need to combine certain protein domains and to keep an intact reading frame in fusion transcripts. Additionally, the information that we have assembled affords a global view of the oncogenic mechanisms and domain architectures that are used by fusion proteins. This can be used to assess the functional impact of novel chromosomal translocations and to predict the position of breakpoints in the genes involved.	[Ortiz de Mendibil, Inigo; Vizmanos, Jose L.; Novo, Francisco J.] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain	University of Navarra	de Mendibil, IO (corresponding author), Univ Navarra, Dept Genet, E-31080 Pamplona, Spain.	fnovo@unav.es	Novo, Francisco/M-7596-2015; Vizmanos, José L./G-2833-2012	Novo, Francisco/0000-0003-4961-3097; Vizmanos, José L./0000-0001-7416-3679	Institute of Health Carlos III [FIS PI040037]; Spanish Ministry of Education and Science [SAF 2007-62473]; PIUNA Program of the University of Navarra; Caja Navarra Foundation [10.830]; Government of Navarra [Jeronimo de Ayanz award]	Institute of Health Carlos III(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); PIUNA Program of the University of Navarra; Caja Navarra Foundation; Government of Navarra	This work has been funded with the help of the Institute of Health Carlos III (FIS PI040037), Spanish Ministry of Education and Science (SAF 2007-62473), the PIUNA Program of the University of Navarra and the Caja Navarra Foundation through the Program You choose, you decide (Project 10.830). F.J.N is the recipient of a Jeronimo de Ayanz award from the Government of Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2007, LEUKEMIA, V21, P352, DOI 10.1038/sj.leu.2404503; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; Ashur-Fabian O, 2008, LEUKEMIA, V22, P200, DOI 10.1038/sj.leu.2404991; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Bizarro S, 2007, CANCER GENET CYTOGEN, V178, P61, DOI 10.1016/j.cancergencyto.2007.05.023; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Catalano A, 2007, BLOOD, V110, P4073, DOI 10.1182/blood-2007-06-095554; Chinen Y, 2008, ONCOGENE, V27, P2249, DOI 10.1038/sj.onc.1210857; Esteyries S, 2008, LEUKEMIA, V22, P663, DOI 10.1038/sj.leu.2404930; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Gorello P, 2008, LEUKEMIA, V22, P216, DOI 10.1038/sj.leu.2404894; Grand FH, 2007, EXP HEMATOL, V35, P1723, DOI 10.1016/j.exphem.2007.07.002; HAMPTON OA, 2008, GENOME RES      1209; Hoglund M, 2006, ONCOGENE, V25, P2674, DOI 10.1038/sj.onc.1209290; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mirault ME, 2006, AM J HUM GENET, V79, P779, DOI 10.1086/507791; Mitelman F, 2005, GENE CHROMOSOME CANC, V43, P350, DOI 10.1002/gcc.20212; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Moller E, 2008, GENE CHROMOSOME CANC, V47, P21, DOI 10.1002/gcc.20501; Nebral K, 2007, BRIT J HAEMATOL, V139, P269, DOI 10.1111/j.1365-2141.2007.06731.x; Novo FJ, 2006, TRENDS GENET, V22, P193, DOI 10.1016/j.tig.2006.02.001; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan Q, 2008, ONCOGENE, V27, P3414, DOI 10.1038/sj.onc.1210999; Raphael BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r59; Rowe D, 2007, HAEMATOLOGICA, V92, P1433, DOI 10.3324/haematol.11536; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Struski S, 2008, HAEMATOLOGICA, V93, P467, DOI 10.3324/haematol.11988; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zhong CH, 2008, LEUKEMIA, V22, P723, DOI 10.1038/sj.leu.2405084	47	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4805	10.1371/journal.pone.0004805	http://dx.doi.org/10.1371/journal.pone.0004805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279687	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496200002
J	Gusti, A; Baumberger, N; Nowack, M; Pusch, S; Eisler, H; Potuschak, T; De Veylder, L; Schnittger, A; Genschik, P				Gusti, Andi; Baumberger, Nicolas; Nowack, Moritz; Pusch, Stefan; Eisler, Herfried; Potuschak, Thomas; De Veylder, Lieven; Schnittger, Arp; Genschik, Pascal			The Arabidopsis thaliana F-Box Protein FBL17 Is Essential for Progression through the Second Mitosis during Pollen Development	PLOS ONE			English	Article							CELL-CYCLE; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; PROLIFERATION; PHOSPHORYLATION; DEGRADATION; PROTEOLYSIS; DIVISION; COMPLEX; CDKA,1	In fungi and metazoans, the SCF-type Ubiquitin protein ligases (E3s) play a critical role in cell cycle regulation by degrading negative regulators, such as cell cycle-dependent kinase inhibitors (CKIs) at the G1-to-S-phase checkpoint. Here we report that FBL17, an Arabidopsis thaliana F-box protein, is involved in cell cycle regulation during male gametogenesis. FBL17 expression is strongly enhanced in plants co-expressing E2Fa and DPa, transcription factors that promote S-phase entry. FBL17 loss-of-function mutants fail to undergo pollen mitosis II, which generates the two sperm cells in mature A. thaliana pollen. Nonetheless, the single sperm cell-like cell in fbl17 mutants is functional but will exclusively fertilize the egg cell of the female gametophyte, giving rise to an embryo that will later abort, most likely due to the lack of functional endosperm. Seed abortion can, however, be overcome by mutations in FIE, a component of the Polycomb group complex, overall resembling loss-of-function mutations in the A. thaliana cyclin-dependent kinase CDKA;1. Finally we identified ASK11, as an SKP1-like partner protein of FBL17 and discuss a possible mechanism how SCFFBL17 may regulate cell division during male gametogenesis.	[Gusti, Andi; Baumberger, Nicolas; Eisler, Herfried; Potuschak, Thomas; Schnittger, Arp; Genschik, Pascal] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France; [Nowack, Moritz; Pusch, Stefan; Schnittger, Arp] Univ Cologne, Max Planck Inst Zuchtungsforschung, Max Delbruck Lab, Lehrstuhl Botan 3, D-5000 Cologne, Germany; [De Veylder, Lieven] VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Veylder, Lieven] Univ Ghent, Dept Mol Genet, Ghent, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society; University of Cologne; Flanders Institute for Biotechnology (VIB); Ghent University	Gusti, A (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France.	pascal.genschik@ibmp-ulp.u-strasbg.fr	Schnittger, Arp/F-8989-2010; Pusch, Stefan/H-3152-2019; de veylder, lieven/AAM-9909-2020; Schnittger, Arp/AAO-6920-2020	Schnittger, Arp/0000-0001-7067-0091; Pusch, Stefan/0000-0002-3407-4249; de veylder, lieven/0000-0003-1150-4426; Schnittger, Arp/0000-0001-7067-0091; GENSCHIK, Pascal/0000-0002-4107-5071; Potuschak, Thomas/0000-0002-2632-4981; gusti, andi/0000-0003-1988-9260; Nowack, Moritz/0000-0001-8918-7577	CNRS; EU NoE [LSHG-CT-2005-018683]; VW foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); EU NoE; VW foundation(Volkswagen)	Funding was provided by the CNRS to P.G and A.S., the EU NoE (Rubicon LSHG-CT-2005-018683) to P.G. and the VW foundation to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Baroux C, 2007, CURR OPIN GENET DEV, V17, P473, DOI 10.1016/j.gde.2007.09.004; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; del Pozo JC, 2002, PLANT CELL, V14, P3057, DOI 10.1105/tpc.006791; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dissmeyer N, 2007, PLANT CELL, V19, P972, DOI 10.1105/tpc.107.050401; Doelling JH, 2007, PLANT PHYSIOL, V145, P801, DOI 10.1104/pp.106.095323; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; GENSCHIK P, 2007, ANN PLANT REV, P87; Grini PE, 2002, GENETICS, V162, P1911; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; Hengst L, 2004, NAT CELL BIOL, V6, P1153, DOI 10.1038/ncb1204-1153; Howden R, 1998, GENETICS, V149, P621; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Jakoby MJ, 2006, PLANT PHYSIOL, V141, P1293, DOI 10.1104/pp.106.081406; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim HJ, 2008, NATURE, V455, P1134, DOI 10.1038/nature07289; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Marrocco K, 2006, PLANT J, V45, P423, DOI 10.1111/j.1365-313X.2005.02635.x; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Ren H, 2008, PLANT J, V53, P705, DOI 10.1111/j.1365-313X.2007.03370.x; Serralbo O, 2006, P NATL ACAD SCI USA, V103, P13250, DOI 10.1073/pnas.0602410103; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Verkest A, 2005, PLANT CELL, V17, P1723, DOI 10.1105/tpc.105.032383; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang H, 1997, NATURE, V386, P451, DOI 10.1038/386451a0; WANG H, 2007, ANN PLANT REV, P62; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Zhao DH, 2003, PLANT MOL BIOL, V53, P163, DOI 10.1023/B:PLAN.0000009273.81702.b5	59	110	114	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4780	10.1371/journal.pone.0004780	http://dx.doi.org/10.1371/journal.pone.0004780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277118	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496100011
J	Mullenders, J; Fabius, AWM; Madiredjo, M; Bernards, R; Beijersbergen, RL				Mullenders, Jasper; Fabius, Armida W. M.; Madiredjo, Mandy; Bernards, Rene; Beijersbergen, Roderick L.			A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway	PLOS ONE			English	Article								Background: The p53 tumor suppressor gene is mutated in about half of human cancers, but the p53 pathway is thought to be functionally inactivated in the vast majority of cancer. Understanding how tumor cells can become insensitive to p53 activation is therefore of major importance. Using an RNAi-based genetic screen, we have identified three novel genes that regulate p53 function. Results: We have screened the NKI shRNA library targeting 8,000 human genes to identify modulators of p53 function. Using the shRNA barcode technique we were able to quickly identify active shRNA vectors from a complex mixture. Validation of the screening results indicates that the shRNA barcode technique can reliable identify active shRNA vectors from a complex pool. Using this approach we have identified three genes, ARNTL, RBCK1 and TNIP1, previously unknown to regulate p53 function. Importantly, ARNTL (BMAL1) is an established component of the circadian regulatory network. The latter finding adds to recent observations that link circadian rhythm to the cell cycle and cancer. We show that cells having suppressed ARNTL are unable to arrest upon p53 activation associated with an inability to activate the p53 target gene p21(CIP1). Conclusions: We identified three new regulators of the p53 pathway through a functional genetic screen. The identification of the circadian core component ARNTL strengthens the link between circadian rhythm and cancer.	[Mullenders, Jasper; Fabius, Armida W. M.; Madiredjo, Mandy; Bernards, Rene; Beijersbergen, Roderick L.] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands; [Mullenders, Jasper; Fabius, Armida W. M.; Madiredjo, Mandy; Bernards, Rene; Beijersbergen, Roderick L.] Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Mullenders, J (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands.	r.bijersbergen@nki.nl	Mullenders, Jasper/J-2398-2015	Mullenders, Jasper/0000-0003-3737-6901; Beijersbergen, Roderick/0000-0003-0116-4130; Bernards, Rene/0000-0001-8677-3423	Dutch Cancer Society; EU 6th framework program TRANSFOG	Dutch Cancer Society(KWF Kankerbestrijding); EU 6th framework program TRANSFOG	This research was funded by the Dutch Cancer Society (KWF) and by the EU 6th framework program TRANSFOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qian XZ, 2008, INT J CANCER, V122, P1400, DOI 10.1002/ijc.23243; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Tatematsu K, 2005, J BIOL CHEM, V280, P22937, DOI 10.1074/jbc.M413476200; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	47	103	111	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4798	10.1371/journal.pone.0004798	http://dx.doi.org/10.1371/journal.pone.0004798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277210	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496100017
J	Sayyed-Ahmad, A; Kaznessis, YN				Sayyed-Ahmad, Abdallah; Kaznessis, Yiannis N.			Determining the Orientation of Protegrin-1 in DLPC Bilayers Using an Implicit Solvent-Membrane Model	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ANTIMICROBIAL PEPTIDE; LIPID-BILAYERS; BROAD-SPECTRUM; STABILITY; ENERGY; ELECTROSTATICS; DEFENSINS; MUTATIONS; INSERTION	Continuum models that describe the effects of solvent and biological membrane molecules on the structure and behavior of antimicrobial peptides, holds a promise to improve our understanding of the mechanisms of antimicrobial action of these peptides. In such methods, a lipid bilayer model membrane is implicitly represented by multiple layers of relatively low dielectric constant embedded in a high dielectric aqueous solvent, while an antimicrobial peptide is accounted for by a dielectric cavity with fixed partial charge at the center of each one of its atoms. In the present work, we investigate the ability of continuum approaches to predict the most probable orientation of the beta-hairpin antimicrobial peptide Protegrin-1 (PG-1) in DLPC lipid bilayers by calculating the difference in the transfer free energy from an aqueous environment to a membrane-water environment for multiple orientations. The transfer free energy is computed as a sum of two terms; polar/electrostatic and non-polar. They both include energetic and entropic contributions to the free energy. We numerically solve the Poisson-Boltzmann equation to calculate the electrostatic contribution to the transfer free energy, while the non-polar contribution to the free energy is approximated using a linear solvent accessible surface area relationships. The most probable orientation of PG-1 is that with the lowest relative transfer free energy. Our simulation results indicate that PG-1 assumes an oblique orientation in DLPC lipid bilayers. The predicted most favorable orientation was with a tilt angle of 19 degrees, which is in qualitative agreement with the experimentally observed orientations derived from solid-state NMR data.	[Sayyed-Ahmad, Abdallah; Kaznessis, Yiannis N.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Sayyed-Ahmad, Abdallah; Kaznessis, Yiannis N.] Univ Minnesota, Digital Technol Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sayyed-Ahmad, A (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	yiannis@cems.umn.edu	, Asa/W-3080-2019; Kaznessis, Yiannis N/H-1795-2015	, Asa/0000-0003-2415-8403; Kaznessis, Yiannis/0000-0002-5088-1104	NIH [GM 070989]; National Computational Science Alliance [TG-MCA04N033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Computational Science Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH (GM 070989). The authors gratefully acknowledge the computational support from the Minnesota Supercomputing Institute. This work also was partially supported by the National Computational Science Alliance under TG-MCA04N033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT RG, 1981, BIOCHIM BIOPHYS ACTA, V643, P191, DOI 10.1016/0005-2736(81)90232-7; Baker N, 2000, J COMPUT CHEM, V21, P1343, DOI 10.1002/1096-987X(20001130)21:15<1343::AID-JCC2>3.0.CO;2-K; Bechor D, 2001, BIOPHYS J, V80, P643, DOI 10.1016/S0006-3495(01)76045-6; Berneche S, 1998, BIOPHYS J, V75, P1603, DOI 10.1016/S0006-3495(98)77604-0; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Bransburg-Zabary S, 2002, BIOCHEMISTRY-US, V41, P6946, DOI 10.1021/bi0120704; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Choi HS, 2006, BIOMACROMOLECULES, V7, P403, DOI 10.1021/bm050579z; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Gidalevitz D, 2003, P NATL ACAD SCI USA, V100, P6302, DOI 10.1073/pnas.0934731100; Haider S, 2005, BIOPHYS J, V88, P3310, DOI 10.1529/biophysj.104.052019; Harwig SSL, 1996, EUR J BIOCHEM, V240, P352, DOI 10.1111/j.1432-1033.1996.0352h.x; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Khandelia H, 2005, PEPTIDES, V26, P2037, DOI 10.1016/j.peptides.2005.03.058; Khandelia H, 2007, BBA-BIOMEMBRANES, V1768, P509, DOI 10.1016/j.bbamem.2006.11.015; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Langham AA, 2006, MOL SIMULAT, V32, P193, DOI 10.1080/08927020600612205; Langham AA, 2006, BIOPOLYMERS, V84, P219, DOI 10.1002/bip.20397; Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; ORSOLYA T, 2005, J PEPT SCI, V80, P717; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Sansom MSP, 1997, BIOPHYS J, V73, P2404, DOI 10.1016/S0006-3495(97)78269-9; Sayyed-Ahmad A, 2004, J COMPUT CHEM, V25, P1068, DOI 10.1002/jcc.20039; SEIICHIRO T, 2005, J CHEM PHYS, V122; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Sengupta D, 2005, PROTEINS, V58, P913, DOI 10.1002/prot.20383; Shepherd CM, 2003, BIOCHEM J, V370, P233, DOI 10.1042/BJ20021255; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Steinstraesser L, 2001, CRIT CARE MED, V29, P1431, DOI 10.1097/00003246-200107000-00022; Tanizaki S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1865992; Ulmschneider MB, 2007, BIOPHYS J, V92, P2338, DOI 10.1529/biophysj.106.081810; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yamaguchi S, 2002, BIOCHEMISTRY-US, V41, P9852, DOI 10.1021/bi0257991; YECHIEL S, 2002, J PEPT SCI, V66, P236; Zanetti M, 2002, CURR PHARM DESIGN, V8, P779, DOI 10.2174/1381612023395457; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	45	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4799	10.1371/journal.pone.0004799	http://dx.doi.org/10.1371/journal.pone.0004799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277199	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496100018
J	Waak, J; Weber, SS; Waldenmaier, A; Gorner, K; Alunni-Fabbroni, M; Schell, H; Vogt-Weisenhorn, D; Pham, TT; Reumers, V; Baekelandt, V; Wurst, W; Kahle, PJ				Waak, Jens; Weber, Stephanie S.; Waldenmaier, Andrea; Goerner, Karin; Alunni-Fabbroni, Marianna; Schell, Heinrich; Vogt-Weisenhorn, Daniela; Pham, Thu-Trang; Reumers, Veerle; Baekelandt, Veerle; Wurst, Wolfgang; Kahle, Philipp J.			Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1	FASEB JOURNAL			English	Article						nitric oxide synthase; mitogen-activated protein kinase; Toll-like receptor signaling; neuroinflammation; lipopolysaccharide	OXIDATIVE STRESS; DJ-1-DEFICIENT MICE; PROTEIN STABILITY; NITRIC-OXIDE; IN-VIVO; EXPRESSION; MUTATIONS; LIPOPOLYSACCHARIDE; NEUROPROTECTION; LOCALIZATION	The Parkinson's disease (PD)-associated gene DJ-1 mediates direct neuroprotection. The up-regulation of DJ-1 in reactive astrocytes also suggests a role in glia. Here we show that DJ-1 regulates proinflammatory responses in mouse astrocyte-rich primary cultures. When treated with a Toll-like receptor 4 agonist, the bacterial endotoxin lipopolysaccharide (LPS), Dj-1-knockout astrocytes generated >10 times more nitric oxide (NO) than littermate controls. Lentiviral reintroduction of DJ-1 restored the NO response to LPS. The enhanced NO production in Dj-1(-/-) astrocytes was mediated by a signaling pathway involving reactive oxygen species leading to specific hyperinduction of type II NO synthase [inducible NO synthase ( iNOS)]. These effects coincided with significantly increased phosphorylation of p38 mitogen-activated protein kinase (MAPK), and p38(MAPK) inhibition suppressed NO production and iNOS mRNA and protein induction. Dj-1(-/-) astrocytes also induced the proinflammatory mediators cyclooxygenase-2 and interleukin-6 significantly more strongly, but not nerve growth factor. Finally, primary neuron cultures grown on Dj-1(-/-) astrocytes became apoptotic in response to LPS in an iNOS-dependent manner, directly demonstrating the neurotoxic potential of astrocytic DJ-1 deficiency. These findings identify DJ-1 as a regulator of proinflammatory responses and suggest that loss of DJ-1 contributes to PD pathogenesis by deregulation of astrocytic neuroinflammatory damage.-Waak, J., Weber, S. S., Waldenmaier, A., Gorner, K., Alunni-Fabbroni, M., Schell, H., Vogt-Weisenhorn, D., Pham, T.-T., Reumers, V., Baekelandt, V., Wurst, W., Kahle, P. J. Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB J. 23, 2478-2489 (2009)	[Kahle, Philipp J.] Univ Clin Tubingen, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Waldenmaier, Andrea; Goerner, Karin; Alunni-Fabbroni, Marianna] BBD, Advalytix Prod, Olympus Life Sci Res Europe, Munich, Germany; [Vogt-Weisenhorn, Daniela; Pham, Thu-Trang; Wurst, Wolfgang] Helmholtz Ctr Munich, Inst Dev Genet, Neuherberg, Germany; [Reumers, Veerle; Baekelandt, Veerle] Katholieke Univ Leuven, Div Mol Med, Dept Mol & Cellular Med, Lab Neurobiol & Gene Therapy, Leuven, Belgium	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Olympus Corporation; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; KU Leuven	Kahle, PJ (corresponding author), Univ Clin Tubingen, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Dept Neurodegenerat, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de	Baekelandt, Veerle/ABB-9736-2020	Baekelandt, Veerle/0000-0001-8966-2921; Vogt Weisenhorn, Daniela/0000-0002-4566-6506; Wurst, Wolfgang/0000-0003-4422-7410	German Ministry of Education and Research National Genome Research Network; German Research Council Collaborative Research Center; Novartis; Helmholtz Alliance "Aging Brain,"; Hertie Foundation; Flemish Foundation for Scientific Research (FWO Vlaanderen)	German Ministry of Education and Research National Genome Research Network(Federal Ministry of Education & Research (BMBF)); German Research Council Collaborative Research Center(German Research Foundation (DFG)); Novartis(Novartis); Helmholtz Alliance "Aging Brain,"; Hertie Foundation; Flemish Foundation for Scientific Research (FWO Vlaanderen)(FWO)	This work was supported by grants from the German Ministry of Education and Research National Genome Research Network and the German Research Council Collaborative Research Center (SFB596 "Molecular Mechanisms of Neurodegeneration"), a Novartis collaborative research grant, the Helmholtz Alliance "Aging Brain," and the Hertie Foundation. V. R. was supported by a travel grant of the Flemish Foundation for Scientific Research (FWO Vlaanderen). We thank Lars Stolze [Hertie-Institut fur klinische Hirnforschung (HIH), Tubingen, Germany] for advice and donation of anti-CD11b, Ingo Autenrieth for helpful discussions, and Hidenori Ichijo and Thomas Gasser for support and critically reading the manuscript.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Badera V, 2005, BRAIN RES, V1041, P102, DOI 10.1016/j.brainres.2005.02.006; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; GalveRoperh I, 1997, J NEUROSCI RES, V49, P569, DOI 10.1002/(SICI)1097-4547(19970901)49:5<569::AID-JNR7>3.0.CO;2-9; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gorner K, 2004, J BIOL CHEM, V279, P6943, DOI 10.1074/jbc.M309204200; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Manning-Bog AB, 2007, NEUROBIOL DIS, V27, P141, DOI 10.1016/j.nbd.2007.03.014; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miklossy J, 2006, EXP NEUROL, V197, P275, DOI 10.1016/j.expneurol.2005.10.034; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Mullett SJ, 2009, NEUROPATHOLOGY, V29, P125, DOI 10.1111/j.1440-1789.2008.00955.x; Mullett SJ, 2009, NEUROBIOL DIS, V33, P28, DOI 10.1016/j.nbd.2008.09.013; Nagashima R, 2008, NEUROSCI LETT, V440, P232, DOI 10.1016/j.neulet.2008.05.100; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Rizzu P, 2004, ANN NEUROL, V55, P113, DOI 10.1002/ana.10782; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamaguchi H, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-10; Yanagida T, 2006, J PHARMACOL SCI, V102, P243, DOI 10.1254/jphs.SC0060098; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	45	135	139	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2478	2489		10.1096/fj.08-125153	http://dx.doi.org/10.1096/fj.08-125153			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19276172				2022-12-25	WOS:000268836700016
J	Betterle, N; Ballottari, M; Zorzan, S; de Bianchi, S; Cazzaniga, S; Dall'Osto, L; Morosinotto, T; Bassi, R				Betterle, Nico; Ballottari, Matteo; Zorzan, Simone; de Bianchi, Silvia; Cazzaniga, Stefano; Dall'Osto, Luca; Morosinotto, Tomas; Bassi, Roberto			Light-induced Dissociation of an Antenna Hetero-oligomer Is Needed for Non-photochemical Quenching Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II MEMBRANES; HARVESTING COMPLEX; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; GRANA MEMBRANES; HIGHER-PLANTS; SUPRAMOLECULAR ORGANIZATION; CHLAMYDOMONAS-REINHARDTII; PHOTOSYNTHETIC MEMBRANES; THYLAKOID MEMBRANES	PsbS plays a major role in activating the photoprotection mechanism known as "non-photochemical quenching," which dissipates chlorophyll excited states exceeding the capacity for photosynthetic electron transport. PsbS activity is known to be triggered by low lumenal pH. However, the molecular mechanism by which this subunit regulates light harvesting efficiency is still unknown. Here we show that PsbS controls the association/dissociation of a five-subunit membrane complex, composed of two monomeric Lhcb proteins (CP29 and CP24) and the trimeric LHCII-M. Dissociation of this supercomplex is indispensable for the onset of non-photochemical fluorescence quenching in high light, strongly suggesting that protein subunits catalyzing the reaction of heat dissipation are buried into the complex and thus not available for interaction with PsbS. Consistently, we showed that knock-out mutants on two subunits participating to the B4C complex were strongly affected in heat dissipation. Direct observation by electron microscopy and image analysis showed that B4C dissociation leads to the redistribution of PSII within grana membranes. We interpreted these results to mean that the dissociation of B4C makes quenching sites, possibly CP29 and CP24, available for the switch to an energy-quenching conformation. These changes are reversible and do not require protein synthesis/degradation, thus allowing for changes in PSII antenna size and adaptation to rapidly changing environmental conditions.	[Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35131 Padua, Italy	University of Verona; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Str Le Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Cazzaniga, Stefano/ABG-3898-2021; Morosinotto, Tomas/AAC-3188-2019; Dall'Osto, Luca/A-9384-2010; Ballottari, Matteo/N-1916-2019; Betterle, Nico/AAE-1004-2021	Cazzaniga, Stefano/0000-0002-2824-7916; Morosinotto, Tomas/0000-0002-0803-7591; Ballottari, Matteo/0000-0001-8410-3397; Betterle, Nico/0000-0002-7556-6696; bassi, roberto/0000-0002-4140-8446; Dall'Osto, Luca/0000-0001-9497-5156	FISR IDROBIO; Italian Ministry of Research Special Fund for Basic Research;  [PRIN 20073YHRLE];  [FIRB RBLA0345SF002]	FISR IDROBIO; Italian Ministry of Research Special Fund for Basic Research(Ministry of Education, Universities and Research (MIUR)); ; 	Supported by Grant PRIN 20073YHRLE.; Supported by Grants FIRB RBLA0345SF002 (Solanacee) and FISR IDROBIO. from the Italian Ministry of Research Special Fund for Basic Research. To whom correspondence should be addressed: Dipartimento Scientifico e Tecnologico, Universita di Verona, Strada Le Grazie 15, I-37134 Verona, Italy. Tel.: 39-045-802-7915; Fax: 39-045-802-7929; E-mail: bassi@sci.univr.it.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; BRIANTAIS JM, 1994, PHOTOSYNTH RES, V40, P287, DOI 10.1007/BF00034778; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Frigerio S, 2007, J BIOL CHEM, V282, P29457, DOI 10.1074/jbc.M705132200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; LINDAHL M, 1995, EUR J BIOCHEM, V231, P503, DOI 10.1111/j.1432-1033.1995.tb20725.x; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nield J, 2000, NAT STRUCT BIOL, V7, P44; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; Tikkanen M, 2006, PLANT MOL BIOL, V62, P779, DOI 10.1007/s11103-006-9044-8; Tremmel IG, 2003, BBA-BIOENERGETICS, V1607, P97, DOI 10.1016/j.bbabio.2003.09.004; TREMOLIERES A, 1994, EUR J BIOCHEM, V221, P721, DOI 10.1111/j.1432-1033.1994.tb18785.x; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	56	245	249	2	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15255	15266		10.1074/jbc.M808625200	http://dx.doi.org/10.1074/jbc.M808625200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19307183	Green Published, hybrid			2022-12-25	WOS:000266288200060
J	Tewari, N; Kalkunte, S; Murray, DW; Sharma, S				Tewari, Neetu; Kalkunte, Satyan; Murray, David W.; Sharma, Surendra			The Water Channel Aquaporin 1 Is a Novel Molecular Target of Polychlorinated Biphenyls for in Utero Anomalies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMNIOTIC-FLUID VOLUME; PRETERM LABOR; NK CELLS; EXPRESSION; IL-10; WOMEN; CONSUMPTION; EXPOSURE; PCBS; INTERLEUKIN-10	Despite serious health risks in humans and wild life, the underlying mechanisms that explain the gene-environment effects of chemical toxicants are largely unknown. Polychlorinated biphenyls (PCBs) are one of the most ubiquitous environmental toxicants worldwide, with reported epidemiological evidence for reproductive and neurocognitive anomalies in humans. Here, we show that Aroclor 1254, a mixture of structurally distinct PCBs, causes preterm birth in interleukin (IL)-10(-/-) mice at a dose that does not show any adverse effects in wild type mice, highlighting the significance of IL-10 as an anti-toxicant cytokine. Aroclor 1254-treated IL-10(-/-) mice demonstrated increased amniotic fluid, intrauterine growth restriction, and reduced litter size with postnatal neuromotor defects. Further, our results identify aquaporin 1 (AQP1), a potent effector of fluid volume regulation and angiogenic activity, as a novel placental target of PCBs. In vivo or in vitro exposure to Aroclor 1254 coupled with IL-10 deficiency significantly reduced the protein content of AQP1. Reduced uterine AQP1 levels were associated with defective spiral artery transformation. Importantly, recombinant IL-10 reversed PCB-induced in vivo and in vitro effects. These data demonstrate for the first time that the IL-10-AQP1 axis is a novel regulator of PCB-induced in utero effects.	Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02905 USA; [Murray, David W.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Brown University	Sharma, S (corresponding author), 101 Dudley St, Providence, RI 02905 USA.	ssharma@wihri.org	Moore, Thomas/F-2033-2010		National Institutes of Health Award [P20RR018728]; National Center for Research Resources; Superfund Basic Research Program Award [P42ES013660]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660] Funding Source: NIH RePORTER	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Superfund Basic Research Program Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Award P20RR018728 through the National Center for Research Resources. This work was also supported in part by Superfund Basic Research Program Award P42ES013660.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Aldo PB, 2007, AM J REPROD IMMUNOL, V58, P98, DOI 10.1111/j.1600-0897.2007.00493.x; ARNOLD DL, 1995, FOOD CHEM TOXICOL, V33, P457, DOI 10.1016/0278-6915(95)00018-W; Baibergenova A, 2003, ENVIRON HEALTH PERSP, V111, P1352, DOI 10.1289/ehp.6053; Beall MH, 2007, PLACENTA, V28, P824, DOI 10.1016/j.placenta.2006.12.004; Beall MH, 2007, PLACENTA, V28, P421, DOI 10.1016/j.placenta.2006.06.005; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Dumont FJ, 2003, EXPERT OPIN THER PAT, V13, P1551, DOI 10.1517/13543776.13.10.1551; Gerhard I, 1998, ENVIRON HEALTH PERSP, V106, P675, DOI 10.2307/3434097; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Gray KA, 2005, AM J EPIDEMIOL, V162, P17, DOI 10.1093/aje/kwi158; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Hanna N, 2006, AM J REPROD IMMUNOL, V55, P19, DOI 10.1111/j.1600-0897.2005.00342.x; Harman CR, 2008, SEMIN PERINATOL, V32, P288, DOI 10.1053/j.semperi.2008.04.012; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; HENSEN LG, 2008, PCBS HUMAN ENV DISPO, P1; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Kaikunte S, 2008, PLACENTA, V29, P871, DOI 10.1016/j.placenta.2008.07.009; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; KINSKY R, 1990, AM J REPROD IMMUNOL, V23, P73, DOI 10.1111/j.1600-0897.1990.tb00675.x; Kostyniak PJ, 1999, ENVIRON RES, V80, pS166, DOI 10.1006/enrs.1998.3939; Krishnan L, 1996, J IMMUNOL, V156, P644; Lee CK, 2007, REPROD FERT DEVELOP, V19, P539, DOI 10.1071/RD06117; Lee SE, 2008, J MATERN-FETAL NEO M, V21, P89, DOI 10.1080/14767050701830514; Liu H, 2008, PLACENTA, V29, P840, DOI 10.1016/j.placenta.2008.07.010; Mann SE, 2005, AM J OBSTET GYNECOL, V192, P2041, DOI 10.1016/j.ajog.2005.02.046; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mendola P, 1997, AM J EPIDEMIOL, V146, P955, DOI 10.1093/oxfordjournals.aje.a009222; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Parham P, 2004, J EXP MED, V200, P951, DOI 10.1084/jem.20041783; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Plevyak M, 2002, AM J REPROD IMMUNOL, V47, P242, DOI 10.1034/j.1600-0897.2002.01060.x; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Ross PS, 2000, SCIENCE, V289, P1878; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sadowsky DW, 2003, AM J OBSTET GYNECOL, V188, P252, DOI 10.1067/mob.2003.70; SAFE S, 1987, POLYCHLORINATED BIPH, P1; Sugawara N, 2006, ARCH TOXICOL, V80, P286, DOI 10.1007/s00204-005-0042-4; Trautman MS, 1997, J SOC GYNECOL INVEST, V4, P247, DOI 10.1016/S1071-5576(97)00045-2; Tsukimori K, 2008, ENVIRON HEALTH PERSP, V116, P626, DOI 10.1289/ehp.10686; *US EPA, 1996, 8082A18082A56 US EPA; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Weintraub M, 2008, ENVIRON RES, V107, P412, DOI 10.1016/j.envres.2008.03.001; *WHO, 2003, 55 CICADS WHO INT PR; Yu ML, 2000, INT J EPIDEMIOL, V29, P672, DOI 10.1093/ije/29.4.672; [No title captured]	50	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15224	15232		10.1074/jbc.M808892200	http://dx.doi.org/10.1074/jbc.M808892200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332547	Green Published, hybrid			2022-12-25	WOS:000266288200057
J	Frydenvang, K; Lash, LL; Naur, P; Postila, PA; Pickering, DS; Smith, CM; Gajhede, M; Sasaki, M; Sakai, R; Pentikainen, OT; Swanson, GT; Kastrup, JS				Frydenvang, Karla; Lash, L. Leanne; Naur, Peter; Postila, Pekka A.; Pickering, Darryl S.; Smith, Caleb M.; Gajhede, Michael; Sasaki, Makoto; Sakai, Ryuichi; Pentikainen, Olli T.; Swanson, Geoffrey T.; Kastrup, Jette S.			Full Domain Closure of the Ligand-binding Core of the Ionotropic Glutamate Receptor iGluR5 Induced by the High Affinity Agonist Dysiherbaine and the Functional Antagonist 8,9-Dideoxyneodysiherbaine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; AMINO-ACID; PHARMACOLOGICAL-PROPERTIES; KAINATE; GLUR5; DESENSITIZATION; ACTIVATION; MECHANISM; CRYSTALLOGRAPHY	The prevailing structural model for ligand activation of ionotropic glutamate receptors posits that agonist efficacy arises from the stability and magnitude of induced domain closure in the ligand-binding core structure. Here we describe an exception to the correlation between ligand efficacy and domain closure. A weakly efficacious partial agonist of very low potency for homomeric iGluR5 kainate receptors, 8,9-dideoxyneodysiherbaine (MSVIII-19), induced a fully closed iGluR5 ligand-binding core. The degree of relative domain closure, similar to 30 degrees, was similar to that we resolved with the structurally related high affinity agonist dysiherbaine and to that of L-glutamate. The pharmacological activity of MSVIII-19 was confirmed in patch clamp recordings from transfected HEK293 cells, where MSVIII-19 predominantly inhibits iGluR5-2a, with little activation apparent at a high concentration (1 mM) of MSVIII-19 (<1% of mean glutamate-evoked currents). To determine the efficacy of the ligand quantitatively, we constructed concentration-response relationships for MSVIII-19 following potentiation of steady-state currents with concanavalin A (EC50 = 3.6 mu M) and on the nondesensitizing receptor mutant iGluR5-2b(Y506C/L768C) (EC50 = 8.1 mu M). MSVIII-19 exhibited a maximum of 16% of full agonist efficacy, as measured in parallel recordings with glutamate. Molecular dynamics simulations and electrophysiological recordings confirm that the specificity of MSVIII-19 for iGluR5 is partly attributable to interdomain hydrogen bond residues Glu(441) and Ser(721) in the iGluR5-S1S2 structure. The weaker interactions of MSVIII-19 with iGluR5 compared with dysiherbaine, together with altered stability of the interdomain interaction, may be responsible for the apparent uncoupling of domain closure and channel opening in this kainate receptor subunit.	[Frydenvang, Karla; Naur, Peter; Gajhede, Michael; Kastrup, Jette S.] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Pickering, Darryl S.] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Lash, L. Leanne; Smith, Caleb M.; Swanson, Geoffrey T.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Postila, Pekka A.; Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Postila, Pekka A.; Pentikainen, Olli T.] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Sasaki, Makoto] Tohoku Univ, Grad Sch Life Sci, Lab Biostruct Chem, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Sakai, Ryuichi] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	University of Copenhagen; University of Copenhagen; Northwestern University; Feinberg School of Medicine; University of Jyvaskyla; University of Jyvaskyla; Tohoku University; Hokkaido University	Kastrup, JS (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark.	jsk@farma.ku.dk	Postila, Pekka/Z-1177-2019; Pentikäinen, Olli T/E-1980-2012; Sasaki, Makoto/AAE-5204-2019	Postila, Pekka/0000-0002-2947-7991; Pentikäinen, Olli T/0000-0001-7188-4016; Sasaki, Makoto/0000-0003-2964-7986; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287	National Institutes of Health, NINDS [R01 NS44322]; Dansync Center for Synchrotron Radiation; Danish Medical Research Council; European Community; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044322] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dansync Center for Synchrotron Radiation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS44322 (to G. T. S.). This work was also supported by grants from the Dansync Center for Synchrotron Radiation, the Danish Medical Research Council, the European Community (Access to Research Infrastructure Action of the Improving Human Potential Programme) (to K. F., P. N., M. G., and J.S.K.) and by the Sigrid Juselius Foundation (to O.T.P.).	Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Bahar M, 2006, ACTA CRYSTALLOGR D, V62, P1170, DOI 10.1107/S0907444906032197; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bowie D, 2003, J PHYSIOL-LONDON, V547, P373, DOI 10.1113/jphysiol.2002.033076; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dingledine R, 1999, PHARMACOL REV, V51, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Hald H, 2007, J BIOL CHEM, V282, P25726, DOI 10.1074/jbc.M700137200; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kubo M, 2004, PROTEINS, V56, P411, DOI 10.1002/prot.20154; Lash LL, 2008, J PHARMACOL EXP THER, V324, P484, DOI 10.1124/jpet.107.129890; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Naur P, 2005, FEBS LETT, V579, P1154, DOI 10.1016/j.febslet.2005.01.012; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Nielsen BS, 1998, EUR J PHARMACOL, V360, P227, DOI 10.1016/S0014-2999(98)00668-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakai R, 1997, J AM CHEM SOC, V119, P4112, DOI 10.1021/ja963953z; Sakai R, 2001, J PHARMACOL EXP THER, V296, P650; Sanders JM, 2005, J PHARMACOL EXP THER, V314, P1068, DOI 10.1124/jpet.105.086389; Sasaki M, 1999, TETRAHEDRON LETT, V40, P3195, DOI 10.1016/S0040-4039(99)00413-X; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 2002, NEURON, V34, P589, DOI 10.1016/S0896-6273(02)00676-1; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178	52	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14219	14229		10.1074/jbc.M808547200	http://dx.doi.org/10.1074/jbc.M808547200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297335	Green Published, hybrid			2022-12-25	WOS:000266286100028
J	Rambaud, J; Desroches, J; Balsalobre, A; Drouin, J				Rambaud, Juliette; Desroches, Julien; Balsalobre, Aurelio; Drouin, Jacques			TIF1 beta/KAP-1 Is a Coactivator of the Orphan Nuclear Receptor NGFI-B/Nur77	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; CORTICOTROPIN-RELEASING HORMONE; T-BOX FACTOR; PROOPIOMELANOCORTIN GENE; NGFI-B; TRANSCRIPTION FACTOR; GLUCOCORTICOID-RECEPTOR; PARAVENTRICULAR NUCLEUS; COREPRESSOR COMPLEX; REPRESSOR DOMAIN	In efforts to define mechanisms of transcriptional activation by the orphan nuclear receptor NGFI-B (Nur77), we identified TIF1 beta by mass spectrometry within a nuclear protein complex containing NGFI-B. TIF1 beta, also known as KAP-1 (KRAB domain-associated protein) or KRIP-1, acts as a transcriptional corepressor for many transcription factors, in particular for the Kruppel-associated box domain-containing zinc finger transcription factors. TIF1 beta is also an intrinsic component of two chromatin remodeling and histone deacetylase complexes, the N-CoR1 and nucleosome remodeling and deacetylation complexes. In contrast to these activities, we report that TIF1 beta is a coactivator of NGFI-B and that it is as potent as the SRC coactivators in this context. Using pull-down assays and immunoprecipitation, we showed that TIF1 beta interacts directly with NGFI-B and with other Nur family members. NGFI-B is an important mediator of hypothalamic corticotropin-releasing hormone (CRH) activation of proopiomelanocortin (POMC) transcription, and TIF1 beta enhances transcription mediated through the NGFI-B target, the Nur response element (NurRE). The NurRE binds Nur factor dimers and is responsive to signaling pathways. In keeping with the role of NGFI-B as mediator of CRH signaling, we found that TIF1 beta is recruited to the POMC promoter following CRH stimulation and that TIF1 beta potentiates CRH and protein kinase A signaling through the NurRE; it acts synergistically with the SRC2 coactivator. However, the actions of TIF1 beta and SRC2 were mapped to different NGFI-B AF-1 subdomains. Taken together, these results indicate that TIF1 beta is an important coactivator of NGFI-B-dependent transcription.	[Rambaud, Juliette; Desroches, Julien; Balsalobre, Aurelio; Drouin, Jacques] Inst Rech Clin Montreal, Mol Genet Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Balsalobre, A (corresponding author), 110 Ave Pins O, Montreal, PQ H2W 1R7, Canada.	Aurelio.Balsalobre@ircm.qc.ca; Jacques.Drouin@ircm.qc.ca		Drouin, Jacques/0000-0001-8226-5691	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to J.D.).	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Bandoh S, 1997, J NEUROENDOCRINOL, V9, P3, DOI 10.1046/j.1365-2826.1997.00571.x; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; BIRNBERG NC, 1983, P NATL ACAD SCI-BIOL, V80, P6982, DOI 10.1073/pnas.80.22.6982; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GAGNER JP, 1987, MOL ENDOCRINOL, V1, P677, DOI 10.1210/mend-1-10-677; GAGNER JP, 1985, MOL CELL ENDOCRINOL, V40, P25, DOI 10.1016/0303-7207(85)90154-6; HONKANIEMI J, 1994, MOL BRAIN RES, V25, P234, DOI 10.1016/0169-328X(94)90158-9; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; LABRIE F, 1982, SCIENCE, V216, P1007, DOI 10.1126/science.6281886; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; LE DB, 1996, EMBO J, V15, P6701; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Maira M, 2003, J BIOL CHEM, V278, P46523, DOI 10.1074/jbc.M305626200; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Martens C, 2005, MOL ENDOCRINOL, V19, P885, DOI 10.1210/me.2004-0333; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; PARKES D, 1993, MOL ENDOCRINOL, V7, P1357, DOI 10.1210/me.7.10.1357; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; REISINE T, 1985, P NATL ACAD SCI USA, V82, P8261, DOI 10.1073/pnas.82.23.8261; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; TREMBLAY Y, 1988, P NATL ACAD SCI USA, V85, P8890, DOI 10.1073/pnas.85.23.8890; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; WATSON MA, 1990, DEVELOPMENT, V110, P173; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116	55	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14147	14156		10.1074/jbc.M809023200	http://dx.doi.org/10.1074/jbc.M809023200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321449	hybrid, Green Published			2022-12-25	WOS:000266286100021
J	Randall, A; Griffith, JD				Randall, Adrian; Griffith, Jack D.			Structure of Long Telomeric RNA Transcripts THE G-RICH RNA FORMS A COMPACT REPEATING STRUCTURE CONTAINING G-QUARTETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TELOMERES; G-QUADRUPLEX; VISUALIZATION; CHROMATIN	Recent studies have identified RNA transcripts arising from mammalian telomeres with the transcript of the C-rich strand (r(5'-UUAGGG-3')(n)) being much more abundant than transcripts of the G-rich strand. Here we used transmission electron microscopy, CD, and nuclease digestion to investigate the structure of similar to 640-nucleotide (nt) RNA transcripts of the C-rich and G-rich strands of mammalian telomeric DNA. The CD spectrum of the C-rich RNA in low salt (10 mM KCl) or high salt (100 mM KCl) was typical of mixed sequence RNA, whereas the CD spectrum for the G-rich RNA differed with changes characteristic of parallel G-quadruplexes at the higher salt concentration. Electron microscopy visualization of the C-rich RNA revealed relatively extended unstructured molecules 59.7 +/- 17.8 nm in length and with a width consistent with single-stranded RNA following metal coating. In contrast, the G-rich RNA was observed as round particles and short, thick rods with the rods being most prevalent in high salt conditions and absent in low salt. The rods were 22.7 +/- 4.8 nm in length and 7.6 nm in width. Digestion of the G-rich RNA with T1 RNA nuclease revealed a ladder of bands whose sizes were integral multiples of 24 nt plus a 4-nt overhang. These observations suggest a model in which G-rich telomeric RNA folds into chains of particles each consisting of four (UUAGGG) repeats stabilized by parallel G-quartets and joined by UUA linkers. These chains further condense to form short rods and round particles.	[Randall, Adrian; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819, ES013773]; Glenn Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31819 and ES013773 (to J.D.G.). This work was also supported by an award from the Glenn Foundation.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; FAJKUS J, 1995, MOL GEN GENET, V247, P633, DOI 10.1007/BF00290355; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; NAKAMURA TM, 1995, EMBO J, V14, P4849, DOI 10.1002/j.1460-2075.1995.tb00166.x; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nosek J., 2008, ORIGIN EVOLUTION TEL; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Pedroso IM, 2009, NUCLEIC ACIDS RES, V37, P1541, DOI 10.1093/nar/gkn1081; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Qi JY, 2007, BIOCHEMISTRY-US, V46, P7599, DOI 10.1021/bi602392u; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Stansel RM, 2001, EMBO J, V20, P5532; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; WANG YH, 1994, J MOL BIOL, V236, P64, DOI 10.1006/jmbi.1994.1118; Westhof E, 2000, STRUCTURE, V8, pR55, DOI 10.1016/S0969-2126(00)00112-X; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Xu Y, 2008, J AM CHEM SOC, V130, P11179, DOI 10.1021/ja8031532; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h	25	59	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					13980	13986		10.1074/jbc.M900631200	http://dx.doi.org/10.1074/jbc.M900631200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329435	Green Published, hybrid			2022-12-25	WOS:000266286100004
J	Droppelmann, CA; Gutierrez, J; Vial, C; Brandan, E				Droppelmann, Cristian A.; Gutierrez, Jaime; Vial, Cecilia; Brandan, Enrique			Matrix Metalloproteinase-2-deficient Fibroblasts Exhibit an Alteration in the Fibrotic Response to Connective Tissue Growth Factor/CCN2 because of an Increase in the Levels of Endogenous Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GENE-EXPRESSION; TGF-BETA; SKELETAL-MUSCLE; INTEGRIN ALPHA(V)BETA(3); ADHESION RECEPTOR; RNA EXPRESSION; HUMAN LIVER; FACTOR CCN2; ACTIVATION; INHIBITORS	Matrix metalloproteinase-2 (MMP-2) is an important extracellular matrix remodeling enzyme, and it has been involved in different fibrotic disorders. The connective tissue growth factor (CTGF/CCN2), which is increased in these pathologies, induces the production of extracellular matrix proteins. To understand the fibrotic process observed in diverse pathologies, we analyzed the fibroblast response to CTGF when MMP-2 activity is inhibited. CTGF increased fibronectin (FN) amount, MMP-2 mRNA expression, and gelatinase activity in 3T3 cells. When MMP-2 activity was inhibited either by the metalloproteinase inhibitor GM-6001 or in MMP-2-deficient fibroblasts, an increase in the basal amount of FN together with a decrease of its levels in response to CTGF was observed. This paradoxical effect could be explained by the fact that the excess of FN could block the access to other ligands, such as CTGF, to integrins. This effect was emulated in fibroblasts by adding exogenous FN or RGDS peptides or using anti-integrin alpha(V) subunit-blocking antibodies. Additionally, in MMP-2-deficient cells CTGF did not induce the formation of stress fibers, focal adhesion sites, and ERK phosphorylation. Anti-integrin alpha(V) subunit-blocking antibodies inhibited ERK phosphorylation in control cells. Finally, in MMP-2-deficient cells, FN mRNA expression was not affected by CTGF, but degradation of I-125-FN was increased. These results suggest that expression, regulation, and activity of MMP-2 can play an important role in the initial steps of fibrosis and shows that FN levels can regulate the cellular response to CTGF.	[Droppelmann, Cristian A.; Gutierrez, Jaime; Vial, Cecilia; Brandan, Enrique] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Ctr Regenerac Envejecimiento, Dept Biol Celular & Mol,Millenium Inst Fundamenta, Santiago, Chile	Pontificia Universidad Catolica de Chile	Brandan, E (corresponding author), Catholic Univ Chile, Dept Cell & Mol Biol, Fac Biol Sci, POB 114-D, Santiago, Chile.	ebrandan@bio.puc.cl	Vial, Maria Cecilia/GVS-4266-2022; Brandan, Enrique/A-7063-2017	Droppelmann, Cristian A./0000-0002-0474-6112; Brandan, Enrique/0000-0002-6820-5059; Vial, Cecilia/0000-0002-0399-6144	Fondo de Financiamiento de Centros de Excelencia en Investigacion (FONDAP-Biomedicine) [13980001]; Center for Aging and Regeneration (CARE) [PFB12/2007]; Muscular Dystrophy Association [89419]; FONDECYT [3060100]; Ministerio de Planificacion y Cooperacion (Chile)	Fondo de Financiamiento de Centros de Excelencia en Investigacion (FONDAP-Biomedicine)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Center for Aging and Regeneration (CARE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Muscular Dystrophy Association(Muscular Dystrophy Association); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ministerio de Planificacion y Cooperacion (Chile)	This work was supported in part by Fondo de Financiamiento de Centros de Excelencia en Investigacion (FONDAP-Biomedicine) Grant 13980001, Center for Aging and Regeneration (CARE) Grant PFB12/2007, Muscular Dystrophy Association Grant 89419, FONDECYT Grant 3060100 (to C. D.), and funds from the Ministerio de Planificacion y Cooperacion (Chile).	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Balcerzak D, 2001, J ANIM SCI, V79, P94; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Chen YJ, 2001, EXP CELL RES, V271, P109, DOI 10.1006/excr.2001.5364; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-54; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; HERBST H, 1991, VIRCHOWS ARCH B, V60, P295, DOI 10.1007/BF02899560; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Hsu CC, 2007, INT J EXP PATHOL, V88, P437, DOI 10.1111/j.1365-2613.2007.00554.x; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jansen PL, 2007, J INVEST DERMATOL, V127, P1762, DOI 10.1038/sj.jid.5700765; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Kossakowska AE, 1998, AM J PATHOL, V153, P1895, DOI 10.1016/S0002-9440(10)65703-3; Kumar V., 2005, ROBBINS PATHOLOGIC B, V7th ed., P87; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069; Makowski GS, 1996, ANAL BIOCHEM, V236, P353, DOI 10.1006/abio.1996.0179; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; Mezzano V, 2007, J CELL COMMUN SIGNAL, V1, P205, DOI 10.1007/s12079-008-0018-2; MOULD AP, 1991, J BIOL CHEM, V266, P3579; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Oggionni T, 2006, EUR J HISTOCHEM, V50, P317; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rajendran R, 2006, Indian J Dent Res, V17, P161; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Roestenberg P, 2004, DIABETES CARE, V27, P1164, DOI 10.2337/diacare.27.5.1164; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; SANCHEZAPARICIO P, 1994, J CELL BIOL, V126, P271, DOI 10.1083/jcb.126.1.271; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Werbajh SE, 1998, FEBS LETT, V440, P277, DOI 10.1016/S0014-5793(98)01473-2; Williams EJ, 2000, J HEPATOL, V32, P754, DOI 10.1016/S0168-8278(00)80244-5; Yang M, 2007, WOUND REPAIR REGEN, V15, P817, DOI 10.1111/j.1524-475X.2007.00284.x; Yu Q, 2000, GENE DEV, V14, P163; Zanotti S, 2007, MATRIX BIOL, V26, P615, DOI 10.1016/j.matbio.2007.06.004	75	29	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13551	13561		10.1074/jbc.M807352200	http://dx.doi.org/10.1074/jbc.M807352200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19276073	Green Published, hybrid			2022-12-25	WOS:000265877300032
J	Sundararaj, KP; Samuvel, DJ; Li, YC; Sanders, JJ; Lopes-Virella, MF; Huang, Y				Sundararaj, Kamala P.; Samuvel, Devadoss J.; Li, Yanchun; Sanders, John J.; Lopes-Virella, Maria F.; Huang, Yan			Interleukin-6 Released from Fibroblasts Is Essential for Up-regulation of Matrix Metalloproteinase-1 Expression by U937 Macrophages in Coculture CROSS-TALKING BETWEEN FIBROBLASTS AND U937 MACROPHAGES EXPOSED TO HIGH GLUCOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIODONTAL-DISEASE; TISSUE INHIBITOR; GENE-EXPRESSION; KAPPA-B; COLLAGENASE; INVOLVEMENT; ACTIVATION; MONOCYTES; TIMP-1; KINASE	Matrix metalloproteinases (MMPs) play a key role in periodontal disease. Although it is known that macrophages and fibroblasts are co-localized and express MMPs in the diseased periodontal tissue, the effect of interaction between these two cell types on MMP expression has not been well elucidated. Furthermore although it is known that diabetes is associated with accelerated periodontal tissue destruction, it remains unknown whether hyperglycemia, a major metabolic abnormality in diabetes, regulates MMP expression by affecting the cross-talking between fibroblasts and macrophages. In this study, human gingival fibroblasts and U937 macrophages were cocultured in a two-compartment transwell culture system, and the cells were treated with normal or high glucose. We found that coculture of fibroblasts and U937 macrophages led to an augmentation of MMP-1 expression by U937 macrophages, and high glucose further enhanced this augmentation. Similar observations were also made in the coculture of fibroblasts and human primary monocytes. We also found that interleukin 6 (IL-6) released by fibroblasts was essential for the augmentation of MMP-1 expression by U937 macrophages. Furthermore our results showed that high glucose, IL-6, and lipopolysaccharide had a synergistic effect on MMP-1 expression. Finally our study indicated that MAPK pathways and activator protein-1 transcription factor were involved in the coculture- and high glucose-augmented MMP-1 expression. In conclusion, this study demonstrates that IL-6 derived from fibroblasts is essential for MMP-1 up-regulation by cross-talking between fibroblasts and U937 macrophages exposed to high glucose, revealing an IL-6-dependent mechanism in MMP-1 up-regulation.	[Li, Yanchun; Lopes-Virella, Maria F.; Huang, Yan] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29403 USA; [Sundararaj, Kamala P.; Samuvel, Devadoss J.; Lopes-Virella, Maria F.; Huang, Yan] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29403 USA; [Sanders, John J.] Med Univ S Carolina, Coll Dent Med, Dept Stomatol, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Huang, Y (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 114 Doughty St, Charleston, SC 29403 USA.	huangyan@musc.edu	li, yan/GTI-4638-2022		National Institutes of Health [DE16353]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE16353 (to Y. H.). This work was also supported by a merit review grant from the Department of Veterans Affairs (to Y. H.).	Aho S, 1997, EUR J BIOCHEM, V247, P503, DOI 10.1111/j.1432-1033.1997.00503.x; Aiba T, 1996, EUR J ORAL SCI, V104, P562, DOI 10.1111/j.1600-0722.1996.tb00142.x; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Cole CM, 2008, J PERIODONTAL RES, V43, P717, DOI 10.1111/j.1600-0765.2008.01082.x; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; de Souza AP, 2003, J CLIN PERIODONTOL, V30, P154, DOI 10.1034/j.1600-051X.2003.300202.x; Dennison DK, 1997, PERIODONTOL 2000, V14, P54, DOI 10.1111/j.1600-0757.1997.tb00192.x; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Domeij H, 2005, BIOCHEM BIOPH RES CO, V338, P1825, DOI 10.1016/j.bbrc.2005.10.137; Ejeil AL, 2003, J PERIODONTOL, V74, P188, DOI 10.1902/jop.2003.74.2.188; Hou LT, 2003, J PERIODONTAL RES, V38, P247, DOI 10.1034/j.1600-0765.2003.02601.x; HUYBRECHTSGODIN G, 1979, BIOCHEM J, V184, P643, DOI 10.1042/bj1840643; Irwin CR, 2002, J PERIODONTOL, V73, P741, DOI 10.1902/jop.2002.73.7.741; Kim S, 2003, J PHARMACOL SCI, V91, P177; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Kumar MS, 2006, J PERIODONTOL, V77, P1803, DOI 10.1902/jop.2006.050293; Legendre F, 2005, J RHEUMATOL, V32, P1307; Maldonado A, 2004, J PERIODONTAL RES, V39, P415, DOI 10.1111/j.1600-0765.2004.00756.x; Mealey B, 1999, J PERIODONTOL, V70, P935; Nareika A, 2005, AM J PHYSIOL-ENDOC M, V289, pE534, DOI 10.1152/ajpendo.00462.2004; Nareika A, 2008, J ENDOCRINOL, V196, P45, DOI 10.1677/JOE-07-0145; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; PETROVICH I, 1983, VOP PITANIYA, V5, P28; Reynolds J J, 1996, Oral Dis, V2, P70; RIFKIN BR, 1993, J PERIODONTOL, V64, P819, DOI 10.1902/jop.1993.64.8s.819; Romanelli R, 1999, INFECT IMMUN, V67, P2319, DOI 10.1128/IAI.67.5.2319-2326.1999; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Ryan ME, 2000, PERIODONTOL 2000, V24, P226, DOI 10.1034/j.1600-0757.2000.2240111.x; Skaleric U, 2006, INFECT IMMUN, V74, P7010, DOI 10.1128/IAI.00071-06; SOCRANSKY SS, 1991, J PERIODONTAL RES, V26, P195, DOI 10.1111/j.1600-0765.1991.tb01646.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tuter G, 2002, J PERIODONTOL, V73, P487, DOI 10.1902/jop.2002.73.5.487; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499	35	68	68	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13714	13724		10.1074/jbc.M806573200	http://dx.doi.org/10.1074/jbc.M806573200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307187	hybrid, Green Published			2022-12-25	WOS:000265877300049
J	Maddika, S; Sy, SMH; Chen, JJ				Maddika, Subbareddy; Sy, Shirley M. -H.; Chen, Junjie			Functional Interaction between Chfr and Kif22 Controls Genomic Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHECKPOINT PROTEIN; CHROMOKINESIN KID; CHROMOSOME ALIGNMENT; METAPHASE; SPINDLE; LIGASE; DOMAIN; ENTRY; XKID	Proper activation of checkpoint during mitotic stress is an important mechanism to prevent genomic instability. Chfr (Check point protein with FHA (Forkhead-associated domain) and RING domains) is a ubiquitin-protein isopeptide ligase (E3) that is important for the control of an early mitotic checkpoint, which delays entry into metaphase in response to mitotic stress. Because several lines of evidence indicate that Chfr is a potential tumor suppressor, it is critically important for us to identify Chfr substrates and understand how Chfr may regulate these substrates, control mitotic transitions, and thus, act as a tumor suppressor in vivo. Here, we report the discovery of a new Chfr-associated protein Kif22, a chromokinesin that binds to both DNA and microtubules. We demonstrated that Kif22 is a novel substrate of Chfr. We showed that Chfr-mediated Kif22 down-regulation is critical for the maintenance of chromosome stability. Collectively, our results reveal a new substrate of Chfr that plays a role in the maintenance of genome integrity.	[Maddika, Subbareddy; Sy, Shirley M. -H.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu		Sy, Ming Hui/0000-0002-2731-6692	National Institutes of Health [CA113381]; NATIONAL CANCER INSTITUTE [R01CA113381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113381 (to J.C).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chaturvedi P, 2002, CANCER RES, V62, P1797; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Yajima J, 2003, EMBO J, V22, P1067, DOI 10.1093/emboj/cdg102; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	18	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12998	13003		10.1074/jbc.M900333200	http://dx.doi.org/10.1074/jbc.M900333200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19321445	Green Published, hybrid			2022-12-25	WOS:000265688300047
J	Lagadec, C; Meignan, S; Adriaenssens, E; Foveau, B; Vanhecke, E; Romon, R; Toillon, RA; Oxombre, B; Hondermarck, H; Le Bourhis, X				Lagadec, C.; Meignan, S.; Adriaenssens, E.; Foveau, B.; Vanhecke, E.; Romon, R.; Toillon, R-A; Oxombre, B.; Hondermarck, H.; Le Bourhis, X.			TrkA overexpression enhances growth and metastasis of breast cancer cells	ONCOGENE			English	Article						neurotrophins; tyrosine kinase receptors; anoikis	FACTOR RECEPTOR; NEUROTROPHIN RECEPTORS; SIGNALING PATHWAYS; FACTOR EXPRESSION; PROSTATE-CANCER; SINGLE-AGENT; CARCINOMA; SURVIVAL; ANOIKIS; ACTIVATION	The Trk family of neurotrophin tyrosine kinase receptors is emerging as an important player in carcinogenic progression in non-neuronal tissues. Here, we show that breast tumors present high levels of TrkA and phospho-TrkA compared to normal breast tissues. To further evaluate the precise functions of TrkA overexpression in breast cancer development, we have performed a series of biological tests using breast cancer cells that stablyov erexpress TrkA. We show that ( 1) TrkA overexpression promoted cell growth, migration and invasion in vitro; ( 2) overexpression of TrkA per se conferred constitutive activation of its tyrosine kinase activity; ( 3) signal pathways including PI3K-Akt and ERK/p38 MAP kinases were activated byTrkA overexpression and were required for the maintenance of a more aggressive cellular phenotype; and ( 4) TrkA overexpression enhanced tumor growth, angiogenesis and metastasis of xenografted breast cancer cells in immunode efficient mice. Moreover, recovered metastatic cells from the lungs exhibited enhanced anoikis resistance that was abolished by the pharmacological inhibitor K252a, suggesting that TrkA-promoted breast tumor metastasis could be mediated at least in part by enhancing anoikis resistance. Together, these results provide the first direct evidence that TrkA overexpression enhances the tumorigenic properties of breast cancer cells and point to TrkA as a potential target in breast cancer therapy. Oncogene ( 2009) 28, 1960-1970; doi:10.1038/onc.2009.61; published online 30 March 2009	[Lagadec, C.; Meignan, S.; Adriaenssens, E.; Foveau, B.; Vanhecke, E.; Romon, R.; Toillon, R-A; Oxombre, B.; Hondermarck, H.; Le Bourhis, X.] Univ Lille 1, INSERM, U908, IFR 147, F-59655 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Le Bourhis, X (corresponding author), Univ Lille 1, INSERM, U908, IFR 147, Batiment SN3, F-59655 Villeneuve Dascq, France.	xuefen.lebourhis@univ-lille1.fr	Le+Bourhis, Xuefen/AAL-5141-2021; Lagadec, chann/E-4250-2010; Toillon, Robert-Alain/Q-2286-2018; Meignan, Samuel/E-9628-2017	Lagadec, chann/0000-0002-5182-2069; Toillon, Robert-Alain/0000-0001-5483-2118; 	la Ligue Nationale Contre le Cancer; INSERM; le Ministere de l'Education Nationale and la Region Nord/Pas-de-Calais	la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); le Ministere de l'Education Nationale and la Region Nord/Pas-de-Calais(Region Hauts-de-France)	We acknowledge the excellent technical assistance of Isabelle Lefebvre. This work was supported by la Ligue Nationale Contre le Cancer ( Equipe Labellisee 2009), INSERM, le Ministere de l'Education Nationale and la Region Nord/Pas-de-Calais plus the FEDER.	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Aragona M, 2001, CANCER INVEST, V19, P692, DOI 10.1081/CNV-100106144; Campos X, 2007, GYNECOL ONCOL, V104, P168, DOI 10.1016/j.ygyno.2006.07.007; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Chiarenza A, 2001, CANCER RES, V61, P3002; Davidson B, 2004, BREAST CANCER RES TR, V83, P119, DOI 10.1023/B:BREA.0000010704.17479.8a; Davidson B, 2003, CLIN CANCER RES, V9, P2248; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dolle L, 2003, ONCOGENE, V22, P5592, DOI 10.1038/sj.onc.1206805; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Hedley BD, 2008, CLIN EXP METASTAS, V25, P727, DOI 10.1007/s10585-008-9184-0; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; McGregor LM, 1999, P NATL ACAD SCI USA, V96, P4540, DOI 10.1073/pnas.96.8.4540; Mercurio AM, 2005, J MAMMARY GLAND BIOL, V10, P283, DOI 10.1007/s10911-006-9001-9; Muka J, 2003, VITAM HORM, V66, P385, DOI 10.1016/S0083-6729(03)01011-2; Nakanishi K, 2002, CANCER RES, V62, P2971; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Sawaki M, 2004, TUMORI J, V90, P40, DOI 10.1177/030089160409000110; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; Tagliabue E, 2000, J BIOL CHEM, V275, P5388, DOI 10.1074/jbc.275.8.5388; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Zhu ZW, 1999, J CLIN ONCOL, V17, P2419, DOI 10.1200/JCO.1999.17.8.2419	31	154	159	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2009	28	18					1960	1970		10.1038/onc.2009.61	http://dx.doi.org/10.1038/onc.2009.61			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	442DT	19330021				2022-12-25	WOS:000265820900003
J	Oh, H; Irvine, KD				Oh, H.; Irvine, K. D.			In vivo analysis of Yorkie phosphorylation sites	ONCOGENE			English	Article						Warts; hippo; yorkie; Drosophila; tumor; phosphorylation	CELL CONTACT INHIBITION; YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; TEAD/TEF FAMILY; GROWTH-CONTROL; HIPPO PATHWAY; DROSOPHILA; YAP; APOPTOSIS; MECHANISM	The co-activator Yorkie (Yki) mediates transcriptional regulation effectedby the Drosophila Fat-Warts (Wts) Hippo (Hpo) pathways. Yki is inhibitedby Wts-mediated phosphorylation, and a Wts phosphorylation site at Ser168 has been identified. Here we identify two additional Wts phosphorylation sites on Yki, and examine the respective contribution of all three sites to Yki nuclear localization and activity. Our results show that although Ser168 is the most critical site, all three phosphorylation sites influence Yki localization and activity in vivo, and can be sites of regulation by Wts. Thus, investigations of the role of Yki and its mammalian homolog Yes-associated protein (YAP) in development and oncogenesis should include evaluations of additional sites. The WW domains of Yki are not required for its phosphorylation, but instead are positively required for its activity. We also identify two potential sites of phosphorylation by an unknown kinase, which could influence phosphorylation of Ser168 by Wts, suggesting that there are additional mechanisms for regulating Yki/YAP activity.	[Oh, H.; Irvine, K. D.] Rutgers State Univ, Dept Mol Biol & Biochem, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08855 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Waksman Inst, Howard Hughes Med Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08855 USA.	irvine@waksman.rutgers.edu			Howard Hughes Medical Institute; NIH [1F32GM079817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079817] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P Beachy, D Pan, J Jiang, G Halder and the Bloomington Drosophila Stock Center for antibodies, plasmids and Drosophila stocks, and C Rauskolb for comments on the paper. This research was supported by the Howard Hughes Medical Institute and NIH post-doctoral fellowship 1F32GM079817 to HO.	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	20	134	140	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2009	28	17					1916	1927		10.1038/onc.2009.43	http://dx.doi.org/10.1038/onc.2009.43			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PX	19330023	Green Accepted			2022-12-25	WOS:000265640600004
J	Nikkila, J; Coleman, KA; Morrissey, D; Pylkas, K; Erkko, H; Messick, TE; Karppinen, SM; Amelina, A; Winqvist, R; Greenberg, RA				Nikkila, J.; Coleman, K. A.; Morrissey, D.; Pylkas, K.; Erkko, H.; Messick, T. E.; Karppinen, S-M; Amelina, A.; Winqvist, R.; Greenberg, R. A.			Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function	ONCOGENE			English	Article						RAP80; breast cancer; BRCA1; ubiquitin	DOUBLE-STRAND BREAKS; TARGETS BRCA1; STROMAL CELLS; PROTEIN; MUTATIONS; SUSCEPTIBILITY; REPAIR; COMPLEX; GENES; RNF8	Germline mutations in two major susceptibility genes, BRCA1 and BRCA2, account for nearly 20% of familial breast cancers. A majority of the remaining genetic factors involved in heritable breast cancer susceptibility are, however, unknown. Recently, a new BRCA1-interacting protein, receptor associated protein 80 (RAP80), was identified. RAP80 plays an important role in BRCA1-mediated DNA damage responses (DDRs) by recruiting BRCA1 to DNA double-strand breaks (DSBs). A comprehensive screening of DNA from affected index cases of 112 BRCA1/BRCA2 mutation-negative Finnish breast cancer families revealed altogether 10 alterations in RAP80, one of which, c.241-243delGAA, resulted in a single glutamic acid deletion at residue 81 in a highly conserved region of ubiquitin interaction motif 1. The resultant delE81 protein product displayed significantly reduced ubiquitin binding and DSB localization. Expression of the RAP80 delE81 allele impaired both BRCA1 and ABRA1 DSB recruitment, thus compromising BRCA1-mediated DDR signaling. Compared with wildtype RAP80, expression of the delE81 allele was associated with a significant increase in cytogenetically detectable chromosomal aberrations, particularly chromatid breaks. Although evidently quite rare, these results suggest that critical constitutional mutations in RAP80 abrogate DDR function and may be involved in genetic predisposition to cancer.	[Coleman, K. A.; Morrissey, D.; Messick, T. E.; Greenberg, R. A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Nikkila, J.; Pylkas, K.; Erkko, H.; Karppinen, S-M; Amelina, A.; Winqvist, R.] Univ Oulu, Oulu Univ Hosp, Dept Clin Genet, Canc Genet Lab, Oulu, Finland; [Nikkila, J.; Pylkas, K.; Erkko, H.; Karppinen, S-M; Amelina, A.; Winqvist, R.] Univ Oulu, Oulu Univ Hosp, Bioctr Oulu, Oulu, Finland; [Greenberg, R. A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Oulu; University of Oulu; University of Pennsylvania; Pennsylvania Medicine	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd,BRB 2-3 Rm 513, Philadelphia, PA 19104 USA.	robert.winqvist@oulu.fi; rogergr@mail.med.upenn.edu		Pylkas, Katri/0000-0002-2449-0521; Karppinen, Sanna/0000-0001-6233-9075; Winqvist, Robert/0000-0003-0932-9104; Messick, Troy/0000-0001-7914-1524	Finnish Breast Cancer Group; Cancer Foundation of Northern Finland; Orion-Farmos Research Foundation; Academy of Finland; Finnish Cancer Society; Foundation for the Finnish Cancer Institute and the Sigrid Juselius Foundation; NIH [T32-GM-007229]; National Cancer Institute [1K08CA106597-01]; Sidney Kimmel Foundation Scholar Award; Mary Kay Ash Charitable Foundation Cancer Research; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [K08CA106597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	Finnish Breast Cancer Group; Cancer Foundation of Northern Finland; Orion-Farmos Research Foundation; Academy of Finland(Academy of Finland); Finnish Cancer Society; Foundation for the Finnish Cancer Institute and the Sigrid Juselius Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Foundation Scholar Award; Mary Kay Ash Charitable Foundation Cancer Research; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dr Aki Mustonen, Dr Jaakko Ignatius, Dr Ylermi Soini, Dr Mervi Grip and Dr Arja Jukkola-Vuorinen for their contribution, and nurses Kari Mononen and Outi Kajula for their help in patient contacts and Ms Helmi Konola for technical assistance. We also gratefully acknowledge Dr Junjie Chen for the antibodies to ABRA1, and Dr David Livingston for critical discussion of the manuscript before submission. The Finnish Breast Cancer Group, the Cancer Foundation of Northern Finland, the Orion-Farmos Research Foundation, the Academy of Finland, the Finnish Cancer Society, the Foundation for the Finnish Cancer Institute and the Sigrid Juselius Foundation to RW, the NIH training grant T32-GM-007229 to KAC and the National Cancer Institute K08 award 1K08CA106597-01, the Sidney Kimmel Foundation Scholar Award, the Mary Kay Ash Charitable Foundation Cancer Research Grant and funds from the Abramson Family Cancer Research Institute to RAG financially supported this study.	Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; Allinen M, 2001, BRIT J CANCER, V85, P209, DOI 10.1054/bjoc.2001.1858; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Heikkinen K, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e131; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huusko P, 1998, AM J HUM GENET, V62, P1544, DOI 10.1086/301880; ISOLA J, 1994, AM J PATHOL, V145, P1301; Karppinen SM, 2006, EUR J CANCER, V42, P2647, DOI 10.1016/j.ejca.2006.05.030; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Novak DJ, 2009, BREAST CANCER RES TR, V117, P453, DOI 10.1007/s10549-008-0134-y; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rapakko K, 2001, BRIT J CANCER, V84, P116, DOI 10.1054/bjoc.2000.1530; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Schwab M, 2002, CANCER LETT, V175, P1, DOI 10.1016/S0304-3835(01)00752-2; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	51	57	59	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2009	28	16					1843	1852		10.1038/onc.2009.33	http://dx.doi.org/10.1038/onc.2009.33			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PW	19305427	Green Accepted			2022-12-25	WOS:000265640500003
J	Iyer, SS; Accardi, CJ; Ziegler, TR; Blanco, RA; Ritzenthaler, JD; Rojas, M; Roman, J; Jones, DP				Iyer, Smita S.; Accardi, Carolyn J.; Ziegler, Thomas R.; Blanco, Roberto A.; Ritzenthaler, Jeffrey D.; Rojas, Mauricio; Roman, Jesse; Jones, Dean P.			Cysteine Redox Potential Determines Pro-Inflammatory IL-1 beta Levels	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; THIOL/DISULFIDE REDOX; PROTEIN-SYNTHESIS; PLASMA; GLUTATHIONE; STATE; INTERLEUKIN-1; EXPRESSION; CYTOKINES	Background: Cysteine (Cys) and its disulfide, cystine (CySS) represent the major extracellular thiol/disulfide redox control system. The redox potential (E-h) of Cys/CySS is centered at approximately -80 mV in the plasma of healthy adults, and oxidation of Eh Cys/CySS is implicated in inflammation associated with various diseases. Methodology/Principal Findings: The purpose of the present study was to determine whether oxidized E-h Cys/CySS is a determinant of interleukin (IL)-1 beta levels. Results showed a 1.7-fold increase in secreted pro-IL-1 beta levels in U937 monocytes exposed to oxidized E-h Cys/CySS (246 mV), compared to controls exposed to a physiological E-h of 280 mV (P,<0.01). In LPS-challenged mice, preservation of plasma E-h Cys/CySS from oxidation by dietary sulfur amino acid (SAA) supplementation, was associated with a 1.6-fold decrease in plasma IL-1 beta compared to control mice fed an isonitrogenous SAA-adequate diet (P<0.01). Analysis of Eh Cys/CySS and IL-1 beta in human plasma revealed a significant positive association between oxidized Eh Cys/CySS and IL-1 beta after controlling for age, gender, and BMI (P<0.001). Conclusions/Significance: These data show that oxidized extracellular E-h Cys/CySS is a determinant of IL-1 beta levels, and suggest that strategies to preserve E-h Cys/CySS may represent a means to control IL-1 beta in inflammatory disease states.	[Iyer, Smita S.; Jones, Dean P.] Emory Univ, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA; [Accardi, Carolyn J.; Ziegler, Thomas R.; Blanco, Roberto A.] Emory Univ, Div Endocrinol Metabolism & Lipids, Atlanta, GA 30322 USA; [Ritzenthaler, Jeffrey D.; Rojas, Mauricio; Roman, Jesse; Jones, Dean P.] Emory Univ, Div Pulmonary Allergy & Critical Care Med, Atlanta, GA 30322 USA; [Iyer, Smita S.; Rojas, Mauricio] Emory Univ, Ctr Translat Res Lung, Atlanta, GA 30322 USA; [Rojas, Mauricio] Emory Univ, McKelvey Ctr Lung Transplant Pulmonary Vasc Dis, Atlanta, GA 30322 USA; [Iyer, Smita S.; Jones, Dean P.] Emory Univ, Clin Biomarkers Lab, Atlanta, GA 30322 USA; [Roman, Jesse] Emory Univ, Atlanta VA Med Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Iyer, SS (corresponding author), Emory Univ, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA.	dpjones@emory.edu	Iyer, Smita/S-5398-2017; Iyer, Swaminathan/GRS-9668-2022		NIH [ES009047, ES01195]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR023356, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH Grants ES009047, ES01195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2007, AM J PHYSIOL-REG I, V293, pR1069, DOI 10.1152/ajpregu.00195.2007; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Compher C, 2008, JPEN-PARENTER ENTER, V32, P645, DOI 10.1177/0148607108326070; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Fan Z, 2007, AM J PATHOL, V171, P938, DOI 10.2353/ajpath.2007.061083; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; HUNTER EAL, 1994, J NUTR, V124, P2319, DOI 10.1093/jn/124.12.2319; INOUE Y, 1995, J SURG RES, V58, P693, DOI 10.1006/jsre.1995.1109; Iyer SS, 2009, AM J RESP CELL MOL, V40, P90, DOI 10.1165/rcmb.2007-0447OC; Jensen GL, 2008, JPEN-PARENTER ENTER, V32, P656, DOI 10.1177/0148607108324585; Jiang SN, 2005, INVEST OPHTH VIS SCI, V46, P1054, DOI 10.1167/iovs.04-0949; Johnson JM, 2008, CLIN CHIM ACTA, V396, P43, DOI 10.1016/j.cca.2008.06.020; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kao SJ, 2006, CLIN EXP PHARMACOL P, V33, P33, DOI 10.1111/j.1440-1681.2006.04320.x; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; Malmezat T, 2000, AM J PHYSIOL-ENDOC M, V279, pE1391; MINAMIYA Y, 1995, AM J RESP CRIT CARE, V152, P348, DOI 10.1164/ajrccm.152.1.7599844; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Moriarty-Craige SE, 2005, AM J OPHTHALMOL, V140, P1020, DOI 10.1016/j.ajo.2005.06.043; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Moriarty-Craige SE, 2007, AM J OPHTHALMOL, V143, P206, DOI 10.1016/j.ajo.2006.09.056; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Nkabyo YS, 2006, J NUTR, V136, P1242, DOI 10.1093/jn/136.5.1242; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Ramirez A, 2007, AM J PHYSIOL-LUNG C, V293, pL972, DOI 10.1152/ajplung.00010.2007; Ritzenthaler J, 1998, IMMUNOLOGY, V95, P264; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Waehre T, 2004, CIRCULATION, V109, P1966, DOI 10.1161/01.CIR.0000125700.33637.B1; YEH M, 2007, DETERMINING MONITORI	44	77	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e5017	10.1371/journal.pone.0005017	http://dx.doi.org/10.1371/journal.pone.0005017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PO	19325908	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499600005
J	Amine, A; Rivera, S; Opolon, P; Dekkal, M; Biard, DSF; Bouamar, H; Louache, F; McKay, MJ; Bourhis, J; Deutsch, E; Vozenin-Brotons, MC				Amine, Abdessamad; Rivera, Sofia; Opolon, Paule; Dekkal, Mehdi; Biard, Denis S. F.; Bouamar, Hakim; Louache, Fawzia; McKay, Michael J.; Bourhis, Jean; Deutsch, Eric; Vozenin-Brotons, Marie-Catherine			Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells	PLOS ONE			English	Article								Cervical cancer is frequently associated with HPV infection. The expression of E6 and E7 HPV oncoproteins is a key factor in its carcinogenicity and might also influence its virulence, including metastatic conversion. The cellular mechanisms involved in metastatic spread remain elusive, but pro-adhesive receptors and their ligands, such as SDF-1 alpha and CXCR4 are implicated. In the present study, we assessed the possible relationship between SDF-1 alpha/CXCR4 signaling, E6/E7 status and the metastatic process. We found that SDF-1 alpha stimulated the invasion of E6/E7-positive cancer cell lines (HeLa and TC-1) in Matrigel though CXCR4 and subsequent Rho/ROCK activation. In pulmonary metastatic foci generated by TC-1 cells IV injection a high proportion of cells expressed membrane-associated CXCR4. In both cases models (in vitro and in vivo) cell adhesion and invasion was abrogated by CXCR4 immunological blockade supporting a contribution of SDF-1 alpha/CXCR4 to the metastatic process. E6 and E7 silencing using stable knock-down and the approved anti-viral agent, Cidofovir decreased CXCR4 gene expression as well as both, constitutive and SDF-1 alpha-induced cell invasion. In addition, Cidofovir inhibited lung metastasis (both adhesion and invasion) supporting contribution of E6 and E7 oncoproteins to the metastatic process. Finally, potential signals activated downstream SDF-1 alpha/CXCR4 and involved in lung homing of E6/E7-expressing tumor cells were investigated. The contribution of the Rho/ROCK pathway was suggested by the inhibitory effect triggered by Cidofovir and further confirmed using Y-27632 (a small molecule ROCK inhibitor). These data suggest a novel and highly translatable therapeutic approach to cervix cancer, by inhibition of adhesion and invasion of circulating HPV-positive tumor cells, using Cidofovir and/or ROCK inhibition.	[Amine, Abdessamad; Rivera, Sofia; Dekkal, Mehdi; Bourhis, Jean; Deutsch, Eric; Vozenin-Brotons, Marie-Catherine] Inst Radioprotect & Surete Nucl, Inst Gustave Roussy, Lab UPRES, EA Radiosensibilite Tumeurs & Tissue Sains 27 10, Villejuif, France; [Opolon, Paule] Inst Gustave Roussy, Lab Vectorol Transfert Genes, UMR 8121, Villejuif, France; [Biard, Denis S. F.] Inst A Lwoff, CNRS, INSERM, CEA DSV iRCM, BP 8, Villejuif, France; [Bouamar, Hakim; Louache, Fawzia] Inst Gustave Roussy, INSERM, U 790, Villejuif, France; [McKay, Michael J.] Australian Natl Univ, Canberra, ACT, Australia; [McKay, Michael J.] Canberra Hosp, Canberra, ACT, Australia	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Australian National University; Australian National University; Canberra Hospital	Amine, A (corresponding author), Inst Radioprotect & Surete Nucl, Inst Gustave Roussy, Lab UPRES, EA Radiosensibilite Tumeurs & Tissue Sains 27 10, Villejuif, France.	vozenin@igr.fr	McKay, Michael/ABA-9029-2021; Louache, Fawzia/M-4901-2017; Vozenin, Marie-Catherine/AAR-2268-2021	Louache, Fawzia/0000-0002-4247-5421; Vozenin, Marie-Catherine/0000-0002-2109-8073; Bourhis, Jean/0000-0001-5162-1171; BIARD, Denis Serge Francois/0000-0001-9697-4392; deutsch, eric/0000-0002-8223-3697; Sofia, Rivera/0000-0002-3096-5642	Association pour la Recherche sur le Cancer [fellows, 3881, 4970]; Electricite de France	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Electricite de France	A. A. and S. R. are fellows of the Association pour la Recherche sur le Cancer. D. B. acknowledges a grant from Electricite de France. This study was partly supported by the Association pour la Recherche sur le Cancer, contract n 3881 and 4970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim B, 2002, ONCOGENE, V21, P2334, DOI 10.1038/sj.onc.1205006; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amine A, 2006, RADIAT RES, V166, P600, DOI 10.1667/RR0423.1; Andrei G, 1998, ONCOL RES, V10, P533; Andrei G, 2001, ONCOL RES, V12, P397, DOI 10.3727/096504001108747855; Bai L, 2006, INT J GYNECOL CANCER, V16, P718, DOI 10.1111/j.1525-1438.2006.00380.x; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Charette ST, 2007, ONCOGENE, V26, P7386, DOI 10.1038/sj.onc.1210541; CHEN LP, 1993, P NATL ACAD SCI USA, V90, P6523, DOI 10.1073/pnas.90.14.6523; CLAAS ECJ, 1989, AM J PATHOL, V135, P703; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Donne AJ, 2007, HEAD NECK-J SCI SPEC, V29, P741, DOI 10.1002/hed.20572; FUCHS PG, 1989, INT J CANCER, V43, P41, DOI 10.1002/ijc.2910430110; Hostetler KY, 2006, MOL CANCER THER, V5, P156, DOI 10.1158/1535-7163.MCT-05-0200; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Lai CH, 2007, J CLIN ONCOL, V25, P3628, DOI 10.1200/JCO.2007.11.2995; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Liang ZX, 2005, CANCER RES, V65, P967; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lin KY, 1996, CANCER RES, V56, P21; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2002, CANCER RES, V62, P7328; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; Peng SB, 2005, MOL CANCER RES, V3, P227; Rein DT, 2004, J GENE MED, V6, P1281, DOI 10.1002/jgm.606; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; Sirianni N, 2005, ORAL ONCOL, V41, P423, DOI 10.1016/j.oraloncology.2004.11.003; Smith-McCune K, 1999, P NATL ACAD SCI USA, V96, P6999, DOI 10.1073/pnas.96.12.6999; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu SF, 2006, CLIN CANCER RES, V12, P2032, DOI 10.1158/1078-0432.CCR-05-2567; Yasmeen A, 2007, CELL CYCLE, V6, P2038, DOI 10.4161/cc.6.16.4555; Yoshida S, 2008, J VIROL, V82, P8820, DOI 10.1128/JVI.02363-07; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang JP, 2007, INT J GYNECOL CANCER, V17, P478, DOI 10.1111/j.1525-1438.2007.00786.x; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; ZURHAUSEN H, 2009, VIROLOGY	53	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e5018	10.1371/journal.pone.0005018	http://dx.doi.org/10.1371/journal.pone.0005018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325708	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499400007
J	Boggio, PS; Fregni, F; Valasek, C; Ellwood, S; Chi, R; Gallate, J; Pascual-Leone, A; Snyder, A				Boggio, Paulo S.; Fregni, Felipe; Valasek, Claudia; Ellwood, Sophie; Chi, Richard; Gallate, Jason; Pascual-Leone, Alvaro; Snyder, Allan			Temporal Lobe Cortical Electrical Stimulation during the Encoding and Retrieval Phase Reduces False Memories	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DC BRAIN POLARIZATION; HUMAN MOTOR CORTEX; SEMANTIC DEMENTIA; FUTURE; EXCITABILITY; BEHAVIOR; ATROPHY; LESIONS; HUMANS	A recent study found that false memories were reduced by 36% when low frequency repetitive transcranial magnetic stimulation (rTMS) was applied to the left anterior temporal lobe after the encoding (study) phase. Here we were interested in the consequences on a false memory task of brain stimulation throughout the encoding and retrieval task phases. We used transcranial direct current stimulation (tDCS) because it has been shown to be a useful tool to enhance cognition. Specifically, we examined whether tDCS can induce changes in a task assessing false memories. Based on our preliminary results, three conditions of stimulation were chosen: anodal left/cathodal right anterior temporal lobe (ATL) stimulation ("bilateral stimulation''); anodal left ATL stimulation (with a large contralateral cathodal electrode - referred as "unilateral stimulation'') and sham stimulation. Our results showed that false memories were reduced significantly after the two active conditions (unilateral and bilateral stimulation) as compared with sham stimulation. There were no significant changes in veridical memories. Our findings show that false memories are reduced by 73% when anodal tDCS is applied to the anterior temporal lobes throughout the encoding and retrieval stages, suggesting a possible strategy for improving certain aspects of learning.	[Fregni, Felipe; Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Dept Neurol,Med Sch, Boston, MA 02215 USA; [Boggio, Paulo S.; Valasek, Claudia] Univ Prebiteriana Mackenzie, Cognitive Neurosci Lab, Sao Paulo, Brazil; [Boggio, Paulo S.; Valasek, Claudia] Univ Prebiteriana Mackenzie, Ctr Hlth & Biol Sci, Dev Disorders Program, Sao Paulo, Brazil; [Ellwood, Sophie; Chi, Richard; Gallate, Jason; Snyder, Allan] Univ Sydney, Ctr Mind, Sydney, NSW 2006, Australia	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; University of Sydney	Boggio, PS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Dept Neurol,Med Sch, Boston, MA 02215 USA.	boggio@mackenzie.br; ffregni@bidmc.harvard.edu	Boggio, Paulo S/K-6272-2012; Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Boggio, Paulo S/0000-0002-6109-0447; Pascual-Leone, Alvaro/0000-0001-8975-0382; Ellwood, Sophie/0000-0002-9530-7253; Fregni, Felipe/0000-0001-9359-8643	Harvard Club of Australia foundation; CNPQ	Harvard Club of Australia foundation; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	There was limited partial support to this study - from (i) Harvard Club of Australia foundation that funded the trip of F.F. to A.S. laboratory as to finalize this paper and (2) support for research assistant from CNPQ - Brazilian funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2004, NEUROREPORT, V15, P2491, DOI 10.1097/00001756-200411150-00012; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Bartlett F.C., 1932, REMEMBERING STUDY EX; Beversdorf DQ, 2000, P NATL ACAD SCI USA, V97, P8734, DOI 10.1073/pnas.97.15.8734; Brainerd CJ, 2007, PSYCHOL SCI, V18, P442, DOI 10.1111/j.1467-9280.2007.01919.x; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; FRITH U, 2003, AUTISM MIND BRAIN; Gainotti G, 2007, NEUROPSYCHOLOGIA, V45, P1591, DOI 10.1016/j.neuropsychologia.2006.12.013; Gallate J, 2009, NEUROSCI LETT, V449, P151, DOI 10.1016/j.neulet.2008.11.021; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Holliday RE, 2006, MEMORY, V14, P624, DOI 10.1080/09658210600736525; Hou C, 2000, NEUROPSY NEUROPSY BE, V13, P29; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; McDermott KB, 1999, MEMORY, V7, P661; Miller BL, 1998, NEUROLOGY, V51, P978, DOI 10.1212/WNL.51.4.978; Mummery CJ, 2000, ANN NEUROL, V47, P36; NITSCHE M, 2008, BRAIN STIMUL, P206; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pobric G, 2008, J COGNITIVE NEUROSCI, V20, P170, DOI 10.1162/jocn.2008.20005; Pobric G, 2007, P NATL ACAD SCI USA, V104, P20137, DOI 10.1073/pnas.0707383104; Rosso SM, 2001, J NEUROL, V248, P965, DOI 10.1007/s004150170049; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Snyder Allan, 2004, Journal of Integrative Neuroscience, V3, P31, DOI 10.1142/S0219635204000361; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001	33	76	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4959	10.1371/journal.pone.0004959	http://dx.doi.org/10.1371/journal.pone.0004959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PK	19319182	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200008
J	Zinner, D; Arnold, ML; Roos, C				Zinner, Dietmar; Arnold, Michael L.; Roos, Christian			Is the New Primate Genus Rungwecebus a Baboon?	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MITOCHONDRIAL PHYLOGENY; HYBRIDIZATION PATTERNS; UPPER MIOCENE; DNA; EVOLUTION; KIPUNJI; AFFINITIES; INFERENCE; CLIMATE	Background: In 2005, a new primate species from Tanzania, the kipunji, was described and recognized as a member of the mangabey genus Lophocebus. However, molecular investigations based upon a number of papionins, including a limited sample of baboons of mainly unknown geographic origin, identified the kipunji as a sister taxon to Papio and not as a member of Lophocebus. Accordingly, the kipunji was separated into its own monotypic genus, Rungwecebus. Methodology/Principal Findings: We compare available mitochondrial and nuclear sequence data from the voucher specimen of Rungwecebus to other papionin lineages, including a set of geographically proximal (parapatric) baboon samples. Based on mitochondrial sequence data the kipunji clusters with baboon lineages that lie nearest to it geographically, i.e. populations of yellow and chacma baboons from south-eastern Africa, and thus does not represent a sister taxon to Papio. Nuclear data support a Papio+Rungwecebus clade, but it remains questionable whether Rungwecebus represents a sister taxon to Papio, or whether it is nested within the genus as depicted by the mitochondrial phylogeny. Conclusions/Significance: Our study clearly supports a close relationship between Rungwecebus and Papio and might indicate that the kipunji is congeneric with baboon species. However, due to its morphological and ecological uniqueness Rungwecebus more likely represents a sister lineage to Papio and experienced later introgressive hybridization. Presumably, male (proto-)kipunjis reproduced with sympatric female baboons. Subsequent backcrossing of the hybrids with kipunjis would have resulted in a population with a nuclear kipunji genome, but which retained the yellow/chacma baboon mitochondrial genome. Since only one kipunji specimen was studied, it remains unclear whether all members of the new genus have been impacted by intergeneric introgression or rather only some populations. Further studies with additional Rungwecebus samples are necessary to elucidate the complete evolutionary history of this newly-described primate genus.	[Zinner, Dietmar; Roos, Christian] Deutsch Primatenzentrum GmbH, Gottingen, Germany; [Arnold, Michael L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Deutsches Primatenzentrum (DPZ); University System of Georgia; University of Georgia	Zinner, D (corresponding author), Deutsch Primatenzentrum GmbH, Gottingen, Germany.	dzinner@gwdg.de			German Science Foundation [DFG ZI 548/3-1]; National Science Foundation [DEB-0345123]	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	German Science Foundation Grant (DFG ZI 548/3-1) supported DZ. National Science Foundation Grant DEB-0345123 supported MLA. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2001, AM J PRIMATOL, V53, P139, DOI 10.1002/ajp.1; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Arnold ML, 2008, RETICULATE EVOLUTION AND HUMANS: ORIGINS AND ECOLOGY, P1, DOI 10.1093/acprof:oso/9780199539581.001.0001; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; BURRELL A, 2008, PHYLOGENETICS POPULA; Chakraborty D, 2007, MOL PHYLOGENET EVOL, V44, P838, DOI 10.1016/j.ympev.2007.04.007; Davenport TRB, 2008, ORYX, V42, P352, DOI 10.1017/S0030605308000422; Davenport TRB, 2006, SCIENCE, V312, P1378, DOI 10.1126/science.1125631; DELSON E, 1993, THEROPITHECUS, P157, DOI 10.1017/CBO9780511565540.006; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUNBAR RIM, 1974, J HUM EVOL, V3, P187, DOI 10.1016/0047-2484(74)90176-6; Ehardt Carloyn L., 2006, Primate Conservation, V21, P81, DOI 10.1896/0898-6207.21.1.81; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Gautier-Hion A., 1999, HIST NATURELLE PRIMA; Goossens Benoit, 2000, Conservation Genetics, V1, P157, DOI 10.1023/A:1026535006318; Groves CP, 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holliday TW, 2003, CURR ANTHROPOL, V44, P653, DOI 10.1086/377663; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jablonski N.G., 1993, THEROPITHECUS RISE F; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Jolly CJ, 1997, INT J PRIMATOL, V18, P597, DOI 10.1023/A:1026367307470; Jones T, 2005, SCIENCE, V308, P1161, DOI 10.1126/science.1109191; Karanth KP, 2005, P NATL ACAD SCI USA, V102, P5090, DOI 10.1073/pnas.0408354102; Kingdon J., 1997, KINGDON FIELDGUIDE A; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lorenz JG, 2005, PHILOS T R SOC B, V360, P1869, DOI 10.1098/rstb.2005.1718; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Newman TK, 2004, AM J PHYS ANTHROPOL, V124, P17, DOI 10.1002/ajpa.10340; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Olson LE, 2008, MOL PHYLOGENET EVOL, V48, P789, DOI 10.1016/j.ympev.2008.04.031; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; RAMBAUT A, 2006, FIGREE TREE FIGURE D; RAMBAUT A, 2005, TRACER V1 3 MCMC TRA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2008, MOL PHYLOGENET EVOL, V47, P629, DOI 10.1016/j.ympev.2008.03.006; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Singleton M, 2009, J HUM EVOL, V56, P25, DOI 10.1016/j.jhevol.2008.07.012; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tattersall I, 1999, P NATL ACAD SCI USA, V96, P7117, DOI 10.1073/pnas.96.13.7117; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Tung J, 2008, MOL ECOL, V17, P1998, DOI 10.1111/j.1365-294X.2008.03723.x; Turner A, 1999, HUMAN EVOLUT SER, P76; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wildman DE, 2004, MOL PHYLOGENET EVOL, V32, P287, DOI 10.1016/j.ympev.2003.12.014; ZINNER D, 2001, MITOCHONDRIAL UNPUB; ZINNER D, PRIMATES GA IN PRESS; Zinner Dietmar, 2008, Zoologische Garten, V77, P303, DOI 10.1016/j.zoolgart.2008.05.002; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	63	59	62	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4859	10.1371/journal.pone.0004859	http://dx.doi.org/10.1371/journal.pone.0004859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OL	19295908	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496700002
J	Kilner, JM; Marchant, JL; Frith, CD				Kilner, James M.; Marchant, Jennifer L.; Frith, Chris D.			Relationship between Activity in Human Primary Motor Cortex during Action Observation and the Mirror Neuron System	PLOS ONE			English	Article							CORTICAL OSCILLATORY ACTIVITY; S-R COMPATIBILITY; PREMOTOR CORTEX; FACILITATION; IMITATION; MODULATION; MOVEMENT; REPRESENTATIONS; LATERALIZATION; PERCEPTION	The attenuation of the beta cortical oscillations during action observation has been interpreted as evidence of a mirror neuron system (MNS) in humans. Here we investigated the modulation of beta cortical oscillations with the viewpoint of an observed action. We asked subjects to observe videos of an actor making a variety of arm movements. We show that when subjects were observing arm movements there was a significant modulation of beta oscillations overlying left and right sensorimotor cortices. This pattern of attenuation was driven by the side of the screen on which the observed movement occurred and not by the hand that was observed moving. These results are discussed in terms of the firing patterns of mirror neurons in F5 which have been reported to have similar properties.	[Kilner, James M.; Marchant, Jennifer L.; Frith, Chris D.] Wellcome Trust Ctr Neuroimaging, London, England; [Frith, Chris D.] Univ Aarhus, CFIN, Niels Bohr Project Interacting Minds, DK-8000 Aarhus, Denmark	University of London; University College London; Aarhus University	Kilner, JM (corresponding author), Wellcome Trust Ctr Neuroimaging, London, England.	j.kilner@fil.ion.ucl.ac.uk	Kilner, James M/A-2040-2010; Frith, Chris/A-2171-2009	Kilner, James/0000-0002-6632-6797; Frith, Chris/0000-0002-8665-0690	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	This work was funded by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2003, EXP BRAIN RES, V148, P17, DOI 10.1007/s00221-002-1255-x; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GATTIS M, 2002, IMITATIVE MIND DEV E, P183, DOI DOI 10.1017/CBO9780511489969; GAZZOLA V, 2008, CEREB CORTE IN PRESS; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Heyes C, 2004, PSYCHON B REV, V11, P703, DOI 10.3758/BF03196623; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kiebel S, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P211, DOI 10.1016/B978-012372560-8/50016-4; Kilner J, 2005, EUR J NEUROSCI, V21, P2547, DOI 10.1111/j.1460-9568.2005.04069.x; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Kilner JM, 2003, NEUROIMAGE, V18, P67, DOI 10.1006/nimg.2002.1322; Kilner JM, 2000, J NEUROSCI, V20, P8838; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Morin O, 2008, NEUROPHYSIOL CLIN, V38, P189, DOI 10.1016/j.neucli.2008.02.005; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257	51	71	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4925	10.1371/journal.pone.0004925	http://dx.doi.org/10.1371/journal.pone.0004925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290052	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496500019
J	Koestler, SA; Rottner, K; Lai, F; Block, J; Vinzenz, M; Small, V				Koestler, Stefan A.; Rottner, Klemens; Lai, Frank; Block, Jennifer; Vinzenz, Marlene; Small, Victor			F- and G-Actin Concentrations in Lamellipodia of Moving Cells	PLOS ONE			English	Article								Cells protrude by polymerizing monomeric (G) into polymeric (F) actin at the tip of the lamellipodium. Actin filaments are depolymerized towards the rear of the lamellipodium in a treadmilling process, thereby supplementing a G-actin pool for a new round of polymerization. In this scenario the concentrations of F- and G-actin are principal parameters, but have hitherto not been directly determined. By comparing fluorescence intensities of bleached and unbleached regions of lamellipodia in B16-F1 mouse melanoma cells expressing EGFP-actin, before and after extraction with Triton X-100, we show that the ratio of F- to G-actin is 3.2+/-0.9. Using electron microscopy to determine the F- actin content, this ratio translates into F- and G-actin concentrations in lamellipodia of approximately 500 mu M and 150 mu M, respectively. The excess of G-actin, at several orders of magnitude above the critical concentrations at filament ends indicates that the polymerization rate is not limited by diffusion and is tightly controlled by polymerization/ depolymerization modulators.	[Koestler, Stefan A.; Vinzenz, Marlene; Small, Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Rottner, Klemens; Lai, Frank; Block, Jennifer] Helmholtz Ctr Infect Res HZI, Cytoskeleton Dynam Grp, Braunschweig, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Helmholtz Association; Helmholtz-Center for Infection Research	Small, V (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria.	vic.small@imba.oeaw.ac.at		Rottner, Klemens/0000-0003-4244-4198; Koestler, Stefan/0000-0002-7223-8291	Human Frontier Science Program Organisation (HFSPO); The Vienna Science Research and Technology Fund (WWTF); The City of Vienna/Zentrum fur Innovation und Technologie; Deutsche Forschungsgemeinschaft [FOR629]	Human Frontier Science Program Organisation (HFSPO)(Human Frontier Science Program); The Vienna Science Research and Technology Fund (WWTF); The City of Vienna/Zentrum fur Innovation und Technologie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Human Frontier Science Program Organisation (HFSPO); The Vienna Science Research and Technology Fund (WWTF); The City of Vienna/Zentrum fur Innovation und Technologie via the Spot of Excellence grant Center of Molecular and Cellular Nanostructure. KR was supported in part by the Deutsche Forschungsgemeinschaft (FOR629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; BRAY D, 1976, J MOL BIOL, V105, P527, DOI 10.1016/0022-2836(76)90233-3; CHEN WT, 1981, J CELL BIOL, V90, P187, DOI 10.1083/jcb.90.1.187; Dunn GA, 1980, CELL ADHESION MOTILI, P409; FECHHEIMER M, 1983, CELL MOTIL CYTOSKEL, V3, P349, DOI 10.1002/cm.970030406; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; HEACOCK CS, 1984, EXP CELL RES, V153, P402, DOI 10.1016/0014-4827(84)90609-8; Hoglund A S, 1980, J Muscle Res Cell Motil, V1, P127, DOI 10.1007/BF00711795; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; MOSELARSEN P, 1982, CELL, V31, P681, DOI 10.1016/0092-8674(82)90323-3; Novak IL, 2008, BIOPHYS J, V95, P1627, DOI 10.1529/biophysj.108.130096; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	25	87	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4810	10.1371/journal.pone.0004810	http://dx.doi.org/10.1371/journal.pone.0004810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277198	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496100027
J	Cao, G; van der Wijst, J; van der Kemp, A; van Zeeland, F; Bindels, RJ; Hoenderop, JG				Cao, Gang; van der Wijst, Jenny; van der Kemp, AnneMiete; van Zeeland, Femke; Bindels, Rene J.; Hoenderop, Joost G.			Regulation of the Epithelial Mg2+ Channel TRPM6 by Estrogen and the Associated Repressor Protein of Estrogen Receptor Activity (REA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; SECONDARY HYPOCALCEMIA; MAGNESIUM TRANSPORT; TRANSIENT RECEPTOR; CATION CHANNEL; KINASE DOMAIN; ALPHA; HYPOMAGNESEMIA; CA2+; PHOSPHORYLATION	The maintenance of the Mg2+ balance of the body is essential for neuromuscular excitability, protein synthesis, nucleic acid stability, and numerous enzymatic systems. The Transient Receptor Potential Melastatin 6 (TRPM6) functions as the gatekeeper of transepithelial Mg2+ transport. However, the molecular regulation of TRPM6 channel activity remains elusive. Here, we identified the repressor of estrogen receptor activity ( REA) as an interacting protein of TRPM6 that binds to the 6(th), 7(th), and 8(th) beta-sheets in its alpha-kinase domain. Importantly, REA and TRPM6 are coexpressed in renal Mg2+-transporting distal convoluted tubules (DCT). We demonstrated that REA significantly inhibits TRPM6, but not its closest homologue TRPM7, channel activity. This inhibition occurs in a phosphorylation-dependent manner, since REA has no effect on the TRPM6 phosphotransferase-deficient mutant (K1804R), while it still binds to this mutant. Moreover, activation of protein kinase C by phorbol 12-myristate 13-acetate-PMA potentiated the inhibitory effect of REA on TRPM6 channel activity. Finally, we showed that the interaction between REA and TRPM6 is a dynamic process, as short-term 17 beta-estradiol treatment disassociates the binding between these proteins. In agreement with this, 17 beta-estradiol treatment significantly stimulates the TRPM6-mediated current in HEK293 cells. These results suggest a rapid pathway for the effect of estrogen on Mg2+ homeostasis in addition to its transcriptional effect. Together, these data indicate that REA operates as a negative feedback modulator of TRPM6 in the regulation of active Mg2+ (re) absorption and provides new insight into the molecular mechanism of renal transepithelial Mg2+ transport.	[Cao, Gang; van der Wijst, Jenny; van der Kemp, AnneMiete; van Zeeland, Femke; Bindels, Rene J.; Hoenderop, Joost G.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Nijmegen Ctr Mol Life Sci,Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Nijmegen Ctr Mol Life Sci,Dept Physiol, 286 Psysiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@ncmls.ru.nl	Hoenderop, Joost G.J./H-8047-2014; van der Wijst, Jenny/T-1620-2019; van der Wijst, Jenny/D-9726-2016; Bindels, René JM/B-9824-2013	Hoenderop, Joost G.J./0000-0002-1816-8544; van der Wijst, Jenny/0000-0002-1547-516X; van der Wijst, Jenny/0000-0002-1547-516X; Bindels, René JM/0000-0003-1167-1339	Netherlands Organization of Scientific Research [ZonMW 9120.6110, ALW818.02.001]; European Science Foundation; Dutch Kidney Foundation [C03.6017, C08.2252]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Science Foundation(European Science Foundation (ESF)European Commission); Dutch Kidney Foundation	This work was supported by the Netherlands Organization of Scientific Research (ZonMW 9120.6110, ALW818.02.001), the EURYI award from the European Science Foundation, and the Dutch Kidney Foundation (C03.6017, C08.2252).	BOGOROCH R, 1975, ANAT REC, V183, P437, DOI 10.1002/ar.1091830308; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Chubanov V, 2007, J BIOL CHEM, V282, P7656, DOI 10.1074/jbc.M611117200; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Fu XD, 2007, SEMIN REPROD MED, V25, P178, DOI 10.1055/s-2007-973430; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 1999, BIOCHEM BIOPH RES CO, V261, P488, DOI 10.1006/bbrc.1999.1059; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MCNAIR P, 1984, MINER ELECTROL METAB, V10, P84; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SEELIG MS, 1993, J AM COLL NUTR, V12, P442, DOI 10.1080/07315724.1993.10718335; Simoncini T, 2006, ANN NY ACAD SCI, V1089, P424, DOI 10.1196/annals.1386.001; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Vetter T, 2002, CURR OPIN NEPHROL HY, V11, P403, DOI 10.1097/00041552-200207000-00006; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005	45	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14788	14795		10.1074/jbc.M808752200	http://dx.doi.org/10.1074/jbc.M808752200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329436	hybrid, Green Published			2022-12-25	WOS:000266288200014
J	Molina-Ortiz, I; Bartolome, RA; Hernandez-Varas, P; Colo, GP; Teixido, J				Molina-Ortiz, Isabel; Bartolome, Ruben A.; Hernandez-Varas, Pablo; Colo, Georgina P.; Teixido, Joaquin			Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine- promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; TYROSINE PHOSPHORYLATION; MATRIX-METALLOPROTEINASE; ACTIN CYTOSKELETON; TUMOR PROGRESSION; EPITHELIAL-CELLS; P120 CATENIN; IN-VITRO; ADHESION; EXPRESSION	Melanoma cells express the chemokine receptor CXCR4 that confers high invasiveness upon binding to its ligand CXCL12. Melanoma cells at initial stages of the disease show reduction or loss of E-cadherin expression, but recovery of its expression is frequently found at advanced phases. We overexpressed E-cadherin in the highly invasive BRO lung metastatic cell melanoma cell line to investigate whether it could influence CXCL12-promoted cell invasion. Overexpression of E-cadherin led to defective invasion of melanoma cells across Matrigel and type I collagen in response to CXCL12. A decrease in individual cell migration directionality toward the chemokine and reduced adhesion accounted for the impaired invasion. A p190RhoGAP-dependent inhibition of RhoA activation was responsible for the impairment in chemokine-stimulated E-cadherin melanoma transfectant invasion. Furthermore, we show that p190RhoGAP and p120ctn associated predominantly on the plasma membrane of cells overexpressing E-cadherin, and that E-cadherin-bound p120ctn contributed to RhoA inactivation by favoring p190RhoGAP-RhoA association. These results suggest that melanoma cells at advanced stages of the disease could have reduced metastatic potency in response to chemotactic stimuli compared with cells lacking E-cadherin, and the results indicate that p190RhoGAP is a central molecule controlling melanoma cell invasion.	[Molina-Ortiz, Isabel; Bartolome, Ruben A.; Hernandez-Varas, Pablo; Colo, Georgina P.; Teixido, Joaquin] Ctr Invest Biol, Dept Cellular & Mol Physiopathol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Teixido, J (corresponding author), Ctr Invest Biol, Dept Cellular & Mol Physiopathol, Ramiro Maeztu 9, Madrid 28040, Spain.	joaquint@cib.csic.es	Teixidó, Joaquin/J-8543-2014; Bartolome, Ruben A/M-1873-2014	Bartolome, Ruben A/0000-0002-3292-1491; Hernandez-Varas, Pablo/0000-0001-8664-9203	Ministerio de Ciencia e Innovacion [SAF2005-02119, SAF2008-00479]; RETICS [RD06/0020/0011]; Fundacion de Investigacion Medica Mutua Madrilena	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); RETICS; Fundacion de Investigacion Medica Mutua Madrilena	This work was supported in part by Grants SAF2005-02119 and SAF2008-00479 from the Ministerio de Ciencia e Innovacion, by RETICS RD06/0020/0011, and by a grant from the Fundacion de Investigacion Medica Mutua Madrilena.	Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOUTON AH, 1991, MOL CELL BIOL, V11, P945, DOI 10.1128/MCB.11.2.945; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cowley GP, 1996, J PATHOL, V179, P183, DOI 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W; Danen EHJ, 1996, MELANOMA RES, V6, P127, DOI 10.1097/00008390-199604000-00007; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Fincham VJ, 1999, J CELL SCI, V112, P947; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Haskell MD, 2001, J CELL SCI, V114, P1699; Hsu MY, 2000, J CELL SCI, V113, P1535; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Longo-Imedio MI, 2005, INT J CANCER, V117, P861, DOI 10.1002/ijc.21269; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2002, CANCER RES, V62, P7328; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Silye R, 1998, J PATHOL, V186, P350, DOI 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K; TANG A, 1994, J CELL SCI, V107, P983; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tikoo A, 2000, GENE, V257, P23, DOI 10.1016/S0378-1119(00)00387-5; van Golen KL, 2000, CANCER RES, V60, P5832; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; Yagi T, 2000, GENE DEV, V14, P1169	55	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15147	15157		10.1074/jbc.M807834200	http://dx.doi.org/10.1074/jbc.M807834200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19293150	Green Published, hybrid			2022-12-25	WOS:000266288200050
J	Ranjan, R; Ahmed, A; Gourinath, S; Sharma, P				Ranjan, Ravikant; Ahmed, Anwar; Gourinath, Samudrala; Sharma, Pushkar			Dissection of Mechanisms Involved in the Regulation of Plasmodium falciparum Calcium-dependent Protein Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; B-LIKE ENZYME; MALARIA PARASITE; PHOSPHOINOSITIDE HYDROLYSIS; SIGNALING PATHWAY; XANTHURENIC ACID; GAMETE FORMATION; IDENTIFICATION; MOSQUITO; CDPK	Recent studies have demonstrated that calcium-dependent protein kinases (CDPKs) are used by calcium to regulate a variety of biological processes in the malaria parasite Plasmodium. CDPK4 has emerged as an important enzyme for parasite development, because its gene disruption in rodent parasite Plasmodium berghei causes major defects in sexual differentiation of the parasite (Billker, O., Dechamps, S., Tewari, R., Wenig, G., Franke-Fayard, B., and Brinkmann, V. (2004) Cell 117, 503514). Despite these findings, it is not very clear how PfCDPK4 or any other PfCDPK is regulated by calcium at the molecular level. We report the biochemical characterization and elucidation of molecular mechanisms involved in the regulation of PfCDPK4. PfCDPK4 was detected on gametocyte periphery, and its activity in the parasite was regulated by phospholipase C. Even though the Junction Domain (JD) of PfCDPK4 shares moderate sequence homology with that of the plant CDPKs, it plays a pivotal role in PfCDPK4 regulation as previously reported for some plant CDPKs. The regions of the J-domain involved in interaction with both the kinase domain and the calmodulin-like domain were mapped. We propose a model for PfCDPK regulation by calcium, which may also prove useful for design of inhibitors against PfCDPK4 and other members of the PfCDPK family.	[Ranjan, Ravikant; Ahmed, Anwar; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.res.in	Ahmed, Anwar/AAL-7789-2021; Ranjan, Ravikant/AAT-1000-2021; Ahmed, Anwar/ADH-1445-2022	Ranjan, Ravikant/0000-0002-3997-4879; Ahmed, Anwar/0000-0001-8147-714X	National Institutes of Health [RO1AI075459]; Wellcome Trust Senior Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Research Fellowship(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI075459 from NIAID. This work was also supported by a Wellcome Trust Senior Research Fellowship awarded to ( to P. S.).	Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias SL, 2005, MOL BIOCHEM PARASIT, V141, P71, DOI 10.1016/j.molbiopara.2005.01.015; Garcia CRS, 1999, PARASITOL TODAY, V15, P488, DOI 10.1016/S0169-4758(99)01571-9; Gazarini ML, 2004, BIOCHEM BIOPH RES CO, V321, P138, DOI 10.1016/j.bbrc.2004.06.141; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; KAWAMOTO F, 1990, MOL BIOCHEM PARASIT, V42, P101, DOI 10.1016/0166-6851(90)90117-5; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin DT, 1996, MOL BIOCHEM PARASIT, V78, P67, DOI 10.1016/S0166-6851(96)02608-4; MARTIN SK, 1994, J PARASITOL, V80, P371, DOI 10.2307/3283406; MCCALLUMDEIGHTON N, 1992, MOL BIOCHEM PARASIT, V50, P317, DOI 10.1016/0166-6851(92)90229-D; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; OGWANG R, 1993, BIOCHEM PHARMACOL, V46, P1601, DOI 10.1016/0006-2952(93)90329-U; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Williams JL, 1999, AM J TROP MED HYG, V60, P7, DOI 10.4269/ajtmh.1999.60.7; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Yoo BC, 1996, BIOCHEMISTRY-US, V35, P12029, DOI 10.1021/bi9606612; Zhang L, 2002, BIOCHEM J, V368, P145, DOI 10.1042/BJ20020780; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7	43	43	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15267	15276		10.1074/jbc.M900656200	http://dx.doi.org/10.1074/jbc.M900656200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19307175	hybrid, Green Published			2022-12-25	WOS:000266288200061
J	Panov, A; Schonfeld, P; Dikalov, S; Hemendinger, R; Bonkovsky, HL; Brooks, BR				Panov, Alexander; Schonfeld, Peter; Dikalov, Sergey; Hemendinger, Richelle; Bonkovsky, Herbert L.; Brooks, Benjamin Rix			The Neuromediator Glutamate, through Specific Substrate Interactions, Enhances Mitochondrial ATP Production and Reactive Oxygen Species Generation in Nonsynaptic Brain Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL SYNAPSE; SUCCINATE-DEHYDROGENASE; RAT-BRAIN; COMPLEX-I; ASPARTATE-AMINOTRANSFERASE; METABOLIC COMPARTMENTATION; TRANSPORTER EAAT4; BOVINE BRAIN; DISEASE; ACID	The finding that upon neuronal activation glutamate is transported postsynaptically from synaptic clefts and increased lactate availability for neurons suggest that brain mitochondria (BM) utilize a mixture of substrates, namely pyruvate, glutamate, and the tricarboxylic acid cycle metabolites. We studied how glutamate affected oxidative phosphorylation and reactive oxygen species (ROS) production in rat BM oxidizing pyruvate + malate or succinate. Simultaneous oxidation of glutamate + pyruvate + malate increased state 3 and uncoupled respiration by 52 and 71%, respectively. The state 4 ROS generation increased 100% overBMoxidizing pyruvate + malate and 900% over that of BM oxidizing glutamate + malate. Up to 70% of ROS generation was associated with reverse electron transport. These effects of pyruvate + glutamate + malate were observed only with BM and not with liver or heart mitochondria. The effects of glutamate + pyruvate on succinate-supported respiration and ROS generation were not organ-specific and depended only on whether mitochondria were isolated with or without bovine serum albumin. With the non-bovine serum albumin brain and heart mitochondria oxidizing succinate, the addition of pyruvate and glutamate abrogated inhibition of Complex II by oxaloacetate. We conclude that (i) during neuronal activation, simultaneous oxidation of glutamate + pyruvate temporarily enhances neuronal mitochondrial ATP production, and (ii) intrinsic inhibition of Complex II by oxaloacetate is an inherent mechanism that protects against ROS generation during reverse electron transport.	[Panov, Alexander] Carolinas Med Ctr, Carolinas Neuromuscular ALS Ctr, Cannon Res Ctr, Charlotte, NC 28203 USA; [Schonfeld, Peter] Otto Von Guericke Univ, Fak Med, Inst Biochem, D-39120 Magdeburg, Germany; [Dikalov, Sergey] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA	Carolinas Medical Center; Otto von Guericke University; Emory University	Panov, A (corresponding author), Carolinas Med Ctr, Carolinas Neuromuscular ALS Ctr, Cannon Res Ctr, 1000 Blythe Blvd, Charlotte, NC 28203 USA.	alexander.panov@carolinashealthcare.org	Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230; Dikalov, Sergey/0000-0003-2976-6184	DK [RO1 38825]; Carolinas HealthCare Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825] Funding Source: NIH RePORTER	DK; Carolinas HealthCare Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant DK RO1 38825 (to H. L. B.). This work was also supported by the Carolinas HealthCare Foundation. Some of the data in this work have been presented at scientific meetings and published as abstracts (35, 36).	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; ACKRELL BAC, 1975, J BIOL CHEM, V250, P7114; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; BALAZS R, 1965, BIOCHEM J, V95, P497, DOI 10.1042/bj0950497; BALAZS R, 1965, J NEUROCHEM, V12, P63, DOI 10.1111/j.1471-4159.1965.tb11940.x; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Bohr VA, 2007, NEUROSCIENCE, V145, P1183, DOI 10.1016/j.neuroscience.2007.03.015; Brasnjo G, 2004, P NATL ACAD SCI USA, V101, P6273, DOI 10.1073/pnas.0308149101; CHO SW, 1995, EUR J BIOCHEM, V233, P340, DOI 10.1111/j.1432-1033.1995.340_1.x; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehnes Y, 1998, J NEUROSCI, V18, P3606; ERECINSKA M, 1994, J NEUROCHEM, V63, P1033; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hertz L, 2004, NEUROCHEM INT, V45, P285, DOI 10.1016/j.neuint.2003.08.016; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; KANAI Y, 1993, FASEB J, V7, P1450, DOI 10.1096/fasebj.7.15.7903261; KAUPPINEN RA, 1986, EUR J BIOCHEM, V158, P159, DOI 10.1111/j.1432-1033.1986.tb09733.x; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Massie A, 2008, J COMP NEUROL, V511, P155, DOI 10.1002/cne.21823; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; McKenna MC, 2000, NEUROCHEM INT, V37, P229, DOI 10.1016/S0197-0186(00)00042-5; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; NICHOLLS DG, 1993, EUR J BIOCHEM, V212, P613, DOI 10.1111/j.1432-1033.1993.tb17700.x; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; PANOV A, 2008, AMYOTR LAT SCLER, V9, pS2; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Panov AV, 2006, FREE RADICAL BIO MED, V41, pS167; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; RUSCAK M, 1982, J NEUROCHEM, V39, P210, DOI 10.1111/j.1471-4159.1982.tb04720.x; Schagger H, 2001, J BIOL CHEM, V276, P37861; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; TILLAKARATNE NJK, 1995, COMP BIOCHEM PHYS A, V112, P247, DOI 10.1016/0300-9629(95)00099-2; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Tretter L, 2007, NEUROCHEM INT, V50, P139, DOI 10.1016/j.neuint.2006.07.010; VINOGRAD.AD, 1972, BIOCHEM BIOPH RES CO, V49, P441, DOI 10.1016/0006-291X(72)90430-5; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zoccarato F, 2007, BIOCHEM J, V406, P125, DOI 10.1042/BJ20070215	53	48	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14448	14456		10.1074/jbc.M900985200	http://dx.doi.org/10.1074/jbc.M900985200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19304986	Green Published, hybrid			2022-12-25	WOS:000266286100051
J	Sotillo, E; Garriga, J; Padgaonkar, A; Kurimchak, A; Cook, JG; Grana, X				Sotillo, Elena; Garriga, Judit; Padgaonkar, Amol; Kurimchak, Alison; Cook, Jeanette Gowen; Grana, Xavier			Coordinated Activation of the Origin Licensing Factor CDC6 and CDK2 in Resting Human Fibroblasts Expressing SV40 Small T Antigen and Cyclin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; DNA-REPLICATION; MAMMALIAN CDC6; A PROMOTER; E2F; GROWTH; TRANSFORMATION; TRANSCRIPTION; KINASE; PHOSPHORYLATION	We have previously shown that SV40 small t antigen (st) cooperates with deregulated cyclin E to activate CDK2 and bypass quiescence in normal human fibroblasts (NHF). Here we show that st expression in serum-starved and density-arrested NHF specifically induces up-regulation and loading of CDC6 onto chromatin. Coexpression of cyclin E results in further accumulation of CDC6 onto chromatin concomitantly with phosphorylation of CDK2 on Thr-160 and CDC6 on Ser-54. Investigation of the mechanism leading to CDC6 accumulation and chromatin loading indicates that st is a potent inducer of cdc6 mRNA expression and increases CDC6 protein stability. We also show that CDC6 expression in quiescent NHF efficiently promotes cyclin E loading onto chromatin, but it is not sufficient to activate CDK2. Moreover, we show that CDC6 expression is linked to phosphorylation of the activating T loop of CDK2 in serum-starved NHF stimulated with mitogens or ectopically expressing cyclin E and st. Our data suggest a model where the combination of st and deregulated cyclin E result in cooperative and coordinated activation of both an essential origin licensing factor, CDC6, and an activity required for origin firing, CDK2, resulting in progression from quiescence to S phase.	[Sotillo, Elena; Garriga, Judit; Padgaonkar, Amol; Kurimchak, Alison; Grana, Xavier] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Kurimchak, Alison; Grana, Xavier] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Chapel Hill	Grana, X (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, AHP Bldg Rm 308,3307 N Broad St, Philadelphia, PA 19140 USA.	xavier@temple.edu		Cook, Jeanette/0000-0003-0849-7405; Sotillo, Elena/0000-0002-3993-1932; Grana, Xavier/0000-0001-7134-0473	National Institutes of Health [CA095569]; Career Development Award [K02 AI01823]; NATIONAL CANCER INSTITUTE [P01CA095569, K01CA094907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI001823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA095569 (to X. G. and J. G.) and a Career Development Award (K02 AI01823) (to X. G.).	Abbas T, 2007, CELL CYCLE, V6, P843, DOI 10.4161/cc.6.7.4000; Araki K, 2008, ONCOGENE, V27, P5696, DOI 10.1038/onc.2008.184; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Calbo J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Duursma AM, 2005, CELL CYCLE, V4, P1725, DOI 10.4161/cc.4.12.2193; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Lolli G, 2005, CELL CYCLE, V4, P572, DOI 10.4161/cc.4.4.1607; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Machida YJ, 2005, J BIOL CHEM, V280, P6253, DOI 10.1074/jbc.R400037200; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Porras A, 1996, J VIROL, V70, P6902; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Skoczylas C, 2005, VIROLOGY, V332, P596, DOI 10.1016/j.virol.2004.12.017; Sotillo E, 2008, J BIOL CHEM, V283, P11280, DOI 10.1074/jbc.M709055200; Vilaboa N, 2004, NUCLEIC ACIDS RES, V32, P6454, DOI 10.1093/nar/gkh981; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603	42	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14126	14135		10.1074/jbc.M900687200	http://dx.doi.org/10.1074/jbc.M900687200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321444	Green Published, hybrid			2022-12-25	WOS:000266286100019
J	Smriti; Zou, P; Mchaourab, HS				Smriti; Zou, Ping; Mchaourab, Hassane S.			Mapping Daunorubicin-binding Sites in the ATP-binding Cassette Transporter MsbA Using Site-specific Quenching by Spin Labels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC FAMILY TRANSPORTER; ESCHERICHIA-COLI MSBA; P-GLYCOPROTEIN; MULTIDRUG TRANSPORTER; DRUG-BINDING; STRUCTURAL MECHANISMS; ANTIBIOTIC-RESISTANCE; FEMTOSECOND DYNAMICS; CYTOPLASMIC MEMBRANE; MUTATIONAL ANALYSIS	ATP-binding cassette (ABC) transporters transduce the free energy of ATP hydrolysis to power the mechanical work of substrate translocation across cell membranes. MsbA is an ABC transporter implicated in trafficking lipid A across the inner membrane of Escherichia coli. It has sequence similarity and overlapping substrate specificity with multidrug ABC transporters that export cytotoxic molecules in humans and prokaryotes. Despite rapid advances in structure determination of ABC efflux transporters, little is known regarding the location of substrate-binding sites in the transmembrane segment and the translocation pathway across the membrane. In this study, we have mapped residues proximal to the daunorubicin (DNR)-binding site in MsbA using site-specific, ATP-dependent quenching of DNR intrinsic fluorescence by spin labels. In the nucleotide-free MsbA intermediate, DNR-binding residues cluster at the cytoplasmic end of helices 3 and 6 at a site accessible from the membrane/water interface and extending into an aqueous chamber formed at the interface between the two transmembrane domains. Binding of a nonhydrolyzable ATP analog inverts the transporter to an outward-facing conformation and relieves DNR quenching by spin labels suggesting DNR exclusion from proximity to the spin labels. The simplest model consistent with our data has DNR entering near an elbow helix parallel to the water/membrane interface, partitioning into the open chamber, and then translocating toward the periplasm upon ATP binding.	[Smriti; Zou, Ping; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), 2215 Garland Ave,741 Light Hall, Nashville, TN 37232 USA.	mchaourab@vanderbilt.edu	Mishra, Smriti/D-4034-2009	Mishra, Smriti/0000-0002-6765-5007	National Institutes of Health [R01-GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM077659 from the NIGMS.	Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LONDON E, 1982, MOL CELL BIOCHEM, V45, P181; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743; Poelarends GJ, 2002, BBA-BIOENERGETICS, V1555, P1, DOI 10.1016/S0005-2728(02)00246-3; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Qu Q, 2002, BIOCHEMISTRY-US, V41, P4744, DOI 10.1021/bi0120897; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11873, DOI 10.1073/pnas.211440298; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	48	33	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13904	13913		10.1074/jbc.M900837200	http://dx.doi.org/10.1074/jbc.M900837200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19278995	Green Published, hybrid			2022-12-25	WOS:000265877300066
J	Kim, SJ; Nian, C; McIntosh, CHS				Kim, Su-Jin; Nian, Cuilan; McIntosh, Christopher H. S.			Glucose-dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 Modulate beta-Cell Chromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOSIS-SPECIFIC PHOSPHORYLATION; MITOTIC CHROMOSOME CONDENSATION; ACTIVATED PROTEIN-KINASE; HISTONE H3; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CREB; PATHWAY; STRESS; P38	Chromatin can exert a regulatory effect on gene transcription by modulating the access of transcription factors to target genes. In the present study, we examined whether nuclear actions of the incretin hormones, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, involve modulation of beta-cell chromatin structure. Stimulation of INS-1(832/13) beta-cells or dispersed mouse islets with glucose-dependent insulinotropic polypeptide or glucagon-like peptide1 resulted in the post-translational modification of core H3 histones, through acetylation and phosphorylation. Both increased histone H3 acetyltransferase and reduced histone deacetylase activities contributed. Subsequent studies demonstrated that incretin-mediated histone H3 modifications involved activation of protein kinase A, p42/44 mitogen-activated protein kinase (MAPK), and p38 MAPK signaling modules, resulting in the activation of mitogen-and stress-activated kinase-1. Additionally, modification of histone H3 increased its association with the transcription factor, phosphorylated cAMP-response element-binding protein (phosphoCREB) and with cAMP-responsive CREB coactivator 2. Incretin-activated CREB-related Bcl-2 transcription was greatly reduced by a histone acetyltransferase inhibitor, demonstrating the functional importance of histone H3 modification. This appears to be the first demonstration of beta-cell chromatin modification in response to the incretins and the studies indicate that their regulatory effects involve coordinated nuclear interactions between specific signaling modules, chromatin-modifying enzymes and transcription factors.	Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Cellular Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research ( to C. H. S. M.).	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2002, CHEM BIOL, V9, P1167, DOI 10.1016/S1074-5521(02)00265-X; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Cai R, 2001, BIOCHEM BIOPH RES CO, V283, P445, DOI 10.1006/bbrc.2001.4786; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Davie James R, 2003, Sci STKE, V2003, pPE33; DE CD, 1999, TRENDS BIOCHEM SCI, V24, P281; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; KARNWOWSKADESAU.P, 2007, BIOCHEM BIOPH RES CO, V361, P349; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; Kim SJ, 2005, J BIOL CHEM, V280, P28692, DOI 10.1074/jbc.M504913200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	49	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12896	12904		10.1074/jbc.M809046200	http://dx.doi.org/10.1074/jbc.M809046200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279000	Green Published, hybrid			2022-12-25	WOS:000265688300035
J	Qiu, ZJ; Dyer, KD; Xie, ZH; Radinger, M; Rosenberg, HF				Qiu, Zhijun; Dyer, Kimberly D.; Xie, Zhihui; Radinger, Madeleine; Rosenberg, Helene F.			GATA Transcription Factors Regulate the Expression of the Human Eosinophil-derived Neurotoxin (RNase 2) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-CELL LINE; INTRONIC ENHANCER; CATIONIC PROTEIN; RIBONUCLEASE GENES; RNS2 GENE; PROMOTER; FAMILY; DIFFERENTIATION; EVOLUTION; SEQUENCE	The transcription factors GATA-1 and GATA-2 have been implicated in promoting differentiation of eosinophilic leukocytes. In this study, we examined the roles of GATA-1 and GATA-2 in activating transcription of the secretory ribonuclease, the eosinophil- derived neurotoxin (EDN/RNase 2). Augmented expression of both GATA-1 and GATA-2 was detected in eosinophil promyelocyte HL-60 clone 15 cells in response to biochemical differentiation with butyric acid. Deletion or mutation of one or both of the two consensus GATA-binding sites in the extended 1000-bp 5' promoter of the EDN gene resulted in profound reduction in reporter gene activity. Antibody-augmented electrophoretic mobility shift and chromatin immunoprecipitation analyses indicate that GATA-1 and GATA-2 proteins bind to both functional GATA consensus sequences in the EDN promoter. Interestingly, RNA silencing of GATA-1 alone had no impact on EDN expression; silencing of GATA-2 resulted in diminished expression of EDN, and also diminished expression of GATA-1 in both butyric acid-induced HL-60 clone 15 cells and in differentiating human eosinophils derived from CD34(+) hematopoietic progenitors. Likewise, overexpression of GATA-2 in uninduced HL-60 clone 15 cells resulted in augmented transcription of both EDN and GATA-1. Taken together, our data suggest that GATA-2 functions directly via interactions with the EDN promoter and also indirectly, via its ability to regulate the expression of GATA-1 in differentiating eosinophils and eosinophil cell lines.	[Qiu, Zhijun; Dyer, Kimberly D.; Xie, Zhihui; Radinger, Madeleine; Rosenberg, Helene F.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rosenberg, HF (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Rm 11C215,9000 Rockville Pike, Bethesda, MD 20892 USA.	hrosenberg@niaid.nih.gov		Radinger, Madeleine/0000-0002-0652-7378	National Institutes of Health [AI00941, AI00942]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI00941 and AI00942 NIAID (Division of Intramural Research).	Baltus B, 1999, J LEUKOCYTE BIOL, V66, P683, DOI 10.1002/jlb.66.4.683; Barnes PJ, 2001, J ALLERGY CLIN IMMUN, V108, pS72, DOI 10.1067/mai.2001.116435; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Cantor AB, 2005, INT J HEMATOL, V81, P378, DOI 10.1532/IJH97.04180; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; Dyer KD, 2004, MAMM GENOME, V15, P126, DOI 10.1007/s00335-003-2304-x; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Escoubet-Lozach L, 2002, J ALLERGY CLIN IMMUN, V110, P553, DOI 10.1067/mai.2002.128076; FISCHKOFF SA, 1984, J EXP MED, V160, P179, DOI 10.1084/jem.160.1.179; Foster PS, 2008, CURR MOL MED, V8, P585, DOI 10.2174/156652408785748013; FREDENS K, 1982, J ALLERGY CLIN IMMUN, V70, P361, DOI 10.1016/0091-6749(82)90025-2; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Handen JS, 1997, J BIOL CHEM, V272, P1665, DOI 10.1074/jbc.272.3.1665; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Leckie Maggie J, 2003, Am J Respir Med, V2, P245; Lowry JA, 2006, INT J BIOCHEM CELL B, V38, P6, DOI 10.1016/j.biocel.2005.06.017; McNagny K, 2002, J EXP MED, V195, pf43, DOI 10.1084/jem.20020636; Migliaccio AR, 2005, ANN NY ACAD SCI, V1044, P142, DOI 10.1196/annals.1349.019; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Roboz G J, 1999, Curr Opin Hematol, V6, P164, DOI 10.1097/00062752-199905000-00007; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Shimizu R, 2005, SEMIN CELL DEV BIOL, V16, P129, DOI 10.1016/j.semcdb.2004.11.001; Tang XB, 2001, CELL MOL LIFE SCI, V58, P2008, DOI 10.1007/PL00000833; Tiffany HL, 1996, J BIOL CHEM, V271, P12387, DOI 10.1074/jbc.271.21.12387; TIFFANY HL, 1995, J LEUKOCYTE BIOL, V58, P49; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; van Dijk TB, 1998, BLOOD, V91, P2126, DOI 10.1182/blood.V91.6.2126.2126_2126_2132; Wang HY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-89; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Yamaguchi Y, 1999, BLOOD, V94, P1429, DOI 10.1182/blood.V94.4.1429.416k13_1429_1439; Yang D, 2000, J BIOL CHEM, V275, P9425, DOI 10.1074/jbc.275.13.9425; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397; ZON LI, 1992, NUCLEIC ACIDS RES, V20, P1812, DOI 10.1093/nar/20.7.1812; ZON LI, 1993, BLOOD, V81, P3234	49	20	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13099	13109		10.1074/jbc.M807307200	http://dx.doi.org/10.1074/jbc.M807307200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279013	Green Published, hybrid			2022-12-25	WOS:000265688300057
J	Wicovsky, A; Henkler, F; Salzmann, S; Scheurich, P; Kneitz, C; Wajant, H				Wicovsky, A.; Henkler, F.; Salzmann, S.; Scheurich, P.; Kneitz, C.; Wajant, H.			Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation	ONCOGENE			English	Article						apoptosis; NF-kappa B; TNF; TNFR1; TNFR2; TRAF1	NF-KAPPA-B; FACTOR-ALPHA; CELL-DEATH; SUPEROXIDE-DISMUTASE; INDUCED APOPTOSIS; FACTOR (TRAF)-1; T-LYMPHOCYTES; LIPID RAFTS; ACTIVATION; TRAF2	It has been shown that tumor necrosis factor receptor-2 (TNFR2) stimulation leads to degradation of TNF receptor associated factor-2 (TRAF2) and inhibition of TNFR1-induced activation of NF kappa B and JNK. Here, we show that TRAF1 inhibits TNFR2-induced proteasomal degradation of TRAF2 and relieves TNFR1-induced activation of NF kappa B from the inhibitory effect of TNFR2. TRAF1 co-recruited with TRAF2 to both TNF receptors. Despite lackingan amino-terminal RING/zinc-finger domain, TRAF1 did not interfere with TNFR1-induced activation of JNK and NF kappa B. It is noted that physiological expression levels of TRAF1 enhanced NF kappa B activation and interleukin-8 (IL8) production induced by TNFR2. Thus, TRAF1 shifts the quality of integrated TNFR1-TNFR2 signaling from apoptosis induction to proinflammatory NF kappa B signaling.	[Wicovsky, A.; Henkler, F.; Salzmann, S.; Kneitz, C.; Wajant, H.] Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, D-97070 Wurzburg, Germany; [Scheurich, P.] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany	University of Wurzburg; University of Stuttgart	Wajant, H (corresponding author), Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Roentgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949	Deutsche Forschungsgemeinschaft [B7, HE 5275/2-1, Wa1025/8-1]; IZKF Wurzburg [A-49]; Weyth Biopharma	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Wurzburg; Weyth Biopharma	The project was supported by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 487, project B7, HE 5275/2-1 and Wa1025/8-1), IZKF Wurzburg (project A-49) and Weyth Biopharma (Forschungspreis Rheumatologie 2007).	Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Baxter GT, 1999, J BIOL CHEM, V274, P9539, DOI 10.1074/jbc.274.14.9539; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Declercq W, 1998, J IMMUNOL, V161, P390; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Henkler F, 2003, J BIOL CHEM, V278, P29216, DOI 10.1074/jbc.M211090200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Irmler M, 2000, FEBS LETT, V468, P129, DOI 10.1016/S0014-5793(00)01206-0; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; Krippner-Heidenreich A, 2008, J IMMUNOL, V180, P8176, DOI 10.4049/jimmunol.180.12.8176; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Murray J, 1997, BLOOD, V90, P2772, DOI 10.1182/blood.V90.7.2772.2772_2772_2783; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Speiser DE, 1996, EUR J IMMUNOL, V26, P3055, DOI 10.1002/eji.1830261235; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; VANDENABEELE P, 1995, J IMMUNOL, V154, P2904; VERCAMMEN D, 1995, CYTOKINE, V7, P463, DOI 10.1006/cyto.1995.0063; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Weingartner M, 2002, J BIOL CHEM, V277, P34853, DOI 10.1074/jbc.M205149200; Weiss T, 1997, J IMMUNOL, V158, P2398; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	43	57	60	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1769	1781		10.1038/onc.2009.29	http://dx.doi.org/10.1038/onc.2009.29			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19287455				2022-12-25	WOS:000265640400004
J	van Eijk, M; Aten, J; Bijl, N; Ottenhoff, R; van Roomen, CPAA; Dubbelhuis, PF; Seeman, I; Ghauharali-van der Vlugt, K; Overkleeft, HS; Arbeeny, C; Groen, AK; Aerts, JMFG				van Eijk, Marco; Aten, Jan; Bijl, Nora; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Dubbelhuis, Peter F.; Seeman, Ingar; Ghauharali-van der Vlugt, Karen; Overkleeft, Hermen S.; Arbeeny, Cynthia; Groen, Albert K.; Aerts, Johannes M. F. G.			Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation	PLOS ONE			English	Article							MACROPHAGE INFILTRATION; GANGLIOSIDE GM3; RESISTANCE; FAT; INHIBITION; CERAMIDE; ADIPONECTIN; ADIPOCYTES; RECEPTOR; TOLL-LIKE-RECEPTOR-4	Adipose tissue is a critical mediator in obesity-induced insulin resistance. Previously we have demonstrated that pharmacological lowering of glycosphingolipids and subsequently GM3 by using the iminosugar AMP-DNM, strikingly improves glycemic control. Here we studied the effects of AMP-DNM on adipose tissue function and inflammation in detail to provide an explanation for the observed improved glucose homeostasis. Leptin-deficient obese (Lep(Ob)) mice were fed AMP-DNM and its effects on insulin signalling, adipogenesis and inflammation were monitored in fat tissue. We show that reduction of glycosphingolipid biosynthesis in adipose tissue of Lep(Ob) mice restores insulin signalling in isolated ex vivo insulin-stimulated adipocytes. We observed improved adipogenesis as the number of larger adipocytes was reduced and expression of genes like peroxisome proliferator-activated receptor (PPAR) gamma, insulin responsive glucose transporter (GLUT)-4 and adipsin increased. In addition, we found that adiponectin gene expression and protein were increased by AMP-DNM. As a consequence of this improved function of fat tissue we observed less inflammation, which was characterized by reduced numbers of adipose tissue macrophages (crown-like structures) and reduced levels of the macrophage chemo attractants monocyte-chemoattractant protein-1 (Mcp-1/Ccl2) and osteopontin (OPN). In conclusion, pharmacological lowering of glycosphingolipids by inhibition of glucosylceramide biosynthesis improves adipocyte function and as a consequence reduces inflammation in adipose tissue of obese animals.	[van Eijk, Marco; Bijl, Nora; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Dubbelhuis, Peter F.; Seeman, Ingar; Ghauharali-van der Vlugt, Karen; Groen, Albert K.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Overkleeft, Hermen S.] Leiden Univ, Gorleaus Inst, Dept Organ Chem, Leiden, Netherlands; [Arbeeny, Cynthia] Genzyme Corp, Framingham, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; Sanofi-Aventis; Genzyme Corporation	van Eijk, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.c.vaneijk@amc.uva.nl	Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112; Overkleeft, Herman/0000-0001-6976-7005	Dutch Diabetes Foundation [2007.11.017]	Dutch Diabetes Foundation	This work was supported by the Dutch Diabetes Foundation by grant 2007.11.017. The Dutch Diabetes foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gray SL, 2007, NUTR REV, V65, pS7, DOI [10.1111/j.1753-4887.2007.tb00331.x, 10.1301/nr.2007.jun.S7-S12]; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kundu S K, 1981, Methods Enzymol, V72, P174; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Shen C, 2004, INT IMMUNOPHARMACOL, V4, P939, DOI 10.1016/j.intimp.2004.04.008; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Vlugt KGVD, 2008, CLIN CHIM ACTA, V389, P109, DOI 10.1016/j.cca.2007.12.001; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	57	90	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4723	10.1371/journal.pone.0004723	http://dx.doi.org/10.1371/journal.pone.0004723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305508	Green Published, Green Submitted, gold			2022-12-25	WOS:000265498800001
J	Hacini-Rachinel, F; Gheit, H; Le Luduec, JB; Dif, F; Nancey, S; Kaiserlian, D				Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Dif, Fariel; Nancey, Stephane; Kaiserlian, Dominique			Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Cells	PLOS ONE			English	Article								Probiotics are believed to alleviate allergic and inflammatory skin disorders, but their impact on pathogenic effector T cells remains poorly documented. Here we show that oral treatment with the probiotic bacteria L. casei (DN-114 001) alone alleviates antigen-specific skin inflammation mediated by either protein-specific CD4(+) T cells or hapten-specific CD8(+) T cells. In the model of CD8(+) T cell-mediated skin inflammation, which reproduces allergic contact dermatitis in human, inhibition of skin inflammation by L. casei is not due to impaired priming of hapten-specific IFN gamma-producing cytolytic CD8(+) effector T cells. Alternatively, L. casei treatment reduces the recruitment of CD8(+) effector T cells into the skin during the elicitation (i.e. symptomatic) phase of CHS. Inhibition of skin inflammation by L. casei requires MHC class II-restricted CD4(+) T cells but not CD1d-restricted NK-T cells. L casei treatment enhanced the frequency of FoxP3(+) Treg in the skin and increased the production of IL-10 by CD4(+)CD25(+) regulatory T cells in skin draining lymph nodes of hapten-sensitized mice. These data demonstrate that orally administered L. casei (DN-114 001) efficiently alleviate T cell-mediated skin inflammation without causing immune suppression, via mechanisms that include control of CD8(+) effector T cells and involve regulatory CD4(+) T cells. L. casei (DN-114 001) may thus represent a probiotic of potential interest for immunomodulation of T cell-mediated allergic skin diseases in human.	[Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Nancey, Stephane; Kaiserlian, Dominique] Univ Lyon, Lyon, France; [Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Nancey, Stephane; Kaiserlian, Dominique] INSERM, U851, Lyon, France; [Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Nancey, Stephane; Kaiserlian, Dominique] Univ Lyon 1, IFR128, Lyon, France; [Dif, Fariel] Danone Res, Palaiseau, France; [Nancey, Stephane] Ctr Hosp Lyon Sud, Serv Gastroenterol, Hospices Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Danone Nutricia; CHU Lyon	Hacini-Rachinel, F (corresponding author), Univ Lyon, Lyon, France.	dominique.kaiserlian@inserm.fr	KAISERLIAN, Dominique/G-3325-2013; NANCEY, STEPHANE/Y-5093-2019	KAISERLIAN, Dominique/0000-0001-6252-4916; NANCEY, STEPHANE/0000-0003-2088-1442; LE LUDUEC, Jean-Benoit/0000-0002-1046-2941	INSERM; Danone Research Center Palaiseau, France; DANONE	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Danone Research Center Palaiseau, France(Danone Nutricia); DANONE(Danone Nutricia)	This work was supported by institutional grant from INSERM (infrastructure charges), and from grant from Danone Research Center (Palaiseau, France). F. Hacini-Rachinel is the recipient of a CIFRE this grant from DANONE. Danone as a private company has no role in study design, data collection or interpretation. The authors have no financial conflict of interest.	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760; Cavani A, 1998, J INVEST DERMATOL, V111, P621, DOI 10.1046/j.1523-1747.1998.00334.x; Chapat L, 2004, EUR J IMMUNOL, V34, P2520, DOI 10.1002/eji.200425139; Chen JP, 2005, EUR J IMMUNOL, V35, P690, DOI 10.1002/eji.200425577; Desvignes C, 2000, J IMMUNOL, V164, P2515, DOI 10.4049/jimmunol.164.5.2515; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dubois B, 2003, BLOOD, V102, P3295, DOI 10.1182/blood-2003-03-0727; ENK AH, 1995, J INVEST DERMATOL, V105, P80; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Krasteva M, 1998, J IMMUNOL, V160, P1181; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mahnke K, 2007, EUR J IMMUNOL, V37, P2117, DOI 10.1002/eji.200636841; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Nancey S, 2006, GASTROENTEROLOGY, V131, P485, DOI 10.1053/j.gastro.2006.05.018; Okazaki F, 2002, J DERMATOL, V29, P699, DOI 10.1111/j.1346-8138.2002.tb00206.x; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Ring S, 2006, EUR J IMMUNOL, V36, P2981, DOI 10.1002/eji.200636207; Roelofs-Haarhuis K, 2004, J IMMUNOL, V173, P1043, DOI 10.4049/jimmunol.173.2.1043; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schultz M, 2005, J MICROBIOL METH, V61, P389, DOI 10.1016/j.mimet.2005.01.007; Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	35	78	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4903	10.1371/journal.pone.0004903	http://dx.doi.org/10.1371/journal.pone.0004903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300508	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496800005
J	Williams, C; Shai, RM; Wu, YC; Hsu, YH; Sitzer, T; Spann, B; McCleary, C; Mo, Y; Miller, CA				Williams, Celia; Shai, Ruty Mehrian; Wu, Yongchun; Hsu, Ya-Hsuan; Sitzer, Traci; Spann, Bryan; McCleary, Carol; Mo, Yi; Miller, Carol A.			Transcriptome Analysis of Synaptoneurosomes Identifies Neuroplasticity Genes Overexpressed in Incipient Alzheimer's Disease	PLOS ONE			English	Article								In Alzheimer's disease (AD), early deficits in learning and memory are a consequence of synaptic modification induced by toxic beta-amyloid oligomers (oA beta). To identify immediate molecular targets downstream of oA beta binding, we prepared synaptoneurosomes from prefrontal cortex of control and incipient AD (IAD) patients, and isolated mRNAs for comparison of gene expression. This novel approach concentrates synaptic mRNA, thereby increasing the ratio of synaptic to somal mRNA and allowing discrimination of expression changes in synaptically localized genes. In IAD patients, global measures of cognition declined with increasing levels of dimeric A beta (dA beta). These patients also showed increased expression of neuroplasticity related genes, many encoding 3'UTR consensus sequences that regulate translation in the synapse. An increase in mRNA encoding the GluR2 subunit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) was paralleled by elevated expression of the corresponding protein in IAD. These results imply a functional impact on synaptic transmission as GluR2, if inserted, maintains the receptors in a low conductance state. Some overexpressed genes may induce early deficits in cognition and others compensatory mechanisms, providing targets for intervention to moderate the response to dA beta.	[Williams, Celia; Mo, Yi; Miller, Carol A.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Sitzer, Traci; Spann, Bryan; McCleary, Carol; Miller, Carol A.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Miller, Carol A.] Univ So Calif, Keck Sch Med, Program Neurosci, Los Angeles, CA 90033 USA; [Wu, Yongchun] Univ So Calif, Keck Sch Med, Norris Med Lib, Los Angeles, CA 90033 USA; [Shai, Ruty Mehrian; Hsu, Ya-Hsuan] Univ So Calif, Keck Sch Med, Inst Genet Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Williams, C (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	carolmil@usc.edu			Alzheimer's Disease Research Center [2P50 AG005142]; California Alzheimer's Disease program research [04-35517]; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	Alzheimer's Disease Research Center; California Alzheimer's Disease program research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Alzheimer's Disease Research Center (2P50 AG005142) and the California Alzheimer's Disease program research (04-35517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Bell KFS, 2006, NEUROBIOL AGING, V27, P1644, DOI 10.1016/j.neurobiolaging.2005.09.034; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; EDGAR R, 2002, GENE EXPRESSION OMNI, P207; Fischbach GD, 2006, NAT MED, V12, P734, DOI 10.1038/nm0706-734; Gabel LA, 2004, J NEUROSCI, V24, P10579, DOI 10.1523/JNEUROSCI.2185-04.2004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; HUNG AY, 1993, ACTIVATION PROTEIN K, P22959; JAFFREY SR, 2001, SCIENCE, P9; Jimenez CR, 2002, J NEUROCHEM, V81, P735, DOI 10.1046/j.1471-4159.2002.00873.x; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Liolitsa D, 2002, J NEUROL NEUROSUR PS, V73, P261, DOI 10.1136/jnnp.73.3.261; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Matsuoka Y, 2002, NEUROSCI RES, V42, P299, DOI 10.1016/S0168-0102(02)00010-X; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Mufson EJ, 2006, PROG BRAIN RES, V158, P197, DOI 10.1016/S0079-6123(06)58010-0; Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7; MUSLIMOV IA, 2004, DENDRITIC TRANSPORT, P52613; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Parameshwaran K, 2007, SYNAPSE, V61, P367, DOI 10.1002/syn.20386; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; RAO A, 1991, J NEUROSCI, V11, P2881; Ryan MM, 2004, BIOL PSYCHIAT, V55, P329, DOI 10.1016/j.biopsych.2003.10.016; Sala C, 2003, J NEUROSCI, V23, P6327; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senda Takao, 2005, Anatomical Science International, V80, P121, DOI 10.1111/j.1447-073x.2005.00106.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Shimomura A, 2005, NEUROSCI LETT, V375, P81, DOI 10.1016/j.neulet.2004.10.074; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sung YJ, 2004, MOL BRAIN RES, V126, P81, DOI 10.1016/j.molbrainres.2004.03.013; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Teter B, 2004, J MOL NEUROSCI, V23, P167, DOI 10.1385/JMN:23:3:167; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Watt TJ, 2005, BIOTECHNIQUES, V38, P109, DOI 10.2144/05381RR03; WEIQIN Z, 2008, ALZHEIMERS DEMENT, V4, pT197; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8	94	88	89	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4936	10.1371/journal.pone.0004936	http://dx.doi.org/10.1371/journal.pone.0004936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295912	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496700009
J	Bozek, K; Relogio, A; Kielbasa, SM; Heine, M; Dame, C; Kramer, A; Herzel, H				Bozek, Katarzyna; Relogio, Angela; Kielbasa, Szymon M.; Heine, Markus; Dame, Christof; Kramer, Achim; Herzel, Hanspeter			Regulation of Clock-Controlled Genes in Mammals	PLOS ONE			English	Article							ERYTHROPOIETIN MESSENGER-RNA; CIRCADIAN TRANSCRIPTION; BINDING SITES; E-BOX; NF-Y; EXPRESSION; MECHANISM; PROTEINS; PROMOTER; MOUSE	The complexity of tissue-and day time-specific regulation of thousands of clock-controlled genes (CCGs) suggests that many regulatory mechanisms contribute to the transcriptional output of the circadian clock. We aim to predict these mechanisms using a large scale promoter analysis of CCGs. Our study is based on a meta-analysis of DNA-array data from rodent tissues. We searched in the promoter regions of 2065 CCGs for highly overrepresented transcription factor binding sites. In order to compensate the relatively high GC-content of CCG promoters, a novel background model to avoid a bias towards GC-rich motifs was employed. We found that many of the transcription factors with overrepresented binding sites in CCG promoters exhibit themselves circadian rhythms. Among the predicted factors are known regulators such as CLOCK:BMAL1, DBP, HLF, E4BP4, CREB, ROR alpha and the recently described regulators HSF1, STAT3, SP1 and HNF-4 alpha. As additional promising candidates of circadian transcriptional regulators PAX-4, C/EBP, EVI-1, IRF, E2F, AP-1, HIF-1 and NF-Y were identified. Moreover, GC-rich motifs (SP1, EGR, ZF5, AP-2, WT1, NRF-1) and AT-rich motifs (MEF-2, HMGIY, HNF-1, OCT-1) are significantly overrepresented in promoter regions of CCGs. Putative tissue-specific binding sites such as HNF-3 for liver, NKX2.5 for heart or Myogenin for skeletal muscle were found. The regulation of the erythropoietin (Epo) gene was analysed, which exhibits many binding sites for circadian regulators. We provide experimental evidence for its circadian regulated expression in the adult murine kidney. Basing on a comprehensive literature search we integrate our predictions into a regulatory network of core clock and clock-controlled genes. Our large scale analysis of the CCG promoters reveals the complexity and extensiveness of the circadian regulation in mammals. Results of this study point to connections of the circadian clock to other functional systems including metabolism, endocrine regulation and pharmacokinetics.	[Bozek, Katarzyna; Relogio, Angela; Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Bozek, Katarzyna] Max Planck Inst Informat, Saarbrucken, Germany; [Kielbasa, Szymon M.] Max Planck Inst Mol Genet, Berlin, Germany; [Heine, Markus; Kramer, Achim] Universitasmed Berlin, Lab Chronobiol, Berlin, Germany; [Dame, Christof] Universitatsmed Berlin, Klin Charite, Dept Neonatol, Campus Virchow, Berlin, Germany	Humboldt University of Berlin; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Herzel, H (corresponding author), Humboldt Univ, Inst Theoret Biol, Berlin, Germany.	h.herzel@biologie.hu-berlin.de	Relógio, Angela/M-4959-2016; Kiełbasa, Szymon M./K-2792-2019; Kiełbasa, Szymon/G-1636-2018	Relógio, Angela/0000-0002-9165-2439; Kiełbasa, Szymon/0000-0003-2805-6535; Kramer, Achim/0000-0001-9671-6078	Deutsche Forschungsgemeinschaft [SFB 618]; EU; 6th European Framework program EUCLOCK	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); 6th European Framework program EUCLOCK	The Deutsche Forschungsgemeinschaft (SFB 618) and the EU (BIOSIM network) are acknowledged for financial support. Research in A.K.'s lab is supported by the 6th European Framework program EUCLOCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozek K, 2007, GENOME INFORM SER, V18, P65; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Chen W, 2000, MOL BRAIN RES, V81, P43, DOI 10.1016/S0169-328X(00)00160-1; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Csernus V, 2003, NEUROENDOCRINOL LETT, V24, P404; Dame C, 1998, BLOOD, V92, P3218, DOI 10.1182/blood.V92.9.3218; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Haus E, 2007, ADV DRUG DELIVER REV, V59, P985, DOI 10.1016/j.addr.2007.01.001; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hrushesky WJM, 2000, JPN J CLIN ONCOL, V30, P529, DOI 10.1093/jjco/hyd134; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kielbasa SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-237; Kim JH, 2001, J BIOL CHEM, V276, P18153, DOI 10.1074/jbc.M101661200; Klausen T, 1996, EUR J APPL PHYSIOL O, V72, P297, DOI 10.1007/BF00599688; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Leclerc GM, 2005, ENDOCRINOLOGY, V146, P2782, DOI 10.1210/en.2005-0100; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Nicolas M, 2003, BIOCHEM J, V371, P265, DOI 10.1042/BJ20021166; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pasqualetti P, 1996, Riv Eur Sci Med Farmacol, V18, P91; Ptitsyn AA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S15; RAHMANN S, 2003, STAT APPL GENET MOL, V22; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; TAN CC, 1992, AM J PHYSIOL, V263, pF474, DOI 10.1152/ajprenal.1992.263.3.F474; TEBOUL M, 2008, MOL ENDOCRINOL; Tokita K, 2007, CANCER SCI, V98, P1752, DOI 10.1111/j.1349-7006.2007.00597.x; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WIDE L, 1989, BRIT J HAEMATOL, V72, P85, DOI 10.1111/j.1365-2141.1989.tb07657.x; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	59	180	187	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4882	10.1371/journal.pone.0004882	http://dx.doi.org/10.1371/journal.pone.0004882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287494	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496400021
J	Kim, MK; Shin, JM; Eun, HC; Chung, JH				Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho			The Role of p300 Histone Acetyltransferase in UV-Induced Histone Modifications and MMP-1 Gene Transcription	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; MATRIX METALLOPROTEINASES; ULTRAVIOLET-B; EXPRESSION; P53; ACETYLATION; ACTIVATION; SKIN; INHIBITION; INDUCTION	Matrix metalloproteinase (MMP)-1 promotes ultraviolet (UV)-triggered long-term detrimental effects such as cancer formation and premature skin aging. Although histone modifications may play a crucial role in the transcriptional regulation of MMP-1, the relationship between UV-induced histone modification and MMP-1 expression is not completely understood. Here, we identify regulators of histone acetylation that may link UV-mediated DNA damage and MMP-1 induction by UV in cultured human dermal fibroblasts (HDFs) in vitro. UV irradiation of HDFs induced MMP-1 expression and increased the level of phosphorylation of H2AX (gamma-H2AX), p53 and the acetylation of histone H3 (acetyl-H3). Total histone deacetylase (HDAC) enzymatic activity was decreased by UV irradiation, while histone acetyltransferase (HAT) activity was increased. Suppression of p300 histone acetyltransferase (p300HAT) activity by the p300HAT inhibitor anacardic acid (AA) or by down-regulation of p300 by siRNA prevented UV-induced MMP-1 expression and inhibited UV-enhanced gamma-H2AX, p53 level, and acetyl-H3. Using chromatin immunoprecipitation assays, we observed that gamma-H2AX, p53, acetyl-H3, p300 and gamma-Jun were consistently recruited by UV to a distinct region (-2067/-1768) adjacent to the p300 binding site (-1858/-1845) in the MMP-1 promoter. In addition, these recruitments of gamma-H2AX, p53, acetyl-H3, p300 and c-Jun to the p300-2 site were significantly abrogated by post-treatment with AA. Furthermore, overexpression of p300 increased the basal and UV-induced MMP-1 promoter activity. Our results suggest that p300HAT plays a critical role in the transcriptional regulation of MMP-1 by UV.	[Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho] Seoul Natl Univ Hosp, Clin Res Inst, Lab Cutaneous Aging Res, Seoul, South Korea; [Kim, Min-Kyoung; Shin, Jung-Min; Eun, Hee Chul; Chung, Jin Ho] Seoul Natl Univ, Inst Dermatol Sci, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Chung, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.	jhchung@snu.ac.kr	Eun, Hee Chul/J-5568-2012; Chung, Jin Ho/C-3604-2011		Korean Government;  [KRF-2005-015-E00166]	Korean Government(Korean Government); 	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, KRF-2005-015-E00166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Davidson SM, 2005, CHEMBIOCHEM, V6, P162, DOI 10.1002/cbic.200400246; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Fuchs B, 2003, FEBS LETT, V553, P104, DOI 10.1016/S0014-5793(03)00984-0; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kim HH, 2006, J LIPID RES, V47, P921, DOI 10.1194/jlr.M500420-JLR200; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Mai A, 2006, J MED CHEM, V49, P6897, DOI 10.1021/jm060601m; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Nelson KK, 2006, J BIOL CHEM, V281, P14100, DOI 10.1074/jbc.M601820200; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Ravanti L, 1999, J BIOL CHEM, V274, P37292, DOI 10.1074/jbc.274.52.37292; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7; Seo JY, 2001, J INVEST DERMATOL, V116, P915, DOI 10.1046/j.1523-1747.2001.01358.x; Shan B, 2003, J BIOL CHEM, V278, P44009, DOI 10.1074/jbc.M302671200; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Terp GE, 2000, J BIOMOL STRUCT DYN, V17, P933, DOI 10.1080/07391102.2000.10506582; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Yu YC, 2005, CELL CYCLE, V4, P1043, DOI 10.4161/cc.4.8.1928; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	42	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2009	4	3							e4864	10.1371/journal.pone.0004864	http://dx.doi.org/10.1371/journal.pone.0004864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OI	19287485	Green Published, gold			2022-12-25	WOS:000265496400013
J	Mai, PL; Chatterjee, N; Hartge, P; Tucker, M; Brody, L; Struewing, JP; Wacholder, S				Mai, Phuong L.; Chatterjee, Nilanjan; Hartge, Patricia; Tucker, Margaret; Brody, Lawrence; Struewing, Jeffery P.; Wacholder, Sholom			Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma	PLOS ONE			English	Article							KIN-COHORT; SURVIVAL; RISK; PENETRANCE; WOMEN	Background: Although the increase in risk of developing breast, ovarian, and prostate cancer in BRCA1 and BRCA2 mutation carriers has been studied extensively, its impact on mortality is not well quantified. Further, possible effect of BRCA mutations on non-cancer mortality risk has not been examined. Methodology/Principal Findings: Using mortality data from the relatives of 5,287 genotyped participants, of whom 120 carried a BRCA Ashkenazi Jewish founder mutation, in a community-based study of the Ashkenazi Jewish population in the Washington D. C area, we examined the association between the three Ashkenazi BRCA founder mutations and risk of overall and non-cancer mortality. To examine risks beyond the established effects of these mutations, we analyzed the data excluding both deaths and follow-up times after reported diagnosis of melanoma and cancer of the breast, ovary, prostate, and pancreas. Using an extension of the kin-cohort method that accounts for informative censoring, we estimated that, in the absence of breast, ovarian, and pancreatic cancers, and melanoma, female carriers had a life expectancy that was 6.8 years lower (95% CI: 1.2-10.5) than non-carriers. In male mutation carriers, the reduction in life expectancy, in the absence of prostate and pancreatic cancers and melanoma, was 3.7 (95% CI: -0.4, 6.8) years. When deaths and follow-up times after any cancer diagnosis were excluded, the difference in life expectancy was 5.7 years for women (95% CI: -0.1, 10.4) and 3.7 years for men (95% CI: -0.4, 6.9). An overall test of association for men and women together showed a statistically significant association between BRCA1/2 mutations and increased non-cancer mortality (p=0.024). Conclusions/Significance: These findings suggest that there may be unknown effects of BRCA1/2 mutations on nonneoplastic diseases that cause death at older ages.	[Mai, Phuong L.] NCI, Clin Genet Branch, Rockville, MD USA; [Chatterjee, Nilanjan; Wacholder, Sholom] NCI, Biostat Branch, Rockville, MD USA; [Hartge, Patricia] NCI, Off Director Biostat & Epidemiol Program, Rockville, MD USA; [Tucker, Margaret] NCI, Div Canc Epidemiol & Genet, Genet Epidemiol Branch, Rockville, MD USA; [Brody, Lawrence; Struewing, Jeffery P.] Natl Human Genome Res Inst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Mai, PL (corresponding author), NCI, Clin Genet Branch, Rockville, MD USA.	maip@mail.nih.gov	Struewing, Jeffery P/I-7502-2013; Tucker, Margaret A/B-4297-2015	Struewing, Jeffery P/0000-0002-4848-3334; 	Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000120] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Byrd LM, 2008, CANCER EPIDEM BIOMAR, V17, P1535, DOI 10.1158/1055-9965.EPI-07-2792; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chatterjee N, 2003, GENET EPIDEMIOL, V25, P303, DOI 10.1002/gepi.10269; Chatterjee N, 2001, BIOMETRICS, V57, P245, DOI 10.1111/j.0006-341X.2001.00245.x; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Dizin E, 2006, J BIOL CHEM, V281, P24236, DOI 10.1074/jbc.M602176200; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gail MH, 1999, GENET EPIDEMIOL, V16, P15, DOI 10.1002/(SICI)1098-2272(1999)16:1<15::AID-GEPI3>3.0.CO;2-8; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lee JS, 1999, JNCI-J NATL CANCER I, V91, P259, DOI 10.1093/jnci/91.3.259; Liebens FP, 2007, EUR J CANCER, V43, P238, DOI 10.1016/j.ejca.2006.07.019; Moller P, 2007, INT J CANCER, V121, P1017, DOI 10.1002/ijc.22789; Moore DF, 2001, GENET EPIDEMIOL, V20, P210, DOI 10.1002/1098-2272(200102)20:2<210::AID-GEPI4>3.0.CO;2-I; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Shukla V, 2006, CANCER RES, V66, P7151, DOI 10.1158/0008-5472.CAN-05-4570; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Wacholder S, 1998, AM J EPIDEMIOL, V148, P623, DOI 10.1093/aje/148.7.623	31	43	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4812	10.1371/journal.pone.0004812	http://dx.doi.org/10.1371/journal.pone.0004812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277124	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496100029
J	Martin, S; Henley, JM; Holman, D; Zhou, M; Wiegert, O; van Spronsen, M; Joels, M; Hoogenraad, CC; Krugers, HJ				Martin, Stephane; Henley, Jeremy M.; Holman, David; Zhou, Ming; Wiegert, Olof; van Spronsen, Myrrhe; Joels, Marian; Hoogenraad, Casper C.; Krugers, Harmen J.			Corticosterone Alters AMPAR Mobility and Facilitates Bidirectional Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GLUCOCORTICOID-RECEPTOR; DENDRITIC SPINES; STRESS; ACTIVATION; TRANSMISSION; TRAFFICKING; HIPPOCAMPUS; ENDOCYTOSIS; DIFFUSION	Background: The stress hormone corticosterone has the ability both to enhance and suppress synaptic plasticity and learning and memory processes. However, until today there is very little known about the molecular mechanism that underlies the bidirectional effects of stress and corticosteroid hormones on synaptic efficacy and learning and memory processes. In this study we investigate the relationship between corticosterone and AMPA receptors which play a critical role in activity-dependent plasticity and hippocampal-dependent learning. Methodology/Principal Findings: Using immunocytochemistry and live cell imaging techniques we show that corticosterone selectively increases surface expression of the AMPAR subunit GluR2 in primary hippocampal cultures via a glucocorticoid receptor and protein synthesis dependent mechanism. In agreement, we report that corticosterone also dramatically increases the fraction of surface expressed GluR2 that undergo lateral diffusion. Furthermore, our data indicate that corticosterone facilitates NMDAR-invoked endocytosis of both synaptic and extra-synaptic GluR2 under conditions that weaken synaptic transmission. Conclusion/Significance: Our results reveal that corticosterone increases mobile GluR2 containing AMPARs. The enhanced lateral diffusion properties can both facilitate the recruitment of AMPARs but under appropriate conditions facilitate the loss of synaptic AMPARs (LTD). These actions may underlie both the facilitating and suppressive effects of corticosteroid hormones on synaptic plasticity and learning and memory and suggest that these hormones accentuate synaptic efficacy.	[Martin, Stephane; Henley, Jeremy M.; Holman, David] Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TH, Avon, England; [Zhou, Ming; Wiegert, Olof; Joels, Marian; Krugers, Harmen J.] Univ Amsterdam, SILS, CNS, NL-1012 WX Amsterdam, Netherlands; [van Spronsen, Myrrhe; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Martin, Stephane] CNRS, IN2M IPMC, F-06560 Valbonne, France	University of Bristol; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Hoogenraad, CC (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	c.hoogenraad@erasmusmc.nl; h.krugers@uva.nl	Hoogenraad, Casper/B-8866-2011; Martin, Stéphane/G-5954-2012; Joëls, Marian/P-6415-2016	Hoogenraad, Casper/0000-0002-2666-0758; Martin, Stéphane/0000-0001-6771-7645; Joels, Marian/0000-0002-4826-6209; Henley, Jeremy/0000-0003-3589-8335	EU [GRIPPANT, PL 005320]; MRC; Wellcome Trust; Netherlands Organization for Scientific Research [051.02.010]; NWO-ZonMw-VIDI award; Dutch Brain foundation [13F05(2)]; Royal Dutch Academy of Arts and Sciences [05CDP013]; Human Frontier Science Program Career Development Award; European Science Foundation European Young Investigators award; MRC [G9629038, G0601810] Funding Source: UKRI; Medical Research Council [G9629038, G0601810] Funding Source: researchfish	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO-ZonMw-VIDI award; Dutch Brain foundation; Royal Dutch Academy of Arts and Sciences; Human Frontier Science Program Career Development Award; European Science Foundation European Young Investigators award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr. Morgan Sheng for GluR1-2 C-terminal antibodies and useful comments, Nanda Keijzer, Yasuko Nakamura and Samantha Spangler for preparing hippocampal cultures. This work was supported by grants from the EU (GRIPPANT, PL 005320), the MRC and the Wellcome Trust to JMH; the Netherlands Organization for Scientific Research (NWO Cognition program 051.02.010 to H.K. and NWO-ZonMw-VIDI award to C.C.H); the Dutch Brain foundation (13F05(2) to H.K.); the Royal Dutch Academy of Arts and Sciences (05CDP013) to H.K. and M.Z., the Human Frontier Science Program Career Development Award (HFSP-CDA to C.C.H) and the European Science Foundation European Young Investigators award (ESF-EURYI to C.C.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarez Deborah N., 2006, CNS & Neurological Disorders-Drug Targets, V5, P521, DOI 10.2174/187152706778559345; Alfarez DN, 2002, NEUROSCIENCE, V115, P1119, DOI 10.1016/S0306-4522(02)00483-9; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Coussens CM, 1997, J NEUROPHYSIOL, V78, P1; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Holman D, 2007, J NEUROSCI METH, V160, P302, DOI 10.1016/j.jneumeth.2006.09.018; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Jaskolski F, 2009, NEUROSCIENCE, V158, P19, DOI 10.1016/j.neuroscience.2008.01.075; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Stein V, 2003, J NEUROSCI, V23, P5503; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiegert O, 2005, NEUROSCIENCE, V135, P403, DOI 10.1016/j.neuroscience.2005.05.039; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204	34	96	97	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4714	10.1371/journal.pone.0004714	http://dx.doi.org/10.1371/journal.pone.0004714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19305644	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600024
J	Wright, JA; Wang, XY; Brown, DR				Wright, Josephine A.; Wang, Xiaoyan; Brown, David R.			Unique copper-induced oligomers mediate alpha-synuclein toxicity	FASEB JOURNAL			English	Article						Parkinson's disease; cell death; Lewy bodies; metal	RAPID CELLULAR DEGENERATION; DISEASE-LINKED MUTATIONS; TARGETING A-BETA; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LEWY BODIES; HUMAN-BRAIN; NEURODEGENERATIVE DISEASE	Parkinson's disease and a number of other neurodegenerative diseases have been linked to either genetic mutations in the alpha-synuclein gene or show evidence of aggregates of the alpha-synuclein protein, sometimes in the form of Lewy bodies. There currently is no clear evidence of a distinct neurotoxic species of alpha-synuclein to explain the death of neurons in these diseases. We undertook to assess the toxicity of alpha-synuclein via exogenous application in cell culture. Initially, we showed that only aggregated alpha-synuclein is neurotoxic and requires the presence copper but not iron. Other members of the synuclein family showed no toxicity in any form and inherited point mutations did not alter the effective toxic concentration of alpha-synuclein. Through protein fractionation techniques, we were able to isolate an oligomeric species responsible for the toxicity of alpha-synuclein. This oligomeric species has a unique stellate appearance under EM and again, requires association with copper to induce cell death. The results allow us to suggest that the toxic species of alpha-synuclein in vivo could possibly be these stellate oligomers and not fibrils. Our data provide a link between the recently noted association of copper and alpha-synuclein and a potential role for the combination in causing neurodegeneration.-Wright, J. A., Wang, X., Brown, D. R. Unique copper-induced oligomers mediate alpha-synuclein toxicity. FASEB J. 23, 2384-2393 (2009)	[Wright, Josephine A.; Wang, Xiaoyan; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Wright, Josephine/0000-0003-4588-8827	Alzheimer's Research Trust UK [ART/PPG2005B/8]; Alzheimers Research UK [ART-PPG2005B-8] Funding Source: researchfish	Alzheimer's Research Trust UK; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	The authors thank Ursula Potter for her expertise in electron microscopy imaging and the Alzheimer's Research Trust UK for funding (ART/PPG2005B/8).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Bharathi, 2007, BIOCHEM BIOPH RES CO, V359, P115, DOI 10.1016/j.bbrc.2007.05.060; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; El-Agnaf OMA, 2000, J STRUCT BIOL, V130, P300, DOI 10.1006/jsbi.2000.4262; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; GOLDBERG WJ, 1981, CLIN CHEM, V27, P562; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee EN, 2003, J NEUROCHEM, V84, P1128, DOI 10.1046/j.1471-4159.2003.01612.x; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; PALL HS, 1987, LANCET, V2, P238; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Squitti R, 2006, NEUROLOGY, V67, P76, DOI 10.1212/01.wnl.0000223343.82809.cf; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; WARREN PJ, 1960, BRAIN, V83, P709, DOI 10.1093/brain/83.4.709; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244	84	117	117	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2384	2393		10.1096/fj.09-130039	http://dx.doi.org/10.1096/fj.09-130039			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19325037				2022-12-25	WOS:000268836700007
J	Lucas, ME; Crider, KS; Powell, DR; Kapoor-Vazirani, P; Vertino, PM				Lucas, Mary E.; Crider, Krista S.; Powell, Doris R.; Kapoor-Vazirani, Priya; Vertino, Paula M.			Methylation-sensitive Regulation of TMS1/ASC by the Ets Factor, GA-binding Protein-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GABP; LYSOZYME DOWNSTREAM ENHANCER; CASPASE RECRUITMENT DOMAIN; ABERRANT METHYLATION; DNA METHYLATION; ACTIVATING ADAPTER; PROSTATE-CANCER; GENE-EXPRESSION; BREAST-CANCER; RECEPTOR GENE	Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP)alpha. Supershift analysis indicated that the GABP alpha binding partner, GABP beta 1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABP alpha/beta 1 in trans. GABP alpha was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABP alpha led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABP alpha.	Emory Univ, Winship Canc Inst, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Lucas, Mary E.; Powell, Doris R.; Kapoor-Vazirani, Priya; Vertino, Paula M.] Emory Univ, Winship Canc Inst, Dept Radiat Oncol & Hematol, Atlanta, GA 30322 USA; [Lucas, Mary E.; Powell, Doris R.; Kapoor-Vazirani, Priya; Vertino, Paula M.] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Vertino, PM (corresponding author), 1365-C Clifton Rd NE,Rm 4086, Atlanta, GA 30322 USA.	pvertin@emory.edu		Crider, Krista/0000-0001-6997-5955	National Institutes of Health NCI [2RO1 CA077337]; NATIONAL CANCER INSTITUTE [R01CA077337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM078787, T32GM008490] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NCI Grant 2RO1 CA077337.	Ammerpohl O, 1997, GENE, V200, P75, DOI 10.1016/S0378-1119(97)00377-6; Atlas E, 2001, ONCOGENE, V20, P7110, DOI 10.1038/sj.onc.1204890; Aurrekoetxea-Hernandez K, 2000, J VIROL, V74, P4988, DOI 10.1128/JVI.74.11.4988-4998.2000; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; CARDOT P, 1994, BIOCHEMISTRY-US, V33, P12139, DOI 10.1021/bi00206a017; Collard RL, 2006, PROSTATE, V66, P687, DOI 10.1002/pros.20371; Conway KE, 2000, CANCER RES, V60, P6236; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Flory E, 1996, J VIROL, V70, P2260, DOI 10.1128/JVI.70.4.2260-2268.1996; Guan X, 2003, INT J CANCER, V107, P202, DOI 10.1002/ijc.11376; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hoare S, 1999, ENDOCRINOLOGY, V140, P2268, DOI 10.1210/en.140.5.2268; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Imaki H, 2003, CANCER RES, V63, P4607; Kang HS, 2008, J MOL BIOL, V377, P636, DOI 10.1016/j.jmb.2008.01.054; Kapoor-Vazirani P, 2008, CANCER RES, V68, P6810, DOI 10.1158/0008-5472.CAN-08-0141; Levine JJ, 2003, ONCOGENE, V22, P3475, DOI 10.1038/sj.onc.1206430; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Parsons MJ, 2006, ONCOGENE, V25, P6948, DOI 10.1038/sj.onc.1209684; Parsons MJ, 2009, CANCER RES, V69, P1706, DOI 10.1158/0008-5472.CAN-08-2351; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Resendes KK, 2006, MOL CELL BIOL, V26, P3060, DOI 10.1128/MCB.26.8.3060-3070.2006; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Sawa C, 1996, NUCLEIC ACIDS RES, V24, P4954, DOI 10.1093/nar/24.24.4954; Schmitz A, 1997, J BIOL CHEM, V272, P20850, DOI 10.1074/jbc.272.33.20850; Schweppe RE, 2003, J BIOL CHEM, V278, P16863, DOI 10.1074/jbc.M213063200; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stimson KM, 2002, J BIOL CHEM, V277, P4951, DOI 10.1074/jbc.M109809200; Stone AR, 2004, AM J PATHOL, V165, P1151, DOI 10.1016/S0002-9440(10)63376-7; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Virmani A, 2003, INT J CANCER, V106, P198, DOI 10.1002/ijc.11206; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yokomori N, 1998, MOL ENDOCRINOL, V12, P1241, DOI 10.1210/me.12.8.1241; YOKOMORI N, 1995, MOL CELL BIOL, V15, P5355; Yokoyama T, 2003, CANCER LETT, V202, P101, DOI 10.1016/j.canlet.2003.08.027; Zhao H, 2006, J BIOL CHEM, V281, P30573, DOI 10.1074/jbc.M606803200	49	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14698	14709		10.1074/jbc.M901104200	http://dx.doi.org/10.1074/jbc.M901104200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324871	Green Published, hybrid			2022-12-25	WOS:000266288200006
J	Sallee, JL; Burridge, K				Sallee, Jennifer L.; Burridge, Keith			Density-enhanced Phosphatase 1 Regulates Phosphorylation of Tight Junction Proteins and Enhances Barrier Function of Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SELECTIVE DEPHOSPHORYLATION; TYROSINE-PHOSPHATASE; BETA-CATENIN; POSSIBLE INVOLVEMENT; ENDOTHELIAL-CELLS; ADHERENS JUNCTION; ETA SUPPRESSES; OCCLUDIN; RECEPTOR; GROWTH	Cell-cell adhesion is a dynamic process that can activate multiple signaling pathways. These signaling pathways can be regulated through reversible tyrosine phosphorylation events. The level of tyrosine phosphorylation of junctional proteins reflects the balance between protein-tyrosine kinase and protein-tyrosine phosphatase activity. The receptor-tyrosine phosphatase DEP-1 (CD148/PTP-eta) has been implicated in cell growth and differentiation as well as in regulating phosphorylation of junctional proteins. However, the role of DEP-1 in regulating tight junction phosphorylation and the integrity of cell-cell junctions is still under investigation. In this study, we used a catalytically dead substrate-trapping mutant of DEP-1 to identify potential substrates at cell-cell junctions. We have shown that in epithelial cells the trapping mutant of DEP-1 interacts with the tight junction proteins occludin and ZO-1 in a tyrosine phosphorylation-dependent manner. In contrast, PTP-PEST, Shp2, and PTP mu did not interact with these proteins, suggesting that the interaction of DEP-1 with occludin and ZO-1 is specific. In addition, occludin and ZO-1 were dephosphorylated by DEP-1 but not these other phosphatases in vitro. Overexpression of DEP-1 increased barrier function as measured by transepithelial electrical resistance and also reduced paracellular flux of fluorescein isothiocyanate-dextran following a calcium switch. Reduced DEP-1 expression by small interfering RNA had a small but significant increase in junction permeability. These data suggest that DEP-1 can modify the phosphorylation state of tight junction proteins and play a role in regulating permeability.	[Sallee, Jennifer L.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sallee, JL (corresponding author), 12-026 Lineberger Canc Ctr, Chapel Hill, NC 27599 USA.	jennifer_sallee@med.unc.edu			National Institutes of Health [GM29860, HL45100]; Department of Defense Breast Cancer Research Program [W81XWH-06-1-033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM29860 and HL45100.; Supported by Department of Defense Breast Cancer Research Program pre-doctoral fellowship W81XWH-06-1-0333. To whom correspondence should be addressed: 12-026 Lineberger Cancer Center, Chapel Hill, NC 27599-7295. Tel.: 919-966-5783; E-mail: jennifer_sallee@med.unc.edu.	Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Borges LG, 1996, CIRC RES, V79, P570, DOI 10.1161/01.RES.79.3.570; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Collares-Buzato CB, 1998, EUR J CELL BIOL, V76, P85, DOI 10.1016/S0171-9335(98)80020-4; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hollande F, 2001, AM J PHYSIOL-GASTR L, V280, pG910, DOI 10.1152/ajpgi.2001.280.5.G910; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Iuliano R, 2003, CANCER RES, V63, P882; Jallal B, 1997, J BIOL CHEM, V272, P12158, DOI 10.1074/jbc.272.18.12158; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Keane MM, 1996, CANCER RES, V56, P4236; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Martelli ML, 1998, EXP CELL RES, V245, P195, DOI 10.1006/excr.1998.4257; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Mitic LL, 1999, J CELL BIOL, V146, P683, DOI 10.1083/jcb.146.3.683; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Persson C, 2002, FEBS LETT, V517, P27, DOI 10.1016/S0014-5793(02)02570-X; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; STADDON JM, 1995, J CELL SCI, V108, P609; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; VANITALLIE CM, 1995, J CELL SCI, V108, P1735; Wachtel M, 1999, J CELL SCI, V112, P4347; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	61	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14997	15006		10.1074/jbc.M901901200	http://dx.doi.org/10.1074/jbc.M901901200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332538	Green Published, hybrid			2022-12-25	WOS:000266288200036
J	Lama, A; Pawaria, S; Bidon-Chanal, A; Anand, A; Gelpi, JL; Arya, S; Marti, M; Estrin, DA; Luque, FJ; Dikshit, KL				Lama, Amrita; Pawaria, Sudesh; Bidon-Chanal, Axel; Anand, Arvind; Gelpi, Jose Luis; Arya, Swati; Marti, Marcelo; Estrin, Dario A.; Luque, F. Javier; Dikshit, Kanak L.			Role of Pre-A Motif in Nitric Oxide Scavenging by Truncated Hemoglobin, HbN, of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; DYNAMICAL REGULATION; MOLECULAR-DYNAMICS; MIGRATION PATHWAYS; NO DETOXIFICATION; OXYGEN-BINDING; PROTEIN; O-2; MACROPHAGES	Mycobacterium tuberculosis truncated hemoglobin, HbN, is endowed with a potent nitric-oxide dioxygenase activity and has been found to relieve nitrosative stress and enhance in vivo survival of a heterologous host, Salmonella enterica Typhimurium, within the macrophages. These findings implicate involvement of HbN in the defense of M. tuberculosis against nitrosative stress. The protein carries a tunnel system composed of a short and a long tunnel branch that has been proposed to facilitate diatomic ligand migration to the heme and an unusual Pre-A motif at the N terminus, which does not contribute significantly to the structural integrity of the protein, as it protrudes out of the compact globin fold. Strikingly, deletion of Pre-A region from the M. tuberculosis HbN drastically reduces its ability to scavenge nitric oxide (NO), whereas its insertion at the N terminus of Pre-A lacking HbN of Mycobacterium smegmatis improved its nitric-oxide dioxygenase activity. Titration of the oxygenated adduct of HbN and its mutants with NO indicated that the stoichiometric oxidation of protein is severalfold slower when the Pre-A region is deleted in HbN. Molecular dynamics simulations show that the excision of Pre-A motif results in distinct changes in the protein dynamics, which cause the gate of the tunnel long branch to be trapped into a closed conformation, thus impeding migration of diatomic ligands toward the heme active site. The present study, thus, unequivocally demonstrates vital function of Pre-A region in NO scavenging and unravels its unique role by which HbN might attain its efficient NO-detoxification ability.	[Lama, Amrita; Pawaria, Sudesh; Anand, Arvind; Arya, Swati; Dikshit, Kanak L.] Council Sci & Ind Res India, Inst Microbial Technol, Chandigarh 160036, India; [Marti, Marcelo; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, Inst Quim Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina; [Bidon-Chanal, Axel; Gelpi, Jose Luis; Luque, F. Javier] Univ Barcelona, Fac Pharm, Dept Phys Chem, E-08028 Barcelona, Spain; [Bidon-Chanal, Axel; Gelpi, Jose Luis; Luque, F. Javier] Univ Barcelona, Fac Pharm, Inst Biomed IBUB, E-08028 Barcelona, Spain	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Buenos Aires; University of Barcelona; University of Barcelona	Dikshit, KL (corresponding author), Council Sci & Ind Res India, Inst Microbial Technol, Sector 39 A, Chandigarh 160036, India.	kanak@imtech.res.in	Estrin, Dario/AAY-7549-2020; Luque, F. Javier/L-9652-2014; Bidon-Chanal, Axel/C-4536-2017; Gelpí, Josep Ll./M-6401-2013	Luque, F. Javier/0000-0002-8049-3567; Bidon-Chanal, Axel/0000-0002-1666-1490; Gelpí, Josep Ll./0000-0002-0566-7723; Marti, Marcelo/0000-0002-7911-9340; Estrin, Dario/0000-0002-5006-7225	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Spanish Ministerio de Ciencia e Innovacion [SAF2008-05595-C02-01, PCI2006-A7-0688]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 25667]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad de Buenos Aires; John Simon Guggenheim Foundation; European Union	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Spanish Ministerio de Ciencia e Innovacion(Council of Scientific & Industrial Research (CSIR) - IndiaMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad de Buenos Aires(University of Buenos AiresConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); John Simon Guggenheim Foundation; European Union(European Commission)	This work was supported by the Department of Biotechnology, Government of India, and Council of Scientific and Industrial Research, Spanish Ministerio de Ciencia e Innovacion Grants SAF2008-05595-C02-01 and PCI2006-A7-0688, Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 25667, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad de Buenos Aires, the John Simon Guggenheim Foundation, and the European Union FP7 program (project NOstress).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; COUTURE M, 1994, MOL GEN GENET, V243, P185, DOI 10.1007/BF00280316; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Fenton M J, 1998, Curr Opin Hematol, V5, P72, DOI 10.1097/00062752-199801000-00012; Fenton MJ, 1996, INFECT IMMUN, V64, P683, DOI 10.1128/IAI.64.3.683-690.1996; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Hill DR, 1996, J BACTERIOL, V178, P6587, DOI 10.1128/jb.178.22.6587-6598.1996; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaur R, 2002, APPL ENVIRON MICROB, V68, P152, DOI 10.1128/AEM.68.1.152-160.2002; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200	39	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14457	14468		10.1074/jbc.M807436200	http://dx.doi.org/10.1074/jbc.M807436200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329431	hybrid, Green Published			2022-12-25	WOS:000266286100052
J	Wang, J; Lou, HY; Pedersen, CJ; Smith, AD; Perez, RG				Wang, Jian; Lou, Haiyan; Pedersen, Courtney J.; Smith, Amanda D.; Perez, Ruth G.			14-3-3 zeta Contributes to Tyrosine Hydroxylase Activity in MN9D Cells LOCALIZATION OF DOPAMINE REGULATORY PROTEINS TO MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES TRYPTOPHAN 5-MONOOXYGENASE; LEWY BODY DISEASE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; CEREBRAL-CORTEX; PHOSPHATASE 2A; PHOSPHORYLATION; KINASE; BRAIN; BODIES	The 14-3-3 proteins stimulate the activation of tyrosine hydroxylase (TH), the rate-limiting catecholamine biosynthetic enzyme. To explore if particular endogenous 14-3-3 isoforms specifically affected TH activity and dopamine synthesis, we utilized rodent nigrostriatal tissues and midbrain-derived MN9D dopaminergic cells. Extracts from ventral midbrain and MN9D cells contained similar pools of 14-3-3 mRNAs, with 14-3-3 zeta being relatively abundant in both. Protein levels of 14-3-3 zeta were also abundant. [P-32]Orthophosphate labeling of MN9D cells, followed by co-immunoprecipitation with pan-TH and pan-14-3-3 antibodies brought down similar amounts of phosphorylated TH in each, confirming that 14-3-3-bound phosphorylated TH in our cells. Co-immunoprecipitation of striatal tissues with a pan-TH antibody precipitated 14-3-3 zeta but not another potential TH regulatory isoform, 14-3-3 eta. In whole cell extracts from MN9D cells after 14-3-3 small interfering RNA treatments, we found that 14-3-3 zeta knockdown significantly reduced TH activity and dopamine synthesis whereas knockdown of 14-3-3 eta had no effect. 14-3-3 zeta was found co-localized on mitochondria with TH, and its knockdown by small interfering RNA reduced TH phosphorylation and TH activity in the mitochondrial pool. Together the data support a role for 14-3-3 zeta as an endogenous activator of TH in midbrain dopaminergic neurons and furthermore, identify mitochondria as a potential novel site for dopamine synthesis, with implications for Parkinson disease.	[Wang, Jian; Lou, Haiyan; Pedersen, Courtney J.; Smith, Amanda D.; Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Wang, Jian; Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Wang, Jian; Lou, Haiyan; Pedersen, Courtney J.; Smith, Amanda D.; Perez, Ruth G.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Wang, Jian] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200042, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University	Perez, RG (corresponding author), 3501 5th Ave,BST3 7021, Pittsburgh, PA 15260 USA.	perezrg@pitt.edu	Perez, Ruth G./AAK-9844-2020	Pedersen, Courtney/0000-0002-5917-2742	National Institutes of Health NINDS [NS42094]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094, R21NS045336] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grant NS42094. This work was also supported by the Michael J. Fox Foundation.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Baxter HC, 2002, BIOCHEM SOC T, V30, P387, DOI 10.1042/bst0300387; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Berg D, 2003, ANN NEUROL, V54, P135, DOI 10.1002/ana.10621; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bevilaqua LRM, 2001, J BIOL CHEM, V276, P40411, DOI 10.1074/jbc.M105280200; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chen XQ, 2005, J CEREBR BLOOD F MET, V25, P338, DOI 10.1038/sj.jcbfm.9600032; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; DAMUNI Z, 1987, J BIOL CHEM, V262, P5133; DAUBNER SC, 1993, PROTEIN SCI, V2, P1452, DOI 10.1002/pro.5560020909; Dong Y, 2008, J NEUROCHEM, V107, P1589, DOI 10.1111/j.1471-4159.2008.05721.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FUKUDA T, 1993, ACTA PATHOL JAPON, V43, P545; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hornykiewicz O, 1975, Natl Inst Drug Abuse Res Monogr Ser, P13; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; JACKSON D, 1993, J PHARMACOL EXP THER, V267, P912; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; KULJIS RO, 1989, NEUROSCI LETT, V106, P49, DOI 10.1016/0304-3940(89)90200-0; Kumer SC, 1996, J NEUROCHEM, V67, P443; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MOORE RY, 1978, ANNU REV NEUROSCI, V1, P129, DOI 10.1146/annurev.ne.01.030178.001021; NAKASHIMA S, 1984, J NEUROL SCI, V66, P91, DOI 10.1016/0022-510X(84)90144-8; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Okauchi H, 2004, HISTOCHEM CELL BIOL, V121, P181, DOI 10.1007/s00418-004-0622-z; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; ROSS ME, 1981, BRAIN RES, V208, P493; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; SCHAPIRA AHV, 1992, MUTAT RES, V275, P133, DOI 10.1016/0921-8734(92)90018-K; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Smith AD, 2002, NEUROPSYCHOPHARMACOL, V26, P756, DOI 10.1016/S0893-133X(01)00420-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Toska K, 2002, ANN NY ACAD SCI, V971, P66, DOI 10.1111/j.1749-6632.2002.tb04435.x; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Toyooka K, 2002, MOL BRAIN RES, V100, P13, DOI 10.1016/S0169-328X(02)00129-8; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Ubl A, 2002, MOL BRAIN RES, V108, P33, DOI 10.1016/S0169-328X(02)00510-7; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; WAGNER J, 1979, J CHROMATOGR, V164, P41, DOI 10.1016/S0378-4347(00)81570-4; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229	62	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14011	14019		10.1074/jbc.M901310200	http://dx.doi.org/10.1074/jbc.M901310200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19289463	Green Published, hybrid			2022-12-25	WOS:000266286100007
J	Himmel, M; Ritter, A; Rothemund, S; Pauling, BV; Rottner, K; Gingras, AR; Ziegler, WH				Himmel, Mirko; Ritter, Anett; Rothemund, Sven; Pauling, Bjoerg V.; Rottner, Klemens; Gingras, Alexandre R.; Ziegler, Wolfgang H.			Control of High Affinity Interactions in the Talin C Terminus HOW TALIN DOMAINS COORDINATE PROTEIN DYNAMICS IN CELL ADHESIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN-BINDING-SITES; F-ACTIN-BINDING; I/LWEQ MODULE; INTEGRIN ACTIVATION; STRUCTURAL BASIS; CYTOPLASMIC DOMAIN; FOCAL ADHESIONS; SEQUENCE; IBS2	In cell-extracellular matrix junctions (focal adhesions), the cytoskeletal protein talin is central to the connection of integrins to the actin cytoskeleton. Talin is thought to mediate this connection via its two integrin, (at least) three actin, and several vinculin binding sites. The binding sites are cryptic in the head-to-rod autoinhibited cytoplasmic form of the protein and require (stepwise) conformational activation. This activation process, however, remains poorly understood, and there are contradictory models with respect to the determinants of adhesion site localization. Here, we report turnover rates and protein-protein interactions in a range of talin rod domain constructs varying in helix bundle structure. We conclude that several bundles of the C terminus cooperate to regulate targeting and concomitantly tailor high affinity interactions of the talin rod in cell adhesions. Intrinsic control of ligand binding activities is essential for the coordination of adhesion site function of talin.	[Himmel, Mirko; Ritter, Anett; Rothemund, Sven; Ziegler, Wolfgang H.] Univ Leipzig, Fac Med, IZKF Leipzig, Inselstr 22, D-04103 Leipzig, Germany; [Pauling, Bjoerg V.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany; [Gingras, Alexandre R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Leipzig University; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; University of Leicester	Ziegler, WH (corresponding author), Univ Leipzig, Fac Med, IZKF Leipzig, Inselstr 22, D-04103 Leipzig, Germany.	wolfgang.ziegler@medizin.uni-leipzig.de	Gingras, Alexandre R/E-1867-2011; Rottner, Klemens/AAE-5030-2020	Gingras, Alexandre R/0000-0002-5373-0176; Himmel, Mirko/0000-0001-7872-8016; Rottner, Klemens/0000-0003-4244-4198; Ziegler, Wolfgang H./0000-0003-4529-1916	Deutsche Forschungsgemeinschaft [Zi545/3 (SPP1150), Zi545/5-1, Ro2414/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Zi545/3 (SPP1150) and Zi545/5-1 ( to W. H. Z.) and Ro2414/1-1 ( to K. R.).	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Bulinski JC, 2001, J CELL SCI, V114, P3885; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Franco SJ, 2006, CELL MOTIL CYTOSKEL, V63, P563, DOI 10.1002/cm.20145; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hemmings L, 1996, J CELL SCI, V109, P2715; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Liu SC, 2000, J CELL SCI, V113, P3563; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xu WM, 1998, DEVELOPMENT, V125, P327; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	45	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13832	13842		10.1074/jbc.M900266200	http://dx.doi.org/10.1074/jbc.M900266200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19278997	Green Published, hybrid			2022-12-25	WOS:000265877300060
J	Woollard, KJ; Sturgeon, S; Chin-Dusting, JPF; Salem, HH; Jackson, SP				Woollard, Kevin J.; Sturgeon, Sharelle; Chin-Dusting, Jaye P. F.; Salem, Hatem H.; Jackson, Shaun P.			Erythrocyte Hemolysis and Hemoglobin Oxidation Promote Ferric Chloride-induced Vascular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED HEMOGLOBIN; HEME OXYGENASE-1 DEFICIENCY; ENDOTHELIAL-CELL INJURY; THROMBUS FORMATION; ARTERIAL THROMBOSIS; LIPID-PEROXIDATION; MURINE MODEL; NITRIC-OXIDE; E-SELECTIN; IN-VIVO	The release of redox-active iron and heme into the bloodstream is toxic to the vasculature, contributing to the development of vascular diseases. How iron induces endothelial injury remains ill defined. To investigate this, we developed a novel ex vivo perfusion chamber that enables direct analysis of the effects of FeCl3 on the vasculature. We demonstrate that FeCl3 treatment of isolated mouse aorta, perfused with whole blood, was associated with endothelial denudation, collagen exposure, and occlusive thrombus formation. Strikingly exposing vessels to FeCl3 alone, in the absence of perfused blood, was associated with only minor vascular injury. Whole blood fractionation studies revealed that FeCl3-induced vascular injury was red blood cell (erythrocyte)-dependent, requiring erythrocyte hemolysis and hemoglobin oxidation for endothelial denudation. Overall these studies define a unique mechanism of Fe3+-induced vascular injury that has implications for the understanding of FeCl3-dependent models of thrombosis and vascular dysfunction associated with severe intravascular hemolysis.	[Sturgeon, Sharelle; Salem, Hatem H.; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Woollard, Kevin J.; Chin-Dusting, Jaye P. F.] Monash Univ, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia	Monash University; Baker Heart and Diabetes Institute; Monash University	Jackson, SP (corresponding author), Monash Univ, Australian Ctr Blood Dis, Burnet Tower,6th Floor,89 Commercial Rd, Melbourne, Vic 3004, Australia.	shaun.jackson@med.monash.edu.au		Jackson, Shaun/0000-0002-4750-1991; Woollard, Kevin/0000-0002-9839-5463	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council.	Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076; CADROY Y, 1990, BLOOD, V75, P2185; Carmichael FJL, 2000, CRIT CARE MED, V28, P2283, DOI 10.1097/00003246-200007000-00017; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Everse J, 1997, FREE RADICAL BIO MED, V22, P1075, DOI 10.1016/S0891-5849(96)00499-6; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; KO KM, 1990, MOL CELL BIOCHEM, V95, P125; Kulkarni S, 2007, BLOOD, V110, P1879, DOI 10.1182/blood-2006-08-040980; Lamy ML, 2000, ANESTHESIOLOGY, V92, P646, DOI 10.1097/00000542-200003000-00007; Levy AP, 2006, CURR MOL MED, V6, P479, DOI 10.2174/156652406778018626; Liu XY, 2003, AM J PHYSIOL-CELL PH, V285, pC1036, DOI 10.1152/ajpcell.00164.2003; Lubos E, 2008, FRONT BIOSCI-LANDMRK, V13, P5323, DOI 10.2741/3084; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; MOTTERLINI R, 1995, AM J PHYSIOL-HEART C, V269, pH648, DOI 10.1152/ajpheart.1995.269.2.H648; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nagababu E, 2000, BIOCHEM BIOPH RES CO, V273, P839, DOI 10.1006/bbrc.2000.3025; Olsen SB, 1996, CIRCULATION, V93, P327, DOI 10.1161/01.CIR.93.2.327; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roest M, 1999, CIRCULATION, V100, P1268, DOI 10.1161/01.CIR.100.12.1268; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sachs UJH, 2007, CIRC RES, V100, P979, DOI 10.1161/01.RES.0000261936.85776.5f; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; SULLIVAN JL, 1981, LANCET, V1, P1293; TABBARA IA, 1992, MED CLIN N AM, V76, P649, DOI 10.1016/S0025-7125(16)30345-5; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; Tseng MT, 2006, THROMB RES, V118, P275, DOI 10.1016/j.thromres.2005.09.004; Wagener FADTG, 1997, P SOC EXP BIOL MED, V216, P456; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Woollard KJ, 2008, CIRC RES, V103, P1128, DOI 10.1161/CIRCRESAHA.108.180273; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165	46	81	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13110	13118		10.1074/jbc.M809095200	http://dx.doi.org/10.1074/jbc.M809095200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276082	Green Published, hybrid			2022-12-25	WOS:000265688300058
J	Jinawath, N; Vasoontara, C; Yap, KL; Thiaville, MM; Nakayama, K; Wang, TL; Shih, IM				Jinawath, N.; Vasoontara, C.; Yap, K-L; Thiaville, M. M.; Nakayama, K.; Wang, T-L; Shih, I-M			NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway	ONCOGENE			English	Article						ovarian; NAC-1; chemoresistance; paclitaxel	CHROMATIN-REMODELING GENE; KAPPA-B; POZ/BTB PROTEIN; C-MYC; TUMOR-SUPPRESSOR; TAXOL-RESISTANCE; IN-VITRO; CARCINOMA; EXPRESSION; SURVIVAL	Nucleus accumbens-1 (Nac1 or NAC-1) belongs to the BTB/POZ (Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad complex) transcription factor family and is a novel protein that potentially participates in self-renewal and pluripotency in embryonic stem cells. In human cancer, NAC-1 is upregulated in several types of neoplasms, but particularly in recurrent chemoresistant ovarian carcinomas, suggesting a biological role for NAC-1 in the development of drug resistance in ovarian cancer. We have assessed this possibility and shown a correlation between NAC-1 expression and ex vivo paclitaxel resistance in ovarian serous carcinoma tissues and cell lines. We found that expression of Gadd45-gamma-interacting protein 1 (Gadd45gip1), a downstream target negatively regulated by NAC-1, was reduced in paclitaxel-resistant cells. Ectopic expression of NAC-1 or knockdown of Gadd45gip1 conferred paclitaxel resistance, whereas NAC-1 knockdown or ectopic expression of Gadd45gip1 increased paclitaxel sensitivity. Furthermore, silencing NAC-1 expression or disrupting NAC-1 homodimerization by a dominant negative NAC-1 protein that contained only the BTB/POZ domain induced the expression of Gadd45 gamma, which interacted with Gadd45gip1. Reducing Gadd45 gamma expression by small hairpin RNAs partially enhanced paclitaxel resistance. Thus, this study provides new evidence that NAC-1 upregulation and homodimerization contribute to tumor recurrence by equipping ovarian cancer cells with the paclitaxel-resistant phenotype through negative regulation of the Gadd45 pathway. Oncogene (2009) 28, 1941-1948; doi:10.1038/onc.2009.37; published online 23 March 2009	[Jinawath, N.; Vasoontara, C.; Yap, K-L; Thiaville, M. M.; Wang, T-L; Shih, I-M] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA; [Jinawath, N.; Vasoontara, C.; Yap, K-L; Thiaville, M. M.; Wang, T-L; Shih, I-M] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21231 USA; [Jinawath, N.; Vasoontara, C.; Yap, K-L; Thiaville, M. M.; Wang, T-L; Shih, I-M] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21231 USA; [Nakayama, K.] Shimane Univ, Dept Gynecol & Obstet, Izumo, Shimane, Japan	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Shimane University	Shih, IM (corresponding author), Johns Hopkins Med Inst, Dept Pathol, CRB 2,Room 306,1550 Orleans St, Baltimore, MD 21231 USA.	ishih@jhmi.edu	sdsd, shihieih/ABE-6190-2020	Yap, Kai Lee/0000-0003-4496-5464	NIH [RO1CA103937, RO1CA129080]; HERA women's cancer foundation; NATIONAL CANCER INSTITUTE [R01CA103937, R01CA129080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HERA women's cancer foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is in memory of Ms Sean Patrick, the founder of HERA women's cancer foundation who has fought courageously with recurrent ovarian cancer. The authors appreciate the valuable comments from members in our laboratory. This work is supported by NIH RO1CA103937 (IMS), NIH RO1CA129080 ( IMS) and the HERA women's cancer foundation OSB1 (NJ, USA).	Abeysinghe HR, 1999, CANCER GENET CYTOGEN, V114, P136, DOI 10.1016/S0165-4608(99)00064-3; Abhiman S, 2008, BIOINFORMATICS, V24, P458, DOI 10.1093/bioinformatics/btn007; BAKER VV, 1990, GYNECOL ONCOL, V38, P340, DOI 10.1016/0090-8258(90)90069-W; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cha XY, 1997, J NEUROSCI, V17, P6864; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Davidson B, 2007, HUM PATHOL, V38, P1030, DOI 10.1016/j.humpath.2006.12.009; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dimova I, 2006, EUR J CANCER, V42, P674, DOI 10.1016/j.ejca.2005.11.022; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Holloway RW, 2002, GYNECOL ONCOL, V87, P8, DOI 10.1006/gyno.2002.6797; Ishibashi M, 2008, CLIN CANCER RES, V14, P3149, DOI 10.1158/1078-0432.CCR-07-4358; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kalivas PW, 1999, SYNAPSE, V33, P153, DOI 10.1002/(SICI)1098-2396(199908)33:2<153::AID-SYN5>3.0.CO;2-N; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; Korutla L, 2005, J NEUROCHEM, V94, P786, DOI 10.1111/j.1471-4159.2005.03206.x; Korutla L, 2007, J NEUROCHEM, V101, P611, DOI 10.1111/j.1471-4159.2006.04387.x; Liu GH, 2006, INT J GYNECOL CANCER, V16, P1777, DOI 10.1111/j.1525-1438.2006.00652.x; Loizzi V, 2003, AM J OBSTET GYNECOL, V189, P1301, DOI 10.1067/S0002-9378(03)00629-X; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; Mackler S, 2008, BEHAV BRAIN RES, V187, P48, DOI 10.1016/j.bbr.2007.08.036; Mao TL, 2006, HUM PATHOL, V37, P1169, DOI 10.1016/j.humpath.2006.04.008; Materna V, 2007, VIRCHOWS ARCH, V450, P187, DOI 10.1007/s00428-006-0346-7; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nakayama K, 2007, CANCER RES, V67, P8058, DOI 10.1158/0008-5472.CAN-07-1357; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Nakayama K, 2006, CANCER BIOL THER, V5, P630, DOI 10.4161/cbt.5.6.2675; Qiu WH, 2004, AM J PATHOL, V165, P1689, DOI 10.1016/S0002-9440(10)63425-6; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yeasmin S, 2008, CLIN CANCER RES, V14, P1686, DOI 10.1158/1078-0432.CCR-07-4085; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zerbini LF, 2005, CLIN CANCER RES, V11, P6409, DOI 10.1158/1078-0432.CCR-05-1475; Zerbini LF, 2005, CELL CYCLE, V4, P18, DOI 10.4161/cc.4.1.1363; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	44	67	73	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2009	28	18					1941	1948		10.1038/onc.2009.37	http://dx.doi.org/10.1038/onc.2009.37			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	442DT	19305429	Green Accepted			2022-12-25	WOS:000265820900001
J	Damy, T; Kirsch, M; Khouzami, L; Caramelle, P; Le Corvoisier, P; Roudot-Thoraval, F; Dubois-Rande, JL; Hittinger, L; Pavoine, C; Pecker, F				Damy, Thibaud; Kirsch, Matthias; Khouzami, Lara; Caramelle, Philippe; Le Corvoisier, Philippe; Roudot-Thoraval, Francoise; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pavoine, Catherine; Pecker, Francoise			Glutathione Deficiency in Cardiac Patients Is Related to the Functional Status and Structural Cardiac Abnormalities	PLOS ONE			English	Article								Background: The tripeptide glutathione (L-gamma-glutamyl-cysteinyl-glycine) is essential to cell survival, and deficiency in cardiac and systemic glutathione relates to heart failure progression and cardiac remodelling in animal models. Accordingly, we investigated cardiac and blood glutathione levels in patients of different functional classes and with different structural heart diseases. Methods: Glutathione was measured using standard enzymatic recycling method in venous blood samples obtained from 91 individuals, including 15 healthy volunteers and 76 patients of New York Heart Association (NYHA) functional class I to IV, undergoing cardiac surgery for coronary artery disease, aortic stenosis or terminal cardiomyopathy. Glutathione was also quantified in right atrial appendages obtained at the time of surgery. Results: In atrial tissue, glutathione was severely depleted (-58%) in NYHA class IV patients compared to NYHA class I patients (P = 0.002). In patients with coronary artery disease, this depletion was related to the severity of left ventricular dysfunction (P = 0.006). Compared to healthy controls, blood glutathione was decreased by 21% in NYHA class I patients with structural cardiac disease (P<0.01), and by 40% in symptomatic patients of NYHA class II to IV (P<0.0001). According to the functional NYHA class, significant depletion in blood glutathione occurred before detectable elevation in blood sTNFR1, a marker of symptomatic heart failure severity, as shown by the exponential relationship between these two parameters in the whole cohort of patients (r = 0.88). Conclusions: This study provides evidence that cardiac and systemic glutathione deficiency is related to the functional status and structural cardiac abnormalities of patients with cardiac diseases. These data also suggest that blood glutathione test may be an interesting new biomarker to detect asymptomatic patients with structural cardiac abnormalities.	[Damy, Thibaud; Kirsch, Matthias; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pecker, Francoise] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Chirurg Cardiaque, Creteil, France; [Damy, Thibaud; Khouzami, Lara; Caramelle, Philippe; Le Corvoisier, Philippe; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pavoine, Catherine; Pecker, Francoise] INSERM, U955, Creteil, France; [Damy, Thibaud; Kirsch, Matthias; Khouzami, Lara; Caramelle, Philippe; Le Corvoisier, Philippe; Roudot-Thoraval, Francoise; Dubois-Rande, Jean-Luc; Hittinger, Luc; Pavoine, Catherine; Pecker, Francoise] Univ Paris 12, Fac Med, UMR S955, F-94010 Creteil, France; [Le Corvoisier, Philippe] INSERM, Ctr Investigat Clin 006, Creteil, France; [Le Corvoisier, Philippe] Grp Hosp Henri Mondor Albert Chenevier, Creteil, France; [Roudot-Thoraval, Francoise] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Rech Clin Sante Publ, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Damy, T (corresponding author), Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Chirurg Cardiaque, Creteil, France.	francoise.pecker@inserm.fr	Pavoine, Catherine/N-4405-2018; le corvoisier, philippe/AAO-2862-2020	Pavoine, Catherine/0000-0002-0598-5545; Le Corvoisier, Philippe/0000-0003-0402-9591; Hittinger, Luc/0000-0003-1933-5815	Institut National de la Sante et de la Recherche Medicale; Assistance Publique des Hopitaux de Paris; Universite Paris 12; Association Francaise contre les Myopathies	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique des Hopitaux de Paris; Universite Paris 12; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The funders for the present work were: Institut National de la Sante et de la Recherche Medicale, the Assistance Publique des Hopitaux de Paris (as a Contrat d'Interface to F.P.), the Universite Paris 12 and the Association Francaise contre les Myopathies (as an aide aux etudes to L.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Amadou A, 2002, AM J PHYSIOL-CELL PH, V282, pC1339, DOI 10.1152/ajpcell.00471.2001; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; Cailleret M, 2004, CIRCULATION, V109, P406, DOI 10.1161/01.CIR.0000109499.00587.FF; Carnes CA, 2007, J BIOL CHEM, V282, P28063, DOI 10.1074/jbc.M704893200; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Deswal A, 2001, CIRCULATION, V103, P2055; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; FERRARI R, 1995, CIRCULATION, V92, P1479, DOI 10.1161/01.CIR.92.6.1479; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Hill MF, 1997, CIRCULATION, V96, P2414; Isaac DL, 2008, CURR OPIN CARDIOL, V23, P127, DOI 10.1097/HCO.0b013e3282f43039; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; Lang CA, 2000, J LAB CLIN MED, V135, P402, DOI 10.1067/mlc.2000.105977; Maisel A, 2004, J AM COLL CARDIOL, V44, P1328, DOI 10.1016/j.jacc.2004.06.015; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Nishii M, 2008, J AM COLL CARDIOL, V51, P2329, DOI 10.1016/j.jacc.2007.11.085; Nozaki N, 1997, JPN CIRC J, V61, P657, DOI 10.1253/jcj.61.657; Ozaydin M, 2008, EUR HEART J, V29, P625, DOI 10.1093/eurheartj/ehn011; Pfister R, 2004, EUR J HEART FAIL, V6, P289, DOI 10.1016/j.ejheart.2003.12.012; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Tang WHW, 2007, CIRCULATION, V116, pE99, DOI 10.1161/CIRCULATIONAHA.107.185267; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yucel D, 1998, CLIN CHEM, V44, P148	37	73	73	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4871	10.1371/journal.pone.0004871	http://dx.doi.org/10.1371/journal.pone.0004871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319187	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499200002
J	Chang, YW; Ko, TP; Lee, CD; Chang, YC; Lin, KA; Chang, CS; Wang, AHJ; Wang, TF				Chang, Yu-Wei; Ko, Tzu-Ping; Lee, Chien-Der; Chang, Yuan-Chih; Lin, Kuei-Ann; Chang, Chia-Seng; Wang, Andrew H. -J.; Wang, Ting-Fang			Three New Structures of Left-Handed RadA Helical Filaments: Structural Flexibility of N-Terminal Domain Is Critical for Recombinase Activity	PLOS ONE			English	Article							DOUBLE-STRANDED DNA; PROTEIN BINDS DNA; CRYSTAL-STRUCTURE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; METHANOCOCCUS-VOLTAE; SURFACE; DMC1; LONG; ADP	RecA family proteins, including bacterial RecA, archaeal RadA, and eukaryotic Dmc1 and Rad51, mediate homologous recombination, a reaction essential for maintaining genome integrity. In the presence of ATP, these proteins bind a single-strand DNA to form a right-handed nucleoprotein filament, which catalyzes pairing and strand exchange with a homologous double-stranded DNA (dsDNA), by as-yet unknown mechanisms. We recently reported a structure of RadA left-handed helical filament, and here present three new structures of RadA left-handed helical filaments. Comparative structural analysis between different RadA/Rad51 helical filaments reveals that the N-terminal domain (NTD) of RadA/Rad51, implicated in dsDNA binding, is highly flexible. We identify a hinge region between NTD and polymerization motif as responsible for rigid body movement of NTD. Mutant analysis further confirms that structural flexibility of NTD is essential for RadA's recombinase activity. These results support our previous hypothesis that ATP-dependent axial rotation of RadA nucleoprotein helical filament promotes homologous recombination.	[Chang, Yu-Wei; Lee, Chien-Der; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Chang, Yu-Wei; Ko, Tzu-Ping; Lin, Kuei-Ann; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chang, Yuan-Chih; Chang, Chia-Seng] Acad Sinica, Inst Phys, Taipei, Taiwan; [Lee, Chien-Der; Wang, Ting-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Chang, YW (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; tfwang@gate.sinica.edu.tw	CHANG, Yuan-Chih/J-2609-2016; Chang, Chia-Seng/AAP-8155-2021; Wang, Ting-Fang/ABI-3818-2020	CHANG, Yuan-Chih/0000-0002-0289-3768; Wang, Ting-Fang/0000-0001-6306-9505	Academia Sincia [Investigator Award, AS96IBC3]; National Science Council [NSC96-2321-B-001-019]; National Core Facility of High-Throughput Protein Crystallography [NSC97-3112-B-001-011-Y]	Academia Sincia; National Science Council(Ministry of Science and Technology, Taiwan); National Core Facility of High-Throughput Protein Crystallography	This work was supported by Academia Sincia (Investigator Award Grant to TFW and AS96IBC3 to AHJW), National Science Council (NSC96-2321-B-001-019 to TFW) and a National Core Facility of High-Throughput Protein Crystallography Grant (NSC97-3112-B-001-011-Y to AHJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Aihara H, 1997, J MOL BIOL, V274, P213, DOI 10.1006/jmbi.1997.1403; Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000858; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Egelman EH, 2008, BIOESSAYS, V30, P791, DOI 10.1002/bies.20791; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2006, BIOCHEMISTRY-US, V45, P13537, DOI 10.1021/bi060938q; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Kurumizaka H, 1996, J BIOL CHEM, V271, P33515, DOI 10.1074/jbc.271.52.33515; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Lee MH, 2004, BIOCHEM BIOPH RES CO, V323, P845, DOI 10.1016/j.bbrc.2004.08.163; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; Rehrauer WM, 1996, J BIOL CHEM, V271, P11996, DOI 10.1074/jbc.271.20.11996; Sheng DH, 2008, EXTREMOPHILES, V12, P147, DOI 10.1007/s00792-007-0113-y; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; STORY RM, 1993, SCIENCE, V259, P1892, DOI 10.1126/science.8456313; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Wang TF, 2008, BIOESSAYS, V30, P1254, DOI 10.1002/bies.20850; Wang TF, 2008, BIOESSAYS, V30, P48, DOI 10.1002/bies.20694; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; YU X, 1990, BIOPHYS J, V57, P555, DOI 10.1016/S0006-3495(90)82571-6	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4890	10.1371/journal.pone.0004890	http://dx.doi.org/10.1371/journal.pone.0004890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295907	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496700004
J	Flores, I; Blasco, MA				Flores, Ignacio; Blasco, Maria A.			A p53-Dependent Response Limits Epidermal Stem Cell Functionality and Organismal Size in Mice with Short Telomeres	PLOS ONE			English	Article								Telomere maintenance is essential to ensure proper size and function of organs with a high turnover. In particular, a dwarf phenotype as well as phenotypes associated to premature loss of tissue regeneration, including the skin (hair loss, hair graying, decreased wound healing), are found in mice deficient for telomerase, the enzyme responsible for maintaining telomere length. Coincidental with the appearance of these phenotypes, p53 is found activated in several tissues from these mice, where is thought to trigger cellular senescence and/or apoptotic responses. Here, we show that p53 abrogation rescues both the small size phenotype and restitutes the functionality of epidermal stem cells (ESC) of telomerase-deficient mice with dysfunctional telomeres. In particular, p53 ablation restores hair growth, skin renewal and wound healing responses upon mitogenic induction, as well as rescues ESCmobilization defects in vivo and defective ESC clonogenic activity in vitro. This recovery of ESC functions is accompanied by a downregulation of senescence markers and an increased proliferation in the skin and kidney of telomerase-deficient mice with critically short telomeres without changes in apoptosis rates. Together, these findings indicate the existence of a p53-dependent senescence response acting on stem/progenitor cells with dysfunctional telomeres that is actively limiting their contribution to tissue regeneration, thereby impinging on tissue fitness.	[Flores, Ignacio; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Flores, I (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain.	mblasco@cnio.es	Flores, Ignacio/E-8304-2016; Blasco, Maria A./M-1694-2014	Flores, Ignacio/0000-0001-8789-6396; Blasco, Maria A./0000-0002-4211-233X	MCyT [SAF2005-00277, GEN2001-4856-C13-08]; Regional Government of Madrid [GR/SAL/0597/2004]; European Union [FIGH-CT-2002-00217, LSHC-CT-2003-506803, FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, LSHC-CT-2004-502943]; Spanish Association Against Cancer (AECC)	MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); Spanish Association Against Cancer (AECC)	M. A. Blasco laboratory is funded by the MCyT (SAF2005-00277, GEN2001-4856-C13-08), by the Regional Government of Madrid (GR/SAL/0597/2004), European Union (TELOSENS FIGH-CT-2002-00217, INTACT LSHC-CT-2003-506803, ZINCAGE FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, MOL CANCER MED LSHC-CT-2004-502943) and the Spanish Association Against Cancer (AECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; FLORES I, 2008, GENES DEV; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Krishnamurthy Janakiraman, 2007, Cell Stem Cell, V1, P9, DOI 10.1016/j.stem.2007.05.004; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Siegl-Cachedenier I, 2007, J CELL BIOL, V179, P277, DOI 10.1083/jcb.200704141; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019	46	54	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2009	4	3							e4934	10.1371/journal.pone.0004934	http://dx.doi.org/10.1371/journal.pone.0004934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OL	19295915	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496700008
J	Haley, NJ; Seelig, DM; Zabel, MD; Telling, GC; Hoover, EA				Haley, Nicholas J.; Seelig, Davis M.; Zabel, Mark D.; Telling, Glenn C.; Hoover, Edward A.			Detection of CWD Prions in Urine and Saliva of Deer by Transgenic Mouse Bioassay	PLOS ONE			English	Article								Chronic wasting disease (CWD) is a prion disease affecting captive and free-ranging cervids (e. g. deer, elk, and moose). The mechanisms of CWD transmission are poorly understood, though bodily fluids are thought to play an important role. Here we report the presence of infectious prions in the urine and saliva of deer with chronic wasting disease (CWD). Prion infectivity was detected by bioassay of concentrated, dialyzed urine and saliva in transgenic mice expressing the cervid PrP gene (Tg[CerPrP] mice). In addition, PrPCWD was detected in pooled and concentrated urine by protein misfolding cyclic amplification (PMCA). The concentration of abnormal prion protein in bodily fluids was very low, as indicated by: undetectable PrPCWD levels by traditional assays (western blot, ELISA) and prolonged incubation periods and incomplete TSE attack rates in inoculated Tg(CerPrP) mice (373(+/-)3days in 2 of 9 urine-inoculated mice and 342(+/-)109 days in 8 of 9 saliva-inoculated mice). These findings help extend our understanding of CWD prion shedding and transmission and portend the detection of infectious prions in body fluids in other prion infections.	[Haley, Nicholas J.; Seelig, Davis M.; Zabel, Mark D.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Telling, Glenn C.] Univ Kentucky, Dept Mol Biol & Genet, Lexington, KY 40506 USA	Colorado State University; University of Kentucky	Haley, NJ (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@colostate.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805	NIH/NCRR Ruth L. Kirschstein Institutional [T32 R07072-03]; NIH/NIAID [NO1-AI-25491-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER	NIH/NCRR Ruth L. Kirschstein Institutional(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NCRR Ruth L. Kirschstein Institutional T32 R07072-03 and NIH/NIAID NO1-AI-25491-02 (EAH, GCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskaia O, 2008, J VET DIAGN INVEST, V20, P141, DOI 10.1177/104063870802000201; ARCHIBALD DW, 1990, AIDS RES HUM RETROV, V6, P1425, DOI 10.1089/aid.1990.6.1425; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Gresham A, 2008, VET REC, V162, P525, DOI 10.1136/vr.162.16.525-c; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Hamir AN, 2006, J VET DIAGN INVEST, V18, P110, DOI 10.1177/104063870601800118; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Harnir AN, 2008, CAN J VET RES, V72, P63; Johnson C, 2003, J WILDLIFE DIS, V39, P576, DOI 10.7589/0090-3558-39.3.576; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Nacar A, 2008, RENAL FAILURE, V30, P507, DOI 10.1080/08860220802064713; O'Rourke KI, 2007, NEUROREPORT, V18, P1935, DOI 10.1097/WNR.0b013e3282f1ca2f; OCHERT AS, 1994, PCR METH APPL, V3, P365; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	36	164	167	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4848	10.1371/journal.pone.0004848	http://dx.doi.org/10.1371/journal.pone.0004848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293928	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496600003
J	Graziano, M; Sigman, M				Graziano, Martin; Sigman, Mariano			The Spatial and Temporal Construction of Confidence in the Visual Scene	PLOS ONE			English	Article							ICONIC MEMORY; CONSCIOUSNESS; ERRORS; RECOGNITION; PERCEPTION; RESOLUTION; ATTENTION; AWARENESS; STORAGE	Human subjects can report many items of a cluttered field a few hundred milliseconds after stimulus presentation. This memory decays rapidly and after a second only 3 or 4 items can be stored in working memory. Here we compared the dynamics of objective performance with a measure of subjective report and we observed that 1) Objective performance beyond explicit subjective reports (blindsight) was significantly more pronounced within a short temporal interval and within specific locations of the visual field which were robust across sessions 2) High confidence errors (False beliefs) were largely confined to a small spatial window neighboring the cue. The size of this window did not change in time 3) Subjective confidence showed a moderate but consistent decrease with time, independent of all other experimental factors. Our study allowed us to asses quantitatively the temporal and spatial access to an objective response and to subjective reports.	[Graziano, Martin; Sigman, Mariano] Univ Buenos Aires, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Graziano, M (corresponding author), Univ Buenos Aires, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina.	sigman@df.uba.ar		Graziano, Martin/0000-0002-6876-7211	Human Frontiers Science Program; SECYT, PICT [38366]; National Research Council of Argentina (CONICET) [fellowship]	Human Frontiers Science Program(Human Frontier Science Program); SECYT, PICT(ANPCyTSecretaria de Ciencia y Tecnologia (SECYT)); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by the Human Frontiers Science Program and by the SECYT, PICT 38366. MG has a fellowship of the National Research Council of Argentina (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars B.J., 1989, COGNITIVE THEORY CON; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter RM, 2003, P NATL ACAD SCI USA, V100, P1399, DOI 10.1073/pnas.0334049100; CHOW SL, 1991, J GEN PSYCHOL, V118, P147, DOI 10.1080/00221309.1991.9711140; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen L, 1998, BRAIN, V121, P1641, DOI 10.1093/brain/121.9.1641; CORALLO G, 2008, PSYCHOL SCI IN PRESS; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DICK AO, 1969, J EXP PSYCHOL, V82, P279, DOI 10.1037/h0028147; Fang F, 2008, J VISION, V8, DOI 10.1167/8.9.6; FERRAND L, 1994, MEM COGNITION, V22, P431, DOI 10.3758/BF03200868; GEGENFURTNER KR, 1993, J EXP PSYCHOL HUMAN, V19, P845, DOI 10.1037/0096-1523.19.4.845; Graziano M, 2008, J VISION, V8, DOI 10.1167/8.5.9; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; HAGENAAR R, 1995, ACTA PSYCHOL, V88, P89, DOI 10.1016/0001-6918(94)E0062-K; Hagenaar R, 1997, MEM COGNITION, V25, P641, DOI 10.3758/BF03211305; Hazeltine RE, 1997, J EXP PSYCHOL HUMAN, V23, P263; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Koch Christof, 2004, QUEST CONSCIOUSNESS; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Latimer C, 2000, Q J EXP PSYCHOL-A, V53, P765, DOI 10.1080/027249800410544; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Mack A., 1998, INATTENTIONAL BLINDN; Mattler U, 2005, PERCEPT PSYCHOPHYS, V67, P285, DOI 10.3758/BF03206492; MCKONE E, 1995, J EXP PSYCHOL LEARN, V21, P1108, DOI 10.1037/0278-7393.21.5.1108; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; MEWHORT DJK, 1981, MEM COGNITION, V9, P50, DOI 10.3758/BF03196951; MISHKIN M, 1952, J EXP PSYCHOL, V43, P43, DOI 10.1037/h0061361; Neisser U., 1967, COGNITIVE PSYCHOL; OSTROSKYSOLIS F, 1991, BRAIN COGNITION, V17, P42, DOI 10.1016/0278-2626(91)90065-G; Overgaard M, 2006, CONSCIOUS COGN, V15, P629, DOI 10.1016/j.concog.2006.10.004; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Popple AV, 2007, VISION RES, V47, P2973, DOI 10.1016/j.visres.2007.06.022; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; TOWNSEND VM, 1973, J EXP PSYCHOL, V98, P113, DOI 10.1037/h0034309; Watanabe K, 2002, VISION RES, V42, P2645, DOI 10.1016/S0042-6989(02)00296-1; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; WOLFORD G, 1980, PERCEPT PSYCHOPHYS, V27, P409, DOI 10.3758/BF03204459	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4909	10.1371/journal.pone.0004909	http://dx.doi.org/10.1371/journal.pone.0004909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290055	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496500010
J	Lortie, CJ; Munshaw, M; Zikovitz, A; Hierro, J				Lortie, Christopher J.; Munshaw, Michael; Zikovitz, Andrea; Hierro, Jose			Cage Matching: Head to Head Competition Experiments of an Invasive Plant Species from Different Regions as a Means to Test for Differentiation	PLOS ONE			English	Article							STARTHISTLE CENTAUREA-SOLSTITIALIS; YELLOW STARTHISTLE; DYNAMICS; COMMUNITY; DENSITY; POPULATION; RESISTANCE; EVOLUTION; HISTORY; ACHENES	Many hypotheses are prevalent in the literature predicting why some plant species can become invasive. However, in some respects, we lack a standard approach to compare the breadth of various studies and differentiate between alternative explanations. Furthermore, most of these hypotheses rely on 'changes in density' of an introduced species to infer invasiveness. Here, we propose a simple method to screen invasive plant species for potential differences in density effects between novel regions. Studies of plant competition using density series are a fundamental tool applied to virtually every aspect of plant population ecology to better understand evolution. Hence, we use a simple density series with substitution contrasting the performance of Centaurea solstitialis in monoculture (from one region) to mixtures (seeds from two regions). All else being equal, if there is no difference between the introduced species in the two novel regions compared, Argentina and California, then there should be no competitive differences between intra and inter-regional competition series. Using a replicated regression design, seeds of each species were sown in the greenhouse at 5 densities in monoculture and mixed and grown till onset of flowering. Centaurea seeds from California had higher germination while seedlings had significantly greater survival than Argentina. There was no evidence for density dependence in any measure for the California region but negative density dependence was detected in the germination of seeds from Argentina. The relative differences in competition also differed between regions with no evidence of differential competitive effects of seeds from Argentina in mixture versus monoculture while seeds from California expressed a relative cost in germination and relative growth rate in mixtures with Argentina. In the former instance, lack of difference does not mean 'no ecological differences' but does suggest that local adaptation in competitive abilities has not occurred. Importantly, this method successfully detected differences in the response of an invasive species to changes in density between novel regions which suggests that it is a useful preliminary means to explore invasiveness.	[Lortie, Christopher J.; Munshaw, Michael] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Zikovitz, Andrea] Univ Toronto, Toronto, ON, Canada; [Hierro, Jose] Univ La Pampa, Conicet, Santa Rosa, La Pampa, Argentina	York University - Canada; University of Toronto; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lortie, CJ (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	lortie@yorku.ca	lortie, christopher j/F-6241-2014	lortie, christopher j/0000-0002-4291-7023	NSERC [Discovery Grant]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	An NSERC Discovery Grant to Dr. Lortie funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Bakker J, 2001, PLANT ECOL, V157, P117, DOI 10.1023/A:1013972403293; Benefield CB, 2001, WEED SCI, V49, P83, DOI 10.1614/0043-1745(2001)049[0083:RBOYSM]2.0.CO;2; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Carrete M, 2008, OIKOS, V117, P1115, DOI 10.1111/j.0030-1299.2008.16968.x; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; D'Antonio C.M., 1999, ECOSYSTEMOSF DKTURBE, P413; D'Antonio CM, 2001, ECOLOGY, V82, P89, DOI 10.1890/0012-9658(2001)082[0089:FIDOTI]2.0.CO;2; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Ewel JJ., 1986, ECOLOGY BIOL INVASIO, P214, DOI DOI 10.1007/978-1-4612-4988-7_13; Figueroa ME, 2003, J ECOL, V91, P616, DOI 10.1046/j.1365-2745.2003.00794.x; Genton BJ, 2005, OECOLOGIA, V146, P404, DOI 10.1007/s00442-005-0234-x; GERLACH JD, 2003, ECOLOGICAL APPL, V13; Gibson DJ, 1999, J ECOL, V87, P1, DOI 10.1046/j.1365-2745.1999.00321.x; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Joley DB, 2003, CAN J BOT, V81, P993, DOI [10.1139/B03-093, 10.1139/b03-093]; JOLEY DB, 1992, WEED SCI, V40, P190, DOI 10.1017/S0043174500057209; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Lortie CJ, 2002, J ECOL, V90, P435, DOI 10.1046/j.1365-2745.2002.00686.x; MacDougall AS, 2006, J VEG SCI, V17, P47, DOI 10.1111/j.1654-1103.2006.tb02422.x; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; MADDOX DM, 1985, WEED SCI, V33, P315, DOI 10.1017/S0043174500082357; Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297; Meirmans PG, 2003, J EVOLUTION BIOL, V16, P343, DOI 10.1046/j.1420-9101.2003.00515.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Pauchard A, 2004, DIVERS DISTRIB, V10, P371, DOI 10.1111/j.1366-9516.2004.00116.x; PITCAIRN MJ, 1998, BIOL CONTROL PROGRAM; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2007, DIVERS DISTRIB, V13, P299, DOI 10.1111/j.1472-4642.2007.00337.x; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; SHELEY RL, 1994, J RANGE MANAGE, V47, P450, DOI 10.2307/4002995; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Von Holle B, 2005, J ECOL, V93, P16, DOI 10.1111/j.0022-0477.2004.00946.x; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Willis AJ, 2000, ECOL LETT, V3, P275, DOI 10.1046/j.1461-0248.2000.00149.x	42	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4823	10.1371/journal.pone.0004823	http://dx.doi.org/10.1371/journal.pone.0004823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283070	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496300006
J	Lawo, NC; Wackers, FL; Romeis, J				Lawo, Nora C.; Wackers, Felix L.; Romeis, Jorg			Indian Bt Cotton Varieties Do Not Affect the Performance of Cotton Aphids	PLOS ONE			English	Article							HONEYDEW SUGAR COMPOSITION; PROPYLAEA-JAPONICA COLEOPTERA; NONTARGET HERBIVORE; GOSSYPII HOMOPTERA; EXTRAFLORAL NECTAR; NUTRITIONAL STATE; TRANSGENIC CROPS; FOOD SOURCE; PHLOEM SAP; INSECT	Cotton varieties expressing Cry proteins derived from the soil bacterium Bacillus thuringiensis (Bt) are grown worldwide for the management of pest Lepidoptera. To prevent non-target pest outbreaks and to retain the biological control function provided by predators and parasitoids, the potential risk that Bt crops may pose to non-target arthropods is addressed prior to their commercialization. Aphids play an important role in agricultural systems since they serve as prey or host to a number of predators and parasitoids and their honeydew is an important energy source for several arthropods. To explore possible indirect effects of Bt crops we here examined the impact of Bt cotton on aphids and their honeydew. In climate chambers we assessed the performance of cotton aphids, Aphis gossypii Glover (Hemiptera: Aphididae) when grown on three Indian Bt (Cry1Ac) cotton varieties (MECH 12, MECH 162, MECH 184) and their non-transformed near isolines. Furthermore, we examined whether aphids pick up the Bt protein and analyzed the sugar composition of aphid honeydew to evaluate its suitability for honeydew-feeders. Plant transformation did not have any influence on aphid performance. However, some variation was observed among the three cotton varieties which might partly be explained by the variation in trichome density. None of the aphid samples contained Bt protein. As a consequence, natural enemies that feed on aphids are not exposed to the Cry protein. A significant difference in the sugar composition of aphid honeydew was detected among cotton varieties as well as between transformed and non-transformed plants. However, it is questionable if this variation is of ecological relevance, especially as honeydew is not the only sugar source parasitoids feed on in cotton fields. Our study allows the conclusion that Bt cotton poses a negligible risk for aphid antagonists and that aphids should remain under natural control in Bt cotton fields.	[Lawo, Nora C.; Romeis, Jorg] Agroscope Reckenholz Tanikon Res Stn ART Zurich, Zurich, Switzerland; [Wackers, Felix L.] Univ Lancaster, Lancaster LA1 4YW, England	Swiss Federal Research Station Agroscope; Lancaster University	Lawo, NC (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART Zurich, Zurich, Switzerland.	joerg.romeis@art.admin.ch	Romeis, Joerg/J-5360-2013	Romeis, Joerg/0000-0003-3652-8360	Swiss Agency for Development and Cooperation (SDC) in Berne, Switzerland; Department of Biotechnology (DBT) in Delhi, India	Swiss Agency for Development and Cooperation (SDC) in Berne, Switzerland; Department of Biotechnology (DBT) in Delhi, India(Department of Biotechnology (DBT) India)	The study was compiled within the Pulse Network of the Indo-Swiss Collaboration in Biotechnology (ISCB). The study was funded by the Swiss Agency for Development and Cooperation (SDC) in Berne, Switzerland, and the Department of Biotechnology (DBT) in Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 1998, APPL ENTOMOL ZOOL, V33, P357, DOI 10.1303/aez.33.357; Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bambawale OM, 2004, CURR SCI INDIA, V86, P1628; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Bourguet Denis, 2002, Environmental Biosafety Research, V1, P49, DOI 10.1051/ebr:2002005; Brookes G., 2008, AgBioForum, V11, P21; Burgio G, 2007, B ENTOMOL RES, V97, P211, DOI 10.1017/S0007485307004920; BYRNE DN, 1990, J INSECT PHYSIOL, V36, P433, DOI 10.1016/0022-1910(90)90061-J; Costa HS, 1999, J ENTOMOL SCI, V34, P305, DOI 10.18474/0749-8004-34.3.305; Cui Jinjie, 2000, Acta Phytophylacica Sinica, V27, P141; Davison AC, 1997, BOOTSTRAP METHODS TH; Deng Shu-Dong, 2003, Acta Entomologica Sinica, V46, P1; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; Fadamiro HY, 2001, ANN ENTOMOL SOC AM, V94, P909, DOI 10.1603/0013-8746(2001)094[0909:EOPSDO]2.0.CO;2; Faria CA, 2008, BASIC APPL ECOL, V9, P286, DOI 10.1016/j.baae.2007.02.001; Faria CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000600; Fischer MK, 2002, J INSECT PHYSIOL, V48, P319, DOI 10.1016/S0022-1910(01)00179-2; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Fitt Gary P., 2008, V5, P303, DOI 10.1007/978-1-4020-8373-0_11; FORRESTER NW, 1993, B ENTOMOL RES, pR1; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Head G, 2001, ENTOMOL EXP APPL, V99, P37, DOI 10.1023/A:1018913429026; HENDRIX DL, 1992, COMP BIOCHEM PHYS B, V101, P23, DOI 10.1016/0305-0491(92)90153-I; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Hogervorst PAM, 2009, AGR FOREST ENTOMOL, V11, P161, DOI 10.1111/j.1461-9563.2008.00412.x; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Liu XD, 2005, ECOL ENTOMOL, V30, P307, DOI 10.1111/j.0307-6946.2005.00690.x; Lozzia G. C., 1998, Bollettino di Zoologia Agraria e di Bachicoltura, V30, P153; Lumbierres B, 2004, ECOL ENTOMOL, V29, P309, DOI 10.1111/j.0307-6946.2004.00597.x; Mellet MA, 2007, INDIAN J EXP BIOL, V45, P554; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Obrist LB, 2005, ENTOMOL EXP APPL, V115, P409, DOI 10.1111/j.1570-7458.2005.00298.x; Pons X, 2005, EUR J ENTOMOL, V102, P73, DOI 10.14411/eje.2005.010; Qaim M, 2006, REV AGR ECON, V28, P48, DOI 10.1111/j.1467-9353.2006.00272.x; Qaim Matin, 2008, V5, P329, DOI 10.1007/978-1-4020-8373-0_12; Ramirez-Romero R, 2008, PESTIC BIOCHEM PHYS, V91, P110, DOI 10.1016/j.pestbp.2008.01.010; Raps A, 2001, MOL ECOL, V10, P525, DOI 10.1046/j.1365-294x.2001.01236.x; Romeis J, 2009, ENVIRONMENTAL IMPACT OF GENETICALLY MODIFIED CROPS, P165, DOI 10.1079/9781845934095.0165; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2003, OECOLOGIA, V134, P528, DOI 10.1007/s00442-002-1144-9; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Schuler TH, 2005, B ENTOMOL RES, V95, P243, DOI 10.1079/BER2004356; Schuler TH, 2001, MOL ECOL, V10, P1845, DOI 10.1046/j.0962-1083.2001.01309.x; Siekmann G, 2001, OIKOS, V95, P425, DOI 10.1034/j.1600-0706.2001.950307.x; Stapel JO, 1997, ENVIRON ENTOMOL, V26, P617, DOI 10.1093/ee/26.3.617; Steppuhn A, 2004, FUNCT ECOL, V18, P812, DOI 10.1111/j.0269-8463.2004.00920.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Teran-Vargas AP, 2005, J ECON ENTOMOL, V98, P2203, DOI 10.1603/0022-0493-98.6.2203; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003; Wackers FL, 2004, ECOLOGY, V85, P1512, DOI 10.1890/03-0422; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; WEATHERSBEE AA, 1994, J ECON ENTOMOL, V87, P258, DOI 10.1093/jee/87.1.258; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; Winkler K, 2006, BASIC APPL ECOL, V7, P133, DOI 10.1016/j.baae.2005.06.001; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Xue K, 2008, SCI CHINA SER C, V51, P145, DOI 10.1007/s11427-008-0028-6; Yao I, 2001, OECOLOGIA, V128, P36, DOI 10.1007/s004420100633; Zhang GF, 2006, ENVIRON ENTOMOL, V35, P143, DOI 10.1603/0046-225X-35.1.143; Zhang GF, 2008, ENVIRON ENTOMOL, V37, P1035, DOI 10.1603/0046-225X(2008)37[1035:RBOTNI]2.0.CO;2	72	67	73	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4804	10.1371/journal.pone.0004804	http://dx.doi.org/10.1371/journal.pone.0004804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279684	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496200001
J	Higashi, M; Ishikawa, C; Yu, JY; Toyoda, A; Kawana, H; Kurokawa, K; Matsuda, M; Kitagawa, M; Harigaya, K				Higashi, Morihiro; Ishikawa, Chieko; Yu, Jianyong; Toyoda, Akihiro; Kawana, Hidetada; Kurokawa, Kazuo; Matsuda, Michiyuki; Kitagawa, Motoo; Harigaya, Kenichi			Human Mena Associates with Rac1 Small GTPase in Glioblastoma Cell Lines	PLOS ONE			English	Article								Mammarian enabled (Mena), a member of the Enabled (Ena)/Vasodilator-stimulated phosphoprotein (VASP) family of proteins, has been implicated in cell motility through regulation of the actin cytoskeleton assembly, including lamellipodial protrusion. Rac1, a member of the Rho family GTPases, also plays a pivotal role in the formation of lamellipodia. Here we report that human Mena (hMena) colocalizes with Rac1 in lamellipodia, and using an unmixing assisted acceptor depletion fluorescence resonance energy transfer (u-adFRET) analysis that hMena associates with Rac1 in vivo in the glioblastoma cell line U251MG. Depletion of hMena by siRNA causes cells to be highly spread with the formation of lamellipodia. This cellular phenotype is canceled by introduction of a dominant negative form of Rac1. A Rac activity assay and FRET analysis showed that hMena knock-down cells increased the activation of Rac1 at the lamellipodia. These results suggest that hMena possesses properties which help to regulate the formation of lamellipodia through the modulation of the activity of Rac1.	[Higashi, Morihiro; Ishikawa, Chieko; Yu, Jianyong; Toyoda, Akihiro; Kawana, Hidetada; Kitagawa, Motoo; Harigaya, Kenichi] Chiba Univ, Grad Sch Med, Chiba, Japan; [Kurokawa, Kazuo] RIKEN Discovery Res Inst, Mol Membrane Biol Lab, Wako, Saitama, Japan; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan	Chiba University; RIKEN; Kyoto University	Higashi, M (corresponding author), Chiba Univ, Grad Sch Med, Chiba, Japan.	harigaya@faculty.chiba-u.jp	Kurokawa, Kazuo/E-9130-2013; Kitagawa, Motoo/W-8468-2019; Higashi, Morihiro/AAN-3575-2020	Kurokawa, Kazuo/0000-0003-3549-4795; Kitagawa, Motoo/0000-0003-1036-840X; Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science and Technology, Japan [12215018]; Japan Society for the Promotion of Science [13670163]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research Priority Area 12215018 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K.H.) and a Grant-in-Aid for Scientific Research 13670163 from the Japan Society for the Promotion of Science (to K.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di WL, 2005, J CELL SCI, V118, P1505, DOI 10.1242/jcs.01733; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Gambaryan S, 2001, HISTOCHEM CELL BIOL, V116, P535, DOI 10.1007/s00418-001-0353-3; GEIGER B, 1984, J CELL BIOL, V99, pS83, DOI 10.1083/jcb.99.1.83s; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Giesemann T, 2003, J NEUROSCI, V23, P8330; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Machesky LM, 2002, NATURE, V417, P494, DOI 10.1038/417494a; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Ridley AJ, 2001, J CELL SCI, V114, P2713; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	48	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4765	10.1371/journal.pone.0004765	http://dx.doi.org/10.1371/journal.pone.0004765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277120	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496100010
J	Serganova, I; Moroz, E; Vider, J; Gogiberidze, G; Moroz, M; Pillarsetty, N; Doubrovin, M; Minn, A; Thaler, HT; Massague, J; Gelovani, J; Blasberg, R				Serganova, Inna; Moroz, Ekaterina; Vider, Jelena; Gogiberidze, George; Moroz, Maxim; Pillarsetty, Nagavarakishore; Doubrovin, Michael; Minn, Andy; Thaler, Howard T.; Massague, Joan; Gelovani, Juri; Blasberg, Ronald			Multimodality imaging of TGF beta signaling in breast cancer metastases	FASEB JOURNAL			English	Article						Smads complex; herpes simplex virus type one thymidine kinase; green fluorescent protein; FEAU; positron emission tomography; bioluminescence; bone resorption	GROWTH-FACTOR-BETA; ANIMAL-MODELS; BONE METASTASIS; IN-VIVO; REPORTER GENE; CELLS; FLUORESCENT; EXPRESSION; BIOLUMINESCENT; INDUCTION	The skeleton is a preferred site for breast cancer metastasis. We have developed a multimodality imaging approach to monitor the transforming growth factor beta (TGF beta) signaling pathway in bone metastases, sequentially over time in the same animal. As model systems, two MDA-MB-231 breast cancer cells lines with different metastatic tropisms, SCP2 and SCP3, were transduced with constitutive and TGF beta-inducible reporter genes and were tested in vitro and in living animals. The sites and expansion of metastases were visualized by bioluminescence imaging using a constitutive firefly luciferase reporter, while TGF beta signaling in metastases was monitored by microPET imaging of HSV1-TK/GFP expression with [F-18] FEAU and by a more sensitive and cost-effective bioluminescence reporter, based on nonsecreted Gaussia luciferase. Concurrent and sequential imaging of metastases in the same animals provided insight into the location and progression of metastases, and the timing and course of TGF beta signaling. The anticipated and newly observed differences in the imaging of tumors from two related cell lines have demonstrated that TGF beta signal transduction pathway activity can be noninvasively imaged with high sensitivity and reproducibility, thereby providing the opportunity for an assessment of novel treatments that target TGF beta signaling.-Serganova, I., Moroz, E., Vider, J., Gogiberidze, G., Moroz, M., Pillarsetty, N., Doubrovin, M., Minn, A., Thaler, H. T., Massague, J., Gelovani, J., Blasberg, R. Multimodality imaging of TGF beta signaling in breast	[Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Dept Neurol, SKI, New York, NY 10021 USA; [Pillarsetty, Nagavarakishore; Doubrovin, Michael; Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Minn, Andy; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Blasberg, R (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Dept Neurol, SKI, MH Box 52,1275 York Ave, New York, NY 10021 USA.	blasberg@neurol.mskcc.org	Vider, Jelena/AAW-8577-2020; Vider, Jelena/B-9663-2011; Doubrovin, Mikhail/C-5859-2017	Vider, Jelena/0000-0003-1696-9812; Doubrovin, Mikhail/0000-0001-6607-2646; Serganova, Inna/0000-0003-3561-8663; Pillarsetty, Naga Vara Kishore/0000-0002-1750-7436; Minn, Andy/0000-0003-1418-0906; Massague, Joan/0000-0001-9324-8408	U. S. National Institutes of Health (NIH) [P50CA86438-01, P01CA094060, R24 CA83084, P30CA08748]; NATIONAL CANCER INSTITUTE [P01CA094060, P50CA086438, R24CA083084, P30CA008748] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Lyudmila Ageyeva and Katerina Dyomina for excellent technical assistance; Dr. R. J. Brentjens [Memorial Sloan-Kettering Cancer Center (MSKCC)] for providing a plasmid SFG-exGLuc-IRES-GFP; Dr. V. Ponomarev for valuable discussions; and Dr. S. Larson for help and generous support. This work was supported by U. S. National Institutes of Health (NIH) grant P50CA86438-01 and partly by NIH grant P01CA094060. Technical services were provided by the MSKCC Small-Animal Imaging Core Facility, supported in part by NIH Small Animal Imaging Resource Program grant R24 CA83084 and NIH center grant P30CA08748.	ARGUELLO F, 1990, CANCER, V65, P98, DOI 10.1002/1097-0142(19900101)65:1<98::AID-CNCR2820650121>3.0.CO;2-K; Arvanitis C, 2008, CANCER BIOL THER, V7, P1947, DOI 10.4161/cbt.7.12.6947; Berger F, 2002, EUR J NUCL MED MOL I, V29, P1225, DOI 10.1007/s00259-002-0850-1; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Cowey S, 2007, CLIN EXP METASTAS, V24, P389, DOI 10.1007/s10585-007-9076-8; Deroose CM, 2007, J NUCL MED, V48, P295; Doubrovin M, 2001, P NATL ACAD SCI USA, V98, P9300, DOI 10.1073/pnas.161091198; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; EILON G, 1978, NATURE, V276, P726, DOI 10.1038/276726a0; Fritz V, 2007, BONE, V40, P1032, DOI 10.1016/j.bone.2006.11.026; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; HEALY AM, 1994, J BIOL CHEM, V269, P19095; Jakubowiak A, 2000, J BIOL CHEM, V275, P40282, DOI 10.1074/jbc.C000485200; Kaijzel EL, 2007, CLIN CANCER RES, V13, P3490, DOI 10.1158/1078-0432.CCR-07-0402; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Miyagawa T, 2008, J NUCL MED, V49, P637, DOI 10.2967/jnumed.107.046227; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Ponomarev V, 2001, NEOPLASIA, V3, P480, DOI 10.1038/sj.neo.7900204; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rosol TJ, 2003, CANCER-AM CANCER SOC, V97, P748, DOI 10.1002/cncr.11150; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Sugano Y, 2003, ONCOGENE, V22, P2309, DOI 10.1038/sj.onc.1206305; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Tjuvajev JG, 1996, CANCER RES, V56, P4087; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Winkelmann CT, 2006, MOL IMAGING, V5, P105, DOI 10.2310/7290.2006.00011; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZENTELLA A, 1991, MOL CELL BIOL, V11, P4952, DOI 10.1128/MCB.11.10.4952	39	44	46	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2662	2672		10.1096/fj.08-126920	http://dx.doi.org/10.1096/fj.08-126920			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19325038	Green Published			2022-12-25	WOS:000268836700034
J	Xu, W; Yi, L; Feng, YM; Chen, L; Liu, JS				Xu, Wei; Yi, Lina; Feng, Yumei; Chen, Ling; Liu, Jinsong			Structural Insight into the Activation Mechanism of Human Pancreatic Prophospholipase A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PHOSPHOLIPASE A(2); CRYSTAL-STRUCTURE; GROUP IB; BINDING; CRYSTALLOGRAPHY; PURIFICATION; PROPEPTIDE; PROGRAM; ZYMOGEN; ENZYME	Pancreatic phospholipase A2 (phospholipase A2 group 1B, G1B) belongs to the superfamily of secreted phospholipase A2 (PLA2) enzymes. G1B has been proposed to be a potential target for diseases such as hypertension, obesity, and diabetes. Human pancreatic prophospholipase A2 (pro-hG1B) is activated by cleavage of the first seven-residue propeptide (phospholipase A2 propeptide, PROP). However, questions still remain on the mode of action for pro-hG1B. In this work, we expressed pro-hG1B in Pichia pastoris and determined the crystal structure at 1.55-angstrom resolution. The x-ray structure demonstrates that pro-hG1B forms a trimer. In addition, PROP occupies the catalytic cavity and can be self-cleaved at 37 degrees C. A new membrane-bound surface and activation mechanism are proposed based on the trimeric model of pro-hG1B. We also propose a new autoproteolytic mechanism for pro-hG1B by the reaction triad Asp49-Arg0-Ser(-2) that is similar to the serine protease catalytic triad.	[Xu, Wei; Yi, Lina; Feng, Yumei; Chen, Ling; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Xu, Wei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Chen, Ling; Liu, Jinsong] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, L (corresponding author), 3rd Floor,Guangzhou Int Business Incubator,Guangz, Guangzhou 510663, Guangdong, Peoples R China.	chen_ling@gibh.ac.cn; liu_jinsong@gibh.ac.cn	Xu, Wei/GQZ-2075-2022	Xu, Wei/0000-0002-3135-5010	National Basic Research Program of China [2007CB914301, 2006CB910202, 2005CB523008]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (No. 2007CB914301, 2006CB910202, and 2005CB523008).	Bahnson BJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P96, DOI 10.1016/j.abb.2004.08.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng HQ, 2004, ACTA BIOCH BIOPH SIN, V36, P583, DOI 10.1093/abbs/36.9.583; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P118, DOI 10.1016/0005-2744(68)90249-0; DELANO WL, 2002, PYMOL VERSION 1 0R1; DIJKSTRA BW, 1978, J MOL BIOL, V124, P53, DOI 10.1016/0022-2836(78)90146-8; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DIJKSTRA BW, 1981, NATURE, V289, P604, DOI 10.1038/289604a0; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; EGMOND MR, 1983, BIOCHIM BIOPHYS ACTA, V744, P23, DOI 10.1016/0167-4838(83)90335-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein TM, 2001, BIOCHEMISTRY-US, V40, P11411, DOI 10.1021/bi011228h; ESKOLA JU, 1983, CLIN CHEM, V29, P1772; FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342; Frossard PM, 1995, CLIN GENET, V48, P284; GRATAROLI R, 1982, EUR J BIOCHEM, V122, P111, DOI 10.1111/j.1432-1033.1982.tb05855.x; GUDGEON AM, 1991, ANN CLIN BIOCHEM, V28, P497, DOI 10.1177/000456329102800513; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kolko M, 2007, ACTA OPHTHALMOL SCAN, V85, P317, DOI 10.1111/j.1600-0420.2006.00809.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUOPIO T, 1995, APMIS, V103, P69, DOI 10.1111/j.1699-0463.1995.tb01081.x; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Mayer JM, 2000, DIGESTION, V62, P164, DOI 10.1159/000007809; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; *OXF DIFFR, 2008, CRYSALIS VERS 1 171; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g; PETERS AR, 1992, BIOCHEMISTRY-US, V31, P10024, DOI 10.1021/bi00156a023; Qin S, 2005, J BIOL CHEM, V280, P36773, DOI 10.1074/jbc.M506789200; Qin S, 2004, J MOL BIOL, V344, P71, DOI 10.1016/j.jmb.2004.09.034; Rae D, 1996, SCAND J GASTROENTERO, V31, P24, DOI 10.3109/00365529609104995; RAE D, 1995, CLIN BIOCHEM, V28, P71, DOI 10.1016/0009-9120(94)00068-7; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schoenberg MH, 1997, CHIRURG, V68, P1112, DOI 10.1007/s001040050330; Segelke BW, 1998, J MOL BIOL, V279, P223, DOI 10.1006/jmbi.1998.1759; Steiner RA, 2001, ACTA CRYSTALLOGR D, V57, P516, DOI 10.1107/S0907444901002530; THUNNISSEN MMGM, 1993, J MOL BIOL, V232, P839, DOI 10.1006/jmbi.1993.1435; Tomoo K, 1997, BBA-PROTEIN STRUCT M, V1340, P178, DOI 10.1016/S0167-4838(97)00041-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002	49	20	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16659	16666		10.1074/jbc.M808029200	http://dx.doi.org/10.1074/jbc.M808029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19297324	Green Published, hybrid			2022-12-25	WOS:000266730900061
J	Bodrato, N; Franco, L; Fresia, C; Guida, L; Usai, C; Salis, A; Moreschi, I; Ferraris, C; Verderio, C; Basile, G; Bruzzone, S; Scarfi, S; De Flora, A; Zocchi, E				Bodrato, Nicoletta; Franco, Luisa; Fresia, Chiara; Guida, Lucrezia; Usai, Cesare; Salis, Annalisa; Moreschi, Iliana; Ferraris, Chiara; Verderio, Claudia; Basile, Giovanna; Bruzzone, Santina; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Activates the Murine Microglial Cell Line N9 through the Second Messenger Cyclic ADP-ribose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; TEMPERATURE-SIGNALING CASCADE; INTRACELLULAR CALCIUM; STIMULATES PROLIFERATION; EXTRACELLULAR NAD(+); TRPM2 CHANNELS; HIGH-AFFINITY; RECEPTOR; CD38; CHEMOTAXIS	Abscisic acid (ABA) is a phytohormone regulating important functions in higher plants, notably responses to abiotic stress. Recently, chemical or physical stimulation of human granulocytes was shown to induce production and release of endogenous ABA, which activates specific cell functions. Here we provide evidence that ABA stimulates several functional activities of the murine microglial cell line N9 (NO and tumor necrosis factor-alpha production, cell migration) through the second messenger cyclic ADP-ribose and an increase of intracellular calcium. ABA production and release occur in N9 cells stimulated with bacterial lipopolysaccharide, phorbol myristate acetate, the chemoattractant peptide f-MLP, or beta-amyloid, the primary plaque component in Alzheimer disease. Finally, ABA priming stimulates N9 cell migration toward beta-amyloid. These results indicate that ABA is a pro-inflammatory hormone inducing autocrine microglial activation, potentially representing a new target for anti-inflammatory therapies aimed at limiting microglia-induced tissue damage in the central nervous system.	[Ferraris, Chiara; Basile, Giovanna; Bruzzone, Santina; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Ferraris, Chiara; Basile, Giovanna; Bruzzone, Santina; Scarfi, Sonia; De Flora, Antonio] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Fresia, Chiara; Guida, Lucrezia; Ferraris, Chiara; Bruzzone, Santina; Scarfi, Sonia; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Verderio, Claudia] Univ Milan, Dept Pharmacol, CNR, Inst Neurosci, I-20129 Milan, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Milan	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy.	ezocchi@unige.it	Scarfi, Sonia/AAJ-2387-2020; Verderio, Claudia/K-4415-2016; Bruzzone, Santina/A-4264-2015; Salis, Annalisa/R-9241-2018	Scarfi, Sonia/0000-0002-7079-6919; Verderio, Claudia/0000-0001-7216-5873; Bruzzone, Santina/0000-0003-2034-3716; FRESIA, CHIARA MARTA/0000-0002-9177-4655; Salis, Annalisa/0000-0002-3082-2908; Usai, Cesare/0000-0001-8863-7759	Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education; University and Scientific Research [MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2]; Regione Liguria; University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education(Fondazione AIRC per la ricerca sul cancro); University and Scientific Research; Regione Liguria(Regione Liguria); University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	This work was supported in part by grants from the Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education; University and Scientific Research Grants MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, and MIUR FIRB RBIP06LSS2; grants from Regione Liguria, and grants from the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia.	Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berruet L, 1998, BIOCHEM MOL BIOL INT, V46, P847; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 1998, FEBS LETT, V433, P275, DOI 10.1016/S0014-5793(98)00929-6; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189; CHEN FSC, 1988, AGR BIOL CHEM TOKYO, V52, P1273; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; De Simone R, 2007, J NEUROIMMUNOL, V190, P53, DOI 10.1016/j.jneuroim.2007.07.020; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200; Franco L, 2006, J NEUROCHEM, V99, P165, DOI 10.1111/j.1471-4159.2006.04031.x; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; GebickeHaerter PJ, 1996, NEUROCHEM INT, V29, P1; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Guida L, 2004, J BIOL CHEM, V279, P22066, DOI 10.1074/jbc.M314137200; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Khoo KM, 1998, BIOCHEM MOL BIOL INT, V44, P841; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Lee H, 2004, J NEUROIMMUNOL, V156, P88, DOI 10.1016/j.jneuroim.2004.07.008; LEE HC, 2002, CYCLIC ADP RIBOSE NA; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Moreno-Garcia ME, 2004, EUR J BIOCHEM, V271, P1025, DOI 10.1111/j.1432-1033.2004.04006.x; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Nakamura Y, 2003, BRAIN RES, V962, P122, DOI 10.1016/S0006-8993(02)03979-3; Paris D, 2000, NEUROSCI LETT, V278, P5, DOI 10.1016/S0304-3940(99)00901-5; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; Podesta M, 2000, FASEB J, V14, P680, DOI 10.1096/fasebj.14.5.680; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Tan J, 1999, J NEUROIMMUNOL, V97, P77, DOI 10.1016/S0165-5728(99)00053-3; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	61	59	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14777	14787		10.1074/jbc.M802604200	http://dx.doi.org/10.1074/jbc.M802604200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329433	Green Published, hybrid			2022-12-25	WOS:000266288200013
J	Salomon, D; Bonshtien, A; Mayrose, M; Zhang, C; Shokat, KM; Sessa, G				Salomon, Dor; Bonshtien, Arale; Mayrose, Maya; Zhang, Chao; Shokat, Kevan M.; Sessa, Guido			Bypassing Kinase Activity of the Tomato Pto Resistance Protein with Small Molecule Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-DISEASE RESISTANCE; BACTERIAL SPECK DISEASE; CHEMICAL-GENETIC APPROACH; HYPERSENSITIVE RESPONSE; CELL-DEATH; INNATE IMMUNITY; SALICYLIC-ACID; LEUCINE-RICH; AVRPTO; RECEPTOR	The tomato (Solanum lycopersicum) protein kinase Pto confers resistance to Pseudomonas syringae pv. tomato bacteria expressing the AvrPto and AvrPtoB effector proteins. Pto specifically recognizes both effectors by direct physical interactions triggering activation of immune responses. Here, we used a chemical-genetic approach to sensitize Pto to analogs of PP1, an ATP-competitive small molecule inhibitor. By using PP1 analogs in combination with the sensitized Pto (Pto(as)), we examined the role of Pto kinase activity in effector recognition and signal transduction. Strikingly, while PP1 analogs efficiently inhibited kinase activity of Ptoas in vitro, they enhanced interactions of Pto(as) with AvrPto and AvrPtoB in a yeast two-hybrid system. In addition, in the presence of PP1 analogs, Pto(as) bypassed mutations either at an autophosphorylation site critical for the Pto-AvrPto interaction or at catalytically essential residues and interacted with both effectors. Moreover, in the presence of the PP1 analog 3MB-PP1, a kinase-deficient form of Pto(as) triggered an AvrPto-dependent hypersensitive response in planta. These findings suggest that, rather than phosphorylation per se, a conformational change likely triggered by autophosphorylation in Pto and mimicked by ligand binding in Ptoas is a prerequisite for recognition of bacterial effectors. Following recognition, kinase activity appears to be dispensable for Pto signaling in planta. The chemical-genetic strategy applied here to develop specific small molecule inhibitors of Pto represents an invaluable tool for the study of biological functions of other plant protein kinases in vivo.	[Sessa, Guido] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Tel Aviv University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sessa, G (corresponding author), Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	guidos@post.tau.ac.il		Salomon, Dor/0000-0002-2009-9453	Binational Science Foundation [2001124, 2007091]	Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by Binational Science Foundation Grants 2001124 and 2007091.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Bohmer M, 2007, PLANT MOL BIOL, V65, P817, DOI 10.1007/s11103-007-9245-9; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Brueggeman R, 2008, P NATL ACAD SCI USA, V105, P14970, DOI 10.1073/pnas.0807270105; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; GOLEMIS EA, 1995, CURRENT PROTOCOLS MO, V3; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Levin SE, 2008, J BIOL CHEM, V283, P15419, DOI 10.1074/jbc.M709000200; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Quintaje SB, 2008, MOL CELL PROTEOMICS, V7, P1409, DOI 10.1074/mcp.R700001-MCP200; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; REYNOLDS A, 1989, CURRENT PROTOCOLS MO, V2; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Sessa G, 1998, J BIOL CHEM, V273, P15860, DOI 10.1074/jbc.273.25.15860; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xiao FM, 2007, PLANT J, V52, P595, DOI 10.1111/j.1365-313X.2007.03259.x; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	53	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15289	15298		10.1074/jbc.M809724200	http://dx.doi.org/10.1074/jbc.M809724200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332544	Green Published, hybrid			2022-12-25	WOS:000266288200063
J	Bourdeau, RW; Malito, E; Chenal, A; Bishop, BL; Musch, MW; Villereal, ML; Chang, EB; Mosser, EM; Rest, RF; Tang, WJ				Bourdeau, Raymond W.; Malito, Enrico; Chenal, Alexandre; Bishop, Brian L.; Musch, Mark W.; Villereal, Mitch L.; Chang, Eugene B.; Mosser, Elise M.; Rest, Richard F.; Tang, Wei-Jen			Cellular Functions and X-ray Structure of Anthrolysin O, a Cholesterol-dependent Cytolysin Secreted by Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO MODEL; PERFRINGOLYSIN-O; LISTERIOLYSIN-O; MEMBRANE INSERTION; BIOLOGICAL WEAPON; THETA-TOXIN; MECHANISM; CALCIUM; PROTEIN; ENTRY	Anthrolysin O (ALO) is a pore-forming, cholesterol-dependent cytolysin (CDC) secreted by Bacillus anthracis, the etiologic agent for anthrax. Growing evidence suggests the involvement of ALO in anthrax pathogenesis. Here, we show that the apical application of ALO decreases the barrier function of human polarized epithelial cells as well as increases intracellular calcium and the internalization of the tight junction protein occludin. Using pharmacological agents, we also found that barrier function disruption requires increased intracellular calcium and protein degradation. We also report a crystal structure of the soluble state of ALO. Based on our analytical ultracentrifugation and light scattering studies, ALO exists as a monomer. Our ALO structure provides the molecular basis as to how ALO is locked in a monomeric state, in contrast to other CDCs that undergo antiparallel dimerization or higher order oligomerization in solution. ALO has four domains and is globally similar to perfringolysinO(PFO) and intermedilysin (ILY), yet the highly conserved undecapeptide region in domain 4 (D4) adopts a completely different conformation in all three CDCs. Consistent with the differences within D4 and at the D2-D4 interface, we found that ALO D4 plays a key role in affecting the barrier function of C2BBE cells, whereas PFO domain 4 cannot substitute for this role. Novel structural elements and unique cellular functions of ALO revealed by our studies provide new insight into the molecular basis for the diverse nature of the CDC family.	[Bourdeau, Raymond W.; Malito, Enrico; Bishop, Brian L.; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Musch, Mark W.; Chang, Eugene B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Villereal, Mitch L.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Chenal, Alexandre] Inst Pasteur, CNRS, URA 2185,Dept Biol Struct & Chim, Unite Biochim Interact Macromol, F-75724 Paris 15, France; [Mosser, Elise M.; Rest, Richard F.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA	University of Chicago; University of Chicago; University of Chicago; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Drexel University	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; Bourdeau, Raymond/0000-0003-2202-1980; Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [DK38510, GM62548, AI66503]; University of Chicago [DK42086]; American Health Assistance Foundation; Great Lakes Regional Center of Excellence; University of Chicago FACCTS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago(University of Chicago); American Health Assistance Foundation; Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Chicago FACCTS(University of Chicago); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK38510 (to E. B. C.), National Institutes of Health Grants GM62548 and AI66503, and a pilot grant from Digestive Disease Research Core Center of the University of Chicago (National Institutes of Health Grant DK42086). This work was also supported by the American Health Assistance Foundation (to E. M. M.), a pilot grant from the Great Lakes Regional Center of Excellence, and a University of Chicago FACCTS grant (to W. J. T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beatty ME, 2003, ARCH INTERN MED, V163, P2527, DOI 10.1001/archinte.163.20.2527; Beauregard KE, 1999, INFECT IMMUN, V67, P3026, DOI 10.1128/IAI.67.6.3026-3030.1999; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chitlaru T, 2006, J BACTERIOL, V188, P3551, DOI 10.1128/JB.188.10.3551-3571.2006; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Gilbert RJC, 2005, STRUCTURE, V13, P1097, DOI 10.1016/j.str.2005.04.019; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guttmann DM, 2000, FEMS MICROBIOL LETT, V188, P7, DOI 10.1111/j.1574-6968.2000.tb09160.x; Heffernan BJ, 2007, FEMS MICROBIOL LETT, V271, P98, DOI 10.1111/j.1574-6968.2007.00713.x; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; IWAMOTO M, 1990, EUR J BIOCHEM, V194, P25, DOI 10.1111/j.1432-1033.1990.tb19422.x; Kumar P, 2002, INFECT IMMUN, V70, P4997, DOI 10.1128/IAI.70.9.4997-5007.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma TY, 2000, MICROSC RES TECHNIQ, V51, P156, DOI 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J; MADARA JL, 1990, AM J PATHOL, V137, P1273; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Mosser EM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-56; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; PETERSON MD, 1993, J CELL SCI, V105, P445; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Raymond B, 2007, PLOS PATHOG, V3, P1907, DOI 10.1371/journal.ppat.0030187; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Ross CL, 2006, J BACTERIOL, V188, P7823, DOI 10.1128/JB.00525-06; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; RUTTEN MJ, 1991, PHARMACOLOGY, V42, P156, DOI 10.1159/000138793; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shannon JG, 2003, INFECT IMMUN, V71, P3183, DOI 10.1128/IAI.71.6.3183-3189.2003; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Somosy Z, 2003, CELL MOL BIOL, V49, P59; Tai YH, 1996, J MEMBRANE BIOL, V149, P71; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; TWETEN RK, 1991, J BIOL CHEM, V266, P12449; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027	71	69	70	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14645	14656		10.1074/jbc.M807631200	http://dx.doi.org/10.1074/jbc.M807631200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307185	Green Published, hybrid			2022-12-25	WOS:000266286100070
J	Chan, SW; Lim, CJ; Loo, LS; Chong, YF; Huang, CX; Hong, WJ				Chan, Siew Wee; Lim, Chun Jye; Loo, Li Shen; Chong, Yaan Fun; Huang, Caixia; Hong, Wanjin			TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; REGULATE CELL-PROLIFERATION; HIPPO SIGNALING PATHWAY; TUMOR-SUPPRESSOR GENE; ORGAN SIZE; CONTACT INHIBITION; TEAD/TEF FAMILY; BANTAM MICRORNA; YAP; PROTEIN	The transcriptional coactivators YAP and TAZ are downstream targets inhibited by the Hippo tumor suppressor pathway. The expression level of TAZ is recently shown to be elevated in invasive breast cancer cells and some primary breast cancers. TAZ is important for breast cancer cell migration, invasion, and tumorigenesis, but the underlying mechanism is not defined. In this study, we show that TAZ interacts with TEAD transcriptional factors. Knockdown of TEADs suppresses TAZ-mediated oncogenic transformation of MCF10A cells. Uncoupling TAZ from Hippo regulation by S89A mutation enhances its transforming ability. Several residues located in the N-terminal region of TAZ are identified to be important for interaction with TEADs, and these same residues are equally important for TAZ to transform MCF10A cells. Mechanistically, TAZ mutants defective in interaction with TEADs fail to accumulate in the nucleus. Live cell imaging of enhanced green fluorescent protein-TAZ and its mutant defective in TEAD interaction suggests that TEAD interaction mediates nuclear retention. These results reveal a novel mechanism for TEADs to regulate nuclear retention and thus the transforming ability of TAZ.	[Chan, Siew Wee; Lim, Chun Jye; Loo, Li Shen; Chong, Yaan Fun; Huang, Caixia; Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hong, WJ (corresponding author), 61 Biopolis Dr, Singapore 138673, Singapore.	mcbhwj@imcb.a-star.edu.sg	HONG, Wanjin/E-9927-2010		Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Bandura JL, 2008, DEV CELL, V14, P315, DOI 10.1016/j.devcel.2008.02.010; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lam-Himlin DM, 2006, J GASTROINTEST CANC, V37, P103, DOI 10.1007/s12029-007-0010-8; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rodriguez S, 2005, CANCER GENET CYTOGEN, V157, P140, DOI 10.1016/j.cancergencyto.2004.08.017; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Singh B, 2001, CANCER RES, V61, P4506; Skotheim RI, 2006, CELL ONCOL, V28, P315; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tian Y, 2004, J VIROL, V78, P12657, DOI 10.1128/JVI.78.22.12657-12664.2004; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Weber RG, 1996, ONCOGENE, V13, P983; Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	59	179	184	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14347	14358		10.1074/jbc.M901568200	http://dx.doi.org/10.1074/jbc.M901568200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324876	Green Published, hybrid			2022-12-25	WOS:000266286100041
J	Liu, Q; Li, J; Khoury, J; Colgan, SP; Ibla, JC				Liu, Qian; Li, Jing; Khoury, Joseph; Colgan, Sean P.; Ibla, Juan C.			Adenosine Signaling Mediates SUMO-1 Modification of I kappa B alpha during Hypoxia and Reoxygenation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; UBIQUITIN-LIKE PROTEIN; NUCLEAR-PORE COMPLEX; ACUTE LUNG INJURY; TRANSCRIPTIONAL ACTIVITY; SUMOYLATION; CD73; INTERLEUKIN-6; RANGAP1; ECTONUCLEOTIDASES	Small ubiquitin-like modifier 1 (SUMO-1) modification of I kappa B alpha has been described to actively participate in NF kappa B regulation. Following proteosomal degradation of I kappa B alpha, an auto-regulatory loop consisting of transcriptional activation of I kappa B alpha gene and SUMO-1 modification of newly synthesized I kappa B alpha proceeds. The SUMOylated I kappa B alpha form is resistant to signal-induced degradation, consequently halting NF kappa B activation. We describe a mechanistic model by which adenosine (Ado) signaling results in significant accumulation of SUMO-1 modified I kappa B alpha with subsequent attenuation of NF kappa B activation. Using models of hypoxia followed by reoxygenation (H/R), we have documented an H/R cycle-dependent increase in extracellular Ado correlating with increases in the cytoplasmic pool of I kappa B alpha/SUMO-1. We demonstrate a dose-dependent increase in I kappa B alpha/SUMO in cells treated with the general Ado receptor agonist NECA and abolished by Ado receptor antagonists. Experiments in cells exposed to cycles of H/R followed by hypoxia demonstrated differential patterns of SUMOylation and phosphorylation of I kappa B alpha, greatly impacting its proteosomal degradation by the 26 S proteasome. Assays targeting knockdown and overexpression of SUMO-1 demonstrated significant regulation of NF kappa B activation and NF kappa B-mediated gene transcription (interleukin-6). These results were confirmed in vivo using wild type and cd73 null mouse lung tissue. In summary, we present an endogenous mechanism by which cells and tissues acquire anti-inflammatory properties by recruiting a nondegradable form of I kappa B alpha, a major control point for NF kappa B activation via Ado signaling.	[Liu, Qian; Li, Jing; Khoury, Joseph; Ibla, Juan C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Liu, Qian] Chongqing Med Univ, Childrens Hosp, Dept Surg, Chongqing 400014, Peoples R China; [Li, Jing] Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cell & Tissue Engn, Chongqing 400016, Peoples R China; [Colgan, Sean P.] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol, Mucosal Inflammat Program, Denver, CO 80220 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Chongqing Medical University; Chongqing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ibla, JC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anesthesiol Perioperat & Pain Med, Bader 3,300 Longwood Ave, Boston, MA 02115 USA.	juan.ibla@childrens.harvard.edu			Robert M. Smith Award; Department of Anesthesiology; Eleanor and Miles Shore 50th Anniversary Fellowship Program	Robert M. Smith Award; Department of Anesthesiology; Eleanor and Miles Shore 50th Anniversary Fellowship Program	This work was supported by Funds from the Robert M. Smith Award, the Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital, and the Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine, Children's Hospital Boston, and Harvard Medical School (to J.C.I.).	ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Boddy MN, 1996, ONCOGENE, V13, P971; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Hay RT, 1999, PHILOS T R SOC B, V354, P1601, DOI 10.1098/rstb.1999.0504; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kroetz Mary B, 2005, Yale J Biol Med, V78, P197; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Muraoka A, 2008, BIOCHEM BIOPH RES CO, V377, P1031, DOI 10.1016/j.bbrc.2008.09.149; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	35	30	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13686	13695		10.1074/jbc.M809275200	http://dx.doi.org/10.1074/jbc.M809275200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297320	hybrid, Green Published			2022-12-25	WOS:000265877300046
J	Nayak, D; Guo, Q; Sousa, R				Nayak, Dhananjaya; Guo, Qing; Sousa, Rui			A Promoter Recognition Mechanism Common to Yeast Mitochondrial and Phage T7 RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION; CRYSTAL-STRUCTURE; SIGMA-70 SUBUNIT; MUTANT FORMS; IN-VITRO; SPECIFICITY; RELEASE; COMPLEX; DNA; BACTERIOPHAGE-T3	Yeast mitochondrial (YMt) and phage T7 RNA polymerases (RNAPs) are two divergent representatives of a large family of single subunit RNAPs that are also found in the mitochondria and chloroplasts of higher eukaryotes, mammalian nuclei, and many other bacteriophage. YMt and phage T7 promoters differ greatly in sequence and length, and the YMt RNAP uses an accessory factor for initiation, whereas T7 RNAP does not. We obtain evidence here that, despite these apparent differences, both the YMt and T7 RNAPs utilize a similar promoter recognition loop to bind their respective promoters. Mutations in this element in YMt RNAP specifically disrupt mitochondrial promoter utilization, and experiments with site-specifically tethered chemical nucleases indicate that this element binds the mitochondrial promoter almost identically to how the promoter recognition loop from the phage RNAP binds its promoter. Sequence comparisons reveal that the other members of the single subunit RNAP family display loops of variable sequence and size at a position corresponding to the YMt and T7 RNAP promoter recognition loops. We speculate that these elements may be involved in promoter recognition in most or all of these enzymes and that this element's structure allows it to accommodate significant sequence and length variation to provide a mechanism for rapid evolution of new promoter specificities in this RNAP family.	[Nayak, Dhananjaya; Guo, Qing; Sousa, Rui] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Sousa, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	sousa@biochem.uthscsa.edu	Nayak, Dhananjaya/B-2802-2015	Nayak, Dhananjaya/0000-0003-0529-9411; Sousa, Rui/0000-0003-4314-121X	National Institutes of Health [GMS52522]; Welch Foundation [AQ-1486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMS52522. This work was also supported by Welch Foundation Grant AQ-1486 (to R. S.).	BAILEY JN, 1983, P NATL ACAD SCI-BIOL, V80, P2814, DOI 10.1073/pnas.80.10.2814; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; BROWN JE, 1986, NUCLEIC ACIDS RES, V14, P3521, DOI 10.1093/nar/14.8.3521; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; CHAMBERLIN M, 1983, METHOD ENZYMOL, V101, P540; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Guo Q, 2005, J BIOL CHEM, V280, P14956, DOI 10.1074/jbc.M500518200; Guo Q, 2005, J BIOL CHEM, V280, P3474, DOI 10.1074/jbc.M412287200; JAEHNING JA, 1993, MOL MICROBIOL, V8, P1, DOI 10.1111/j.1365-2958.1993.tb01197.x; Liere K, 1999, EMBO J, V18, P249, DOI 10.1093/emboj/18.1.249; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; MULLER DK, 1989, BIOCHEMISTRY-US, V28, P3306, DOI 10.1021/bi00434a028; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Nayak D, 2007, J MOL BIOL, V371, P490, DOI 10.1016/j.jmb.2007.05.070; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P6165, DOI 10.1021/bi700058b; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P1714, DOI 10.1021/bi061905d; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	35	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13641	13647		10.1074/jbc.M900718200	http://dx.doi.org/10.1074/jbc.M900718200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307179	hybrid, Green Published			2022-12-25	WOS:000265877300041
J	Popescu, M; Gurel, Z; Ronni, T; Song, CH; Hung, KY; Payne, KJ; Dovat, S				Popescu, Marcela; Gurel, Zafer; Ronni, Tapani; Song, Chunhua; Hung, Ka Ying; Payne, Kimberly J.; Dovat, Sinisa			Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING PROTEINS; TRANSCRIPTION FACTOR; CENTROMERIC HETEROCHROMATIN; UBIQUITIN LIGASE; MUTANT MICE; GENE; PHOSPHORYLATION; EXPRESSION; ISOFORMS	Ikaros encodes a zinc finger protein that is involved in gene regulation and chromatin remodeling. The majority of Ikaros localizes at pericentromeric heterochromatin (PC-HC) where it regulates expression of target genes. Ikaros function is controlled by posttranslational modification. Phosphorylation of Ikaros by CK2 kinase determines its ability to bind DNA and exert cell cycle control as well as its subcellular localization. We report that Ikaros interacts with protein phosphatase 1 (PP1) via a conserved PP1 binding motif, RVXF, in the C-terminal end of the Ikaros protein. Point mutations of the RVXF motif abolish Ikaros-PP1 interaction and result in decreased DNA binding, an inability to localize to PC-HC, and rapid degradation of the Ikaros protein. The introduction of alanine mutations at CK2-phosphorylated residues increases the half-life of the PP1-non-binding Ikaros mutant. This suggests that dephosphorylation of these sites by PP1 stabilizes the Ikaros protein and prevents its degradation. In the nucleus, Ikaros forms complexes with ubiquitin, providing evidence that Ikaros degradation involves the ubiquitin/proteasome pathway. In vivo, Ikaros can target PP1 to the nucleus, and a fraction of PP1 colocalizes with Ikaros at PC-HC. These data suggest a novel function for the Ikaros protein; that is, the targeting of PP1 to PC-HC and other chromatin structures. We propose a model whereby the function of Ikaros is controlled by the CK2 and PP1 pathways and that a balance between these two signal transduction pathways is essential for normal cellular function and for the prevention of malignant transformation.	[Dovat, Sinisa] Univ Wisconsin, Dept Pediat, Div Pediat Hematol Oncol, Madison, WI 53792 USA; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	University of Wisconsin System; University of Wisconsin Madison; Loma Linda University; Loma Linda University	Dovat, S (corresponding author), Univ Wisconsin, Dept Pediat, Div Pediat Hematol Oncol, 600 Highland Ave, Madison, WI 53792 USA.	dovat@wisc.edu	song, chunhua/K-7882-2016; Payne, Kimberly/AAS-6814-2020; Gurel, Zafer/AAF-3072-2021; Hung, Ka Ying Sharon/AAI-1685-2021; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Payne, Kimberly/0000-0002-7025-5821; Hung, Ka Ying Sharon/0000-0002-4084-6030; song, chunhua/0000-0002-4081-2543; Dovat, Sinisa/0000-0003-3906-6165	National Institutes of Health [T32 HL07899, K12 CA 087718, 5K01 DK066163, K22 CA 111392]; University of Wisconsin Institute for Clinical and Translational Research through National Institutes of Health Clinical and Translational Science Award [1UL1RR025011]; Midwest Athletes Against Childhood Cancer Award; St. Baldrick's Foundation Career Development; University of Wisconsin Medical Education and Research Committee New Investigator Program; NATIONAL CANCER INSTITUTE [K22CA111392, K12CA087718] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK066163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Institute for Clinical and Translational Research through National Institutes of Health Clinical and Translational Science Award; Midwest Athletes Against Childhood Cancer Award; St. Baldrick's Foundation Career Development; University of Wisconsin Medical Education and Research Committee New Investigator Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL07899 and K12 CA 087718 ( to M. P.), 5K01 DK066163 ( to K. J. P.), and K22 CA 111392 ( to S. D.). This project was supported in part by the University of Wisconsin Institute for Clinical and Translational Research, funded through National Institutes of Health Clinical and Translational Science Award 1UL1RR025011. This work was also supported by a Midwest Athletes Against Childhood Cancer Award, St. Baldrick's Foundation Career Development grant, and by the University of Wisconsin Medical Education and Research Committee New Investigator Program ( to S. D.).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; ALESSANDRINI A, 1987, P NATL ACAD SCI USA, V84, P1799, DOI 10.1073/pnas.84.7.1799; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cohen PTW, 2002, J CELL SCI, V115, P241; Crescenzi B, 2004, HAEMATOLOGICA, V89, P281; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; GROVES T, 1995, J IMMUNOL, V154, P5011; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liberg D, 2003, TRENDS IMMUNOL, V24, P567, DOI 10.1016/j.it.2003.09.008; MIZUGUCHI J, 1986, J IMMUNOL, V137, P2162; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nakase K, 2000, CANCER RES, V60, P4062; Nakayama H, 1999, CANCER RES, V59, P3931; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Rudenko A, 2003, EMBO REP, V4, P59, DOI 10.1038/sj.embor.embor712; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wang XJ, 2008, J BIOL CHEM, V283, P12076, DOI 10.1074/jbc.M801571200; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368	54	56	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13869	13880		10.1074/jbc.M900209200	http://dx.doi.org/10.1074/jbc.M900209200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19282287	Green Published			2022-12-25	WOS:000265877300063
J	Wilcox, KC; Zhou, L; Jordon, JK; Huang, Y; Yu, YB; Redler, RL; Chen, X; Caplow, M; Dokholyan, NV				Wilcox, Kyle C.; Zhou, Li; Jordon, Joshua K.; Huang, Yi; Yu, Yanbao; Redler, Rachel L.; Chen, Xian; Caplow, Michael; Dokholyan, Nikolay V.			Modifications of Superoxide Dismutase (SOD1) in Human Erythrocytes A POSSIBLE ROLE IN AMYOTROPHIC LATERAL SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIOLATION; CRYSTAL-STRUCTURE; DISULFIDE BOND; FAMILIAL ALS; AGGREGATION; BINDING; CU; GLUTATHIONYLATION; OXIDATION; MUTANTS	Over 100 mutations in Cu/Zn-superoxide dismutase (SOD1) result in familial amyotrophic lateral sclerosis. Dimer dissociation is the first step in SOD1 aggregation, and studies suggest nearly every amino acid residue in SOD1 is dynamically connected to the dimer interface. Post-translational modifications of SOD1 residues might be expected to have similar effects to mutations, but few modifications have been identified. Here we show, using SOD1 isolated from human erythrocytes, that human SOD1 is phosphorylated at threonine 2 and glutathionylated at cysteine 111. A second SOD1 phosphorylation was observed and mapped to either Thr-58 or Ser-59. Cysteine 111 glutathionylation promotes SOD1 monomer formation, a necessary initiating step in SOD1 aggregation, by causing a 2-fold increase in the K-d. This change in the dimer stability is expected to result in a 67% increase in monomer concentration, 315 nM rather than 212 nM at physiological SOD1 concentrations. Because protein glutathionylation is associated with redox regulation, our finding that glutathionylation promotes SOD1 monomer formation supports a model in which increased oxidative stress promotes SOD1 aggregation.	[Wilcox, Kyle C.; Zhou, Li; Jordon, Joshua K.; Redler, Rachel L.; Chen, Xian; Caplow, Michael; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27510 USA; [Wilcox, Kyle C.; Chen, Xian; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27510 USA; [Zhou, Li; Chen, Xian] Univ N Carolina, Duke Michael Hooker Proteom Ctr, Chapel Hill, NC 27510 USA; [Dokholyan, Nikolay V.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27510 USA; [Huang, Yi; Yu, Yanbao] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Huang, Yi; Yu, Yanbao] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fudan University; Fudan University	Chen, X (corresponding author), 120 Mason Farm Rd,3072 Genet Med Bldg, Chapel Hill, NC 27599 USA.	xian_chen@med.unc.edu; dokh@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; , Proteomics Core UNC/AFQ-7201-2022; Wilcox, Kyle/C-2383-2011; Yu, Yanbao/G-3035-2010	Dokholyan, Nikolay/0000-0002-8225-4025; Yu, Yanbao/0000-0003-2994-1974	National Institutes of Health [R01GM080742, 1R01AI064806-01A2]; United States Department of Energy Grant (BER) [DE-FG02-07ER64422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Grant (BER)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM080742 ( to N. V. D.) and 1R01AI064806-01A2 ( to X. C.). This work was also supported by United States Department of Energy Grant ( BER) DE-FG02-07ER64422 ( to X. C.).	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Borchers CH, 2006, P NATL ACAD SCI USA, V103, P3094, DOI 10.1073/pnas.0511289103; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; GOSCIN SA, 1972, BIOCHIM BIOPHYS ACTA, V289, P276, DOI 10.1016/0005-2744(72)90078-2; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; KUROBE N, 1990, CLIN CHIM ACTA, V187, P11, DOI 10.1016/0009-8981(90)90257-S; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; Maher P, 2006, ANTIOXID REDOX SIGN, V8, P1941, DOI 10.1089/ars.2006.8.1941; Marklund SL, 1997, J NEUROCHEM, V69, P675; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nakanishi T, 1998, J NEUROSCI METH, V81, P41, DOI 10.1016/S0165-0270(98)00012-0; Pflieger D, 2008, MOL CELL PROTEOMICS, V7, P326, DOI 10.1074/mcp.M700282-MCP200; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RICHARDSON JS, 1975, P NATL ACAD SCI USA, V72, P1349, DOI 10.1073/pnas.72.4.1349; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200	37	92	94	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13940	13947		10.1074/jbc.M809687200	http://dx.doi.org/10.1074/jbc.M809687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299510	hybrid, Green Published			2022-12-25	WOS:000265877300069
J	Saito, Y; Ashida, H; Sakiyama, T; de Marsac, NT; Danchin, A; Sekowska, A; Yokota, A				Saito, Yohtaro; Ashida, Hiroki; Sakiyama, Tomoko; de Marsac, Nicole Tandeau; Danchin, Antoine; Sekowska, Agnieszka; Yokota, Akiho			Structural and Functional Similarities between a Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (RuBisCO)-like Protein from Bacillus subtilis and Photosynthetic RuBisCO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; METHIONINE SALVAGE PATHWAY; 5-METHYLTHIORIBOSE 1-PHOSPHATE ISOMERASE; LARGE-SUBUNIT GENES; RIBULOSEBISPHOSPHATE CARBOXYLASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; ENZYMATIC CHARACTERIZATION; SULFUR METABOLISM; CRYSTAL-STRUCTURE; OXYGENASE	The sequences classified as genes for various ribulose-1,5-bisphosphate (RuBP) carboxylase/oxygenase (RuBisCO)-like proteins (RLPs) are widely distributed among bacteria, archaea, and eukaryota. In the phylogenic tree constructed with these sequences, RuBisCOs and RLPs are grouped into four separate clades, forms I-IV. In RuBisCO enzymes encoded by form I, II, and III sequences, 19 conserved amino acid residues are essential for CO2 fixation; however, 1-11 of these 19 residues are substituted with other amino acids in form IV RLPs. Among form IV RLPs, the only enzymatic activity detected to date is a 2,3-diketo-5-methylthiopentyl 1-phosphate (DK-MTP-1-P) enolase reaction catalyzed by Bacillus subtilis, Microcystis aeruginosa, and Geobacillus kaustophilus form IV RLPs. RLPs from Rhodospirillum rubrum, Rhodopseudomonas palustris, Chlorobium tepidum, and Bordetella bronchiseptica were inactive in the enolase reaction. DK-MTP-1-P enolase activity of B. subtilis RLP required Mg2+ for catalysis and, like RuBisCO, was stimulated by CO2. Four residues that are essential for the enolization reaction of RuBisCO, Lys175, Lys201, Asp203, and Glu204, were conserved in RLPs and were essential for DK-MTP-1-P enolase catalysis. Lys123, the residue conserved in DK-MTP-1-P enolases, was also essential for B. subtilis RLP enolase activity. Similarities between the active site structures of RuBisCO and B. subtilis RLP were examined by analyzing the effects of structural analogs of RuBP on DK-MTP-1-P enolase activity. A transition state analog for the RuBP carboxylation of RuBisCO was a competitive inhibitor in the DK-MTP-1-P enolase reaction with a K-i value of 103 mu M. RuBP and D-phosphoglyceric acid, the substrate and product, respectively, of RuBisCO, were weaker competitive inhibitors. These results suggest that the amino acid residues utilized in the B. subtilis RLP enolase reaction are the same as those utilized in the RuBisCO RuBP enolization reaction.	[Saito, Yohtaro; Ashida, Hiroki; Sakiyama, Tomoko; Yokota, Akiho] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [de Marsac, Nicole Tandeau] Inst Pasteur, Dept Microbiol, F-75724 Paris 15, France; [Danchin, Antoine; Sekowska, Agnieszka] Inst Pasteur, Dept Genet Bacterial Genomes, F-75724 Paris 15, France	Nara Institute of Science & Technology; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Yokota, A (corresponding author), 8916-5 Takayama, Nara 6300192, Japan.	yokota@bs.naist.jp	Saito, Yohtaro/C-9838-2017	Saito, Yohtaro/0000-0002-1024-5154; Danchin, Antoine/0000-0002-6350-5001	Japan Society for the Promotion of Science [17208031, 18688021]; Asahi Glass Foundation [FY2004-2006]; Nissan Science Foundation [FY2005-2007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Glass Foundation; Nissan Science Foundation	This work was supported in part by Japan Society for the Promotion of Science Grants-in-aid for Scientific Research 17208031 and 18688021, Asahi Glass Foundation Grant FY2004-2006 for General Science and Technology, and Nissan Science Foundation Grant FY2005-2007.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; Ashida H, 2005, RES MICROBIOL, V156, P611, DOI 10.1016/j.resmic.2005.01.014; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Ashida H, 2008, BIOSCI BIOTECH BIOCH, V72, P959, DOI 10.1271/bbb.70651; Ashida H, 2008, J EXP BOT, V59, P1543, DOI 10.1093/jxb/ern104; BADGER MR, 1981, BIOCHEMISTRY-US, V20, P2219, DOI 10.1021/bi00511a023; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Carre-Mlouka A, 2006, J BIOL CHEM, V281, P24462, DOI 10.1074/jbc.M602973200; CHRAMBACH A, 1971, SCIENCE, V172, P440, DOI 10.1126/science.172.3982.440; CHU DK, 1975, PLANT PHYSIOL, V55, P720, DOI 10.1104/pp.55.4.720; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HARTMAN FC, 1985, J BIOL CHEM, V260, P3968; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORIMER GH, 1981, BIOCHEMISTRY-US, V20, P1236, DOI 10.1021/bi00508a028; Matsuda Y, 1996, PLANT PHYSIOL, V110, P1283, DOI 10.1104/pp.110.4.1283; MCCURRY SD, 1977, J BIOL CHEM, V252, P8344; MIZIORKO HM, 1983, ANNU REV BIOCHEM, V52, P507, DOI 10.1146/annurev.bi.52.070183.002451; MORITA N, 1981, AGR BIOL CHEM TOKYO, V45, P2665, DOI 10.1080/00021369.1981.10864947; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; PAULSEN JM, 1966, BIOCHEMISTRY-US, V5, P2350, DOI 10.1021/bi00871a025; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; Portis AR, 2007, PHOTOSYNTH RES, V94, P121, DOI 10.1007/s11120-007-9225-6; Roy Harry, 2000, VVolume 9, P53; Saito Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2021, DOI 10.1271/bbb.70209; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Selesi D, 2005, APPL ENVIRON MICROB, V71, P175, DOI 10.1128/AEM.71.1.175-184.2005; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tamura H, 2008, PROTEIN SCI, V17, P126, DOI 10.1110/ps.073169008; Taylor TC, 1997, J MOL BIOL, V265, P432, DOI 10.1006/jmbi.1996.0738; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; van der Wielen PWJJ, 2006, FEMS MICROBIOL LETT, V259, P326, DOI 10.1111/j.1574-6968.2006.00284.x; Vislisel JM, 2007, ANAL BIOCHEM, V365, P31, DOI 10.1016/j.ab.2007.03.002; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; YOKOTA A, 1991, PLANT CELL PHYSIOL, V32, P755; YOKOTA A, 1985, BIOCHEM BIOPH RES CO, V131, P1075, DOI 10.1016/0006-291X(85)90200-1; YOKOTA A, 1991, J BIOCHEM-TOKYO, V110, P246, DOI 10.1093/oxfordjournals.jbchem.a123565; Yokota A, 2008, ADV PL BIOCH MOL BIO, V1, P81, DOI 10.1016/S1755-0408(07)01004-1	49	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13256	13264		10.1074/jbc.M807095200	http://dx.doi.org/10.1074/jbc.M807095200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279009	hybrid, Green Published			2022-12-25	WOS:000265688300072
J	Kannan, S; Huang, H; Seeger, D; Audet, A; Chen, YY; Huang, CH; Gao, HW; Li, SG; Wu, M				Kannan, Shibichakravarthy; Huang, Huang; Seeger, Drew; Audet, Aaron; Chen, Yaoyu; Huang, Canhua; Gao, Hongwei; Li, Shaoguang; Wu, Min			Alveolar Epithelial Type II Cells Activate Alveolar Macrophages and Mitigate P. Aeruginosa Infection	PLOS ONE			English	Article							SRC KINASE LYN; PSEUDOMONAS-AERUGINOSA; DEFICIENT MICE; PHAGOCYTOSIS; HOST; EXPRESSION; SECRETION; PHOSPHORYLATION; RESISTANCE; INHIBITION	Although alveolar epithelial type II cells (AECII) perform substantial roles in the maintenance of alveolar integrity, the extent of their contributions to immune defense is poorly understood. Here, we demonstrate that AECII activates alveolar macrophages (AM) functions, such as phagocytosis using a conditioned medium from AECII infected by P. aeruginosa. AECII-derived chemokine MCP-1, a monocyte chemoattractant protein, was identified as a main factor in enhancing AM function. We proposed that the enhanced immune potency of AECII may play a critical role in alleviation of bacterial propagation and pneumonia. The ability of phagocytosis and superoxide release by AM was reduced by MCP-1 neutralizing antibodies. Furthermore, MCP-1(-/-) mice showed an increased bacterial burden under PAO1 and PAK infection vs. wt littermates. AM from MCP-1(-/-) mice also demonstrated less superoxide and impaired phagocytosis over the controls. In addition, AECII conditioned medium increased the host defense of airway in MCP-1(-/-) mice through the activation of AM function. Mechanistically, we found that Lyn mediated NFkB activation led to increased gene expression and secretion of MCP-1. Consequently Lyn(-/-) mice had reduced MCP-1 secretion and resulted in a decrease in superoxide and phagocytosis by AM. Collectively, our data indicate that AECII may serve as an immune booster for fighting bacterial infections, particularly in severe immunocompromised conditions.	[Kannan, Shibichakravarthy; Huang, Huang; Seeger, Drew; Audet, Aaron; Gao, Hongwei; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Chen, Yaoyu; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA; [Huang, Canhua; Wu, Min] Sichuan Univ, W China Hosp, State Key Lab Biother, Chengdu, Peoples R China	University of North Dakota Grand Forks; University of Massachusetts System; University of Massachusetts Worcester; Sichuan University	Wu, M (corresponding author), Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA.	minwu@medicine.nodak.edu	chen, yaoyu/A-4236-2011; Seeger, Drew/ABH-5020-2020	Seeger, Drew/0000-0002-9382-2753; Wu, Min/0000-0003-1205-982X; Kannan, Shibichakravarthy/0000-0002-5389-6272	NIH [ES014690, P20 RR017699]; American Heart Association; National Key Basic Research Program of China [2006CB504300]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES014690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH ES014690 and P20 RR017699, American Heart Association Scientist Development Grant (National Office). The work is also supported by National Key Basic Research Program of China (973Program #2006CB504300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Baran CP, 2003, J BIOL CHEM, V278, P38628, DOI 10.1074/jbc.M305021200; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Das A, 2007, AM J PHYSIOL-LUNG C, V292, pL74, DOI 10.1152/ajplung.00103.2006; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Hauser AR, 1999, INFECT IMMUN, V67, P5530, DOI 10.1128/IAI.67.10.5530-5537.1999; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Maresso AW, 2004, J BIOL CHEM, V279, P38402, DOI 10.1074/jbc.M405707200; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Neff TA, 2005, AM J PATHOL, V166, P685, DOI 10.1016/S0002-9440(10)62290-0; O'Brien AD, 1998, J LAB CLIN MED, V131, P417, DOI 10.1016/S0022-2143(98)90142-1; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Subramanian A, 2006, LEUKEMIA RES, V30, P1141, DOI 10.1016/j.leukres.2006.02.006; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Wisniowski PE, 2000, AM J RESP CRIT CARE, V162, P733, DOI 10.1164/ajrccm.162.2.9808015; Wu M, 2002, ELECTROPHORESIS, V23, P2373, DOI 10.1002/1522-2683(200208)23:15<2373::AID-ELPS2373>3.0.CO;2-W; WU M, 1995, BIOCONJUGATE CHEM, V6, P587, DOI 10.1021/bc00035a013; Wu M, 2001, P NATL ACAD SCI USA, V98, P14589, DOI 10.1073/pnas.251451498; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zhu F, 2006, CELL MOL IMMUNOL, V3, P107	45	65	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4891	10.1371/journal.pone.0004891	http://dx.doi.org/10.1371/journal.pone.0004891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305493	gold, Green Published, Green Submitted			2022-12-25	WOS:000265498800002
J	Smith, IM; Glazer, CA; Mithani, SK; Ochs, MF; Sun, W; Bhan, S; Vostrov, A; Abdullaev, Z; Lobanenkov, V; Gray, A; Liu, C; Chang, SS; Ostrow, KL; Westra, WH; Begum, S; Dhara, M; Califano, J				Smith, Ian M.; Glazer, Chad A.; Mithani, Suhail K.; Ochs, Michael F.; Sun, Wenyue; Bhan, Sheetal; Vostrov, Alexander; Abdullaev, Ziedulla; Lobanenkov, Victor; Gray, Andrew; Liu, Chunyan; Chang, Steven S.; Ostrow, Kimberly L.; Westra, William H.; Begum, Shahnaz; Dhara, Mousumi; Califano, Joseph			Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer	PLOS ONE			English	Article								Background: Epigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by promoter demethylation have been sporadically reported. We used an integrative method to analyze expression in primary head and neck squamous cell carcinoma (HNSCC) and pharmacologically demethylated cell lines to identify aberrantly demethylated and expressed candidate proto-oncogenes and cancer testes antigens in HNSCC. Methodology/Principal Findings: We noted coordinated promoter demethylation and simultaneous transcriptional upregulation of proto-oncogene candidates with promoter homology, and phylogenetic footprinting of these promoters demonstrated potential recognition sites for the transcription factor BORIS. Aberrant BORIS expression correlated with upregulation of candidate proto-oncogenes in multiple human malignancies including primary non-small cell lung cancers and HNSCC, induced coordinated proto-oncogene specific promoter demethylation and expression in non-tumorigenic cells, and transformed NIH3T3 cells. Conclusions/Significance: Coordinated, epigenetic unmasking of multiple genes with growth promoting activity occurs in aerodigestive cancers, and BORIS is implicated in the coordinated promoter demethylation and reactivation of epigenetically silenced genes in human cancers.	[Smith, Ian M.; Glazer, Chad A.; Sun, Wenyue; Bhan, Sheetal; Gray, Andrew; Liu, Chunyan; Chang, Steven S.; Ostrow, Kimberly L.; Dhara, Mousumi; Califano, Joseph] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Mithani, Suhail K.] Johns Hopkins Med Inst, Dept Surg, Div Plastic & Reconstruct Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Westra, William H.; Begum, Shahnaz] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Vostrov, Alexander; Abdullaev, Ziedulla; Lobanenkov, Victor] Inst Allergy & Infect Dis, NIH, Rockville, MD USA; [Califano, Joseph] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Greater Baltimore Medical Center	Califano, J (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu	Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021	Lobanenkov, Victor/0000-0001-6665-3635; Mithani, Suhail/0000-0002-3762-0831; Sun, Wenyue/0000-0003-1673-0895	NIH [T32 grant]; Flight Attendant Medical Research Institute [Clinical Innovator Award]; National Cancer Institute SPORE [5P50CA096784-05]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001021, ZIAAI000860, Z01AI001021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH T32 grant, Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the National Cancer Institute SPORE (5P50CA096784-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Bolli M, 2005, INT J CANCER, V115, P960, DOI 10.1002/ijc.20953; Cho Hearn J, 2006, Cancer Immun, V6, P12; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteves LID, 2006, INT J MOL MED, V17, P397; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Foldi M, 2007, ONCOL REP, V17, P841; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; HANADA M, 1993, BLOOD, V82, P1820; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu LH, 2007, ANTI-CANCER DRUG, V18, P427, DOI 10.1097/CAD.0b013e328013d99e; *IGC, 2005, EXPO EXPR PROJ ONC; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; MANGUES R, 1995, MOL CARCINOGEN, V14, P94, DOI 10.1002/mc.2940140205; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nagao T, 2003, J BIOL CHEM, V278, P10668, DOI 10.1074/jbc.M206104200; NGUYEN P, 2008, MOL CELL BIOL; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Prawitt D, 2005, NAT GENET, V37, P785, DOI 10.1038/ng0805-785; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Staiger WI, 2006, ONCOL REP, V16, P657; Suzuki T, 2007, ONCOL REP, V18, P329; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; TSAI JR, 2007, LUNG CANC; TSANG WP, 2007, ONCOGENE; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Volker HU, 2007, EUR ARCH OTO-RHINO-L, V264, P1431, DOI 10.1007/s00405-007-0394-x; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548; ZHANG S, 2007, CANC LETT; Zhou H, 2001, ONCOGENE, V20, P6009, DOI 10.1038/sj.onc.1204830	51	83	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4961	10.1371/journal.pone.0004961	http://dx.doi.org/10.1371/journal.pone.0004961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305507	gold, Green Submitted, Green Published			2022-12-25	WOS:000265498800010
J	VanderLeest, HT; Rohling, JHT; Michel, S; Meijer, JH				vanderLeest, Henk Tjebbe; Rohling, Jos H. T.; Michel, Stephan; Meijer, Johanna H.			Phase Shifting Capacity of the Circadian Pacemaker Determined by the SCN Neuronal Network Organization	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; SINGLE-CELL; OSCILLATORS; CLOCK; RHYTHMS; DEFICIENT; AMPLITUDE; BEHAVIOR; SYSTEM	Background: In mammals, a major circadian pacemaker that drives daily rhythms is located in the suprachiasmatic nuclei (SCN), at the base of the hypothalamus. The SCN receive direct light input via the retino-hypothalamic tract. Light during the early night induces phase delays of circadian rhythms while during the late night it leads to phase advances. The effects of light on the circadian system are strongly dependent on the photoperiod to which animals are exposed. An explanation for this phenomenon is currently lacking. Methodology and Principal Findings: We recorded running wheel activity in C57 mice and observed large amplitude phase shifts in short photoperiods and small shifts in long photoperiods. We investigated whether these different light responses under short and long days are expressed within the SCN by electrophysiological recordings of electrical impulse frequency in SCN slices. Application of N-methyl-D-aspartate (NMDA) induced sustained increments in electrical activity that were not significantly different in the slices from long and short photoperiods. These responses led to large phase shifts in slices from short days and small phase shifts in slices from long days. An analysis of neuronal subpopulation activity revealed that in short days the amplitude of the rhythm was larger than in long days. Conclusions: The data indicate that the photoperiodic dependent phase responses are intrinsic to the SCN. In contrast to earlier predictions from limit cycle theory, we observed large phase shifting responses in high amplitude rhythms in slices from short days, and small shifts in low amplitude rhythms in slices from long days. We conclude that the photoperiodic dependent phase responses are determined by the SCN and propose that synchronization among SCN neurons enhances the phase shifting capacity of the circadian system.	[vanderLeest, Henk Tjebbe; Rohling, Jos H. T.; Michel, Stephan; Meijer, Johanna H.] Leiden Univ, Dept Mol Cell Biol, Neurophysiol Lab, Med Ctr, Leiden, Netherlands; [Rohling, Jos H. T.] Leiden Univ, Leiden Inst Advanced Comp Sci, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Meijer, JH (corresponding author), Leiden Univ, Dept Mol Cell Biol, Neurophysiol Lab, Med Ctr, Leiden, Netherlands.	J.H.Meijer@lumc.nl	Rohling, Jos/AAC-3516-2022; Michel, Stephan/ABC-4211-2021	Rohling, Jos H T/0000-0001-5721-2715	Netherlands Organization for Scientific Research (NWO) [805.47. 212]; EUCLOCK program of the EU	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EUCLOCK program of the EU	This research was supported by Netherlands Organization for Scientific Research (NWO), program grant nr 805.47. 212 From Molecule to Cell, and by "Entrainment of the circadian clock" - EUCLOCK program of the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Beersma DGM, 2008, J BIOL RHYTHM, V23, P362, DOI 10.1177/0748730408317992; Bendova Z, 2006, PHYSIOL RES, V55, P623, DOI 10.33549/physiolres.930849; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; Colwell CS, 2005, NAT NEUROSCI, V8, P10, DOI 10.1038/nn0105-10; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Evans JA, 2004, AM J PHYSIOL-REG I, V286, pR539, DOI 10.1152/ajpregu.00456.2003; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Indic P, 2007, J BIOL RHYTHM, V22, P211, DOI 10.1177/0748730407301238; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; PITTENDRIGH CS, 1984, CIBA F SYMP, V104, P26; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R, 2002, INTEGR PHYS BEH SCI, V37, P114, DOI 10.1007/BF02688824; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rohling J, 2006, J BIOL RHYTHM, V21, P301, DOI 10.1177/0748730406290317; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Sumova A, 2003, J BIOL RHYTHM, V18, P134, DOI 10.1177/0748730403251801; Takahashi J. S., 2001, CIRCADIAN CLOCKS; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Welsh DK, 2007, J NEUROPHYSIOL, V97, P1885, DOI 10.1152/jn.00063.2007; Winfree A.T., 2000, GEOMETRY BIOL TIME	38	75	77	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2009	4	3							e4976	10.1371/journal.pone.0004976	http://dx.doi.org/10.1371/journal.pone.0004976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PG	19305510	Green Submitted, Green Published, gold			2022-12-25	WOS:000265498800018
J	Carthagena, L; Bergamaschi, A; Luna, JM; David, A; Uchil, PD; Margottin-Goguet, F; Mothes, W; Hazan, U; Transy, C; Pancino, G; Nisole, S				Carthagena, Laetitia; Bergamaschi, Anna; Luna, Joseph M.; David, Annie; Uchil, Pradeep D.; Margottin-Goguet, Florence; Mothes, Walther; Hazan, Uriel; Transy, Catherine; Pancino, Gianfranco; Nisole, Sebastien			Human TRIM Gene Expression in Response to Interferons	PLOS ONE			English	Article								Background: Tripartite motif (TRIM) proteins constitute a family of proteins that share a conserved tripartite architecture. The recent discovery of the anti-HIV activity of TRIM5 alpha in primate cells has stimulated much interest in the potential role of TRIM proteins in antiviral activities and innate immunity. Principal Findings: To test if TRIM genes are up-regulated during antiviral immune responses, we performed a systematic analysis of TRIM gene expression in human primary lymphocytes and monocyte-derived macrophages in response to interferons (IFNs, type I and II) or following Fc gamma R-mediated activation of macrophages. We found that 27 of the 72 human TRIM genes are sensitive to IFN. Our analysis identifies 9 additional TRIM genes that are up-regulated by IFNs, among which only 3 have previously been found to display an antiviral activity. Also, we found 2 TRIM proteins, TRIM9 and 54, to be specifically up-regulated in Fc gamma R-activated macrophages. Conclusions: Our results present the first comprehensive TRIM gene expression analysis in primary human immune cells, and suggest the involvement of additional TRIM proteins in regulating host antiviral activities.	[Carthagena, Laetitia; Margottin-Goguet, Florence; Hazan, Uriel; Transy, Catherine; Nisole, Sebastien] Univ Paris 05, Inst Cochin, CNRS, Dept Malad Infect,UMR 8104, Paris, France; [Carthagena, Laetitia; Margottin-Goguet, Florence; Hazan, Uriel; Transy, Catherine; Nisole, Sebastien] INSERM, U567, Paris, France; [Bergamaschi, Anna; David, Annie; Pancino, Gianfranco] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Luna, Joseph M.; Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Sect Microb Pathogenesis, New Haven, CT 06520 USA; [Hazan, Uriel; Nisole, Sebastien] Univ Paris 07, UFR Sci Vivant, F-75221 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; UDICE-French Research Universities; Universite Paris Cite	Carthagena, L (corresponding author), Univ Paris 05, Inst Cochin, CNRS, Dept Malad Infect,UMR 8104, Paris, France.	sebastien.nisole@inserm.fr	Nisole, Sébastien/ABA-2367-2021; Margottin-Goguet, Florence/F-9272-2013; Pancino, Gianfranco/A-5519-2010	Nisole, Sébastien/0000-0001-9793-419X; Margottin-Goguet, Florence/0000-0002-3124-6690; Luna, Joseph/0000-0003-2415-9203; Uchil, Pradeep/0000-0002-7236-858X	Sidaction; Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS)	Sidaction; Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by grants from Sidaction and from Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; BERGAMINI A, 1994, BLOOD, V84, P3405; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dauffy J, 2006, J LEUKOCYTE BIOL, V79, P173, DOI 10.1189/jlb.0205083; David A, 2006, J IMMUNOL, V177, P6291, DOI 10.4049/jimmunol.177.9.6291; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; LAVAU C, 1995, ONCOGENE, V11, P871; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyer M, 2003, TISSUE ANTIGENS, V61, P63, DOI 10.1034/j.1399-0039.2003.610105.x; Nakasato N, 2006, BIOCHEM BIOPH RES CO, V351, P540, DOI 10.1016/j.bbrc.2006.10.061; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Orimo A, 2000, GENOMICS, V69, P143, DOI 10.1006/geno.2000.6318; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perez-Bercoff D, 2003, J VIROL, V77, P4081, DOI 10.1128/JVI.77.7.4081-4094.2003; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rhodes DA, 2002, IMMUNOLOGY, V106, P246, DOI 10.1046/j.1365-2567.2002.01417.x; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Stadler M, 1995, ONCOGENE, V11, P2565; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Taylor MW, 2004, J INTERF CYTOK RES, V24, P107, DOI 10.1089/107999004322813354; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Zhang Z, 2006, INT J INF TECH DECIS, V5, P353, DOI 10.1142/S0219622006001976; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	60	194	205	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4894	10.1371/journal.pone.0004894	http://dx.doi.org/10.1371/journal.pone.0004894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290053	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496500009
J	Scholz, J; Triantafyllou, C; Whitfield-Gabrieli, S; Brown, EN; Saxe, R				Scholz, Jonathan; Triantafyllou, Christina; Whitfield-Gabrieli, Susan; Brown, Emery N.; Saxe, Rebecca			Distinct Regions of Right Temporo-Parietal Junction Are Selective for Theory of Mind and Exogenous Attention	PLOS ONE			English	Article							BRAIN; FMRI; THINKING; ANATOMY; TASKS; MRI	In functional magnetic resonance imaging (fMRI) studies, a cortical region in the right temporo-parietal junction (RTPJ) is recruited when participants read stories about people's thoughts ('Theory of Mind'). Both fMRI and lesion studies suggest that a region near the RTPJ is associated with attentional reorienting in response to an unexpected stimulus. Do Theory of Mind and attentional reorienting recruit a single population of neurons, or are there two neighboring but distinct neural populations in the RTPJ? One recent study compared these activations, and found evidence consistent with a single common region. However, the apparent overlap may have been due to the low resolution of the previous technique. We tested this hypothesis using a high-resolution protocol, within-subjects analyses, and more powerful statistical methods. Strict conjunction analyses revealed that the area of overlap was small and on the periphery of each activation. In addition, a bootstrap analysis identified a reliable 6-10 mm spatial displacement between the peak activations of the two tasks; the same magnitude and direction of displacement was observed in within-subjects comparisons. In all, these results suggest that there are neighboring but distinct regions within the RTPJ implicated in Theory of Mind and orienting attention.	[Scholz, Jonathan] Georgia Inst Technol, Sch Comp Sci, Atlanta, GA 30332 USA; [Triantafyllou, Christina; Whitfield-Gabrieli, Susan; Brown, Emery N.; Saxe, Rebecca] Massachusetts Inst Technol, Dept Brain & Cognitive Sci, Cambridge, MA 02139 USA	University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT)	Scholz, J (corresponding author), Georgia Inst Technol, Sch Comp Sci, Atlanta, GA 30332 USA.	saxe@mit.edu	Triantafyllou, Christina/E-7724-2011	Lauwereyns, Jan/0000-0003-0551-2550	John Merck fellowship; Ellison Medical Foundation; Packard Foundation; Simons Foundation;  [R01 DA015644]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015644] Funding Source: NIH RePORTER	John Merck fellowship; Ellison Medical Foundation(Lawrence Ellison Foundation); Packard Foundation(The David & Lucile Packard Foundation); Simons Foundation; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RS was supported by a John Merck fellowship and grants from the Ellison Medical Foundation, the Packard Foundation and the Simons Foundation. EB was supported by R01 DA015644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffermann WF, 2002, NEUROIMAGE, V17, P583, DOI 10.1006/nimg.2002.1223; BAKER N, 2004, J VISION, V4, P88; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Huettel SA, 2004, CEREB CORTEX, V14, P165, DOI 10.1093/cercor/bhg115; Lutcke H, 2008, CEREB CORTEX, V18, P508, DOI 10.1093/cercor/bhm090; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Pajevic S, 2003, J MAGN RESON, V161, P1, DOI 10.1016/S1090-7807(02)00178-7; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Perner J, 2006, SOC NEUROSCI-UK, V1, P245, DOI 10.1080/17470910600989896; POSNER MI, 1984, J NEUROSCI, V4, P1863; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Tibshirani R.J., 1993, MONOGRAPHS STAT APPL, VVolume 57, P1; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; ZAIICHIK D, 1990, COGNITION, V35, P41	25	158	158	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4869	10.1371/journal.pone.0004869	http://dx.doi.org/10.1371/journal.pone.0004869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OJ	19290043	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496500006
J	Koseska, A; Zaikin, A; Kurths, J; Garcia-Ojalvo, J				Koseska, Aneta; Zaikin, Alexey; Kurths, Juergen; Garcia-Ojalvo, Jordi			Timing Cellular Decision Making Under Noise via Cell-Cell Communication	PLOS ONE			English	Article							COHERENCE RESONANCE; SYSTEM; AMPLIFICATION; CLOCK	Many cellular processes require decision making mechanisms, which must act reliably even in the unavoidable presence of substantial amounts of noise. However, the multistable genetic switches that underlie most decision-making processes are dominated by fluctuations that can induce random jumps between alternative cellular states. Here we show, via theoretical modeling of a population of noise-driven bistable genetic switches, that reliable timing of decision-making processes can be accomplished for large enough population sizes, as long as cells are globally coupled by chemical means. In the light of these results, we conjecture that cell proliferation, in the presence of cell-cell communication, could provide a mechanism for reliable decision making in the presence of noise, by triggering cellular transitions only when the whole cell population reaches a certain size. In other words, the summation performed by the cell population would average out the noise and reduce its detrimental impact.	[Koseska, Aneta; Kurths, Juergen] Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany; [Zaikin, Alexey] UCL, Dept Math, London WC1E 6BT, England; [Zaikin, Alexey] UCL, Inst Women Hlth, London WC1E 6BT, England; [Kurths, Juergen] Humboldt Univ, Inst Phys, D-1086 Berlin, Germany; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis Engn Nuclear, Terrassa, Spain	University of Potsdam; University of London; University College London; University of London; University College London; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung; Universitat Politecnica de Catalunya	Koseska, A (corresponding author), Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany.	alexey.zaikin@ucl.ac.uk	Zaikin, Alexey/T-7171-2019; Zaikin, Alexey/K-6581-2017; Garcia-Ojalvo, Jordi/A-4574-2009	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Garcia-Ojalvo, Jordi/0000-0002-3716-7520	Federal Ministry of Education and Research [0313924]; VW-foundation; CESCA-CEPBA through European ACCESS programm; Ministerio de Educacion y Ciencia Spain [FIS2006-11452]; European Commission (GABA project); Ministerio de Ciencia e Innovacion (Spain); EU through the Network of Excellence BioSim [LSHB-CT-2004-005137]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); VW-foundation(Volkswagen); CESCA-CEPBA through European ACCESS programm; Ministerio de Educacion y Ciencia Spain(Spanish Government); European Commission (GABA project)(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU through the Network of Excellence BioSim	A.K. and J.K. acknowledge the GoFORSYS project funded by the Federal Ministry of Education and Research, Grant Nr. 0313924, A.Z. acknowledges financial support from VW-foundation and CESCA-CEPBA through European ACCESS programm, J.G.O. from the Ministerio de Educacion y Ciencia (Spain, project FIS2006-11452), the European Commission (GABA project), and the I3 program of the Ministerio de Ciencia e Innovacion (Spain), and J.K. from the EU through the Network of Excellence BioSim, Contract No. LSHB-CT-2004-005137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ENRIGHT JT, 1980, SCIENCE, V209, P1542, DOI 10.1126/science.7433976; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbach M, 2008, PHYSICA D, V237, P316, DOI 10.1016/j.physd.2007.09.004; Jung P, 2001, EUROPHYS LETT, V56, P29, DOI 10.1209/epl/i2001-00483-y; Koseska A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031916; Kuznetsov A, 2005, SIAM J APPL MATH, V65, P392, DOI 10.1137/S0036139903436029; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Pikovsky A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.050601; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schmid G, 2001, EUROPHYS LETT, V56, P22, DOI 10.1209/epl/i2001-00482-6; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Tanouchi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000167; Toral R, 2003, EUROPHYS LETT, V61, P162, DOI 10.1209/epl/i2003-00207-5; Wang MS, 2004, CHEMPHYSCHEM, V5, P1602, DOI 10.1002/cphc.200400255; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	25	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4872	10.1371/journal.pone.0004872	http://dx.doi.org/10.1371/journal.pone.0004872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283068	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496300010
J	Kron, K; Pethe, V; Briollais, L; Sadikovic, B; Ozcelik, H; Sunderji, A; Venkateswaran, V; Pinthus, J; Fleshner, N; van der Kwast, T; Bapat, B				Kron, Ken; Pethe, Vaijayanti; Briollais, Laurent; Sadikovic, Bekim; Ozcelik, Hilmi; Sunderji, Alia; Venkateswaran, Vasundara; Pinthus, Jehonathan; Fleshner, Neil; van der Kwast, Theodorus; Bapat, Bharati			Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays	PLOS ONE			English	Article								Background: Promoter and 59 end methylation regulation of tumour suppressor genes is a common feature of many cancers. Such occurrences often lead to the silencing of these key genes and thus they may contribute to the development of cancer, including prostate cancer. Methodology/Principal Findings: In order to identify methylation changes in prostate cancer, we performed a genome-wide analysis of DNA methylation using Agilent human CpG island arrays. Using computational and gene-specific validation approaches we have identified a large number of potential epigenetic biomarkers of prostate cancer. Further validation of candidate genes on a separate cohort of low and high grade prostate cancers by quantitative MethyLight analysis has allowed us to confirm DNA hypermethylation of HOXD3 and BMP7, two genes that may play a role in the development of high grade tumours. We also show that promoter hypermethylation is responsible for downregulated expression of these genes in the DU-145 PCa cell line. Conclusions/Significance: This study identifies novel epigenetic biomarkers of prostate cancer and prostate cancer progression, and provides a global assessment of DNA methylation in prostate cancer.	[Kron, Ken; Pethe, Vaijayanti; Briollais, Laurent; Ozcelik, Hilmi; Sunderji, Alia; Bapat, Bharati] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Sunderji, Alia; Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Sadikovic, Bekim] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON, Canada; [Venkateswaran, Vasundara] Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON, Canada; [Pinthus, Jehonathan] McMaster Univ, Dept Surg, Div Urol, Hamilton, ON L8S 4L8, Canada; [Fleshner, Neil] Univ Toronto, Univ Hlth Network, Dept Surg, Div Urol, Toronto, ON, Canada; [van der Kwast, Theodorus] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Bapat, Bharati] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Kron, K (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	BAPAT@lunenfeld.ca	Pinthus, Jehonathan/AAQ-1667-2021; Briollais, Laurent/A-2941-2013; Ozcelik, Hilmi/A-3952-2011; Bapat, Bharati/B-5839-2014	Van der Kwast, Theodorus/0000-0001-8640-5786	Canadian Prostate Cancer Research Initiative, National Cancer Institute of Canada [18568]; Ontario Student Opportunity Trust Fund; Scace Prostate Cancer Fellowship	Canadian Prostate Cancer Research Initiative, National Cancer Institute of Canada; Ontario Student Opportunity Trust Fund; Scace Prostate Cancer Fellowship	Canadian Prostate Cancer Research Initiative, National Cancer Institute of Canada (#18568). Ontario Student Opportunity Trust Fund, Scace Prostate Cancer Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bryzgunova OE, 2008, ANN NY ACAD SCI, V1137, P222, DOI 10.1196/annals.1448.039; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Hadnagy A, 2008, MOL CANCER THER, V7, P740, DOI 10.1158/1535-7163.MCT-07-2284; Hamada J, 2001, INT J CANCER, V93, P516, DOI 10.1002/ijc.1357; HERMAN JG, 1995, CANCER RES, V55, P4525; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li LC, 2005, JNCI-J NATL CANCER I, V97, P103, DOI 10.1093/jnci/dji010; Lopez-Beltran A, 2006, VIRCHOWS ARCH, V448, P111, DOI 10.1007/s00428-005-0102-4; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Mehrotra J, 2008, PROSTATE, V68, P152, DOI 10.1002/pros.20675; Meiers I, 2007, PATHOLOGY, V39, P299, DOI 10.1080/00313020701329906; Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415; Miyazaki YJ, 2002, ONCOGENE, V21, P798, DOI 10.1038/sj.onc.1205126; Okubo Y, 2002, CLIN EXP METASTAS, V19, P503, DOI 10.1023/A:1020346211686; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rodriguez BAT, 2008, CARCINOGENESIS, V29, P1459, DOI 10.1093/carcin/bgn115; Sadikovic B, 2008, J BIOL CHEM, V283, P4051, DOI 10.1074/jbc.M707506200; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; TANIGUCHI Y, 1995, BLOOD, V85, P2786, DOI 10.1182/blood.V85.10.2786.bloodjournal85102786; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yan PS, 2001, CANCER RES, V61, P8375; YANG YH, 2001, NORMALIZATION CDNA M, P141; Ye L, 2008, UROL ONCOL-SEMIN ORI, V26, P190, DOI 10.1016/j.urolonc.2007.03.027; Yu F, 2000, NUCLEIC ACIDS RES, V28, P2201, DOI 10.1093/nar/28.10.2201	44	68	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2009	4	3							e4830	10.1371/journal.pone.0004830	http://dx.doi.org/10.1371/journal.pone.0004830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OH	19283074	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496300008
J	Nguyen, TH; Mai, NL; Le, TP; Ha, V; Nguyen, TC; Tran, TH; Nguyen, TH; Farrar, JJ; Dunstan, SJ				Nguyen Thi Hue; Mai Ngoc Lanh; Le Thi Phuong; Ha Vinh; Nguyen Tran Chinh; Tran Tinh Hien; Nguyen T. Hieu; Farrar, Jeremy J.; Dunstan, Sarah J.			Toll-Like Receptor 4 (TLR4) and Typhoid Fever in Vietnam	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENETIC-CONTROL; SUSCEPTIBILITY; MUTATIONS; INNATE; LIPOPOLYSACCHARIDE; ASSOCIATION; FAMILY; MICE; DISEASE	Understanding the host genetic susceptibility to typhoid fever may provide a better understanding of pathogenesis and help in the development of new therapeutics and vaccines. Here we determine the genetic variation within the human TLR4 gene encoding the principal receptor for bacterial endotoxin recognition in typhoid fever patients. It is possible that genetic variants of TLR4 could detrimentally affect the innate immune response against S. typhi infection. Mutation detection and genotyping of TLR4 was performed on DNA from 414 Vietnamese typhoid fever patients and 372 population controls. dHPLC detected a total of 10 polymorphisms within the upstream and exonic regions of TLR4, of which 7 are novel. Two SNPs, T4025A and C4215G, were more frequent in typhoid cases than in controls however due to their low allele frequencies they showed borderline significance (T4025A: OR 1.9, 95% CI 0.9-4.3, P 0.07 and C4215G: OR 6.7, 95% CI 0.8-307, P 0.04). Six missense mutations were identified, with 5/6 positioned in the ectoplasmic domain. Four missense mutations and one promoter SNP (A-271G) were only present in typhoid cases, albeit at low allele frequencies. Here we determined the extent of genetic variation within TLR4 in a Vietnamese population and suggest that TLR4 may be involved in defense against typhoid fever in this population.	[Nguyen Thi Hue; Farrar, Jeremy J.; Dunstan, Sarah J.] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nguyen Thi Hue; Ha Vinh; Nguyen Tran Chinh; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Mai Ngoc Lanh; Le Thi Phuong] Dong Thap Provinc Hosp, Dong Thap, Vietnam; [Farrar, Jeremy J.; Dunstan, Sarah J.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX1 2JD, England; [Nguyen T. Hieu] Hung Vuong Hosp, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Nguyen, TH (corresponding author), Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.	sdunstan@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Dunstan, Sarah/AAO-9597-2020	Farrar, Jeremy/0000-0002-2700-623X; Dunstan, Sarah/0000-0001-7873-933X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	The Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allen A, 2003, PEDIATR INFECT DIS J, V22, P1018, DOI 10.1097/01.inf.0000095431.15606.68; Ameziane N, 2003, ARTERIOSCL THROM VAS, V23, pE61, DOI 10.1161/01.ATV.0000101191.92392.1D; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Bernheiden M, 2001, J ENDOTOXIN RES, V7, P447, DOI 10.1179/096805101101533061; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Child NJA, 2003, BIOCHEM SOC T, V31, P652, DOI 10.1042/bst0310652; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Dunstan SJ, 2005, J INFECT DIS, V191, P1068, DOI 10.1086/428593; Dunstan SJ, 2001, J INFECT DIS, V183, P261, DOI 10.1086/317940; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Gibbs R, 2005, NATURE, V437, P1233, DOI 10.1038/4371233a; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Nishiya T, 2006, BIOCHEM BIOPH RES CO, V341, P1128, DOI 10.1016/j.bbrc.2006.01.074; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Smirnova I, 2001, GENETICS, V158, P1657; Smirnova I, 2000, GENOME BIOL, V1; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463	47	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4800	10.1371/journal.pone.0004800	http://dx.doi.org/10.1371/journal.pone.0004800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277200	gold, Green Published			2022-12-25	WOS:000265496100019
J	Gorlovoy, P; Larionov, S; Pham, TTH; Neumann, H				Gorlovoy, Philipp; Larionov, Sergey; Pham, Thao Thi Hien; Neumann, Harald			Accumulation of tau induced in neurites by microglial proinflammatory mediators	FASEB JOURNAL			English	Article						neuroinflammation; neurodegeneration; cytokines; tumor necrosis factor-alpha; Alzheimer disease	LIFETIME IMAGING MICROSCOPY; PAIRED HELICAL FILAMENTS; ACTIVATED PROTEIN-KINASE; AMYLOID-BETA PROTEIN; N-TERMINAL KINASE; ALZHEIMERS-DISEASE; MOUSE MODEL; TNF-ALPHA; NEURODEGENERATIVE DISEASE; FLUORESCENT PROTEINS	Aggregated fibrillary microtubule-associated protein tau is the major component of neurofibrillary tangles in Alzheimer's disease. The exact molecular mechanism of tau aggregation is unknown. Microglial cell activation and migration toward amyloid-beta plaques precede the appearance of dysmorphic neurites and formation of neurofibrillary tangles. Here, we analyzed the accumulation of tau at a distance range of expected spontaneous aggregation by fluorescence lifetime-based Forster resonance energy transfer in cultured primary murine neurons cotransfected with the human tau gene tagged to the green fluorescent protein variants Citrine (tau-Citrine) and Cerulean (tau-Cerulean). No spontaneous accumulation of cotransfected tau-Citrine and tau-Cerulean was detected in untreated neurons. Coculture of neurons with activated microglia induced aggregation of tau in neurites. Treatment of neurons with tumor necrosis factor-alpha (TNF-alpha) stimulated reactive oxygen species generation and resulted in the accumulation of tau-Citrine and tau-Cerulean in neurites, which was inhibited by neutralization of TNF and the free radical inhibitor 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox). These data demonstrate that activated microglia and the microglial-derived proinflammatory cytokine TNF can induce accumulation of the aggregation-prone tau molecules in neurites via reactive oxygen species.-Gorlovoy, P., Larionov, S., Pham, T. T. H., Neumann, H. Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J. 23, 2502-2513 (2009)	[Neumann, Harald] Univ Bonn, Neural Regenerat Unit, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; Hertie Fdn, Bonn, Germany	University of Bonn	Neumann, H (corresponding author), Univ Bonn, Neural Regenerat Unit, Inst Reconstruct Neurobiol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	hneuman1@uni-bonn.de	Neumann, Harald/A-9718-2010	Neumann, Harald/0000-0002-5071-5202	Hertie-Foundation; Walter-und-Ilse-Rose-Foundation; Deutsche Forschungsgemeinschaft [SFB704, KFO177]; European Union (NeuroproMiSe)	Hertie-Foundation; Walter-und-Ilse-Rose-Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (NeuroproMiSe)(European Commission)	We thank O. Brustle for general support. We thank Dr. A. Moussif for technical advice and C. Frank, J. Schumacher, and R. Hass for excellent technical support of cell cultures and molecular biology. We also thank Dr. D. Piston (Vanderbilt University Medical Center, Nashville, TN, USA) for Cerulean, Dr. O. Griesbeck (Max Planck Institute of Neurobiology, Munich, Germany) for Citrine, and Dr. E. Ponimaskin (University Gottingen, Gottingen, Germany) for N1E-115 neuroblastoma cell line. The Neural Regeneration Group at the University Bonn is supported by the Hertie-Foundation and Walter-und-Ilse-Rose-Foundation. This project was supported by the Deutsche Forschungsgemeinschaft (SFB704, KFO177) and the European Union (NeuroproMiSe).	Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Behl C, 1999, PROG NEUROBIOL, V57, P301, DOI 10.1016/S0301-0082(98)00055-0; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; Combs CK, 2001, J NEUROSCI, V21, P1179; Dawson HN, 2001, J CELL SCI, V114, P1179; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Forster T., 1965, MODERN QUANTUM CHEM, V3, P93; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hoffmann B, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937829; Horiguchi T, 2003, AM J PATHOL, V163, P1021, DOI 10.1016/S0002-9440(10)63462-1; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ibi M, 2006, FREE RADICAL BIO MED, V40, P1785, DOI 10.1016/j.freeradbiomed.2006.01.009; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li R, 2004, J NEUROSCI, V24, P1760, DOI 10.1523/JNEUROSCI.4580-03.2004; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Mrak RE, 2007, J NEUROPATH EXP NEUR, V66, P683, DOI 10.1097/nen.0b013e31812503e1; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Walsh DT, 2005, NEUROPATH APPL NEURO, V31, P491, DOI 10.1111/j.1365-2990.2005.00666.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	53	102	108	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2009	23	8					2502	2513		10.1096/fj.08-123877	http://dx.doi.org/10.1096/fj.08-123877			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UE	19289607				2022-12-25	WOS:000268836700018
J	Manolaridis, I; Mumtsidu, E; Konarev, P; Makhov, AM; Fullerton, SW; Sinz, A; Kalkhof, S; McGeehan, JE; Cary, PD; Griffith, JD; Svergun, D; Kneale, GG; Tucker, PA				Manolaridis, Ioannis; Mumtsidu, Eleni; Konarev, Peter; Makhov, Alexander M.; Fullerton, Stephen W.; Sinz, Andrea; Kalkhof, Stefan; McGeehan, John E.; Cary, Peter D.; Griffith, Jack D.; Svergun, Dmitri; Kneale, Geoff G.; Tucker, Paul A.			Structural and Biophysical Characterization of the Proteins Interacting with the Herpes Simplex Virus 1 Origin of Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; SINGLE-STRANDED-DNA; RAY SOLUTION SCATTERING; TYPE-1 UL9 PROTEIN; I ORIGIN; VIRAL ORIGIN; BOX I; BIOLOGICAL MACROMOLECULES; TRIPHOSPHATASE-ACTIVITY; ICP8	The C terminus of the herpes simplex virus type 1 origin-binding protein, UL9ct, interacts directly with the viral single-stranded DNA-binding protein ICP8. We show that a 60-amino acid C-terminal deletion mutant of ICP8 (ICP8 Delta C) also binds very strongly to UL9ct. Using small angle x-ray scattering, the low resolution solution structures of UL9ct alone, in complex with ICP8 Delta C, and in complex with a 15-mer double-stranded DNA containing Box I of the origin of replication are described. Size exclusion chromatography, analytical ultracentrifugation, and electrophoretic mobility shift assays, backed up by isothermal titration calorimetry measurements, are used to show that the stoichiometry of the UL9ct-dsDNA(15-mer) complex is 2: 1 at micromolar protein concentrations. The reaction occurs in two steps with initial binding of UL9ct to DNA (K-d similar to 6 nM) followed by a second binding event (K-d similar to 0.8 nM). It is also shown that the stoichiometry of the ternary UL9ct-ICP8 Delta C-dsDNA(15-mer) complex is 2: 1: 1, at the concentrations used in the different assays. Electron microscopy indicates that the complex assembled on the extended origin, oriS, rather than Box I alone, is much larger. The results are consistent with a simple model whereby a conformational switch of the UL9 DNA-binding domain upon binding to Box I allows the recruitment of a UL9-ICP8 complex by interaction between the UL9 DNA-binding domains.	[Manolaridis, Ioannis; Mumtsidu, Eleni; Konarev, Peter; Fullerton, Stephen W.; Svergun, Dmitri; Tucker, Paul A.] European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Manolaridis, Ioannis; McGeehan, John E.; Cary, Peter D.; Kneale, Geoff G.] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England; [Makhov, Alexander M.; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sinz, Andrea; Kalkhof, Stefan] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany; [Konarev, Peter; Svergun, Dmitri] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	European Molecular Biology Laboratory (EMBL); University of Portsmouth; University of North Carolina; University of North Carolina Chapel Hill; Martin Luther University Halle Wittenberg; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Tucker, PA (corresponding author), European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	tucker@embl-hamburg.de	Kalkhof, Stefan/Z-2000-2019; Konarev, Petr V/W-1380-2017	Kalkhof, Stefan/0000-0001-6121-7105; McGeehan, John/0000-0002-6750-1462; Svergun, Dmitri/0000-0003-0830-5696; Konarev, Petr/0000-0002-5606-1596	European Union [LSHG-CT-2004-S11960]; National Institutes of Health [GM31819, CA19014]; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by contract LSHG-CT-2004-S11960 from the European Union Integrated Project "VIZIER."; We thank the staff of EMBL-SAXS group for support and for access to the X33 beamline and Borries Demeler for invaluable advice on the interpretation of the analytical ultracentrifugation measurements. We thank Luminita Damian for help in ITC data analysis and interpretation. Electron microscopic work was supported by National Institutes of Health Grants GM31819 and CA19014 to J. D. Griffith, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.	Arana ME, 2001, J BIOL CHEM, V276, P6840, DOI 10.1074/jbc.M007219200; Aslani A, 2000, J BIOL CHEM, V275, P5880, DOI 10.1074/jbc.275.8.5880; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Aslani A, 2001, P NATL ACAD SCI USA, V98, P7194, DOI 10.1073/pnas.121177198; Boehmer PE, 1998, J BIOL CHEM, V273, P2676, DOI 10.1074/jbc.273.5.2676; BOEHMER PE, 1993, J BIOL CHEM, V268, P1220; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DODSON MS, 1993, J BIOL CHEM, V268, P1213; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P80; ELIAS P, 1992, J BIOL CHEM, V267, P17424; FIERER DS, 1995, J BIOL CHEM, V270, P7330, DOI 10.1074/jbc.270.13.7330; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hammarsten O, 1997, NUCLEIC ACIDS RES, V25, P1753, DOI 10.1093/nar/25.9.1753; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; KOFF A, 1991, J VIROL, V65, P3284, DOI 10.1128/JVI.65.6.3284-3292.1991; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE CK, 1985, J VIROL, V54, P731, DOI 10.1128/JVI.54.3.731-738.1985; Lee SSK, 1999, J BIOL CHEM, V274, P18613, DOI 10.1074/jbc.274.26.18613; Lee SSK, 1997, P NATL ACAD SCI USA, V94, P2838, DOI 10.1073/pnas.94.7.2838; Macao B, 2004, J BIOL CHEM, V279, P29211, DOI 10.1074/jbc.M400371200; Makhov AM, 1996, J MOL BIOL, V258, P789, DOI 10.1006/jmbi.1996.0287; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; Mapelli M, 2005, J BIOL CHEM, V280, P2990, DOI 10.1074/jbc.M406780200; MARTIN DW, 1994, J VIROL, V68, P3674, DOI 10.1128/JVI.68.6.3674-3681.1994; MCLEAN GW, 1994, J GEN VIROL, V75, P2699, DOI 10.1099/0022-1317-75-10-2699; Monahan SJ, 1998, VIROLOGY, V241, P122, DOI 10.1006/viro.1997.8953; Murata LB, 1999, J BIOL CHEM, V274, P37079, DOI 10.1074/jbc.274.52.37079; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G, 1982, GEN THEORY SMALL ANG, P17; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; STABELL EC, 1993, NUCLEIC ACIDS RES, V21, P5203, DOI 10.1093/nar/21.22.5203; Stow ND, 1998, VIROLOGY, V240, P183, DOI 10.1006/viro.1997.8910; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; WONG SW, 1991, J VIROL, V65, P2601, DOI 10.1128/JVI.65.5.2601-2611.1991	52	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16343	16353		10.1074/jbc.M806134200	http://dx.doi.org/10.1074/jbc.M806134200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19329432	Green Published, hybrid			2022-12-25	WOS:000266730900032
J	Liu, XJ; Bellamy, COC; Bailey, MA; Mullins, LJ; Dunbar, DR; Kenyon, CJ; Brooker, G; Kantachuvesiri, S; Maratou, K; Ashek, A; Clark, AF; Fleming, S; Mullins, JJ				Liu, Xiaojun; Bellamy, Christopher O. C.; Bailey, Matthew A.; Mullins, Linda J.; Dunbar, Donald R.; Kenyon, Christopher J.; Brooker, Gillian; Kantachuvesiri, Surasak; Maratou, Klio; Ashek, Ali; Clark, Allan F.; Fleming, Stewart; Mullins, John J.			Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYP1A1-REN2 TRANSGENIC RATS; DEPENDENT MALIGNANT HYPERTENSION; TERMINAL CATALYTIC DOMAIN; ASP-LYS-PRO; BLOOD-PRESSURE; PHASE HYPERTENSION; NITRIC-OXIDE; AC-SDKP; GENE; TGR(MREN2)27	Severe forms of hypertension are characterized by high blood pressure combined with end organ damage. Through the development and refinement of a transgenic rat model of malignant hypertension incorporating the mouse renin gene, we previously identified a quantitative trait locus on chromosome 10, which affects malignant hypertension severity and morbidity. We next generated an inducible malignant hypertensive model where the timing, severity, and duration of hypertension was placed under the control of the researcher, allowing development of and recovery from end organ damage to be investigated. We have now generated novel consomic Lewis and Fischer rat strains with inducible hypertension and additional strains that are reciprocally congenic for the refined chromosome 10 quantitative trait locus. We have captured a modifier of end organ damage within the congenic region and, using a range of bioinformatic, biochemical and molecular biological techniques, have identified angiotensin-converting enzyme as the modifier of hypertension-induced tissue microvascular injury. Reciprocal differences between angiotensin-converting enzyme and the anti-inflammatory tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro in the kidney, a tissue susceptible to end organ damage, suggest a mechanism for the amelioration of hypertension-dependent damage.	[Liu, Xiaojun; Bailey, Matthew A.; Mullins, Linda J.; Dunbar, Donald R.; Kenyon, Christopher J.; Brooker, Gillian; Ashek, Ali; Clark, Allan F.; Mullins, John J.] Univ Edinburgh, Mol Physiol Lab, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Bellamy, Christopher O. C.] Royal Edinburgh Infirm, Dept Pathol, Edinburgh EH16 4SA, Midlothian, Scotland; [Kantachuvesiri, Surasak] Mahidol Univ, Bangkok 10400, Thailand; [Maratou, Klio] Hammersmith Hosp, Ctr Clin Sci, MRC, London W12 ONN, England; [Fleming, Stewart] Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; Mahidol University; Imperial College London; University of Dundee	Mullins, JJ (corresponding author), Univ Edinburgh, Mol Physiol Lab, Ctr Cardiovasc Sci, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	j.mullins@ed.ac.uk	Bailey, Matthew A./AAH-3395-2020; Dunbar, Donald R/A-7093-2012	Bailey, Matthew A./0000-0003-4244-5668; Mullins, Linda/0000-0002-6743-8707; Maratou, Klio/0000-0001-6061-2322	Kidney Research UK; Wellcome Trust [WTO53646]; EURATools consortium; MRC [G0701528] Funding Source: UKRI; Medical Research Council [G0701528, G9900991B] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Wellcome Trust(Wellcome TrustEuropean Commission); EURATools consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Kidney Research UK( formerly National Kidney Research Fund) award ( to J. M. and S. F.), Wellcome Trust Programme Grant WTO53646, the Wellcome Trust Cardiovascular Research and Functional Genomics initiatives, and the EURATools consortium.	Bader M, 1996, CLIN EXP PHARMACOL P, V23, pS81, DOI 10.1111/j.1440-1681.1996.tb02818.x; Bailey MA, 1998, AM J PHYSIOL-RENAL, V275, pF878, DOI 10.1152/ajprenal.1998.275.6.F878; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Cavasin MA, 2007, HYPERTENSION, V50, P130, DOI 10.1161/HYPERTENSIONAHA.106.084103; Challah M, 1998, ARTERIOSCL THROM VAS, V18, P235, DOI 10.1161/01.ATV.18.2.235; Collidge TA, 2004, PROG BIOPHYS MOL BIO, V84, P301, DOI 10.1016/j.pbiomolbio.2003.11.003; Edmunds E, 2000, J HUM HYPERTENS, V14, P159, DOI 10.1038/sj.jhh.1000967; Engler S, 1998, REGUL PEPTIDES, V77, P3, DOI 10.1016/S0167-0115(98)00120-7; Espinel Eugenia, 2005, J Clin Hypertens (Greenwich), V7, P11, DOI 10.1111/j.1524-6175.2005.03879.x; Evans RG, 2004, J HYPERTENS, V22, P1439, DOI 10.1097/01.hjh.0000133744.85490.9d; Fleming S, 2000, J PATHOL, V192, P135; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Graciano ML, 2007, AM J PHYSIOL-RENAL, V292, pF1858, DOI 10.1152/ajprenal.00469.2006; Howard LL, 2005, AM J PHYSIOL-RENAL, V288, pF810, DOI 10.1152/ajprenal.00148.2004; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Iwai N, 1999, CIRCULATION, V100, P1923, DOI 10.1161/01.CIR.100.18.1923; Jafarian-Tehrani M, 2000, MOL MED, V6, P319, DOI 10.1007/BF03401940; Kantachuvesiri S, 1999, KIDNEY INT, V56, P414, DOI 10.1046/j.1523-1755.1999.00571.x; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Kincaid-Smith P, 1981, Aust N Z J Med, V11, P64, DOI 10.1111/j.1445-5994.1981.tb03564.x; Krege JH, 1997, HYPERTENSION, V29, P150, DOI 10.1161/01.HYP.29.1.150; Langheinrich M, 1996, AM J HYPERTENS, V9, P506, DOI 10.1016/0895-7061(95)00400-9; Lee MA, 1996, AM J PHYSIOL-ENDOC M, V270, pE919, DOI 10.1152/ajpendo.1996.270.6.E919; LIP GYH, 1994, J HYPERTENS, V12, P1297; LIP GYH, 1995, J HYPERTENS, V13, P915, DOI 10.1097/00004872-199508000-00013; Mitchell KD, 2005, AM J PHYSIOL-RENAL, V289, pF1210, DOI 10.1152/ajprenal.00461.2004; Mitchell KD, 2006, J RENIN-ANGIO-ALDO S, V7, P74, DOI 10.3317/jraas.2006.013; Montgomery HE, 1998, J HYPERTENS, V16, P635, DOI 10.1097/00004872-199816050-00011; MORTON JJ, 1983, CLIN SCI, V64, P359, DOI 10.1042/cs0640359; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Opay AL, 2006, AM J PHYSIOL-RENAL, V291, pF612, DOI 10.1152/ajprenal.00032.2006; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF1584, DOI 10.1152/ajprenal.00124.2007; Patterson ME, 2008, AM J PHYSIOL-RENAL, V294, pF205, DOI 10.1152/ajprenal.00150.2007; Patterson ME, 2005, AM J PHYSIOL-RENAL, V289, pF754, DOI 10.1152/ajprenal.00419.2004; Peng HM, 2007, HYPERTENSION, V49, P695, DOI 10.1161/01.HYP.0000258406.66954.4f; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Pool JL, 2000, INT J CLIN PRACT, P4; Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/00004872-200403000-00023; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Stefansson B, 2000, BLOOD PRESSURE, V9, P104, DOI 10.1080/080370500453429; Tian XL, 2003, BIOCHEM PHARMACOL, V66, P1037, DOI 10.1016/S0006-2952(03)00457-X; Wei Y, 2007, HYPERTENSION, V50, P384, DOI 10.1161/HYPERTENSIONAHA.107.089284; Whaley-Connell A, 2007, AM J PHYSIOL-ENDOC M, V293, pE355, DOI 10.1152/ajpendo.00632.2006; WHITWORTH CE, 1994, KIDNEY INT, V46, P1528, DOI 10.1038/ki.1994.437	48	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15564	15572		10.1074/jbc.M806584200	http://dx.doi.org/10.1074/jbc.M806584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19307186	Green Published, hybrid			2022-12-25	WOS:000266501000025
J	Rangaswami, H; Marathe, N; Zhuang, SH; Chen, YC; Yeh, JC; Frangos, JA; Boss, GR; Pilz, RB				Rangaswami, Hema; Marathe, Nisha; Zhuang, Shunhui; Chen, Yongchang; Yeh, Jiunn-Chern; Frangos, John A.; Boss, Gerry R.; Pilz, Renate B.			Type II cGMP-dependent Protein Kinase Mediates Osteoblast Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; REQUIRES NUCLEAR TRANSLOCATION; INCREASES BONE-FORMATION; C-FOS EXPRESSION; GENE-EXPRESSION; CYCLIC-GMP; SIGNAL-TRANSDUCTION; HYPERTROPHIC DIFFERENTIATION; TRANSCRIPTIONAL REGULATION	Continuous bone remodeling in response to mechanical loading is critical for skeletal integrity, and interstitial fluid flow is an important stimulus for osteoblast/osteocyte growth and differentiation. However, the biochemical signals mediating osteoblast anabolic responses to mechanical stimulation are incompletely understood. In primary human osteoblasts and murine MC3T3-E1 cells, we found that fluid shear stress induced rapid expression of c-fos, fra-1, fra-2, and fosB/Delta fosB mRNAs; these genes encode transcriptional regulators that maintain skeletal integrity. Fluid shear stress increased osteoblast nitric oxide (NO) synthesis, leading to activation of cGMP-dependent protein kinase (PKG). Pharmacological inhibition of the NO/cGMP/PKG signaling pathway blocked shear-induced expression of all four fos family genes. Induction of these genes required signaling through MEK/Erk, and Erk activation was NO/cGMP/PKG-dependent. Treating cells with a membrane-permeable cGMP analog partly mimicked the effects of fluid shear stress on Erk activity and fos family gene expression. In cells transfected with small interfering RNAs (siRNA) specific for membrane-bound PKG II, shear- and cGMP-induced Erk activation and fos family gene expression was nearly abolished and could be restored by transducing cells with a virus encoding an siRNA-resistant form of PKG II; in contrast, siRNA-mediated repression of the more abundant cytosolic PKG I isoform was without effect. Thus, we report a novel function for PKG II in osteoblast mechanotransduction, and we propose a model wherebyNO/cGMP/PKGII-mediated Erk activation and induction of c-fos, fra-1, fra-2, and fosB/Delta fosB play a key role in the osteoblast anabolic response to mechanical stimulation.	[Boss, Gerry R.; Pilz, Renate B.] Univ Calif San Diego, Dept Med & Canc Ctr, La Jolla, CA 92093 USA; [Yeh, Jiunn-Chern; Frangos, John A.] La Jolla Bioengn Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; La Jolla Bioengineering Institute	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med & Canc Ctr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300]; Training [T32-HL007261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300, R01AR046797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR051300 (to R. B. P., H. R., S. Z., and J.-C.Y.) and Training Grant T32-HL007261 (to N.M.).	Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Adiseshaiah P, 2003, J BIOL CHEM, V278, P47423, DOI 10.1074/jbc.M303505200; Adiseshaiah P, 2008, BIOCHEM BIOPH RES CO, V371, P304, DOI 10.1016/j.bbrc.2008.04.063; Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6; Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Bergula AP, 2004, BONE, V34, P562, DOI 10.1016/j.bone.2003.11.025; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Broderick KE, 2007, MOL ENDOCRINOL, V21, P1148, DOI 10.1210/me.2005-0389; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chae HJ, 1997, J PHARM PHARMACOL, V49, P897, DOI 10.1111/j.2042-7158.1997.tb06132.x; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Chikuda H, 2005, J BONE MINER METAB, V23, P200, DOI 10.1007/s00774-004-0598-8; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Fitzgerald J, 1999, FASEB J, V13, P553, DOI 10.1096/fasebj.13.3.553; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fox SW, 1996, AM J PHYSIOL-ENDOC M, V270, pE955, DOI 10.1152/ajpendo.1996.270.6.E955; Gallagher JA, 2003, METH MOLEC MED, V80, P3; GAMM DM, 1995, J BIOL CHEM, V270, P27380, DOI 10.1074/jbc.270.45.27380; Gille H, 1996, MOL CELL BIOL, V16, P1094; Granet C, 2002, CELL SIGNAL, V14, P679, DOI 10.1016/S0898-6568(02)00008-6; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Gudi T, 2000, ONCOGENE, V19, P6324, DOI 10.1038/sj.onc.1204007; Gudi T, 1996, J BIOL CHEM, V271, P4597; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Gudi T, 1999, FASEB J, V13, P2143, DOI 10.1096/fasebj.13.15.2143; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hikiji H, 1997, FEBS LETT, V410, P238, DOI 10.1016/S0014-5793(97)00597-8; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Idriss SD, 1999, J BIOL CHEM, V274, P9489, DOI 10.1074/jbc.274.14.9489; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jamal SA, 2004, J BONE MINER RES, V19, P1512, DOI 10.1359/JBMR.040716; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; Jiang GL, 2002, AM J PHYSIOL-ENDOC M, V283, pE383, DOI 10.1152/ajpendo.00547.2001; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Johnson DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE205, DOI 10.1152/ajpendo.1996.271.1.E205; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Klein-Nulend J, 1998, BIOCHEM BIOPH RES CO, V250, P108, DOI 10.1006/bbrc.1998.9270; Kletsas D, 2002, J CELL PHYSIOL, V190, P313, DOI 10.1002/jcp.10052; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; LIAN JB, 1998, J CELL BIOCHEM, V30, pS62; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; MacPherson H, 1999, BONE, V24, P179, DOI 10.1016/S8756-3282(98)00173-2; Mancini L, 2000, BIOCHEM BIOPH RES CO, V274, P477, DOI 10.1006/bbrc.2000.3164; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Moalli MR, 2000, J BONE MINER RES, V15, P1346, DOI 10.1359/jbmr.2000.15.7.1346; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Murakami M, 1999, CELL GROWTH DIFFER, V10, P333; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Peake MA, 2000, J APPL PHYSIOL, V89, P2498, DOI 10.1152/jappl.2000.89.6.2498; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; PILZ RB, 1995, FASEB J, V9, P552, DOI 10.1096/fasebj.9.7.7737465; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Schlossmann J, 2005, FRONT BIOSCI-LANDMRK, V10, P1279, DOI 10.2741/1618; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stevens HY, 2003, METH MOLEC MED, V80, P381; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wimalawansa SJ, 1996, BONE, V18, P301, DOI 10.1016/8756-3282(96)00005-1; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200; Zhao X, 2005, J BIOL CHEM, V280, P32683, DOI 10.1074/jbc.M505486200	94	71	78	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14796	14808		10.1074/jbc.M806486200	http://dx.doi.org/10.1074/jbc.M806486200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19282289	Green Published, hybrid			2022-12-25	WOS:000266288200015
J	Yu, W; Lin, Y; Yao, J; Huang, W; Lei, QY; Xiong, Y; Zhao, SM; Guan, KL				Yu, Wei; Lin, Yan; Yao, Jun; Huang, Wei; Lei, Qunying; Xiong, Yue; Zhao, Shimin; Guan, Kun-Liang			Lysine 88 Acetylation Negatively Regulates Ornithine Carbamoyltransferase Activity in Response to Nutrient Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCARBAMYLASE DEFICIENCY; HISTONE ACETYLTRANSFERASE; COA SYNTHETASE; ACTIVATION; MUTATIONS; SUBSTRATE; GENE; DEACETYLATION; METABOLISM; REPRESSES	Ornithine carbamoyltransferase (OTC) is a key enzyme in the urea cycle to detoxify ammonium produced from amino acid catabolism. OTC deficiency is an X-linked genetic disorder ranging from fatal in newborns to hyperammonemia and anorexia in adults. Through affinity purification of acetylated peptides and mass spectrometry, we identified that OTC is acetylated on lysine residues, including Lys(88), which is also mutated in OTC-deficient patients. OTC acetylation was confirmed to occur under physiological conditions. Biochemical characterizations revealed that OTC Lys(88) acetylation decreases the affinity for carbamoyl phosphate, one of the two OTC substrates, and the maximum velocity, whereas the Km for ornithine, the other OTC substrate, is not affected. Furthermore, Lys(88) acetylation is regulated by both extracellular glucose and amino acid availability, indicating that OTC activity may be regulated by cellular metabolic status. Our results provide an example of the novel mechanism of regulating metabolic enzyme activity through protein acetylation.	[Yu, Wei; Huang, Wei; Zhao, Shimin] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Yu, Wei; Lin, Yan; Yao, Jun; Huang, Wei; Lei, Qunying; Xiong, Yue; Zhao, Shimin; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Lei, Qunying] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhao, SM (corresponding author), Fudan Univ, Sch Life Sci, Ming Dao Bldg 805,138 Yixue Yuan Rd, Shanghai 200032, Peoples R China.	zhaosm@fudan.edu.cn; kuguan@ucsd.edu	Lei, Qun-Ying/J-1390-2017; YU, WEI/C-3822-2012; Guan, Kun-Liang/ADK-7088-2022	Lei, Qun-Ying/0000-0002-8547-8518; YU, WEI/0000-0001-9898-4607	Chinese Ministry of Education; State Key Development Programs of Basic Research of China [2009CB918401, 2006CB806700]; National High Technology Research and Development Program of China [2006AA02A308]; Chinese National Science Foundation [30600112, 30871255]; Shanghai Key Basic Research Project [06JC14086, 07PJ14011, 08JC1400900]	Chinese Ministry of Education(Ministry of Education, China); State Key Development Programs of Basic Research of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Project	This work was supported by the 985 Program from the Chinese Ministry of Education, the State Key Development Programs of Basic Research of China (Grants 2009CB918401 and 2006CB806700), the National High Technology Research and Development Program of China (Grant 2006AA02A308), the Chinese National Science Foundation (Grants 30600112 and 30871255), and the Shanghai Key Basic Research Project (Grants 06JC14086, 07PJ14011, and 08JC1400900).	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; ARN PH, 1990, NEW ENGL J MED, V322, P1652, DOI 10.1056/NEJM199006073222307; Arranz JA, 2007, J INHERIT METAB DIS, V30, P217, DOI 10.1007/s10545-007-0429-x; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ha Y, 1997, P NATL ACAD SCI USA, V94, P9550, DOI 10.1073/pnas.94.18.9550; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAUSER ER, 1990, NEW ENGL J MED, V322, P1641, DOI 10.1056/NEJM199006073222305; HAYASE K, 1992, J NUTR, V122, P1143, DOI 10.1093/jn/122.5.1143; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; LERMANSAGIE T, 1995, CLIN PEDIATR, V34, P163, DOI 10.1177/000992289503400310; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oechsner M, 1998, J NEUROL NEUROSUR PS, V64, P680, DOI 10.1136/jnnp.64.5.680; PAUSCH J, 1985, EUR J BIOCHEM, V150, P189, DOI 10.1111/j.1432-1033.1985.tb09006.x; REISH O, 1993, BIOCHEM MED METAB B, V50, P169, DOI 10.1006/bmmb.1993.1058; Scaglia F, 2004, J NUTR, V134, p2775S, DOI 10.1093/jn/134.10.2775S; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi DS, 1998, J BIOL CHEM, V273, P34247, DOI 10.1074/jbc.273.51.34247; Shi DS, 2001, BIOCHEM J, V354, P501, DOI 10.1042/0264-6021:3540501; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Valentini G, 1996, EUR J BIOCHEM, V239, P397, DOI 10.1111/j.1432-1033.1996.0397u.x; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Ye XH, 1996, J BIOL CHEM, V271, P3639; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	31	45	52	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13669	13675		10.1074/jbc.M901921200	http://dx.doi.org/10.1074/jbc.M901921200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318352	hybrid, Green Published			2022-12-25	WOS:000265877300044
J	Kitatani, K; Sheldon, K; Rajagopalan, V; Anelli, V; Jenkins, RW; Sun, Y; Grabowski, GA; Obeid, LM; Hannun, YA				Kitatani, Kazuyuki; Sheldon, Kely; Rajagopalan, Vinodh; Anelli, Viviana; Jenkins, Russell W.; Sun, Ying; Grabowski, Gregory A.; Obeid, Lina M.; Hannun, Yusuf A.			Involvement of Acid beta-Glucosidase 1 in the Salvage Pathway of Ceramide Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; NOVO SPHINGOLIPID BIOSYNTHESIS; DE-NOVO; RECYCLING PATHWAYS; CANCER CELLS; SAPOSIN-C; PROTEIN; METABOLISM; SPHINGOMYELIN; SPHINGOSINE	Activation of protein kinase C (PKC) promotes the salvage pathway of ceramide formation, and acid sphingomyelinase has been implicated, in part, in providing substrate for this pathway (Zeidan, Y. H., and Hannun, Y. A. (2007) J. Biol. Chem. 282, 11549-11561). In the present study, we examined whether acid beta-glucosidase 1 (GBA1), which hydrolyzes glucosylceramide to form lysosomal ceramide, was involved in PKC-regulated formation of ceramide from recycled sphingosine. Glucosylceramide levels declined after treatment of MCF-7 cells with a potent PKC activator, phorbol 12-myristate 13-acetate (PMA). Silencing GBA1 by small interfering RNAs significantly attenuated acid glucocerebrosidase activity and decreased PMA-induced formation of ceramide by 50%. Silencing GBA1 blocked PMA-induced degradation of glucosylceramide and generation of sphingosine, the source for ceramide biosynthesis. Reciprocally, forced expression of GBA1 increased ceramide levels. These observations indicate that GBA1 activation can generate the source (sphingosine) for PMA-induced formation of ceramide through the salvage pathway. Next, the role of PKC delta, a direct effector of PMA, in the formation of ceramide was determined. By attenuating expression of PKC delta, cells failed to trigger PMA-induced alterations in levels of ceramide, sphingomyelin, and glucosylceramide. Thus, PKC delta activation is suggested to stimulate the degradation of both sphingomyelin and glucosylceramide leading to the salvage pathway of ceramide formation. Collectively, GBA1 is identified as a novel source of regulated formation of ceramide, and PKC delta is an upstream regulator of this pathway.	[Kitatani, Kazuyuki; Sheldon, Kely; Rajagopalan, Vinodh; Anelli, Viviana; Jenkins, Russell W.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Obeid, Lina M.] Med Ctr, Dept Vet Affairs, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hannun, YA (corresponding author), 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu	Rajagopalan, Vinodh/AAG-4769-2020; Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; obeid, lina/0000-0002-0734-0847; ANELLI, Viviana Vittoria/0000-0003-1964-3252	National Institutes of Health [CA87584, AG01683, DK36729, C06 PR018823]; Medical Scientist Training Program training [GM08716]; Medical University of South Carolina.; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program training; Medical University of South Carolina.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87584 (to Y.A.H.), AG01683 (to L.M.O.), and DK36729 (to G.A.G.). This work was also supported by Medical Scientist Training Program training Grant GM08716 (to R.W.J.) and the Lipidomics Core, supported in part by National Institutes of Health Grant C06 PR018823, at the Medical University of South Carolina.	Alattia JR, 2007, P NATL ACAD SCI USA, V104, P17394, DOI 10.1073/pnas.0704998104; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Degner SC, 2006, J NUTR, V136, P421, DOI 10.1093/jn/136.2.421; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; FABBRO D, 1991, J BIOL CHEM, V266, P15021; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Garzotto M, 1998, CANCER RES, V58, P2260; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Lee SO, 2007, BIOCHEM BIOPH RES CO, V354, P165, DOI 10.1016/j.bbrc.2006.12.181; Linn SC, 2001, BIOCHEM SOC T, V29, P831, DOI 10.1042/0300-5127:0290831; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; REVAK SD, 1985, J CLIN INVEST, V76, P1182, DOI 10.1172/JCI112074; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; RIBONI L, 1994, FEBS LETT, V352, P323, DOI 10.1016/0014-5793(94)00984-8; RIBONI L, 1993, FEBS LETT, V322, P257, DOI 10.1016/0014-5793(93)81582-K; Riboni L, 1998, ANN NY ACAD SCI, V845, P46, DOI 10.1111/j.1749-6632.1998.tb09661.x; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; SMITH ER, 1995, J BIOL CHEM, V270, P18749, DOI 10.1074/jbc.270.32.18749; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; TRINCHERA M, 1990, BIOCHEM J, V270, P815, DOI 10.1042/bj2700815; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Ziulkoski AL, 2001, BIOCHEM BIOPH RES CO, V281, P971, DOI 10.1006/bbrc.2001.4440	43	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12972	12978		10.1074/jbc.M802790200	http://dx.doi.org/10.1074/jbc.M802790200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279011	Green Published, hybrid			2022-12-25	WOS:000265688300044
J	Liu, Y; Zhang, YW; Wang, X; Zhang, H; You, XQ; Liao, FF; Xu, HX				Liu, Yun; Zhang, Yun-wu; Wang, Xin; Zhang, Han; You, Xiaoqing; Liao, Francesca-Fang; Xu, Huaxi			Intracellular Trafficking of Presenilin 1 Is Regulated by beta-Amyloid Precursor Protein and Phospholipase D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; TRANS-GOLGI NETWORK; GAMMA-SECRETASE COMPLEX; AXONAL-TRANSPORT; ANTEROGRADE TRANSPORT; CELLULAR MECHANISMS; MAMMALIAN-CELLS; CLEAVING ENZYME; DISTINCT SITES; APP	Excessive accumulation of beta-amyloid peptides in the brain is a major cause for the pathogenesis of Alzheimer disease. beta-Amyloid is derived from beta-amyloid precursor protein (APP) through sequential cleavages by beta- and gamma-secretases, whose enzymatic activities are tightly controlled by subcellular localization. Delineation of how intracellular trafficking of these secretases and APP is regulated is important for understanding Alzheimer disease pathogenesis. Although APP trafficking is regulated by multiple factors including presenilin 1 (PS1), a major component of the gamma-secretase complex, and phospholipase D1 (PLD1), a phospholipid-modifying enzyme, regulation of intracellular trafficking of PS1/gamma-secretase and beta-secretase is less clear. Here we demonstrate that APP can reciprocally regulate PS1 trafficking; APP deficiency results in faster transport of PS1 from the trans-Golgi network to the cell surface and increased steady state levels of PS1 at the cell surface, which can be reversed by restoring APP levels. Restoration of APP in APP-deficient cells also reduces steady state levels of other gamma-secretase components (nicastrin, APH-1, and PEN-2) and the cleavage of Notch by PS1/gamma-secretase that is more highly correlated with cell surface levels of PS1 than with APP overexpression levels, supporting the notion that Notch is mainly cleaved at the cell surface. In contrast, intracellular trafficking of beta-secretase (BACE1) is not regulated by APP. Moreover, we find that PLD1 also regulates PS1 trafficking and that PLD1 overexpression promotes cell surface accumulation of PS1 in an APP-independent manner. Our results clearly elucidate a physiological function of APP in regulating protein trafficking and suggest that intracellular trafficking of PS1/gamma-secretase is regulated by multiple factors, including APP and PLD1.	[Liu, Yun; Zhang, Yun-wu; Wang, Xin; Zhang, Han; You, Xiaoqing; Liao, Francesca-Fang; Xu, Huaxi] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Zhang, Yun-wu; Zhang, Han; You, Xiaoqing; Xu, Huaxi] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; Xiamen University	Xu, HX (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	xuh@burnham.org	Zhang, YW/G-3999-2010; Wang, Xin/A-8119-2017; Xu, Huaxi/AAV-7177-2021	Zhang, Yun-wu/0000-0002-7152-7630	National Institutes of Health [R01 NS046673, R01 AG030197, R01 AG021173, R01 NS054880]; Alzheimer's Association; American Health Assistance Foundation; National Natural Science Foundation of China [30672198, 30840036]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, R01NS054880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030197, R01AG021173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS046673, R01 AG030197, and R01 AG021173 ( to H. X.) and R01 NS054880 ( to F.- F. L.). This work was also supported by grants from the Alzheimer's Association ( to H. X. and F.- F. L.), the American Health Assistance Foundation ( to H. X.), and National Natural Science Foundation of China Grants 30672198 and 30840036 ( to Y. Z.).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1993, J BIOL CHEM, V268, P3021; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Multhaup G, 2006, NEURODEGENER DIS, V3, P270, DOI 10.1159/000095266; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Satpute-Krishnan P, 2003, AGING CELL, V2, P305, DOI 10.1046/j.1474-9728.2003.00069.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Scheper W, 2000, HUM MOL GENET, V9, P303, DOI 10.1093/hmg/9.2.303; Scheper W, 2004, MOL BRAIN RES, V122, P17, DOI 10.1016/j.molbrainres.2003.11.013; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Sisodia SS, 2002, SCIENCE, V295, P805, DOI 10.1126/science.1069661; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Waragai M, 1997, BIOCHEM BIOPH RES CO, V239, P480, DOI 10.1006/bbrc.1997.7488; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhang YW, 2007, CURR MOL MED, V7, P687, DOI 10.2174/156652407782564462; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	79	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12145	12152		10.1074/jbc.M808497200	http://dx.doi.org/10.1074/jbc.M808497200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276086	hybrid, Green Published			2022-12-25	WOS:000265494600046
J	Yin, H; Chu, A; Li, W; Wang, B; Shelton, F; Otero, F; Nguyen, DG; Caldwell, JS; Chen, YA				Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice			Lipid G Protein-coupled Receptor Ligand Identification Using beta-Arrestin PathHunter (TM) Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; BREAST-CANCER CELLS; CB2 CANNABINOID RECEPTORS; CHAIN FATTY-ACIDS; SPHINGOSINE 1-PHOSPHATE; N-ARACHIDONYLGLYCINE; NEUROPATHIC PAIN; ORPHAN RECEPTOR; GENE-EXPRESSION; IN-VITRO	A growing number of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors. These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports. We used the beta-arrestin PathHunter (TM) assay system, a newly developed, generic GPCR assay format that measures beta-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing. This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation. We screened a large number of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of similar to 400 lipid molecules to try to identify the receptor ligand in an unbiased fashion. GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate. The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids. G2A receptor was confirmed to be an oxidized free fatty acid receptor. In addition, we discovered that 3,3'-diindolylmethane, a dietary molecule from cruciferous vegetables, which has known anti-cancer properties, to be a CB2 receptor partial agonist, with binding affinity around 1 mu M. The anti-inflammatory effect of 3,3-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB2.	[Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice] Novartis Res Fdn, Genom Inst, GPCR Platform, San Diego, CA 92121 USA	Novartis	Chen, YA (corresponding author), Novartis Res Fdn, Genom Inst, GPCR Platform, San Diego, CA 92121 USA.	achen@gnf.org		Nguyen, Deborah/0000-0002-1694-0617				Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Arevalo-Martin A, 2008, BRIT J PHARMACOL, V153, P216, DOI 10.1038/sj.bjp.0707466; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chen I, 1998, CARCINOGENESIS, V19, P1631, DOI 10.1093/carcin/19.9.1631; Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; Dyson A, 2005, PAIN, V116, P129, DOI 10.1016/j.pain.2005.03.037; Flygare J, 2008, SEMIN CANCER BIOL, V18, P176, DOI 10.1016/j.semcancer.2007.12.008; Ge XK, 1996, BIOCHEM BIOPH RES CO, V228, P153, DOI 10.1006/bbrc.1996.1631; Gong YX, 2006, CANCER RES, V66, P4880, DOI 10.1158/0008-5472.CAN-05-4162; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hirose M, 2003, BIOORG MED CHEM LETT, V13, P4497, DOI 10.1016/j.bmcl.2003.08.038; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Ignatov A, 2003, J NEUROSCI, V23, P907; JELLINCK PH, 1993, BIOCHEM PHARMACOL, V45, P1129, DOI 10.1016/0006-2952(93)90258-X; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Le HT, 2003, J BIOL CHEM, V278, P21136, DOI 10.1074/jbc.M300588200; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin P, 2003, J BIOL CHEM, V278, P14379, DOI 10.1074/jbc.M209101200; Lotersztajn S, 2008, BRIT J PHARMACOL, V153, P286, DOI 10.1038/sj.bjp.0707511; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Niedernberg A, 2003, CELL SIGNAL, V15, P435, DOI 10.1016/S0898-6568(02)00119-5; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Paugh SW, 2006, MOL PHARMACOL, V70, P41, DOI 10.1124/mol.105.020552; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Siehler Sandra, 2008, Biotechnology Journal, V3, P471, DOI 10.1002/biot.200800001; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Weng JR, 2007, CANCER RES, V67, P7815, DOI 10.1158/0008-5472.CAN-07-0794; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Xue L, 2008, J NUTR BIOCHEM, V19, P336, DOI 10.1016/j.jnutbio.2007.05.004; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677	62	251	261	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12328	12338		10.1074/jbc.M806516200	http://dx.doi.org/10.1074/jbc.M806516200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19286662	hybrid, Green Published			2022-12-25	WOS:000265494600064
J	Sassi-Messai, S; Gibert, Y; Bernard, L; Nishio, SI; Lagneau, KFF; Molina, J; Andersson-Lendahl, M; Benoit, G; Balaguer, P; Laudet, V				Sassi-Messai, Sana; Gibert, Yann; Bernard, Laure; Nishio, Shin-Ichi; Lagneau, Karine F. Ferri; Molina, Jose; Andersson-Lendahl, Monika; Benoit, Gerard; Balaguer, Patrick; Laudet, Vincent			The Phytoestrogen Genistein Affects Zebrafish Development through Two Different Pathways	PLOS ONE			English	Article								Background: Endocrine disrupting chemicals are widely distributed in the environment and derive from many different human activities or can also be natural products synthesized by plants or microorganisms. The phytoestrogen, genistein (49, 5, 7-trihydroxy-isoflavone), is a naturally occurring compound found in soy products. Genistein has been the subject of numerous studies because of its known estrogenic activity. Methodology/Principal Findings: We report that genistein exposure of zebrafish embryos induces apoptosis, mainly in the hindbrain and the anterior spinal cord. Timing experiments demonstrate that apoptosis is induced during a precise developmental window. Since adding ICI 182,780, an ER antagonist, does not rescue the genistein-induced apoptosis and since there is no synergistic effect between genistein and estradiol, we conclude that this apoptotic effect elicited by genistein is estrogen-receptors independent. However, we show in vitro, that genistein binds and activates the three zebrafish estrogen receptors ER alpha, ER beta-A and ER beta-B. Furthermore using transgenic ERE-Luciferase fish we show that genistein is able to activate the estrogen pathway in vivo during larval stages. Finally we show that genistein is able to induce ectopic expression of the aromatase-B gene in an ER-dependent manner in the anterior brain in pattern highly similar to the one resulting from estrogen treatment at low concentration. Conclusion/Significance: Taken together these results indicate that genistein acts through at least two different pathways in zebrafish embryos: (i) it induces apoptosis in an ER-independent manner and (ii) it regulates aromatase-B expression in the brain in an ER-dependent manner. Our results thus highlight the multiplicity of possible actions of phytoestrogens, such as genistein. This suggests that the use of standardized endpoints to study the effect of a given compound, even when this compound has well known targets, may carry the risk of overlooking interesting effects of this compound.	[Sassi-Messai, Sana; Gibert, Yann; Bernard, Laure; Nishio, Shin-Ichi; Benoit, Gerard; Laudet, Vincent] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France; [Lagneau, Karine F. Ferri] Univ Lyon 1, CNRS, Apoptosis & Oncogenesis Lab, Inst Biol Chim Proteines, Inst Fed Biosci Gerland Lyon Sud, F-69365 Lyon, France; [Andersson-Lendahl, Monika] Karolinska Inst, Dept Biosci & Nutr, Lab Med Nutr, Stockholm, Sweden; [Molina, Jose; Balaguer, Patrick] Inst Rech Cancerol Montpellier IRCM, Equipe INSERM, U896, Montpellier, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Sassi-Messai, S (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France.	Vincent.Laudet@ens-lyon.fr	Molina-Molina, José Manuel/F-1055-2017; Andersson Lendahl, Monika/ABE-5981-2021; Balaguer, Patrick/I-2973-2016	Molina-Molina, José Manuel/0000-0002-3657-1548; Andersson Lendahl, Monika/0000-0002-5690-8515; BENOIT, Gerard/0000-0001-9462-6570	European Community; French Ministry of Research (MENRT); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon; association pour la Recherche contre le Cancer (ARC) [fellowship]	European Community(European Commission); French Ministry of Research (MENRT)(Ministry of Research, France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by the European Community (CASCADE network of excellence), French Ministry of Research (MENRT) , Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure de Lyon and an association pour la Recherche contre le Cancer (ARC) fellowship to YG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Bennetau-Pelissero C, 2001, GEN COMP ENDOCR, V121, P173, DOI 10.1006/gcen.2000.7585; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Burvall K, 2004, LIFE SCI, V75, P2733, DOI 10.1016/j.lfs.2004.03.037; Cai QY, 1996, NUTR CANCER, V25, P1, DOI 10.1080/01635589609514423; Carvan Michael J. III, 2000, Annals of the New York Academy of Sciences, V919, P133; Chan WH, 2007, ACTA PHARMACOL SIN, V28, P238, DOI 10.1111/j.1745-7254.2007.00498.x; Chen H, 2007, CHINESE MED J-PEKING, V120, P898, DOI 10.1097/00029330-200705020-00009; Choi EJ, 2004, LIFE SCI, V75, P499, DOI 10.1016/j.lfs.2004.01.010; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Detrich HW, 1999, METHODS CELL BIOL, V59, P3, DOI 10.1016/S0091-679X(08)61816-6; Eggert US, 2006, CURR OPIN CHEM BIOL, V10, P232, DOI 10.1016/j.cbpa.2006.04.010; Ellis PA, 1997, INT J CANCER, V72, P608, DOI 10.1002/(SICI)1097-0215(19970807)72:4<608::AID-IJC10>3.0.CO;2-7; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Fukutake M, 1996, FOOD CHEM TOXICOL, V34, P457, DOI 10.1016/0278-6915(96)87355-8; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gross-Sorokin MY, 2006, ENVIRON HEALTH PERSP, V114, P147, DOI 10.1289/ehp.8068; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Henley DV, 2006, ENDOCRINOLOGY, V147, pS25, DOI 10.1210/en.2005-1117; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hsieh RW, 2006, J BIOL CHEM, V281, P17909, DOI 10.1074/jbc.M513684200; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Ismail IA, 2007, EUR J PHARMACOL, V575, P12, DOI 10.1016/j.ejphar.2007.07.039; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kazeto Y, 2004, AQUAT TOXICOL, V69, P25, DOI 10.1016/j.aquatox.2004.04.008; Kime DE, 1999, SCI TOTAL ENVIRON, V225, P3, DOI 10.1016/S0048-9697(98)00328-3; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiparissis Y, 2003, ENVIRON HEALTH PERSP, V111, P1158, DOI 10.1289/ehp.5928; Kiparissis Y, 2001, ENVIRON SCI TECHNOL, V35, P2423, DOI 10.1021/es001679+; Kishida M, 2001, ENDOCRINOLOGY, V142, P740, DOI 10.1210/en.142.2.740; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lawry J, 2004, METH MOLEC MED, V88, P183; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; Lewis JG, 2005, STEROIDS, V70, P974, DOI 10.1016/j.steroids.2005.06.008; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MAKELA S, 1994, ENVIRON HEALTH PERSP, V102, P572, DOI 10.1289/ehp.94102572; MAKELA S, 1995, P SOC EXP BIOL MED, V208, P51; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Margueron R, 2004, J MOL ENDOCRINOL, V32, P583, DOI 10.1677/jme.0.0320583; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Panzica G, 2005, DOMEST ANIM ENDOCRIN, V29, P436, DOI 10.1016/j.domaniend.2005.02.010; Patisaul HB, 2005, J NEUROENDOCRINOL, V17, P57, DOI 10.1111/j.1365-2826.2005.01268.x; PELISSERO C, 1991, J STEROID BIOCHEM, V38, P293, DOI 10.1016/0960-0760(91)90100-J; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Potter SM, 1998, AM J CLIN NUTR, V68, p1375S, DOI 10.1093/ajcn/68.6.1375S; Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Strauss L, 1998, TOXICOL LETT, V103, P349, DOI 10.1016/S0378-4274(98)00332-4; Tchoudakova A, 2001, J STEROID BIOCHEM, V78, P427, DOI 10.1016/S0960-0760(01)00120-0; THISSE C, 1993, DEVELOPMENT, V119, P1203; Valachovicova T, 2004, MINI-REV MED CHEM, V4, P881, DOI 10.2174/1389557043403387; Waring RH, 2005, MOL CELL ENDOCRINOL, V244, P2, DOI 10.1016/j.mce.2005.02.007; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhang LL, 2002, COMP BIOCHEM PHYS C, V132, P203, DOI 10.1016/S1532-0456(02)00067-4; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	70	53	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4935	10.1371/journal.pone.0004935	http://dx.doi.org/10.1371/journal.pone.0004935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319186	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499200005
J	Willard, FS; Willard, MD; Kimple, AJ; Soundararajan, M; Oestreich, EA; Li, XY; Sowa, NA; Kimple, RJ; Doyle, DA; Der, CJ; Zylka, MJ; Snider, WD; Siderovski, DP				Willard, Francis S.; Willard, Melinda D.; Kimple, Adam J.; Soundararajan, Meera; Oestreich, Emily A.; Li, Xiaoyan; Sowa, Nathaniel A.; Kimple, Randall J.; Doyle, Declan A.; Der, Channing J.; Zylka, Mark J.; Snider, William D.; Siderovski, David P.			Regulator of G-Protein Signaling 14 (RGS14) Is a Selective H-Ras Effector	PLOS ONE			English	Article								Background: Regulator of G-protein signaling (RGS) proteins have been well-described as accelerators of G alpha-mediated GTP hydrolysis ("GTPase-accelerating proteins'' or GAPs). However, RGS proteins with complex domain architectures are now known to regulate much more than G alpha GTPase activity. RGS14 contains tandem Ras-binding domains that have been reported to bind to Rap-but not Ras GTPases in vitro, leading to the suggestion that RGS14 is a Rap-specific effector. However, more recent data from mammals and Drosophila imply that, in vivo, RGS14 may instead be an effector of Ras. Methodology/Principal Findings: Full-length and truncated forms of purified RGS14 protein were found to bind indiscriminately in vitro to both Rap-and Ras-family GTPases, consistent with prior literature reports. In stark contrast, however, we found that in a cellular context RGS14 selectively binds to activated H-Ras and not to Rap isoforms. Co-transfection /co-immunoprecipitation experiments demonstrated the ability of full-length RGS14 to assemble a multiprotein complex with components of the ERK MAPK pathway in a manner dependent on activated H-Ras. Small interfering RNA-mediated knockdown of RGS14 inhibited both nerve growth factor-and basic fibrobast growth factor-mediated neuronal differentiation of PC12 cells, a process which is known to be dependent on Ras-ERK signaling. Conclusions/Significance: In cells, RGS14 facilitates the formation of a selective Ras? GTP-Raf-MEK-ERK multiprotein complex to promote sustained ERK activation and regulate H-Ras-dependent neuritogenesis. This cellular function for RGS14 is similar but distinct from that recently described for its closely-related paralogue, RGS12, which shares the tandem Ras-binding domain architecture with RGS14.	[Willard, Francis S.; Willard, Melinda D.; Kimple, Adam J.; Oestreich, Emily A.; Kimple, Randall J.; Der, Channing J.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Li, Xiaoyan; Sowa, Nathaniel A.; Zylka, Mark J.; Snider, William D.; Siderovski, David P.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC USA; [Kimple, Randall J.; Der, Channing J.; Siderovski, David P.] Univ N Carolina, Lineberger Comprehensive Canc Ctr, Chapel Hill, NC USA; [Soundararajan, Meera; Doyle, Declan A.] Univ Oxford, Struct Genom Consortium, Oxford, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford	Willard, FS (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	willardfs@lilly.com; dsiderov@med.unc.edu	Kimple, Randall/L-6460-2019; Siderovski, David Peter/AAA-9603-2019	Kimple, Randall/0000-0001-8336-8000; Siderovski, David Peter/0000-0002-0688-8210; Soundararajan, Meera/0000-0003-4687-0151; Kimple, Adam/0000-0003-1670-8401; Der, Channing/0000-0002-7751-2747	U.S. National Institutes of Health [R01CA127152, R01NS060725, R01GM074268]; Wellcome Trust [1097737]; Novartis Research Foundation; GlaxoSmithKline; Merck & Co., Inc; Ontario Genomics Institute; Canadian Institutes of Health Research; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Canadian Foundation for Innovation; VINNOVA; Swedish Agency for Innovation Systems; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Karolinska Institute; PhRMA Foundation [predoctoral fellowship]; NATIONAL CANCER INSTITUTE [R01CA127152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Novartis Research Foundation; GlaxoSmithKline(GlaxoSmithKline); Merck & Co., Inc(Merck & Company); Ontario Genomics Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Foundation for Innovation(Canada Foundation for Innovation); VINNOVA(Vinnova); Swedish Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institute(Karolinska Institutet); PhRMA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants to C.J.D. [R01CA127152], M.J.Z. and W.D.S. [R01NS060725], and D.P.S. [R01GM074268]. The Structural Genomics Consortium is a registered charity [#1097737] funded by the Wellcome Trust, the Novartis Research Foundation, GlaxoSmithKline, Merck & Co., Inc., Genome Canada through the Ontario Genomics Institute, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, the Canadian Foundation for Innovation, VINNOVA, the Swedish Agency for Innovation Systems, the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, and the Karolinska Institute. M.D.W. was supported by a PhRMA Foundation predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altin JG, 1991, GROWTH FACTORS, V4, P145, DOI 10.3109/08977199109000265; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Goldfinger LE, 2008, MOL BIOSYST, V4, P293, DOI 10.1039/b716887j; Hains MD, 2004, METHOD ENZYMOL, V389, P71; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; James P, 1996, GENETICS, V144, P1425; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Martin-McCaffrey L, 2005, CELL CYCLE, V4, P953, DOI 10.4161/cc.4.7.1787; Martin-McCaffrey L, 2004, DEV CELL, V7, P763, DOI 10.1016/j.devcel.2004.10.004; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mittal V, 2006, BIOCHEM J, V394, P309, DOI 10.1042/BJ20051086; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; NG NFL, 1993, J BIOL CHEM, V268, P25329; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Peterson SN, 1996, J BIOL CHEM, V271, P29903, DOI 10.1074/jbc.271.47.29903; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Snow BE, 2002, METHOD ENZYMOL, V344, P740; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Soundararajan M, 2007, BIOCHEM J, V401, P679, DOI 10.1042/BJ20060555; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Willard FS, 2004, METHOD ENZYMOL, V389, P320; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048	57	32	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4884	10.1371/journal.pone.0004884	http://dx.doi.org/10.1371/journal.pone.0004884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319189	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499200003
J	Chen, JH; Martin-Gronert, MS; Tarry-Adkins, J; Ozanne, SE				Chen, Jian-Hua; Martin-Gronert, Malgorzata S.; Tarry-Adkins, Jane; Ozanne, Susan E.			Maternal Protein Restriction Affects Postnatal Growth and the Expression of Key Proteins Involved in Lifespan Regulation in Mice	PLOS ONE			English	Article								We previously reported that maternal protein restriction in rodents influenced the rate of growth in early life and ultimately affected longevity. Low birth weight caused by maternal protein restriction followed by catch-up growth (recuperated animals) was associated with shortened lifespan whereas protein restriction and slow growth during lactation (postnatal low protein: PLP animals) increased lifespan. We aim to explore the mechanistic basis by which these differences arise. Here we investigated effects of maternal diet on organ growth, metabolic parameters and the expression of insulin/IGF1 signalling proteins and Sirt1 in muscle of male mice at weaning. PLP mice which experienced protein restriction during lactation had lower fasting glucose (P = 0.038) and insulin levels (P = 0.046) suggesting improved insulin sensitivity. PLP mice had higher relative weights (adjusted by body weight) of brain (P = 0.0002) and thymus (P = 0.031) compared to controls suggesting that enhanced functional capacity of these two tissues is beneficial to longevity. They also had increased expression of insulin receptor substrate 1 (P = 0.021) and protein kinase C zeta (P = 0.046). Recuperated animals expressed decreased levels of many insulin signalling proteins including P13 kinase subunits p85 alpha (P = 0.018), p110 beta (P = 0.048) and protein kinase C zeta (P = 0.006) which may predispose these animals to insulin resistance. Sirt1 protein expression was reduced in recuperated offspring. These observations suggest that maternal protein restriction can affect major metabolic pathways implicated in regulation of lifespan at a young age which may explain the impact of maternal diet on longevity.	[Chen, Jian-Hua; Martin-Gronert, Malgorzata S.; Tarry-Adkins, Jane; Ozanne, Susan E.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chen, JH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England.	jhc36@cam.ac.uk		Ozanne, Susan/0000-0001-8753-5144	BBSRC; European Union; British Heart Foundation; Parthenon Trust; BBSRC [BB/E00797X/1, BB/E002161/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002161/1, BB/E00797X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); British Heart Foundation(British Heart Foundation); Parthenon Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC, the European Union, the British Heart Foundation and the Parthenon Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2008, EXP GERONTOL, V43, P74, DOI 10.1016/j.exger.2007.06.003; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; FRIEDMAN DB, 1988, GENETICS, V118, P75; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Holzenberger M, 2004, HORM RES, V62, P89, DOI 10.1159/000080765; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsieh CC, 2002, MECH AGEING DEV, V123, P1245, DOI 10.1016/S0047-6374(02)00037-4; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Liu LZ, 2006, BIOCHEMISTRY-MOSCOW+, V71, P701, DOI 10.1134/S0006297906070017; Longo VD, 2009, EXP GERONTOL, V44, P70, DOI 10.1016/j.exger.2008.06.005; Martin-Gronert MS, 2006, BIOCHEM SOC T, V34, P779, DOI 10.1042/BST0340779; Martin-Gronert MS, 2008, AM J PHYSIOL-REG I, V294, pR494, DOI 10.1152/ajpregu.00530.2007; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; Masternak MM, 2005, EXP GERONTOL, V40, P679, DOI 10.1016/j.exger.2005.06.003; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2004, SEMIN PERINATOL, V28, P81, DOI 10.1053/j.semperi.2003.10.015; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Paolisso G, 1996, AM J PHYSIOL-ENDOC M, V270, pE890, DOI 10.1152/ajpendo.1996.270.5.E890; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447	54	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4950	10.1371/journal.pone.0004950	http://dx.doi.org/10.1371/journal.pone.0004950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308256	Green Submitted, Green Published, gold			2022-12-25	WOS:000265499000005
J	Power, KA; McRedmond, JP; de Stefani, A; Gallagher, WM; Gaora, PO				Power, Karen A.; McRedmond, James P.; de Stefani, Andreas; Gallagher, William M.; Gaora, Peadar O.			High-Throughput Proteomics Detection of Novel Splice Isoforms in Human Platelets	PLOS ONE			English	Article							MESSENGER-RNA; DATABASE; SURFACE; POLYMORPHISMS; EXPRESSION; PEPTIDES; MODEL; VIEW; ASD	Alternative splicing (AS) is an intrinsic regulatory mechanism of all metazoans. Recent findings suggest that 100% of multiexonic human genes give rise to splice isoforms. AS can be specific to tissue type, environment or developmentally regulated. Splice variants have also been implicated in various diseases including cancer. Detection of these variants will enhance our understanding of the complexity of the human genome and provide disease-specific and prognostic biomarkers. We adopted a proteomics approach to identify exon skip events - the most common form of AS. We constructed a database harboring the peptide sequences derived from all hypothetical exon skip junctions in the human genome. Searching tandem mass spectrometry (MS/MS) data against the database allows the detection of exon skip events, directly at the protein level. Here we describe the application of this approach to human platelets, including the mRNA-based verification of novel splice isoforms of ITGA2, NPEPPS and FH. This methodology is applicable to all new or existing MS/MS datasets.	[Power, Karen A.; McRedmond, James P.; Gallagher, William M.; Gaora, Peadar O.] Univ Coll Dublin, UCD Conway Inst, Dublin 2, Ireland; [Power, Karen A.; McRedmond, James P.; Gallagher, William M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland; [de Stefani, Andreas] NovaUCD, Belfield Innovat Pk, Dublin, Ireland; [Gaora, Peadar O.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Med & Med Sci, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin	Power, KA (corresponding author), Univ Coll Dublin, UCD Conway Inst, Dublin 2, Ireland.	peadar.ogaora@ucd.ie	O'Gaora, Peadar/F-9400-2011	O'Gaora, Peadar/0000-0002-6417-7054; Gallagher, William/0000-0002-4307-5999	InnoMed; University College Dublin; Higher Education Authority of Ireland; Science Foundation Ireland [04/BR/B0527]; Strategic Research Cluster, Network of Excellence of Functional Biomaterials	InnoMed; University College Dublin; Higher Education Authority of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Strategic Research Cluster, Network of Excellence of Functional Biomaterials(Science Foundation Ireland)	Funding is acknowledged from the EU FP6 Integrated Project, InnoMed (in particular, the PredTox subgroup; http://www.innomed-predtox.com), as well as University College Dublin under its Research Demonstratorship scheme (for part-support of KAP). The UCD Conway Institute is funded by the Programme for Research in Third Level Institutions, as administered by the Higher Education Authority of Ireland. The work was also supported by funding from Science Foundation Ireland (04/BR/B0527) to JMcR and the Strategic Research Cluster, Network of Excellence of Functional Biomaterials, to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Censarek P, 2007, THROMB HAEMOSTASIS, V98, P1309, DOI 10.1160/TH07-05-0346; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matarin M, 2008, J CEREBR BLOOD F MET, V28, P81, DOI 10.1038/sj.jcbfm.9600508; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mo F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-537; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Newland SA, 2007, BLOOD, V109, P4806, DOI 10.1182/blood-2006-09-047449; Ozelo MC, 2004, THROMB HAEMOSTASIS, V92, P384, DOI 10.1160/TH03-12-0744; Rustin P, 2002, NAT GENET, V30, P352, DOI 10.1038/ng0402-352; Santoro SA, 1999, BLOOD, V93, P3575, DOI 10.1182/blood.V93.11.3575.411a45_3575_3577; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Sugnet C W, 2004, Pac Symp Biocomput, P66; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Tress ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r162; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	43	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e5001	10.1371/journal.pone.0005001	http://dx.doi.org/10.1371/journal.pone.0005001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308253	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499000013
J	Hennah, W; Porteous, D				Hennah, William; Porteous, David			The DISC1 Pathway Modulates Expression of Neurodevelopmental, Synaptogenic and Sensory Perception Genes	PLOS ONE			English	Article								Background: Genetic and biological evidence supports a role for DISC1 across a spectrum of major mental illnesses, including schizophrenia and bipolar disorder. There is evidence for genetic interplay between variants in DISC1 and in biologically interacting loci in psychiatric illness. DISC1 also associates with normal variance in behavioral and brain imaging phenotypes. Methodology: Here, we analyze public domain datasets and demonstrate correlations between variants in the DISC1 pathway genes and levels of gene expression. Genetic variants of DISC1, NDE1, PDE4B and PDE4D regulate the expression of cytoskeletal, synaptogenic, neurodevelopmental and sensory perception proteins. Interestingly, these regulated genes include existing targets for drug development in depression and psychosis. Conclusions: Our systematic analysis provides further evidence for the relevance of the DISC1 pathway to major mental illness, identifies additional potential targets for therapeutic intervention and establishes a general strategy to mine public datasets for insights into disease pathways.	[Hennah, William; Porteous, David] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hennah, W (corresponding author), Natl Publ Hlth Inst, FIMM Inst Mol Med Finland, Dept Mol Med, Helsinki, Finland.	william.hennah@ed.ac.uk	Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Hennah, William/0000-0002-4462-4208	EMBO [research fellow]; UK Medical Research Council; MRC [G0600214, G0902166, G0100266] Funding Source: UKRI; Medical Research Council [G0600214, G9900991B, G0700704B, G0902166, G0100266] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Hennah is a long term EMBO research fellow. This work was funded in part by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BRADSHAW NJ, 2008, BIOCH BIOPHYS RES CO; Bray NJ, 2008, SCHIZOPHRENIA BULL, V34, P412, DOI 10.1093/schbul/sbn013; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HEDRICK PW, 1987, GENETICS, V117, P331; HENNAH W, 2008, MOL PSYCHIAT; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Pickard BS, 2007, PSYCHIAT GENET, V17, P129, DOI 10.1097/YPG.0b013e328014492b; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Takao T, 2007, EUR NEUROPSYCHOPHARM, V17, P273, DOI 10.1016/j.euroneuro.2006.09.002; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	33	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2009	4	3							e4906	10.1371/journal.pone.0004906	http://dx.doi.org/10.1371/journal.pone.0004906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OM	19300510	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496800007
J	Nadai, Y; Eyzaguirre, LM; Sill, A; Cleghorn, F; Nolte, C; Charurat, M; Collado-Chastel, S; Jack, N; Bartholomew, C; Pape, JW; Figueroa, P; Blattner, WA; Carr, JK				Nadai, Yuka; Eyzaguirre, Lindsay M.; Sill, Anne; Cleghorn, Farley; Nolte, Claudine; Charurat, Manhattan; Collado-Chastel, Santiago; Jack, Noreen; Bartholomew, Courtenay; Pape, Jean W.; Figueroa, Peter; Blattner, William A.; Carr, Jean K.			HIV-1 Epidemic in the Caribbean Is Dominated by Subtype B	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; AFRICA	Background: The molecular epidemiology of HIV-1 in the Caribbean has been described using partial genome sequencing; subtype B is the most common subtype in multiple countries. To expand our knowledge of this, nearly full genome amplification, sequencing and analysis was conducted. Methodology/Principal Findings: Virion RNA from sera collected in Haiti, Dominican Republic, Jamaica and Trinidad and Tobago were reverse transcribed, PCR amplified, sequenced and phylogenetically analyzed. Nearly full genomes were completed for 15 strains; partial pol was done for 67 strains. All but one of the 67 strains analyzed in pol were subtype B; the exception was a unique recombinant of subtypes B and C collected in the Dominican Republic. Of the nearly full genomes of 14 strains that were subtype B in pol, all were subtype B from one end of the genome to the other and not inter-subtype recombinants. Surprisingly, the Caribbean subtype B strains clustered significantly with each other and separate from subtype B from other parts of the pandemic. Conclusions: The more complete analysis of HIV-1 from 4 Caribbean countries confirms previous research using partial genome analysis that the predominant subtype in circulation was subtype B. The Caribbean strains are phylogenetically distinct from other subtype B strains although the biological meaning of this finding is unclear.	[Nadai, Yuka; Eyzaguirre, Lindsay M.; Sill, Anne; Cleghorn, Farley; Charurat, Manhattan; Bartholomew, Courtenay; Blattner, William A.; Carr, Jean K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Nolte, Claudine; Pape, Jean W.] Cornell Univ, Weill Med Coll, New York, NY USA; [Nolte, Claudine; Pape, Jean W.] GHESKIO, Port au Prince, Haiti; [Collado-Chastel, Santiago] Inst Biomed Studies, Santo Domingo, Dominican Rep; [Jack, Noreen] Med Res Fdn, Port Spain, Trinidad Tobago; [Figueroa, Peter] Minist Hlth, Kingston, Jamaica	University System of Maryland; University of Maryland Baltimore; Cornell University	Nadai, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	jecarr@ihv.umaryland.edu			National Institute of Allergy and Infectious Disease [1R21 A1057084-02]; Institute of Human Virology, University of Maryland, Baltimore; AITRP in Brazil, Caribbean and Nigeria; NIH [5K43TW001041]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute of Human Virology, University of Maryland, Baltimore; AITRP in Brazil, Caribbean and Nigeria; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by 1R21 A1057084-02 from the National Institute of Allergy and Infectious Disease (PI: F Cleghorn, then WA Blattner) and also by the Institute of Human Virology, University of Maryland, Baltimore, AITRP in Brazil, Caribbean and Nigeria, NIH grant # 5K43TW001041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila MM, 2002, J ACQ IMMUN DEF SYND, V29, P422, DOI 10.1097/00126334-200204010-00015; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Casado G, 2005, JAIDS-J ACQ IMM DEF, V40, P532, DOI 10.1097/01.qai.0000186363.27587.c0; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Gittens MV, 2003, AIDS RES HUM RETROV, V19, P313, DOI 10.1089/088922203764969519; Heslop OD, 2005, W INDIAN MED J, V54, P279; INCIARDI JA, 2005, AIDS CARE S, V17; Jensen Mark A., 2003, AIDS Reviews, V5, P104; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mastro TD, 1997, AIDS, V11, P113, DOI 10.1097/00002030-199701000-00017; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Nadai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001420; REITZ MS, 1992, AIDS RES HUM RETROV, V8, P1950; *UNAIDS, 2007, 2007 AIDS EP UPD REG; *UNAIDS, 2006, 2006 AIDS EP UPD; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; WHEELER VW, 1994, INT J STD AIDS, V5, P79, DOI 10.1177/095646249400500201	17	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2009	4	3							e4814	10.1371/journal.pone.0004814	http://dx.doi.org/10.1371/journal.pone.0004814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OG	19279683	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496200003
J	Petersen, J; Poulsen, L; Birgens, H; Dufva, M				Petersen, Jesper; Poulsen, Lena; Birgens, Henrik; Dufva, Martin			Microfludic Device for Creating Ionic Strength Gradients over DNA Microarrays for Efficient DNA Melting Studies and Assay Development	PLOS ONE			English	Article							ALLELE-SPECIFIC HYBRIDIZATION; REVEALS; CHIP	The development of DNA microarray assays is hampered by two important aspects: processing of the microarrays is done under a single stringency condition, and characteristics such as melting temperature are difficult to predict for immobilized probes. A technical solution to these limitations is to use a thermal gradient and information from melting curves, for instance to score genotypes. However, application of temperature gradients normally requires complicated equipment, and the size of the arrays that can be investigated is restricted due to heat dissipation. Here we present a simple microfluidic device that creates a gradient comprising zones of defined ionic strength over a glass slide, in which each zone corresponds to a subarray. Using this device, we demonstrated that ionic strength gradients function in a similar fashion as corresponding thermal gradients in assay development. More specifically, we noted that (i) the two stringency modulators generated melting curves that could be compared, (ii) both led to increased assay robustness, and (iii) both were associated with difficulties in genotyping the same mutation. These findings demonstrate that ionic strength stringency buffers can be used instead of thermal gradients. Given the flexibility of design of ionic gradients, these can be created over all types of arrays, and encompass an attractive alternative to temperature gradients, avoiding curtailment of the size or spacing of subarrays on slides associated with temperature gradients.	[Petersen, Jesper; Birgens, Henrik] Copenhagen Univ Hosp, Dept Haematol, Herlev, Denmark; [Poulsen, Lena; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Petersen, J (corresponding author), Copenhagen Univ Hosp, Dept Haematol, Herlev, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012	Dufva, Martin/0000-0001-5449-0189; Petersen, Jesper/0000-0001-6116-5114	Danish Government	Danish Government	The study was financed by a Danish Government PhD-study grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2003, BIOTECHNIQUES, V34, P1082, DOI 10.2144/03345dd05; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Drobyshev AL, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng001; Dufva M, 2004, BIOTECHNIQUES, V37, P286, DOI 10.2144/04372MT02; Dufva M, 2006, ANAL BIOCHEM, V352, P188, DOI 10.1016/j.ab.2006.03.008; Frey BJ, 2005, NAT GENET, V37, P991, DOI 10.1038/ng1630; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Jobs M, 2003, GENOME RES, V13, P916, DOI 10.1101/gr.801103; Kajiyama T, 2003, GENOME RES, V13, P467, DOI 10.1101/gr.790603; Lee HH, 2006, LAB CHIP, V6, P1163, DOI 10.1039/b605507a; Liu WT, 2005, APPL ENVIRON MICROB, V71, P6453, DOI 10.1128/AEM.71.10.6453-6457.2005; Mao HB, 2002, ANAL CHEM, V74, P5071, DOI 10.1021/ac025851z; Marcy Y, 2008, BIOTECHNIQUES, V44, P913, DOI 10.2144/000112758; Matsuoka M, 2004, DICKENSIAN, V100, P111; Noerholm M, 2004, LAB CHIP, V4, P28, DOI 10.1039/b311991b; Petersen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1081; Poulsen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn600; Pozhitkov A, 2005, APPL ENVIRON MICROB, V71, P8663, DOI 10.1128/AEM.71.12.8663-8676.2005; Pozhitkov AE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm154; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; STROMQVIST ML, 2007, J MOL DIAGN, V9, P30; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Vainrub A, 2003, BIOPOLYMERS, V68, P265, DOI 10.1002/bip.10271; Vainrub A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041905; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913; Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064	31	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4808	10.1371/journal.pone.0004808	http://dx.doi.org/10.1371/journal.pone.0004808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OF	19277213	gold, Green Submitted, Green Published			2022-12-25	WOS:000265496100025
J	Jansen, S; Andries, M; Derua, R; Waelkens, E; Bollen, M				Jansen, Silvia; Andries, Maria; Derua, Rita; Waelkens, Etienne; Bollen, Mathieu			Domain Interplay Mediated by an Essential Disulfide Linkage Is Critical for the Activity and Secretion of the Metastasis-promoting Enzyme Autotaxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID; NUCLEOTIDE PYROPHOSPHATASES/PHOSPHODIESTERASES; LYSOPHOSPHOLIPASE-D; IDENTIFICATION; INVOLVEMENT	Autotaxin or NPP2 (nucleotide pyrophosphatase/phosphodiesterase 2) is a secreted lysophospholipase-D that promotes metastasis and tumor growth by its ability to generate lysophosphatidic acid. Considerable evidence suggests that inhibitors of NPP2 can be used as a novel therapy for the treatment of cancer. Although most attention is currently directed toward the development of inhibitors of the catalytic site, we have explored whether NPP2 can also be targeted through its non-catalytic nuclease-like domain. We demonstrate here that the catalytic and nuclease-like domains are covalently linked by an essential disulfide bridge between Cys(413) and Cys(805). Within the nuclease-like domain, residues 829-850 are involved in the secretion of NPP2, and Lys(852) is required for the expression of catalytic activity. These data show that the nuclease-like domain is crucial for catalysis by NPP2 and is a possible target to generate inhibitors.	[Jansen, Silvia; Andries, Maria; Bollen, Mathieu] Univ Louvain, Dept Mol Cell Biol, Lab Biosignalling & Therapeut, B-3000 Louvain, Belgium; [Derua, Rita; Waelkens, Etienne] Univ Louvain, Dept Mol Cell Biol, Lab Prot Phosphorylat & Prote, B-3000 Louvain, Belgium		Bollen, M (corresponding author), KULeuven, Dept Mol Celbiol, Campus Gasthuisberg,Herestraat 49,Box 901, B-3000 Louvain, Belgium.	Mathieu.Bollen@med.kuleuven.be			Scientific Research Flanders [0524.06]; Flemish Concerted Research Action; Prime Minister's office [IAP/V-05]	Scientific Research Flanders(FWO); Flemish Concerted Research Action; Prime Minister's office	This work was supported by grants from the Fund for Scientific Research Flanders (Grant G. 0524.06), a Flemish Concerted Research Action, and the Prime Minister's office (Grant IAP/V-05).	Baumforth KRN, 2005, BLOOD, V106, P2138, DOI 10.1182/blood-2005-02-0471; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Cimpean A, 2004, BIOCHEM J, V381, P71, DOI 10.1042/BJ20040465; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Gijsbers R, 2003, BIOCHEM J, V371, P321, DOI 10.1042/BJ20021943; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Hoelzinger DB, 2008, J NEURO-ONCOL, V86, P297, DOI 10.1007/s11060-007-9480-6; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Jansen S, 2007, J BIOL CHEM, V282, P11084, DOI 10.1074/jbc.M611503200; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Mazereeuw-Hautier J, 2005, J INVEST DERMATOL, V125, P421, DOI 10.1111/j.0022-202X.2005.23855.x; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Parrill AL, 2008, BIOORGAN MED CHEM, V16, P1784, DOI 10.1016/j.bmc.2007.11.018; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; van Meeteren LA, 2008, CANCER LETT, V266, P203, DOI 10.1016/j.canlet.2008.02.052; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196	22	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14296	14302		10.1074/jbc.M900790200	http://dx.doi.org/10.1074/jbc.M900790200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329427	Green Published, hybrid			2022-12-25	WOS:000266286100036
J	Sakaguchi, M; Kataoka, K; Abarzua, F; Tanimoto, R; Watanabe, M; Murata, H; Than, SS; Kurose, K; Kashiwakura, Y; Ochiai, K; Nasu, Y; Kumon, H; Huh, N				Sakaguchi, Masakiyo; Kataoka, Ken; Abarzua, Fernando; Tanimoto, Ryuta; Watanabe, Masami; Murata, Hitoshi; Than, Swe Swe; Kurose, Kaoru; Kashiwakura, Yuji; Ochiai, Kazuhiko; Nasu, Yasutomo; Kumon, Hiromi; Huh, Nam-ho			Overexpression of REIC/Dkk-3 in Normal Fibroblasts Suppresses Tumor Growth via Induction of Interleukin-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; REDUCED EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; T-CELLS; ACTIVATION; APOPTOSIS; MICE; MICROENVIRONMENT	We previously showed that the tumor suppressor gene REIC/Dkk-3, when overexpressed by an adenovirus (Ad-REIC), exhibited a dramatic therapeutic effect on human cancers through a mechanism triggered by endoplasmic reticulum stress. Adenovirus vectors show no target cell specificity and thus may elicit unfavorable side effects through infection of normal cells even upon intra-tumoral injection. In this study, we examined possible effects of Ad-REIC on normal cells. We found that infection of normal human fibroblasts (NHF) did not cause apoptosis but induced production of interleukin (IL)-7. The induction was triggered by endoplasmic reticulum stress and mediated through IRE1 alpha, ASK1, p38, and IRF-1. When Ad-REIC-infected NHF were transplanted in a mixture with untreated human prostate cancer cells, the growth of the cancer cells was significantly suppressed. Injection of an IL-7 antibody partially abrogated the suppressive effect of Ad-REIC-infected NHF. These results indicate that Ad-REIC has another arm against human cancer, an indirect host-mediated effect because of overproduction of IL-7 by mis-targeted NHF, in addition to its direct effect on cancer cells.	[Sakaguchi, Masakiyo; Kataoka, Ken; Abarzua, Fernando; Tanimoto, Ryuta; Murata, Hitoshi; Than, Swe Swe; Kurose, Kaoru; Huh, Nam-ho] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; [Abarzua, Fernando; Tanimoto, Ryuta; Watanabe, Masami; Kashiwakura, Yuji; Nasu, Yasutomo; Kumon, Hiromi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama 7008558, Japan; [Ochiai, Kazuhiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Innovat Ctr Okayama Nanobiotargeted Therapy, Okayama 7008558, Japan	Okayama University; Okayama University; Okayama University	Huh, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, 2-5-1 Shikatachou, Okayama 7008558, Japan.	namu@md.okayama-u.ac.jp	MURATA, Hitoshi/B-2327-2011; KATAOKA, Ken/B-1607-2011; Sakaguchi, Masakiyo/B-2280-2011	OCHIAI, Kazuhiko/0000-0002-5736-0598	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20015031]; Special Coordination Funds for Promoting Science and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant 20015031 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N.H.) and by Special Coordination Funds for Promoting Science and Technology (to H. K.).	Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Aragane Y, 1997, J IMMUNOL, V158, P5393; BAI L, 1993, INT J CANCER, V53, P451, DOI 10.1002/ijc.2910530317; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BUDZYNSKI W, 1994, IMMUNOPHARM IMMUNOT, V16, P319, DOI 10.3109/08923979409007097; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Fricker J, 1996, MOL MED TODAY, V2, P2, DOI 10.1016/1357-4310(96)88745-4; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Gollob JA, 1999, J IMMUNOL, V162, P4472; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Kawasaki K, 2009, CANCER GENE THER, V16, P65, DOI 10.1038/cgt.2008.58; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kobayashi K, 2002, GENE, V282, P151, DOI 10.1016/S0378-1119(01)00838-1; Kurose K, 2004, J UROLOGY, V171, P1314, DOI 10.1097/01.ju.0000101047.64379.d4; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miller PW, 2000, HUM GENE THER, V11, P53, DOI 10.1089/10430340050016157; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nozaki I, 2001, INT J ONCOL, V19, P117; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200; Sekine Y, 2006, CURR MOL MED, V6, P87, DOI 10.2174/156652406775574541; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Sportes C, 2007, ADV EXP MED BIOL, V601, P321; STOKER AW, 1990, J CELL BIOL, V111, P217, DOI 10.1083/jcb.111.1.217; Tanimoto R, 2007, INT J MOL MED, V19, P363; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Wittig B, 2001, HUM GENE THER, V12, P267, DOI 10.1089/10430340150218404; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	39	57	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14236	14244		10.1074/jbc.M808002200	http://dx.doi.org/10.1074/jbc.M808002200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19279003	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000266286100030
J	van Dieck, J; Fernandez-Fernandez, MR; Veprintsev, DB; Fersht, AR				van Dieck, Jan; Fernandez-Fernandez, Maria R.; Veprintsev, Dmitry B.; Fersht, Alan R.			Modulation of the Oligomerization State of p53 by Differential Binding of Proteins of the S100 Family to p53 Monomers and Tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CALCIUM; METASTASIS; ACTIVATION; DOMAIN; MUTATIONS; STABILITY; INSIGHTS; GROWTH	We investigated the ways S100B, S100A1, S100A2, S100A4, and S100A6 bind to the different oligomeric forms of the tumor suppressor p53 in vitro, using analytical ultracentrifugation and multiangle light scattering. It is established that members of the S100 protein family bind to the tetramerization domain (residues 325-355) of p53 when it is uncovered in the monomer, and so binding can disrupt the tetramer. We found a stoichiometry of one dimer of S100 bound to a monomer of p53. We discovered that some S100 proteins could also bind to the tetramer. S100B bound the tetramer and also disrupted the dimer by binding monomeric p53. S100A2 bound monomeric p53 as well as tetrameric, whereas S100A1 only bound monomeric p53. S100A6 bound more tightly to tetrameric than to monomeric p53. We also identified an additional binding site for S100 proteins in the transactivation domain (1-57) of p53. Based on our results and published observations in vivo, we propose a model for the binding of S100 proteins to p53 that can explain both activation and inhibition of p53-mediated transcription. Depending on the concentration of p53 and the member of the S100 family, binding can alter the balance between monomer and tetramer in either direction.	[Fersht, Alan R.] MRC Ctr Prot Engn, Cambridge CB2 0QH, England; MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Fersht, AR (corresponding author), MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	arf25@cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Fersht, Alan R/B-2189-2008	Veprintsev, Dmitry B/0000-0002-3583-5409; Fernandez-Fernandez, Maria Rosario/0000-0002-9128-5296	MRC [MC_U105474168] Funding Source: UKRI; Medical Research Council [MC_U105474168] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Appella E, 2000, PATHOL BIOL, V48, P227; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Chene Patrick, 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P151, DOI 10.2174/1568011013354741; Davies MPA, 1996, ONCOGENE, V13, P1631; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kim C, 2008, J CHROMATOGR A, V1213, P181, DOI 10.1016/j.chroma.2008.10.052; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Slomnicki LP, 2009, INT J BIOCHEM CELL B, V41, P784, DOI 10.1016/j.biocel.2008.08.007; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; TRATHNIGG B, 1995, PROG POLYM SCI, V20, P615, DOI 10.1016/0079-6700(95)00005-Z; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9	37	88	89	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13804	13811		10.1074/jbc.M901351200	http://dx.doi.org/10.1074/jbc.M901351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297317	Green Published, hybrid			2022-12-25	WOS:000265877300057
J	Zheng, J; Huang, J; Mao, YT; Liu, SQ; Sun, X; Zhu, XH; Ma, T; Zhang, L; Ji, JF; Zhang, YH; Yin, CC; Qiu, XY				Zheng, Jie; Huang, Jing; Mao, Yuntao; Liu, Shiqing; Sun, Xin; Zhu, Xiaohui; Ma, Teng; Zhang, Li; Ji, Jiafu; Zhang, Youhui; Yin, C. Cameron; Qiu, Xiaoyan			Immunoglobulin Gene Transcripts Have Distinct V(H)DJ(H) Recombination Characteristics in Human Epithelial Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; CHAIN CONSTANT-REGION; DNA-POLYMERASE-ETA; SOMATIC HYPERMUTATION; ABERRANT EXPRESSION; BREAST-CANCER; TUMOR-CELLS; B-CELLS; REARRANGEMENT; LYMPHOCYTES	It was well accepted that only B-lymphocytes and plasma cells expressed immunoglobulin (Ig) gene. However, our group and others have confirmed that non-B-cells, such as epithelial cancer cells, can also express Ig. The aim of this work is to elucidate the role of non-B-cell-derived Ig by investigating the characteristics of the Ig heavy chain (IgH) gene repertoire in epithelial cancer cells. We cloned and sequenced 89 V(H)DJ(H) (V-D-J recombination of the IgH variable region) transcripts by microdissecting cells from eight different types of epithelial cancers and two cancer cell lines (HT-29 and HeLa S3). The cancer-derived Ig gene repertoire showed specific restricted patterns of V(H)DJ(H) recombination with seven sets of predominant V(H)DJ(H) sequences. Surprisingly, within a set of V(H)DJ(H) recombination, the variable (V) sequences derived from different cancer types had not only identical heavy chain variable (V-H), diversity (D), and joining (JH) segments usage, but also identical junctions and mutation targets in the V-H region. The V(H gamma)DJ(H gamma) (but not V(H mu)DJ(H mu)) in the cancer-derived sequences had a high mutation rate; however, it was shown that the mechanism of hypermutation was different from antigen selection in B-cell-derived V(H gamma)DJ(H gamma) sequences. In contrast to V(H mu)DJ(H mu), the V(H gamma)DJ(H gamma) sequences did not appear to originate from classical class switching. These results suggest that cancer-derived Ig genes have a distinct repertoire that may have implications for their role in carcinogenesis.	[Zheng, Jie; Huang, Jing; Mao, Yuntao; Liu, Shiqing; Sun, Xin; Zhu, Xiaohui; Ma, Teng; Zhang, Li; Qiu, Xiaoyan] Peking Univ, Ctr Human Dis Genom, Beijing 100191, Peoples R China; [Zhang, Youhui] Chinese Acad Med Sci, Inst Canc, Dept Immunol, Beijing 100021, Peoples R China; [Zhang, Youhui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ji, Jiafu] Peking Univ, Sch Oncol, Dept Surg, Beijing 100142, Peoples R China; [Yin, C. Cameron] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; University of Texas System; UTMD Anderson Cancer Center	Qiu, XY (corresponding author), Peking Univ, Ctr Human Dis Genom, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	qiuxy@bjmu.edu.cn	Mao, Yuntao/E-9168-2012; ma, teng/C-3274-2014	ma, teng/0000-0003-2826-721X; JI, JIAFU/0000-0001-6878-5543; Ma, Teng/0000-0002-8360-1543	Natural Sciences Foundation, China [30371609, 30572094]	Natural Sciences Foundation, China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Grants 30371609 and 30572094 from the Natural Sciences Foundation, China.	Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; BARTRAM CR, 1986, BLUT, V52, P203, DOI 10.1007/BF00321079; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; CLEARY ML, 1984, P NATL ACAD SCI-BIOL, V81, P593, DOI 10.1073/pnas.81.2.593; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Dorner T, 1997, J IMMUNOL, V158, P2779; Fraternali-Orcioni G, 1999, AM J SURG PATHOL, V23, P717, DOI 10.1097/00000478-199906000-00012; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; Gregersen H, 2001, HAEMATOLOGICA, V86, P1172; Hansen MH, 2001, P NATL ACAD SCI USA, V98, P12659, DOI 10.1073/pnas.171460798; Hori H, 2000, Nihon Shokakibyo Gakkai Zasshi, V97, P1373; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; MANJULA S, 1992, ACTA NEUROCHIR, V115, P103, DOI 10.1007/BF01406366; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mayorov VI, 2005, J IMMUNOL, V174, P7781, DOI 10.4049/jimmunol.174.12.7781; Messmer BT, 2004, BLOOD, V103, P3490, DOI 10.1182/blood-2003-10-3407; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821; NERI A, 1987, BLOOD, V70, P1519; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Nzula S, 2003, CANCER RES, V63, P3275; O'Brien PM, 2001, CANCER IMMUNOL IMMUN, V50, P523, DOI 10.1007/s00262-001-0234-6; Olubuyide I O, 1993, Afr J Med Med Sci, V22, P57; Oprea M, 2001, J IMMUNOL, V166, P892, DOI 10.4049/jimmunol.166.2.892; Qiu XY, 2003, CANCER RES, V63, P6488; Qu X., 1996, CHINESE J IMMUNOLOGY, V5, P296; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Spencer J, 1999, J IMMUNOL, V162, P6596; TAMARU J, 1995, AM J PATHOL, V147, P1398; Taylor DD, 1998, ONCOL REP, V5, P1519; TENENBAUM N, 1992, ANN MED INTERNE, V143, P89; TONEGAWA S, 1976, P NATL ACAD SCI USA, V73, P203, DOI 10.1073/pnas.73.1.203; Wang D., 2000, J BEIJING MED U, V32, P310; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhu XH, 2008, APPL IMMUNOHISTO M M, V16, P232, DOI 10.1097/PAI.0b013e31814c915a; ZUNIGA MC, 1982, P NATL ACAD SCI-BIOL, V79, P3015, DOI 10.1073/pnas.79.9.3015	42	55	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13610	13619		10.1074/jbc.M809524200	http://dx.doi.org/10.1074/jbc.M809524200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19293154	Green Published, hybrid			2022-12-25	WOS:000265877300038
J	Creagh, EM; Brumatti, G; Sheridan, C; Duriez, PJ; Taylor, RC; Cullen, SP; Adrain, C; Martin, SJ				Creagh, Emma M.; Brumatti, Gabriela; Sheridan, Clare; Duriez, Patrick J.; Taylor, Rebecca C.; Cullen, Sean P.; Adrain, Colin; Martin, Seamus J.			Bicaudal Is a Conserved Substrate for Drosophila and Mammalian Caspases and Is Essential for Cell Survival	PLOS ONE			English	Article							INDUCED APOPTOSIS; C-ELEGANS; ACTIVATION; DEATH; INHIBITOR; DRONC; IDENTIFICATION; COMPLEX; PATHWAYS; PROTEINS	Members of the caspase family of cysteine proteases coordinate cell death through restricted proteolysis of diverse protein substrates and play a conserved role in apoptosis from nematodes to man. However, while numerous substrates for the mammalian cell death-associated caspases have now been described, few caspase substrates have been identified in other organisms. Here, we have utilized a proteomics-based approach to identify proteins that are cleaved by caspases during apoptosis in Drosophila D-Mel2 cells, a subline of the Schneider S2 cell line. This approach identified multiple novel substrates for the fly caspases and revealed that bicaudal/beta NAC is a conserved substrate for Drosophila and mammalian caspases. RNAi-mediated silencing of bicaudal expression in Drosophila D-Mel2 cells resulted in a block to proliferation, followed by spontaneous apoptosis. Similarly, silencing of expression of the mammalian bicaudal homologue, beta NAC, in HeLa, HEK293T, MCF-7 and MRC5 cells also resulted in spontaneous apoptosis. These data suggest that bicaudal/beta NAC is essential for cell survival and is a conserved target of caspases from flies to man.	[Creagh, Emma M.; Brumatti, Gabriela; Sheridan, Clare; Duriez, Patrick J.; Taylor, Rebecca C.; Cullen, Sean P.; Adrain, Colin; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin, Ireland	Trinity College Dublin	Creagh, EM (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin, Ireland.	martinsj@tcd.ie	Adrain, Colin/I-6259-2013; Creagh, Emma/AAX-1064-2021	Adrain, Colin/0000-0001-7597-4393; Creagh, Emma/0000-0001-7631-4370; Taylor, Rebecca/0000-0003-3429-3123; Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [PI.1/B038]; Health Research Board of Ireland [post-doctoral fellowship]; Irish Research Council for Science and Engineering Technologies (IRCSET) [post-doctoral fellowship]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; Irish Research Council for Science and Engineering Technologies (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by a grant from Science Foundation Ireland (PI.1/B038) to S.J.M.. E.M.C. was supported, in part, by a post-doctoral fellowship award from the Health Research Board of Ireland. G.B. was supported, in part, by a post-doctoral fellowship award from the Irish Research Council for Science and Engineering Technologies (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Igaki T, 2002, J BIOL CHEM, V277, P23103, DOI 10.1074/jbc.C200222200; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Markesich DC, 2000, DEVELOPMENT, V127, P559; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Taylor RC, 2007, J BIOL CHEM, V282, P15011, DOI 10.1074/jbc.M611051200; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2009	4	3							e5055	10.1371/journal.pone.0005055	http://dx.doi.org/10.1371/journal.pone.0005055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PP	19330035	Green Published, gold, Green Accepted			2022-12-25	WOS:000265499700005
J	Burns, DM; Ying, WH; Kauppinen, TM; Zhu, KQ; Swanson, RA				Burns, David M.; Ying, Weihai; Kauppinen, Tiina M.; Zhu, Keqing; Swanson, Raymond A.			Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase	PLOS ONE			English	Article								Background: The formation of ADP-ribose polymers on target proteins by poly(ADP-ribose) polymerases serves a variety of cell signaling functions. In addition, extensive activation of poly(ADP-ribose) polymerase-1 (PARP-1) is a dominant cause of cell death in ischemia-reperfusion, trauma, and other conditions. Poly(ADP-ribose) glycohydrolase (PARG) degrades the ADP-ribose polymers formed on acceptor proteins by PARP-1 and other PARP family members. PARG exists as multiple isoforms with differing subcellular localizations, but the functional significance of these isoforms is uncertain. Methods/Principal Findings: Primary mouse astrocytes were treated with an antisense phosphorodiamidate morpholino oligonucleotide (PMO) targeted to exon 1 of full-length PARG to suppress expression of this nuclear-specific PARG isoform. The antisense-treated cells showed down-regulation of both nuclear PARG immunoreactivity and nuclear PARG enzymatic activity, without significant alteration in cytoplasmic PARG activity. When treated with the genotoxic agent MNNG to induced PARP-1 activation, the antisense-treated cells showed a delayed rate of nuclear PAR degradation, reduced nuclear condensation, and reduced cell death. Conclusions/Significance: These results support a preferentially nuclear localization for full-length PARG, and suggest a key role for this isoform in the PARP-1 cell death pathway.	[Burns, David M.; Ying, Weihai; Kauppinen, Tiina M.; Zhu, Keqing; Swanson, Raymond A.] VA Med Ctr, San Francisco, CA USA; [Burns, David M.; Ying, Weihai; Kauppinen, Tiina M.; Zhu, Keqing; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Burns, DM (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	raymond.swanson@ucsf.edu	Kauppinen, Tiina/I-1009-2019	Swanson, Raymond/0000-0002-3664-5359; Kauppinen, Tiina/0000-0001-7219-9862	U.S. Dept. of Veterans Affairs; NIH [RO1 NS41421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041421] Funding Source: NIH RePORTER	U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. Dept. of Veterans Affairs and by the NIH (RO1 NS41421; RAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ame JC, 1999, MOL CELL BIOCHEM, V193, P75, DOI 10.1023/A:1006912210439; Bakondi E, 2004, EXP DERMATOL, V13, P170, DOI 10.1111/j.0906-6705.2004.0150.x; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cozzi A, 2006, J CEREBR BLOOD F MET, V26, P684, DOI 10.1038/sj.jcbfm.9600222; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; FORMENTINI L, 2008, BR J PHARM; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Haince JF, 2006, BBA-MOL CELL RES, V1763, P226, DOI 10.1016/j.bbamcr.2005.11.015; HERTZER NR, 1985, J VASC SURG, V2, P661, DOI 10.1067/mva.1985.avs0020661; Hwang JJ, 2002, J NEUROCHEM, V82, P894, DOI 10.1046/j.1471-4159.2002.01040.x; Jaiswal AS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-3; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Lu XCM, 2003, BRAIN RES, V978, P99, DOI 10.1016/S0006-8993(03)02774-4; MENARD L, 1987, BIOCHEM CELL BIOL, V65, P668, DOI 10.1139/o87-088; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Purrello VS, 2002, MECH AGEING DEV, V123, P511, DOI 10.1016/S0047-6374(01)00354-2; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scortegagna M, 2000, NEUROCHEM RES, V25, P861, DOI 10.1023/A:1007577710066; Sevigny MB, 2003, MOL BRAIN RES, V117, P213, DOI 10.1016/S0169-328X(03)00325-5; Sheline CT, 2003, EUR J NEUROSCI, V18, P1402, DOI 10.1046/j.1460-9568.2003.02865.x; St-Laurent JF, 2007, DNA REPAIR, V6, P329, DOI 10.1016/j.dnarep.2006.10.027; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; TANUMA SI, 1986, J BIOL CHEM, V261, P965; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579	40	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2009	4	3							e4896	10.1371/journal.pone.0004896	http://dx.doi.org/10.1371/journal.pone.0004896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PK	19319190	gold, Green Published, Green Submitted			2022-12-25	WOS:000265499200004
J	Grosskinsky, S; Schott, M; Brenner, C; Cutler, SJ; Kraiczy, P; Zipfel, PF; Simon, MM; Wallich, R				Grosskinsky, Sonja; Schott, Melanie; Brenner, Christiane; Cutler, Sally J.; Kraiczy, Peter; Zipfel, Peter F.; Simon, Markus M.; Wallich, Reinhard			Borrelia recurrentis Employs a Novel Multifunctional Surface Protein with Anti-Complement, Anti-Opsonic and Invasive Potential to Escape Innate Immunity	PLOS ONE			English	Article								Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of B. recurrentis, termed HcpA, and demonstrate that it binds human complement regulators, Factor H, CFHR-1, and simultaneously, the host protease plasminogen. Cell surface bound factor H was found to retain its activity and to confer resistance to complement attack. Moreover, ectopic expression of HcpA in a B. burgdorferi B313 strain, deficient in Factor H binding proteins, protected the transformed spirochetes from complement-mediated killing. Furthermore, HcpA-bound plasminogen/plasmin endows B. recurrentis with the potential to resist opsonization and to degrade extracellular matrix components. Together, the present study underscores the high virulence potential of B. recurrentis. The elucidation of the molecular basis underlying the versatile strategies of B. recurrentis to escape innate immunity and to persist in human tissues, including the brain, may help to understand the pathological processes underlying louse-borne relapsing fever.	[Grosskinsky, Sonja; Schott, Melanie; Brenner, Christiane; Wallich, Reinhard] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Cutler, Sally J.] Univ E London, Sch Hlth & Biosci, Stratford, England; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Zipfel, Peter F.] Leibniz Inst Nat Products Res, Dept Infect Biol, Jena, Germany; [Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, Freiburg, Germany	Ruprecht Karls University Heidelberg; University of East London; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Max Planck Society	Grosskinsky, S (corresponding author), Univ Heidelberg, Inst Immunol, Neuenheimer Feld 305, D-6900 Heidelberg, Germany.	wallich@uni-hd.de	Cutler, Sally/AAT-3350-2020		Deutsche Forschungsgemeinschaft [Wa 533/7-1, Wa 533/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by the Deutsche Forschungsgemeinschaft to RW (Wa 533/7-1 and Wa 533/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1982, J EXP MED, V156, P1312, DOI 10.1084/jem.156.5.1312; Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; BARBOUR AG, 1991, MOL MICROBIOL, V5, P489, DOI 10.1111/j.1365-2958.1991.tb02132.x; BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155, DOI 10.1146/annurev.mi.44.100190.001103; BRISSETTE CA, 2008, BORRELIA BURGDORFERI, DOI DOI 10.1128/IAI.01133-08; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Coleman AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003010; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; CUTLER SJ, 2001, MOL MED MICROBIOLOGY, P2093; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Houhamdi L, 2005, J INFECT DIS, V191, P1898, DOI 10.1086/429920; Hovis KM, 2006, INFECT IMMUN, V74, P4519, DOI 10.1128/IAI.00377-06; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Kraiczy P, 2004, INT J MED MICROBIOL, V293, P152, DOI 10.1016/S1433-1128(04)80029-9; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; KRAMER MD, 1990, IMMUNOBIOLOGY, V181, P357, DOI 10.1016/S0171-2985(11)80504-8; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; KUHN S, 1995, J IMMUNOL, V155, P5663; McDowell JV, 2003, J CLIN MICROBIOL, V41, P3905, DOI 10.1128/JCM.41.8.3905-3910.2003; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Neeleman C, 1999, INFECT IMMUN, V67, P4517, DOI 10.1128/IAI.67.9.4517-4524.1999; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Ras NM, 2000, RES MICROBIOL, V151, P5, DOI 10.1016/S0923-2508(00)00133-9; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rossmann E, 2008, INT J MED MICROBIOL, V298, P272, DOI 10.1016/j.ijmm.2008.02.003; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Scott JC, 2005, EMERG INFECT DIS, V11, P1722, DOI 10.3201/eid1111.050483; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SOUTHERN PM, 1969, MEDICINE, V48, P129, DOI 10.1097/00005792-196903000-00002; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; SUNDNES KO, 1993, LANCET, V342, P1213, DOI 10.1016/0140-6736(93)92190-5; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	51	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4858	10.1371/journal.pone.0004858	http://dx.doi.org/10.1371/journal.pone.0004858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19308255	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265499000003
J	Cattoli, G; Monne, I; Fusaro, A; Joannis, TM; Lombin, LH; Aly, MM; Arafa, AS; Sturm-Ramirez, KM; Couacy-Hymann, E; Awuni, JA; Batawui, KB; Awoume, KA; Aplogan, GL; Sow, A; Ngangnou, AC; Hamza, IMEN; Gamatie, D; Dauphin, G; Domenech, JM; Capua, I				Cattoli, Giovanni; Monne, Isabella; Fusaro, Alice; Joannis, Tony M.; Lombin, Lami H.; Aly, Mona M.; Arafa, Abdel S.; Sturm-Ramirez, Katharine M.; Couacy-Hymann, Emmanuel; Awuni, Joseph A.; Batawui, Komla B.; Awoume, Kodzo A.; Aplogan, Gilbert L.; Sow, Adama; Ngangnou, Andre C.; Hamza, Iman M. El Nasri; Gamatie, Djibo; Dauphin, Gwenaelle; Domenech, Joseph M.; Capua, Ilaria			Highly Pathogenic Avian Influenza Virus Subtype H5N1 in Africa: A Comprehensive Phylogenetic Analysis and Molecular Characterization of Isolates	PLOS ONE			English	Article							A VIRUSES; NEURAMINIDASE INHIBITORS; PCR ASSAY; HEMAGGLUTININ; EVOLUTION; BINDING; INTRODUCTIONS; MUTATIONS; NIGERIA; H7	Highly pathogenic avian influenza virus A/H5N1 was first officially reported in Africa in early 2006. Since the first outbreak in Nigeria, this virus spread rapidly to other African countries. From its emergence to early 2008, 11 African countries experienced A/H5N1 outbreaks in poultry and human cases were also reported in three of these countries. At present, little is known of the epidemiology and molecular evolution of A/H5N1 viruses in Africa. We have generated 494 full gene sequences from 67 African isolates and applied molecular analysis tools to a total of 1,152 A/H5N1 sequences obtained from viruses isolated in Africa, Europe and the Middle East between 2006 and early 2008. Detailed phylogenetic analyses of the 8 gene viral segments confirmed that 3 distinct sublineages were introduced, which have persisted and spread across the continent over this 2-year period. Additionally, our molecular epidemiological studies highlighted the association between genetic clustering and area of origin in a majority of cases. Molecular signatures unique to strains isolated in selected areas also gave us a clearer picture of the spread of A/H5N1 viruses across the continent. Mutations described as typical of human influenza viruses in the genes coding for internal proteins or associated with host adaptation and increased resistance to antiviral drugs have also been detected in the genes coding for transmembrane proteins. These findings raise concern for the possible human health risk presented by viruses with these genetic properties and highlight the need for increased efforts to monitor the evolution of A/H5N1 viruses across the African continent. They further stress how imperative it is to implement sustainable control strategies to improve animal and public health at a global level.	[Cattoli, Giovanni; Monne, Isabella; Fusaro, Alice; Capua, Ilaria] Ist Zooprofilatt Sperle Venezie, OIE FAO Reference Lab Avian Influenza & Newcastle, Legnaro, PD, Italy; [Joannis, Tony M.; Lombin, Lami H.] Natl Vet Res Inst, Vom, Nigeria; [Aly, Mona M.; Arafa, Abdel S.] Natl Lab Qual Control Poultry Product, Cairo, Egypt; [Sturm-Ramirez, Katharine M.] Fogarty Int Ctr, NIH, Bethesda, MD USA; [Couacy-Hymann, Emmanuel] Lab Cent Pathol Anim, Bingerville, Cote Ivoire; [Awuni, Joseph A.] Accra Vet Lab, Accra, Ghana; [Batawui, Komla B.; Awoume, Kodzo A.] Lab Cent Vet, Lome, Togo; [Aplogan, Gilbert L.] Lab Diagnost Vet Serosurveillance, Parakou, Benin; [Sow, Adama] Lab Natl Elevage, Ouagadougou, Burkina Faso; [Ngangnou, Andre C.] Lab Natl Vet, Garoua, Cameroon; [Hamza, Iman M. El Nasri] Cent Vet Res Lab, Khartoum, Sudan; [Gamatie, Djibo] Direct Lab Vet, Niamey, Niger; [Dauphin, Gwenaelle; Domenech, Joseph M.] Food & Agr Org UN, AGAH Div, Rome, Italy	IZS delle Venezie; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Food & Agriculture Organization of the United Nations (FAO)	Cattoli, G (corresponding author), Ist Zooprofilatt Sperle Venezie, OIE FAO Reference Lab Avian Influenza & Newcastle, Legnaro, PD, Italy.	gcattoli@izsvenezie.it	Monne, Isabella/K-7652-2016; Fusaro, Alice/J-4538-2019; Arafa, Abdelsatar/L-2724-2013	Monne, Isabella/0000-0002-6564-4689; Fusaro, Alice/0000-0002-8213-5472; Arafa, Abdelsatar/0000-0001-6370-2526; Awuni, Joseph Agebase/0000-0003-0940-9462	Food and Agricultural Organization of the United Nations (UN-FAO); EU-projects EPIZONE; FLUTRAIN	Food and Agricultural Organization of the United Nations (UN-FAO); EU-projects EPIZONE; FLUTRAIN	The Food and Agricultural Organization of the United Nations (UN-FAO) financially supported part of this project and facilitated samples collection and submission. The EU-projects EPIZONE (Network of excellence for epizootic disease diagnosis and control) and FLUTRAIN (Training and technology transfer of avian influenza diagnostics and disease management skills) also contributed to the realization of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1981, AVIAN PATHOL, V10, P281, DOI 10.1080/03079458108418477; Bertolotti L, 2007, VIROLOGY, V360, P143, DOI 10.1016/j.virol.2006.10.030; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; *EUR COMM, 2005, OFFICIAL J EUROPEA L, V10; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Joannis T, 2006, VET REC, V158, P309, DOI 10.1136/vr.158.9.309-b; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Monne I, 2008, EMERG INFECT DIS, V14, P637, DOI 10.3201/eid1404.071178; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; SAAD MD, 2007, DETECTION OSELTAMIVI; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Swan S., 2004, SMALL SCALE POULTRY; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; *WHO, CUM NUMB CONF HUM GA; *WHO WORLD ORG AN, 2008, EMERG INFECT DIS JUL; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Zhou JJ, 2007, ARCH VIROL, V152, P1515, DOI 10.1007/s00705-007-0985-2	34	86	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4842	10.1371/journal.pone.0004842	http://dx.doi.org/10.1371/journal.pone.0004842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290041	Green Submitted, gold, Green Published			2022-12-25	WOS:000265496500002
J	Wu, DM; Pang, YH; Ke, YH; Yu, JX; He, Z; Tautz, L; Mustelin, T; Ding, S; Huang, ZW; Feng, GS				Wu, Dongmei; Pang, Yuhong; Ke, Yuehai; Yu, Jianxiu; He, Zhao; Tautz, Lutz; Mustelin, Tomas; Ding, Sheng; Huang, Ziwei; Feng, Gen-Sheng			A Conserved Mechanism for Control of Human and Mouse Embryonic Stem Cell Pluripotency and Differentiation by Shp2 Tyrosine Phosphatase	PLOS ONE			English	Article							SELF-RENEWAL; DIVERGENT PATHS; SUPPRESSION; PROLIFERATION; MAINTENANCE; ACTIVATION; MAINTAIN; DELETION; STAT3; MICE	Recent studies have suggested distinctive biological properties and signaling mechanisms between human and mouse embryonic stem cells (hESCs and mESCs). Herein we report that Shp2, a protein tyrosine phosphatase with two SH2 domains, has a conserved role in orchestration of intracellular signaling cascades resulting in initiation of differentiation in both hESCs and mESCs. Homozygous deletion of Shp2 in mESCs inhibited differentiation into all three germ layers, and siRNA-mediated knockdown of Shp2 expression in hESCs led to a similar phenotype of impaired differentiation. A small molecule inhibitor of Shp2 enzyme suppressed both hESC and mESC differentiation capacity. Shp2 modulates Erk, Stat3 and Smad pathways in ES cells and, in particular, Shp2 regulates BMP4-Smad pathway bi-directionally in mESCs and hESCs. These results reveal a common signaling mechanism shared by human and mouse ESCs via Shp2 modulation of overlapping and divergent pathways.	[Wu, Dongmei; Pang, Yuhong; Ke, Yuehai; Yu, Jianxiu; He, Zhao; Tautz, Lutz; Mustelin, Tomas; Huang, Ziwei; Feng, Gen-Sheng] Burnham Inst Med Res, Program Signal Transduct, La Jolla, CA USA; [Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute	Wu, DM (corresponding author), Burnham Inst Med Res, Program Signal Transduct, La Jolla, CA USA.	gfeng@burnham.org	Tautz, Lutz/M-9989-2014; he, zhao/S-4989-2019; Yu, Jianxiu/A-7214-2012	Tautz, Lutz/0000-0002-4075-6238; Mustelin, Tomas/0000-0001-5912-8840	NIH [R01CA78606, P20GM075059]; California Institute of Regenerative Medicine (CIRM) [postdoctoral fellowship]; NATIONAL CANCER INSTITUTE [R01CA078606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01CA78606 and a pilot project of P20GM075059 to G.S.F.. Y.P. is a recipient of a postdoctoral fellowship from California Institute of Regenerative Medicine (CIRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2003, BLOOD, V102, P2074, DOI 10.1182/blood-2003-04-1171; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Lai LA, 2004, TOP CURR GENET, V5, P275; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sumi T, 2004, STEM CELLS, V22, P861, DOI 10.1634/stemcells.22-5-861; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	43	45	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2009	4	3							e4914	10.1371/journal.pone.0004914	http://dx.doi.org/10.1371/journal.pone.0004914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OJ	19290061	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496500013
J	Abraham, A; von Cramon, DY				Abraham, Anna; von Cramon, D. Yves			Reality = Relevance? Insights from Spontaneous Modulations of the Brain's Default Network when Telling Apart Reality from Fiction	PLOS ONE			English	Article							WANDERING MINDS; NEURAL SYSTEMS; MEMORY; SELF; ACTIVATION; METAANALYSIS; HIPPOCAMPUS; PERCEPTION; THINKING; CONTEXT	Background: Although human beings regularly experience fictional worlds through activities such as reading novels and watching movies, little is known about what mechanisms underlie our implicit knowledge of the distinction between reality and fiction. The first neuroimaging study to address this issue revealed that the mere exposure to contexts involving real entities compared to fictional characters led to engagement of regions in the anterior medial prefrontal and posterior cingulate cortices (amPFC, PCC). As these core regions of the brain's default network are involved during self-referential processing and autobiographical memory retrieval, it was hypothesized that real entities may be conceptually coded as being more personally relevant to us than fictional characters. Methodology/Principal Findings: In the present functional magnetic resonance imaging (fMRI) study, we directly test the hypothesis that entity-associated personal relevance is the critical factor underlying the differential engagement of these brain regions by comparing the brain's response when processing contexts involving family or friends (high relevance), famous people (medium relevance), or fictional characters (low relevance). In line with predictions, a gradient pattern of activation was observed such that higher entity-associated personal relevance was associated with stronger activation in the amPFC and the PCC. Conclusions/Significance: The results of the study have several important implications. Firstly, they provide informed grounds for characterizing the dynamics of reality-fiction distinction. Secondly, they provide further insights into the functions of the amPFC and the PCC. Thirdly, in view of the current debate related to the functional relevance and specificity of brain's default network, they reveal a novel approach by which the functions of this network can be further explored.	[Abraham, Anna; von Cramon, D. Yves] Max Planck Inst Human Brain & Cognit Sci, Dept Cognit Neurol, Leipzig, Germany; [Abraham, Anna] Univ Giessen, Dept Clin Psychol, D-35390 Giessen, Germany; [von Cramon, D. Yves] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	Max Planck Society; Justus Liebig University Giessen; Max Planck Society	Abraham, A (corresponding author), Max Planck Inst Human Brain & Cognit Sci, Dept Cognit Neurol, Leipzig, Germany.	abraham@cbs.mpg.de			Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	The study was funded by the Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2008, BRAIN RES, V1233, P106, DOI 10.1016/j.brainres.2008.07.084; Abraham A, 2008, J COGNITIVE NEUROSCI, V20, P965, DOI 10.1162/jocn.2008.20059; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2007, HIPPOCAMPUS, V17, P420, DOI 10.1002/hipo.20287; BARGH JA, 1982, J PERS SOC PSYCHOL, V43, P425, DOI 10.1037/0022-3514.43.3.425; Boyer P, 1997, CHILD DEV, V68, P1012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Chaminade T, 2007, SOC COGN AFFECT NEUR, V2, P206, DOI 10.1093/scan/nsm017; Eichenbaum HB, 1998, HIPPOCAMPUS, V8, P197, DOI 10.1002/(SICI)1098-1063(1998)8:3<197::AID-HIPO1>3.0.CO;2-H; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fitzsimons GM, 2003, J PERS SOC PSYCHOL, V84, P148, DOI 10.1037/0022-3514.84.1.148; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Gillath O, 2006, PERS SOC PSYCHOL B, V32, P1375, DOI 10.1177/0146167206290339; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2007, SOC COGN AFFECT NEUR, V2, P199, DOI 10.1093/scan/nsm011; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mason MF, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1141078; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Moscovitch M, 2008, CAN J EXP PSYCHOL, V62, P62, DOI 10.1037/1196-1961.62.1.62; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; ROSENGREN KS, 1994, CHILD DEV, V65, P1605, DOI 10.2307/1131283; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schmitz TW, 2006, NEUROIMAGE, V30, P1050, DOI 10.1016/j.neuroimage.2005.10.030; Skolnick D., 2006, ARCHITECTURE IMAGINA, P73, DOI [DOI 10.1093/ACPROF:OSO/9780199275731.001.0001, DOI 10.1093/ACPROF:OSO/9780199275731.003.0005]; Skolnick D, 2006, COGNITION, V101, pB9, DOI 10.1016/j.cognition.2005.10.001; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Spreng RN, 2008, J COGN NEUROSCI; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Szpunar KK, 2008, CONSCIOUS COGN, V17, P330, DOI 10.1016/j.concog.2007.04.006; Talairach J., 1988, COPLANAR STEREOTAXIC; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; van den Bos W, 2007, COGN AFFECT BEHAV NE, V7, P337, DOI 10.3758/CABN.7.4.337; Woolley JD, 2007, DEVELOPMENTAL SCI, V10, P681, DOI 10.1111/j.1467-7687.2007.00612.x; Woolley JD, 2006, CHILD DEV, V77, P1778, DOI 10.1111/j.1467-8624.2006.00973.x; Woolley JD, 1997, CHILD DEV, V68, P991, DOI 10.2307/1132282; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	53	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2009	4	3							e4741	10.1371/journal.pone.0004741	http://dx.doi.org/10.1371/journal.pone.0004741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OF	19277108	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000265496100008
J	Zhang, C; Yang, N; Yang, CH; Ding, HS; Luo, C; Zhang, Y; Wu, MJ; Zhang, XW; Shen, X; Jiang, HL; Meng, LH; Ding, J				Zhang, Chao; Yang, Na; Yang, Chun-hao; Ding, Hua-sheng; Luo, Cheng; Zhang, Yu; Wu, Mao-jiang; Zhang, Xiong-wen; Shen, Xu; Jiang, Hua-Liang; Meng, Ling-hua; Ding, Jian			S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton	PLOS ONE			English	Article								Background: Deregulation of the phosphatidylinositol 3-kinases (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway plays a central role in tumor formation and progression, providing validated targets for cancer therapy. S9, a hybrid of alpha-methylene-gamma-lactone and 2-phenyl indole compound, possessed potent activity against this pathway. Methodology/Principal Findings: Effects of S9 on PI3K-Akt-mTOR pathway were determined by Western blot, immunofluorescence staining and in vitro kinas assay. The interactions between tubulin and S9 were investigated by polymerization assay, CD, and SPR assay. The potential binding modes between S9 and PI3K, mTOR or tubulin were analyzed by molecular modeling. Anti-tumor activity of S9 was evaluated in tumor cells and in nude mice bearing human cancer xenografts. S9 abrogated EGF-activated PI3K-Akt-mTOR signaling cascade and Akt translocation to cellular membrane in human tumor cells. S9 possessed inhibitory activity against both PI3K and mTOR with little effect on other tested 30 kinases. S9 also completely impeded hyper-phosphorylation of Akt as a feedback of inhibition of mTOR by rapamycin. S9 unexpectedly arrested cells in M phase other than G1 phase, which was distinct from compounds targeting PI3K-Akt-mTOR pathway. Further study revealed that S9 inhibited tubulin polymerization via binding to colchicine-binding site of tubulin and resulted in microtubule disturbance. Molecular modeling indicated that S9 could potentially bind to the kinase domains of PI3K p110 alpha subunit and mTOR, and shared similar hydrophobic interactions with colchicines in the complex with tubulin. Moreover, S9 induced rapid apoptosis in tumor cell, which might reflect a synergistic cooperation between blockade of both PI3-Akt-mTOR signaling and tubulin cytoskeleton. Finally, S9 displayed potent antiproliferative activity in a panel of tumor cells originated from different tissue types including drug-resistant cells and in nude mice bearing human tumor xenografts. Conclusions/Significance: Taken together, S9 targets both PI3K-Akt-mTOR signaling and microtubule cytoskeleton, which combinatorially contributes its antitumor activity and provides new clues for anticancer drug design and development.	[Zhang, Chao; Yang, Na; Zhang, Xiong-wen; Meng, Ling-hua; Ding, Jian] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China; [Yang, Chun-hao; Ding, Hua-sheng; Wu, Mao-jiang] Chinese Acad Sci, Shanghai Inst Mat Med, Div Organ Synthesis, Shanghai 200031, Peoples R China; [Luo, Cheng; Zhang, Yu; Shen, Xu; Jiang, Hua-Liang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Shen, Xu; Jiang, Hua-Liang] East China Univ Sci & Technol, Sch Pharm, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology	Zhang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	lhmeng@mail.shcnc.ac.cn; jding@mail.shcnc.ac.cn	Zhang, Yu/J-5225-2014; meng, linghua/Y-8110-2019		Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-YW-R-25]; National Natural Science Foundation of China [30721005, 90713034]; Science and Technology Commission of Shanghai Municipality Pujiang Talent Program [08PJ14114, 07dz05906]	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Pujiang Talent Program(Science & Technology Commission of Shanghai Municipality (STCSM))	Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R-25), National Natural Science Foundation of China (30721005, 90713034), Science and Technology Commission of Shanghai Municipality Pujiang Talent Program (08PJ14114), Grant 07dz05906. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Ding HS, 2005, BIOORG MED CHEM LETT, V15, P4799, DOI 10.1016/j.bmcl.2005.07.050; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gastpar R, 1998, J MED CHEM, V41, P4965, DOI 10.1021/jm980228l; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P1091; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Maira SM, 2008, EXPERT OPIN THER TAR, V12, P223, DOI 10.1517/14728222.12.2.223 ; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NOBES CD, 1995, J CELL SCI, V108, P225; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; PANDA HPM, RAPID TREADMILLING B; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Tong YG, 2006, MOL PHARMACOL, V69, P1226, DOI 10.1124/mol.105.020537; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wipf P, 2005, ORG BIOMOL CHEM, V3, P2053, DOI 10.1039/B504418a; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang C, 2006, BRIT J PHARMACOL, V148, P741, DOI 10.1038/sj.bjp.0706741; Zhang LH, 2006, CANCER RES, V66, P951, DOI 10.1158/0008-5472.CAN-05-2083	33	85	94	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4881	10.1371/journal.pone.0004881	http://dx.doi.org/10.1371/journal.pone.0004881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293927	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496600007
J	Treadway, MT; Grant, MM; Ding, ZH; Hollon, SD; Gore, JC; Shelton, RC				Treadway, Michael T.; Grant, Merida M.; Ding, Zhaohua; Hollon, Steven D.; Gore, John C.; Shelton, Richard C.			Early Adverse Events, HPA Activity and Rostral Anterior Cingulate Volume in MDD	PLOS ONE			English	Article							HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; DEPRESSION; AMYGDALA; WOMEN; GYRUS; MRI	Background: Prior studies have independently reported associations between major depressive disorder (MDD), elevated cortisol concentrations, early adverse events and region-specific decreases in grey matter volume, but the relationships among these variables are unclear. In the present study, we sought to evaluate the relationships between grey matter volume, early adverse events and cortisol levels in MDD. Methods/Results: Grey matter volume was compared between 19 controls and 19 individuals with MDD using voxel-based morphometry. A history of early adverse events was assessed using the Childhood Trauma Questionnaire. Subjects also provided salivary cortisol samples. Depressed patients showed decreased grey matter volume in the rostral ACC as compared to controls. Rostral ACC volume was inversely correlated with both cortisol and early adverse events. Conclusions: These findings suggest a key relationship between ACC morphology, a history of early adverse events and circulating cortisol in the pathophysiology of MDD.	[Treadway, Michael T.; Grant, Merida M.; Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ding, Zhaohua; Gore, John C.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Dept Radiol & Radiol Sci, Nashville, TN USA; [Shelton, Richard C.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Treadway, MT (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	merida.grant@vanderbilt.edu	Ding, Zhaohua/AHC-7551-2022; Treadway, Michael/O-9056-2017	Ding, Zhaohua/0000-0002-1805-2955; 	NIMH [K01 MH073092, K02 MH01697, R01 MH60713]; National Center for Research Resources, National Institutes of Health [M01 RR-00095]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060713, K01MH073092, K02MH001697] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an NIMH career development award K01 MH073092 to M.M.G., an NIMH career development award K02 MH01697 to S.D.H. and grant R01 MH60713 to S.D.H. and R.C.S. and grant M01 RR-00095 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; Akana SF, 2001, J NEUROENDOCRINOL, V13, P625, DOI 10.1046/j.1365-2826.2001.00676.x; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Campbell S, 2006, CURR OPIN PSYCHIATR, V19, P25, DOI 10.1097/01.yco.0000194371.47685.f2; Cerqueira JJ, 2005, J PSYCHIATR RES, V39, P451, DOI 10.1016/j.jpsychires.2005.01.003; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; DIORIO D, 1993, J NEUROSCI, V13, P3839; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matsuo K, 2007, MOL PSYCHIATR, V12, P158, DOI 10.1038/sj.mp.4001894; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MAYBERG HS, 2003, BR MED B, V265, P193; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; SALVADORE G, 2008, BIOL PSYCHIAT   0924; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHONING S, 2008, HUM BRAIN MAPP  1211; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1999, J NEUROSCI, V19, P5034; Thase ME, 2002, HANDBOOK OF DEPRESSION, P192; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wagner G, 2006, BIOL PSYCHIAT, V59, P958, DOI 10.1016/j.biopsych.2005.10.025	36	268	271	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4887	10.1371/journal.pone.0004887	http://dx.doi.org/10.1371/journal.pone.0004887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325704	Green Published, Green Submitted, gold			2022-12-25	WOS:000265499400001
J	Willemssen, R; Muller, T; Schwarz, M; Falkenstein, M; Beste, C				Willemssen, Rita; Mueller, Thomas; Schwarz, Michael; Falkenstein, Michael; Beste, Christian			Response Monitoring in De Novo Patients with Parkinson's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; PREFRONTAL CORTEX; ERROR NEGATIVITY; DOPAMINE; TASK; SCHIZOPHRENIA; COMPENSATION; ATROPHY	Background: Parkinson's disease (PD) is accompanied by dysfunctions in a variety of cognitive processes. One of these is error processing, which depends upon phasic decreases of medial prefrontal dopaminergic activity. Until now, there is no study evaluating these processes in newly diagnosed, untreated patients with PD ("de novo PD''). Methodology/Principal Findings: Here we report large changes in performance monitoring processes using event-related potentials (ERPs) in de novo PD-patients. The results suggest that increases in medial frontal dopaminergic activity after an error (Ne) are decreased, relative to age-matched controls. In contrast, neurophysiological processes reflecting general motor response monitoring (Nc) are enhanced in de novo patients. Conclusions/Significance: It may be hypothesized that the Nc-increase is at costs of dopaminergic activity after an error; on a functional level errors may not always be detected and correct responses sometimes be misinterpreted as errors. This pattern differs from studies examining patients with a longer history of PD and may reflect compensatory processes, frequently occurring in pre-manifest stages of PD. From a clinical point of view the clearly attenuated Ne in the de novo PD patients may prove a useful additional tool for the early diagnosis of basal ganglia dysfunction in PD.	[Willemssen, Rita; Falkenstein, Michael; Beste, Christian] WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Mueller, Thomas] St Joseph Hosp, Klin Weissensee, Dept Neurol, Berlin, Germany; [Schwarz, Michael] Klin Dortmund, Dept Neurol, Dortmund, Germany; [Beste, Christian] Ruhr Univ Bochum, Inst Cognitive Neurosci Biopsychol, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Klinikum Dortmund; Ruhr University Bochum	Willemssen, R (corresponding author), WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	willemssen@ifado.de	Falkenstein, Michael/ABA-7497-2020; Müller, Thomas/C-9317-2011; Ferrari, Davide/F-5644-2015; Di Virgilio, Francesco/J-3754-2018	Muller, Tobias/0000-0002-9801-3496; Ferrari, Davide/0000-0002-5727-9204; Di Virgilio, Francesco/0000-0003-3566-1362	Deutsche Forschungsgemeinschaft (DFG) [FA 211/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant FA 211/16-1 to 3 from the Deutsche Forschungsgemeinschaft (DFG). No other financial and material support for this research and work was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; BEST C, 2004, PLOS ONE, V1, pE86; Beste C, 2008, HUM BRAIN MAPP, V29, P121, DOI 10.1002/hbm.20374; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Eppinger B, 2007, BIOL PSYCHOL, V75, P52, DOI 10.1016/j.biopsycho.2006.12.001; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hautzinger M., 1995, BECK DEPRESSIONS INV; Heaton R., 2003, WCST CV4 WISCONSIN C; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Lehrl S., 1977, MEHRFACHWAHL WORTSCH; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Mathewson KJ, 2005, BIOL PSYCHOL, V70, P88, DOI 10.1016/j.biopsycho.2004.12.005; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Muller T, 2000, J NEUROL SCI, V181, P98, DOI 10.1016/S0022-510X(00)00436-6; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Stemmer B, 2007, CLIN NEUROPHYSIOL, V118, P1223, DOI 10.1016/j.clinph.2007.02.019; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040	38	163	173	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4898	10.1371/journal.pone.0004898	http://dx.doi.org/10.1371/journal.pone.0004898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PO	19325909	Green Published, gold			2022-12-25	WOS:000265499600002
